<SEC-DOCUMENT>0000310764-22-000028.txt : 20220211
<SEC-HEADER>0000310764-22-000028.hdr.sgml : 20220211
<ACCEPTANCE-DATETIME>20220211130217
ACCESSION NUMBER:		0000310764-22-000028
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		113
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220211
DATE AS OF CHANGE:		20220211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STRYKER CORP
		CENTRAL INDEX KEY:			0000310764
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				381239739
		STATE OF INCORPORATION:			MI
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13149
		FILM NUMBER:		22618845

	BUSINESS ADDRESS:	
		STREET 1:		2825 AIRVIEW BLVD
		CITY:			KALAMAZOO
		STATE:			MI
		ZIP:			49002
		BUSINESS PHONE:		2693892600

	MAIL ADDRESS:	
		STREET 1:		2825 AIRVIEW BLVD
		CITY:			KALAMAZOO
		STATE:			MI
		ZIP:			49002
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>syk-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2,d:2e9b98e114ab4a2ba09a958d786789f3--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:syk="http://www.stryker.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>syk-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N180LTEtMS0xLTIzMDI1_d10435cb-2318-43cd-99d7-7a726e0974d2">false</ix:nonNumeric><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N182LTEtMS0xLTIzMDI1_1fdaf828-ac13-4b53-bf22-0fac1645c9f8">2021</ix:nonNumeric><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N183LTEtMS0xLTIzMDI1_e7245d39-81b4-48e6-876f-e0f7c9cbfddc">FY</ix:nonNumeric><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N18xMC0xLTEtMS0yMzAyNQ_dde6150e-1c29-4dfa-84ad-21dfd93ba444">0000310764</ix:nonNumeric><ix:nonNumeric contextRef="i6b608d92cc6341009d4822438ed62daa_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i1414fc84d6974d41bca891469be2cf89_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i57b5bdf8abc14627b4fc2cab97dcf73d_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="syk-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260807f9ca594869a1e64938a93873d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.125Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic937960950424623b2f472ba5bd35835_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i168731c7369c4ff38564f21924b77d5f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i9063bd1a2e38494a9c87d8c5d2de23d8_I20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic69cd9d39a21490cbfb14c8af977c010_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5100993b55004a07983c6ce4012e89e1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id065545fd0a8490a93760d3d3f7caa20_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b0a96f76e6b47348aeab92e410030dc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71b5c77df023413fa94d61740f8d881c_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d988183992473c80ec9e89791c037f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9becb79080734381bcde3430445f8f12_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80170d6b8dff45988d17971402b2a956_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b0f8910e1148c7bcf2487217ae6387_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i977f185fff7246a097ea0082fe62710a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2670a9c10b1d408ab40717a9709b224d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i867a13b6e18b444dbd004c9492789fdf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7552bdaa82d04e2faaa8351a026b88bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f4ae1d1be414b55b5e9656c3e8710fe_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib351518cfdd249e5884ad627fecac581_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c69abfa681e4e24818ac3eadfd6f813_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9bd43403e564ca1aaf610bb52886cb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d120045c43c4af3a896790950cd8059_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f87b165979c46dfb2cc60987739eabc_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d74fabbcc44d498a3ffcb580f01a68_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2367b67252704359babdcb904dbe95f8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bca8038e1b46fc9b2afd0ead1648d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69388e86ae64de6bf4faca02b97d13f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if42e188b90414f3b945a27e7e2b1974f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b608d92cc6341009d4822438ed62daa_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea80d9ec270a42ddb859da9ac5218675_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1414fc84d6974d41bca891469be2cf89_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e2f3cb539e04b21a6d749132943270d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57b5bdf8abc14627b4fc2cab97dcf73d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d5184394bb4869a0faafe74b973913_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i6b444fdfd4114975835f712db85f57df_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i390e0b268e414b8f9d49e0d83841a8a0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i764c1f66472a4d62a4a8976787e08574_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c0c3f21be164ebea0b665c3e075dca9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3f8d2756374f598396b4e9f1242e4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309806bb11ff41a2a9e882a99bad0aed_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id287ce7c576e4ea3925b95b5da00c78c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf17bc05109f4e979b894e6b5c677384_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24bf8fb2be2c4a3089319f9462f2f44d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75b07ba08eb4425189e18508e67ef022_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadbc6876b0c4a2e9b96d00656980180_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0204ee9ab1854e4bb45e61ddc5a338a2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac738aea624e43db94884598610ec371_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed282f1ecf14d7d80d3e4b74e03cdf3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6477d0161a4843db9d24e33b01902361_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if72d972689ad4922b7665802f781c461_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10b621eadd294693b0520b76f0f11d92_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fdfaed011624ea2b76682b408d01222_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7728f777c79940228eafdad70914c783_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b08d632247540e0b3c29c04aacd461f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecb4bd223e1a4a24889683e87146a929_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61e348f6119d46a88d69fe763e6cf9fa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i341271d78c7a4206947bca3b7cde395f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c49a6e730644609880acbc477da03e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic119b1fa0c0143538533bba2f3b95138_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f89663db2e4dcd91f2a239604498e7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08a811a396c54be69d7679faeabb9796_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia168ec9d45e74093b60a8c0db927613f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8aa2f3c162a4b938419bc9018039728_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92bc71ae63244b42848463e8f166f45e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76acfc033a4b4a1fb195cec65bb11702_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02851b5d44484d838b322bb70419e1fd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18219da346bb4cf8b4922993ee49a73a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifea456eb74734994a3ba7247aac1dda2_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6858a6cd717d489e810d6a92befb51b9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3313eb4600a44b6faccc26b2974f7496_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7312fb8079f489ca025dfd4b3f324d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1054325428345d2aca70dffa2f35f05_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i838adf850af9448e83d8cb2ca7ee3cce_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6aa60e488594c2e9d84921cd2278f0d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib601c6c2389846cf9f085ecbf9e004cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f5ff37751b4228bd155d7017fca70e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2d20f3fc714b3fb42530500f7a77c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88f85a0225bb45ff93c9e5a28ffbadea_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b0b8f766624b5aa1783ef3697e9b20_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i304183cc0af4431d9b285023ea26a72d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab91cf46dd9e42daaab5e9e0c7a6f3d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99c3ffb583b64bec8e62c626a9117c9c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied70e04d41a84cddb788cfd887902d21_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6720a7b09590406fa78b5cbf501d252d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa7261b15f94c2eb63be5955c04b03d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i697479f2046e497ea88627c07ee8852e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ec948b236274ddf8f4810eb5cc97ce9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic29ffe107ea24e1389192f99d0a767a7_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93218ae922f45f5a1cf776dc39c830f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac0d485d1c2f45c1a9cab57c8ab1300c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2c8448f9de9491eb03da17046dc00a1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd688039b6c24b09ac8456cead87b0be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7a0419c3734edf884537ca4e542fdf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib81829ee9e6345368cf338d2658cdc6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5349cb00c0ad4a4083b3dc3c6c276bad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81957f0cf1484ba38b95f8c9ecc5a5d9_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0a15234cbb4344bb4ca7e8ab0ab171_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a31d5a18104fff9025782da56d7787_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a6260841aa5465bb9e462b166e24b07_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if31b6de31d4f46c0a7a11072d41c2800_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id45dd029eb07468ca3154dc544a63e6e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ba7e2e0e4db4edfbca7ef8727fc3908_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54354e05970043bdb07f6e9c15ed0abf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9191aefdf04dd8b33791fa64741598_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425cac663597403caf6cc7508116f568_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b53aa1b3f2142aaa114bc47e6623cc9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a17e906ae8452da05c7bb782ac6172_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53bf28c4e64640c1bbea6979d86e3f4f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib993db761cc4478a866ff2db39f59836_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1debb8f23cc84c6fb84fe03a3c972ba6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fc24ab232c447f986a9240dc08901c5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b80df0a367428b8b9a465b8e3c21fb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i282a513298204115a77781c1dd5f4247_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc3891e66b1a4f0f87e7010e0d1e8784_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idda804ddfb2c4bff8ee7c14205d1311e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfc063acf78e4bd08280c305320cc7e0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieec5e2be30f44eb99d345e1094f393a1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i678ed992a3df4a148ac4cda3936f752b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fdd98e5a1a84c7fbf7bd96a78a60fdc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03dee15ce37348bbad87d69932241272_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fef7e7698de4e8caf1c760d79d20d4c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3a823fe4ca4366b2768db2d8b5b0d5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1886d202248d4d57b78e584a981fc5cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib44b439abfc245aebc3340a2b62a8221_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80ef92b6615045d4b2062896ded9bbc5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69c1f527ffb40c695af85cc7c5db79f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c8fc671d26d49df8904f1b61f9081e8_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b9a67d017a8431f92a32c80c6879b56_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57502b50a979495bb8c5df03c59bac37_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f03e61dba444a09a7a52d84fea542ce_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b1c2cee07b498e95d93aa7b85803e9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d762e565f504e11951b765770476668_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07256403bc854160be4404f8370b023a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide46d2faceb7499aab7014ec2fd595c9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba2d61f5af8485dbf21906bf0f4aa74_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3226395d1abb430c8b2c0c5dc6845197_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7d60c4249bc459a90844052b4ecb962_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ff7aabafd94e57bd5bb96fbf4651e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83a3271cb4ba4c8e8f3b440f5b6593b4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idccdb90407784aa4a69cbad64bd54ec6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia229486a6b2a46e4b942600ec82f03e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ba6c463bf0b45e09760a30ab1e70dba_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5658ed54f3ad41b58d8370fdbe277451_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f50b1a58554482a86eae0ad88635b27_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ef25118cc84ec18b82cbbb33c9b30c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bedb945b15e46caa838af3a4e317243_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5797053cbabf44609ba2cdc56f6172fd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icddb0ba9518f400295350436917a4675_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f940887fab4704bda5bc6c6fea7411_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9813457a2c14f50beeed7c796c5110c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iace6d4c12e6c4fe6a1850720afff5392_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab379c875cb4b7f9423c749112e591b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7c7e8c817e145e7bc500185970a7013_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87e93dcc049342eebd756e5c81bbfbff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i020998449ee2432dade781d8bc329ee5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4676f03bd98643798e246bce4a1c147c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i502bdbefb4c34395a270e6c9b341feb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fd7d93013184f0ca7e953d189769dfb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98fd63c6a75c40488a06a9d1e613e709_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff585920b6b14ebf8d44cd9a2a7fc0db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21f8b1b147fc47e2bbd9b9fe11fe0ced_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33d0a2073a7a4d0fae7425d288bd85ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117668a485ee43269f7894ff6ae82f17_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida582d9988574d51a2b01b103a5a8a6b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27dc0843d36f4d878697133f92c598f0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia95d03ec4c304d95b51a3255f385445c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb1a995f6d44f929f32898b0817d377_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f453ede78574f968dfbe085d836b77b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ab79e1bc08243479d364fa5853b1565_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia21cd3e409fc4facace34555a676001b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343cabe069354ccc80f2d13debe7af55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd1e97e19e549f89dabedef1ee76cc1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40113d80d11149059ac26617f2747527_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c9d232100d84c2e8972344f330c6c32_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75d60a29285a47bd9dbc5f7c302733eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i422ff4d02b404759bd7b1f0c73386fdf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72f5e6753fb047f083791a2c3417aef7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic949228136a2440aacee861045d52a3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if052be85296d424e88865bee7451cdfe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1631a54bab5c46b5b4aa3ef428c4dc63_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5884ae7cccbb493f97bb398967d7295a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffdc28f3e70c4e53945b14cca5be1a87_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae1a4031263e473ca84441dad4d88d84_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77ef480dc7b44db865d51b857328728_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a2bb2e21adb4f2195ccceb311822e54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77590a767d2049249161295a41700dff_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib71901facd4f4729bb4febf8e4920a38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5048a5d933134912a55ce66af02172d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f71580f58e546cf876aaa64b8e407f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic458786f6f7742209e0810cafdb1e076_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if86c13e7f54a4d9187b804efa3279ece_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cb34c13848b40abb54bfb7dd12daee8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie912fa0d38354d10abc6f0c684c92709_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8cc2de29096642bca27e8292c94be78c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib731b835ed4545e1bf7663a732660d5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba140370805745c5a0fb0139f3a35e36_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb0885ab9cf4a3b872895d9b26c1c8d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i768aa1a212a548f6bc9e1ad4200680af_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if80d5916400446cf8c33be284e7e7cd8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0494473994284c7a818935d1810c26c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i324abdc30a554b10b518a4193f5e987c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i460e2f30ab50432dac45998c777bd1cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4dc5032a74e422eab08db6029f2c3b1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2743dba7228949dca22bfab3555187d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="i5774498f250b4e62a2507047bb5117c5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7dfbfda7e7d44de0983bcfc3b451374f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8de6a926a954c7a98e473efb5dedd75_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4707a4f73d24ec7a3a6643b3e285e4d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ae0b2359894631bfe4ff8951b7344f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd5321432b28479688d8bb70e0d59233_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b361079402f49b293ad59e81c8db765_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eda5abebfc549a98ed646efb1e15dd8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78ff6405f6b0476e87ad1a72d4cb5be6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5680505765904a7ebbce9f048aa9a5ee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib06a055c0fae428c8432833a0e6bf453_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6502455d90c34a3aaf15f94591105bdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i257b8d69f7304529920e40c42cf14686_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb4525f47584c4b928961c3e9bf0ff0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia94684ce07ac4a0185a0636e0cf54469_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e5a4e63e93f48f7aa5592b92b80c4b1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if68a82d67ba747f0a26113ba47cf0600_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49d219ac7c654bcf972997c5b2dd66b6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic221ec9a6dfc4d74aeaf33001f372d3c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if601c0b3db3f4bf6b658f2a814d47b69_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cdd6bf737b54325b92c62a86f71c0e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e2f7288e37e48a380d856a6d3266bf1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia56f6022aefe44f2a5667c14a9b6b6eb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c3f013d29b7403e858fcea9c856f7b3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90e7300ba45a44d6a213473b74b90080_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia01979f1a5154e80af303f7109f5141e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1ea07cf8bba4d6d887c5a458dad34dc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i409d18f675da455fb23e202a25fb4438_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04146303369749e39910cfe8eff8042d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5a5b88eef254543b043aeb672c43431_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb9e3dbe30fa4e8483b2654e5a21a079_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7543006b3a34df28528413b4f7b31d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie86883fa09384666942eeaed442415af_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92f15013f92346ce9cbb36e9eb568f54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83dc60f460124dd497581e888b4bf1d8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9114115d56ad4c4989ad2dd4e097974d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dbe5a4ec071427fae8b82afb24fb3ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325e4a8aeca94b2b83d09801b01f101e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87e455dc94234eef9fc977210d2059b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad787f8161cd41d2b2c226f217b85d4f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80cfb23b43fb45ffa9c91c4dc0f78098_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2773bb7f8a4c4bd3a58a536ad8bf8188_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8362bd7aefad4b4fb6e9f334fa0974c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98223ace52234752a935caf8d514b359_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia32555db427549cf9768af83a8cc5401_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i473fc27ada8b4437a7ed06daba0e7b45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987f109f9d8b453ea9245f3f52a146d6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i114b53cb59c34cb288582b77e4ec30d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:GaussMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8d99e6390a74a8995e89bd1ff83d52b_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A1625ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="rate"><xbrli:measure>utr:Rate</xbrli:measure></xbrli:unit><xbrli:context id="i02a06683c940495480de29089bda742b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A225ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie342e96c09a9482c9aa9e2e4ff4011f5_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A1625ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67fb41d08feb476290e5560aab4e4702_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A225ConvertibleNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e620065e6e24e2a8d665f88e64e892d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cfff0a7aec247bc86688fccbb9b397f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42136052eabf40fba1fdf489034458a0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i515431d49ca14980ada9296078f4f0a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if70c7c8d0bbd4f9582508d0d23fd23b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9db0a793155f4536896d92116fb53672_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66cb47dd385f4d9999a85414eafe4457_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff23dccda5944e118af54005133b53e7_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i620617bf01d945178f16bb399ad57f75_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99bfd05a796d4880b00788fe7096a885_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86c45f56956e48e19de6ba723be12789_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i537ba5d8a2cc42d0ac3ebe24c14114dd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60bff9d7fe1740a4b1b56d78df05e951_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i881fb152f349470ca7abba8d476e11a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iededa4a8c527471b85a48d5b54ad644d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i007c06d259e748828bb28c412ab4ac98_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia88bc7ee7b9745fc9352da5322ebb656_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1087bf354d78467a8a499c466b98e2ec_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b19b159bc734f8dac7b4ac724153ffb_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae25731565a4034b3ee7bd4f65f29f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib56b6a79e10d4b8da543faad8f04faef_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee70c5decbda497da7a729394169c742_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf40de1dc0a747ac9e71b3ec9fe5e6ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95da961ae17b47f3858471949c39deb9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3abb2d8e94114546ba385f6ac936e9fe_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0dadbfef3164e62895c0f78a8172e34_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie504e126295140d895f1b405fdae8218_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75223e6f266b49d0b5c29ab50334c3ca_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd0b79e9ffdf4577bae842aae7525d95_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0fc5ea9fc4492a91cafecdf0d6fe28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic68919f3a22244c1b7ff50822c238456_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dde6a23c87c43a39fd81af819d0e532_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11a3a9e009874da393fcb3dac86134c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d6bbd2cf290410eb553761cf7b1b304_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30c2cd9df03f4990802edf10bafe3d39_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i509624184e844f5fb011955bbb2c778e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c4be753853f42df931435723368c9e5_D20211001-20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e6f3514db1476f817d3a34bf82751a_I20211031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfbd20d36f4c4a0187acc94dfb9c9db4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ef4c1ea02da4ea596abd614114f7393_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i917ab770a5bd4746b5a9e3300c4046b4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaae71a75450b45cfa06a432fbf4e56b6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9765b80413243c19a3bd125fa129236_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c71a79ff0d4a66b82c64b38f8ef166_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba8cdba131854e1fa2af1d12976b473e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfca18fe7ca64a799cd68aefb09fb4c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3509c57093a64b75a06052277ba0acb3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0227faa616da4a128a3d998d9f6db05d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i480109c130434062bd13171059d5ef31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4681c2f77d9349a8a13546c839684f90_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df1eb79fd5744fd8983118adebb9623_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e7e1ef2be4408ea79112316a123192_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0caf73b3889a40929b9da7a96bb99d5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad5a5038c5da499f92e3e8046651aa71_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2fe3da873b14e1e9acb5a1220a5e06d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id90b056e95f44ff5abeae3d32e78c913_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0e14c0d1dcf411ab03235f607eb6313_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee9e48c2079044c18c3f5e95f5b196b3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63e97ef977d04cbe98290d564401c76b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i336901cefd4f43fba19050323af4c966_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3086dc119ed744e3be6f3fca238a2adf_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09191cd775d5416fac1419996ab55482_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23484026c90c4eba9c47bf90db97349a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i323fcbeea7cf43648faf64c65504341c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38d1fc1af0074b52bfb9bcd1fd97816a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e46902a0d4641b6aad2beef3aed8f86_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic725b5e5cada4fe09f8bbb6ff2a948e9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia68e51613f0e40deb45d9d94d6e67b14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7def3071dac84fbf93b4831fce46ae80_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd80c3cd55641208b41aaa854e69a3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4a79159e25947238adcf8348dd4618a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10d1a9bafbac4422919540ab667b2004_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a5a0db81617461dbfb08c50f5a369e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa94a4981170459daf10d0648f64494e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibce21f74de924d9091f5bc5d627d39d4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37083d398075438da83a8349d52ed8c6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5cc983b0708b43efbe69262c949402dd_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.125Due2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cd24230505248839fa2f817aad88236_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie57390308e744f2da47656cbcb7dd7ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f988e7869e24ec3bddc891426b08439_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01ba6c5c269d4255a194114389cbf28c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a02b6d2c274ed99fc738e0c58fe623_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91262a514140409ebdc684fab644ffa5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc0ea2e735eb45ac82e987217fe33ed3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia67b9db95e8d4be5bc9dae41d9dc8f3c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0472521a2c54bd8a5c77c14ed66218b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232384248c814e63916518edfbade00d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i001424c220ec43b8bcc76dd7bf700136_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604a2bd489464dd7a650d828b235f087_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f45f3a6f31f4b0da0d211a6aef869d9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dddab9268854061b35a9e07a6318dd6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife6a4f6e1674412fa1a94fcd3d311a14_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i610ab94283ee44cebe2aff94198af011_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebfde9edb94c4bffa0897fbc6d059649_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0732c03ffb524a518cf83d8eea84056b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5881fc803ed74916a236a87615ed0ee2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae7b85422cd47d9891e57aba56d1654_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice25e379b81f4476bc629c2369aaa8d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a7ab2b119e94e27bd120bc5f0693216_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73ac471a7a3844b192433916f6cb498b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i316fb40a5796411d9e52da1c35ca3e5e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69c2080de3934abf904eba7abade7988_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47733b1c7ef048cbb418c5fcc8c43a27_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i164f42b17a9f4770bd5118f6cd88f3c2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idccdaec3350743cea685af7c28bdb255_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30492a5243574d7bb61e3c33c92232cf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06973aac182492f9622c7ad7902fabf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba09bb97f57e482fb3622b4b9a6a4342_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8b81436534b4ed681424a5481d1d2a3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id692e1a1c6d14320af222fb9457d39b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic458106dafdd43c2a2d64c80f80f0d0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69cf095ab3ce444bb44754bf320b5332_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie48c458d392e4f3194b70925a5318b6f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b168e0fd23c4ecbb3d1680b32078cc4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84cef904fd4a491cbb3a73b26683ced7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i301b21993d364219b05cf96921f44824_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b725428866433e884015213e1d73d8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if49057198523407d8323dce5d51c3441_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf04f9985f9c460593117679dd0de816_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>syk:segment</xbrli:measure></xbrli:unit><xbrli:context id="id53460c344454415a413587e43a832f0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c65783cfed742208972bad227653460_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45973f2c9a854e2e920f89b3e8dee9d8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie114ed237e0d41beb5a9e2242dabd291_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if615c66e93d841248401204d2f87e7b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05efb2548ebd4f34ab5c73e347583ae8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0d499873474314be3c66b63d45f691_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0adfcfa572a94aca9a60b62275d83075_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74c68f4da1164491bf77ae9dcbfb0545_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1a1b44063cf47ac91f386a31d08238d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i044e8aa931854b8a94b1419803337ca9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i493d054bdb1142bab91a099618a17c2e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b60b72af8d496098920a748eea6ac8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb45f65a673b4ca8bc5380e9dc457005_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i742ba6c7339d481cad355c3643d8c974_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia89a77a86ad54db68756036c89894730_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7510c322dcd240709c6c6e3c9f02d28a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdaebd90ff5a43aebff037d5206f643c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i508e0970774e4040bebaa29eefb5413a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabea30f6f342483e92b55ff45d124cfd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65e2baa3bf9f407e86be3aa79c350743_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366d502111bb4b0ea5b40b0854ccb69c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79f9e9c317bd4f439e0b474fd5b011ae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21fb41ce5c5541289a9c9bda6cc8d0d5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04ca0caf148b4cfea6977517521fc1a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd51320aa2454e7a9423a3b8924b52cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c0ca347e0e442d5b711eeee83cb8a15_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id822d7baa9eb43998e1a14bbe5f9067f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84d77376c3524f3bae2890c5d42f27a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695bf958a588401eb4c0e69af671f48a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f6e97d92584c358e1d36baee8c2703_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0df0e910952f41b38ad92de86d9e751c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia507b09a8414413ba7d85ab4c02407b5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c818b44abbb48aca50ce62cb4244e4d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fba5cf2d76346acb78e2f001edc09ac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:GlobalERPSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b99ad9aa574362a2b36a60d0085869_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ba1ecd7eafa4f05988a82a4023b511f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbe329076697427a86d128a21c73111a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied06158ff7d045f39f524189c541c016_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000310764</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcz_0fe618e2-40f4-424c-8f6b-de0aff8c5781">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"></td><td style="width:49.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:486.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NDY1ZmQyN2M1ODc1NGEyY2I5Y2UzODUxZDQ1YjJjNTEvdGFibGVyYW5nZTo0NjVmZDI3YzU4NzU0YTJjYjljZTM4NTFkNDViMmM1MV8wLTAtMS0xLTIzMDI1_4a5d8ae7-11f0-4d77-aa84-558d1bc7e56c">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8xMjA_0be505a2-238d-4768-88db-032439bd5c5d"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8xMjA_ebf27604-7709-49a7-ac37-a995eae6c4d9">December 31</ix:nonNumeric>, 2021</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:540.00pt"><tr><td style="width:1.0pt"></td><td style="width:49.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:486.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6Y2Y1NTdmMmJlMjY4NDY4ODk0OTJhZTc2NjBiM2UzMWMvdGFibGVyYW5nZTpjZjU1N2YyYmUyNjg0Njg4OTQ5MmFlNzY2MGIzZTMxY18wLTAtMS0xLTIzMDI1_3ff8ebe5-1543-4255-b05f-8f250d9eefce">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commission file number: <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzY5_2e2c8dc2-f8ce-4640-b683-2ece12a451ab">001-13149</ix:nonNumeric> </span></div><div style="text-align:center"><img src="syk-20211231_g1.jpg" alt="syk-20211231_g1.jpg" style="height:53px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc0_9b9d7101-ba85-469c-8061-8ef3d92fdb0f">STRYKER CORP</ix:nonNumeric>ORATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.194%"><tr><td style="width:1.0%"></td><td style="width:15.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.093%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.748%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.457%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8wLTAtMS0xLTIzMDI1_708a5db1-0720-46d8-88b7-9d66f120f973">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8wLTYtMS0xLTIzMDI1_a1d30f91-b28e-4633-9d15-9c9a8f671914">38-1239739</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTAtMS0xLTIzMDI1_64b339c5-ab53-4d5f-9702-ed906ba4404f">2825 Airview Boulevard,</ix:nonNumeric></span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTItMS0xLTIzMDI1_e9918d3f-ba51-4113-a155-30a0a0ac5af5">Kalamazoo,</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTQtMS0xLTIzMDI1_1b19917c-9af5-4a4c-b786-271cb587b3c3">Michigan</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTYtMS0xLTIzMDI1_38194ae9-a403-41be-bcf4-d0c7977cd527">49002</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV82LTMtMS0xLTIzMDI1_fae20751-ea19-46e5-8759-49f1530d2a70">(269)</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV82LTQtMS0xLTIzMDI1_e1b79e4c-fa0c-4792-a416-315bcf03d6f3">385-2600</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.873%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTAtMS0xLTIzMDI1_c3f81d73-1c30-42db-a067-91b7c179dfde">Common Stock, $.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTEtMS0xLTIzMDI1_2ca0fbf0-5697-4ac6-9be9-ff096ca9d2f3">SYK</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTItMS0xLTIzMDI1_b2e6ef5a-489a-445e-b182-9cc1c9b20615">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTAtMS0xLTIzMDI1_28318eca-5af4-4930-95a2-154ee860de9c">1.125% Notes due 2023</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTEtMS0xLTIzMDI1_9eccedfb-7afa-43ac-b629-c90246372ab2">SYK23</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTItMS0xLTIzMDI1_84f88c2d-28c8-4005-8bb5-ff4b0cf38b47">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTAtMS0xLTIzMDI1_8c72c479-f559-4222-acfa-83ed7dfc4661">0.250% Notes due 2024</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTEtMS0xLTIzMDI1_e4014138-9921-4d87-a1ba-825405e34b7e">SYK24A</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTItMS0xLTIzMDI1_cdb25d2b-ed6e-44ba-90a1-13bc13de02ab">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTAtMS0xLTIzMDI1_9f0587db-fd96-4e10-be51-d7df52dcc1fa">2.125% Notes due 2027</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTEtMS0xLTIzMDI1_0c0dbd7c-9e75-4240-9d8a-b796966fef08">SYK27</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTItMS0xLTIzMDI1_173c3859-d2c0-4625-acd6-eff492802107">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTAtMS0xLTIzMDI1_cd2088e0-b404-471b-81f1-1bcf1751e8b1">0.750% Notes due 2029</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTEtMS0xLTIzMDI1_0c7d845c-419a-411f-b563-43055f9fe624">SYK29</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTItMS0xLTIzMDI1_dedbb784-552e-4555-95a1-2990b8b65816">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTAtMS0xLTIzMDI1_c16f9c0b-41ba-4bb1-b7dd-30e250d94fc9">2.625% Notes due 2030</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTEtMS0xLTIzMDI1_f67c0030-4ba0-4029-a417-d8527fd8822e">SYK30</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTItMS0xLTIzMDI1_af0c8762-0af7-466c-9b23-454c0f2fb9e8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTAtMS0xLTIzMDI1_f3556ae7-6d44-4d97-85e8-d76694c2ec8e">1.000% Notes due 2031</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTEtMS0xLTIzMDI1_44461ff1-0c9b-4973-a439-8fe2f22890a1">SYK31</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTItMS0xLTIzMDI1_6eaa1cf0-1c7f-48eb-8a15-b28e01943685">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Securities registered pursuant to Section&#160;12(g) of the Act: <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:Security12gTitle" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcw_ce07d6eb-1392-428b-b8ab-259738ce4085">None</ix:nonNumeric> </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcx_b896fdb6-9246-4787-a295-5f569ab96883">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act.&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;    </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc1_0f515132-ccd8-4971-9bbf-cd8401279077">No</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc2_2c74957d-0e0a-4cd3-ba95-875e2f11364c">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc3_cb3fc25a-4c15-4dcf-a991-862ef8421b0b">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.997%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.092%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8wLTAtMS0xLTIzMDI1_3551eb71-e9cc-4a18-a785-901f185cd344">Large accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8wLTUtMS0xLTIzMDI1_871146d5-67dc-45fd-b57a-e969b6628265">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Small reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8xLTMtMS0xLTIzMDI1_fb6af7a0-6924-4d90-8c9a-421716bac389">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcy_2abd16d5-c7c3-4cd3-9cc5-4cc5256053b4">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).&#160;&#160;&#160;&#160;Yes&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc4_9058fca8-f197-4ef9-adc0-52a65e644f0d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i168731c7369c4ff38564f21924b77d5f_I20210630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNDE4_cc7b02bb-b02c-4d99-adef-1a25bc31896b">91,942,474,363</ix:nonFraction> at June&#160;30, 2021. There were <ix:nonFraction unitRef="shares" contextRef="i9063bd1a2e38494a9c87d8c5d2de23d8_I20220131" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNDM5_47545ae2-482a-4808-a7fb-21ad9a209f8f">377,544,686</ix:nonFraction> shares outstanding of the registrant&#8217;s common stock, $0.10 par value, on January&#160;31, 2022.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc5_9f0dae95-fd89-4f37-9861-8d2998883da4" escape="true">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2022 Annual Meeting of Shareholders (the 2022 proxy statement) are incorporated by reference into Part III.</ix:nonNumeric></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART I</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Business</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Risk Factors</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unresolved Staff Comments</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_19">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Properties</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_22">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Legal Proceedings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_25">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mine Safety Disclosures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_28">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_34">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selected Financial Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_37">11</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_40">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Quantitative and Qualitative Disclosures About Market Risk</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_73">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements and Supplementary Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_76">20</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm (PCAOB ID: <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183L2ZyYWc6ZjAyNzRmODRlMDc3NDZhY2E5ZmZiODlhZjVmYWU1MjMvdGFibGU6NjljNjQ3M2RiOWMyNGE5YjgzNWU0YTU5YTAxOTkyNGIvdGFibGVyYW5nZTo2OWM2NDczZGI5YzI0YTliODM1ZTRhNTlhMDE5OTI0Yl8xNC0xLTEtMS00MTQ1NS90ZXh0cmVnaW9uOjFhZjVhYTRhMGRkODQyZDU5MmY0NzUwMjNlNDNhNmI0XzEwOTk1MTE2Mjc4NTI_660f1a16-29a3-4fbe-881d-cc845a21f112">42</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_76">20</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_79">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_91">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_94">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_97">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_151">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Controls and Procedures</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_154">38</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_157">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item&#160;9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Disclosure Regarding Foreign Jurisdictions That Prevent Inspections</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_157">39</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Directors, Executive Officers and Corporate Governance</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_163">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Compensation</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_166">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_169">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certain Relationships and Related Transactions, and Director Independence</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_172">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Principal Accounting Fees and Services</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_175">39</a></span></div></td></tr><tr style="height:15pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits, Financial Statement Schedules</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_181">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Form 10-K Summary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_187">43</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_13"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:261.00pt"><tr><td style="width:1.0pt"></td><td style="width:58.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:198.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ITEM 1.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BUSINESS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation (Stryker or the Company) is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. Stryker offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our core values guide our behaviors and actions and are fundamental to how we execute our mission.</span></div><div style="margin-bottom:6pt;text-align:center"><img src="syk-20211231_g2.jpg" alt="syk-20211231_g2.jpg" style="height:186px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and the inventor of several medical products. Our products are sold in over 75 countries through company-owned subsidiaries and branches, as well as, third-party dealers and distributors, and include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties. In the United States most of our products are marketed directly to doctors, hospitals and other healthcare facilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As used herein, and except where the context otherwise requires, "Stryker," "we," "us," and "our" refer to Stryker Corporation and its consolidated subsidiaries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Business Segments and Geographic Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. We have reflected this change in all historical periods presented. Financial information regarding our reportable business segments and certain geographic information is included under "Consolidated Results of Operations" in Item 7 of this report and Note 14 to our Consolidated Financial Statements. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Sales by Reportable Segment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment and intensive care disposable products (Medical), reprocessed and remanufactured medical devices, and other medical device products used in a variety of medical specialties. Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Our neurotechnology offering includes products used for minimally invasive endovascular procedures; a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products (Neuro Cranial); and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular). The craniomaxillofacial implant offering includes cranial, maxillofacial, and chest wall devices, as well as, dural substitutes and sealants. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of five leading global competitors in Instruments; the other four being Zimmer Biomet Holdings, Inc. (Zimmer), Medtronic plc., Johnson &amp; Johnson and ConMed Linvatec, Inc. (a subsidiary of CONMED Corporation). In Endoscopy we compete with Karl Storz GmbH &amp; Co., Olympus Optical Co. Ltd., Smith &amp; Nephew plc (Smith &amp; Nephew), ConMed Linvatec, Arthrex, Inc. and STERIS plc. In Medical our primary competitors are Baxter/Hill-Rom, Inc., Zoll Medical Corporation, Medline Industries and Ferno-Washington, Inc. Stryker is also one of five leading global competitors in Neurotechnology; the other four being Medtronic, Johnson &amp; Johnson, Terumo Corporation and Penumbra, Inc.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of MedSurg and Neurotechnology Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,475</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 Instruments launched a T7 helmet with increased comfort and disposables in orthopaedic instruments, and had strong second year sales of TPX next generation corded power tools for conducting small bone orthopaedic procedures. Endoscopy launched the SLX surgical light portfolio to improve safety in the operating room through customized lighting. In addition, Endoscopy launched the InSpace balloon, the industry&#8217;s first balloon implant for arthroscopic treatment of massive, irreparable rotator cuff tears (MIRCTs). Medical increased penetration and focus in their broad portfolio with significant investment in their specialized sales forces.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we furthered our expansion into the global flow diversion market with the continued launch of the next generation Surpass Evolve&#8482; Flow Diverter in the United States and Brazil, as well as the Surpass Streamline&#8482; Flow Diverter in China and Japan. Also in 2021 we continued the launches of the Trevo NXT and Vecta Aspiration Catheter families, as well as the next generation of the market leading Synchro guidewire in multiple regions of the world.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics products consist primarily of implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. We bring patients and physicians advanced implant designs and specialized instrumentation that make orthopaedic surgery and recovery simpler, faster and more effective. We support surgeons with the technology and services they need as they develop new surgical techniques. The Mako </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Robotic-Arm Assisted Surgical System was designed to help surgeons provide patients with a personalized surgical experience based on their specific diagnosis and anatomy. The Mako System currently offers three applications supporting Partial Knee, Total Hip and Total Knee procedures. Mako is the only robotic-arm assisted technology enabled by 3D CT-based pre-operative planning and, with AccuStop&#8482; haptic technology, Mako provides surgeons the ability to know more about their patients' anatomy so they can cut less in bone preparation and implant placement with intra-operative haptic guidance. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our spinal implant offering includes cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. Our spine enabling technologies portfolio includes best in class imaging solutions, image-guided surgical technology, patient specific implants and digital health solutions supporting surgeons and their patients throughout the continuum of care.</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are one of four leading global competitors for joint replacement and trauma and extremities products and robotics; the other three being Zimmer, DePuy Synthes (a Johnson &amp; Johnson company) and Smith &amp; Nephew. We are one of five leading global competitors in Spine; the other four being Medtronic Sofamor Danek, Inc. (a subsidiary of Medtronic), DePuy Synthes, Nuvasive, Inc. and Globus Medical, Inc.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:30.312%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.415%"></td><td style="width:0.1%"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Composition of Orthopaedics and Spine Net Sales</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we moved to full commercial launch in the United States, and first clinical use in the European Union and Canada, of the new Tornier Perform Humeral&#8482; shoulder implant system for anatomic and reverse shoulder arthroplasty. United States Food and Drug Administration (FDA) approval was received in 2020, Health Canada approval was received in the first quarter of 2021 and European Union approval is expected in early 2022.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Raw Materials and Inventory</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">Raw materials essential to our business are generally readily available from multiple sources; however, certain of our raw materials are currently sourced from single suppliers. Substantially all products we manufacture are stocked in inventory, while certain MedSurg products are assembled to order. Where some electronic components have had limited availability due to current global shortages, we have worked closely with suppliers to ensure this temporary supply constraint did not have a material adverse effect on continuity of supply.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Patents and Trademarks</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Patents and trademarks are significant to our business to the extent that a product or an attribute of a product represents a unique design or process. Patent protection of such products restricts competitors from duplicating these unique designs and features. We seek to obtain patent protection on our products whenever appropriate for protecting our competitive advantage. On December&#160;31, 2021 we owned approximately 4,458 United States patents and approximately 7,199 patents in other countries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our business is generally not seasonal in nature; however, the number of orthopaedic implant surgeries is typically lower in the summer months, and sales of capital equipment are generally </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">higher in the fourth quarter. The dollar amount of customer backlog orders at any given time is not meaningful to an understanding of our business taken as a whole.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In each of our product lines we compete with local and global companies. The development of new and innovative products is important to our success in all areas of our business. Competition in research involving the development and improvement of new and existing products and processes is particularly significant. The competitive environment requires substantial investments in continuing research and maintaining sales forces.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our commitment to innovation, quality and service and our reputation differentiates us in the highly competitive product categories in which we operate and enables us to compete effectively. We believe that our competitive position in the future will depend to a large degree on our ability to develop new products and make improvements to existing products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Regulation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our businesses are subject to varying degrees of governmental regulation in the countries in which we operate, and the general trend is toward increasingly stringent regulation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the United States the Medical Device Amendments of 1976 to the Federal Food, Drug and Cosmetic Act and its subsequent amendments and the regulations issued and proposed thereunder provide for regulation by the FDA of the design, manufacture and marketing of medical devices, including most of our products. Many of our new products fall into FDA classifications that require notification submitted as a 510(k) and review by the FDA before we begin marketing them. Certain of our products require extensive clinical testing, consisting of safety and efficacy studies, followed by pre-market approval (PMA) applications for specific surgical indications. Certain of our products also fall under other FDA classifications, such as drugs and Human Cells, Tissues, and Cellular and Tissue-Based Products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The FDA's Quality System regulations set forth standards for our product design and manufacturing processes, require the maintenance of certain records and provide for inspections of our facilities by the FDA. There are also certain requirements of state, local and foreign governments that must be complied with in the manufacture and marketing of our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The European Union enacted the European Union Medical Device Regulation in May 2017 with an effective date of May 2021, which imposes stricter requirements for the marketing and sale of medical devices, including in the areas of clinical evaluation requirements, quality systems, labeling and post-market surveillance. Additionally, as a result of the exit of the United Kingdom from the European Union (Brexit), new medical device regulations were released by the United Kingdom, which became effective January 1, 2021. A gap analysis against the prior Medical Device Directive (MDD) and a compliance plan are being implemented for both the European Union and United Kingdom regulations to ensure compliance and minimize business disruption. Finally, we are required to comply with the unique regulatory requirements of each country within which we market and sell our products. For example, China's National Medical Products Administration (NMPA) has recently promulgated more stringent regulatory requirements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets in which we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">price regulation and competitive pricing. It is not possible to predict at this time the long-term impact of such cost containment measures on our future business. In addition, business practices in the healthcare industry are scrutinized, particularly in the United States, by federal and state government agencies. The resulting investigations and prosecutions carry the risk of significant civil and criminal penalties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Environment</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to various rules and regulation in the United States and internationally related to the protection of human health and the environment. Our operations involve the use of substances regulated under environmental laws, primarily in manufacturing and sterilization processes. We believe our policies, practices and procedures are properly designed to comply, in all material respects, with applicable environmental laws and regulations. We do not expect compliance with these requirements to have a material effect on purchases of property, plant and equipment, cash flows, net earnings or competitive position. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employees </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 we had approximately 46,000 employees globally, with approximately 25,000 employees in the United States. Our talented employees are an integral reason for our standing as one of the world's leading medical technology companies where, together with our customers, we are driven to make healthcare better. Our company values of integrity, accountability, people and performance are a key component of that mission. Our people, as one of our core values, continue to be a key focus.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our success is dependent on our ability to attract the best talent that reflects our diverse communities. To do so, we continue to focus on the basics of creating a great workplace. We believe in attracting the right people, maintaining and building employee engagement and developing our employees. We believe when people are able to do what they do best, they will look forward to coming to work and, in turn, will deliver great business results. Stryker is made up of hardworking, results-oriented people who are driven to go above and beyond for our customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our leadership team and Board of Directors receive regular updates on our people and culture strategy and provide feedback on our strategy and goals, including alignment to mission and values, peer benchmarking and stakeholder feedback.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Development</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our employee development is extensive and exists at all levels of the organization, including company-wide training on our Code of Conduct, job-related technical training and management and leadership training. Our development programs include on-the-job learning, coaching and mentoring, management and leadership development courses, team building and collaboration training and immersive experiences with expert partners. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We encourage all employees to establish individual development plans, in partnership with their manager, to help employees gain the needed development experience to grow their careers. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Engagement</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An engaged workplace culture that drives performance and business outcomes is central to our mission. Listening to and learning from our employees forms the foundation of an engaging culture. More than 90% of our global employees participate in our annual engagement survey, which provides a valued platform for listening and allows us to take action based on the feedback collected. </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement our annual engagement survey with targeted pulse surveys to gather feedback on topics relevant to the current climate. Additionally, we establish forums for collecting qualitative feedback to gain insights and identify actions we can take to ensure all employees feel included, engaged and able to achieve their full potential.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also provide tools and resources that enable managers and teams to act on the insights we gain from our surveys and to drive employee engagement and strong business outcomes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Diversity, Equity and Inclusion (DE&amp;I)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">An essential part of our culture is respecting each individual&#8217;s strengths and values. Building on this foundation, we are focused on maintaining an inclusive, engaging work environment and prioritizing DE&amp;I in keeping with our values of integrity and people. Our DE&amp;I strategy is centered around these three commitments:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Strengthen the diversity of our workforce</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Advance a culture of inclusion, engagement and belonging</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Maximize the power of inclusion to drive innovation and growth</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are advancing our commitments through the following actions, among others:</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Holding leadership accountable through transparent data, performance objectives and inclusion in our business review process</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Engaging and inspiring all talent and empowering every employee to take action</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Developing our people and processes by removing barriers and optimizing the power of diverse backgrounds, talents and perspectives</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Attracting a diverse talent pool through focused outreach and ensuring an objective hiring process</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Advancing our employee resource groups (ERGs) to expand reach through executive leadership, global presence, funding and aligned strategies</span></div><div style="margin-bottom:3pt;padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:10.35pt">Positively impacting our customers and communities through building and strengthening external partnerships</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December 31, 2021, approximately 36.6% of our global employees were women and 26.0% of our employees in the United States identified as racially or ethnically diverse.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Attracting and Hiring</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We understand that every employee drives our success. We focus on attracting, identifying and selecting strong candidates who will be successful at Stryker and ensuring that each person we hire brings the talent, expertise and passion we need to continue to be successful.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Health and Safety</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ensuring our employees' safety is a top priority. It is a responsibility that we share throughout the company and one that has evolved to meet the needs of our workforce during the pandemic. Employees' safety risks vary depending on the roles they perform, so we tailor our safety efforts accordingly.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Competitive Pay and Benefits</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our compensation and benefits programs are designed to attract and retain top talent and to incentivize performance and alignment to our mission and values.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We offer market-competitive base pay and benefits to our employees in countries around the world. We regularly evaluate our compensation and benefit offerings and levels, using </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">recognized outside consulting firms to ensure fairness and competitiveness in our offerings.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Most of our employees also have variable components to their compensation packages that reward employees based on individual, business unit and/or company-wide performance.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our proxy statement provides more detail on the competitive compensation programs we offer.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Information about our Executive Officers</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.604%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.099%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">As of January 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">First Became an Executive Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2011</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Yin C. Becker</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Communications, Public Affairs and Corporate Marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">William E. Berry Jr.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2014</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">M. Kathryn Fink</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">52</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Human Resources Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Robert S. Fletcher</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vice President, Chief Legal Officer</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Viju S. Menon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Global Quality and Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">J. Andrew Pierce</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, MedSurg and Neurotechnology</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spencer S. Stiles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">45</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Group President, Orthopaedics and Spine</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Each of our executive officers was elected by our Board of Directors to serve in the office indicated until the first meeting of the Board of Directors following the annual meeting of shareholders in 2022 or until a successor is chosen and qualified or until his or her resignation or removal. Each of our executive officers held the position above or served Stryker in various executive or administrative capacities for at least five years, except for Mr. Fletcher and Mr. Menon. Prior to joining Stryker in April 2019, Mr. Fletcher held various legal leadership roles with Johnson &amp; Johnson for the previous 14 years, most recently as the Worldwide Vice President, Litigation. Prior to joining Stryker in April 2018, Mr. Menon held various senior supply chain leadership roles with Verizon Communications Inc. during the previous eight years, most recently as the Chief Supply Chain Officer.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our main corporate website address is </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.stryker.com. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Copies of our filings with the United States Securities and Exchange Commission (SEC) are available free of charge on our website within the "Investors Relations" section as soon as reasonably practicable after having been electronically filed or furnished to the SEC. All SEC filings are also available at the SEC's website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.sec.gov</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_16"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RISK FACTORS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">This report contains statements that are not historical facts and are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current projections about operations, industry conditions, financial condition and liquidity. Words that identify forward-looking statements include words such as "may," "could," "will," "should," "possible," "plan," "predict," "forecast," "potential," "anticipate," "estimate," "expect," "project," "intend," "believe," "may impact," "on track," "goal," "strategy" and words and terms of similar substance used in connection with any discussion of future operating or financial performance, an acquisition or our businesses. In addition, any statements that </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Those statements are not guarantees and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, actual results could differ materially and adversely from these forward-looking statements. Some important factors that could cause our actual results to differ from our expectations in any forward-looking statements include the risks discussed below. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our operations and financial results are subject to various risks and uncertainties discussed below that could materially and adversely affect our business, cash flows, financial condition and results of operations. Additional risks and uncertainties not currently known to us or that we currently deem not to be material may also materially and adversely affect our business, cash flows, financial condition or results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COVID-19 PANDEMIC RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The COVID-19 pandemic has materially adversely affected, and could continue to materially adversely affect, our operations, supply chain, manufacturing, product distribution, customers and other business activities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has led to severe disruptions in the market and the United States and international economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. In response, various governmental authorities and private enterprises have implemented, and may continue to implement, numerous measures to contain the pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. A significant number of our customers, global suppliers, distributors and manufacturing facilities are located in regions that have been affected by the pandemic and those operations have been, and could continue to be, materially affected by restrictive measures implemented in response to the pandemic. As a result, some of our customers, distributors and indirect sales channels have at times been unable to retain employees, distribute or use our products or provide required services. Any delay or shortage in the supply of components or materials or delay in delivering our products may result in our inability to satisfy consumer demand for our products in a timely manner or at </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">all, which could harm our reputation, future sales and profitability. For example, certain of our products contain electronic components and we have experienced, and could continue to experience, limited product availability due to the electronic components shortage in certain product lines. If the shortage persists, we may not be able to obtain electronic components from our suppliers on a timely basis, or at all, or identify any alternative suppliers to provide the electronic components we need to produce our products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the pandemic could adversely impact our ability, and the ability of our third-party suppliers, manufacturers, distributors and customers, to retain key employees and ensure the continued service and availability of skilled personnel necessary to run our, and their, complex operations. To the extent our management or other personnel, or the management or other personnel of our third-party suppliers, manufacturers, distributors and customers, are impacted in significant numbers by the pandemic and are not available to perform their job duties, we could experience delays in, or the suspension of, our manufacturing operations, sales activities, research and product development activities, regulatory work streams, clinical development programs and other important commercial and corporate functions.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Moreover, the actions we take to mitigate the effect of the pandemic on our workforce could reduce the efficiency of our operations or prove insufficient. Our relationships with our employees may be disrupted due to measures implemented in response to the COVID-19 pandemic. We have observed an overall tightening and increasingly competitive labor market due to labor shortages caused in part by the COVID-19 pandemic and responsive measures, which has included increased wages offered by other employers and voluntary attrition of our employees and the employees of our third-party suppliers, manufacturers, distributors and customers.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The extent of the pandemic&#8217;s effect on our business and industry will depend on future developments, including the duration, spread and intensity of the pandemic, including future resurgences and/or the spread of variants, and the successful development, distribution and acceptance of vaccines for COVID-19, all of which are uncertain and difficult to predict. We are not able at this time to estimate with certainty the effect of these and other unforeseen factors on our business, but the adverse impact on our business, cash flows, financial condition and results of operations has been, and could in the future be, material. A prolonged impact of COVID-19 also could heighten many of the other risks described in this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have experienced, and may continue to experience, a significant and unpredictable need to adjust our operations as market demand for certain of our products has shifted and continues to shift or as may be mandated by governmental authorities in response to the COVID-19 pandemic:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Some of our products are particularly sensitive to reductions in elective medical procedures. Elective medical procedures were suspended or reduced at various times in 2020 and 2021 in many of the markets where our products are marketed and sold, which negatively affected our business, cash flows, financial condition and results of operations. It is not possible to predict whether elective medical procedures will again be suspended or reduced in the future and, to the extent individuals and customers are required to continue to de-prioritize, delay or cancel elective procedures as a result of the COVID-19 pandemic or otherwise, our business, cash flows, financial condition and results of operations could be negatively affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, our products in certain divisions, such as Medical, have experienced, and could continue to experience, higher demand as our customers focus on treating COVID-19 patients. Unpredictable increases in demand for certain of our products have exceeded in the past, and could exceed in the future, our capacity to meet such demand timely, which could adversely affect our customer relationships and result in negative publicity. In this regard, the accelerated development and production of products and services in an effort to address medical and other requirements as a result of the pandemic could increase the risk of regulatory enforcement actions, product defects or related claims.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">LEGAL AND REGULATORY RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Current economic and political conditions make tax rules in jurisdictions subject to significant change</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future results of operations could be affected by changes in the effective tax rate as a result of changes in tax laws, regulations and judicial rulings. We are continuing to evaluate the impact of tax reform in the countries in which we operate as new guidance and regulations are published. In addition, further changes in the tax laws could arise, including as a result of the base erosion and profit shifting (BEPS) project undertaken by the Organisation for </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Economic Cooperation and Development (OECD). The OECD, which represents a coalition of member countries, has issued recommendations that, in some cases, would make substantial changes to numerous long-standing tax positions and principles. These contemplated changes, to the extent adopted by OECD members and/or other countries, could increase tax uncertainty and may adversely affect our provision for income taxes.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by future changes in the allocation of income to each of the income tax</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">jurisdictions in which we operate:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We operate in multiple income tax jurisdictions both in the United States and internationally. Accordingly, our management must determine the appropriate allocation of income to each jurisdiction based on current interpretations of complex income tax regulations. Income tax authorities regularly perform audits of our income tax filings. Income tax audits associated with the allocation of income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">The impact of United States healthcare reform legislation on our business remains uncertain: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2010 the Patient Protection and Affordable Care Act (ACA) was enacted. While the provisions of the ACA are intended to expand access to health insurance coverage and improve the quality of healthcare over time, other provisions of the legislation, including Medicare provisions aimed at decreasing costs, comparative effectiveness research, an independent payment advisory board and pilot programs to evaluate alternative payment methodologies, are having a meaningful effect on the way healthcare is developed and delivered and could have a significant effect on our business. There have been ongoing litigation and congressional efforts to modify or repeal all or certain provisions of the ACA. We face uncertainties that might result from modification or repeal of any of the provisions of the ACA, including as a result of current and future executive orders and legislative actions. We cannot predict what other healthcare programs and regulations will ultimately be implemented at the federal or state level or the effect that any future legislation or regulation in the United States may have on our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to extensive governmental regulation relating to the classification, manufacturing, sterilization, labeling, marketing and sale of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The classification, manufacturing, sterilization, labeling, marketing and sale of our products are subject to extensive and evolving regulations and rigorous regulatory enforcement by the FDA, European Union, the NMPA in China, and other governmental authorities in the United States and internationally. The process of obtaining regulatory clearances and/or approvals to market and sell our products can be costly and time consuming and the clearances and/or approvals might not be granted timely. We have ongoing responsibilities under the laws and regulations applicable to the manufacturing of products within our facilities and those contracted by third parties that are subject to periodic inspections by the FDA and other governmental authorities to determine compliance with the quality system, medical device reporting regulations and other requirements. Costs to comply with regulations, including the European Union Medical Device Regulation enacted by the European Union in May 2017 and effective in May 2021, the free trade agreement between the United Kingdom and the European Union that became effective January 1, 2021, and the regulatory laws established by the NMPA in China, and costs associated with remediation can be significant. If we fail to comply with applicable regulatory </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">requirements, we may be subject to a range of sanctions, including substantial fines, warning letters that require corrective action, product seizures, recalls, the suspension of product manufacturing, revocation of approvals, exclusion from future participation in government healthcare programs, substantial fines and criminal prosecution.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to federal, state and foreign healthcare regulations, including anti-bribery, anti-corruption, anti-kickback and false claims laws, globally and could face substantial penalties if we fail to comply with such regulations and laws:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The relationships that we, and third-parties that market and/or sell our products, have with healthcare professionals, such as physicians, hospitals, healthcare organizations and others, are subject to scrutiny under various state and federal laws often referred to collectively as healthcare fraud and abuse laws. In addition, the United States and foreign government regulators have increased the enforcement of the Foreign Corrupt Practices Act (FCPA) and other anti-bribery and anti-kickback laws. We also must comply with a variety of other laws that impose extensive tracking and reporting related to all transfers of value provided to certain healthcare professionals and others. These laws and regulations are broad in scope and are subject to evolving interpretation and we have in the past been, and in the future could be, required to incur substantial costs to investigate, audit and monitor compliance or to alter our practices. Violations of these laws could result in litigation and we may be subject to criminal or civil penalties and sanctions, including substantial fines, imprisonment of current or former employees and exclusion from participation in governmental healthcare programs. In 2013 and 2018 we settled claims brought by the United States Securities and Exchange Commission (SEC) related to the FCPA. Pursuant to these settlements, we paid fines and penalties and retained an independent compliance consultant. We continue to implement recommendations that resulted from the independent compliance consultant&#8217;s review of our commercial practices to enhance our commercial business practices.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to privacy, data protection and data security regulations and laws globally, and could face substantial penalties if we fail to comply with such regulations and laws: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are subject to a variety of laws and regulations globally regarding privacy, data protection, and data security, including those related to the collection, storage, handling, use, disclosure, transfer, and security of personally identifiable healthcare information. For example, in the United States, privacy and security regulations under the Health Insurance Portability and Accountability Act of 1996, including the expanded requirements under the Health Information Technology for Economic and Clinical Health Act of 2009, establish comprehensive standards with respect to the use and disclosure of protected health information (PHI), by covered entities, in addition to setting standards to protect the confidentiality, integrity and security of PHI. Further, the European Union&#8217;s General Data Protection Regulation (GDPR), which became effective in May 2018, applies to all of our activities related to products and services that we offer to European Union customers and employees. The GDPR established requirements regarding the handling of personal data and includes significant penalties for non-compliance (including possible fines of up to 4% of total company revenue). Other governmental authorities around the world are considering similar types of legislative and regulatory proposals concerning data protection, which could impose significant limitations and increase our cost of providing our products and services where we process personal data. These laws and regulations are broad </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">in scope and are subject to evolving interpretation and we have in the past been, and in the future could be, required to incur substantial costs to monitor compliance or to alter our practices.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We are exposed to potential product liability risks inherent in the design, manufacture and marketing of medical devices, many of which are implanted in the human body for long periods of time or indefinitely. We may be exposed to additional potential product liability risks related to products designed, manufactured and marketed in response to the COVID-19 pandemic, including discretionary products and products permitted under the Emergency Use Authorization granted by the FDA. We are currently defendants in a number of product liability matters, including those relating to our Rejuvenate and ABGII Modular-Neck hip stems, LFIT Anatomic CoCr V40 Femoral Heads and the product liability lawsuits and claims relating to Wright legacy hip products discussed in Note 7 to our Consolidated Financial Statements. These matters are subject to many uncertainties and outcomes are not predictable. Further, in November 2020 the European Parliament voted in favor of the European Representative Actions Directive (the Collective Redress Directive), which mandates a class action regime in each member state to facilitate domestic and cross-border class actions in a wide range of areas, including product liability claims with medical devices. The Collective Redress Directive will take effect in 2023 after a 24-month implementation period. The Collective Redress Directive, when implemented, could result in additional litigation risks and significant legal expenses for us. In addition, we may incur significant legal expenses for product liability claims regardless of whether we are found to be liable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Intellectual property litigation and infringement claims could cause us to incur significant expenses or prevent us from selling certain of our products: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The medical device industry is characterized by extensive intellectual property litigation and, from time to time, we are the subject of claims of infringement or misappropriation.&#160;Regardless of outcome, such claims are expensive to defend and divert management and operating personnel from other business issues.&#160;A successful claim or claims of patent or other intellectual property infringement against us could result in payment of significant monetary damages and/or royalty payments or negatively impact our ability to sell current or future products in the affected category.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Dependence on patent and other proprietary rights and failing to protect such rights or to be successful in litigation related to such rights may impact offerings in our product portfolios: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our long-term success largely depends on our ability to market technologically competitive products. If we fail to obtain or maintain adequate intellectual property protection, it could allow others to sell products that directly compete with proprietary features in our product portfolio. Also, our issued patents may be subject to claims challenging their validity and scope and raising other issues. In addition, currently pending or future patent applications may not result in issued patents.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MARKET RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We have exposure to exchange rate fluctuations on cross border transactions and translation of local currency results into United States Dollars:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We report our financial results in United States Dollars and approximately 30% of our net sales are denominated in foreign currencies, including the Australian Dollar, British Pound, Canadian Dollar, Chinese Yuan, Euro and Japanese Yen. Cross border transactions with external parties and intercompany relationships result in increased exposure to </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">foreign currency exchange effects. While we use derivative instruments to manage the impact of currency exchange, our hedging strategies may not be successful, and our unhedged exposures continue to be subject to currency fluctuations. In addition, the weakening or strengthening of the United States Dollar results in favorable or unfavorable translation effects when the results of our foreign locations are translated into United States Dollars.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Additional capital that we may require in the future may not be available to us or may only be available to us on unfavorable terms, which could negatively affect our liquidity: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including operating requirements, current and future acquisitions and the need to refinance existing debt. Our ability to issue additional debt or enter into other financing arrangements on acceptable terms could be adversely affected by our debt levels, unfavorable changes in economic conditions or uncertainties that affect the capital markets, including disruption caused by the COVID-19 pandemic. Changes in credit ratings issued by nationally recognized credit rating agencies could also adversely affect our access to and cost of financing. Higher borrowing costs or the inability to access capital markets could adversely affect our ability to support future growth and operating requirements. In addition, we have experienced, and could continue to experience, loss of sales and profits due to delayed payments or insolvency of healthcare professionals, hospitals and other customers and suppliers facing liquidity issues caused by the COVID-19 pandemic. As a result, we may be compelled to take additional measures to preserve our cash flow, including through the reduction of operating expenses or suspension of dividend payments, at least until the consequences of the pandemic subside.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">BUSINESS AND OPERATIONAL RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to cost containment measures in the United States and other countries resulting in pricing pressures:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Initiatives to limit the growth of general healthcare expenses and hospital costs are ongoing in the markets in which we do business. These initiatives are sponsored by government agencies, legislative bodies and the private sector and include price regulation and competitive pricing. For example, China has implemented a volume-based procurement process designed to decrease prices for medical devices and other products. This has already impacted our joint replacement business on a national level, and our trauma and spine products on a provincial level, and we expect further adoption of volume-based procurement provincially or nationally in China in 2022. Pricing pressure has also increased due to continued consolidation among healthcare providers, trends toward managed care, the shift toward governments becoming the primary payers of healthcare expenses, reduction in reimbursement levels and medical procedure volumes and government laws and regulations relating to sales and promotion, reimbursement and pricing generally. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We operate in a highly competitive industry in which competition in the development and improvement of new and existing products is significant: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The markets in which we compete are highly competitive. New business models, products and surgical procedures are introduced on an ongoing basis and our present or future products could be rendered obsolete or uneconomical by technological advances by us, as we continue to innovate to address physician and patient needs, or by our existing competitors and new market entrants. Our existing competitors and new market entrants may respond more quickly to new or emerging technologies, undertake more extensive marketing campaigns, have greater access to clinical information </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">to support ongoing product position in the market, have greater financial, marketing and other resources or be more successful in attracting potential customers, employees and strategic partners. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to maintain adequate working relationships with healthcare professionals:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We seek to maintain close working relationships with respected physicians and medical personnel in healthcare organizations, such as hospitals and universities, who assist in product research and development. We rely on these professionals to assist us in the development and improvement of proprietary products. As a result of the COVID-19 pandemic, our access to these professionals has been limited as hospitals have restricted access for non-patients, including our research and development specialists and other employees, and governmental authorities have imposed travel restrictions, shutdowns or similar measures, which has adversely affected our ability to develop, market and sell products. If we are unable to maintain these relationships, our ability to develop, market and sell new and improved products could be further adversely affected.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We rely on indirect distribution channels and major distributors that are independent of Stryker: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In many markets, we rely on indirect distribution channels to market, distribute, and sell our products. These indirect channels often are the main point of contact for the healthcare professionals and healthcare organization customers who buy and use our products. Our ability to market, distribute, and sell our products through indirect channels has been adversely affected as a result of precautionary responses to the COVID-19 pandemic, including travel restrictions, suspension and shutdown orders and other measures intended to limit person-to-person contact. Our ability to continue to market, distribute, and sell our products may be at risk if the indirect channels become insolvent, choose to sell competitive products, choose to stop selling medical technology, or are subject to new or additional government regulation, whether related to the COVID-19 pandemic or for unrelated reasons.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We are subject to risks associated with our extensive global operations:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We develop, manufacture and distribute our products globally. Our global operations are subject to risks and potential costs, including changes in reimbursement, changes in regulatory requirements, differing local product preferences and product requirements, diminished protection of intellectual property in some countries, tariffs and other trade protection measures, international trade disputes and import or export requirements, difficulty in staffing and managing foreign operations, introduction of new internal business structures and programs, political and economic instability, such as the United Kingdom's exit from the European Union (Brexit), and disruptions of transportation due to a global pandemic of contagious diseases like COVID-19 or otherwise, such as reduced availability of transportation, port closures, increased border controls or closures, increased transportation costs and increased security threats to our supply chain. Our business could be adversely impacted if we are unable to successfully manage these and other risks of global operations in an increasingly volatile environment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to capitalize on previous or future acquisitions:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In addition to internally developed products, we invest in new products and technologies through acquisitions, including our pending acquisition of Vocera Communications, Inc. Such investments are inherently risky, and we cannot guarantee that any acquisition will be successful or will not have a material unfavorable impact on us. The risks include the activities required and resources allocated to integrate new businesses, diversion of </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">management time that could adversely affect management's ability to focus on other projects, the inability to realize the expected benefits, savings or synergies from the acquisition, the loss of key personnel, litigation resulting from the acquisition and exposure to unexpected liabilities of acquired companies. In addition, we cannot be certain that the businesses we acquire will become or remain profitable.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could experience a failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach or failure of one or more key information technology systems, networks, processes, associated sites or service providers: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We rely extensively on information technology (IT) systems to conduct business. In addition, we rely on networks and services, including internet sites, cloud and SaaS solutions, data hosting and processing facilities and tools and other hardware, software (including open source software) and technical applications and platforms, some of which are managed, hosted, provided and/or used by third-parties or their vendors, to assist in conducting our business. Numerous and evolving cybersecurity threats have posed, and will continue to pose, risks to the security of our IT systems, networks and product offerings, as well as the confidentiality, availability and integrity of our data. Some of our products and services, and information technology systems, contain or use open source software, which poses particular risks, including potential security vulnerabilities, licensing compliance issues and quality issues. A security breach, whether of our products, of our customers&#8217; network security and systems or of third-party hosting services, could impact the use of such products and the security of information stored therein. While we have made investments seeking to address these threats, including monitoring of networks and systems, hiring of experts, employee training and security policies for employees and third-party providers, the techniques used in these attacks change frequently and may be difficult to detect for periods of time and we may face difficulties in anticipating and implementing adequate preventative measures. In addition, a greater number of our employees working remotely during the COVID-19 pandemic has exposed us, and may continue to expose us, to greater risks related to cybersecurity and cyber-liability. If our IT systems are damaged or cease to function properly, the networks or service providers we rely upon fail to function properly, or we or one of our third-party providers suffer a loss or disclosure of our business or stakeholder information due to any number of causes ranging from catastrophic events or power outages to improper data handling or security breaches and our business continuity plans do not effectively address these failures on a timely basis, we may be exposed to reputational, competitive and business harm as well as litigation and regulatory action.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">An inability to successfully manage the implementation of our new commercial global enterprise resource planning (ERP) system could adversely affect our operations and operating results: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are in the process of implementing a new commercial global ERP system. This system will replace many of our existing operating and financial systems. Such an implementation is a major undertaking, both financially and from a management and personnel perspective. Any disruptions, delays or deficiencies in the design and implementation of our new ERP system could adversely affect our ability to process orders, ship products, provide services and customer support, send invoices and track payments, fulfill contractual obligations or otherwise operate our business.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We may be unable to attract and retain key employees:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our sales, technical and other key personnel play an integral role in </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the development, marketing and selling of new and existing products. If we are unable to recruit, hire, develop and retain a talented, competitive work force in our highly competitive industry, or if we are unable to plan effective succession for the future, we may not be able to meet our strategic business objectives. In addition, if we are unable to maintain an inclusive culture that aligns our diverse work force with our mission and values, this could adversely impact our ability to recruit, hire, develop and retain key talent. Further, the ongoing remote work environment in response to COVID-19 could harm our culture and/or decrease employee engagement, which could adversely impact our ability to recruit, hire, develop and retain a talented, competitive work force.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interruption of manufacturing operations could adversely affect our business:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We and our suppliers have manufacturing and supply sites all over the world; however, the manufacturing of certain of our product lines is concentrated in one or more plants or geographic regions. We have principal manufacturing and distribution facilities in the United States in Arizona, California, Florida, Illinois, Indiana, Michigan, Minnesota, New Jersey, Tennessee, Texas, Utah, Virginia and Washington, and outside the United States in China, France, Germany, Ireland, Mexico, the Netherlands, Puerto Rico, Switzerland and Turkey. Damage to our facilities, to our suppliers&#8217; or service providers' facilities, or to our central distribution centers as a result of natural disasters, fires, explosions or otherwise, as well as issues in our manufacturing arising from a failure to follow specific internal protocols and procedures, compliance concerns relating to the quality systems regulation, equipment breakdown or malfunction, IT system failures or cybersecurity incidents, environmental hazard incidents or changes to environmental regulations or other factors, could adversely affect the availability of our products. In the event of an interruption in manufacturing, we may be unable to move quickly to alternate means of producing affected products to meet customer demand. In the event of a significant interruption, we may experience lengthy delays in resuming production of affected products due to the need for regulatory approvals, and we may experience loss of market share, additional expense and harm to our reputation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We use a variety of raw materials, components, devices and third-party services in our global supply chains, production and distribution processes; significant shortages, price increases or unavailability of third-party services could increase our operating costs, require significant capital expenditures, or adversely impact the competitive position of our products:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our reliance on certain suppliers to secure raw materials, components and finished devices, and on certain third-party service providers, such as sterilization service providers, exposes us to product shortages and unanticipated increases in prices, whether due to inflationary pressure, regulatory changes or otherwise. In addition, several raw materials, components, finished devices and services are procured from a sole-source due to the quality considerations, unique intellectual property considerations or constraints associated with regulatory requirements. If sole-source suppliers or service providers are acquired or were unable or unwilling to deliver these materials or services, we may not be able to manufacture or have available one or more products during such period of unavailability and our business could suffer. In certain cases we may not be able to establish additional or replacement suppliers for such materials or service providers for such services in a timely or cost effective manner, largely as a result of FDA and other regulations that require, among other things, validation of materials, components and services prior to their use in or with our products. In addition, </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">during 2021, the market experienced increasing inflationary pressures in part due to global supply chain disruptions, labor shortages and other impacts of the COVID-19 pandemic, which we anticipate will continue in 2022. We may experience inflationary increases in manufacturing costs and operating expenses, caused by the COVID-19 pandemic or as a result of general macroeconomic factors, and may not be able to pass these cost increases on to our customers in a timely manner, which could have a material adverse impact on our profitability and results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Our insurance program may not be adequate to cover future losses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain third-party insurance to cover our exposure to certain property and casualty losses and are self-insured for claims and expenses related to other property and casualty losses, including product liability, intellectual property infringement and enforcement, environmental, and cybersecurity and data privacy losses. We manage a portion of our exposure to self-insured losses through a wholly-owned captive insurance company. Insurance coverage limits provided by third-party insurers and/or our captive insurance company may not be sufficient to fully cover unanticipated losses.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) RISKS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">We could be negatively impacted by ESG and sustainability-related matters:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Governments, investors, customers, employees and other stakeholders are increasingly focusing on corporate ESG practices and disclosures, and expectations in this area are rapidly evolving. On occasion, we announce new initiatives, including goals, under our Corporate Responsibility framework. This framework is aligned with our areas of interest, which include environment and sustainability, social impact, diversity, equity and inclusion and supply chain management, among others. The criteria by which our ESG practices are assessed may change due to the quickly evolving landscape, which could result in greater expectations of us and cause us to undertake costly initiatives to satisfy such new criteria. Moreover, the increasing attention to corporate ESG initiatives could also result in reduced demand for products, reduced profits and increased investigations and litigation. If we are unable to satisfy such new criteria, investors may conclude that our policies and/or actions with respect to ESG matters are inadequate. If we fail or are perceived to have failed to achieve previously announced initiatives or goals or to accurately disclose our progress on such initiatives or goals, our reputation, business, financial condition and results of operations could be adversely impacted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Physical effects of climate change or legal, regulatory or market measures intended to address climate change could adversely affect our operations and operating results:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Risks associated with climate change are subject to increasing societal, regulatory and political focus in the United States and globally. Shifts in weather patterns caused by climate change are expected to increase the frequency, severity or duration of certain adverse weather conditions and natural disasters, such as hurricanes, tornadoes, earthquakes, wildfires, droughts, extreme temperatures or flooding, which could cause more significant business and supply chain interruptions, damage to our products and facilities as well as the infrastructure of hospitals, medical care facilities and other customers, reduced workforce availability, increased costs of raw materials and components, increased liabilities, and decreased revenues than what we have experienced in the past from such events. In addition, increased public concern over climate change could result in new legal or regulatory requirements designed to mitigate the effects of </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">climate change, which could include the adoption of more stringent environmental laws and regulations or stricter enforcement of existing laws and regulations. Such developments could result in increased compliance costs and adverse impacts on raw material sourcing, manufacturing operations and the distribution of our products, which could adversely affect our operations and operating results.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_19"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;1B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">UNRESOLVED STAFF COMMENTS.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_22"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;2.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PROPERTIES.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have approximately 28 company-owned and 328 leased locations worldwide including 50 manufacturing locations. We believe that our properties are in good operating condition and adequate for the manufacture and distribution of our products. We do not anticipate difficulty in renewing existing leases as they expire or in finding alternative facilities.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_25"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;3.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LEGAL PROCEEDINGS.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor and intellectual property, and the matters described in more detail in Note 7 to our Consolidated Financial Statements.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;4.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MINE SAFETY DISCLOSURES.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_31"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART II</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_34"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;5.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our common stock is traded on the New York Stock Exchange under the symbol SYK.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Board of Directors considers payment of cash dividends at its quarterly meetings. On January&#160;31, 2022 there were 2,543 shareholders of record of our common stock.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We did not repurchase any shares in the three months ended December&#160;31, 2021 and the total dollar value of shares that could be acquired under our authorized repurchase program at December&#160;31, 2021 was $1,033. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the fourth quarter 2021 we did not issue shares of our common stock as performance incentive awards to employees. When issued, these shares are not registered under the Securities Act of 1933 based on the conclusion that the awards would not be events of sale within the meaning of Section 2(a)(3) of the Act.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following graph compares our total returns (including reinvestments of dividends) against the Standard&#160;&amp; Poor&#8217;s (S&amp;P) 500 Index and the S&amp;P 500 Health Care Index. The graph assumes $100 (not in millions) invested on December&#160;31, 2016 in our common stock and each of the indices.</span></div><div style="text-align:center"><img src="syk-20211231_g3.jpg" alt="syk-20211231_g3.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:348px"/></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker Corporation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.00</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">130.84</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">134.02</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">181.37</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">214.32</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">236.24</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Index</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">116.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">181.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">S&amp;P 500 Health Care Index</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">129.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">178.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">224.71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_37"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;6.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SELECTED FINANCIAL DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:53.976%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.244%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statement of Earnings Data</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,601</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,140&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,938</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">8,180</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,384&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,983&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,401&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,883&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,537</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,297</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,562</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,356</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,063</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,197)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,083</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,553</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.68&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Dividends declared per share of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.585</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2.135</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.93</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1.745</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance Sheet Data</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash, cash equivalents and current marketable securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,019&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,793&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,893&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,833&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">30,167</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">27,229</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">22,197</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">646&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,479&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,090&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,859&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">14,877</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">13,084</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">12,807</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">11,730</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">9,980</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Flow Data </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,263</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,277</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,191</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2,610</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">1,559</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">703&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">636&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other Data</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Number of shareholders of record</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,636&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,732&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Approximate number of employees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">36,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:9pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_40"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_43"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">About Stryker</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our goal is to achieve sales growth at the high-end of the medical technology (MedTech) industry and maintain our long-term capital allocation strategy that prioritizes: (1) Acquisitions, (2) Dividends and (3) Share repurchases.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">COVID-19 Pandemic</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The COVID-19 pandemic has led to severe disruptions in the market and the global and United States economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. In response, various governmental authorities and private enterprises have implemented numerous measures to contain the pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. A significant number of our customers, global suppliers, vendors, distributors and manufacturing facilities are located in regions that have been affected by the pandemic. Those operations have been materially adversely affected by restrictive government and private enterprise measures implemented in response to the pandemic.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Some of our products are particularly sensitive to reductions in elective medical procedures. Elective medical procedures were suspended in the first quarter of 2020 in many of the markets where our products are marketed and sold, which negatively affected our business, cash flows, financial condition and results of operations through the first quarter of 2021. In the second quarter of 2021 we saw partial recovery of elective procedures in most geographies; however, in the third quarter of 2021 we saw hospitalization rates increase, especially in the United States, as a result of the Delta variant. This, along with the Omicron variant, has continued to adversely impact elective procedures and increased inflationary pressure on our gross margin, including an increase in freight and transportation costs as well as increased absenteeism in the fourth quarter of 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Overview of 2021</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we achieved reported net sales growth of 19.2%. Excluding the impact of acquisitions and divestitures, sales grew 12.6% in constant currency. We reported net earnings of $1,994 and net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$5.21. Excluding the impact of certain items, we achieved adjusted net earnings</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of $3,474 </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">and adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:700;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of $9.09 representing growth of 22.3%. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective December 31, 2021 we changed our reportable business segments to (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine to align to our new internal reporting structure. Refer to Note 14 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We continued our capital allocation strategy by investing $339 in acquisitions and paying $950 in dividends to our shareholders. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we had total long-term debt repayments of $1,151. In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we completed acquisitions for total net cash consideration of $339 and $54 in future milestone payments primarily due upon the achievement of certain regulatory and commercial milestones. In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $120 in cash and up to $40 in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. In January 2022 we announced a definitive merger agreement to acquire all of the issued and outstanding common shares of Vocera Communications, Inc. (Vocera) for $79.25 per share, or an aggregate purchase price of approximately $3.1 billion (including convertible notes). Refer to Note 6 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we did not repurchase any shares of our common stock under our authorized repurchase program. The total dollar value of shares of our common stock that could be acquired under our authorized repurchase program was $1,033 as of December&#160;31, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 we recorded asset impairments of $264, $105 for certain long-lived and intangible assets related to the China volume-based procurement program and the remaining consisting primarily of in-process research and development, other intangible assets and property, plant and equipment as a result of COVID-19-related demand impacts on in-process product development and certain other divestiture and restructuring activities. Refer to Note 15 to our Consolidated Financial Statements for further information.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_46"></div></div></div><div style="margin-top:15pt;padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Refer to "Non-GAAP Financial Measures" for a discussion of non-GAAP financial measures used in this report and a reconciliation to the most directly comparable GAAP financial measure.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED RESULTS OF OPERATIONS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.922%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.688%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.575%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.389%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">64.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,356&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall charges, net of insurance proceeds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">nm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(91.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(303)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(151)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19.2)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,083</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(23.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per diluted share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(23.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:700;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.09</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:40.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.699%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.401%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic and Segment Net Sales</span></div></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr style="height:9pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Constant<br/>Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Geographic:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,927&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment:</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.877%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Supplemental Net Sales Growth Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Percentage Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021 vs. 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020 vs. 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">United States</span></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">International</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">As Reported</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.4</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20.3</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.4</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28.6</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48.9</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">40.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,475</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(6.3)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(6.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(5.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(8.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">nm - not meaningful</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_49"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Consolidated Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales increased 19.2% as reported and 18.1% in constant currency. Excluding the 5.5% impact of acquisitions and divestitures, net sales in constant currency increased by 13.4% from increased unit volume partially offset by 0.8% due to lower prices. The unit volume increase was primarily due to higher shipments across all product lines.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Consolidated net sales in 2020 were significantly negatively impacted by the global response to the COVID-19 pandemic. Consolidated net sales decreased 3.6% as reported and in constant currency. Excluding the 1.2% impact of acquisitions, net </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">sales in constant currency decreased by 4.1% from decreased unit volume and 0.7% due to lower prices. The unit volume decrease was primarily due to lower shipments of instruments, endoscopy, neurotechnology, spine, knee and hip products partially offset by higher shipments of medical products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MedSurg and Neurotechnology Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2021 increased 14.3% as reported and 13.3% in constant currency, as foreign currency exchange rates positively impacted net sales by 1.0%. Excluding the 0.2% impact of acquisitions and divestitures, net sales in constant currency increased by 13.6% from increased </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">unit volume partially offset by 0.5% due to lower prices. The unit volume increase was primarily due to higher shipments across all medsurg and neurotechnology product lines. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology net sales in 2020 decreased 1.5% as reported and 1.5% in constant currency. Excluding the 0.4% impact of acquisitions, net sales in constant currency decreased by 1.8% from decreased unit volume and 0.1% due to lower prices. The unit volume decrease was primarily due to lower shipments of instruments, endoscopy and other medsurg and neurotechnology products partially offset by higher shipments of medical products. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Orthopaedics and Spine Net Sales</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine net sales in 2021 increased 26.0% as reported and 24.8% in constant currency, as foreign currency exchange rates positively impacted net sales by 1.2%. Excluding the 12.8% impact of acquisitions and divestitures, net sales in constant currency increased by 13.2% from increased unit volume partially offset by 1.2% due to lower prices. The unit volume increase was primarily due to higher shipments across all orthopaedics and spine products.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine net sales in&#160;2020&#160;decreased 6.3% as reported and 6.4% in constant currency, as foreign currency exchange rates positively impacted net sales by 0.1%. Excluding the 2.3% impact of acquisitions, net sales in constant currency decreased by 7.1% from unit volume and 1.6% due to lower prices. The unit volume decrease was due to lower shipments of knees, hips and spine products partially offset by higher shipments of other orthopaedic and spine products. </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_52"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Gross Profit</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit as a percentage of net sales increased to 64.1% in 2021 from 63.1% in 2020. Excluding the impact of the items noted below, gross profit increased to 65.9% from 63.8% in 2020 primarily due to leverage from higher sales volumes and favorable product mix, partially offset by lower selling prices. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit was significantly negatively impacted by the global response to the COVID-19 pandemic in 2020, decreasing as a percentage of net sales to 63.1% from 65.1% in 2019. Excluding the impact of the items noted below, gross profit decreased to 63.8% from 65.9% in 2019 primarily due to lower sales volumes, lower selling prices, lower manufacturing volumes and unfavorable product mix due to the postponement of elective medical procedures.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,807</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">63.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">65.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering expenses as a percentage of net sales increased to 7.2% in 2021 from 6.9% in 2020 and 6.5% in 2019. Excluding the impact of the items noted below, expenses increased to 6.6% in 2021 from 6.3% in 2020 and 6.1% in 2019. Disciplined ramp up in spending to facilitate our growth, including projects to develop new products, investments in new technologies and integration of recent acquisitions contributed to the increase.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,235</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">971</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">905</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">915</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expenses as a percentage of net sales in 2021 increased to 37.6% from 37.4% in 2020 and 36.0% in 2019. Both 2021 and 2020 included charges related to certain asset impairments. Refer to Note 15 to our Consolidated Financial Statements for further information. Excluding the impact of the items noted below, expenses increased to 33.6% in 2021 from 33.1% in 2020 and 33.5% in 2019 primarily due to disciplined ramp up in spending to facilitate our growth.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,356</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Charges, Net of Insurance Proceeds</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Recall charges were $103, $17 and $192 in 2021, 2020 and 2019. Charges were primarily due to the previously disclosed Rejuvenate and ABGII Modular-Neck hip stems and LFIT V40 femoral head voluntary recalls. Refer to Note 7 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Amortization of Intangible Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of intangible assets was $619, $472 and $464 in 2021, 2020 and 2019. The increase in 2021 was primarily due to the acquisition of Wright Medical Group N.V. (Wright) in the fourth quarter of 2020. Refer to Notes 6 and 8 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Income</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income decreased as a percentage of sales to 15.1% in 2021 from 15.5% in 2020. Excluding the impact of the items noted below, operating income increased to 25.6% of sales in 2021 from 24.4% in 2020, primarily due to leverage from higher sales volumes partially offset by disciplined spending to facilitate our growth.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating income as a percentage of sales in 2020 decreased to 15.5% from 18.2% in 2019. Excluding the impact of the items noted below, operating income decreased to 24.4% in 2020 from 26.3% in 2019 due to unfavorable product mix and the impact of lower sales volumes from the postponement of elective medical procedures partially offset by continued focus on our operating expense savings actions.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,908</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24.4</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income (expense), net was ($303), ($269) and ($151) in 2021, 2020 and 2019. The increase in net expense in 2021 was primarily due to increased interest expense driven by the additional debt from the bond offerings completed in June 2020 and November 2020. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our effective tax rate was 12.6%, 18.2% and 18.7% for 2021, 2020 and 2019. The effective income tax rate for 2021 reflects the continued lower effective income tax rates as a result of our European operations, certain discrete tax benefits, the tax effect related to the transfer of intellectual property between tax jurisdictions and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective income tax rate for 2020 and 2019 reflects the tax effect related to the transfer of intellectual properties between tax jurisdictions, the effective income tax rates as a result of our European operations and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net Earnings</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net earnings increased to $1,994 or $5.21 per diluted share from $1,599 or $4.20 per diluted share in 2020 and decreased from $2,083 or $5.48 per diluted share in 2019. Adjusted net earnings per diluted share</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> of $9.09 increased 22.3% from $7.43 in 2020 compared to $8.26 in 2019. The impact of foreign currency exchange rates increased net earnings per diluted share by approximately $0.19 in 2021 and reduced net earnings per diluted share by approximately $0.02 and $0.14 in 2020 and 2019.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.190%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Percent Net Sales</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,083</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped up to fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20.3</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_55"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non-GAAP financial measures, including percentage sales growth in constant currency; percentage organic sales growth; adjusted gross profit; adjusted selling, general and administrative expenses; adjusted research, development and engineering expenses; adjusted operating income; adjusted other income (expense), net; adjusted effective income tax rate; adjusted net earnings; adjusted net earnings per diluted share (Diluted EPS); free cash flow; and free cash flow conversion. We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes percentage sales growth in constant currency and the other adjusted measures described above are important indicators of our operations because they exclude items that may not be indicative of or are unrelated to our core operating results and provide a baseline for analyzing trends in our underlying businesses. Management uses these non-GAAP financial measures for reviewing the operating results of reportable business segments and analyzing potential future business trends in connection with our budget process and bases certain management incentive compensation on these non-GAAP financial measures. To measure percentage sales growth in constant currency, we remove the impact of changes in foreign currency exchange rates that affect the comparability and trend of sales. Percentage sales&#160;growth in constant currency is calculated by translating current and prior year results at the same foreign currency exchange rate. To measure percentage organic sales growth, we remove the impact of changes in foreign currency exchange rates, acquisitions and divestitures, which affect the comparability and trend of sales. Percentage organic sales growth is calculated by translating current year and prior year results at the same foreign currency exchange rates excluding the impact of acquisitions and divestitures. To measure earnings performance on a consistent and comparable basis, we exclude certain items that affect the comparability of operating results and the trend of earnings. To measure free cash flow, we adjust cash provided by operating activities by the amount of purchases of property, plant and equipment and proceeds from long-lived asset disposals and remove the impact of certain legal settlements and recall payments. To measure free cash flow conversion we divide free cash flow by adjusted net earnings. These adjustments are irregular in timing and may not be </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">indicative of our past and future performance. The following are examples of the types of adjustments that may be included in a period:</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Acquisition and integration-related costs</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Costs related to integrating recently acquired businesses (e.g., costs associated with the termination of sales relationships, workforce reductions and other integration-related activities) and specific costs (e.g., inventory step-up and deal costs) related to the consummation of the acquisition process.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Amortization of purchased intangible assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Periodic amortization expense related to purchased intangible assets. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Restructuring-related and other charges</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Costs associated with the termination of sales relationships in certain countries, workforce reductions, elimination of product lines, certain long-lived and intangible asset impairments and associated costs and other restructuring-related activities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Medical device regulations.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Costs specific to updating our quality system, product labeling, asset write-offs and product remanufacturing to comply with the new medical device reporting regulations and other requirements of the European Union and the more stringent regulations for medical devices in China.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Recall-related matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Our best estimate of the minimum of the range of probable loss to resolve the Rejuvenate, LFIT V40 and other product recalls.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Regulatory and legal matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Our best estimate of the </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">minimum of the range of probable loss to resolve certain regulatory matters and other legal settlements. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10.5pt">Tax matters</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Charges represent the impact of accounting for certain significant and discrete tax items.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names. These adjusted financial measures should not be considered in isolation or as a substitute for reported sales growth, gross profit, selling, general and administrative expenses, research, development and engineering expenses, operating income, other income (expense), net, effective income tax rate, net earnings and net earnings per diluted share, the most directly comparable GAAP financial measures. These non-GAAP financial measures are an additional way of viewing aspects of our operations when viewed with our GAAP results and the reconciliations to corresponding GAAP financial measures at the end of the discussion of Consolidated Results of Operations below. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The weighted-average diluted shares outstanding used in the calculation of non-GAAP net earnings per diluted share are the same as those used in the calculation of reported net earnings per diluted share for the respective period.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_58"></div></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of the Most Directly Comparable GAAP Financial Measure to Non-GAAP Financial Measure</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,968</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,427</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,235</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(303)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,994</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.21</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(319)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(358)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.02)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">11,267</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,133</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(299)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,474</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14.9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9.09</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,057</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,361</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(269)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,599</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4.20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">472&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(406)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.04&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,755</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">905</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,499</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(265)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,827</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7.43</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">16</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:4pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:26.299%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.132%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.441%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross Profit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Selling, General &amp; Administrative Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Research, Development &amp; Engineering Expenses</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Operating Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other Income (Expense), Net</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective<br/>Tax Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Diluted EPS</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,696</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,356</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">971</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(151)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,083</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory stepped-up to fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other acquisition and integration-related</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of purchased intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Adjusted</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,807</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,984</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">915</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,908</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(181)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,139</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">15.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8.26</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_61"></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FINANCIAL CONDITION AND LIQUIDITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,277&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(859)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4,701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,455)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Effect of exchange rate changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,394)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">721</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We believe our financial condition continues to be of high quality, as evidenced by our ability to generate substantial cash from operations and to readily access capital markets at competitive rates despite the COVID-19 pandemic. Operating cash flow provides the primary source of cash to fund operating needs and capital expenditures. Excess operating cash is used first to fund acquisitions to complement our portfolio of businesses. Other discretionary uses include dividends and share repurchases. We supplement operating cash flow with debt to fund our activities as necessary. Our overall cash position reflects our business results and a global cash management strategy that takes into account liquidity management, economic factors and tax considerations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash provided by operating activities was $3,263, $3,277 and $2,191 in 2021, 2020 and 2019. The slight decrease from 2020 was primarily due to higher accounts receivable, partially offset by increased net earnings and accounts payable. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash used in investing activities was $859, $4,701 and $1,455 in 2021, 2020 and 2019. The decrease in cash used in 2021 was primarily due to decreased payments for acquisitions and certain other businesses and related assets. In 2020 we acquired Wright, while in 2019 we acquired Mobius Imaging and Cardan Robotics and certain other businesses and related assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash provided by (used in) financing activities was ($2,365), ($11) and $3 in 2021, 2020 and 2019. The increase in cash used in financing activities was primarily driven by long-term debt repayments of $1,151 and dividend payments of $950 in 2021. In 2020 we secured a $400 term loan in November, issued $600 of notes in November and $2,300 of notes in June, which was offset by total debt repayments of $2,297 and dividend payments of $863. There were no share repurchases in 2021 or 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain debt levels that we consider appropriate after evaluating a number of factors including cash requirements for ongoing operations, investment and financing plans (including acquisitions and share repurchase activities) and overall cost of capital. Refer to Note 10 to our Consolidated Financial Statements for further information.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:63.453%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends paid per common share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.08&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total dividends paid to common shareholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">950&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total amount paid to repurchase common stock </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares of repurchased common stock (in millions) </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents and marketable securities were $3,019 and $3,024, and our current assets exceeded current liabilities by $5,468 and $4,666 on December&#160;31, 2021 and 2020. We anticipate being able to support our short-term liquidity and operating needs from a variety of sources including cash from operations, commercial paper and existing credit lines. In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. The primary changes were to increase the aggregate principal amount of the facility by $750 to $2,250, extend the maturity date to October 26, 2026, increase the leverage ratio to 3.75 and provide LIBOR replacement language.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We raised funds in the capital markets in 2020 and 2019 and may continue to do so from time-to-time. We continue to have strong investment-grade short-term and long-term debt ratings that we believe should enable us to refinance our debt as needed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our cash, cash equivalents and marketable securities held in locations outside the United States was approximately 26% and 30% on December&#160;31, 2021 and 2020. We intend to use this cash to expand operations organically and through acquisitions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Guarantees and Other Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONTRACTUAL OBLIGATIONS AND FORWARD-LOOKING CASH REQUIREMENTS</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 7 to our Consolidated Financial Statements, in 2021 we recorded charges to earnings related to the Rejuvenate and ABG II and LFIT Anatomic CoCr V40 Femoral Heads recall matters and recorded product liabilities relating to Wright legacy hip products claims. Recorded reserves represent the minimum of the range of probable cost remaining to resolve these matters. The final outcome of these matters is dependent on many variables that are difficult to predict. The ultimate cost to entirely resolve these matters may be materially different from the amount of the current estimates and could have a material adverse effect on our financial position, results of operations and cash flows. We are not able to reasonably estimate the future periods in which payments will be made.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 11 to our Consolidated Financial Statements, on December&#160;31, 2021 we had a reserve for </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">uncertain income tax positions of $444. Due to uncertainties regarding the ultimate resolution of income tax audits, we are not able to reasonably estimate the future periods in which any income tax payments to settle these uncertain income tax positions will be made.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As further described in Note 12 to our Consolidated Financial Statements, on December&#160;31, 2021 our defined benefit pension plans were underfunded by $493, of which approximately $491 related to plans outside the United States. Due to the rules affecting tax-deductible contributions in the jurisdictions in which the plans are offered and the impact of future plan asset performance, changes in interest rates and potential changes in legislation in the United States and other foreign jurisdictions, we are not able to reasonably estimate the amounts that may be required to fund defined benefit pension plans. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.109%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Contractual Obligations</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023 - 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025 - 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">After 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total debt</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,589&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,790&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest payments</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unconditional purchase obligations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States Tax Cuts and Jobs Act Transition Tax</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19,331</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,370</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,923</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,238</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,800</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_67"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In preparing our financial statements in accordance with generally accepted accounting principles, there are certain accounting policies, which may require substantial judgment or estimation in their application. We believe these accounting policies and the others set forth in Note 1 to our Consolidated Financial Statements are critical to understanding our results of operations and financial condition.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Actual results could differ from our estimates and assumptions, and any such differences could be material to our results of operations and financial condition. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventory Reserves</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We maintain reserves for excess and obsolete inventory resulting from the potential inability to sell certain products at prices in excess of current carrying costs. We make estimates regarding the future recoverability of the costs of these products and record provisions based on historical experience, expiration of sterilization dates and expected future trends. If actual product life cycles, product demand or acceptance of new product introductions are less favorable than projected by management, additional inventory write downs may be required, which could unfavorably affect future operating results.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our annual tax rate is determined based on our income, statutory tax rates and the tax impacts of items treated differently for tax purposes than for financial reporting purposes. Tax law requires certain items be included in the tax return at different times than the items are reflected in the financial statements. Some of these differences are permanent, such as expenses that are not deductible in our tax return, and some differences are temporary and reverse over time, such as depreciation expense. These temporary differences create deferred tax assets and liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets generally represent the tax effect of items that can be used as a tax deduction or credit in future years for which we have already recorded the tax benefit in our income statement. Deferred tax liabilities generally represent tax expense recognized in our financial statements for which payment was deferred, the tax effect of expenditures for which a deduction was taken in our tax return but has not yet been recognized in our </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">financial statements or assets recorded at fair value in business combinations for which there was no corresponding tax basis adjustment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inherent in determining our annual tax rate are judgments regarding business plans, tax planning opportunities and expectations about future outcomes. Realization of certain deferred tax assets is dependent upon generating sufficient taxable income in the appropriate jurisdiction prior to the expiration of the carryforward periods. Although realization is not assured, management believes it is more likely than not that our deferred tax assets, net of valuation allowances, will be realized.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple jurisdictions with complex tax policy and regulatory environments. In certain of these jurisdictions, we may take tax positions that management believes are supportable but are potentially subject to successful challenge by the applicable taxing authority. These differences of interpretation with the respective governmental taxing authorities can be impacted by the local economic and fiscal environment. We evaluate our tax positions and establish liabilities in accordance with the applicable accounting guidance on uncertainty in income taxes. We review these tax uncertainties in light of changing facts and circumstances, such as the progress of tax audits, and adjust them accordingly. We have a number of audits in process in various jurisdictions. Although the resolution of these tax positions is uncertain, based on currently available information, we believe that it is more likely than not that the ultimate outcomes will not have a material adverse effect on our financial position, results of operations or cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due to the number of estimates and assumptions inherent in calculating the various components of our tax provision, certain changes or future events, such as changes in tax legislation, geographic mix of earnings, completion of tax audits or earnings repatriation plans, could have an impact on those estimates and our effective tax rate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Acquisitions, Goodwill and Intangibles, and Long-Lived Assets</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our financial statements include the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded on the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Significant judgment is required in estimating the fair value of intangible assets and in assigning their respective useful lives. Accordingly, we typically obtain the assistance of third-party valuation specialists for significant items. The fair value estimates are based on available historical information and on future expectations and assumptions deemed reasonable by management but are inherently uncertain. We typically use an income method to estimate the fair value of intangible assets, which is based on forecasts of the expected future cash flows attributable to the respective assets. Significant estimates and assumptions inherent in the valuations reflect a consideration of other marketplace participants and include the amount and timing of future cash flows (including expected growth rates and profitability), the underlying product or technology life cycles, the economic barriers to entry and the discount rate applied to the cash flows. Unanticipated market or macroeconomic events and circumstances may occur that could affect the accuracy or validity of the estimates and assumptions. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Determining the useful life of an intangible asset also requires judgment. With the exception of certain trade names, the majority of our acquired intangible assets (e.g., certain trademarks or </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">brands, customer and distributor relationships, patents and technologies) are expected to have determinable useful lives. Our assessment as to the useful lives of these intangible assets is based on a number of factors including competitive environment, market share, trademark, brand history, underlying product life cycles, operating plans and the macroeconomic environment of the countries in which the trademarked or branded products are sold. Our estimates of the useful lives of determinable-lived intangibles are primarily based on these same factors. Determinable-lived intangible assets are amortized to expense over their estimated useful life. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations, IPRD is considered to be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions, IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of indefinite-lived intangible assets and goodwill is not amortized but is tested at least annually for impairment. Our impairment testing for goodwill is performed separately from our impairment testing of indefinite-lived intangibles. We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we also use a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. In those circumstances we test goodwill for impairment by reviewing the carrying value compared to the fair value at the reporting unit level. We test individual indefinite-lived intangibles by reviewing the individual carrying values compared to the fair value. We determine the fair value of our reporting units and indefinite-lived intangible assets based on the income approach. Under the income approach, we calculate the fair value of our reporting units and indefinite-lived intangible assets based on the present value of estimated future cash flows. Considerable management judgment is necessary to evaluate the impact of operating and macroeconomic changes and to estimate future cash flows to measure fair value. Assumptions used in our impairment evaluations, such as forecasted growth rates and cost of capital, are consistent with internal projections and operating plans. We believe such assumptions and estimates are also comparable to those that would be used by other marketplace participants. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our annual impairment testing indicated that all reporting unit goodwill fair values significantly exceeded their respective recorded values. Future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates and future cash flow projections, could result in significantly different estimates of the fair values. A significant reduction in the estimated fair values could result in impairment charges that could materially affect our results of operations.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review our other long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows, which is at the individual asset level or the asset group level. The undiscounted cash flows expected to be generated by the related assets are estimated over their useful life based on updated projections. If the evaluation indicates that the carrying amount of </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">the assets may not be recoverable, any potential impairment is measured based upon the fair value of the related assets or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale, if any, are recorded at the lower of carrying amount or fair value less costs to sell. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Legal and Other Contingencies</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor and intellectual property, and other matters that are more fully described in Note 7 to our Consolidated Financial Statements. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages, as well as other compensatory and equitable relief, that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, for the resolution of these legal matters is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those projected by management, additional expense may be incurred, which could unfavorably affect future operating results. We are currently self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_70"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NEW ACCOUNTING PRONOUNCEMENTS</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Refer to Note 1 to our Consolidated Financial Statements for further information.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_73"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;7A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We sell our products globally and, as a result, our financial results could be significantly affected by factors such as market risk exposure from weak economic conditions, exchange rate risk and the impacts of the COVID-19 pandemic on our operations and financial results. Our operating results are primarily exposed to changes in exchange rates among the United States Dollar, Australian Dollar, British Pound, Canadian Dollar, Chinese Yuan, Euro and Japanese Yen. We develop and manufacture products in the United States, Canada, China, France, Germany, India, Ireland, Mexico, Puerto Rico, Switzerland and Turkey and incur costs in the applicable local currencies. This global deployment of facilities serves to partially mitigate the impact of currency exchange rate changes on our cost of sales. Refer to Notes 1, 4 and 5 to our Consolidated Financial Statements for information regarding our use of derivative instruments to mitigate these risks. A hypothetical 10% change in foreign currencies relative to the United States Dollar would change the December&#160;31, 2021 fair value of these instruments by approximately $514. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are not able to quantify the impacts of the COVID-19 pandemic on our financial results. Qualitative disclosures about the COVID-19 pandemic are included in Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Part I, Item 1A "Risk Factors" of this Form 10-K.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">19</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_76"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.984%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;8.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Stryker Corporation and subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of earnings and comprehensive income, shareholders&#8217; equity, and cash flows, for each of the three years in the period ended December 31, 2021, and the related notes and the financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8220;). In our opinion, the consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Company at December 31, 2021 and 2020, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with U.S. generally accepted accounting principles. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 11, 2022 expressed an unqualified opinion thereon. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product Liabilities</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As described in Note 7 to the consolidated financial statements, the Company recognized $385 million of liabilities at December 31, 2021 for product liability matters relating to claims for certain products. The Company establishes liabilities for product claims to the extent probable future losses are estimable based on quantitative and qualitative information from various sources.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Auditing management&#8217;s estimate of product liabilities was especially challenging due to the significant measurement uncertainty associated with the product liabilities estimate that involved management&#8217;s significant judgment and analysis. Further, the product liability is sensitive to significant management assumptions, including average costs per claim and the number of future claims, including those resulting in revision surgery.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated management&#8217;s design and tested the operating effectiveness of the controls over the Company&#8217;s product liability estimation process, including management's assessment of the assumptions, and the completeness and accuracy of the data underlying the product liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">To evaluate the liabilities for product claims, we performed audit procedures that included, among others, testing the completeness and accuracy of the underlying claims and average cost per claim data and obtaining legal confirmation letters to evaluate the liabilities recognized. We involved our actuarial specialists in the evaluation of the methodologies and significant assumptions applied by management in estimating the product liabilities and range of probable losses. We also evaluated the adequacy of the Company&#8217;s disclosures included in Note 7 related to these liabilities.</span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncertain Tax Positions</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Description of the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As described in Note 11 to the consolidated financial statements, the Company operates in multiple jurisdictions with complex tax policy and regulatory environments and establishes reserves for uncertain tax positions in accordance with the accounting guidance governing uncertainty in income taxes. Uncertainty in a tax position may arise because tax laws are subject to interpretation. The Company uses significant judgment to (1) determine whether, based on the technical merits, a tax position is more likely than not to be sustained and (2) measure the amount of tax benefit that qualifies for recognition. At December 31, 2021, the Company had accrued liabilities of $444 million relating to uncertain tax positions.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Auditing management&#8217;s analysis of the Company&#8217;s uncertain tax positions and the related unrecognized tax benefits was especially challenging as the analysis involved significant auditor judgment due to complex interpretations of tax laws, legal rulings and determination of arm&#8217;s length pricing for intercompany transactions.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s accounting process for uncertain tax positions. For example, we tested controls over management&#8217;s identification of uncertain tax positions and its application of the recognition and measurement principles, including management&#8217;s review of the inputs and calculations of unrecognized income tax benefits.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:107%">Our audit procedures included, among others, evaluating the assumptions the Company used to develop its uncertain tax positions and related unrecognized income tax benefit amounts by jurisdiction. We also tested the completeness and accuracy of the underlying data used by the Company to calculate its uncertain tax positions. For example, we involved our tax professionals to evaluate tax technical merits, which included, for certain intercompany transactions, assessing the Company&#8217;s assumptions and pricing methodology to determine they were arm&#8217;s length and complied with local jurisdictional laws and regulations. We also evaluated the estimated liabilities for unrecognized income tax benefits in consideration of current tax controversy and litigation trends in similar positions challenged by tax authorities. We also evaluated the adequacy of the Company&#8217;s disclosures included in Note 11 related to these tax matters.</span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183Ni9mcmFnOmM5ZTY3ZmY4ZGE1NDQzOTc5ODc0NTNjYWEyYzQwNTJiL3RleHRyZWdpb246YzllNjdmZjhkYTU0NDM5Nzk4NzQ1M2NhYTJjNDA1MmJfMTA5OTUxMTYzMTQ1OA_63c3477f-44bd-4329-89c1-057e95812330">ERNST&#160;&amp; YOUNG LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 1974</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183Ni9mcmFnOmM5ZTY3ZmY4ZGE1NDQzOTc5ODc0NTNjYWEyYzQwNTJiL3RleHRyZWdpb246YzllNjdmZjhkYTU0NDM5Nzk4NzQ1M2NhYTJjNDA1MmJfMTA5OTUxMTYzMTQ1OQ_7d5b455e-6224-4aeb-9701-2cd180f51ec4">Grand Rapids, Michigan</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;11, 2022 </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:60.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS0xLTEtMS0yMzAyNQ_576d31c0-b92a-4803-a51a-79bc689f8b8b">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS0zLTEtMS0yMzAyNQ_58cb7640-2719-4f00-96a7-1ede97a18db9">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS01LTEtMS0yMzAyNQ_caa47653-9a38-474b-847f-a57ca4584b5b">14,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi0xLTEtMS0yMzAyNQ_8970dc25-f1e8-40df-aa6e-2500b8593e9c">6,140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi0zLTEtMS0yMzAyNQ_611c33c5-c0bb-42a6-b30b-2f1722c825c4">5,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi01LTEtMS0yMzAyNQ_260f64e0-cb6a-4c2a-90c3-0336ef8d64e5">5,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy0xLTEtMS0yMzAyNQ_ce839a67-9817-4a0a-ba75-5d37d06bc5ed">10,968</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy0zLTEtMS0yMzAyNQ_9fbcebcf-8874-4d60-ba62-83ab7d690ba4">9,057</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy01LTEtMS0yMzAyNQ_e4958492-9dd3-417b-833b-242f5f133c0a">9,696</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research, development and engineering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC0xLTEtMS0yMzAyNQ_9d157aac-2fc5-419f-9621-070e07421f44">1,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC0zLTEtMS0yMzAyNQ_6cfeee48-c7a6-4583-b53a-619ec52ef826">984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC01LTEtMS0yMzAyNQ_50732c2e-a8a2-4f88-984c-1c059aa79a99">971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Selling, general and administrative expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS0xLTEtMS0yMzAyNQ_f512b7a7-0008-4a75-aedb-651017c3b48e">6,427</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS0zLTEtMS0yMzAyNQ_6793984f-41ca-4c5d-9257-e3b5512a75c9">5,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS01LTEtMS0yMzAyNQ_d25a8e9b-8447-4ab0-b2a7-0e269d868f44">5,356</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi0xLTEtMS0yMzAyNQ_b5ed0d82-2060-4f54-abb1-fa99c6967192">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi0zLTEtMS0yMzAyNQ_4692e582-4e6a-45f3-ba69-0c11438e5179">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi01LTEtMS0yMzAyNQ_2ffdae45-c9ec-4fb5-8b0f-ba4de7c3b838">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy0xLTEtMS0yMzAyNQ_ebb43dd7-a52a-4df4-b762-8c72fdc9daf0">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy0zLTEtMS0yMzAyNQ_e9d19f31-c2b0-434d-bdfc-d89f41263876">472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy01LTEtMS0yMzAyNQ_82721372-ad78-473f-a3ab-b91993c2597c">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC0xLTEtMS0yMzAyNQ_ad7bcb0f-ad2f-46e5-9250-05237e7b78ca">8,384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC0zLTEtMS0yMzAyNQ_920a7995-adef-433a-a2d3-fc009e5a3386">6,834</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC01LTEtMS0yMzAyNQ_7910d698-beb9-41c2-a922-3f8881b2fc28">6,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS0xLTEtMS0yMzAyNQ_378bef28-a5fb-4ebd-8aab-91becd77c43b">2,584</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS0zLTEtMS0yMzAyNQ_2f096e34-7489-4cbc-adb4-527b9581f657">2,223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS01LTEtMS0yMzAyNQ_771dda8b-7eb5-4a44-b504-4c9d90d31cb7">2,713</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtMS0xLTEtMjMwMjU_cd3057fa-d2fa-48a1-90b3-7cac711e175f">303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtMy0xLTEtMjMwMjU_0862f688-9f8a-40df-ac1d-f9e11ac4550e">269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtNS0xLTEtMjMwMjU_aceedd32-5e16-4543-9e74-96e88fdbc5d5">151</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtMS0xLTEtMjMwMjU_c875b40c-68a0-414c-a88a-08a23d36e374">2,281</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtMy0xLTEtMjMwMjU_9b386541-ba09-4511-bb2f-fb9d80aa5d0d">1,954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtNS0xLTEtMjMwMjU_eb5434d6-8589-4753-83ae-c7868e7d076a">2,562</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItMS0xLTEtMjMwMjU_3802d5e9-5278-44e0-8e7c-35b2e8cfa27e">287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItMy0xLTEtMjMwMjU_45f40ecf-1389-4ab1-8ffb-da07edd6e989">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItNS0xLTEtMjMwMjU_5c3a9407-a5b0-4f52-b6c6-95e0fd5be565">479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtMS0xLTEtMjMwMjU_efddda4e-d598-4d28-b0f0-3019930c3370">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtMy0xLTEtMjMwMjU_480a3f47-8839-447a-b439-063e2fd3dcad">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtNS0xLTEtMjMwMjU_a279b7c4-737f-4bb5-91f3-1fbe36744b8d">2,083</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtMS0xLTEtMjMwMjU_abfa5a03-f678-434b-a16a-35837c9fc149">5.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtMy0xLTEtMjMwMjU_c82e0560-4466-4db2-8c4e-21fc01ad7bf1">4.26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtNS0xLTEtMjMwMjU_524e06c1-f8e7-4d3f-a544-6c860d2e863a">5.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctMS0xLTEtMjMwMjU_32fc9a87-94c9-427e-8098-d2a46e524df0">5.21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctMy0xLTEtMjMwMjU_6f99b1db-ad94-4c83-9c8e-7f1f444b523b">4.20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctNS0xLTEtMjMwMjU_c8f478e0-b476-4717-b5e4-b5fcab814b11">5.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-average shares outstanding (in millions):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtMS0xLTEtMjMwMjU_9c2ed527-2681-41f8-a5ca-973822c1a279">377.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtMy0xLTEtMjMwMjU_5d26c076-522b-4bb7-973f-4203b77f6d6d">375.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtNS0xLTEtMjMwMjU_768719d2-c1ed-4881-b261-b07b2f2c0164">374.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of dilutive employee stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtMS0xLTEtMjMwMjU_4fc118e2-9400-4bd1-a404-485b5a8dd19c">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtMy0xLTEtMjMwMjU_a4daa3dc-ce6c-419e-8db6-03e4fd341729">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtNS0xLTEtMjMwMjU_08e89c29-21bd-42d8-a857-8ed69f3ca274">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItMS0xLTEtMjMwMjU_70c7546f-9201-4427-b050-663324335acb">382.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItMy0xLTEtMjMwMjU_4c62a8fb-5243-4530-9891-00514466b247">380.3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItNS0xLTEtMjMwMjU_94322009-9631-474e-aa6d-6ffe362f1bc3">379.9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Anti-dilutive shares excluded from the calculation of dilutive employee stock compensation were de minimis in all periods.</span></div><div><span><br/></span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_82"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"></td><td style="width:60.320%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS0xLTEtMS0yMzAyNQ_efddda4e-d598-4d28-b0f0-3019930c3370">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS0zLTEtMS0yMzAyNQ_480a3f47-8839-447a-b439-063e2fd3dcad">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS01LTEtMS0yMzAyNQ_a279b7c4-737f-4bb5-91f3-1fbe36744b8d">2,083</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy0xLTEtMS0yMzAyNQ_f55c94b1-7f80-40a3-bffa-f9284a15540f">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy0zLTEtMS0yMzAyNQ_8ea83412-a7ff-40a3-b07c-e5226ae6e27c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy01LTEtMS0yMzAyNQ_5f32596a-9b04-400a-96a1-4993a39114f7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pension plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC0xLTEtMS0yMzAyNQ_951742ef-d182-48a1-9301-a54b96431a55">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC0zLTEtMS0yMzAyNQ_2111338b-c37e-4a92-ae91-38b900bec6a1">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC01LTEtMS0yMzAyNQ_e65a33c6-92e6-49ec-ada1-2f8fdc92eabf">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unrealized gains (losses) on designated hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS0xLTEtMS0yMzAyNQ_c7b7b901-1b32-4963-94d0-c1a3a89e5fd1">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS0zLTEtMS0yMzAyNQ_b7636fa0-3a8b-4d18-af10-6bf67ec9b3a4">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS01LTEtMS0yMzAyNQ_bb900503-d2ba-41ab-8ce1-85b7337d04b1">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial statement translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi0xLTEtMS0yMzAyNQ_94ab791e-038e-437c-8a22-c547f2a64b26">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi0zLTEtMS0yMzAyNQ_740a71c7-1b4e-434b-89d5-528e6ea13dc7">414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi01LTEtMS0yMzAyNQ_93eb0319-6b7b-442f-a655-b783f0f45bf1">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total other comprehensive income (loss), net of tax</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy0xLTEtMS0yMzAyNQ_215ea511-1a3c-4bbc-866c-2bfb8743737d">626</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy0zLTEtMS0yMzAyNQ_847cab85-47e1-4c3a-a10f-13540b96682e">551</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy01LTEtMS0yMzAyNQ_b335662d-6d9c-4736-8f4b-f4305bd6452f">25</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC0xLTEtMS0yMzAyNQ_b5815bc4-2082-4349-b9c9-60ec4441ad51">2,620</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC0zLTEtMS0yMzAyNQ_8fbbdef5-ef04-446d-8949-c3aef9055ee7">1,048</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC01LTEtMS0yMzAyNQ_cf750b8f-cdf0-4a0d-9702-dd495c6b98f3">2,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">22</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMy0xLTEtMS0yMzAyNQ_f669424e-adae-4dce-8c4f-bddbfc02e208">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMy0zLTEtMS0yMzAyNQ_4f7448fa-e388-4b10-81fc-3c49c16a9ac1">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNC0xLTEtMS0yMzAyNQ_6b0dde91-8375-47e6-9236-9c296e6bf202">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNC0zLTEtMS0yMzAyNQ_c274eaa0-721a-4d5e-a60c-af251e1ad746">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, less allowance of $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0wLTEtMS0yMzAyNS90ZXh0cmVnaW9uOjkzOGJiODkyYWMwNTRkNmRhMDRiMjBjMDVmZjk0MzkzXzEwOTk1MTE2Mjc4NDI_ab31f520-26ad-42fc-bb27-1b96db9dc39d">167</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0wLTEtMS0yMzAyNS90ZXh0cmVnaW9uOjkzOGJiODkyYWMwNTRkNmRhMDRiMjBjMDVmZjk0MzkzXzEwOTk1MTE2Mjc4NTA_e56cbd69-307d-4904-b5d4-fc27dca051a8">131</ix:nonFraction> in 2020)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0xLTEtMS0yMzAyNQ_3ed000a7-0aae-47e7-bf86-8a669a5bbab9">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0zLTEtMS0yMzAyNQ_7ab29e00-973a-4946-8af6-97fcdb0cb1dd">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Inventories:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Materials and supplies</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNy0xLTEtMS0yMzAyNQ_d1e2a0b3-8c30-44ce-966c-a54117ff1d55">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNy0zLTEtMS0yMzAyNQ_bdb537f5-a1f6-4f2a-b44a-90ff73717e56">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOC0xLTEtMS0yMzAyNQ_2f9bae07-3495-47fd-b206-17d351f00976">264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOC0zLTEtMS0yMzAyNQ_aacb0915-f4d0-4d1e-a486-a8daa641f1b3">251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOS0xLTEtMS0yMzAyNQ_68cccc80-3eca-449a-a9e8-23450a6fbfc8">2,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOS0zLTEtMS0yMzAyNQ_1bb5d33a-c7d9-4f6a-a636-e4797f2bf2d5">2,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTAtMS0xLTEtMjMwMjU_344bff1a-9d05-46f3-b522-122f4995b8b1">3,314</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTAtMy0xLTEtMjMwMjU_3cd3e72e-add9-4f4b-bc7c-9657bea7b67d">3,494</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTEtMS0xLTEtMjMwMjU_d0354aa2-b21f-484d-83fa-4b0427543935">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTEtMy0xLTEtMjMwMjU_4a59bd0c-1b10-4e41-a0c5-e50bec7b4a9e">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTItMS0xLTEtMjMwMjU_1f246715-4761-4c29-b4b7-255b44d3b1ad">10,017</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTItMy0xLTEtMjMwMjU_bb24116a-2aa8-451d-8d36-94c87cebdfd8">9,707</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Land, buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTQtMS0xLTEtMjMwMjU_8856f107-5ead-4ffc-ae2b-584e34620c2e">1,656</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="syk:LandBuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTQtMy0xLTEtMjMwMjU_071d0cff-b621-4b29-8fb8-6ff412e7c2b3">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTUtMS0xLTEtMjMwMjU_309b4e26-7200-4f0a-ac37-4466d7843da2">3,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTUtMy0xLTEtMjMwMjU_75eb7dee-a784-4778-9510-0bd7b606c50e">3,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTYtMS0xLTEtMjMwMjU_0a2744ff-f3fb-4e11-9f6c-5577f03861d5">5,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTYtMy0xLTEtMjMwMjU_3b1ee16e-f0ac-4948-9513-f53779788a36">5,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less allowance for depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTctMS0xLTEtMjMwMjU_861d6d31-bfbb-4c8d-9d33-7d1ab36a79ca">2,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTctMy0xLTEtMjMwMjU_fb761439-f3f4-46c1-ae3a-079ba04b5305">2,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTgtMS0xLTEtMjMwMjU_dc772d78-fa73-4cc7-b9fb-7ec1d52e5af6">2,833</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTgtMy0xLTEtMjMwMjU_20565ca6-eab0-4368-840e-dbc13e8125b5">2,752</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTktMS0xLTEtMjMwMjU_e93d0412-3298-4ccb-bba2-1ebb0239b8eb">12,918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTktMy0xLTEtMjMwMjU_e035639f-413c-4ffe-80ca-fee10ec0a8cc">12,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjAtMS0xLTEtMjMwMjU_d90df628-f9d6-47cd-b2e3-9ba988910c6f">4,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjAtMy0xLTEtMjMwMjU_7513880f-eb8f-401f-83c9-8a38ee87c6c2">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjEtMS0xLTEtMjMwMjU_81bc0299-8998-4045-8708-cebdffd88049">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjEtMy0xLTEtMjMwMjU_03b13b07-c241-4fdd-ad35-dca09dc5c92b">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjItMS0xLTEtMjMwMjU_31cc7f3a-d845-488a-97c1-f6e3ca9117a9">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjItMy0xLTEtMjMwMjU_6a50402a-27c0-4024-a1d8-615b5856de51">2,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjMtMS0xLTEtMjMwMjU_d5bcff3a-5859-4106-bf48-9ba9a3979e0e">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjMtMy0xLTEtMjMwMjU_99b8ec2b-f804-4f28-a012-40dd28a08248">34,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and shareholders' equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjctMS0xLTEtMjMwMjU_91738494-12d8-4bf4-9ffc-502c71e1f4f6">1,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjctMy0xLTEtMjMwMjU_f46cc54d-199a-45ec-851b-44e600cf0ae7">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjgtMS0xLTEtMjMwMjU_3094e8db-daf6-46ee-8c55-18f9ffc32e61">1,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjgtMy0xLTEtMjMwMjU_d5eb77cf-543b-4875-97fc-7fbb3d857611">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjktMS0xLTEtMjMwMjU_68ae4a16-0d56-496b-9802-49e9815651e3">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjktMy0xLTEtMjMwMjU_477b03be-5589-4e81-84f6-58c488173343">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividend payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzAtMS0xLTEtMjMwMjU_30232250-9555-479c-9c42-fa62fe7641a7">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DividendsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzAtMy0xLTEtMjMwMjU_26c5e234-79bd-4a15-9b2c-5a6154682fe2">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued product liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:CustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzEtMS0xLTEtMjMwMjU_6a4ea2d8-7757-44b2-92e1-b6e542936837">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CustomerRefundLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzEtMy0xLTEtMjMwMjU_57d38da9-1ec7-4532-8ebf-dc76a70c4012">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzItMS0xLTEtMjMwMjU_db44c85a-5628-4931-855a-7ba12b5f12ad">1,465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzItMy0xLTEtMjMwMjU_a5a4f516-4c88-4116-9db0-da0699ce7bdd">1,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzMtMS0xLTEtMjMwMjU_ddfc969c-8e88-4a41-91e7-0000efeb2ce6">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzMtMy0xLTEtMjMwMjU_a2ea9a44-f57c-4f02-823e-c97c58cacf31">761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzQtMS0xLTEtMjMwMjU_34dc9f72-0405-44aa-a0b9-fbd8cbf28fd4">4,549</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzQtMy0xLTEtMjMwMjU_50556c53-3d05-4cb3-9306-bdbc74abd253">5,041</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt, excluding current maturities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzUtMS0xLTEtMjMwMjU_b79db30b-d0b4-41ef-96c0-49b5bea33dd0">12,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzUtMy0xLTEtMjMwMjU_20d36bbe-b53c-49f3-a716-55a79cb691fd">13,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzYtMS0xLTEtMjMwMjU_5984005b-3d99-44d0-a0eb-a94bc6292a7a">913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzYtMy0xLTEtMjMwMjU_9b74ebc6-f464-4f22-9070-4fc49122cf6d">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzctMS0xLTEtMjMwMjU_c433e3d5-76c4-4ad9-800a-2e2cf7c398a6">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzctMy0xLTEtMjMwMjU_8fc93805-49fa-4be1-a758-3104e8c056f7">1,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzgtMS0xLTEtMjMwMjU_18e11406-1d55-42cf-a3fe-a3c2a1328702">19,754</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzgtMy0xLTEtMjMwMjU_11992636-6e70-41d9-a0a1-3803892fb77c">21,246</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMC0xLTEtMjMwMjUvdGV4dHJlZ2lvbjo2NGM3MzgyZTNkNzE0YjY2OTc0NDM1Y2E2YTdiMjljN18xMDk5NTExNjI3ODE0_270c0ede-f4e7-4d6d-9d4f-5ff960123867"><ix:nonFraction unitRef="usdPerShare" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMC0xLTEtMjMwMjUvdGV4dHJlZ2lvbjo2NGM3MzgyZTNkNzE0YjY2OTc0NDM1Y2E2YTdiMjljN18xMDk5NTExNjI3ODE0_45a0ac46-e0ea-4b97-83c9-fb2d36b45527">0.10</ix:nonFraction></ix:nonFraction> par value</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMS0xLTEtMjMwMjU_a1ae0af4-ebf8-4436-bd77-6ef02b87f776">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CommonStockValueOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMy0xLTEtMjMwMjU_badbdf8a-1d9d-4190-859e-774c6bfcf6e0">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDEtMS0xLTEtMjMwMjU_860bc0ab-8ec9-4b1f-a157-00c3c7dbfa96">1,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDEtMy0xLTEtMjMwMjU_4098aa5c-bb06-4718-9e54-5c70b6e6ea9a">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDItMS0xLTEtMjMwMjU_56f4af5b-5a0f-4c3f-b7f8-f487987de17f">13,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDItMy0xLTEtMjMwMjU_4de7c158-7630-459c-9758-8332b7e4cd3d">12,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDMtMS0xLTEtMjMwMjU_e822613a-1a4c-4fa1-9e2e-4c4c96187163">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDMtMy0xLTEtMjMwMjU_8a17f001-518b-4cc1-a28b-3ba03a2c423e">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDYtMS0xLTEtMjMwMjU_ac0e3ea2-08f9-4533-9df1-1ee5b744158f">14,877</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDYtMy0xLTEtMjMwMjU_191182c8-116a-48ff-9132-f38ce544d6aa">13,084</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities &amp; shareholders' equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDctMS0xLTEtMjMwMjU_9e318553-03fa-40bf-87cb-9db122966dce">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDctMy0xLTEtMjMwMjU_813a28be-176b-40cf-979d-ebbfdc5cb80c">34,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">23</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF SHAREHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.684%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy0xLTEtMS0yMzAyNQ_e112e826-d75f-41a0-98bf-50694b4e522e">376.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy0yLTEtMS0yMzAyNQ_ffd7fe26-7189-4d73-ac69-bf0534c7a091">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy00LTEtMS0yMzAyNQ_7b5de39b-c5aa-4680-828a-52719a3ac4ca">374.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy01LTEtMS0yMzAyNQ_2a3ec75d-40a6-457f-9c47-d96ba5ad8ff4">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71b5c77df023413fa94d61740f8d881c_I20181231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy03LTEtMS0yMzAyNQ_1bd9161a-e78a-40f7-a85e-6620a1f1cb91">374.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b5c77df023413fa94d61740f8d881c_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy04LTEtMS0yMzAyNQ_fed38a89-59f3-4520-a1a9-372e56b4bb83">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC0xLTEtMS0yMzAyNQ_b4d43c72-6173-4041-a83a-3ee94df8ece5">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC0yLTEtMS0yMzAyNQ_92dfc6ff-8351-4474-a6c3-b0d15bea67d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC00LTEtMS0yMzAyNQ_6157e2cb-3c53-44b8-9616-b62c267b9d81">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC01LTEtMS0yMzAyNQ_fe8b7ee5-0510-4205-9944-6eda27f0cf3f">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC03LTEtMS0yMzAyNQ_67f01820-86d8-4ca4-8d9e-f22f539d6964">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC04LTEtMS0yMzAyNQ_33e2c806-580c-435a-840f-4ee76f95e476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS0xLTEtMS0yMzAyNQ_14c50095-a9ba-4062-845f-bb931bcb1da0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS0yLTEtMS0yMzAyNQ_e761221f-b397-488e-90df-d66d7e053b36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS00LTEtMS0yMzAyNQ_63cbdc03-4378-4b3d-ae81-09a5bd142a31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS01LTEtMS0yMzAyNQ_4d02ac4e-8c41-4b67-acc7-c1a8a15e15cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231" decimals="-5" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS03LTEtMS0yMzAyNQ_bd1b6a4e-00fd-41dc-bb7c-e7c123c6d2ff">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS04LTEtMS0yMzAyNQ_971de6d4-8dac-4c68-87e3-fc61bfc8e4b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9becb79080734381bcde3430445f8f12_I20211231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi0xLTEtMS0yMzAyNQ_76286a11-3fc4-4de1-9b79-642dd02f42b5">377.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9becb79080734381bcde3430445f8f12_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi0yLTEtMS0yMzAyNQ_d4a72fcb-85b8-47e1-bcef-e97eafd11e52">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi00LTEtMS0yMzAyNQ_ee48170d-7ac7-4857-8194-2926f39936cb">376.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi01LTEtMS0yMzAyNQ_c9e519fe-f499-4887-9cf8-96cca933b451">38</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi03LTEtMS0yMzAyNQ_f2253c10-cd7b-4219-8e6f-dc0f5fcfbeb6">374.5</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi04LTEtMS0yMzAyNQ_e0def1a7-1927-4c67-b199-5c674f97c0c5">37</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80170d6b8dff45988d17971402b2a956_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC0yLTEtMS0yMzAyNQ_97ab4dc1-14ea-44a1-8055-7010055f9c76">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC01LTEtMS0yMzAyNQ_67832f40-6a47-428f-b8c3-bfd730ea6f1a">1,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01b0f8910e1148c7bcf2487217ae6387_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC04LTEtMS0yMzAyNQ_f29435af-2642-4861-84bd-2fde1c26aeb4">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under stock compensation and benefit plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS0yLTEtMS0yMzAyNQ_bc12cb53-71bc-499b-b8d1-7418b2e446fd">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS01LTEtMS0yMzAyNQ_f8998e11-fe0c-429b-bf39-66f52cf73e18">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS04LTEtMS0yMzAyNQ_a9ab0641-0087-466b-b914-569b447e74c5">50</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtMi0xLTEtMjMwMjU_dbc7f827-6a94-43ce-9057-90af1c78ce2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtNS0xLTEtMjMwMjU_836720d8-54ef-4436-853a-d6fe8a9c6843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtOC0xLTEtMjMwMjU_1ab33fa4-13b3-451f-bd3b-f2d6723df349">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtMi0xLTEtMjMwMjU_0f889b29-1689-4a1f-95cd-ed20b8e0206d">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtNS0xLTEtMjMwMjU_0e721307-8421-40b3-9918-43e592772d90">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtOC0xLTEtMjMwMjU_b31e1cf4-0c04-49b5-a48b-e094c2a92abd">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2670a9c10b1d408ab40717a9709b224d_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItMi0xLTEtMjMwMjU_b1e33528-10cd-4f93-82f3-71dd2cd96108">1,890</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80170d6b8dff45988d17971402b2a956_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItNS0xLTEtMjMwMjU_def9d93b-c6fc-47a6-9bfd-fa00848f9076">1,741</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItOC0xLTEtMjMwMjU_a7578ed9-b1f2-4f3a-ac2c-45ac3b8c0b1f">1,628</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867a13b6e18b444dbd004c9492789fdf_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtMi0xLTEtMjMwMjU_1c0d5c53-bb2c-4f0f-85c3-0f4d22256cbd">12,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7552bdaa82d04e2faaa8351a026b88bb_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtNS0xLTEtMjMwMjU_23d39ed2-d7ab-4048-8c2d-2e47a7636385">11,748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f4ae1d1be414b55b5e9656c3e8710fe_I20181231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtOC0xLTEtMjMwMjU_4000ea8c-7e8e-4e4d-9c62-1d9f57763443">10,765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtMi0xLTEtMjMwMjU_5f1825d7-5377-4264-97cc-2a094abceb60">1,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtNS0xLTEtMjMwMjU_5c9392db-f5e6-46a3-b90f-8a6e6fcc4fe1">1,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtOC0xLTEtMjMwMjU_f6df8f8d-d764-491e-9388-fbc306318ff3">2,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctMi0xLTEtMjMwMjU_8cadb417-a310-4cc5-8edc-a69d326eb8ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctNS0xLTEtMjMwMjU_074e5714-3a91-4ea7-8a59-bfcbcc890cae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231" decimals="-6" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctOC0xLTEtMjMwMjU_bb40b426-79e1-4ad1-a4fe-45a0e9065207">299</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash dividends declared</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtMi0xLTEtMjMwMjU_af4c9830-ccfb-4d7c-b593-68b19b2ab8c5">976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtNS0xLTEtMjMwMjU_eef5dfdc-94aa-427e-834b-7154a58ba672">885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231" decimals="-6" name="us-gaap:DividendsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtOC0xLTEtMjMwMjU_f0187554-997a-4d7a-ac9a-cb02037d57e6">801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c69abfa681e4e24818ac3eadfd6f813_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktMi0xLTEtMjMwMjU_5efa4b92-f9e6-469d-a1b8-e2b81527a1cb">13,480</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i867a13b6e18b444dbd004c9492789fdf_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktNS0xLTEtMjMwMjU_cbdc76bb-139f-42f0-bc11-c8dd29b98da2">12,462</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7552bdaa82d04e2faaa8351a026b88bb_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktOC0xLTEtMjMwMjU_736f6562-bac9-4c67-bced-9600f1b4d80a">11,748</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beginning</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9bd43403e564ca1aaf610bb52886cb9_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtMi0xLTEtMjMwMjU_9a7e9862-40f7-44d8-84ee-b32782408e49">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d120045c43c4af3a896790950cd8059_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtNS0xLTEtMjMwMjU_1daecf69-3527-4ea2-a133-3d39a1ee1328">606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f87b165979c46dfb2cc60987739eabc_I20181231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtOC0xLTEtMjMwMjU_0eed849d-f514-4185-9f76-94e242711a53">631</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItMi0xLTEtMjMwMjU_215ea511-1a3c-4bbc-866c-2bfb8743737d">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i82d74fabbcc44d498a3ffcb580f01a68_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItNS0xLTEtMjMwMjU_8c55c68c-54a4-4141-a3fc-160205264ff8">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2367b67252704359babdcb904dbe95f8_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItOC0xLTEtMjMwMjU_3d0cf487-e823-4feb-94b1-dbccf6575fed">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ending</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52bca8038e1b46fc9b2afd0ead1648d5_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtMi0xLTEtMjMwMjU_448641b7-6cbd-4954-b7bb-919f331f83b9">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id9bd43403e564ca1aaf610bb52886cb9_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtNS0xLTEtMjMwMjU_14f9ec9c-f77b-4f04-9743-c82667d88cbb">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d120045c43c4af3a896790950cd8059_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtOC0xLTEtMjMwMjU_522e7fc3-cf75-4b7f-85a2-ae7edde5e326">606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItMi0xLTEtMjMwMjU_b231cd23-ce38-4f93-8283-262ce677c46f">14,877</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItNS0xLTEtMjMwMjU_d538b82f-fd79-40cc-a35e-e6a4328e006f">13,084</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItOC0xLTEtMjMwMjU_385070d0-f442-406f-8791-a915d93221b2">12,807</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">24</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_94"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stryker Corporation and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:64.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.029%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi0xLTEtMS0yMzAyNQ_3df55106-f95c-47ac-8a3d-80680765f463">1,994</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi0zLTEtMS0yMzAyNQ_965a96fa-8f12-4d08-8025-6484f947ca2b">1,599</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi01LTEtMS0yMzAyNQ_2c0daef5-5114-4285-bc60-519c1f88d796">2,083</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC0xLTEtMS0yMzAyNQ_f2c253e4-e834-4aea-a9b4-00f5d35edda2">371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC0zLTEtMS0yMzAyNQ_0e40b889-1143-4f03-bcd4-a4c2571c1a86">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC01LTEtMS0yMzAyNQ_db115b2d-995c-4092-9355-42a085fe1172">314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS0xLTEtMS0yMzAyNQ_70a721a1-b9a0-467a-b1f5-19c1cec0c8d8">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS0zLTEtMS0yMzAyNQ_c33449d3-ae86-4c4b-9b40-23afcbc61821">472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS01LTEtMS0yMzAyNQ_30410867-05ee-499a-a084-e2e0f9599460">464</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Asset impairments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi0xLTEtMS0yMzAyNQ_a30afed6-6643-40d9-bdc7-a07f9a9cab82">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi0zLTEtMS0yMzAyNQ_a26d73ac-80fa-4141-8832-8085c6098d44">215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi01LTEtMS0yMzAyNQ_8d588abb-efb7-4f89-a543-1a489d936ce2">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy0xLTEtMS0yMzAyNQ_ed413208-7825-4204-b17d-d86b85ab78bf">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy0zLTEtMS0yMzAyNQ_4bb403cf-268c-4d7e-9c0e-5239ec6d455f">142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy01LTEtMS0yMzAyNQ_401c82df-1cf6-4523-9e27-be096b4d1a0c">127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC0xLTEtMS0yMzAyNQ_a6344878-dd11-41b6-922a-c670ee20dd89">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC0zLTEtMS0yMzAyNQ_13ed8c61-f19a-442b-aff6-5d4e3ed53cc3">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ProductLiabilityAccrualPeriodExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC01LTEtMS0yMzAyNQ_8012491c-8d20-4c73-bf4e-517a0cefa06e">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of inventory stepped up to fair value at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS0xLTEtMS0yMzAyNQ_028a005b-f46a-4b1a-ac45-19dcebaa6107">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS0zLTEtMS0yMzAyNQ_180582de-0a45-4faa-9f1f-40873ce4ce3b">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="syk:SaleOfInventorySteppedUpToFairValueAtAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS01LTEtMS0yMzAyNQ_3ceb7d85-0c48-49ef-873a-ca57f8f0942f">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income tax (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtMS0xLTEtMjMwMjU_fecf9d82-598e-47b5-8fa8-5d4494790e53">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtMy0xLTEtMjMwMjU_febbd873-e852-426e-b372-2079257db484">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtNS0xLTEtMjMwMjU_20db6c9a-486c-4826-b8c7-b46340a3eb44">126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItMS0xLTEtMjMwMjU_73a86460-fe6d-4ef6-844e-9c6dbf8e2673">377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItMy0xLTEtMjMwMjU_ecbd7b1d-a679-47d1-9317-aa3919c9cb9c">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItNS0xLTEtMjMwMjU_c551603b-a33f-47cf-82de-7ee26b45e7f7">563</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtMS0xLTEtMjMwMjU_df808829-0b66-49bf-a23d-a7ff3d48d750">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtMy0xLTEtMjMwMjU_4311a59f-9d0a-4ee7-bb15-5efb4a81cd2d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtNS0xLTEtMjMwMjU_e4901894-9b73-4eac-a3a1-fbeae81d51d0">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtMS0xLTEtMjMwMjU_6b0337d1-f4db-4c34-909f-58f488f7343f">329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtMy0xLTEtMjMwMjU_09a33139-e642-4603-84ec-0ad51689a06f">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayableTrade" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtNS0xLTEtMjMwMjU_beda7aee-5bcd-4c15-a65c-d2f353f6886c">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtMS0xLTEtMjMwMjU_662cec57-3744-415e-8137-a03267d25daf">315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtMy0xLTEtMjMwMjU_ff6a5d55-0922-4b7d-9fe7-59032a4cccc9">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtNS0xLTEtMjMwMjU_ca30c153-e0cf-4822-9a71-756f3337a7a2">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recall-related payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtMS0xLTEtMjMwMjU_06363cdf-fefd-4ccf-9e02-4ae259142d34">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtMy0xLTEtMjMwMjU_5f4b830b-97d8-4078-a3f4-755bc6a60f03">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="syk:Changeinaccrualforrecallexpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtNS0xLTEtMjMwMjU_2c1c2717-9839-4621-b1b1-316a1580a640">177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctMS0xLTEtMjMwMjU_1e4fdece-4969-4645-a8d0-3d99fac954c7">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctMy0xLTEtMjMwMjU_7aa5fa75-8457-4daf-9072-da0d4b00d899">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctNS0xLTEtMjMwMjU_9db1e658-a6e7-45d0-ab7f-98d73a56ea01">105</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtMS0xLTEtMjMwMjU_6d6e6959-38fc-4870-a3f8-92aa71e9aa9f">47</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtMy0xLTEtMjMwMjU_63a220ae-0f06-49b3-a6d2-3d09dc3851cd">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtNS0xLTEtMjMwMjU_589ad054-2ca6-4b09-83d8-6b7440ba085c">129</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktMS0xLTEtMjMwMjU_cffef309-827c-4b5d-b0d6-199a9257c2e1">3,263</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktMy0xLTEtMjMwMjU_320b19e0-d975-4859-90b7-0bfc18d1d12a">3,277</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktNS0xLTEtMjMwMjU_2c9adcc4-3c35-4f61-b2e0-5d94d18d5db9">2,191</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtMS0xLTEtMjMwMjU_a98cb2d5-47e1-47e2-bdc0-87e94e2d5e74">339</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtMy0xLTEtMjMwMjU_6bbd5ec5-5ebb-4c1d-bd12-2939df494f16">4,222</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtNS0xLTEtMjMwMjU_5164b874-d282-43b7-9cd3-c621f5997531">802</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItMS0xLTEtMjMwMjU_93b20542-4a45-4c76-a61a-cd5e98f72b99">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItMy0xLTEtMjMwMjU_2cda6e37-df87-488f-9644-ab2456db6fba">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItNS0xLTEtMjMwMjU_0e04ccbb-774e-4ca9-8fee-e04281460f05">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtMS0xLTEtMjMwMjU_ba6ddc91-4284-4299-80b0-9da825c5aeed">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtMy0xLTEtMjMwMjU_c5d02bb0-4f15-4774-bc95-51e7f55cdcd5">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtNS0xLTEtMjMwMjU_43de930b-2f69-4948-a2e0-f2f42c60463e">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtMS0xLTEtMjMwMjU_67e60813-ccc3-4332-a6e7-bfb7b0ab9205">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtMy0xLTEtMjMwMjU_7ccfa7bc-5865-4143-b655-76922d97902b">487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtNS0xLTEtMjMwMjU_3da3a8ec-1de3-4fc9-8b29-00a6923f6498">649</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other investing, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtMS0xLTEtMjMwMjU_389f108f-148f-4d89-bf27-7320978e475b">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtMy0xLTEtMjMwMjU_22fa90cc-0ad6-491a-8608-d9fadccb95cc">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtNS0xLTEtMjMwMjU_dff97249-6bd6-4e5a-953a-7fbd5e1a6a75">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtMS0xLTEtMjMwMjU_b9585afa-a11f-4b34-8dc1-5e4b54c65227">859</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtMy0xLTEtMjMwMjU_0f400da3-b114-4cbd-8896-63eb3df04d81">4,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtNS0xLTEtMjMwMjU_18eb4ceb-f4a9-4174-b8a9-3733ae573802">1,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds and payments on short-term borrowings, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtMS0xLTEtMjMwMjU_ebcdb3b2-13e7-473d-a494-ce99e8fb48b9">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtMy0xLTEtMjMwMjU_709ed988-a3e0-4fae-8374-b3c71d2ceb21">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtNS0xLTEtMjMwMjU_c6cb5d35-46a3-47be-ac59-e0781c509119">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktMS0xLTEtMjMwMjU_9ddc465b-95c6-4523-b849-74a89c73b87f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktMy0xLTEtMjMwMjU_26e73151-2e87-438b-b499-8c2d5b4df789">3,292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktNS0xLTEtMjMwMjU_4d1671d5-629e-4b3a-8485-03b33ba24849">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtMS0xLTEtMjMwMjU_4a274cca-9cf5-4e82-aada-b71deda2617d">1,151</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtMy0xLTEtMjMwMjU_ffb97cd1-a2bf-4764-82fe-b6b24fda8f98">2,297</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtNS0xLTEtMjMwMjU_a5a5ce1b-dc98-4fa1-b169-170437039275">1,342</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of dividends </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtMS0xLTEtMjMwMjU_3b6d4f42-8c06-47b8-a78c-c829ea5bb4f7">950</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtMy0xLTEtMjMwMjU_785027ed-9c8f-405d-bae0-3ca28e1f4ab2">863</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtNS0xLTEtMjMwMjU_35c1aa53-72b0-4e3f-af75-f5e1f3273e0b">778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItMS0xLTEtMjMwMjU_7a72c17d-9ac4-4493-a1f7-17ba2a4aa5da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItMy0xLTEtMjMwMjU_ed509646-eb09-43f8-87ca-1dd3610fd069">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItNS0xLTEtMjMwMjU_fa78d15b-fc03-4108-bb6d-6ee1e3c8fd29">307</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for taxes from withheld shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtMS0xLTEtMjMwMjU_bec53dc4-a56e-4c35-9a83-a7faf5ff97f9">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtMy0xLTEtMjMwMjU_619e3dc8-a04c-461a-9ecb-5d230bbba2a0">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtNS0xLTEtMjMwMjU_cb8d6f2b-db38-4384-834a-9ac7aa6ce01c">136</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other financing, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtMS0xLTEtMjMwMjU_eb06fa32-fa29-471d-b97a-b4f38a7fe4d8">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtMy0xLTEtMjMwMjU_bc6e3ec4-b119-495f-a00a-baf5abf24a42">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtNS0xLTEtMjMwMjU_7631844b-1c86-41ed-a1ad-f6977b9c202f">69</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtMS0xLTEtMjMwMjU_48d22f50-d08d-469a-a1dd-37c36b3e2da6">2,365</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtMy0xLTEtMjMwMjU_53fba18c-24d3-4f69-9551-8ae5adbf4430">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtNS0xLTEtMjMwMjU_5d755991-1f62-4400-8495-f2d8652873af">3</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctMS0xLTEtMjMwMjU_70aca0a7-8b44-42d6-9928-b02893b2306e">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctMy0xLTEtMjMwMjU_64817ff2-69d8-4aaa-9580-f57d2e3d6f28">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctNS0xLTEtMjMwMjU_447628f0-13f4-4fb4-acf9-56573797ccf0">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change in cash and cash equivalents</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtMS0xLTEtMjMwMjU_e0e9f222-e450-4d6d-9a9a-ffa60118e129">1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtMy0xLTEtMjMwMjU_48ba9a08-2498-45e3-ae59-ff19a592cd07">1,394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtNS0xLTEtMjMwMjU_a2907ff5-634c-4ca3-aeaa-9dd75799c4d5">721</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktMS0xLTEtMjMwMjU_70e12ffa-7c87-4abd-8ee2-b0ecd94b3787">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktMy0xLTEtMjMwMjU_53e34578-2c41-42d4-b1f4-3b250ae537fe">4,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if42e188b90414f3b945a27e7e2b1974f_I20181231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktNS0xLTEtMjMwMjU_5d4642ae-bc95-453d-b5f6-16128a92c234">3,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtMS0xLTEtMjMwMjU_dbf08034-f1db-4ac2-bb05-9dc67a358846">2,944</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtMy0xLTEtMjMwMjU_5ab8a06e-b216-42a7-96ea-d3e113b15fb4">2,943</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtNS0xLTEtMjMwMjU_c1d99b06-6492-4b0b-a14e-d18408bf3e8d">4,337</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosure:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for income taxes, net of refunds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtMS0xLTEtMjMwMjU_1ea9d80c-330d-4b6d-a0d4-a692fe0eab07">622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtMy0xLTEtMjMwMjU_d9af285e-c62d-44b6-8aa7-5e7fb8245c44">323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtNS0xLTEtMjMwMjU_735dd655-f1b8-4735-8e6c-69ac7e28a98e">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for interest on debt</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtMS0xLTEtMjMwMjU_34331bc2-c8d7-4072-b9b6-80954bfdfae3">325</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtMy0xLTEtMjMwMjU_0abbadca-4205-4d57-a8b4-76b0db9031c6">304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtNS0xLTEtMjMwMjU_4fa472ad-692f-4287-aa30-52f7b6089d11">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to Consolidated Financial Statements.</span></div><div style="text-align:right"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">25</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_100"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 1 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDcy_a95e7b67-1cfc-4de6-bc14-dc9250a4c7c2" continuedAt="id6d32d58c2a349d9b68032c5dfb26ab8" escape="true">SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="id6d32d58c2a349d9b68032c5dfb26ab8" continuedAt="iba25ee9783044ad6a7ff6ff7b7f13ac0"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDU2_c9372f3c-04ea-44a0-8436-7d4bb3664e85" escape="true">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDcz_c8ba6cb6-cc92-4c8e-9caa-4a63a3bda55c" escape="true">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. Prior years' segment results have been reclassified to conform with current year presentation in our Consolidated Financial Statements.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDk1_ce977648-3d70-4b7c-9155-0f97da48c476" escape="true">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTQ5_79bf21ab-67c8-45b7-886f-42623cd467f6" continuedAt="if6c25544b1ca41b1af0081a87cc23d19" escape="true">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</ix:nonNumeric></span></div><ix:continuation id="if6c25544b1ca41b1af0081a87cc23d19"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTMx_2224d0ab-7210-483d-a144-a4db62730723" continuedAt="ifa529bc5bb5d4b11b98bd5d087862a97" escape="true">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct </ix:nonNumeric></span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="iba25ee9783044ad6a7ff6ff7b7f13ac0" continuedAt="i319a83c3ec12495e8dfcd22353d6b373"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ifa529bc5bb5d4b11b98bd5d087862a97">overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTE4_0da427e1-2e57-480d-b60b-93524163a1ad" escape="true">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDY3_bd170f0a-f2d0-49c2-8740-70b6152e83ee" escape="true">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMjA5_4c5f802a-c34e-4cda-9f0e-819547e26650" escape="true">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTkw_b14145d6-08c1-436a-95da-0590e0c2b013" escape="true">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:MarketableSecuritiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDkz_e54d547b-57da-4849-9632-1d75a005cc1f" escape="true">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDc2_bd6dc106-a5dc-4295-bb4b-24d29f1a102b" escape="true">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDYy_713957b7-03a1-4b55-a606-1950611f3732" escape="true">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</ix:nonNumeric></span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">26</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><ix:continuation id="i319a83c3ec12495e8dfcd22353d6b373" continuedAt="i5e042afa96254968a6ee7e9a1a8e4870"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:FairValueOptionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTIw_3762e395-7625-4e24-b791-b139643e8135" continuedAt="i3a38a894b9324770a32f51daab20a7cc" escape="true">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2021 and 2020. Refer to Notes 3 and 10 for further details. </ix:nonNumeric></span></div><ix:continuation id="i3a38a894b9324770a32f51daab20a7cc"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMjEy_7c3950d8-5947-4a4b-adc7-ee2db930f92b" continuedAt="i74223f03127e4e5f95a7dc0684dca7e1" escape="true">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</ix:nonNumeric></span></div><ix:continuation id="i74223f03127e4e5f95a7dc0684dca7e1" continuedAt="i33aa10b802d24bbca8b3dabd0ca4fd50"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i33aa10b802d24bbca8b3dabd0ca4fd50" continuedAt="iedc2ab4933e344b9acfbd0241fecbfbd"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense in the Consolidated Statements of Earnings. </span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="iedc2ab4933e344b9acfbd0241fecbfbd">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</ix:continuation> </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTEy_6ad4bc5c-0cce-4e2d-be5e-36b97bae8e94" escape="true">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06">three</span> to <ix:nonNumeric contextRef="iea80d9ec270a42ddb859da9ac5218675_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzEy_b9227eb4-99d9-4593-94b1-8d410d8a5e52">30</ix:nonNumeric> years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee">three</span> to <ix:nonNumeric contextRef="i8e2f3cb539e04b21a6d749132943270d_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzYy_728765da-4faf-494b-b638-e968e827989b">15</ix:nonNumeric> years for machinery and equipment.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTY4_2654fa57-3f63-4a88-83a7-99a5c3b6f323" continuedAt="id15f83277c1c4289ac50ea224fa7074b" escape="true">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</ix:nonNumeric></span></div><ix:continuation id="id15f83277c1c4289ac50ea224fa7074b" continuedAt="i366ec4d926334d35bc2dc25804dc24bb"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b">four</span> to <ix:nonNumeric contextRef="id4d5184394bb4869a0faafe74b973913_D20210101-20211231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTE3_5be6124c-3ef5-4723-8cad-33e8d0e47974">40</ix:nonNumeric> years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div></ix:continuation></div></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">27</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i5e042afa96254968a6ee7e9a1a8e4870" continuedAt="i0968c54f6a4a41f0bac47ef8aa6fdfe2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i366ec4d926334d35bc2dc25804dc24bb">be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDgy_946ad359-9922-49fc-b025-66bf77c85c96" continuedAt="i29add6304ac84c28b068c0e94bb2f739" escape="true">We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i29add6304ac84c28b068c0e94bb2f739">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> S<ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDYz_1a88a979-89a6-45b1-9081-dcd22106f28e" continuedAt="ib3b6a0b3f1c04c0b855c42fad1320dcf" escape="true">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to <ix:nonNumeric contextRef="i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE3MDI1_a70c00f8-eecc-438b-ab82-d5c23a6b0352">10</ix:nonNumeric> years and become exercisable in varying installments.</ix:nonNumeric></span></div><ix:continuation id="ib3b6a0b3f1c04c0b855c42fad1320dcf" continuedAt="i31b6aa8f488d41cd98ea28c2f2a92610"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a <ix:nonNumeric contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" name="syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTYz_c38b7668-f7d7-4ebd-a97c-1007d53417d6">three-year</ix:nonNumeric> period and are settled in stock. PSUs are earned over a <ix:nonNumeric contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTM3_75a86afd-2278-455c-b896-3e444bc781a6">three-year</ix:nonNumeric> performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that <ix:nonNumeric contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDg3_3f0a9e05-f9f4-4f2d-ba86-1c754915806b">three-year</ix:nonNumeric> performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div></ix:continuation></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i0968c54f6a4a41f0bac47ef8aa6fdfe2"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i31b6aa8f488d41cd98ea28c2f2a92610">determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTk0_66723606-d978-4bf6-9cac-20a7a81d8e72" continuedAt="ida1bd635db66464293fcead391d290da" escape="true">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ida1bd635db66464293fcead391d290da">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</ix:continuation></span></div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDU1_fa7c769b-610f-4145-b5a6-9a6138588815" escape="true"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021 the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. We are evaluating the impact this update will have on our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_103"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM5MTU_24de83e5-abcf-4a74-bde2-5a127ae84f73" continuedAt="i12e751776de04513ae0a2dc23167f254" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><ix:continuation id="i12e751776de04513ae0a2dc23167f254" continuedAt="i08821eb7431e45cfaab70f4ee39a8849"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2021 less than <ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="syk:PercentageofServiceRevenueRecognizeoverTime" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzQyMw_4ffc7b30-2659-43e2-bd5f-b559bf7d3683">10</ix:nonFraction>% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div></ix:continuation></div></div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM5MTI_407244ed-1aee-40c8-8ac2-ae1017d389d7" continuedAt="ieeedad2ca30841fda7b51ecb940a987e" escape="true"></ix:nonNumeric><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i08821eb7431e45cfaab70f4ee39a8849" continuedAt="i80e96d6f33fc42bb952c5c5cb391e424"><ix:continuation id="ieeedad2ca30841fda7b51ecb940a987e"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b444fdfd4114975835f712db85f57df_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItMS0xLTEtMjMwMjU_fa614726-b80e-42da-b0e6-19534d3a45a4">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390e0b268e414b8f9d49e0d83841a8a0_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItMy0xLTEtMjMwMjU_c530c6ad-656f-47e3-a974-15b8ee7d3f3c">1,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764c1f66472a4d62a4a8976787e08574_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItNS0xLTEtMjMwMjU_03d94d4d-5cda-4d21-ae19-cdcb4bb5dbbf">1,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0c3f21be164ebea0b665c3e075dca9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtMS0xLTEtMjMwMjU_14f40034-980e-4888-8061-8a212c489c90">2,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3f8d2756374f598396b4e9f1242e4b_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtMy0xLTEtMjMwMjU_e0b63fcc-e5d8-4833-bad6-60d6e3312dbf">1,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i309806bb11ff41a2a9e882a99bad0aed_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtNS0xLTEtMjMwMjU_386d9901-ac6b-419d-80f2-cb78cab9ab0e">1,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id287ce7c576e4ea3925b95b5da00c78c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtMS0xLTEtMjMwMjU_e1ce6fb5-27ab-4bd9-a2d9-961c524ff786">2,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf17bc05109f4e979b894e6b5c677384_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtMy0xLTEtMjMwMjU_8c1e014e-238a-406c-811f-855913a46bf9">2,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24bf8fb2be2c4a3089319f9462f2f44d_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtNS0xLTEtMjMwMjU_14ff0c97-feec-4ea1-983e-d4917881560d">2,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75b07ba08eb4425189e18508e67ef022_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMS0xLTEtMzE1NjU_19af1f2e-75b7-4a7d-8aaa-7724163048f0">1,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadbc6876b0c4a2e9b96d00656980180_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMy0xLTEtMzE1NjU_3900bf95-65a8-4ce7-8c39-e41ac07847e6">973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0204ee9ab1854e4bb45e61ddc5a338a2_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtNS0xLTEtMzE1NjA_97a92601-a2e1-4917-bb66-323b4b923f03">924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac738aea624e43db94884598610ec371_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMS0xLTEtMzE1NjU_cda187a9-6d28-4847-acfc-82dc37bfd49f">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieed282f1ecf14d7d80d3e4b74e03cdf3_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMy0xLTEtMzE1NjU_536f6432-ca02-47a1-828d-993119478098">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6477d0161a4843db9d24e33b01902361_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtNS0xLTEtMzE1NjA_f148bbc1-e22d-4705-84ef-48c5cf4dc916">1,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if72d972689ad4922b7665802f781c461_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMS0xLTEtMjMwMjU_519b6ad3-8e1c-47d0-b426-85f8365cc279">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b621eadd294693b0520b76f0f11d92_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMy0xLTEtMjMwMjU_2d0da474-1a1b-470b-84a7-5a47273d7cc1">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fdfaed011624ea2b76682b408d01222_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtNS0xLTEtMjMwMjU_3d7a06a2-506d-4a7e-8200-70585d07d533">286</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMS0xLTEtMjMwMjU_55703639-0ce6-4f97-93aa-f8ab68d9bd03">9,538</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMy0xLTEtMjMwMjU_4faecf89-b1ad-4d02-a446-d033febb9300">8,345</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7728f777c79940228eafdad70914c783_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtNS0xLTEtMjMwMjU_b8f6f2e4-0f7a-4e50-9490-8f57a3e33c34">8,475</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b08d632247540e0b3c29c04aacd461f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtMS0xLTEtMjMwMjU_b4c4500b-6eda-422c-970d-8185aa7be65f">1,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb4bd223e1a4a24889683e87146a929_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtMy0xLTEtMjMwMjU_e0a45d4a-e142-468b-aa36-2e7f82a90cbc">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61e348f6119d46a88d69fe763e6cf9fa_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtNS0xLTEtMjMwMjU_019a0008-048f-4874-aab1-c91df4f20a55">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341271d78c7a4206947bca3b7cde395f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktMS0xLTEtMjMwMjU_05ea5c51-2861-4ed7-9cd2-a7ac77b56fdc">1,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c49a6e730644609880acbc477da03e8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktMy0xLTEtMjMwMjU_13882114-c07f-4ba2-b1e2-5c5ff16bed99">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic119b1fa0c0143538533bba2f3b95138_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktNS0xLTEtMjMwMjU_687aa992-d135-4edd-ba5c-4f2badc9980a">1,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f89663db2e4dcd91f2a239604498e7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTEtMS0xLTIzMDI1_1d313c00-e517-4075-b06a-b54289b994c9">2,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08a811a396c54be69d7679faeabb9796_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTMtMS0xLTIzMDI1_c262fc23-b3ed-438e-9979-919d118f5445">1,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia168ec9d45e74093b60a8c0db927613f_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTUtMS0xLTIzMDI1_17d6f15f-e724-4e2e-b5c3-0b9b7c1429f2">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8aa2f3c162a4b938419bc9018039728_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTEtMS0xLTMxNTI2_066b95dc-f07c-4160-bfba-263f90a1c261">1,167</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92bc71ae63244b42848463e8f166f45e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTMtMS0xLTMxNTM3_fe3c8b2c-ee0b-4d36-bc31-0b6ef6332c62">1,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76acfc033a4b4a1fb195cec65bb11702_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTUtMS0xLTMxNTU0_ec1e30f3-f237-4b1b-af53-7e5bd3b6f30c">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02851b5d44484d838b322bb70419e1fd_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTEtMS0xLTIzMDI1_c359e339-6654-49f5-bdb8-39de1c393018">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18219da346bb4cf8b4922993ee49a73a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTMtMS0xLTIzMDI1_52adbcfb-6db8-4ee1-a067-93d9dfeb8149">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifea456eb74734994a3ba7247aac1dda2_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTUtMS0xLTIzMDI1_1e98d4ce-fb02-44f7-9f0d-401c2c984e86">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTEtMS0xLTIzMDI1_72423750-332d-47d6-89e4-0ebfb346b346">7,570</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTMtMS0xLTIzMDI1_fd029953-870c-4f94-ac6b-a703ac8d58c3">6,006</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6858a6cd717d489e810d6a92befb51b9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTUtMS0xLTIzMDI1_175345e7-00a0-4245-b687-e9cb0914a230">6,409</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTEtMS0xLTIzMDI1_5e4deed3-8850-4ced-ab1c-c9787d64be75">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTMtMS0xLTIzMDI1_7deb32ce-6fc1-4670-8d7c-cb2b34847243">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTUtMS0xLTIzMDI1_d17afd4b-eb27-49b6-956f-e6aacd44d15e">14,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3313eb4600a44b6faccc26b2974f7496_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItMS0xLTEtMjMwMjU_dd2ebf22-ed52-4c76-bd17-100321b7110d">1,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7312fb8079f489ca025dfd4b3f324d5_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItMy0xLTEtMjMwMjU_23bb998d-2d1c-4eb6-90d9-02dc0249cb30">1,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1054325428345d2aca70dffa2f35f05_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItNS0xLTEtMjMwMjU_5536f072-6569-46a1-8c19-f06a571e7dcc">1,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i838adf850af9448e83d8cb2ca7ee3cce_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtMS0xLTEtMjMwMjU_529b9159-651b-4a28-b90b-3a63fd3b4f81">1,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6aa60e488594c2e9d84921cd2278f0d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtMy0xLTEtMjMwMjU_0ae01584-bd5f-4cd4-9367-492393c0c1a7">1,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib601c6c2389846cf9f085ecbf9e004cc_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtNS0xLTEtMjMwMjU_7dcca2a5-8899-43fc-bf3e-5904d5eb0a30">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f5ff37751b4228bd155d7017fca70e_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtMS0xLTEtMjMwMjU_8bee544a-172a-4e3f-84ae-7f948f6bb15d">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2d20f3fc714b3fb42530500f7a77c7_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtMy0xLTEtMjMwMjU_b9c1bf1e-b7b3-4920-b96a-0fe9fca07fc6">1,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88f85a0225bb45ff93c9e5a28ffbadea_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtNS0xLTEtMjMwMjU_f36b90df-2f40-44f9-8192-820abcc89440">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b0b8f766624b5aa1783ef3697e9b20_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMS0xLTEtMzE2Mjg_13e34781-0709-4027-ab59-ebe7d7dcc9d2">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i304183cc0af4431d9b285023ea26a72d_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMy0xLTEtMzE2Mzk_7e6c63cc-7ced-469e-85d9-f148a9f4a6ab">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab91cf46dd9e42daaab5e9e0c7a6f3d7_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtNS0xLTEtMzE2NzU_9c7b65b2-f80e-4d61-a021-a88ace6f7874">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c3ffb583b64bec8e62c626a9117c9c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMS0xLTEtMzE2Mjg_4bf59dcd-77ee-46f3-951d-cccec28dab36">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied70e04d41a84cddb788cfd887902d21_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMy0xLTEtMzE2Mzk_e1834623-08f6-4af1-93e8-42691f0edec9">801</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6720a7b09590406fa78b5cbf501d252d_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtNS0xLTEtMzE2NzU_bf8f6058-5469-4ab1-a932-972a24a8b3a4">890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fa7261b15f94c2eb63be5955c04b03d_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMS0xLTEtMjMwMjU_a7ecee4a-17fa-4eea-af1a-1a66dd011ee1">273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i697479f2046e497ea88627c07ee8852e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMy0xLTEtMjMwMjU_3c893da3-d41b-49c5-a50d-2bd0e1e51080">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ec948b236274ddf8f4810eb5cc97ce9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtNS0xLTEtMjMwMjU_78b57d68-efaa-4dfb-94b9-f0341ad8ca17">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic29ffe107ea24e1389192f99d0a767a7_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMS0xLTEtMjMwMjU_bd3830db-33c6-46ae-b6df-89ef24840948">7,026</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib93218ae922f45f5a1cf776dc39c830f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMy0xLTEtMjMwMjU_15f9ba47-569c-44ec-af07-38bfff6c451b">6,218</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac0d485d1c2f45c1a9cab57c8ab1300c_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtNS0xLTEtMjMwMjU_2fe445b7-6a59-4c05-8fe6-838b48c03065">6,470</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2c8448f9de9491eb03da17046dc00a1_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtMS0xLTEtMjMwMjU_0afd6afe-4755-41e9-ad4a-7d9794c2721b">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd688039b6c24b09ac8456cead87b0be_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtMy0xLTEtMjMwMjU_122dc794-fdb4-48b4-8697-49dbb5186f62">1,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7a0419c3734edf884537ca4e542fdf_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtNS0xLTEtMjMwMjU_3797036d-2c1f-4473-83ef-8ebace78b90a">1,347</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib81829ee9e6345368cf338d2658cdc6c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktMS0xLTEtMjMwMjU_2d049fda-4dec-4de0-9cd7-af1a67593b3f">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5349cb00c0ad4a4083b3dc3c6c276bad_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktMy0xLTEtMjMwMjU_a5f06f35-9b4c-4c6d-a63d-1ca6a680f327">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81957f0cf1484ba38b95f8c9ecc5a5d9_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktNS0xLTEtMjMwMjU_cf102e5b-db6e-44fc-9644-0bd93881a0b6">882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad0a15234cbb4344bb4ca7e8ab0ab171_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTEtMS0xLTIzMDI1_0a6f242a-bdb7-4826-9808-f442d2ab2e20">1,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a31d5a18104fff9025782da56d7787_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTMtMS0xLTIzMDI1_adb4785e-9157-4193-afcd-9dcafd1fb601">1,139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a6260841aa5465bb9e462b166e24b07_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTUtMS0xLTIzMDI1_b2154907-57c5-425d-aa8b-fc81543009a5">1,051</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if31b6de31d4f46c0a7a11072d41c2800_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTEtMS0xLTMxNzE5_a868d2a3-c2bd-47f0-9f25-d4d63a2cc823">831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45dd029eb07468ca3154dc544a63e6e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTMtMS0xLTMxNzI4_28a7870d-50cb-4944-ba37-5420ffa9fed1">764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ba7e2e0e4db4edfbca7ef8727fc3908_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTUtMS0xLTMxOTA5_43f0668f-0186-4916-afaa-ebc73e767549">873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54354e05970043bdb07f6e9c15ed0abf_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTEtMS0xLTIzMDI1_e47b97e6-360b-4549-b2b5-5315e8e7713d">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f9191aefdf04dd8b33791fa64741598_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTMtMS0xLTIzMDI1_f85ef8d2-02f4-4773-b13f-9a4d2126d521">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425cac663597403caf6cc7508116f568_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTUtMS0xLTIzMDI1_c7e2dfa5-72bc-443e-8848-51f88817c3d7">334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b53aa1b3f2142aaa114bc47e6623cc9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTEtMS0xLTIzMDI1_5b197314-036a-49b1-9116-068499c1475e">5,295</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a17e906ae8452da05c7bb782ac6172_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTMtMS0xLTIzMDI1_74b1c0ba-403f-4759-8b3c-55cacf7e05e9">4,237</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53bf28c4e64640c1bbea6979d86e3f4f_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTUtMS0xLTIzMDI1_2c37c4f3-723e-43f5-adf8-4a1979a28f6f">4,487</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTEtMS0xLTIzMDI1_d20c92ce-9b3d-4748-8127-37583df5b3b0">12,321</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTMtMS0xLTIzMDI1_47d63077-0185-4351-8c13-a49502296e8c">10,455</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib993db761cc4478a866ff2db39f59836_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTUtMS0xLTIzMDI1_b3c81fcb-ed29-46ae-bb10-9b50730802ee">10,957</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1debb8f23cc84c6fb84fe03a3c972ba6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItMS0xLTEtMjMwMjU_1e64ddea-525e-4dfa-974a-8b1250ab0de5">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fc24ab232c447f986a9240dc08901c5_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItMy0xLTEtMjMwMjU_17a280d7-353a-435a-ba74-bad3bf107ac1">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b80df0a367428b8b9a465b8e3c21fb_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItNS0xLTEtMjMwMjU_a3803128-d65c-4f49-a179-25d5d6a9b6da">417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i282a513298204115a77781c1dd5f4247_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtMS0xLTEtMjMwMjU_0c6618e8-0d14-4783-b031-1d21c0daaae1">471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3891e66b1a4f0f87e7010e0d1e8784_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtMy0xLTEtMjMwMjU_4aa32511-6ae8-403e-a38c-9de488c04804">355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idda804ddfb2c4bff8ee7c14205d1311e_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtNS0xLTEtMjMwMjU_e6f21711-e7ff-429b-b661-c95e9d7a9e04">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfc063acf78e4bd08280c305320cc7e0_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtMS0xLTEtMjMwMjU_703e7139-99cb-461f-8620-689d3e715e9c">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieec5e2be30f44eb99d345e1094f393a1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtMy0xLTEtMjMwMjU_7471fd2f-5504-4d2b-ad4f-499af85c1e38">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678ed992a3df4a148ac4cda3936f752b_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtNS0xLTEtMjMwMjU_b32a05eb-cceb-4117-b413-d368e83eb40f">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fdd98e5a1a84c7fbf7bd96a78a60fdc_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMS0xLTEtMzE3NDA_88ec889a-28a3-4833-aee4-c6b9a03e8b27">737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03dee15ce37348bbad87d69932241272_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMy0xLTEtMzE3NDc_0ab4451d-93d5-41ad-84c8-b2206d0ea2bd">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fef7e7698de4e8caf1c760d79d20d4c_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtNS0xLTEtMzE5MTk_775d224d-5977-4163-9b58-e6c6240d0614">533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd3a823fe4ca4366b2768db2d8b5b0d5_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMS0xLTEtMzE3NDA_54b8a8db-244f-4a09-a1a5-67b8a8431140">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1886d202248d4d57b78e584a981fc5cb_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMy0xLTEtMzE3NDc_1acd305e-1792-4236-998f-eca71a80aaf7">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib44b439abfc245aebc3340a2b62a8221_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtNS0xLTEtMzE5MTk_b385474c-5a30-4662-91fa-d59fcc77cb66">169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80ef92b6615045d4b2062896ded9bbc5_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMS0xLTEtMjMwMjU_ed3c204a-3ac1-40a6-a36c-f9027b5385b2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie69c1f527ffb40c695af85cc7c5db79f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMy0xLTEtMjMwMjU_c5475549-b372-412a-b67e-7282a322676d">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c8fc671d26d49df8904f1b61f9081e8_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtNS0xLTEtMjMwMjU_3fb5a27f-be65-4ef6-81fd-b4da8fccdb81">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9a67d017a8431f92a32c80c6879b56_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMS0xLTEtMjMwMjU_f9d1efcc-6e56-401d-9682-387e481de195">2,512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57502b50a979495bb8c5df03c59bac37_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMy0xLTEtMjMwMjU_0d95e129-68a5-4386-9cd8-a7e3317de8e1">2,127</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f03e61dba444a09a7a52d84fea542ce_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtNS0xLTEtMjMwMjU_0366d2a5-e3bd-46dd-9ece-3235ea704bd3">2,005</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b1c2cee07b498e95d93aa7b85803e9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtMS0xLTEtMjMwMjU_0d547f30-c8c4-4f12-bb46-911155817e20">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d762e565f504e11951b765770476668_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtMy0xLTEtMjMwMjU_b1485343-14c7-4c94-8dc9-eaae2a57b88f">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07256403bc854160be4404f8370b023a_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtNS0xLTEtMjMwMjU_3d2ec7fb-2564-4152-b059-2b051857f35b">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide46d2faceb7499aab7014ec2fd595c9_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktMS0xLTEtMjMwMjU_a527ada7-13bb-4cb0-825b-e44e76705888">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba2d61f5af8485dbf21906bf0f4aa74_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktMy0xLTEtMjMwMjU_3d439e91-baf2-4fdb-86a7-446e84824968">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3226395d1abb430c8b2c0c5dc6845197_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktNS0xLTEtMjMwMjU_33251442-f24e-4c0d-8b45-8fc00efdd2bf">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7d60c4249bc459a90844052b4ecb962_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTEtMS0xLTIzMDI1_1b68d6cc-b7c8-47d2-b1ba-c0bc75c9596e">798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ff7aabafd94e57bd5bb96fbf4651e1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTMtMS0xLTIzMDI1_59faccbd-1388-462b-82b4-0b93961fd2d9">583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83a3271cb4ba4c8e8f3b440f5b6593b4_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTUtMS0xLTIzMDI1_97d9f5cd-9842-4dbf-9d11-8a18968f2c14">588</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccdb90407784aa4a69cbad64bd54ec6_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTEtMS0xLTMxNzU4_44d25a9b-223c-43ab-b79b-5ef620ffb2e3">336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia229486a6b2a46e4b942600ec82f03e1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTMtMS0xLTMxNzY3_3343245d-1d2d-4b41-a194-d875e37d1161">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ba6c463bf0b45e09760a30ab1e70dba_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTUtMS0xLTMxOTMw_27310203-e4c1-4ffb-8f19-90146831f0ec">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5658ed54f3ad41b58d8370fdbe277451_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTEtMS0xLTIzMDI1_49a9f448-2e66-460f-8e22-e839b0f5e546">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f50b1a58554482a86eae0ad88635b27_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTMtMS0xLTIzMDI1_09d65a5a-7f74-426d-85be-0a553775e509">77</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14ef25118cc84ec18b82cbbb33c9b30c_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTUtMS0xLTIzMDI1_059c180d-d9b8-41c0-af08-10c562b0d9ce">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3bedb945b15e46caa838af3a4e317243_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTEtMS0xLTIzMDI1_23dfe4b7-2325-45a1-aeea-f545467a1cca">2,275</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5797053cbabf44609ba2cdc56f6172fd_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTMtMS0xLTIzMDI1_14a1353b-ff91-4813-9892-550659e06463">1,769</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icddb0ba9518f400295350436917a4675_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTUtMS0xLTIzMDI1_70111dcc-3b4a-44c2-8597-936dd89fc944">1,922</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f940887fab4704bda5bc6c6fea7411_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTEtMS0xLTIzMDI1_1342f731-6c79-4cc5-95dd-78dd7877a482">4,787</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9813457a2c14f50beeed7c796c5110c_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTMtMS0xLTIzMDI1_740ae4a7-3a1f-4d60-af6d-5a99340ec7a5">3,896</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace6d4c12e6c4fe6a1850720afff5392_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTUtMS0xLTIzMDI1_10926004-0247-4135-a8bd-8f90e54eb611">3,927</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment and intensive care disposable products (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i80e96d6f33fc42bb952c5c5cb391e424" continuedAt="i18d14d1ca0494d279147f443d159781d"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2021 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i18d14d1ca0494d279147f443d159781d">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM4ODg_b9629d30-9da5-4baa-a69e-15a643f65c34">529</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:ContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM4OTU_4744393c-318d-4af7-b62d-89a54446c16f">416</ix:nonFraction> on December&#160;31, 2021 and December&#160;31, 2020.</ix:continuation> </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_106"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2NzQ_b59af354-8068-4480-a742-81ac6d17839b" continuedAt="i3dc962f6eaa8457e9273c8a0d2580b66" escape="true">FAIR VALUE MEASUREMENTS </ix:nonNumeric></span></div><ix:continuation id="i3dc962f6eaa8457e9273c8a0d2580b66" continuedAt="i03c78c3933ce41cb856c109b46b77813"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.107%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i03c78c3933ce41cb856c109b46b77813" continuedAt="i201c885d373e499aa6b0ddcde6c37fab"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges are included in Level 2 and we use inputs other than quoted prices that are observable for the asset or liability. The Level 2 derivative instruments are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense and the changes in the time value of money within other income (expense), net.</span></div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2ODI_3109835c-91c4-40ae-b5fb-a25d11cb1811" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzItMS0xLTEtMjMwMjU_60092604-734c-45f6-b743-e6b08f8cc85f">2,944</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzItMi0xLTEtMjMwMjU_c02967d1-06b2-434a-8a53-d28aa5af2f4a">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzMtMS0xLTEtMjMwMjU_2d77047b-4638-40e4-8e59-8a3e2cb548d7">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="us-gaap:TradingSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzMtMi0xLTEtMjMwMjU_9221a273-d1e0-40da-9c4c-8e7b1aa91c7a">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzQtMS0xLTEtMjMwMjU_84c505e6-54eb-4a3a-97e2-ef65122f9658">3,137</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzQtMi0xLTEtMjMwMjU_e169311d-fe98-406c-b982-55ee0716cf78">3,114</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7c7e8c817e145e7bc500185970a7013_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzYtMS0xLTEtMjMwMjU_965a0586-370b-46fb-b8b7-e0db7a603482">48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e93dcc049342eebd756e5c81bbfbff_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzYtMi0xLTEtMjMwMjU_2c497967-e25e-4868-9503-cef83e4996c2">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020998449ee2432dade781d8bc329ee5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzctMS0xLTEtMjMwMjU_b36a9f06-86e2-4ebc-8544-c71a89ce6be4">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4676f03bd98643798e246bce4a1c147c_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzctMi0xLTEtMjMwMjU_39cc927c-6db9-4912-8d65-1df99d6cdca0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i502bdbefb4c34395a270e6c9b341feb4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzgtMS0xLTEtMjMwMjU_1d8255d0-884f-4993-8d59-d8ea61eb7e1a">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd7d93013184f0ca7e953d189769dfb_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzgtMi0xLTEtMjMwMjU_dd879cc7-c544-459a-80ed-83a8dd242a47">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98fd63c6a75c40488a06a9d1e613e709_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzktMS0xLTEtMjMwMjU_5be2249a-bd7b-4425-aa97-32f1248250b2">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff585920b6b14ebf8d44cd9a2a7fc0db_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzktMi0xLTEtMjMwMjU_6f6b4f58-1e8e-4fee-9f2e-e6de55721192">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21f8b1b147fc47e2bbd9b9fe11fe0ced_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEwLTEtMS0xLTIzMDI1_0cdeb44f-700a-499e-8b92-1552991a1a46">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33d0a2073a7a4d0fae7425d288bd85ec_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEwLTItMS0xLTIzMDI1_2246a745-14f3-4f3f-a4b2-5e46bf29a083">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i117668a485ee43269f7894ff6ae82f17_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzExLTEtMS0xLTIzMDI1_00c7d4ea-48a8-4a42-9163-7ef0cb07f00e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida582d9988574d51a2b01b103a5a8a6b_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzExLTItMS0xLTIzMDI1_941d5a98-0ada-45e0-ba41-671017c87b2a">81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dc0843d36f4d878697133f92c598f0_I20211231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEyLTEtMS0xLTIzMDI1_de084dbc-f3a6-4e82-8ed9-4fdc199c8880">212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95d03ec4c304d95b51a3255f385445c_I20201231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEyLTItMS0xLTIzMDI1_d3d5b178-8d15-4b88-9659-8b21881488f6">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE0LTEtMS0xLTIzMDI1_59ee5cb7-fe67-4070-b99f-4e08b3305626">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE0LTItMS0xLTIzMDI1_1d6bf7c2-17ac-4270-99b7-c55e4c529da5">101</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE1LTEtMS0xLTIzMDI1_4854d7bb-830e-4333-b4e8-d84bd9892357">3,424</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE1LTItMS0xLTIzMDI1_5ba089a3-1bd3-4599-b999-56f258da9b8d">3,215</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzItMS0xLTEtMjMwMjU_475001d4-bb32-4bf4-9ce7-c5abe1e453d3">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzItMi0xLTEtMjMwMjU_170c5ff9-e054-4afc-9c03-19b5deff62c6">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzMtMS0xLTEtMjMwMjU_9022f586-fbce-404d-a2dc-571c01abf93e">193</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzMtMi0xLTEtMjMwMjU_e7db1b12-508f-45bb-9a20-91915da8f3c5">171</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dc0843d36f4d878697133f92c598f0_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzQtMS0xLTEtMjMwMjU_fbce751e-e00a-4ad0-aca4-aa5da4819927">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95d03ec4c304d95b51a3255f385445c_I20201231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzQtMi0xLTEtMjMwMjU_c18037d2-07d5-4358-8ecf-ebd2eab04c77">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f453ede78574f968dfbe085d836b77b_I20211231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzUtMS0xLTEtMjMwMjU_709658ea-4260-491b-8932-eeaeda98b402">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab79e1bc08243479d364fa5853b1565_I20201231" decimals="-6" name="us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzUtMi0xLTEtMjMwMjU_2f37693a-4f67-49de-ba77-ced38b29be99">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzYtMS0xLTEtMjMwMjU_a8ffb9b6-a04f-43e9-848b-5657e8eb00f5">17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzYtMi0xLTEtMjMwMjU_a3e19733-bc6f-48b0-a165-f53c6de9d359">213</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21cd3e409fc4facace34555a676001b_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzgtMS0xLTEtMjMwMjU_cfebb3c5-fb78-4e71-b609-fd2ed4493763">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i343cabe069354ccc80f2d13debe7af55_I20191231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzgtMi0xLTEtMjMwMjU_1eb9334d-569c-49af-bbf0-5149915e1c3e">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzktMS0xLTEtMjMwMjU_4053167a-a87b-415c-9fb4-94b560833c7c">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzktMi0xLTEtMjMwMjU_f47d167b-b774-4794-8baa-dae19bd0e9a9">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEwLTEtMS0xLTIzMDI1_07c7e482-89f7-4c08-ba20-82ba1f89567b">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEwLTItMS0xLTIzMDI1_0ea3f001-f762-4ce1-b77d-1d999db5eb1f">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzExLTEtMS0xLTIzMDI1_eea8c6fa-229e-4752-a35c-88494da2a8fd">148</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzExLTItMS0xLTIzMDI1_c60b5bc1-e4ca-43f6-a789-c6da3229603c">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEyLTEtMS0xLTIzMDI1_36056d0d-41fe-44e1-8905-83fa7208e3d6">306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21cd3e409fc4facace34555a676001b_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEyLTItMS0xLTIzMDI1_8fb7111b-d287-41ad-865b-0482269755b0">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEzLTEtMS0xLTIzMDI1_d57a5bb4-e4a4-49d1-ba45-ff8e2237b111">306</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21cd3e409fc4facace34555a676001b_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEzLTItMS0xLTIzMDI1_429af5a9-0a0a-4d71-b24e-7177ee570506">393</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzE0LTEtMS0xLTIzMDI1_917b0f00-c504-4848-a7d9-d07f7d06b405">516</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LiabilitiesFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzE0LTItMS0xLTIzMDI1_100e7f52-c04b-4a48-b5c8-91b0aff4361e">777</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2ODY_0d22b2c6-ad88-4401-8feb-c5d8d86115e4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.417%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.142%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzItMS0xLTEtMjMwMjU_7148cdd0-d22d-4bd9-9e8d-f34301d93368">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzItMi0xLTEtMjMwMjU_e8e8affe-d186-4c36-880a-9c1f1b3aad4c">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzMtMS0xLTEtMjMwMjU_455c5240-7cdb-47ef-81eb-facb7f1c69b7">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzMtMi0xLTEtMjMwMjU_4777f9bb-b1d2-4695-b21e-27e9dd9daffe">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNDQ_77ac7da7-5973-461a-89ed-67785fae0c5c">68</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNDg_54927b68-ed3a-4a0c-8b32-506e69000a68">102</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:MarketableSecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNTU_5939c647-15d1-4ae7-a653-9dc7b4301667">155</ix:nonFraction> in 2021, 2020 and 2019, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i201c885d373e499aa6b0ddcde6c37fab">investments before recovery of their amortized cost basis, which may be maturity.</ix:continuation></span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_109"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 4 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxNzc_dd4841c9-b48c-4dc0-84d3-e7685bd5bb4e" continuedAt="i81173f01ee43428b8ac1682dcba780f5" escape="true">DERIVATIVE INSTRUMENTS</ix:nonNumeric></span></div><ix:continuation id="i81173f01ee43428b8ac1682dcba780f5" continuedAt="i46dcf42302ba42e2924f93444b2789df"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxODI_e5c39dd5-c138-45fb-99ed-ad32b2047414" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.424%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.661%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMS0xLTEtMjMwMjU_e40e4ff4-4793-4885-9511-f61656328911">973</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40113d80d11149059ac26617f2747527_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMi0xLTEtMjMwMjU_8d8b3c7d-a6e2-4842-ad3e-300d260a4e87">2,266</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9d232100d84c2e8972344f330c6c32_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMy0xLTEtMjMwMjU_6f3c4aa3-d9e1-4d50-b3a2-b1bcb7996c46">5,512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d60a29285a47bd9dbc5f7c302733eb_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtNC0xLTEtMjMwMjU_585a0ae3-eb29-4952-9baf-c67f85eca082">8,751</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzItNC0xLTEtMjMwMjU_63d87aee-8a15-4544-ad56-5a82c96cf78b">4.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i422ff4d02b404759bd7b1f0c73386fdf_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMS0xLTEtMjMwMjU_2db7af46-26e8-4181-b2bc-9dcf08c58c7b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72f5e6753fb047f083791a2c3417aef7_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMi0xLTEtMjMwMjU_d1f79bb7-8dbb-4176-8401-e29e0a07eed5">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic949228136a2440aacee861045d52a3b_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMy0xLTEtMjMwMjU_e6601a4d-0e01-4f61-9d4f-e0674a2e133d">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if052be85296d424e88865bee7451cdfe_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtNC0xLTEtMjMwMjU_7d81b00e-832a-4a52-8efd-624655e797a9">146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1631a54bab5c46b5b4aa3ef428c4dc63_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMS0xLTEtMjMwMjU_4ef4722b-1c39-43dc-9904-e61aa95b25ae">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5884ae7cccbb493f97bb398967d7295a_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMi0xLTEtMjMwMjU_8e57fce4-ac4e-4713-af99-8f0183e74b58">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdc28f3e70c4e53945b14cca5be1a87_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMy0xLTEtMjMwMjU_4c85922f-7d83-407e-9a5f-b1e80443064c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1a4031263e473ca84441dad4d88d84_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtNC0xLTEtMjMwMjU_85c3c713-ca67-4084-872a-2b5ccada6d46">66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if77ef480dc7b44db865d51b857328728_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMS0xLTEtMjMwMjU_a326a88d-51bb-4409-89cf-4dbb34b08b7d">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a2bb2e21adb4f2195ccceb311822e54_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMi0xLTEtMjMwMjU_965ebd8a-9528-4fb7-9cf3-de29e9072706">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i77590a767d2049249161295a41700dff_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMy0xLTEtMjMwMjU_32d372f2-96a0-415f-8baf-014ffbff51e5">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib71901facd4f4729bb4febf8e4920a38_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtNC0xLTEtMjMwMjU_b1ee1e24-b869-4be2-a4a4-04e0578c4d80">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMS0xLTEtMjMwMjU_1573ddb1-568a-4326-b73b-0c1c8c666444">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i40113d80d11149059ac26617f2747527_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMi0xLTEtMjMwMjU_2b277d64-edd7-4e5c-997d-6d463f38a7f4">104</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c9d232100d84c2e8972344f330c6c32_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMy0xLTEtMjMwMjU_e20bca9f-fec5-4661-ad3a-72caf2ff6cc8">82</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75d60a29285a47bd9dbc5f7c302733eb_I20211231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtNC0xLTEtMjMwMjU_54309fcd-493d-4b9e-aeba-b9c014bd866c">195</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTEtMS0xLTIzMDI1_5ae19bd0-8195-4ac3-9f38-739ad2caa8f6">949</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5048a5d933134912a55ce66af02172d8_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTItMS0xLTIzMDI1_ee0168a7-245a-4daf-968e-e9443a3fdcad">1,828</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTMtMS0xLTIzMDI1_f77d8779-3b35-48ca-96f7-29bb4ccf632d">5,382</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTQtMS0xLTIzMDI1_2672b79e-d430-47f4-a340-88afa2302574">8,159</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231" name="us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzExLTQtMS0xLTIzMDI1_450e8ea3-ecb3-4b13-b97d-4e168d11263a">4.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f71580f58e546cf876aaa64b8e407f9_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTEtMS0xLTIzMDI1_9690031f-5738-494a-ba62-bd4379d9609e">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic458786f6f7742209e0810cafdb1e076_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTItMS0xLTIzMDI1_c4324c33-2b20-4fd4-8ff1-b7570a7bdf88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86c13e7f54a4d9187b804efa3279ece_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTMtMS0xLTIzMDI1_59fce278-dd67-47b8-965d-220a8db7b153">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cb34c13848b40abb54bfb7dd12daee8_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTQtMS0xLTIzMDI1_edac5746-9af9-45ea-b139-4c07dcd8c624">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie912fa0d38354d10abc6f0c684c92709_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTEtMS0xLTIzMDI1_c609ac9a-8c8c-4bb1-b959-8e8026f638fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cc2de29096642bca27e8292c94be78c_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTItMS0xLTIzMDI1_1f9749c3-be5f-4e77-92aa-392cc77a6852">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib731b835ed4545e1bf7663a732660d5b_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTMtMS0xLTIzMDI1_bd37312e-dcdc-496d-ad5c-7919305846fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba140370805745c5a0fb0139f3a35e36_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTQtMS0xLTIzMDI1_53259ff1-ef82-44fe-a7c9-d9210cc33362">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7bb0885ab9cf4a3b872895d9b26c1c8d_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTEtMS0xLTIzMDI1_186c0c52-b326-4b3b-8381-6020afe91fe0">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i768aa1a212a548f6bc9e1ad4200680af_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTItMS0xLTIzMDI1_bd338192-3642-4427-835b-a48c1f42fa4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if80d5916400446cf8c33be284e7e7cd8_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTMtMS0xLTIzMDI1_0dd13be0-e14b-4995-8ad2-0a1dfe0de7dc">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0494473994284c7a818935d1810c26c5_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTQtMS0xLTIzMDI1_5a1ca5c8-9ef7-4754-aa25-89045ae55904">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i324abdc30a554b10b518a4193f5e987c_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTEtMS0xLTIzMDI1_fd93d2fc-a04c-445d-a452-d49a5a01253c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i460e2f30ab50432dac45998c777bd1cb_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTItMS0xLTIzMDI1_fbc9762c-7f2f-4f88-9bd1-f02967c4d5bf">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4dc5032a74e422eab08db6029f2c3b1_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTMtMS0xLTIzMDI1_cfe46ed8-15dc-4053-9231-727a1db2c179">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2743dba7228949dca22bfab3555187d4_I20201231" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTQtMS0xLTIzMDI1_848c54e2-559b-403e-a8f4-3b8a8d8f0d94">27</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTEtMS0xLTIzMDI1_104d871a-0d5b-49bd-8f2f-c9d382722e39">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5048a5d933134912a55ce66af02172d8_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTItMS0xLTIzMDI1_83b0f7cb-93e3-4c27-beda-22351e68b852">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTMtMS0xLTIzMDI1_0274c328-ee47-4f70-b74d-d01175250afc">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231" decimals="-6" sign="-" name="us-gaap:DerivativeFairValueOfDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTQtMS0xLTIzMDI1_bef05138-c203-4adc-af72-6ce6988cc591">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;<ix:nonFraction unitRef="eur" contextRef="i40113d80d11149059ac26617f2747527_I20211231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg0MzE_e395a83d-9987-4164-902f-c75949e348ca">2.0</ix:nonFraction>&#160;billion and &#8364;<ix:nonFraction unitRef="eur" contextRef="i5048a5d933134912a55ce66af02172d8_I20201231" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg0NDU_2e625046-36d6-47d5-8000-0f03f4d1c5d5">1.5</ix:nonFraction>&#160;billion at December 31, 2021 and 2020 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;<ix:nonFraction unitRef="eur" contextRef="i40113d80d11149059ac26617f2747527_I20211231" decimals="-8" name="syk:DerivativeNotionalAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg1MDQ_b4c2ad71-c7dc-44d6-893a-9b788777a793"><ix:nonFraction unitRef="eur" contextRef="i5048a5d933134912a55ce66af02172d8_I20201231" decimals="-8" name="syk:DerivativeNotionalAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg1MDQ_f25b7af8-d16f-4299-ab16-587418e2ab9c">4.4</ix:nonFraction></ix:nonFraction>&#160;billion at December 31, 2021 and 2020 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 the total after-tax gain (loss) in AOCI related to designated net investment hedges was ($<ix:nonFraction unitRef="usd" contextRef="i40113d80d11149059ac26617f2747527_I20211231" decimals="-6" name="us-gaap:NetInvestmentHedgeDerivativeAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2MTc_5d62c988-c27c-4dfe-a507-e055e92f140b">34</ix:nonFraction>).</span></div><div style="margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxODA_8106341a-c64e-41f5-b157-a470db243afe" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:28.871%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.277%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5774498f250b4e62a2507047bb5117c5_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItMi0xLTEtMjMwMjU_8f2fc38b-6a3f-4861-8ad1-b59fb22f489c">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfbfda7e7d44de0983bcfc3b451374f_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItMy0xLTEtMjMwMjU_056e3420-b85b-4931-9a9e-4bf171905099">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8de6a926a954c7a98e473efb5dedd75_D20190101-20191231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItNC0xLTEtMjMwMjU_d9f6527e-a560-4d91-9e7b-0bd14433b5a5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4707a4f73d24ec7a3a6643b3e285e4d_D20210101-20211231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtMi0xLTEtMjMwMjU_d1405cdf-dfb6-44ac-b7bc-fa575a83d679">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ae0b2359894631bfe4ff8951b7344f_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtMy0xLTEtMjMwMjU_8194597f-906e-4944-b981-c283c85e4773">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd5321432b28479688d8bb70e0d59233_D20190101-20191231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtNC0xLTEtMjMwMjU_310e6f8b-0864-49ac-b4f4-74b3e0a30203">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8b361079402f49b293ad59e81c8db765_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtMi0xLTEtMjMwMjU_25cb2dec-a3d4-41cd-b592-164a0fae5f81">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1eda5abebfc549a98ed646efb1e15dd8_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtMy0xLTEtMjMwMjU_27675aa1-82a3-4a55-a0e3-357eefb28122">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78ff6405f6b0476e87ad1a72d4cb5be6_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtNC0xLTEtMjMwMjU_5dc0fa5d-4069-47d9-b31f-7aa08512927b">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtMi0xLTEtMjMwMjU_e654c59d-5688-4f7b-a57e-12869cfb89cc">13</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtMy0xLTEtMjMwMjU_129a0c7a-082e-46db-8708-600303bcaf1b">20</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5680505765904a7ebbce9f048aa9a5ee_D20190101-20191231" decimals="-6" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtNC0xLTEtMjMwMjU_00012feb-57ca-413c-9153-ab2ba05bf5ee">9</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $<ix:nonFraction unitRef="usd" contextRef="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2OTQ_db7f587d-96d5-4057-906a-7931f6047971">9</ix:nonFraction> and net investment hedges of $<ix:nonFraction unitRef="usd" contextRef="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231" decimals="-6" name="us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE3MjY_282a66de-4338-4f07-9fa9-409369617658">37</ix:nonFraction> recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2021. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i46dcf42302ba42e2924f93444b2789df"><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 a loss of $<ix:nonFraction unitRef="usd" contextRef="ib06a055c0fae428c8432833a0e6bf453_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTcw_349000ba-9229-43f3-b7ad-7d6f278dc990">11</ix:nonFraction> was reclassified from AOCI to other income (expense), net in earnings relating to the termination of forward starting interest rate swaps with notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i6502455d90c34a3aaf15f94591105bdc_I20211231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTc5_221607d1-b891-426c-bd0f-1f51e0eeed88">750</ix:nonFraction> designated as cash flow hedges as we now consider it probable that the original forecasted debt issuances will not occur. Pretax gains of $<ix:nonFraction unitRef="usd" contextRef="i257b8d69f7304529920e40c42cf14686_D20210101-20211231" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTc1_24f428c6-f025-4dbb-8e58-fc5c22bb071f">5</ix:nonFraction> recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2021. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 5 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90ZXh0cmVnaW9uOmJlNDgxMzdiZGI1MTQ3ZWViY2ZkMDRlNzg3ZDYwNmRkXzgy_e4b1debd-59a8-4492-b040-db6bada5b15f" continuedAt="ie822dd9fb21e4157bf72ccb23151417e" escape="true">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:justify"><ix:continuation id="ie822dd9fb21e4157bf72ccb23151417e"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90ZXh0cmVnaW9uOmJlNDgxMzdiZGI1MTQ3ZWViY2ZkMDRlNzg3ZDYwNmRkXzc3_80e1eb03-e566-4b1b-bb6d-5f628e77faa1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:26.565%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.868%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.902%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.871%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb4525f47584c4b928961c3e9bf0ff0_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMS0xLTEtMjMwMjU_2a0b2565-1ea8-4b5e-adfc-febe667d725c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia94684ce07ac4a0185a0636e0cf54469_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMi0xLTEtMjMwMjU_0a500896-f3c1-4609-bd7a-4ed6071c2394">179</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e5a4e63e93f48f7aa5592b92b80c4b1_I20191231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMy0xLTEtMjMwMjU_200baf08-5734-4beb-9487-97c8a0412b85">47</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if68a82d67ba747f0a26113ba47cf0600_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtNC0xLTEtMjMwMjU_624bd90f-fc47-4f12-af21-9a717e542283">471</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtNS0xLTEtMjMwMjU_b44e48f6-f839-4201-9c1d-9412359dd743">606</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMS0xLTEtMjMwMjU_3a313cc9-94b1-4885-a84d-fc0eb54540cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMi0xLTEtMjMwMjU_27623612-06f9-4bda-bad5-d2cd508654f5">117</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMy0xLTEtMjMwMjU_6132d724-3577-40e0-9d9d-57b1ca990a55">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItNC0xLTEtMjMwMjU_35a3fba8-80e8-4160-ab8c-f9cd34616971">459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItNS0xLTEtMjMwMjU_98fadf19-8e78-4e30-a49a-4510a80bd3a8">640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMS0xLTEtMjMwMjU_6f75550a-8da8-4af6-9862-7863beaad4f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMi0xLTEtMjMwMjU_4d58d290-7a44-41d6-8bdd-05f614e31c2e">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMy0xLTEtMjMwMjU_26009c8a-ee51-4788-bb54-deb884cb9631">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtNC0xLTEtMjMwMjU_5c0d80f7-4484-4243-9997-d2a8989ed116">66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtNS0xLTEtMjMwMjU_82b07007-e6bf-466f-98ed-37e6f9a0d4a4">111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49d219ac7c654bcf972997c5b2dd66b6_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMS0xLTEtMjMwMjU_e8fbd877-b124-4208-a37c-73a10e40fd25">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic221ec9a6dfc4d74aeaf33001f372d3c_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMi0xLTEtMjMwMjU_89fe8dff-3fc3-45b2-95f0-be30dfe88275">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if601c0b3db3f4bf6b658f2a814d47b69_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMy0xLTEtMjMwMjU_5649dc81-6b0c-4b40-a715-85f90db33426">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8cdd6bf737b54325b92c62a86f71c0e8_D20200101-20201231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtNC0xLTEtMjMwMjU_f34d3cfe-cf56-4b1e-aed6-8443e2830de3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e2f7288e37e48a380d856a6d3266bf1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtNS0xLTEtMjMwMjU_bcb77be8-41af-435c-b627-141e15ec298c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia56f6022aefe44f2a5667c14a9b6b6eb_D20200101-20201231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMS0xLTEtMjMwMjU_505868f7-bd5d-47b6-951b-656e698d1295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c3f013d29b7403e858fcea9c856f7b3_D20200101-20201231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMi0xLTEtMjMwMjU_1bae552e-00ae-4ec6-ad6b-a1e427860b51">12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i90e7300ba45a44d6a213473b74b90080_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMy0xLTEtMjMwMjU_a80a28b4-bfc1-436d-a588-c7c1530b79b7">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia01979f1a5154e80af303f7109f5141e_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtNC0xLTEtMjMwMjU_3b7fd721-f172-43ee-b33a-a48047ef85c1">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie1ea07cf8bba4d6d887c5a458dad34dc_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtNS0xLTEtMjMwMjU_69c337b6-e188-46cd-bc05-b862bb5395a2">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMS0xLTEtMjMwMjU_e70dc434-83ed-4382-98eb-cd08bc2068f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i409d18f675da455fb23e202a25fb4438_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMi0xLTEtMjMwMjU_b4a2605a-f8c3-4bd9-a86b-2081821c643c">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMy0xLTEtMjMwMjU_1c61adfc-8a93-45ea-95f1-0f353ebaec2c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctNC0xLTEtMjMwMjU_8d962153-ba50-4de4-a93e-1cad8a11109f">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctNS0xLTEtMjMwMjU_125ad22c-a6f4-47a9-b067-54b39f6d1c38">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMS0xLTEtMjMwMjU_ded7e880-f3e7-4063-8b3b-7d28c2cc92dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i409d18f675da455fb23e202a25fb4438_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMi0xLTEtMjMwMjU_e3059515-e6d2-4868-9d02-480ae4be0023">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMy0xLTEtMjMwMjU_ac046d4c-3085-459f-8ac5-f7443000247f">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtNC0xLTEtMjMwMjU_5ad0ffa8-b77e-49c8-afaf-2811697c12e2">414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtNS0xLTEtMjMwMjU_9ae8eeea-da53-4ad0-90f2-14faa39b9a1a">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04146303369749e39910cfe8eff8042d_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMS0xLTEtMjMwMjU_3ab8fba3-4a77-403a-a699-121a8a4dea40">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5a5b88eef254543b043aeb672c43431_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMi0xLTEtMjMwMjU_df84203c-539a-44b6-8c09-2b48db015798">259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb9e3dbe30fa4e8483b2654e5a21a079_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMy0xLTEtMjMwMjU_717b168c-0b54-4a18-bdb8-3b47f9e5d1b4">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7543006b3a34df28528413b4f7b31d8_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktNC0xLTEtMjMwMjU_4ca6dcd1-a6f2-45a4-9f49-a93cb8d8b3db">885</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktNS0xLTEtMjMwMjU_177eb9a4-5f64-4c5d-80f4-412236bf2972">1,157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTEtMS0xLTIzMDI1_0488ce62-6ef6-4d3a-a902-444fb1438268">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTItMS0xLTIzMDI1_d813e9f1-dbf7-4526-9d8e-bcf41549de41">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTMtMS0xLTIzMDI1_6e115de2-f64b-4d68-bc3c-d31b6cd3db89">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86883fa09384666942eeaed442415af_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTQtMS0xLTIzMDI1_6b341d27-3fa2-4da0-8602-f35f2a62ac40">551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTUtMS0xLTIzMDI1_62949f42-b3cd-4c1c-b916-e034484108c7">724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTEtMS0xLTIzMDI1_dcc0e172-99e2-4c64-9624-bc40c9ab95db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTItMS0xLTIzMDI1_00de21fd-952e-4aa5-8e3b-1d6ba33a574c">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTMtMS0xLTIzMDI1_b8a00174-a3a7-4f0a-a13c-8616c5589c2a">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie86883fa09384666942eeaed442415af_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTQtMS0xLTIzMDI1_566a56a1-8c80-4392-b5c0-b45d37cd3bef">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTUtMS0xLTIzMDI1_b22fe032-36d7-4d38-a781-def3069bc797">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92f15013f92346ce9cbb36e9eb568f54_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTEtMS0xLTIzMDI1_140f3147-ac1b-425c-b9d8-af0e60463056">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83dc60f460124dd497581e888b4bf1d8_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTItMS0xLTIzMDI1_1c255202-bb14-47f8-9366-8db4eab90c31">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9114115d56ad4c4989ad2dd4e097974d_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTMtMS0xLTIzMDI1_af784e56-7758-42e2-8f81-e7035401188d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5dbe5a4ec071427fae8b82afb24fb3ca_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTQtMS0xLTIzMDI1_ae525f0f-e690-47b1-b254-e2ed2fb031df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325e4a8aeca94b2b83d09801b01f101e_D20210101-20211231" decimals="-6" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTUtMS0xLTIzMDI1_67bee0ce-1d9e-47c9-bd86-1da220b91908">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87e455dc94234eef9fc977210d2059b3_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTEtMS0xLTIzMDI1_d2156aa9-78a0-461b-be64-49fce7a7f76a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad787f8161cd41d2b2c226f217b85d4f_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTItMS0xLTIzMDI1_ec2ba100-623f-4e5b-88ac-23919837cc71">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80cfb23b43fb45ffa9c91c4dc0f78098_D20210101-20211231" decimals="-6" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTMtMS0xLTIzMDI1_70a76aaf-4df5-4bf9-bebc-38c68012b4c3">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2773bb7f8a4c4bd3a58a536ad8bf8188_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTQtMS0xLTIzMDI1_009be060-b586-42f4-8f3e-2ed6f7ed2e09">35</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8362bd7aefad4b4fb6e9f334fa0974c4_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTUtMS0xLTIzMDI1_283f0d87-c3ad-4d9e-a777-15470f252074">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTEtMS0xLTIzMDI1_844a2413-4d12-4072-b69c-f55d831049cb">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98223ace52234752a935caf8d514b359_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTItMS0xLTIzMDI1_16059a21-8a11-4ce9-a701-dcaad460f83b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTMtMS0xLTIzMDI1_60ea4d6b-970f-4822-b3ba-cf062602242d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTQtMS0xLTIzMDI1_2fa1d505-03e9-490d-8272-bc98a7b97536">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTUtMS0xLTIzMDI1_d3d13f7c-2149-4122-9696-8507ecac6be6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTEtMS0xLTIzMDI1_d85e66d4-06d9-4c5a-8afb-c0aa015f60e4">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98223ace52234752a935caf8d514b359_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTItMS0xLTIzMDI1_3d2c7c41-953c-4a2e-bacd-04f0887d1c07">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTMtMS0xLTIzMDI1_06ba6e65-1ccb-45d3-9e4a-6ce9c5fd1697">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTQtMS0xLTIzMDI1_fc34c8cd-3150-4066-b75a-76026ce296d9">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTUtMS0xLTIzMDI1_d204c003-c2ab-46ad-a9d6-d2d335cf0041">626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia32555db427549cf9768af83a8cc5401_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTEtMS0xLTIzMDI1_c8a422c4-9da1-4ef0-8e95-0faface59940">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i473fc27ada8b4437a7ed06daba0e7b45_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTItMS0xLTIzMDI1_a907f740-51d0-4782-8dc0-65ab9a6a028d">155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987f109f9d8b453ea9245f3f52a146d6_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTMtMS0xLTIzMDI1_545045a2-854a-41c0-bbba-783433b9a2f2">40</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i114b53cb59c34cb288582b77e4ec30d5_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTQtMS0xLTIzMDI1_fb1a9b28-df70-4da0-9df5-27bdc0e0dc87">416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTUtMS0xLTIzMDI1_e2000a9d-f558-4300-8480-5ce9b0548138">531</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_115"></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxNDk_bae58a98-edd0-4b2f-ab11-efacc7c81e51" continuedAt="if51cfcf6e1204bcfbbd495beb8040a18" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="if51cfcf6e1204bcfbbd495beb8040a18" continuedAt="i92cb281385264079a260e952af844b32"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzIzNQ_86c49c62-4682-4f10-ad55-2060f4caef19">393</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzI0Mg_c7598287-951c-413e-a7aa-cd3f6d30ba86">4,304</ix:nonFraction> in 2021 and 2020. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $<ix:nonFraction unitRef="usd" contextRef="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930" decimals="-6" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzEwOTk1MTE2MjkxMTg1_bf4cd066-f1ee-422a-800c-964beb9318fc">120</ix:nonFraction> in cash and up to $<ix:nonFraction unitRef="usd" contextRef="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930" decimals="-6" name="syk:BusinessCombinationContingentConsiderationFutureMilestonePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzEwOTk1MTE2MjkxMTkx_05ff5648-a304-4967-a1b6-77295eec37b4">40</ix:nonFraction> in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2020 we completed the acquisition of Wright Medical Group N.V. (Wright) for $<ix:nonFraction unitRef="usdPerShare" contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130" decimals="2" name="syk:BusinessCombinationConsiderationTransferredPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzM0OA_b0c1abc6-8177-4913-b4fa-88997745c550">30.75</ix:nonFraction> per share, or an aggregate purchase price of $<ix:nonFraction unitRef="usd" contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzM5Ng_65294506-c470-4974-878f-f18d8ccdc67c">4.1</ix:nonFraction> billion ($<ix:nonFraction unitRef="usd" contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130" decimals="-8" name="syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzQwMA_a2e9695f-e2f0-41d5-830b-fd6a0924eb49">5.6</ix:nonFraction> billion including convertible notes). Wright is a global medical device company focused on extremities and biologics. Wright is part of our Trauma and Extremities business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November and December 2020 note holders elected to redeem the <ix:nonFraction unitRef="rate" contextRef="ib8d99e6390a74a8995e89bd1ff83d52b_I20201130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzczMA_304aa849-b60f-40ed-83dc-dbff8843022f">1.625</ix:nonFraction>% and <ix:nonFraction unitRef="rate" contextRef="i02a06683c940495480de29089bda742b_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzczNw_d1572545-f1ab-4612-93ab-6395e377fe26">2.25</ix:nonFraction>% convertible notes assumed in the Wright acquisition for $<ix:nonFraction unitRef="usd" contextRef="ie342e96c09a9482c9aa9e2e4ff4011f5_D20201101-20201130" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxMzk_ae31962d-fd8d-46d0-b6de-495ddc92bc77">864</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i67fb41d08feb476290e5560aab4e4702_D20201201-20201231" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzgwMw_510979bf-fb37-4c77-8421-b263405cd892">576</ix:nonFraction>. These repayments are classified as financing activities.</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i92cb281385264079a260e952af844b32" continuedAt="i1ac4a6da25874594944f73e8fd687fcf"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2020 we completed the acquisition of OrthoSensor, Inc. (OrthoSensor). OrthoSensor is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor is part of our Joint Replacement business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Had the above acquisitions taken place as of the beginning of the comparable prior year, our consolidated financial results of operations in the aggregate would not have been materially different. Accordingly, we have not disclosed pro forma financial information. </span></div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxNDA_cf842f2f-2959-445c-ad0b-ba0d6f2083e1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.878%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Wright</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzMtMi0xLTEtMjMwMjU_ec266daa-7c6b-495b-84a1-afa8d45ae12f">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzQtMi0xLTEtMjMwMjU_0a711aec-5eba-41b7-b7fe-44fc4de435e0">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzUtMi0xLTEtMjMwMjU_9d641f57-f0bc-4406-8c1c-58741898f706">440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzYtMi0xLTEtMjMwMjU_bbde2715-6adb-451a-8764-c0336092bacb">343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzctMi0xLTEtMjMwMjU_2b0f741e-fb54-47e9-ba98-bf35b02fa900">1,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzgtMi0xLTEtMjMwMjU_0a7b67fb-e858-40b1-82be-db6876051e47">503</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzktMi0xLTEtMjMwMjU_dbec81c1-4b4e-40a1-ae6f-f7315590ee83">218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEwLTItMS0xLTIzMDI1_8cb9ebb3-f2cc-4b6f-a05e-73a42c1cb064">296</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9cfff0a7aec247bc86688fccbb9b397f_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEyLTItMS0xLTIzMDI1_34ace730-16ef-4a15-9414-4de2110cbd96">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology and patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42136052eabf40fba1fdf489034458a0_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEzLTItMS0xLTIzMDI1_882d7760-6fd5-4b58-b91d-5c93a151b7cb">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i515431d49ca14980ada9296078f4f0a5_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE0LTItMS0xLTIzMDI1_816bdda1-d569-4cf1-8769-9cfad8099ac7">58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE2LTItMS0xLTIzMDI1_49050f5f-b4dd-4cd1-b4b0-70ed58327af1">3,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE3LTItMS0xLTIzMDI1_d936ea7a-1c18-409a-8492-b86f17869aff">4,081</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if70c7c8d0bbd4f9582508d0d23fd23b9_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE4LTItMS0xLTIzMDI1_1a52c8af-f7a7-42f9-9bd6-1c21f5d74077">12</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for 2021 acquisitions were based on preliminary valuations, primarily related to intangible assets, product liabilities and deferred income taxes. Our estimates and assumptions are subject to change within the measurement period. The purchase price allocations for Wright, OrthoSensor and other 2020 acquisitions were finalized in 2021 without material adjustments. </span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i1ac4a6da25874594944f73e8fd687fcf">In January 2022 we announced a definitive merger agreement to acquire all of the issued and outstanding common shares of Vocera Communications, Inc. (Vocera) for $<ix:nonFraction unitRef="usdPerShare" contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131" decimals="2" name="syk:BusinessCombinationConsiderationTransferredPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTU5_d6107e62-7059-4c17-8d6b-be766c8346dd">79.25</ix:nonFraction> per share, or an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131" decimals="-8" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTY3_1f1515be-d1a5-4100-9eb9-0489ca993a19">3.1</ix:nonFraction>&#160;billion (including convertible notes). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Vocera for $<ix:nonFraction unitRef="usdPerShare" contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131" decimals="2" name="syk:BusinessCombinationConsiderationTransferredPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTgx_d908c9ce-7be0-4682-8603-ca697b158127">79.25</ix:nonFraction> per share in cash. The boards of directors of both Stryker and Vocera have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2022, subject to completion of the tender offer and other customary conditions. Vocera has emerged as a leading platform in the digital care coordination and communication category. Following closing, we plan to integrate Vocera into our Medical business within MedSurg and Neurotechnology.</ix:continuation> </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_118"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 7 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMjM_2d4e2b46-d234-4f06-aeb8-cb67659e2d8d" continuedAt="i168ca7179a24454893fa5a65904635c3" escape="true">CONTINGENCIES AND COMMITMENTS</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i168ca7179a24454893fa5a65904635c3" continuedAt="i144be682aa12492fa7db4b4d9c96b2db">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to </ix:continuation></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">31</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i144be682aa12492fa7db4b4d9c96b2db" continuedAt="i32ed31254a1246958c575e6968b1ca8b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In December 2021, we reached a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreements, including the financial terms, are confidential.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With the acquisition of Wright as more fully described in Note 6, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2021, we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyLossInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzEwOTk1MTE2Mjg0MjY1_4ba6df96-1c43-4b88-b703-467003e1b7d4">103</ix:nonFraction> and made payments of $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:LossContingencyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzEwOTk1MTE2Mjg0Mjcx_e6feca69-eaf8-4a63-9902-059d04232cb1">221</ix:nonFraction>, primarily related to Rejuvenate and ABG II Modular-Neck hip stems. Based on the information that has been received, we have estimated the remaining range of probable loss related to recall matters globally to be approximately $<ix:nonFraction unitRef="usd" contextRef="i9db0a793155f4536896d92116fb53672_I20211231" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzM1ODM_b271ae7c-ee65-4316-b905-35f2e8c8f723">385</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i66cb47dd385f4d9999a85414eafe4457_I20211231" decimals="-6" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzM1ODk_253d5fc6-30c8-48d2-8f06-6d16c330d070">520</ix:nonFraction>. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i32ed31254a1246958c575e6968b1ca8b"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMjU_2c4a309b-abf4-482d-8142-50b4a7166bcb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.359%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMS0xLTEtMjMwMjU_61b53a44-5f9c-49de-a625-f0d1d60a4584">419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMy0xLTEtMjMwMjU_5a487a44-bb5a-4339-971a-d4307bbb1651">423</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMS0xLTEtMjMwMjU_e6baf5fb-9cac-4fc0-b49b-4d6bc870bc4c">112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMy0xLTEtMjMwMjU_dfa1802a-1c92-4e23-ae76-fbf46f80fe25">109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMS0xLTEtMjMwMjU_5e00aa87-cee8-4f1a-aa5d-f1c9d6209696">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMy0xLTEtMjMwMjU_916931ae-6a0f-45d7-a043-f49e2bbefdb6">325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzktMS0xLTEtMjMwMjU_8f9b433a-e63a-4a94-9c33-6c38388adb2e">5.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzktMy0xLTEtMjMwMjU_a6330a76-f043-46b1-afeb-9ac50bdb214f">5.6</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzExLTEtMS0xLTIzMDI1_50809e26-3fcd-4119-ab9f-535a6ba2d326">2.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzExLTMtMS0xLTIzMDI1_a8d6a7c1-d351-4475-ad89-3fa35c128fba">2.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU1OTI_5c0d2cdb-1eb7-4d73-b8d0-5f557732102d">133</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU1OTY_d15f631a-bf2f-405c-9891-7b41b4686bb3">130</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OperatingLeaseExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU2MDQ_f5d9d165-6951-4659-b92d-0c68174c93f7">133</ix:nonFraction> in 2021, 2020 and 2019.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMTY_78a87957-b678-4085-855f-32559a83e193" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMS0xLTEtMjMwMjU_a0f86969-6a19-4118-ba96-047c9976ac72">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMi0xLTEtMjMwMjU_4794a3b2-6c26-479e-9906-2ccdee2a7186">1,226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMy0xLTEtMjMwMjU_50772e0c-a692-47dd-a7de-0b61fb55473d">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNC0xLTEtMjMwMjU_3159de3a-8032-42d3-b8db-65d6633fb76f">1,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNS0xLTEtMjMwMjU_a18e618f-568d-4f71-b868-cbaa6074d8ba">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNi0xLTEtMjMwMjU_f6506b41-26e9-405b-b86d-cd44f7138137">7,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMS0xLTEtMjMwMjU_c1436b6c-24f3-4b1e-9c4b-8e9ecfac4ee9">1,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMi0xLTEtMjMwMjU_47e480d7-5744-4168-8eba-6ade75683f0b">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMy0xLTEtMjMwMjU_463cd46b-af1c-4d85-8aea-bec5abe27e8a">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNC0xLTEtMjMwMjU_58237d0d-b651-4279-9d19-b5efcf6026b0">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNS0xLTEtMjMwMjU_4258f37b-d7da-4d75-81e5-838e421f787f">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNi0xLTEtMjMwMjU_cd2ecdad-54f6-4d28-92c1-afe81424224d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMS0xLTEtMjMwMjU_9d00964f-66b0-46cf-98b4-930d74ff6b46">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMi0xLTEtMjMwMjU_cadf415a-c785-4732-be6a-7603cc651365">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMy0xLTEtMjMwMjU_b6077530-394f-47b7-9e85-58290e976d98">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNC0xLTEtMjMwMjU_b27718a3-85e2-482a-9bcc-34ab07f2c910">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNS0xLTEtMjMwMjU_8545d4e8-e594-43a5-8748-1e804b3e9bb4">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNi0xLTEtMjMwMjU_b19b5153-b814-4c8f-8531-07c169db2d00">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_124"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE5NA_8cebc729-22dd-48f1-836d-e0359ff5577c" continuedAt="i2aff31af9f6c46ba8e47b58ff681d6ad" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i2aff31af9f6c46ba8e47b58ff681d6ad" continuedAt="i17fb298dab3a4c2abf8f7d9d0a0d0016"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We completed our annual impairment tests of goodwill in 2021 and 2020 and concluded in each year that <ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE0OQ_c820a4c0-b965-4835-8ce7-43b748d55459"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE0OQ_fbf0ac34-da11-4de2-a97e-2284681de21d">no</ix:nonFraction></ix:nonFraction> impairments exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzEwOTk1MTE2MjgwMjc_a767844b-001a-4f72-a2cf-5172eec35887" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.681%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.612%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff23dccda5944e118af54005133b53e7_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMS0xLTEtNDMxNjc_dfb11809-1076-4ece-9cdd-19756da25519">5,377</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i620617bf01d945178f16bb399ad57f75_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMi0xLTEtNDMxNjc_cd656150-6127-4fc1-9b30-daeac9e5829d">3,692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMy0xLTEtNDMxNjc_9a2a754a-e008-472f-b056-0dd57de2a758">9,069</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMS0xLTEtNDMxNjc_f44f16f9-13c2-4c3c-ab9c-cf9184da4525">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMi0xLTEtNDMxNjc_5777b3f9-d7d0-4d87-8146-d571a11498ea">3,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMy0xLTEtNDMxNjc_93c2f0ea-e7ef-4a9a-b1bc-8b3360a4f13a">3,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMS0xLTEtNDMxNjc_1d07374b-541b-49a7-99c4-c28cc187b8a1">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMi0xLTEtNDMxNjc_f9cee979-23f6-4912-8aee-bd383b6ac597">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMy0xLTEtNDMxNjc_ca4e8d12-ee26-4eef-aba8-b9238f8b8ee4">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99bfd05a796d4880b00788fe7096a885_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMS0xLTEtNDMxNjc_7e795822-84ff-4c5d-a7d2-46000e082bd4">5,459</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86c45f56956e48e19de6ba723be12789_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMi0xLTEtNDMxNjc_0047cf7f-8ba0-4c3c-89b4-e5ebc79946d2">7,319</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMy0xLTEtNDMxNjc_2ae6a15a-c365-4cca-835a-bfae2465167d">12,778</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMS0xLTEtNDMxNjc_c9e89347-2e01-4b5e-8521-f6ba1ac093a0">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMi0xLTEtNDMxNjc_fca43d7f-5977-46a2-a65f-8230d3b7faa7">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMy0xLTEtNDMxNjc_b2f7d438-bcf8-4237-bcbd-4ccebe82a0b1">282</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMS0xLTEtNDMxNjc_d3accd65-7a58-407c-96c4-51806c6eb52a">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMi0xLTEtNDMxNjc_7f54bc97-7285-4470-94c7-ddc5885d84bf">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMy0xLTEtNDMxNjc_d9bb8b96-ee8d-4dbd-9ae7-091e7e50dd2d">142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i537ba5d8a2cc42d0ac3ebe24c14114dd_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMS0xLTEtNDMxNjc_52332105-495b-447e-b3d6-84af232a0fad">5,669</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60bff9d7fe1740a4b1b56d78df05e951_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMi0xLTEtNDMxNjc_92b13358-817a-4eb2-adaf-3bdb91e22705">7,249</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMy0xLTEtNDMxNjc_7bac092f-2a2b-45ce-b9ea-71a5f760b0ee">12,918</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">32</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i17fb298dab3a4c2abf8f7d9d0a0d0016"><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE4Mg_4fdb46d8-fa52-44d0-8ff0-4ef2a387e3a2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.888%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i881fb152f349470ca7abba8d476e11a0_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMS0xLTEtMjMwMjU_57b2b2f7-e7c5-4541-a3fb-d656d5929550">13</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMi0xLTEtMjMwMjU_0a557ffb-dfd0-4bb0-820c-2f671f6166fc">5,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMy0xLTEtMjMwMjU_aad735f5-1924-44d1-92f6-3e0bae86a89a">1,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtNC0xLTEtMjMwMjU_0c3900fe-01e6-48ef-af10-59ee57f2e93a">3,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iededa4a8c527471b85a48d5b54ad644d_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMS0xLTEtMjMwMjU_0b9cc9ac-0ed9-431f-978e-9f568f763737">13</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMi0xLTEtMjMwMjU_46812070-31cb-4533-8456-a03cc74440ad">5,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMy0xLTEtMjMwMjU_213e6c62-eeb7-40d2-9365-b84fa1657f9a">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtNC0xLTEtMjMwMjU_ced90d70-7ecd-4c25-bdda-e39eabba624d">3,732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia88bc7ee7b9745fc9352da5322ebb656_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMS0xLTEtMjMwMjU_c7b7cd81-bd5b-4e39-81a9-ba5515c8f2b4">15</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMi0xLTEtMjMwMjU_70a93eb4-0a03-4ec6-9c3e-8607451d1d39">2,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMy0xLTEtMjMwMjU_f118858f-f572-48a2-b1b1-c4249cdc1e83">1,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtNC0xLTEtMjMwMjU_6d74daa9-5d9f-46a2-8e3d-81b9b200f82a">1,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1087bf354d78467a8a499c466b98e2ec_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMS0xLTEtMjMwMjU_a3d2cf8a-bcba-4160-90cb-f080e38a5ede">15</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMi0xLTEtMjMwMjU_6e392cc9-1723-4700-8c4c-9de7e6a83e95">2,352</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMy0xLTEtMjMwMjU_a771294e-cd28-47ba-b669-b5337c67b1c8">988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctNC0xLTEtMjMwMjU_791d8d97-f433-45c7-a8e0-4f563f3118cb">1,364</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7b19b159bc734f8dac7b4ac724153ffb_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMS0xLTEtMjMwMjU_6013910b-39e5-4b49-ad1a-d4804b18adb1">12</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMi0xLTEtMjMwMjU_b60dba45-75f6-4a12-bdc3-71ae64fb490f">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMy0xLTEtMjMwMjU_fc257bd0-cdb2-45dc-988f-57a8bc2793d0">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktNC0xLTEtMjMwMjU_49acc26e-85fd-4c6c-92ee-3f1c7e4aea6b">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib56b6a79e10d4b8da543faad8f04faef_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTEtMS0xLTIzMDI1_b1e96430-510d-48db-9f76-494e582ed727">12</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee70c5decbda497da7a729394169c742_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTItMS0xLTIzMDI1_070b5f5f-dc8a-447f-b939-f751666993ea">346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee70c5decbda497da7a729394169c742_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTMtMS0xLTIzMDI1_7ea089ed-b2df-439a-9041-1ef0c7b6b7aa">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee70c5decbda497da7a729394169c742_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTQtMS0xLTIzMDI1_409ccf2b-96a5-45c6-8d5a-0e4cb431ad81">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="icf40de1dc0a747ac9e71b3ec9fe5e6ec_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTEtMS0xLTIzMDI1_79f17832-3ea4-49bf-9737-21d5a540106c">16</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95da961ae17b47f3858471949c39deb9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTItMS0xLTIzMDI1_9ee847ec-3d03-4787-9d9e-19079d727747">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95da961ae17b47f3858471949c39deb9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTMtMS0xLTIzMDI1_5be52195-7f14-4044-8c74-5ff314555e3e">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95da961ae17b47f3858471949c39deb9_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTQtMS0xLTIzMDI1_ff03b40d-483e-48d9-b906-fde1f6236728">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3abb2d8e94114546ba385f6ac936e9fe_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTEtMS0xLTIzMDI1_bf966f60-b2d2-49ca-b21f-e3a7adf45287">17</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTItMS0xLTIzMDI1_af52aadf-5ed6-459b-9e84-aeca4004f4e8">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTMtMS0xLTIzMDI1_4f18c356-22b0-4592-befa-26677fbac076">162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTQtMS0xLTIzMDI1_6a52bbb1-35ae-4324-9b4d-86aa5de3ee0a">266</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTItMS0xLTIzMDI1_3454115d-6641-4e85-a498-4c20cf108b47">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTMtMS0xLTIzMDI1_b6439e5d-9701-4f70-ab44-58d25c9faf0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTQtMS0xLTIzMDI1_c6f627f9-9660-4aec-81d7-d5bdfea99b3e">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie504e126295140d895f1b405fdae8218_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTItMS0xLTIzMDI1_a7496b1d-fc12-4427-80e0-da9cf6532d18">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie504e126295140d895f1b405fdae8218_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTMtMS0xLTIzMDI1_92b8cf91-e652-4fa9-82d5-c1b2a927922b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie504e126295140d895f1b405fdae8218_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTQtMS0xLTIzMDI1_97aa6abd-c979-43a2-97c5-43d5ffc7b340">97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i75223e6f266b49d0b5c29ab50334c3ca_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTEtMS0xLTIzMDI1_ae31f40e-a55d-4733-b4e9-ed4194426775">9</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTItMS0xLTIzMDI1_34454b97-b1f6-426d-bc19-251b3cf34d0e">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTMtMS0xLTIzMDI1_43cd4a33-7e1f-4717-9e2b-2f1fb778b2b1">87</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTQtMS0xLTIzMDI1_a9a7b07f-b153-4808-813e-bc0734a2cefa">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4c0fc5ea9fc4492a91cafecdf0d6fe28_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTEtMS0xLTIzMDI1_05a1abe5-7d64-4b8d-add8-e0275dd18492">8</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTItMS0xLTIzMDI1_7c050847-a7f6-4f84-aaa3-049529a362b4">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTMtMS0xLTIzMDI1_1ad0b2bc-8022-40c6-8e41-4e47f721f4ec">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTQtMS0xLTIzMDI1_62b1c29a-fd94-4c31-b4e9-58b787cee731">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTEtMS0xLTIzMDI1_d9d748e0-5a8e-4dbd-9591-c5a5bae0ceaf">14</ix:nonNumeric></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTItMS0xLTIzMDI1_bcf8d4dc-6da4-4643-9bdd-cd5b1dd5fa9a">8,542</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTMtMS0xLTIzMDI1_5d24ecbd-af97-4725-a0d5-55f8617c5296">3,702</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTQtMS0xLTIzMDI1_05bdc358-4f49-4a9d-b052-81a0b8d7dd94">4,840</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTEtMS0xLTIzMDI1_d476f649-6add-4716-819c-13918b7b6350">14</ix:nonNumeric></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTItMS0xLTIzMDI1_9cdc700b-8adb-42e4-afb2-1e8b84c82ca0">8,656</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTMtMS0xLTIzMDI1_5689f378-f22c-4428-b620-ac1679e7e3c3">3,102</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTQtMS0xLTIzMDI1_c0d2e434-d182-4e01-b62e-8afac0447191">5,554</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzIwMQ_2d34361f-dfbc-4043-aea3-b0d734dd58e2" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.787%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMC0xLTEtMjMwMjU_2cdd8465-65a0-4d54-8c2e-0db03caccf57">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMS0xLTEtMjMwMjU_f6c7dce3-b779-4878-89fe-44fff28b6da6">558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMi0xLTEtMjMwMjU_7da7f344-ef0b-4b50-8080-37a20be58d05">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMy0xLTEtMjMwMjU_d5a17c40-05aa-483b-972b-46aa77cf2c98">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItNC0xLTEtMjMwMjU_f1501e1b-dffa-40e7-8ef1-8582153fe46a">447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_127"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 9 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNTM_3a90fd6f-4c73-4e7e-9bc9-71083641f94f" continuedAt="ibe7d01865fc645878dd9d58348880736" escape="true">CAPITAL STOCK</ix:nonNumeric></span></div><ix:continuation id="ibe7d01865fc645878dd9d58348880736" continuedAt="ibac30b4dbb2c47f9b49115b0e98bf5d0"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to <ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="INF" name="syk:CommonAndPreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzEzMA_bf07cc8c-9b65-407e-94d7-10c54910ec13">1,000,500,000</ix:nonFraction>, divided into two classes consisting of <ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE3Mw_0412d01a-3912-48a4-ad38-de6f80934826">500,000</ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE4Ng_86525ef3-a704-4d7a-ac15-919571e1a12c">1</ix:nonFraction> par value preferred stock and <ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIxOQ_40d3605f-5936-4101-9718-c373838bf833">1,000,000,000</ix:nonFraction> shares of common stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2NQ_f8bb0419-251d-404d-ace7-d7d0aa3b859b">0.10</ix:nonFraction>. <ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2OQ_4847f81d-260e-4a74-92b3-6e876eaf27bd">No</ix:nonFraction> shares of preferred stock were outstanding on December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2021. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2021 the total dollar value of shares that could be purchased under our authorized repurchase program was $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzc3Mg_869042c5-f0a9-4d70-aa85-ea531bdd8171">1,033</ix:nonFraction>.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were <ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzg0OA_fdc59df4-8a09-46d2-b06a-19ca552c8fe9">25</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzg2Mw_3eefc531-74f7-40ba-b5d5-d967f4e98b82">28</ix:nonFraction> million&#160;on December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNzA_e74d24a8-359a-4dd5-94fd-b1c10cc0f9f6" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.060%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.555%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItMS0xLTEtMjMwMjU_51452e6d-b343-459c-b2ec-5750c5627a1e">53.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItMy0xLTEtMjMwMjU_b9e9123e-e452-4015-b20d-3fbd197468cc">39.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItNS0xLTEtMjMwMjU_6e12ad45-7ebb-4faf-8b78-925fb05fb623">36.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtMS0xLTEtMjMwMjU_4f61fe78-ebe3-48c1-a9f6-65b3d2309e3a">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtMy0xLTEtMjMwMjU_f07f9d8f-7b4b-4802-917a-5dcee756bae6">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtNS0xLTEtMjMwMjU_21b1ae12-7424-408d-bb7d-5cccc446d82e">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtMS0xLTEtMjMwMjU_ac9be1ab-52e3-4689-8a90-211bf5a730fe">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtMy0xLTEtMjMwMjU_a9910e73-60c0-426f-8775-22df918a4493">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtNS0xLTEtMjMwMjU_2c2fd7fb-3915-4d68-8a3f-cde90c157419">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtMS0xLTEtMjMwMjU_dd90c22b-03f4-41bd-b495-419ad9c25834">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtMy0xLTEtMjMwMjU_ac2fad0f-0ee5-45ad-b6ce-82e384012055">18.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtNS0xLTEtMjMwMjU_167a64f0-11c7-4fe9-9233-d1fe167b461c">18.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctMS0xLTEtMjMwMjU_a643b685-2fa4-434e-9cd4-34790c241561">5.9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctMy0xLTEtMjMwMjU_c08219ee-1a23-4ceb-837d-de39cbfe242c">5.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctNS0xLTEtMjMwMjU_064700b3-3e57-44f7-9b30-f4e68d30a17d">5.9</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="ibac30b4dbb2c47f9b49115b0e98bf5d0"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNTg_08c2dec8-4586-48fe-8ac7-a05ccd46ed42" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:22.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.173%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.513%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.196%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2021 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzItMS0xLTEtMjMwMjU_473aad86-7a72-40e6-bd70-687598334411">12.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzItMy0xLTEtMjMwMjU_9bc0df0f-a320-45eb-bd58-24fb4bf06e21">131.72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzMtMS0xLTEtMjMwMjU_bc4a6f73-4f17-4bd4-93cd-e0da6d337115">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzMtMy0xLTEtMjMwMjU_9e6e0643-51b2-4877-b90c-dda1b9852b9a">235.35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzQtMS0xLTEtMjMwMjU_6f609744-85fb-472e-a952-b105975cae0a">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzQtMy0xLTEtMjMwMjU_39712b1e-8199-48c5-9208-7e1fde211442">96.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzUtMS0xLTEtMjMwMjU_260d9320-151b-4a78-bf38-a5f54b7b4641">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzUtMy0xLTEtMjMwMjU_04b772a6-992c-4c58-8648-5c5ad14cdf83">192.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtMS0xLTEtMjMwMjU_1ab24ef1-682f-40e3-ae05-b784148dcb46">12.1</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtMy0xLTEtMjMwMjU_af0b5d7d-353b-4307-82b3-a6adf8af3f6b">150.17</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtNS0xLTEtMjMwMjU_9b4711fb-3a5c-4743-8ce6-b1dc627e5d31">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtNy0xLTEtMjMwMjU_d2c0b182-84cb-47a3-b54d-ab0714117525">1,424.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctMS0xLTEtMjMwMjU_f45c5330-09b9-42e4-a97b-c93950327ac6">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctMy0xLTEtMjMwMjU_bf96c117-cee6-4064-a18e-116ad0576ad8">113.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctNS0xLTEtMjMwMjU_10b14ac7-0e54-4aa7-9895-b838efd3edc4">4.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctNy0xLTEtMjMwMjU_fa60a5c9-8f36-473b-86b0-6524bc6faafa">1,086.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtMS0xLTEtMjMwMjU_a9a0f622-27e2-4e80-86b6-bd0513a2a1a1">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtMy0xLTEtMjMwMjU_c3062977-9f38-4c3a-84be-e94320cb4163">199.41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtNS0xLTEtMjMwMjU_f79457dd-d0e6-4426-bcd4-aaa50d8484be">7.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtNy0xLTEtMjMwMjU_4b3ec1b5-477b-441e-87f0-3bd92524367a">313.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5MzE_8e2b18ac-3db3-4d7d-bb36-6cf51bda578c">253</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5MzU_f59a627b-dcf3-47d4-acc4-d7d333a8f7ff">258</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5NDM_b6f2dbcc-53f6-4cde-9599-7d8f6b457af7">294</ix:nonFraction> in 2021, 2020 and 2019. Exercise prices for options outstanding ranged from $<ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwMTY_80cdff1d-c96e-4256-86c2-c998131b1b83">53.60</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwMjI_a4fdc1ad-4ba8-410d-9897-181446ceb428">270.94</ix:nonFraction> on December&#160;31, 2021. On December&#160;31, 2021 there was $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwNDg_f9ed12a8-a666-42e3-a85f-e811fcec9674">101</ix:nonFraction> of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIyNTQ_e6f4c33c-9cef-4a1c-99d5-e8eefe57776d">1.5</ix:nonNumeric> years.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNjQ_10180a84-36e9-4598-b46c-d3e9d2c78b5f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:40.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.217%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.221%"></td><td style="width:0.1%"></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1dde6a23c87c43a39fd81af819d0e532_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtMS0xLTEtMjMwMjU_dd4625a8-6af5-43be-956c-564a7256a429">0.8</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11a3a9e009874da393fcb3dac86134c0_I20201231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtMy0xLTEtMjMwMjU_c566e50b-7ae2-490f-8d38-675abd9970b1">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1dde6a23c87c43a39fd81af819d0e532_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtNS0xLTEtMjMwMjU_554d923b-48fb-44ee-87e2-373df21ccb27">187.72</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11a3a9e009874da393fcb3dac86134c0_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtNy0xLTEtMjMwMjU_63c08f0d-bc64-40ba-bbf3-9e12e9a9b9e2">185.46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtMS0xLTEtMjMwMjU_4e79e18b-5b5e-471e-b48d-46762666e27d">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtMy0xLTEtMjMwMjU_c6e8b4bc-b077-4a9e-91be-84b41278d77c">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtNS0xLTEtMjMwMjU_3e023301-faa9-4481-9969-5e15acab624f">230.61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtNy0xLTEtMjMwMjU_b38511c4-f5ad-4a9d-878e-d2d5c440f353">233.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtMS0xLTEtMjMwMjU_2e5f0fd0-0e8c-43d2-b4b4-44ba21b826c5">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtMy0xLTEtMjMwMjU_d4da3b78-78e7-4fd8-9485-dfca28e2f1aa">0.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtNS0xLTEtMjMwMjU_1b98f521-4788-4ab3-bda8-fc603094651a">179.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtNy0xLTEtMjMwMjU_2d17413b-e59c-42f2-9ee4-0fad540012c0">153.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtMS0xLTEtMjMwMjU_66e3f60f-02a5-4797-b3a5-554775dd3cb9">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtMy0xLTEtMjMwMjU_b4e79c81-62f3-417e-a514-6f963ccee035">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtNS0xLTEtMjMwMjU_ad4ddedd-42a0-4b9d-af8a-8dc3b2169607">187.38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtNy0xLTEtMjMwMjU_95acbc45-8ddd-40bc-b161-cc819958204e">160.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctMS0xLTEtMjMwMjU_988185fe-18e7-410d-841a-2d1bf9b6b867">0.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctMy0xLTEtMjMwMjU_50ff2ff8-ceb2-42aa-ac2f-c198a1733465">0.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctNS0xLTEtMjMwMjU_43ceecd2-ab42-4a29-b6ae-714591c45e32">213.16</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctNy0xLTEtMjMwMjU_9b38373b-78bd-4a24-9db2-bca368dfc0f4">210.73</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 there was $<ix:nonFraction unitRef="usd" contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIyNzY_78334624-68e8-4694-94d3-9433befd771c">71</ix:nonFraction> of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI0NDA_2eba4f30-824e-49e9-b4e4-fa56a2c08f73">one year</ix:nonNumeric>. The weighted-average grant date fair value per share of RSUs granted was $<ix:nonFraction unitRef="usdPerShare" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1MTc_b943c391-ac25-40ec-be47-f7eee3f3ade6">230.61</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i30c2cd9df03f4990802edf10bafe3d39_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1MjQ_a2425eae-2984-4bdf-8319-03294711d0d0">208.96</ix:nonFraction> in 2021 and 2020. The fair value of RSUs and PSUs vested in 2021 was $<ix:nonFraction unitRef="usd" contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1OTA_66ce66e1-1606-4f8e-8530-619004a4a1f0">63</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" decimals="-6" name="syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1OTc_56bdc8bc-19c8-40ba-ae33-bee097d93abf">5</ix:nonFraction>. On December&#160;31, 2021 there was $<ix:nonFraction unitRef="usd" contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2MTc_e54fee63-75e7-4cc0-9e81-7f1fa2c3df94">18</ix:nonFraction> of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately <ix:nonNumeric contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI3ODA_1a67bb26-b924-4e2b-84cf-30232a703b84">one year</ix:nonNumeric>. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as <ix:nonFraction unitRef="number" contextRef="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231" decimals="INF" name="syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMwMTU_79280fcc-cd42-4ada-a9a7-fe3de6982145">95</ix:nonFraction>% of the closing stock price on the last trading day of a purchase period. We issued <ix:nonFraction unitRef="shares" contextRef="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxMDE_9d553bbd-fcf0-4e1c-9773-670658fd0eb3">183,964</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i509624184e844f5fb011955bbb2c778e_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxMDg_c1025c00-04ab-4fac-92f0-10e71f157c27">209,837</ix:nonFraction> shares under the ESPP in 2021 and 2020.</span></div></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_130"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 10 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NzQ_c5159ae2-cae4-462d-a033-6439034ccf10" continuedAt="i73c03b7a295e4b9aac938a6b7c1fe1ba" escape="true">DEBT AND CREDIT FACILITIES</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i73c03b7a295e4b9aac938a6b7c1fe1ba" continuedAt="if6e47438a40e4f31a39b8c946f3c6696">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2021. </ix:continuation></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="if6e47438a40e4f31a39b8c946f3c6696" continuedAt="if0992b00c7d3498c839f9b799512c845"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. The primary changes were to increase the aggregate principal amount of the facility by $<ix:nonFraction unitRef="usd" contextRef="i1c4be753853f42df931435723368c9e5_D20211001-20211031" decimals="-6" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0Mjk_2d8af661-a397-479b-8c6e-87f5c7f8d5ce">750</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="ia9e6f3514db1476f817d3a34bf82751a_I20211031" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0MzU_1843826b-1046-433a-9dfa-7adae2726180">2,250</ix:nonFraction>, extend the maturity date to October 26, 2026, increase the leverage ratio to <ix:nonFraction unitRef="number" contextRef="ia9e6f3514db1476f817d3a34bf82751a_I20211031" decimals="INF" name="syk:DebtInstrumentCovenantLeverageRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0NDg_d6c3ade7-4e19-4fc2-a82b-199354b9f9f0">3.75</ix:nonFraction> and provide LIBOR replacement language. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the first quarter of 2022, our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding under our commercial paper program from $<ix:nonFraction unitRef="usd" contextRef="icfbd20d36f4c4a0187acc94dfb9c9db4_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzM2NQ_00ffd9b4-8bfa-42ac-8f23-4554a8781ac0">1,500</ix:nonFraction> to $<ix:nonFraction unitRef="usd" contextRef="i9ef4c1ea02da4ea596abd614114f7393_I20220331" decimals="-6" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MjgzOTQ2_0c03160c-f6e5-45c4-8de2-681368354931">2,250</ix:nonFraction>, with maturities up to <ix:nonNumeric contextRef="i917ab770a5bd4746b5a9e3300c4046b4_D20210101-20211231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzQyMg_ab9039ea-efca-4685-beed-8a48d3af5bd2">397</ix:nonNumeric> days from the date of issuance. On December&#160;31, 2021 there were <ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:CommercialPaper" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzQ3NA_6354993f-1413-4561-964c-df78193a8859">no</ix:nonFraction> borrowings outstanding under our credit facility or commercial paper program.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1ODE_0bf74acb-751b-4670-91d7-ac4c75143440" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"></td><td style="width:2.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.616%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.463%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaae71a75450b45cfa06a432fbf4e56b6_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtMS0xLTEtMjMwMjU_bcb19652-893c-4494-916b-89d55d642eee">2.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaae71a75450b45cfa06a432fbf4e56b6_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtNS0xLTEtMjMwMjU_bdcddc55-21c0-4400-a1fb-68adf03bb084">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9765b80413243c19a3bd125fa129236_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtNy0xLTEtMjMwMjU_c9f4a914-9347-4a57-a528-568ac4217ac5">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtMS0xLTEtMjMwMjU_9ba98f81-378d-4fd5-81d3-b4ccc96324f2">1.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtNS0xLTEtMjMwMjU_b2acc7c1-11a2-4691-9e93-d99f46d4f52f">622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10c71a79ff0d4a66b82c64b38f8ef166_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtNy0xLTEtMjMwMjU_32d38406-ee93-480b-98b0-b1de25a7fc50">668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba8cdba131854e1fa2af1d12976b473e_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctMS0xLTEtMjMwMjU_9ca089a3-e877-42ed-9ef4-819d24fa0be3">0.600</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba8cdba131854e1fa2af1d12976b473e_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctNS0xLTEtMjMwMjU_dedff6e8-9967-4aae-886d-6bc1b4c6404c">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfca18fe7ca64a799cd68aefb09fb4c3_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctNy0xLTEtMjMwMjU_5a7b55ed-3841-463a-bd27-a3cfd8a55c63">597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3509c57093a64b75a06052277ba0acb3_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtMS0xLTEtMjMwMjU_9d8dd9f1-3af2-4cfc-9acd-48d24e39a9ef">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3509c57093a64b75a06052277ba0acb3_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtNS0xLTEtMjMwMjU_32b133eb-7118-42de-a2f9-2d3853617a6c">593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0227faa616da4a128a3d998d9f6db05d_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtNy0xLTEtMjMwMjU_c4b58d61-eb04-4772-a9cd-e5322e7123e2">590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktMS0xLTEtMjMwMjU_adb2b5d9-912c-41ce-8b60-095cd04d1cc8">0.250</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktNS0xLTEtMjMwMjU_9edc46f2-5f3a-4d0a-a27e-095444f0cf5f">958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480109c130434062bd13171059d5ef31_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktNy0xLTEtMjMwMjU_92164e7f-8036-476c-bed0-5b762c6ef2a6">1,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4681c2f77d9349a8a13546c839684f90_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTEtMS0xLTIzMDI1_2c22ddf8-b40e-461a-ab20-c566c233dd90">1.150</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4681c2f77d9349a8a13546c839684f90_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTUtMS0xLTIzMDI1_fdc7888c-42e2-4f97-af38-e7f34f720050">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0df1eb79fd5744fd8983118adebb9623_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTctMS0xLTIzMDI1_898b2198-5893-4255-86db-a82d86a1cbb1">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23e7e1ef2be4408ea79112316a123192_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTEtMS0xLTIzMDI1_cc283834-242b-4caa-b3b3-0b2f35a83708">3.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e7e1ef2be4408ea79112316a123192_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTUtMS0xLTIzMDI1_cba90777-645c-4694-a7ea-f64e0ba44949">748</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0caf73b3889a40929b9da7a96bb99d5c_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTctMS0xLTIzMDI1_13df252f-68f7-4009-972c-0e453b544e86">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iad5a5038c5da499f92e3e8046651aa71_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTEtMS0xLTIzMDI1_9a0f024a-0282-4085-8db8-feeb28d614a4">3.500</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad5a5038c5da499f92e3e8046651aa71_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTUtMS0xLTIzMDI1_7d3f3901-644e-4e77-8c30-3b162b9ebb42">994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2fe3da873b14e1e9acb5a1220a5e06d_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTctMS0xLTIzMDI1_fb796610-c0dd-4103-ae0f-c5b49da9c677">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTEtMS0xLTIzMDI1_c244fbd4-0c39-4c3f-ae6a-f6d8fd77cd28">2.125</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTUtMS0xLTIzMDI1_eea00892-f661-43dd-81d8-92f92e3034f9">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id90b056e95f44ff5abeae3d32e78c913_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTctMS0xLTIzMDI1_9b2bf091-ec23-4757-8fa3-14e62f2a796b">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie0e14c0d1dcf411ab03235f607eb6313_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTEtMS0xLTIzMDI1_0a01f452-cafa-4b4a-b49a-f81f42821168">3.650</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0e14c0d1dcf411ab03235f607eb6313_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTUtMS0xLTIzMDI1_fbb3ea95-ce7b-4f25-bf6d-648e5e62cc48">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9e48c2079044c18c3f5e95f5b196b3_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTctMS0xLTIzMDI1_c2a4dcc3-557a-4c81-8e53-d78b9e3b8ca7">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63e97ef977d04cbe98290d564401c76b_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTEtMS0xLTIzMDI1_bbb63566-4a96-44af-b043-789c2e95a79b">0.750</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63e97ef977d04cbe98290d564401c76b_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTUtMS0xLTIzMDI1_ac10a217-54cd-46b2-8845-d0bfcc1518df">901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i336901cefd4f43fba19050323af4c966_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTctMS0xLTIzMDI1_29f2faf4-76d5-4efd-9635-e4d96b03fb33">969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3086dc119ed744e3be6f3fca238a2adf_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTEtMS0xLTIzMDI1_1d2ad17c-c663-4190-b728-d9b8f44018cc">1.950</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3086dc119ed744e3be6f3fca238a2adf_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTUtMS0xLTIzMDI1_ad76eee0-2960-44d8-81bd-2b4087d5e8fe">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09191cd775d5416fac1419996ab55482_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTctMS0xLTIzMDI1_27243f53-ab67-47b8-aed1-30c4a10107e5">989</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTEtMS0xLTIzMDI1_07930e44-afc5-4f69-a19a-b8e7326edcf3">2.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTUtMS0xLTIzMDI1_b1119b58-e230-4582-ba28-cbb7183a3fa5">727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23484026c90c4eba9c47bf90db97349a_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTctMS0xLTIzMDI1_7b1054cb-b009-44f1-9f5a-2ebf44339e43">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i323fcbeea7cf43648faf64c65504341c_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTEtMS0xLTIzMDI1_f5810192-346c-46e2-b123-6983a31075b7">1.000</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i323fcbeea7cf43648faf64c65504341c_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTUtMS0xLTIzMDI1_7cb88ef5-6de4-4936-8eac-90c7f5c63e88">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d1fc1af0074b52bfb9bcd1fd97816a_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTctMS0xLTIzMDI1_9119aa74-b57e-49dd-9f22-7f9209aaa2d9">903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4e46902a0d4641b6aad2beef3aed8f86_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTEtMS0xLTIzMDI1_b7dc770e-81de-40ff-a374-6ac981456e73">4.100</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e46902a0d4641b6aad2beef3aed8f86_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTUtMS0xLTIzMDI1_14a5e6a1-d57c-4d0e-85d4-cdc0e7ecfa4d">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic725b5e5cada4fe09f8bbb6ff2a948e9_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTctMS0xLTIzMDI1_5899427b-f69d-47fb-acc2-b71bbb9f29b2">392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia68e51613f0e40deb45d9d94d6e67b14_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTEtMS0xLTIzMDI1_e2965202-ad33-45fd-a8a5-94a60cb3322c">4.375</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia68e51613f0e40deb45d9d94d6e67b14_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTUtMS0xLTIzMDI1_3a974246-5b97-4e25-a731-0206d868cbd5">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7def3071dac84fbf93b4831fce46ae80_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTctMS0xLTIzMDI1_7421c842-eade-43ff-b882-43340af270a0">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idbd80c3cd55641208b41aaa854e69a3d_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTEtMS0xLTIzMDI1_34e9ea78-3911-405f-90c1-a09c028333ce">4.625</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd80c3cd55641208b41aaa854e69a3d_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTUtMS0xLTIzMDI1_83741bcf-05bb-426c-b9b9-27cf2e1753aa">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4a79159e25947238adcf8348dd4618a_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTctMS0xLTIzMDI1_36035a7b-bc1c-44c0-aa1b-cbea756d7a55">981</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i10d1a9bafbac4422919540ab667b2004_I20211231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTEtMS0xLTIzMDI1_3b664456-c6b9-4163-906e-5854accbd501">2.900</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10d1a9bafbac4422919540ab667b2004_I20211231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTUtMS0xLTIzMDI1_155e32b5-70a2-4679-bcd0-f97198f75237">642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a5a0db81617461dbfb08c50f5a369e5_I20201231" decimals="-6" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTctMS0xLTIzMDI1_03dc7edd-e8a2-4be4-bdb8-be8f22ca9ae4">641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa94a4981170459daf10d0648f64494e_I20211231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIzLTUtMS0xLTIzMDI1_f264b713-8878-4abd-9f46-b3ed0a1fed71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibce21f74de924d9091f5bc5d627d39d4_I20201231" decimals="-6" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIzLTctMS0xLTIzMDI1_7dbf3a37-2d6c-4504-94ca-8210108865ad">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI1LTUtMS0xLTIzMDI1_7e9fecdb-9e5b-4f8d-8c7d-323bbd94b66c">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:OtherLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI1LTctMS0xLTIzMDI1_d50a14d6-f28f-4355-8e65-b264842bf01d">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI2LTUtMS0xLTIzMDI1_77bd6add-f582-42da-8364-5e9418e996cf">12,479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI2LTctMS0xLTIzMDI1_2e9d82af-d865-44d7-b61c-71afe0b46b9d">13,991</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI3LTUtMS0xLTIzMDI1_d00a4ad0-3ec8-492f-8faa-973ac418efd1">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI3LTctMS0xLTIzMDI1_bc2e5327-8f28-4b62-a207-9a64183d63d3">761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI4LTUtMS0xLTIzMDI1_ba7469eb-8502-4c24-aebd-5f14834b200b">12,472</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI4LTctMS0xLTIzMDI1_bd347483-f49e-4ee1-9a52-af4bb80e8a24">13,230</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMwLTUtMS0xLTIzMDI1_3672a8d7-6102-4170-be6a-ab30d8855401">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMwLTctMS0xLTIzMDI1_62babf86-90cb-4d4b-bdd2-e31277195939">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMxLTUtMS0xLTIzMDI1_949228ad-01ea-4284-8345-b303dea5cab5">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMxLTctMS0xLTIzMDI1_c8298f08-1537-4de9-a7b9-916f4b3a38f1">2,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMyLTUtMS0xLTIzMDI1_0f80134f-47c2-43eb-943b-26a3af252b4a">13,391</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMyLTctMS0xLTIzMDI1_36e67ac7-ae6d-4c54-b98f-e173ee110c75">15,022</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2021 we repaid $<ix:nonFraction unitRef="usd" contextRef="i37083d398075438da83a8349d52ed8c6_I20210331" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NTI_8d64c4a6-12b8-406c-bb8d-f78ef5aecb40">750</ix:nonFraction> of senior unsecured notes with a coupon of <ix:nonFraction unitRef="number" contextRef="i37083d398075438da83a8349d52ed8c6_I20210331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NTg_470a0852-222d-42a3-ac40-092e4231d073">2.625</ix:nonFraction>% that were due on March 15, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2021 we repaid the $<ix:nonFraction unitRef="usd" contextRef="i5cc983b0708b43efbe69262c949402dd_I20210930" decimals="-6" name="us-gaap:DebtInstrumentRepurchasedFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NjY_52506499-03f3-479a-bf00-7d0970076e3e">400</ix:nonFraction> term loan that was due on November 10, 2023. </span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="if0992b00c7d3498c839f9b799512c845">Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1Mzc_9ed4897b-1425-441f-9574-75d419d4f4ff">337</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NDE_87c850c6-0c08-4d92-b9bf-e6b12ec1a230">315</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NDk_e5d45c8e-f526-4542-ad9a-d971c35513f1">287</ix:nonFraction> in 2021, 2020 and 2019.</ix:continuation> </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_136"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 11 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NTg_4bafe76d-6e26-4240-b1ba-4637fa1ac89b" continuedAt="i13dcd2eeef9646d1be183f0522a199e7" escape="true">INCOME TAXES</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i13dcd2eeef9646d1be183f0522a199e7" continuedAt="ie9d2a67566934274a6638820d2417636"> </ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="ie9d2a67566934274a6638820d2417636" continuedAt="i7c0692c94f6b4075a5e6942ae3e90f2b">Our effective tax rate was <ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzU2_63551539-d65e-4c53-b3ba-fbd5c0828f8c">12.6</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzYw_92524013-cb8f-4f37-b7e4-05363dd02860">18.2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzY3_618d5565-93ec-4f8e-aa78-7c751b627ee2">18.7</ix:nonFraction>% for 2021, 2020 and 2019. The effective income tax rate for 2021 reflects the continued lower effective income tax rates as a result of our European operations, certain discrete tax benefits, the tax effect related to the transfer of intellectual property between tax jurisdictions and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries. The effective </ix:continuation></span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i7c0692c94f6b4075a5e6942ae3e90f2b" continuedAt="ic8d437abe502429c8fb6d32e8c56a93a"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income tax rate for 2020 and 2019 reflects the tax effect related to the transfer of intellectual properties between tax jurisdictions, the effective income tax rates as a result of our European operations and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries.</span></div><div style="margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5Nzg_626fcf72-6f77-4f59-82a3-b7e9acd387e5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItMS0xLTEtMjMwMjU_359872f4-980f-453a-9bda-cd1f4ba6a874">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItMy0xLTEtMjMwMjU_6193731c-f392-48e7-be2e-531e16fbf122">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItNS0xLTEtMjMwMjU_4717522d-038a-40b5-9030-c8b8e1aca871">21.0</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtMS0xLTEtMjMwMjU_c02cbb40-6019-4e04-bfad-9ccf9e3959ef">2.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtMy0xLTEtMjMwMjU_6f1ee0b0-2e04-4be7-8e4a-fffc77631449">0.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtNS0xLTEtMjMwMjU_39b1c123-b934-4b66-8d07-9797eb1c65a6">1.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtMS0xLTEtMjMwMjU_cad92842-2d6d-4c2e-b0b6-04a31555fb19">6.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtMy0xLTEtMjMwMjU_c0ccf61a-251a-4e32-89e2-9cda7f001c49">3.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtNS0xLTEtMjMwMjU_b44ac4df-69ff-4424-87a1-b638f4a8b9c3">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctMS0xLTEtMjMwMjU_82a8c13d-3697-432e-95b0-38738f1d8dda">1.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctMy0xLTEtMjMwMjU_151f6948-b506-40fd-9ed6-567568a3e3cf">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctNS0xLTEtMjMwMjU_c2bf68e1-7377-4a57-a976-c7d5f830cf07">0.5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtMS0xLTEtMjMwMjU_26e8879c-2007-4a48-8cf5-42d96bb8fa76">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtMy0xLTEtMjMwMjU_37d0d001-41c2-4f02-baeb-a9bb40bad656">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" sign="-" name="syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtNS0xLTEtMjMwMjU_fd0a5c39-572b-4d01-a531-fdf2a3bb7d10">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktMS0xLTEtMjMwMjU_87a24bae-cb67-497d-8122-1cec817f0f1c">3.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktMy0xLTEtMjMwMjU_6ce70f65-fcb1-4537-9418-f8a4115eb7a6">1.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktNS0xLTEtMjMwMjU_fe09361c-d148-4058-88cf-6d6baeef3b6f">2.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTEtMS0xLTIzMDI1_041707be-d789-4298-b2a5-41bf12b31579">12.6</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTMtMS0xLTIzMDI1_7e464275-f01b-4e17-9870-9d80bfd57b07">18.2</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTUtMS0xLTIzMDI1_ba04e098-441c-44c8-bee6-4cc0c6082a02">18.7</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NzQ_7ee3fb1e-655c-4055-ad0d-93e23a17030b" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItMS0xLTEtMjMwMjU_296e2ba8-4c94-4b1c-a861-87db74af9c70">433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItMy0xLTEtMjMwMjU_62fc2d7f-8cf4-4887-9623-6283ce9eec71">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItNS0xLTEtMjMwMjU_50d52c9d-7b84-49f9-b7d4-d3656a552e95">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtMS0xLTEtMjMwMjU_d8ae28cb-5890-4f9e-9ad1-26eaae022e25">1,848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtMy0xLTEtMjMwMjU_1b81521e-0b42-42bb-8615-c5a02697f39d">1,715</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtNS0xLTEtMjMwMjU_2539cc01-f9fa-4d99-9b99-756b998c7310">2,196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtMS0xLTEtMjMwMjU_b721ccbd-c072-40ea-85a3-b3e606ce95e2">2,281</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtMy0xLTEtMjMwMjU_af4b2fd6-5704-4f40-9d6e-d7310cfa9d34">1,954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtNS0xLTEtMjMwMjU_d7235464-2433-4489-bd1f-8986e257f8cc">2,562</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.259%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItMS0xLTEtMjMwMjU_8c920819-3190-4ca7-9053-1fde67ca067a">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItMy0xLTEtMjMwMjU_4df06e38-3958-4093-bf60-c496859828d7">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItNS0xLTEtMjMwMjU_8afce2a6-1362-44c1-b1c3-12243a33dfa6">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtMS0xLTEtMjMwMjU_bdb99c25-00f9-404d-aeb7-7f942844f1f5">97</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtMy0xLTEtMjMwMjU_64bd5a94-5174-407f-ba7a-c8aa3ba00f70">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtNS0xLTEtMjMwMjU_db19f1a9-7762-4c00-987c-3f71d98b85d4">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtMS0xLTEtMjMwMjU_3a30f87f-de5b-4177-bf79-68c79aa9053a">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtMy0xLTEtMjMwMjU_a30a5a02-035f-408d-a306-851cd122f07d">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtNS0xLTEtMjMwMjU_a6b57c39-060f-4665-9af0-2070d321b66c">324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtMS0xLTEtMjMwMjU_57349091-bd3c-4b6d-ac74-0051da4c5fd3">524</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtMy0xLTEtMjMwMjU_e661691b-d8ec-499a-ba17-8bec4242ea36">307</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtNS0xLTEtMjMwMjU_e46afea8-17a1-4137-8c97-cfe54281cee3">353</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax (benefit) expense:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctMS0xLTEtMjMwMjU_040014e9-f209-44f1-b8f9-10ec0608fdc1">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctMy0xLTEtMjMwMjU_e9415c4d-aa41-42ec-af16-e95db8504b01">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctNS0xLTEtMjMwMjU_1b88d840-2042-4675-8659-773e5545d1fa">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtMS0xLTEtMjMwMjU_c9ad2e79-bf26-4be4-ab92-0052f85df668">23</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtMy0xLTEtMjMwMjU_505fab99-a82c-49ae-ba40-bfd0d3d544f7">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtNS0xLTEtMjMwMjU_e68bbd36-7f5f-4c4b-8ef5-516dac3a306e">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktMS0xLTEtMjMwMjU_63d23911-17f9-47e5-96ec-8125f902e5e7">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktMy0xLTEtMjMwMjU_231576e8-6e39-4ff9-943b-12c19e421d57">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktNS0xLTEtMjMwMjU_7b348f52-c24b-4267-acdf-99628278f6b4">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax (benefit) expense </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTEtMS0xLTIzMDI1_d390c488-b953-49d9-a51b-98a32b0614a1">237</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTMtMS0xLTIzMDI1_1b97422e-a4b9-4fff-80f1-0a02b646f7af">48</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTUtMS0xLTIzMDI1_48f2bbab-9cc5-4a38-a3b7-3fdd3a9e59f3">126</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTEtMS0xLTIzMDI1_dc20b051-4c45-45f4-b0b3-ba90fc039e81">287</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTMtMS0xLTIzMDI1_09bd6dee-107b-4e01-8850-0b1bb43802ca">355</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTUtMS0xLTIzMDI1_fb7683d9-7654-4441-a4d8-ad8db960b390">479</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties included in other income (expense), net were expense of ($<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE3OTE_268d19bd-7dbc-4983-aff8-0c4bf3570751">23</ix:nonFraction>), ($<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE3OTU_a2c72fc5-bcf5-4218-ac7b-5c62329094ff">35</ix:nonFraction>) and ($<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE4MDI_baf82994-a1b7-4616-8ef5-802ccbc8f2d9">9</ix:nonFraction>) in 2021, 2020 and 2019. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NTE_4f76dfeb-2151-405b-a9e9-b70514cccaad">283</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NTU_14d9b578-7fc8-4220-8a8f-9a351a6fc1e1">41</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NjI_fd9d5d8d-1a36-4404-87da-64b249e21281">50</ix:nonFraction> in 2021, 2020 and 2019.</span></div><div><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5ODI_25b39db9-d3c5-4769-9a7e-6eceb10ff88e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.463%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzItMS0xLTEtMjMwMjU_6a0273c0-90ab-4b96-b191-d0a585b141cf">513</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzItMy0xLTEtMjMwMjU_1d0f5e0f-5e1e-44f6-93b1-959030124d9b">434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzMtMS0xLTEtMjMwMjU_8814c025-3910-48f8-b51f-4c2ac51bfb9a">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzMtMy0xLTEtMjMwMjU_9f744985-e6ed-47dd-9daa-ac9391548876">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzQtMS0xLTEtMjMwMjU_50f7ee3c-9f40-4c8c-af00-48eb3bd0189c">501</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzQtMy0xLTEtMjMwMjU_75dd8419-b994-493a-9c95-5246817af252">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzUtMS0xLTEtMjMwMjU_40ce8810-71bc-49a0-bad2-ef61d30d98b3">1,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="syk:DeferredTaxAssetsDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzUtMy0xLTEtMjMwMjU_d97af8f0-9651-4de7-96cb-20505a4429bf">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzYtMS0xLTEtMjMwMjU_e5de67bb-bbd7-4090-92c1-695ce0b4a7b3">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzYtMy0xLTEtMjMwMjU_cf48fad2-4a8b-4125-a18c-40f654e3bb8d">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzctMS0xLTEtMjMwMjU_717026d4-c4c8-424f-83dd-ffeda496759a">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzctMy0xLTEtMjMwMjU_71233818-ecd2-4eb8-a4a8-d94758978874">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzgtMS0xLTEtMjMwMjU_69c0778a-7e5a-4acd-8004-b60b10a30a81">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzgtMy0xLTEtMjMwMjU_98a2fbe9-7ad0-4594-b4b1-ea29d78b472d">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzktMS0xLTEtMjMwMjU_4e001adf-d548-404b-9d69-e83c6837d973">191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzktMy0xLTEtMjMwMjU_0ea53301-34c8-434c-b82b-af2cfd2fd30e">166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEwLTEtMS0xLTIzMDI1_974bdb82-aaf0-4ac9-a0b1-679da3d858bd">2,861</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEwLTMtMS0xLTIzMDI1_de8ae276-8b33-4e6f-8ee6-a93d06c1b4bf">3,063</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzExLTEtMS0xLTIzMDI1_52a9eb25-1ddc-4a75-be6b-53f00f321f28">164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzExLTMtMS0xLTIzMDI1_c58d19db-4318-4784-809a-8e4d3e40465f">203</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEyLTEtMS0xLTIzMDI1_a2d99987-8f2c-4786-947e-9e8f5a00cf98">2,697</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEyLTMtMS0xLTIzMDI1_caab2b3d-b285-4b79-ab3c-6aaced7c5b15">2,860</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE0LTEtMS0xLTIzMDI1_87c95137-347b-4e0f-85aa-469c8cfe1b0e">891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="syk:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE0LTMtMS0xLTIzMDI1_7175d4c5-a418-4e76-809f-5c2ceeaf673e">1,286</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE1LTEtMS0xLTIzMDI1_cfc4777d-fd19-4791-aa12-c64a2eee7af5">114</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE1LTMtMS0xLTIzMDI1_f627d6ae-d467-453c-a67b-f67fe7e08f6b">161</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE3LTEtMS0xLTIzMDI1_9b072fe8-3ca9-4307-89d2-9ec8f6526f1a">1,005</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE3LTMtMS0xLTIzMDI1_0c7d023f-da68-4024-8cf3-c26830b41815">1,447</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE4LTEtMS0xLTIzMDI1_00efef77-7e8c-4524-8bb0-cd6aef752c8d">1,692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE4LTMtMS0xLTIzMDI1_4d9fa596-b220-475b-926f-2c80f94e5e15">1,413</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIwLTEtMS0xLTIzMDI1_4a6302a9-8909-41c8-8faf-8c0d377e26cb">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIwLTMtMS0xLTIzMDI1_8f48a59a-4164-496e-a91e-ac5735a0cab8">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIxLTEtMS0xLTIzMDI1_cb80e344-8e57-4a54-a4f8-29ee7c2869ca">68</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIxLTMtMS0xLTIzMDI1_dfa41b67-aaa2-49b3-8e53-ebf3a9e47e0f">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIyLTEtMS0xLTIzMDI1_6fd43af1-062d-4ca6-9547-ee08c0afc1c6">1,692</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIyLTMtMS0xLTIzMDI1_06f7ba01-beda-4439-91c6-4b44e5ba2848">1,413</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest and penalties were $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIwMjI_8b8063ee-2dd2-405e-917d-2e0d33e015fd">150</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIwMjk_96f56ca3-5f08-4c08-bdc9-04eeee43a7c0">133</ix:nonFraction> on December&#160;31, 2021 and 2020 which were reported in current and noncurrent accrued expenses and other liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards totaling $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIxNzM_89966d7b-2c4b-4f06-bb08-3604112d5f60">602</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIxODE_8aa3fbc5-2138-4369-88ac-95d246d26c77">192</ix:nonFraction> being subject to a full valuation allowance ($<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIyMjk_a234bb93-cfe1-4c77-9418-1f6efc39fc78">183</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231" decimals="-6" name="syk:OperatingLossCarryforwardsSubjectToValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIyMzY_2a77e8ba-b616-415d-914c-ee3359981170">106</ix:nonFraction> related to the Wright acquisition) on December&#160;31, 2021 are available to reduce future taxable earnings of certain domestic and foreign </span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="ic8d437abe502429c8fb6d32e8c56a93a" continuedAt="i7152f1b21285477a8b9e7797569d95ad"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">subsidiaries. United States loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i1cd24230505248839fa2f817aad88236_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI0MTA_fa9cd445-b8e6-477b-84a8-2a7c9ddceda9">403</ix:nonFraction> expire through 2045. International loss carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI0NzA_3ebd5739-c1c9-4e93-9fbf-eabf36b0991d">198</ix:nonFraction> begin to expire in 2022; however, some have no expiration. We also have tax credit carryforwards of $<ix:nonFraction unitRef="usd" contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231" decimals="-6" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI1NzM_d8f52fbc-882e-4afd-9b13-92a5723ffd8e">104</ix:nonFraction> with $<ix:nonFraction unitRef="usd" contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231" decimals="-6" name="us-gaap:TaxCreditCarryforwardValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI1ODE_095ed2e8-12d4-4477-99c4-418e0526654a">83</ix:nonFraction> being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2022; however, some have no expiration. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act ("the Act") was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SummaryOfIncomeTaxContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NjQ_b3bd2b62-6d33-4639-a1b4-f60939900e3d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.258%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzItMS0xLTEtMjMwMjU_9caf8130-22a0-4fdd-9efb-9152a626a719">457</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzItMy0xLTEtMjMwMjU_722ee445-2508-4e86-9ff5-eb1244d85b27">472</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzMtMS0xLTEtMjMwMjU_31ffd91c-bf8e-4d52-93c6-cda6f4cb6475">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzMtMy0xLTEtMjMwMjU_8c403ef2-797c-4413-b878-01208e58b543">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzQtMS0xLTEtMjMwMjU_7f5fa2dd-b4ee-4d58-b8af-1ba0ac7aa16d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzQtMy0xLTEtMjMwMjU_872ac5f0-4ecc-4a88-85a1-2a3986b483f5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements and resolutions of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzYtMS0xLTEtMjMwMjU_7be4a944-ddb7-4d5e-8d71-e7c81660d4ba">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzYtMy0xLTEtMjMwMjU_737a3138-3d0f-4308-8ccd-3693444c4dcf">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzctMS0xLTEtMjMwMjU_20b44f91-3af6-49f1-bc5c-0c7c9c39552b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzctMy0xLTEtMjMwMjU_ea9d9f30-2948-492e-9d15-75dc040b0563">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzgtMS0xLTEtMjMwMjU_455a2ce8-f064-48e3-adb7-afa652f91341">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzgtMy0xLTEtMjMwMjU_e1f61d8b-4fec-4132-872a-4d9b243756b4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEwLTEtMS0xLTIzMDI1_e1741942-92b8-4b2c-8756-d5160ffa575b">444</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEwLTMtMS0xLTIzMDI1_38043969-2955-4dd7-89b6-0bfec6d53dca">457</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEyLTEtMS0xLTIzMDI1_24100d80-bc02-4e59-b93e-bc1361d79b8b">444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEyLTMtMS0xLTIzMDI1_36d5208d-23b1-4c85-8162-bffd9b7a7e58">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzM0NTU_d1d1ce2c-c25a-4969-b84f-61467e8a9dff">445</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzM0NjI_a62eedbc-9d4e-4233-869c-82e4e07a1298">456</ix:nonFraction> in 2021 and 2020 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.</span></div></ix:continuation><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i7152f1b21285477a8b9e7797569d95ad">In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax years are open from 2014 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2006 through the current year.</ix:continuation> </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_139"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 12 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NDE_f420cf0f-08a5-40b2-9dbd-9ff552e709dc" continuedAt="i9c35b32eafcd44fe9738eeb9ecad5e2d" escape="true">RETIREMENT PLANS</ix:nonNumeric></span></div><ix:continuation id="i9c35b32eafcd44fe9738eeb9ecad5e2d" continuedAt="i7f5f341ad744480bbfa99dc4cde5df34"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock </span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><ix:continuation id="i7f5f341ad744480bbfa99dc4cde5df34" continuedAt="i4ac2671f27144de5bdef6d99f1cf2807"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:DefinedContributionPlanDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5MzI_3d07e18e-b967-46f6-bb3b-f995c548bf11" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtMS0xLTEtMjMwMjU_0076aaeb-0077-4857-9842-20b19afdcbc4">259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtMy0xLTEtMjMwMjU_ab91f6cc-7b54-461c-b5a3-d2ac07ff2aa8">235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtNS0xLTEtMjMwMjU_bc0f6fe3-9cb5-40ab-9a40-f7cb2214c490">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItMS0xLTEtMjMwMjU_d04e3c73-8b27-4eb7-99a8-1f273d80395e">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItMy0xLTEtMjMwMjU_d245053d-0108-4cd2-8ab6-15893787b6d8">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItNS0xLTEtMjMwMjU_2442aec9-a4c4-4d44-8518-f86c5daae32e">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtMS0xLTEtMjMwMjU_39d0745e-0f1d-4d9b-96e4-a5a82fe02c8b">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtMy0xLTEtMjMwMjU_abd95d59-889d-47f1-aa67-5545eadf5692">542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtNS0xLTEtMjMwMjU_b6898402-aee0-48f3-bd71-1819bacba15a">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtMS0xLTEtMjMwMjU_8920ee4c-9124-44bc-8a3b-59e16d2ea29d">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtMy0xLTEtMjMwMjU_cc518458-edc8-4bdc-803f-5f6d4beb2cdc">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-5" name="syk:DefinedContributionRetirementPlansCommonStockHeldByCompany" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtNS0xLTEtMjMwMjU_14a5bb55-f57f-4bb3-83ef-903e1da6ff7f">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtMS0xLTEtMjMwMjU_eb01eb96-2449-4048-ad8c-0f6db83b2be9">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtMy0xLTEtMjMwMjU_555d0305-f518-4c1e-a1e4-27d3f4bce236">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="2" name="syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtNS0xLTEtMjMwMjU_66a8b5af-660d-4cf6-b720-c526b266340c">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. Substantially all of the defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5Mjc_f5b1e1d4-f69b-472e-ba4b-260695b98752" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:61.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.427%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.430%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItMS0xLTEtMjMwMjU_cbd85a0e-bd11-4b27-95aa-a13fbfdc46c8">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItMy0xLTEtMjMwMjU_981b8751-09c5-4c0e-9fc3-4703d6a53ee9">63</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItNS0xLTEtMjMwMjU_aa8bf3ba-0102-4c58-be53-c619c22006a6">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtMS0xLTEtMjMwMjU_4d743944-9535-447e-ba57-8fd3f32c27a4">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtMy0xLTEtMjMwMjU_c49e37b5-a4c7-427b-b97f-3fb77b3ff8c0">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtNS0xLTEtMjMwMjU_9bdb2f1e-da97-4fa5-8091-f478c5e0eb62">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtMS0xLTEtMjMwMjU_e9691ce8-caad-48e5-9d6c-cf6633a0f9bb">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtMy0xLTEtMjMwMjU_13befa4c-b7fb-46b2-9af3-fe883fea7249">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtNS0xLTEtMjMwMjU_6c25ab7c-48e0-4667-8c8b-8d2c815a3e42">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtMS0xLTEtMjMwMjU_dac270e4-ab81-4c91-b1de-a530e08c6f11">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtMy0xLTEtMjMwMjU_bbee48d8-c342-4f07-92eb-56a881b04e70">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtNS0xLTEtMjMwMjU_3ee6e3c9-0f7b-4f5c-870b-c3bb2bba9cde">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtMS0xLTEtMjMwMjU_3a051aed-4a6c-4d6d-9592-637cad08ed34">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtMy0xLTEtMjMwMjU_f5e01d4a-1b40-4235-a6b3-b4285d11792c">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtNS0xLTEtMjMwMjU_01e422d9-fa07-400c-ae43-9e5c03b0b689">9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMS0xLTEtMzQyODM_d5e68a6f-4f9f-48fa-9a7b-7fcd65983ce8">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMS0xLTEtMjMwMjU_ccd4b9bf-e349-44e9-ab09-f91c705df9cf">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMy0xLTEtMjMwMjU_a5b4686c-4f4f-4beb-8ffd-87bd964f976f">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctNS0xLTEtMjMwMjU_d7cc8076-6f5b-4fa4-a599-57db2cb5d1ba">49</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktMS0xLTEtMjMwMjU_ae449117-49a6-4d35-befa-1eac532c3c2e">132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktMy0xLTEtMjMwMjU_074b870a-9ac5-43a7-a977-32346386e45c">117</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktNS0xLTEtMjMwMjU_2c7697a4-1161-468b-91bb-29b13bc4a7fc">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTEtMS0xLTIzMDI1_6625a3a6-ebf9-4871-8751-9bf803054d93">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTMtMS0xLTIzMDI1_597a93fc-034d-4041-b74b-bc1d03d27911">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTUtMS0xLTIzMDI1_ce9450c6-eec7-4ac6-a7a6-bcdbd08e0204">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTEtMS0xLTIzMDI1_d593343a-2f93-461b-990e-8cea111fc3a7">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTMtMS0xLTIzMDI1_2bc8c47d-359d-48e4-9fb9-0b53e4864ddd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTUtMS0xLTIzMDI1_85f183ab-d73e-481b-8264-388b8de2da09">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTEtMS0xLTM0MzEy_f6a3d9b7-8d77-4028-93e7-27c1b00bd148">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTMtMS0xLTM0MzEy_583b0ded-6d94-4e3d-9f1b-6302a0a01c56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTUtMS0xLTM0MzEy_dc022016-b37a-43fd-bda8-cae673440b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTEtMS0xLTIzMDI1_73d8615d-fdcb-4461-837c-39adb41c5738">138</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTMtMS0xLTIzMDI1_58a81195-dc3a-4ce1-b925-e46bb2c2c3eb">105</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTUtMS0xLTIzMDI1_85fb5e12-61eb-4385-96a5-d8f0ab03dd06">66</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTEtMS0xLTIzMDI1_241c72a5-4670-4612-9b94-4cd9b89f0c30">64</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTMtMS0xLTIzMDI1_4ca3a661-037f-4089-8d5e-6ee9636da648">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTUtMS0xLTIzMDI1_5c3e1124-a2ce-4156-94d6-973059c0e694">115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTEtMS0xLTIzMDI1_0da37e06-b161-4406-b6cb-c76ead196d2c">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTMtMS0xLTIzMDI1_9bf2c151-0d6e-4950-9beb-a4ed61717263">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTUtMS0xLTIzMDI1_409f7f31-8ae8-4ba7-b568-09b4d42f3f5f">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTEtMS0xLTIzMDI1_0ca23ba2-df76-4cbd-b85f-f7b8dced1de0">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTMtMS0xLTIzMDI1_38780902-037d-4936-94a6-49c4c15f8910">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTUtMS0xLTIzMDI1_4cd64d6b-a2bd-4c59-b9ca-0e4d071b8b59">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTEtMS0xLTIzMDI1_572f911d-3520-49ed-a73c-947ce17476d0">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTMtMS0xLTIzMDI1_4e0594ad-46d5-4468-8d79-d3dde803b2ab">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTUtMS0xLTIzMDI1_e2406dfa-2ef8-499c-ac09-e07ba12a9df8">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTEtMS0xLTIzMDI1_cfa0dacb-e1f5-49ac-bd37-64a803749487">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTMtMS0xLTIzMDI1_f3020b82-6b71-4ca0-8a6d-15171aaa66bd">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="3" name="syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTUtMS0xLTIzMDI1_52058103-d5d5-4914-9a25-5ef90161718f">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.</span></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">35</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i4ac2671f27144de5bdef6d99f1cf2807"><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NTg_2a35ad95-9984-4bd8-ba7f-8accba2c093d" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEtMS0xLTEtMjMwMjU_96b25926-ae90-4957-924f-ffc488d8a90d">543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEtMy0xLTEtMjMwMjU_35f15642-ac32-424e-ba25-b240ba3956e6">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzItMS0xLTEtMjMwMjU_15c0ebac-01d2-4353-80f8-c7dee7ed907f">1,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzItMy0xLTEtMjMwMjU_1b0f5742-066e-4038-8884-fe3bbcb1fe64">1,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzMtMS0xLTEtMjMwMjU_edc3323b-f27b-451a-a4c7-c9bcacdc6966">493</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanFundedStatusOfPlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzMtMy0xLTEtMjMwMjU_5302603f-4b30-41bf-9bb4-73aacae43511">596</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzUtMS0xLTEtMjMwMjU_402bbfd7-6916-4305-86ff-5e59c71ac361">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzUtMy0xLTEtMjMwMjU_c0516d49-a845-4799-8f8a-29ede4846004">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzYtMS0xLTEtMjMwMjU_e567b62e-dd3b-430b-85d1-047172be7404">491</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzYtMy0xLTEtMjMwMjU_f39ba92f-74af-4f1e-9576-95c0f3798b94">594</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f988e7869e24ec3bddc891426b08439_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzgtMS0xLTEtMjMwMjU_ba1a46cb-fa58-4062-b7da-81381e04ad2b">215</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i01ba6c5c269d4255a194114389cbf28c_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzgtMy0xLTEtMjMwMjU_3c2cbcd9-1de1-43d4-830f-dd8d47ad266e">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f988e7869e24ec3bddc891426b08439_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzktMS0xLTEtMjMwMjU_eca8c864-1fab-42fa-8651-9e50807d89cc">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01ba6c5c269d4255a194114389cbf28c_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzktMy0xLTEtMjMwMjU_72d00304-deee-4e1c-9284-60c70e92c7bd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEwLTEtMS0xLTIzMDI1_cb9d8022-1fcb-48eb-84e7-907a96daa4c6">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEwLTMtMS0xLTIzMDI1_30f2b067-74a6-4344-9876-4598aa1712e6">346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5MjU_aa843161-aaf8-4588-a1b1-657fab739f18" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzItMS0xLTEtMjMwMjU_f3bff267-5724-420e-85dc-97700f0a0234">1,118</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzItMy0xLTEtMjMwMjU_79dc21e3-abc0-438a-a886-f15a4c7b3ded">869</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzMtMS0xLTEtMjMwMjU_bca3abf7-7bea-465c-af74-a51076c4a853">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzMtMy0xLTEtMjMwMjU_59503c01-10bb-445a-ac83-dfa73d968617">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzQtMS0xLTEtMjMwMjU_75992b4e-fcbd-4640-a187-2bb64e9210fe">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzQtMy0xLTEtMjMwMjU_5344486c-183e-443c-9383-78453df01eb2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzUtMS0xLTEtMjMwMjU_394698f1-94c0-4c66-9eec-c57f9d4789e6">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzUtMy0xLTEtMjMwMjU_db7e63d0-b8a6-4e5e-a49e-c7dbac75eda2">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzYtMS0xLTEtMjMwMjU_f548e94e-2168-4896-9626-17812f258693">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzYtMy0xLTEtMjMwMjU_72f02a32-ded2-4f92-a44b-fd74a529b4da">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzctMS0xLTEtMjMwMjU_73434bd1-0cdd-495a-963b-15fcf2994824">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActuarialGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzctMy0xLTEtMjMwMjU_2d850148-8b92-4ab9-97ee-50adda36e486">110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzktMS0xLTEtMjMwMjU_c76c3ee6-8fc6-4bc6-b3a6-099377ca44d7">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzktMy0xLTEtMjMwMjU_1adcc140-c34a-4ff4-9933-fadaa8e75830">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEwLTEtMS0xLTIzMDI1_fb06f5a1-975b-4c08-b35f-34141585e8a2">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEwLTMtMS0xLTIzMDI1_05c95d53-598d-4244-bbc4-5d0c8e203c2d">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzExLTEtMS0xLTIzMDI1_1edebcb4-a923-43ab-a66f-3926c0646e06">1,036</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzExLTMtMS0xLTIzMDI1_88ec882f-335b-4fe6-b180-2a6934a765b0">1,118</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEyLTEtMS0xLTIzMDI1_15377ad8-b772-48a0-b197-3e84e1097f67">987</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEyLTMtMS0xLTIzMDI1_5802478d-f3df-41be-aab4-57c9f940376d">1,056</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NjU_fb4ddca7-3f2a-4d1e-87a0-058bedcc2826" continuedAt="i63e3143d5b0140e7bae920cb90d5483c" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.474%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzItMS0xLTEtMjMwMjU_3c3d1695-f747-4784-8cc2-ccd352a0467a">522</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzItMy0xLTEtMjMwMjU_22327dfc-a23b-4688-ac49-795b9288fb6d">428</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzMtMS0xLTEtMjMwMjU_4ea8084a-c9e8-41d4-a37e-e5b0b67a9ae7">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzMtMy0xLTEtMjMwMjU_142b6df0-3f99-469d-bd2b-a62b2209d791">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzQtMS0xLTEtMjMwMjU_fc433650-73d7-452c-a9cc-fd5866cfc979">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanContributionsByEmployer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzQtMy0xLTEtMjMwMjU_ba69a34f-0acb-4e2c-a4bc-798191bc34b3">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzUtMS0xLTEtMjMwMjU_e9405da9-b0d3-42c0-8a70-0e026362bea3">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzUtMy0xLTEtMjMwMjU_7b6ab299-ef88-4e36-b126-5f333b6cda8d">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzYtMS0xLTEtMjMwMjU_e64f1576-8681-4f4e-8d68-ef6dd4ba50d8">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzYtMy0xLTEtMjMwMjU_db8af639-849a-4b37-b85e-889bb8570408">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzgtMS0xLTEtMjMwMjU_8926910d-38db-4990-aa91-5edff27153a0">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzgtMy0xLTEtMjMwMjU_edd025c6-8ce0-4b71-97a4-05c004ffa061">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzktMS0xLTEtMjMwMjU_09d2ac28-ce53-4069-b7c5-b5b0ce829220">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzktMy0xLTEtMjMwMjU_d44d064c-45cc-4a5c-a05b-0d0c7dc4fc22">522</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5Mjk_198159bf-33aa-456b-8ed2-c681f278ecc6" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:33.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.649%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Target</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItMS0xLTEtMjMwMjU_bb23d893-debb-434f-b325-4b287339cd18">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItMy0xLTEtMjMwMjU_57619031-9e10-455b-a186-d44ca482986b">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i91262a514140409ebdc684fab644ffa5_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItNS0xLTEtMjMwMjU_544b9d3b-f853-4eb6-b327-aa5935f9ab77">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc0ea2e735eb45ac82e987217fe33ed3_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtMS0xLTEtMjMwMjU_d8ee7b38-6216-451c-b987-973fee95e550">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icc0ea2e735eb45ac82e987217fe33ed3_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtMy0xLTEtMjMwMjU_ec9b1a25-3eb9-4a69-b252-6d32be2bf3aa">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia67b9db95e8d4be5bc9dae41d9dc8f3c_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtNS0xLTEtMjMwMjU_5a18f3bf-84af-4072-900b-e3905428a3a1">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0472521a2c54bd8a5c77c14ed66218b_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtMS0xLTEtMjMwMjU_1585c374-01fe-4398-a56e-b93a5ed7062c">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if0472521a2c54bd8a5c77c14ed66218b_I20211231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtMy0xLTEtMjMwMjU_c433042c-ce91-4cee-9864-ac7fdc588034">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i232384248c814e63916518edfbade00d_I20201231" decimals="2" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtNS0xLTEtMjMwMjU_cdedcaf5-211d-46e1-9da6-d75f3e2f98e1">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtMS0xLTEtMjMwMjU_ef864a7a-3e5b-491c-9593-b7e3388c56c0">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtMy0xLTEtMjMwMjU_41b18140-1e47-4d2d-ad6c-59dcd958f8aa">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="INF" name="us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtNS0xLTEtMjMwMjU_f2b5661b-2481-4b2f-8881-edce5795228a">100</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><ix:continuation id="i63e3143d5b0140e7bae920cb90d5483c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.220%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.511%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i001424c220ec43b8bcc76dd7bf700136_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMS0xLTEtMjMwMjU_38187ed2-bbc0-4c4a-b9dc-b9479889f822">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604a2bd489464dd7a650d828b235f087_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMi0xLTEtMjMwMjU_b4035904-5cd5-443e-9ea7-7d4c61cf8d56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f45f3a6f31f4b0da0d211a6aef869d9_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMy0xLTEtMjMwMjU_8ab2a14a-1ac0-4e96-a5c4-5e0e944f9b56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dddab9268854061b35a9e07a6318dd6_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItNC0xLTEtMjMwMjU_18c4cc59-aa4d-465c-8bf6-748fa9e29563">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6a4f6e1674412fa1a94fcd3d311a14_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMS0xLTEtMjMwMjU_1264abae-7d7b-4aab-8dba-365fdf4b5529">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i610ab94283ee44cebe2aff94198af011_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMi0xLTEtMjMwMjU_b2671cda-d7d8-4af7-9959-1656d95cdab3">119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebfde9edb94c4bffa0897fbc6d059649_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMy0xLTEtMjMwMjU_537834e2-a4af-4db2-90a6-9848c021b15a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtNC0xLTEtMjMwMjU_86d04425-8147-49e3-a78e-a0640ceee898">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0732c03ffb524a518cf83d8eea84056b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMS0xLTEtMjMwMjU_a756d44b-ac5c-4da2-b7a9-174b9c29eb2a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5881fc803ed74916a236a87615ed0ee2_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMi0xLTEtMjMwMjU_7965a798-33f7-4b25-b153-4397dbdf6618">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae7b85422cd47d9891e57aba56d1654_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMy0xLTEtMjMwMjU_0706eebe-e422-40c1-b805-d261586220f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice25e379b81f4476bc629c2369aaa8d8_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtNC0xLTEtMjMwMjU_543c21a2-3314-4cb8-ae85-4a4c46209858">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a7ab2b119e94e27bd120bc5f0693216_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMS0xLTEtMjMwMjU_2100ae6f-89e8-4ae4-ae89-4a91a6f90fd5">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73ac471a7a3844b192433916f6cb498b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMi0xLTEtMjMwMjU_0e27b468-d376-485a-9022-a12cfc869d75">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i316fb40a5796411d9e52da1c35ca3e5e_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMy0xLTEtMjMwMjU_fe30e129-6d9e-477e-9368-f42824e4d0ec">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c2080de3934abf904eba7abade7988_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtNC0xLTEtMjMwMjU_a87a9a42-5602-4edc-830c-1958f3ab73fc">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMS0xLTEtMjMwMjU_86e4bd4c-1d40-4347-b73c-19374c0ff35f">55</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMi0xLTEtMjMwMjU_c9c4f292-48b7-482a-b05d-7e5321cadf39">389</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMy0xLTEtMjMwMjU_3af8860e-bc3b-4ee8-93ee-871977d886a5">99</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtNC0xLTEtMjMwMjU_2ee97a46-cd47-409e-804f-bbc601ed7718">543</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47733b1c7ef048cbb418c5fcc8c43a27_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMS0xLTEtMjMwMjU_bab1e86d-4ee5-47e7-b6f5-6b058973b019">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i164f42b17a9f4770bd5118f6cd88f3c2_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMi0xLTEtMjMwMjU_328a92c9-2917-4392-bdcd-8883f88287d2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idccdaec3350743cea685af7c28bdb255_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMy0xLTEtMjMwMjU_132515f3-bceb-45ca-8cc3-15756a0a7cf7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30492a5243574d7bb61e3c33c92232cf_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtNC0xLTEtMjMwMjU_7d67be2b-a48f-49d8-9d34-6070f8059b23">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06973aac182492f9622c7ad7902fabf_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMS0xLTEtMjMwMjU_14407cea-126d-412b-b60a-32be99a8dbcf">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba09bb97f57e482fb3622b4b9a6a4342_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMi0xLTEtMjMwMjU_506bd493-0e97-4ec7-8fc9-92f088468dab">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8b81436534b4ed681424a5481d1d2a3_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMy0xLTEtMjMwMjU_bea53d64-dbc7-409b-996b-b155299a7cb9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91262a514140409ebdc684fab644ffa5_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktNC0xLTEtMjMwMjU_c307c624-07ac-4735-b98d-78e5fcfca767">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id692e1a1c6d14320af222fb9457d39b9_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTEtMS0xLTIzMDI1_131f63c7-9780-41a6-9887-aab0e7424ea5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic458106dafdd43c2a2d64c80f80f0d0f_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTItMS0xLTIzMDI1_d8e9d24b-cf58-4bce-8f6b-39f472c36fd4">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69cf095ab3ce444bb44754bf320b5332_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTMtMS0xLTIzMDI1_2dc0d47b-6bc7-467f-897e-aa8e0b344283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie48c458d392e4f3194b70925a5318b6f_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTQtMS0xLTIzMDI1_0bce9e89-3f67-4dd9-b9d9-90cdcbcad1bc">203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b168e0fd23c4ecbb3d1680b32078cc4_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTEtMS0xLTIzMDI1_54facd34-7d4d-4c6d-8b3d-10d29955c0ef">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84cef904fd4a491cbb3a73b26683ced7_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTItMS0xLTIzMDI1_fd66b98a-51ce-4516-ace7-a12412ee64d6">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i301b21993d364219b05cf96921f44824_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTMtMS0xLTIzMDI1_314c2aea-6537-4c8e-b082-c163dc4592aa">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b725428866433e884015213e1d73d8_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTQtMS0xLTIzMDI1_b99b4b3e-aa18-4b89-88f8-e78a4cc5d465">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTEtMS0xLTIzMDI1_990683b8-b14c-441b-81d6-0075d125b524">46</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTItMS0xLTIzMDI1_54221d31-19c9-4de0-a520-016425d61770">372</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia21cd3e409fc4facace34555a676001b_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTMtMS0xLTIzMDI1_a2f32e23-6ad7-4428-834f-97b4db1589f4">104</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:DefinedBenefitPlanFairValueOfPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTQtMS0xLTIzMDI1_06911699-07b6-4f27-9175-4f66e00d4d2a">522</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $<ix:nonFraction unitRef="usd" contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE2NDkyNjc0NDM3MDM_cc6d2882-5100-463c-bfb6-df0103b99f7c">5</ix:nonFraction> decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $<ix:nonFraction unitRef="usd" contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE2NDkyNjc0NDM2ODk_6d565607-3b6d-4c68-861f-edd095012e7d">21</ix:nonFraction> to our defined benefit pension plans in 2022.</span></div><div style="margin-bottom:1pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NTA_75474dc9-3e3a-47ae-8545-2dce7bd01f64" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.535%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027-2031</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMC0xLTEtMjMwMjU_3c30552c-9d9c-43ff-8448-6659556afb0d">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMS0xLTEtMjMwMjU_77a3eecd-46e2-4b22-879f-4094514353ee">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMi0xLTEtMjMwMjU_b93a2344-8ebd-4336-a86d-ddfdd53ece1d">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMy0xLTEtMjMwMjU_10352b7f-fa42-452f-be1b-30b9594561fb">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItNC0xLTEtMjMwMjU_83fd8076-a5d5-4b7d-80a4-6e02163f30bc">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItNS0xLTEtMjMwMjU_3c41cfa8-1c71-4981-be47-4a51363a1846">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div id="i2e9b98e114ab4a2ba09a958d786789f3_142"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 13 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:QuarterlyFinancialInformationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90ZXh0cmVnaW9uOjU0NmVmOTYxZTQ0ODQ3YmI5YTZhNjAyYmM2NzU2MmUxXzYz_e1e8361b-e596-47dd-9f1b-bca7e6ff914b" continuedAt="if0ef573dfa6541f3bdc7609df306f44a" escape="true">SUMMARY OF QUARTERLY DATA (UNAUDITED)</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:justify"><ix:continuation id="if0ef573dfa6541f3bdc7609df306f44a"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90ZXh0cmVnaW9uOjU0NmVmOTYxZTQ0ODQ3YmI5YTZhNjAyYmM2NzU2MmUxXzU2_9aaa8290-3ef4-42c5-9e2e-2923981c9fae" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.031%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.368%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMS0xLTEtMjMwMjU_7a658886-bbd8-4c90-860d-2f10ea2d9413">3,953</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMi0xLTEtMjMwMjU_6d5d8d48-6ce8-4802-9cc2-e6a4961a9471">4,294</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMy0xLTEtMjMwMjU_47137661-28cb-4bc8-a88a-6e10aab317f6">4,160</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtNC0xLTEtMjMwMjU_8ac4d13f-1b33-4482-a5b2-2c3530a1baf3">4,701</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMS0xLTEtMjMwMjU_94d82587-7efa-44c7-b8a0-1370b6560d76">2,509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMi0xLTEtMjMwMjU_541c82f3-94d9-4793-a730-44252db7410c">2,772</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMy0xLTEtMjMwMjU_ea169c75-3a95-432e-896d-5959602fc3fd">2,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItNC0xLTEtMjMwMjU_16f89beb-4c70-4faa-b15b-6427289f9d52">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMS0xLTEtMjMwMjU_75ae51a9-fa54-4b80-b0f2-d34790d322d3">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMi0xLTEtMjMwMjU_7d21a2a6-c97c-442a-b623-334a6324eb77">662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMy0xLTEtMjMwMjU_07daab05-ad5a-4df7-afdc-b1de360156a2">495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtNC0xLTEtMjMwMjU_0cff2bd8-27f9-46b8-b07c-c3b0ebc99541">757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMS0xLTEtMjMwMjU_5aaa3c0f-d081-4265-b81a-5a2ec003b0ef">302</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMi0xLTEtMjMwMjU_75c37bc3-2427-443c-a3e5-eabc432f86c4">592</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMy0xLTEtMjMwMjU_c879cbe4-68db-45bb-ae40-bd2ceeb7dc66">438</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtNC0xLTEtMjMwMjU_da5191db-2a51-4393-9468-6ea1c51a056d">662</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMS0xLTEtMjMwMjU_61a72a9a-16d0-4911-bc7b-f83115d2e218">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMi0xLTEtMjMwMjU_dd3570a8-9642-4d20-9009-b8dd16f3befa">1.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMy0xLTEtMjMwMjU_fc605a3d-9c78-4e54-bfa7-3e69f79cc522">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtNC0xLTEtMjMwMjU_d7555816-c494-4e0a-b2c1-bb7d2470ee66">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMS0xLTEtMjMwMjU_de3bb338-d916-473c-ab5c-dac3b24a58cb">0.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMi0xLTEtMjMwMjU_ee1b7fad-cf73-4707-a70e-df2419a501b7">1.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMy0xLTEtMjMwMjU_df049e7f-0fe6-42a9-9ee9-3ff2285f9b73">1.14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctNC0xLTEtMjMwMjU_e5118491-392e-423d-b0c9-7be24f8a90cb">1.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTEtMS0xLTIzMDI1_027d075c-2b78-445e-a79a-d849948b17bb">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTItMS0xLTIzMDI1_6d9ae1f6-7568-4309-ac85-0be8c115edc7">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTMtMS0xLTIzMDI1_08dc71ee-157d-4167-83ba-d56155ff4dd9">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTQtMS0xLTIzMDI1_439db36c-1cfb-4b8e-bd80-59f1d46731a2">0.695</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTEtMS0xLTIzMDI1_5afc19f3-ef2b-49e9-afcc-d5f255eddb2e">3,588</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTItMS0xLTIzMDI1_fb1765c2-80f8-4cda-8b0e-e30fb70cbd9e">2,764</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTMtMS0xLTIzMDI1_da230822-4a26-4e8e-b757-c7205c93ec70">3,737</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTQtMS0xLTIzMDI1_b7057368-3add-4596-8c6c-e615a594ce5a">4,262</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTEtMS0xLTIzMDI1_1ff3e03f-774c-4e35-97ef-21e3b0a97f8a">2,331</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTItMS0xLTIzMDI1_0c77e7bb-66bd-4185-9788-4fdabd6a73e0">1,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTMtMS0xLTIzMDI1_a336742b-1a20-4e00-900c-e42a70f10989">2,461</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="-6" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTQtMS0xLTIzMDI1_d0cfa3f0-37f4-48a6-9b27-842339c3813b">2,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTEtMS0xLTIzMDI1_16b40ca3-819d-4b74-811d-cb07699554c7">590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTItMS0xLTIzMDI1_ed92e8f4-bf09-47c0-abbc-176320335680">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTMtMS0xLTIzMDI1_90e904ad-f95b-4b49-a2e7-ca6b62898fb0">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTQtMS0xLTIzMDI1_33f8acc8-a818-4292-b02e-c3113e224acd">671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTEtMS0xLTIzMDI1_f849a3f4-6c78-4e6f-86f6-2306593f5813">493</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="-6" sign="-" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTItMS0xLTIzMDI1_67e97f08-40b5-43dc-9d79-25752a686f5e">83</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTMtMS0xLTIzMDI1_50bdb909-a93a-4af5-995c-20c05215a338">621</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTQtMS0xLTIzMDI1_d526b666-6e62-4cc2-93b9-5888942c19d8">568</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTEtMS0xLTIzMDI1_5ddd63ce-6eb5-43f2-8381-0170b3263cba">1.32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTItMS0xLTIzMDI1_59493a30-12b7-46a0-9f49-d41e41b1b404">0.22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTMtMS0xLTIzMDI1_d19fc5f3-7c1a-4028-9c0c-c8006008604e">1.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTQtMS0xLTIzMDI1_a9f9bd48-87c8-414d-8a8f-8fa04d8c94bc">1.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTEtMS0xLTIzMDI1_4c950d28-114f-464e-be39-2e7a852915a6">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTItMS0xLTIzMDI1_ce5cd7f1-17be-4343-94fa-c96909229e48">0.22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTMtMS0xLTIzMDI1_6e1aa472-ae5e-46c3-b195-6a0535b24989">1.63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTQtMS0xLTIzMDI1_480d8bfa-e4e3-4405-9b2c-97bb5cfe0a73">1.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTEtMS0xLTIzMDI1_04bea81f-0d8b-42d7-b600-053af922ce19">0.575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTItMS0xLTIzMDI1_dc206aab-2c03-4a9b-980a-1016c46b4567">0.575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTMtMS0xLTIzMDI1_fc8a914a-3da4-416c-9ecd-a209a5891ef5">0.575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTQtMS0xLTIzMDI1_ad6facca-0949-4231-b264-6585ee719b27">0.630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_145"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 14 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0Nzk_b8d94263-677b-4a27-a9e6-177a926b8ba6" continuedAt="i4f25aa907c21459ca5ab0a3793cf7dca" escape="true">SEGMENT AND GEOGRAPHIC DATA</ix:nonNumeric></span></div><ix:continuation id="i4f25aa907c21459ca5ab0a3793cf7dca" continuedAt="i1890870de4b64a298f908cf8f87426bc"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective December 31, 2021 we segregate our operations into <ix:nonFraction unitRef="segment" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzEwOTk1MTE2Mjc5ODEz_7d139eaa-16a6-4c55-bab4-768291cf1de0">two</ix:nonFraction> reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine. This change realigns the Company's reportable business segments to its new internal reporting structure and how the Company manages its businesses as a result of the transition of responsibilities of our President and Chief Operating Officer, and the division of responsibilities between Group President, MedSurg and Neurotechnology, and Group President, Orthopaedics and Spine, in the fourth quarter of 2021. We have reflected these changes in all historical periods presented.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NjY_1508db55-2442-490b-84ac-4f2f362d8d43" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMS0xLTEtMzc2MTA_95457f49-bb80-4882-bc21-8d6849e5d488">9,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMi0xLTEtMzc2MTA_a0d7f320-9b9a-4050-acaf-6850ac43504e">8,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMy0xLTEtMzc2MTA_13307655-cdfd-4e2a-91f4-48e4eeabfbdc">8,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMS0xLTEtMjMwMjU_549159bb-5286-4b64-877f-0a7688be3927">7,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMi0xLTEtMjMwMjU_36ddd8bb-2c2b-4610-9e0e-2c631a015a16">6,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMy0xLTEtMjMwMjU_e16300e1-5d23-4f7e-b53a-ed77a61aaff6">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMS0xLTEtMjMwMjU_f835aed6-ac19-4073-be89-0fbf8f70e1ee">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMi0xLTEtMjMwMjU_d46a1480-2428-4b50-b384-af34f926e10d">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMy0xLTEtMjMwMjU_83c5d24f-3c31-4448-9f45-5f1ab87b0b41">14,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMS0xLTEtMzc2MjI_7825f6e0-ba68-4537-aebd-6e0b927767dc">518</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMi0xLTEtMzc2MjI_8a53f787-2d2f-455b-873c-c15166398a29">496</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMy0xLTEtMzc2MjI_b0c3a250-9def-466b-aa51-91a28dcb3ce4">488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMS0xLTEtMjMwMjU_8961b12f-7bd8-4222-8819-3bc7ec7b8e1c">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMi0xLTEtMjMwMjU_266bd4e3-c17c-444b-99aa-7870fac5e54b">458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMy0xLTEtMjMwMjU_65b5f898-dea2-4cd2-b952-5abdd8c6c790">457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMS0xLTEtMjMwMjU_fa5f871e-7f2c-4337-afdc-6ad4f8fa4b91">1,147</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMi0xLTEtMjMwMjU_c5061983-314c-4673-9162-1274e045eeaf">954</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMy0xLTEtMjMwMjU_8126cfef-5ffd-4f0e-ae7d-88ca599af75a">945</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMS0xLTEtMjMwMjU_72914865-3688-4425-b662-d975bcc93172">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMi0xLTEtMjMwMjU_4a057daa-1305-4beb-9cd7-3b4d50408235">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c65783cfed742208972bad227653460_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMy0xLTEtMjMwMjU_550093c8-54ca-4d63-91ad-6bd70c2710df">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTEtMS0xLTIzMDI1_56ee9942-b8c9-4750-8ed2-7e889f37e540">1,272</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTItMS0xLTIzMDI1_144fe88d-759f-4b27-889b-74b3ed6bcbde">1,076</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTMtMS0xLTIzMDI1_a0ec8dc9-85ac-459b-bec6-ab0a7e478c2b">1,044</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMS0xLTEtMzc2MzE_f9b94219-fcb3-492f-81e7-a1434f75853d">2,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMi0xLTEtMzc2MzE_be2fa8bc-57c0-4ff4-9c74-9c84bb4a5d38">2,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMy0xLTEtMzc2MzE_6ea5d344-ae81-4854-b237-7f9734e505c8">2,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTEtMS0xLTIzMDI1_9fb42689-8eb7-48e6-877a-77d8f1694113">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTItMS0xLTIzMDI1_73bcd528-c263-4da3-b3cf-b9917bb5d9e5">1,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTMtMS0xLTIzMDI1_39315ac0-2961-4d29-ad84-2a0682854c9f">2,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTEtMS0xLTIzMDI1_0403821b-7d45-46e8-8bd3-fddb5418efcf">4,987</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTItMS0xLTIzMDI1_3a7a34c8-8660-4fa7-b2c8-9a273859579c">4,002</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperations" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTMtMS0xLTIzMDI1_04989722-eae1-442d-ade6-c04b055c73bd">4,388</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTEtMS0xLTIzMDI1_e4086dbc-ae61-4436-964f-5acb4524c030">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTItMS0xLTIzMDI1_3d5e5f81-48b6-487c-8409-a9b521628181">503</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTMtMS0xLTIzMDI1_6681e19c-e73e-4241-95bf-df2639f1a002">480</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTEtMS0xLTIzMDI1_bb2fbfc7-653e-40f0-892c-32456be66d53">585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTItMS0xLTIzMDI1_388d9565-9b23-4c0d-ac79-d49e20273243">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTMtMS0xLTIzMDI1_a10c2ae6-baa3-4405-8f14-93d49f596c41">275</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTEtMS0xLTIzMDI1_e3e59f29-cdcb-4499-a453-4c86c76a1f25">619</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTItMS0xLTIzMDI1_354aa48b-ba87-4f4a-82a4-b791ca691627">472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTMtMS0xLTIzMDI1_c51e3688-e050-42b7-841b-517a13f669b3">464</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTEtMS0xLTIzMDI1_ce77936e-4176-42cd-a550-0b321d21802e">386</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTItMS0xLTIzMDI1_0986b35a-6071-4ad4-a6a1-a33d47075942">458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="us-gaap:RestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTMtMS0xLTIzMDI1_22295871-bd74-4f24-bc0c-b5c5a02f1493">226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTEtMS0xLTIzMDI1_09d7806e-da00-4a7e-915f-20331a2b6f0a">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTItMS0xLTIzMDI1_97f5d4ca-76f5-4978-bc69-71ee511e361f">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="syk:MedicalDeviceRegulationsExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTMtMS0xLTIzMDI1_3bd65b3c-f230-42e9-8949-01a51bd1e226">62</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTEtMS0xLTIzMDI1_57873bdc-5efb-4479-9f2d-c9927815be52">103</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTItMS0xLTIzMDI1_56e8ec59-0aef-4e3e-b44a-6d438bdfb23a">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="syk:RejuvenateABGIIHipRecallCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTMtMS0xLTIzMDI1_0ed6225e-7550-4545-af43-e7dccbde003b">192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTEtMS0xLTIzMDI1_5abfc781-92c7-4664-b36f-4e553312a8c3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTItMS0xLTIzMDI1_71974682-4add-4f59-b59f-7a55b8e56116">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" sign="-" name="us-gaap:LegalFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTMtMS0xLTIzMDI1_cb3dc646-4447-48f5-9ecc-c40a36eb8206">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTEtMS0xLTIzMDI1_177dcc1f-66ae-4fe1-a10f-10ccffa87a02">2,584</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTItMS0xLTIzMDI1_a16d2f4d-d455-4e88-b187-25bc3f955e99">2,223</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTMtMS0xLTIzMDI1_7ea87a26-5654-4933-9f12-b61d2a128903">2,713</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">36</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><ix:continuation id="i1890870de4b64a298f908cf8f87426bc"><div style="text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NzM_c7981d35-6686-4f06-8ed3-63347d0bb398" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.693%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.694%"></td><td style="width:0.1%"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45973f2c9a854e2e920f89b3e8dee9d8_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMS0xLTEtMzc2NDE_83847cca-b44c-4526-b9ff-d28c46c80307">15,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie114ed237e0d41beb5a9e2242dabd291_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMi0xLTEtMzc2NDE_4f2f51b2-7fbd-4fde-834b-17e6fe5f3be5">15,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if615c66e93d841248401204d2f87e7b9_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMy0xLTEtMzc2NDE_98e9284c-1e6d-434c-86ff-2510032a613e">16,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05efb2548ebd4f34ab5c73e347583ae8_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMS0xLTEtMjMwMjU_a6d40476-3d48-4d64-9a61-428588f39360">18,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0d499873474314be3c66b63d45f691_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMi0xLTEtMjMwMjU_8a941633-1452-4d12-9180-ece7a862e2a5">18,090</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0adfcfa572a94aca9a60b62275d83075_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMy0xLTEtMjMwMjU_7252e3a5-be81-4b39-acd0-42af62994e12">12,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i74c68f4da1164491bf77ae9dcbfb0545_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMS0xLTEtMjMwMjU_27e28d49-2c18-4477-87fd-11aa36c42a8b">33,367</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1a1b44063cf47ac91f386a31d08238d_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMi0xLTEtMjMwMjU_e1da3831-a5b7-4425-97d7-5458ba67d069">33,340</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i044e8aa931854b8a94b1419803337ca9_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMy0xLTEtMjMwMjU_b20b63d1-19ca-4a1a-837c-3f24979daabf">28,797</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i493d054bdb1142bab91a099618a17c2e_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMS0xLTEtMjMwMjU_2c435a4e-7335-41a7-9f64-572bf34ec048">1,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89b60b72af8d496098920a748eea6ac8_I20201231" decimals="-6" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMi0xLTEtMjMwMjU_f8d4843a-272b-4d68-9847-5cdd3644fa24">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb45f65a673b4ca8bc5380e9dc457005_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMy0xLTEtMjMwMjU_7c3581f9-733a-43f1-b876-5a8b2eda9c10">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMS0xLTEtMjMwMjU_2dd82e0f-ec5d-4c70-bad7-c9651e732f51">34,631</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMi0xLTEtMjMwMjU_6c1e3134-f50a-4811-bf5b-b91d7dcfaef6">34,330</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMy0xLTEtMjMwMjU_62e0618f-ded9-430c-91e0-7de1fd2cd347">30,167</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMS0xLTEtMzc2NTA_8b959fcf-f6d8-47e7-87f0-e5c746dcf03c">197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMi0xLTEtMzc2NTA_c56a2614-df17-47a4-8679-18ab6aebc071">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMy0xLTEtMzc2NTA_c429fe15-4fd8-4994-b991-88b1d96c8b5d">281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMS0xLTEtMjMwMjU_9854d27c-6bc5-4440-8ae9-80def063ebd6">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMi0xLTEtMjMwMjU_d8910843-23aa-4ef6-b2f6-58127116b46d">150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMy0xLTEtMjMwMjU_8a6a7126-f924-4ac1-92ba-3ae44e996e9e">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTEtMS0xLTIzMDI1_e26d9398-52dd-4d34-a20f-43afc6b2ec79">362</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTItMS0xLTIzMDI1_f6e76dd6-30cf-45e7-a8f5-f5f491a6add3">342</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTMtMS0xLTIzMDI1_702a98b9-1f67-4bc5-8ea9-af4dd26eb35f">419</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTEtMS0xLTIzMDI1_83132bf6-92b4-4a3b-8762-bc3031e1c955">163</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTItMS0xLTIzMDI1_093634d9-3b1e-45e1-93d2-c930b6be7803">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c65783cfed742208972bad227653460_D20190101-20191231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTMtMS0xLTIzMDI1_35ceeafd-b54e-4db3-b640-9b9dcace4be4">230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTEtMS0xLTIzMDI1_e70c5b87-5eb9-4749-b8f2-0f45619798c2">525</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTItMS0xLTIzMDI1_c359389b-0a08-454d-bfd2-ba66d456a021">487</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="syk:CapitalExpendituresDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTMtMS0xLTIzMDI1_6f9d543c-039a-4fbd-9ad8-bbe552f7ccf7">649</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div><div style="margin-bottom:3pt;text-align:justify"><ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NjM_054deed8-cb18-4925-a3fb-104f7799f1bb" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.750%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.846%"></td><td style="width:0.1%"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMS0xLTEtMjMwMjU_2c6e5a95-ff35-41fc-93b6-945156ea1567">12,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMi0xLTEtMjMwMjU_5b5daa0c-6559-483a-aa4b-cde1c5731747">10,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib993db761cc4478a866ff2db39f59836_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMy0xLTEtMjMwMjU_6d6f3a47-a786-4044-b989-c5e1ab7b3922">10,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i742ba6c7339d481cad355c3643d8c974_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtNS0xLTEtMjMwMjU_11070896-8d12-45c8-884f-39dbeb3a7a57">1,717</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89a77a86ad54db68756036c89894730_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtNi0xLTEtMjMwMjU_b94ab027-895e-4eaa-b302-14670e7c5052">1,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7510c322dcd240709c6c6e3c9f02d28a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMS0xLTEtMjMwMjU_1b78003f-8d07-429b-b655-5d54926b91b8">2,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdaebd90ff5a43aebff037d5206f643c_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMi0xLTEtMjMwMjU_12bc8c86-21a5-4c79-b8db-03739c5bcb76">1,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i508e0970774e4040bebaa29eefb5413a_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMy0xLTEtMjMwMjU_f9b738e6-a320-4683-8eed-df1d92561e54">1,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabea30f6f342483e92b55ff45d124cfd_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtNS0xLTEtMjMwMjU_c614f5ba-4807-46fb-accc-ca0f7dff312c">941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65e2baa3bf9f407e86be3aa79c350743_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtNi0xLTEtMjMwMjU_bd2b972d-6fad-4c6b-9b46-d17f96c299d0">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366d502111bb4b0ea5b40b0854ccb69c_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMS0xLTEtMjMwMjU_50a05946-7c5d-4232-9ea2-4d0b344be7d9">1,973</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79f9e9c317bd4f439e0b474fd5b011ae_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMi0xLTEtMjMwMjU_b6453d15-3c6c-4343-967a-a8f5ea9d6d70">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21fb41ce5c5541289a9c9bda6cc8d0d5_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMy0xLTEtMjMwMjU_5d4e82ab-cec2-4de7-9517-c9655ecf1793">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04ca0caf148b4cfea6977517521fc1a6_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtNS0xLTEtMjMwMjU_c6c615d4-4140-46f9-907a-914b3f136cc8">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd51320aa2454e7a9423a3b8924b52cc_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtNi0xLTEtMjMwMjU_4256c474-3f42-4ee0-ba41-8c3cad9cc351">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c0ca347e0e442d5b711eeee83cb8a15_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMS0xLTEtMjMwMjU_fed42931-1c6f-422b-b5bc-8a7eae5d719f">515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id822d7baa9eb43998e1a14bbe5f9067f_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMi0xLTEtMjMwMjU_ffcd2f92-8b24-471b-8659-119e61801e6a">448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84d77376c3524f3bae2890c5d42f27a5_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMy0xLTEtMjMwMjU_3764d106-f9dd-4d5d-953d-49be66739a76">422</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695bf958a588401eb4c0e69af671f48a_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtNS0xLTEtMjMwMjU_79527c5d-ca65-43b1-b46c-a63aebe54a2c">99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54f6e97d92584c358e1d36baee8c2703_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtNi0xLTEtMjMwMjU_107c9ef1-0306-4b55-9420-f71cd49553a6">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMS0xLTEtMjMwMjU_12fd64a6-5877-441d-8c87-1e134310c736">17,108</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMi0xLTEtMjMwMjU_9bddc9af-d706-497a-81ea-43a02051da26">14,351</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMy0xLTEtMjMwMjU_af39769e-0daf-41fb-ad99-e15b2c5a576b">14,884</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctNS0xLTEtMjMwMjU_9b255c75-a7e4-4c66-b936-bf02d20319ba">2,833</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctNi0xLTEtMjMwMjU_94b715d2-adf7-4555-b907-17e80bd2b232">2,752</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div id="i2e9b98e114ab4a2ba09a958d786789f3_148"></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">NOTE 15 - <ix:nonNumeric contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231" name="us-gaap:AssetImpairmentChargesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzUyMA_65ee8cbf-28b0-4fdc-a605-cbde408b0672" continuedAt="ib79b67d629ef4af380fd94c5d247679b" escape="true">ASSET IMPAIRMENTS</ix:nonNumeric></span></div><ix:continuation id="ib79b67d629ef4af380fd94c5d247679b" continuedAt="i8d4af2df7d6b48bcb983feb28440907e"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The government in China has launched regional and national programs for volume-based procurement ("VBP") of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. We expect that the prices required for a successful bid will, nevertheless, negatively impact our existing commercial operations of joint replacement and trauma products in China. As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="i0df0e910952f41b38ad92de86d9e751c_D20210701-20210930" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA2OTg1MTU_c6c4e54f-21a9-4c84-b482-187f095077e4">105</ix:nonFraction> to impair certain long-lived and intangible assets in the third quarter of 2021. These charges were included in selling, general and administrative expenses. Spine products are part of the VBP program in one province and it is not clear to what extent spine products will be included in further provincial or national VBP programs. We do not expect any significant impairments related to the potential Spine VBP programs. Our business in China represented approximately <ix:nonFraction unitRef="number" contextRef="ia507b09a8414413ba7d85ab4c02407b5_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA3MDE3MDQ_f66043b6-abf4-4f83-b1dc-4375a0c6d0fc">2.5</ix:nonFraction>% of our revenues for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Aside from the impairments from the VBP programs, we recorded asset impairments of $<ix:nonFraction unitRef="usd" contextRef="i1c818b44abbb48aca50ce62cb4244e4d_D20210101-20211231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA3MDE2OTU_29675f32-7ec1-4a35-a5d5-018d20742185">159</ix:nonFraction> in 2021 consisting primarily of in-</span></div></ix:continuation></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i8d4af2df7d6b48bcb983feb28440907e" continuedAt="i4eebc16dc6e54251b3da29f09b58b56f">process research and development, other intangible assets and property, plant and equipment as a result of COVID-19-related demand impacts on in-process product development and certain other divestiture and restructuring activities. </ix:continuation></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:continuation id="i4eebc16dc6e54251b3da29f09b58b56f">In 2020 we suspended certain in-process investments resulting in charges of $<ix:nonFraction unitRef="usd" contextRef="i5fba5cf2d76346acb78e2f001edc09ac_D20200101-20201231" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzY1OTcwNjk3NzEzMjY_171cd60c-baa1-48f0-b427-98ce34820bf0">195</ix:nonFraction> to impair certain long-lived assets (primarily the portion of our investment in a new global ERP system that was in-process of being developed for future deployment) and product line and other exit costs. These charges were included in cost of sales and selling, general and administrative expenses</ix:continuation>.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_151"></div><div><span><br/></span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">37</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.</span></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.&#160;</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_154"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9A.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CONTROLS AND PROCEDURES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management, with the participation of the Chief Executive Officer and Chief Financial Officer (the Certifying Officers), evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended) (Exchange Act) as of December&#160;31, 2021. Based on that evaluation, the Certifying Officers concluded that the Company&#8217;s disclosure controls and procedures were effective as of December&#160;31, 2021.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">There was no change to our internal control over financial reporting during the fourth quarter of 2021 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). The Company's internal control over financial reporting was designed to provide reasonable assurance to the Company's management and Board of Directors regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that: (i) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company's assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company's management assessed the effectiveness of our internal control over financial reporting on December&#160;31, 2021. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Internal Control-Integrated Framework (2013)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. Based on this assessment, management concluded that our internal control over financial reporting was effective as of December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker&#8217;s independent registered public accounting firm has issued an audit report on their assessment of the effectiveness of the Company&#8217;s internal control over financial reporting.</span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Stryker Corporation</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have audited Stryker Corporation and subsidiaries&#8217; internal control over financial reporting as of December 31, 2021, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, Stryker Corporation and subsidiaries (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on the COSO criteria. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the 2021 consolidated financial statements of the Company and our report dated February 11, 2022 expressed an unqualified opinion thereon. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis for Opinion </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s </span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">38</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="width:100.000%"><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">/s/&#160;&#160;&#160;&#160;ERNST&#160;&amp; YOUNG LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Grand Rapids, Michigan</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">February&#160;11, 2022 </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_157"></div><div style="margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9B.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OTHER INFORMATION.</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_1099511629539"></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;9C.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_160"></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART III</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_163"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;10.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our executive officers appears under the caption "Information about our Executive Officers" in Part I, Item 1 of this report.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding our directors and certain corporate governance and other matters appearing under the captions "Proposal 1&#8212;Election of Directors," "Corporate Governance," and "Additional Information&#8212;Delinquent Section 16(a) Reports" in the 2022 proxy statement is incorporated herein by reference.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate Governance Guidelines adopted by our Board of Directors, as well as the charters of each of the Audit Committee, the Governance and Nominating Committee and the Compensation Committee and the Code of Ethics applicable to the principal executive officer, president, principal financial officer and principal accounting officer or controller or persons performing similar functions are posted on the "Corporate Governance" section of our website at </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">www.stryker.com</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_166"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;11.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXECUTIVE COMPENSATION.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding the compensation of our management appearing under the captions "Compensation Discussion and Analysis," "Compensation Committee Report," "Executive Compensation" and "Compensation of Directors" in the 2022 proxy statement is incorporated herein by reference.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_169"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;12.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Stock Ownership" in the 2022 proxy statement is incorporated herein by reference. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 we had an equity compensation plan under which options were granted at a price not less than fair market value at the date of grant and under which awards of restricted stock units (RSUs) and performance stock units (PSUs) were made. Options and RSUs were also awarded under a previous plan. Additional information regarding our equity compensation plans appears in Note 1 and Note 9 to our Consolidated Financial Statements. On December&#160;31, 2021 we </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"></div><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">also had a stock performance incentive award program pursuant to which shares of our common stock were and may be issued to certain employees with respect to performance. The status of these plans, each of which were previously submitted to and approved by our shareholders, on December&#160;31, 2021 is as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:23.107%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Plan</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;<br/>securities to be issued upon exercise&#160;of&#160;<br/>outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average exercise price of outstanding&#160;<br/>options, warrants and rights</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of&#160;securities remaining available for future issuance under equity compensation&#160;<br/>plans (excluding shares&#160;reflected&#160;in&#160;<br/>the&#160;first&#160;column)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2006 Long-Term Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">752,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">61.46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2008 Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4,189,238</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Long-Term Incentive Plan</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:120%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,314,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">156.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">25,210,811</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">2011 Performance Incentive Award Plan</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">293,449</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">29,693,498</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2011 Long-Term Incentive Plan securities to be issued upon exercise include 717,277 RSUs and 202,424 PSUs. The weighted-average exercise prices does not take these awards into account. </span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_172"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;13.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Corporate Governance" and "Corporate Governance&#8212;Certain Relationships and Related Party Transactions" in the 2022 proxy statement is incorporated herein by reference.</span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_175"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.625%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;14.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PRINCIPAL ACCOUNTING FEES AND SERVICES.</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The information under the caption "Proposal 2&#8212;Ratification of Appointment of Our Independent Registered Public Accounting Firm" in the 2022 proxy statement is incorporated herein by reference.</span></div></div></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">39</span></div></td></tr></table></div></div></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:3pt double #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PART IV</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_181"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;15.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EXHIBITS, FINANCIAL STATEMENT SCHEDULES.</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:4.478%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.254%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a)&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The following Consolidated Financial Statements are set forth in Part II, Item 8 of this report.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Report of Independent Registered Public Accounting Firm</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_76">20</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Earnings for 2021, 2020 and 2019</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_79">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Comprehensive Income for 2021, 2020 and 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_82">22</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Balance Sheets on 2021 and 2020</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_85">23</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Shareholders&#8217; Equity for 2021, 2020 and 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_91">24</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Consolidated Statements of Cash Flows for 2021, 2020 and 2019</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_94">25</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Notes to Consolidated Financial Statements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i2e9b98e114ab4a2ba09a958d786789f3_97">26</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 2.</span></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Financial Statement Schedules</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Consolidated Financial Statement schedule of Stryker Corporation and its subsidiaries is:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Deductions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Charged&#160;to<br/>Costs &amp;<br/>Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Uncollectible Amounts Written Off, Net of Recoveries</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Effect of Changes in Foreign Currency Exchange Rates</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance<br/>at End<br/>of Period</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">DEDUCTED FROM ASSET ACCOUNTS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allowance for Doubtful Accounts:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b99ad9aa574362a2b36a60d0085869_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTMtMS0xLTIzMDI1_1be414fc-ca31-48d6-866c-a1a8034a10af">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTUtMS0xLTIzMDI1_04fc56a2-a07d-4bad-b72f-4b2898440768">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTctMS0xLTIzMDI1_c3bc17d8-5589-4a78-9551-66382c0a6fbe">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTktMS0xLTIzMDI1_e3ca17ec-d5d7-4ec9-9244-c4a61e87605b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba1ecd7eafa4f05988a82a4023b511f_I20211231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTExLTEtMS0yMzAyNQ_97fb3250-bb1d-4363-a70b-904d80b1a2bc">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2020</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbe329076697427a86d128a21c73111a_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTMtMS0xLTIzMDI1_090cc894-37e8-4354-bb04-b5193f88a2b6">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTUtMS0xLTIzMDI1_7e4f394a-7a0f-478e-9f2c-287abc397179">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTctMS0xLTIzMDI1_e83d23d9-a38a-4444-a4d0-78288d622837">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTktMS0xLTIzMDI1_450008f9-d36b-40a9-a14c-caa2c70c72f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55b99ad9aa574362a2b36a60d0085869_I20201231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTExLTEtMS0yMzAyNQ_51753013-aa0f-4e13-b8ef-a7cb5be52b84">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Year ended December&#160;31, 2019</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied06158ff7d045f39f524189c541c016_I20181231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTMtMS0xLTIzMDI1_5f3ded63-dd26-4df6-b89a-e1dc130df79b">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTUtMS0xLTIzMDI1_a26b9cce-1dd6-4026-a424-27fd2b00c2c8">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesDeductions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTctMS0xLTIzMDI1_4eb7248f-06bc-4565-892c-532f47fea64e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTktMS0xLTIzMDI1_eaffec1c-2b27-4c12-8005-142aa1a97102">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbe329076697427a86d128a21c73111a_I20191231" decimals="-6" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTExLTEtMS0yMzAyNQ_9ad255a3-47c0-42da-983f-47866c1d13a5">88</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All other schedules for which provision is made in the applicable accounting regulation of the United States Securities and Exchange Commission are not required under the related instructions or are inapplicable and, therefore, have been omitted.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(a) 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibits</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_184"></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">FORM 10-K&#8212;ITEM 15(a) 3. AND ITEM&#160;15(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">STRYKER CORPORATION AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 2&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm">Agreement and Plan of Merger, dated as of August 29, 2018, by and among Stryker Corporation, Austin Merger Sub Corp. and K2M Group Holdings, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company's Form 8-K dated August </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm">30</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm">, 2018 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519285387/d818709dex21.htm">Purchase Agreement, dated as of November 4, 2019, among Stryker Corporation, Stryker B.V. and Wright Medical Group N.V. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated November 6, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#169;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312522006816/d105293dex21.htm">Agreement and Plan of Merger, dated as of January 6, 2022, by and among Stryker Corporation, Voice Merger Sub Corp., and Vocera Communications, Inc. &#8212; Incorporated by reference to Exhibit 2.1 to the Company&#8217;s Form 8-K dated January 11, 2022 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 3&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Articles of Incorporation and By-Laws</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000205/ex3i10qq32018.htm">Restated Articles of Incorporation &#8212; Incorporated by reference to Exhibit 3(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2018 (Commission File No. 00-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000009/ex3isyk-amendedbylawsxfeb2.htm">Amended and Restated Bylaws &#8212; Incorporated by reference to Exhibit 3.1 to the Company's Form 8-K dated February 5, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 4&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Instruments defining the rights of security holders, including indentures&#8212;We agree to furnish to the Commission upon request a copy of each instrument pursuant to which long-term debt of Stryker Corporation and its subsidiaries not exceeding 10% of the total assets of Stryker Corporation and its consolidated subsidiaries is authorized.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312510007135/dex41.htm">Indenture, dated January 15, 2010, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.1 to the Company's Form 8-K dated January 15, 2010 (Commission File No. 000-09165).</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.455%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dollar amounts in millions except per share amounts or as otherwise specified.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312513123574/d508904dex43.htm">Fifth Supplemental Indenture (including the form of 2043 note) dated March 25, 2013, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated March 25, 2013 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312514175095/d720177dex42.htm">Sixth Supplemental Indenture (including the form of 2024 note), dated May 1, 2014, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated May 1, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312514175095/d720177dex43.htm">Seventh Supplemental Indenture (including the form of 2044 note), dated May 1, 2014, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated May 1, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312515358209/d46878dex42.htm">Eighth Supplemental Indenture (including the form of 2025 note), dated October 29, 2015, between Stryker Corporation and U.S. Bank National association.&#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated October 29, 2015 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex43.htm">Tenth Supplemental Indenture (including the form of the 2021 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex44.htm">Eleventh Supplemental Indenture (including the form of the 2026 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association.&#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516499457/d159431dex45.htm">Twelfth Supplemental Indenture (including the form of the 2046 note), dated March 10, 2016, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.5 to the Company's Form 8-K dated March 10, 2016 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518073610/d518544dex42.htm">Fourteenth Supplemental Indenture (including the form of the 2028 note), dated March 7, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated March 7, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex42.htm">Fifteenth Supplemental Indenture (including the form of the 2023 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex43.htm">Sixteenth Supplemental Indenture (including the form of the 2027 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312518339720/d661644dex44.htm">Seventeenth Supplemental Indenture (including the form of the 2030 note), dated November 30, 2018, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated November 30, 2018 (Commission File No. 000-09615).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex42.htm">Nineteenth Supplemental Indenture (including the form of the 2024 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.2 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex43.htm">Twentieth Supplemental Indenture (including the form of the 2029 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.3 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312519305266/d103227dex44.htm">Twenty-First Supplemental Indenture (including the form of the 2031 note), dated December 3, 2019, between Stryker Corporation and U.S. Bank National Association. &#8212; Incorporated by reference to Exhibit 4.4 to the Company's Form 8-K dated December 3, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex42.htm">Twenty-Second Supplemental Indenture (including the form of the 2025 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association, as trustee - Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex43.htm">Twenty-Third Supplemental Indenture (including the form of the 2030 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.3 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520160734/d927297dex44.htm">Twenty-Fourth Supplemental Indenture (including the form of the 2050 note), dated June 4, 2020, between Stryker Corporation and U.S. Bank National Association &#8212; Incorporated by reference to Exhibit 4.4 to the Company&#8217;s Form 8-K dated June 4, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520301421/d36871dex42.htm">Twenty-Fifth Supplemental Indenture (including the form of the 2023 note), dated November 23, 2020, between Stryker Corporation and U.S. Bank National Association, as trustee &#8212; Incorporated by reference to Exhibit 4.2 to the Company&#8217;s Form 8-K dated November 23, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex4xx1231202110k.htm">Description of Securities</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;10&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Material contracts</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10i2022nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10i2022nqstockoptionawar.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10i2022nqstockoptionawar.htm"> under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10ii2022rsustockoptionaw.htm">Form of grant notice and terms and conditions for restricted stock units granted in 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10ii2022rsustockoptionaw.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10ii2022rsustockoptionaw.htm"> under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iii2022psustockoptiona.htm">Form of grant notice and terms and conditions for performance stock units granted in 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iii2022psustockoptiona.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="ex10iii2022psustockoptiona.htm"> under the 2011 Long-Term Incentive Plan.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(iv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">Form of grant notice and terms and conditions for stock options granted in 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm"> under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(i</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">) to the Company's Form 10-K for the year ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10i2021nqstockoptionawar.htm"> (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(v)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10ii2021rsuawardletteran.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2021 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vi)*</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">Form of grant notice and terms and conditions for performance stock units granted in 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm"> under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">Incorporated by reference to Exhibit 10(i</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">ii</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">) to the Company's Form 10-K for the year ended December 31, 20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm">20</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000027/ex10iii2021psuawardlettera.htm"> (Commission File No. 001-13149).</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">41</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(vii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000111/ex10i630202110q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2021 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(viii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000125/ex10i-630202010q.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2020 under the 2011 Long-Term Incentive Plan to non-employee directors &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended June 30, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10i1231201910k.htm">2011 Long-Term Incentive Plan (as amended effective February 4, 2020) &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(x)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10ii1231201910k.htm">Form of grant notice and terms and conditions for stock options granted in 2020 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iii1231201910k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2020 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iii1231201910k.htm">Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iv1231201910k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2020 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10iv1231201910k.htm">Incorporated by reference to Exhibit 10(iv) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10v1231201910k.htm">Form of terms and conditions for restricted stock units granted to non-employee directors in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10v1231201910k.htm">Incorporated by reference to Exhibit 10(v) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xiv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10vi1231201910k.htm">Supplemental Savings and Retirement Plan (as amended effective January 1, 2008 and January 1, 2019)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000014/ex10vi1231201910k.htm">Incorporated by reference to Exhibit 10(vi) to the Company's Form 10-K for the year ended December 31, 2019 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xv)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10ii12311810k.htm">Form of grant notice and terms and conditions for stock options granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10ii12311810k.htm">Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iii12311810k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iii12311810k.htm">Incorporated by reference to Exhibit 10(iii) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xvii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iv12311810k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2019 under the 2011 Long-Term Incentive Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076419000014/ex10iv12311810k.htm">Incorporated by reference to Exhibit 10(iv) to the Company's Form 10-K for the year ended December 31, 2018 (Commission File No 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xviii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076417000034/sykex10ii12311610k.htm">2006 Long-Term Incentive Plan (as amended effective February 7, 2017)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076417000034/sykex10ii12311610k.htm">Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10ii12311710k.htm">Form of grant notice and terms and conditions for stock options granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xx)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10iii12311710k.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iii) to the Company&#8217;s Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxi)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000031/ex10iv12311710k.htm">Form of grant notice and terms and conditions for performance stock units granted in 2018 under the 2011 Long-Term Incentive Plan &#8212; Incorporated by reference to Exhibit 10(iv) to the Company&#8217;s Form 10-K for the year ended December 31, 2017 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000185/ex10ii10qq22018.htm">Form of grant notice and terms and conditions for restricted stock units granted in 2018 under the 2011 Long-Term Incentive Plan to non-employee directors</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000185/ex10ii10qq22018.htm">Incorporated by reference to Exhibit 10(ii) to the Company&#8217;s Form 10-Q for the quarterly period ended June 30, 2018 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076407000052/sykex101.htm">Stryker Corporation Executive Bonus Plan</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076407000052/sykex101.htm">Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated February 21, 2007 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxiv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xiv.htm">Form of Indemnification Agreement for Directors</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xiv.htm">Incorporated by reference to Exhibit 10 (xiv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxv)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076409000035/sykex10xv.htm">Form of Indemnification Agreement for Certain Officers&#8212;Incorporated by reference to Exhibit 10 (xv) to the Company's Form 10-K for the year ended December 31, 2008 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvi)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076415000022/ex10xxiii10k2014.htm">Settlement Agreement between Howmedica Osteonics Corp. and the counsel listed on the signature pages thereto, dated as of November 3, 2014 (Rejuvenate and ABF II Hip Implant Products Liability Litigation)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076415000022/ex10xxiii10k2014.htm">Incorporated by reference to Exhibit 10xxiii to the Company's Form 10-K for the year ended December 31, 2014 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxvii)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">Letter Agreement between Stryker Corporation and Glenn Boehnlein</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">Incorporated by reference to Exhibit 10.2 to the Company's Form 8-K dated January 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">6</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076416000206/syk8kex10212616.htm">, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxviii)</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#169; </span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">Credit Agreement, dated as of August 19, 2016, among Stryker Corporation and certain subsidiaries, as designated borrowers; the lenders party thereto; and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">Incorporated by reference to Exhibit 4.1 to the Company&#8217;s 8-K dated August </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">23</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312516688904/d245821dex41.htm">, 2016 (Commission File No. 000-09165).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxix)*</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm">Letter Agreement between Stryker Corporation and Timothy</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm"> J.</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm"> Scannell &#8212; Incorporated by reference to Exhibit 10.1 to the Company&#8217;s Form 8-K dated August 1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm">8</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000123/sykex1018162021.htm">, 2021 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxx)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076421000146/ex10i2021creditagreement.htm">Credit Agreement, dated as of October 26, 2021, among Stryker Corporation as borrower; the lenders party thereto; and Wells Fargo Bank, N.A., as administrative agent &#8212; Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended September 30, 2021 (Commission File No. 001-13149). </a></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxi)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10iamendcreditagreement.htm">Amendment No. 1, dated as of April 30, 2020, to Credit Agreement, dated as of August 19, 2016, among Stryker Corporation and certain of its subsidiaries, as designated borrowers; the lenders party thereto; and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10iamendcreditagreement.htm">Incorporated by reference to Exhibit 10(i) to the Company's Form 10-Q for the quarterly period ended March 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">42</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076420000069/ex10ii364creditagreement.htm">Credit Agreement, dated as of April 30, 2020, among Stryker Corporation as borrower; the lenders party thereto; and Bank of America, N.A., as administrative agent &#8212; Incorporated by reference to Exhibit 10(ii) to the Company's Form 10-Q for the quarterly period ended March 31, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(xxxiii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520292302/d77015dex101.htm">Term Loan Agreement, dated as of November 10, 2020, among Stryker Corporation, as borrower, the lenders party thereto and Bank of America, N.A., as administrative agent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000031076418000195/sykex21agreementandplanofm.htm"> &#8212; </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/310764/000119312520292302/d77015dex101.htm">Incorporated by reference to Exhibit 10.1 to the Company's Form 8-K dated November 13, 2020 (Commission File No. 001-13149).</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 21&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Subsidiaries of the registrant</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex21i1231202110k.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 23&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consent of experts and counsel</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex23i1231202110k.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 31&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Rule 13a-14(a) Certifications</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31i1231202110k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex31ii1231202110k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit 32&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18 U.S.C. Section 1350 Certifications</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(i)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32i1231202110k.htm">Certification by Principal Executive Officer of Stryker Corporation.</a></span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(ii)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex32ii1231202110k.htm">Certification by Principal Financial Officer of Stryker Corporation.</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exhibit&#160;101&#8212;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL (Inline Extensible Business Reporting Language) Documents</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Instance Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Schema Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Label Linkbase Document</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">iXBRL Presentation Linkbase Document</span></td></tr><tr><td colspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Compensation arrangement</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furnished with this Form 10-K</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.123%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#169;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Stryker hereby agrees to furnish supplementally a copy of any omitted schedule upon request by the U.S. Securities and Exchange Commission.</span></td></tr></table></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_187"></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ITEM&#160;16.</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FORM 10-K SUMMARY.</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">None.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">43</span></div></td></tr></table></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STRYKER CORPORATION                                                                                                                         2021 FORM 10-K</span></div></div><div style="text-align:justify"><span><br/></span></div><div id="i2e9b98e114ab4a2ba09a958d786789f3_190"></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.929%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">STRYKER CORPORATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 11, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on the date indicated above on behalf of the registrant and in the capacities indicated.&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:47.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.997%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ KEVIN A. LOBO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GLENN S. BOEHNLEIN</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Kevin A. Lobo</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ WILLIAM E. BERRY JR.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">William E. Berry, Jr.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Vice President, Chief Accounting Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ALLAN C. GOLSTON</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ ANDREW K. SILVERNAIL</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Allan C. Golston</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Andrew K. Silvernail</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ MARY K. BRAINERD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ LISA M. SKEETE TATUM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mary K. Brainerd</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lisa M. Skeete Tatum</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ GIOVANNI CAFORIO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RONDA E. STRYKER</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ronda E. Stryker</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SRIKANT M. DATAR</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ RAJEEV SURI</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Srikant M. Datar, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Rajeev Suri</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ SHERILYN S. MCCOY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sherilyn S. McCoy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">44</span></div></td></tr></table></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.20
<SEQUENCE>2
<FILENAME>ex4xx1231202110k.htm
<DESCRIPTION>EX-4.20
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i68c311fb2d9145429477127ee7872619_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Capital Stock</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following description is a summary of certain terms of the capital stock of Stryker Corporation (&#8220;Stryker&#8221; or the &#8220;Company&#8221;). It does not purport to be complete and is subject in all respects to the applicable provisions of the Michigan Business Corporation Act, as amended, or the MBCA, our Restated Articles of Incorporation, as amended, or our articles, and our By-laws, as amended, or our by-laws. As used in this exhibit, and except where the context otherwise requires, &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Stryker Corporation.</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Capital Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our authorized capital stock consists of (1) 1,000,000,000 shares of common stock, $0.10 par value per share and (2) 500,000 shares of preferred stock, $1.00 par value per share. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each share of common stock entitles the holder thereof to one vote for each share held by it of record on each matter submitted to a vote. Other than the election of directors, if an action is to be taken by vote of the shareholders, it will be authorized by a majority of the votes cast by the holders of shares entitled to vote on the action, unless a greater vote is required in our articles or by-laws. Directors are elected by a majority of the votes cast by the holders of shares entitled to vote (and for such purpose, a majority of the votes cast means that the number of shares voted &#8220;for&#8221; a nominee must exceed the number of votes cast &#8220;against&#8221; that nominee)&#894; provided, however, that if as of the record date for a meeting at which directors will be elected, there are more nominees than positions on the board of directors to be filled by election at such meeting, each director shall be elected by a plurality of the votes cast at the election.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Subject to the prior payment or provision therefor of dividends on the preferred stock, if any, holders of the common stock are entitled to receive ratably such dividends, if any, as may be declared from time to time by our Board of Directors out of funds legally available therefor. Holders of our common stock have no conversion, preemptive or other rights to subscribe for any securities of ours, and there are no redemption or sinking fund provisions with respect to such shares. In the event of any liquidation, dissolution or distribution of our assets and after satisfaction of the preferential requirements of the preferred stock, if any, holders of common stock will be entitled to share ratably in the distribution of the remaining assets of the Company available for distribution. The rights, preferences and privileges of holders of common stock are subject to applicable law and the rights of the holders of any shares of preferred stock and any additional classes of stock that we may issue in the future.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles authorize our Board of Directors to issue up to 500,000 shares of preferred stock in one or more series, with such distinctive designation or title and in such number of shares as may be authorized by our Board of Directors. Our Board of Directors is authorized to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prescribe the relative rights and preferences of each series, and the limitations applicable thereto, including but not limited to the following&#58; (1) the voting powers, full, special, or limited, or no voting powers&#894; (2) the rate, terms and conditions on which dividends will be paid, whether such dividends will be cumulative, and what preference such dividends shall have in relation to the dividends on other series or classes of stock&#894; (3) the rights, terms and conditions, if any, for conversion of preferred stock into shares of other series or classes of stock&#894; (4) any right of the Company to redeem the shares of preferred stock, and the price, time and conditions of redemption, including the provisions for any sinking fund&#894; and (5) the rights of holders of preferred stock in relation to the rights of other series and classes of stock upon the liquidation, dissolution or distribution of our assets. Unless otherwise provided by our Board of Directors, upon redemption or conversion, shares of preferred stock will revert to authorized but unissued shares and may be reissued as shares of any series of preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitation of Liability</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles provide that, to the full extent authorized or permitted by the MBCA, directors of Stryker will not be personally liable to Stryker or its shareholders for any acts or omissions in such person&#8217;s capacity as a director. Such limitation of liability does not affect the availability of equitable remedies such as injunctive relief or rescission. These provisions will not limit the liability of directors under federal securities laws.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Statutory, Articles and By-law Provisions Affecting Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain provisions in our articles and by-laws and the MBCA may have the effect of delaying, deferring or preventing a change of control of the Company or may operate only with respect to extraordinary corporate transactions involving the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Business Combination Act</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are subject to the provisions of Chapter 7A of the MBCA, which provides that business combinations between a Michigan corporation and a beneficial owner of shares entitled to 10% or more of the voting power of such corporation generally require the affirmative vote of 90% of the votes of each class of stock entitled to vote and not less than two-thirds of each class of stock entitled to vote (excluding voting shares owned by such 10% owner). Chapter 7A defines a &#8220;business combination&#8221; to encompass any merger, consolidation, share exchange, sale of assets, stock issue, liquidation, or reclassification of securities involving an interested shareholder or certain affiliates. An &#8220;interested shareholder&#8221; is generally any person who owns 10% or more of the voting shares of the corporation. An &#8220;affiliate&#8221; is a person who directly or indirectly controls, is controlled by, or is under common control with, a specified person. Such requirements do not apply if the transaction satisfies fairness standards, other specified conditions are met and the interested shareholder has been such for at least five years.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Article and By-Law Provisions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our articles and by-laws include a number of provisions that may have the effect of encouraging persons considering unsolicited tender offers or other unilateral takeover proposals to negotiate with our Board of Directors rather than pursue non- negotiated takeover attempts. These provisions include an advance notice requirement for director nominations and actions to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be taken at annual meetings of shareholders and the availability of authorized but unissued blank check preferred stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advance Notice Requirement</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our by-laws set forth advance notice procedures with regard to shareholder proposals relating to the nomination of candidates for election as directors or new business to be presented at meetings of shareholders. These procedures provide that notice of such shareholder proposals must be timely given in writing to the secretary of Stryker prior to the meeting at which the action is to be taken. Generally, to be timely, notice must be received at the principal executive offices of Stryker not less than 90 days nor more than 120 days prior to the meeting. The advance notice requirement does not give the Board of Directors any power to approve or</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">disapprove shareholder director nominations or proposals but may have the effect of precluding the consideration of certain business at a meeting if the proper notice procedures are not followed.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Special Meetings of Shareholders</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Under our by-laws, special meetings of shareholders may be called by the chair of our Board of Directors, our chief executive officer, our president or by order of our Board of Directors. Our by-laws provide that a special meeting of the shareholders shall be called by the chief executive officer upon written request of one or more record holders of shares of our common stock representing not less than 25% of our issued and outstanding shares of common stock.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Blank Check Preferred Stock</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our preferred stock could be deemed to have an anti-takeover effect in that, if a hostile takeover situation should arise, shares of preferred stock could be issued to purchasers sympathetic with our management or others in such a way as to render more difficult or to discourage a merger, tender offer, proxy contest, the assumption of control by a holder of a large block of our securities or the removal of incumbent management.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The effects of the issuance of one or more series of the preferred stock on the holders of our common stock could include&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">reduction of the amount otherwise available for payments of dividends on common stock if dividends are payable on the series of preferred stock&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">restrictions on dividends on our common stock if dividends on the series of preferred stock are in arrears&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">dilution of the voting power of our common stock if the series of preferred stock has voting rights, including a possible &#8220;veto&#8221; power if the series of preferred stock has class voting rights&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">dilution of the equity interest of holders of our common stock if the series of preferred stock is convertible, and is converted, into our common stock&#894; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">restrictions on the rights of holders of our common stock to share in our assets upon liquidation until satisfaction of any liquidation preference granted to the holders of the series of preferred stock.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The transfer agent and registrar for our common stock is American Stock Transfer &#38; Trust Company, LLC.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Listing</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Our common stock is listed on the New York Stock Exchange under the symbol &#8220;SYK.&#8221;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Description of Debt Securities&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">1.125% Notes due 2023</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">2.125% Notes due 2027</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">2.625% Notes due 2030</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company previously filed a registration statement on Form S-3 (File No. 333-209526), which was filed with the Securities and Exchange Commission on February 12, 2016 and covers the issuance of the Company&#8217;s 1.125% Notes due 2023 (the &#8220;2023 notes&#8221;), the 2.125% Notes due 2027 (the &#8220;2027 notes&#8221;), and the 2.625% Notes due 2030 (the &#8220;2030 notes&#8221; and together with the 2023 notes, the 2027 notes and the 2030 notes, the &#8220;notes&#8221;). The notes are governed by a base indenture dated January 15, 2010 between the Company and U.S. Bank National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, the 2027 notes and the 2030 notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with the notes offered of the same series, will constitute a single series of securities under the Indenture. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, the 2027 notes and the 2030 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK23,&#8221; &#8220;SYK27,&#8221; and &#8220;SYK30,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">U.S. Bank National Association is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Fixed Rate Notes</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The 2023 notes, 2027 notes and 2030 notes bear interest from the date of issuance, payable annually on November 30 of each year, beginning November 30, 2019, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes, to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of the notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate is determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars do not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption</font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may redeem the notes prior to October 31, 2023 in the case of the 2023 notes, August 31, 2027 in the case of the 2027 notes and August 31, 2030 in the case of the 2030 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">100% of the principal amount of the applicable series of the notes to be redeemed&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> an amount determined by the Quotation Agent (as defined below) equal to the sum of the </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to October 31, 2023 with respect to the 2023 notes, August 31, 2027 with respect to the 2027 notes and August 31, 2030 with respect to the 2030 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below), plus 25 basis points with respect to the 2023 notes, 30 basis points with respect to the 2027 notes and 35 basis points with respect to the 2030 notes, plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after October 31, 2023 in the case of the 2023 notes, August 31, 2027, in the case of the 2027 notes and August 31, 2030, in the case of the 2030 notes, we may redeem the applicable series of the notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of the notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of the notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Government Bond&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Comparable </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Government Bond Rate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 a.m. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be mailed (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the applicable series of the notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of the notes or portions thereof called for redemption. If less than all of the applicable series of the notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if less than all of a series of notes are to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of the Fixed Rate Notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212;Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All payments of principal, interest, and premium, if any, in respect of the notes will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#894; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#894;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#894;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#894; or</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:2.01pt"> in the case of any combination of the above numbered items. </font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption,&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of notes of such series to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#894; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">notice is given not more than 30 days following such repurchase pursuant to the Change of Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#894; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the adoption of a plan relating to our liquidation or dissolution&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#894; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt"> the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#894; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director). &#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#894; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the meaning of Section 3(a)(62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person. The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on te date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time the corporation or the business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages in favor of us or a Restricted Subsidiary&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages (other than any Mortgage imposed by ERISA) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction for a term of not more than three years including renewals&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of the Indenture&#58;</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#894; (2) investments in Unrestricted Subsidiaries&#894; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. For the avoidance of doubt, a change in generally accepted accounting principles subsequent to the issue date of the notes shall not be deemed an incurrence of Indebtedness.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">interest has such voting power by reason of any contingency.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:40.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Description of Debt Securities&#58;</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">0.250% Notes due 2024</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">0.750% Notes due 2029</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.000 % Notes due 2031</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Company has an effective a registration statement on Form S-3 (File No. 333-229539), which was filed with the Securities and Exchange Commission on February 7, 2019 and covers the issuance of the Company&#8217;s 0.250% Notes due 2024 (the &#8220;2024 notes&#8221;), the 0.750% Notes due 2029 (the &#8220;2029 notes&#8221;) and the 1.000% Notes due 2031 (the &#8220;2031 notes&#8221; and together with the 2024 notes, the 2029 notes and the 2031 notes, the &#8220;notes&#8221;). The notes are governed by a base indenture dated January 15, 2010 between the Company and U.S. Bank National Association, as trustee, as supplemented by the applicable supplemental indenture governing a particular series of notes (as so supplemented, the &#8220;Indenture&#8221;). This summary is subject to and qualified in its entirety by reference to all of the provisions of the Indenture and the notes, including definitions of certain terms used in the Indenture and the notes. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">General</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes were issued as separate series of debt securities under the Indenture. The notes are senior unsecured obligations of ours and rank equally in right of payment with our other existing and future senior unsecured indebtedness. The notes are not secured by any of our assets. Any future claims of our secured lenders with respect to assets securing their loans will be prior to any claim of the holders of the notes with respect to those assets. Holders of secured debt that we have now or may issue in the future may foreclose on the assets securing such debt, reducing the cash flow from the foreclosed property available for payment of unsecured debt, including the notes. Holders of our secured debt also would have priority over unsecured creditors in the event of our bankruptcy, liquidation or similar proceeding to the extent of the value of the collateral securing such debt. The notes are structurally subordinated to all liabilities of our subsidiaries, including trade payables. Because we conduct many of our operations through our subsidiaries, our right to participate in any distribution of the assets of a subsidiary when it winds up its business is subject to the prior claims of the creditors of that subsidiary. This means that your right to payment as a holder of our notes is also subject to the prior claims of these creditors if a subsidiary liquidates or reorganizes or otherwise winds up its business. If we are a creditor of any of our subsidiaries, our right as a creditor would be subordinated to any security interest in the assets of those subsidiaries and any indebtedness of our subsidiaries senior in right of payment to that held by us. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture does not limit the amount of notes, unsecured debentures or other evidences of indebtedness that we may issue under the Indenture and provides that notes, unsecured debentures or other evidences of indebtedness may be issued from time to time in one or more series. We may from time to time, without notice to or the consent of the holders of the notes, create and issue additional notes of any series having the same ranking and terms and conditions as the notes of the same series, except for the issue date, the public offering price and, in some cases, the first interest payment date. Any additional notes having such similar terms, together with the notes offered of the same series, will constitute a single series of securities under the Indenture. If the additional notes of a series, if any, are not fungible with the notes of that series offered for U.S. federal income tax purposes, the additional notes have a separate CUSIP number.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We issued the notes in fully registered book-entry form without coupons and in denominations of &#8364;100,000 and integral multiples of &#8364;1,000 thereafter.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Principal of and interest on the notes are payable, and the notes are transferable or exchangeable, at the office or offices or agency maintained by us for these purposes. Payment of interest on the notes may be made at our option by check mailed to the registered holders thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The 2024 notes, the 2029 notes and the 2031 notes are listed on the New York Stock Exchange under the symbols &#8220;SYK24A,&#8221; &#8220;SYK29&#8221; and &#8220;SYK31,&#8221; respectively. We have no obligation to maintain such listings, and we may delist any series of the notes at any time.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Elavon Financial Services DAC is paying agent for the notes. U.S. Bank National Association will is registrar and transfer agent for the notes. Upon notice to the trustee, we may change the paying agent, registrar or transfer agent.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Interest</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The 2024 notes and 2031 notes bear interest from the date of issuance, payable annually on December 3 of each year, beginning December 3, 2020, and the 2029 notes bear interest from the date of issuance, payable annually on March 1 of each year, beginning March 1, 2021, to the persons in whose names such notes are registered at the close of business on the business day (for this purpose, a day on which Clearstream and Euroclear are open for business) immediately preceding the relevant interest payment. Interest on the notes is computed on the basis of the actual number of days in the period for which interest is being calculated and the actual number of days from and including the last date on which interest was paid on the notes (or December 3, 2019, if no interest has been paid on the applicable series of notes), to, but excluding, the next scheduled interest payment date. This payment convention is referred to as Actual&#47;Actual (ICMA) as defined in the rulebook of the International Capital Market Association.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If any interest payment date would otherwise be a day that is not a business day, such interest payment date will be postponed to the next date that is a business day and no interest will accrue on the amounts payable from and after such interest payment date to the next business day. If the maturity date of any series of notes falls on a day that is not a business day, the related payment of principal, premium, if any, and interest will be made on the next business day as if it were made on the date such payment was due, and no interest will accrue on the amounts so payable for the period from and after such date to the next business day.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Business Day</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">For purposes of the notes, a &#8220;business day&#8221; is any day that is not a Saturday, Sunday or other day on which banking institutions in New York City, London or another place of payment on the notes are authorized or required by law to close and on which the Trans-European Automated Real-Time Gross Settlement Express Transfer system (the TARGET2 system), or any successor thereto, is open.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Issuance in euro</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">All payments of interest, premium, if any, and principal, including payments made upon any redemption or repurchase of the notes, will be made in euro&#894; provided that if the euro is unavailable to us due to the imposition of exchange controls or other circumstances beyond our control or if the euro is no longer being used by the then member states of the European Monetary Union that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to us or so used. In such circumstances, the amount payable on any date in euro will be converted into U.S. dollars at the rate mandated by the Board of Governors of the Federal Reserve System as of the close of business on the second business day prior to the relevant payment date or, if the Board of Governors of the Federal Reserve System has not announced a rate of conversion, on the basis of the most recent U.S. dollar&#47;euro exchange rate published in The Wall Street Journal on or prior to the second business day prior to the relevant payment date or, in the event The Wall Street Journal has not published such exchange rate, the rate will be determined in our sole discretion on the basis of the most recently available market exchange rate for the euro. Any payment in respect of the notes so made in U.S. dollars will not constitute an Event of Default (as defined in the Indenture). Neither the trustee nor the paying agent shall have any responsibility for any calculation or conversion in connection with the foregoing.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Investors are subject to foreign exchange risks as to payments of principal, premium, if any, and interest that may have important economic and tax consequences to them. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Optional Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We may redeem the notes prior to November 3, 2024 in the case of the 2024 notes, December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to the greater of&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">100% of the principal amount of the applicable series of notes to be redeemed&#894; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">an amount determined by the Quotation Agent (as defined below) equal to the sum of the present values of the remaining scheduled payments of principal, premium, if any, and interest thereon (not including any portion of such payments of interest accrued to the date of redemption) to November 3, 2024 with respect to the 2024 notes, December 1, 2028 with respect to the 2029 notes and September 3, 2031 with respect to the 2031 notes, discounted to the date of redemption on an annual basis (Actual&#47;Actual (ICMA) at the Comparable Government Bond Rate (as defined below)), plus 15 basis points with respect to the 2024 notes, 20 basis points with respect to the 2029 notes and 25 basis points with respect to the 2031 notes,</font></div><div style="padding-left:36pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">plus accrued and unpaid interest thereon to, but not including, the date of redemption.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">On or after November 3, 2024 in the case of the 2024 notes, December 1, 2028 in the case of the 2029 notes and September 3, 2031 in the case of the 2031 notes, we may redeem the applicable series of notes, in whole, at any time, or in part, from time to time, at our option, for cash, at a redemption price equal to 100% of the principal amount of such series of notes, plus accrued and unpaid interest to, but not including, the redemption date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The principal amount of any note remaining outstanding after a redemption in part shall be &#8364;100,000 or a higher integral multiple of &#8364;1,000. Notwithstanding the foregoing, installments of interest on any series of notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">Comparable Government Bond</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means, in relation to any Comparable Government Bond Rate calculation, at the discretion of an independent investment bank selected by us (the &#8220;Quotation Agent&#8221;), a German government bund whose maturity is closest to the par call date, or if such Quotation Agent in its discretion determines that such similar bond is not in issue, such other German government bund as such Quotation Agent may, with the advice of three brokers of, and&#47;or market makers in, German government bunds selected by us, determine to be appropriate for determining the Comparable Government Bond Rate.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:138%">Comparable Government Bond Rate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8221; means the price, expressed as a percentage (rounded to three decimal places, with 0.0005 being rounded upwards), at which the gross redemption yield on the notes to be redeemed, if they were to be purchased at such price on the third business day prior to the date fixed for redemption, would be equal to the gross redemption yield on such business day of the Comparable Government Bond on the basis of the middle market price of the Comparable Government Bond prevailing at 11&#58;00 A.M. (London time) on such business day as determined by the Quotation Agent selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notice of any redemption will be sent (or, in the case of notes held in book-entry form, be transmitted electronically) at least 10 days but not more than 60 days before the redemption date to each registered holder of the applicable series of notes to be redeemed. Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the applicable series of notes or portions thereof called for redemption. If less than all of the applicable series of notes are to be redeemed, the notes to be redeemed will be selected by the trustee in accordance with the standard procedures of the depositary. If the notes to be redeemed are not global notes then held by Euroclear or Clearstream, the trustee will select the notes to be redeemed on a pro rata basis. If the notes are listed on the NYSE or any other national securities exchange, the trustee will select notes in compliance with the requirements of the NYSE or other principal national securities exchange on which the notes are listed. </font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, if less than all of a series of notes is to be redeemed, no notes of such series of a principal amount of &#8364;100,000 or less shall be redeemed in part. If money sufficient to pay the redemption price on the series of notes (or portions thereof) to be redeemed on the redemption date is deposited with the paying agent on or before the redemption date and certain other conditions are satisfied, then on and after such redemption date, interest will cease to accrue on such series of notes (or such portion thereof) called for redemption.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Special Mandatory Redemption</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If we do not satisfy the minimum tender and other conditions in the Purchase Agreement and consummate the Wright Tender Offer on or prior to February 4, 2021, or if, prior to such date, we notify the trustee in writing that the Purchase Agreement has been terminated (each, a &#8220;Special Mandatory Redemption Event&#8221;), the provisions set forth below will be applicable (other than with respect to the 2029 notes). The 2029 notes will not be subject to the special mandatory redemption and will remain outstanding (unless otherwise redeemed) even if the Wright Tender Offer is not consummated on or prior to February 4, 2021. If a Special Mandatory Redemption Event occurs, we will be required to redeem each series of notes (other than the 2029 notes) in the manner set forth below in whole and not in part at a special mandatory redemption price (the &#8220;Special Mandatory Redemption Price&#8221;) equal to 101% of the aggregate principal amount of such series, plus accrued and unpaid interest, if any, to, but excluding, the Special Mandatory </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Redemption Date (as defined below) (subject to the right of holders of record on the relevant record date to receive interest due on any interest payment date that is on or prior to the Special Mandatory Redemption Date).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Upon the occurrence of a Special Mandatory Redemption Event, we will promptly (but in no event later than ten business days following such Special Mandatory Redemption Event) notify the trustee in writing of such event (such notice to include the officers&#8217; certificate required by the Indenture), and the trustee shall, no later than five business days following receipt of such notice from us, notify the holders of each series of notes (such date of notification to such holders, the &#8220;Redemption Notice Date&#8221;) that all of the outstanding notes will be redeemed at the Special Mandatory Redemption Price on the third business day following the Redemption Notice Date (such date, the &#8220;Special Mandatory Redemption Date&#8221;) automatically and without any further action by the holders of the notes, in each case in accordance with the applicable provisions of the Indenture. At or prior to 12&#58;00 p.m. (New York City time) on the business day immediately preceding the Special Mandatory Redemption Date, we will deposit with the trustee funds sufficient to pay the Special Mandatory Redemption Price for the notes. If such deposit is made as provided above, the notes will cease to bear interest on and after the Special Mandatory Redemption Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If we fail to pay the Special Mandatory Redemption Price, it will be an event of default with respect to each series of notes (other than the 2029 notes) under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Optional Redemption for Tax Reasons</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes of any series may be redeemed at our option in whole, but not in part, on not less than 10 nor more than 60 days&#8217; prior notice, at 100% of the principal amount of such series together with accrued and unpaid interest, if any, to, but excluding, the redemption date if, as a result of any change in, or amendment to, the laws, regulations or rulings of the United States (or any political subdivision or taxing authority thereof or therein having power to tax), or any change in official position regarding application or interpretation of those laws, regulations or rulings (including a holding by a court of competent jurisdiction), which change, amendment, application or interpretation is announced or becomes effective on or after the original issue date with respect to the notes, we become or, based upon a written opinion of independent counsel selected by us, will become obligated to pay additional amounts as described below in &#8220;&#8212; Payment of Additional Amounts.&#8221;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Payment of Additional Amounts</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">All payments of principal, interest, and premium, if any, in respect of the notes are will be made free and clear of, and without withholding or deduction for, any present or future taxes, assessments, duties or governmental charges of whatever nature imposed, levied or collected by </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">the United States (or any political subdivision or taxing authority thereof or therein having power to tax), unless such withholding or deduction is required by law or the official interpretation or administration thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will, subject to the exceptions and limitations set forth below, pay as additional interest in respect of the notes such additional amounts as are necessary in order that the net payment by us of the principal of, premium, if any, and interest in respect of the notes to a holder who is not a United States person (as defined below), after withholding or deduction for any present or future tax, assessment, duties or other governmental charge imposed by the United States (or any political subdivision or taxing authority thereof or therein having power to tax), will not be less than the amount provided in the notes to be then due and payable&#59; provided, however, that the foregoing obligation to pay additional amounts shall not apply&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the holder (or the beneficial owner for whose benefit such holder holds such note), or a fiduciary, settlor, beneficiary, member or shareholder of the holder if the holder is an estate, trust, partnership or corporation, or a person holding a power over an estate or trust administered by a fiduciary holder, being considered as&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been engaged in a trade or business in the United States or having or having had a permanent establishment in the United States&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">having a current or former connection with the United States (other than a connection arising solely as a result of the ownership of the notes, the receipt of any payment in respect of the notes or the enforcement of any rights hereunder), including being or having been a citizen or resident of the United States&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a personal holding company, a passive foreign investment company or a controlled foreign corporation for U.S. federal income tax purposes, a foreign tax-exempt organization, or a corporation that has accumulated earnings to avoid U.S. federal income tax&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being or having been a &#8220;10-percent shareholder&#8221; of the Company as defined in section 871(h)(3) of the United States Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or any successor provision&#59; or</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">being a bank receiving payments on an extension of credit made pursuant to a loan agreement entered into in the ordinary course of its trade or business, as described in section 881(c)(3)(A) of the Code or any successor provision&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any holder that is not the sole beneficial owner of the notes, or a portion of the notes, or that is a fiduciary, partnership, limited liability company or other fiscally transparent entity, but only to the extent that a beneficial owner with respect to the holder, a beneficiary or settlor with respect to the fiduciary, or a beneficial owner or member of the partnership, limited liability company or other fiscally transparent entity would not have </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">been entitled to the payment of an additional amount had the beneficiary, settlor, beneficial owner or member received directly its beneficial or distributive share of the payment&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge that would not have been imposed but for the failure of the holder or any other person to comply with certification, identification or information reporting requirements concerning the nationality, residence, identity or connection with the United States of the holder or beneficial owner of the notes, if compliance is required by statute, by regulation of the United States or any taxing authority therein or by an applicable income tax treaty to which the United States is a party as a precondition to exemption from such tax, assessment or other governmental charge&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed otherwise than by withholding by us or a paying agent from the payment&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge required to be withheld by any paying agent from any payment of principal of or interest on any notes, if such payment can be made without such withholding by any other paying agent&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any estate, inheritance, gift, sales, transfer, wealth, capital gains or personal property tax or similar tax, assessment or other governmental charge, or excise tax imposed on the transfer of notes&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">7)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to the extent any tax, assessment or other governmental charge would not have been imposed but for the presentation by the holder of any note, where presentation is required, for payment on a date more than 30 days after the date on which payment became due and payable or the date on which payment thereof is duly provided for, whichever occurs later except to the extent that the beneficiary or holder thereof would have been entitled to the payment of additional amounts had such note been presented for payment on any day during such 30-day period&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">8)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge imposed under sections 1471 through 1474 of the Code (or any amended or successor provisions), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to section 1471(b) of the Code or any fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such sections of the Code, whether currently in effect or as published and amended from time to time&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">9)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">to any tax, assessment or other governmental charge that is imposed or withheld solely by reason of a change in law, regulation, or administrative or judicial interpretation that becomes effective more than 15 days after the payment becomes due or is duly provided for, whichever occurs later&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">10)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:2.01pt">in the case of any combination of the above numbered items.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The notes are subject in all cases to any tax, fiscal or other law or regulation or administrative or judicial interpretation applicable to the notes. Except as specifically provided under this heading &#8220;&#8212;Payment of Additional Amounts,&#8221; we are not required to make any payment for any tax, assessment or other governmental charge imposed by any government or a political subdivision or taxing authority of or in any government or political subdivision.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">As used under this heading &#8220;&#8212;Payment of Additional Amounts&#8221; and under the heading &#8220;&#8212;Optional Redemption for Tax Reasons,&#8221; the term &#8220;United States&#8221; means the United States of America, its territories and possessions, the states of the United States and the District of Columbia, and the term &#8220;United States person&#8221; means (i) any individual who is a citizen or resident of the United States for U.S. federal income tax purposes, (ii) a corporation, partnership or other entity created or organized in or under the laws of the United States, any state of the United States or the District of Columbia (other than a partnership that is not treated as a United States person for United States federal income tax purposes), (iii) any estate the income of which is subject to U.S. federal income taxation regardless of its source, or (iv) any trust if a United States court can exercise primary supervision over the administration of the trust and one or more United States persons can control all substantial trust decisions, or if a valid election is in place to treat the trust as a United States person.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Repurchase at the Option of Holders Upon Change of Control Repurchase Event</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If a Change of Control Repurchase Event (as defined below) occurs in respect of a series of notes, unless we have exercised our right to redeem the notes of such series as described above under &#8220;&#8212;Optional Redemption or &#8220;Optional Redemption for Tax Reasons&#8221; or have been required to redeem the notes as described under &#8220;&#8212;Special Mandatory Redemption&#8221; we will be required to make an offer (a &#8220;Change of Control Offer&#8221;) to each holder of such series of notes to repurchase all or any part (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) of that holder&#8217;s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the date of such repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice will, if mailed prior to the date of consummation of the Change of Control, state that the offer to purchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will comply with the requirements of Rule 14e-1 under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">On the Change of Control Repurchase Event payment date, we will, to the extent lawful&#58;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">accept for payment all notes or portions of notes (in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount) properly tendered pursuant to our offer&#59;</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered&#59; and</font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:138%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">deliver or cause to be delivered to the trustee for cancellation the notes properly accepted, together with an officers&#8217; certificate stating the aggregate principal amount of notes being repurchased by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered&#59; provided, that each new note will be in minimum denominations of &#8364;100,000 and integral multiples of &#8364;1,000 original principal amount above that amount.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We will not be required to make a Change of Control Offer upon a Change of Control Repurchase Event if (i) a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for a Change of Control Offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer or (ii) we have previously or concurrently mailed a redemption notice with respect to all of the outstanding notes as described under &#8220;Optional Redemption&#8221; above.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">If holders of not less than 90% in aggregate principal amount of the outstanding notes of any series validly tender and do not withdraw such notes in a Change of Control Offer and we, or any third party making such an offer in lieu of us as described above, purchases all of the notes of such series validly tendered and not withdrawn by such holders, we or such third party will have the right, upon not less than 10 days nor more than 60 days&#8217; prior notice, provided that such notice is given not more than 30 days following such repurchase pursuant to the Change of </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Control Offer described above, to redeem all notes of such series that remain outstanding following such purchase on a date specified in such notice (the &#8220;Second Change of Control Payment Date&#8221;) and at a price in cash equal to 101% of the aggregate principal amount of notes of such series repurchased plus any accrued and unpaid interest on the notes repurchased to, but not including, the Second Change of Control Payment Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Below Investment Grade Rating Event&#8221; means the notes of such series are rated below Investment Grade by each of the Rating Agencies on any date during the period commencing upon the first public notice of the occurrence of a Change of Control or our intention to effect a Change of Control and ending 60 days following public notice of the occurrence of the related Change of Control (which period shall be extended so long as the rating of the notes of such series is under publicly announced consideration for possible downgrade by any of the Rating Agencies, provided that no such extension shall occur if on such 60th day the notes of such series are rated Investment Grade by at least one of such Rating Agency and are not subject to review for possible downgrade by such Rating Agency)&#59; provided further that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if the Rating Agencies making the reduction in rating to which this definition would otherwise apply do not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Change of Control&#8221; means the occurrence of any of the following&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our assets and those of our subsidiaries taken as a whole to any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one of our subsidiaries&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the adoption of a plan relating to our liquidation or dissolution&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the first day on which a majority of the members of our Board of Directors are not Continuing Directors&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:8.01pt">the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any &#8220;person&#8221; (as that term is used in Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries, becomes the beneficial owner (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b)(i) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (ii) immediately following that transaction, no person is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of such holding company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Change of Control Repurchase Event&#8221; means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Continuing Directors&#8221; means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes&#59; or (2) was nominated for election, elected or appointed to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination, election or appointment (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating categories of Moody&#8217;s) and a rating of BBB- or better by S&#38;P (or its equivalent under any successor rating categories of S&#38;P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service Inc., a subsidiary of Moody&#8217;s Corporation, and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Rating Agency&#8221; means (1) each of Moody&#8217;s and S&#38;P&#59; and (2) if any of Moody&#8217;s or S&#38;P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a &#8220;nationally recognized statistical rating organization&#8221; within the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">meaning of Section 3(a) (62) under the Exchange Act, selected by us as a replacement agency for Moody&#8217;s or S&#38;P, or both of them, as the case may be.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;S&#38;P&#8221; means S&#38;P Global Ratings Inc., a division of S&#38;P Global Inc. and its successors.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Voting Stock&#8221; of any specified person as of any date means the capital stock of such person that is at the time entitled to vote generally in the election of the board of directors of such person.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The definition of &#8220;Change of Control&#8221; includes a phrase relating to the direct or indirect sale, transfer, conveyance or other disposition of &#8220;all or substantially all&#8221; of our assets and those of our subsidiaries, taken as a whole. Although there is a limited body of case law interpreting the phrase &#8220;substantially all,&#8221; there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase the notes as a result of a sale, transfer, conveyance or other disposition of less than all of our assets and the assets of our subsidiaries, taken as a whole, to another person or group may be uncertain.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Certain Covenants</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Limitation on Liens</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture contains a covenant that we will not, and we will not permit any of our Restricted Subsidiaries to, issue, assume or guarantee any Indebtedness secured by any Mortgage upon any of our Principal Properties or those of any of our Restricted Subsidiaries without equally and ratably securing the notes (and, if we so determine, any other Indebtedness ranking equally with the notes) with such Indebtedness.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">This covenant will not prevent us or any of our Restricted Subsidiaries from issuing, assuming or guaranteeing&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any purchase money mortgage on such Principal Property prior to, simultaneously with or within 180 days after the later of (1) the acquisition or completion of construction or completion of substantial reconstruction, renovation, remodeling, expansion or improvement (each, a &#8220;substantial improvement&#8221;) of such Principal Property or (2) the placing in operation of such property after the acquisition or completion of any such construction or substantial improvement&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages on a Principal Property existing at the time of acquisition, including acquisition through merger or consolidation&#59; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages existing on the date of the initial issuance of the notes, Mortgages on assets of a corporation or other business entity existing on the date it becomes a Restricted Subsidiary or is merged or consolidated with us or a Restricted Subsidiary or at the time </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">the corporation or other business entity sells, leases or otherwise disposes of its property as an entirety or substantially as an entirety to us or a Restricted Subsidiary or Mortgages on the assets of a Subsidiary that is newly designated as a Restricted Subsidiary if the Mortgage would have been permitted under the provisions of this paragraph if such Mortgage was created while the Subsidiary was a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages in favor of us or a Restricted Subsidiary&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages for taxes, assessments or governmental charges or levies that are not delinquent or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Carriers&#8217;, warehousemen&#8217;s, materialmen&#8217;s, repairmen&#8217;s, mechanic&#8217;s, landlords&#8217; and other similar Mortgages arising in ordinary course of business that are not delinquent or remain payable without penalty or that are being contested in good faith&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages (other than any Mortgage imposed by ERISA) consisting of pledges or deposits required in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other social security legislation&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Easements, rights-of-way, restrictions, encroachments, imperfections and other similar encumbrances affecting real property that, in the aggregate, are not substantial in amount and do not in any case materially detract from the value of the Principal Property subject thereto or materially interfere with the ordinary conduct of our and our Subsidiaries&#8217; business, taken as a whole&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising by reason of deposits with, or the giving of any form of security to, any governmental agency or anybody created or approved by law or governmental regulation, including any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages arising from filing Uniform Commercial Code financing statements relating solely to leases&#59; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">Mortgages to secure Indebtedness incurred to extend, renew, refinance or replace Indebtedness secured by any Mortgages referred to above, provided that the principal amount of the extended, renewed, refinanced or replaced Indebtedness does not exceed the principal amount of Indebtedness so extended, renewed, refinanced or replaced, plus transaction costs and fees, and that any such Mortgage applies only to the same property or assets subject to the prior permitted Mortgage (and, in the case of real property, improvements).</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:138%">Limitations on Sale and Leaseback Transactions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The Indenture contains a covenant that we will not, and will not permit our Restricted Subsidiaries to, enter into any arrangement with any person providing for the leasing by us or any Restricted Subsidiary of any Principal Property owned or acquired thereafter that has been or is to be sold or transferred by us or such Restricted Subsidiary to such person with the intention of taking back a lease of such Principal Property, a &#8220;sale and leaseback transaction,&#8221; without </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">equally and ratably securing the notes (and, if we shall so determine, any other Indebtedness ranking equally with the notes), unless&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">within 180 days after the receipt of the proceeds of the sale or transfer, we or any Restricted Subsidiary apply an amount equal to the greater of the net proceeds of the sale or transfer or the fair value of such Principal Property at the time of such sale or transfer to any (or a combination) of (1) the prepayment or retirement (other than any mandatory prepayment or retirement) of our Senior Funded Debt or (2) the purchase, construction, development, expansion or improvement of other comparable property, subject in each case to credits for voluntary retirements of Senior Funded Debt&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">we or such Restricted Subsidiary would be entitled, at the effective date of the sale or transfer, to incur Indebtedness secured by a Mortgage on such Principal Property, in an amount at least equal to the Attributable Debt in respect of the sale and leaseback transaction, without equally and ratably securing the notes pursuant to &#8220;&#8212;Limitation on Liens&#8221; described above.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">The foregoing restriction will not apply to&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction for a term of not more than three years including renewals&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within three years after the later of (1) the date of the issuance of the notes under the Supplemental Indenture, or (2) the date such Principal Property was acquired&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction with respect to a Principal Property if a binding commitment with respect thereto is entered into within 180 days after the later of the date such property was acquired and, if applicable, the date such property was first placed in operation&#59; or</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">any sale and leaseback transaction between us and a Restricted Subsidiary or between Restricted Subsidiaries.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Exception to Limitations for Exempted Debt</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">Notwithstanding the limitations in the Indenture on liens and sale and leaseback transactions, we or our Restricted Subsidiaries may, in addition to amounts permitted under such restrictions and without equally and ratably securing the notes, create or assume and renew, extend or replace Mortgages, or enter into sale and leaseback transactions without any obligation to retire any Senior Funded Debt of us or any Restricted Subsidiary, provided that at the time of such creation, assumption, renewal, extension or replacement of a Mortgage or at the time of entering into such sale and leaseback transactions, and after giving effect thereto, Exempted Debt does not exceed 15% of our Consolidated Net Tangible Assets.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:138%">Definitions</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">For purposes of the Indenture&#58;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Attributable Debt&#8221; in respect of a sale and leaseback transaction means, at the time of determination, the present value (discounted at the imputed rate of interest of such transaction as determined in good faith by us) of the obligation of the lessee for net rental payments during the remaining term of the lease included in such sale and leaseback transaction (including any period for which such lease has been extended or may, at the option of the lessor, be extended). The term &#8220;net rental payments&#8221; under any lease for any period means the sum of the rental and other payments required to be paid in such period by the lessee thereunder, not including any amounts required to be paid by such lessee (whether or not designated as rental or additional rent) on account of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges required to be paid by such lessee thereunder or any amount required to be paid by lessee thereunder contingent upon the amount of maintenance and repairs, insurance, taxes, assessments, water rates or similar charges. In the case of any lease that is terminable by the lessee upon the payment of a penalty, such net amount shall be the lesser of (x) the net amount determined assuming termination upon the first date such lease may be terminated (in which case the net amount shall also include the amount of the penalty, but shall not include any rent that would be required to be paid under such lease subsequent to the first date upon which it may be so terminated) or (y) the net amount determined assuming no such termination.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Consolidated Net Tangible Assets&#8221; means the total amounts of assets (less depreciation and valuation reserves and other reserves and items deductible from gross book value of specific asset accounts under generally accepted accounting principles) that under generally accepted accounting principles would be included on a consolidated balance sheet of us and our consolidated Restricted Subsidiaries after deducting (1) all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendable or renewable at the obligor&#8217;s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed&#59; (2) investments in Unrestricted Subsidiaries&#59; and (3) all trade names, trademarks, licenses, patents, copyrights and goodwill, organizational and development costs, deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized, and amortized debt discount and expense, less unamortized premium.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Exempted Debt&#8221; means the sum of the following items outstanding as of the date Exempted Debt is being determined (1) Indebtedness of us and our Restricted Subsidiaries secured by a Mortgage and not permitted to exist under the Indenture and (2) Attributable Debt </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">of us and our Restricted Subsidiaries in respect of all sale and leaseback transactions not permitted under the Indenture.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Funded Debt&#8221; means Indebtedness that matures more than one year from the date of creation, or that is extendable or renewable at the sole option of the obligor so that it may become payable more than one year from such date. Funded Debt does not include (1) obligations created pursuant to leases, (2) any Indebtedness or portion thereof maturing by its terms within one year from the time of any computation of the amount of outstanding Funded Debt unless such Indebtedness shall be extendable or renewable at the sole option of the obligor in such manner that it may become payable more than one year from such time, or (3) any Indebtedness for the payment or redemption of which money in the necessary amount shall have been deposited in trust either at or before the maturity date thereof.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Indebtedness&#8221; means any and all of the obligations of a person for money borrowed that in accordance with generally accepted accounting principles would be reflected on the balance sheet of such person as a liability as of the date of which the Indebtedness is to be determined. Notwithstanding the foregoing, a change in generally accepted accounting principles subsequent to November 30, 2018 shall not be deemed an incurrence of Indebtedness.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Investment&#8221; means any investment in stock, evidences of Indebtedness, loans or advances, however made or acquired, but does not include our account receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business, or any evidences of Indebtedness, loans or advance made in connection with the sale to any Subsidiary of our accounts receivable or the accounts receivable of any Restricted Subsidiary arising from transactions in the ordinary course of business.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Mortgage&#8221; means any mortgage, security interest, pledge, lien or other encumbrance.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Principal Property&#8221; means all real property and improvements thereon owned by us or a Restricted Subsidiary, including, without limitation, any manufacturing, warehouse, distribution or research facility, and improvements therein, having a net book value in excess of 2% of Consolidated Net Tangible Assets that is located within the United States, excluding its territories and possessions and Puerto Rico. This term does not include any real property and improvements thereon that our Board of Directors declares by resolution not to be of material importance to the total business conducted by us and our Restricted Subsidiaries taken as a whole.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Restricted Subsidiary&#8221; means a Subsidiary that owns a Principal Property.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Senior Funded Debt&#8221; means all Funded Debt (except Funded Debt, the payment of which is subordinated to the payment of the notes).</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Subsidiary&#8221; means a corporation, partnership or other legal entity of which, in the case of a corporation, more than 50% of the outstanding voting stock is owned, directly or indirectly, by us or by one or more other Subsidiaries, or by us and one or more other Subsidiaries or, in the case of any partnership or other legal entity, more than 50% of the ordinary capital interests is, at the time, directly or indirectly owned or controlled by us or by one or more other Subsidiaries. For the purposes of this definition, &#8220;voting stock&#8221; means the equity interest that ordinarily has voting power for the election of directors, managers or trustees of an entity, or persons performing similar functions, whether at all times or only so long as no senior class of equity interest has such voting power by reason of any contingency.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8220;Unrestricted Subsidiary&#8221; means any Subsidiary other than a Restricted Subsidiary.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Consolidation, Merger and Sale of Assets</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We may consolidate or merge with or into any other corporation, and we may sell or transfer all or substantially all of our assets to another corporation, provided, among other things, that (a) we are the surviving corporation or the corporation formed by or resulting from any such</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">consolidation or merger or the transferee of such assets shall be a corporation organized and existing under the laws of the United States, any state thereof or the District of Columbia and shall expressly assume by supplemental indenture payment of the principal of, and premium, if any, and interest, if any, on the notes issued under the Indenture and the performance and observance of the Indenture and (b) we or such successor corporation shall not immediately thereafter be in default under the Indenture.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Events of Default</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The following events are defined in the Indenture as &#8220;Events of Default&#8221;&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of any installment of interest on any series of notes for 30 days after becoming due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the payment of principal or premium, if any, of any series of notes when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the deposit of any sinking fund payment, when due&#894;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">default in the performance of any other covenant for 90 days after notice, which must be sent by either the trustee or holders of 25% of the principal amount of the notes of the affected series&#894; and</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:138%;padding-left:13.8pt">certain events of bankruptcy, insolvency or reorganization.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default occurs and continues with respect to a series of notes, either the trustee or the holders of at least 25% in principal amount of the outstanding notes of such series may declare the entire principal amount of all the notes of such series to be due and payable&#894; provided that, in the case of an Event of Default involving certain events of bankruptcy, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 4(xx)</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">insolvency or reorganization, such acceleration is automatic&#894; and, provided further, that after such acceleration, but before a judgment or decree based on acceleration, the holders of a majority in aggregate principal amount of the outstanding notes of that series may, subject to certain conditions, rescind and annul such acceleration if all Events of Default, other than the nonpayment of accelerated principal, have been cured or waived. </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10i2022nqstockoptionawar.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i9f640fda6bd743d8bd4474c3fbb87ee6_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font><br></font></div><div style="text-align:right"><img alt="image_1a.jpg" src="image_1a.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:139px"></div><div style="margin-bottom:0.1pt"><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"> A. Lobo</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kalamazoo MI 49002 USA</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P 269 389 7353</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div><font><br></font></div><div><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">February 2, 2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Name Last Name</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear First Name&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I am pleased to inform you that you are one of a select group of individuals receiving a stock option award in 2022. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are awarding you a nonstatutory stock option for xxx shares of Stryker Corporation Common Stock at a price of USD $xxx.xx per share. Except as otherwise provided in the Terms and Conditions, you may exercise this option at 20% per year beginning on February 2, 2023, and it will expire on February 1, 2032.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> between March 1 and March 31, 2022</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The detailed terms of the option are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long-Term Incentive Plan. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with the award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2022. The exercisability of the options is conditioned on you having signed the Non-Compete Agreement by March 31, 2022, where permitted by applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You can find additional educational materials on the UBS One Source web site in the Resources section, including the Stock Option brochure and Stock Option Tax Questions &#38; Answers.  </font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are committed to growing talent and want our people to experience rewarding careers at Stryker. Your valuable contributions helped us deliver strong results during a challenging year and I look forward to our continued business growth and success.</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div><img alt="image_0a.jpg" src="image_0a.jpg" style="height:114px;margin-bottom:5pt;vertical-align:text-bottom;width:98px"></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO NONSTATUTORY STOCK OPTIONS GRANTED</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND </font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTATED</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Options to purchase Shares of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2022 are subject to these Terms and Conditions Relating to Nonstatutory Stock Options Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference.  In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan.  For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;Upon the termination of your employment with your Employer, your right to exercise the Options shall be only as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If your employment is terminated by reason of Disability (as such term is defined in the 2011 Plan) or death, you, your legal representative or your estate shall have the right, for a period of one (1) year following such termination, to exercise the Options with respect to all or any part of the Shares subject thereto, regardless of whether the right to purchase such Shares had vested on or before the date of your termination by Disability or death.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;If your employment is terminated by reason of Retirement (as such term is defined in the 2011 Plan) prior to the date that your Options become fully vested, you will continue to vest in your Options in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer. You (or your estate in the event of your death after your termination by Retirement) shall have the right, at any time on or prior to the 10th anniversary of the grant date, to exercise the vested portion of the Options.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;If you cease to be an Employee for any reason other than those provided in (a) or (b) above, you or your estate (in the event of your death after such termination) may, within the 30-day period following such termination, exercise the Options with respect to only such number of Shares as to which the right of exercise had vested on or before the Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the effective date of termination of your employment with your Employer.   If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of (i) the date on which notice of termination is provided to you, (ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, the Options shall not be exercisable in whole or in part (i) after the 10th anniversary of the grant date or (ii) except as provided in Section 3(c) hereof or in the event of termination of employment because of Disability, Retirement or death, unless you shall have continued in the employ of the Company or one of its Subsidiaries for one (1) year following the date of grant of the Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, if you are eligible for Retirement but cease to be an Employee for any other reason before you retire, the right to exercise the Options shall be determined as if your employment ceased by reason of Retirement.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)&#160;&#160;&#160;&#160;If you are both an Employee and a Director, the provisions of this Section&#160;2 shall not apply until such time as you are neither an Employee nor a Director. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The number of Shares subject to the Options and the price to be paid therefor shall be subject to adjustment and the term and exercise dates hereof may be accelerated as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the Options the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled.  The Options shall also be appropriately amended as to price and other terms as may be necessary to reflect the foregoing events.  In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Common Stock shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the Options, such adjustment shall be made in accordance with such determination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Fractional Shares resulting from any adjustment in the Options may be settled in cash or otherwise as the Committee shall determine, in its sole discretion.  Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Committee shall have the power to amend the Options to permit the exercise of the Options (and to terminate any unexercised Options) prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii)&#160;the merger or consolidation of the Company or your Employer with or into any other unrelated corporation. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;To exercise the Options, you must complete the on-line exercise procedures as established through the Stock Plan Administrator at </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> or by telephone at +1 860 727 1515 (or such other direct dial-in number that may be established from time to time).  As part of such procedures, you shall be required to specify the number of Shares that you elect to purchase and the date on which such purchase is to be made, and you shall be required to make full payment of the Exercise Price.  An Option shall not be deemed to have been exercised (i.e., the exercise date shall not be deemed to have occurred) until the notice of such exercise and payment in full of the Exercise Price are provided.  The exercise date will be defined by the New York Stock Exchange (&#8220;NYSE&#8221;) trading hours. If an exercise is completed after the market close or on a weekend, the exercise will be dated the next following trading day.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Exercise Price may be paid in such manner as the Committee may specify from time to time in its sole discretion and as established through Stock Plan Administrator, including (but not limited to) the following methods&#58; (i) by a net exercise arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the largest whole number of Shares with an aggregate Fair Market Value on the date of purchase sufficient to cover the aggregate Exercise Price&#59; (ii) by a broker-assisted cashless exercise transaction pursuant to which the Stock Plan Administrator loans funds to you to enable you to pay the aggregate Exercise Price and purchase Shares, and then sells a sufficient &#91;whole&#93; number of the purchased Shares on your behalf to enable you to repay the aggregate Exercise Price (with the remaining Shares and&#47;or cash then delivered by Stock Plan Administrator to you) or (iii) cash payment.  In cases where you utilize the net exercise arrangement and the Fair Market Value of the number of whole Shares withheld or sold, as applicable, is greater than the aggregate Exercise Price, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the Options, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends and any proceeds derived from the sale of the Shares acquired pursuant to the Options) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different).  In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different).  Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;If you are resident</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or employed in a country that is a member of the European Union, the grant of the Options and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;).  To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Options, including the grant of the Options, the vesting of the Options, the exercise of the Options, the subsequent sale of any Shares acquired pursuant to the Options and the receipt of any dividends and (ii) do not commit to structure the terms of the grant or any aspect of the Options to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to the delivery of Shares upon exercise of your Options, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company may withhold a number of whole Shares otherwise issuable upon exercise of the Options that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares.  The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items.  In cases where the Fair Market Value of the number of whole Shares withheld at the time of exercise is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable. In the event that withholding in Shares is prohibited or problematic under applicable law or causes adverse consequences to the Company or your Employer, your Employer may withhold the Tax-Related Items required to be withheld with respect to the Shares (i) from the proceeds of the sale of Shares acquired upon exercise of the Options either through a voluntary sale or through a mandatory sale arranged by the Company (on your behalf pursuant to this authorization without further consent), or (ii) in cash from your regular salary and&#47;or wages or other amounts payable to you.  In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) upon exercise of the Options unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such Options.  By accepting these Options, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or wages or other amounts payable to you as provided for hereunder.  All other Tax-Related Items related to the Options and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;The Options are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the Options or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary or during the one-year period following termination of employment, any unexercised portion of the Options shall be rescinded and you shall return to the Company all Shares that were acquired upon exercise of the Options that you have not disposed of and the Company shall repay you an amount for each such Share equal to the lesser of the Exercise Price or the Fair Market Value of a Share at such time.  Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon exercise of the Options that you have disposed of.  For purposes of the preceding sentence, the profit shall be the positive difference between the Fair Market Value of the Shares at the time of disposition and the Exercise Price.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;The Options shall be transferable only by will or the laws of descent and distribution and shall be exercisable during your lifetime only by you.  If you purport to make any transfer of the Options, except as aforesaid, the Options and all rights thereunder shall terminate immediately.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;The Options shall not be exercisable in whole or in part, and the Company shall not be obligated to issue any Shares subject to the Options, if such exercise and sale would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time.  The Options are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the Options under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the Options, the Options may not be exercised in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;The grant of the Options shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time.  You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the exercise of the Options until the date of issuance of such Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time.  The grant of the Options under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of Options or any other award under the 2011 Plan or other benefits in lieu thereof in the future.  Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, the vesting provisions and the exercise price.  Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;Your participation in the 2011 Plan is voluntary.  The value of the Options and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any).  Any grant under the 2011 Plan, including the grant of the Options, is not part of normal or expected compensation for purposes of calculating any </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.&#160;&#160;&#160;&#160;The Options are Nonstatutory Stock Options and shall not be treated as Incentive Stock Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants Options under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the Options under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the Options, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all Options or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160; The Company transfers your personal data to the Stock Plan Administrator.  In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner.  The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160; The Company and the Stock Plan Administrator are based in the United States.  You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160; Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan.  This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.&#160;&#160;&#160;&#160;The grant of the Options is not intended to be a public offering of securities in your country of residence (and country of employment, if different).  The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law).  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should purchase Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of your Options. Investment in Shares involves a degree of risk.  Before deciding to purchase Shares pursuant to the Options, you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">under the 2011 Plan or the disposition of them.  Further, you should carefully review all of the materials related to the Options and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.&#160;&#160;&#160;&#160;All questions concerning the construction, validity and interpretation of the Options and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof.  Any disputes regarding the Options or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;The Company may, in its sole discretion, decide to deliver any documents related to the Options or other awards granted to you under the 2011 Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Options be drawn up in English.  If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the Options translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., Options) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different).&#160; Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information.&#160; Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.&#160; Third parties include fellow employees. &#160;Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.&#160; You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.&#160;&#160;&#160;&#160;Notwithstanding any provisions of these Terms and Conditions to the contrary, the Options shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#8220;Addendum&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25.&#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on the Options, any Shares acquired pursuant to the Options and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the award and the 2011 Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">This Section 26 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your Options, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such Options and Shares.  You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you.  For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.  In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">By accepting the grant of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">,</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">*****************************</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO NONSTATUTORY STOCK OPTIONS GRANTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the Options are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;).  All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions.  Pursuant to Section 24 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;) &#47; Switzerland and the United Kingdom*</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 17 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A.  and grants Options under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(a)&#160;&#160;&#160;&#160;Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the Options under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan.  The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(b)&#160;&#160;&#160;&#160;Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator.  In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner.  The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(c)&#160;&#160;&#160;&#160;International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(d)&#160;&#160;&#160;&#160;Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems.  If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">(e)&#160;&#160;&#160;&#160;Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the grant of the Options, nor the issuance of Shares subject to the exercise of the Options, constitutes a public offering in Argentina. The grant of Options pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina. </font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1.&#160;&#160;&#160;&#160;Options Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the Options is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian Offer Document can be accessed at &#91;UBS INSERT LINK HERE&#93;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Name&#58;          ___________________________    Number of Shares&#58; _____________________</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><br>Date of Grant&#58; ___________________________    Exercise Price&#58;   _____________________</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  For the Options to be subject to taxation at the time of grant, you must affirmatively accept the Options in writing within 60 days of the date of grant specified above by signing below and returning this original executed Addendum to&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock Plan Administration Department</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2825 Airview Blvd.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kalamazoo, Michigan 49002 (U.S.A)</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">I hereby accept the ________ (number) Options granted to me by the Company on the date of grant.  I also acknowledge that I have been encouraged to discuss the acceptance of the Options and the applicable </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">tax treatment with a financial and&#47;or tax advisor, and that my decision to accept the Options is made with full knowledge of the applicable consequences.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%"><br></font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date of Acceptance&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><br>If you fail to affirmatively accept the Options in writing within 60 days of the date of grant, the Options will not be subject to taxation at the time of grant but instead will be subject to taxation on the date you exercise the Options (or such other treatment as may apply under Belgian tax law at the time of exercise).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Payment of Exercise Price Limited to Cash Payment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in Section 4 of the Terms and Conditions, you shall be permitted to pay the Exercise Price only by means of a cash payment (the net exercise method and the cashless exercise method shall not be permitted).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Undertaking for Qualifying Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are accepting the Options in writing within 60 days of the date of grant and wish to have the Options subject to a lower valuation for Belgium tax purposes pursuant to the article 43, &#167;6 of the Belgian law of 26 March 1999, you may agree and undertake to (a) not exercise the Options before the end of the third calendar year following the calendar year in which the date of grant falls, and (b) not transfer the Options under any circumstances (except on rights your heir might have in the Options upon your death).  If you wish to make this undertaking, you must sign below and return this executed Addendum to the address listed above. </font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#58;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Printed Name&#58;&#160;&#160;&#160;&#160;_______________________________</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the Options, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the Options, if any, is not part of your remuneration from employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the Options, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the exercise of the Options, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Non-Qualified Securities</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  All or a portion of the Shares subject to your Options may be &#34;non-qualified securities&#34; within the meaning of the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Income Tax Act</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Canada).  The Company shall provide you with additional information and&#47;or appropriate notification regarding the characterization of the Options for Canadian income tax purposes as may be required by the </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Income Tax Act</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (Canada) and the regulations thereunder.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Exercise by Using Previously Owned Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are resident in Canada, you shall not be permitted to use previously-owned Shares for exercising the Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following supplements Section 2(c) of the Terms and Conditions as well as any other section required to give effect to the same&#58;  </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the Options and receive Shares upon exercise under the 2011 Plan, if any, will terminate as of the actual Termination Date.  For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the Options under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a resident of Quebec, by accepting the Options, you acknowledge and agree that it is your express wish that the Terms and Conditions, this Addendum, as well as all other documents, notices and legal proceedings entered into, given or instituted pursuant to your Option, either directly or indirectly, be drawn up in English.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  En acceptant l'allocation de votre Options, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de votre Option, soient r&#233;dig&#233;s en anglais.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.  PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 14 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose.  Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the Options are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK</font><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of Options upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding any provision in the Terms and Conditions or the Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the Option upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the Option upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 5 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#160;By accepting the Options, you acknowledge and agree that it is your express wish that the Terms and Conditions, this Addendum, as well as all&#160;other documents, notices and legal proceedings entered into, given or instituted pursuant to your Option, either directly or indirectly, be drawn up in English.  </font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">En acceptant l'allocation de votre Option, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de votre Option, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the Options and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong.  You are hereby advised to exercise caution in relation to the offer thereunder.  If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the Options shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;).  To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the Options shall be null and void.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the Options does not constitute an employment relationship between you and the Company.  You have been granted the Options as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer.  Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company's grant of the Options and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the Options may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum.   As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability.  The value of the Options is an extraordinary item of compensation outside the scope of your employment contract, if any.  The Options are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As a condition to the grant of the Options, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered Options in Stryker Corporation. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange.  You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;phx.corporate-ir.net&#47;phoenix.zhtml&#63;c&#61;118965&#38;p&#61;irol-irhome</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#93;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall replace Section 18 of the Terms and Conditions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the Options under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  You should note that, as a result, the&#160;Options are subject to section 257 of the SFA and&#160;you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the&#160;Options&#160;in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act.  Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., Options or Shares) in the Company or any related company.  In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired upon exercise of the Options).  These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company.  In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 7 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon exercise of the Options.  If you fail to advise the Company of the gain realized upon exercise, you may be liable for a fine.  You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa.  As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations.  Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information and Deemed Acceptance of Options</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; Neither the Options nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa.&#160; The </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the Options offer must be finalized on or before the 60th day following the grant date.&#160; If you do not want to accept the Options, you are required to decline the Options no later than the 60th day following the grant date.&#160; If you do not reject the Options on or before the 60th day following the grant date,&#160;you will be deemed to accept the Options.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accepting the Options, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan.  You understand that the Company has unilaterally, gratuitously and in its sole discretion granted Options under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis.  Consequently, you understand that the Options are granted on the assumption and condition that the Options and the Shares acquired upon exercise of the Options shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the Options shall be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the Options, any unvested Options as of the date you cease active employment and any vested portion of the Options not exercised within the post-termination exercise period set out in the Terms and Conditions will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article&#160;40 of the Workers&#8217; Statute.  You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your Options.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#00006f;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWEDEN</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exercise by Cash Payment Only</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are a local national of Sweden, you may exercise the Options only by means of a cash payment or such other methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in the Terms and Conditions to the contrary, if you are a local national of Sweden, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash, or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law. Additionally, the Company and&#47;or the Employer may withhold Tax-Related Items from salary in an amount up to the statutory maximum withholding limitations, however, the Company and&#47;or your Employer will not withhold amounts in excess of your statutory maximum withholding limitations. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this document nor any other materials relating to the Options (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey.  The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board.  You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the Options is available only for select Employees of the Company </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and its Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the Options. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(i)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">No Exercise by Using Existing Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 4 of the Terms and Conditions to the contrary, if you are resident in the United Kingdom, you shall not be permitted to use existing Shares for exercising the Options and paying the Exercise Price.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall supplement Section 7 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 7 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and the Subsidiary that employs you for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to exercise the Options as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the Options.  Upon the grant of the Options, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10ii2022rsustockoptionaw.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i93afd37780d8490ca1442cc00d7c775f_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:right"><img alt="image_12a.jpg" src="image_12a.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:137px"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"> A. Lobo</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kalamazoo MI 49002 USA</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P 269 389 7353</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">February 2, 2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Name Last Name</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear First Name&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I am pleased to inform you that you are one of a select group of individuals receiving a restricted stock units (RSUs) award in 2022. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are awarding you xxx RSUs with respect to Common Stock of Stryker Corporation. Except as otherwise provided in the Terms and Conditions, one-third of these RSUs will vest on March 21 of each of the three years beginning March 21, 2023.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> between March 1 and March 31, 2022</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The detailed terms of the RSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long-Term Incentive Plan. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with the award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2022. The vesting of the RSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2022, where permitted by applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">You can find additional educational materials on the UBS One Source web site in the Resources section, including the RSU brochure and RSU Tax Questions &#38; Answers.  </font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are committed to growing talent and want our people to experience rewarding careers at Stryker. Your valuable contributions helped us deliver strong results during a challenging year and I look forward to our continued business growth and success.</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div><img alt="image_02a.jpg" src="image_02a.jpg" style="height:114px;margin-bottom:5pt;vertical-align:text-bottom;width:98px"></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO RESTRICTED STOCK UNITS GRANTED</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND </font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTATED</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;The Restricted Stock Units (&#8220;RSUs&#8221;) with respect to Common Stock of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2022 are subject to these Terms and Conditions Relating to Restricted Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference.  In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan.  For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;Your right to receive the Shares issuable pursuant to the RSUs shall be only as follows&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If you continue to be an Employee, you will receive the Shares underlying the RSUs that have become vested as soon as administratively possible following the vesting date as set forth in the award letter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;If you cease to be an Employee by reason of Disability (as such term is defined in the 2011 Plan or determined under local law) or death prior to the date that your RSUs become fully vested, you or your estate will become fully vested in your RSUs, and you, your legal representative or your estate will receive all of the underlying Shares as soon as administratively practicable following your termination by Disability or death.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;If you cease to be an Employee by reason of Retirement (as such term is defined in the 2011 Plan or determined under local law) prior to the date that your RSUs become fully vested, you (or your estate in the event of your death after your termination by Retirement) will continue to vest in your RSUs in accordance with the vesting schedule as set forth in the award letter as if you had continued your employment with your Employer.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;If you cease to be an Employee prior to the date that your RSUs become fully vested for any reason other than those provided in (b) or (c) above, you shall cease vesting in your RSUs effective as of your Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the effective date of termination of your employment with your Employer.  If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">i) the date on which notice of termination is provided to you, (ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;Notwithstanding the foregoing, the Company may, in its sole discretion, settle your RSUs in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law, (2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;The number of Shares subject to the RSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore subject to the RSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled.  The other terms of the RSUs shall also be appropriately amended as may be necessary to reflect the foregoing events.  In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the RSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Fractional Shares resulting from any adjustment in the RSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion.  Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Committee shall have the power to amend the RSUs to permit the immediate vesting of the RSUs (and to terminate any unvested RSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;If you are resident and&#47;or employed outside of the United States, you agree, as a condition of the grant of the RSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the RSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different).  In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different).  Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the RSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;).  To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6.&#160;&#160;&#160;&#160;Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes and&#47;or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the RSUs, including the grant of the RSUs, the vesting of the RSUs, the subsequent sale of any Shares acquired pursuant to </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the RSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items. Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares.  The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items.  In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable.  In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you. In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such RSUs.  By accepting these RSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder.  All other Tax-Related Items related to the RSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The RSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the RSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested RSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the RSUs that you have not disposed of.  Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the RSUs that you have disposed of.  For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;The RSUs shall be transferable only by will or the laws of descent and distribution.  If you purport to make any transfer of the RSUs, except as aforesaid, the RSUs and all rights thereunder shall terminate immediately.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;The RSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the RSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time.  The RSUs are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the RSUs under any securities exchange requirements or under </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the RSUs, the RSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;The grant of the RSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time.  You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the RSUs until the date of issuance of such Shares.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12. &#160;&#160;&#160;&#160;You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time.  The grant of the RSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of RSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future.  Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions.  Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;Your participation in the 2011 Plan is voluntary.  The value of the RSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any).  Any grant under the 2011 Plan, including the grant of the RSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants RSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the RSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the RSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all RSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;The Company transfers your personal data to the Stock Plan Administrator.  In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner.  The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Company and the Stock Plan Administrator are based in the United States.  You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan.  This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)&#160;&#160;&#160;&#160;You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.&#160;&#160;&#160;&#160;The grant of the RSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different).  The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law).  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should acquire Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the RSUs.  The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them.  Further, you should carefully review all of the materials related to the RSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;All questions concerning the construction, validity and interpretation of the RSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof.  Any disputes regarding the RSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.&#160;&#160;&#160;&#160;The Company may, in its sole discretion, decide to deliver any documents related to the RSUs or other awards granted to you under the 2011 Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19.&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the RSUs be drawn up in English.  If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the RSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., RSUs) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different).&#160; Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information.&#160; Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.&#160; Third parties include fellow employees. &#160;Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">applicable Company insider trading policy.&#160; You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;Notwithstanding any provisions of these Terms and Conditions to the contrary, the RSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#8220;Addendum&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in an Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23. &#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on the RSUs, any Shares acquired pursuant to the RSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:145%">24. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:145%">This Section 24 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:145%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your RSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such RSUs and Shares.  You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you.  For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.  In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail. </font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:145%">25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:145%">By accepting the grant of the RSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">***********************</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><div id="i93afd37780d8490ca1442cc00d7c775f_4"></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO RESTRICTED STOCK UNITS GRANTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the RSUs are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;).  All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions.  Pursuant to Section 22 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;) &#47; Switzerland and the United Kingdom*</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 15 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A.  and grants RSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.99pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the RSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan.  The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.28pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator.  In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="padding-left:22.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:12.55pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your personal data is transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.19pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems.  If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:11.99pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the grant of the RSUs, nor the issuance of Shares subject to the RSUs, constitutes a public offering in Argentina. The grant of RSUs pursuant to the 2011 Plan is a private placement and is not subject to any filing or disclosure requirements in Argentina. </font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">1.&#160;&#160;&#160;&#160;RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the RSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian Offer document can be accessed here &#91;UBS INSERT LINK HERE&#93;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the RSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the RSUs, if any, is not part of your remuneration from employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the RSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the RSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following supplements Section 2(b) of the Terms and Conditions as well as any other section required to give effect to the same&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the RSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date.  For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the RSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#160;If you are a resident of Quebec, by accepting your RSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all&#160;other documents, notices and legal proceedings entered into, given or instituted pursuant to your RSUs, either directly or indirectly, be drawn up in English.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">En acceptant l'allocation de vos RSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de vos RSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHILE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall replace Section 16 of the Terms and Conditions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the RSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#8220;CMF&#8221;)&#59;</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n para el Mercado Financiero Chilena (&#8220;CMF&#8221;)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a People&#8217;s Republic of China (&#8220;PRC&#8221;) national, the grant of the RSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#8220;Cash Proceeds&#8221;).  Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you.  The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion.  If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Additionally, if the Company changes its </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock Plan Administrator</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock Plan Administrator</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions.  You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you.  You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-bottom:0.1pt"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 13 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose.  Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the RSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of RSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the RSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the RSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 6 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#160;By accepting your RSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all&#160;other documents, notices and legal proceedings entered into, given or instituted pursuant to your RSUs, either directly or indirectly, be drawn up in English.  </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  En acceptant l'allocation de vos RSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de vos RSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Important Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the RSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong.  You are hereby advised to exercise caution in relation to the offer thereunder.  If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the RSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;).  To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the RSUs shall be null and void.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the RSUs does not constitute an employment relationship between you and the Company.  You have been granted the RSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer.  Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information.</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> You expressly recognize and acknowledge that the Company's grant of RSUs and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the RSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum.   As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability.  The value of the RSUs is an extraordinary item of compensation outside the scope of your employment contract, if any.  The RSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As a condition to the grant of the RSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless you otherwise elect by contacting Stryker no later than April 29, 2022, you hereby agree that upon Retirement eligibility, the RSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered RSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange.  You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;</font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;phx.corporate-ir.net&#47;phoenix.zhtml&#63;c&#61;118965&#38;p&#61;irol-irhome</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">&#93;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RUSSIA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may be required to repatriate certain cash amounts received with respect to the RSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#8220;</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">CBR</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the RSUs and&#47;or selling the Shares acquired pursuant to the RSUs</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of RSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of RSUs and your participation in the 2011 Plan (collectively, &#8220;Grant Materials&#8221;) do not constitute advertising or a solicitation within the Russian Federation.  In connection with your grant of RSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">securities offering or public circulation of Shares within the Russian Federation. </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are solely responsible for complying with applicable Russian exchange control regulations.  Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., shares of foreign companies such as the Company).  Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.   </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall replace Section 16 of the Terms and Conditions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the RSUs under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  You should note that, as a result, the&#160;RSUs are subject to section 257 of the SFA and&#160;you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the&#160;RSUs&#160;in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act.  Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., RSUs or Shares) in the Company or any related company.  In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the Restricted Stock Units).  These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company.  In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 6 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the RSUs.  If you fail to advise your Employer of the gain realized upon vesting of the RSUs, you may be liable for a fine.  You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa.  As the Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations.  Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information and Deemed Acceptance of RSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; Neither the RSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa.&#160; The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the RSU offer must be finalized on or before the 60th day following the grant date.&#160; If you do not want to accept the RSUs, you are required to decline the RSUs no later than the 60th day following the grant date.&#160; If you do not reject the RSUs on or before the 60th day following the grant date, you will be deemed to accept the RSUs.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accepting the RSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan.  You understand that the Company has unilaterally, gratuitously and in its sole discretion granted RSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis.  Consequently, you understand that the RSUs are granted on the assumption and condition that the RSUs and the Shares acquired upon vesting of the RSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the RSUs shall be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the RSUs, any unvested RSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article&#160;40 of the Workers&#8217; Statute.  You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your RSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#34;FINMA&#34;).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THAILAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey.  The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board.  You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the RSUs is available only for select Employees of the Company and its Subsidiaries and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the RSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall supplement Section 6 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 6 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(ii)</font></div></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="margin-bottom:0.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the RSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the RSUs.  Upon the grant of the RSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ex10iii2022psustockoptiona.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic99b4f2f51a646078c5993d8b1c4038c_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:right"><img alt="image_11a.jpg" src="image_11a.jpg" style="height:36px;margin-bottom:5pt;vertical-align:text-bottom;width:139px"></div><div><font><br></font></div><div><font style="color:#ffb500;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%">Kevin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:100%"> A. Lobo</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2825 Airview Boulevard</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kalamazoo MI 49002 USA</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">P 269 389 7353</font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">www.stryker.com</font></div><div><font><br></font></div><div><font style="color:#ffb500;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Personal and confidential</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">February 2, 2022&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">First Name Last Name</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Dear First Name&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">I am pleased to inform you that as an SLT member, you are receiving a performance stock units (PSUs) award in 2022. We use these awards to reward performers who we believe will be key contributors to our growth well into the future. The total Award Date Value (ADV) of your award is approximately USD $xx,xxx. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">We are awarding you xxx PSUs. The number of PSUs actually earned will be dependent upon Stryker&#8217;s financial performance during the three-year period ending December 31, 2024.  Refer to the Terms and Conditions accompanying the 2022 PSUs award for specific criteria associated with vesting in such award.  In order to earn any of the PSUs, you must be continuously employed with Stryker through the vesting date of March 21, 2025 except as otherwise provided in the Terms and Conditions.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%">You must &#8220;Accept&#8221; the award online via the UBS One Source web site located at </font><font style="color:#529cdb;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">www.ubs.com&#47;onesource&#47;SYK</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:100%"> between March 1 and March 31, 2022</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">.  The detailed terms of the PSUs are in the Terms and Conditions, any applicable country addendum and the provisions of the Company's 2011 Long-Term Incentive Plan. Those documents, together with the related Prospectus, are available on the UBS One Source web site, and you should read them before accepting the award. In addition, you may be asked to sign the most recent version of Stryker&#8217;s Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement (&#8220;Non-Compete Agreement&#8221;) in connection with the award. If you are asked to sign the Non-Compete Agreement, it will be emailed to you and you will be asked to sign the document electronically via Adobe Sign by March 31, 2022. The vesting of the PSUs is conditioned on you having signed the Non-Compete Agreement by March 31, 2022, where permitted by applicable law.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thank you for your efforts in helping us deliver strong results. With your help, I look forward to our continued business growth and success.</font></div><div style="margin-bottom:0.1pt"><font><br></font></div><div style="margin-bottom:0.1pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Sincerely,</font></div><div><img alt="image_01a.jpg" src="image_01a.jpg" style="height:114px;margin-bottom:5pt;vertical-align:text-bottom;width:98px"></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></div><div><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Chair and CEO</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO PERFORMANCE STOCK UNITS GRANTED</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 LONG-TERM INCENTIVE PLAN, AS AMENDED AND </font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RESTATED</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Performance Stock Units with respect to Common Stock of Stryker Corporation (the &#8220;Company&#8221;) granted to you during 2022 (the &#8220;PSUs&#8221;) are subject to these Terms and Conditions Relating to Performance Stock Units Granted Pursuant to the 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;Terms and Conditions&#8221;) and all of the terms and conditions of the Stryker Corporation 2011 Long-Term Incentive Plan, as Amended and Restated (the &#8220;2011 Plan&#8221;), which is incorporated herein by reference.  In the case of a conflict between these Terms and Conditions and the terms of the 2011 Plan, the provisions of the 2011 Plan will govern. Capitalized terms used but not defined herein have the meaning provided therefor in the 2011 Plan.  For purposes of these Terms and Conditions, &#8220;Employer&#8221; means the Company or any Subsidiary that employs you on the applicable date, and &#34;Stock Plan Administrator&#34; means UBS Financial Services Inc. (or any other independent service provider engaged by the Company to assist with the implementation, operation and administration of the 2011 Plan).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Vesting</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Except as provided in Section 8(a), the vesting of your PSUs is dependent upon your remaining continuously employed with your Employer through March 21, 2025 (the &#8220;Vesting Date&#8221;) as well as upon the Company&#8217;s financial performance during the three-year period ending December 31, 2024 (the &#8220;Performance Period&#8221;).  Specifically, the vesting of any of the PSUs is dependent upon attainment of the Threshold Performance Target as set forth in Section 3.  If the Threshold Performance Target is attained, then the vesting of 50% of the PSUs (the &#8220;EPS PSUs&#8221;) is dependent on Adjusted EPS Growth as set forth in Section 4, and vesting of the remaining 50% of the PSUs (the &#8220;Sales Growth PSUs&#8221;) is dependent on the Sales Growth Percentile Ranking as set forth in Section 5.  The actual number of your PSUs that become vested, if any, shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Threshold Performance Target</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If the Company&#8217;s Adjusted EPS Growth as of the last day of the Performance Period is less than 3.0%, none of your PSUs shall become vested and all of your PSUs shall be forfeited as of the last day of the Performance Period.  If the Company&#8217;s Adjusted EPS Growth as of the last day of the Performance Period is 3.0% or greater (the &#8220;Threshold Performance Target&#8221;) and, except as provided in Section 8(a), you remain in the continuous employment of Stryker through the Vesting Date, you shall become eligible to vest in up to 200% of your PSUs, although the actual number of your PSUs that become vested shall be determined based on exercise of negative discretion by the Committee in accordance with Sections 4, 5 and 6 below.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Adjusted EPS Growth</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If the Threshold Performance Target is attained and, except as provided in Section 8(a), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the EPS PSUs determined based on the Company&#8217;s Adjusted EPS Growth using the table below, applying straight line interpolation rounded down to the nearest whole number of EPS PSUs for Adjusted EPS Growth resulting in vested EPS PSUs between 50% and 100% or between 100% and 200%.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.975%"><tr><td style="width:1.0%"></td><td style="width:20.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">&#60; Minimum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Minimum</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Target</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Maximum</font></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Adjusted EPS Growth</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">Less than 6.0%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">6.0%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">9.0%</font></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">12% or more</font></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Vested Percent of EPS PSUs</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">200%</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any EPS PSUs that do not become vested in accordance with the foregoing shall be forfeited.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;As soon as administratively practicable following the Vesting Date (but in no event later than December 31, 2025), the Company shall issue you the Shares underlying the vested EPS PSUs. </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;For purposes of these Terms and Conditions&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;&#8220;Adjusted EPS&#8221; for a calendar year shall mean the Company&#8217;s diluted net earnings per share for such year as determined under U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) but subject to such adjustments, if any, for non-GAAP financial measures that are reflected in a reconciliation to the GAAP financial statements included in the Company&#8217;s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;&#8220;Adjusted EPS Growth&#8221; shall mean the sum of the Annual Percentage Change in Adjusted EPS for the three (3) calendar years in the Performance Period divided by three (3).</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;&#8220;Annual Percentage Change in Adjusted EPS&#8221; for calendar year shall mean the amount by which the Adjusted EPS for such calendar year has increased or decreased relative to the immediately preceding calendar year, expressed as a positive or negative percentage (depending on whether Adjusted EPS increased or decreased) of the Adjusted EPS for such preceding calendar year. </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, the Committee shall have discretion to make such adjustments to the foregoing metrics as it deems appropriate to reflect the impact of corporate transactions, accounting or tax law changes or extraordinary, unusual, nonrecurring or infrequent items&#59; provided, however, that for purposes of calculating the Threshold Performance Target in Section 3, in no case shall such adjustments have the net aggregate effect of increasing Adjusted EPS Growth.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sales Growth Percentile Ranking</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If the Threshold Performance Target is attained and, except as provided in Section 8(a), you have remained in the continuous employment of Stryker through the Vesting Date, then subject to Section 6 you shall become vested in the percentage of the Sales Growth PSUs based upon the Company&#8217;s Sales Growth Percentile Ranking, as determined using the table below, applying straight line interpolation rounded down to the nearest whole number of Sales Growth PSUs for Sales Growth Percentile Ranking resulting in vested Sales Growth PSUs between 50% and 100% or between 100% and 200%.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:0.1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.975%"><tr><td style="width:1.0%"></td><td style="width:20.982%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.881%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Sales Growth Percentile Ranking </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Below 33</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">33</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">50</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">75th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:115%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">and Above</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:133%">Vested Percent of Sales Growth PSUs</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">0%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">50%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">100%</font></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:133%">200%</font></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Any Sales Growth PSUs that do not become vested in accordance with the foregoing shall be forfeited, and if the Company&#8217;s Average Sales Growth in the Performance Period is equal to or less than zero, all of the Sales Growth PSUs shall be forfeited (irrespective of the Sales Growth Percentile Ranking).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:115%">(b)&#160;&#160;&#160;&#160;As soon as administratively practicable following the Vesting Date (but in no event later than December 31, 2025), the Company shall issue you the Shares underlying the vested Sales Growth PSUs. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;For purposes of these Terms and Conditions and subject to Section 5(d) below&#58;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)&#160;&#160;&#160;&#160;&#8220;Average Sales Growth&#8221; shall mean, for the Company and each company in the Comparison Group, the sum of the Sales Growth for each Reporting Period ending within the Performance Period divided by three&#59;</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)&#160;&#160;&#160;&#160;&#8220;Comparison Group&#8221; shall mean&#58;</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Abbott Laboratories</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Agilent Technologies, Inc.</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Baxter International Inc.</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Becton, Dickinson and Company</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Boston Scientific Corporation</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Cerner Corporation</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Danaher Corporation</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Fresenius Medical Care AG &#38; Co. KGaA</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">General Electric Company (Healthcare)</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Johnson &#38; Johnson (Medical Devices)</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Laboratory Corporation of America Holdings</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Medtronic plc</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Quest Diagnostics Incorporated</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Royal Philips (combined segments of Diagnosis &#38; Treatment and Connected Care)</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Siemens Healthineers AG</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Smith &#38; Nephew plc</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Thermo Fisher Scientific Inc.</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">3M Company (Healthcare)</font></div><div style="padding-left:180pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9642;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:14.49pt">Zimmer Biomet Holdings, Inc.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For purposes of the foregoing, any company for which Sales Growth cannot be calculated for three full annual Reporting Periods ending within the Performance Period</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall be excluded.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)&#160;&#160;&#160;&#160;&#8220;Net Sales&#8221; shall mean, for the Company and each company in the Comparison Group, net sales as publicly reported for the applicable Reporting Period.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)&#160;&#160;&#160;&#160;&#8220;Reporting Period&#8221; shall mean a calendar year in the case of the Company and each company in the Comparison Group that reports on a calendar year basis, and in the case of any other company in the Comparison Group, the four fiscal quarters that include the last fiscal quarter ending prior to December 31 for which such company has publicly reported prior to the following February 28.</font></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)&#160;&#160;&#160;&#160;&#8220;Sales Growth&#8221; for a Reporting Period shall mean the amount by which Net Sales has increased or decreased relative to the immediately preceding Reporting Period, expressed as a positive or negative percentage (depending on whether Net Sales increased or decreased) of the Net Sales for such preceding Reporting Period.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)&#160;&#160;&#160;&#160;&#8220;Sales Growth Percentile Ranking&#8221; shall mean the percentile ranking of the Company&#8217;s Average Sales Growth relative to the Average Sales Growth for each company in the Comparison Group, rounded to the whole nearest percentile.  For this purpose, the percentile ranking shall be calculated as 1 &#8211; (Rank-1)&#47;(Total of the Comparison Group plus the Company-1).  For example, if the Company ranked 5</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> out of 20 companies including itself, the percentile rank would be calculated as 1 &#8211; (5-1)&#47;(20-1) or 1 &#8211; (4&#47;19) or 1-0.21 or the 79</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:7.8pt;font-weight:400;line-height:100%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> percentile.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)&#160;&#160;&#160;&#160;The Committee may make such revisions and adjustments to each of the items set forth in Sections 5(c)(i)-(vi) as it may determine necessary and appropriate in its discretion.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Discretion of the Committee</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything in these Terms or Conditions or the 2011 Plan to the contrary, provided that the Threshold Performance Target has been attained, the Committee shall have the power and authority, in its sole and absolute exercise of negative discretion, </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">to reduce or increase the vested PSUs such that the actual earned PSUs will be greater than or less than the vested PSUs, which increase or reduction may be made by taking into account any criteria the Committee deems appropriate&#59; provided further that notwithstanding anything in these Terms or Conditions to the contrary you shall not become vested in more than 200% of your PSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In connection with your PSUs, you shall be entitled to receive all of the cash dividends for which the record date occurs during the period between the commencement of the Performance Period and the Vesting Date with respect to each Share underlying your vested PSUs (&#8220;Dividend Equivalents&#8221;).  Dividend Equivalents shall be converted into their equivalent number of additional PSUs rounded down to the nearest whole number of PSUs based on the Fair Market Value of a Share on the Vesting Date, provided, that the maximum number of additional PSUs you may receive upon such conversion shall be equal to 200% of your originally granted PSUs.  Such additional PSUs shall be subject to the terms and conditions applicable to the PSUs to which the Dividend Equivalents relate, including, without limitation, the vesting, forfeiture, and payment form and timing provisions contained herein.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8.&#160;&#160;&#160;&#160;In the event you cease to remain in the continuous employment of the Company or a Subsidiary for the entire period commencing on the grant date and ending on the applicable Vesting Date, your right to receive the Shares issuable pursuant to the PSUs shall be only as follows&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;If you cease to be an Employee prior to the Vesting Date by reason of Disability (as such term is defined in the 2011 Plan), death or Retirement (as such term is defined in the 2011 Plan), you or your estate will become vested on the Vesting Date in a pro-rata portion (determined by dividing (a) the number of days during the Performance Period in which you were an Employee by (b) the total number of days during the Performance Period) of your PSUs based upon the Company&#8217;s Adjusted EPS Growth and Sales Growth Percentile Ranking for the Performance Period as determined pursuant to Sections 3, 4 and 5 of these Terms and Conditions. Any pro rata portion shall be rounded down to the nearest whole number of PSUs. You, your legal representative or your estate will receive all of the underlying Shares attributable to the vested PSUs as soon as administratively practicable following (and in no event more than ninety (90) days after) the Vesting Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">If you cease to be an Employee for any reason other than those provided in (a) above and your Termination Date is prior to the Vesting Date, you shall immediately forfeit all PSUs granted hereunder effective as of your Termination Date. If you are a resident of or employed in the United States, &#8220;Termination Date&#8221; shall mean the effective date of termination of your employment with your Employer. If you are resident or employed outside of the United States, &#8220;Termination Date&#8221; shall mean the earliest of (i) the date on which notice of termination is provided to you, (ii) the last day of your active service with your Employer, or (iii) the last day on which you are an Employee of your Employer, as determined in each case without including any required advance notice period and irrespective of the status of the termination under local labor or employment laws. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9.&#160;&#160;&#160;&#160;Notwithstanding the foregoing, the Company may, in its sole discretion, settle the PSUs (and any Dividend Equivalents) in the form of&#58; (i) a cash payment to the extent settlement in Shares (1) is prohibited under local law, (2) would require you, the Company and&#47;or your Employer to obtain the approval of any governmental and&#47;or regulatory body in your country of residence (and country of employment, if different), or (3) is administratively burdensome&#59; or (ii) Shares, but require you to immediately sell such Shares (in which case, the Company shall have the authority to issue sales instructions in relation to such Shares on your behalf).</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10.&#160;&#160;&#160;&#160;The number of Shares subject to the PSUs shall be subject to adjustment and the vesting dates hereof may be accelerated as follows&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;In the event that the Shares, as presently constituted, shall be changed into or exchanged for a different number or kind of shares of stock or other securities of the Company or of another corporation (whether by reason of merger, consolidation, recapitalization, reclassification, split-up, combination of shares, or otherwise) or if the number of such Shares shall be increased through the payment of a stock dividend or a dividend on the Shares of rights or warrants to purchase securities of the Company shall be made, then there shall be substituted for or added to each Share theretofore </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">subject to the PSUs the number and kind of shares of stock or other securities into which each outstanding Share shall be so changed, or for which each such Share shall be exchanged, or to which each such Share shall be entitled.  The other terms of the PSUs shall also be appropriately amended as may be necessary to reflect the foregoing events.  In the event there shall be any other change in the number or kind of the outstanding Shares, or of any stock or other securities into which such Shares shall have been exchanged, then if the Committee shall, in its sole discretion, determine that such change equitably requires an adjustment in the PSUs, such adjustment shall be made in accordance with such determination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)&#160;&#160;&#160;&#160;Fractional Shares resulting from any adjustment in the PSUs may be settled in cash or otherwise as the Committee shall determine, in its sole discretion.  Notice of any adjustment will be given to you and such adjustment (whether or not such notice is given) shall be effective and binding for all purposes hereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)&#160;&#160;&#160;&#160;The Committee shall have the power to amend the PSUs to permit the immediate vesting of the PSUs (and to terminate any unvested PSUs) and the distribution of the underlying Shares prior to the effectiveness of (i) any disposition of substantially all of the assets of the Company or your Employer, (ii) the shutdown, discontinuance of operations or dissolution of the Company or your Employer, or (iii) the merger or consolidation of the Company or your Employer with or into any other unrelated corporation. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11.&#160;&#160;&#160;&#160;If you are resident or employed outside of the United States, you agree, as a condition of the grant of the PSUs, to repatriate all payments attributable to the Shares and&#47;or cash acquired under the 2011 Plan (including, but not limited to, dividends, dividend equivalents and any proceeds derived from the sale of the Shares acquired pursuant to the PSUs) if required by and in accordance with local foreign exchange rules and regulations in your country of residence (and country of employment, if different).  In addition, you also agree to take any and all actions, and consent to any and all actions taken by the Company and its Subsidiaries, as may be required to allow the Company and its Subsidiaries to comply with local laws, rules and regulations in your country of residence (and country of employment, if different).  Finally, you agree to take any and all actions as may be required to comply with your personal legal and tax obligations under local laws, rules and regulations in your country of residence (and country of employment, if different).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12.&#160;&#160;&#160;&#160;If you are resident and&#47;or employed in a country that is a member of the European Union, the grant of the PSUs and these Terms and Conditions are intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the &#8220;Age Discrimination Rules&#8221;).  To the extent that a court or tribunal of competent jurisdiction determines that any provision of these Terms and Conditions are invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13.&#160;&#160;&#160;&#160;Regardless of any action the Company and&#47;or your Employer take with respect to any or all income tax (including U.S. federal, state and local taxes or non-U.S. taxes), social insurance, payroll tax, payment on account or other tax-related withholding (&#8220;Tax-Related Items&#8221;), you acknowledge that the ultimate liability for all Tax-Related Items legally due by you is and remains your responsibility and that the Company and your Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including the grant of the PSUs, the vesting of the PSUs, the subsequent sale of any Shares acquired pursuant to the PSUs and the receipt of any dividends or dividend equivalents and (ii) do not commit to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate your liability for Tax-Related Items.  Further, if you become subject to taxation in more than one country between the grant date and the date of any relevant taxable or tax withholding event, as applicable, you acknowledge that your Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one country.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Prior to any taxable event, if your country of residence (and&#47;or your country of employment, if different) requires withholding of Tax-Related Items, the Company shall withhold a number of whole </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-bottom:6pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Shares that have an aggregate Fair Market Value that the Company, taking into account local requirements and administrative issues, determines in its sole discretion is appropriate to cover withholding for Tax-Related Items with respect to the Shares.  The cash equivalent of the Shares withheld will be used to settle the obligation to withhold the Tax-Related Items.  In cases where the Fair Market Value of the number of whole Shares withheld is greater than the amount required to be paid to the relevant government authorities with respect to withholding for Tax-Related Items, the Company shall make a cash payment to you equal to the difference as soon as administratively practicable.  In the event that withholding in Shares is prohibited or problematic under applicable law or otherwise may trigger adverse consequences to the Company or your Employer, your Employer shall withhold the Tax-Related Items required to be withheld with respect to the Shares in cash from your regular salary and&#47;or wages or other amounts payable to you.  In the event the withholding requirements are not satisfied through the withholding of Shares or through your regular salary and&#47;or wages or any other amounts payable to you by your Employer, no Shares will be issued to you (or your estate) unless and until satisfactory arrangements (as determined by the Board of Directors) have been made by you with respect to the payment of any Tax-Related Items that the Company or your Employer determines, in its sole discretion, should be withheld or collected with respect to such PSUs.  By accepting these PSUs, you expressly consent to the withholding of Shares and&#47;or withholding from your regular salary and&#47;or wages or other amounts payable to you as provided for hereunder.  All other Tax-Related Items related to the PSUs and any Shares delivered in payment thereof are your sole responsibility.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The PSUs are intended to be exempt from the requirements of Code Section 409A. The 2011 Plan and these Terms and Conditions shall be administered and interpreted in a manner consistent with this intent. If the Company determines that these Terms and Conditions are subject to Code Section 409A and that it has failed to comply with the requirements of that Section, the Company may, at the Company&#8217;s sole discretion and without your consent, amend these Terms and Conditions to cause them to comply with Code Section 409A or be exempt from Code Section 409A. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15.&#160;&#160;&#160;&#160;If you were required to sign the &#8220;Stryker Confidentiality, Intellectual Property, Non-Competition and Non-Solicitation Agreement&#8221; or a similar agreement in order to receive the PSUs or have previously signed such an agreement and you breach any non-competition, non-solicitation or non-disclosure provision or provision as to ownership of inventions contained therein at any time while employed by the Company or a Subsidiary, or during the one-year period following termination of employment, any unvested PSUs shall be rescinded and you shall return to the Company all Shares that were acquired upon vesting of the PSUs that you have not disposed of.  Further, you shall pay to the Company an amount equal to the profit realized by you (if any) on all Shares that were acquired upon vesting of the PSUs that you have disposed of.  For purposes of the preceding sentence, the profit shall be the Fair Market Value of the Shares at the time of disposition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">16.&#160;&#160;&#160;&#160;The PSUs shall be transferable only by will or the laws of descent and distribution.  If you shall purport to make any transfer of the PSUs, except as aforesaid, the PSUs and all rights thereunder shall terminate immediately.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17.&#160;&#160;&#160;&#160;The PSUs shall not be vested in whole or in part, and the Company shall not be obligated to issue any Shares subject to the PSUs, if such issuance would, in the opinion of counsel for the Company, violate the Securities Act of 1933 or any other U.S. federal, state or non-U.S. statute having similar requirements as it may be in effect at the time.  The PSUs are subject to the further requirement that, if at any time the Board of Directors shall determine in its discretion that the listing or qualification of the Shares subject to the PSUs under any securities exchange requirements or under any applicable law, or the consent or approval of any governmental regulatory body, is necessary or desirable as a condition of or in connection with the issuance of Shares pursuant to the PSUs, the PSUs may not be vested in whole or in part unless such listing, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Board of Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18.&#160;&#160;&#160;&#160;The grant of the PSUs shall not confer upon you any right to continue in the employ of your Employer nor limit in any way the right of your Employer to terminate your employment at any time.  You shall have no rights as a shareholder of the Company with respect to any Shares issuable upon the vesting of the PSUs until the date of issuance of such Shares.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19. &#160;&#160;&#160;&#160;You acknowledge and agree that the 2011 Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole discretion, at any time.  The grant of the PSUs under the 2011 Plan is a one-time benefit and does not create any contractual or other right to receive a grant of PSUs or any other award under the 2011 Plan or other benefits in lieu thereof in the future.  Future grants, if any, will be at the sole discretion of the Company, including, but not limited to, the form and timing of any grant, the number of Shares subject to the grant, and the vesting provisions.  Any amendment, modification or termination of the 2011 Plan shall not constitute a change or impairment of the terms and conditions of your employment with your Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">20.&#160;&#160;&#160;&#160;Your participation in the 2011 Plan is voluntary.  The value of the PSUs and any other awards granted under the 2011 Plan is an extraordinary item of compensation outside the scope of your employment (and your employment contract, if any).  Any grant under the 2011 Plan, including the grant of the PSUs, is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension, or retirement benefits or similar payments.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">21.&#160;&#160;&#160;&#160;These Terms and Conditions shall bind and inure to the benefit of the Company, its successors and assigns and you and your estate in the event of your death.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">22.&#160;&#160;&#160;&#160;The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A. and grants PSUs under the 2011 Plan to employees of the Company and Subsidiaries in its sole discretion. In conjunction with the Company&#8217;s grant of the PSUs under the 2011 Plan and its ongoing administration of such awards, the Company is providing the following information about its data collection, processing and transfer practices (&#8220;Personal Data Activities&#8221;). In accepting the grant of the PSUs, you expressly and explicitly consent to the Personal Data Activities as described herein.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.49pt">The Company collects, processes and uses your personal data, including your name, home address, email address, and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all PSUs or any other equity compensation awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan. The Company&#8217;s legal basis for the collection, processing and usage of your personal data is your consent.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.78pt">The Company transfers your personal data to the Stock Plan Administrator. In the future, the Company may select a different Stock Plan Administrator and share your personal data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.05pt">The Company and the Stock Plan Administrator are based in the United States.  You should note that your country of residence may have enacted data privacy laws that are different from the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is your consent.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-align:justify;text-indent:49.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.69pt">Your participation in the 2011 Plan and your grant of consent is purely voluntary. You may deny or withdraw your consent at any time. If you do not consent, or if you withdraw your consent, you may be unable to participate in the 2011 Plan.  This would not affect your existing employment or salary&#59; instead, you merely may forfeit the opportunities associated with the 2011 Plan.</font></div><div style="padding-left:49.5pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under the data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country or residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of your personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">23.&#160;&#160;&#160;&#160;The grant of the PSUs is not intended to be a public offering of securities in your country of residence (and country of employment, if different).  The Company has not submitted any registration statement, prospectus or other filing(s) with the local securities authorities (unless otherwise required under local law).  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">No employee of the Company is permitted to advise you on whether you should acquire Shares under the 2011 Plan or provide you with any legal, tax or financial advice with respect to the grant of the PSUs.  The acquisition of Shares involves certain risks, and you should carefully consider all risk factors and tax considerations relevant to the acquisition of Shares under the 2011 Plan or the disposition of them.  Further, you should carefully review all of the materials related to the PSUs and the 2011 Plan, and you should consult with your personal legal, tax and financial advisors for professional advice in relation to your personal circumstances.</font></div><div style="margin-bottom:0.1pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">24.&#160;&#160;&#160;&#160;All questions concerning the construction, validity and interpretation of the PSUs and the 2011 Plan shall be governed and construed according to the laws of the state of Michigan, without regard to the application of the conflicts of laws provisions thereof.  Any disputes regarding the PSUs or the 2011 Plan shall be brought only in the state or federal courts of the state of Michigan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">25.&#160;&#160;&#160;&#160;The Company may, in its sole discretion, decide to deliver any documents related to the PSUs or other awards granted to you under the 2011 Plan by electronic means.  You hereby consent to receive such documents by electronic delivery and agree to participate in the 2011 Plan through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">26.&#160;&#160;&#160;&#160;The invalidity or unenforceability of any provision of the 2011 Plan or these Terms and Conditions shall not affect the validity or enforceability of any other provision of the 2011 Plan or these Terms and Conditions.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">27.&#160;&#160;&#160;&#160;If you are resident outside of the United States, you acknowledge and agree that it is your express intent that these Terms and Conditions, the 2011 Plan and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the PSUs be drawn up in English.  If you have received these Terms and Conditions, the 2011 Plan or any other documents related to the PSUs translated into a language other than English and the meaning of the translated version is different than the English version, the English version will control. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28.&#160;&#160;&#160;&#160;You acknowledge that, depending on your or your broker's country of residence or where the Shares are listed, you may be subject to insider trading restrictions and&#47;or market abuse laws which may affect your ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., PSUs) or rights linked to the value of Shares during such times you are considered to have &#8220;inside information&#8221; regarding the Company as defined in the laws or regulations in your country of employment (and country of residence, if different).&#160; Local insider trading laws and regulations may prohibit the cancellation or amendment of orders you placed before you possessed inside information.&#160; Furthermore, you could be prohibited from (i) disclosing the inside information to any third party (other than on a &#8220;need to know&#8221; basis) and (ii) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.&#160; Third parties include fellow employees. &#160;Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.&#160; You acknowledge that it is your responsibility to comply with any restrictions and are advised to speak to your personal advisor on this matter.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">29.&#160;&#160;&#160;&#160;Notwithstanding any provisions of these Terms and Conditions to the contrary, the PSUs shall be subject to any special terms and conditions for your country of residence (and country of employment, if different) set forth in an addendum to these Terms and Conditions (an &#8220;Addendum&#8221;).  Further, if you transfer your residence and&#47;or employment to another country reflected in an </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Addendum to these Terms and Conditions at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such special terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  In all circumstances, any applicable Addendum shall constitute part of these Terms and Conditions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">30.&#160;&#160;&#160;&#160;The Company reserves the right to impose other requirements on the PSUs, any Shares acquired pursuant to the PSUs and your participation in the 2011 Plan to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan.  Such requirements may include (but are not limited to) requiring you to sign any agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">31.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">This Section 31 applies only to those persons whom the Company&#8217;s Recoupment Policy applies (the corporate officers elected by the Company&#8217;s Board of Directors other than Assistant Controllers, Assistant Secretaries and Assistant Treasurers). </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding any other provision of these Terms and Conditions to the contrary, you acknowledge and agree that your PSUs, any Shares acquired pursuant thereto and&#47;or any amount received with respect to any sale of such Shares are subject to potential cancellation, recoupment, rescission, payback or other action in accordance with the terms of the Company&#8217;s Recoupment Policy as in effect on the date of grant (a copy of which has been furnished to you) and as the Recoupment Policy may be amended from time to time in order to comply with changes in laws, rules or regulations that are applicable to such PSUs and Shares.  You agree and consent to the Company&#8217;s application, implementation and enforcement of (a) the Recoupment Policy and (b) any provision of applicable law relating to cancellation, recoupment, rescission or payback of compensation and expressly agree that the Company may take such actions as are necessary to effectuate the Recoupment Policy (as applicable to you) or applicable law without further consent or action being required by you.  For purposes of the foregoing, you expressly and explicitly authorize the Company to issue instructions, on your behalf, to any brokerage firm and&#47;or third party administrator engaged by the Company to hold your Shares and other amounts acquired under the 2011 Plan to re-convey, transfer or otherwise return such Shares and&#47;or other amounts to the Company.  In the case of a conflict between these Terms and Conditions and the Recoupment Policy, the terms of the Recoupment Policy shall prevail.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">32.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">By accepting the grant of the PSUs, you acknowledge that you have read these Terms and Conditions, the Addendum to these Terms and Conditions (as applicable) and the 2011 Plan and specifically accept and agree to the provisions therein.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">***********************</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">STRYKER CORPORATION</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ADDENDUM TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TERMS AND CONDITIONS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RELATING TO PERFORMANCE STOCK UNITS GRANTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PURSUANT TO THE 2011 PLAN, AS AMENDED AND RESTATED</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In addition to the terms of the 2011 Plan and the Terms and Conditions, the PSUs are subject to the following additional terms and conditions (the &#8220;Addendum&#8221;).  All capitalized terms as contained in this Addendum shall have the same meaning as set forth in the 2011 Plan and the Terms and Conditions.  Pursuant to Section 29 of the Terms and Conditions, if you transfer your residence and&#47;or employment to another country reflected in an Addendum at the time of transfer, the special terms and conditions for such country will apply to you to the extent the Company determines, in its sole discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local law, rules and regulations, or to facilitate the operation and administration of the award and the 2011 Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate your transfer).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Data Privacy Information&#58; European Union (&#8220;EU&#8221;) &#47; European Economic Area (&#8220;EEA&#8221;) &#47; Switzerland and the United Kingdom*</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">*The below information is for data privacy purposes only and you should determine whether any other special terms and conditions apply to your awards in these jurisdictions.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Data Privacy</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you reside and&#47;or you are employed in the EU &#47; EEA, Switzerland or the United Kingdom the following provision replaces Section 22 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company is located at 2825 Airview Boulevard Kalamazoo, Michigan 49002, U.S.A.  and grants PSUs under the 2011 Plan to employees of the Company and its Subsidiaries in its sole discretion. You should review the following information about the Company&#8217;s data processing practices. </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Collection, Processing and Usage</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Pursuant to applicable data protection laws, you are hereby notified that the Company collects, processes and uses certain personally-identifiable information about you for the legitimate interest of implementing, administering and managing the 2011 Plan and generally administering equity awards&#59; specifically, including your name, home address, email address and telephone number, date of birth, social insurance number or other identification number, salary, citizenship, job title, any Shares or directorships held in the Company, and details of all options or any other awards granted, canceled, exercised, vested, or outstanding in your favor, which the Company receives from you or your Employer. In granting the PSUs under the 2011 Plan, the Company will collect your personal data for purposes of allocating Shares and implementing, administering and managing the 2011 Plan.  The Company&#8217;s collection, processing, use and transfer of your personal data is necessary for the performance of the Company&#8217;s contractual obligations under the Plan and pursuant to the Company&#8217;s legitimate interest of managing and generally administering employee equity awards. Your refusal to provide personal data would make it impossible for the Company to perform its contractual obligations and may affect your ability to participate in the 2011 Plan. As such, by participating in the 2011 Plan, you voluntarily acknowledge the collection, processing and use of your personal data as described herein.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.78pt;text-decoration:underline">Stock Plan Administration Service Provider</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company transfers participant data to the Stock Plan Administrator.  In the future, the Company may select a different Stock Plan Administrator and share your data with another company that serves in a similar manner. The Stock Plan Administrator will open an account for you, if an account is not already in place, to receive and trade Shares acquired under the 2011 Plan. You will be asked to agree on separate terms and data processing practices with the Stock Plan Administrator, which is a condition to your ability to participate in the 2011 Plan.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:35.05pt;text-decoration:underline">International Data Transfers</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company and the Stock Plan Administrator are based in the United States. The Company can only meet its contractual obligations to you if your </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">personal data is transferred to the United States. The Company&#8217;s legal basis for the transfer of your personal data to the United States is to satisfy its contractual obligations to you and&#47;or its use of the standard data protection clauses adopted by the EU Commission.</font></div><div style="padding-left:72pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:33.69pt;text-decoration:underline">Data Retention</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Company will use your personal data only as long as is necessary to implement, administer and manage your participation in the 2011 Plan or as required to comply with legal or regulatory obligations, including under tax and security laws. When the Company no longer needs your personal data, the Company will remove it from its systems.  If the Company keeps your data longer, it would be to satisfy legal or regulatory obligations and the Company&#8217;s legal basis would be for compliance with relevant laws or regulations.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:34.49pt;text-decoration:underline">Data Subject Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You may have a number of rights under data privacy laws in your country of residence. For example, your rights may include the right to (i) request access or copies of personal data the Company processes, (ii) request rectification of incorrect data, (iii) request deletion of data, (iv) place restrictions on processing, (v) lodge complaints with competent authorities in your country of residence, and&#47;or (vi) request a list with the names and addresses of any potential recipients of the Participant&#8217;s personal data.  To receive clarification regarding your rights or to exercise your rights, you should contact your local HR manager or the Company&#8217;s Human Resources Department. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ARGENTINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the grant of the PSUs, nor the issuance of Shares subject to the PSUs, constitutes a public offering in Argentina. The grant of PSUs pursuant to the 2011 Plan is a private placement and not subject to any filing or disclosure requirements in Argentina. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRALIA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are (a) a director of a Subsidiary incorporated in Australia, or (b) a person who is a management-level executive of a Subsidiary incorporated in Australia and who also is a director of a Subsidiary incorporated outside of the Australia, the grant of the PSUs is conditioned upon satisfaction of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Australian Offer document can be accessed here &#91;UBS INSERT LINK HERE&#93;</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">AUSTRIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BELGIUM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BRAZIL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1. &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Labor Law Acknowledgment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. By accepting the PSUs, you acknowledge and agree, for all legal purposes, that (a) the benefits provided under the Terms and Conditions and the 2011 Plan are the result of commercial transactions unrelated to your employment&#59; (b) the Terms and Conditions and the 2011 Plan are not a part of the terms and conditions of your employment&#59; and (c) the income from the PSUs, if any, is not part of your remuneration from employment.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Compliance with Law</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  By accepting the PSUs, you acknowledge and agree to comply with applicable Brazilian laws and to pay any and all applicable taxes associated with the vesting of the PSUs, the issuance and&#47;or sale of Shares acquired under the 2011 Plan and the receipt of any dividends.</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CANADA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following supplements Section 8(b) of the Terms and Conditions as well as any other section required to give effect to the same&#58;  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event of your termination of employment for any reason (other than by reason of death, Disability or Retirement), either by you or by the Employer, with or without cause, your rights to vest or to continue to vest in the PSUs and receive Shares under the 2011 Plan, if any, will terminate as of the actual Termination Date.  For this purpose, the &#8220;Termination Date&#8221; shall mean the last day on which you are actively employed by the Employer, and shall not include or be extended by any period following such day during which you are in receipt of or eligible to receive any notice of termination, pay in lieu of notice of termination, severance pay or any other payments or damages, whether arising under statute, contract or at common law. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued entitlement to vesting during a statutory notice period, your right to vest in the PSUs under the 2011 Plan, if any, will terminate effective as of the last day of your minimum statutory notice period, but you will not earn or be entitled to pro-rated vesting if the vesting date falls after the end of your statutory notice period, nor will you be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#160;If you are a resident of Quebec, by accepting your PSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all&#160;other documents, notices and legal proceedings entered into, given or instituted pursuant to your PSUs, either directly or indirectly, be drawn up in English.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">En acceptant l'allocation de vos PSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de vos PSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022  TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHILE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Private Placement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall replace Section 23 of the Terms and Conditions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the PSUs hereunder is not intended to be a public offering of securities in Chile but instead is intended to be a private placement.  </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">The starting date of the offer will be the grant date, and this offer conforms to General Ruling no. 336 of the Chilean Commission for the Financial Markets (&#8220;CMF&#8221;)&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">The offer deals with securities not registered in the registry of securities or in the registry of foreign securities of the CMF, and therefore such securities are not subject to its oversight&#59; </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">The Company, as the issuer, is not obligated to provide public information in Chile regarding the foreign securities, as such securities are not registered with the CMF&#59; and </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">The Shares, as foreign securities, shall not be subject to public offering as long as they are not registered with the corresponding registry of securities in Chile.</font></div><div style="margin-top:6pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">a)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:7.57pt">La fecha de inicio de la oferta ser&#225; el de la fecha de otorgamiento y esta oferta se acoge a la norma de Car&#225;cter General n&#176; 336 de la </font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Comisi&#243;n para el Mercado Financiero Chilena (&#8220;CMF&#8221;)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">b)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.86pt">La oferta versa sobre valores no inscritos en el registro de valores o en el registro de valores extranjeros que lleva la CMF, por lo que tales valores no est&#225;n sujetos a la fiscalizaci&#243;n de &#233;sta&#59; </font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">c)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:8.13pt">Por tratar de valores no inscritos no existe la obligaci&#243;n por parte del emisor de entregar en chile informaci&#243;n p&#250;blica respecto de esos valores&#59; y</font></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">d)</font><font style="background-color:#ffffff;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:6.77pt">Esos valores no podr&#225;n ser objeto de oferta p&#250;blica mientras no sean inscritos en el registro de valores correspondiente.</font></div><div style="margin-top:6pt;text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">CHINA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">PSUs Conditioned on Satisfaction of Regulatory Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a People&#8217;s Republic of China (&#8220;PRC&#8221;) national, the grant of the PSUs is conditioned upon the Company securing all necessary approvals from the PRC State Administration of Foreign Exchange to permit the operation of the 2011 Plan and the participation of PRC nationals employed by your Employer, as determined by the Company in its sole discretion.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Sale of Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in the 2011 Plan, upon any termination of employment with your Employer, you shall be required to sell all Shares acquired under the 2011 Plan within such time period as may be established by the PRC State Administration of Foreign Exchange.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.  &#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge and agree that you will be required immediately to repatriate to the PRC the proceeds from the sale of any Shares acquired under the 2011 Plan, as well as any other cash amounts attributable to the Shares acquired under the 2011 Plan (collectively, &#8220;Cash Proceeds&#8221;).  Further, you acknowledge and agree that the repatriation of the Cash Proceeds must be effected through a special bank account established by your Employer, the Company or one of its Subsidiaries, and you hereby consent and agree that the Cash Proceeds may be transferred to such account by the Company on your behalf prior to being delivered to you.  The Cash Proceeds may be paid to you in U.S. dollars or local currency at the Company&#8217;s discretion.  If the Cash Proceeds are paid to you in U.S. dollars, you understand that a U.S. dollar bank account must be established and maintained in China so that the proceeds may be deposited into such account. Additionally, if the Company changes its Stock Plan Administrator, you acknowledge and agree that the Company may transfer any Shares issued under the 2011 Plan to the new designated Stock Plan Administrator if necessary for legal or administrative reasons. You agree to sign any documentation necessary to facilitate the transfer.  If the Cash Proceeds are paid to you in local currency, you acknowledge and agree that the Company is under no obligation to secure any particular exchange conversion rate and that the Company may face delays in converting the Cash Proceeds to local currency due to exchange control restrictions.  You agree to bear any currency fluctuation risk between the time the Shares are sold and the Cash Proceeds are converted into local currency and distributed to you.  You further agree to comply with any other requirements that may be imposed by your Employer, the Company and its Subsidiaries in the future in order to facilitate compliance with exchange control requirements in the PRC.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COLOMBIA</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 20 of the Terms and Conditions you acknowledge that, pursuant to Article 128 of the Colombian Labor Code, the 2011 Plan and related benefits do not constitute a component of your &#8220;salary&#8221; for any legal purpose. Therefore, they will not be included and&#47;or considered for purposes of calculating any and all labor benefits, such as legal&#47;fringe benefits, </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">vacations, indemnities, payroll taxes, social insurance contributions and&#47;or any other labor-related amount which may be payable.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Shares subject to the PSUs are not and will not be registered in the Colombian registry of publicly traded securities (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Registro Nacional de Valores y Emisores</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">) and therefore the Shares may not be offered to the public in Colombia. Nothing in this document should be construed as the making of a public offer of securities in Colombia.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">COSTA RICA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">DENMARK</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Treatment of PSUs upon Termination of Employment</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision in the Terms and Conditions or the 2011 Plan to the contrary, unless you are a member of registered management who is not considered a salaried employee, the treatment of the PSUs upon a termination of employment which is not a result of death shall be governed by Sections 4 and 5 of the Danish Act on Stock Option in Employment Relations. However, if the provisions in the Terms and Conditions or the Plan governing the treatment of the PSUs upon a termination of employment are more favorable, then the provisions of the Terms and Conditions or the 2011 Plan will govern.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FINLAND</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding of Tax-Related Items</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything in Section 13 of the Terms and Conditions to the contrary, if you are a local national of Finland, any Tax-Related Items shall be withheld only in cash from your regular salary&#47;wages or other amounts payable to you in cash or such other withholding methods as may be permitted under the 2011 Plan and allowed under local law.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">FRANCE</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Use of English Language</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  &#160;By accepting your PSUs, you acknowledge and agree that it is your wish that the Terms and Conditions, this Addendum, as well as all&#160;other documents, notices and legal proceedings entered into, given or instituted pursuant to your PSUs, either directly or indirectly, be drawn up in English.  </font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Langue anglaise</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.  En acceptant l'allocation de vos PSUs, vous reconnaissez et acceptez avoir souhait&#233; que le Termes et Conditions, le pr&#233;sent avenant, ainsi que tous autres documents ex&#233;cut&#233;s, avis donn&#233;s et proc&#233;dures judiciaires intent&#233;es, relatifs, directement ou indirectement,&#160;&#224; l'allocation de vos PSUs, soient r&#233;dig&#233;s en anglais</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022  TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">HONG KONG</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Importance Notice.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> Warning&#58; The contents of the Terms and Conditions, this Addendum, the 2011 Plan, and all other materials pertaining to the PSUs and&#47;or the 2011 Plan have not been reviewed by any regulatory authority in Hong Kong.  You are hereby advised to exercise caution in relation to the offer thereunder.  If you have any doubts about any of the contents of the aforesaid materials, you should obtain independent professional advice.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Lapse of Restrictions</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If, for any reason, Shares are issued to you within six (6) months of the grant date, you agree that you will not sell or otherwise dispose of any such Shares prior to the six-month anniversary of the grant date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Settlement in Shares</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Notwithstanding anything to the contrary in this Addendum, the Terms and Conditions or the 2011 Plan, the PSUs shall be settled only in Shares (and may not be settled in cash).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Nature of the Plan</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The Company specifically intends that the 2011 Plan will not be treated as an occupational retirement scheme for purposes of the Occupational Retirement Schemes Ordinance (&#8220;ORSO&#8221;).  To the extent any court, tribunal or legal&#47;regulatory body in Hong Kong determines that the 2011 Plan constitutes an occupational retirement scheme for the purposes of ORSO, the grant of the PSUs shall be null and void.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">INDIA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Repatriation Requirements</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly agree to repatriate all sale proceeds and dividends attributable to Shares acquired under the 2011 Plan in accordance with local foreign exchange rules and regulations. Neither the Company, your Employer or any of the Company&#8217;s Subsidiaries shall be liable for any fines or penalties resulting from your failure to comply with applicable laws, rules or regulations.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">IRELAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ITALY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">JAPAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">MEXICO</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Commercial Relationship</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize that your participation in the 2011 Plan and the Company&#8217;s grant of the PSUs does not constitute an employment relationship between you and the Company.  You have been granted the PSUs as a consequence of the commercial relationship between the Company and the Subsidiary in Mexico that employs you, and the Company&#8217;s Subsidiary in Mexico is your sole employer.  Based on the foregoing, (a) you expressly recognize the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan do not establish any rights between you and the Company&#8217;s Subsidiary in Mexico that employs you, (b) the 2011 Plan and the benefits you may derive from your participation in the 2011 Plan are not part of the employment conditions and&#47;or benefits provided by the Company&#8217;s Subsidiary in Mexico that employs you, and (c) any modification or amendment of the 2011 Plan by the Company, or a termination of the 2011 Plan by the Company, shall not constitute a change or impairment of the terms and conditions of your employment with the Company&#8217;s Subsidiary in Mexico that employs you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You expressly recognize and acknowledge that the Company's grant of PSUs and the underlying Shares under the Plan have not been registered with the National Register of Securities maintained by the Mexican National Banking and Securities Commission and cannot be offered or sold publicly in Mexico.  In addition, the 2011 Plan, the Terms and Conditions and any other document relating to the PSUs may not be publicly distributed in Mexico. These materials are addressed to you only because of your existing relationship with the Company and these materials should not be reproduced or copied in any form. The offer contained in these materials does not constitute a public offering of securities but rather constitutes a private placement of securities addressed specifically to individuals who are present employees of the Employer in Mexico made in accordance with the provisions of the Mexican Securities Market Law, and any rights under such offering shall not be assigned or transferred.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Extraordinary Item of Compensation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You expressly recognize and acknowledge that your participation in the 2011 Plan is a result of the discretionary and unilateral decision of the Company, as well as your free and voluntary decision to participate in the 2011 Plan in accord with the terms and conditions of the 2011 Plan, the Terms and Conditions, and this Addendum.   As such, you acknowledge and agree that the Company may, in its sole discretion, amend and&#47;or discontinue your participation in the 2011 Plan at any time and without any liability.  The value of the PSUs is an extraordinary item of compensation outside the scope of your employment contract, if any.  The PSUs are not part of your regular or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the Company&#8217;s Subsidiary in Mexico that employs you.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NETHERLANDS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Waiver of Termination Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  As a condition to the grant of the PSUs, you hereby waive any and all rights to compensation or damages as a result of the termination of your employment with the Company and your Employer for any reason whatsoever, insofar as those rights result or may </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">result from (a) the loss or diminution in value of such rights or entitlements under the 2011 Plan, or (b) you ceasing to have rights under or ceasing to be entitled to any awards under the 2011 Plan as a result of such termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Tax Deferral Upon Retirement</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Unless you otherwise elect by contacting Stryker no later than April 29, 2022, you hereby agree that upon Retirement eligibility, the PSUs shall not become taxable until the date of settlement when Shares are actually delivered or otherwise made available.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">NEW ZEALAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">WARNING</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You are being offered PSUs to be settled in the form of shares of Stryker Corporation common stock. If the Company runs into financial difficulties and is wound up, you may lose some or all your investment. New Zealand law normally requires people who offer financial products to give information to investors before they invest. This requires those offering financial products to have disclosed information that is important for investors to make an informed decision. The usual rules do not apply to this offer because it is an offer made under the Employee Share Scheme exemption. As a result, you may not be given all the information usually required. You will also have fewer other legal protections for this investment. You should ask questions, read all documents carefully, and seek independent financial advice before accepting the offer. The Company&#8217;s Shares are currently traded on the New York Stock Exchange under the ticker symbol &#8220;SYK&#8221; and Shares acquired under the 2011 Plan may be sold through this exchange.  You may end up selling the Shares at a price that is lower than the value of the Shares when you acquired them. The price will depend on the demand for the Company's Shares. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">The Company&#8217;s most recent annual report (which includes the Company&#8217;s financial statements) is available at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">http&#58;&#47;&#47;phx.corporate-ir.net&#47;phoenix.zhtml&#63;c&#61;118965&#38;p&#61;irol-irhome</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">. You are entitled to receive a copy of this report, free of charge, upon written request to the Company at </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">POLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PORTUGAL</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PUERTO RICO</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ROMANIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">RUSSIA</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">IMPORTANT EMPLOYEE NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You may be required to repatriate certain cash amounts received with respect to the PSUs to Russia as soon as you intend to use those cash amounts for any purpose, including reinvestment. If the repatriation requirement applies, such funds must initially be credited to you through a foreign currency account at an authorized bank in Russia. After the funds are initially received in Russia, they may be further remitted to foreign banks in accordance with Russian exchange control laws. Under the Directive N 5371-U of the Russian Central Bank (the &#8220;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">CBR</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), the repatriation requirement may not apply in certain cases with respect to cash amounts received in an account that is considered by the CBR to be a foreign brokerage account. Statutory exceptions to the repatriation requirement also may apply. </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">You should contact your personal advisor to ensure compliance with the applicable exchange control requirements prior to vesting in the PSUs and&#47;or selling the Shares acquired pursuant to the PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECURITIES LAW NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The grant of PSUs and the issuance of Shares upon vesting are not intended to be an offering of securities with the Russian Federation, and the Terms and </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Conditions, the 2011 Plan, this Addendum and all other materials that you receive in connection with the grant of PSUs and your participation in the 2011 Plan (collectively, &#8220;Grant Materials&#8221;) do not constitute advertising or a solicitation within the Russian Federation.  In connection with your grant of PSUs, the Company has not submitted any registration statement, prospectus or other filing with the Russian Federal Bank or any other governmental or regulatory body within the Russian Federation, and the Grant Materials expressly may not be used, directly or indirectly, for the purpose of making a securities offering or public circulation of Shares within the Russian Federation.  Any Shares acquired under the 2011 Plan will be maintained on your behalf outside of Russia. Moreover, you will not be permitted to sell or otherwise alienate any Shares directly to other Russian legal entities or individuals.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EXCHANGE CONTROL NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are solely responsible for complying with applicable Russian exchange control regulations.  Since the exchange control regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current regulations. As noted, it is your personal responsibility to comply with Russian exchange control laws, and neither the Company nor any Subsidiary will be liable for any fines or penalties resulting from failure to comply with applicable laws.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ANTI-CORRUPTION NOTIFICATION</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Anti-corruption laws prohibit certain public servants, their spouses and their dependent children from owning any foreign source financial instruments (</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">e</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">g</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">., shares of foreign companies such as the Company).  Accordingly, you should inform the Company if you are covered by these laws as this relates to your acquisition of Shares under the 2011 Plan.</font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SINGAPORE</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Qualifying Person Exemption</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall replace Section 23 of the Terms and Conditions&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The grant of the PSUs under the 2011 Plan is being made pursuant to the &#8220;Qualifying Person&#8221; exemption&#8221; under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (&#8220;SFA&#8221;).  The 2011 Plan has not been lodged or registered as a prospectus with the Monetary Authority of Singapore.  You should note that, as a result, the&#160;PSUs are subject to section 257 of the SFA and&#160;you will not be able to make (a) any subsequent sale of the Shares in Singapore or (ii) any offer of such subsequent sale of the Shares subject to the&#160;PSUs&#160;in Singapore, unless such sale or offer is made pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA (Chapter 289, 2006 Ed.).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Director Reporting Notification</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  If you are a director, associate director or shadow director of a Singapore company, you are subject to certain notification requirements under the Singapore Companies Act.  Among these requirements is an obligation to notify the Singapore company in writing when you receive an interest (e.g., PSUs or Shares) in the Company or any related company.  In addition, you must notify the Singapore company when you sell Shares (including when you sell Shares acquired at vesting of the Performance Stock Units).  These notifications must be made within two business days of acquiring or disposing of any interest in the Company or any related company.  In addition, a notification must be made of Participant&#8217;s interests in the Company or any related company within two business days of becoming a director.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH AFRICA</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In addition to the provisions of Section 13 of the Terms and Conditions, you agree to notify your Employer in South Africa of the amount of any gain realized upon vesting of the PSUs.  If you fail to advise your Employer of the gain realized upon vesting of the PSUs, you may be liable for a fine.  You will be responsible for paying any difference between the actual tax liability and the amount withheld.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exchange Control Obligations</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You are solely responsible for complying with applicable exchange control regulations and rulings (the &#8220;Exchange Control Regulations&#8221;) in South Africa.  As the </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Exchange Control Regulations change frequently and without notice, you should consult your legal advisor prior to the acquisition or sale of Shares under the 2011 Plan to ensure compliance with current Exchange Control Regulations.  Neither the Company nor any of its Subsidiaries will be liable for any fines or penalties resulting from your failure to comply with applicable laws.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information and Deemed Acceptance of PSUs</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.&#160; Neither the PSUs nor the underlying Shares shall be publicly offered or listed on any stock exchange in South Africa.&#160; The offer is intended to be private pursuant to Section 96 of the Companies Act and is not subject to the supervision of any South African governmental authority. Pursuant to Section 96 of the Companies Act, the PSU offer must be finalized on or before the 60th day following the grant date.&#160; If you do not want to accept the PSUs, you are required to decline the PSUs no later than the 60th day following the grant date.&#160; If you do not reject the PSUs on or before the 60th day following the grant date, you will be deemed to accept the PSUs.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SOUTH KOREA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SPAIN</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Acknowledgement of Discretionary Nature of the 2011 Plan&#59; No Vested Rights</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  In accepting the PSUs, you acknowledge that you consent to participation in the 2011 Plan and have received a copy of the 2011 Plan.  You understand that the Company has unilaterally, gratuitously and in its sole discretion granted PSUs under the 2011 Plan to individuals who may be employees of the Company or its Subsidiaries throughout the world.  The decision is a limited decision that is entered into upon the express assumption and condition that any grant will not economically or otherwise bind the Company or any of its Subsidiaries on an ongoing basis.  Consequently, you understand that the PSUs are granted on the assumption and condition that the PSUs and the Shares acquired upon vesting of the PSUs shall not become a part of any employment contract (either with the Company or any of its Subsidiaries) and shall not be considered a mandatory benefit, salary for any purposes (including severance compensation) or any other right whatsoever.  In addition, you understand that this grant would not be made to you but for the assumptions and conditions referenced above. Thus, you acknowledge and freely accept that should any or all of the assumptions be mistaken or should any of the conditions not be met for any reason, the PSUs shall be null and void.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">You understand and agree that, as a condition of the grant of the PSUs, any unvested PSUs as of the date you cease active employment will be forfeited without entitlement to the underlying Shares or to any amount of indemnification in the event of the termination of employment by reason of, but not limited to, (i) material modification of the terms of employment under Article 41 of the Workers&#8217; Statute or (ii) relocation under Article&#160;40 of the Workers&#8217; Statute.  You acknowledge that you have read and specifically accept the conditions referred to in the Terms and Conditions regarding the impact of a termination of employment on your PSUs.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">BY SIGNING BELOW, YOU ACKNOWLEDGE, UNDERSTAND AND AGREE TO THE PROVISIONS OF THE 2011 PLAN, THE TERMS AND CONDITIONS AND THIS ADDENDUM.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PLEASE SIGN AND RETURN THIS ADDENDUM VIA EMAIL NO LATER THAN APRIL 29, 2022 TO </font><font style="color:#0000ff;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">STOCKPLANADMINISTRATION&#64;STRYKER.COM</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">___________________________________&#160;&#160;&#160;&#160;            ______________________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Employee Signature&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employee Name (Printed)</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">_____________________</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Neither this document nor any other materials relating to the RSUs (a) constitutes a prospectus according to articles 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;FinSA&#8221;) (b) may be publicly distributed or otherwise made publicly available in Switzerland to any person other than an employee of the Company or (c) has been or will be filed with, approved or supervised by any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority, including the Swiss Financial Market Supervisory Authority (&#8220;FINMA&#8221;).</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TAIWAN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Notice</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The offer of participation in the 2011 Plan is available only for employees of the Company and its Subsidiaries. The offer of participation in the 2011 Plan is not a public offer of securities by a Taiwanese company.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">THAILAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No country specific provisions.</font></div><div><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TURKEY</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  Under Turkish law, you are not permitted to sell any Shares acquired under the 2011 Plan within Turkey.  The Shares are currently traded on the New York Stock Exchange, which is located outside of Turkey, under the ticker symbol &#8220;SYK&#8221; and the Shares may be sold through this exchange.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Intermediary Obligation</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  You acknowledge that any activity related to investments in foreign securities (e.g., the sale of Shares) should be conducted through a bank or financial intermediary institution licensed by the Turkey Capital Markets Board and should be reported to the Turkish Capital Markets Board.  You solely are responsible for complying with this requirement and should consult with a personal legal advisor for further information regarding any obligations in this respect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED ARAB EMIRATES</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Securities Law Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The offer of the PSUs is available only for select Employees of the Company </font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and its Subsidiaries </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">and is in the nature of providing incentives in the United Arab Emirates. The 2011 Plan and the Terms and Conditions are intended for distribution only to such individuals and must not be delivered to, or relied on by any other person. Prospective purchasers of securities should conduct their own due diligence. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Emirates Securities and Commodities Authority has no responsibility for reviewing or verifying any documents in connection with this statement, including the 2011 Plan and the Terms and Conditions, or any other incidental communication materials distributed in connection with the PSUs. Further, neither the Ministry of Economy nor the Dubai Department of Economic Development has approved this statement nor taken steps to verify the information set out in it, and has no responsibility for it. Residents of the United Arab Emirates who have any questions regarding the contents of the 2011 Plan and the Terms and Conditions should obtain independent advice.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="background-color:#d9d9d9;color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">UNITED KINGDOM</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Income Tax and Social Insurance Contribution Withholding</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">.  The following provision shall supplement Section 13 of the Terms and Conditions&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation to Section 13 of the Terms and Conditions, you agree that you are liable for all Tax-Related Items and hereby covenant to pay all such Tax-Related Items, as and when requested by the Company, your Employer or by Her Majesty&#8217;s Revenue and Customs (&#8220;HMRC&#8221;) (or any other tax authority or any other relevant authority). You also agree to indemnify and keep indemnified </font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.1pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exhibit 10(iii)</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">the Company and your Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay to HMRC on your behalf (or any other tax authority or any other relevant authority).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Exclusion of Claim</font><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. You acknowledge and agree that you will have no entitlement to compensation or damages in consequence of the termination of your employment with the Company and your Employer for any reason whatsoever and whether or not in breach of contract, insofar as any purported claim to such entitlement arises or may arise from your ceasing to have rights under or to be entitled to vest in the PSUs as a result of such termination of employment (whether the termination is in breach of contract or otherwise), or from the loss or diminution in value of the PSUs.  Upon the grant of the PSUs, you shall be deemed irrevocably to have waived any such entitlement.</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:100%">****************************</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.1pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>6
<FILENAME>ex21i1231202110k.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic0e2855ae5b94c9280b6fca840f18bbf_1"></div><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">STRYKER CORPORATION LIST OF SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of December&#160;31, 2021</font></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2Hip Holdings SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Aimago SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alcott Indemnity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Vermont</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arrinex, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold + Fritz GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Consulting GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold GmbH  &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Berchtold Holding Switzerland GmbH </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics USA, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">BioMimetic Therapeutics, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cartiva, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changzhou Orthomed Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">EnMovi, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Entellus Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gauss Surgical Singapore Pte. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gauss Surgical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gongping (Shanghai) Medical Devices Trading Co. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYS Tech, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HeartSine Technologies Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">HeartSine Technologies, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica International S. de R.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Panama</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Howmedica Osteonics Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hygia Healthcare Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Alabama</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hyperbranch Medical Technologies, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imascap SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Imorphics Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSD Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Infinity MSF Corp.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">InstruMedics, L.L.C</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Invuity, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ivy Sports Medicine, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jiangsu Chuangyi Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Jolife AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M Group Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">K2M, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Loon Intermediateco, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">MAKO Surgical Corp</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mobius Imaging, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Muka Metal Ticaret ve Sanayi Anaonim Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nettrick Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Corp</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Novadaq Technologies ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NV Stryker SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Belgium</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OOO &#34;Stryker&#34;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orneo &#214;zel Sa&#287;l&#305;k Hizmetleri Medikal Ticaret Anonim &#350;irketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoHelix Surgical Designs, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthomed (Hong Kong) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoSensor Korea, Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthosensor, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OrthoSpace US Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ortho-Space, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Israel</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Orthovita, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Pennsylvania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">P.C. Sweden Holding AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control (Shanghai) Sales Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Brazil Vendas Ltda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Holdings Co&#246;peratief U.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Holdings Inc</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Investments, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Lebanon Sales Offshore s.a.l.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Manufacturing, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Operations Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control Sales Limited Liability Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Russia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Physio-Control, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Washington</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PTH West, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SafeAir AG </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Co&#1255;peratief U.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings II, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products Holdings III, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sage Products, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SCI Calyx SA</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Scopis GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spirox, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SSI Divestiture, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stanmore Implants Worldwide Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stanmore, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Massachusetts</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Barbados) Foreign Sales Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Barbados</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Beijing) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Shanghai) Healthcare Products Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Suzhou) Medical Technology Co Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker (Thailand) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thailand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker AB</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sweden</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Asia Holdings C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Australia Pty. Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Austria GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Austria</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Berchtold B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Beteiligungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada Holding Company ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada Manufacturing ULC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canada ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Canadian Management, ULC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Capital B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker China Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Colombia SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Colombia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Communications, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Chile) y Compania Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Chile</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Corporation (Malaysia) Sdn. Bhd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malaysia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Customs Brokers, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Czech Republic s.r.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Czech Republic</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Delaware, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker do Brasil Ltda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker EMEA Supply Chain Services B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Employment Company, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Holdings Co&#246;peratief U.A</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations B.V. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings I B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings II B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings III B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Holdings, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker European Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Far East, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Foreign Acquisitions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Funding B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Global Technology Center Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks GmbH &#38; Co KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Grundst&#252;cks Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Iberia, S.L. Unipersonal</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Spain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker IFSC Designated Activity Company</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker India Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">India</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Acquisitions B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker International Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Italia S.r.l. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Italy</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Japan K.K.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Korea Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Korea</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Lebanon (Offshore) S.A.L.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Lebanon</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Leibinger GmbH &#38; Co. KG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Luxembourg Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Luxembourg</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Malta Holdings Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Malta</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Manufacturing S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mauritius Holding Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mauritius</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Medical London LP</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Medtech K.K.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Japan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Medtech Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Mexico SA de CV</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Nederland B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker New Zealand Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New Zealand</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker NV Operations Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Osteonics AG</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Pacific Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Performance Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - New Jersey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Poland Services sp. z o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Polska sp.z.o.o.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Poland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Portugal - Produtos Medicos, Unipessoal, Lda.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Portugal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Professional Latin America S. de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico Sales, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Puerto Rico, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Puerto Rico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Renovation Services, LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Romania SRL</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Romania</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sales LLC </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Michigan</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Servicios Administrativos S.de R.L. de C.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Singapore Private Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker South Africa (Proprietary) Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Africa</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine Sarl</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Switzerland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Spine SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Sustainability Solutions, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Turkey</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Tijuana Operations, S. de R.L. de C.V. </font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mexico</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Trauma GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Turkish Holdings B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr></table></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:60.75pt;width:100%"><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 21(i)</font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.410%"><tr><td style="width:1.0%"></td><td style="width:71.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.645%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">State or Country of Incorporation</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Unite, Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Bermuda</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Verwaltungs GmbH</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Germany</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stryker Vietnam Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vietnam</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">SYK Costa Rica Services Sociedad De Responsabilidad Limitada</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thermedx LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Ohio</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMG France SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TMJ Solutions, LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Orthopedics Ireland Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ireland</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Pty Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier SAS</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">France</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier Scandinavia A&#47;S</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Denmark</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier UK Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier US Holdings, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tornier, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (China) Medical Instrument Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (B.V.I.) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">British Virgin Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings (Hong Kong) Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trauson Holdings Company Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cayman Islands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trooper Holdings Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TSO3 Corporation</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TSO3 Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright DutchCo B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Australia Pty Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Australia</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Brasil Ltda</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Brazil</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Costa Rica, S.A.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costa Rica</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Device (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Group, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Netherlands B.V.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Netherlands</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Singapore Pte Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Singapore</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical Technology, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright Medical UK Ltd</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wright PacRim, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical Consulting (Shanghai) Co., Ltd.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical Hong Kong Limited</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Hong Kong</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">ZipLine Medical, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">USA - Delaware</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker Corporation directly or indirectly owns 100% of the outstanding voting securities of each of the above-named subsidiaries, with the exception of any designated by an asterisk (*), which Stryker Corporation directly or indirectly owns a majority of the outstanding voting securities.</font></div><div style="text-align:center"><font><br></font></div><div style="height:38.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>7
<FILENAME>ex23i1231202110k.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i2efc7c9b5c4a4461a9127dc745533e1d_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font><br></font></div><div style="padding-left:72pt;text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">Exhibit 23(i)</font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">Consent of Independent Registered Public Accounting Firm</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-78201) pertaining to the 1998 Stock Option Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statement (Form S-8 No. 333-140961) pertaining to the 2006 Long-Term Incentive Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:11pt">Registration Statements (Form S-8 No. 333-150396 and Form S-8 333-221959) pertaining to the 2008 Employee Stock Purchase Plan of Stryker Corporation, and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%;padding-left:10.5pt">Registration Statements (Form S-8 No. 333-179142 and Form S-8 333-221958) pertaining to the 2011 Long-Term Incentive Plan of Stryker Corporation&#59;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:117%">of our reports dated February 11, 2022, with respect to the consolidated financial statements and schedule of Stryker Corporation and subsidiaries and the effectiveness of internal control over financial reporting of Stryker Corporation and subsidiaries included in this Annual Report (Form 10-K) for the year ended December 31, 2021.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:116%">&#47;s&#47; ERNST &#38; YOUNG LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">Grand Rapids, Michigan</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:140%">February 11, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>8
<FILENAME>ex31i1231202110k.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i50bfcc4e640344e4b0d0981283308073_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(i)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin A. Lobo, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2021 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>9
<FILENAME>ex31ii1231202110k.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i3d4d5c2078fb492c984ea1dc8c2b7c83_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 31(ii)</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Glenn S. Boehnlein, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.  I have reviewed this Annual Report on Form 10-K for the year ended December&#160;31, 2021 of Stryker Corporation&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.  The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)  Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)  Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.  The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:6.671%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>10
<FILENAME>ex32i1231202110k.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i148ab3da777149368c812496ac895c6d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(i) </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2021 (the &#34;Report&#34;), I, Kevin A. Lobo, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN A. LOBO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin A. Lobo</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair, Chief Executive Officer and President</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>11
<FILENAME>ex32ii1231202110k.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5138cbed3fac4cd6905a2bfb0d84a965_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exhibit 32(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </font></div><div style="margin-top:9pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report on Form 10-K of Stryker Corporation (the &#34;Company&#34;) for the year ended December&#160;31, 2021 (the &#34;Report&#34;), I, Glenn S. Boehnlein, Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:4pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:6.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.811%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.342%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 11, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; GLENN S. BOEHNLEIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glenn S. Boehnlein</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vice President, Chief Financial Officer</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>syk-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:syk="http://www.stryker.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.stryker.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="syk-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.stryker.com/role/COVERPAGE">
        <link:definition>0001001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.stryker.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfEarnings" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings">
        <link:definition>1001003 - Statement - Consolidated Statements Of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1002004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets">
        <link:definition>1003005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParentheticals" roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals">
        <link:definition>1004006 - Statement - Consolidated Balance Sheets (Parentheticals)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfShareholdersEquity" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity">
        <link:definition>1005007 - Statement - Consolidated Statements Of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsOfCashFlows" roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows">
        <link:definition>1006008 - Statement - Consolidated Statements Of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesPolicies" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2403401 - Disclosure - Significant Accounting Policies (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.stryker.com/role/RevenueRecognition">
        <link:definition>2104102 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.stryker.com/role/RevenueRecognitionTables">
        <link:definition>2305301 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>2406402 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregatedSalesAnalysisDetails" roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails">
        <link:definition>2407403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.stryker.com/role/FairValueMeasurements">
        <link:definition>2108103 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.stryker.com/role/FairValueMeasurementsTables">
        <link:definition>2309302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails">
        <link:definition>2410404 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAvailableForSaleSecuritiesDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails">
        <link:definition>2411405 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2412406 - Disclosure - Fair Value Measurements (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstruments" roleURI="http://www.stryker.com/role/DerivativeInstruments">
        <link:definition>2113104 - Disclosure - Derivative Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsTables" roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables">
        <link:definition>2314303 - Disclosure - Derivative Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails">
        <link:definition>2415407 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsNarrativeDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails">
        <link:definition>2416408 - Disclosure - Derivative Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsMovementsoutofOCIDetails" roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails">
        <link:definition>2417409 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCI" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI">
        <link:definition>2118105 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCITables" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables">
        <link:definition>2319304 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
        <link:definition>2420410 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Acquisitions" roleURI="http://www.stryker.com/role/Acquisitions">
        <link:definition>2121106 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsTables" roleURI="http://www.stryker.com/role/AcquisitionsTables">
        <link:definition>2322305 - Disclosure - Acquisitions (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsNarrativeDetails" roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails">
        <link:definition>2423411 - Disclosure - Acquisitions (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails">
        <link:definition>2424412 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitments" roleURI="http://www.stryker.com/role/ContingenciesandCommitments">
        <link:definition>2125107 - Disclosure - Contingencies and Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsTables" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables">
        <link:definition>2326306 - Disclosure - Contingencies and Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsNarrativeDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails">
        <link:definition>2427413 - Disclosure - Contingencies and Commitments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesLeaseCostDetails" roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails">
        <link:definition>2428414 - Disclosure - Commitments and Contingencies - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails">
        <link:definition>2429415 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2130108 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2331307 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails">
        <link:definition>2432416 - Disclosure - Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails">
        <link:definition>2433417 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails">
        <link:definition>2434418 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStock" roleURI="http://www.stryker.com/role/CapitalStock">
        <link:definition>2135109 - Disclosure - Capital Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockTables" roleURI="http://www.stryker.com/role/CapitalStockTables">
        <link:definition>2336308 - Disclosure - Capital Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockNarrativeDetails" roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails">
        <link:definition>2437419 - Disclosure - Capital Stock (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockOptionGrantAssumptionsDetails" roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails">
        <link:definition>2438420 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofStockOptionActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails">
        <link:definition>2439421 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CapitalStockSummaryofRSUandPSUActivityDetails" roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails">
        <link:definition>2440422 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilities" roleURI="http://www.stryker.com/role/DebtandCreditFacilities">
        <link:definition>2141110 - Disclosure - Debt and Credit Facilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesTables" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables">
        <link:definition>2342309 - Disclosure - Debt and Credit Facilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesNarrativeDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails">
        <link:definition>2443423 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails">
        <link:definition>2444424 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1">
        <link:definition>2444424 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.stryker.com/role/IncomeTaxes">
        <link:definition>2145111 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.stryker.com/role/IncomeTaxesTables">
        <link:definition>2346310 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2447425 - Disclosure - Income Taxes (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails">
        <link:definition>2448426 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails">
        <link:definition>2449427 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>2450428 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails">
        <link:definition>2451429 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1">
        <link:definition>2451429 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails">
        <link:definition>2452430 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlans" roleURI="http://www.stryker.com/role/RetirementPlans">
        <link:definition>2153112 - Disclosure - Retirement Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansTables" roleURI="http://www.stryker.com/role/RetirementPlansTables">
        <link:definition>2354311 - Disclosure - Retirement Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails">
        <link:definition>2455431 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails">
        <link:definition>2456432 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofChangeinBenefitObligationsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails">
        <link:definition>2457433 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansChangeinPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails">
        <link:definition>2458434 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails">
        <link:definition>2459435 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails">
        <link:definition>2460436 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansNarrativeDetails" roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails">
        <link:definition>2461437 - Disclosure - Retirement Plans (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RetirementPlansExpectedBenefitPaymentsDetails" roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails">
        <link:definition>2462438 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnaudited" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited">
        <link:definition>2163113 - Disclosure - Summary of Quarterly Data (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedTables" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables">
        <link:definition>2364312 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofQuarterlyDataUnauditedDetails" roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails">
        <link:definition>2465439 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicData" roleURI="http://www.stryker.com/role/SegmentandGeographicData">
        <link:definition>2166114 - Disclosure - Segment and Geographic Data</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataTables" roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables">
        <link:definition>2367313 - Disclosure - Segment and Geographic Data (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails">
        <link:definition>2468440 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataSegmentInformationDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails">
        <link:definition>2469441 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails">
        <link:definition>2470442 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairments" roleURI="http://www.stryker.com/role/AssetImpairments">
        <link:definition>2171115 - Disclosure - Asset Impairments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AssetImpairmentsDetails" roleURI="http://www.stryker.com/role/AssetImpairmentsDetails">
        <link:definition>2472443 - Disclosure - Asset Impairments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsNotes" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes">
        <link:definition>2173116 - Disclosure - Schedule II Valuation and Qualifying Accounts (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ScheduleIIValuationandQualifyingAccountsDetails" roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails">
        <link:definition>2474444 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" abstract="false" name="TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2027Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OtherOrthopaedicsMember" abstract="true" name="OtherOrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CustomerAndDistributorRelationshipsMember" abstract="true" name="CustomerAndDistributorRelationshipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_TraumaandExtremitiesMember" abstract="true" name="TraumaandExtremitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_DerivativeNotionalAmount1" abstract="false" name="DerivativeNotionalAmount1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_EndoscopyMember" abstract="true" name="EndoscopyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_HipsMember" abstract="true" name="HipsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3650Due2028Member" abstract="true" name="SeniorUnsecuredNotes3650Due2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_MedicalDeviceRegulationsExpense" abstract="false" name="MedicalDeviceRegulationsExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" abstract="false" name="BusinessCombinationContingentConsiderationFutureMilestonePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_LongLivedAssetsAndIntangibleAssetsMember" abstract="true" name="LongLivedAssetsAndIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" abstract="false" name="AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.950Due2030Member" abstract="true" name="SeniorUnsecuredNotes1.950Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.150Due2025Member" abstract="true" name="SeniorUnsecuredNotes1.150Due2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_BusinessCombinationConsiderationTransferredPricePerShare" abstract="false" name="BusinessCombinationConsiderationTransferredPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4625Due2046Member" abstract="true" name="SeniorUnsecuredNotes4625Due2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_RejuvenateABGIIHipRecallCharges" abstract="false" name="RejuvenateABGIIHipRecallCharges" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DebtInstrumentCovenantLeverageRatio" abstract="false" name="DebtInstrumentCovenantLeverageRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="syk_OtherForeignCountriesMember" abstract="true" name="OtherForeignCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.250due2024Member" abstract="true" name="SeniorUnsecuredNotes0.250due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OtherIncomeexpenseMember" abstract="true" name="OtherIncomeexpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_A225ConvertibleNotesMember" abstract="true" name="A225ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" abstract="true" name="InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" abstract="false" name="WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" abstract="false" name="PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0600Due2023Member" abstract="true" name="SeniorUnsecuredNotes0600Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375due2025MemberMember" abstract="true" name="SeniorUnsecuredNotes3.375due2025MemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" abstract="false" name="BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SignificantAccountingPoliciesAbstract" abstract="true" name="SignificantAccountingPoliciesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SpineMember" abstract="true" name="SpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_InstrumentsMember" abstract="true" name="InstrumentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockValueHeldByCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CommonAndPreferredStockSharesAuthorized" abstract="false" name="CommonAndPreferredStockSharesAuthorized" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2030Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_CapitalExpendituresDuringPeriod" abstract="false" name="CapitalExpendituresDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_LandBuildingsAndImprovementsGross" abstract="false" name="LandBuildingsAndImprovementsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.625Due2030Member" abstract="true" name="SeniorUnsecuredNotes2.625Due2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_MedSurgAndNeurotechnologyMember" abstract="true" name="MedSurgAndNeurotechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes3.375due2024Member" abstract="true" name="SeniorUnsecuredNotes3.375due2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" abstract="true" name="ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" abstract="false" name="SaleOfInventorySteppedUpToFairValueAtAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_CapitalStockAbstract" abstract="true" name="CapitalStockAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_DeferredTaxAssetsDepreciationAndAmortization" abstract="false" name="DeferredTaxAssetsDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" abstract="false" name="DefinedContributionRetirementPlansCommonStockHeldByCompany" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" abstract="false" name="FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_GaussMember" abstract="true" name="GaussMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_PerformanceStockUnitPsusMember" abstract="true" name="PerformanceStockUnitPsusMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotesDueNovember2023Member" abstract="true" name="SeniorUnsecuredNotesDueNovember2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_MedicalMember" abstract="true" name="MedicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes0.750due2029Member" abstract="true" name="SeniorUnsecuredNotes0.750due2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2625Due2021Member" abstract="true" name="SeniorUnsecuredNotes2625Due2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes4.375due2044Member" abstract="true" name="SeniorUnsecuredNotes4.375due2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_GlobalERPSystemMember" abstract="true" name="GlobalERPSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes350Due2026Member" abstract="true" name="SeniorUnsecuredNotes350Due2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.125Due2023Member" abstract="true" name="SeniorUnsecuredNotes1.125Due2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_AuditorInformationAbstract" abstract="true" name="AuditorInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" abstract="false" name="IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_A1625ConvertibleNotesMember" abstract="true" name="A1625ConvertibleNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_VoceraMember" abstract="true" name="VoceraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_WrightMember" abstract="true" name="WrightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OperatingLossCarryforwardsSubjectToValuationAllowance" abstract="false" name="OperatingLossCarryforwardsSubjectToValuationAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.125Due2021Member" abstract="true" name="SeniorUnsecuredNotes1.125Due2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_OrthopaedicsAndSpineMember" abstract="true" name="OrthopaedicsAndSpineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_NeurovascularMember" abstract="true" name="NeurovascularMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.900due2050Member" abstract="true" name="SeniorUnsecuredNotes2.900due2050Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_PercentageofServiceRevenueRecognizeoverTime" abstract="false" name="PercentageofServiceRevenueRecognizeoverTime" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="syk_NeuroCranialMember" abstract="true" name="NeuroCranialMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes1.000due2031Member" abstract="true" name="SeniorUnsecuredNotes1.000due2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes410Due2043Member" abstract="true" name="SeniorUnsecuredNotes410Due2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_KneesMember" abstract="true" name="KneesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="syk_Changeinaccrualforrecallexpenses" abstract="false" name="Changeinaccrualforrecallexpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" abstract="false" name="GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="syk_SeniorUnsecuredNotes2.125Due2027Member" abstract="true" name="SeniorUnsecuredNotes2.125Due2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>13
<FILENAME>syk-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93e916c4-3bd1-49df-8a1e-e29bb7f14761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4354aec3-0a80-427a-9672-f4c7d8c28d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93e916c4-3bd1-49df-8a1e-e29bb7f14761" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4354aec3-0a80-427a-9672-f4c7d8c28d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_92d49fdc-1f7d-4d40-ba6e-9bd4b31ed5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_93e916c4-3bd1-49df-8a1e-e29bb7f14761" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_92d49fdc-1f7d-4d40-ba6e-9bd4b31ed5a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_717b9d3a-ae4c-4598-94dc-004ea06fe95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f0e17006-12d9-4299-ad89-7feb4f6638e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_717b9d3a-ae4c-4598-94dc-004ea06fe95a" xlink:to="loc_us-gaap_OperatingIncomeLoss_f0e17006-12d9-4299-ad89-7feb4f6638e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_a187904c-f6e8-4e2c-ab28-d8f70b86eba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_717b9d3a-ae4c-4598-94dc-004ea06fe95a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_a187904c-f6e8-4e2c-ab28-d8f70b86eba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fc5c1e10-6633-4e3e-a8a8-4b74d0449247" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_57d74b26-192f-47df-bb86-7769dd711c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fc5c1e10-6633-4e3e-a8a8-4b74d0449247" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_57d74b26-192f-47df-bb86-7769dd711c50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7e90e66f-7aed-4404-a37b-4e0ba83df25c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_fc5c1e10-6633-4e3e-a8a8-4b74d0449247" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_7e90e66f-7aed-4404-a37b-4e0ba83df25c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b08ae1bd-745a-4b10-a367-506f6112b2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_95824f89-d2ba-46dc-97a5-2be8b1f127cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b08ae1bd-745a-4b10-a367-506f6112b2d4" xlink:to="loc_us-gaap_Revenues_95824f89-d2ba-46dc-97a5-2be8b1f127cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_61ee040a-360e-4c31-9c76-7e5194bc5bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b08ae1bd-745a-4b10-a367-506f6112b2d4" xlink:to="loc_us-gaap_CostOfRevenue_61ee040a-360e-4c31-9c76-7e5194bc5bdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_32465dd8-529d-496c-9ce9-55205dc05be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4b9aacd7-cf41-4ed0-8196-40408c04b588" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_32465dd8-529d-496c-9ce9-55205dc05be4" xlink:to="loc_us-gaap_GrossProfit_4b9aacd7-cf41-4ed0-8196-40408c04b588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_b3b1ed23-debc-40d2-93d6-40f4b8e3448e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_32465dd8-529d-496c-9ce9-55205dc05be4" xlink:to="loc_us-gaap_OperatingExpenses_b3b1ed23-debc-40d2-93d6-40f4b8e3448e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_a84078b1-5260-4e9f-b3be-c9d7b5b0edd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a95cab6a-a785-4c73-9267-e859e76cd029" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a84078b1-5260-4e9f-b3be-c9d7b5b0edd0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a95cab6a-a785-4c73-9267-e859e76cd029" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_be7893b8-8018-44a0-886b-abaa4c24bc12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a84078b1-5260-4e9f-b3be-c9d7b5b0edd0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_be7893b8-8018-44a0-886b-abaa4c24bc12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_eea18250-89d2-4536-90c8-94b626f7117c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a84078b1-5260-4e9f-b3be-c9d7b5b0edd0" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_eea18250-89d2-4536-90c8-94b626f7117c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_d8b7e56a-b959-4f96-854f-a5d66191a6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_a84078b1-5260-4e9f-b3be-c9d7b5b0edd0" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_d8b7e56a-b959-4f96-854f-a5d66191a6a8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b038a334-eaf4-49b8-be8f-d5713c0ec561" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e64c9a75-c89c-4253-bae1-673fc1a749bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b038a334-eaf4-49b8-be8f-d5713c0ec561" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_e64c9a75-c89c-4253-bae1-673fc1a749bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_25c67c25-6718-441d-93cd-06f3c2ecf745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b038a334-eaf4-49b8-be8f-d5713c0ec561" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_25c67c25-6718-441d-93cd-06f3c2ecf745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f2eb0acd-9c7d-487d-8de7-86bd74ddcb65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b038a334-eaf4-49b8-be8f-d5713c0ec561" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_f2eb0acd-9c7d-487d-8de7-86bd74ddcb65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_beff9223-a8b6-4aa8-a7a9-a0da4ff3ba3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b038a334-eaf4-49b8-be8f-d5713c0ec561" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_beff9223-a8b6-4aa8-a7a9-a0da4ff3ba3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d0e64bca-3eff-47c3-a2b9-679c4547c886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1879260-a260-42c8-a450-27668e34ad6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d0e64bca-3eff-47c3-a2b9-679c4547c886" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d1879260-a260-42c8-a450-27668e34ad6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a99ce220-2849-4f76-bb20-d96f9bb7c921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_d0e64bca-3eff-47c3-a2b9-679c4547c886" xlink:to="loc_us-gaap_NetIncomeLoss_a99ce220-2849-4f76-bb20-d96f9bb7c921" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_644a32f6-cff8-4180-8d26-4c6144f57694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca9869e8-6e90-4193-b5c9-b063ca4f03a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_644a32f6-cff8-4180-8d26-4c6144f57694" xlink:to="loc_us-gaap_Liabilities_ca9869e8-6e90-4193-b5c9-b063ca4f03a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6221397c-70ef-49ef-9f93-a26c42ed86bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_644a32f6-cff8-4180-8d26-4c6144f57694" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6221397c-70ef-49ef-9f93-a26c42ed86bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e71152d8-dc18-4cff-9f4d-9fdfc29f0c92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e71152d8-dc18-4cff-9f4d-9fdfc29f0c92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4fb0de0b-9b8a-41a4-89ed-cb2bd78de762" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4fb0de0b-9b8a-41a4-89ed-cb2bd78de762" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_54d51d19-fb2d-4136-97d2-59d7c29bfa99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:to="loc_us-gaap_InventoryNet_54d51d19-fb2d-4136-97d2-59d7c29bfa99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_5624f3d2-43fc-4fc8-b385-b5adc3e55d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_5624f3d2-43fc-4fc8-b385-b5adc3e55d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b8f6c62-7fa7-4c60-89f2-da954aa78be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0629bb21-3b0e-4250-9113-d7106732f123" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0b8f6c62-7fa7-4c60-89f2-da954aa78be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_3708cf95-21b8-4c48-8c2c-55c8b344372c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_55a94cc6-c3e3-4410-a0d5-995d65c97b02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3708cf95-21b8-4c48-8c2c-55c8b344372c" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_55a94cc6-c3e3-4410-a0d5-995d65c97b02" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_48e5e549-c063-4fca-b430-afe614a7abdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3708cf95-21b8-4c48-8c2c-55c8b344372c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_48e5e549-c063-4fca-b430-afe614a7abdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8d428eb1-cbda-4671-95a0-9ed348be60a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_3708cf95-21b8-4c48-8c2c-55c8b344372c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_8d428eb1-cbda-4671-95a0-9ed348be60a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_50c9b601-4ba5-43ce-82f2-c67d011e24f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_AssetsCurrent_50c9b601-4ba5-43ce-82f2-c67d011e24f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ed629a22-91cd-44da-8ee4-b30d5ca33850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ed629a22-91cd-44da-8ee4-b30d5ca33850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e4a507d3-c060-4758-9a00-7daefe65220c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_Goodwill_e4a507d3-c060-4758-9a00-7daefe65220c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f6326f05-ddae-4195-8900-f0d38501661a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f6326f05-ddae-4195-8900-f0d38501661a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e1c2d70c-fbf6-47b2-8e14-08873c580011" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e1c2d70c-fbf6-47b2-8e14-08873c580011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bed8da8b-dc15-4bf4-b8df-390dfcb0f523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_36ea1671-76d0-46fc-9291-1c631af12529" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bed8da8b-dc15-4bf4-b8df-390dfcb0f523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_96c6952e-1944-4aa0-b5ac-2277a530e065" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_DebtCurrent_96c6952e-1944-4aa0-b5ac-2277a530e065" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_4ac706d8-7c01-4ede-8308-0593c3aff5df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_4ac706d8-7c01-4ede-8308-0593c3aff5df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_84ed5021-4197-4374-a7cf-61dbb4ead7e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_84ed5021-4197-4374-a7cf-61dbb4ead7e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_8a06754b-8c3f-4128-9523-f5bcb5b3c3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_8a06754b-8c3f-4128-9523-f5bcb5b3c3d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_7863a080-47ae-4199-9d86-718673f2fd56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_DividendsPayableCurrent_7863a080-47ae-4199-9d86-718673f2fd56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_f3f53969-11c1-423c-a0ba-3998efe22a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_f3f53969-11c1-423c-a0ba-3998efe22a2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_07694c67-ea5e-4aa0-88b3-0a28a26aeea6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_6df2ec28-e436-45b2-b601-aec3d20f17dc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_07694c67-ea5e-4aa0-88b3-0a28a26aeea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a5a9cc7f-31dc-40d0-aa9e-07d9a7a986f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_6b5905e5-aaa8-4961-929a-5c7ef501c5b5" xlink:href="syk-20211231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a5a9cc7f-31dc-40d0-aa9e-07d9a7a986f5" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_6b5905e5-aaa8-4961-929a-5c7ef501c5b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_4c48f798-aa66-4458-809a-fea9fd05cd0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_a5a9cc7f-31dc-40d0-aa9e-07d9a7a986f5" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_4c48f798-aa66-4458-809a-fea9fd05cd0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ae7532-077e-4a21-9d58-998f857c5d31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_487c50ed-4994-4ebd-8a00-6745b1c5b2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ae7532-077e-4a21-9d58-998f857c5d31" xlink:to="loc_us-gaap_CommonStockValueOutstanding_487c50ed-4994-4ebd-8a00-6745b1c5b2bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd81a046-1c6b-4be3-b7ed-a0b8d12b38b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ae7532-077e-4a21-9d58-998f857c5d31" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_fd81a046-1c6b-4be3-b7ed-a0b8d12b38b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6851614f-667c-4298-994e-c94b92bb6ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ae7532-077e-4a21-9d58-998f857c5d31" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6851614f-667c-4298-994e-c94b92bb6ba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb176482-5fb1-44f9-aeec-e218a171a7dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_20ae7532-077e-4a21-9d58-998f857c5d31" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_fb176482-5fb1-44f9-aeec-e218a171a7dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_26c30369-efd2-4061-bd01-38832b4fb535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_34b8240a-ae4d-47a5-91ff-96a67a049ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_26c30369-efd2-4061-bd01-38832b4fb535" xlink:to="loc_us-gaap_LiabilitiesCurrent_34b8240a-ae4d-47a5-91ff-96a67a049ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_f9ac852c-6787-419c-980b-469cb8f9abb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_26c30369-efd2-4061-bd01-38832b4fb535" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_f9ac852c-6787-419c-980b-469cb8f9abb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cc6d9797-e790-4135-8b89-d73ed82e0d23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_26c30369-efd2-4061-bd01-38832b4fb535" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_cc6d9797-e790-4135-8b89-d73ed82e0d23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a6850564-8113-4dd5-ae2a-512397cf1268" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_26c30369-efd2-4061-bd01-38832b4fb535" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a6850564-8113-4dd5-ae2a-512397cf1268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d53f89f4-f1df-4d2d-93ca-4ecf9307cfe4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_78356408-e0d6-475b-b049-0a38e6e24bd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d53f89f4-f1df-4d2d-93ca-4ecf9307cfe4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_78356408-e0d6-475b-b049-0a38e6e24bd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_50091ef0-9326-4def-9cde-44af7fc8366d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d53f89f4-f1df-4d2d-93ca-4ecf9307cfe4" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_50091ef0-9326-4def-9cde-44af7fc8366d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c12ae85d-5910-4712-928d-6634a5135819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_c12ae85d-5910-4712-928d-6634a5135819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_6185439d-d597-4c77-9e71-66c0120ce260" xlink:href="syk-20211231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_6185439d-d597-4c77-9e71-66c0120ce260" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5cb39f53-c19d-4f06-a867-fa5288e49c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_5cb39f53-c19d-4f06-a867-fa5288e49c95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82daed31-c283-4e24-b991-ae40d42ed61c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_82daed31-c283-4e24-b991-ae40d42ed61c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_79beb349-e407-4187-acd6-ad66372e1b38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_79beb349-e407-4187-acd6-ad66372e1b38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_93263738-e75d-4536-882e-809a5a0f4f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_AdjustmentForAmortization_93263738-e75d-4536-882e-809a5a0f4f91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3a6595db-2303-4b94-ba38-33f5ab943523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_3a6595db-2303-4b94-ba38-33f5ab943523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b6fcb32a-fad5-49b8-8e22-22c8b1a7630a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_NetIncomeLoss_b6fcb32a-fad5-49b8-8e22-22c8b1a7630a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_5f6dabe8-d2ab-49d3-b61e-c21a6671059c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_5f6dabe8-d2ab-49d3-b61e-c21a6671059c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_4a0d3a9d-2fb6-40f5-b382-e224a0a3de58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_Depreciation_4a0d3a9d-2fb6-40f5-b382-e224a0a3de58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ef65a0eb-abe0-4b03-8a9c-a761502354a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_ShareBasedCompensation_ef65a0eb-abe0-4b03-8a9c-a761502354a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1e39e36a-6fb0-4ceb-8ef9-1c209222c41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_1e39e36a-6fb0-4ceb-8ef9-1c209222c41e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_4b0bc082-6256-406c-ba3d-8ae287a10867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_AssetImpairmentCharges_4b0bc082-6256-406c-ba3d-8ae287a10867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_110bc99f-47c0-4512-904b-b7e49428f696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_110bc99f-47c0-4512-904b-b7e49428f696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_fc3c9593-731c-4b2c-8f8d-7855e64d2971" xlink:href="syk-20211231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a2540443-e764-469d-a1db-c5911422f9fd" xlink:to="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_fc3c9593-731c-4b2c-8f8d-7855e64d2971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ca4b0ad7-0346-44e7-8c14-760a4c7bbf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ca4b0ad7-0346-44e7-8c14-760a4c7bbf2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e7bf2db1-64d9-422e-b1eb-08c2df26bb5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_e7bf2db1-64d9-422e-b1eb-08c2df26bb5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_38aacc95-2d5b-4ebb-afde-249f4959629d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_38aacc95-2d5b-4ebb-afde-249f4959629d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5f7f12c7-2e1f-4d51-a241-c0448ab9f694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5f7f12c7-2e1f-4d51-a241-c0448ab9f694" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f1af0d93-1474-439a-bb04-2ebed185af03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_caadd69d-9269-4bbc-9764-c5f8d962a1fe" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f1af0d93-1474-439a-bb04-2ebed185af03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_fdaa1848-9bd0-4023-9918-299046574461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_fdaa1848-9bd0-4023-9918-299046574461" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_897fbff3-e53a-4f09-9ace-00a99550cd45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_897fbff3-e53a-4f09-9ace-00a99550cd45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_7fad0520-8d5e-4fc2-8ab9-fc68b89ad728" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_PaymentsOfDividends_7fad0520-8d5e-4fc2-8ab9-fc68b89ad728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e66ac560-878b-4fca-b2e4-407f9cdb0771" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e66ac560-878b-4fca-b2e4-407f9cdb0771" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_67c2c4e0-8706-4e36-a199-682c1fde590e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_67c2c4e0-8706-4e36-a199-682c1fde590e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_d930bd61-4e39-4b78-be4e-92e2f82c72db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_d930bd61-4e39-4b78-be4e-92e2f82c72db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_98306ce9-5b1d-424f-aade-611a00e3b5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_562cc932-95e7-4807-ab1e-a2cd28b1dc5f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_98306ce9-5b1d-424f-aade-611a00e3b5fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a61d1d3-fb77-40e4-a9a3-2ce3462bb9c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40b70562-61ee-4ae9-a6c7-2acfe0674050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a61d1d3-fb77-40e4-a9a3-2ce3462bb9c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_40b70562-61ee-4ae9-a6c7-2acfe0674050" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bba58c3-5617-457d-9ee2-4e89f8ec2bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a61d1d3-fb77-40e4-a9a3-2ce3462bb9c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bba58c3-5617-457d-9ee2-4e89f8ec2bc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d063598d-9d81-43bb-a37a-07dabe6af337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a61d1d3-fb77-40e4-a9a3-2ce3462bb9c1" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d063598d-9d81-43bb-a37a-07dabe6af337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d777af2-13ad-4898-9aed-77069891908d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1a61d1d3-fb77-40e4-a9a3-2ce3462bb9c1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d777af2-13ad-4898-9aed-77069891908d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0339dba4-a498-4c93-8c4f-d517b4f044de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_859af685-a08c-4516-9859-901a1b64e14e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0339dba4-a498-4c93-8c4f-d517b4f044de" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_859af685-a08c-4516-9859-901a1b64e14e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_bd3c239b-bf82-4d3e-b3f9-e005c9118500" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet_0339dba4-a498-4c93-8c4f-d517b4f044de" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_bd3c239b-bf82-4d3e-b3f9-e005c9118500" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dbec3244-2aed-42f0-a391-86f9bc0c3c25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_dbec3244-2aed-42f0-a391-86f9bc0c3c25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_239be843-410f-4008-9213-78a0d657bc0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_239be843-410f-4008-9213-78a0d657bc0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5ef60b99-fc9e-4543-890f-12719461a7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5ef60b99-fc9e-4543-890f-12719461a7dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bf1a23e2-da3b-4fed-8435-fa174d91c7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_Goodwill_bf1a23e2-da3b-4fed-8435-fa174d91c7ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_942fc1e1-99f7-4da7-951c-b2ce00e191f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_942fc1e1-99f7-4da7-951c-b2ce00e191f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6a5623dd-cc26-4483-9002-e144a18e9288" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_6a5623dd-cc26-4483-9002-e144a18e9288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_940ea831-8acd-4b01-b90d-45cfbe1c1045" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_940ea831-8acd-4b01-b90d-45cfbe1c1045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_284ffabf-86b1-4d33-b151-85919d3ae393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_284ffabf-86b1-4d33-b151-85919d3ae393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_d1877098-0be9-4f6d-a50a-d49b1d197d7c" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_d1877098-0be9-4f6d-a50a-d49b1d197d7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d49fdcad-9a29-47f3-9e06-76ca921fb9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_63e199f6-893f-4640-bc9c-1a440960ce42" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d49fdcad-9a29-47f3-9e06-76ca921fb9ae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ec5b6adc-42c6-4142-8de8-bb556c819a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1eaad410-36bb-4920-81b6-b28614e3e91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ec5b6adc-42c6-4142-8de8-bb556c819a18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_1eaad410-36bb-4920-81b6-b28614e3e91d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48b48f50-7022-41dc-9c3c-98d637127955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ec5b6adc-42c6-4142-8de8-bb556c819a18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_48b48f50-7022-41dc-9c3c-98d637127955" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c4dd8f26-b19d-48a1-a5ab-e7fe55a46701" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3c2fdf1e-9432-4f51-b3e6-ed4360dbe0d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c4dd8f26-b19d-48a1-a5ab-e7fe55a46701" xlink:to="loc_us-gaap_DebtCurrent_3c2fdf1e-9432-4f51-b3e6-ed4360dbe0d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3ac042e4-95e9-4cf7-bbca-f1a3f9c4c2a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_c4dd8f26-b19d-48a1-a5ab-e7fe55a46701" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3ac042e4-95e9-4cf7-bbca-f1a3f9c4c2a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_1b938399-910d-4f15-bfc1-e51466fa69da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_75993460-2791-45c5-94da-3fe188c708c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_1b938399-910d-4f15-bfc1-e51466fa69da" xlink:to="loc_us-gaap_UnsecuredDebt_75993460-2791-45c5-94da-3fe188c708c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_a100c22a-d6c9-437f-afa4-c81298ca3d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_1b938399-910d-4f15-bfc1-e51466fa69da" xlink:to="loc_us-gaap_OtherLongTermDebt_a100c22a-d6c9-437f-afa4-c81298ca3d38" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f199df72-fffd-4e52-bd2d-862eeb41797f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_1b938399-910d-4f15-bfc1-e51466fa69da" xlink:to="loc_us-gaap_LongTermDebt_f199df72-fffd-4e52-bd2d-862eeb41797f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d3949880-fef0-490b-a373-7b64156a9253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d3949880-fef0-490b-a373-7b64156a9253" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9705df61-fede-42b8-89d4-36108277f37b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_9705df61-fede-42b8-89d4-36108277f37b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_32176768-cb0b-4f81-b3cd-850282cdc15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_32176768-cb0b-4f81-b3cd-850282cdc15b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_d87c25c3-0575-46d3-89ae-56dbe5185610" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_d87c25c3-0575-46d3-89ae-56dbe5185610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_473bac0a-1af6-4d37-a896-69d28c0eb79a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_473bac0a-1af6-4d37-a896-69d28c0eb79a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_27585b29-5872-4319-9902-83feddcc55a7" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c9120c64-784a-4ca0-ae69-e4e6bcf93af2" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_27585b29-5872-4319-9902-83feddcc55a7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c57917e9-3a4e-41f1-8156-e473708de209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6225b0eb-55a2-43fe-9c49-56e20902b99a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c57917e9-3a4e-41f1-8156-e473708de209" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_6225b0eb-55a2-43fe-9c49-56e20902b99a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_51545dfd-875b-4aab-b6a5-5888f5562ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c57917e9-3a4e-41f1-8156-e473708de209" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_51545dfd-875b-4aab-b6a5-5888f5562ddd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e3840ab-c16d-46eb-b238-897f75be3210" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_55c167b3-07f6-4088-b675-6b1bb326e9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e3840ab-c16d-46eb-b238-897f75be3210" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_55c167b3-07f6-4088-b675-6b1bb326e9f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_812eca80-51ea-4b3d-8160-e822b592be32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e3840ab-c16d-46eb-b238-897f75be3210" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_812eca80-51ea-4b3d-8160-e822b592be32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_72c874e7-652d-4150-94cd-0c6eae77dd80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1e3840ab-c16d-46eb-b238-897f75be3210" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_72c874e7-652d-4150-94cd-0c6eae77dd80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9d92ab92-810e-4aa6-ba8e-d168115edb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_02a199b6-5175-4fcb-83e0-9c696a6aae2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9d92ab92-810e-4aa6-ba8e-d168115edb3a" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_02a199b6-5175-4fcb-83e0-9c696a6aae2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d240ebd8-d478-4fbf-bf99-76cdbd477311" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9d92ab92-810e-4aa6-ba8e-d168115edb3a" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d240ebd8-d478-4fbf-bf99-76cdbd477311" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_22e2013f-dfd2-48c8-8554-e45fe81dae79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_9d92ab92-810e-4aa6-ba8e-d168115edb3a" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_22e2013f-dfd2-48c8-8554-e45fe81dae79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8603bbb4-d3f4-479d-b168-ca8e44fdfd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c52ed635-dc6e-4c30-a1eb-56ef2d7c0f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8603bbb4-d3f4-479d-b168-ca8e44fdfd0b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_c52ed635-dc6e-4c30-a1eb-56ef2d7c0f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_655b7998-4c75-4bfa-adb9-d42d324c65e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_8603bbb4-d3f4-479d-b168-ca8e44fdfd0b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_655b7998-4c75-4bfa-adb9-d42d324c65e8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87cdfc71-eae0-4c23-8ab0-b0c94f8f073a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_007d3367-01bc-4dbb-a834-86ff8bedc35f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87cdfc71-eae0-4c23-8ab0-b0c94f8f073a" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_007d3367-01bc-4dbb-a834-86ff8bedc35f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_63de428a-bc06-4a0c-9dd1-65d513b85ace" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_87cdfc71-eae0-4c23-8ab0-b0c94f8f073a" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_63de428a-bc06-4a0c-9dd1-65d513b85ace" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_493f3062-3660-4a79-aca6-c8a3ca36ddbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_493f3062-3660-4a79-aca6-c8a3ca36ddbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_d520d56e-f989-4040-959a-22d43c1949d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_d520d56e-f989-4040-959a-22d43c1949d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_936f4c5e-3c34-4d3f-acb3-c17eb8b6f631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_936f4c5e-3c34-4d3f-acb3-c17eb8b6f631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_adccd114-1aba-4bad-95ae-7df12117d58c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_adccd114-1aba-4bad-95ae-7df12117d58c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f814874a-20f1-41dd-b54b-bbfc43075a28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f814874a-20f1-41dd-b54b-bbfc43075a28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_87efb395-dbcd-4f58-b65e-139451f6b055" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_87efb395-dbcd-4f58-b65e-139451f6b055" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b5bc7f3c-2026-4e6d-8f1e-0355fe542b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b5bc7f3c-2026-4e6d-8f1e-0355fe542b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_869cb96c-2f72-41d7-94a9-66e9931cc6a6" xlink:href="syk-20211231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_70e7ecfb-6ff0-4ff2-b5e7-3ffa73a62955" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_869cb96c-2f72-41d7-94a9-66e9931cc6a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_edce369e-55b4-4af1-8bd2-e70aacf9945f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0cdc8a98-7daf-4549-86a3-9dc40350affd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_edce369e-55b4-4af1-8bd2-e70aacf9945f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0cdc8a98-7daf-4549-86a3-9dc40350affd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_516aacd5-800b-4ffc-b954-5562a115e1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_edce369e-55b4-4af1-8bd2-e70aacf9945f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_516aacd5-800b-4ffc-b954-5562a115e1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_dc43cb83-abee-4a45-a9a6-fddb14d7aa93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_abe80160-9007-4a9e-ad70-f17b8b6c840d" xlink:href="syk-20211231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_dc43cb83-abee-4a45-a9a6-fddb14d7aa93" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_abe80160-9007-4a9e-ad70-f17b8b6c840d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_ef70e4f4-a6ac-4e3e-a5fa-c4233abe6a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_dc43cb83-abee-4a45-a9a6-fddb14d7aa93" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_ef70e4f4-a6ac-4e3e-a5fa-c4233abe6a7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f99c3b8-fe97-4114-9928-1d8a709ffc7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e768e8d3-fe73-4d96-9b2c-f065dbaf6764" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f99c3b8-fe97-4114-9928-1d8a709ffc7e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e768e8d3-fe73-4d96-9b2c-f065dbaf6764" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_061eef31-934b-42e4-9a2a-10d1b6f8b33f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_5f99c3b8-fe97-4114-9928-1d8a709ffc7e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_061eef31-934b-42e4-9a2a-10d1b6f8b33f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bb866fa2-a38d-4604-be0a-e4ea73814592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_031648c6-c138-4418-a4e0-7a4dd7e6d513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bb866fa2-a38d-4604-be0a-e4ea73814592" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_031648c6-c138-4418-a4e0-7a4dd7e6d513" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c4f56068-1ddb-46cd-9198-46b160f21556" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_bb866fa2-a38d-4604-be0a-e4ea73814592" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_c4f56068-1ddb-46cd-9198-46b160f21556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8080a2b7-e760-4efc-94b4-4d1efc33fe81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3597a92e-8abf-4769-b3ea-29def2b90e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8080a2b7-e760-4efc-94b4-4d1efc33fe81" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_3597a92e-8abf-4769-b3ea-29def2b90e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5d35e87b-4207-45d1-bfb1-2345de0c9cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_8080a2b7-e760-4efc-94b4-4d1efc33fe81" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_5d35e87b-4207-45d1-bfb1-2345de0c9cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9217dcf6-4918-4895-976e-a0eb053d86a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_a6626c5a-0fce-4a40-a49c-1c524015fd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9217dcf6-4918-4895-976e-a0eb053d86a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_a6626c5a-0fce-4a40-a49c-1c524015fd8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_b18a0199-bbbc-4da4-9d5c-34301145a207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9217dcf6-4918-4895-976e-a0eb053d86a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_b18a0199-bbbc-4da4-9d5c-34301145a207" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_243adf0d-2ded-4d61-b404-f82b5d35f043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9217dcf6-4918-4895-976e-a0eb053d86a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_243adf0d-2ded-4d61-b404-f82b5d35f043" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_29585f5e-ad65-43c9-aedd-e287ace97f94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_9217dcf6-4918-4895-976e-a0eb053d86a9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_29585f5e-ad65-43c9-aedd-e287ace97f94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_ef990d43-b5f2-4365-9fd4-b23d879e89a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_ef990d43-b5f2-4365-9fd4-b23d879e89a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c42ea8f4-9893-4e8e-8e8c-fee6330561fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c42ea8f4-9893-4e8e-8e8c-fee6330561fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fbb73ed5-2068-4b59-82f8-04e6b3d7efa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_fbb73ed5-2068-4b59-82f8-04e6b3d7efa5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b42526d2-2212-4ab6-8230-1ddae7613e92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_b42526d2-2212-4ab6-8230-1ddae7613e92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0be1118b-b5d1-460b-a5a7-78e5f373cb17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0be1118b-b5d1-460b-a5a7-78e5f373cb17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6c6cd59-7e34-410e-b770-e52fa71c4afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_32d9eae3-79b3-412d-bcec-dbad637c9f30" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_f6c6cd59-7e34-410e-b770-e52fa71c4afc" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>syk-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20211231.xsd#COVERPAGE"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended" id="i4d5d1aa9ef5c43159ae4654f066705f4_COVERPAGE">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cc70eb77-4eee-4f52-ac96-69fdcb6daec6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentType_cc70eb77-4eee-4f52-ac96-69fdcb6daec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e3e4efda-2fdb-4e57-84a0-3b322509e217" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentAnnualReport_e3e4efda-2fdb-4e57-84a0-3b322509e217" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8144d5dd-4787-4196-938b-3cbe336012b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentPeriodEndDate_8144d5dd-4787-4196-938b-3cbe336012b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ab59b9e7-64f8-4c48-9030-27949baa2baf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_CurrentFiscalYearEndDate_ab59b9e7-64f8-4c48-9030-27949baa2baf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_830c2699-7e61-4f12-877b-c54204d808a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentTransitionReport_830c2699-7e61-4f12-877b-c54204d808a7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_968772b1-a7b9-4a2c-bce5-59554b86e672" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityFileNumber_968772b1-a7b9-4a2c-bce5-59554b86e672" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1e100121-ebf8-4589-940e-68dbee905bda" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityRegistrantName_1e100121-ebf8-4589-940e-68dbee905bda" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8f2a031b-ceaa-48f3-97f6-5462f238d59d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8f2a031b-ceaa-48f3-97f6-5462f238d59d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3573a780-a061-4e37-9888-bc712055288c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityTaxIdentificationNumber_3573a780-a061-4e37-9888-bc712055288c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2d1a32a3-cbdf-4a52-ac67-dec11affab96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressAddressLine1_2d1a32a3-cbdf-4a52-ac67-dec11affab96" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c031efb7-a9ea-4168-8ba8-a860efe0a1f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressCityOrTown_c031efb7-a9ea-4168-8ba8-a860efe0a1f7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b5d41a0e-e70f-4b42-abc9-e364b49713d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressStateOrProvince_b5d41a0e-e70f-4b42-abc9-e364b49713d4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_877aba98-c73d-4ce9-8636-a431574533ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressPostalZipCode_877aba98-c73d-4ce9-8636-a431574533ac" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f9ef7c8e-2798-48ac-a6e4-922a277496fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_CityAreaCode_f9ef7c8e-2798-48ac-a6e4-922a277496fd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2b7fedb5-41be-49df-ab85-cfef4c12fba0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_LocalPhoneNumber_2b7fedb5-41be-49df-ab85-cfef4c12fba0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a4eb1bd9-b824-4e71-9e8a-8cf506874b48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_Security12bTitle_a4eb1bd9-b824-4e71-9e8a-8cf506874b48" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8a6dbda0-b1af-4ab3-96de-9cfed494c032" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_TradingSymbol_8a6dbda0-b1af-4ab3-96de-9cfed494c032" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_54f5217c-4424-48b8-a94e-7f91167c2ecf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_SecurityExchangeName_54f5217c-4424-48b8-a94e-7f91167c2ecf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_109486b8-ef5a-4eec-be18-121557c731d6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_Security12gTitle_109486b8-ef5a-4eec-be18-121557c731d6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_37ed6386-6a58-42b3-9047-dcc468c94b0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_37ed6386-6a58-42b3-9047-dcc468c94b0b" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_985f9891-1c8e-4b48-b694-1690940f1e1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityVoluntaryFilers_985f9891-1c8e-4b48-b694-1690940f1e1f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_39304c39-f459-4936-9b8a-7aa6f00ff11d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCurrentReportingStatus_39304c39-f459-4936-9b8a-7aa6f00ff11d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d9739fa6-9d2b-4363-82ff-f263e2983f77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityInteractiveDataCurrent_d9739fa6-9d2b-4363-82ff-f263e2983f77" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_23fd2636-91aa-4ae7-adf3-0ebe3f99a106" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityFilerCategory_23fd2636-91aa-4ae7-adf3-0ebe3f99a106" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1877ee05-c95a-4d45-ac29-3bd88d35d867" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityEmergingGrowthCompany_1877ee05-c95a-4d45-ac29-3bd88d35d867" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2c236e1b-dafe-49d1-9501-a2ef68387d12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntitySmallBusiness_2c236e1b-dafe-49d1-9501-a2ef68387d12" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_db200e36-1e35-4790-8ccd-bcb68cd42a3c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_db200e36-1e35-4790-8ccd-bcb68cd42a3c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9c1a991a-9bef-4e7f-91d3-f3f63c04e142" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityShellCompany_9c1a991a-9bef-4e7f-91d3-f3f63c04e142" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_889d05d9-33a3-40f8-ad6e-6e4f9003d265" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityPublicFloat_889d05d9-33a3-40f8-ad6e-6e4f9003d265" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bcc6a037-ce1e-41bd-8c93-ddf2b44812a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bcc6a037-ce1e-41bd-8c93-ddf2b44812a7" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4d1de819-2aea-487d-becd-73374e61d888" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4d1de819-2aea-487d-becd-73374e61d888" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bc190ec7-c294-495f-b0aa-22da7e55a994" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_AmendmentFlag_bc190ec7-c294-495f-b0aa-22da7e55a994" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_948cd82c-fa1e-41b0-ad2e-9b3bd40cb929" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentFiscalYearFocus_948cd82c-fa1e-41b0-ad2e-9b3bd40cb929" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7c4d07b7-613a-46d0-8127-5aa678667760" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7c4d07b7-613a-46d0-8127-5aa678667760" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1b103284-9619-431a-98a9-ebec1b16f7ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCentralIndexKey_1b103284-9619-431a-98a9-ebec1b16f7ea" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_49db516a-9afa-4d4f-aa89-59121beead1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:to="loc_us-gaap_ClassOfStockDomain_49db516a-9afa-4d4f-aa89-59121beead1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:to="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e5024913-ea7c-4fa2-8a01-7e0e909d4a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_us-gaap_CommonStockMember_e5024913-ea7c-4fa2-8a01-7e0e909d4a53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_488b8694-2172-4cc1-923b-98baeffd7413" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_488b8694-2172-4cc1-923b-98baeffd7413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_f166a011-8344-456d-b1dd-247f6109711e" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_f166a011-8344-456d-b1dd-247f6109711e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_f7a5bb8a-5848-4109-9e74-0be92235344f" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_f7a5bb8a-5848-4109-9e74-0be92235344f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_42c88076-3918-4067-9a27-2eb893c99aaf" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_42c88076-3918-4067-9a27-2eb893c99aaf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_01de6523-4c62-4b7f-9087-e300e0b2dcc7" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_01de6523-4c62-4b7f-9087-e300e0b2dcc7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_088092bb-4a1a-40b4-bd27-4c6b7eb9eb95" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_088092bb-4a1a-40b4-bd27-4c6b7eb9eb95" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended" id="id09148821f5248cf8483a67d0dc1de77_ConsolidatedStatementsOfShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67a9f211-3bce-4e5a-b5bb-c76a41e032d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67a9f211-3bce-4e5a-b5bb-c76a41e032d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3eda12cf-36b0-40f1-b457-554aa62cc595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3eda12cf-36b0-40f1-b457-554aa62cc595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4b22c1bc-8eb0-4fdf-b7a9-ce541e1447c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4b22c1bc-8eb0-4fdf-b7a9-ce541e1447c3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0bd18aa1-28c1-4ae0-95cc-2b90f659ea6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0bd18aa1-28c1-4ae0-95cc-2b90f659ea6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2886782c-9acc-4790-ab8d-7c037e36c21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2886782c-9acc-4790-ab8d-7c037e36c21d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4efcab49-ebcf-4a6a-b47d-3879355fa9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4efcab49-ebcf-4a6a-b47d-3879355fa9eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4650c7c2-5485-4732-954f-53ca26cf3782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4650c7c2-5485-4732-954f-53ca26cf3782" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_adeb94ea-c25c-4ea8-b33c-bd81b9ce8ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_NetIncomeLoss_adeb94ea-c25c-4ea8-b33c-bd81b9ce8ec1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_a733426a-1bc4-484a-badd-2be3907b9b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_DividendsCash_a733426a-1bc4-484a-badd-2be3907b9b86" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d23dabe-b3f0-4e79-992b-34480074b3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d23dabe-b3f0-4e79-992b-34480074b3df" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_efc17d97-f572-412b-80b7-5b508555d2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_165274c6-d438-4a6c-a90b-84f93b188bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:to="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6b0c3198-49e4-46c2-81da-84e94492687b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:to="loc_us-gaap_EquityComponentDomain_6b0c3198-49e4-46c2-81da-84e94492687b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:to="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1381541e-15ea-4f69-a90d-5802c69f882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_CommonStockMember_1381541e-15ea-4f69-a90d-5802c69f882b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_67b60266-e33c-4a7b-abac-c4150ee90e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_67b60266-e33c-4a7b-abac-c4150ee90e8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3d9e96ed-188f-4dee-abaf-24add34d5cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_RetainedEarningsMember_3d9e96ed-188f-4dee-abaf-24add34d5cd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c738f1-5baf-49eb-ab4d-27190fed8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c738f1-5baf-49eb-ab4d-27190fed8a52" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i04b93d32ca394dcaad826ceef7c408f7_SignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8e8580d6-5c82-4bf0-9118-da6fd524ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8e8580d6-5c82-4bf0-9118-da6fd524ef8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c277ec92-06c7-47b8-a1a1-efde72dae2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c277ec92-06c7-47b8-a1a1-efde72dae2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a78523fc-1a02-493b-8266-6f6146807e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a78523fc-1a02-493b-8266-6f6146807e3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_cf18b140-f49c-4838-b436-720dedb710bb" xlink:href="syk-20211231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_cf18b140-f49c-4838-b436-720dedb710bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46fb79f0-1952-4526-b765-9fc784d7fba5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_46fb79f0-1952-4526-b765-9fc784d7fba5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_be7f883c-8f12-48fd-a07e-03e92aafb59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_be7f883c-8f12-48fd-a07e-03e92aafb59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a6e1ea77-40a8-4309-a89b-2e872783db2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a6e1ea77-40a8-4309-a89b-2e872783db2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fa0887e0-c0de-45ba-9007-274712d60f3e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:to="loc_srt_RangeMember_fa0887e0-c0de-45ba-9007-274712d60f3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:to="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9351778-2df0-4283-8249-6b8e18af8bbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:to="loc_srt_MinimumMember_c9351778-2df0-4283-8249-6b8e18af8bbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ec30723-e93e-48e4-9a35-cfa37a930a7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:to="loc_srt_MaximumMember_2ec30723-e93e-48e4-9a35-cfa37a930a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e17e8757-91e2-48be-98c3-1efd6579f5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e17e8757-91e2-48be-98c3-1efd6579f5ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7b760725-7e99-4a44-be88-cef8ff81c382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7b760725-7e99-4a44-be88-cef8ff81c382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_bb0aa0e5-86d0-4935-9bc5-8370668ddda7" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_syk_PerformanceStockUnitPsusMember_bb0aa0e5-86d0-4935-9bc5-8370668ddda7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended" id="i8477a0ce6add4dddb532d8e75f091a83_RevenueRecognitionDisaggregatedSalesAnalysisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a5753f63-00d9-483b-a1af-18ced02d5ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:to="loc_us-gaap_Revenues_a5753f63-00d9-483b-a1af-18ced02d5ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8b7f670-07a3-4f50-a60c-159e073f8393_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:to="loc_us-gaap_SegmentDomain_b8b7f670-07a3-4f50-a60c-159e073f8393_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:to="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_bf30e640-44c5-47f1-a1a8-ef115adedbff" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_bf30e640-44c5-47f1-a1a8-ef115adedbff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_84545138-f3fc-4cdb-9262-e71da0aabbc3" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:to="loc_syk_OrthopaedicsAndSpineMember_84545138-f3fc-4cdb-9262-e71da0aabbc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6b28704b-2f49-4eb6-9021-35f11d23499c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:to="loc_srt_ProductsAndServicesDomain_6b28704b-2f49-4eb6-9021-35f11d23499c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:to="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_a7bb5fc6-6d3f-4488-9844-f2f18357ba54" xlink:href="syk-20211231.xsd#syk_InstrumentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_InstrumentsMember_a7bb5fc6-6d3f-4488-9844-f2f18357ba54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_f9c33e68-30d4-4519-9b2c-6d4e33aebd9c" xlink:href="syk-20211231.xsd#syk_EndoscopyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_EndoscopyMember_f9c33e68-30d4-4519-9b2c-6d4e33aebd9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_4fd234d1-e09b-4507-bc56-38804b3cf433" xlink:href="syk-20211231.xsd#syk_MedicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_MedicalMember_4fd234d1-e09b-4507-bc56-38804b3cf433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_621a7dbb-c043-4bb6-a9d2-5f4c89abab36" xlink:href="syk-20211231.xsd#syk_NeurovascularMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_NeurovascularMember_621a7dbb-c043-4bb6-a9d2-5f4c89abab36" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_4dd44e39-ccb0-4a26-ab0e-7a0001c083bf" xlink:href="syk-20211231.xsd#syk_NeuroCranialMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_NeuroCranialMember_4dd44e39-ccb0-4a26-ab0e-7a0001c083bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_d43fd259-2b3b-4978-b377-94f908ed85d5" xlink:href="syk-20211231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_OtherOrthopaedicsMember_d43fd259-2b3b-4978-b377-94f908ed85d5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_6836f752-071d-49ac-9b70-1304ec985e96" xlink:href="syk-20211231.xsd#syk_KneesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_KneesMember_6836f752-071d-49ac-9b70-1304ec985e96" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_f9005f85-c6c6-4611-b460-5bad81786a84" xlink:href="syk-20211231.xsd#syk_HipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_HipsMember_f9005f85-c6c6-4611-b460-5bad81786a84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_a0d1f1de-4cb9-4793-add5-9b7bf8e594ce" xlink:href="syk-20211231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_TraumaandExtremitiesMember_a0d1f1de-4cb9-4793-add5-9b7bf8e594ce" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_4dad00ee-1bb9-480e-b5ca-3549ba4a79be" xlink:href="syk-20211231.xsd#syk_SpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_SpineMember_4dad00ee-1bb9-480e-b5ca-3549ba4a79be" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f758f896-de07-46e2-b317-82966a6fa502_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:to="loc_srt_SegmentGeographicalDomain_f758f896-de07-46e2-b317-82966a6fa502_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:to="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed9cb12d-f1a2-4c95-af27-22ce74731435" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:to="loc_country_US_ed9cb12d-f1a2-4c95-af27-22ce74731435" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_35b695c1-6280-4a36-a076-6b6fa9a1e3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:to="loc_us-gaap_NonUsMember_35b695c1-6280-4a36-a076-6b6fa9a1e3df" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended" id="i17c5d27f53364d39862d3698fdd7e66d_FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:to="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1a010b70-f888-4b2e-a5eb-78b836a4bcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1a010b70-f888-4b2e-a5eb-78b836a4bcb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_402c4db9-80e5-4b00-ad60-b1ffa47fffef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_TradingSecuritiesDebt_402c4db9-80e5-4b00-ad60-b1ffa47fffef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_98420cb2-e70b-4f4b-a80e-de64fc1b6896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_98420cb2-e70b-4f4b-a80e-de64fc1b6896" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_5560045e-a2e8-485a-9dfc-3278b93a6e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_DerivativeAssets_5560045e-a2e8-485a-9dfc-3278b93a6e9d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9ef43867-2caf-42a7-8c2a-3f1bd54a63b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_59aefdd8-fefa-4cc7-8efb-066ff2ad5d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_59aefdd8-fefa-4cc7-8efb-066ff2ad5d14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a2553ce-f229-47f9-866c-7ca0d2e74306" xlink:href="syk-20211231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a2553ce-f229-47f9-866c-7ca0d2e74306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f8d0a3af-769e-4ac4-93b1-1178b4b0fbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f8d0a3af-769e-4ac4-93b1-1178b4b0fbbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26a911d8-68ff-46dc-ae38-1b4636416956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26a911d8-68ff-46dc-ae38-1b4636416956" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c2d16b5f-4a18-4242-9b72-5e45871abc57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c2d16b5f-4a18-4242-9b72-5e45871abc57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_055d0cb7-2ff5-406e-8344-89a00d19fc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_055d0cb7-2ff5-406e-8344-89a00d19fc2e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d238552c-53c3-4b84-89ee-c5df67bfdd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d238552c-53c3-4b84-89ee-c5df67bfdd5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21d34f12-d1d8-413e-a841-9708a0bf7147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_56dee52b-8810-44b4-aad5-4b60d3d5680c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_56dee52b-8810-44b4-aad5-4b60d3d5680c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff503108-6cf4-4adb-a141-bddd9ae7dcf6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff503108-6cf4-4adb-a141-bddd9ae7dcf6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9f0e1490-f858-401b-95a1-2cfc0688a38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9f0e1490-f858-401b-95a1-2cfc0688a38b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_70a8615d-db4f-4869-b086-9bcfdf6183f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_70a8615d-db4f-4869-b086-9bcfdf6183f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bb2319d3-1b46-4590-86d7-9ec876ade914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bb2319d3-1b46-4590-86d7-9ec876ade914" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_77462c90-c417-42c5-834e-c190af83e3a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_77462c90-c417-42c5-834e-c190af83e3a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_06e72fd8-57f7-49ee-a493-4be233ec669c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_06e72fd8-57f7-49ee-a493-4be233ec669c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2d8ec849-79d8-48ab-95ce-bf821dd6d616_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2d8ec849-79d8-48ab-95ce-bf821dd6d616_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_9bd0aaa1-c965-4c1a-b28a-1c61cd7379d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_9bd0aaa1-c965-4c1a-b28a-1c61cd7379d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b5d9b3de-ac90-4c0d-b6a6-55df6b8b0f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b5d9b3de-ac90-4c0d-b6a6-55df6b8b0f89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f283e33a-1a70-4a56-b74a-50596508881e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f283e33a-1a70-4a56-b74a-50596508881e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_c37297c3-565f-4679-9739-a254d62615dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_c37297c3-565f-4679-9739-a254d62615dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_33a06b42-33bd-4833-bbee-6eea7ebbe48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_33a06b42-33bd-4833-bbee-6eea7ebbe48f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ebc3c407-0393-48b7-a7f6-88d787d5648c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ebc3c407-0393-48b7-a7f6-88d787d5648c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4a32b15f-49e4-4c1b-a174-6600150a330f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4a32b15f-49e4-4c1b-a174-6600150a330f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24ef2c80-4fe5-458d-b1f4-c30e22e0e4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:to="loc_us-gaap_InterestRateSwapMember_24ef2c80-4fe5-458d-b1f4-c30e22e0e4eb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i01209781fcfb477a909d695110f1843e_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss_3bfa6921-7785-4db5-a564-52be3a8542d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:to="loc_us-gaap_MarketableSecuritiesGainLoss_3bfa6921-7785-4db5-a564-52be3a8542d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:to="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_90a4e04a-a4ff-4aa6-9827-b146993d9ba7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_90a4e04a-a4ff-4aa6-9827-b146993d9ba7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_97c85030-d715-4d01-9a30-003c9869a73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_97c85030-d715-4d01-9a30-003c9869a73a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended" id="ia2f816a3759f453e9c1a03c824f25798_DerivativeInstrumentsForwardCurrencyExchangeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cb8403ab-0063-440e-958f-68f9ab7cc539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cb8403ab-0063-440e-958f-68f9ab7cc539" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_10abdeb8-e41c-49c1-8ff2-f202d90e5b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_10abdeb8-e41c-49c1-8ff2-f202d90e5b68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c75a0810-abc6-4470-98d7-f7f926b38d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c75a0810-abc6-4470-98d7-f7f926b38d8a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_792c7cd2-7714-42e1-856a-2b8db5d17dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_792c7cd2-7714-42e1-856a-2b8db5d17dca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d9c54ca3-a641-4c4c-aff2-e709988908ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d9c54ca3-a641-4c4c-aff2-e709988908ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_408aa044-1222-476d-9dc0-b39cd831190e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_408aa044-1222-476d-9dc0-b39cd831190e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ffedd5d1-582c-4e54-b906-57629ac95a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:to="loc_us-gaap_CashFlowHedgingMember_ffedd5d1-582c-4e54-b906-57629ac95a6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f422f474-7647-4aaf-9c03-eea1ce59a672_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f422f474-7647-4aaf-9c03-eea1ce59a672_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_09a35718-e3ec-4a32-9be8-5e40f6a16456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:to="loc_us-gaap_ForeignExchangeContractMember_09a35718-e3ec-4a32-9be8-5e40f6a16456" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c311b118-bbae-478b-bd27-24df246e734b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:to="loc_us-gaap_HedgingDesignationDomain_c311b118-bbae-478b-bd27-24df246e734b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:to="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b171e7ea-96d4-4ce9-bbd7-d32802be2341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b171e7ea-96d4-4ce9-bbd7-d32802be2341" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c1c54815-fced-4ef5-aff3-a3c50fae7d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:to="loc_us-gaap_NondesignatedMember_c1c54815-fced-4ef5-aff3-a3c50fae7d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a160b92e-6e1b-415c-80e7-6fb7db962ba9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a160b92e-6e1b-415c-80e7-6fb7db962ba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2985647a-2d9b-4ec0-b3c7-3e9ea7f3817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2985647a-2d9b-4ec0-b3c7-3e9ea7f3817d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_63631012-e8ba-480d-8271-99b5be0263da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_63631012-e8ba-480d-8271-99b5be0263da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_5d23cc28-ff2c-4ddb-ab37-0cc288aafce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_5d23cc28-ff2c-4ddb-ab37-0cc288aafce8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_09bc63bd-17d9-4129-a1ae-2db64c40eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_09bc63bd-17d9-4129-a1ae-2db64c40eb5b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended" id="ic6dad6f00ea849d79cd291cd02e0a46b_DerivativeInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc0727ff-0adf-443b-ba9a-6f2aba934c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc0727ff-0adf-443b-ba9a-6f2aba934c99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DerivativeNotionalAmount1_a11c7e31-8fdf-4eb9-939b-53b1bab7de35" xlink:href="syk-20211231.xsd#syk_DerivativeNotionalAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_syk_DerivativeNotionalAmount1_a11c7e31-8fdf-4eb9-939b-53b1bab7de35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_78207c7d-6ab5-4dc2-82d4-9057e1c4351f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_78207c7d-6ab5-4dc2-82d4-9057e1c4351f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3950d8fa-0b74-4abb-a9a2-f82fe9083cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3950d8fa-0b74-4abb-a9a2-f82fe9083cf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_3b9de826-3ebf-4647-afbc-64b108350154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_3b9de826-3ebf-4647-afbc-64b108350154" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c2113a31-c0a6-40fb-9d85-a91f2fc6f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c2113a31-c0a6-40fb-9d85-a91f2fc6f16c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:to="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2faaddfe-47e3-45df-85f3-7f63b6653a23_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:to="loc_us-gaap_HedgingDesignationDomain_2faaddfe-47e3-45df-85f3-7f63b6653a23_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:to="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_56c8fc0e-d863-42f4-887f-d3d5a277ea1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_56c8fc0e-d863-42f4-887f-d3d5a277ea1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6da3beaf-572b-46da-8635-1b18b65ab4ad_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6da3beaf-572b-46da-8635-1b18b65ab4ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bb761bd9-c4ca-40d2-bde6-2b8ff74a0284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bb761bd9-c4ca-40d2-bde6-2b8ff74a0284" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_50cef1f1-b82e-484d-8d1e-5cf95545fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_InterestRateSwapMember_50cef1f1-b82e-484d-8d1e-5cf95545fd92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9f42e3c9-04ef-4e9f-b6df-d4e9eaff1718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_CashFlowHedgingMember_9f42e3c9-04ef-4e9f-b6df-d4e9eaff1718" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended" id="ia9e93e8b6dfa49188ccfe095b5ecf5b0_DerivativeInstrumentsMovementsoutofOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_33df770e-0b4c-4dda-b496-0e091a4c3b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_33df770e-0b4c-4dda-b496-0e091a4c3b85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_198e9335-ac24-4128-bb41-5b70f0fecad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_198e9335-ac24-4128-bb41-5b70f0fecad1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:to="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d0a50c53-bc00-46bf-8335-6245379b98e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:to="loc_us-gaap_HedgingDesignationDomain_d0a50c53-bc00-46bf-8335-6245379b98e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d207ceca-4382-4096-846c-6ae7d86f04ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d207ceca-4382-4096-846c-6ae7d86f04ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33070987-6e7a-44ae-b3fb-fd2879f42aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:to="loc_us-gaap_NondesignatedMember_33070987-6e7a-44ae-b3fb-fd2879f42aea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f7e88f1a-595d-4b6d-b40a-c35de45799cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f7e88f1a-595d-4b6d-b40a-c35de45799cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_485e6e69-f763-48c7-9ced-1ad6f513192d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:to="loc_us-gaap_ForeignExchangeContractMember_485e6e69-f763-48c7-9ced-1ad6f513192d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_17f3fd27-c58b-437e-815c-db9889f35b74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_17f3fd27-c58b-437e-815c-db9889f35b74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1cd8a1c6-3f17-41ab-8b78-d1a5735d2f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:to="loc_us-gaap_CostOfSalesMember_1cd8a1c6-3f17-41ab-8b78-d1a5735d2f6d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_35e5f469-0b2c-47a0-8be3-5c5092659e65" xlink:href="syk-20211231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:to="loc_syk_OtherIncomeexpenseMember_35e5f469-0b2c-47a0-8be3-5c5092659e65" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended" id="i00eb080343f74965b1d6fbb60a287900_AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ee2bb69c-8abb-435b-96c3-a18854731846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ee2bb69c-8abb-435b-96c3-a18854731846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2b726c54-e0b0-4a8e-bc55-028d229bd0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2b726c54-e0b0-4a8e-bc55-028d229bd0e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_df092a0b-9e15-4a4b-ab2b-ba0ef32f9718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_df092a0b-9e15-4a4b-ab2b-ba0ef32f9718" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_06c39fdd-341b-4703-9526-f33ab1bb02a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_CostOfRevenue_06c39fdd-341b-4703-9526-f33ab1bb02a0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9c7a2444-e15d-456c-bfea-4119fd501b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9c7a2444-e15d-456c-bfea-4119fd501b9d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5d0cb901-b269-400c-ab45-b60e2549885e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5d0cb901-b269-400c-ab45-b60e2549885e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3df44c7a-495b-47f3-9892-a643e2543ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3df44c7a-495b-47f3-9892-a643e2543ece" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7cb4454a-578f-4cc9-a6ca-76a965aaf8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_deca72c2-5aea-4041-853a-4804340f3c6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:to="loc_us-gaap_EquityComponentDomain_deca72c2-5aea-4041-853a-4804340f3c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:to="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ce745bab-3272-4866-9719-a4049271bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ce745bab-3272-4866-9719-a4049271bd96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a5d9f66-cbf2-4cc1-8b8b-0ddf2cf25066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a5d9f66-cbf2-4cc1-8b8b-0ddf2cf25066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7e0bb358-21db-49f6-b038-32ad21bbc443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7e0bb358-21db-49f6-b038-32ad21bbc443" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78dd7713-f25e-4d80-9b08-74ae4383d00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78dd7713-f25e-4d80-9b08-74ae4383d00e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c54257c7-5962-4557-a76e-77e2f17392a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_c54257c7-5962-4557-a76e-77e2f17392a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ce5da169-7d74-48e0-bde2-8c2870aea5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ce5da169-7d74-48e0-bde2-8c2870aea5c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6f084cbc-99f7-4d06-b55a-010f41704ae7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6f084cbc-99f7-4d06-b55a-010f41704ae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_114f426b-524a-46b9-845c-32bfb0107c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:to="loc_us-gaap_CostOfSalesMember_114f426b-524a-46b9-845c-32bfb0107c90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_54ce0c28-448c-460e-b45e-251b68938e25" xlink:href="syk-20211231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:to="loc_syk_OtherIncomeexpenseMember_54ce0c28-448c-460e-b45e-251b68938e25" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended" id="id394dc1d8d8f465ea1ea10ea9618b97d_AcquisitionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2b99ff4d-3bfa-40f8-8ff5-621a3a516239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2b99ff4d-3bfa-40f8-8ff5-621a3a516239" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_0c9d4dd7-0e5a-4fb1-a481-00096ed610c3" xlink:href="syk-20211231.xsd#syk_BusinessCombinationContingentConsiderationFutureMilestonePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_0c9d4dd7-0e5a-4fb1-a481-00096ed610c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_5fbf9e2e-0615-41e3-8ef5-c45257cbec04" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_5fbf9e2e-0615-41e3-8ef5-c45257cbec04" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_6a14ed41-d504-40ff-9bfc-4f4f247faecc" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_6a14ed41-d504-40ff-9bfc-4f4f247faecc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_00184d93-ca93-4439-81fc-45eecbcf8b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_00184d93-ca93-4439-81fc-45eecbcf8b01" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5c0e8e19-a52b-433d-ab68-2930a08a45e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5c0e8e19-a52b-433d-ab68-2930a08a45e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e804feb-bee1-4ae7-8ecb-70e60e0c7778_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8e804feb-bee1-4ae7-8ecb-70e60e0c7778_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember_475bb662-c158-4549-8c0f-0c7d1fe42fa2" xlink:href="syk-20211231.xsd#syk_GaussMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_GaussMember_475bb662-c158-4549-8c0f-0c7d1fe42fa2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_f0c9935a-6e63-468a-8674-a08c997fd99b" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_WrightMember_f0c9935a-6e63-468a-8674-a08c997fd99b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_7f51c4ac-01b0-485e-bac6-49377870f6af" xlink:href="syk-20211231.xsd#syk_VoceraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_VoceraMember_7f51c4ac-01b0-485e-bac6-49377870f6af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_73305c29-a5f4-4948-a495-697f1d61595a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_73305c29-a5f4-4948-a495-697f1d61595a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A1625ConvertibleNotesMember_6ab36dfc-36b8-4281-8069-27603616c874" xlink:href="syk-20211231.xsd#syk_A1625ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:to="loc_syk_A1625ConvertibleNotesMember_6ab36dfc-36b8-4281-8069-27603616c874" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A225ConvertibleNotesMember_f69b735c-2bbf-4a24-85da-7b1562cb984f" xlink:href="syk-20211231.xsd#syk_A225ConvertibleNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:to="loc_syk_A225ConvertibleNotesMember_f69b735c-2bbf-4a24-85da-7b1562cb984f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6ec0e387-c72d-4b7a-8340-70a05aa39920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:to="loc_us-gaap_SubsequentEventMember_6ec0e387-c72d-4b7a-8340-70a05aa39920" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended" id="i8c703f9d676e487589270c7999359c4a_AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95dbeb2a-f71f-469a-ba2e-e86adf70b092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95dbeb2a-f71f-469a-ba2e-e86adf70b092" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5cafd5f2-1c1d-4649-ae38-ed9b4c5c89e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5cafd5f2-1c1d-4649-ae38-ed9b4c5c89e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3ffaabb8-6ce1-4d88-938a-80f6d7db6369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3ffaabb8-6ce1-4d88-938a-80f6d7db6369" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dda1641b-a662-4dc2-b287-3067c8ef2d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dda1641b-a662-4dc2-b287-3067c8ef2d0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_4b01d5a8-f130-471d-b3de-e802b4d1bd4a" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_4b01d5a8-f130-471d-b3de-e802b4d1bd4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4512f51a-bc92-440e-8555-6e7ef920440d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4512f51a-bc92-440e-8555-6e7ef920440d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_0edc358f-79a9-48a3-8f94-17f7db8e7cbd" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_0edc358f-79a9-48a3-8f94-17f7db8e7cbd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_369d48a6-1a23-48e5-8f8d-3a5f9082252a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_369d48a6-1a23-48e5-8f8d-3a5f9082252a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_76baa34a-aa01-483b-bc42-11585f6c846c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_76baa34a-aa01-483b-bc42-11585f6c846c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c2d9755-e685-4b57-b29b-afeb1f354623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_Goodwill_3c2d9755-e685-4b57-b29b-afeb1f354623" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17782c21-1fb9-4a3e-a11e-0cbd7ee1d587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17782c21-1fb9-4a3e-a11e-0cbd7ee1d587" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4fe85c7c-428a-466f-a009-338dedc21133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4fe85c7c-428a-466f-a009-338dedc21133" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8355f85a-05e7-47c8-809a-c41204d75e3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8355f85a-05e7-47c8-809a-c41204d75e3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_6407287c-556b-4f36-893a-995471208888" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:to="loc_syk_WrightMember_6407287c-556b-4f36-893a-995471208888" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_da72fdd0-7be5-4f21-bb5c-1621d9c2e977_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_da72fdd0-7be5-4f21-bb5c-1621d9c2e977_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_f5f63425-ae85-490e-9c60-9e8f1f2fffb7" xlink:href="syk-20211231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_f5f63425-ae85-490e-9c60-9e8f1f2fffb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_65e4ce4e-3f3e-4d32-a1bf-c9cec3faa702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_65e4ce4e-3f3e-4d32-a1bf-c9cec3faa702" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_81c65397-1e05-4bf5-93c6-b3bfcfbe0248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_us-gaap_TradeNamesMember_81c65397-1e05-4bf5-93c6-b3bfcfbe0248" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended" id="i8ae09cbd74314ac789b2325aea72f075_ContingenciesandCommitmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_b1bd2fa1-1a6c-4c13-ae8d-b37e95fa82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_b1bd2fa1-1a6c-4c13-ae8d-b37e95fa82b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_3bf3212a-2384-493d-912a-b846854e0d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_3bf3212a-2384-493d-912a-b846854e0d66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_af4e8076-25b5-46a7-8fbc-400ce24b69f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_af4e8076-25b5-46a7-8fbc-400ce24b69f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_f1004892-2f77-4f73-975d-5b20d6a93cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_OperatingLeaseExpense_f1004892-2f77-4f73-975d-5b20d6a93cee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:to="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b9dc26b4-138b-445e-84da-1db145e74d0a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:to="loc_srt_RangeMember_b9dc26b4-138b-445e-84da-1db145e74d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:to="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9c369997-9c1e-4ff0-9722-1fb074b679f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:to="loc_srt_MinimumMember_9c369997-9c1e-4ff0-9722-1fb074b679f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b19ad84a-7967-4332-9c60-0ddc161f9e6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:to="loc_srt_MaximumMember_b19ad84a-7967-4332-9c60-0ddc161f9e6c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails" xlink:type="extended" id="if126338b7f2348cca0d64bed1dffb279_GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:to="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c8b96899-a3ba-4030-a560-e1328d977353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_Goodwill_c8b96899-a3ba-4030-a560-e1328d977353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_73bd732d-287f-4ff3-82d3-0f0f6e65da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_73bd732d-287f-4ff3-82d3-0f0f6e65da72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_303d293f-ffc2-44ee-ba74-0aa0cef13f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_303d293f-ffc2-44ee-ba74-0aa0cef13f8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c3bd5a1c-ad81-4dff-9e92-7be45990e8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_fe892027-2a6f-4f9e-b199-3e994090ce81_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:to="loc_us-gaap_SegmentDomain_fe892027-2a6f-4f9e-b199-3e994090ce81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:to="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_700dec69-2212-47d2-bf5f-2e7dde756794" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_700dec69-2212-47d2-bf5f-2e7dde756794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_334d9c67-5240-4620-b364-19a71572f5a4" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:to="loc_syk_OrthopaedicsAndSpineMember_334d9c67-5240-4620-b364-19a71572f5a4" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended" id="i36646c71240044a7a36257af0be4faa0_GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0b902ce6-8599-42b5-87a2-2d1dbc1d0d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0b902ce6-8599-42b5-87a2-2d1dbc1d0d0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c99205c-125e-40d9-aaf9-b888b7224b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c99205c-125e-40d9-aaf9-b888b7224b51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6bed7902-981c-42e0-8d45-567a4946ad85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6bed7902-981c-42e0-8d45-567a4946ad85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_009c142d-0a6c-4d9a-8830-2792ceec929c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_009c142d-0a6c-4d9a-8830-2792ceec929c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ca769a57-3234-4e09-872b-63338dd0a335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ca769a57-3234-4e09-872b-63338dd0a335" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c9b982d3-bdcb-4bd7-b2e3-3daa762479af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c9b982d3-bdcb-4bd7-b2e3-3daa762479af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_80357718-7830-40b9-b934-10ae60d3944b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_PatentsMember_80357718-7830-40b9-b934-10ae60d3944b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c86ec9aa-b504-4a15-b345-a2149a946de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_TrademarksMember_c86ec9aa-b504-4a15-b345-a2149a946de0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1d06a7c2-e852-46da-af33-9dfb2a72c867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1d06a7c2-e852-46da-af33-9dfb2a72c867" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8fabb8cc-d995-493d-bfb8-7cff135047e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8fabb8cc-d995-493d-bfb8-7cff135047e1" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended" id="i5b2d7b1f9d31488080106e43a457a747_CapitalStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_0243292e-7a99-48e7-87fb-b4b78a7d006f" xlink:href="syk-20211231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_0243292e-7a99-48e7-87fb-b4b78a7d006f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a6059804-a1b8-4dae-82e0-5ab1363afddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a6059804-a1b8-4dae-82e0-5ab1363afddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f486a40e-8c63-442d-8f0b-8f3ef4887599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f486a40e-8c63-442d-8f0b-8f3ef4887599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_811f70fa-0a8e-4313-98b9-388a3a7079c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_811f70fa-0a8e-4313-98b9-388a3a7079c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_839da37e-8bcf-46db-b514-1576444501f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_839da37e-8bcf-46db-b514-1576444501f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_39961a8c-42a0-4080-88bb-690d0f2b74cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_39961a8c-42a0-4080-88bb-690d0f2b74cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_33e3f74e-c6a6-424f-b59d-044fa1d6d64c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_33e3f74e-c6a6-424f-b59d-044fa1d6d64c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_dbf99092-e180-4c54-86f3-9c10ce06fbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_dbf99092-e180-4c54-86f3-9c10ce06fbb2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fbd16b2f-9830-4c84-a55f-272276c7655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fbd16b2f-9830-4c84-a55f-272276c7655c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f12e090e-a035-42a0-8558-605a83cdd82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f12e090e-a035-42a0-8558-605a83cdd82f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cbdf1da9-3add-4c3c-a36e-59aee3058004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cbdf1da9-3add-4c3c-a36e-59aee3058004" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3f3e14cf-0222-4d62-88f9-1609a7983349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3f3e14cf-0222-4d62-88f9-1609a7983349" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_88c8cff9-1525-498f-b3a3-3a1cdd4e5ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_88c8cff9-1525-498f-b3a3-3a1cdd4e5ed2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_48d8eaf6-0eed-4743-a46c-f5222df748f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_48d8eaf6-0eed-4743-a46c-f5222df748f9" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5c3a6fd0-b59b-42ff-9181-f3e978e89da1" xlink:href="syk-20211231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5c3a6fd0-b59b-42ff-9181-f3e978e89da1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_74187bee-298b-4155-981c-3dec42ed8d05" xlink:href="syk-20211231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_74187bee-298b-4155-981c-3dec42ed8d05" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_44ed964d-3e9a-4982-b5e2-e8235866be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_44ed964d-3e9a-4982-b5e2-e8235866be49" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:to="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eff8fb-e74f-4e42-9314-5d12f8f6acff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d0eff8fb-e74f-4e42-9314-5d12f8f6acff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0ced5254-f01d-44fe-83c7-405fc91306f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0ced5254-f01d-44fe-83c7-405fc91306f0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_e0d3faf7-b576-4dcf-ba46-f86c1c007e91" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_syk_PerformanceStockUnitPsusMember_e0d3faf7-b576-4dcf-ba46-f86c1c007e91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9bc6a639-3ff2-4c6a-9e27-1d3b0ec7d916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_us-gaap_EmployeeStockMember_9bc6a639-3ff2-4c6a-9e27-1d3b0ec7d916" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended" id="idd594c4bd9014b7c92395fe94b6d4b9f_CapitalStockSummaryofRSUandPSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6fd6815c-92bc-475a-a203-c51f63801ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6fd6815c-92bc-475a-a203-c51f63801ef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_936b84ec-85b1-4325-b38a-275abde8fdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_936b84ec-85b1-4325-b38a-275abde8fdf4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a500091-82a0-4baa-b69d-e07ac847c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a500091-82a0-4baa-b69d-e07ac847c70e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a1801044-b86a-4c9a-baca-226f1d684b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a1801044-b86a-4c9a-baca-226f1d684b7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81b64755-b467-48e2-9eb4-3f91e9b4b531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85dd886e-a690-4dc6-9cad-dec1f0d52c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85dd886e-a690-4dc6-9cad-dec1f0d52c81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f0f121de-1280-4f67-99c6-1f48354e2383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f0f121de-1280-4f67-99c6-1f48354e2383" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fbdaabb3-3cf8-41d2-bd6a-a775b85604ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fbdaabb3-3cf8-41d2-bd6a-a775b85604ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9f1b1bac-d126-415a-8505-12b021a6a170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9f1b1bac-d126-415a-8505-12b021a6a170" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f7f782ca-2244-434b-8031-56e956811cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:to="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1754cdb1-f105-4b88-8b5b-46b130417db3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1754cdb1-f105-4b88-8b5b-46b130417db3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1b060f95-65a0-4afd-8a26-a0ae0e4192f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1b060f95-65a0-4afd-8a26-a0ae0e4192f6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_b7ff712c-c1ba-465e-87a3-3a4f353802e5" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:to="loc_syk_PerformanceStockUnitPsusMember_b7ff712c-c1ba-465e-87a3-3a4f353802e5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended" id="i8c2f0ca900784963a1a29851bd599d7f_DebtandCreditFacilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_ec4eeee8-4824-4d2d-80b3-1eb342212fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_ec4eeee8-4824-4d2d-80b3-1eb342212fa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_504c0e02-31f5-40ff-9838-eaeb7b2eb860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_504c0e02-31f5-40ff-9838-eaeb7b2eb860" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DebtInstrumentCovenantLeverageRatio_cafd6151-1f03-423d-ac9b-50fdb1c97e80" xlink:href="syk-20211231.xsd#syk_DebtInstrumentCovenantLeverageRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_syk_DebtInstrumentCovenantLeverageRatio_cafd6151-1f03-423d-ac9b-50fdb1c97e80" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_63bfbbca-8183-460f-bf09-f43376c20121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentTerm_63bfbbca-8183-460f-bf09-f43376c20121" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_adbf5bcc-7763-4a1c-8a62-b6039da1bec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_CommercialPaper_adbf5bcc-7763-4a1c-8a62-b6039da1bec4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b21b7581-2a5d-4d4a-b5fa-c568df647f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b21b7581-2a5d-4d4a-b5fa-c568df647f67" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_edfeba96-ec95-4382-b610-eb4cf549a098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_edfeba96-ec95-4382-b610-eb4cf549a098" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_24651b2f-b012-4b80-ae28-e51aa5eea628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_InterestExpenseDebt_24651b2f-b012-4b80-ae28-e51aa5eea628" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0b87444d-6c3f-45a7-bf83-2e5d31f27b20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0b87444d-6c3f-45a7-bf83-2e5d31f27b20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember_d5f41d6b-e9cf-4bf3-8cad-388bc657b2c8" xlink:href="syk-20211231.xsd#syk_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_CreditAgreementMember_d5f41d6b-e9cf-4bf3-8cad-388bc657b2c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e01970f6-f86f-4577-a5ed-25afdce218f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_us-gaap_CommercialPaperMember_e01970f6-f86f-4577-a5ed-25afdce218f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2625Due2021Member_0821d94b-39ce-4804-aad6-0ddde7275f41" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2625Due2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_SeniorUnsecuredNotes2625Due2021Member_0821d94b-39ce-4804-aad6-0ddde7275f41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2021Member_bf8a1793-5c97-4972-a2e7-0eaa703d677b" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2021Member_bf8a1793-5c97-4972-a2e7-0eaa703d677b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_78a1e448-93bd-425b-b65e-7cf95d8ecff7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:to="loc_us-gaap_CreditFacilityDomain_78a1e448-93bd-425b-b65e-7cf95d8ecff7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:to="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fd613ab7-5cde-48d4-9bc7-a46598738e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fd613ab7-5cde-48d4-9bc7-a46598738e23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_dc5df015-a9c9-46c4-9a6e-895fa36f4eca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_dc5df015-a9c9-46c4-9a6e-895fa36f4eca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_532f8a0b-b94b-462c-83a0-51e307914d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:to="loc_us-gaap_SubsequentEventMember_532f8a0b-b94b-462c-83a0-51e307914d8f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended" id="ia18d36a85d7d45c69e498aab2f00a484_DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db6fce35-1392-4ae7-93ea-c768ebf53408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db6fce35-1392-4ae7-93ea-c768ebf53408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_30474ff2-a263-48ae-9563-17d28fb704fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_UnsecuredDebt_30474ff2-a263-48ae-9563-17d28fb704fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6c298eb2-3fa8-4895-9a06-8cc0c68c3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LongTermDebt_6c298eb2-3fa8-4895-9a06-8cc0c68c3fdd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_38f9a262-8b67-42b4-9b4d-9e24ae738104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_OtherLongTermDebt_38f9a262-8b67-42b4-9b4d-9e24ae738104" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_897b9739-cc51-4a95-9c6f-6cf8a55d153d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_897b9739-cc51-4a95-9c6f-6cf8a55d153d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_397f5111-19f2-4822-8f79-c224e92522a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtCurrent_397f5111-19f2-4822-8f79-c224e92522a4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2911b641-7a80-4804-a5e9-87f2bf23d46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2911b641-7a80-4804-a5e9-87f2bf23d46c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_16f0debe-03bf-4c33-bc8c-f8506919102c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_16f0debe-03bf-4c33-bc8c-f8506919102c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e4871354-10ab-4a4b-a75a-38167dbd0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e4871354-10ab-4a4b-a75a-38167dbd0a6c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1869325e-9342-45c5-9ba1-cb5eaba56b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1869325e-9342-45c5-9ba1-cb5eaba56b2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:to="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d56e52a6-0241-4457-a9c2-8ee9a5d313c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d56e52a6-0241-4457-a9c2-8ee9a5d313c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2625Due2021Member_d89546ca-6871-4b67-850f-b4d1f8dbab80" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2625Due2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes2625Due2021Member_d89546ca-6871-4b67-850f-b4d1f8dbab80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_dbe52327-d160-4144-9b3c-61aaf9da9dd4" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_dbe52327-d160-4144-9b3c-61aaf9da9dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1eb5a49f-564c-4441-8d6e-13f35cd98eea" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1eb5a49f-564c-4441-8d6e-13f35cd98eea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member_531d8998-e484-44da-9fba-83ca1efd4c1c" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2024Member_531d8998-e484-44da-9fba-83ca1efd4c1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_d6de71c0-179e-47fc-ab14-67612fac1e54" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_d6de71c0-179e-47fc-ab14-67612fac1e54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_374fa367-5aee-45e7-bfa2-39c95fa60b94" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_374fa367-5aee-45e7-bfa2-39c95fa60b94" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_ccf8f209-7e2a-416e-b631-0ca976b9d98e" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_ccf8f209-7e2a-416e-b631-0ca976b9d98e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member_88f3c2ee-38ec-4a11-874c-a483e96a7f46" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes350Due2026Member_88f3c2ee-38ec-4a11-874c-a483e96a7f46" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_bf827cc2-4055-4e53-83a4-363f77b0aba1" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_bf827cc2-4055-4e53-83a4-363f77b0aba1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member_0994d6a2-82c6-4846-9bc9-e5bd240575cd" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3650Due2028Member_0994d6a2-82c6-4846-9bc9-e5bd240575cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_90877271-ba1b-4adf-852d-805a7b2b7b29" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_90877271-ba1b-4adf-852d-805a7b2b7b29" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_b19f5668-d40a-42d3-a340-367fb063f9fa" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_b19f5668-d40a-42d3-a340-367fb063f9fa" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_5fe5721a-bf71-4b75-8e1a-755b5a0ff39d" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_5fe5721a-bf71-4b75-8e1a-755b5a0ff39d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_fc201ae0-76ed-4e8b-8487-0e7b0ebb32a4" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_fc201ae0-76ed-4e8b-8487-0e7b0ebb32a4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member_d2499d36-ca85-4872-85e1-1e496f9a61c5" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes410Due2043Member_d2499d36-ca85-4872-85e1-1e496f9a61c5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_e0704810-e6a2-4aa9-93ac-56affaa84cbb" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_e0704810-e6a2-4aa9-93ac-56affaa84cbb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_e79272e9-36b1-4345-b711-31834e0e9887" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_e79272e9-36b1-4345-b711-31834e0e9887" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_226e8263-4a86-417d-b3d9-5a932f3016bc" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_226e8263-4a86-417d-b3d9-5a932f3016bc" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember_e27105c8-0800-4664-998f-5b747401fbce" xlink:href="syk-20211231.xsd#syk_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_TermLoanMember_e27105c8-0800-4664-998f-5b747401fbce" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="ieac4ff2f27d54574975f0e72de816a16_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f18411d7-c2e0-4046-a3d9-33644c19148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f18411d7-c2e0-4046-a3d9-33644c19148f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_25170ee5-133a-4b76-8144-f9d6f776a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_25170ee5-133a-4b76-8144-f9d6f776a20f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_75d22e7b-a925-4569-979f-aa5ecff4c53f" xlink:href="syk-20211231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_75d22e7b-a925-4569-979f-aa5ecff4c53f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d4144429-b39c-4e95-984a-d4e89b821e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d4144429-b39c-4e95-984a-d4e89b821e3a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4c5b7b5f-6fd6-484d-aa68-6c84f7e15704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4c5b7b5f-6fd6-484d-aa68-6c84f7e15704" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_6dee6d67-ad2b-41dc-829b-8f05edc8d61f" xlink:href="syk-20211231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_6dee6d67-ad2b-41dc-829b-8f05edc8d61f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_704608e7-4a58-44ec-8e3d-3d572fdd03b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_704608e7-4a58-44ec-8e3d-3d572fdd03b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_6ef88a69-3755-4a6c-a215-a2a10861519d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_6ef88a69-3755-4a6c-a215-a2a10861519d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_014e3347-4928-4303-a07f-547ca506b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_014e3347-4928-4303-a07f-547ca506b969" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_14aa2ff6-71a4-45dc-a82d-6667ac3043bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_14aa2ff6-71a4-45dc-a82d-6667ac3043bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a580fb6e-46a0-4c66-be78-5ca542c467c4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:to="loc_country_US_a580fb6e-46a0-4c66-be78-5ca542c467c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_620c2fa8-3bdc-4093-9804-fce02775af71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:to="loc_us-gaap_ForeignCountryMember_620c2fa8-3bdc-4093-9804-fce02775af71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_5b7e3a2b-7f51-453f-983c-e02ce4f4982a" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:to="loc_syk_WrightMember_5b7e3a2b-7f51-453f-983c-e02ce4f4982a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended" id="i3118b61983e84f5787e7fa7ebb8d6b3d_RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5d7adb23-416c-499d-8619-b03c3ee461eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5d7adb23-416c-499d-8619-b03c3ee461eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cee8583e-bbaf-43db-a117-9cf94bd082bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cee8583e-bbaf-43db-a117-9cf94bd082bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d67262bd-8f5a-44d9-8817-5c603e4e55cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d67262bd-8f5a-44d9-8817-5c603e4e55cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bf6e058b-4bf3-4bdc-99e3-0b1987b45966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bf6e058b-4bf3-4bdc-99e3-0b1987b45966" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c7ee68a3-d8da-49d0-bdad-e6192c4258d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c7ee68a3-d8da-49d0-bdad-e6192c4258d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2ac56c31-a0d4-431b-b3de-17b6cbb0c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2ac56c31-a0d4-431b-b3de-17b6cbb0c3a0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_8f8ebb84-116d-436c-83f0-eeca601f353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_8f8ebb84-116d-436c-83f0-eeca601f353b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9126da46-de31-4337-b42a-001ad96ebb91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:to="loc_us-gaap_EquityComponentDomain_9126da46-de31-4337-b42a-001ad96ebb91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:to="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_46e634bf-56cf-4de7-b48e-96e462b6593c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_46e634bf-56cf-4de7-b48e-96e462b6593c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended" id="i66bcb776d9e349ba8abd690eb16df230_RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_afc2339a-058d-4fc3-af50-e48f26a9faed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_afc2339a-058d-4fc3-af50-e48f26a9faed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_96f8bc4b-4b82-4aad-8c85-86e29f6a4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_96f8bc4b-4b82-4aad-8c85-86e29f6a4eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_a6f425dc-e059-402c-bcf9-e9fdf5432c54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_a6f425dc-e059-402c-bcf9-e9fdf5432c54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_4deb39b2-3454-49b3-b99f-d75b9bc1740c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_4deb39b2-3454-49b3-b99f-d75b9bc1740c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef65c6ad-aa7a-4ca1-8d9a-b4a5a84c4e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef65c6ad-aa7a-4ca1-8d9a-b4a5a84c4e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_6db478ce-f411-4701-8106-ee3bc07afb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_6db478ce-f411-4701-8106-ee3bc07afb20" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended" id="i3048d5fe91b04e5783290bb90e14c37f_RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_117e711d-eec4-4d03-a2aa-2e976818da67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_117e711d-eec4-4d03-a2aa-2e976818da67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_6e13d501-fea6-4896-ae01-5ca7cf13a155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_6e13d501-fea6-4896-ae01-5ca7cf13a155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_2586bef7-e7cb-499f-b28a-00c9abee4494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_2586bef7-e7cb-499f-b28a-00c9abee4494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_6482a05e-79bb-4c4a-b3cb-2a4637406331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_6482a05e-79bb-4c4a-b3cb-2a4637406331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_811ad380-a527-4f84-82c4-f82b9bcc9db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_811ad380-a527-4f84-82c4-f82b9bcc9db5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_18a95a2a-7bc2-4c96-9e1e-0e55faf403aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_18a95a2a-7bc2-4c96-9e1e-0e55faf403aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_87c9b464-1702-4cba-8964-b1278ccfcafa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_87c9b464-1702-4cba-8964-b1278ccfcafa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d73f9200-6d9a-415a-8f98-c6a076fdb9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d73f9200-6d9a-415a-8f98-c6a076fdb9ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fc14298f-f4c0-437b-bb09-cac07291bfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fc14298f-f4c0-437b-bb09-cac07291bfd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dca231a7-efce-4d8f-aa10-685e0f389ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dca231a7-efce-4d8f-aa10-685e0f389ced" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended" id="i12833323b7fe4bc9a9e5a2c4ce322196_RetirementPlansNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_83cdd07c-b07f-44b3-91f5-1f6dce01a97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_83cdd07c-b07f-44b3-91f5-1f6dce01a97c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_e8060b8a-8f9e-45f7-80a6-a52827e8b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_e8060b8a-8f9e-45f7-80a6-a52827e8b8ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21c00146-22c1-46dc-9b70-2f90f4ab24df_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_21c00146-22c1-46dc-9b70-2f90f4ab24df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_33113892-4321-4b89-9761-badc9913e91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_33113892-4321-4b89-9761-badc9913e91c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended" id="i1db647f8f45c467d85c33fffff95c8af_SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_399a28f6-04a6-4f34-8d5b-4e5070e81a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_NumberOfReportableSegments_399a28f6-04a6-4f34-8d5b-4e5070e81a60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7e9ed8b2-e20f-4317-8fb7-f0b3f0c7442c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_Revenues_7e9ed8b2-e20f-4317-8fb7-f0b3f0c7442c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ea6b4132-a8aa-45b5-a45e-71f9ec5e1d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ea6b4132-a8aa-45b5-a45e-71f9ec5e1d5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3366de32-8b42-4e9b-aa50-12dddf6a094c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_OperatingIncomeLoss_3366de32-8b42-4e9b-aa50-12dddf6a094c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_367676ab-dd2c-48ed-98ff-652903e32c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_367676ab-dd2c-48ed-98ff-652903e32c2a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_397aa00b-bac4-408d-932f-d18eefe9d93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_397aa00b-bac4-408d-932f-d18eefe9d93c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5d19f554-d861-4c5b-96f3-89cf0fd8af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5d19f554-d861-4c5b-96f3-89cf0fd8af0a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_3ef0048f-fdf3-4a58-b2b8-9bc5fdd83a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_RestructuringCosts_3ef0048f-fdf3-4a58-b2b8-9bc5fdd83a47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_db633979-e43c-445f-848b-77849b785b91" xlink:href="syk-20211231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_db633979-e43c-445f-848b-77849b785b91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_39543249-7720-42a8-ad9c-5bac39d87d58" xlink:href="syk-20211231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_39543249-7720-42a8-ad9c-5bac39d87d58" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_66af6255-e117-410c-b484-202c3c837620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_LegalFees_66af6255-e117-410c-b484-202c3c837620" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_be4615b1-2491-4136-a3b1-d44c96ef8d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_NetIncomeLoss_be4615b1-2491-4136-a3b1-d44c96ef8d82" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:to="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_62379f9d-5ccf-489e-94a8-b58e7a75292e_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:to="loc_srt_ConsolidationItemsDomain_62379f9d-5ccf-489e-94a8-b58e7a75292e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:to="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_536d4f84-95f5-4756-b47a-2609cd1e7b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_OperatingSegmentsMember_536d4f84-95f5-4756-b47a-2609cd1e7b8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0e5825fd-384c-4e01-9443-e14ac7a5c804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0e5825fd-384c-4e01-9443-e14ac7a5c804" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_44223a06-fe46-43b7-a308-6967cc0815f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_44223a06-fe46-43b7-a308-6967cc0815f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:to="loc_us-gaap_SegmentDomain_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:to="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_b69ebb4b-1189-4c63-841d-524cda5deee7" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_b69ebb4b-1189-4c63-841d-524cda5deee7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_e435ce9d-cb31-4488-9777-2a8783d777e9" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:to="loc_syk_OrthopaedicsAndSpineMember_e435ce9d-cb31-4488-9777-2a8783d777e9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended" id="i59f161d759004c559b93debc95bed612_SegmentandGeographicDataSegmentInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_174e99dc-3942-44a8-8281-cef25e067529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:to="loc_us-gaap_Assets_174e99dc-3942-44a8-8281-cef25e067529" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_effa5aca-b816-4f32-b57b-9e1ec80eb827" xlink:href="syk-20211231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_effa5aca-b816-4f32-b57b-9e1ec80eb827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:to="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_269bd462-d847-4a54-891c-963a8a685378_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:to="loc_srt_ConsolidationItemsDomain_269bd462-d847-4a54-891c-963a8a685378_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:to="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b217a384-f581-48cf-bcd3-811929190587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:to="loc_us-gaap_OperatingSegmentsMember_b217a384-f581-48cf-bcd3-811929190587" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9fbfff8c-4226-4dfc-8bbf-a0da36755b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9fbfff8c-4226-4dfc-8bbf-a0da36755b40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a314d562-4360-4fe0-8de0-a254f98d67d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:to="loc_us-gaap_SegmentDomain_a314d562-4360-4fe0-8de0-a254f98d67d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:to="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_ec9a56f5-1847-494d-b235-3e4a89d92afc" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_ec9a56f5-1847-494d-b235-3e4a89d92afc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_0bda45a7-2845-4036-9de5-7827e817bfde" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:to="loc_syk_OrthopaedicsAndSpineMember_0bda45a7-2845-4036-9de5-7827e817bfde" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended" id="i5fc1f14179f64129b1898ec077c7ceff_SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_222b47d2-43b5-4d25-8292-a26da6242da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:to="loc_us-gaap_Revenues_222b47d2-43b5-4d25-8292-a26da6242da0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_48d0a2a4-2d62-435b-8a53-aa0b33134eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_48d0a2a4-2d62-435b-8a53-aa0b33134eb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:to="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8a699375-33e5-44bb-9440-b19cd2911671_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:to="loc_srt_SegmentGeographicalDomain_8a699375-33e5-44bb-9440-b19cd2911671_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:to="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c7a2571c-d3f4-4b42-830b-7df44ad4f60a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_country_US_c7a2571c-d3f4-4b42-830b-7df44ad4f60a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_99837da7-37ad-46d5-8f19-4f7b1f315f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_us-gaap_EMEAMember_99837da7-37ad-46d5-8f19-4f7b1f315f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f23520bb-a5ad-496f-b4d0-99ff3156f26a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_srt_AsiaPacificMember_f23520bb-a5ad-496f-b4d0-99ff3156f26a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_5bd5e663-ca06-444b-921f-7c6735c2ac59" xlink:href="syk-20211231.xsd#syk_OtherForeignCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_syk_OtherForeignCountriesMember_5bd5e663-ca06-444b-921f-7c6735c2ac59" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AssetImpairmentsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended" id="i64050792fc01470b8d362797f96e8328_AssetImpairmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_722328a1-d4e7-405b-b9eb-c32ff0af8586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:to="loc_us-gaap_AssetImpairmentCharges_722328a1-d4e7-405b-b9eb-c32ff0af8586" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_de601d70-214a-49da-be35-eab763b0befd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_de601d70-214a-49da-be35-eab763b0befd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9e779425-e209-43ec-8d72-caf7638d19db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9e779425-e209-43ec-8d72-caf7638d19db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ebde2e53-7b33-45be-b017-ec4c1fd1ac5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ebde2e53-7b33-45be-b017-ec4c1fd1ac5e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2d369e6e-a956-4065-983f-8a79384dacd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2d369e6e-a956-4065-983f-8a79384dacd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_2695580b-80f7-45aa-b69e-734c4cd11a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_2695580b-80f7-45aa-b69e-734c4cd11a0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7b1f0090-598c-4d33-8d76-60b9f8a29608_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:to="loc_srt_SegmentGeographicalDomain_7b1f0090-598c-4d33-8d76-60b9f8a29608_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:to="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_f381a912-6c66-4b5f-9dc8-c7eb75e2b24c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:to="loc_country_CN_f381a912-6c66-4b5f-9dc8-c7eb75e2b24c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_cfaf2eef-faf7-40f3-beb5-9c83f1629137" xlink:href="syk-20211231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_cfaf2eef-faf7-40f3-beb5-9c83f1629137" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_bda12586-3a77-4835-8d0b-9a6c5ef2541d" xlink:href="syk-20211231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_bda12586-3a77-4835-8d0b-9a6c5ef2541d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GlobalERPSystemMember_68de5add-dcf0-40ee-b478-da83c2f4c527" xlink:href="syk-20211231.xsd#syk_GlobalERPSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_GlobalERPSystemMember_68de5add-dcf0-40ee-b478-da83c2f4c527" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended" id="i988e44110e804ef0b62f87b6af2bdbfd_ScheduleIIValuationandQualifyingAccountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b775dfc6-1460-4330-99e6-bbcfc050a794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b775dfc6-1460-4330-99e6-bbcfc050a794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2ad60c7e-16be-441d-aa8a-fb57aea94859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2ad60c7e-16be-441d-aa8a-fb57aea94859" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68501bb0-5661-4413-bee0-8af4b517429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68501bb0-5661-4413-bee0-8af4b517429a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_21c7cd99-5165-4225-a408-016f5dc57392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_21c7cd99-5165-4225-a408-016f5dc57392" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b543d6cd-798d-414d-8e1b-17488f6e5b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_f6b09c0d-b970-44f6-b81b-ba4d7ce01cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_f6b09c0d-b970-44f6-b81b-ba4d7ce01cf8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>syk-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_6780b485-cc95-4634-95db-336c47fcbb28_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_624100a1-6d47-418a-aee0-b638600cdcfe_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments during period</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualPayments" xlink:to="lab_us-gaap_LossContingencyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_90ff797e-e229-41ec-b495-8120cbd3fcaa_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_e7ceb44f-8fa2-4c4b-9d28-d0cf509758b0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosure:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_97c2facb-a60f-42f1-a696-c4e23209a76e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_ad626577-eac1-4dd4-b9b4-8ad49060a498_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actuarial (gains) losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanActuarialGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_fa9f20fe-fb8e-4151-8793-6378bbc3c5dd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_9211f605-b7c3-43b1-8bf1-7cdf8ce66c76_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and integration-related charges</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Integration Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationIntegrationRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4aaada5d-d250-41e5-a021-b9fb2312d496_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3de6c741-ee34-40eb-a93b-1ab4ec850c74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3bc40be7-f5fb-4bcc-9e60-08dcfd838741_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_cc9b9380-c564-4263-bb1f-10cdbda13556_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_fd029666-e699-4bd2-8e19-c6549793eaef_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_74a0c144-92dd-4e0e-8fbd-ad7b69a072fe_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_65890193-a96f-47ae-b888-4179b817c79e_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_589bb5da-165a-425b-ab86-b4c84d781064_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_f688ebc2-e44e-4eb5-a54a-f16ce6fbbccc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_c8e9c665-291e-4a0a-8053-498a19172c65_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e818466c-f89f-4ebd-8115-4e9bb4caec1d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_78cc7648-9ffe-4ee2-9edb-a5f210b3bcb8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss and other credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_e9814410-d36a-4786-ae0f-f3ae0d1727cf_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_ffef5c6b-966c-48ae-896d-2e12e9038994_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_1367a150-99ca-4c7b-a51c-2151737d09d6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_7cb55bc7-7922-4e4e-9530-825e62e02c62_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d8c9c2b0-ac04-4ec1-81d2-6293654ccc6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ea754e14-a123-4f60-8951-083e208a47c5_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9565eb6d-e5c8-4810-9224-caa996a83de7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_695b9bba-6db8-4517-b16c-db4d3a93e4a5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalMember_c0e885d2-f889-4ac5-8c54-4df9bfb1c173_terseLabel_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical</link:label>
    <link:label id="lab_syk_MedicalMember_label_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:label id="lab_syk_MedicalMember_documentation_en-US" xlink:label="lab_syk_MedicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember" xlink:href="syk-20211231.xsd#syk_MedicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalMember" xlink:to="lab_syk_MedicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_51ec83df-2c8b-47a1-bed2-642ef754bcf3_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b37b24f3-fe3a-478e-8b02-37147b4176f6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_1d93262d-6957-49b5-bb31-f8e909b40f28_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_762bc455-09f5-4238-a52e-bf8d697155f7_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe, Middle East, Africa</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c59d817d-2efb-4def-ad2b-dbaae92723bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Cancelled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_52ec4129-af45-4691-9dcb-5172a7cab2fe_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_cc68889c-aefd-4982-bd5e-b6aab046ff53_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_b9c2704a-6825-4f7c-89b3-07ba7364ae4b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_7dda4d57-58f6-4e1b-af7e-5c1eb9b50768_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Cancelled or forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6bc989ce-0f13-4f64-81d1-f62a3f8e0045_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_13adb134-9d60-49dd-aad7-4d2e73ac3ab6_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency Translation</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_0db2094b-6d0d-4105-92d9-8737f2daa421_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities&#8212;accrued compensation</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_53897e19-0315-47b6-88ff-996f34698afc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_bb91ffb3-70d4-4fe1-9c55-e06ce740012f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Pension Cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_26445581-5a6a-4aff-9b19-4d079393d6c0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_d08ea314-4791-4a49-a3e1-34d3cdbabb24_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d441571c-7b78-4219-bc74-71345c9edcc2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_53e97376-09e2-4615-ae45-58393c83e8b2_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_89e381f3-13aa-4846-957c-aaca9a718cbc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_93f94273-f3d8-4f2c-a2ca-fd518491b44e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_314a081a-7d13-4a11-a1eb-6f254060984a_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_1d3fbb4b-3420-46fb-bc8c-8cd22e1d0483_verboseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_75ae58d8-8533-4df2-9b66-68249f95da29_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_93a83c02-4ffd-49da-87ba-01b0f7ed5990_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_eb8542b4-db8f-4648-8df0-12fecc0896c3_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3f426998-99f5-4c18-aed4-d51186bc214a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d553248c-f19c-4a3b-90c6-ea3ca88e2e1f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_44bf4316-2f72-429d-ad2d-c732766fd2c6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_432aadf2-7461-4ecf-890e-fcfcc7862a8a_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_8706f74f-cc55-4cd1-980b-290d7b3459c5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_6c2968e5-3737-495b-9ede-d1666808e0a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GlobalERPSystemMember_1f1a02ac-8557-4758-91ab-114d1e177166_terseLabel_en-US" xlink:label="lab_syk_GlobalERPSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global ERP System</link:label>
    <link:label id="lab_syk_GlobalERPSystemMember_label_en-US" xlink:label="lab_syk_GlobalERPSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global ERP System [Member]</link:label>
    <link:label id="lab_syk_GlobalERPSystemMember_documentation_en-US" xlink:label="lab_syk_GlobalERPSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Global ERP System</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GlobalERPSystemMember" xlink:href="syk-20211231.xsd#syk_GlobalERPSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GlobalERPSystemMember" xlink:to="lab_syk_GlobalERPSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_30993bde-c98d-46bd-ab0d-341e6b01c295_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Contracts, Liability, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:to="lab_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_3212df71-2293-489f-9b86-6c9a28695819_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ad449550-2691-4bca-85a2-ef8784d3aa49_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_bcb25212-e42e-4c72-9859-e59e3f84ebe7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised during period, exercise price range, lower range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_b76bb0d0-c981-4cbf-a450-2a2ddc4a6709_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charged&#160;to Costs &amp; Expenses</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_fb8a46ae-a758-45c0-93cd-be18e284e0cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_ea8aad56-e798-4267-a811-d331b334ca61_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0dfec55d-0519-4ee5-97e9-225e3486fc89_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_2fc15bf1-22f3-4fc8-9ebc-3fec181d7a0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_e73ed546-3eaf-495e-8a1c-2a9bb84bd1ee_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average life of intangible assets</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c720ce71-c98b-4ab7-a10b-78c4015fb844_verboseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period (Years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_71adc713-4071-4ad3-8da7-be6a0533c3f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining shares authorized to be repurchased</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_5cfcc9d5-ef3b-4012-ae33-da5fde3cfd95_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Debt Security [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:to="lab_us-gaap_DefinedBenefitPlanDebtSecurityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_d550016e-ca28-4a4a-be18-0bb6e342e5ef_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_0f6b04fd-c34f-4239-99f4-1b8910e21243_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_973e75ec-7713-4e16-b1e2-9748f315b60e_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0249320b-37a3-4606-a18c-96d9e16b4ac9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_55b40b00-657b-4c86-9746-85ee7322e3a9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net actuarial gain (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_5a6cc992-7f60-49ef-8d1f-349fe7ea7317_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_26b2a720-eced-4cb4-a4b2-0d6469a17673_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrent" xlink:to="lab_us-gaap_DividendsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_ef3d737e-da17-4d0f-b908-077c7146a11c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_411ac359-b4ac-4d3a-b1ee-f1692ebeb8b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_3a3d3b8f-25bd-4165-bc82-fb55242c907e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_28e24e47-0088-4b9f-8c7b-b0808d8311eb_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual return</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_79969c46-90bb-4ae4-a7c6-5159a60e9a33_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Charges during period</link:label>
    <link:label id="lab_us-gaap_LossContingencyLossInPeriod_label_en-US" xlink:label="lab_us-gaap_LossContingencyLossInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Loss in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyLossInPeriod" xlink:to="lab_us-gaap_LossContingencyLossInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_87f48fc2-7cc6-499c-b864-4ff7d7b15f40_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7bb930b2-739c-4d49-8c9a-770f510ed8b3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_3abfd788-8106-4bc6-ace6-a4fe501085c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities&#8212;other liabilities</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability, Defined Benefit Plan, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:to="lab_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_A1625ConvertibleNotesMember_74afd0e9-e0b2-4726-928a-5aedeab2fa17_terseLabel_en-US" xlink:label="lab_syk_A1625ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Convertible Notes</link:label>
    <link:label id="lab_syk_A1625ConvertibleNotesMember_label_en-US" xlink:label="lab_syk_A1625ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Convertible Notes [Member]</link:label>
    <link:label id="lab_syk_A1625ConvertibleNotesMember_documentation_en-US" xlink:label="lab_syk_A1625ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.625% Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A1625ConvertibleNotesMember" xlink:href="syk-20211231.xsd#syk_A1625ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_A1625ConvertibleNotesMember" xlink:to="lab_syk_A1625ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f2284f42-0909-478a-aa6f-d62bcc24c673_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Award [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_6e5b8162-9309-4f2d-98e9-b8482f933a34_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_36302bb5-ae7a-4cf9-83d9-bd6a9ac0ebe4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d66ec923-6409-41dd-b0a8-645e455899e3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4c5e8a38-e46c-4da6-a85c-f75cdf6aa662_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_fbf01904-f39e-4b73-ae2d-6bf716944c2b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_8a5db9ae-e55d-4368-a971-6c0a5bb499e0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_e797650c-bcad-4ced-b2cb-c36a80fe2a28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercisable at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_076aa36c-0741-4329-ab0e-b3e07d4b6190_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options expected to vest (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_9f8fa76c-b832-4c23-8c55-bd96c5e5660f_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_136ca7c4-3231-4eec-be52-1a083e758f1f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d400cfe1-865d-4b3d-b121-3eb7664eb789_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_9492fbd4-7d60-422c-8418-fa4696aa79fc_terseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reconciling Items [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_96eaa978-91f6-48c5-a6e5-7a7775959cdc_negatedTerseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intellectual property transfer</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCosts_16eb2ded-608d-481a-af35-39dcb510f260_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring-related and other charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCosts_label_en-US" xlink:label="lab_us-gaap_RestructuringCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCosts" xlink:to="lab_us-gaap_RestructuringCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_320bd4e3-a9c3-469f-9f49-fc32c01812a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_87e43578-7a1a-44e3-86de-361ec56d5002_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_b1dfe97f-ebec-4820-a12e-12918680c7da_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_aee4e77b-a022-430c-9d59-9a893c5d83d3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_b280023d-2d22-466c-9939-b95ca38b9a1c_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4625Due2046Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.625% due 2046</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:to="lab_syk_SeniorUnsecuredNotes4625Due2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_ab6c4bad-524f-40f9-afdb-c71639ae50c6_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_0691913b-d277-49eb-8f8c-6f2746e77314_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% Notes due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.625Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% Due 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.625Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_a87c3982-532c-4a03-9b90-aae481f054ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options outstanding at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4fae2d89-755c-4a7f-8ba8-37f000bbaeca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options outstanding at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_8807ce8a-2bec-47e5-bd1d-ecde10de2a02_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForNotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Allowance, Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForNotesReceivableMember" xlink:to="lab_us-gaap_AllowanceForNotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b22a535d-b19e-4000-beca-d91cb3e2125f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ae6184a8-5ca5-48ed-af3c-9b89dac69a81_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_2a5fb140-9558-46fe-bb35-9245611682a2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_bd734319-9b2f-4dd8-8b60-c782341f971e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_4f9408a1-24b3-479a-9e1f-bdf7619559e5_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of senior unsecured notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_0f591779-560e-4096-b2b0-6d48127a4213_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3650Due2028Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.650% due 2028 [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:to="lab_syk_SeniorUnsecuredNotes3650Due2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CN_0c8cd0ff-11e0-4454-8bbe-4853a7258b11_terseLabel_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:label id="lab_country_CN_label_en-US" xlink:label="lab_country_CN" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_913dd0e1-1235-46f8-9198-cfbe63a684ae_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies and Commitments</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_53c69e48-d206-482c-8a00-97c691b135d0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_a755a934-8618-46b5-a1d9-85a5d06e0f50_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_f6eba70d-3d95-4b0c-99aa-e42c9e4a7c5d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, interest on income tax expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Interest on Income Taxes Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_982c3780-2762-4536-8b77-3ff95397665c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_72942208-b33b-46ef-a9c2-60369eec567d_negatedLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLoss_11dd95dc-bcc9-4537-a179-08c8188302e5_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, gain (loss)</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesGainLoss" xlink:to="lab_us-gaap_MarketableSecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_567c1f18-8868-444a-ac56-ab52a81c7e94_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_f77a6cce-86c7-4910-81b0-3cc53b33c908_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, repurchased face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Repurchased Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentRepurchasedFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_97c208a4-ff02-42c1-b1ff-9e04b7ade112_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_e76ccde5-ee6d-417c-aba2-e429b8a37ea0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b8ac5d4d-3d1d-43c6-ac88-2232e4813832_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_de51769b-ec65-4e71-a83d-c22d51696963_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_d49bbb36-a61b-4d73-8cf6-a93f472e4e24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_db580f17-432b-479a-9c5f-04e17314012f_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1b35561f-eef6-4e0a-958f-fee323c981d4_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_b18a1ea6-fed6-4c42-a452-f431676689f1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Target plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Target Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_c03c3684-4dc4-4606-84fa-e464f632592e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestmentsMember" xlink:to="lab_us-gaap_OtherLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f564d3c0-9436-4743-a4e0-76bfa1735a0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_4a722422-5e46-4623-87dd-db8568fa5760_verboseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_99494e70-99e0-49ae-82e9-d942779243cd_terseLabel_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Units (PSUs)</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_label_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:label id="lab_syk_PerformanceStockUnitPsusMember_documentation_en-US" xlink:label="lab_syk_PerformanceStockUnitPsusMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Stock Unit (PSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PerformanceStockUnitPsusMember" xlink:to="lab_syk_PerformanceStockUnitPsusMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2625Due2021Member_90321a5c-3fa5-4976-a733-f39bb9956d05_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 2.625% due 2021</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2625Due2021Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 2.625% due 2021 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2625Due2021Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 2.625% due 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2625Due2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:to="lab_syk_SeniorUnsecuredNotes2625Due2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_8d7f32ac-8cdd-4ec4-b8a1-5e90a6149277_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value</link:label>
    <link:label id="lab_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue" xlink:to="lab_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_d7db8e34-62e5-48ab-bdcb-05b6beac4d67_verboseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity on existing facilities</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_90ca1609-20da-47c0-a52f-094cac4081b0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_dc07fc3f-ed7a-4781-b56b-9e8b0d9bfdd3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_80690f7d-b1f8-49cc-8448-43bec25f8874_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3ac57513-bc5b-4a42-b217-5e86a25ac17a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_d2b45ac0-1d32-4961-9563-4ed1d7e51ce5_terseLabel_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_label_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:label id="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_documentation_en-US" xlink:label="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:href="syk-20211231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:to="lab_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_6d1e6d19-f57d-4f5c-b2d8-4af7d2864990_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_afcf8b3e-5e87-4a29-a7d9-f16b04eef029_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Nonvested at January 1 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8b834d7f-9f85-46b4-ad32-6f14525e75b2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Nonvested at December 31 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_f2c2eba8-7953-469d-bb0b-45506ed3009d_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5f381613-869f-4bd1-8bed-75121399efbb_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_d4f080eb-1fad-4104-ac8a-74fdd2276e7e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5125cc53-a362-49c6-8733-5a5186acce77_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_896e5b5b-7d3e-4bce-ac36-bd1388dd5249_verboseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_a8b4db2b-70f2-4e3b-b585-4518e8e4118c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_f2b53dcd-ee2c-41cb-80d6-68ecb3f8640f_terseLabel_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares vested during the period</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_label_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:label id="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_documentation_en-US" xlink:label="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:href="syk-20211231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:to="lab_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_9ee08f9c-bd5f-47e6-a646-4c1974d1f523_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ecaaef5f-38bc-4059-a16c-9f09cac91ea2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregated Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8b364f13-901c-4e2d-a8ea-db6975b042c0_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_26d34a0f-e062-42b9-843e-2610a9afadbe_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_ffc6169d-66e1-4fd7-9653-30c007b34530_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Information on Net Sales and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_0da8c72d-a430-4129-a21f-ddda07b6dabc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan expense</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_1ff3bc7f-6068-4882-b555-47a66db0526c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_ed915e43-2b82-49ee-a95b-2f19bbdbb9fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_387d4178-0ca8-47a8-88a1-16899acb7025_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentGross" xlink:to="lab_us-gaap_MachineryAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_0b6b1c0b-3683-4287-8cb4-ef067ebd6284_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_c35820f4-dba7-4cc9-801e-cb71813070b8_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets for Plan Benefits, Defined Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:to="lab_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_750b308a-824a-45be-aa79-4550660351a5_terseLabel_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to full valuation allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_label_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:label id="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_documentation_en-US" xlink:label="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject to Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:href="syk-20211231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:to="lab_syk_OperatingLossCarryforwardsSubjectToValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_5bfe50ed-1674-47a1-851b-0af86ecd144f_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_373b1e06-c99a-46f1-860d-d17720beff2f_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_f64a369a-7ad8-4c55-b3af-294f9a9224fa_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum term</link:label>
    <link:label id="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_label_en-US" xlink:label="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Remaining Maturity of Foreign Currency Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:to="lab_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_efbaa428-e110-4ce3-be25-fd8b57d83275_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds and payments on short-term borrowings, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_6c7b0098-d3be-4f7d-a6e3-9784b50ea25b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_2de53262-441e-4ebc-b91a-a7cbafb93622_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development and Engineering Expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_f8de5390-0b04-4c52-b797-79f3f2b7a4e6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate purchase price of acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_962b99fd-a734-41dc-9fa6-32844905c418_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_0d130c7b-934c-4b95-a936-acba95283747_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_26ec7c1f-f581-4785-a2f0-2e8359b4d3bf_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Changes in Foreign Currency Exchange Rates</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesAdjustments_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_929f9c96-da4d-40dd-9d87-27774706612c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanAssetCategoriesDomain_label_en-US" xlink:label="lab_us-gaap_PlanAssetCategoriesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain" xlink:to="lab_us-gaap_PlanAssetCategoriesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_4a27a19b-4c4c-4fa6-9cc0-a5571065dcf6_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b21783f9-2f73-4842-8b2e-cd9851363d8e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets measured at fair value</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_dee7682a-2bf5-4369-8503-a3f000c79e82_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d2b8cf7b-e804-4c8f-a83e-24b88b24c25c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_eb4db1af-a564-4143-8675-6e6c0d6abe10_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_bda87e56-cde7-432a-a1cb-bdb816a34a5a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_ac64df6c-101c-4df4-b7e1-b54e372f60a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_63763606-b58d-4dd3-8f88-b28506025c85_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_5ce4fc0f-07d2-4868-a775-8464f9f18b07_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year income tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_02690b36-f20e-4cd1-9c4c-a87933992720_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities &amp; shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_66f5960b-7165-45da-945d-625f01c2e855_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_847655f9-ff5f-4a1d-8f98-aa0d06314998_terseLabel_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:label id="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:href="syk-20211231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:to="lab_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_89caa122-c65c-468c-9315-2c678707e878_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_53045e6c-529e-4965-a5f9-086303aeaecf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_0877b163-b7e4-48a0-b9d6-f1c4206bb05e_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_f61078e3-7bf3-4f89-8617-ab8374f13349_terseLabel_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of acquisitions, including convertible notes</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_label_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Convertible Notes</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_documentation_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Including Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:to="lab_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_12ada300-2ef4-4824-825c-737a62c30dd4_verboseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States agency debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_588b266c-3bee-4778-8c37-6c373b51c8cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1f370149-664e-4e4a-bc2f-d3882b36a4e3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_adf8292e-0bd4-4047-b41d-172c8650714e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_9c2edc71-f5bf-4af4-8008-a6c67f4de40a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_972f71f8-defb-4381-8d5f-5e34438aa2c8_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_d76cb7e2-5228-4146-9a5d-36478b752783_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_72adcd90-f990-43cc-b87a-d1a066ec9aa8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_429f25d7-f8f1-43b5-ac19-61bde16879f1_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_c2d3f8e4-5953-4095-b6e2-7fb292c01d66_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_e21ac9f9-d4ab-473b-830a-f515f4a1d8a1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7769807a-afdd-4b2e-b0c1-b485f9136fd2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_6e57b613-a825-40b6-9cdb-969a97f60bfc_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_52104fb4-3a36-4c71-9864-f7b4de23ce51_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements and resolutions of income tax audits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_807a3a3e-a262-4df9-aba9-87cd967babb2_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_42c4280a-1b35-4e66-b7c2-2e8b39d5d5f7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeuroCranialMember_7de0f8e0-35ad-4d5b-83fd-bf8649f3029d_terseLabel_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial</link:label>
    <link:label id="lab_syk_NeuroCranialMember_label_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial [Member]</link:label>
    <link:label id="lab_syk_NeuroCranialMember_documentation_en-US" xlink:label="lab_syk_NeuroCranialMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuro Cranial</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember" xlink:href="syk-20211231.xsd#syk_NeuroCranialMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeuroCranialMember" xlink:to="lab_syk_NeuroCranialMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d18564ad-6bd5-4e83-9009-34740fc05366_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_2bbb07d2-a260-45bc-9c16-1782021e04d4_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_bb248669-f29b-47b1-9c51-cd37e6547db3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7691bca7-62d8-45a3-a5fc-0eadeb0315c5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_7b801a11-4301-4b68-be2a-c1b557ba5e43_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_8a020bc3-8c52-4007-a933-a1c7644dadc5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities measured at fair value</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_cc11b3a4-5cfd-45a8-82b9-6b0530922882_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1da672ab-b8ff-4c8f-b371-2e79cf197fad_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherIncomeexpenseMember_d3084310-1d9f-4f95-b652-5521f74012b3_terseLabel_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_463b172e-8b35-4cb2-b4c4-54ac87d82029_verboseLabel_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_label_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:label id="lab_syk_OtherIncomeexpenseMember_documentation_en-US" xlink:label="lab_syk_OtherIncomeexpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember" xlink:href="syk-20211231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherIncomeexpenseMember" xlink:to="lab_syk_OtherIncomeexpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ecb89af6-8e35-45bb-aeb1-b7813efeaab5_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_43c40714-60d5-4546-86e9-84320f60358b_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending uncertain tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_305b1eef-7320-4a3f-be5b-164da33be4f1_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_939e5e9b-d0fc-4b49-9659-bc706c5df462_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_eabaa869-14dc-4f7b-b1ae-8c54434025d2_negatedTerseLabel_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax related to repatriation of foreign earnings</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_label_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:label id="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_documentation_en-US" xlink:label="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:to="lab_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_94cf876a-5a40-4166-bcb4-7409a97b912f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TermLoanMember_ddf8f2d8-9c6c-4d58-b68f-7673a89572cb_terseLabel_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_syk_TermLoanMember_label_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_syk_TermLoanMember_documentation_en-US" xlink:label="lab_syk_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember" xlink:href="syk-20211231.xsd#syk_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TermLoanMember" xlink:to="lab_syk_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_0f5d00a4-48c3-45da-a1a0-27348b150f56_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_b58e7f5e-4cf7-42b3-8426-c5a51959ee2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a6e9ebe0-4f49-4f6e-b982-91291d075b5b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_d874cbcc-0d08-4c8a-9b21-37f3032c3cad_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialDataAbstract_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Data [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract" xlink:to="lab_us-gaap_QuarterlyFinancialDataAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a0e45ed1-afce-473d-81b0-8ce784837c6b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_5ac6caf4-1d35-4195-93d0-9652e2400e3c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_c7052770-d6aa-4c34-a990-a1c106b3e997_terseLabel_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall-related payments</link:label>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_label_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrual for recall expenses</link:label>
    <link:label id="lab_syk_Changeinaccrualforrecallexpenses_documentation_en-US" xlink:label="lab_syk_Changeinaccrualforrecallexpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in accrual for recall expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses" xlink:href="syk-20211231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_Changeinaccrualforrecallexpenses" xlink:to="lab_syk_Changeinaccrualforrecallexpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_304e704e-7036-4760-aea1-3dd4c00fe6db_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d0264685-f76a-470d-a07e-109bd7f74c3f_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Credit Facilities</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_14b94f76-f30a-4ea6-948a-450ed98eb379_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Statement Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_c94dbbdf-2105-4b98-b7ee-497ff2351760_negatedTerseLabel_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="syk-20211231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_d30327b0-e7cc-459e-b190-bca718eafe29_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0f36b357-461d-4922-beae-0616ef40c381_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Exercisable at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_5c419b51-c70f-4a3f-bc63-f46c9170a629_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_8292ca2a-409d-47a3-b1db-16cd58f996d2_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_ee554498-aaf0-4edb-80b2-5279be721a8a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign government debt securities</link:label>
    <link:label id="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security, Government, Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_ForeignGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_b994a879-4e65-4c9b-a005-2a77006f9435_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Options outstanding at December 31 (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_213e5836-d831-4cc9-b8fe-099565234d51_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_45613104-fc31-42d6-8b6b-bfc88e3a04f6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_113b7ff5-8b27-4b7f-8424-7baa38e520f6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_f8af7849-8be0-427a-b4dd-f55ad8b0192a_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_c81e3a72-92e6-4674-ad83-f86ad572b803_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_4cea46a1-21a6-439b-b516-f64757edbeb6_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_47d47a51-deef-487a-8b59-c6f79e63a395_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gains (losses)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_33d16053-f850-4c16-827c-10d52e0366c3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment operating income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperations_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_1432f337-435c-4432-a998-36c019edd805_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_32b5e9a1-e383-47c5-9834-1bceb290c78c_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_ec5f5568-0089-4f60-ab21-d324694fe0a0_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_a6210028-4807-40ed-a3f8-4a4df1a76c50_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product-related liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNetAbstract_a8e81525-2c85-4a2d-8936-437829b7dae8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories:</link:label>
    <link:label id="lab_us-gaap_InventoryNetAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNetAbstract" xlink:to="lab_us-gaap_InventoryNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b458187d-4d43-4d77-bb8c-9557a8aa2327_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost not yet recognized, period for recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ebbd9604-285e-46d9-b1f6-80c17efcdd6e_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7f9c0cfa-f4b8-4eb9-897e-4c7cf02fa9fa_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_59c3b4fa-b9ac-4e6a-9a4b-d8703e14345c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions and adjustments</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_cc34c06c-0ca5-48f1-a521-2aeaec278d44_terseLabel_en-US" xlink:label="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future regulatory and commercial milestones</link:label>
    <link:label id="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_label_en-US" xlink:label="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Future Milestone Payments</link:label>
    <link:label id="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_documentation_en-US" xlink:label="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Future Milestone Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:href="syk-20211231.xsd#syk_BusinessCombinationContingentConsiderationFutureMilestonePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:to="lab_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67c88714-6b4f-4717-8104-9bfe7cea3fdf_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a5eafe53-0a8e-4b03-abaf-e0c1110f9ff3_periodStartLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_41f9b4be-f786-4d88-a5d6-1285222c3c18_periodEndLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), End of Period</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_01729090-b40e-481e-93ac-aabc4c6587c9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ea411492-e9c3-4860-8323-c6ba960494b6_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_c3b9656e-5e9f-4eb9-9c03-7748288126fc_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_4df8913a-e050-49e1-af43-e8917faf6591_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded status</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Funded (Unfunded) Status of Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:to="lab_us-gaap_DefinedBenefitPlanFundedStatusOfPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a55e9c10-6ed2-4504-bc07-037c84517da7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_be4bd672-dcc4-4556-9fd5-4b60f0e4213d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_0802aa69-be8b-4c84-9a2a-e2de3a2bdff7_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_c1bd2d52-0850-4d8a-adea-b15d504fa514_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3ba633f9-5c55-4908-8e75-0ed3a61297e4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_94c37b56-3994-4fa1-8da2-c4993c7316a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of RSU and PSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_779b62c6-4d7c-4973-a1ab-fc728b6df103_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_83960318-ab95-432f-ba14-49bc84f30b4e_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4ca9df60-1940-4bec-a14c-2c4f5c865d26_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_ea0107f0-1eef-4607-b380-0e3b134162a5_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_0d33f427-e28a-433f-8d0b-19cc4bd231c3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_e6ba216e-d90c-48ed-814f-997f1eecaddd_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_d449db36-81c7-4692-9a34-7110e49b97f6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_08c147ad-7dfb-40aa-abeb-228b8d5d3306_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_7d78aebf-21bc-478e-8d0e-bb021cfad825_totalLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_cf1d368a-ed62-4011-8c35-c89e301a17d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Costs of Retirement Plans [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_dd040266-cb4c-4c65-b22d-543837fda39b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_b468250d-7fbe-4225-aed9-93ad9b5ce101_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unresolved Income Tax Positions</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Income Tax Contingencies [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_1a29369a-a029-4b02-b496-9f56858cc55f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_3ee84825-b3cb-4ff4-9ca4-11fe895a2bc2_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes410Due2043Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.10% due 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes410Due2043Member" xlink:to="lab_syk_SeniorUnsecuredNotes410Due2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_e6f498c7-628c-4754-9b34-1cc152654fa7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_7161b060-b886-43c5-933e-6fe5467d9425_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_97da3ba8-c539-4a56-be4e-6afdeba09b93_terseLabel_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, value as a percentage of total plan assets</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_label_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:label id="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:href="syk-20211231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:to="lab_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_250919b3-bea4-47e0-9a23-3e993402765d_terseLabel_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of sales recognized as services over time (less than)</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_label_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:label id="lab_syk_PercentageofServiceRevenueRecognizeoverTime_documentation_en-US" xlink:label="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Service Revenue Recognize over Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:href="syk-20211231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:to="lab_syk_PercentageofServiceRevenueRecognizeoverTime" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_f9117fa0-0bda-4df9-a644-96a93a03c9c3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_4f979723-f0cd-4c16-81ff-ed54d71b788d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest and penalties</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Examination, Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_7800773a-7034-405b-aa35-ba59d8e015b6_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of dividends</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_b7493084-4feb-47f6-a8b5-01829ffd76ef_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_2feb1996-c046-41a5-8056-05726fbc004d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current income tax expense:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_355f1a6f-688f-40df-89b9-46e5df493695_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_0b2c3c57-cc9f-48df-ac0c-97c56a57e644_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized net actuarial loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_e4ccf322-d32c-47fb-87a4-64925a5f597e_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_6892f6ea-1170-488a-b29b-99b687d4b0c5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AuditorInformationAbstract_label_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information [Abstract]</link:label>
    <link:label id="lab_syk_AuditorInformationAbstract_documentation_en-US" xlink:label="lab_syk_AuditorInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract" xlink:href="syk-20211231.xsd#syk_AuditorInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AuditorInformationAbstract" xlink:to="lab_syk_AuditorInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1098c3de-2ca5-4a5d-84ef-0ebfa584129b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, $.10 Par Value</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_69b9f593-c9d7-4b1f-a17d-d6ce86b910c2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_7f1bc32e-65bd-43eb-a6e5-2ca77b5af8c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_3df6fabb-77a9-4a07-8675-d7c144be3356_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Data</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8bed8d11-b8f5-4120-b01e-12f27675987a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_94607bfc-5dd3-478a-993e-0e628dd2920f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment net earnings (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_a090500c-b0c6-4911-b0bc-0244029cd5a9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense funded with Stryker common stock</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1edf0f63-6888-45cb-9a41-5263c957ff82_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_25b4db1e-f7fa-46b9-9082-cd05d1db86c3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0a8217db-e67a-41dd-b32e-bbfce5be4660_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_f16004a8-e316-4d12-a822-2cab71638286_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_641c57e9-a6e8-4482-83fa-da56624ceede_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_7dff2c10-8ca0-45fb-88fa-b055488392b6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_33fda65e-2661-4be9-a1bd-35d2c72892f6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_cd919c46-7142-49e9-a731-7de0ab0e5c14_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment:</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_a5e39ff1-dd0f-452a-999d-1dedb85503c6_terseLabel_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_label_en-US" xlink:label="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:to="lab_us-gaap_AOCIAttributableToParentNetOfTaxRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_4307f733-3832-45cc-b069-b31b42d4616d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8bf7e43a-a797-47c5-b05b-9194b1878f49_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_77cb460b-ddf6-44f2-907b-bf9efb3db6ea_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_fe76bec2-7d7c-4833-a241-278841e0ecaf_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.125% Notes due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.125Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_1d8497ed-f48a-4360-9b0d-5a1e4e3e2410_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_1c1d4329-3db5-4e89-8329-0b9cecec0b7a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027-2031</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_fd2b1240-b9fa-4890-aef0-a824c4b3063d_negatedTerseLabel_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical device regulations</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_label_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:label id="lab_syk_MedicalDeviceRegulationsExpense_documentation_en-US" xlink:label="lab_syk_MedicalDeviceRegulationsExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Device Regulations Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense" xlink:href="syk-20211231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedicalDeviceRegulationsExpense" xlink:to="lab_syk_MedicalDeviceRegulationsExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_01fc1918-f74e-4b10-9f94-ed5ca0f13275_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_893ff435-8fd5-4ee6-a29b-104e02c8df7c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_74777d43-280f-4f73-9fb9-adcc160b127c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_de895586-65e9-4741-9a60-77ce29ecfc10_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_28064bdd-496c-4714-8203-eac96f35f754_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_559044a9-425c-45b3-9e17-d27644e797b5_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_92252ba3-b24a-4fe3-91a0-c652428f78e1_verboseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_6248e4e5-e1ae-4054-83c5-a9b8ba413443_terseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_label_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_910bd1e7-4128-4f3c-9f0c-d467fcb702d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits paid</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Benefits Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DerivativeNotionalAmount1_657ff4a6-aff7-40ba-8cb2-5915b333bb07_terseLabel_en-US" xlink:label="lab_syk_DerivativeNotionalAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amount</link:label>
    <link:label id="lab_syk_DerivativeNotionalAmount1_label_en-US" xlink:label="lab_syk_DerivativeNotionalAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount1</link:label>
    <link:label id="lab_syk_DerivativeNotionalAmount1_documentation_en-US" xlink:label="lab_syk_DerivativeNotionalAmount1" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DerivativeNotionalAmount1" xlink:href="syk-20211231.xsd#syk_DerivativeNotionalAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DerivativeNotionalAmount1" xlink:to="lab_syk_DerivativeNotionalAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_d3a51ea4-9abc-4484-993c-c41f132283ca_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_label_en-US" xlink:label="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impaired Long-Lived Assets Held and Used, Asset Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:to="lab_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalFees_4b65fccd-3f7e-406f-aea4-deb1ab7fe3b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory and legal matters</link:label>
    <link:label id="lab_us-gaap_LegalFees_label_en-US" xlink:label="lab_us-gaap_LegalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalFees" xlink:to="lab_us-gaap_LegalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e9795232-313a-4747-a268-6f3134a046af_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investing, net</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_fd87b50f-a328-46cf-8a2f-69a077c7ed3c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock, shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_bcdf3e2f-cb6a-4e6d-9258-6981b2907e06_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange impact</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6b7b4cae-2ff7-4c1c-8b6d-a447c94ce839_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_200f2aa1-864c-4dae-86af-8e5d926af00d_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward, valuation allowance</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardValuationAllowance_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:to="lab_us-gaap_TaxCreditCarryforwardValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_4b5bf0e3-ba1a-4f33-8502-6e4635e2d9ea_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_e16efd54-070e-432e-80a5-cf95de4ded30_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, fair value, net</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fair Value, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d104105b-6d12-4318-bd07-fa1f00775059_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_d2dcc274-e909-4a80-83de-232d1af49ad6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Employer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:to="lab_us-gaap_DefinedBenefitPlanContributionsByEmployer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_1e911a7a-25d5-4096-9f31-05e258b87222_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending accumulated benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_04141072-febf-4ac7-8050-a7a8107688fe_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_fb21df2d-7914-4c64-a17e-cbe184f74b53_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_fb65b1f7-f3cc-4064-8c5d-777b100741b5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_38983359-590d-405c-b813-0fa47e7f95fc_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.000% Notes due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_32e8da0c-be0d-458d-af4e-a80ed70305f6_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.000due2031Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 1.000% due 2031 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.000due2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_9b472c0d-598e-458a-8246-980e3e4c88a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_26837fee-3a78-4bc7-8cc8-ab831d54dbbe_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_59d45d93-efe8-43b2-a639-aecc39baa768_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db362d66-e96d-4e34-8620-7228597ac7c5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_54045985-398b-4fff-bc97-f993873e062c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Options outstanding at December 31</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_15a55937-9a43-4f56-a842-34ac3d865551_terseLabel_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_label_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets [Member]</link:label>
    <link:label id="lab_syk_LongLivedAssetsAndIntangibleAssetsMember_documentation_en-US" xlink:label="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:href="syk-20211231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:to="lab_syk_LongLivedAssetsAndIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_e3eae697-940d-4143-b026-5b89a5ab6558_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_8a517e7a-ca9b-4def-b457-881c102f2698_negatedTerseLabel_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liabilities</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_label_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Product Liabilities</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_documentation_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Product Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:to="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_b7c50324-0483-4fd8-aaa5-797efd1fc227_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_5e2c17c1-f74f-4f16-a0f7-a6aba370e0ae_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Fair Value of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ae3b8990-154a-46e7-95b5-763ef8351fc4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_476fe712-7058-4697-a620-e57bfa12caaa_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_0b1313db-648d-4387-af52-5295b10990c0_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized net actuarial loss</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8f73c19d-fdcb-401c-a845-69ec4530eb36_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Exercisable at December 31</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_5f3c4710-b702-431e-8919-120f3eca4cbf_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_PurchaseObligationFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_cc64c565-5fc7-4e21-a0af-3c04d296f4f8_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_878143e9-fba6-4339-a7d9-f7153514efc4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_92d92a29-25cc-412d-ba29-ba258c8503d4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9c403952-9d66-441b-b5cc-8310fafb6e78_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchases of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_97361cb6-fc3a-44f0-a974-88b02f2f0b9e_terseLabel_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_label_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:label id="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_documentation_en-US" xlink:label="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:href="syk-20211231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:to="lab_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_398730ec-56b7-4bd5-8d2a-dc6fea81dd04_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025 [Member] [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:to="lab_syk_SeniorUnsecuredNotes3.375due2025MemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_bd595f59-c6fb-4fa1-93a1-fa17b1e79157_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_869c951a-7f14-481c-96bd-7def8597fc95_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_3d7fe92a-f30a-40b7-9085-0ff2011e07e3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Expected Benefit Payments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2021Member_c90c2236-413e-4c32-bee9-84ab44f00463_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2021</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2021Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2021 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.125Due2021Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125% Due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.125Due2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1e38272e-91b3-48d4-a271-3e8c4301006d_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_6cabecff-52c5-40c2-95d0-95d78799261d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_bcdfb353-920d-46e1-b034-81f69b1170b9_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes4.375due2044Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 4.375% due 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:to="lab_syk_SeniorUnsecuredNotes4.375due2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_a49ed690-8c44-4e19-be22-9ba2ca084270_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_e3971304-4069-439c-a0c0-4a1375b0d7ba_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_287f35f4-3250-4cc3-8a3e-629a1947b39e_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income (AOCI)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_f2476f6f-6118-45e7-88ee-d07d6dc2b657_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_585406f4-5cd3-47e2-b097-6d4219441d9f_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_bfd485f7-96e7-48a9-b177-80d607664d6e_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_c51949a3-fb28-4d2c-90df-4fdf54fc3dfe_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_4f3e40ee-583f-4748-8862-d8c54f0de153_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) expense:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_39a120e0-0c28-4618-a4cb-d2dcd9565e59_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_24a8b8b5-8f17-417a-b824-24d0b856d99f_terseLabel_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_label_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:label id="lab_syk_DeferredTaxAssetsDepreciationAndAmortization_documentation_en-US" xlink:label="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:href="syk-20211231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:to="lab_syk_DeferredTaxAssetsDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherOrthopaedicsMember_773fb4b8-3d42-4569-ad21-7f445f7936c0_terseLabel_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_label_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Orthopaedics [Member]</link:label>
    <link:label id="lab_syk_OtherOrthopaedicsMember_documentation_en-US" xlink:label="lab_syk_OtherOrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Orthopaedics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember" xlink:href="syk-20211231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherOrthopaedicsMember" xlink:to="lab_syk_OtherOrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_875c7c8c-7b14-44aa-80f3-a5eefae4d794_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_206583b8-05ea-43d2-818f-08264f67f1d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_dd23b01b-1d28-4a1c-841d-faf97acea91c_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_7c6e26d3-8f03-4d67-947f-4487aa07f78e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_6ba65e91-8a29-4096-a144-7f91bcd60395_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_ba5168a6-dbff-426f-affb-79aee03f527a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_6b58a5f5-066d-41d3-a5b9-7234e4e62460_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_a2318285-9da6-4f61-a8f3-6f205ce9c2c1_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_075afbf1-d213-40a1-afc2-8913627866b3_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.250due2024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.250% due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.250due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_04e9ce2f-5d65-4ba5-b84a-76e11c7cb26d_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_ef3d22ca-2302-406a-a417-206f69ad138e_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_939c0640-889d-413e-9816-d2a4e7bacdf4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_bbd61f30-2fad-4cc3-b460-c33e92aaf268_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6eb459c2-5f77-42f5-9b2b-278c6cf8afe9_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_8df93df6-61ca-48c3-aa9a-45b768ae1f9a_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_8e9f9ba4-0b50-445c-84b8-7584720c8026_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_b63bb1d4-02f7-486d-a81d-59840410be52_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity securities</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:to="lab_us-gaap_DefinedBenefitPlanEquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f8bd8bbb-f1df-4bf6-92b3-87a1134d460a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_KneesMember_0b9b4f9f-b477-45bb-8b4e-806402676b26_terseLabel_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees</link:label>
    <link:label id="lab_syk_KneesMember_label_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees [Member]</link:label>
    <link:label id="lab_syk_KneesMember_documentation_en-US" xlink:label="lab_syk_KneesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Knees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember" xlink:href="syk-20211231.xsd#syk_KneesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_KneesMember" xlink:to="lab_syk_KneesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_8689e728-bd1c-4b2e-af5f-f697870085cd_verboseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States treasury debt securities</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_b137e0ae-cafc-4fa5-a3fd-8a13fcb51edc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_3aded576-20d5-43b0-b3e5-c32898fe69e2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_WrightMember_4968509d-e659-4f8c-af4a-6646fd437d8b_terseLabel_en-US" xlink:label="lab_syk_WrightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wright</link:label>
    <link:label id="lab_syk_WrightMember_label_en-US" xlink:label="lab_syk_WrightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wright [Member]</link:label>
    <link:label id="lab_syk_WrightMember_documentation_en-US" xlink:label="lab_syk_WrightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wright [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_WrightMember" xlink:to="lab_syk_WrightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_13e35ea3-daf0-4b5d-b44d-605018a77501_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0600Due2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.600% due 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:to="lab_syk_SeniorUnsecuredNotes0600Due2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_13ebfc3f-ec36-45fc-ba68-63f5780ae1b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_ef0816b7-fda2-47eb-b95c-7d84cde68dfe_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes350Due2026Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.50% due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes350Due2026Member" xlink:to="lab_syk_SeniorUnsecuredNotes350Due2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_5ad36b00-c5f4-4719-806f-d78e00b912b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_4be81737-ea55-4f3c-8149-9be724eb1a48_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncollectible Amounts Written Off, Net of Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_e5207e57-8dea-4c49-b329-5891f3ebebdc_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SignificantAccountingPoliciesAbstract_e1b2e0f4-c2c5-4a5a-aff4-385e4f832e8f_terseLabel_en-US" xlink:label="lab_syk_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_syk_SignificantAccountingPoliciesAbstract_label_en-US" xlink:label="lab_syk_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:label id="lab_syk_SignificantAccountingPoliciesAbstract_documentation_en-US" xlink:label="lab_syk_SignificantAccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SignificantAccountingPoliciesAbstract" xlink:href="syk-20211231.xsd#syk_SignificantAccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract" xlink:to="lab_syk_SignificantAccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_dc192151-d744-47c2-995d-799949178d7e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_2c1792de-d81b-40cf-8a45-68fda7bff3f3_verboseLabel_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through three years</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_label_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value</link:label>
    <link:label id="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_documentation_en-US" xlink:label="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:href="syk-20211231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="lab_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_5fefc483-06d7-4034-8e1f-1a9bc42f70dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Cancelled or forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_00151d01-bb9b-4a32-ac25-138ced783efa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_546b0e8a-77e4-4efc-b10a-63e0bb384b2e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1f9082b5-26fb-4fb0-ae28-2e3ee8eadd20_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a0738af3-ba9b-4fe1-a843-0d91fde198c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_f2aa733b-3ebc-4f5d-a787-72b1c3cb08c5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_5bad254f-e144-46fe-b818-7007191f1a26_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_3ec96ed6-4944-4e9f-a721-455bedd6ab1c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_2f40c804-108d-485c-afd7-5be44949333d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less allowance of $167 ($131 in 2020)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_05daf0c7-4b0b-43b0-9987-05d65c5b6d4b_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_aeda1b24-adeb-47f5-9ad8-da8b999f837b_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_ee9564f6-2082-48db-ac80-8ccad994ba4b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_9e55dae4-bf4c-458e-a13c-8789e9d3d5b8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_1181e990-0f87-42c2-8ebf-916f8dedfc77_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_f97fb09c-2e1c-4b67-95a0-156ee985158d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_fdaab5a4-434f-4d55-bb48-8d6e93d371d3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_be7d7618-db93-4551-abed-89fadeb7e545_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_87caea20-a404-4df0-980b-7c24a59ca849_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_fb8d5507-825d-4617-9d94-b85c04ecfd9b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e5984cf3-8c27-4a58-b4ae-91eb78c70e9e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_6d1fe5ee-f806-4011-a2b8-204b7b577380_negatedLabel_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall-related matters</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_label_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:label id="lab_syk_RejuvenateABGIIHipRecallCharges_documentation_en-US" xlink:label="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rejuvenate / ABG II Hip Recall Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:href="syk-20211231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_RejuvenateABGIIHipRecallCharges" xlink:to="lab_syk_RejuvenateABGIIHipRecallCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_1a8c1c29-446d-4053-8ae1-18cb4d5a94a5_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_f094e387-871f-403c-ab49-14e1735690ea_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_784f63f2-a159-4b5b-aa2d-598b9f011a0d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:label id="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_label_en-US" xlink:label="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:to="lab_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_71e7b00c-62d3-4e7c-946d-8b90424f2bd6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_d9512c2c-a506-4212-ad39-59c972a2354f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_1746f88c-9d59-4dd4-9cff-428459a025ab_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual plan asset allocations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:to="lab_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_07dbe428-8606-47a9-8ff9-ff5cc9c15c8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_e29052a5-a958-4aad-8fbc-a030352888ff_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0b11b36b-fc36-4565-a684-0cdc594c3af6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and Other Financial Information by Business Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_a4f868ec-c121-4c01-9db3-04423a908a39_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_774584be-77f4-407d-a24f-c9ad82f1494c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_984c092d-e8b6-4fe3-83ed-485d2c99d704_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_89b20bc4-65b0-430c-ab2d-5ce08c323492_terseLabel_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, buildings and improvements</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_label_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:label id="lab_syk_LandBuildingsAndImprovementsGross_documentation_en-US" xlink:label="lab_syk_LandBuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land, Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross" xlink:href="syk-20211231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_LandBuildingsAndImprovementsGross" xlink:to="lab_syk_LandBuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1e589a19-56e3-4b58-ba9d-b57f5d2adf6a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_82ebaea2-3949-423b-af53-2504c08ba301_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_9a036f87-65e5-49c7-9859-39b0022d0734_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b09bb5b5-6e35-4345-b7dc-d7bb362b8ff6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_816e4f66-c135-4fb0-9822-aa9d2e6503ee_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cec10a67-c8e7-4379-9f5e-4c61b2e906a8_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8f08c423-4004-4654-9b8f-ed12f49e095c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_ce7e3d00-8ce3-4bae-9c86-8ba9ae4ece5b_terseLabel_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_label_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:label id="lab_syk_CapitalExpendituresDuringPeriod_documentation_en-US" xlink:label="lab_syk_CapitalExpendituresDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod" xlink:href="syk-20211231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalExpendituresDuringPeriod" xlink:to="lab_syk_CapitalExpendituresDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_6ad1a4b2-30a6-4305-930e-bdab3fc4148f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_3a524186-2527-4a33-9aa9-76a144d27f57_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par per share</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_72a71554-23af-4da9-b806-3cf207829e86_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_3551ee45-0dac-41bb-af94-65bff23cf730_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_326823ec-64d6-47e3-b88d-d73b6bd06de6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value per share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_707a1413-f2a8-4c48-9540-81bbd98c336b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e2bb142d-a86b-4897-b24e-46280e21a882_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_bf367f29-76a4-4c45-931b-22c267f0f09c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_551dccc5-52d7-42bc-8b90-afd3e205574d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial statement translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_c1bfa58e-77e8-4943-be1e-fdd2baa58b20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the ESPP</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_584deb81-727a-4ded-8918-0416d8faf7d5_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.125% Notes due 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.125Due2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.125% Due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.125Due2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_TraumaandExtremitiesMember_f789d95c-9c3d-4ec1-9f4c-2a53f7f96e0d_terseLabel_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_label_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:label id="lab_syk_TraumaandExtremitiesMember_documentation_en-US" xlink:label="lab_syk_TraumaandExtremitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trauma and Extremities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember" xlink:href="syk-20211231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_TraumaandExtremitiesMember" xlink:to="lab_syk_TraumaandExtremitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6659cadd-e58e-4af6-ad25-3f098f1f53d4_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:to="lab_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_af5fe145-184c-4058-af46-840a39d80517_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6df24486-b9c7-4787-b1cb-5a4faa5575e7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_5d6e2ba2-6417-4267-b466-261c10769b2b_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaper_3e0e9163-e701-45f2-90b7-e5b18d2497a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaper_label_en-US" xlink:label="lab_us-gaap_CommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaper" xlink:to="lab_us-gaap_CommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_99a2953f-7c2a-4d78-9145-b30ff84d75aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise&#160;Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_365d57f7-46dc-4610-bcb1-167599854536_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_HipsMember_7e0fe3e3-ef32-4d8f-b0c5-82a9a886ff78_terseLabel_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips</link:label>
    <link:label id="lab_syk_HipsMember_label_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips [Member]</link:label>
    <link:label id="lab_syk_HipsMember_documentation_en-US" xlink:label="lab_syk_HipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hips [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember" xlink:href="syk-20211231.xsd#syk_HipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_HipsMember" xlink:to="lab_syk_HipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_eb2dc2c0-1e09-48a7-b19e-e9ffe5577c10_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under stock compensation and benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_62a28d78-cadc-4ae2-9a17-6d03b5b7b1db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_ebf92498-aae8-4d82-adc9-8ff3461e7d7f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_025bfdfa-3dc8-4539-9d29-19531f4b244a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionAbstract" xlink:to="lab_us-gaap_RevenueRecognitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_ca16423f-d737-46fe-bc31-aa9d2892c398_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Allocation of Plan Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_772c28e7-67c8-4dca-93a0-07e7026fa08d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Accumulated Postemployment Benefit Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Projected Benefit Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_de5b522f-978b-4ffe-9069-2bec48f13493_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.150Due2025Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.150% Due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.150Due2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_34f7049a-1975-40a2-8735-ab671419912a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_c7bcbfab-9e3c-4c36-b286-108768a4ebf3_terseLabel_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_label_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine [Member]</link:label>
    <link:label id="lab_syk_OrthopaedicsAndSpineMember_documentation_en-US" xlink:label="lab_syk_OrthopaedicsAndSpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics and Spine</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OrthopaedicsAndSpineMember" xlink:to="lab_syk_OrthopaedicsAndSpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_f5c4273c-56f2-428a-9e4d-5d76470e21cb_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c6d2f85d-1515-412d-a09d-cbe32ce82705_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b4497435-3771-4baf-a0ac-859343578d52_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_2dff8b5f-23dd-4fb6-9d65-132cba54a216_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6ab5a199-3d92-4383-a44c-189061140e4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_9ee7fd03-3dd3-4743-aa9f-ee90b6f46cf1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_16599094-ef1e-4c10-8583-1940ddb99fb8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less valuation allowances</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_a1c00522-2d95-46a3-9e35-05676395b6b2_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_c692e262-e5dc-4460-b8b4-4ce3fa368649_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_5d0321e7-cd8f-47cd-aa6b-3e119906f0c1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains (losses) on designated hedges</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_07465b01-87b5-4cb6-a5c8-a023b4ff396c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_097531df-7adb-4694-b7eb-22339f933e97_verboseLabel_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation arrangements</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_label_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities</link:label>
    <link:label id="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_documentation_en-US" xlink:label="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:href="syk-20211231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:to="lab_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_2e2e308b-c788-49a7-afce-f5dcffdbfc7e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived intangible asset, useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_aa8e0ea0-b3e1-46ff-920f-b3e75a52869a_terseLabel_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</link:label>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_label_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment [Member]</link:label>
    <link:label id="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_documentation_en-US" xlink:label="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:href="syk-20211231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:to="lab_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_3f7e69b8-c6bb-44be-9b0a-b36c7255fbf4_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_1e5426ec-3d9a-4147-b6c5-dd5f61e42424_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_f487614e-4a3f-47ab-82c5-b37bd9652d29_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable, Trade</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableTrade" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3668dbe3-5473-4205-8752-3bc43b6e8547_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_a8adfbf1-72ee-446b-9f87-7e55fcc8314e_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermDebt_b352574b-a313-4e14-8284-a24130ac1ff0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term debt</link:label>
    <link:label id="lab_us-gaap_OtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_OtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermDebt" xlink:to="lab_us-gaap_OtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_a6fab1a0-194b-4479-b8e7-8f383d600f53_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange</link:label>
    <link:label id="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_label_en-US" xlink:label="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Translation and Purchase Accounting Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:to="lab_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_c89d9b5a-ce6f-45fe-bd2e-0c7aa3ca1fb2_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedge gain (loss) to be reclassified within twelve months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6ce0a2e3-53df-43f9-9d76-a0c450d959e8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_ce8aeb46-ca06-4133-8eaa-b4a1179f23dd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost and transition amount</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cf1b44c6-d18e-4344-a58e-37c5687778b5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_b1c38d62-6dee-44aa-b17a-a7244dd7a94b_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_77d5b13f-f287-4720-9c9e-37764fde596b_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a49797d5-4a83-4bd6-bb76-69b211d83d28_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_cacf925b-7938-4a6e-b106-71a72345f51a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest on debt</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_02b63048-caac-4ce4-9eea-e122b43d7c7a_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f2ca41bf-0bc5-4688-8ad0-7243af4c4e3c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_bb470cf0-d4d4-4c1c-bf5d-7ccda5561598_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOptionTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueOptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Option [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOptionTextBlock" xlink:to="lab_us-gaap_FairValueOptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_59680960-7ca7-45bc-a4b5-e26b98c1c881_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_5e4d72e3-492c-4c25-a323-6476b6f397e4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, development and engineering expenses</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_fab7b3b4-e581-40bb-a589-b37485e41a26_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_deb7a27e-8423-4f93-9314-f10cb1b2f858_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_VoceraMember_25320c34-029c-4697-8f5f-bd404719c329_terseLabel_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera</link:label>
    <link:label id="lab_syk_VoceraMember_label_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera [Member]</link:label>
    <link:label id="lab_syk_VoceraMember_documentation_en-US" xlink:label="lab_syk_VoceraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vocera</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember" xlink:href="syk-20211231.xsd#syk_VoceraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_VoceraMember" xlink:to="lab_syk_VoceraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_71b4325e-fe43-4c74-82b1-161daeaf8070_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CreditAgreementMember_3409472a-7aa1-4a90-bad1-a9b8def22b28_terseLabel_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_syk_CreditAgreementMember_label_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_syk_CreditAgreementMember_documentation_en-US" xlink:label="lab_syk_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember" xlink:href="syk-20211231.xsd#syk_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CreditAgreementMember" xlink:to="lab_syk_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_b1df4cc0-ac7c-47a6-9d2f-82eac570ca21_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_c96b7052-f0af-4dcc-a104-d8d00c1afd39_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_b21eb558-cb80-4652-b700-56eeb6652b72_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Undistributed Foreign Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4890e191-63b8-4505-bc95-89cbb1dcab06_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_5a82a12f-6390-4a07-8311-a1acacb59767_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforward, amount</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1a81c616-4940-4c3f-ba71-a97438c40157_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_4ffcaf1f-e92b-4af3-b9aa-f9ca0c1d5b4c_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_5e3d5206-1fcc-4483-a098-387908d96213_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_2f4c1680-ea4d-4595-a48b-285b8a8ef4aa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation, Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_ab34beb3-73bd-4acb-96c9-3879c3e17e4f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e26eb81c-0301-44df-aa24-43a9dd2cdbc8_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7d524cef-f9ee-48a4-8ef9-6fa251a6ab7b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ac406f17-eee7-45b2-aa43-0c8bba558ba4_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share of common stock (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7ae77dbc-a38c-4c06-a1a8-5cb76215a218_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_7db8589b-fd52-4c25-80b9-6f5e9ec71e38_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_b7667db7-5f97-45ec-b727-52e6d748f75d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of dilutive employee stock compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_9f07f51a-f691-4e11-8616-7820927077bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_6a55d085-140e-4e3a-937d-5acb1d7d2dd6_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_b62db373-7cae-451a-8cc2-a5986f68ae13_terseLabel_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Purchase Obligations and Minimum Lease Payments</link:label>
    <link:label id="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_label_en-US" xlink:label="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Obligation, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:to="lab_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_c22500e2-0f3b-48de-b039-201ff0a837d7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized prior service credit</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:to="lab_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e66830dd-d777-4f65-9c07-3382d7aa009a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_1e2e23fa-0744-42ab-9145-b51982e97e2b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes, net of refunds</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_b638ea50-d5e2-4b7d-8902-697d2c741855_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes2.900due2050Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.900% due 2050 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:to="lab_syk_SeniorUnsecuredNotes2.900due2050Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_6ef8e328-7045-4a96-959b-605b5b1f905e_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_67310f59-c08c-487c-8500-59e08baf49f1_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c180ca38-1418-44f9-b5f4-80af6ed74519_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_bc7b0fb4-97f8-405e-a033-e819cf21d003_terseLabel_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Quarterly Data (Unaudited)</link:label>
    <link:label id="lab_us-gaap_QuarterlyFinancialInformationTextBlock_label_en-US" xlink:label="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:to="lab_us-gaap_QuarterlyFinancialInformationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_19e2aa72-a01b-403a-9b72-c545978e8ee0_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_ea6ae545-d936-4c7e-90c9-83523749d25c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_d9725ab1-3eee-4b5d-b061-4b74045f46ba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bd365ba0-c761-4f7c-ab26-7a568289cf58_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_0d2042d3-c0d7-46ef-9eeb-43ebddc5ef12_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_07c7d66b-6ff4-44a4-b913-1de689737a99_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares outstanding (in millions):</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4492768a-7219-4e48-a7f1-b14c7b1e8b20_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities&#8212;Other liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c2cf5609-1a75-458f-864f-74ae079081b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_18c4d1f6-8d8f-4f3c-a767-c3fbc08d7b6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense and penalties included in other income (expense), net</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_b85189ea-d3f8-42a2-a855-999207777dd2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_41f67bab-0618-406a-8f37-44eea0d982b9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SpineMember_75c73b8f-371f-4ef1-883d-af3b0c3a3637_terseLabel_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine</link:label>
    <link:label id="lab_syk_SpineMember_label_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine [Member]</link:label>
    <link:label id="lab_syk_SpineMember_documentation_en-US" xlink:label="lab_syk_SpineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember" xlink:href="syk-20211231.xsd#syk_SpineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SpineMember" xlink:to="lab_syk_SpineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_2a21bfa5-eb75-4bb2-8f4d-0dcc6784887c_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_76acb48f-177d-4609-9213-54f7acc87f6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bdd8b34d-d2da-4db0-9c5c-8e950f840115_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_OtherForeignCountriesMember_319524ca-70f1-4c6e-9cc6-f0d66f8dd70a_terseLabel_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_label_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:label id="lab_syk_OtherForeignCountriesMember_documentation_en-US" xlink:label="lab_syk_OtherForeignCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other foreign countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember" xlink:href="syk-20211231.xsd#syk_OtherForeignCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_OtherForeignCountriesMember" xlink:to="lab_syk_OtherForeignCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e2a09d82-a8dc-4229-9fd7-989c65ca2ee3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_1cf0c3fc-9761-4da6-9a29-c62cd54b7d74_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_786f5124-c018-475a-a0fa-d5b8b2042061_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_d07bbd88-0039-407b-936e-e446323e9d8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_b7ac4f70-a9c5-4d01-b80a-ac44f1e7e2de_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes1.950Due2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.950% Due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:to="lab_syk_SeniorUnsecuredNotes1.950Due2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12gTitle_1a1f32da-5f4f-44d8-9b0f-899c100895d9_terseLabel_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:label id="lab_dei_Security12gTitle_label_en-US" xlink:label="lab_dei_Security12gTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(g) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12gTitle" xlink:to="lab_dei_Security12gTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_778b3408-be78-4af7-a0cc-fe3f20380775_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_950a14f6-7334-42d7-8d65-dcb8548c5f45_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities:</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_f1dcff8d-cafd-41b0-b68e-0debe599a70c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_31597f44-0c71-41bf-a76e-762abc267dc8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_16294648-219d-43b3-b065-b8dd9a08e4bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_47d73df6-2022-432c-bc1d-c3126ef1fdf0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_33fc6790-2f9c-47c1-b018-81e2a2d7913c_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_4d83ade7-482d-40be-b0c9-a24d98ada82a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_17397651-1c6c-4c4a-84e7-6e676d9f71c0_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 1.125%, due 2023</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2023 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2023Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_40c3820d-6ec8-4919-b6e6-82a1397e923e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CapitalStockAbstract_7c113c5b-7339-4116-a2b1-62940af12347_terseLabel_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_label_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:label id="lab_syk_CapitalStockAbstract_documentation_en-US" xlink:label="lab_syk_CapitalStockAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CapitalStockAbstract" xlink:to="lab_syk_CapitalStockAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_fce2f94f-31b1-4520-999c-d89217af378c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_ed8c5d9e-d807-4276-b3ab-0a9fcbb4ddcb_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_871a204b-686d-4ebe-ae71-6aadb0b48412_terseLabel_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred, price per share (in dollars per share)</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_label_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Price Per Share</link:label>
    <link:label id="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare_documentation_en-US" xlink:label="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:to="lab_syk_BusinessCombinationConsiderationTransferredPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_dc0755be-c97d-4a7c-bd71-1c756c9b112a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_4602cb40-e13b-4700-b9da-e2171f3cf0ce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Quarterly Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quarterly Financial Information [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_aaa4f457-5f71-4904-ac15-7c1353907f1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_0e570505-2adc-431e-b9c9-2908d5d66f07_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_632786bd-705f-4690-846f-8dbe047e2844_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States state and local income taxes, less federal deduction</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_15d2d4a8-bda5-42a3-ba55-f343f7e190d7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of time deposits</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_70b2aadb-20ad-4f6e-aff0-3ee796204ce4_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_2b9a6a3f-73a1-4055-b6d9-5c06f8d9a04e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_d867f8b1-62bb-493d-8af9-8d9029865c88_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised during period, exercise price range, upper range limit</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_a2d4f627-6609-400c-a356-3180e7822257_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_0f7ae098-a969-47d2-938a-8cec893471ea_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading marketable securities</link:label>
    <link:label id="lab_us-gaap_TradingSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_TradingSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecuritiesDebt" xlink:to="lab_us-gaap_TradingSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_bb76b028-862b-4d73-b624-7b68d970b740_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairments</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:to="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c1a07e71-d42b-422d-81e8-9aa15a20cfb4_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_34429161-6ea8-45ba-9691-8b7d3df305c1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Property, Plant &amp; Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_3d022e86-ebed-4eef-8be4-37f8d7af565f_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_63e4f848-67a6-4801-bab3-3866ac34e686_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_70e512cb-ae22-448b-acc6-1a8876786036_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Information about Plan Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:to="lab_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_f1028d7b-43cc-46c5-b9b3-fdd9be8f1e68_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_8051d422-7a52-4772-954b-bc2c6466c914_periodStartLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_dff975fe-e430-47e0-9055-17f9d6258814_periodEndLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending projected benefit obligations</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanBenefitObligation_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Benefit Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:to="lab_us-gaap_DefinedBenefitPlanBenefitObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_8596d76b-beda-4cc2-a60a-fc97804e009a_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, 2.625% due 2030</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2030 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2030Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_11774104-b880-403d-8735-97dd82e48297_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities Of Long-Term Debt Disclosures</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a05fe213-3257-46b3-9e7a-c65e395217cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_4c229aad-47ca-43b2-9f51-11a1b935ed06_terseLabel_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_label_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology [Member]</link:label>
    <link:label id="lab_syk_MedSurgAndNeurotechnologyMember_documentation_en-US" xlink:label="lab_syk_MedSurgAndNeurotechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedSurg and Neurotechnology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_MedSurgAndNeurotechnologyMember" xlink:to="lab_syk_MedSurgAndNeurotechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_07b8eb9a-4d01-4195-b352-3a7cf1e051e6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_f34d1419-2e5e-4219-9dbc-6077572f0207_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_87cc2008-4bb9-49a8-a16c-4ce86674a139_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d3294a2a-4bda-4e5b-9ff5-5e2cafbe9483_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings per share of common stock:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_380fb7bd-c0ac-4f60-b2b6-ff7a84ba1201_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_3fc0ffbe-379e-441f-914c-4833edf60b0b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_3984f576-0ba9-49f4-bb9b-1a5c10c08a0a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_380d4e7a-344b-42f2-acf2-ad61c5923f78_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_732cbd2f-aa15-4509-a2a4-430804b5f2c6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total recognized in net periodic benefit cost and OCI</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_423ea9b0-9c34-4e95-a586-da23aae080cb_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net sales</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_67884fca-06dc-467c-9086-59ca8fc3b317_negatedTerseLabel_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:to="lab_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_48ed0825-f44d-4f5f-904d-cce55191f0aa_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of gain (loss) from AOCI to earnings</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_6c46fcfc-1c76-48cc-a1ef-496de6134993_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_500bdd7f-2a05-4464-b5e7-9dca071ea7b9_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.750% Notes due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_a65bf963-546e-4d35-93c3-fb42d5438318_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes0.750due2029Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 0.750% due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:to="lab_syk_SeniorUnsecuredNotes0.750due2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_82240921-1add-4ede-927a-2fea2d9a2a4d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Options expected to vest (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_93240470-1607-4510-8edf-8054b613b8d8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_920fdc42-272a-4452-bbd7-167c7ece55b4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_GaussMember_cc46e127-4894-4704-b657-deff6a915e5f_terseLabel_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss</link:label>
    <link:label id="lab_syk_GaussMember_label_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss [Member]</link:label>
    <link:label id="lab_syk_GaussMember_documentation_en-US" xlink:label="lab_syk_GaussMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gauss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember" xlink:href="syk-20211231.xsd#syk_GaussMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_GaussMember" xlink:to="lab_syk_GaussMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_03b6b449-52f3-497f-bfe3-e5ef713e8aa0_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency exchange forward contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_1cc4e1fd-03d6-4df2-96bc-d98b21a21437_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Contributions by Plan Participant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:to="lab_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_66d5e9e7-a31e-446c-9926-46d5781ecc77_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options outstanding at January 1 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4222d58f-5449-4020-8fc2-4b37e3d80577_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, Options outstanding at December 31 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_9b690ff3-d5ae-496a-a238-e54a86cd397d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_ab5ee22e-dd9c-4600-b44b-499357688938_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, excluding current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_10e35a8d-d8b8-4182-a878-070c8444d704_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_4ff3b9f9-65e8-4098-a332-a293ed86b1a9_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_930f62ae-99e7-453b-b276-f4a861ebc8be_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_b1e753d3-da29-4bce-b498-f954eeffa122_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_6deef652-ba0a-4053-8b02-a7f6d490caf7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c2780b51-9f6e-402d-bffd-30d45633fc0a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Exercisable at December 31 (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_055aae1e-3e27-4c8f-a85a-aecb2bd2e055_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_7db88468-49da-4948-8b7f-0f9c314898f5_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Plan Assets, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_5b2d5698-e844-452a-a15a-bddb150adf1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1b3ee557-f36f-4eda-b905-5459009fa317_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_84ad5020-5f43-40ec-b21e-95de90eb97d6_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_a527536c-e89b-4e6e-a7cd-a6d3bf9c6e3d_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of possible loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_9acdba81-4979-41d1-ba1a-7f1745f60cae_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_8286e58f-d663-44a7-8db6-4fc36fa8a82d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OtherDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherDebtSecuritiesMember" xlink:to="lab_us-gaap_OtherDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_1f7350c3-1313-4b88-9a24-ff84ae5634b6_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_115c0d36-52c9-498f-9211-a7d9e3fd7d7d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated future employer contributions in next fiscal year</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_b767c52b-1143-4859-852d-24204c7d9ef5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_0fa73ef4-8dd0-4805-ad9d-bd6b7366ef85_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_0d96ac3d-ded5-4204-935a-83ff95d07965_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_A225ConvertibleNotesMember_142f966f-6c45-41a8-975b-db318e170e61_terseLabel_en-US" xlink:label="lab_syk_A225ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Notes</link:label>
    <link:label id="lab_syk_A225ConvertibleNotesMember_label_en-US" xlink:label="lab_syk_A225ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Notes [Member]</link:label>
    <link:label id="lab_syk_A225ConvertibleNotesMember_documentation_en-US" xlink:label="lab_syk_A225ConvertibleNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A225ConvertibleNotesMember" xlink:href="syk-20211231.xsd#syk_A225ConvertibleNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_A225ConvertibleNotesMember" xlink:to="lab_syk_A225ConvertibleNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3b30b0bc-0110-4b57-a22e-6638ebb757e0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a298a5b0-2959-4906-afa5-09fc3cc5bd2e_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_b2b60e8f-0b11-448b-8f49-d603bb2780e2_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_28f6d4df-dea5-4500-a6bb-be3ed77d9c02_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_5115be0f-2e5f-414c-99d1-a4dc4cfb840c_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_3a79fadf-bd61-402d-afcb-47c79b85c776_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_c9bddf26-a0a9-45cf-a826-e399d08d764f_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_0801a7f7-40fd-4f41-abda-55a541231e6d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_23a7c5b5-d049-488d-b1d6-0ecc17ea5e98_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ec0abd51-992d-4b96-b68f-9f63fe4058e3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_3e1d06aa-4861-468f-84b6-a6c6712a7e33_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ec88cbf5-2454-43ec-94ac-8bd046df205f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_e012dc14-4d0b-41ec-bf3f-c75848e51ac1_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_06725776-ba84-49d2-af74-cf2ed4b2aa04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Company's Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_95399233-6d0d-4601-8fa3-c216dcd86275_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_97d9170c-3ee1-46e0-aaa1-82f8507d63b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_74508ae6-694c-4282-bed6-8f3c5256eb67_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale marketable securities</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b5480e9c-fb12-4a91-b154-313a3f451d98_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_44c97801-767b-48b7-aff6-1a609bf78bff_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued product liabilities</link:label>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_99251266-1ea4-49ca-a51e-80a524a85e5b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_55a11add-b833-40f6-b5e1-5ebfd5352f29_terseLabel_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate used to determine projected benefit obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_label_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:label id="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_documentation_en-US" xlink:label="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Used in the Determination of the Projected Benefit Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:href="syk-20211231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:to="lab_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4e4e0079-480a-4f14-b415-b55a79e540b3_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_3e2d9945-9197-4838-835a-e95932f6d0b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_c2d085dd-fd69-4f46-b74a-87d863735881_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_88cd8c45-7596-45b5-adea-4322b1c98785_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_819a68f1-095b-4f3a-b41a-31ffca38ecba_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_25023fb2-d440-4014-a231-d1df9fe9f134_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f5e10f9a-f718-4866-be2c-5936b272e65c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5a7b16be-72e7-4a0f-ad42-6d910f386092_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_0aacaf16-1f4e-4b70-bd79-7fb786b4d6b3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statute of limitations expirations and other</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0369f19b-6e66-4e71-9407-b5c0c97d5aff_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedges</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_82445530-1e73-4623-a2b0-b71146713df2_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_5318e8de-c026-45c3-92a2-56ed8f27c295_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_9d6e0e45-5acc-4cbe-ae20-787a1e09cff0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_dbef6af9-0f3b-43e3-a338-3192248ceee0_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_bfc808be-984c-4797-a4b5-adf92dd1ed9c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_ef096fa6-3cca-4a8f-b313-2a532b70584d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c409792-8a4e-45dc-9324-5a205fdeba07_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_2f364106-21d6-4432-ab47-fc4a6e993c4d_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_a3f24932-ccdc-4297-b6a7-25ed59332ac4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a28ebe7b-fe7e-424a-8bc4-3fda45ae6ae7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_5a4f6b85-31ce-4424-834b-580ba51a517c_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_2a70f361-6f01-4d8c-ba40-463f444d472c_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:to="lab_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_0dece4dd-2d67-4148-a43f-e1048b5aad48_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4083bee6-f302-47a1-ad6d-f8ec317cba26_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2848ff50-5980-4925-858e-34b562120b7c_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less allowance for depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_e3685804-5955-46eb-a3b6-ba4e4e799439_terseLabel_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common and Preferred Stock, shares authorized (in shares)</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_label_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:label id="lab_syk_CommonAndPreferredStockSharesAuthorized_documentation_en-US" xlink:label="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common And Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:href="syk-20211231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CommonAndPreferredStockSharesAuthorized" xlink:to="lab_syk_CommonAndPreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a805e2db-b234-491c-8188-428a22c1b245_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2b6aebc8-78f5-4e52-a98b-328639ef3543_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value, Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_InstrumentsMember_f81a0ff3-0703-432e-bd06-b0763a01730a_terseLabel_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments</link:label>
    <link:label id="lab_syk_InstrumentsMember_label_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:label id="lab_syk_InstrumentsMember_documentation_en-US" xlink:label="lab_syk_InstrumentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Instruments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember" xlink:href="syk-20211231.xsd#syk_InstrumentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_InstrumentsMember" xlink:to="lab_syk_InstrumentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_2d3dc80b-b3b1-4baf-a0f5-3c956819dc4d_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_eee282f4-5816-46e8-8cb0-baf53243001c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_b7b20da8-e776-4499-a55e-a445a9022fcf_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected option life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_8c2b9760-fd94-44a3-8836-5fc9f28a9dd1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_a702f8c8-4503-48b7-a896-b3be410e5283_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1dce4c33-e951-4423-b9e9-59182655109c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes from withheld shares</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_92aadfd0-9a76-4eb4-bbf2-96db70df9e14_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_2198f3a3-d036-4521-aa0c-265284dadc52_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_7dedc836-4cb0-47d9-8432-00ab2b8f9125_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_937e4577-aa4a-4640-8531-adc373927110_terseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotes3.375due2024Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes 3.375% due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:to="lab_syk_SeniorUnsecuredNotes3.375due2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DebtInstrumentCovenantLeverageRatio_9f2bd063-182a-4c54-91ec-2cc58e775b9f_terseLabel_en-US" xlink:label="lab_syk_DebtInstrumentCovenantLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio</link:label>
    <link:label id="lab_syk_DebtInstrumentCovenantLeverageRatio_label_en-US" xlink:label="lab_syk_DebtInstrumentCovenantLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio</link:label>
    <link:label id="lab_syk_DebtInstrumentCovenantLeverageRatio_documentation_en-US" xlink:label="lab_syk_DebtInstrumentCovenantLeverageRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DebtInstrumentCovenantLeverageRatio" xlink:href="syk-20211231.xsd#syk_DebtInstrumentCovenantLeverageRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DebtInstrumentCovenantLeverageRatio" xlink:to="lab_syk_DebtInstrumentCovenantLeverageRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_18fa4439-3286-4f41-950a-9d334056bcc1_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_20ccacc4-1aff-431b-9d87-4258e2142b98_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification out of Accumulated Other Comprehensive Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8fd85524-0d12-4489-9bb2-6fa99dad1569_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_32b37414-904a-4f6a-a1f1-d181fcd2dcdd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, Options expected to vest</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ea723959-9a88-470a-8230-9f926102f7a5_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_04a67433-d322-43fa-8ce0-fa5072246004_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_e1a02f8b-089a-4937-9bb5-aa813a39e261_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_347bed7e-aa68-4f95-91b7-e025c338239e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_4768b944-c906-46bf-80cd-57d08debb37c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_b9b994ff-51e0-40ed-a98f-f20a9edbb805_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_b8ad76c2-57d5-465a-98a2-ce45b9cb664b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:to="lab_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_69b8057b-4391-48c9-9bc2-972bcfd38ba4_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, shares</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:href="syk-20211231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_fa2f118d-fe8f-43e1-a404-ebcdce53393a_terseLabel_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stryker common stock held by plan, amount</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_label_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:label id="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_documentation_en-US" xlink:label="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Retirement Plans Common Stock Value Held by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:href="syk-20211231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:to="lab_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_b36bbd9c-85c9-4ee4-939b-246463eed06b_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate and asset-backed debt securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_15621c45-f7d2-4286-b519-5afa0b7d19e8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_395e187a-f61a-4c27-9ab5-b5d4f766da93_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_32502337-a2d3-46fb-a576-45d43d8a5188_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Future Benefit Payment, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_EndoscopyMember_bfd0669c-a2c5-40c2-bcdd-413eb367934b_terseLabel_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy</link:label>
    <link:label id="lab_syk_EndoscopyMember_label_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:label id="lab_syk_EndoscopyMember_documentation_en-US" xlink:label="lab_syk_EndoscopyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Endoscopy [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember" xlink:href="syk-20211231.xsd#syk_EndoscopyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_EndoscopyMember" xlink:to="lab_syk_EndoscopyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_1408f19b-1d17-49e1-bb45-5f4b28aa5cfe_terseLabel_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recall charges</link:label>
    <link:label id="lab_us-gaap_ProductLiabilityAccrualPeriodExpense_label_en-US" xlink:label="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Accrual, Period Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:to="lab_us-gaap_ProductLiabilityAccrualPeriodExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_63b88a56-0aa8-4de0-aeda-3c7acdb6ed43_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Unclassified [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAbstract" xlink:to="lab_us-gaap_LongTermDebtAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_8b815d40-622b-4e12-b684-36a00c00c167_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_a6da3add-c870-4b28-8c13-4cadf4baa0ff_terseLabel_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and distributor relationships</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_label_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships [Member]</link:label>
    <link:label id="lab_syk_CustomerAndDistributorRelationshipsMember_documentation_en-US" xlink:label="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer and Distributor Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:href="syk-20211231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_CustomerAndDistributorRelationshipsMember" xlink:to="lab_syk_CustomerAndDistributorRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_NeurovascularMember_a387df86-7efb-49ab-b447-8245f780ef19_terseLabel_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular</link:label>
    <link:label id="lab_syk_NeurovascularMember_label_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular [Member]</link:label>
    <link:label id="lab_syk_NeurovascularMember_documentation_en-US" xlink:label="lab_syk_NeurovascularMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neurovascular</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember" xlink:href="syk-20211231.xsd#syk_NeurovascularMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_NeurovascularMember" xlink:to="lab_syk_NeurovascularMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_5f1e9ac8-c4a7-4588-90d2-07e517ec0d48_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Range [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_e2ece425-3680-42fe-be71-0e4b13fb4a0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_f3d192fb-fc05-4cb7-83f1-f98ba7362f2c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a9b297d6-21f1-4801-8df2-feee1208dc7c_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_5db6d099-64f1-430e-934a-6f2ea27f64f7_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_089e70e5-ab1a-444a-a10f-37dbe3ebee3e_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_04a5709e-757f-4319-9041-809b754123da_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_05effe7c-b42c-4a4f-9a30-9f9024545bf3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_35bc257d-6539-4148-a305-373952bb8a73_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_24e289fd-b159-4c62-96d1-4bfb167113be_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_860a181d-2546-4d0d-a665-758c49fa02e5_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at End of Period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_99e0863d-f9cc-4949-a9dc-04cf859eef56_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailment gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_1f7f1f2c-f77c-46c4-84fd-189c3ba856b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign income tax at rates other than 21%</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_fc7d2884-6891-4730-bf69-c79ff36b5408_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_75e4f958-4857-4993-8d68-095992416eea_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_5f748b95-d9ff-4d12-a0c8-995ed8abcca9_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_b43a45b6-0e7c-4a5c-b781-c1d179030c2f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_36624aec-d75a-4734-a745-22832963084f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_27077d00-e08a-4d5e-ab68-ad9b75ac2281_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in the Net Carrying Amount of Goodwill by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_e956198e-504f-48f1-b65e-43305bfc3eb2_negatedLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in estimate</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_787a0fee-63f1-431d-9271-60997d84b08e_terseLabel_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_label_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:label id="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_documentation_en-US" xlink:label="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:href="syk-20211231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:to="lab_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_91c6e63f-c26c-412b-9324-b1449cc9f174_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3bb31436-988e-4865-b213-017c2af1cbc2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_9816bae5-b5be-41a8-8cb8-dd7c4451b8a4_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_ede76200-1157-41eb-a765-ef9d948c8fe1_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.10 par value</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_fc5a8f7b-ec8b-49c3-96c5-00a5f4719e03_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology and patents</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_f57a1624-7cff-4b7e-9d92-4655fb0ad6e9_verboseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technologies</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_7c27b9c4-4270-461f-b1dc-19806ed7690c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4963c4f7-f477-4d96-b362-1ab8e27d3d84_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_8a305438-c707-4f42-bc6a-06489c69ffa3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_44753323-2321-48f5-b1f3-88ed0ec744f7_verboseLabel_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes,2.125%, due 2027</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_label_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2027 [Member]</link:label>
    <link:label id="lab_syk_SeniorUnsecuredNotesDueNovember2027Member_documentation_en-US" xlink:label="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Notes, Due November 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:to="lab_syk_SeniorUnsecuredNotesDueNovember2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_86380f1d-54a3-4613-8d84-a455cb07f503_terseLabel_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of inventory stepped up to fair value at acquisition</link:label>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_label_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:label id="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_documentation_en-US" xlink:label="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Inventory, Stepped-Up to Fair Value at Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:href="syk-20211231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:to="lab_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_9714aa27-98df-4e95-8263-1ab0fb9249d6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_2498ea1f-d80e-418c-bb9b-166d783f0a14_terseLabel_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of closing stock price under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_label_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:label id="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_documentation_en-US" xlink:label="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Closing Stock Price Represents Purchase Price Under ESPP</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:href="syk-20211231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:to="lab_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e43382f6-f8bf-427d-9c6a-bc45809ba71e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_83a7e14f-d2a6-46d7-afae-5c288e496708_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_27d82ab3-e8d0-47fc-95df-5906b1ac099a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term, Options expected to vest (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>syk-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:bfe75720-d063-4203-b03c-9c45e28dd378,g:5ab58def-d89f-418e-bff6-4b4619ff75e2-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.stryker.com/role/COVERPAGE" xlink:type="simple" xlink:href="syk-20211231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_53cab153-4ce2-4744-b7e0-76ba5b12513f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_53cab153-4ce2-4744-b7e0-76ba5b12513f" xlink:to="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_49db516a-9afa-4d4f-aa89-59121beead1d" xlink:to="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_e5024913-ea7c-4fa2-8a01-7e0e909d4a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_us-gaap_CommonStockMember_e5024913-ea7c-4fa2-8a01-7e0e909d4a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_488b8694-2172-4cc1-923b-98baeffd7413" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2023Member_488b8694-2172-4cc1-923b-98baeffd7413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_f166a011-8344-456d-b1dd-247f6109711e" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_f166a011-8344-456d-b1dd-247f6109711e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_f7a5bb8a-5848-4109-9e74-0be92235344f" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.125Due2027Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes2.125Due2027Member_f7a5bb8a-5848-4109-9e74-0be92235344f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_42c88076-3918-4067-9a27-2eb893c99aaf" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_42c88076-3918-4067-9a27-2eb893c99aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_01de6523-4c62-4b7f-9087-e300e0b2dcc7" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.625Due2030Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes2.625Due2030Member_01de6523-4c62-4b7f-9087-e300e0b2dcc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_088092bb-4a1a-40b4-bd27-4c6b7eb9eb95" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d2f95ce5-9826-4760-b290-6886b4ebe65a" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_088092bb-4a1a-40b4-bd27-4c6b7eb9eb95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_1452876d-13fa-4651-a7ca-27fad1674e6a" xlink:to="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_cc70eb77-4eee-4f52-ac96-69fdcb6daec6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentType_cc70eb77-4eee-4f52-ac96-69fdcb6daec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e3e4efda-2fdb-4e57-84a0-3b322509e217" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentAnnualReport_e3e4efda-2fdb-4e57-84a0-3b322509e217" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8144d5dd-4787-4196-938b-3cbe336012b2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentPeriodEndDate_8144d5dd-4787-4196-938b-3cbe336012b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ab59b9e7-64f8-4c48-9030-27949baa2baf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_CurrentFiscalYearEndDate_ab59b9e7-64f8-4c48-9030-27949baa2baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_830c2699-7e61-4f12-877b-c54204d808a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentTransitionReport_830c2699-7e61-4f12-877b-c54204d808a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_968772b1-a7b9-4a2c-bce5-59554b86e672" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityFileNumber_968772b1-a7b9-4a2c-bce5-59554b86e672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_1e100121-ebf8-4589-940e-68dbee905bda" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityRegistrantName_1e100121-ebf8-4589-940e-68dbee905bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_8f2a031b-ceaa-48f3-97f6-5462f238d59d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityIncorporationStateCountryCode_8f2a031b-ceaa-48f3-97f6-5462f238d59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3573a780-a061-4e37-9888-bc712055288c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityTaxIdentificationNumber_3573a780-a061-4e37-9888-bc712055288c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_2d1a32a3-cbdf-4a52-ac67-dec11affab96" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressAddressLine1_2d1a32a3-cbdf-4a52-ac67-dec11affab96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c031efb7-a9ea-4168-8ba8-a860efe0a1f7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressCityOrTown_c031efb7-a9ea-4168-8ba8-a860efe0a1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b5d41a0e-e70f-4b42-abc9-e364b49713d4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressStateOrProvince_b5d41a0e-e70f-4b42-abc9-e364b49713d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_877aba98-c73d-4ce9-8636-a431574533ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityAddressPostalZipCode_877aba98-c73d-4ce9-8636-a431574533ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f9ef7c8e-2798-48ac-a6e4-922a277496fd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_CityAreaCode_f9ef7c8e-2798-48ac-a6e4-922a277496fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2b7fedb5-41be-49df-ab85-cfef4c12fba0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_LocalPhoneNumber_2b7fedb5-41be-49df-ab85-cfef4c12fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a4eb1bd9-b824-4e71-9e8a-8cf506874b48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_Security12bTitle_a4eb1bd9-b824-4e71-9e8a-8cf506874b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8a6dbda0-b1af-4ab3-96de-9cfed494c032" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_TradingSymbol_8a6dbda0-b1af-4ab3-96de-9cfed494c032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_54f5217c-4424-48b8-a94e-7f91167c2ecf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_SecurityExchangeName_54f5217c-4424-48b8-a94e-7f91167c2ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12gTitle_109486b8-ef5a-4eec-be18-121557c731d6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_Security12gTitle_109486b8-ef5a-4eec-be18-121557c731d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_37ed6386-6a58-42b3-9047-dcc468c94b0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_37ed6386-6a58-42b3-9047-dcc468c94b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_985f9891-1c8e-4b48-b694-1690940f1e1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityVoluntaryFilers_985f9891-1c8e-4b48-b694-1690940f1e1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_39304c39-f459-4936-9b8a-7aa6f00ff11d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCurrentReportingStatus_39304c39-f459-4936-9b8a-7aa6f00ff11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_d9739fa6-9d2b-4363-82ff-f263e2983f77" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityInteractiveDataCurrent_d9739fa6-9d2b-4363-82ff-f263e2983f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_23fd2636-91aa-4ae7-adf3-0ebe3f99a106" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityFilerCategory_23fd2636-91aa-4ae7-adf3-0ebe3f99a106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1877ee05-c95a-4d45-ac29-3bd88d35d867" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityEmergingGrowthCompany_1877ee05-c95a-4d45-ac29-3bd88d35d867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_2c236e1b-dafe-49d1-9501-a2ef68387d12" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntitySmallBusiness_2c236e1b-dafe-49d1-9501-a2ef68387d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_db200e36-1e35-4790-8ccd-bcb68cd42a3c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_IcfrAuditorAttestationFlag_db200e36-1e35-4790-8ccd-bcb68cd42a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9c1a991a-9bef-4e7f-91d3-f3f63c04e142" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityShellCompany_9c1a991a-9bef-4e7f-91d3-f3f63c04e142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_889d05d9-33a3-40f8-ad6e-6e4f9003d265" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityPublicFloat_889d05d9-33a3-40f8-ad6e-6e4f9003d265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_bcc6a037-ce1e-41bd-8c93-ddf2b44812a7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_bcc6a037-ce1e-41bd-8c93-ddf2b44812a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4d1de819-2aea-487d-becd-73374e61d888" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_4d1de819-2aea-487d-becd-73374e61d888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_bc190ec7-c294-495f-b0aa-22da7e55a994" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_AmendmentFlag_bc190ec7-c294-495f-b0aa-22da7e55a994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_948cd82c-fa1e-41b0-ad2e-9b3bd40cb929" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentFiscalYearFocus_948cd82c-fa1e-41b0-ad2e-9b3bd40cb929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_7c4d07b7-613a-46d0-8127-5aa678667760" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_DocumentFiscalPeriodFocus_7c4d07b7-613a-46d0-8127-5aa678667760" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_1b103284-9619-431a-98a9-ebec1b16f7ea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5ac46a3a-12c5-4ff3-a96d-13ee0588014e" xlink:to="loc_dei_EntityCentralIndexKey_1b103284-9619-431a-98a9-ebec1b16f7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AuditInformation" xlink:type="simple" xlink:href="syk-20211231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_AuditorInformationAbstract_2618642b-a863-450a-aeab-7ee347e88d54" xlink:href="syk-20211231.xsd#syk_AuditorInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_07d9e124-1fb1-4506-b10d-7d22774832b5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_2618642b-a863-450a-aeab-7ee347e88d54" xlink:to="loc_dei_AuditorFirmId_07d9e124-1fb1-4506-b10d-7d22774832b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_0e71b0cf-f30f-4bb7-b619-a66d558bbfe5" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_2618642b-a863-450a-aeab-7ee347e88d54" xlink:to="loc_dei_AuditorName_0e71b0cf-f30f-4bb7-b619-a66d558bbfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_44d24e2a-9932-4998-8fef-edecbf78013e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_AuditorInformationAbstract_2618642b-a863-450a-aeab-7ee347e88d54" xlink:to="loc_dei_AuditorLocation_44d24e2a-9932-4998-8fef-edecbf78013e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ae15f058-07b8-4560-af00-85f0c2ffd540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_Revenues_ae15f058-07b8-4560-af00-85f0c2ffd540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d93e7775-8772-4851-8794-7b5c24e0f15f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_CostOfRevenue_d93e7775-8772-4851-8794-7b5c24e0f15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f30288a2-ecd0-42e7-8c0f-6880c2b7286a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_GrossProfit_f30288a2-ecd0-42e7-8c0f-6880c2b7286a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_9dda22b6-7af1-4fad-941e-0597e44642fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_9dda22b6-7af1-4fad-941e-0597e44642fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c058e5e4-f1a3-4b85-9e56-6c2c59886b94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_c058e5e4-f1a3-4b85-9e56-6c2c59886b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7f207358-d658-4f20-bb6b-0f0e00560f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_7f207358-d658-4f20-bb6b-0f0e00560f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_57024185-85ad-445d-8a61-d20b27d62a57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_57024185-85ad-445d-8a61-d20b27d62a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ea50e4e2-ff9b-45c0-bf78-bb13bd50a7f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_OperatingExpenses_ea50e4e2-ff9b-45c0-bf78-bb13bd50a7f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3a8799bb-7dd5-49fc-bb79-e1377db5162b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_OperatingIncomeLoss_3a8799bb-7dd5-49fc-bb79-e1377db5162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_881ed575-c356-4275-88ca-f3d4df142859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_881ed575-c356-4275-88ca-f3d4df142859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a35f5fac-1c10-451e-a1ae-bb24fab2fc76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a35f5fac-1c10-451e-a1ae-bb24fab2fc76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6d654474-e649-437f-ae3e-bf4dcad5c8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6d654474-e649-437f-ae3e-bf4dcad5c8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2d56b9ab-8b62-4b7c-949c-f0d590a01b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_NetIncomeLoss_2d56b9ab-8b62-4b7c-949c-f0d590a01b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a3d5c13a-050e-4ae3-9bd0-c62922299672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_EarningsPerShareAbstract_a3d5c13a-050e-4ae3-9bd0-c62922299672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e84d9e7b-7c95-4244-91c2-7f5deae046dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a3d5c13a-050e-4ae3-9bd0-c62922299672" xlink:to="loc_us-gaap_EarningsPerShareBasic_e84d9e7b-7c95-4244-91c2-7f5deae046dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9ba0d978-98ff-4cca-b926-2adca146396b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a3d5c13a-050e-4ae3-9bd0-c62922299672" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9ba0d978-98ff-4cca-b926-2adca146396b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a3adffe3-9135-4def-89f5-15e79145ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_c5c05ce0-306f-4372-917b-e0c81450722e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a3adffe3-9135-4def-89f5-15e79145ad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8cdedeeb-3988-4476-80ee-ff89397968da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a3adffe3-9135-4def-89f5-15e79145ad6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_8cdedeeb-3988-4476-80ee-ff89397968da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_93c08434-31ed-4c0d-99e7-a62f7ecd2a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a3adffe3-9135-4def-89f5-15e79145ad6d" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_93c08434-31ed-4c0d-99e7-a62f7ecd2a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52daf67f-ed0c-45be-a803-f0f7a81bfefe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_a3adffe3-9135-4def-89f5-15e79145ad6d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52daf67f-ed0c-45be-a803-f0f7a81bfefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_06f23ab9-1bd9-4404-aea8-3a6a92edab22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee81fff3-e872-4e1a-93cb-fa057731e966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_06f23ab9-1bd9-4404-aea8-3a6a92edab22" xlink:to="loc_us-gaap_NetIncomeLoss_ee81fff3-e872-4e1a-93cb-fa057731e966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_06f23ab9-1bd9-4404-aea8-3a6a92edab22" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cbe6e181-13df-4992-9a3d-8274f31b3ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cbe6e181-13df-4992-9a3d-8274f31b3ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c0536013-5c0c-4da9-ae74-f4edee1ab88f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_c0536013-5c0c-4da9-ae74-f4edee1ab88f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2902dc19-d993-4bfb-805d-302bb6bd5a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_2902dc19-d993-4bfb-805d-302bb6bd5a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b31fe53e-1fab-4860-b632-db514d6aa919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_b31fe53e-1fab-4860-b632-db514d6aa919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6457fcb6-4cc8-4da1-a17f-1c5d5fa8064a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_41482f8a-6848-430a-a116-d998866470d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6457fcb6-4cc8-4da1-a17f-1c5d5fa8064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2fbc064-5393-4449-b9ea-28cfd435ea1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_06f23ab9-1bd9-4404-aea8-3a6a92edab22" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_b2fbc064-5393-4449-b9ea-28cfd435ea1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_47668255-a20d-495f-b3fc-f5608d1dc8de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47668255-a20d-495f-b3fc-f5608d1dc8de" xlink:to="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4adad011-ade3-4f8f-ac57-cbc497d34eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4adad011-ade3-4f8f-ac57-cbc497d34eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3401b45e-9f4f-4698-9624-e21a84667319" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_3401b45e-9f4f-4698-9624-e21a84667319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_29804b86-4d81-4f73-8348-dfbf6ee57174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_29804b86-4d81-4f73-8348-dfbf6ee57174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNetAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_7e06cf8a-10ab-45e3-a7af-89c4fda727c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_7e06cf8a-10ab-45e3-a7af-89c4fda727c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ef51ea33-2040-4f1d-a56d-9eb1f7c3affc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_ef51ea33-2040-4f1d-a56d-9eb1f7c3affc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_555c9848-8a6e-4428-91fe-881bd40c67d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_555c9848-8a6e-4428-91fe-881bd40c67d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_75f8de6a-dab2-4d41-bb41-5d02294ef1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryNetAbstract_45137b47-c461-4d90-ad16-9ad61afafb06" xlink:to="loc_us-gaap_InventoryNet_75f8de6a-dab2-4d41-bb41-5d02294ef1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_649a4c78-d37e-4226-8e9c-5d610db253a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_649a4c78-d37e-4226-8e9c-5d610db253a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bb52d047-a822-4c8f-b65e-ac8233c424fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d18fb180-3ce7-4723-9d10-ad2f8ea74e2c" xlink:to="loc_us-gaap_AssetsCurrent_bb52d047-a822-4c8f-b65e-ac8233c424fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LandBuildingsAndImprovementsGross_95182158-e972-4a87-801f-4b33f4117c5d" xlink:href="syk-20211231.xsd#syk_LandBuildingsAndImprovementsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:to="loc_syk_LandBuildingsAndImprovementsGross_95182158-e972-4a87-801f-4b33f4117c5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentGross_18b05798-5370-4f33-af36-b8596c914ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:to="loc_us-gaap_MachineryAndEquipmentGross_18b05798-5370-4f33-af36-b8596c914ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_24598956-7aa0-4231-a871-cda9fa74775a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_24598956-7aa0-4231-a871-cda9fa74775a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9a95229e-68f5-4a5e-96ae-4bb9c14bb4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_9a95229e-68f5-4a5e-96ae-4bb9c14bb4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1f1eb93b-2753-435a-818e-ea9de9ece0e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_243f78a3-414f-4f96-8f86-9d6f33beb1cd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1f1eb93b-2753-435a-818e-ea9de9ece0e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_514a55e6-2c6a-45f7-be25-95aa672ec23b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_Goodwill_514a55e6-2c6a-45f7-be25-95aa672ec23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2cc71dc7-8e6c-4c59-9126-00a1bb7db2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2cc71dc7-8e6c-4c59-9126-00a1bb7db2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_309aceb9-83d6-441c-8b5a-391719faf583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_309aceb9-83d6-441c-8b5a-391719faf583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_38495dd2-d323-41dc-8c46-a3f03f982505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_38495dd2-d323-41dc-8c46-a3f03f982505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e91cadef-f32c-4e5f-b800-d56564c40f93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_65c2a947-0b10-4842-8353-e8fc52dc9f52" xlink:to="loc_us-gaap_Assets_e91cadef-f32c-4e5f-b800-d56564c40f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a607a7a3-06a0-4384-b0ad-840255262c38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47668255-a20d-495f-b3fc-f5608d1dc8de" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a607a7a3-06a0-4384-b0ad-840255262c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a607a7a3-06a0-4384-b0ad-840255262c38" xlink:to="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_b916185b-af16-4da3-8b67-2afc617c65be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_b916185b-af16-4da3-8b67-2afc617c65be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b79f0e0b-ac4e-4292-8e2d-ff64b05e0063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b79f0e0b-ac4e-4292-8e2d-ff64b05e0063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_8c82dc04-0ebc-45d6-8597-f767080391f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_8c82dc04-0ebc-45d6-8597-f767080391f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrent_0c8989ef-8cc0-40dc-889f-a2266c9acaad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_DividendsPayableCurrent_0c8989ef-8cc0-40dc-889f-a2266c9acaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_4b5e5b5a-758e-434b-9236-9bdb53cb2120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_4b5e5b5a-758e-434b-9236-9bdb53cb2120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d86c0d97-7b20-4f4b-b4e7-76d6b6d1da91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d86c0d97-7b20-4f4b-b4e7-76d6b6d1da91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_603083ea-09ae-436b-917f-c0214c2a2978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_DebtCurrent_603083ea-09ae-436b-917f-c0214c2a2978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_4db31fcf-5bf0-4f98-9532-8cdc48293012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1bb3bec1-66e0-42f9-8ade-7d8dbbd32c5a" xlink:to="loc_us-gaap_LiabilitiesCurrent_4db31fcf-5bf0-4f98-9532-8cdc48293012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cb1af2e0-1495-4428-8b4d-35e6d668fbbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cb1af2e0-1495-4428-8b4d-35e6d668fbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4e1582c7-6e5f-42a5-b2f8-d3b9ac72296c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4e1582c7-6e5f-42a5-b2f8-d3b9ac72296c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d2d0d5f7-5275-4991-a506-c46921556061" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d2d0d5f7-5275-4991-a506-c46921556061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_969a7f96-77dc-46aa-beff-4ec6bc13d272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_6e3fea04-f5f3-4f25-a019-c58d457b1614" xlink:to="loc_us-gaap_Liabilities_969a7f96-77dc-46aa-beff-4ec6bc13d272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a607a7a3-06a0-4384-b0ad-840255262c38" xlink:to="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_9e87900c-1bce-4dc1-86a5-790ff008570a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:to="loc_us-gaap_CommonStockValueOutstanding_9e87900c-1bce-4dc1-86a5-790ff008570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cf8dc819-19c6-4eae-bc62-879a9ae4a00f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cf8dc819-19c6-4eae-bc62-879a9ae4a00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9e65bde8-50e3-4105-8ad0-86b0c2aa1882" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9e65bde8-50e3-4105-8ad0-86b0c2aa1882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09746df9-6cf1-437b-a376-160c2f2754ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_09746df9-6cf1-437b-a376-160c2f2754ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10793299-762b-448c-ac5e-18e7686e9a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_4cf192ef-d136-48c8-982e-5bb9df099194" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_10793299-762b-448c-ac5e-18e7686e9a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bd0098-943b-42ff-947b-75270713c22a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a607a7a3-06a0-4384-b0ad-840255262c38" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_79bd0098-943b-42ff-947b-75270713c22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c37ed496-0997-4224-a413-da32eb381284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_47668255-a20d-495f-b3fc-f5608d1dc8de" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c37ed496-0997-4224-a413-da32eb381284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedBalanceSheetsParentheticals"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_c7df8f4d-ecd6-4dec-aab4-f6586c75c934" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e8b04a48-c538-455f-84e7-fd9cbe6956bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7df8f4d-ecd6-4dec-aab4-f6586c75c934" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e8b04a48-c538-455f-84e7-fd9cbe6956bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e76bd7a-105d-4595-862f-55bc34ea1f40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_c7df8f4d-ecd6-4dec-aab4-f6586c75c934" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_1e76bd7a-105d-4595-862f-55bc34ea1f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1e0166ad-b670-4b99-b90d-32476d2d3b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1e0166ad-b670-4b99-b90d-32476d2d3b10" xlink:to="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6b0c3198-49e4-46c2-81da-84e94492687b" xlink:to="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1381541e-15ea-4f69-a90d-5802c69f882b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_CommonStockMember_1381541e-15ea-4f69-a90d-5802c69f882b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_67b60266-e33c-4a7b-abac-c4150ee90e8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_67b60266-e33c-4a7b-abac-c4150ee90e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3d9e96ed-188f-4dee-abaf-24add34d5cd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_RetainedEarningsMember_3d9e96ed-188f-4dee-abaf-24add34d5cd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c738f1-5baf-49eb-ab4d-27190fed8a52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_41c5addd-52fe-4d4f-a723-9156cb10aeca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_93c738f1-5baf-49eb-ab4d-27190fed8a52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_4eb8e60b-f51a-48ff-a45b-15d3555f61ea" xlink:to="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_20930e7b-d22b-4b88-8aac-acb038c19916" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67a9f211-3bce-4e5a-b5bb-c76a41e032d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_67a9f211-3bce-4e5a-b5bb-c76a41e032d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_3eda12cf-36b0-40f1-b457-554aa62cc595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_3eda12cf-36b0-40f1-b457-554aa62cc595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4b22c1bc-8eb0-4fdf-b7a9-ce541e1447c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_4b22c1bc-8eb0-4fdf-b7a9-ce541e1447c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0bd18aa1-28c1-4ae0-95cc-2b90f659ea6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_0bd18aa1-28c1-4ae0-95cc-2b90f659ea6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2886782c-9acc-4790-ab8d-7c037e36c21d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_2886782c-9acc-4790-ab8d-7c037e36c21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4efcab49-ebcf-4a6a-b47d-3879355fa9eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_4efcab49-ebcf-4a6a-b47d-3879355fa9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4650c7c2-5485-4732-954f-53ca26cf3782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4650c7c2-5485-4732-954f-53ca26cf3782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_adeb94ea-c25c-4ea8-b33c-bd81b9ce8ec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_NetIncomeLoss_adeb94ea-c25c-4ea8-b33c-bd81b9ce8ec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_a733426a-1bc4-484a-badd-2be3907b9b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_DividendsCash_a733426a-1bc4-484a-badd-2be3907b9b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d23dabe-b3f0-4e79-992b-34480074b3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7d23dabe-b3f0-4e79-992b-34480074b3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_efc17d97-f572-412b-80b7-5b508555d2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_efc17d97-f572-412b-80b7-5b508555d2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_165274c6-d438-4a6c-a90b-84f93b188bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3b291a32-a952-424e-b83b-d7b44ff131e7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_165274c6-d438-4a6c-a90b-84f93b188bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="simple" xlink:href="syk-20211231.xsd#ConsolidatedStatementsOfCashFlows"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6fcbdd6f-e60f-4aab-a82a-6d563d7890d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6fcbdd6f-e60f-4aab-a82a-6d563d7890d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_819ef9d8-40f0-4d24-a7f3-930c0810d5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6fcbdd6f-e60f-4aab-a82a-6d563d7890d6" xlink:to="loc_us-gaap_NetIncomeLoss_819ef9d8-40f0-4d24-a7f3-930c0810d5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6fcbdd6f-e60f-4aab-a82a-6d563d7890d6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_5cbebae9-3199-43e3-9eb3-38dfeccbb654" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_Depreciation_5cbebae9-3199-43e3-9eb3-38dfeccbb654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_9e0dcf28-52cb-46ec-8667-c4fae3e84d1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_AdjustmentForAmortization_9e0dcf28-52cb-46ec-8667-c4fae3e84d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_5a248820-09eb-4d2a-8c92-9b88b1e6849e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_AssetImpairmentCharges_5a248820-09eb-4d2a-8c92-9b88b1e6849e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b4f932d9-5b0a-40aa-9ed7-a8011f2ae3e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_ShareBasedCompensation_b4f932d9-5b0a-40aa-9ed7-a8011f2ae3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_18297bed-1242-4214-b9e3-ba26d192a812" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductLiabilityAccrualPeriodExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_ProductLiabilityAccrualPeriodExpense_18297bed-1242-4214-b9e3-ba26d192a812" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_64a5f3ff-c833-47cc-bb37-854c0e2d53d1" xlink:href="syk-20211231.xsd#syk_SaleOfInventorySteppedUpToFairValueAtAcquisition"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition_64a5f3ff-c833-47cc-bb37-854c0e2d53d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2f2060a2-d2aa-40d6-98af-e77f55a1ff98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_2f2060a2-d2aa-40d6-98af-e77f55a1ff98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_aded91bc-423d-4240-b7ec-179578281ee8" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa456013-e84a-4c3d-b03f-913eff2c665a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_aa456013-e84a-4c3d-b03f-913eff2c665a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8d138506-4d22-4544-91fe-a1fd52b5199f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8d138506-4d22-4544-91fe-a1fd52b5199f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_685b7d82-f596-48b8-bff2-f7468e4d5235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_685b7d82-f596-48b8-bff2-f7468e4d5235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_761702ac-96fd-4fac-b3a1-eba4f043eed5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_761702ac-96fd-4fac-b3a1-eba4f043eed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_Changeinaccrualforrecallexpenses_9f54523f-83dc-443e-82e3-fd1f9b12896e" xlink:href="syk-20211231.xsd#syk_Changeinaccrualforrecallexpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_syk_Changeinaccrualforrecallexpenses_9f54523f-83dc-443e-82e3-fd1f9b12896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d413cdb6-f232-44b0-b9db-8a80cb1aede2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_d413cdb6-f232-44b0-b9db-8a80cb1aede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4e692df4-caa5-4af8-9b7d-66f8470469ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9d3bbfa4-bd61-4679-a68e-322397ab2cd4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_4e692df4-caa5-4af8-9b7d-66f8470469ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7157f1f-1741-43b5-8137-3b8a40fb5859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_6fcbdd6f-e60f-4aab-a82a-6d563d7890d6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c7157f1f-1741-43b5-8137-3b8a40fb5859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a39d215d-7928-4345-b90e-78427b8ce8af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a39d215d-7928-4345-b90e-78427b8ce8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6e550185-0f70-4f89-89dc-d084561c1f66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_6e550185-0f70-4f89-89dc-d084561c1f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_b67ba8b8-ee14-47a6-b821-11ef857708cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_b67ba8b8-ee14-47a6-b821-11ef857708cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a83192b-249b-4025-aa8a-852632aa5ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_6a83192b-249b-4025-aa8a-852632aa5ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_755657b8-39a2-41ad-b69c-18810cf05848" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_755657b8-39a2-41ad-b69c-18810cf05848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaccae7d-c624-43a2-af1c-1456bdf75360" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1684ca60-6a6c-428b-ae72-e8fd26d79220" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aaccae7d-c624-43a2-af1c-1456bdf75360" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e7f670e6-553a-4695-ab09-2024c53318d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfShortTermDebt_e7f670e6-553a-4695-ab09-2024c53318d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a6e00f13-54f4-41a7-9296-a852bcecdd8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a6e00f13-54f4-41a7-9296-a852bcecdd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5ced7b59-6c6f-4c46-ac09-3ec4b4c73271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5ced7b59-6c6f-4c46-ac09-3ec4b4c73271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_31d513c5-64ae-4e87-91a1-0a7d32d7ed34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_PaymentsOfDividends_31d513c5-64ae-4e87-91a1-0a7d32d7ed34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e9e646a8-7bea-403d-99a4-d3f1c8e8079c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e9e646a8-7bea-403d-99a4-d3f1c8e8079c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8a76753c-f160-403a-9349-1d001da8a156" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8a76753c-f160-403a-9349-1d001da8a156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ecaf8c7f-dc53-49c8-937e-aff525e6476f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_ecaf8c7f-dc53-49c8-937e-aff525e6476f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ebc16b06-1c71-45a9-bdfd-1085e35ca272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1f247c10-e4c6-468f-b6ad-1fc8bfcbac23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ebc16b06-1c71-45a9-bdfd-1085e35ca272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8cff0c3-8873-41a0-a027-5c51548c4ee3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f8cff0c3-8873-41a0-a027-5c51548c4ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b7963a51-59d1-47bd-8b84-a412bb7a4148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b7963a51-59d1-47bd-8b84-a412bb7a4148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fba64c0-f492-43a8-aa33-7fb7e43616cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8fba64c0-f492-43a8-aa33-7fb7e43616cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a4603ad0-7717-4118-b799-2799ea454fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a4603ad0-7717-4118-b799-2799ea454fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_26428250-c84f-4607-badb-bace6fb2220b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_3f103681-48d2-472a-9142-a71b37af61fb" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_26428250-c84f-4607-badb-bace6fb2220b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_a9f3822f-7cff-4bc3-bce6-45b29eef8aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_26428250-c84f-4607-badb-bace6fb2220b" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_a9f3822f-7cff-4bc3-bce6-45b29eef8aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_47ab03ff-fac1-4759-9865-17ace2a5e887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_26428250-c84f-4607-badb-bace6fb2220b" xlink:to="loc_us-gaap_InterestPaidNet_47ab03ff-fac1-4759-9865-17ace2a5e887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="simple" xlink:href="syk-20211231.xsd#SignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_SignificantAccountingPoliciesAbstract_be95b441-9a08-49f2-a1c3-607a3a2dac52" xlink:href="syk-20211231.xsd#syk_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_03ad2302-fd49-411a-a225-499c5752c54e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_be95b441-9a08-49f2-a1c3-607a3a2dac52" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_03ad2302-fd49-411a-a225-499c5752c54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="syk-20211231.xsd#SignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:href="syk-20211231.xsd#syk_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_2bbbc726-1a65-4474-b479-a40be141ba65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_NatureOfOperations_2bbbc726-1a65-4474-b479-a40be141ba65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_ca97cd87-d20c-4acc-8ece-6201b929dc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_ca97cd87-d20c-4acc-8ece-6201b929dc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_8a3a461f-cdf3-4b1a-9e5d-37a0c1583ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_UseOfEstimates_8a3a461f-cdf3-4b1a-9e5d-37a0c1583ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_5f2be759-bf10-4b88-96b0-80590b4d0757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_5f2be759-bf10-4b88-96b0-80590b4d0757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_cf20901a-d039-40f0-8965-e77f16cb3e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_cf20901a-d039-40f0-8965-e77f16cb3e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7c25efc5-91a8-4c6d-9603-76114c124b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_7c25efc5-91a8-4c6d-9603-76114c124b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_179ea9b2-5c56-4fe9-ab03-9c71b9a3bc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_179ea9b2-5c56-4fe9-ab03-9c71b9a3bc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7bcb6f14-4c66-4f97-b071-8b2e13f1325e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_7bcb6f14-4c66-4f97-b071-8b2e13f1325e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6b031407-948a-490b-943d-3e68f38b9261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6b031407-948a-490b-943d-3e68f38b9261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_d1063487-ec4a-44af-8176-6ad4a6486e70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_d1063487-ec4a-44af-8176-6ad4a6486e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_bd8320d6-fe0e-448a-96f4-d78838d1b31d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_bd8320d6-fe0e-448a-96f4-d78838d1b31d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5dd647a6-a0b1-46a9-9673-20ecd105c510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5dd647a6-a0b1-46a9-9673-20ecd105c510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOptionTextBlock_5cd26d7b-3b5a-4263-90b0-ee91ba4aae2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOptionTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_FairValueOptionTextBlock_5cd26d7b-3b5a-4263-90b0-ee91ba4aae2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_783d190e-0a9c-42dd-bf53-64e1383932eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_783d190e-0a9c-42dd-bf53-64e1383932eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6ff70baf-4d9c-4340-861d-1e2eebd569e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6ff70baf-4d9c-4340-861d-1e2eebd569e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c261a939-f618-45e1-84c3-ec157ae236bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c261a939-f618-45e1-84c3-ec157ae236bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_81afc6d1-ff89-4f21-9271-938586486319" xlink:href="syk-20211231.xsd#syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock_81afc6d1-ff89-4f21-9271-938586486319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_88f4452a-5719-41ff-a661-324395618335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_88f4452a-5719-41ff-a661-324395618335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_2fa4dd3e-8f31-4de9-a166-7a0f0676e0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_2fa4dd3e-8f31-4de9-a166-7a0f0676e0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ead40097-5aba-4a68-85d8-1a00cbdf9c31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_fbcef469-098e-42c1-a08c-cbd999c43e54" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ead40097-5aba-4a68-85d8-1a00cbdf9c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_SignificantAccountingPoliciesAbstract_6986e0fa-00eb-41a0-8e48-8f7c3292a485" xlink:href="syk-20211231.xsd#syk_SignificantAccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_SignificantAccountingPoliciesAbstract_6986e0fa-00eb-41a0-8e48-8f7c3292a485" xlink:to="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_46fb79f0-1952-4526-b765-9fc784d7fba5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_be7f883c-8f12-48fd-a07e-03e92aafb59e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_be7f883c-8f12-48fd-a07e-03e92aafb59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a6e1ea77-40a8-4309-a89b-2e872783db2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_810ffc82-e4de-4a45-ba4a-c53829d8f4b2" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a6e1ea77-40a8-4309-a89b-2e872783db2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fa0887e0-c0de-45ba-9007-274712d60f3e" xlink:to="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9351778-2df0-4283-8249-6b8e18af8bbc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:to="loc_srt_MinimumMember_c9351778-2df0-4283-8249-6b8e18af8bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2ec30723-e93e-48e4-9a35-cfa37a930a7c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_906c5fe7-20b5-4a6f-82b1-b48484d0cb54" xlink:to="loc_srt_MaximumMember_2ec30723-e93e-48e4-9a35-cfa37a930a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4e7bb6b2-f7fb-45a1-94c2-e15e67f54c75" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e17e8757-91e2-48be-98c3-1efd6579f5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e17e8757-91e2-48be-98c3-1efd6579f5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7b760725-7e99-4a44-be88-cef8ff81c382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7b760725-7e99-4a44-be88-cef8ff81c382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_bb0aa0e5-86d0-4935-9bc5-8370668ddda7" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8a046190-be7f-45c5-9739-d5f78e94168a" xlink:to="loc_syk_PerformanceStockUnitPsusMember_bb0aa0e5-86d0-4935-9bc5-8370668ddda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ed3a476-b980-4997-892f-b17ccf7a9868" xlink:to="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8e8580d6-5c82-4bf0-9118-da6fd524ef8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_8e8580d6-5c82-4bf0-9118-da6fd524ef8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c277ec92-06c7-47b8-a1a1-efde72dae2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_c277ec92-06c7-47b8-a1a1-efde72dae2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a78523fc-1a02-493b-8266-6f6146807e3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a78523fc-1a02-493b-8266-6f6146807e3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_cf18b140-f49c-4838-b436-720dedb710bb" xlink:href="syk-20211231.xsd#syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4914af62-8996-4151-a8ec-99621aa9521b" xlink:to="loc_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod_cf18b140-f49c-4838-b436-720dedb710bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognition" xlink:type="simple" xlink:href="syk-20211231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_d540dad0-f427-4cbe-a9bf-9456497ee23a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5a7599a8-c30d-40df-a532-8665be743357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_d540dad0-f427-4cbe-a9bf-9456497ee23a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_5a7599a8-c30d-40df-a532-8665be743357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="syk-20211231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_bcc7aea7-fdd1-48fd-bfdf-1ddd8dc9b839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c4a3b75f-069f-4394-acd2-d82f99612873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_bcc7aea7-fdd1-48fd-bfdf-1ddd8dc9b839" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c4a3b75f-069f-4394-acd2-d82f99612873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_09fce26a-5eb6-4a71-b19b-1018a5f75da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageofServiceRevenueRecognizeoverTime_57a6c427-874c-4a32-83d3-894c8efbc8b8" xlink:href="syk-20211231.xsd#syk_PercentageofServiceRevenueRecognizeoverTime"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_09fce26a-5eb6-4a71-b19b-1018a5f75da3" xlink:to="loc_syk_PercentageofServiceRevenueRecognizeoverTime_57a6c427-874c-4a32-83d3-894c8efbc8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1c9063cc-bae6-469f-babb-a1ac1739b79e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_09fce26a-5eb6-4a71-b19b-1018a5f75da3" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1c9063cc-bae6-469f-babb-a1ac1739b79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RevenueRecognitionDisaggregatedSalesAnalysisDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionAbstract_a0d9f8f2-03cd-4e14-8d4e-469c64e2a971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRecognitionAbstract_a0d9f8f2-03cd-4e14-8d4e-469c64e2a971" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8b7f670-07a3-4f50-a60c-159e073f8393" xlink:to="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_bf30e640-44c5-47f1-a1a8-ef115adedbff" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_bf30e640-44c5-47f1-a1a8-ef115adedbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_84545138-f3fc-4cdb-9262-e71da0aabbc3" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b83ee604-a739-4831-b7dd-b11e619483f3" xlink:to="loc_syk_OrthopaedicsAndSpineMember_84545138-f3fc-4cdb-9262-e71da0aabbc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6b28704b-2f49-4eb6-9021-35f11d23499c" xlink:to="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InstrumentsMember_a7bb5fc6-6d3f-4488-9844-f2f18357ba54" xlink:href="syk-20211231.xsd#syk_InstrumentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_InstrumentsMember_a7bb5fc6-6d3f-4488-9844-f2f18357ba54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EndoscopyMember_f9c33e68-30d4-4519-9b2c-6d4e33aebd9c" xlink:href="syk-20211231.xsd#syk_EndoscopyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_EndoscopyMember_f9c33e68-30d4-4519-9b2c-6d4e33aebd9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalMember_4fd234d1-e09b-4507-bc56-38804b3cf433" xlink:href="syk-20211231.xsd#syk_MedicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_MedicalMember_4fd234d1-e09b-4507-bc56-38804b3cf433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeurovascularMember_621a7dbb-c043-4bb6-a9d2-5f4c89abab36" xlink:href="syk-20211231.xsd#syk_NeurovascularMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_NeurovascularMember_621a7dbb-c043-4bb6-a9d2-5f4c89abab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_NeuroCranialMember_4dd44e39-ccb0-4a26-ab0e-7a0001c083bf" xlink:href="syk-20211231.xsd#syk_NeuroCranialMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_NeuroCranialMember_4dd44e39-ccb0-4a26-ab0e-7a0001c083bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherOrthopaedicsMember_d43fd259-2b3b-4978-b377-94f908ed85d5" xlink:href="syk-20211231.xsd#syk_OtherOrthopaedicsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_OtherOrthopaedicsMember_d43fd259-2b3b-4978-b377-94f908ed85d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_KneesMember_6836f752-071d-49ac-9b70-1304ec985e96" xlink:href="syk-20211231.xsd#syk_KneesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_KneesMember_6836f752-071d-49ac-9b70-1304ec985e96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_HipsMember_f9005f85-c6c6-4611-b460-5bad81786a84" xlink:href="syk-20211231.xsd#syk_HipsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_HipsMember_f9005f85-c6c6-4611-b460-5bad81786a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TraumaandExtremitiesMember_a0d1f1de-4cb9-4793-add5-9b7bf8e594ce" xlink:href="syk-20211231.xsd#syk_TraumaandExtremitiesMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_TraumaandExtremitiesMember_a0d1f1de-4cb9-4793-add5-9b7bf8e594ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SpineMember_4dad00ee-1bb9-480e-b5ca-3549ba4a79be" xlink:href="syk-20211231.xsd#syk_SpineMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_1893fd53-d632-4767-a750-ca7c045cf02a" xlink:to="loc_syk_SpineMember_4dad00ee-1bb9-480e-b5ca-3549ba4a79be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f758f896-de07-46e2-b317-82966a6fa502" xlink:to="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ed9cb12d-f1a2-4c95-af27-22ce74731435" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:to="loc_country_US_ed9cb12d-f1a2-4c95-af27-22ce74731435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_35b695c1-6280-4a36-a076-6b6fa9a1e3df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d512d907-5034-4030-967f-75e13299a56e" xlink:to="loc_us-gaap_NonUsMember_35b695c1-6280-4a36-a076-6b6fa9a1e3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e6ef8fc-fd40-4d55-ae91-20cbe4212486" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a5753f63-00d9-483b-a1af-18ced02d5ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32cecf23-ed65-470a-ae08-909ea773e832" xlink:to="loc_us-gaap_Revenues_a5753f63-00d9-483b-a1af-18ced02d5ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_88c4e6eb-0be3-4216-a5b2-f13010eb51dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_0c01d772-b2d1-42c3-9dae-796218639f99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_88c4e6eb-0be3-4216-a5b2-f13010eb51dc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_0c01d772-b2d1-42c3-9dae-796218639f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1e46a9b3-7608-4059-862f-ef61bb0f1992" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3e187253-2f2d-4a58-81cf-8733ed090658" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e46a9b3-7608-4059-862f-ef61bb0f1992" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_3e187253-2f2d-4a58-81cf-8733ed090658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d5ac3e09-abd2-43cf-9893-fbf944f31462" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1e46a9b3-7608-4059-862f-ef61bb0f1992" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_d5ac3e09-abd2-43cf-9893-fbf944f31462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4801c9e5-f22c-42f4-a2dd-ddad00a9503c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4801c9e5-f22c-42f4-a2dd-ddad00a9503c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_ff503108-6cf4-4adb-a141-bddd9ae7dcf6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_9f0e1490-f858-401b-95a1-2cfc0688a38b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_9f0e1490-f858-401b-95a1-2cfc0688a38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_70a8615d-db4f-4869-b086-9bcfdf6183f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_70a8615d-db4f-4869-b086-9bcfdf6183f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_bb2319d3-1b46-4590-86d7-9ec876ade914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_057a3947-4cff-44d6-9d7b-f26eb58300ac" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_bb2319d3-1b46-4590-86d7-9ec876ade914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_77462c90-c417-42c5-834e-c190af83e3a4" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_06e72fd8-57f7-49ee-a493-4be233ec669c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_2fb47755-7bca-450e-b999-2f7c019c48dd" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_06e72fd8-57f7-49ee-a493-4be233ec669c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2d8ec849-79d8-48ab-95ce-bf821dd6d616" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_9bd0aaa1-c965-4c1a-b28a-1c61cd7379d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_9bd0aaa1-c965-4c1a-b28a-1c61cd7379d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b5d9b3de-ac90-4c0d-b6a6-55df6b8b0f89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_ForeignGovernmentDebtSecuritiesMember_b5d9b3de-ac90-4c0d-b6a6-55df6b8b0f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f283e33a-1a70-4a56-b74a-50596508881e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_f283e33a-1a70-4a56-b74a-50596508881e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_c37297c3-565f-4679-9739-a254d62615dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_c37297c3-565f-4679-9739-a254d62615dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_33a06b42-33bd-4833-bbee-6eea7ebbe48f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_ec8bd2e5-cbdb-4732-8fcf-9dc8be4aa6a9" xlink:to="loc_us-gaap_CertificatesOfDepositMember_33a06b42-33bd-4833-bbee-6eea7ebbe48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_ebc3c407-0393-48b7-a7f6-88d787d5648c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_4a32b15f-49e4-4c1b-a174-6600150a330f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:to="loc_us-gaap_ForeignExchangeContractMember_4a32b15f-49e4-4c1b-a174-6600150a330f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_24ef2c80-4fe5-458d-b1f4-c30e22e0e4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_bb9903ec-6421-4a95-b90a-9557e1f7682b" xlink:to="loc_us-gaap_InterestRateSwapMember_24ef2c80-4fe5-458d-b1f4-c30e22e0e4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0f163fb0-3063-4c1d-90f1-820f9b458b87" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:to="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1a010b70-f888-4b2e-a5eb-78b836a4bcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1a010b70-f888-4b2e-a5eb-78b836a4bcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecuritiesDebt_402c4db9-80e5-4b00-ad60-b1ffa47fffef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradingSecuritiesDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_TradingSecuritiesDebt_402c4db9-80e5-4b00-ad60-b1ffa47fffef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_98420cb2-e70b-4f4b-a80e-de64fc1b6896" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_98420cb2-e70b-4f4b-a80e-de64fc1b6896" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_5560045e-a2e8-485a-9dfc-3278b93a6e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_DerivativeAssets_5560045e-a2e8-485a-9dfc-3278b93a6e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_9ef43867-2caf-42a7-8c2a-3f1bd54a63b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_DerivativeAssets_9ef43867-2caf-42a7-8c2a-3f1bd54a63b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_59aefdd8-fefa-4cc7-8efb-066ff2ad5d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8ac25b6a-34a9-4c4c-847a-7f4237582be4" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_59aefdd8-fefa-4cc7-8efb-066ff2ad5d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3edcbe84-54ff-4612-bd69-2ea386750901" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a2553ce-f229-47f9-866c-7ca0d2e74306" xlink:href="syk-20211231.xsd#syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities_3a2553ce-f229-47f9-866c-7ca0d2e74306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f8d0a3af-769e-4ac4-93b1-1178b4b0fbbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure_f8d0a3af-769e-4ac4-93b1-1178b4b0fbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26a911d8-68ff-46dc-ae38-1b4636416956" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_26a911d8-68ff-46dc-ae38-1b4636416956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c2d16b5f-4a18-4242-9b72-5e45871abc57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_c2d16b5f-4a18-4242-9b72-5e45871abc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_055d0cb7-2ff5-406e-8344-89a00d19fc2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_055d0cb7-2ff5-406e-8344-89a00d19fc2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d238552c-53c3-4b84-89ee-c5df67bfdd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_d238552c-53c3-4b84-89ee-c5df67bfdd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21d34f12-d1d8-413e-a841-9708a0bf7147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract_b0263e6f-6e7c-40f6-a1ec-7124dd071513" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_21d34f12-d1d8-413e-a841-9708a0bf7147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_56dee52b-8810-44b4-aad5-4b60d3d5680c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_8d4e3ae6-1039-4ff2-9bc5-71050008f456" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_56dee52b-8810-44b4-aad5-4b60d3d5680c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsAvailableForSaleSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4f62eb2e-6362-4b20-a931-355d544e82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e3abd275-d821-4f06-974f-502ed3ee02b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4f62eb2e-6362-4b20-a931-355d544e82b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_e3abd275-d821-4f06-974f-502ed3ee02b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_1207492d-e864-40f2-a8b0-076fe6ace4e9" xlink:href="syk-20211231.xsd#syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4f62eb2e-6362-4b20-a931-355d544e82b2" xlink:to="loc_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_1207492d-e864-40f2-a8b0-076fe6ace4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f39d9cf7-e1a6-4752-ad98-3f5b0a7cbff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f39d9cf7-e1a6-4752-ad98-3f5b0a7cbff2" xlink:to="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_90a4e04a-a4ff-4aa6-9827-b146993d9ba7" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_97c85030-d715-4d01-9a30-003c9869a73a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_10bd7b68-f7df-4b8a-84da-c1eca7f0fa68" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_97c85030-d715-4d01-9a30-003c9869a73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_1f005a47-3b0d-4853-9b7e-525c3117d3d4" xlink:to="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesGainLoss_3bfa6921-7785-4db5-a564-52be3a8542d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e8a3c8f3-8770-42bf-8416-315480dc47ee" xlink:to="loc_us-gaap_MarketableSecuritiesGainLoss_3bfa6921-7785-4db5-a564-52be3a8542d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstruments" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstruments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ed6976ac-8493-4e28-be3b-fbae2a103169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9a716a2d-c840-4ed3-bfc3-a1abf041b60d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ed6976ac-8493-4e28-be3b-fbae2a103169" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9a716a2d-c840-4ed3-bfc3-a1abf041b60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a6a6768-aec5-4577-981c-114f9626aebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8c9772f8-205d-44e3-bb94-4a25a427dc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a6a6768-aec5-4577-981c-114f9626aebc" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_8c9772f8-205d-44e3-bb94-4a25a427dc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dcb82d07-60da-430e-b6fd-6933c5c9688f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_3a6a6768-aec5-4577-981c-114f9626aebc" xlink:to="loc_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_dcb82d07-60da-430e-b6fd-6933c5c9688f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca07aa45-1825-4dad-b30a-8ba15df27af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_ca07aa45-1825-4dad-b30a-8ba15df27af6" xlink:to="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_408aa044-1222-476d-9dc0-b39cd831190e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_ffedd5d1-582c-4e54-b906-57629ac95a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_734905ea-38ab-4d6b-b8ed-df3e9ccc4c6a" xlink:to="loc_us-gaap_CashFlowHedgingMember_ffedd5d1-582c-4e54-b906-57629ac95a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f422f474-7647-4aaf-9c03-eea1ce59a672" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_09a35718-e3ec-4a32-9be8-5e40f6a16456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_b5b0e204-7a6c-447d-be2f-5598d54ca070" xlink:to="loc_us-gaap_ForeignExchangeContractMember_09a35718-e3ec-4a32-9be8-5e40f6a16456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_c311b118-bbae-478b-bd27-24df246e734b" xlink:to="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b171e7ea-96d4-4ce9-bbd7-d32802be2341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_b171e7ea-96d4-4ce9-bbd7-d32802be2341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c1c54815-fced-4ef5-aff3-a3c50fae7d99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c78b165b-f6dd-455c-a33d-d66d1c926dd3" xlink:to="loc_us-gaap_NondesignatedMember_c1c54815-fced-4ef5-aff3-a3c50fae7d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_a160b92e-6e1b-415c-80e7-6fb7db962ba9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_2985647a-2d9b-4ec0-b3c7-3e9ea7f3817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_2985647a-2d9b-4ec0-b3c7-3e9ea7f3817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_63631012-e8ba-480d-8271-99b5be0263da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_63631012-e8ba-480d-8271-99b5be0263da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_5d23cc28-ff2c-4ddb-ab37-0cc288aafce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_5d23cc28-ff2c-4ddb-ab37-0cc288aafce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_09bc63bd-17d9-4129-a1ae-2db64c40eb5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_143f09ed-f299-4346-83f9-e980ef3addd3" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_09bc63bd-17d9-4129-a1ae-2db64c40eb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_dbcf49e6-99ee-4950-941c-6ed150b6271a" xlink:to="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cb8403ab-0063-440e-958f-68f9ab7cc539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cb8403ab-0063-440e-958f-68f9ab7cc539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_10abdeb8-e41c-49c1-8ff2-f202d90e5b68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1_10abdeb8-e41c-49c1-8ff2-f202d90e5b68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c75a0810-abc6-4470-98d7-f7f926b38d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_c75a0810-abc6-4470-98d7-f7f926b38d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_792c7cd2-7714-42e1-856a-2b8db5d17dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_792c7cd2-7714-42e1-856a-2b8db5d17dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d9c54ca3-a641-4c4c-aff2-e709988908ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e7e2ec41-b355-4f2d-a2e6-29f0a615f642" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeNet_d9c54ca3-a641-4c4c-aff2-e709988908ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_029e4755-42b0-4ed5-b430-f9a0433eca5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_029e4755-42b0-4ed5-b430-f9a0433eca5e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:to="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2faaddfe-47e3-45df-85f3-7f63b6653a23" xlink:to="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_56c8fc0e-d863-42f4-887f-d3d5a277ea1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_89c540dc-a971-4b4b-a233-7ce036f9a9c3" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_56c8fc0e-d863-42f4-887f-d3d5a277ea1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6da3beaf-572b-46da-8635-1b18b65ab4ad" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_bb761bd9-c4ca-40d2-bde6-2b8ff74a0284" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_ForeignExchangeContractMember_bb761bd9-c4ca-40d2-bde6-2b8ff74a0284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_50cef1f1-b82e-484d-8d1e-5cf95545fd92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_InterestRateSwapMember_50cef1f1-b82e-484d-8d1e-5cf95545fd92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_9f42e3c9-04ef-4e9f-b6df-d4e9eaff1718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_40b9039a-1bef-4cfe-bb85-ecc0546ffddb" xlink:to="loc_us-gaap_CashFlowHedgingMember_9f42e3c9-04ef-4e9f-b6df-d4e9eaff1718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_952808a6-ae9c-473c-9310-784a83a3bac3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc0727ff-0adf-443b-ba9a-6f2aba934c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc0727ff-0adf-443b-ba9a-6f2aba934c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DerivativeNotionalAmount1_a11c7e31-8fdf-4eb9-939b-53b1bab7de35" xlink:href="syk-20211231.xsd#syk_DerivativeNotionalAmount1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_syk_DerivativeNotionalAmount1_a11c7e31-8fdf-4eb9-939b-53b1bab7de35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_78207c7d-6ab5-4dc2-82d4-9057e1c4351f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue_78207c7d-6ab5-4dc2-82d4-9057e1c4351f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3950d8fa-0b74-4abb-a9a2-f82fe9083cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_3950d8fa-0b74-4abb-a9a2-f82fe9083cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_3b9de826-3ebf-4647-afbc-64b108350154" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_3b9de826-3ebf-4647-afbc-64b108350154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c2113a31-c0a6-40fb-9d85-a91f2fc6f16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_99e9efee-f2b3-41a0-a2f4-53f809424ff0" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_c2113a31-c0a6-40fb-9d85-a91f2fc6f16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DerivativeInstrumentsMovementsoutofOCIDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c390e803-4cc0-46ac-84ca-0f76c4523a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c390e803-4cc0-46ac-84ca-0f76c4523a68" xlink:to="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0a50c53-bc00-46bf-8335-6245379b98e7" xlink:to="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d207ceca-4382-4096-846c-6ae7d86f04ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_d207ceca-4382-4096-846c-6ae7d86f04ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_33070987-6e7a-44ae-b3fb-fd2879f42aea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_ae320b1b-01fb-488b-a23f-caef38d1b0b7" xlink:to="loc_us-gaap_NondesignatedMember_33070987-6e7a-44ae-b3fb-fd2879f42aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f7e88f1a-595d-4b6d-b40a-c35de45799cb" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_485e6e69-f763-48c7-9ced-1ad6f513192d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e5f78a7c-c612-4322-b22c-04a764c6eb67" xlink:to="loc_us-gaap_ForeignExchangeContractMember_485e6e69-f763-48c7-9ced-1ad6f513192d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_17f3fd27-c58b-437e-815c-db9889f35b74" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_1cd8a1c6-3f17-41ab-8b78-d1a5735d2f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:to="loc_us-gaap_CostOfSalesMember_1cd8a1c6-3f17-41ab-8b78-d1a5735d2f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_35e5f469-0b2c-47a0-8be3-5c5092659e65" xlink:href="syk-20211231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_24cf8743-26d9-4af8-99eb-16a0337e39ea" xlink:to="loc_syk_OtherIncomeexpenseMember_35e5f469-0b2c-47a0-8be3-5c5092659e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ec1fa7b4-7aae-43f4-9a87-9dd31326032d" xlink:to="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_33df770e-0b4c-4dda-b496-0e091a4c3b85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_33df770e-0b4c-4dda-b496-0e091a4c3b85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_198e9335-ac24-4128-bb41-5b70f0fecad1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ef8b430e-9100-47c9-a4c1-eb98198a07fd" xlink:to="loc_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax_198e9335-ac24-4128-bb41-5b70f0fecad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="simple" xlink:href="syk-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCI"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_ca816887-c3b7-4c01-9339-cd1db7a658f2" xlink:href="syk-20211231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_67111a1e-a218-43b3-ad79-3b88011bc847" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_ca816887-c3b7-4c01-9339-cd1db7a658f2" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_67111a1e-a218-43b3-ad79-3b88011bc847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="simple" xlink:href="syk-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCITables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_05f4b7b3-5b58-4851-b4ef-cbd52c100639" xlink:href="syk-20211231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_43495587-5065-422d-b027-af17ad1814f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_05f4b7b3-5b58-4851-b4ef-cbd52c100639" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_43495587-5065-422d-b027-af17ad1814f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_4f97287a-fdca-4fdd-b3db-001c1783a1c2" xlink:href="syk-20211231.xsd#syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract_4f97287a-fdca-4fdd-b3db-001c1783a1c2" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_deca72c2-5aea-4041-853a-4804340f3c6e" xlink:to="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ce745bab-3272-4866-9719-a4049271bd96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ce745bab-3272-4866-9719-a4049271bd96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a5d9f66-cbf2-4cc1-8b8b-0ddf2cf25066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_3a5d9f66-cbf2-4cc1-8b8b-0ddf2cf25066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7e0bb358-21db-49f6-b038-32ad21bbc443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_7e0bb358-21db-49f6-b038-32ad21bbc443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78dd7713-f25e-4d80-9b08-74ae4383d00e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_f573b4cc-359b-490e-afbf-6c87fd230467" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_78dd7713-f25e-4d80-9b08-74ae4383d00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis_c54257c7-5962-4557-a76e-77e2f17392a8" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ce5da169-7d74-48e0-bde2-8c2870aea5c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain_b19672e1-fffb-4c06-a06e-51cd4f72bd3e" xlink:to="loc_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember_ce5da169-7d74-48e0-bde2-8c2870aea5c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6f084cbc-99f7-4d06-b55a-010f41704ae7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_114f426b-524a-46b9-845c-32bfb0107c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:to="loc_us-gaap_CostOfSalesMember_114f426b-524a-46b9-845c-32bfb0107c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherIncomeexpenseMember_54ce0c28-448c-460e-b45e-251b68938e25" xlink:href="syk-20211231.xsd#syk_OtherIncomeexpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_55ea1b36-e59b-4426-a5a4-fe752d51699f" xlink:to="loc_syk_OtherIncomeexpenseMember_54ce0c28-448c-460e-b45e-251b68938e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_149c294b-cbc0-4975-918f-602a86a75a59" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AOCIAttributableToParentNetOfTaxRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_bd547e4a-5f90-433f-8df3-94ba336362a3" xlink:to="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ee2bb69c-8abb-435b-96c3-a18854731846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ee2bb69c-8abb-435b-96c3-a18854731846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2b726c54-e0b0-4a8e-bc55-028d229bd0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_2b726c54-e0b0-4a8e-bc55-028d229bd0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_df092a0b-9e15-4a4b-ab2b-ba0ef32f9718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_df092a0b-9e15-4a4b-ab2b-ba0ef32f9718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_06c39fdd-341b-4703-9526-f33ab1bb02a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_CostOfRevenue_06c39fdd-341b-4703-9526-f33ab1bb02a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_9c7a2444-e15d-456c-bfea-4119fd501b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_9c7a2444-e15d-456c-bfea-4119fd501b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5d0cb901-b269-400c-ab45-b60e2549885e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5d0cb901-b269-400c-ab45-b60e2549885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3df44c7a-495b-47f3-9892-a643e2543ece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3df44c7a-495b-47f3-9892-a643e2543ece" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7cb4454a-578f-4cc9-a6ca-76a965aaf8c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AOCIAttributableToParentNetOfTaxRollForward_bb9e7ca0-f814-4c1c-a1bd-e61256ee49e9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7cb4454a-578f-4cc9-a6ca-76a965aaf8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/Acquisitions" xlink:type="simple" xlink:href="syk-20211231.xsd#Acquisitions"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/Acquisitions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_8a76581d-86df-4fb4-9cec-c281da597510" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d88123d1-c107-4322-a3d2-a9a1e06dd2b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_8a76581d-86df-4fb4-9cec-c281da597510" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d88123d1-c107-4322-a3d2-a9a1e06dd2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsTables" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_136976f4-8369-41cc-907b-329e40d14625" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_02d4fbf8-d73b-40bb-8bc9-122ada31ebb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_136976f4-8369-41cc-907b-329e40d14625" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_02d4fbf8-d73b-40bb-8bc9-122ada31ebb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b7a4d714-34cd-47e9-a1b4-86f01891e3d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b7a4d714-34cd-47e9-a1b4-86f01891e3d6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8e804feb-bee1-4ae7-8ecb-70e60e0c7778" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GaussMember_475bb662-c158-4549-8c0f-0c7d1fe42fa2" xlink:href="syk-20211231.xsd#syk_GaussMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_GaussMember_475bb662-c158-4549-8c0f-0c7d1fe42fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_f0c9935a-6e63-468a-8674-a08c997fd99b" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_WrightMember_f0c9935a-6e63-468a-8674-a08c997fd99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_VoceraMember_7f51c4ac-01b0-485e-bac6-49377870f6af" xlink:href="syk-20211231.xsd#syk_VoceraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a0bc6501-0854-48a9-a1b4-8b90984dc77d" xlink:to="loc_syk_VoceraMember_7f51c4ac-01b0-485e-bac6-49377870f6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_73305c29-a5f4-4948-a495-697f1d61595a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A1625ConvertibleNotesMember_6ab36dfc-36b8-4281-8069-27603616c874" xlink:href="syk-20211231.xsd#syk_A1625ConvertibleNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:to="loc_syk_A1625ConvertibleNotesMember_6ab36dfc-36b8-4281-8069-27603616c874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_A225ConvertibleNotesMember_f69b735c-2bbf-4a24-85da-7b1562cb984f" xlink:href="syk-20211231.xsd#syk_A225ConvertibleNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_03c378ac-8cd7-454b-baa9-fd2813dfb531" xlink:to="loc_syk_A225ConvertibleNotesMember_f69b735c-2bbf-4a24-85da-7b1562cb984f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8a172215-f1e3-4dc8-a5db-7bcf1c454f5c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6ec0e387-c72d-4b7a-8340-70a05aa39920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_1e2466f6-f617-4c0e-94ca-7e87d19ea9c2" xlink:to="loc_us-gaap_SubsequentEventMember_6ec0e387-c72d-4b7a-8340-70a05aa39920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_60f22a4c-17ce-43a3-b439-ea5a21b05dbd" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2b99ff4d-3bfa-40f8-8ff5-621a3a516239" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_2b99ff4d-3bfa-40f8-8ff5-621a3a516239" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_0c9d4dd7-0e5a-4fb1-a481-00096ed610c3" xlink:href="syk-20211231.xsd#syk_BusinessCombinationContingentConsiderationFutureMilestonePayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments_0c9d4dd7-0e5a-4fb1-a481-00096ed610c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_5fbf9e2e-0615-41e3-8ef5-c45257cbec04" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredPricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredPricePerShare_5fbf9e2e-0615-41e3-8ef5-c45257cbec04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_6a14ed41-d504-40ff-9bfc-4f4f247faecc" xlink:href="syk-20211231.xsd#syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes_6a14ed41-d504-40ff-9bfc-4f4f247faecc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_00184d93-ca93-4439-81fc-45eecbcf8b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_00184d93-ca93-4439-81fc-45eecbcf8b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_5c0e8e19-a52b-433d-ab68-2930a08a45e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27934d4d-76f2-40b5-82c3-fcaddeda1923" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_5c0e8e19-a52b-433d-ab68-2930a08a45e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_a780e271-f9a2-4d54-9517-5e9984332ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_a780e271-f9a2-4d54-9517-5e9984332ef6" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8355f85a-05e7-47c8-809a-c41204d75e3b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_6407287c-556b-4f36-893a-995471208888" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31e07bfe-671f-462a-b103-8c24ecc6dfa2" xlink:to="loc_syk_WrightMember_6407287c-556b-4f36-893a-995471208888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_da72fdd0-7be5-4f21-bb5c-1621d9c2e977" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CustomerAndDistributorRelationshipsMember_f5f63425-ae85-490e-9c60-9e8f1f2fffb7" xlink:href="syk-20211231.xsd#syk_CustomerAndDistributorRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_syk_CustomerAndDistributorRelationshipsMember_f5f63425-ae85-490e-9c60-9e8f1f2fffb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_65e4ce4e-3f3e-4d32-a1bf-c9cec3faa702" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_65e4ce4e-3f3e-4d32-a1bf-c9cec3faa702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_81c65397-1e05-4bf5-93c6-b3bfcfbe0248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3381f577-4377-4213-a026-422a8e9adfd0" xlink:to="loc_us-gaap_TradeNamesMember_81c65397-1e05-4bf5-93c6-b3bfcfbe0248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a2f2c209-d684-421f-8cf4-fdba72a4da18" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95dbeb2a-f71f-469a-ba2e-e86adf70b092" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95dbeb2a-f71f-469a-ba2e-e86adf70b092" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5cafd5f2-1c1d-4649-ae38-ed9b4c5c89e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_5cafd5f2-1c1d-4649-ae38-ed9b4c5c89e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3ffaabb8-6ce1-4d88-938a-80f6d7db6369" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_3ffaabb8-6ce1-4d88-938a-80f6d7db6369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dda1641b-a662-4dc2-b287-3067c8ef2d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_dda1641b-a662-4dc2-b287-3067c8ef2d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_4b01d5a8-f130-471d-b3de-e802b4d1bd4a" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt_4b01d5a8-f130-471d-b3de-e802b4d1bd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4512f51a-bc92-440e-8555-6e7ef920440d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4512f51a-bc92-440e-8555-6e7ef920440d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_0edc358f-79a9-48a3-8f94-17f7db8e7cbd" xlink:href="syk-20211231.xsd#syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities_0edc358f-79a9-48a3-8f94-17f7db8e7cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_369d48a6-1a23-48e5-8f8d-3a5f9082252a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_369d48a6-1a23-48e5-8f8d-3a5f9082252a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_76baa34a-aa01-483b-bc42-11585f6c846c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_76baa34a-aa01-483b-bc42-11585f6c846c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3c2d9755-e685-4b57-b29b-afeb1f354623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_Goodwill_3c2d9755-e685-4b57-b29b-afeb1f354623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17782c21-1fb9-4a3e-a11e-0cbd7ee1d587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_17782c21-1fb9-4a3e-a11e-0cbd7ee1d587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4fe85c7c-428a-466f-a009-338dedc21133" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_dda3c986-b303-45dc-9a9d-7e534bde9431" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4fe85c7c-428a-466f-a009-338dedc21133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="simple" xlink:href="syk-20211231.xsd#ContingenciesandCommitments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7065fd6d-ba96-4555-9bdc-7e1107cc720d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_98e3582e-3387-4aaa-97a5-d53530aa826c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7065fd6d-ba96-4555-9bdc-7e1107cc720d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_98e3582e-3387-4aaa-97a5-d53530aa826c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="simple" xlink:href="syk-20211231.xsd#ContingenciesandCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3e27fe01-3f8b-4ccf-8dc6-b118547f43d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_1abea18c-004c-4031-8b6f-87835200d998" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3e27fe01-3f8b-4ccf-8dc6-b118547f43d1" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_1abea18c-004c-4031-8b6f-87835200d998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_acf7b946-fa4c-410f-b85d-517313471fe4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_3e27fe01-3f8b-4ccf-8dc6-b118547f43d1" xlink:to="loc_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock_acf7b946-fa4c-410f-b85d-517313471fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#ContingenciesandCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_72fbd695-428c-44a4-87f7-fde3ba4e3107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_72fbd695-428c-44a4-87f7-fde3ba4e3107" xlink:to="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:to="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b9dc26b4-138b-445e-84da-1db145e74d0a" xlink:to="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_9c369997-9c1e-4ff0-9722-1fb074b679f4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:to="loc_srt_MinimumMember_9c369997-9c1e-4ff0-9722-1fb074b679f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b19ad84a-7967-4332-9c60-0ddc161f9e6c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_821e9bd0-cd27-44af-86c1-43f66bcb8540" xlink:to="loc_srt_MaximumMember_b19ad84a-7967-4332-9c60-0ddc161f9e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_030a6fe5-d4c6-4efd-ac2f-6dc059e887da" xlink:to="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyLossInPeriod_b1bd2fa1-1a6c-4c13-ae8d-b37e95fa82b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyLossInPeriod_b1bd2fa1-1a6c-4c13-ae8d-b37e95fa82b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualPayments_3bf3212a-2384-493d-912a-b846854e0d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyAccrualPayments_3bf3212a-2384-493d-912a-b846854e0d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_af4e8076-25b5-46a7-8fbc-400ce24b69f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_af4e8076-25b5-46a7-8fbc-400ce24b69f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_f1004892-2f77-4f73-975d-5b20d6a93cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c64706c3-0eac-4de4-bbe6-c67fb59c47f6" xlink:to="loc_us-gaap_OperatingLeaseExpense_f1004892-2f77-4f73-975d-5b20d6a93cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CommitmentsandContingenciesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_33897c7f-99cc-4508-b19d-2801615ba36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_33897c7f-99cc-4508-b19d-2801615ba36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1ff18d9-05d1-45f0-ab0b-aa069483f8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c1ff18d9-05d1-45f0-ab0b-aa069483f8b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_95017b09-525f-43aa-9e9d-c2c695a25f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_95017b09-525f-43aa-9e9d-c2c695a25f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5bc58f39-e3ed-4c18-a852-f8b0f8668262" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5bc58f39-e3ed-4c18-a852-f8b0f8668262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09bee5c0-9b57-4525-8393-7522e38e34b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_09bee5c0-9b57-4525-8393-7522e38e34b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_74b9a4c1-ee5f-4eb1-8807-dcf0ecefeec7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_74b9a4c1-ee5f-4eb1-8807-dcf0ecefeec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_111d9071-f495-4e80-b8c1-4f5db7b47552" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_111d9071-f495-4e80-b8c1-4f5db7b47552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6f3efad4-8dc5-4479-b648-4f4c45ce04d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e75cea1d-f77b-4b0b-ad6a-71187d97f18b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_6f3efad4-8dc5-4479-b648-4f4c45ce04d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6fa9a8d0-ec2d-41c5-a227-22eb07ed5d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_6fa9a8d0-ec2d-41c5-a227-22eb07ed5d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1fe51eb4-a9f7-49ad-ab7e-2148f9790641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_1fe51eb4-a9f7-49ad-ab7e-2148f9790641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_89426182-11da-40ed-8f3e-2ca3bbaf71f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_89426182-11da-40ed-8f3e-2ca3bbaf71f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5dddbce5-4bbf-44c2-8f59-01418e8d503e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_5dddbce5-4bbf-44c2-8f59-01418e8d503e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c76631e2-abf6-46f0-b6d8-7362a42cac34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_c76631e2-abf6-46f0-b6d8-7362a42cac34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4692927-1532-4240-bf09-f96b7dc9ac4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_e4692927-1532-4240-bf09-f96b7dc9ac4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PurchaseObligationFiscalYearMaturityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_84dd359e-0066-447f-bbd2-923fb1a275dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_84dd359e-0066-447f-bbd2-923fb1a275dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_57a100c6-408a-430c-b486-9f181e5bf58f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear_57a100c6-408a-430c-b486-9f181e5bf58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_28bf52e6-0c3d-435f-9403-3ed59890c331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear_28bf52e6-0c3d-435f-9403-3ed59890c331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_61b5f446-ac5a-480d-9d18-2ebab1c8caf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear_61b5f446-ac5a-480d-9d18-2ebab1c8caf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_b7d3a3a6-ad6b-437f-8ca5-ac6a6028a539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear_b7d3a3a6-ad6b-437f-8ca5-ac6a6028a539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_82f6d969-ed33-4ae3-9cba-e6909b89030c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PurchaseObligationFiscalYearMaturityAbstract_e946bede-a5fd-414d-9d63-51ea83e0e434" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear_82f6d969-ed33-4ae3-9cba-e6909b89030c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a9187707-d875-49b2-9a4c-733cdbb6ba64" xlink:to="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b0d35289-eb3d-4480-8555-423653e0080e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b0d35289-eb3d-4480-8555-423653e0080e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e559c2fe-8002-447e-b217-dabee34f2066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e559c2fe-8002-447e-b217-dabee34f2066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53d17aee-b948-43d4-804f-96a33c32f5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_53d17aee-b948-43d4-804f-96a33c32f5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_52ef44f8-b61d-4834-9e16-f51653d0f38d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_52ef44f8-b61d-4834-9e16-f51653d0f38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fe137692-3fc3-4a73-9284-0b9cff5a8b06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_fe137692-3fc3-4a73-9284-0b9cff5a8b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_50d40899-e482-4a2f-ab59-ac3b553188a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9a1e3402-e434-45fb-bc77-3b38f4b85cdf" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_50d40899-e482-4a2f-ab59-ac3b553188a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_02e0f654-48a6-46ac-87ce-d806342e5e93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_399cf2da-5bb9-4bfd-b516-8a963357d367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_02e0f654-48a6-46ac-87ce-d806342e5e93" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_399cf2da-5bb9-4bfd-b516-8a963357d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf3a2a35-2532-430e-9aa0-17e8b489d683" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_3d423016-85a2-4842-97e9-2f7be98c3bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf3a2a35-2532-430e-9aa0-17e8b489d683" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_3d423016-85a2-4842-97e9-2f7be98c3bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_be3762d9-8d43-42ca-8613-f7bb0d297734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf3a2a35-2532-430e-9aa0-17e8b489d683" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_be3762d9-8d43-42ca-8613-f7bb0d297734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83776789-0416-47e4-93be-7fac6a09f085" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cf3a2a35-2532-430e-9aa0-17e8b489d683" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_83776789-0416-47e4-93be-7fac6a09f085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07af6456-e169-4fbf-b42d-11ed1729124a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_07af6456-e169-4fbf-b42d-11ed1729124a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_fe892027-2a6f-4f9e-b199-3e994090ce81" xlink:to="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_700dec69-2212-47d2-bf5f-2e7dde756794" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_700dec69-2212-47d2-bf5f-2e7dde756794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_334d9c67-5240-4620-b364-19a71572f5a4" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_b6b995e7-b521-4aad-9870-ef9fbd08041c" xlink:to="loc_syk_OrthopaedicsAndSpineMember_334d9c67-5240-4620-b364-19a71572f5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_5d1ced05-d679-4628-9e86-1b51b770e95f" xlink:to="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_06129c6b-7b45-4a65-94cd-2ea1b4282097" xlink:to="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c8b96899-a3ba-4030-a560-e1328d977353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_Goodwill_c8b96899-a3ba-4030-a560-e1328d977353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_73bd732d-287f-4ff3-82d3-0f0f6e65da72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_73bd732d-287f-4ff3-82d3-0f0f6e65da72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_303d293f-ffc2-44ee-ba74-0aa0cef13f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments_303d293f-ffc2-44ee-ba74-0aa0cef13f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c3bd5a1c-ad81-4dff-9e92-7be45990e8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_cfb2ca5f-fe02-47d4-ad6b-1cbbc2e094f9" xlink:to="loc_us-gaap_Goodwill_c3bd5a1c-ad81-4dff-9e92-7be45990e8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dbfbcc31-4e12-4238-9a2a-82d5701f2306" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_dd69a0b7-ec5e-4afd-af5e-dc5e99f4e334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dbfbcc31-4e12-4238-9a2a-82d5701f2306" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_dd69a0b7-ec5e-4afd-af5e-dc5e99f4e334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dbfbcc31-4e12-4238-9a2a-82d5701f2306" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_52dfa2d3-5c06-484d-b96b-7cb7b3fa9aaf" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_ca769a57-3234-4e09-872b-63338dd0a335" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_ca769a57-3234-4e09-872b-63338dd0a335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_c9b982d3-bdcb-4bd7-b2e3-3daa762479af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_CustomerRelationshipsMember_c9b982d3-bdcb-4bd7-b2e3-3daa762479af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_80357718-7830-40b9-b934-10ae60d3944b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_PatentsMember_80357718-7830-40b9-b934-10ae60d3944b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_c86ec9aa-b504-4a15-b345-a2149a946de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_TrademarksMember_c86ec9aa-b504-4a15-b345-a2149a946de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_1d06a7c2-e852-46da-af33-9dfb2a72c867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_1d06a7c2-e852-46da-af33-9dfb2a72c867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_8fabb8cc-d995-493d-bfb8-7cff135047e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_deeb1610-9467-405f-bbf6-0bbece051116" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_8fabb8cc-d995-493d-bfb8-7cff135047e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_760d6748-a348-4c1c-8c62-1187129bcf38" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0b902ce6-8599-42b5-87a2-2d1dbc1d0d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_0b902ce6-8599-42b5-87a2-2d1dbc1d0d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c99205c-125e-40d9-aaf9-b888b7224b51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_9c99205c-125e-40d9-aaf9-b888b7224b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6bed7902-981c-42e0-8d45-567a4946ad85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6bed7902-981c-42e0-8d45-567a4946ad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_009c142d-0a6c-4d9a-8830-2792ceec929c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_9e189626-e2a8-4efb-a908-c562c5befc84" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_009c142d-0a6c-4d9a-8830-2792ceec929c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_443fae44-5e80-4c01-a356-1f1fe689d368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_443fae44-5e80-4c01-a356-1f1fe689d368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6f4263d6-5a5c-4cfa-9566-3edf2b8f32c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6f4263d6-5a5c-4cfa-9566-3edf2b8f32c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c47fbe7d-54ab-4ccf-a873-ef433fdaa7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_c47fbe7d-54ab-4ccf-a873-ef433fdaa7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dfe91d8f-233b-49c4-8a99-5d72de7a01e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_dfe91d8f-233b-49c4-8a99-5d72de7a01e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d39dca62-6425-41f5-89f4-dd37253f51fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc6dc1ff-e526-444c-9c73-a0d586031f71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d39dca62-6425-41f5-89f4-dd37253f51fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStock" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStock"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_cba16e27-53ea-4362-b8fb-2579eefd424a" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0847e5ed-2dee-4051-8260-f89faa62b6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_cba16e27-53ea-4362-b8fb-2579eefd424a" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0847e5ed-2dee-4051-8260-f89faa62b6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockTables" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_e0f03ef4-a5c8-4f06-922b-702971237b44" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_cda08bca-678b-4707-bdd8-674ed0aa3185" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_e0f03ef4-a5c8-4f06-922b-702971237b44" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_cda08bca-678b-4707-bdd8-674ed0aa3185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_04713743-ae17-468d-9c27-ee8f101f0c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_e0f03ef4-a5c8-4f06-922b-702971237b44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_04713743-ae17-468d-9c27-ee8f101f0c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_6c06f005-cc82-452f-be4e-699fc093e60c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_e0f03ef4-a5c8-4f06-922b-702971237b44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_6c06f005-cc82-452f-be4e-699fc093e60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_b6555d27-cf86-4ab7-8950-83a73765ac89" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_b6555d27-cf86-4ab7-8950-83a73765ac89" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:to="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d0eff8fb-e74f-4e42-9314-5d12f8f6acff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_0ced5254-f01d-44fe-83c7-405fc91306f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_0ced5254-f01d-44fe-83c7-405fc91306f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_e0d3faf7-b576-4dcf-ba46-f86c1c007e91" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_syk_PerformanceStockUnitPsusMember_e0d3faf7-b576-4dcf-ba46-f86c1c007e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_9bc6a639-3ff2-4c6a-9e27-1d3b0ec7d916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53cf1af9-6f00-492f-b0ed-4339841730e8" xlink:to="loc_us-gaap_EmployeeStockMember_9bc6a639-3ff2-4c6a-9e27-1d3b0ec7d916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_84bde1cc-430f-436b-8ce5-f3ad99db8855" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CommonAndPreferredStockSharesAuthorized_0243292e-7a99-48e7-87fb-b4b78a7d006f" xlink:href="syk-20211231.xsd#syk_CommonAndPreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_CommonAndPreferredStockSharesAuthorized_0243292e-7a99-48e7-87fb-b4b78a7d006f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_a6059804-a1b8-4dae-82e0-5ab1363afddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_a6059804-a1b8-4dae-82e0-5ab1363afddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f486a40e-8c63-442d-8f0b-8f3ef4887599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f486a40e-8c63-442d-8f0b-8f3ef4887599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_811f70fa-0a8e-4313-98b9-388a3a7079c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_811f70fa-0a8e-4313-98b9-388a3a7079c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_839da37e-8bcf-46db-b514-1576444501f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_839da37e-8bcf-46db-b514-1576444501f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_39961a8c-42a0-4080-88bb-690d0f2b74cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_39961a8c-42a0-4080-88bb-690d0f2b74cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_33e3f74e-c6a6-424f-b59d-044fa1d6d64c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_33e3f74e-c6a6-424f-b59d-044fa1d6d64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_dbf99092-e180-4c54-86f3-9c10ce06fbb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_dbf99092-e180-4c54-86f3-9c10ce06fbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fbd16b2f-9830-4c84-a55f-272276c7655c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_fbd16b2f-9830-4c84-a55f-272276c7655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f12e090e-a035-42a0-8558-605a83cdd82f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_f12e090e-a035-42a0-8558-605a83cdd82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cbdf1da9-3add-4c3c-a36e-59aee3058004" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_cbdf1da9-3add-4c3c-a36e-59aee3058004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3f3e14cf-0222-4d62-88f9-1609a7983349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3f3e14cf-0222-4d62-88f9-1609a7983349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_88c8cff9-1525-498f-b3a3-3a1cdd4e5ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_88c8cff9-1525-498f-b3a3-3a1cdd4e5ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_48d8eaf6-0eed-4743-a46c-f5222df748f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_48d8eaf6-0eed-4743-a46c-f5222df748f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5c3a6fd0-b59b-42ff-9181-f3e978e89da1" xlink:href="syk-20211231.xsd#syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue_5c3a6fd0-b59b-42ff-9181-f3e978e89da1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_74187bee-298b-4155-981c-3dec42ed8d05" xlink:href="syk-20211231.xsd#syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp_74187bee-298b-4155-981c-3dec42ed8d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_44ed964d-3e9a-4982-b5e2-e8235866be49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_96d18524-6e83-4d11-94a5-716e4941c87f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_44ed964d-3e9a-4982-b5e2-e8235866be49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockOptionGrantAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8bc4f459-935d-4c60-891a-cc78eda6d71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8bc4f459-935d-4c60-891a-cc78eda6d71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccfb0e7c-8239-4d68-b75f-58a6034069b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ccfb0e7c-8239-4d68-b75f-58a6034069b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3a002c37-dd9c-4e53-ad5f-c6dde711247c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3a002c37-dd9c-4e53-ad5f-c6dde711247c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e5d6b602-9f42-47b5-969c-73815202d52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_e5d6b602-9f42-47b5-969c-73815202d52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44148a26-48cc-4ab1-8f02-7c0c66e2ca61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_a9e92048-c4b9-4a02-9a2b-f1e990cd1392" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_44148a26-48cc-4ab1-8f02-7c0c66e2ca61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockSummaryofStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b6dbad9-2b60-45df-a6ad-815bbac2af1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3b6dbad9-2b60-45df-a6ad-815bbac2af1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ab49325b-29a5-454a-8dbb-1cd1d47cea2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_ab49325b-29a5-454a-8dbb-1cd1d47cea2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a96baaa-9a34-4fff-ac30-54429817eb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2a96baaa-9a34-4fff-ac30-54429817eb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b77f6547-75cc-4eca-a1bf-14033247ddc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b77f6547-75cc-4eca-a1bf-14033247ddc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_35f31a43-cbd4-4f64-b6c5-083215081b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_71455f57-ddf6-4a7c-be5d-85d2157a49d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_35f31a43-cbd4-4f64-b6c5-083215081b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_796d96c0-3772-4ddd-9294-8ee5c2f7cac9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_796d96c0-3772-4ddd-9294-8ee5c2f7cac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280b7fd4-912b-442b-988b-44ea9b182927" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_280b7fd4-912b-442b-988b-44ea9b182927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5499efd9-3bce-40e9-b307-cedd868d8289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5499efd9-3bce-40e9-b307-cedd868d8289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ffc3dcab-1792-4612-a306-33d781e62255" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ffc3dcab-1792-4612-a306-33d781e62255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9dd6a051-b3f8-4536-8855-b996787f1038" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9dd6a051-b3f8-4536-8855-b996787f1038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_29f218f7-9638-44b1-8f30-2f4af79f79c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_29f218f7-9638-44b1-8f30-2f4af79f79c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ead545f2-5455-4d28-bfab-7c4ec4f17aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_1de0b5fd-74a6-487e-8f4c-46b1bb506529" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ead545f2-5455-4d28-bfab-7c4ec4f17aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_23d528e1-a1ec-4e53-93e0-bac86ae8b87d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_23d528e1-a1ec-4e53-93e0-bac86ae8b87d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6a736f86-b54b-4bb0-b192-308e02e054f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_6a736f86-b54b-4bb0-b192-308e02e054f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_fc50b148-4f8a-4a21-a746-6443db00f5cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a8ffb098-5a66-423b-b435-ef4404c72272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a8ffb098-5a66-423b-b435-ef4404c72272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2b7c6775-1074-4fc9-92c3-7a04239af739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_2b7c6775-1074-4fc9-92c3-7a04239af739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_d57665d3-3f8d-4b4c-a4ac-bb51d53e4f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_d57665d3-3f8d-4b4c-a4ac-bb51d53e4f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1764041d-c9bb-4f01-9f51-88901ec740d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_1764041d-c9bb-4f01-9f51-88901ec740d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_55a594d5-7fd3-4d3d-bbfa-da424a894f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_55a594d5-7fd3-4d3d-bbfa-da424a894f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a2ea9657-feb5-46f2-a18e-e8ffc831e787" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3a3d3a2b-39b0-4e8e-be50-46975e6493a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_a2ea9657-feb5-46f2-a18e-e8ffc831e787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#CapitalStockSummaryofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalStockAbstract_afb9f7c6-9e3f-413b-902d-d393a25f10c0" xlink:href="syk-20211231.xsd#syk_CapitalStockAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_syk_CapitalStockAbstract_afb9f7c6-9e3f-413b-902d-d393a25f10c0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:to="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1754cdb1-f105-4b88-8b5b-46b130417db3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1b060f95-65a0-4afd-8a26-a0ae0e4192f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1b060f95-65a0-4afd-8a26-a0ae0e4192f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_PerformanceStockUnitPsusMember_b7ff712c-c1ba-465e-87a3-3a4f353802e5" xlink:href="syk-20211231.xsd#syk_PerformanceStockUnitPsusMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dcedc267-bb47-41ae-8f48-9cac3ad07d72" xlink:to="loc_syk_PerformanceStockUnitPsusMember_b7ff712c-c1ba-465e-87a3-3a4f353802e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_2736f6da-d664-4054-ad54-e28b81dd64da" xlink:to="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6fd6815c-92bc-475a-a203-c51f63801ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6fd6815c-92bc-475a-a203-c51f63801ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_936b84ec-85b1-4325-b38a-275abde8fdf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_936b84ec-85b1-4325-b38a-275abde8fdf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a500091-82a0-4baa-b69d-e07ac847c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_4a500091-82a0-4baa-b69d-e07ac847c70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a1801044-b86a-4c9a-baca-226f1d684b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a1801044-b86a-4c9a-baca-226f1d684b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81b64755-b467-48e2-9eb4-3f91e9b4b531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f2d94dcd-26f4-4a27-93fd-7b6f25cff19d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81b64755-b467-48e2-9eb4-3f91e9b4b531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa52a11-d999-482c-8d85-59fab154bab6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85dd886e-a690-4dc6-9cad-dec1f0d52c81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_85dd886e-a690-4dc6-9cad-dec1f0d52c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f0f121de-1280-4f67-99c6-1f48354e2383" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f0f121de-1280-4f67-99c6-1f48354e2383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fbdaabb3-3cf8-41d2-bd6a-a775b85604ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_fbdaabb3-3cf8-41d2-bd6a-a775b85604ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9f1b1bac-d126-415a-8505-12b021a6a170" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_9f1b1bac-d126-415a-8505-12b021a6a170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f7f782ca-2244-434b-8031-56e956811cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fe93d64a-054b-4d53-a405-56d98a3c328e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f7f782ca-2244-434b-8031-56e956811cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilities"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_012a04e3-9825-490f-881b-b88028e37fbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_ba728ed4-19c7-446a-8710-f7a3697e462e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_012a04e3-9825-490f-881b-b88028e37fbb" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_ba728ed4-19c7-446a-8710-f7a3697e462e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_eaac866b-ad04-435c-b852-07e397d140f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_914f1481-5430-463e-bffc-080961ee1228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_eaac866b-ad04-435c-b852-07e397d140f9" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_914f1481-5430-463e-bffc-080961ee1228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_a9697f4d-372d-49b0-b471-e3c7c6037a44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_a9697f4d-372d-49b0-b471-e3c7c6037a44" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0b87444d-6c3f-45a7-bf83-2e5d31f27b20" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CreditAgreementMember_d5f41d6b-e9cf-4bf3-8cad-388bc657b2c8" xlink:href="syk-20211231.xsd#syk_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_CreditAgreementMember_d5f41d6b-e9cf-4bf3-8cad-388bc657b2c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_e01970f6-f86f-4577-a5ed-25afdce218f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_us-gaap_CommercialPaperMember_e01970f6-f86f-4577-a5ed-25afdce218f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2625Due2021Member_0821d94b-39ce-4804-aad6-0ddde7275f41" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2625Due2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_SeniorUnsecuredNotes2625Due2021Member_0821d94b-39ce-4804-aad6-0ddde7275f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.125Due2021Member_bf8a1793-5c97-4972-a2e7-0eaa703d677b" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.125Due2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_0d9a049b-ddff-4359-b49c-a1f6dd23cb05" xlink:to="loc_syk_SeniorUnsecuredNotes1.125Due2021Member_bf8a1793-5c97-4972-a2e7-0eaa703d677b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_78a1e448-93bd-425b-b65e-7cf95d8ecff7" xlink:to="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_fd613ab7-5cde-48d4-9bc7-a46598738e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a3f2ebcd-fa48-4dbb-862f-03d3dd303931" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_fd613ab7-5cde-48d4-9bc7-a46598738e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_dc5df015-a9c9-46c4-9a6e-895fa36f4eca" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_532f8a0b-b94b-462c-83a0-51e307914d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_68b3cad6-ecae-49d6-b614-baa0d675ea5b" xlink:to="loc_us-gaap_SubsequentEventMember_532f8a0b-b94b-462c-83a0-51e307914d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_42d3a017-e2b8-43a3-893a-f035cb3a5f27" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_ec4eeee8-4824-4d2d-80b3-1eb342212fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_ec4eeee8-4824-4d2d-80b3-1eb342212fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_504c0e02-31f5-40ff-9838-eaeb7b2eb860" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_504c0e02-31f5-40ff-9838-eaeb7b2eb860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DebtInstrumentCovenantLeverageRatio_cafd6151-1f03-423d-ac9b-50fdb1c97e80" xlink:href="syk-20211231.xsd#syk_DebtInstrumentCovenantLeverageRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_syk_DebtInstrumentCovenantLeverageRatio_cafd6151-1f03-423d-ac9b-50fdb1c97e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_63bfbbca-8183-460f-bf09-f43376c20121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentTerm_63bfbbca-8183-460f-bf09-f43376c20121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaper_adbf5bcc-7763-4a1c-8a62-b6039da1bec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaper"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_CommercialPaper_adbf5bcc-7763-4a1c-8a62-b6039da1bec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b21b7581-2a5d-4d4a-b5fa-c568df647f67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentRepurchasedFaceAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentRepurchasedFaceAmount_b21b7581-2a5d-4d4a-b5fa-c568df647f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_edfeba96-ec95-4382-b610-eb4cf549a098" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_edfeba96-ec95-4382-b610-eb4cf549a098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_24651b2f-b012-4b80-ae28-e51aa5eea628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9b11934b-34f7-4724-82d7-f967711f3323" xlink:to="loc_us-gaap_InterestExpenseDebt_24651b2f-b012-4b80-ae28-e51aa5eea628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAbstract_fff873dd-a91e-44b7-b15c-6ff6d34aabd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtAbstract_fff873dd-a91e-44b7-b15c-6ff6d34aabd5" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:to="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d56e52a6-0241-4457-a9c2-8ee9a5d313c9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2625Due2021Member_d89546ca-6871-4b67-850f-b4d1f8dbab80" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2625Due2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes2625Due2021Member_d89546ca-6871-4b67-850f-b4d1f8dbab80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_dbe52327-d160-4144-9b3c-61aaf9da9dd4" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2023Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2023Member_dbe52327-d160-4144-9b3c-61aaf9da9dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1eb5a49f-564c-4441-8d6e-13f35cd98eea" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0600Due2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0600Due2023Member_1eb5a49f-564c-4441-8d6e-13f35cd98eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2024Member_531d8998-e484-44da-9fba-83ca1efd4c1c" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2024Member_531d8998-e484-44da-9fba-83ca1efd4c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.250due2024Member_d6de71c0-179e-47fc-ab14-67612fac1e54" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.250due2024Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0.250due2024Member_d6de71c0-179e-47fc-ab14-67612fac1e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_374fa367-5aee-45e7-bfa2-39c95fa60b94" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.150Due2025Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.150Due2025Member_374fa367-5aee-45e7-bfa2-39c95fa60b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_ccf8f209-7e2a-416e-b631-0ca976b9d98e" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3.375due2025MemberMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3.375due2025MemberMember_ccf8f209-7e2a-416e-b631-0ca976b9d98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes350Due2026Member_88f3c2ee-38ec-4a11-874c-a483e96a7f46" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes350Due2026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes350Due2026Member_88f3c2ee-38ec-4a11-874c-a483e96a7f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_bf827cc2-4055-4e53-83a4-363f77b0aba1" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2027Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2027Member_bf827cc2-4055-4e53-83a4-363f77b0aba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes3650Due2028Member_0994d6a2-82c6-4846-9bc9-e5bd240575cd" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes3650Due2028Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes3650Due2028Member_0994d6a2-82c6-4846-9bc9-e5bd240575cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes0.750due2029Member_90877271-ba1b-4adf-852d-805a7b2b7b29" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes0.750due2029Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes0.750due2029Member_90877271-ba1b-4adf-852d-805a7b2b7b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_b19f5668-d40a-42d3-a340-367fb063f9fa" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.950Due2030Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.950Due2030Member_b19f5668-d40a-42d3-a340-367fb063f9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_5fe5721a-bf71-4b75-8e1a-755b5a0ff39d" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotesDueNovember2030Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotesDueNovember2030Member_5fe5721a-bf71-4b75-8e1a-755b5a0ff39d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes1.000due2031Member_fc201ae0-76ed-4e8b-8487-0e7b0ebb32a4" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes1.000due2031Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes1.000due2031Member_fc201ae0-76ed-4e8b-8487-0e7b0ebb32a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes410Due2043Member_d2499d36-ca85-4872-85e1-1e496f9a61c5" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes410Due2043Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes410Due2043Member_d2499d36-ca85-4872-85e1-1e496f9a61c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4.375due2044Member_e0704810-e6a2-4aa9-93ac-56affaa84cbb" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4.375due2044Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes4.375due2044Member_e0704810-e6a2-4aa9-93ac-56affaa84cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes4625Due2046Member_e79272e9-36b1-4345-b711-31834e0e9887" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes4625Due2046Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes4625Due2046Member_e79272e9-36b1-4345-b711-31834e0e9887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_SeniorUnsecuredNotes2.900due2050Member_226e8263-4a86-417d-b3d9-5a932f3016bc" xlink:href="syk-20211231.xsd#syk_SeniorUnsecuredNotes2.900due2050Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_SeniorUnsecuredNotes2.900due2050Member_226e8263-4a86-417d-b3d9-5a932f3016bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TermLoanMember_e27105c8-0800-4664-998f-5b747401fbce" xlink:href="syk-20211231.xsd#syk_TermLoanMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_18f7733a-ea30-4608-adee-444606b4ec16" xlink:to="loc_syk_TermLoanMember_e27105c8-0800-4664-998f-5b747401fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_87c0476e-cc81-40e0-8e36-87fa93dbed01" xlink:to="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db6fce35-1392-4ae7-93ea-c768ebf53408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_db6fce35-1392-4ae7-93ea-c768ebf53408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_30474ff2-a263-48ae-9563-17d28fb704fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_UnsecuredDebt_30474ff2-a263-48ae-9563-17d28fb704fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6c298eb2-3fa8-4895-9a06-8cc0c68c3fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LongTermDebt_6c298eb2-3fa8-4895-9a06-8cc0c68c3fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebt_38f9a262-8b67-42b4-9b4d-9e24ae738104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_OtherLongTermDebt_38f9a262-8b67-42b4-9b4d-9e24ae738104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_897b9739-cc51-4a95-9c6f-6cf8a55d153d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_897b9739-cc51-4a95-9c6f-6cf8a55d153d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_397f5111-19f2-4822-8f79-c224e92522a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtCurrent_397f5111-19f2-4822-8f79-c224e92522a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2911b641-7a80-4804-a5e9-87f2bf23d46c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2911b641-7a80-4804-a5e9-87f2bf23d46c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_16f0debe-03bf-4c33-bc8c-f8506919102c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_16f0debe-03bf-4c33-bc8c-f8506919102c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e4871354-10ab-4a4b-a75a-38167dbd0a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_e4871354-10ab-4a4b-a75a-38167dbd0a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1869325e-9342-45c5-9ba1-cb5eaba56b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d19b03d1-ac20-48b3-a545-9dccd2d07fd9" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1869325e-9342-45c5-9ba1-cb5eaba56b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="simple" xlink:href="syk-20211231.xsd#DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxes" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f777111b-eeae-4a75-991d-13b2b6f990bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_7017478d-4056-4cda-aa8d-a8b1cd03cb9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f777111b-eeae-4a75-991d-13b2b6f990bd" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_7017478d-4056-4cda-aa8d-a8b1cd03cb9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f464eac2-cad7-4a62-95ba-cea79a692eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_dcf0e76b-205b-4cd2-961c-e42d6b0104ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f464eac2-cad7-4a62-95ba-cea79a692eea" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_dcf0e76b-205b-4cd2-961c-e42d6b0104ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aff922d7-4385-4b5e-8d11-2c2f25bc2d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f464eac2-cad7-4a62-95ba-cea79a692eea" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aff922d7-4385-4b5e-8d11-2c2f25bc2d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c347b504-0c2b-4b27-b857-264358b20cf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f464eac2-cad7-4a62-95ba-cea79a692eea" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c347b504-0c2b-4b27-b857-264358b20cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_2daed6ed-59e7-4f1f-8089-919649964074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SummaryOfIncomeTaxContingenciesTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f464eac2-cad7-4a62-95ba-cea79a692eea" xlink:to="loc_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock_2daed6ed-59e7-4f1f-8089-919649964074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9a5c7ff1-48e0-47d9-9b67-08afbee0f14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9a5c7ff1-48e0-47d9-9b67-08afbee0f14b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_14aa2ff6-71a4-45dc-a82d-6667ac3043bf" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_a580fb6e-46a0-4c66-be78-5ca542c467c4" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:to="loc_country_US_a580fb6e-46a0-4c66-be78-5ca542c467c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_620c2fa8-3bdc-4093-9804-fce02775af71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_8e473e63-3897-4f4b-9e6b-c8babdf7deaa" xlink:to="loc_us-gaap_ForeignCountryMember_620c2fa8-3bdc-4093-9804-fce02775af71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e2985db2-d7f1-43e4-9bd1-aa0be3d96f22" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WrightMember_5b7e3a2b-7f51-453f-983c-e02ce4f4982a" xlink:href="syk-20211231.xsd#syk_WrightMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8840b6d3-85c9-4bd9-904a-328c54f962e0" xlink:to="loc_syk_WrightMember_5b7e3a2b-7f51-453f-983c-e02ce4f4982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8de3220c-68fc-429a-ab4d-49f835f7c827" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f18411d7-c2e0-4046-a3d9-33644c19148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_f18411d7-c2e0-4046-a3d9-33644c19148f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_25170ee5-133a-4b76-8144-f9d6f776a20f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_25170ee5-133a-4b76-8144-f9d6f776a20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_75d22e7b-a925-4569-979f-aa5ecff4c53f" xlink:href="syk-20211231.xsd#syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized_75d22e7b-a925-4569-979f-aa5ecff4c53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d4144429-b39c-4e95-984a-d4e89b821e3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued_d4144429-b39c-4e95-984a-d4e89b821e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4c5b7b5f-6fd6-484d-aa68-6c84f7e15704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4c5b7b5f-6fd6-484d-aa68-6c84f7e15704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_6dee6d67-ad2b-41dc-829b-8f05edc8d61f" xlink:href="syk-20211231.xsd#syk_OperatingLossCarryforwardsSubjectToValuationAllowance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_syk_OperatingLossCarryforwardsSubjectToValuationAllowance_6dee6d67-ad2b-41dc-829b-8f05edc8d61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_704608e7-4a58-44ec-8e3d-3d572fdd03b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_704608e7-4a58-44ec-8e3d-3d572fdd03b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_6ef88a69-3755-4a6c-a215-a2a10861519d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_TaxCreditCarryforwardValuationAllowance_6ef88a69-3755-4a6c-a215-a2a10861519d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_014e3347-4928-4303-a07f-547ca506b969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2ee847d0-724d-47a4-b744-4d41fa2ea24a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense_014e3347-4928-4303-a07f-547ca506b969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7aee5dc6-e545-4dff-b5ba-f8c8359f95f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_7aee5dc6-e545-4dff-b5ba-f8c8359f95f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a9d1ef2c-b55a-426d-b752-7640986bc6c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a9d1ef2c-b55a-426d-b752-7640986bc6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_3e7776bb-431a-4c06-b08f-73462d6282f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_3e7776bb-431a-4c06-b08f-73462d6282f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_eb754869-50c5-40b9-b4b1-15518c6eef29" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent_eb754869-50c5-40b9-b4b1-15518c6eef29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_a2595f54-dfb6-4405-b4f2-bec83cfa556e" xlink:href="syk-20211231.xsd#syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent_a2595f54-dfb6-4405-b4f2-bec83cfa556e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_45cc96a5-373a-4f38-9df8-f97f9a3110f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_45cc96a5-373a-4f38-9df8-f97f9a3110f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9993b794-efee-4ab6-8ff5-54bfaebf4e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3262377d-0eb8-49b0-b1d2-50817ed87b9b" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9993b794-efee-4ab6-8ff5-54bfaebf4e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2075f71a-df76-4af4-b8b3-26aaff93551d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_14c75cdf-8b6e-4a35-a41c-7db3285d06c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2075f71a-df76-4af4-b8b3-26aaff93551d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_14c75cdf-8b6e-4a35-a41c-7db3285d06c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_349b2592-694c-4ae3-af25-73fce86c8f04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2075f71a-df76-4af4-b8b3-26aaff93551d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_349b2592-694c-4ae3-af25-73fce86c8f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ed1366a3-c9de-4a32-828d-ab550c3df373" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2075f71a-df76-4af4-b8b3-26aaff93551d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ed1366a3-c9de-4a32-828d-ab550c3df373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ae9fd1ca-19f9-4c62-8ed6-db1421f295c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae9fd1ca-19f9-4c62-8ed6-db1421f295c9" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_57612eed-38ff-4e75-b6a5-dba20fc6bce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_57612eed-38ff-4e75-b6a5-dba20fc6bce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b61bb6ee-f2e4-4f8c-b5ad-95926412a997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_b61bb6ee-f2e4-4f8c-b5ad-95926412a997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ebed2f95-5797-440b-a758-7419ba2bbbff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ebed2f95-5797-440b-a758-7419ba2bbbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6ace2e4c-d40c-4bb1-a4c2-22939e53c9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e7526cc-8c8d-4d59-812a-54dd63aea2cb" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_6ace2e4c-d40c-4bb1-a4c2-22939e53c9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae9fd1ca-19f9-4c62-8ed6-db1421f295c9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1bc8a1f8-d924-4ff8-9af5-2f211a64973e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_1bc8a1f8-d924-4ff8-9af5-2f211a64973e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_aceed11b-cbf8-4fc0-82ce-32379b2a05df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_aceed11b-cbf8-4fc0-82ce-32379b2a05df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_04393e67-5bcd-45d8-997b-09abf260ac5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_04393e67-5bcd-45d8-997b-09abf260ac5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f2b4331e-51f5-4572-9858-bb644c61d883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_024b2163-bd31-49f9-9ab1-3cc7eeeef7a3" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f2b4331e-51f5-4572-9858-bb644c61d883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aa525818-fd44-40b4-967f-a1a9ccaf687f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae9fd1ca-19f9-4c62-8ed6-db1421f295c9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_aa525818-fd44-40b4-967f-a1a9ccaf687f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_3e42c30a-544b-4784-ae74-7da1f319c496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_3e42c30a-544b-4784-ae74-7da1f319c496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_d824959f-0be2-479f-844e-6db273f42d6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves_d824959f-0be2-479f-844e-6db273f42d6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_be2a4c2f-0375-436d-b0b3-c75074ac6811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_be2a4c2f-0375-436d-b0b3-c75074ac6811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_77866980-851d-4815-bc44-451726003927" xlink:href="syk-20211231.xsd#syk_DeferredTaxAssetsDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_syk_DeferredTaxAssetsDepreciationAndAmortization_77866980-851d-4815-bc44-451726003927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_3838a267-4918-45d5-977e-ae4e20866935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_3838a267-4918-45d5-977e-ae4e20866935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_70a1e742-dc61-4c8e-9ae6-a8f658061b8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_70a1e742-dc61-4c8e-9ae6-a8f658061b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4e8e6aca-8bec-42e7-a6df-ecb86c16d575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_4e8e6aca-8bec-42e7-a6df-ecb86c16d575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_7824095d-9a08-4904-ba3b-5ef546c034bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_7824095d-9a08-4904-ba3b-5ef546c034bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_43d3cf9e-5bfa-4aea-aedd-af1608d91509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_43d3cf9e-5bfa-4aea-aedd-af1608d91509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cd1f04ec-1e3a-42a1-826f-565443249997" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_cd1f04ec-1e3a-42a1-826f-565443249997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_bdffea26-3eb9-42b3-af56-2a74a6f4b457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_38d5c210-01ea-44c3-ad8d-ce3212d6affd" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_bdffea26-3eb9-42b3-af56-2a74a6f4b457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_48ca9f71-e7ff-41a4-9256-e17262543961" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_48ca9f71-e7ff-41a4-9256-e17262543961" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_ac1db38e-929a-43b1-9c7c-3128a64c763c" xlink:href="syk-20211231.xsd#syk_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_48ca9f71-e7ff-41a4-9256-e17262543961" xlink:to="loc_syk_DeferredTaxLiabilitiesDepreciationAndAmortization_ac1db38e-929a-43b1-9c7c-3128a64c763c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a58c974b-54a5-4fd5-a7ec-07b389910eee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_48ca9f71-e7ff-41a4-9256-e17262543961" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings_a58c974b-54a5-4fd5-a7ec-07b389910eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_18266548-49d3-4144-b9a1-ba07ef33384c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_48ca9f71-e7ff-41a4-9256-e17262543961" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_18266548-49d3-4144-b9a1-ba07ef33384c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_98f0a2e5-bfd0-4967-8178-0bbb0aa00317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_98f0a2e5-bfd0-4967-8178-0bbb0aa00317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_3545846a-e096-4448-9fee-4b52be5742f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_3545846a-e096-4448-9fee-4b52be5742f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b6603c3-c80c-46c9-8b15-7cd516fbadc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_10c4ffbb-8ae3-482b-bd82-2275e9d948e8" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_6b6603c3-c80c-46c9-8b15-7cd516fbadc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b08c578a-840b-4e6b-a40e-85f36b2e6ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b08c578a-840b-4e6b-a40e-85f36b2e6ba5" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6b131e4e-acba-46c3-9559-dc45cb6409d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6b131e4e-acba-46c3-9559-dc45cb6409d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_00d604f4-8bd7-43fa-8688-d1eca8d801a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_00d604f4-8bd7-43fa-8688-d1eca8d801a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_bca6a32b-739b-4817-ae21-a67e6a42f1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_bca6a32b-739b-4817-ae21-a67e6a42f1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_abb35b2c-d5e6-4615-922e-270bbbc7b312" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities_abb35b2c-d5e6-4615-922e-270bbbc7b312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_82ba93aa-8a85-40b2-b0b3-e181e75968b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_82ba93aa-8a85-40b2-b0b3-e181e75968b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_6c97f89b-4c6e-4338-8ddd-f0b6db1cd718" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation_6c97f89b-4c6e-4338-8ddd-f0b6db1cd718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_edb06c43-fee9-4cee-a107-f656c49e5a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation_edb06c43-fee9-4cee-a107-f656c49e5a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6978c5ff-93c4-46eb-bf32-387bb635ff7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7f1edd21-2bc7-48a6-93d2-f76334659222" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6978c5ff-93c4-46eb-bf32-387bb635ff7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlans" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlans"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ffc55b68-53a1-4f46-9af4-7b62368221fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_36e1bf2a-9037-4b54-9007-ed41c4957c65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ffc55b68-53a1-4f46-9af4-7b62368221fd" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_36e1bf2a-9037-4b54-9007-ed41c4957c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansTables" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_46d0ddbc-fb9a-4a63-8aeb-4168544e0863" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock_46d0ddbc-fb9a-4a63-8aeb-4168544e0863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_516c89e7-1bf1-46f8-a31c-8e4a5d56567a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock_516c89e7-1bf1-46f8-a31c-8e4a5d56567a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_1ce46316-080e-4993-8f7c-b49e65858714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock_1ce46316-080e-4993-8f7c-b49e65858714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a23c3a97-04dd-4072-b51f-8d63a199bc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock_a23c3a97-04dd-4072-b51f-8d63a199bc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_867ba7ee-340e-47ec-97f7-5b6e992ce58a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock_867ba7ee-340e-47ec-97f7-5b6e992ce58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_2cb051a9-b412-43dd-8df9-3326b10859d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock_2cb051a9-b412-43dd-8df9-3326b10859d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_59a95e55-7392-46a4-9518-4ea6434fada3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_f88d4892-b791-4b23-adf1-4477969e67be" xlink:to="loc_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock_59a95e55-7392-46a4-9518-4ea6434fada3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f5df4e44-51c0-4d40-a16f-29dc83946491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f5df4e44-51c0-4d40-a16f-29dc83946491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4528c491-8a43-426b-9f8a-7d1ea0ce4e15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_4528c491-8a43-426b-9f8a-7d1ea0ce4e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_c80800ed-8dc2-4709-9fb6-907b89cfb024" xlink:href="syk-20211231.xsd#syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany_c80800ed-8dc2-4709-9fb6-907b89cfb024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_e5def3a7-dc30-45e5-9595-f43e0f493a39" xlink:href="syk-20211231.xsd#syk_DefinedContributionRetirementPlansCommonStockHeldByCompany"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:to="loc_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany_e5def3a7-dc30-45e5-9595-f43e0f493a39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_70b42815-db0e-47e4-a73b-f2ed61084354" xlink:href="syk-20211231.xsd#syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1d531bcb-956a-438b-8bac-fc04ffbaa0c5" xlink:to="loc_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany_70b42815-db0e-47e4-a73b-f2ed61084354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_326ac26e-76ac-4e50-8b80-2cdbfa2b6280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_326ac26e-76ac-4e50-8b80-2cdbfa2b6280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_aad4a135-3885-425a-ab4b-aead2cc0d8c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_aad4a135-3885-425a-ab4b-aead2cc0d8c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5420043f-2a86-4c12-9e35-b3bf32f47356" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_5420043f-2a86-4c12-9e35-b3bf32f47356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4b368b82-40d2-40c7-b919-d42fac1cb5d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_4b368b82-40d2-40c7-b919-d42fac1cb5d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_35a48bf1-6627-4b7d-80f8-165d8bc101dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_35a48bf1-6627-4b7d-80f8-165d8bc101dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_ad85328e-51c8-4087-94a8-49296df772ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments_ad85328e-51c8-4087-94a8-49296df772ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_18fb0e26-d577-4c54-b705-c1ec01c1feee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract_abf668ac-8064-4f60-8824-328ade50c797" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_18fb0e26-d577-4c54-b705-c1ec01c1feee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_0d3db659-e2ae-49cb-9840-952c5b38d969" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_0d3db659-e2ae-49cb-9840-952c5b38d969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_7720ee7b-fab3-4393-9275-8ce9fb21318b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax_7720ee7b-fab3-4393-9275-8ce9fb21318b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_53a90bd8-7fc3-4b6b-9f21-c132643a645c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax_53a90bd8-7fc3-4b6b-9f21-c132643a645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_9623dd4d-e4ed-4bad-a9d9-f14f6af543c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax_9623dd4d-e4ed-4bad-a9d9-f14f6af543c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1c298d45-60cc-4c0f-911d-7252f20c01b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1c298d45-60cc-4c0f-911d-7252f20c01b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_633f8e61-50be-4471-a004-d72aff984d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax_633f8e61-50be-4471-a004-d72aff984d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_acf2416e-cb4a-4d04-8251-f238aae83371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate_acf2416e-cb4a-4d04-8251-f238aae83371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f5775533-edf3-40ca-90be-945862855056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets_f5775533-edf3-40ca-90be-945862855056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_205bf536-2df1-4ca9-b76c-26a595cc6f08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:to="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease_205bf536-2df1-4ca9-b76c-26a595cc6f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_11d705d3-4cd3-43da-a5c5-16d8c3e18db2" xlink:href="syk-20211231.xsd#syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract_a5b4b98b-85c8-4bb2-afb0-2e77e81dfebd" xlink:to="loc_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations_11d705d3-4cd3-43da-a5c5-16d8c3e18db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_ec65dd0c-9aa2-47eb-a4c8-d94fe1cacf54" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9126da46-de31-4337-b42a-001ad96ebb91" xlink:to="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_46e634bf-56cf-4de7-b48e-96e462b6593c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8b4f8ccd-9a35-4423-ba49-f742dbd05ac3" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember_46e634bf-56cf-4de7-b48e-96e462b6593c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_85ee6fdf-3c65-4c17-a0ef-fab999f26a17" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1c0fc51a-dd13-45d7-b17c-b63290bb230e" xlink:to="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5d7adb23-416c-499d-8619-b03c3ee461eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_5d7adb23-416c-499d-8619-b03c3ee461eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cee8583e-bbaf-43db-a117-9cf94bd082bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_cee8583e-bbaf-43db-a117-9cf94bd082bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d67262bd-8f5a-44d9-8817-5c603e4e55cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFundedStatusOfPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanFundedStatusOfPlan_d67262bd-8f5a-44d9-8817-5c603e4e55cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bf6e058b-4bf3-4bdc-99e3-0b1987b45966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities_bf6e058b-4bf3-4bdc-99e3-0b1987b45966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c7ee68a3-d8da-49d0-bdad-e6192c4258d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent_c7ee68a3-d8da-49d0-bdad-e6192c4258d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2ac56c31-a0d4-431b-b3de-17b6cbb0c3a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax_2ac56c31-a0d4-431b-b3de-17b6cbb0c3a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_8f8ebb84-116d-436c-83f0-eeca601f353b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract_73a5a3f9-df9b-47bb-85a0-d2376b5ba53f" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax_8f8ebb84-116d-436c-83f0-eeca601f353b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofChangeinBenefitObligationsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b06a43b-dc81-48da-a3b9-6bd5fec40fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b06a43b-dc81-48da-a3b9-6bd5fec40fd0" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_84f7797d-ac7a-44ab-911f-4f441920355b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_84f7797d-ac7a-44ab-911f-4f441920355b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_38cb3416-a655-4ba8-bcfd-82eeb640b6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_38cb3416-a655-4ba8-bcfd-82eeb640b6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_f7c6b986-223e-4959-b781-70c5424c6d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_f7c6b986-223e-4959-b781-70c5424c6d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_6ccd2792-7e73-4542-8328-997aa63749cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation_6ccd2792-7e73-4542-8328-997aa63749cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_15c09977-36b7-42e5-8fd7-bd5df76ca929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant_15c09977-36b7-42e5-8fd7-bd5df76ca929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f6726fd6-4e0b-4861-b416-f353e94c435a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActuarialGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanActuarialGainLoss_f6726fd6-4e0b-4861-b416-f353e94c435a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_9c304bd4-21ae-4645-a940-a95ccb29866b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation_9c304bd4-21ae-4645-a940-a95ccb29866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c4634c5b-8462-4548-90bc-625a20a6e5e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid_c4634c5b-8462-4548-90bc-625a20a6e5e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d18800c7-3530-46f3-bd8f-98c751c192ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanBenefitObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward_8de6fa87-1ded-44b4-b579-54c12a53cc14" xlink:to="loc_us-gaap_DefinedBenefitPlanBenefitObligation_d18800c7-3530-46f3-bd8f-98c751c192ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9b760e2c-352a-4d24-9fcd-d9956fa76a9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_1b06a43b-dc81-48da-a3b9-6bd5fec40fd0" xlink:to="loc_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation_9b760e2c-352a-4d24-9fcd-d9956fa76a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansChangeinPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7bce4725-0e80-4ea0-b87d-aa7361755840" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7bce4725-0e80-4ea0-b87d-aa7361755840" xlink:to="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_52db7253-6a5c-4d50-8308-923894f02bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_52db7253-6a5c-4d50-8308-923894f02bcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_02df5315-4953-4e71-9b3e-bf6030825395" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_02df5315-4953-4e71-9b3e-bf6030825395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab42dd03-8ce4-4f2c-aa29-aba83af84f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanContributionsByEmployer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanContributionsByEmployer_ab42dd03-8ce4-4f2c-aa29-aba83af84f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_7000e830-a7f5-43b4-a3d6-cfea4ac73022" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant_7000e830-a7f5-43b4-a3d6-cfea4ac73022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_32804a19-b3ff-42be-a736-ca2ec087bb22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss_32804a19-b3ff-42be-a736-ca2ec087bb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_ce9be6d9-02e2-4e46-a5d1-556b932b38d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid_ce9be6d9-02e2-4e46-a5d1-556b932b38d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ca67f48b-7fa8-4ec5-8e87-3dd44ff8ebb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward_3c17a93c-e483-4693-aa0a-a5d8dca9591a" xlink:to="loc_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent_ca67f48b-7fa8-4ec5-8e87-3dd44ff8ebb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_987e9e59-5e59-4c24-9d95-7dff57f16602" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_987e9e59-5e59-4c24-9d95-7dff57f16602" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_a6f425dc-e059-402c-bcf9-e9fdf5432c54" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_4deb39b2-3454-49b3-b99f-d75b9bc1740c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_4deb39b2-3454-49b3-b99f-d75b9bc1740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef65c6ad-aa7a-4ca1-8d9a-b4a5a84c4e09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDebtSecurityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_DefinedBenefitPlanDebtSecurityMember_ef65c6ad-aa7a-4ca1-8d9a-b4a5a84c4e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestmentsMember_6db478ce-f411-4701-8106-ee3bc07afb20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_41f17016-eb55-4a71-84e4-d778e97a60bd" xlink:to="loc_us-gaap_OtherLongTermInvestmentsMember_6db478ce-f411-4701-8106-ee3bc07afb20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2185b401-0867-473e-aab7-1c59e6b1589d" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_afc2339a-058d-4fc3-af50-e48f26a9faed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage_afc2339a-058d-4fc3-af50-e48f26a9faed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_96f8bc4b-4b82-4aad-8c85-86e29f6a4eb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_dfbdb19c-8354-4487-a81c-0b6e6c7e4c9a" xlink:to="loc_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations_96f8bc4b-4b82-4aad-8c85-86e29f6a4eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3f46c17d-56f9-45aa-8770-ce270fbdd3ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_3f46c17d-56f9-45aa-8770-ce270fbdd3ad" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:to="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanAssetCategoriesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis_6e13d501-fea6-4896-ae01-5ca7cf13a155" xlink:to="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_2586bef7-e7cb-499f-b28a-00c9abee4494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember_2586bef7-e7cb-499f-b28a-00c9abee4494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_6482a05e-79bb-4c4a-b3cb-2a4637406331" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanEquitySecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_DefinedBenefitPlanEquitySecuritiesMember_6482a05e-79bb-4c4a-b3cb-2a4637406331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_811ad380-a527-4f84-82c4-f82b9bcc9db5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_811ad380-a527-4f84-82c4-f82b9bcc9db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDebtSecuritiesMember_18a95a2a-7bc2-4c96-9e1e-0e55faf403aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanAssetCategoriesDomain_361b7b3d-7ff7-44ac-bb99-cc392834ee5c" xlink:to="loc_us-gaap_OtherDebtSecuritiesMember_18a95a2a-7bc2-4c96-9e1e-0e55faf403aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_87c9b464-1702-4cba-8964-b1278ccfcafa" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d73f9200-6d9a-415a-8f98-c6a076fdb9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d73f9200-6d9a-415a-8f98-c6a076fdb9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_fc14298f-f4c0-437b-bb09-cac07291bfd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_fc14298f-f4c0-437b-bb09-cac07291bfd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_dca231a7-efce-4d8f-aa10-685e0f389ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f85a0938-e428-4540-9a86-eedde486d7bb" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_dca231a7-efce-4d8f-aa10-685e0f389ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_7872a796-83a2-47e4-b195-a4e7be6d467e" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_117e711d-eec4-4d03-a2aa-2e976818da67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanFairValueOfPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_f597d41b-c9af-4473-965c-15994eb996bc" xlink:to="loc_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets_117e711d-eec4-4d03-a2aa-2e976818da67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_64009df2-7810-4606-8c04-ed062a719290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_64009df2-7810-4606-8c04-ed062a719290" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_21c00146-22c1-46dc-9b70-2f90f4ab24df" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_33113892-4321-4b89-9761-badc9913e91c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_703433c9-54e2-45a9-991c-e39ef4d778a4" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_33113892-4321-4b89-9761-badc9913e91c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_807f4d59-51d8-41b5-a713-2d963cb2dbe8" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_83cdd07c-b07f-44b3-91f5-1f6dce01a97c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:to="loc_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets_83cdd07c-b07f-44b3-91f5-1f6dce01a97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_e8060b8a-8f9e-45f7-80a6-a52827e8b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_65424cd5-7888-480a-a95e-edb5f15661bc" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear_e8060b8a-8f9e-45f7-80a6-a52827e8b8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#RetirementPlansExpectedBenefitPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ba0d4da3-af4b-4116-bf53-e395590d27fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths_ba0d4da3-af4b-4116-bf53-e395590d27fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_207b2179-bca8-4055-a3e5-41c5b7573f92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo_207b2179-bca8-4055-a3e5-41c5b7573f92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_c8964d90-5f7b-475c-80e5-afd4dcbe3e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree_c8964d90-5f7b-475c-80e5-afd4dcbe3e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d45a6aa1-29fe-4d23-97ef-494f314b3ade" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour_d45a6aa1-29fe-4d23-97ef-494f314b3ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_5b657ff2-59ab-46fb-8b82-062bfdcc5da8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive_5b657ff2-59ab-46fb-8b82-062bfdcc5da8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_19615bcc-8750-4dd1-88ca-eb83735ffa6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6b81ef88-3a57-489a-af97-25a1ff52cab3" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter_19615bcc-8750-4dd1-88ca-eb83735ffa6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="simple" xlink:href="syk-20211231.xsd#SummaryofQuarterlyDataUnaudited"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_86ef63a6-131e-49ab-92a8-0dda557ea39d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1eae8abb-0195-4f68-b67b-38760321fa56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_86ef63a6-131e-49ab-92a8-0dda557ea39d" xlink:to="loc_us-gaap_QuarterlyFinancialInformationTextBlock_1eae8abb-0195-4f68-b67b-38760321fa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="simple" xlink:href="syk-20211231.xsd#SummaryofQuarterlyDataUnauditedTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_9acd1b6b-fd1a-4d95-a03e-ceafd2c3304e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_2053344a-9b33-4209-8aa5-1b498bdbd316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_9acd1b6b-fd1a-4d95-a03e-ceafd2c3304e" xlink:to="loc_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_2053344a-9b33-4209-8aa5-1b498bdbd316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SummaryofQuarterlyDataUnauditedDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_QuarterlyFinancialDataAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a958cca0-a78b-4b38-8cd7-b799198a8715" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_Revenues_a958cca0-a78b-4b38-8cd7-b799198a8715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_14121f80-c927-4f0b-8c81-6df8f0c7539d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_GrossProfit_14121f80-c927-4f0b-8c81-6df8f0c7539d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2360381b-48b9-468c-9321-b6492b0c11c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2360381b-48b9-468c-9321-b6492b0c11c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d7f071f7-239d-4e30-b641-9a00fc185140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_NetIncomeLoss_d7f071f7-239d-4e30-b641-9a00fc185140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_e3048192-c953-4268-8370-20d1d063c3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_EarningsPerShareBasic_e3048192-c953-4268-8370-20d1d063c3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_63ff4005-3bac-4928-958b-dee27dbaec13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_63ff4005-3bac-4928-958b-dee27dbaec13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_4e8d9658-f5d7-4215-9ed7-bb6ec2603126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_QuarterlyFinancialDataAbstract_51b8e88f-f76a-4e77-8da8-00416f7b1a8e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_4e8d9658-f5d7-4215-9ed7-bb6ec2603126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicData"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicData" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_37526abb-da71-4b19-a3d3-dace777100f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_18826235-8128-46b8-99dd-1fa2b1883990" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_37526abb-da71-4b19-a3d3-dace777100f3" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_18826235-8128-46b8-99dd-1fa2b1883990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataTables"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_783655c6-dff5-4400-a538-fa5b1b6696e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1b897444-5fd9-4b66-840b-d535233e48c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_783655c6-dff5-4400-a538-fa5b1b6696e6" xlink:to="loc_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock_1b897444-5fd9-4b66-840b-d535233e48c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_adf0dd47-5479-403f-ab6d-8569bb1d5936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_783655c6-dff5-4400-a538-fa5b1b6696e6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_adf0dd47-5479-403f-ab6d-8569bb1d5936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_68cc4483-59c6-4ecc-9655-7c7f3ce43660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_783655c6-dff5-4400-a538-fa5b1b6696e6" xlink:to="loc_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock_68cc4483-59c6-4ecc-9655-7c7f3ce43660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ce23f2a9-9440-4753-87da-ddde220984b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_9c9de0e4-ac3c-4091-a8f6-5e1fe07cc02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ce23f2a9-9440-4753-87da-ddde220984b4" xlink:to="loc_us-gaap_NumberOfReportableSegments_9c9de0e4-ac3c-4091-a8f6-5e1fe07cc02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ce23f2a9-9440-4753-87da-ddde220984b4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:to="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_62379f9d-5ccf-489e-94a8-b58e7a75292e" xlink:to="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_536d4f84-95f5-4756-b47a-2609cd1e7b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_OperatingSegmentsMember_536d4f84-95f5-4756-b47a-2609cd1e7b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_0e5825fd-384c-4e01-9443-e14ac7a5c804" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_CorporateNonSegmentMember_0e5825fd-384c-4e01-9443-e14ac7a5c804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_44223a06-fe46-43b7-a308-6967cc0815f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_2e8d7d95-112a-42b8-a040-a7d4486f592e" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_44223a06-fe46-43b7-a308-6967cc0815f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c5c2e143-1fb3-46fe-82ed-d2496c78b1bf" xlink:to="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_b69ebb4b-1189-4c63-841d-524cda5deee7" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_b69ebb4b-1189-4c63-841d-524cda5deee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_e435ce9d-cb31-4488-9777-2a8783d777e9" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0225940a-25cd-4378-a5d8-504a109b1f8f" xlink:to="loc_syk_OrthopaedicsAndSpineMember_e435ce9d-cb31-4488-9777-2a8783d777e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_bf06b6c5-72c8-47be-a155-5143883713e3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_399a28f6-04a6-4f34-8d5b-4e5070e81a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_NumberOfReportableSegments_399a28f6-04a6-4f34-8d5b-4e5070e81a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7e9ed8b2-e20f-4317-8fb7-f0b3f0c7442c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_Revenues_7e9ed8b2-e20f-4317-8fb7-f0b3f0c7442c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ea6b4132-a8aa-45b5-a45e-71f9ec5e1d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ea6b4132-a8aa-45b5-a45e-71f9ec5e1d5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3366de32-8b42-4e9b-aa50-12dddf6a094c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_OperatingIncomeLoss_3366de32-8b42-4e9b-aa50-12dddf6a094c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_367676ab-dd2c-48ed-98ff-652903e32c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_367676ab-dd2c-48ed-98ff-652903e32c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_397aa00b-bac4-408d-932f-d18eefe9d93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationIntegrationRelatedCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_BusinessCombinationIntegrationRelatedCosts_397aa00b-bac4-408d-932f-d18eefe9d93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_5d19f554-d861-4c5b-96f3-89cf0fd8af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_5d19f554-d861-4c5b-96f3-89cf0fd8af0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCosts_3ef0048f-fdf3-4a58-b2b8-9bc5fdd83a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_RestructuringCosts_3ef0048f-fdf3-4a58-b2b8-9bc5fdd83a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedicalDeviceRegulationsExpense_db633979-e43c-445f-848b-77849b785b91" xlink:href="syk-20211231.xsd#syk_MedicalDeviceRegulationsExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_syk_MedicalDeviceRegulationsExpense_db633979-e43c-445f-848b-77849b785b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_RejuvenateABGIIHipRecallCharges_39543249-7720-42a8-ad9c-5bac39d87d58" xlink:href="syk-20211231.xsd#syk_RejuvenateABGIIHipRecallCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_syk_RejuvenateABGIIHipRecallCharges_39543249-7720-42a8-ad9c-5bac39d87d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalFees_66af6255-e117-410c-b484-202c3c837620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_LegalFees_66af6255-e117-410c-b484-202c3c837620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_be4615b1-2491-4136-a3b1-d44c96ef8d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_7f8bc483-82e5-484b-9913-af456f046b0e" xlink:to="loc_us-gaap_NetIncomeLoss_be4615b1-2491-4136-a3b1-d44c96ef8d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataSegmentInformationDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fb3ecb66-4cb4-4e68-bcb9-2847a2e8f72c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fb3ecb66-4cb4-4e68-bcb9-2847a2e8f72c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:to="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_269bd462-d847-4a54-891c-963a8a685378" xlink:to="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b217a384-f581-48cf-bcd3-811929190587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:to="loc_us-gaap_OperatingSegmentsMember_b217a384-f581-48cf-bcd3-811929190587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_9fbfff8c-4226-4dfc-8bbf-a0da36755b40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b960cc80-0590-4e11-88d2-019c566837cd" xlink:to="loc_us-gaap_CorporateNonSegmentMember_9fbfff8c-4226-4dfc-8bbf-a0da36755b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_a314d562-4360-4fe0-8de0-a254f98d67d3" xlink:to="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_MedSurgAndNeurotechnologyMember_ec9a56f5-1847-494d-b235-3e4a89d92afc" xlink:href="syk-20211231.xsd#syk_MedSurgAndNeurotechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:to="loc_syk_MedSurgAndNeurotechnologyMember_ec9a56f5-1847-494d-b235-3e4a89d92afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OrthopaedicsAndSpineMember_0bda45a7-2845-4036-9de5-7827e817bfde" xlink:href="syk-20211231.xsd#syk_OrthopaedicsAndSpineMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_76b00a81-18bf-4a8d-82d0-2efb768cbc7b" xlink:to="loc_syk_OrthopaedicsAndSpineMember_0bda45a7-2845-4036-9de5-7827e817bfde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_331241fd-e5a0-4ff9-a8ca-bae86a356894" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_174e99dc-3942-44a8-8281-cef25e067529" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:to="loc_us-gaap_Assets_174e99dc-3942-44a8-8281-cef25e067529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_CapitalExpendituresDuringPeriod_effa5aca-b816-4f32-b57b-9e1ec80eb827" xlink:href="syk-20211231.xsd#syk_CapitalExpendituresDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_a3923332-2b3a-45a7-92e1-3078c88f753a" xlink:to="loc_syk_CapitalExpendituresDuringPeriod_effa5aca-b816-4f32-b57b-9e1ec80eb827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8ac71058-7cf9-415a-97db-dce3ae40508e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8ac71058-7cf9-415a-97db-dce3ae40508e" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:to="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8a699375-33e5-44bb-9440-b19cd2911671" xlink:to="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_c7a2571c-d3f4-4b42-830b-7df44ad4f60a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_country_US_c7a2571c-d3f4-4b42-830b-7df44ad4f60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_99837da7-37ad-46d5-8f19-4f7b1f315f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_us-gaap_EMEAMember_99837da7-37ad-46d5-8f19-4f7b1f315f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_f23520bb-a5ad-496f-b4d0-99ff3156f26a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_srt_AsiaPacificMember_f23520bb-a5ad-496f-b4d0-99ff3156f26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_OtherForeignCountriesMember_5bd5e663-ca06-444b-921f-7c6735c2ac59" xlink:href="syk-20211231.xsd#syk_OtherForeignCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_76f3e30f-6328-4bd5-943e-33314d7d64ab" xlink:to="loc_syk_OtherForeignCountriesMember_5bd5e663-ca06-444b-921f-7c6735c2ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ffe0bd38-8770-48d8-873f-b79624949314" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_222b47d2-43b5-4d25-8292-a26da6242da0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:to="loc_us-gaap_Revenues_222b47d2-43b5-4d25-8292-a26da6242da0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_48d0a2a4-2d62-435b-8a53-aa0b33134eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6c0297f9-1770-407a-8411-1a274ba8c248" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_48d0a2a4-2d62-435b-8a53-aa0b33134eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairments" xlink:type="simple" xlink:href="syk-20211231.xsd#AssetImpairments"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c13a2298-7735-4884-a4dc-5b301d15433f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock_3d3035c3-187a-439a-bb66-0c3c42884ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_c13a2298-7735-4884-a4dc-5b301d15433f" xlink:to="loc_us-gaap_AssetImpairmentChargesTextBlock_3d3035c3-187a-439a-bb66-0c3c42884ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#AssetImpairmentsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/AssetImpairmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d034dca3-4259-45a3-a03d-96e09b1960d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_d034dca3-4259-45a3-a03d-96e09b1960d6" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9e779425-e209-43ec-8d72-caf7638d19db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ebde2e53-7b33-45be-b017-ec4c1fd1ac5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cad07381-a539-4a18-83a0-90259cf98244" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ebde2e53-7b33-45be-b017-ec4c1fd1ac5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2d369e6e-a956-4065-983f-8a79384dacd7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_2695580b-80f7-45aa-b69e-734c4cd11a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_df16ab8d-29b3-443a-86b1-87f98d693eff" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_2695580b-80f7-45aa-b69e-734c4cd11a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7b1f0090-598c-4d33-8d76-60b9f8a29608" xlink:to="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CN_f381a912-6c66-4b5f-9dc8-c7eb75e2b24c" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CN"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ad5de001-ebca-48f6-a078-e657d8f422e9" xlink:to="loc_country_CN_f381a912-6c66-4b5f-9dc8-c7eb75e2b24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis_fa4fecb7-ff4c-4e17-9dd7-86d077f972ab" xlink:to="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_cfaf2eef-faf7-40f3-beb5-9c83f1629137" xlink:href="syk-20211231.xsd#syk_LongLivedAssetsAndIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_LongLivedAssetsAndIntangibleAssetsMember_cfaf2eef-faf7-40f3-beb5-9c83f1629137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_bda12586-3a77-4835-8d0b-9a6c5ef2541d" xlink:href="syk-20211231.xsd#syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember_bda12586-3a77-4835-8d0b-9a6c5ef2541d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_syk_GlobalERPSystemMember_68de5add-dcf0-40ee-b478-da83c2f4c527" xlink:href="syk-20211231.xsd#syk_GlobalERPSystemMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain_0dc7fe0e-ccce-4db3-b2e0-26beeb8b1df8" xlink:to="loc_syk_GlobalERPSystemMember_68de5add-dcf0-40ee-b478-da83c2f4c527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_5b4acc11-bce9-4638-a136-7b4dd48eceda" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_722328a1-d4e7-405b-b9eb-c32ff0af8586" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:to="loc_us-gaap_AssetImpairmentCharges_722328a1-d4e7-405b-b9eb-c32ff0af8586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_de601d70-214a-49da-be35-eab763b0befd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c843caa8-5a7a-4262-889a-0fb3a18f4fa9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_de601d70-214a-49da-be35-eab763b0befd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="simple" xlink:href="syk-20211231.xsd#ScheduleIIValuationandQualifyingAccountsNotes"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="syk-20211231.xsd#ScheduleIIValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_8c243e01-9025-497d-95c5-c555cc889dae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_8c243e01-9025-497d-95c5-c555cc889dae" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_4a000aab-7f1a-4489-b7d4-e32e3bd3b65a" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForNotesReceivableMember_f6b09c0d-b970-44f6-b81b-ba4d7ce01cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForNotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_ee1d3323-bb98-4023-bf36-3cde418d8078" xlink:to="loc_us-gaap_AllowanceForNotesReceivableMember_f6b09c0d-b970-44f6-b81b-ba4d7ce01cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_83962f98-f11d-4507-a7f2-edeff9ba641f" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b775dfc6-1460-4330-99e6-bbcfc050a794" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b775dfc6-1460-4330-99e6-bbcfc050a794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2ad60c7e-16be-441d-aa8a-fb57aea94859" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2ad60c7e-16be-441d-aa8a-fb57aea94859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68501bb0-5661-4413-bee0-8af4b517429a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_68501bb0-5661-4413-bee0-8af4b517429a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_21c7cd99-5165-4225-a408-016f5dc57392" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesAdjustments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesAdjustments_21c7cd99-5165-4225-a408-016f5dc57392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_b543d6cd-798d-414d-8e1b-17488f6e5b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_76dd1592-14c3-44b4-b7d5-60ffd5dd7b8e" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_b543d6cd-798d-414d-8e1b-17488f6e5b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>image_01a.jpg
<TEXT>
begin 644 image_01a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" )2 ?X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) ZTT2+[CZBJ^H70
MMX6F:0(%/S,W0#UJFFHZQ*S_ &>.$HK81V;&\8SD#% &KG/04,VWM6-9ZTNI
ML5AOT8H2)A$3\A'X5>TZ[DDC5I4;#G"'U'K0!<!##(-%-3&"!Z^M.H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH :\@3&1U.*C-X@*Y4X8$DD],4W4F9+<R*I)!^4CJ#7R;_P
M5]_X*&6W_!-?]D_4_CC]@CU#699Q;Z/ISR[//F(^50>P)(YY^E 'UI'?6\S[
M8) ^.N#TJ5&WKNP1[$8KP;_@G?\ MA:)^W/^RQX8_:$\/^5$=4ML:A;1R[Q#
M*.JDX'/2O>8QA!Q^N: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** $=TC0O(P '4FHOMUN<[9 <=>:+QW%L^R#><<*2 #^-
M>3_M-_M/?!_]F'P--XU^+_C72]+M@0FG0W^KQV[7<Q!Q$H8@L3CM0!=_:N_:
M7^'?[*WP'\2?'KXBZI#!I6@Z7-=2"=\"8HA944?Q,Q& .YK^>/XC?MT?\%7O
M^"V/QQN_#'[)_AW6K;P;%J6R"YTL2P1Z6K*%#SNI 4$$'/\ M"O9/^"N/_!1
M?5O^"K.@_!#]E?X'Z;J&D>'OB+XPAL]?OK>Z<I+)]HB1;=D5>53(<G=G$G2O
MV/\ V"?V(_@]^Q-\!-&^$'PT\*Z9!]DLU&IZK;6"13:A/_$TAR68C[H)/11Q
M0!_/5J/PZ_X+>?\ !'KXQ/XI.E^)/$5E;J)[Z^BN)K[3YE.&(+[B <$_E7[D
M?\$>?^"H?@K_ (*4_L[0>,H3#:^+=&*6OB;2U.UK>0@_-M/(!*M7U#XW\'Z#
MXSL_^$=\6^&[/4M-GC*SVUW&'4C&.A'I7X1?M;Z+\0O^"#7_  5=T'XW?#L-
M9_!?XM>(/M&NV%C;E(+:..0!P67(!_?<>P/2@#]_K.:*> 20R!ESU%2UB^ O
M$&A^)/!VG^(O#FHK=V%[;+-:3QN&#(P!&#WK9WC('K0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ,G("<@8/!)[5^#O_  >+_$K7-#\(?#_X?+JIEAO+E[I8I.BNAC(-?O!<
MQB3$;$[2,'%?SS?\'=,<GC[XO>%;$[EBTB06D>/5V R/7I0!^B'_  ;/^%]9
M\,?\$O/#:7VFFW6[OIKBU## E4JHW'\0:_0R#/E+E<''(]Z^>/\ @ESX,C^'
M7[!?PO\ !<-NL1L?"L(D51]XL[MGZX-?1$98H"X /M0 M%%% !1110 4444
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M ,$SO"LNIZ,MK?ZK?3W=\PP/,5DB\LCU7.[%5)6 _0N%64G(J0444@"BBB@
MH) Y)IK.$3+L!QWJG<7Y4'RY5#$@#//>@"Q=R0O:.6VLI7H1P:^7_P!L+_@J
MI^Q]^P[XAT+X?_&3QFD>I>()MMM963K)Y8R!N?GY1EA^=8O_  5)_P""BNC_
M +)GP*UNS^'&-7\;7NW3=*L;>$R^1<3#"EU3)'!S7\V?BG]FC]IK]L/_ (*!
MZ9^SSK^KR^*?B"6W^)3)?Y&DNDB"?YF.% 8XV]L4 ?UX:!J$%[#'J6Y'2Z"M
M:;!_RR(!!_6MB'(=E?J.A]JP_AUX9_X1'P9HWAN=S+)8:;%"TI4<E5 /2MY
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MGPMI$5C9QD8*JH[_ (DUWQ=!R7'YU!811PV:10MGY<!FZFJ^HRO%'Y,:!][
M')XQGDT 7A+$<D2KP<'YNE.K\DOVG?\ @O%XD\ _\%9/"_[#_P )?#-KJ7AM
MM5CTS7+V&178W#0&8@8!Y&,'TQ7ZT6,ZW5G%<JA421A@I[9% $M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-E4LO
MWL8.2:=39E#1E2#SV'>@#C_C#\7/#'P5^%^L?%/Q?<K!I^DV,MP[L<?=!/\
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M?\$OO^")ND?!>(W=M\5_C]XK2/7#$H,[7$TD2E<#JK)M4Y]37U;\?/"VN?\
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M)&#2@ < 4 )M4'<!S2D ]1110 4444 %%%% !1139'V '('U- #NG6F*S/\
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MI"+:N!^V'_!#_P#X)M> ?V"/V-_#^F1:+:MXK\0VRZCXDU8J&=FD4#R@_4J
MN?\ @1K[3TM)X[B2VD@Q$BXBE_O#.<?K7DW[$_P<UC]G?]GSP]\"?$_Q)N?%
MMWX7LA;OKETR#=CHI(Y/X@&O7+CS5MLIOW !\P+NSST&?:IEHP)+L*?W3R8
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MU $HOAL,TJNB@X"XY)KS[]H;]J+X3?LQ?#__ (6;\9O$8TC2#<I"L\JX^<D
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M "_E0!^M%M9%9#</*65NH9 "?R%2I:L+GSW88_A &*?;1"-3\[-EBWS'IFI
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MMU:2&6$.0PR>C=JEKF/@[\1O#GQ:^'FG?$/PG?K<V&JPB>"5#D$, <#VKIZ
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M]FCP%^S#;:>DMQXM\0#7/.:0J2EB/*9"!_>-T#CVJTFP.W_X-.OV;=.^'/[
M-Q\:;W2K:/5?&.NW$QO858&YLU2,P[L]PS2<CUK]6H@ PQQD9(]:^9?^"._P
MAO\ X&_\$TOA!\,-=MTAO].\'VZ7NQ NZ0@DD^_2OIM1&7WALG&*&K,!]%%%
M( HHHH **** "BBB@ IKIN_$8-.HH @MK""U),* 9//)J>BB@ HHHH ****
M"BBB@ HHHH **1LXX_6F?:$;E7&!UR* )*K7\\D0R& 4??YP<?6I$NXV?874
M$\KSUKY&_P""BO\ P6(_90_X)_\ @1?$'C;Q3%KFJ3W20P^'](:.2X8E@O*M
M*GKVS]* /I;Q'XW\,^ ]!NO%WBKQ?;6VFVT#RS7%W.D21JJDGYG8#H*_.7_@
MH?\ \%N=&T?6_#W[/'[&%TGBKQ'XUA8VFMZ)>13K;@#F,^66PW;\#7RG^TK\
M=/\ @HA_P6F^)NB_#[X">'=3\-?"R:YB74Y8H4") ZACO=%8J_/K_C7Z(?\
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M\_9/\'?!3]K*XM]7USPUJTTUK=:9<RLC12.[&-7+)\IR.@'2O;_B%_P;Q_\
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M.$G)S_$O:OPX_P"#C+1M9_;;_P""R/P6_81\-:]'%>6]O&GF A@AO6@D"_\
MD(U]G^-_^#D7]DGPQ_P4%3]DB4B[\*(B1WGC<,C64,C1"5P6\SG9)F,\<-Q7
MP'^QE?S?\%*_^#GG6_CCX5U(W6@>#-7NK^QU*,_NY+.SG5(=I]65\C'H:TBF
ME=@?T1?#KPQ8>%O!&E^';(AHK*RCAC(&!A5 K;6-4.0*KZ/%#!8)#!%L5. G
M/R^W-6JAN[N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^.'_  52_8>^!/PDD^-6O?'#2[W3I;3SK>'3+GS9Y^G$: C<?:OP._X+"_\
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M+Q9;E"2QMGE@9P3UW$$Y]Z_72$!6.T@KVQ1)I@?AS_P=>_L^^(OA1X_^%?\
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M%/&/:OO?]HW_ (-!9IK*;7?V<?VBHS<Q%VCTS4["6X!/]W>\IV_E7[0? ?\
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M'* ;L]>M?@Y_P='?\$UM8^'?CFU_X*._ ;0+N?4;N\@;Q6;&,M)#/"RM'<C
M. ,)D^BFOWK9,N' SBN3^*GPE\,?%[P)K?P[\<:5'?Z5KUA+:W=K,,A0Z%<C
MWYIQU>H'YJ?\$6O^"[OP=_:;_9HMO"_[0OQ&L/#GC/P=9+;7L^L:A%#_ &G$
MH !4.RY.T@\>E?"G_!:W]NF+_@K3^VE\.OV0/V3II]5T?2M9-O*ZCS$EF21
MTORY^5<,-W/WJ\V_:U_X-H/^"A'P^_:'UNT^ 7P^T_7_  U<:G+<:%J"ZQ#
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M,JC<(VD0!OS)_*OV,^'^@?\ "+>!M'\->9O&GZ5;VP;&,^7$J9_2@#8HHHH
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MALDF5<3D,X/S-C&>*Q?A1X,T?X=_#W2O!'A^VBBL=+M$M[5(4VJ$4 #BNBH
M**** "BBB@ HHHH **** /P0_P""RVGZCKW_  <#_ W2]*OY!)'J>F.ZDGY%
M^VG)'Y&OWHTZ)H+5(F<MM4#<>IK\4?VP/ UY\4/^#GSX=^'I$#P:9X7AOUS_
M -,I;A\_^.5^V<?&0.F>* '4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444R;8$+,/N\_E0!0
M\3W2V.@W]ZS[1#9RN6],*37BO[)R^)O#'PGU77/%&H&07.IWVI0N3_R[&25Q
M^A6NV_:?\;6G@7X&Z_K<YY:T\A?K*PC_ /9Z\0_:@UK4_@Y_P2Z\4^,HKUH;
MS2O AD@*'KY@3'_CK4 ?G;_P1JU+1/VI_P#@M_\ 'O\ :)TV,7%E:73K!,?]
MJ60X_2OW!MX1$V=F!M 7%?BI_P &AWPJFU?X+>/_ -HO4U<3:YXB(8R=3@R'
M/ZU^UL P6 Z;J )**** "BBB@ HHHH **** "BBB@ HHHH *@OIHTVQ2' ?.
M2#SP,U/575+O[$D<Q7*EPA/H3P/U- 'Y=?\ !P7\4T^*7Q%^!'_!.'19I5U?
MXD>,H[_4I%CS"^FP+,Y1O<M$M?I#\-OAOX8\!_#G2OASH&EQVVF:/IL5G%:1
MK@*$55'\J_(GQ[X,UG]I/_@Z:BM[0[[?X4^'8-3^@DLXXC_X]/7[,:<;@PN;
MKKGF@">SMHK6'RH$VKG*KZ5+21_<'TI: "BBB@ HHHH **** "BBB@#\'/!W
MQ=^(GQ=_X.EI4^RP(WAW39]/1AU^S""5S_Z&U?N[8S)/;AXR",D<>QK^?;]@
M+Q!K/BO_ (.EOB$JQ<6-S?6\?_7,63,?_0C7]!D"JL>U%P 3_.@!]%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %-D(Q@C/!X]:=5;4K@P*I\IR,,S,O0 #/- 'SU_P4.\>Z#HG
M@SPO\/-7B+GQAXG@M(XQU^0B7_V2ODW_ (.2/VL[#]FW]@6Q^!>AZBL.M>/1
M;:5:6I8J6M@ &( ]U6O6/V^_&=_K'[?GP'^$4'ANYU.TN9IM5EFC7,5H1'.@
MW>A.T?G7QA_P7<TG0OVM?^"K'P%_9)>X$PT:Y%UJD3X*) RB3;QSG)44 ?HO
M_P $?/@0?V>_^"?'PW^'TE@D,MOX>MVEVQ!2Y,2_,<=3[FOI_:"VX5B_#[0-
M-\*>#=-\+Z-:F&RT^U2WM(R<_NU "_I6W0 4444 %%%% !1110 4444 %%%%
M !1110 56U!V#11!-P=^15FJVI;@%=$)*AB&'0''?ZT ?CG^P;XRE\3_ /!S
M7\>]0U8^2Q\"06\.>^R2S4?HM?LC!]ROPF_;BU/Q-^P+_P ''G@;]H86\NF>
M#_B<D%MJMU"FV!E%KY91F/&3-&K8K]S-+U:TU6PBU#3IA-!<1B6%XW!RI&?Z
MT :"=*6H[643PB4 C=V-24 %%%% !1110 4444 (_P!W.,^U9U]*\;;1, 3]
MQO\ GG5^?_5'G'O7)?%^_73?A[K\]GN2==*G9)0<!2$/- 'X;?\ !'/PU-J?
M_!Q_\:/$][/'<R65WJ -RAX.ZR*_UK]]K<L8]Q/7I7\__P#P:YZ%K_Q#_;_^
M.7Q<U?5$N+JRN)HYKFXR2^]WC'/<X(%?O[89%LH((('.36DP)J***R ****8
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 55U%RJ$'HV%+#JN>,BK54M>O;'3--EU/4)-D5M$TLCYZ*HR?Y4
M ?G[\"/B%XM^*O\ P5J^*7C#7X\^%/ASH2VEO</'_JV$,<KE2>AP[=*^ O\
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M4 -* @+D\=Z F!@,?QIU% " $'ELTI /4444K( HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 9Q1G_ #BH9GE$A"$8 R:?"[2+
MNW CVH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2UB]%G;
MMC[S# -2:7N-HCL<$C.*G>))/]8@8=@10%(.21@= !0 ZBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>image_02a.jpg
<TEXT>
begin 644 image_02a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" )2 ?X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) ZTT2+[CZBJ^H70
MMX6F:0(%/S,W0#UJFFHZQ*S_ &>.$HK81V;&\8SD#% &KG/04,VWM6-9ZTNI
ML5AOT8H2)A$3\A'X5>TZ[DDC5I4;#G"'U'K0!<!##(-%-3&"!Z^M.H ****
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M$&A^)/!VG^(O#FHK=V%[;+-:3QN&#(P!&#WK9WC('K0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ,G("<@8/!)[5^#O_  >+_$K7-#\(?#_X?+JIEAO+E[I8I.BNAC(-?O!<
MQB3$;$[2,'%?SS?\'=,<GC[XO>%;$[EBTB06D>/5V R/7I0!^B'_  ;/^%]9
M\,?\$O/#:7VFFW6[OIKBU## E4JHW'\0:_0R#/E+E<''(]Z^>/\ @ESX,C^'
M7[!?PO\ !<-NL1L?"L(D51]XL[MGZX-?1$98H"X /M0 M%%% !1110 4444
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M ,$SO"LNIZ,MK?ZK?3W=\PP/,5DB\LCU7.[%5)6 _0N%64G(J0444@"BBB@
MH) Y)IK.$3+L!QWJG<7Y4'RY5#$@#//>@"Q=R0O:.6VLI7H1P:^7_P!L+_@J
MI^Q]^P[XAT+X?_&3QFD>I>()MMM963K)Y8R!N?GY1EA^=8O_  5)_P""BNC_
M +)GP*UNS^'&-7\;7NW3=*L;>$R^1<3#"EU3)'!S7\V?BG]FC]IK]L/_ (*!
MZ9^SSK^KR^*?B"6W^)3)?Y&DNDB"?YF.% 8XV]L4 ?UX:!J$%[#'J6Y'2Z"M
M:;!_RR(!!_6MB'(=E?J.A]JP_AUX9_X1'P9HWAN=S+)8:;%"TI4<E5 /2MY
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MGPMI$5C9QD8*JH[_ (DUWQ=!R7'YU!811PV:10MGY<!FZFJ^HRO%'Y,:!][
M')XQGDT 7A+$<D2KP<'YNE.K\DOVG?\ @O%XD\ _\%9/"_[#_P )?#-KJ7AM
MM5CTS7+V&178W#0&8@8!Y&,'TQ7ZT6,ZW5G%<JA421A@I[9% $M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-E4LO
MWL8.2:=39E#1E2#SV'>@#C_C#\7/#'P5^%^L?%/Q?<K!I^DV,MP[L<?=!/\
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M?\$OO^")ND?!>(W=M\5_C]XK2/7#$H,[7$TD2E<#JK)M4Y]37U;\?/"VN?\
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M)&#2@ < 4 )M4'<!S2D ]1110 4444 %%%% !1139'V '('U- #NG6F*S/\
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MI"+:N!^V'_!#_P#X)M> ?V"/V-_#^F1:+:MXK\0VRZCXDU8J&=FD4#R@_4J
MN?\ @1K[3TM)X[B2VD@Q$BXBE_O#.<?K7DW[$_P<UC]G?]GSP]\"?$_Q)N?%
MMWX7LA;OKETR#=CHI(Y/X@&O7+CS5MLIOW !\P+NSST&?:IEHP)+L*?W3R8
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MU $HOAL,TJNB@X"XY)KS[]H;]J+X3?LQ?#__ (6;\9O$8TC2#<I"L\JX^<D
M?S%>?_M;_M\_"G]EK32E]K4&K:M/*RP:9;/NE!7C! Y[U^3/[8FC?\%(?^"P
MGQ1TCX2>'/ NH:;\-K75HKR]FDB= 8PX."2>>%H _0+]J;]L#Q7\:M>L/A/^
MS@4U#1=6\-W<^IZI!AFA#0RE.1P,D+^=? __  :X>'O&&G_MB_'3P3XRL$G@
MTG5[FYD:\0;HI3<J X/\1(8\'(YK]-OAW^R_X#_8=_98\47VCR"YO[3P?*L\
MUP@/ENMN>-Q]"*^.O^#8+QWX2^*7AKXK>+KWPZB>))O&%ZM[J4:\SP_:6V+^
M "_E0!^M%M9%9#</*65NH9 "?R%2I:L+GSW88_A &*?;1"-3\[-EBWS'IFI
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MMU:2&6$.0PR>C=JEKF/@[\1O#GQ:^'FG?$/PG?K<V&JPB>"5#D$, <#VKIZ
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M]FCP%^S#;:>DMQXM\0#7/.:0J2EB/*9"!_>-T#CVJTFP.W_X-.OV;=.^'/[
M-Q\:;W2K:/5?&.NW$QO858&YLU2,P[L]PS2<CUK]6H@ PQQD9(]:^9?^"._P
MAO\ X&_\$TOA!\,-=MTAO].\'VZ7NQ NZ0@DD^_2OIM1&7WALG&*&K,!]%%%
M( HHHH **** "BBB@ IKIN_$8-.HH @MK""U),* 9//)J>BB@ HHHH ****
M"BBB@ HHHH **1LXX_6F?:$;E7&!UR* )*K7\\D0R& 4??YP<?6I$NXV?874
M$\KSUKY&_P""BO\ P6(_90_X)_\ @1?$'C;Q3%KFJ3W20P^'](:.2X8E@O*M
M*GKVS]* /I;Q'XW\,^ ]!NO%WBKQ?;6VFVT#RS7%W.D21JJDGYG8#H*_.7_@
MH?\ \%N=&T?6_#W[/'[&%TGBKQ'XUA8VFMZ)>13K;@#F,^66PW;\#7RG^TK\
M=/\ @HA_P6F^)NB_#[X">'=3\-?"R:YB74Y8H4") ZACO=%8J_/K_C7Z(?\
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M\_9/\'?!3]K*XM]7USPUJTTUK=:9<RLC12.[&-7+)\IR.@'2O;_B%_P;Q_\
M!+SQEX%@\)-^SQ::;-;:9]DL=3M[FX>:W(7"NH$G4=LDU]N06)2S*,FY-J[(
MV/F!<# X;(%<?\;?CCX0_9]^'EWXX\?:]:V]M!A$:>95\UR#\BC&,\>AJ0/Y
M9O\ @J;^Q?XO_P""2G[9MW\ /V?OB]K-WIGBGPRLCR6J/&ZP2/,GE2(A.X#!
M.X],UYS\0/@_XQO_ (7_  ,_9/\ [$NK?6O&7B1;O5(W7;(S7%S);@L!R?DV
MODU^HMW<_"WQ?\5_C#_P64_X*/\ @RQOO"4&EMX>^$.@123"=P!)NA\M?*5]
MQG4*Q9^6ZUQG_!#KX-ZE_P %*OVX=5_X*.?'#P?]F\"_"^TEAT&WO(/+B6=5
M)CC &%/EPNK;@Q^9<'I0!^XW[/GP^M?@;\!O!7PG:^6-?"OA/3M,G&TX9H+:
M.$G)S_$O:OPX_P"#C+1M9_;;_P""R/P6_81\-:]'%>6]O&GF A@AO6@D"_\
MD(U]G^-_^#D7]DGPQ_P4%3]DB4B[\*(B1WGC<,C64,C1"5P6\SG9)F,\<-Q7
MP'^QE?S?\%*_^#GG6_CCX5U(W6@>#-7NK^QU*,_NY+.SG5(=I]65\C'H:TBF
ME=@?T1?#KPQ8>%O!&E^';(AHK*RCAC(&!A5 K;6-4.0*KZ/%#!8)#!%L5. G
M/R^W-6JAN[N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^.'_  52_8>^!/PDD^-6O?'#2[W3I;3SK>'3+GS9Y^G$: C<?:OP._X+"_\
M!=?Q+^W-\3=+\+_!#Q%=VW@G1=174;;^T+0POA3D"55Z\?UJI\#O^#</_@J1
M^T%X4\/Z_P"+KA+'PK<;23<:KF:V0CJD#GYOIQ7Z[?\ !.G_ (-NOV0?V,;6
MV\0^.D'Q \1W5@L=_<^(-*C\E#CE?*+.K<]ZR _)']CO]@#_ (*2?\%HKW2]
M/^*7B6\T/X466H-<+/-&EN-H5?GB4#:Y.T8/J*_7_P#:\\-^!O\ @DY_P1XU
MOX9?LY:+]FN+328M"TA#B.?4+Z_N%M6D(ZNV;@MGV]J^[/#GPX\%_#KPLGAG
MP#X6L=+T^SC#PV5A:K$G'\("  #CTK\^_P#@M@T'Q(_:E_94_9MNKO*ZKX_E
MU>]MD^8-%!:S2)NCZ,JO$&R>XI/8#\[/@G_P;[^#-2_X)?\ Q"_:9_:-O+ZU
M^),EC/J.D@2;?LXAEV2AA_M/S[YS4O\ P9[_ +0_PF\/?M(>-/@]XQM(HO%?
MBC2K27PQ?-&!F*T#I-#N_O,9HCCOMK]1/^"^'Q?@_9P_X))?$NZM);33M0UG
M2X]+T-[=0/-DDFC=L#L6178BOP@\*?LE?%S_ ()B?"O]GK_@JCHT6J3:;K^K
M07E]&N;=+-"$:-2Z[BRS*S-R!CR^];7O"P']:.ED-:B3G+$EBW7/O5BO/?@=
M\;M%^,WP>\/?%WP8T%WI.O:7!>P7D<AV.CCYF!Q@XQ7:)K#A%,]L 7/R%9 1
MCUS65K: 7J*H#603Y8:'>I_>+YO0=L>O:K,,MT_+PH!VPU $U%(K!OPI: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM?QQD,TA.TQG>%)!P.>,8-6
M:9)$9&)R/N\<=Z /P>_X.._^"6?[7W[3G[5NF_&WX'?"R?Q7X>;0([1X/M<A
MFAE+JN5 5FXZG';->1?L>?\ !K7^W_XFD,'QO^/R_"S0]1MHVA7P=)->RCC[
MLT(^S@'GG+&OZ/)+5)$"LJDCD'T/M3?L,83"G:>[ 9_G0!^+N@_\&AGP[CLK
MJS^(?[9>I:M>2N3;:J_A01S[?<_:CBI-*_X,]?V?]+F:=?VF=0>X*G9*?#!E
M(..N#=]:_:#[)&0!(JMCN5IRQ;3\F /8<T ?@I?_ /!G1>O>ZM=^%_VVM9@B
M*NUO;S>$1$)'Q\J[_MAV@G S@XKY;^('_!O'_P %C_@-I=^WP]UR+4-&@NV^
MRMH?BB]^U2@$X8+%&W/MFOZC7M]R%&;<#_>I%M8_+"[0<#@-SSZT ?R1^(OV
MC/\ @M5_P39TV"Y\;^(?B#X903-':7?BA+J>W?Z?:HSD?ABOJC]C#_@[$_:4
M^%VBCPI^T]\/+'X@RJNZ36;2]AL#",=?+2V;>>/45_0!\7/@3\'OC?I\>C?%
MGP+IFN0VYWPP:E:K(BL>I -?#_[3G_!NA_P38^/6MZI\3/$7PUFTB^%G(3_9
M^MW,%O& I.[RT<)Q]* /F+_@G)^V/^RE_P % ?\ @LF?VC/A_P"'QH>H7/A/
M%U:W\R%C-MD7Y&XW=NPK]KTOD;:$4D'()Z]/ID?K7\G^O_\ !+W]HOX$^)_B
M1\;/V7/'6_P]\.I66RU33+P-+M!#;<X+<;_6OT"_X(??\'%6H?%"\T/]EK]L
MZ[F.KM(MKI'BDJ%65P,+$^,#.."2#R* /W#@G2X3?'TSCK3ZJ:7<I+;^9YPD
MW?,KKC# ],8Z_6K2G(SB@!:*** "BBB@ )(' IHD^;:1S[&FO-"5+.V  23[
M5D:MXCTVRLVNI=4AM8B?EGN'"J><=30!MY&<9HK&\/7]M>,CG48YS(I>%X7W
M*R@XSFMF@ HHHH ****5[ %%%%, HHHH **** "D8L/NKGUYI:J:A),)$$4R
MH-^&W'MC- $\L^P?* ?7KQ^0JGJEW"EL[3RE B;W?< %7U.2,5@>./%.F^$?
M+\1Z_K]KI^EQ/BYN+R144#'8D]:_,'_@H;_P4V_:#^*_Q^T;]BO]@N-=5LO$
M4#P:YK\%LC"!20NX.%/3)-"W ^;/^#I;]K'X=>*/'/PN\*?!#QS'=>*?#FO2
M3I=V<Z7 BN!@HOR,<?,!7VM_P3Q_8,_:&^+>K^$OVNOVT?BY>:G=W7@^V$'A
M"-94B1=J[)&)=58E0#C8>O6OAG_@IC_P2H\!_L_7/[-=M%%>77BS6_&EM'XN
MEN]3EE-S++<H"%#,<<,.*_?#X=^'(/#O@C1M'AMTB>RTBVMLA>5"1*H'Y#%:
M2DGL 1V%I8V%JEM8FWCA(B@AM)7547'&54A>@[@UHV\L:(L-LYDS]XD\BKGD
MJ"=JJ,G)XZT+;Q(=T<2@]SBLP*]Y.+8955RS!2I/4'@5\+_M ?L^:I\6/^"X
M'PP^(,\0FTSP1\*;J]$;'*Q3S3W=N&]CB0"ON368V>W;RE!DR-A]"#\OZU^8
M_C']K+XSZ3_P71\3?"7X:J+WR/A9':7%NJAQ RS-<#/IG(_.FDVP/G__ (.]
M_P!ISP3-\-OAI^QI%J).K/XFAU[61!<KA+2&WEBV,I[,9$;.>/0]:A_;5^*5
MG^UI_P $1O /[*'[/'@6]\4:O>^%=!;1-)T^V-P\<5M9NERW[E7*[&DC ;'\
M72OFW_@II\$OB)_P44_X.#-,_9>\5VB?Z1IVAIJOE'"6EJVFPSSY9<8RXQQC
MEJ_>[]G?]CKX ?LN>"=-\ ?"7P5!:Z=X:L'CTJ[NI&FFBCEVEHQ(QWE?D'&>
MPJX^[N!_/W^P+_P4#_X*>_%O]G#2?V"_V6O &JF[^&>C7.GZA=PPREX%E0)"
MKJ8"5*M&YP3SGM5SQ_\ M^?\'&G[(?PR/B+Q_<>)(/#YN?*GOI/"#/\ 9U#!
M3\[6X&._WAG.*^@_@-\1['_@G=_P<O?$OX3>-K6#1_"WQFE1].CAM@D>Z1Y5
MM G'&9&:OV^\3^!?!?Q%\*S>&?$F@6NH:9=0X^R7D(>)NX8K]:F6KN!^.G_!
M(/\ X.2?B-^U7\<-'_9G_:2^&\%N]]IY1/$=SJL41:2/G>T0A4C<%/&[@G&3
M7[+>'/$^A>([87_AO5(;Q&X'E3@X/O@G ^M?!O\ P41_X(^? +Q1^SWXQ\;_
M +//PYAT;QUIV@R2:1/I=Q)$XD#K(VW:>,@-_*OR=_X-V/VU_P!H'X-?\%)Q
M\!_C_P#$'79K'7=/N+.;2]9NI'\N^$L>S:&/' DJ5[VP']-L,XE+ 8PK;21Z
M]Q4E4%N1]K1][8N!\H)X&.^/QJ_GVHV **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ****  C(Q2*,#%+10!!+;^:^V2%2O][/->#_ /!1
M7XHZ3\&_V/\ QYXZU:YEM;:TT.=&NH2<H6C8#I7OC[<D.HP>,U^??_!R5\4U
M^&7_  3#\::7:L4EUZ/[' %?!)QAOT84 >-_\&UO@#P]\4_V,?&FK>*(/[=T
MSQ9XFNH[T7I!\R,[<?>[8Q7R]_P6Z_X("S_L[ZA)^V5^QE:W3V5C=_:;WP_%
M-Y)LY,EC*ASTS_.OU0_X(L_ KPG\"O\ @G-\/++P[9HJ:OI"7UVOEA6\UV()
M)_ 5]*>+O#-CXV\/7_AS7=,@OK&_M'MYK::(%65OE).[.2.WTH _.?\ X-V/
M^"J6K_MJ? N;X3?&76H5\:>#S%9K:HC-)-"H9=S-_$1M7/UK]-[34[>[D:",
M.'CQN#J1C/UK^9C]KCX6>./^"$W_  6+\/>.OAAJ6HKX.\4ZB]VT:RM#"\<D
MB-)$VS<I(+#&<< U_1[\'_'6G_$[P)H?Q%T34!-I^K6"7%M)Y@97#@$<]3[<
M4 =G11D'H:* "BBD9U7[Q_2E= 4+VZM88S&T4C YC;8N=N>O\Z_!S_@ZA_X*
M6^-_ WQ!\/?L4?L^_$.;39;"S-_XCN+*9HY(9B7*P[ACG;L;'^U7[K:X'CT>
MXEM04=%?YW+($DQP3@KD=.<U_*A^T9^R'KW[0G_!3>Q_9N@^-Q^*?BCQYX]>
M;7-1A8M)HUHLI,D"GS9-VR",GJH[8[T[7 _H%_X(>^)_'OB'_@FS\+O$GQ6O
M;J[UJ\T^5&NKK+/(AD8H22<\J <FOL7?\VTKCWKB/@S\,-#^$OPI\._"KP<5
M6P\,:!;:1;%8PA=;>-(@[ <;B$R>>I-=K&,%07RP'.: 'HP=0P[U%=7L=HR"
M5'(<GYE7(7 SR>U/\Q4'S#'^?:JFK>3,L7F9 #Y^:,_SR /QS0M0)%U:W?8R
MJQ5R?G'*C\:;%K=C.YC@?S&4D,L?S8QZXZ5\._\ !3__ (+8_LQ_\$W]'N;"
M]U&W\5^/C:F32O!]GJ#0[AG'SNB.%/?Y@.*_.3]EG_@[;^)NI?'>&#]IKX.:
M5HG@G6)GVW%IJZRR6(+?[$(,G7OCI6\*$I*[0'] 4&H17$*S*C@,<89<8J6.
M59"0H/'>OFC]C[_@J1^Q5^V+%-I'P$^+]C?7]M$'>RU"1;>1@<]%<@GIZ8KZ
M0T^\^UP+*RX)&3A3C\SU_"L9IQ=@+-%(&4C.>*/,0+O+<>M( 9@HR:1I56,R
M'L.A--DE!4%5)!Z8%5-1O(C 6$ZHJ\%V=1S^)H >FNZ:ZAEND()P<.#@^E<)
M^T-^T9\(?V=_AYJGQ$^*WB:UL;'3;1IY4E;,AP.,*O)S7C/[:?\ P5"_97_9
M#^$^K_$"?QSI&M:OI\;PP:5H]XD\K7)&%1DBW,&R1VK\]/V=/V5?VK?^"XL8
M_:$_:=\0Z[X+\(7FI3P1^&1'<*);'+A&(:2+DX1OF7&#0!#\>/VA/BI_P7YU
MC2_A'^S-<:[H7@73=8']M:O;PRVQ>)<J,!MN<C)S[5^F7["__!/#X0?L3_#+
M3/!_ANV&JZM86_ER:[?1JUPQP!][&>WK6Q^Q/^QM\#/V*?A'9?!WX*^&K-+;
M34$,VH-9QI/<E!MW,RC)_$GK7M=M&TL2J2%VOG"<9H _'S_@YIUCQG\*?C#^
MS?\ &W35<Z3X;\>PO?R[^#)YT>S</J17ZX?#/Q ?%GPZT'Q2QR=3T:UNR?>2
M)7_]FK\;_P#@[I^(5QH7@'X4?!RST_SY_$WC"&9+MFYC>*6.3I_P$#BOUV_9
MLBFA_9X\!QW'^L7P9I8D_P!X6D0- ';4444 4M2,WE2*D9^ZV""...M?B#_P
M1:\9ZOXX_P""Z7[6/Q-^.5U-#J6@Z"CP-,<_9HDFA3./3RAG\:_<#4/-6-G1
M <\'(ZBOP*O?CKX$_9A_X*H_\%&OB/<R10 ?#6VL=*1)-F+BXM;.'<".X:0M
M]151TD!UO_!";0O&W[9/_!:#]H[]NGQ!;QW?AWP_>WOARQU/Y3^^2[1;;"GD
M9MH2<BOW"M;0BV^7;LX4H5ZJ.QK\E/\ @T"^!FJ>#?V O$_QNU&65[SXB^+I
M+Q9;E"2QMGE@9P3UW$$Y]Z_72$!6.T@KVQ1)I@?AS_P=>_L^^(OA1X_^%?\
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M%/&/:OO?]HW_ (-!9IK*;7?V<?VBHS<Q%VCTS4["6X!/]W>\IV_E7[0? ?\
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M'* ;L]>M?@Y_P='?\$UM8^'?CFU_X*._ ;0+N?4;N\@;Q6;&,M)#/"RM'<C
M. ,)D^BFOWK9,N' SBN3^*GPE\,?%[P)K?P[\<:5'?Z5KUA+:W=K,,A0Z%<C
MWYIQU>H'YJ?\$6O^"[OP=_:;_9HMO"_[0OQ&L/#GC/P=9+;7L^L:A%#_ &G$
MH !4.RY.T@\>E?"G_!:W]NF+_@K3^VE\.OV0/V3II]5T?2M9-O*ZCS$EF21
MTORY^5<,-W/WJ\V_:U_X-H/^"A'P^_:'UNT^ 7P^T_7_  U<:G+<:%J"ZQ#
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M,JC<(VD0!OS)_*OV,^'^@?\ "+>!M'\->9O&GZ5;VP;&,^7$J9_2@#8HHHH
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MALDF5<3D,X/S-C&>*Q?A1X,T?X=_#W2O!'A^VBBL=+M$M[5(4VJ$4 #BNBH
M**** "BBB@ HHHH **** /P0_P""RVGZCKW_  <#_ W2]*OY!)'J>F.ZDGY%
M^VG)'Y&OWHTZ)H+5(F<MM4#<>IK\4?VP/ UY\4/^#GSX=^'I$#P:9X7AOUS_
M -,I;A\_^.5^V<?&0.F>* '4444 %%%% !1110 4444 %%%% !1110 4444
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M ?G[\"/B%XM^*O\ P5J^*7C#7X\^%/ASH2VEO</'_JV$,<KE2>AP[=*^ O\
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M4 -* @+D\=Z F!@,?QIU% " $'ELTI /4444K( HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 9Q1G_ #BH9GE$A"$8 R:?"[2+
MNW CVH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2UB]%G;
MMC[S# -2:7N-HCL<$C.*G>))/]8@8=@10%(.21@= !0 ZBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
M_]C_X  02D9)1@ ! @$!] 'T  #_VP!#  (! 0$! 0(! 0$" @(" @0# @("
M @4$! ,$!@4&!@8%!@8&!PD(!@<)!P8&" L("0H*"@H*!@@+# L*# D*"@K_
MVP!# 0(" @(" @4# P4*!P8'"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@K_P  1" )2 ?X# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ ) ZTT2+[CZBJ^H70
MMX6F:0(%/S,W0#UJFFHZQ*S_ &>.$HK81V;&\8SD#% &KG/04,VWM6-9ZTNI
ML5AOT8H2)A$3\A'X5>TZ[DDC5I4;#G"'U'K0!<!##(-%-3&"!Z^M.H ****
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M$&A^)/!VG^(O#FHK=V%[;+-:3QN&#(P!&#WK9WC('K0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 ,G("<@8/!)[5^#O_  >+_$K7-#\(?#_X?+JIEAO+E[I8I.BNAC(-?O!<
MQB3$;$[2,'%?SS?\'=,<GC[XO>%;$[EBTB06D>/5V R/7I0!^B'_  ;/^%]9
M\,?\$O/#:7VFFW6[OIKBU## E4JHW'\0:_0R#/E+E<''(]Z^>/\ @ESX,C^'
M7[!?PO\ !<-NL1L?"L(D51]XL[MGZX-?1$98H"X /M0 M%%% !1110 4444
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M ,$SO"LNIZ,MK?ZK?3W=\PP/,5DB\LCU7.[%5)6 _0N%64G(J0444@"BBB@
MH) Y)IK.$3+L!QWJG<7Y4'RY5#$@#//>@"Q=R0O:.6VLI7H1P:^7_P!L+_@J
MI^Q]^P[XAT+X?_&3QFD>I>()MMM963K)Y8R!N?GY1EA^=8O_  5)_P""BNC_
M +)GP*UNS^'&-7\;7NW3=*L;>$R^1<3#"EU3)'!S7\V?BG]FC]IK]L/_ (*!
MZ9^SSK^KR^*?B"6W^)3)?Y&DNDB"?YF.% 8XV]L4 ?UX:!J$%[#'J6Y'2Z"M
M:;!_RR(!!_6MB'(=E?J.A]JP_AUX9_X1'P9HWAN=S+)8:;%"TI4<E5 /2MY
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MGPMI$5C9QD8*JH[_ (DUWQ=!R7'YU!811PV:10MGY<!FZFJ^HRO%'Y,:!][
M')XQGDT 7A+$<D2KP<'YNE.K\DOVG?\ @O%XD\ _\%9/"_[#_P )?#-KJ7AM
MM5CTS7+V&178W#0&8@8!Y&,'TQ7ZT6,ZW5G%<JA421A@I[9% $M%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-E4LO
MWL8.2:=39E#1E2#SV'>@#C_C#\7/#'P5^%^L?%/Q?<K!I^DV,MP[L<?=!/\
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M?\$OO^")ND?!>(W=M\5_C]XK2/7#$H,[7$TD2E<#JK)M4Y]37U;\?/"VN?\
M!03_ (+E>"_#%D\.I_#KX&VCWVH,Q,D46LJVX(,?QYBCX^E<]^VAXG_X; _X
M+J_"']E'SXKKP[\--/EU36(IL-YEXJ32HV%R%  C SZ4 ?H7^PO\,7^%'[)/
MPT\&:GH,=C?V'A2QCO8HH\,LWV9?,+>Y<G\Z]LB3RXUC]!CBJ=G"$MXXXXE0
M1@;$3^Z!@5=3E <8XZ&@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@!&^Z<9Z=J^7O^"MGAWXV>)OV(/%^E_L[S3)XI>W#6
M*02JLF0?X<U]1'&.15=[.WD0JZ+L88*XXH _G^_X)2>%_P#@M?XY^/<GPS_:
MOA\20^ M:T)K&Y.K2P?9U4[02N!G.*_6+_@GG_P2[_9Y_P""?FC7T7P_TE9]
M;U:=YKW5IU)E(;^'=W'7@^M?2C^&K19%FM6\ET& T0P<>F15N&VMT  3D#DD
M=: 'I%$(2!@@C!R/TKX-_P"#ACXRZO\  _\ X)J>-M6TJ$D:S$FFB%#AF+NO
M3'TK[RE 2W.P8^E?F%_P<Q^(#K?[.W@G]G^"X_TWQGXQM(K4;^?E8L1^2&@#
MV'_@WJ\!77PY_P""6WPZTF^TU[>XN;$7$R2+@_,JD?SK[:OHF>,F.0*X'REN
M@/X5YS^S)X#;X7? /P5X#L+:" :9X:M+::WCCV@NL2AF^7OD<GWKBOVX_P!O
M'X0?L7_![5_&WCKQ?IT6H6EE*]EIDTC-)*ZKD9 .[KZ4 ;_[6G[9?P(_8R^'
MTOQ#^.WC*+2K,0,]K&3^\FD49P!G)R<"OQ4B\-?M-?\ !Q=^U9X@TQO%EQI7
MP9T>YCFTJ291")PC(3@;6;.<C)'Z5%X!_9J_:M_X.+/BCIWQ@^/L-SX?^&FC
MZUBWBTHF)WA5@V?]*\W@C@[0.*_<;]E[]ECX0_LJ?"C3/A1\(]!2RT[3;80J
MZQJKS8/+.5 W'- '/_L;_L=_!K]CWX>VG@/X8^'X8Y$LTBO[\D&2=XP%))."
M>_.*]HABP<L. >!Z4D%JD0*!>^<GFI>%&#0 M%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?B3_ ,'<^KW8N/@=I,=N)(9?&2>9'C.[$D?7
MUK]AOV>E9?@)X)5EQCPCIN!Z?Z+'7Y$?\'2FE:9KWQ]_9J\/^(=1DMK.Z\;$
M3LAP& *$9]>:_87X1VMO9?"SPW:6CEHHM!LTB)'55@0#]!0!T+$ $DU!=P)<
M0F*;/'(V]ZDNV"VSL5W87IG&:XWXL?%S0_@_\*M9^*'C75+>SL]#TY[R\DE+
M8C15).2#[4[ ?GK_ ,'.G[=^J_LB_L*GX=> M1GL_%7Q"OCI]C+%#O,=DNS[
M23M/!\MVVDCK6A_P;)_\$\=;_8O_ &,Y_B/\2;:+_A*_B7=C6+E_/#NELRJ(
MU;CC.P/C_:K\POV-;KXM_P#!?K_@L%;>-?CC'<7O@7PGJ4FH7%@I/V.&&%B\
M,(63(/F%"K =01FOZ5_#>FZ3HVFV^@Z'$MM9V=FD5K:1J%6.-,*N!U  &/3B
MAJP&B$4# 4#/H*X/X_\ QD\ ? 3X7ZS\7?BKXHM]'\-Z%9RS:C?S9_<D#Y3C
MOWKO?D@B+._;J:^#_P#@N7J9^*?[/^F_L7>'+J%O$/Q7OTT_3[0L/,GBZ2,.
M^T;ESV^84@(/^"37PPTW]GS]F#X@?M9^(?%%KJT7COQ-J'BV#6T<DR::T<9C
MW9ZM\C]:^2O^#;'X>^+OCU^U%\>O^"@OC>WFO;K6/$TNCZ3/<$KF%&4AU[$;
M6(_"O0/^"\WQ9O?^"='_  28\#_LA_ B[EL]2\2*OAK3%A)$KI$L8E4%>>1,
M!7US_P $:/V.[7]C_P#8(\"_#NXW1ZM=:=]OUF4<&>>8E\MZX4KU]* /K")&
MBC5O+PQ'S$G.*G'3K4<$"Q#AR:DH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ I&16&UAD4M% ";%P!CITH902&QS2TV8N
M$/ECD\?2@".Z(EMY(XG^8#M7XP?\%P8_B1\:O^"G_P"S[\#?#=M-/;Z+KT>H
M70&2BKY<AR?^^Z_8N]OX--CDN[B988(XVEGN7;&%7)/7Z5_.K^WE_P %"_VF
MO'7_  5INO'/[,'AJ]U?3_#NI1:/%>Q6"R[&RBLRD(W0!NM 'ZV_MH_\%3/@
MQ^RGK5]\ =!U&/4/B#%I)FT[2H6W/(V -NT<]6%?G[^R]_P2K_;$_P""FO[0
M=Q^U!^W?XCU&U\)2R[]*\.W8;RRI).PJ_;&!7WE\&_\ @E)\$?%_Q^T#]O[X
MLS:A=^/KW2(7O[:_C8Q^9M0GY,[>H_NBOM/1--BT\F.V2""VSB*UMXPJK^ H
M YKX,_ SX=_ 7P19_#OX;>&;;3=.L;8(T5K$$$F.Y KMHD01@#ICBG"- 2P'
M)&#2@ < 4 )M4'<!S2D ]1110 4444 %%%% !1139'V '('U- #NG6F*S/\
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MI"+:N!^V'_!#_P#X)M> ?V"/V-_#^F1:+:MXK\0VRZCXDU8J&=FD4#R@_4J
MN?\ @1K[3TM)X[B2VD@Q$BXBE_O#.<?K7DW[$_P<UC]G?]GSP]\"?$_Q)N?%
MMWX7LA;OKETR#=CHI(Y/X@&O7+CS5MLIOW !\P+NSST&?:IEHP)+L*?W3R8
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MU $HOAL,TJNB@X"XY)KS[]H;]J+X3?LQ?#__ (6;\9O$8TC2#<I"L\JX^<D
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M "_E0!^M%M9%9#</*65NH9 "?R%2I:L+GSW88_A &*?;1"-3\[-EBWS'IFI
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MMU:2&6$.0PR>C=JEKF/@[\1O#GQ:^'FG?$/PG?K<V&JPB>"5#D$, <#VKIZ
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M]FCP%^S#;:>DMQXM\0#7/.:0J2EB/*9"!_>-T#CVJTFP.W_X-.OV;=.^'/[
M-Q\:;W2K:/5?&.NW$QO858&YLU2,P[L]PS2<CUK]6H@ PQQD9(]:^9?^"._P
MAO\ X&_\$TOA!\,-=MTAO].\'VZ7NQ NZ0@DD^_2OIM1&7WALG&*&K,!]%%%
M( HHHH **** "BBB@ IKIN_$8-.HH @MK""U),* 9//)J>BB@ HHHH ****
M"BBB@ HHHH **1LXX_6F?:$;E7&!UR* )*K7\\D0R& 4??YP<?6I$NXV?874
M$\KSUKY&_P""BO\ P6(_90_X)_\ @1?$'C;Q3%KFJ3W20P^'](:.2X8E@O*M
M*GKVS]* /I;Q'XW\,^ ]!NO%WBKQ?;6VFVT#RS7%W.D21JJDGYG8#H*_.7_@
MH?\ \%N=&T?6_#W[/'[&%TGBKQ'XUA8VFMZ)>13K;@#F,^66PW;\#7RG^TK\
M=/\ @HA_P6F^)NB_#[X">'=3\-?"R:YB74Y8H4") ZACO=%8J_/K_C7Z(?\
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M\_9/\'?!3]K*XM]7USPUJTTUK=:9<RLC12.[&-7+)\IR.@'2O;_B%_P;Q_\
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M.$G)S_$O:OPX_P"#C+1M9_;;_P""R/P6_81\-:]'%>6]O&GF A@AO6@D"_\
MD(U]G^-_^#D7]DGPQ_P4%3]DB4B[\*(B1WGC<,C64,C1"5P6\SG9)F,\<-Q7
MP'^QE?S?\%*_^#GG6_CCX5U(W6@>#-7NK^QU*,_NY+.SG5(=I]65\C'H:TBF
ME=@?T1?#KPQ8>%O!&E^';(AHK*RCAC(&!A5 K;6-4.0*KZ/%#!8)#!%L5. G
M/R^W-6JAN[N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^.'_  52_8>^!/PDD^-6O?'#2[W3I;3SK>'3+GS9Y^G$: C<?:OP._X+"_\
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M+Q9;E"2QMGE@9P3UW$$Y]Z_72$!6.T@KVQ1)I@?AS_P=>_L^^(OA1X_^%?\
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M%/&/:OO?]HW_ (-!9IK*;7?V<?VBHS<Q%VCTS4["6X!/]W>\IV_E7[0? ?\
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M'* ;L]>M?@Y_P='?\$UM8^'?CFU_X*._ ;0+N?4;N\@;Q6;&,M)#/"RM'<C
M. ,)D^BFOWK9,N' SBN3^*GPE\,?%[P)K?P[\<:5'?Z5KUA+:W=K,,A0Z%<C
MWYIQU>H'YJ?\$6O^"[OP=_:;_9HMO"_[0OQ&L/#GC/P=9+;7L^L:A%#_ &G$
MH !4.RY.T@\>E?"G_!:W]NF+_@K3^VE\.OV0/V3II]5T?2M9-O*ZCS$EF21
MTORY^5<,-W/WJ\V_:U_X-H/^"A'P^_:'UNT^ 7P^T_7_  U<:G+<:%J"ZQ#
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M,JC<(VD0!OS)_*OV,^'^@?\ "+>!M'\->9O&GZ5;VP;&,^7$J9_2@#8HHHH
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MALDF5<3D,X/S-C&>*Q?A1X,T?X=_#W2O!'A^VBBL=+M$M[5(4VJ$4 #BNBH
M**** "BBB@ HHHH **** /P0_P""RVGZCKW_  <#_ W2]*OY!)'J>F.ZDGY%
M^VG)'Y&OWHTZ)H+5(F<MM4#<>IK\4?VP/ UY\4/^#GSX=^'I$#P:9X7AOUS_
M -,I;A\_^.5^V<?&0.F>* '4444 %%%% !1110 4444 %%%% !1110 4444
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M ?G[\"/B%XM^*O\ P5J^*7C#7X\^%/ASH2VEO</'_JV$,<KE2>AP[=*^ O\
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M4 -* @+D\=Z F!@,?QIU% " $'ELTI /4444K( HHHI@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 9Q1G_ #BH9GE$A"$8 R:?"[2+
MNW CVH ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2UB]%G;
MMC[S# -2:7N-HCL<$C.*G>))/]8@8=@10%(.21@= !0 ZBBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+"BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>image_11a.jpg
<TEXT>
begin 644 image_11a.jpg
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M?TEF#@#OC/ 00F%&CQ@A'_5Z3Y]9P[KUI7S)4AH.X_?WGU*-DQ_>'P4>*/0
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MSKL*VLN7+I,MFS9K/"T0=[W3*J\A&_@$6#C&!"(G3YRH-=/C79O+I=?" =E
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M#LC&RQK7;:^#QK3C\5V\<)%6;SG@S+'$MH:J2('L2Q<O:OSOC&G3M#0<E:B
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M?\5*4JI0$<F=+;M.>'X/_&@W@VQO99 =F3+(CEW(IKP>SIQ"=^=1(&&.J?-
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M-E *=<TVBV\=6[>1]]YY5]_AQO4;U,D5J@RRO5/4039>U W.HO/U].DR>,
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M@6P\P\P9Q$]3NYDD1^HW4[IPU/ 1&GY!.$6H,LA.V*B\4J88'8,;:#@.X8U
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3+9U<! 16(     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>image_12a.jpg
<TEXT>
begin 644 image_12a.jpg
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'14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>image_1a.jpg
<TEXT>
begin 644 image_1a.jpg
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M?TEF#@#OC/ 00F%&CQ@A'_5Z3Y]9P[KUI7S)4AH.X_?WGU*-DQ_>'P4>*/0
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MSKL*VLN7+I,MFS9K/"T0=[W3*J\A&_@$6#C&!"(G3YRH-=/C79O+I=?" =E
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M#LC&RQK7;:^#QK3C\5V\<)%6;SG@S+'$MH:J2('L2Q<O:OSOC&G3M#0<E:B
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M?\5*4JI0$<F=+;M.>'X/_&@W@VQO99 =F3+(CEW(IKP>SIQ"=^=1(&&.J?-
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M-E *=<TVBV\=6[>1]]YY5]_AQO4;U,D5J@RRO5/4039>U W.HO/U].DR>,
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M@6P\P\P9Q$]3NYDD1^HW4[IPU/ 1&GY!.$6H,LA.V*B\4J88'8,;:#@.X8U
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3+9U<! 16(     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>syk-20211231_g1.jpg
<TEXT>
begin 644 syk-20211231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_[@ .061O8F4 9      !_^$-M$5X:68
M $U- "H    (  <!$@ #     0 !   !&@ %     0   &(!&P %     0
M &H!*  #     0 "   !,0 "    )    '(!,@ "    %    ):':0 $
M 0   *H   $N  K\@   )Q  "OR    G$$%D;V)E(%!H;W1O<VAO<"!#0R R
M,#$U("A-86-I;G1O<V@I #(P,34Z,#DZ,C@@,3$Z-3DZ,S<   >0 P "
M%    020!  "    %    1B2D0 "     S P  "2D@ "     S P  "@ 0 #
M     ?__  "@ @ $     0   N2@ P $     0   ,@     ,C Q-3HP-SHQ
M-B Q,CHP,3HP,  R,#$U.C W.C$V(#$R.C Q.C P      8! P #     0 &
M   !&@ %     0   7P!&P %     0   80!*  #     0 "   " 0 $
M 0   8P" @ $     0  #"          2     $   !(     ?_8_^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  K * # 2(  A$! Q$!_]T
M!  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$!
M 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2
M,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D23
M5&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&
MUN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A
M<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C
M%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W
M1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U5)5NI9^/TWI^1U#))%&+6ZVR(DA@
MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\
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M68,&.$))300Z      #E    $     $       MP<FEN=$]U='!U=     4
M    4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR;0    ]P
M<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0    !
M   /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P!F "  4P!E '0
M=0!P       *<')O;V93971U<     $     0FQT;F5N=6T    ,8G5I;'1I
M;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT    0     0
M$G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;VP      $-L8G)B
M;V]L      !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L
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M8W)O<%)E8W1";W1T;VUL;VYG          QC<F]P4F5C=$QE9G1L;VYG
M      UC<F]P4F5C=%)I9VAT;&]N9P         +8W)O<%)E8W14;W!L;VYG
M       X0DE- ^T      !  2     $  0!(     0 !.$))300F       .
M             #^    X0DE-! T       0    >.$))3009       $
M'CA"24T#\P      "0           0 X0DE-)Q        H  0         !
M.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M   ! #(    ! %H    &       ! #4    ! "T    &       !.$))30/X
M      !P  #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M  #_____________________________ ^@  #A"24T$"       $     $
M  )    "0      X0DE-!!X       0     .$))300:      -=    !@
M            R    N0    4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #(
M,  Q #4 7P!W &4 8@    $                          0
M   "Y    ,@                      0                         0
M     0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T
M,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M
M;&]N9P   ,@     4F=H=&QO;F<   +D    !G-L:6-E<U9L3',    !3V)J
M8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<         !V=R
M;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@
M  UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y<&4
M26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   #(     %)G
M:'1L;VYG   "Y     -U<FQ415A4     0       &YU;&Q415A4     0
M     $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L
M;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R
M>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV
M97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT
M"V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M  QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<
M #A"24T$*       #     (_\        #A"24T$$0       0$ .$))3004
M       $     SA"24T$#      ,/     $   "@    *P   >   %"@   ,
M(  8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(
M" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1
M$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\  $0@ *P"@
M P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,  0($!08'
M" D*"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $# @0"!0<&
M" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3
M\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2E
MM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%
M-0$  A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,58W,T\24&
M%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]525;J6?C]-Z
M?D=0R211BUNMLB)(8-VUFXM][OHL7BV9_C5^NW4<UQZ8\8E6IKQ:*67$-!T]
M1]]5S['M;]-[/2K_ ."K24^Y)+PG_G]_C._[D7_^P=/_ +RI?\_O\9W_ '(O
M_P#8.G_WE24[WUD^O'UHP?K^_H^+F^G@#)QJQ3Z51]MC:'6-]1]3K?=ZC_\
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MSGL=^]753L=_QZL?X\OZ1T?^ID?EH24^>=3ZSG]39B593YIP*&8V+4T0QC&
M-W;?]+<YN^ZS\_\ XME5;/</\7E_1J_J5CW])KVLK8YV6R0;#DM'ZSZSF_GO
MVM]+=_VF^SK%Z-]0>F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\
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M &\ <P!H &\ <    !< 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '
M( !# $, (  R #  ,0 U     0 X0DE-! 8       < "     $! /_A#ZUH
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB
M[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^#0H\>#IX;7!M
M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!8
M35 @0V]R92 U+C8M8S V-R W.2XQ-3<W-#<L(#(P,34O,#,O,S M,C,Z-# Z
M-#(@(" @(" @("(^#0H)/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W
M+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX-"@D)/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+VUM+R(@>&UL;G,Z<W12968](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.G-T
M179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V5%=F5N=",B('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(@>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C O(B!X;7 Z0W)E871O<E1O;VP](D%D;V)E(%!H;W1O
M<VAO<"!#0R R,#$U("A-86-I;G1O<V@I(B!X;7 Z0W)E871E1&%T93TB,C Q
M-2TP-RTQ-E0Q,CHP,3HP,"(@>&UP.DUO9&EF>41A=&4](C(P,34M,#DM,CA4
M,3$Z-3DZ,S<M,#0Z,# B('AM<#I-971A9&%T841A=&4](C(P,34M,#DM,CA4
M,3$Z-3DZ,S<M,#0Z,# B('AM<$U-.DEN<W1A;F-E240](GAM<"YI:60Z839D
M.&4P8S,M-3DR-"TT-#AC+3DR-V4M-#(V,&1D83,Q,F0W(B!X;7!-33I$;V-U
M;65N=$E$/2)A9&]B93ID;V-I9#IP:&]T;W-H;W Z-3$U-C$Y-#@M838X."TQ
M,3<X+3EF.&4M83DQ9&8Y9C)B9F5E(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240](GAM<"YD:60Z,D4Y,SA%034R,S S,3%%-4%".#1"-D8P,D4R-S$X14,B
M(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&AO=&]S:&]P.D-O;&]R36]D93TB
M,R(^#0H)"0D\>&UP34TZ1&5R:79E9$9R;VT@<W12968Z:6YS=&%N8V5)1#TB
M>&UP+FEI9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B
M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z,D4Y,SA%034R,S S,3%%-4%"
M.#1"-D8P,D4R-S$X14,B('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP
M+F1I9#HR13DS.$5!-3(S,#,Q,44U04(X-$(V1C R13(W,3A%0R(O/@T*"0D)
M/'AM<$U-.DAI<W1O<GD^#0H)"0D)/')D9CI397$^#0H)"0D)"3QR9&8Z;&D@
M<W1%=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI
M9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B('-T179T
M.G=H96X](C(P,34M,#DM,CA4,3$Z-3DZ,S<M,#0Z,# B('-T179T.G-O9G1W
M87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#0R R,#$U("A-86-I;G1O<V@I
M(B!S=$5V=#IC:&%N9V5D/2(O(B\^#0H)"0D)"3QR9&8Z;&D@<W1%=G0Z86-T
M:6]N/2)C;VYV97)T960B('-T179T.G!A<F%M971E<G,](F9R;VT@:6UA9V4O
M<&YG('1O(&EM86=E+VIP96<B+SX-"@D)"0D)/')D9CIL:2!S=$5V=#IA8W1I
M;VX](F1E<FEV960B('-T179T.G!A<F%M971E<G,](F-O;G9E<G1E9"!F<F]M
M(&EM86=E+W!N9R!T;R!I;6%G92]J<&5G(B\^#0H)"0D)"3QR9&8Z;&D@<W1%
M=G0Z86-T:6]N/2)S879E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#IA
M-F0X93!C,RTU.3(T+30T.&,M.3(W92TT,C8P9&1A,S$R9#<B('-T179T.G=H
M96X](C(P,34M,#DM,CA4,3$Z-3DZ,S<M,#0Z,# B('-T179T.G-O9G1W87)E
M06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#0R R,#$U("A-86-I;G1O<V@I(B!S
M=$5V=#IC:&%N9V5D/2(O(B\^#0H)"0D)/"]R9&8Z4V5Q/@T*"0D)/"]X;7!-
M33I(:7-T;W)Y/@T*"0D\+W)D9CI$97-C<FEP=&EO;CX-"@D\+W)D9CI21$8^
M#0H\+W@Z>&UP;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0]
M)W<G/S[_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$" @(" @(" @(" @,# P,# P,# P/_VP!# 0$! 0$! 0$! 0$"
M @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P/_P  1" #( N0# 1$  A$! Q$!_\0 'P    8" P$
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M6[R[1[QWA/+/)%F.R=Y9O=!QB5#ZWHL!0Y&KEQFV\2G BHL?#34D* +'&J@
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M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\
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M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\
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M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\
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M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\
M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9'
MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%"
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MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\
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M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\
MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_-
M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\
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M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\
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M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\
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MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U
MZ<^6_P 5>P<7&[_;5'8M'VSU/E:B(,=!;&;=V7W#003NG.@US(&XUD<^_=>Z
M!'_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[
M]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_
M .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U'JO^$9'\V.GIY9H>Q?A
M1721HS)24O;W:R5$[ 7$<35O0E'2!V^@\DJ+_4CW[KW5$?SU_EC?-7^6GOC#
M[)^773>3V"FZDK9MC;WQF1QF[.MM^P8XQ"O.U=[[?J:W#U.0H%J(GJ<=4-39
M6DCFB>>FB66,M[KW1!O?NO=>]^Z]U[W[KW7V@OY#7R1R/RK_ )1OP>[6SM?)
MDMT4?4<?5&ZZRIF\V0K-P=%[@S?357E,JY)=LEGX-C19&1F]4GW@D_M>_=>Z
MUJ/^%Q__ !X7\M__ ,._Y1?^Z;HCW[KW7SU/?NO=>]^Z]U=]_P )O?\ M]K\
M"/\ Q('8/_OD.T/?NO=?8Z]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SH_P#A<%_S
M/WX#?^(?[H_][39GOW7NM&/W[KW7O?NO=7W?\)A/^WYWP5_[6'R#_P#@4>]O
M?NO=?8*]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=46_
M\*0OBC_LVG\H+Y4X+&XW^([SZ3P-!\FMB:8?N)Z;)=)RS;AW>U' H,L]=DNI
MIMQT$*1_N-)6  -^AO=>Z^.S[]U[KWOW7NO>_=>Z^RQ_*2^=>V.UOY)_QU^8
M?86;\M'U!\7,Y!W3EI9D:OBR?Q9PN=V;V)F\IY6 @KLU3]<S9?U:5:*M2061
MU]^Z]U\?/NGM7<_>W<7:_=V]I_N=Y=Q=D[Y[2W94!VD$VY-_[GRFZ\Y(LC@.
MZ-DLM*02 ;>_=>Z#/W[KW7O?NO=?2F_X17?%+^X/P_\ DC\O,WC?!F_D-VWC
M>M=GU51%JDDZZZ/Q=0U3DL;.1^U1YKL#?65HZA5(\DN"C+7T);W7NMU+W[KW
M7O?NO=>]^Z]U\#;L'_C_ '>__AW[E_\ =S6^_=>Z2'OW7NO>_=>Z][]U[K;_
M /\ A+]_(Q_V=3LO&_.[Y2[/-1\3.G-SWZNV7N&AOC/D/VSMVK#%JNBJD\>7
MZGZWR<(;)ZE-)F,Q&F-/GAI\I ONO='._P"%CG\K@;?W%LS^:/U#MP1X?=<F
MWNH_E52XNDTQT.YZ6EBQ'4G;%>L*,5AS^+I4VODJAS'%'4T>'10TM7(WOW7N
MM#+W[KW7O?NO=98)YZ6>&IIII:>IIY8YZ>H@D>&>">%Q)%-#+&5DBEBD4,K*
M05(N.??NO=?8@_X3W?S/H/YG'P!V9N?>><BR'R2Z&_AO3GR+I99D.4R^X\3C
M5.TNTIH;K(U)VMMFF6NFF$<<!SD&4IX1HI??NO=7I^_=>ZU<_P#A7KT-5=N_
MRA,[O_'4355=\:^^^H^X*F2"(R528#-39WI7,( H,AHHYNV*:JJ  55*02-9
M8RP]U[KY2?OW7NO>_=>Z][]U[KZ:'\E[^3?_ "0/Y@7\M7XO?(O<'PXVQNKM
M"OV+3[#[RR*=S_(:@KI.ZNMW.T=_9'+X?"]P4&+P=9NW(8U,_%2T]/3TZ466
M@:&)(7C4>Z]U:3_T#+?R.?\ O!' ?^CN^3?_ -NKW[KW4.7_ (3$?R,IG,C_
M  4Q@9K7$7?WRJITX  M%!WG'$O YL!<^_=>ZQ_] P?\C#_O!6@_]*%^6'_V
M]O?NO=>_Z!@_Y&'_ '@K0?\ I0ORP_\ M[>_=>Z]_P! P?\ (P_[P5H/_2A?
MEA_]O;W[KW7O^@8/^1A_W@K0?^E"_+#_ .WM[]U[KW_0,'_(P_[P5H/_ $H7
MY8?_ &]O?NO=>_Z!@_Y&'_>"M!_Z4+\L/_M[>_=>Z]_T#!_R,/\ O!6@_P#2
MA?EA_P#;V]^Z]TM>M?\ A./_ "8.H>Q=@]L]>_"O&X'?_5^]=J]B;'SDG>/R
M8S<>&WALK.T&Y=LY:3#;@[GRN!RZ8[-8R"8TM=2U-'4!-$T4D;,A]U[J[KW[
MKW7R=/\ A7+_ -OF^S/_ !"'0G_O&^_=>ZUDO?NO=>]^Z]UN.?\ "*'_ +>2
M_)7_ ,4?W?\ ^_YZ ]^Z]U]-SW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W
M[KW7O?NO=>]^Z]U__];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5,?\ PH*^-.PODU_*(^:^
M(WMC<?45_3W3.\?DCL#-54,35VV-\=#X#)=@TE=A:F12U'69W!8BOP<Q6S2T
M.5GA_P!V>_=>Z^-'[]U[KWOW7NO>_=>Z^J[_ ,(]LY69;^3[24%2\C0[8^3O
M=V#QRN&"QT=12;(W*Z1$@!HSD-PSM<7&IB/J"/?NO=5F?\+CR/[A?RWQ<7.[
MOE$0/R0,-T/<V_H+C_;^_=>Z^>K[]U[KWOW7NKO/^$W[I'_.S^ [.ZHI["WZ
M@+L%!>3I+LZ.- 20-4DC!5'U)( Y]^Z]U]CSW[KW7O?NO=>]^Z]U[W[KW7O?
MNO=?.C_X7!?\S]^ W_B'^Z/_ 'M-F>_=>ZT8_?NO=>]^Z]U?=_PF$_[?G?!7
M_M8?(/\ ^!1[V]^Z]U]@KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7
MO?NO=>]^Z]TU9W!XC<^$S.V]P8^ER^!W#BLA@\WBJV,3463Q&6I)J#)8^KB/
M$M+6T=0\<BG]2,1[]U[KX8?SA^-N7^'GS"^2WQ?S*U1FZ.[HW]U]C:RL!6?,
M;8PNX*R/9VX[$*3#N?:;T61B) )BJE) )M[]U[HK'OW7NO>_=>ZV/OA?_-!_
MT'_\)^OYF?PEGW%]COKL3NSI_ ]1TTU5>KJMH_(RAJJ3O/'8ZG#>4X7&['Z#
MKXZA1IBCJMSJYU&1E/NO=:X/OW7NO>_=>ZYQQR32)%$CRRRNL<<<:L\DDCL%
M1$106=W8@  7)]^Z]U]O_P#E<_%:/X3_ ,O3XB?&*2@CQV=ZPZ5VI#ONFB18
MT_TH[I@DWOVM.JJ+Z*KLC<N4E75=M+BY)N??NO='V]^Z]U[W[KW7O?NO=? V
M[!_X_P!WO_X=^Y?_ '<UOOW7NDA[]U[KWOW7NKI/Y('\H3L3^;9\J:+9+KF-
MJ_&GJR?$;H^2?:=##XWQ&V9ZF5L;U_M2LGAEHG[&[%>AFIL>'$BT%+%59"2.
M9*3[>?W7NOL)]4=5==]&]:;&Z=ZDVCAMA=9=:[8Q&S=C[.P%-]KB=O[<P=)'
M18['TL99Y9#'#$#)-*\D]1*S2RN\CLY]U[I*_(_X_P#6?RKZ'[9^./<F$3</
M67<VQL]L+=^-_;6J7'9NC>"/*8FHEBF&/S^!K1%78ZK53)1U]-#.EGC4CW7N
MOB5?.[X==F? 3Y:=V_$SMB!FW1U#O"KP]'G$I9*3'[UV?6QQ9;8V_L-%(TA7
M$;TVE7T>1A0NST_W!ADM+%(H]U[HH_OW7NO>_=>ZN^_D _S.JK^6'\_MB[ZW
M9F:BC^.?='V/3OR/H6DD./H-F9S)0G ]E/3 NGW_ %3N5XLHTJQR5+8@Y&DA
MLU83[]U[K[&=+54M=2TU=0U-/64593PU5'64LT=12U5+41K-3U--40L\4]//
M$X9'4E64@@D'W[KW1?OEQ\>-L_+;XO?(#XR;O:*' =[=1;\ZQJLA+!]P<)5;
MLV[78O$[DIXKC57[9R\\&0IB.5J*9"/I[]U[KX9/:'6^\>F^RNP>H^Q,//M[
M?W5V]MT]>;VP-4"*C#;LV9G*[;NX<9-J527H<MCI8R;"^F_OW7ND+[]U[KWO
MW7NME/\ X3C?SLU_E9]]9KJ?O2ORE5\+OD+F<4>PWI(JO)U'3?8<$46(PW<^
M'Q%.)IZW%-C5CH-STE+&:RKQD%-40K//C8*2H]U[KZP&S=Y;2[$VGMO?FPMS
M8'>>R=XX3&[DVGNW:^5HL[MS<FW\Q215V*S6#S.-FJ:#)XO(T<R2PSPR/'(C
M J2#[]U[I2^_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z^3I_PKE_[?-]F?^(0Z$_\ >-]^Z]UK)>_=>Z][]U[K<<_X10_]O)?D
MK_XH_N__ -_ST![]U[KZ;GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N
MO>_=>Z][]U[K_]??X]^Z]TVY3,X?!TZ5>:RN-P]+),M/'4Y2NI<?3O4.DDJ0
M)-5RPQM,T<+L%!U%5)M8'W[KW3#_ *0]@?\ /<;/_P#0FPO_ -6^_=>Z]_I#
MV!_SW&S_ /T)L+_]6^_=>Z]_I#V!_P ]QL__ -";"_\ U;[]U[KW^D/8'_/<
M;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\ T)L+_P#5OOW7NO?Z0]@?\]QL_P#]
M";"__5OOW7NO?Z0]@?\ /<;/_P#0FPO_ -6^_=>Z]_I#V!_SW&S_ /T)L+_]
M6^_=>Z]_I#V!_P ]QL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[
MKW^D/8'_ #W&S_\ T)L+_P#5OOW7NL-1V5US2PRU-5O_ &334\*&2:>HW5@H
M88HU%V>662O5(T4?4D@#W[KW6G5_PIU_GH_&7;/Q%[,^ _Q;[;V?W1WM\@*2
MGV3VKF^LMP8[=FT.GNJQD:6MWEC<WNW"5%=M^LWSO>EH3@QAH)IJBBH*NLJ*
MS[61:-*KW7NOFI>_=>Z][]U[KWOW7NOK._\ "2KKVMV3_)>Z?S]9 \"]K]N]
M]=A4>M=+345+V!7=:QSZ2 P267KMRA/ZDLP])'OW7NJO/^%P6S*VNZ$^ O8<
M<#-CMK]O=U;,JJG1=8JW?FS-E9R@@,NGT-40=<5+!;C5XB;'3Q[KW7SI??NO
M=>]^Z]T8'XI?(W?7Q"^2G1_R>ZU%++O?HOLO:G9&#H<@95QF:?;F4@K*[;F7
M,!%1_!MS8Q9L?6>,K)]K4R:&5K$>Z]U]=3X*?S^/Y9'SLV%MS.;=^277'2G9
M]?CJ0[GZ*[\WEM_K#?\ MO<#PHU?AL//NRLPV![&HJ>4EH:_ 5%;%) 5:5*>
M7R01>Z]U;%C>VNJLS3K5X?LSK[*TKHDB5.-WGMRNIWCD%XW6:ER4L;(X%P0;
M'\>_=>Z<?](>P/\ GN-G_P#H387_ .K??NO=>_TA[ _Y[C9__H387_ZM]^Z]
MTI:'(4&4I(:_&5M)D:&H#F"MH:F&KI)Q'(T3F&HIWDAD"2HRG239@1]1[]U[
MKYUW_"X+_F?OP&_\0_W1_P"]ILSW[KW6C'[]U[KWOW7NK[O^$PG_ &_.^"O_
M &L/D'_\"CWM[]U[K[!7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>
M_=>Z][]U[KWOW7NOE^_\+*?BC_HA_F+=<?)O#XW[;;?RXZ9QLV9KEBT)6]J]
M'''[ W.NI (V\77-9LYKGUL[N3Q8GW7NM0GW[KW7O?NO=>]^Z]U[W[KW7O?N
MO=6V?R+/BE_LY/\ -:^&O4%?C?XGM#&=J8_MSL6&:'RXZ3872E/4=HYW&9;T
ML$Q^Z6VO#A2>"TN21006!'NO=?:,]^Z]U[W[KW7O?NO=>]^Z]U\#;L'_ (_W
M>_\ X=^Y?_=S6^_=>Z2'OW7NO>_=>Z^L_P#\)+-M;>PG\ESI;,8?!XG%Y7>'
M:G?N<W7DJ#'TM)7;DS%#VEN#:]%E,Y501)/E*^DVY@*&@BEF9W2DI(8@0D:@
M>Z]ULL^_=>Z][]U[K3,_X5\_RN?]F"^-VW_YAO4VW?NNW/BOB?[O]T4^,I=>
M0W=\<LADIJL9VH6%))ZNIZ:W1DI:_@*L6$RN3GF?11Q*/=>Z^9U[]U[KWOW7
MNO>_=>Z^IU_PD]_FB?[./\+Y/B/VEN+[_P"07POQ>%VSC)<C5>3*[Y^.U0?X
M=UMN%#*RRUM5U[)"=L5_C5A!24^*EF=IJX^_=>ZVOO?NO=?- _X6"?RR:[HW
MY-[=_F(=9;>=>I/E%-0[5[D..I2*':'R%V[A?#1Y2L$02"CI.V]E8=:J,JI,
MN8P^3FF?R540;W7NM,;W[KW7O?NO=>]^Z]U>#_*B_GY?-G^5+74^S]C9:C[I
M^,]7DY<AG_C=V9D<@=LT<U;4?<9/*]8;FIUJLQU9N*N=I'D:DCJL14SRM-68
MVJF".GNO=;^?PN_X50?RHOE;C,3C^PNU,A\0.S:N."/(;+^1%$V&VJE:0%JG
MQ'<>&3(];S8:&4@1SY>KP=7*AU&D2S!?=>ZO1V+\G_C3VCCJ?,=9_(?HSL7$
MU:1R4N4V+VUL'=V.J8Y0&BDIZW;^X,A33)(I!4JQ!!X]^Z]T(?\ I#V!_P ]
MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\
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MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$<O\
M-%_OEL/>7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D
M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O
M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI<K31H0\%7!
M1UE+[KW7R1OYCG\L+Y8_RO.ZJOJ#Y+['FI,;D:BOFZT[;V]%6Y#JOMS 4<B
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MY961F5E*LI*LK AE8&Q5@;$$$<CW[KW77OW7NO>_=>Z][]U[KWOW7NOL,_\
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M?]K#Y*__  5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\
MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U
M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O
MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW>
M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_]
MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\
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M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\
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JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>syk-20211231_g2.jpg
<TEXT>
begin 644 syk-20211231_g2.jpg
M_]C_X  02D9)1@ ! 0$ ;0!N  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (/ ]4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MO/\ Q]\1KGPKJT5G:P0S9CWN9,Y&3QTJ3X?_ !$G\6:A<6EW#% Z('C\LGYN
M>1S7QZXKRJ69_P!D<[]M?EV=KVO:^W_!/5_LO$K#?6K>Y:^YWE%,ED6&-Y'.
MU%!8GT KR&[^-5^MU,L%I;M"'8(S9R5SP>M=6=<1Y?P^H/'3:Y[VLK[;_F9X
M/+Z^.YO8J]CV&BLKPOK#:]H%E?NJH\R;F5>@/I7CGC?Q=K*>*[Y%NYK5+>4I
M'&AP HZ'WS7GYYQ7A,DP%''R@YQJVY;::-7N[^1O@\LJXRO.@FDX[_?8]XHK
M-\-WDVH:!I]S<#$\L".^1C)('-:5?7T*T<12A6AM))KYJYY4XNG)P?0****W
M("BBB@ HKP3QEXQUK_A)KQ1>36BP2%8XD.T*!T/OZ\U['X1U"YU3PWI]U=KM
MN)(@7XQD^N*^'R7BS"YYCJ^ HTY1=*^KV=G9^FO1GLXS*ZF#HPKSDFI?Y7-B
MBBBON#Q@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFQ_^2:]NHH \1_X:+\1?]$/^(7_?FQ_^2:/^&B_$7_1#_B%_WYL?_DFO;J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR])K5\[3Z,IPRGV(!J_X@\'Z%XJTZ>PUC1[+4[.9#')#=0*ZE2,$<CBOS/\
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M21(8VDD94C4%F9C@ #J2:^6_BA_P4:^%/P_UR;0M(?4_'6N0L4>U\.6WGHC
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MR*'Q=X+\7>#H96"B\O;#,*Y/5B2IQ] 3[5]:>"O'GAWXC:%!K/AG6+36],F
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MK,*%A2(-P"R*KD^K?B?J?4?#VEZO9O:7VFVEW:NI5H9H5="",$8(H Y3X/\
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M>+;VVDM&UJVO+Z&"08*0N"8Q]-N*_0G]IGP1)\1_@#X[\.0IYD]]I4R1KWW
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M>"?^NNH?^EL]?3] /<^'?^"NO_)N>@_]C%#_ .D]Q7UW\,?^2<^&?^P=;_\
MHL5\B?\ !77_ )-ST'_L8H?_ $GN*^N_AC_R3GPS_P!@ZW_]%B@.A^7GQIUS
MQ+9_\%.=3U7PUX9'C#7]-FMY+/2'F\H2>7:QJ#N[8'-?47_#3'[3G_1N$?\
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M!:_.[_@E?JD.F_$/X[>'[AO+U%M52Y6%N&*1S7".<>QD3\Z_1&@&>2_M:?\
M)L_Q,_[ -U_Z :\6_P""5O\ R:S#_P!A:Z_]EKM/^"A'CR#P/^RKXS5V_P!(
MUB :3;J#\Q:8[<@>PS7&?\$K_P#DUN'_ +"]U_[+0'0^F_B=X L/BG\/M?\
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M9_\ HT4 MSWO]FE0O[.GPN &!_PB^F?^DL=>DUYO^S7_ ,FZ_"[_ +%;2_\
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M*^P_@7\$/#?[/WP]L/"7AFW*6T WSW4@'G7<Q^]+(1U8_D!@# %>@T4 >?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]1?L]_'30OVAOACI?BW1)5!F41WMH3\]I< #S(F'L>A[@@C@UZ50!^>'Q$^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **^3OV6?VL_$GQ^^.OQ
M'\,ZCIECI6C>&_,AMH[<EY)&2X,>]F('4#H..:^L: "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O,OCM\?M"_9^T&PU;7M/U;4;>\N#;
MQII%K]H=6QG+#(P/>O3:CFMXKA0)8DE Y =0?YT ?,_PU_X*"?#KXH?$C1O
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M\!?COX=_:)\"MXK\+QWD6F"[DL]M]$(Y-Z!2> 3Q\X[UZ/7QG_P2?_Y-7?\
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M/B?X,_\ !0_5?$?P:\5^*_%F@6LOB&TU:+1M%T'1MQFU&ZD0E8P#DG!!)(Z
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M -A]?_0&K[[H&SXC_P""N?\ R;#8_P#8?M__ $7+7U9\'?\ DD7@?_L!V/\
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M/"?^"3__ ":NW_8>NO\ T7#7V97QG_P2?_Y-7;_L.W7_ *+AK[,H&]S\[O\
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M<QG\^/QH*/CGX*_L:_%_Q9\)O">LZ-^T/J>AZ7?:=%/;Z;#9RLELC+GRP1.
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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MLO\ Y$H_X4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\
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M_DY3X*_]<=:_]%VU &]_PI+4O^BK>//_  *LO_D2C_A26I?]%6\>?^!5E_\
M(E>HT4 >7?\ "DM2_P"BK>//_ JR_P#D2C_A26I?]%6\>?\ @59?_(E>HT4
M>7?\*2U+_HJWCS_P*LO_ )$H_P"%):E_T5;QY_X%67_R)7J-% 'EW_"DM2_Z
M*MX\_P# JR_^1*/^%):E_P!%6\>?^!5E_P#(E>HT4 >7?\*2U+_HJWCS_P "
MK+_Y$H_X4EJ7_15O'G_@59?_ ")7J-% 'EW_  I+4O\ HJWCS_P*LO\ Y$H_
MX4EJ7_15O'G_ (%67_R)7J-% 'EW_"DM2_Z*MX\_\"K+_P"1*/\ A26I?]%6
M\>?^!5E_\B5ZC10!Y=_PI+4O^BK>//\ P*LO_D2C_A26I?\ 15O'G_@59?\
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M% &S_P *3U+_ **MX\_\"K+_ .1*/^%):E_T5;QY_P"!5E_\B5ZA2T >7?\
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M]:7_ .D,=>W5XC\(_P#DXCXX?]?6E_\ I#'0![=1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5XHG_)YEU_V(EO\ ^E]Q7M=>*)_R>9=?]B);_P#I?<4 >UT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5XA\5O^3E/@K_UQUK_ -%VU>WUXA\5O^3E/@K_ -<=:_\ 1=M0
M![?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %>*_MB?\D US_K\TW_TN@KVJO%?VQ/^2 :Y_P!?FF_^
MET% 'M-+24M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"HYH8[B,QRQK*AY*NH(XY'!J2B@ HHHH **** "BBB@ HHHH **** "BBB@
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M([4 0_\ !,WPGXP7X-^'=:_X3+_BD!+<K_PC?V&/[V,!O.QOZX.,]J\WTO\
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MR[%B)' )&. >!BK^D?&[5O%'[+8^)=E_9^FZQ;Z3)J-[:W,;RPQ20J6FA(#
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M]* /6J*\R'[2'PZ7Q)%H+>)%^VR78T]+C['.+-[GIY(N=GDE\\;=_7CK7IM
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M\#W7@O\ :&^#_AS1O$6G^%-/TGPA-IVCWVK:<MW 9XVC5T16DC E,8C.0V<
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MX6\80#R+B1+6,GR9MVY0\3(HR,9!Q7V=8V-OIEG#:6D$=M:PH(XX8E"JB@8
M '05S>K?"KP?KNM?VOJ'AO3;S4\AC=2VZER1T)/?\: .?_9I\46OC+X"^!M8
MLM";PS9W.F1^3I+9_P!&1<J%&>2N%R,]B*\-\+6'A#Q5_P %!/B!'-_9.I[O
M!MG EOOCD5G,K"4;>[A>#W )KZ[CC6&-4151%& JC  ]*Q['P5H&EZ@M_::/
M96UZI8BXB@59,G(/S8SSD_G0!\O>,(O"O@3]MOX):+ISZ;H]EIOAK4K2&U65
M$$$>S$<?)R!Z USZ>*I+>X^.?PX@LM,N)=;U^[\K5]2U:SM%C-P%+">":59R
ML>2J,D;!E5=O%?7^H>"=!U6\>\NM'LI[UO\ EXD@5I/;YL9KQ'P=X!\7^ ?
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)BB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>syk-20211231_g3.jpg
<TEXT>
begin 644 syk-20211231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** /-_P!L3]H73OV3/V4?B1^TYJFFB^B\
M ^"=3UT6!8K]KDMK9Y4@R.F]U5,]MV:_%_\ X)M?\$9)_P#@O'^S4W_!3/\
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M(XXW)4DS)$ G ; 4\4S_ ((Z?$?Q7_P0U_X*C^*/^"+/[4EAI">#_B)?K?\
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MB\*:;<>+?#=K\7+. 66JS0H9K98I+%W3;*Q4*S,1C!)ZUOW?_!//XU_L'?\
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M1_ #PW#KUZFG3?!J]>6P6Z<0.W]D>)#N*9VDY53G'8>E?G+\5OCU\5?V7_\
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M\#>(/CO8ZSI/C'5?%"WMQ>":ROXY%2X@BA#1!K< +MX(/)[/_P"#2K_@GO\
ML.?M:_\ !/KQU\0?VF_V4? GCO7+#XR7NG66J^*/#L%Y/#:+I.ERK KR*2$#
MRR,%Z9=CWKV7_@[7^$_PS^!G_!%/PE\)O@YX%TOPSX9T3XO:1#I&A:+9K!:V
M<9M-3<I'&H 4;F8X'<F@#S+]MSQ#XH_X)G?\%F?V/O\ @H:OB._M_AY\9?!F
ME>%OB''+>.;1+D6<%A-<2KG:H6WN+&X'&6:RD//(KT/_ (.%_$?B_P#;<_X*
M5_LI_P#!'3X9>)]0M+?7->/B_P"([:3>/%)'IH,D88M&05:.SMM4?:3SYL1X
MR"?8/^"[7[&!_;(_X(,.-#TK[3XD^&G@[2?&WAW8F7_T&R'VQ!CD[K*2ZPHZ
MN(^#@5\P?\&M.E_%_P#X*!?M>?%O_@K]^TR?MVLZ;X7T;X>^'+U@6C>YAL+5
M;V9-WW)/)MK5FQU.H3>IR >#_P#!2#PC^Q7\0O\ @Y1^,'PE_P""@7[4/BKX
M5_"BQ\#:++I^H>%]=>R\N_30M($%NH$$ZA61IB0(Q]T?,._V?_P1S_9(_P""
M%_AK]MG3?B!_P3[_ ."BWQ(^)WQ!\.:!J%VGAC7O%OVJT-E)&+2::2(Z=!NV
M_:4QAP0S*<$ U\A_MU_M(_L%?LL?\'2OQJ^)O_!1KX.:?XY^'S^ -(LHM%U/
MP5:Z]&-0DT/1FAE^S70* JJ2CS.J[B!]XU]Q_P#!,G_@K3_P0#^,G[8GASX&
M_L!?LB:3X$^)/C*UOK'3M9T7X*Z7H3/;PVTE[/#)=6N'$;):%MO(9D3(X! !
M]X?MZ?L=^!_V]/V4/&'[+OCK5+K3(_$>FE=,URP=EN-(OT.^VO(RI!S'*%)7
M(#IO0_*YK\-/A'_P7)_:F_X)Q?\ !/CXI_\ !)GXV:-KES^U'\._$B^!?A//
M##+=2W5G?,ZQW*28)E:U4[K9C_K5N;$*K*KD?T5U^*__  4)\%>#[O\ X/!_
MV4?M7A;3Y/MWPKAU&]WV:'S[R ^)?(N'R/FEC^SV^US\R^3'@C8N #S3_@H=
M_P $^?%G_!+G_@V5O/"7BOQAJ=Q\4_%'CCP_K/Q'UP:M))*E]+-Q8QR[B?)M
MT/E#!VN_FR#'F8'EGP._92_X-E_$OP4\'^(_C%_P5\^+6E>+M0\+:?<^*M+M
M_'3+'9ZD]M&US"H.DOA4E+J!N; 'WCUK]#_^#N;_ )0R^)/^QYT#_P!*C7QK
M^SC_ ,%@O^#7+P3^SSX#\&?%O_@GOX3U/Q7I'@S2[+Q/J,W[.6B73W>H16D4
M=S*TSKNF+2J[&1N6SD\F@#]5?BU\=/@I_P $LO\ @D!<?&?X=>+KSQ!X1^&?
MPFMO^$%U+Q!=B:XUIFMXX=+$T@2/>T\TMNK,$7_6$[1TK\7/^"%/Q9_:K_X)
MT_\ !17X(>*OVO\ QSJ=[X2_;9\!375G<ZK>2.D6H3ZA,=/D;><&>1TMS\O
MCUE.XX]L_P""XG[6?AC_ (*P^&?V0O\ @EW_ ,$_YSI&C_'*ZM?$TMO/I8M1
MI&BPM-:67FVT)(2")8;^X:%3PMC$1VQP7_!7?_@BG_P5G^&'[$MI^T=\8/\
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M%GXO>!OA?XD\,^+/@OI5U>>-_AUXG*17D/EP7$J>7*N0R.UM-$2RJ\;QL'C
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MUQ:E0=K&OWL^(7_!(WQY\7_^"@_[.W_!0[XH_M96VH>)/@?X+.BZYIMG\/\
M[/'XKNFBNTDO5?[<PL-S71?R@DP&W ;!XX#_ (+!_P#!NW\)_P#@JG\?_!?[
M3F@_&_\ X5EXP\.VZ6GB&^@\(C5$\06L4BR6RR)]JM_+EB_>()<N61U4C$:X
M /T:HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'_"#Z1_S\WO_ (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44
M8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;5L44 <M;>&[&7Q)<Z2US=>5%;HZ
MD739R3SWK1_X0?2/^?F]_P# MJ++_D=[W_KRB_F:V* ,?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJV** ,
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VK8HH Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJV** .6MO#=C+XDN=):YNO*BMT=2+ILY)Y[UH_\(/I'_/S>_\
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M;S+QJQQ=MU(J3_A!](_Y^;W_ ,"VK2T[_D'P?]<5_D*FH Q_^$'TC_GYO?\
MP+:C_A!](_Y^;W_P+:MBB@#'_P"$'TC_ )^;W_P+:M>-!%&L:DX50!D\TM%
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MY_"UKK4;77VBW7=<6Z#.))HER9(D)>, EU7!H ]7HHHH *\+_:P_Y+9\#_\
ML>Y?_29J]TKPO]K#_DMGP/\ ^Q[E_P#29J /=**** "BBB@#'\2_\A?1_P#K
M]/\ Z":V*Q_$O_(7T?\ Z_3_ .@FMB@ HHHH **** "BBB@ HHHH Q[+_D=[
MW_KRB_F:V*Q[+_D=[W_KRB_F:V* "BBB@ HHHH **** "BBB@#'LO^1WO?\
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MF_\ 0JV* ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MY3PK:^*9-.D:PU2VC3[3("LD!)W;N36G]B\;_P#0;LO_  &/^-'@?_D$2_\
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MH **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYFMB@ HHHH
M**** "BBB@ HHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\ 0JV* "BB
MB@ HHHH **** "BBB@#'\#_\@B7_ *_9O_0JV*Q_ _\ R")?^OV;_P!"K8H
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MR_\ I,U 'KGV+QO_ -!NR_\  8_XT?8O&_\ T&[+_P !C_C6Q10!C_8O&_\
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MI&L-4MHT^TR K) 2=V[DUI_8O&__ $&[+_P&/^-'@?\ Y!$O_7[-_P"A5L4
M8_V+QO\ ]!NR_P# 8_XT?8O&_P#T&[+_ ,!C_C6Q10!C_8O&_P#T&[+_ ,!C
M_C1]B\;_ /0;LO\ P&/^-;%% &/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P#
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MHH **** "BBB@ HHHH Q_ __ "")?^OV;_T*MBL?P/\ \@B7_K]F_P#0JV*
M"BBB@ HHJ#4M3T[1[&34]7OX;6VA7=-<7$H1$'J6/ J92C"+E)V2!M)79/57
M6M<T;PYILFL:_JMO96L(S+<74H1%_$UYY>?';7O'-U)HGP#\(MK+*Y2;Q!J
M:'3H#WPQPTI'HOU&14NB_L^P:QJ4?BCXT^))O%>I(=T5M<+LL+4^D< X/IEN
MO4C-?///:F.?)E-/VO\ T\;Y:2_[>LW/TIIKHY1.1XEU-*"YO/[/W]?E]Z/
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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MYO?_  +:M+3O^0?!_P!<5_D*FH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
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MH **** "BBB@ HHHH Q[+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYFMB@ HHHH
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M5*G0IJG3245HDM$@HHHJ#0**** "LWQC_P BQ>_]<#6E6;XQ_P"18O?^N!H
MN:=_R#X/^N*_R%35#IW_ "#X/^N*_P A4U !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5YQ\:_VG?A]^SSXGT6S^+D%]HWAG5;"
M\GO?']W;%=#T26&2V2.&_N_]79^?Y[>7)*5C)@9"P9D5O1Z^*O\ @ISX5_90
M\;?M1?L_:!^TO\*/'OQ+,^MS6.F?#WP]8/<^'H3>ZGI%JFN^($,J0/:VDS0I
M&DPDW/=.5B<H2H!ZW^QU^WCX6_;=\;>-)_@_\-/%,?P[\/66EMX5^)6M:)-9
M:?XRFN)+Y;E],\Y5:XMH/LT \_ #M.2H*!7?WJO OV7KCP#X._:+^)WP$\%^
M./$5C'X6TC0I++X6ZR(7L= LIGU$Q:AI<J%G^QW6UHA;.V+8Z=Y:1Q1E%KWV
M@#*\=^$X?'O@?6? MSKNJZ7'K6E7%A)J>A:@]I?6BS1-&9K>=/FAF4-N21>5
M8!AR*^-O^"1GP2^&7[.7Q]_:Y^"_P=\-?V3X<T/XU:2EA9&ZEN'S)X2T2:62
M269GDFEDEDDD>21F=W=F8DDFOMZN2^'WP,^%GPL\:>-/B'X#\+_8-8^(>N0Z
MQXPO/ML\O]H7L5E!91R[)'98L6]K!'MC"*=FX@L68@'S+^RLB?MA?MW_ !5_
M;4\<RK/X7^#FOWWPQ^#EE<-F&SN+54'B+60#E1--='["LHP5AL)%Z2OGPCX+
MZM^V!_P3;_99^%OQNTK]K7X5?%WX;^+?B[;6>O>'?!WA=F34X_%'B.3=J.FZ
MNMV[WETESJ'FE6B$4D:NBA-@=OT/^!_P'^%'[.'@1OAK\&?"O]CZ*^LZCJSV
MAOI[EGO+^\FO;N9I)W>1C)<3RO@MA=VU0JJJCRCX??\ !*[]A[X7?$W3?BAX
M-^%.HP2:%KT^N>&O#5SXSU:Y\/:%JDQ<R7UAHTUTVGV<Y,CD20P(4+DIM))H
M ^AJ*** /+_BM^R5\-?C%XN?QIXHU_Q1;W;P)"8])\1S6T.U!@'8AQGU/>O$
MOB[^RU\//A#\<O@]<>&-<\2W#:CXT,4XU77YKD*$A+C8'/RG(Y(ZCBOKVO"_
MVL/^2V? _P#['N7_ -)FH ]<_P"$'TC_ )^;W_P+:C_A!](_Y^;W_P "VK8H
MH Q_^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:MBB@#E-<\*Z=:ZCIL,<]R1/<E7
M+7#$@;>WI6G_ ,(/I'_/S>_^!;4>)?\ D+Z/_P!?I_\ 036Q0!C_ /"#Z1_S
M\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^
M!;5L44 8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\W
MO_@6U'_"#Z1_S\WO_@6U;%% '*6OA73I/%-U8-/<[([:-E(N&W9)/4UI_P#"
M#Z1_S\WO_@6U%E_R.][_ ->47\S6Q0!C_P#"#Z1_S\WO_@6U'_"#Z1_S\WO_
M (%M6Q10!C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;5L44 8_\ P@^D?\_-
M[_X%M1_P@^D?\_-[_P"!;5L44 8__"#Z1_S\WO\ X%M1_P (/I'_ #\WO_@6
MU;%% '*6OA73I/%-U8-/<[([:-E(N&W9)/4UI_\ "#Z1_P _-[_X%M19?\CO
M>_\ 7E%_,UL4 8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;5L44 8_P#P@^D?
M\_-[_P"!;4?\(/I'_/S>_P#@6U;%% &/_P (/I'_ #\WO_@6U<U\2==^'_PP
MTZ.YUN_U">\NFV:=I5I<,]S>2= J(.3SCGH,^I ,7COXS7IUU_AO\(=*36_$
MG2Y<M_HFF#IOG<=Q_<'/&.N ;?PV^#-EX2U&3QIXMU5]>\472_Z5K%VO^J!_
MY9PKTB0=..2/0<#YROFN)Q]:6%RNS:=IU7K"#ZI?SS7\J=H_;:^%\LJTZDG"
MC\WT7^;\NG7L<KX=^!>O_$VY7Q3\<'EAM-V_3?"4-VS1VX[-._\ RTDQV' _
M$J.!^*/["VN6]_)J7PIU6&XM7)8:;?R[)8O]E7QM<?[VTCU/6O:?C'^T9\&O
M@!_9W_"V_&/]D_VMYW]G_P#$ON)_-\K9YG^IC?;CS$ZXSGC.#CS3QK_P4]_8
MQ\&>$=2\5R?%1[K^S[*2=+2+0KY'N'525B4O %#,V%!8@989(%>?C_#[A_.\
M,J&*A*I5;O[2_P"]<GI\6UNBC;D72*LCGQ. P4J#E6Z:N3>OF[]O+9=CRWPQ
M^Q]\:_$DV&TFRL8!*4:YNM00J"#@\1EF/Y5]"?!W]E[PA\*K S2:A<7NJSIM
MNK]6\L;>NQ%'W5SCJ221GT ^#_\ @E9_P5=TB7Q1X]\&?M4^,WLEUW6YO$/A
MZ[-K/<)"\K8GLE$2.RHH$;1C& %DR<D5]I?\/%_V-O\ HL7_ );VH_\ R/6N
M7>%.0<$9HY0C*=6.TIM.UUO%)17E>U]]3S>'UE>.PL<9ADW=M:[IK^K^C/5?
M^$'TC_GYO?\ P+:C_A!](_Y^;W_P+:L_XI?&WX/_  1T7_A(?B_\3=#\-V94
ME)=9U..#S<=D5B#(?]E02?2OEKXD?\%I?@M'>CP[^S3\)_%?Q-U.9]EG/9V3
M:?I\KYV@":=?,8Y_NQ$'!P:^XH8+%8B/-"#Y>[T7S;LE]YZ^)S+ X27)4FN;
M^5:R?I%7D_DCZU_X0?2/^?F]_P# MJXKXT_%7]G;]G;0O^$B^-7Q:M/#UNR%
MH4O]6(FN .OE1#+RGV537SMHOAG_ (*W?M<Q_:?'7Q!T3X#^%;D?\>7A[3S<
M:S)&>Q>5M\3_ .T&B(_NFO1_A'_P2M_9$^&VLGQKXQ\)7OQ%\43/YEWXF^(]
M^VJSS2'&6,<G[G.>0Q0N,_>-;_5L%1_C5;OM!7_\F=E]W,<WUS,,1_N]#E7\
MU1\OW15Y?)\IX9XJ_P""D'Q+^/=]-X5_X)]_LU>,O%B[S$?%-];O':(W3[\A
M6&+GH9'.1U48JOX8_P"";W[=_P >]8B\8?M.?'O2/"V[YA::?$=:U"-3]Z(-
M+MMK?GD-$&QCBOT%L;&RTRSBT_3;.*WMX4"0P01A$C4= JC@ >@J6CZ[0H_[
MO22\Y>^_Q]W_ ,E#^SL37_WJO)_W8>Y'\&Y_^3V\C\./^"JW[,VC_LH?%5O#
M+:KK7B"XU^""?3/$7BO74OM0N+:.&)99'"D&,>?OC3<BY6-@N0N:^1J_H2^.
MW_!.;]CC]ICQ_)\4/CA\(Y==UR6UBMC>2>)]3@"PQ@A$6.&Y2- ,DX51DL2<
MDDGC?^',O_!-?_HV_P#\O#6?_DROK\KXKP&#P<:=93E/=NRM?LO>V6RV]#X'
M.N!\SS#,)5<.Z<*>T5>2=N[M#5MZMW?J?@_7WW_P1&M]>^)_QUTS3A%YL'@^
M"YFU&5;Z..6.TFM9XHF52P=P)75#L!VATS@'-?:?A7_@CK_P3CU+3I)[W]G3
M>ZW,B _\)=K X#8 XNZ]$^!/_!.;]CC]F?Q_'\4/@?\ ".70M<BM9;87D?B?
M4YPT,@ =&CFN7C<' .&4X*@C! (QSOB+*<VP#HJ$U+>+:CH__ MGL='#G"6>
MY'F<<0ZE-P>DDG*[3[>[NG9H]6_X0?2/^?F]_P# MJ/^$'TC_GYO?_ MJV**
M^%/TPQ_^$'TC_GYO?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "
MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:J/B7PEIECH-U=PW%T6CB)
M>Y8C\1735F^,?^18O?\ K@: *EEX+TJ6SBE:YO,M$I.+IL=*E_X0?2/^?F]_
M\"VK2T[_ )!\'_7%?Y"IJ ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M3]!@<5M45YC^T%^V/^S;^R_9B3XR_%/3].O9%!M-$@8W&H71/W1';1!I#DX
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M"8'AWPOIN@7W@GQ_>SV5A#!/>+\8O$EL+AT0*TGE0WZQQ;B"=B*%7.%   H
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M  +:C_A!](_Y^;W_ ,"VK8HH Y37/"NG6NHZ;#'/<D3W)5RUPQ(&WMZ5I_\
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M(#W+$?B*Z:LWQC_R+%[_ -<#0!4LO!>E2V<4K7-YEHE)Q=-CI4O_  @^D?\
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M(VI_#[_A.]3\-K\5&\3^&H=-==/U.?3KJ_6VEU-;Y[=9;:4C;;F1E7Y4)(%
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MT[_D'P?]<5_D*FJ'3O\ D'P?]<5_D*FH **** "BBB@ HHHH **** "BBB@
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M:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\ WZ%']G:?_P ^,/\
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M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
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MZD_^(H ]:HKR7_AN[]D/_HO&B?\ ?4G_ ,11_P -W?LA_P#1>-$_[ZD_^(H
M]:K-\8_\BQ>_]<#7F_\ PW=^R'_T7C1/^^I/_B*SO%G[='[)-QX<O(;?XY:/
M([0D*B"4DGV 3F@#V73O^0?!_P!<5_D*FKQ^P_;L_9%2QA5_CMHH(B4$$R C
MC_<J;_AN[]D/_HO&B?\ ?4G_ ,10!ZU17DO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !% 'K5%>2_\-W?LA_\ 1>-$_P"^I/\ XBO5-.U"RU;3
MX-5TVX6:WN85EMY4Z.C %6'L00: )J*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#X\_X)BPGXY?$GX\_\%"/$437VH^-OB;J
M?A#P7(2#]D\*^&[J;3+:W@W']V)KZ+4;IQD!GN%S]P8^+O ,_P"POX1\*?!>
MT_X)C_$;XD:5^T9'\9=-L=4^&?BKQY?7/B2STYM7+>(+/Q%HXN)+>UL8[1KN
M4R>4D2NL3PR%WW/^RE1)96<=V]_':1+/(H6281@.P'0$]2!0!+1110!EZMX(
M\%Z]>'4-<\(:7>W!4*9[O3XY'('0;F4G%5C\+OAF00?AUH6",'_B40__ !-;
MM% '/_\ "IOA7_T33P__ .":#_XBC_A4WPK_ .B:>'__  30?_$5T%% '/\
M_"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!\Y_M2?#SP
M!IWQD^"]KI_@;1X(KOQO+'=1PZ9$JS)]F8[7 7##/8U[9_PJ;X5_]$T\/_\
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M$T'_ ,11_P *F^%?_1-/#_\ X)H/_B*Z"B@#G_\ A4WPK_Z)IX?_ /!-!_\
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M_P#X)H/_ (BN@HH Y_\ X5-\*_\ HFGA_P#\$T'_ ,11_P *F^%?_1-/#_\
MX)H/_B*Z"B@#G_\ A4WPK_Z)IX?_ /!-!_\ $4?\*F^%?_1-/#__ ()H/_B*
MZ"B@#G_^%3?"O_HFGA__ ,$T'_Q%'_"IOA7_ -$T\/\ _@F@_P#B*Z"B@#YS
M_8*^'G@#6?@WJMUK'@;1[N5?&^KQK)<Z9%(P1;DA5!92< =!VKVS_A4WPK_Z
M)IX?_P#!-!_\14?PM^%/A'X/>'9_"_@N&=+2XU*XOI!<3F1O.F?>YR>V>@[5
MTE '/_\ "IOA7_T33P__ .":#_XBC_A4WPK_ .B:>'__  30?_$5T%% '/\
M_"IOA7_T33P__P"":#_XBC_A4WPK_P"B:>'_ /P30?\ Q%=!10!S_P#PJ;X5
M_P#1-/#_ /X)H/\ XBC_ (5-\*_^B:>'_P#P30?_ !%=!10!S_\ PJ;X5_\
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M!0.  !T%.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MN/[#\,VEQ%X=L-4N%W!ET](-/%](T8=D2]>3:?G( /9/V=?VYM*^+'BGQ_\
M"WXU_"?5?A-XS^&.EV.K>+M$\5:Q8W%M%I-XEP]OJ,5]:S/!);D6MRKEBC1-
M X=0-K-%^Q/_ ,%%?@7^WUXF^).G_ "/4;S1?AUKUGI?_"2W5L8K;6S<6:72
MW-HK@.]N5<!)2 LHPZ;D96;YM_X)KCX2ZS_P4$^.6C_LQ?&J?XY_"'Q7\/\
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M[B_:R6ZO6 623RXXE2)!N^B/'/Q _9C_ &$_V>OAE_P3B_:9^,GB7X5Z%?\
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M/X1^*=5F^,,FDV?P_P#A_I8MVU/4=2U$,UO:&221+>'"1R222R2+'''$[9.
M#]"^+=&T?5=*-SJFDVUS)8"2XL9+B!7:VF\F2/S(R1\C[)'7<,':[#H37YR?
MLX_\%%/A7_P3/_X-]OV<_CA\1H;>\U#6/ N@^'_!VC7>II90ZAJMQ QB6>YD
MREK;HD<DLT[ B..)B S%48 ^MOV<?VY['XO>-/'GP>^,WP;UOX5>._AMI=EJ
M_B;P[XDU&SNX6TF[6<V^HVUY:2R13P$VMPC?=>-X65E'RD^;6?\ P5<\4>+?
M"&B>)?A#^PC\2/&,TWPPT[Q_XOM-+OM.M5\/Z1?I++9P^9?3P+=W\D,,DOV6
M+E N&=6*@_+_ (2^+7[/'QB_9D^+S?#;]N/P=\9/VBOVC]5\.>!_'NM^ KPB
MST"SU6Y;3H;'38C\]O8V%E/J=PCOF:5XIIG.]@J_0O\ P4)_:#_85ET7Q/\
M\$^/VK_V@?%W[/6D6'@VTU#0?%.G^)DT"#Q/I[P7%M)9:9<*SF]:#"I-8E/,
M<O#B.1&Y /2/VA?^"L'['W[.G[%6B?MQ^)_&DU[X>\8>$!K_ ("T&QMRVK>(
MXVLQ>"*WM?O[EB(:5F 2!=SRLBJ37=?%C]K+1/A?^RYI/[2O_"'W6HMX@&@0
M:%X<BN52>\OM8N[2TL[4.00&,UY$I;!P QQ@5\L[?B%XG_X-PO$7BKX]?"S3
M_#GC&Q_9*\46B6$7AV/37L+0:)=1P!+95'V+S;:&UD>W0*J-A-JA H[:0_\
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M:!I-M8V<'[)9$-K9P+%'&#XHR=JJ !R2>.YH ^O**** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI^-GC9_"_P ._%AUUI+Y[F0W(TVXO+(VZK;P7QM9!$4FD=#-:B109G$/=?\
M!2+]L;6/V /V-_&7[7VG?"RW\96_@FTAN]1T*7Q"VFO- ]Q%"3'*+:<%P90=
MK* 0#\PH ]THKYU_;D_;7^)7[%GP4\%_%.Y^!.B^([_Q1X\T/PK?Z/'XXEM8
MK"ZU2Z2UBE2<Z?(9XTD==V8XSMR0">*]];6K73X+*/Q'>V5E=WA6-+<W@*O.
M1S'&S!3)SG'R@D<X'2@"[15:\UK1M/O;?3;_ %:U@N+QBMI;S3JKSD=0BDY;
M'M7B"_M?^(-/_P""@VO_ +'OBSP=HVF>&]&^#$'CV+QB^NL9)$?49+.2*>)X
MD2V6/R9'+>9("I4DIRM 'O%%?-/CS_@H1;IXM_9JOO@UX5TOQ'X$_:%\32Z=
M:>*IM6DAGM8/['O=2@GAMA"5E25+3[S2H5##Y&SE?I#3]1T_5K--1TJ_AN;>
M4$QSV\H='P<<,.#R"* )J*\$\0?MF:[XO_:E\0?L?_LP?#C3_%GB7P+I%CJ/
MQ)UK7M??3=*\-B]5GLK,O%;W$MS>S1HTPA6-42(!GE4LB-U?P>^,_P 7/%/Q
M1\9?"[XS?!:T\*/X5TC2=0L]<T[Q&=1T_6(KQKU6:&1[>!X_*-GM=)$5@S]"
MA21P#U"BJEIKNAW^E#7K'6;2:Q*%Q>Q7"M$5!()W@XP,')SVI+KQ%X?LM/GU
M:\UVSAM;:0QW%S+=(L<3AMI5F)PI#<8/?B@"Y132Y>+S(-KY7*?-P?3GGBOG
M[]BW]M;Q=^U7XV^,_A?Q5\'M*\)6OP=^)5WX,NM0M_&#ZA_:5S;V]O<M<!&L
MK<0Q&*YCZLQ#!AC #$ ^@Z*@MM3TV]N9K.SU""6:VV_:(HI59HMPW+N .5R.
M1GJ*\.^.G[8&O_"G]L?X&_LRZ#X0T75=+^*VMZYINM:T=>87FBS6&B7>IQH+
M58BK"7[.%WM*I4$X1LA@ >\45736-)EU1]$CU2V:]BB$LEFLZF5$)P&*9R!G
MOC%6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** */B32K
MW6]"N=)T[6I].GGBVQWUL 9(3_>7/&:X7_A2/Q#_ .CC/$O_ 'YA_P *](HK
MS,=E&!S&HIUU*Z5M)SC^$9)?/<QJ4*=5WE?[VOR9YO\ \*1^(?\ T<9XE_[\
MP_X5X_\ M??#/QKX5\.:1K.L?$35?$%G]LDB?[>B@6[LH*D;1_$%8<^@]:^J
M*H>*/"^@^,]!N?#/B;34N[*[39/!)W[@@CD$'!!'((S7S7$' ^7YKDU;"T'*
M,Y+W6ZE22NFFKIR::;5GH[;K4Y,5EU*M0E"-TWYM_J?G57HO[+W@_P 2>,OB
MK#9^'/$-YI)M[.:6YU*R4%XDV[0.>.691SZ^U>N:I^P!X;GU,SZ/\1;RVLRV
M1;3V"RN!Z;PZC_QVO6/A/\&_!?P<T1](\*6KF2<AKR]N&#37##IN(   R<*
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M.,J9+:[CBGA)'.V1%;GI0!LT444 %%%% !1110 4444 %%%% !1110 4444
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ME\')_'<$GBU8/&OAZSO[*VN)-%>QO!))"U[+%"9$N/LK!&==X!3<H8L/2Z*
M/S7T+_@GQ\<? WQO_:$^.G_!-[X17OP!T_Q_\ KW1M+\,:I=VME::KX]>9GM
M=:M[*TFFCL/L\(:$RD1AI+C>L3*K/)Y9XD_8I_;I\3_#CX1_'C]D+]B/Q)\'
MOC%\*OARWA#XH:7K_CG1K.#XBZ-,JG4-+M+RTN+MY+M[HS7D&HW2P!993*S2
M2'Y/U[HH _/C_@H-\/OVK_VTO^"2.O? #X1?\$[O$'A/5]2U+PO:>&?AO?\
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MG6WEE2)7FFMX8TWEB+9V8*&3/TS10!\@_MC_  A_:$\;_P#!3C]E3XX_#OX
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
0B@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050357944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">STRYKER CORP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-1239739<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2825 Airview Boulevard,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kalamazoo,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">49002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(269)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">385-2600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12gTitle', window );">Title of 12(g) Security</a></td>
<td class="text">None<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91,942,474,363<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377,544,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2022 Annual Meeting of Shareholders (the 2022 proxy statement) are incorporated by reference into Part III.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000310764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, $.10 Par Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.10 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member', window );">1.125% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.125% Notes due 2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member', window );">0.250% Notes due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.250% Notes due 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK24A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member', window );">2.125% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.125% Notes due 2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">0.750% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.750% Notes due 2029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member', window );">2.625% Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">2.625% Notes due 2030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">1.000% Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.000% Notes due 2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SYK31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12gTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(g) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection g<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12gTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.125Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.250due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.125Due2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes2.625Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364053882856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_AuditorInformationAbstract', window );"><strong>Auditor Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">ERNST&#160;& YOUNG LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Grand Rapids, Michigan<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AuditorInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Auditor Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AuditorInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048462040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Earnings - USD ($)<br> $ in Thousands, shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
<td class="nump">$ 14,884,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">6,140,000<span></span>
</td>
<td class="nump">5,294,000<span></span>
</td>
<td class="nump">5,188,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">10,968,000<span></span>
</td>
<td class="nump">9,057,000<span></span>
</td>
<td class="nump">9,696,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research, development and engineering expenses</a></td>
<td class="nump">1,235,000<span></span>
</td>
<td class="nump">984,000<span></span>
</td>
<td class="nump">971,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative expenses</a></td>
<td class="nump">6,427,000<span></span>
</td>
<td class="nump">5,361,000<span></span>
</td>
<td class="nump">5,356,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Recall charges</a></td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">192,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">619,000<span></span>
</td>
<td class="nump">472,000<span></span>
</td>
<td class="nump">464,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">8,384,000<span></span>
</td>
<td class="nump">6,834,000<span></span>
</td>
<td class="nump">6,983,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">2,584,000<span></span>
</td>
<td class="nump">2,223,000<span></span>
</td>
<td class="nump">2,713,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(303,000)<span></span>
</td>
<td class="num">(269,000)<span></span>
</td>
<td class="num">(151,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">2,281,000<span></span>
</td>
<td class="nump">1,954,000<span></span>
</td>
<td class="nump">2,562,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">287,000<span></span>
</td>
<td class="nump">355,000<span></span>
</td>
<td class="nump">479,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,994,000<span></span>
</td>
<td class="nump">$ 1,599,000<span></span>
</td>
<td class="nump">$ 2,083,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net earnings per share of common stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 5.29<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="nump">$ 5.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 5.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares outstanding (in millions):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">377.0<span></span>
</td>
<td class="nump">375.5<span></span>
</td>
<td class="nump">374.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Effect of dilutive employee stock compensation (in shares)</a></td>
<td class="nump">5.3<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">382.3<span></span>
</td>
<td class="nump">380.3<span></span>
</td>
<td class="nump">379.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050305352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
<td class="nump">$ 2,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Marketable securities</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Pension plans</a></td>
<td class="nump">104<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Unrealized gains (losses) on designated hedges</a></td>
<td class="nump">50<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Financial statement translation</a></td>
<td class="nump">469<span></span>
</td>
<td class="num">(414)<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">626<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 2,620<span></span>
</td>
<td class="nump">$ 1,048<span></span>
</td>
<td class="nump">$ 2,108<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048834136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,944<span></span>
</td>
<td class="nump">$ 2,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less allowance of $167 ($131 in 2020)</a></td>
<td class="nump">3,022<span></span>
</td>
<td class="nump">2,701<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNetAbstract', window );"><strong>Inventories:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Materials and supplies</a></td>
<td class="nump">691<span></span>
</td>
<td class="nump">678<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">2,359<span></span>
</td>
<td class="nump">2,565<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">3,314<span></span>
</td>
<td class="nump">3,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">662<span></span>
</td>
<td class="nump">488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">10,017<span></span>
</td>
<td class="nump">9,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_LandBuildingsAndImprovementsGross', window );">Land, buildings and improvements</a></td>
<td class="nump">1,656<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MachineryAndEquipmentGross', window );">Machinery and equipment</a></td>
<td class="nump">3,842<span></span>
</td>
<td class="nump">3,636<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total property, plant and equipment</a></td>
<td class="nump">5,498<span></span>
</td>
<td class="nump">5,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less allowance for depreciation</a></td>
<td class="nump">2,665<span></span>
</td>
<td class="nump">2,430<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">2,833<span></span>
</td>
<td class="nump">2,752<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">12,918<span></span>
</td>
<td class="nump">12,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangibles, net</a></td>
<td class="nump">4,840<span></span>
</td>
<td class="nump">5,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other noncurrent assets</a></td>
<td class="nump">2,263<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">34,631<span></span>
</td>
<td class="nump">34,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable</a></td>
<td class="nump">1,129<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">1,092<span></span>
</td>
<td class="nump">925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income taxes</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrent', window );">Dividend payable</a></td>
<td class="nump">263<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Accrued product liabilities</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">1,465<span></span>
</td>
<td class="nump">1,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">761<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">4,549<span></span>
</td>
<td class="nump">5,041<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, excluding current maturities</a></td>
<td class="nump">12,472<span></span>
</td>
<td class="nump">13,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Income taxes</a></td>
<td class="nump">913<span></span>
</td>
<td class="nump">990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other noncurrent liabilities</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,985<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">19,754<span></span>
</td>
<td class="nump">21,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.10 par value</a></td>
<td class="nump">38<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,890<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">13,480<span></span>
</td>
<td class="nump">12,462<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(531)<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders' equity</a></td>
<td class="nump">14,877<span></span>
</td>
<td class="nump">13,084<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities &amp; shareholders' equity</a></td>
<td class="nump">$ 34,631<span></span>
</td>
<td class="nump">$ 34,330<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_LandBuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Land, Buildings and Improvements, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_LandBuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MachineryAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MachineryAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364054131000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parentheticals) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048170424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements Of Shareholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">$ 1,559<span></span>
</td>
<td class="nump">$ 10,765<span></span>
</td>
<td class="num">$ (631)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance, shares at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(299)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 2,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">374.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">12,807<span></span>
</td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">1,628<span></span>
</td>
<td class="nump">11,748<span></span>
</td>
<td class="num">(606)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">1,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">376.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">13,084<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">12,462<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock under stock compensation and benefit plans, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase of common stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash dividends declared</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(976)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance, shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">377.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 14,877<span></span>
</td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 1,890<span></span>
</td>
<td class="nump">$ 13,480<span></span>
</td>
<td class="num">$ (531)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049113224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements Of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 1,994<span></span>
</td>
<td class="nump">$ 1,599<span></span>
</td>
<td class="nump">$ 2,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">371<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of intangible assets</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">472<span></span>
</td>
<td class="nump">464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="nump">264<span></span>
</td>
<td class="nump">215<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductLiabilityAccrualPeriodExpense', window );">Recall charges</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition', window );">Sale of inventory stepped up to fair value at acquisition</a></td>
<td class="nump">266<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) expense</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(377)<span></span>
</td>
<td class="nump">354<span></span>
</td>
<td class="num">(563)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(189)<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade', window );">Accounts payable</a></td>
<td class="nump">329<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">315<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_Changeinaccrualforrecallexpenses', window );">Recall-related payments</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(177)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(105)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other, net</a></td>
<td class="num">(47)<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">3,263<span></span>
</td>
<td class="nump">3,277<span></span>
</td>
<td class="nump">2,191<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(339)<span></span>
</td>
<td class="num">(4,222)<span></span>
</td>
<td class="num">(802)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(49)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from sales of marketable securities</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property, plant and equipment</a></td>
<td class="num">(525)<span></span>
</td>
<td class="num">(487)<span></span>
</td>
<td class="num">(649)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(859)<span></span>
</td>
<td class="num">(4,701)<span></span>
</td>
<td class="num">(1,455)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt', window );">Proceeds and payments on short-term borrowings, net</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">3,292<span></span>
</td>
<td class="nump">2,642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on long-term debt</a></td>
<td class="num">(1,151)<span></span>
</td>
<td class="num">(2,297)<span></span>
</td>
<td class="num">(1,342)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Payments of dividends</a></td>
<td class="num">(950)<span></span>
</td>
<td class="num">(863)<span></span>
</td>
<td class="num">(778)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchases of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(307)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Cash paid for taxes from withheld shares</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing, net</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(2,365)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(38)<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Change in cash and cash equivalents</a></td>
<td class="nump">1<span></span>
</td>
<td class="num">(1,394)<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of year</a></td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
<td class="nump">3,616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of year</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">4,337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosure:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes, net of refunds</a></td>
<td class="nump">622<span></span>
</td>
<td class="nump">323<span></span>
</td>
<td class="nump">457<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest on debt</a></td>
<td class="nump">$ 325<span></span>
</td>
<td class="nump">$ 304<span></span>
</td>
<td class="nump">$ 286<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_Changeinaccrualforrecallexpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in accrual for recall expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_Changeinaccrualforrecallexpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SaleOfInventorySteppedUpToFairValueAtAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Inventory, Stepped-Up to Fair Value at Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SaleOfInventorySteppedUpToFairValueAtAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableTrade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableTrade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductLiabilityAccrualPeriodExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss reported during the period pertaining to product liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductLiabilityAccrualPeriodExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364054325528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text">SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nature of Operations: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Basis of Presentation and Consolidation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. Prior years' segment results have been reclassified to conform with current year presentation in our Consolidated Financial Statements. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Revenue Recognition: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cost of Sales: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Research, Development and Engineering Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Selling, General and Administrative Expenses: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Currency Translation: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash Equivalents: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Marketable Securities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounts Receivable: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Inventories: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</span></div><div style="display:inline-block;vertical-align:top;width:48.333%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financial Instruments:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2021 and 2020. Refer to Notes 3 and 10 for further details. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Derivatives:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div></div><div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"/><div style="display:inline-block;vertical-align:top;width:48.334%"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense in the Consolidated Statements of Earnings. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Property, Plant and Equipment:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee">three</span> to 15 years for machinery and equipment.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill and Other Intangible Assets:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Goodwill, Intangibles and Long-Lived Asset Impairment Tests:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Share-Based Compensation:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Income Taxes:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021 the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. We are evaluating the impact this update will have on our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049996072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">REVENUE RECOGNITION<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2021 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. </span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,475</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,218</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,470</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,957</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,127</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,005</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,769</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,787</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,896</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,927</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">MedSurg and Neurotechnology</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment and intensive care disposable products (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Orthopaedics and Spine</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%">Contract Assets and Liabilities </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2021 contract assets recorded in our Consolidated Balance Sheets were not significant.</span></div>Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $529 and $416 on December&#160;31, 2021 and December&#160;31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058336920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS <div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:85.107%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Quoted market prices in active markets for identical assets or liabilities.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Observable market-based inputs or unobservable inputs that are corroborated by market data.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Unobservable inputs reflecting our assumptions or external inputs from active markets.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges are included in Level 2 and we use inputs other than quoted prices that are observable for the asset or liability. The Level 2 derivative instruments are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense and the changes in the time value of money within other income (expense), net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">393</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">777</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $68, $102 and $155 in 2021, 2020 and 2019, which was recorded in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the </span></div>investments before recovery of their amortized cost basis, which may be maturity.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049966952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments</a></td>
<td class="text">DERIVATIVE INSTRUMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Foreign Currency Hedges</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,266</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,751</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">949</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We had &#8364;2.0&#160;billion and &#8364;1.5&#160;billion at December 31, 2021 and 2020 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#8364;4.4&#160;billion at December 31, 2021 and 2020 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.</span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 the total after-tax gain (loss) in AOCI related to designated net investment hedges was ($34).</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.277%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Pretax gains (losses) on derivatives designated as cash flow hedges of $9 and net investment hedges of $37 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2021. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge </span></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Interest Rate Hedges</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2021 a loss of $11 was reclassified from AOCI to other income (expense), net in earnings relating to the termination of forward starting interest rate swaps with notional amounts of $750 designated as cash flow hedges as we now consider it probable that the original forecasted debt issuances will not occur. Pretax gains of $5 recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2021. The cash flow effect of interest rate hedges is recorded in cash flow from operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058324088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive (Loss) Income (AOCI)</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:26.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(471)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(531)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058331368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Acquisitions</a></td>
<td class="text">ACQUISITIONS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $393 and $4,304 in 2021 and 2020. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $120 in cash and up to $40 in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2020 we completed the acquisition of Wright Medical Group N.V. (Wright) for $30.75 per share, or an aggregate purchase price of $4.1 billion ($5.6 billion including convertible notes). Wright is a global medical device company focused on extremities and biologics. Wright is part of our Trauma and Extremities business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November and December 2020 note holders elected to redeem the 1.625% and 2.25% convertible notes assumed in the Wright acquisition for $864 and $576. These repayments are classified as financing activities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In December 2020 we completed the acquisition of OrthoSensor, Inc. (OrthoSensor). OrthoSensor is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor is part of our Joint Replacement business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Had the above acquisitions taken place as of the beginning of the comparable prior year, our consolidated financial results of operations in the aggregate would not have been materially different. Accordingly, we have not disclosed pro forma financial information. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.878%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Wright</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology and patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,081</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for 2021 acquisitions were based on preliminary valuations, primarily related to intangible assets, product liabilities and deferred income taxes. Our estimates and assumptions are subject to change within the measurement period. The purchase price allocations for Wright, OrthoSensor and other 2020 acquisitions were finalized in 2021 without material adjustments. </span></div>In January 2022 we announced a definitive merger agreement to acquire all of the issued and outstanding common shares of Vocera Communications, Inc. (Vocera) for $79.25 per share, or an aggregate purchase price of approximately $3.1&#160;billion (including convertible notes). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Vocera for $79.25 per share in cash. The boards of directors of both Stryker and Vocera have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2022, subject to completion of the tender offer and other customary conditions. Vocera has emerged as a leading platform in the digital care coordination and communication category. Following closing, we plan to integrate Vocera into our Medical business within MedSurg and Neurotechnology.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058342712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies and Commitments</a></td>
<td class="text">CONTINGENCIES AND COMMITMENTSWe are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Recall Matters</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In December 2021, we reached a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreements, including the financial terms, are confidential.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With the acquisition of Wright as more fully described in Note 6, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2021, we recorded charges of $103 and made payments of $221, primarily related to Rejuvenate and ABG II Modular-Neck hip stems. Based on the information that has been received, we have estimated the remaining range of probable loss related to recall matters globally to be approximately $385 to $520. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%">Leases</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease expense totaled $133, $130, and $133 in 2021, 2020 and 2019.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Future Obligations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049973624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We completed our annual impairment tests of goodwill in 2021 and 2020 and concluded in each year that no impairments exist.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.407%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,377</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,069</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,669</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,249</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,918</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,542</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,702</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,102</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,554</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.787%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049958648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Capital Stock</a></td>
<td class="text">CAPITAL STOCK<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We made no repurchases of shares in 2021. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2021 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares reserved for future compensation grants of our common stock were 25 million and 28 million&#160;on December&#160;31, 2021 and 2020. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.196%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2021 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">131.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">150.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,424.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,086.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">313.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $253, $258, and $294 in 2021, 2020 and 2019. Exercise prices for options outstanding ranged from $53.60 to $270.94 on December&#160;31, 2021. On December&#160;31, 2021 there was $101 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately 1.5 years.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:40.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.221%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">187.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">185.46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213.16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">210.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">On December&#160;31, 2021 there was $71 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $230.61 and $208.96 in 2021 and 2020. The fair value of RSUs and PSUs vested in 2021 was $63 and $5. On December&#160;31, 2021 there was $18 of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately one year. </span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Employee Stock Purchase Plans (ESPP)</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 183,964 and 209,837 shares under the ESPP in 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050021928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt And Credit Facilities</a></td>
<td class="text">DEBT AND CREDIT FACILITIESWe have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2021. <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. The primary changes were to increase the aggregate principal amount of the facility by $750 to $2,250, extend the maturity date to October 26, 2026, increase the leverage ratio to 3.75 and provide LIBOR replacement language. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%">In the first quarter of 2022, our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding under our commercial paper program from $1,500 to $2,250, with maturities up to 397 days from the date of issuance. On December&#160;31, 2021 there were no borrowings outstanding under our credit facility or commercial paper program.</span></div><div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"/><td style="width:2.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.463%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.600%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,991</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2021 we repaid $750 of senior unsecured notes with a coupon of 2.625% that were due on March 15, 2021. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2021 we repaid the $400 term loan that was due on November 10, 2023. </span></div>Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $337, $315, and $287 in 2021, 2020 and 2019.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058049416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES Our effective tax rate was 12.6%, 18.2% and 18.7% for 2021, 2020 and 2019. The effective income tax rate for 2021 reflects the continued lower effective income tax rates as a result of our European operations, certain discrete tax benefits, the tax effect related to the transfer of intellectual property between tax jurisdictions and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries. The effective <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">income tax rate for 2020 and 2019 reflects the tax effect related to the transfer of intellectual properties between tax jurisdictions, the effective income tax rates as a result of our European operations and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,562</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">353</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax (benefit) expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax (benefit) expense </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(237)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest and penalties included in other income (expense), net were expense of ($23), ($35) and ($9) in 2021, 2020 and 2019. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $283, $41 and $50 in 2021, 2020 and 2019.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,063</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,860</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,447)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued interest and penalties were $150 and $133 on December&#160;31, 2021 and 2020 which were reported in current and noncurrent accrued expenses and other liabilities.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards totaling $602 with $192 being subject to a full valuation allowance ($183 and $106 related to the Wright acquisition) on December&#160;31, 2021 are available to reduce future taxable earnings of certain domestic and foreign </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">subsidiaries. United States loss carryforwards of $403 expire through 2045. International loss carryforwards of $198 begin to expire in 2022; however, some have no expiration. We also have tax credit carryforwards of $104 with $83 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2022; however, some have no expiration. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">The Tax Cuts and Jobs Act ("the Act") was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%">We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements and resolutions of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our income tax expense would have been reduced by $445 and $456 in 2021 and 2020 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.</span></div>In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax years are open from 2014 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2006 through the current year.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050028776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Retirement Plans</a></td>
<td class="text">RETIREMENT PLANS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Defined Benefit Plans</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. Substantially all of the defined benefit pension plans have projected benefit obligations in excess of plan assets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Discount Rate</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Expected Return on Plan Assets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investment Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.</span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(208)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(346)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">869</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,056</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">428</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:33.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.652%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Target</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.511%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $5 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $21 to our defined benefit pension plans in 2022.</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.535%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027-2031</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049995352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialInformationTextBlock', window );">Summary of Quarterly Data (Unaudited)</a></td>
<td class="text">SUMMARY OF QUARTERLY DATA (UNAUDITED)<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.031%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,701</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">302</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,764</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,737</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,262</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">568</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialInformationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -URI http://asc.fasb.org/topic&amp;trid=2126967<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=SL124452896-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialInformationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050000104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Data</a></td>
<td class="text">SEGMENT AND GEOGRAPHIC DATA<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effective December 31, 2021 we segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine. This change realigns the Company's reportable business segments to its new internal reporting structure and how the Company manages its businesses as a result of the transition of responsibilities of our President and Chief Operating Officer, and the division of responsibilities between Group President, MedSurg and Neurotechnology, and Group President, Orthopaedics and Spine, in the fourth quarter of 2021. We have reflected these changes in all historical periods presented.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,147</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,272</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,044</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,002</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,388</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,340</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28,797</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,167</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">419</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">649</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. </span></div><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.846%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,833</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049995352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">Asset Impairments</a></td>
<td class="text">ASSET IMPAIRMENTS<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The government in China has launched regional and national programs for volume-based procurement ("VBP") of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. We expect that the prices required for a successful bid will, nevertheless, negatively impact our existing commercial operations of joint replacement and trauma products in China. As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $105 to impair certain long-lived and intangible assets in the third quarter of 2021. These charges were included in selling, general and administrative expenses. Spine products are part of the VBP program in one province and it is not clear to what extent spine products will be included in further provincial or national VBP programs. We do not expect any significant impairments related to the potential Spine VBP programs. Our business in China represented approximately 2.5% of our revenues for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Aside from the impairments from the VBP programs, we recorded asset impairments of $159 in 2021 consisting primarily of in-</span></div>process research and development, other intangible assets and property, plant and equipment as a result of COVID-19-related demand impacts on in-process product development and certain other divestiture and restructuring activities. In 2020 we suspended certain in-process investments resulting in charges of $195 to impair certain long-lived assets (primarily the portion of our investment in a new global ERP system that was in-process of being developed for future deployment) and product line and other exit costs. These charges were included in cost of sales and selling, general and administrative expenses<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048137160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_SignificantAccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of Operations</a></td>
<td class="text">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Basis of Presentation and Consolidation</a></td>
<td class="text">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. Prior years' segment results have been reclassified to conform with current year presentation in our Consolidated Financial Statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Sales</a></td>
<td class="text">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research, Development and Engineering Expenses</a></td>
<td class="text">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Currency Translation</a></td>
<td class="text">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash Equivalents</a></td>
<td class="text">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp; Poor&#8217;s and Fitch) and A2 (Moody&#8217;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp; Poor&#8217;s and Fitch) or Aa (Moody&#8217;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventories</a></td>
<td class="text">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOptionTextBlock', window );">Financial Instruments</a></td>
<td class="text">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2021 and 2020. Refer to Notes 3 and 10 for further details. <div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#8217; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivatives</a></td>
<td class="text">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">measurement of the contracts at month-end spot rates as adjusted by current forward points. </span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#8217; equity is reclassified into earnings and is included in interest expense in the Consolidated Statements of Earnings. </span></div>Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06">three</span> to 30 years for buildings and improvements and <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee">three</span> to 15 years for machinery and equipment.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b">four</span> to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to </span></div>be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock', window );">Goodwill, Intangibles and Long-Lived Asset Impairment Tests</a></td>
<td class="text">We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.<div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to </span></div>determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">New Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2021 the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">. We are evaluating the impact this update will have on our Consolidated Financial Statements.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SignificantAccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SignificantAccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41638-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=d3e41675-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOptionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide.  Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -URI http://asc.fasb.org/topic&amp;trid=2134543<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOptionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 330<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6471895&amp;loc=d3e55923-109411<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124437754&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058054968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregated Revenue</a></td>
<td class="text"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,111&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,959&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,983&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,607&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,264&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">973&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,538</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,345</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,475</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">464&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,570</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,006</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,409</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">United States Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,637&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,542&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,910&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">801&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,026</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,218</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">6,470</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">777&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,295</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,237</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,321</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,455</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">10,957</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">International Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Instruments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Endoscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neurovascular</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Neuro Cranial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,127</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,005</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Knees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Hips</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trauma and Extremities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">583&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">336&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,275</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,769</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,922</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,787</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,896</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,927</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364055956680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Assets Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,944&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trading marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,137</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,114</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Available-for-sale marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and asset-backed debt securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign government debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States agency debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States treasury debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total available-for-sale marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">101</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,424</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,215</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Liabilities Measured at Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred compensation arrangements</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">193</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">171</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency exchange forward contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest rate swap liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2 - Liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contingent consideration:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Beginning</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in estimate </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(148)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Ending</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3 - Liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">306</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">393</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total liabilities measured at fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">516</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">777</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Available-for-sale Securities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.417%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.142%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Fair Value of Available for Sale Securities by Maturity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Due after one year through three years</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049265624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.424%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.805%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.661%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Cash Flow</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Investment</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Non-Designated</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">973</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,266</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,512</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,751</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">82</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">195</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross notional amount</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">949</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,828</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,382</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,159</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Maximum term in years</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Fair value:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(133)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other noncurrent liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total fair value</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(22)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(114)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:28.871%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.804%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.277%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Net Currency Exchange Rate Gains (Losses)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Derivative Instrument</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Recorded in:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Flow</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net Investment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-Designated</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">20</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058055816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract', window );"><strong>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:26.565%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.902%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Marketable Securities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedges</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Financial Statement Translation</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(179)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">47</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(471)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(606)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(414)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(551)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(259)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(885)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,157)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">OCI</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">551&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Reclassifications to:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cost of Sales</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net OCI</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(155)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">40</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(416)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(531)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049997080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase price allocations for our significant acquisitions are:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:76.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.878%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Purchase Price Allocation of Acquired Net Assets</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Wright</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tangible assets acquired:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(218)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(296)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Customer and distributor relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Developed technology and patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%">Purchase price, net of cash acquired</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,081</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">Weighted average life of intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050119400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.359%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6">Right-of-use assets</span></span> </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b">Lease liabilities, current</span></span> </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b">Lease liabilities, noncurrent</span></span> </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average remaining lease term </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.4 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.6 years</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock', window );">Future Purchase Obligations and Minimum Lease Payments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.945%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Thereafter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt repayments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,226&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,564&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,889&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Minimum lease payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 303<br> -Paragraph (a)<br> -Subparagraph (5)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364052020888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in the Net Carrying Amount of Goodwill by Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.612%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.407%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Changes in the Net Carrying Value of Goodwill by Segment</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">MedSurg and Neurotechnology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Orthopaedics and Spine</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,377</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">9,069</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,459</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,319</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,778</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additions and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,669</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">7,249</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,918</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Summary of the Company's Other Intangible Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.440%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.888%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.143%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Other Intangible Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average Amortization Period (Years)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Amount</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Less<br/>Accumulated<br/>Amortization</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net<br/>Carrying<br/>Amount</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Developed technologies</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,956&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,732&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Customer relationships</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Patents</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trademarks</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">266&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">In-process research and development</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Other</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,542</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,702</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,840</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">8,656</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,102</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5,554</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Estimated Amortization Expense</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:19.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.784%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.787%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Amortization Expense</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">558&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364054884824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Fair Value Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:52.060%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.558%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Option Value and Assumptions</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average fair value per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">53.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assumptions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">26.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5.9</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:22.819%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.479%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.173%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.196%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">2021 Stock Option Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares <br/>(in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-Average<br/>Remaining<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding January&#160;1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">131.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235.35&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">96.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Outstanding December&#160;31</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">150.17</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,424.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Exercisable December&#160;31</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">113.56&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,086.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Options expected to vest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">199.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">313.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Summary of RSU and PSU Activity</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:40.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.217%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.221%"/><td style="width:0.1%"/></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares<br/>(in&#160;millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted Average<br/>Grant&#160;Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">RSUs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">PSUs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on January 1</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.8</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">187.72</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">185.46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230.61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">233.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">179.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">153.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Canceled or forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">187.38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">160.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Nonvested on December 31</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">0.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">213.16</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">210.73</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049978232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAbstract', window );"><strong>Long-term Debt, Unclassified [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Maturities Of Long-Term Debt Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:0.1%"/><td style="width:2.401%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.616%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.245%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.463%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Summary of Total Debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Senior unsecured notes:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline">Due</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.125%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.600%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 1, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.250%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.150%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.375%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 1, 2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">748&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">747&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.500%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.125%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.650%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 7, 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.750%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 1, 2029</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.950%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2030</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">November 30, 2030</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">727&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.000%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">December 3, 2031</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">April 1, 2043</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.375%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">May 15, 2044</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4.625%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">March 15, 2046</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">981&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.900%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">June 15, 2050</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Term loan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,991</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less current maturities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total long-term debt</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12,472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">13,230</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="15" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unamortized debt issuance costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Borrowing capacity on existing facilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of senior unsecured notes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,022&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058478088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Effective Income Tax Rate Reconciliation</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">United States federal statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">21.0</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local income taxes, less federal deduction</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign income tax at rates other than 21%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax related to repatriation of foreign earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Effective income tax rate</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">12.6</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.2</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">18.7</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision for Income Taxes</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Earnings Before Income Taxes&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">433&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,848&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,281</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,562</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.259%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Income Tax Expense (Benefit)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Current income tax expense:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">272&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total current income tax expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">524</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">307</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">353</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax (benefit) expense:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States federal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States state and local</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(25)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax (benefit) expense </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(237)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">48</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">126</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">287</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">355</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">479</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.463%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Deferred Income Tax Assets and Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">434&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Product-related liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">State income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net operating loss and other credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,861</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,063</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Less valuation allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(164)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,697</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,860</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Deferred income tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(891)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,286)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Undistributed earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,005)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(1,447)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net deferred income tax assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent deferred income tax assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,692</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,413</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock', window );">Schedule of Unresolved Income Tax Positions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.258%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Uncertain Income Tax Positions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning uncertain tax positions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">472</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to current year income tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Increases related to prior year income tax positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Decreases related to prior year income tax positions:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Settlements and resolutions of income tax audits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Statute of limitations expirations and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending uncertain tax positions</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">444</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">457</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;Income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">444&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048798744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock', window );">Defined Contribution Plan Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Plan expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expense funded with Stryker common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stryker common stock held by plan:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dollar amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">542&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares (in millions)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Value as a percentage of total plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock', window );">Schedule of Costs of Retirement Plans</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:61.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.427%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.430%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Components of Net Periodic Pension Cost</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(41)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of prior service credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized actuarial loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net periodic benefit cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(74)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(49)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Changes in assets and benefit obligations recognized in OCI:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net actuarial gain (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(117)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(74)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Prior service credit and transition amount</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in other comprehensive income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">138</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(105)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(66)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total recognized in net periodic benefit cost and OCI</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">64</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(175)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(115)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Weighted-average rates used to determine net periodic benefit cost:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Discount rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Expected return on plan assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Rate of compensation increase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Weighted-average discount rate used to determine projected benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock', window );">Schedule of Defined Benefit Plans Disclosures</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">543&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefit obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,036)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1,118)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Funded status</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(493)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(596)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Reported as:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Current liabilities&#8212;accrued compensation</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncurrent liabilities&#8212;other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pre-tax amounts recognized in AOCI:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized net actuarial loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Unrecognized prior service credit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(208)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(346)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock', window );">Schedule of Changes in Accumulated Postemployment Benefit Obligations</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Benefit Obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">869</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Service cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interest cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actuarial (gains) losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Curtailment gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending projected benefit obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,036</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,118</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending accumulated benefit obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,056</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock', window );">Schedule of Changes in Fair Value of Plan Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.474%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.396%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Change in Plan Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Beginning fair value of plan assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">428</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Actual return</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employer contributions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Employee contributions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Foreign exchange impact</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Benefits paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Ending fair value of plan assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.220%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.511%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Valuation of Plan Assets </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">55</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">389</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">99</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">543</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">46</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">372</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">104</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">522</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock', window );">Schedule of Allocation of Plan Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"><tr><td style="width:1.0%"/><td style="width:33.770%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.649%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.240%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.652%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Allocation of Plan Assets</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022 Target</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Actual</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Actual</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">100</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock', window );">Schedule of Expected Benefit Payments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.535%"/><td style="width:0.1%"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Estimated Future Benefit Payments</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2027-2031</span></td></tr><tr><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2439-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2410-114920<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2417-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050064200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Summary of Quarterly Data</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.031%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.367%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.368%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021 Quarters</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,953</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,294</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,160</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,701</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,772&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,642&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">302</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">592</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">438</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">662</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings (loss) per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.695&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020 Quarters</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Mar 31</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Jun&#160;30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Sep 30</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Dec 31</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,588</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,764</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">3,737</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,262</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,331&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,548&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,461&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">493</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">621</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">568</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net earnings per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.66&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(0.22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1.49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Dividends declared per share of common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">0.630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124502072&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049984136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock', window );">Reconciliation of Operating Profit (Loss) from Segments to Consolidated</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Results</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">9,538&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,345&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">8,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">7,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">518&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment depreciation and amortization </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,147</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">954</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">945</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total depreciation and amortization</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,272</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,076</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">1,044</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,084&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Segment operating income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,987</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,002</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">4,388</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Items not allocated to segments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(605)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(503)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(480)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Acquisition and integration-related charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(619)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(472)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restructuring-related and other charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(226)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Medical device regulations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(81)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Recall-related matters</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(103)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(192)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Regulatory and legal matters</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Consolidated operating income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,584</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,713</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Sales and Other Financial Information by Business Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.693%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.694%"/><td style="width:0.1%"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Segment Assets and Capital Spending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">15,250&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">16,270&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">18,090&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,527&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,367</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">33,340</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">28,797</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,370&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,631</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">34,330</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">30,167</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Purchases of property, plant and equipment:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">MedSurg and Neurotechnology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Orthopaedics and Spine</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total segment purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">362</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">342</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">419</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Corporate and Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">145&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total purchases of property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">525</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">649</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock', window );">Geographic Information on Net Sales and Long-Lived Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.750%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.842%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.846%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Geographic Information</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Sales</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Net Property, Plant and Equipment</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">12,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,455&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">10,957&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Europe, Middle East, Africa</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">2,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Asia Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">1,617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">422&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">17,108</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,351</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">14,884</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,833</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">2,752</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050172072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod', window );">Performance period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-lived intangible asset, useful life</a></td>
<td class="text">40 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Building and Improvements | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, plant and equipment useful life</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Performance Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364054031576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionAbstract', window );"><strong>Revenue Recognition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_PercentageofServiceRevenueRecognizeoverTime', window );">Percentage of sales recognized as services over time (less than)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 416<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageofServiceRevenueRecognizeoverTime">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Service Revenue Recognize over Time</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageofServiceRevenueRecognizeoverTime</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364039924376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 4,262,000<span></span>
</td>
<td class="nump">$ 3,737,000<span></span>
</td>
<td class="nump">$ 2,764,000<span></span>
</td>
<td class="nump">$ 3,588,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
<td class="nump">$ 14,884,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,321,000<span></span>
</td>
<td class="nump">10,455,000<span></span>
</td>
<td class="nump">10,957,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,787,000<span></span>
</td>
<td class="nump">3,896,000<span></span>
</td>
<td class="nump">3,927,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
<td class="nump">8,475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,026,000<span></span>
</td>
<td class="nump">6,218,000<span></span>
</td>
<td class="nump">6,470,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,512,000<span></span>
</td>
<td class="nump">2,127,000<span></span>
</td>
<td class="nump">2,005,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,111,000<span></span>
</td>
<td class="nump">1,863,000<span></span>
</td>
<td class="nump">1,959,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,637,000<span></span>
</td>
<td class="nump">1,471,000<span></span>
</td>
<td class="nump">1,542,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Instruments | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">474,000<span></span>
</td>
<td class="nump">392,000<span></span>
</td>
<td class="nump">417,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,141,000<span></span>
</td>
<td class="nump">1,763,000<span></span>
</td>
<td class="nump">1,983,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,670,000<span></span>
</td>
<td class="nump">1,408,000<span></span>
</td>
<td class="nump">1,577,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Endoscopy | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
<td class="nump">355,000<span></span>
</td>
<td class="nump">406,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,607,000<span></span>
</td>
<td class="nump">2,524,000<span></span>
</td>
<td class="nump">2,264,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,007,000<span></span>
</td>
<td class="nump">1,910,000<span></span>
</td>
<td class="nump">1,787,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Medical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="nump">614,000<span></span>
</td>
<td class="nump">477,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,188,000<span></span>
</td>
<td class="nump">973,000<span></span>
</td>
<td class="nump">924,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451,000<span></span>
</td>
<td class="nump">381,000<span></span>
</td>
<td class="nump">391,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neurovascular | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,000<span></span>
</td>
<td class="nump">592,000<span></span>
</td>
<td class="nump">533,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,214,000<span></span>
</td>
<td class="nump">972,000<span></span>
</td>
<td class="nump">1,059,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">988,000<span></span>
</td>
<td class="nump">801,000<span></span>
</td>
<td class="nump">890,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Neuro Cranial | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226,000<span></span>
</td>
<td class="nump">171,000<span></span>
</td>
<td class="nump">169,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">277,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">286,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,000<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
<td class="nump">283,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology | Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
<td class="nump">6,409,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,295,000<span></span>
</td>
<td class="nump">4,237,000<span></span>
</td>
<td class="nump">4,487,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,275,000<span></span>
</td>
<td class="nump">1,769,000<span></span>
</td>
<td class="nump">1,922,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">549,000<span></span>
</td>
<td class="nump">464,000<span></span>
</td>
<td class="nump">415,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
<td class="nump">387,000<span></span>
</td>
<td class="nump">334,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,000<span></span>
</td>
<td class="nump">77,000<span></span>
</td>
<td class="nump">81,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,848,000<span></span>
</td>
<td class="nump">1,567,000<span></span>
</td>
<td class="nump">1,815,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,351,000<span></span>
</td>
<td class="nump">1,170,000<span></span>
</td>
<td class="nump">1,347,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Knees | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">497,000<span></span>
</td>
<td class="nump">397,000<span></span>
</td>
<td class="nump">468,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342,000<span></span>
</td>
<td class="nump">1,206,000<span></span>
</td>
<td class="nump">1,383,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,000<span></span>
</td>
<td class="nump">777,000<span></span>
</td>
<td class="nump">882,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Hips | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">520,000<span></span>
</td>
<td class="nump">429,000<span></span>
</td>
<td class="nump">501,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,664,000<span></span>
</td>
<td class="nump">1,722,000<span></span>
</td>
<td class="nump">1,639,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,866,000<span></span>
</td>
<td class="nump">1,139,000<span></span>
</td>
<td class="nump">1,051,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Trauma and Extremities | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">798,000<span></span>
</td>
<td class="nump">583,000<span></span>
</td>
<td class="nump">588,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167,000<span></span>
</td>
<td class="nump">1,047,000<span></span>
</td>
<td class="nump">1,157,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">831,000<span></span>
</td>
<td class="nump">764,000<span></span>
</td>
<td class="nump">873,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine | Spine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 336,000<span></span>
</td>
<td class="nump">$ 283,000<span></span>
</td>
<td class="nump">$ 284,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_InstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_InstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_EndoscopyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_EndoscopyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_MedicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_MedicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeurovascularMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeurovascularMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_NeuroCranialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_NeuroCranialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_OtherOrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_KneesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_KneesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_HipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_HipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_TraumaandExtremitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=syk_SpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=syk_SpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050515960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">3,424<span></span>
</td>
<td class="nump">3,215<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">516<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Available-for-sale marketable securities</a></td>
<td class="nump">2,944<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecuritiesDebt', window );">Trading marketable securities</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">3,137<span></span>
</td>
<td class="nump">3,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities', window );">Deferred compensation arrangements</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">101<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Interest rate swap asset</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure', window );">Foreign currency exchange forward contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">75<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Corporate and asset-backed debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Foreign government debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | United States agency debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | United States treasury debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2) | Available-for-sale marketable securities: | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Available-for-sale marketable securities:</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract', window );"><strong>Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning</a></td>
<td class="nump">393<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Additions</a></td>
<td class="nump">62<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Change in estimate</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Settlements</a></td>
<td class="num">(148)<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending</a></td>
<td class="nump">306<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities measured at fair value</a></td>
<td class="nump">$ 306<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_ForeignGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048785624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Available-For-Sale Securities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in one year or less</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Due after one year through three years</a></td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049988872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesGainLoss', window );">Marketable securities, gain (loss)</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="nump">$ 155<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045254248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Forward Currency Exchange Contracts) (Details) - Foreign currency exchange forward contracts<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">$ 8,751<span></span>
</td>
<td class="nump">$ 8,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1', window );">Maximum term</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">$ 195<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">66<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(133)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">104<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">65<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">5,512<span></span>
</td>
<td class="nump">5,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">82<span></span>
</td>
<td class="num">(114)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">92<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Not Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount</a></td>
<td class="nump">973<span></span>
</td>
<td class="nump">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeNet', window );">Derivative, fair value, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="num">$ (7)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Designated as Hedging Instrument | Other noncurrent liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Derivative liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of the assets less the liabilities of a derivative or group of derivatives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050483192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Narrative) (Details)<br> $ in Millions, &#8364; in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 8,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Reclassification of gain (loss) from AOCI to earnings</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign currency exchange forward contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">2,266<span></span>
</td>
<td class="nump">&#8364; 2.0<span></span>
</td>
<td class="nump">$ 1,828<span></span>
</td>
<td class="nump">&#8364; 1.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DerivativeNotionalAmount1', window );">Notional amount | &#8364;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 4.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue', window );">Derivative, fair value</a></td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Net investment hedges expected to be reclassified to cost of sales and other income (expense)</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Cash flow hedge gain (loss) to be reclassified within twelve months</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, notional amount</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DerivativeNotionalAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative, Notional Amount1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DerivativeNotionalAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all derivative assets designated as hedges of net investment in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048155016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments (Movements out of OCI) (Details) - Foreign currency exchange forward contracts - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">$ 13<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax', window );">Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax</a></td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gains (losses)</a></td>
<td class="num">$ (10)<span></span>
</td>
<td class="num">$ (13)<span></span>
</td>
<td class="num">$ (7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044898456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">$ (1,157)<span></span>
</td>
<td class="num">$ (606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">724<span></span>
</td>
<td class="num">(640)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(101)<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">6,140<span></span>
</td>
<td class="nump">5,294<span></span>
</td>
<td class="nump">$ 5,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(303)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
<td class="num">(151)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">287<span></span>
</td>
<td class="nump">355<span></span>
</td>
<td class="nump">479<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">626<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(531)<span></span>
</td>
<td class="num">(1,157)<span></span>
</td>
<td class="num">(606)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">626<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember', window );">Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(259)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">123<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(32)<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="num">(179)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">104<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">46<span></span>
</td>
<td class="num">(64)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="nump">40<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">50<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">12<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Hedges | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">6<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), Beginning of Period</a></td>
<td class="num">(885)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">OCI</a></td>
<td class="nump">551<span></span>
</td>
<td class="num">(459)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Income taxes</a></td>
<td class="num">(54)<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income (Loss), End of Period</a></td>
<td class="num">(416)<span></span>
</td>
<td class="num">(885)<span></span>
</td>
<td class="num">$ (471)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">469<span></span>
</td>
<td class="num">(414)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income | Cost of Sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income | Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward', window );"><strong>Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">$ (35)<span></span>
</td>
<td class="num">$ (28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AOCIAttributableToParentNetOfTaxRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AOCIAttributableToParentNetOfTaxRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis=us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=syk_OtherIncomeexpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364039731128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 393<span></span>
</td>
<td class="nump">$ 4,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,151<span></span>
</td>
<td class="nump">$ 2,297<span></span>
</td>
<td class="nump">$ 1,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_A1625ConvertibleNotesMember', window );">1.625% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_A225ConvertibleNotesMember', window );">2.25% Convertible Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayments of long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_GaussMember', window );">Gauss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments', window );">Future regulatory and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationConsiderationTransferredPricePerShare', window );">Consideration transferred, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes', window );">Purchase price of acquisitions, including convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember', window );">Vocera | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Aggregate purchase price of acquisitions</a></td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationConsiderationTransferredPricePerShare', window );">Consideration transferred, price per share (in dollars per share)</a></td>
<td class="nump">$ 79.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Including Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationConsiderationTransferredPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationConsiderationTransferredPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationContingentConsiderationFutureMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Future Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationContingentConsiderationFutureMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_A1625ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_A1625ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_A225ConvertibleNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_A225ConvertibleNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_GaussMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_GaussMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_WrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_VoceraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_VoceraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364039853032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 12,918<span></span>
</td>
<td class="nump">$ 12,778<span></span>
</td>
<td class="nump">$ 9,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="nump">$ 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets', window );">Deferred income tax assets</a></td>
<td class="nump">491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="nump">440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">343<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt', window );">Debt</a></td>
<td class="num">(1,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income tax liabilities</a></td>
<td class="num">(503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities', window );">Product liabilities</a></td>
<td class="num">(218)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other liabilities</a></td>
<td class="num">(296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase price, net of cash acquired</a></td>
<td class="nump">$ 4,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average life of intangible assets</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright | Customer and distributor relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright | Developed technology and patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright | Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets:</a></td>
<td class="nump">$ 58<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Product Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_WrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=syk_CustomerAndDistributorRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050366280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies and Commitments (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Charges during period</a></td>
<td class="nump">$ 103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualPayments', window );">Payments during period</a></td>
<td class="nump">221<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">$ 133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Estimate of possible loss</a></td>
<td class="nump">$ 520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow reducing loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124440162&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058089912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies - Lease Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 419<span></span>
</td>
<td class="nump">$ 423<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, noncurrent</a></td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">$ 325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">2.86%<span></span>
</td>
<td class="nump">2.57%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
<td class="text">Other Assets, Noncurrent<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
<td class="text">Other noncurrent liabilities<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048479992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2023</a></td>
<td class="nump">1,226<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2024</a></td>
<td class="nump">1,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2025</a></td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2026</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract', window );"><strong>Purchase obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">2022</a></td>
<td class="nump">1,889<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear', window );">2023</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear', window );">2024</a></td>
<td class="nump">54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear', window );">2025</a></td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear', window );">2026</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Minimum lease payments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">38<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 72<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25383-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048820008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">$ 12,778<span></span>
</td>
<td class="nump">$ 9,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">3,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(142)<span></span>
</td>
<td class="nump">150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">12,918<span></span>
</td>
<td class="nump">12,778<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">5,459<span></span>
</td>
<td class="nump">5,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(13)<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">5,669<span></span>
</td>
<td class="nump">5,459<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Beginning balance</a></td>
<td class="nump">7,319<span></span>
</td>
<td class="nump">3,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions and adjustments</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">3,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments', window );">Foreign exchange</a></td>
<td class="num">(129)<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Ending balance</a></td>
<td class="nump">$ 7,249<span></span>
</td>
<td class="nump">$ 7,319<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e961-128460<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364047974248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">14 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 8,542,000,000<span></span>
</td>
<td class="nump">$ 8,656,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">3,702,000,000<span></span>
</td>
<td class="nump">3,102,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 4,840,000,000<span></span>
</td>
<td class="nump">$ 5,554,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technologies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">13 years<span></span>
</td>
<td class="text">13 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 5,326,000,000<span></span>
</td>
<td class="nump">$ 5,305,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">1,956,000,000<span></span>
</td>
<td class="nump">1,573,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,370,000,000<span></span>
</td>
<td class="nump">$ 3,732,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,324,000,000<span></span>
</td>
<td class="nump">$ 2,352,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">1,174,000,000<span></span>
</td>
<td class="nump">988,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1,150,000,000<span></span>
</td>
<td class="nump">$ 1,364,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 343,000,000<span></span>
</td>
<td class="nump">$ 346,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">286,000,000<span></span>
</td>
<td class="nump">278,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 57,000,000<span></span>
</td>
<td class="nump">$ 68,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 415,000,000<span></span>
</td>
<td class="nump">$ 428,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">199,000,000<span></span>
</td>
<td class="nump">162,000,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">216,000,000<span></span>
</td>
<td class="nump">266,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">29,000,000<span></span>
</td>
<td class="nump">97,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 29,000,000<span></span>
</td>
<td class="nump">$ 97,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Amortization Period (Years)</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 105,000,000<span></span>
</td>
<td class="nump">$ 128,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less Accumulated Amortization</a></td>
<td class="nump">87,000,000<span></span>
</td>
<td class="nump">101,000,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 18,000,000<span></span>
</td>
<td class="nump">$ 27,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364054320072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">$ 447<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048428408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Narrative) (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CommonAndPreferredStockSharesAuthorized', window );">Common and Preferred Stock, shares authorized (in shares)</a></td>
<td class="nump">1,000,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par per share</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="nump">$ 0.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining shares authorized to be repurchased</a></td>
<td class="nump">$ 1,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Capital shares reserved for future issuance</a></td>
<td class="nump">25,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value of options exercised</a></td>
<td class="nump">$ 253<span></span>
</td>
<td class="nump">$ 258<span></span>
</td>
<td class="nump">$ 294<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Options exercised during period, exercise price range, lower range limit</a></td>
<td class="nump">$ 53.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Options exercised during period, exercise price range, upper range limit</a></td>
<td class="nump">$ 270.94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 230.61<span></span>
</td>
<td class="nump">$ 208.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Compensation cost not yet recognized</a></td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation cost not yet recognized, period for recognized</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">$ 233.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue', window );">Shares vested during the period</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock Purchase Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Capital Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp', window );">Percentage of closing stock price under ESPP</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued under the ESPP</a></td>
<td class="nump">183,964<span></span>
</td>
<td class="nump">209,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CommonAndPreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common And Preferred Stock, Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CommonAndPreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Closing Stock Price Represents Purchase Price Under ESPP</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045788168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Option Grant Assumptions) (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalStockAbstract', window );"><strong>Capital Stock [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value per share</a></td>
<td class="nump">$ 53.35<span></span>
</td>
<td class="nump">$ 39.34<span></span>
</td>
<td class="nump">$ 36.30<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">26.90%<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
<td class="nump">18.30%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life (years)</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">5 years 9 months 18 days<span></span>
</td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalStockAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Stock [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalStockAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048091608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of Stock Option Activity) (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at January 1 (in shares) | shares</a></td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Shares, Granted (in shares) | shares</a></td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Shares, Exercised (in shares) | shares</a></td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Cancelled or forfeited (in shares) | shares</a></td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Options outstanding at December 31 (in shares) | shares</a></td>
<td class="nump">12.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at December 31 (in shares) | shares</a></td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Shares, Options expected to vest (in shares) | shares</a></td>
<td class="nump">4.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise&#160;Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at January 1 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 131.72<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">235.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">96.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Cancelled or forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">192.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options outstanding at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">150.17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercisable at December 31 (in dollars per share) | $ / shares</a></td>
<td class="nump">113.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options expected to vest (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 199.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term, Options outstanding at December 31 (in years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Exercisable at December 31 (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term, Options expected to vest (in years)</a></td>
<td class="text">7 years 8 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Options outstanding at December 31 | $</a></td>
<td class="nump">$ 1,424.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Exercisable at December 31 | $</a></td>
<td class="nump">1,086.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, Options expected to vest | $</a></td>
<td class="nump">$ 313.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050495832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital Stock (Summary of RSU and PSU Activity) (Details) - $ / shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 187.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">230.61<span></span>
</td>
<td class="nump">$ 208.96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">179.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">187.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 213.16<span></span>
</td>
<td class="nump">$ 187.72<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember', window );">Performance Stock Units (PSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at January 1 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares, Granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Shares, Vested (in shares)</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Shares, Cancelled (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Shares, Nonvested at December 31 (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)</a></td>
<td class="nump">$ 185.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Granted (in dollars per share)</a></td>
<td class="nump">233.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Vested (in dollars per share)</a></td>
<td class="nump">153.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Cancelled (in dollars per share)</a></td>
<td class="nump">160.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)</a></td>
<td class="nump">$ 210.73<span></span>
</td>
<td class="nump">$ 185.46<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=syk_PerformanceStockUnitPsusMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364039755080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt and Credit Facilities (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommercialPaper', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense, debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">337,000,000<span></span>
</td>
<td class="nump">$ 315,000,000<span></span>
</td>
<td class="nump">$ 287,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember', window );">Credit Agreement | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 2,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DebtInstrumentCovenantLeverageRatio', window );">Leverage ratio</a></td>
<td class="nump">3.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Maturities of time deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">397 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member', window );">Senior Unsecured Notes 2.625% due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.125Due2021Member', window );">Senior Unsecured Notes, 1.125% Due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRepurchasedFaceAmount', window );">Debt instrument, repurchased face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DebtInstrumentCovenantLeverageRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DebtInstrumentCovenantLeverageRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRepurchasedFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of the original debt instrument that was repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRepurchasedFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.125Due2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.125Due2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044907176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermDebt', window );">Other long-term debt</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Total debt</a></td>
<td class="nump">12,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Current maturities of debt</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt</a></td>
<td class="nump">12,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,230<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing capacity on existing facilities</a></td>
<td class="nump">2,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,903<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of senior unsecured notes</a></td>
<td class="nump">$ 13,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,022<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member', window );">Senior Unsecured Notes 2.625% due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member', window );">Senior Unsecured Notes, 1.125%, due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member', window );">Senior Unsecured Notes 0.600% due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member', window );">Senior Unsecured Notes 3.375% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member', window );">Senior Unsecured Notes 0.250% due 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 958<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,030<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member', window );">Senior Unsecured Notes, 1.150% Due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">644<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember', window );">Senior Unsecured Notes 3.375% due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">747<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member', window );">Senior Unsecured Notes 3.50% due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member', window );">Senior Unsecured Notes,2.125%, due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.125%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">909<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member', window );">Senior Unsecured Notes 3.650% due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member', window );">Senior Unsecured Notes 0.750% due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">969<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member', window );">Senior Unsecured Notes, 1.950% Due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member', window );">Senior Unsecured Notes, 2.625% due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member', window );">Senior Unsecured Notes 1.000% due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">903<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member', window );">Senior Unsecured Notes 4.10% due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">392<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member', window );">Senior Unsecured Notes 4.375% due 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member', window );">Senior Unsecured Notes 4.625% due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">981<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member', window );">Senior Unsecured Notes, 2.900% due 2050</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Unsecured debt</a></td>
<td class="nump">$ 642<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=syk_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2625Due2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0600Due2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.250due2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.150Due2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3.375due2025MemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes350Due2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes3650Due2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes0.750due2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.950Due2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotesDueNovember2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes1.000due2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes410Due2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4.375due2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes4625Due2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_SeniorUnsecuredNotes2.900due2050Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=syk_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=syk_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048387864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax, percent</a></td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">18.20%<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest expense and penalties included in other income (expense), net</a></td>
<td class="num">$ (23)<span></span>
</td>
<td class="num">$ (35)<span></span>
</td>
<td class="num">$ (9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized', window );">Net operating loss carryforward recognized</a></td>
<td class="nump">283<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued', window );">Accrued interest and penalties</a></td>
<td class="nump">150<span></span>
</td>
<td class="nump">133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense', window );">Unrecognized tax benefits, interest on income tax expense</a></td>
<td class="nump">445<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember', window );">Wright</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance', window );">Operating loss carryforwards, subject to full valuation allowance</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforward, amount</a></td>
<td class="nump">104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardValuationAllowance', window );">Tax credit carryforward, valuation allowance</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_OperatingLossCarryforwardsSubjectToValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject to Valuation Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_OperatingLossCarryforwardsSubjectToValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense for an underpayment of income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=syk_WrightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=syk_WrightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364050407176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">United States federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">United States state and local income taxes, less federal deduction</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Foreign income tax at rates other than 21%</a></td>
<td class="num">(6.90%)<span></span>
</td>
<td class="num">(3.30%)<span></span>
</td>
<td class="num">(4.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent', window );">Tax related to repatriation of foreign earnings</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent', window );">Intellectual property transfer</a></td>
<td class="num">(2.30%)<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(3.30%)<span></span>
</td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(2.40%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">12.60%<span></span>
</td>
<td class="nump">18.20%<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045190504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Earnings before Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 433<span></span>
</td>
<td class="nump">$ 239<span></span>
</td>
<td class="nump">$ 366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,848<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="nump">2,196<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings before income taxes</a></td>
<td class="nump">$ 757<span></span>
</td>
<td class="nump">$ 495<span></span>
</td>
<td class="nump">$ 662<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
<td class="nump">$ 671<span></span>
</td>
<td class="nump">$ 780<span></span>
</td>
<td class="num">$ (87)<span></span>
</td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">$ 2,281<span></span>
</td>
<td class="nump">$ 1,954<span></span>
</td>
<td class="nump">$ 2,562<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364039741304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Provision for Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current income tax expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">United States federal</a></td>
<td class="nump">$ 155<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="num">$ (17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">International</a></td>
<td class="nump">272<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="nump">324<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">307<span></span>
</td>
<td class="nump">353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred income tax (benefit) expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">United States federal</a></td>
<td class="num">(82)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">United States state and local</a></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(25)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">International</a></td>
<td class="num">(132)<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="nump">117<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax (benefit) expense</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">48<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 287<span></span>
</td>
<td class="nump">$ 355<span></span>
</td>
<td class="nump">$ 479<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045781736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred income tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Inventories</a></td>
<td class="nump">$ 513<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves', window );">Product-related liabilities</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther', window );">Other accrued expenses</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DeferredTaxAssetsDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,194<span></span>
</td>
<td class="nump">1,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State income taxes</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss and other credit carryforwards</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">166<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">2,861<span></span>
</td>
<td class="nump">3,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less valuation allowances</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(203)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred income tax assets</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">2,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred income tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(891)<span></span>
</td>
<td class="num">(1,286)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings', window );">Undistributed earnings</a></td>
<td class="num">(114)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(1,005)<span></span>
</td>
<td class="num">(1,447)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred income tax assets</a></td>
<td class="nump">1,692<span></span>
</td>
<td class="nump">1,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Noncurrent deferred income tax assets</a></td>
<td class="nump">1,760<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Noncurrent liabilities&#8212;Other liabilities</a></td>
<td class="num">$ (68)<span></span>
</td>
<td class="num">$ (117)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxAssetsDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxAssetsDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058467928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning uncertain tax positions</a></td>
<td class="nump">$ 457<span></span>
</td>
<td class="nump">$ 472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year income tax positions</a></td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year income tax positions</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities', window );">Settlements and resolutions of income tax audits</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Statute of limitations expirations and other</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation', window );">Foreign currency translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending uncertain tax positions</a></td>
<td class="nump">$ 444<span></span>
</td>
<td class="nump">$ 457<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from foreign currency translation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364058184968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Plan expense</a></td>
<td class="nump">$ 259<span></span>
</td>
<td class="nump">$ 235<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Expense funded with Stryker common stock</a></td>
<td class="nump">37<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany', window );">Stryker common stock held by plan, amount</a></td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 542<span></span>
</td>
<td class="nump">$ 470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany', window );">Stryker common stock held by plan, shares</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany', window );">Stryker common stock held by plan, value as a percentage of total plan assets</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Held by Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Retirement Plans Common Stock Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364047982648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract', window );"><strong>Components of Net Periodic Pension Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="num">$ (72)<span></span>
</td>
<td class="num">$ (63)<span></span>
</td>
<td class="num">$ (41)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost and transition amount</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial loss</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments', window );">Curtailment gain</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="num">(74)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax', window );">Net actuarial gain (loss)</a></td>
<td class="nump">132<span></span>
</td>
<td class="num">(117)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax', window );">Recognized net actuarial loss</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax', window );">Prior service cost and transition amount</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax', window );">Curtailment gain</a></td>
<td class="num">(9)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Total recognized in OCI</a></td>
<td class="nump">138<span></span>
</td>
<td class="num">(105)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax', window );">Total recognized in net periodic benefit cost and OCI</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="num">$ (175)<span></span>
</td>
<td class="num">$ (115)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract', window );"><strong>Defined Benefit Plan, Assumptions Used in Calculations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate', window );">Discount rate</a></td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets', window );">Expected return on plan assets</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease', window );">Expected return on plan assets</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations', window );">Weighted-average discount rate used to determine projected benefit obligations</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Benefit obligations</a></td>
<td class="num">(1,036)<span></span>
</td>
<td class="num">(1,118)<span></span>
</td>
<td class="num">$ (869)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan', window );">Funded status</a></td>
<td class="num">(493)<span></span>
</td>
<td class="num">(596)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities', window );">Current liabilities&#8212;accrued compensation</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent', window );">Noncurrent liabilities&#8212;other liabilities</a></td>
<td class="num">(491)<span></span>
</td>
<td class="num">(594)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Unrecognized net actuarial loss</a></td>
<td class="num">(208)<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember', window );">Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract', window );"><strong>Defined Benefit Plan, Information about Plan Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax', window );">Unrecognized prior service credit</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax', window );">Unrecognized net actuarial loss</a></td>
<td class="num">$ (215)<span></span>
</td>
<td class="num">$ (354)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Used in the Determination of the Projected Benefit Obligations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2919-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (k)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFundedStatusOfPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFundedStatusOfPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL34724391-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e689-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045188760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Change in Benefit Obligations (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward', window );"><strong>Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Beginning projected benefit obligations</a></td>
<td class="nump">$ 1,118<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="nump">$ 41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation', window );">Foreign exchange impact</a></td>
<td class="num">(70)<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActuarialGainLoss', window );">Actuarial (gains) losses</a></td>
<td class="num">(71)<span></span>
</td>
<td class="nump">110<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation', window );">Curtailment gain</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanBenefitObligation', window );">Ending projected benefit obligations</a></td>
<td class="nump">1,036<span></span>
</td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">$ 869<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation', window );">Ending accumulated benefit obligations</a></td>
<td class="nump">$ 987<span></span>
</td>
<td class="nump">$ 1,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActuarialGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActuarialGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(6)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increase benefit obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in benefit obligation of defined benefit plan from business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=SL108413299-114919<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364059285032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Change in Plan Assets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward', window );"><strong>Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Beginning fair value of plan assets</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanContributionsByEmployer', window );">Employer contributions</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant', window );">Employee contributions</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss', window );">Foreign exchange impact</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid', window );">Benefits paid</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent', window );">Ending fair value of plan assets</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1703-114919<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123453770&amp;loc=d3e1731-114919<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanContributionsByEmployer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution received by defined benefit plan from employer which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanContributionsByEmployer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39716-114964<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contributions received by defined benefit plan from participant which increases plan assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044809112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember', window );">Debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage', window );">Target plan asset allocations</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations', window );">Actual plan asset allocations</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanDebtSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044982216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 543<span></span>
</td>
<td class="nump">$ 522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">(Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">(Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">389<span></span>
</td>
<td class="nump">372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">99<span></span>
</td>
<td class="nump">104<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember', window );">Cash and cash equivalents | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">147<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember', window );">Equity securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">204<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember', window );">Other | (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets', window );">Fair value of plan assets</a></td>
<td class="nump">$ 99<span></span>
</td>
<td class="nump">$ 104<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanFairValueOfPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(01)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(02)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanFairValueOfPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_DefinedBenefitPlanEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis=us-gaap_OtherDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364048749064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Retirement Plans (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="nump">$ 17<span></span>
</td>
<td class="nump">$ 30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">(Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets', window );">Actual return</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear', window );">Estimated future employer contributions in next fiscal year</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4587-114921<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364052069496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Retirement Plans (Expected Benefit Payments) (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo', window );">2023</a></td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree', window );">2024</a></td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour', window );">2025</a></td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive', window );">2026</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter', window );">2027-2031</a></td>
<td class="nump">$ 138<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044829464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Quarterly Data (Unaudited) (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_QuarterlyFinancialDataAbstract', window );"><strong>Quarterly Financial Data [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 4,262,000<span></span>
</td>
<td class="nump">$ 3,737,000<span></span>
</td>
<td class="nump">$ 2,764,000<span></span>
</td>
<td class="nump">$ 3,588,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
<td class="nump">$ 14,884,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">3,045,000<span></span>
</td>
<td class="nump">2,642,000<span></span>
</td>
<td class="nump">2,772,000<span></span>
</td>
<td class="nump">2,509,000<span></span>
</td>
<td class="nump">2,717,000<span></span>
</td>
<td class="nump">2,461,000<span></span>
</td>
<td class="nump">1,548,000<span></span>
</td>
<td class="nump">2,331,000<span></span>
</td>
<td class="nump">10,968,000<span></span>
</td>
<td class="nump">9,057,000<span></span>
</td>
<td class="nump">9,696,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Earnings (loss) before income taxes</a></td>
<td class="nump">757,000<span></span>
</td>
<td class="nump">495,000<span></span>
</td>
<td class="nump">662,000<span></span>
</td>
<td class="nump">367,000<span></span>
</td>
<td class="nump">671,000<span></span>
</td>
<td class="nump">780,000<span></span>
</td>
<td class="num">(87,000)<span></span>
</td>
<td class="nump">590,000<span></span>
</td>
<td class="nump">2,281,000<span></span>
</td>
<td class="nump">1,954,000<span></span>
</td>
<td class="nump">2,562,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 662,000<span></span>
</td>
<td class="nump">$ 438,000<span></span>
</td>
<td class="nump">$ 592,000<span></span>
</td>
<td class="nump">$ 302,000<span></span>
</td>
<td class="nump">$ 568,000<span></span>
</td>
<td class="nump">$ 621,000<span></span>
</td>
<td class="num">$ (83,000)<span></span>
</td>
<td class="nump">$ 493,000<span></span>
</td>
<td class="nump">$ 1,994,000<span></span>
</td>
<td class="nump">$ 1,599,000<span></span>
</td>
<td class="nump">$ 2,083,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.17<span></span>
</td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="nump">$ 1.51<span></span>
</td>
<td class="nump">$ 1.66<span></span>
</td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="nump">$ 1.32<span></span>
</td>
<td class="nump">$ 5.29<span></span>
</td>
<td class="nump">$ 4.26<span></span>
</td>
<td class="nump">$ 5.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share of common stock (in dollars per share)</a></td>
<td class="nump">1.73<span></span>
</td>
<td class="nump">1.14<span></span>
</td>
<td class="nump">1.55<span></span>
</td>
<td class="nump">0.79<span></span>
</td>
<td class="nump">1.49<span></span>
</td>
<td class="nump">1.63<span></span>
</td>
<td class="num">(0.22)<span></span>
</td>
<td class="nump">1.30<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="nump">$ 4.20<span></span>
</td>
<td class="nump">$ 5.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per share of common stock (in dollars per share)</a></td>
<td class="nump">$ 0.695<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.630<span></span>
</td>
<td class="nump">$ 0.575<span></span>
</td>
<td class="nump">$ 0.575<span></span>
</td>
<td class="nump">$ 0.575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_QuarterlyFinancialDataAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_QuarterlyFinancialDataAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045330584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 4,262,000<span></span>
</td>
<td class="nump">$ 3,737,000<span></span>
</td>
<td class="nump">$ 2,764,000<span></span>
</td>
<td class="nump">$ 3,588,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
<td class="nump">$ 14,884,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,272,000<span></span>
</td>
<td class="nump">1,076,000<span></span>
</td>
<td class="nump">1,044,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,584,000<span></span>
</td>
<td class="nump">2,223,000<span></span>
</td>
<td class="nump">2,713,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(619,000)<span></span>
</td>
<td class="num">(472,000)<span></span>
</td>
<td class="num">(464,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="nump">$ 662,000<span></span>
</td>
<td class="nump">$ 438,000<span></span>
</td>
<td class="nump">$ 592,000<span></span>
</td>
<td class="nump">$ 302,000<span></span>
</td>
<td class="nump">$ 568,000<span></span>
</td>
<td class="nump">$ 621,000<span></span>
</td>
<td class="num">$ (83,000)<span></span>
</td>
<td class="nump">$ 493,000<span></span>
</td>
<td class="nump">1,994,000<span></span>
</td>
<td class="nump">1,599,000<span></span>
</td>
<td class="nump">2,083,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember', window );">MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
<td class="nump">8,475,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember', window );">Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
<td class="nump">6,409,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,147,000<span></span>
</td>
<td class="nump">954,000<span></span>
</td>
<td class="nump">945,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,987,000<span></span>
</td>
<td class="nump">4,002,000<span></span>
</td>
<td class="nump">4,388,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,538,000<span></span>
</td>
<td class="nump">8,345,000<span></span>
</td>
<td class="nump">8,475,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518,000<span></span>
</td>
<td class="nump">496,000<span></span>
</td>
<td class="nump">488,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,807,000<span></span>
</td>
<td class="nump">2,414,000<span></span>
</td>
<td class="nump">2,304,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,570,000<span></span>
</td>
<td class="nump">6,006,000<span></span>
</td>
<td class="nump">6,409,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629,000<span></span>
</td>
<td class="nump">458,000<span></span>
</td>
<td class="nump">457,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Segment net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,180,000<span></span>
</td>
<td class="nump">1,588,000<span></span>
</td>
<td class="nump">2,084,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="nump">122,000<span></span>
</td>
<td class="nump">99,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">Segment Reconciling Items</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">Segment operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(605,000)<span></span>
</td>
<td class="num">(503,000)<span></span>
</td>
<td class="num">(480,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationIntegrationRelatedCosts', window );">Acquisition and integration-related charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(585,000)<span></span>
</td>
<td class="num">(242,000)<span></span>
</td>
<td class="num">(275,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(619,000)<span></span>
</td>
<td class="num">(472,000)<span></span>
</td>
<td class="num">(464,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring-related and other charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(386,000)<span></span>
</td>
<td class="num">(458,000)<span></span>
</td>
<td class="num">(226,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_MedicalDeviceRegulationsExpense', window );">Medical device regulations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(107,000)<span></span>
</td>
<td class="num">(81,000)<span></span>
</td>
<td class="num">(62,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_RejuvenateABGIIHipRecallCharges', window );">Recall-related matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(103,000)<span></span>
</td>
<td class="num">(17,000)<span></span>
</td>
<td class="num">(192,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalFees', window );">Regulatory and legal matters</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(6,000)<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,584,000<span></span>
</td>
<td class="nump">$ 2,223,000<span></span>
</td>
<td class="nump">$ 2,713,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_MedicalDeviceRegulationsExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Device Regulations Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_MedicalDeviceRegulationsExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_RejuvenateABGIIHipRecallCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rejuvenate / ABG II Hip Recall Charges</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_RejuvenateABGIIHipRecallCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationIntegrationRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationIntegrationRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364045196968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Segment Information) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">$ 34,631<span></span>
</td>
<td class="nump">$ 34,330<span></span>
</td>
<td class="nump">$ 30,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">525<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="nump">649<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">33,367<span></span>
</td>
<td class="nump">33,340<span></span>
</td>
<td class="nump">28,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">342<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | MedSurg and Neurotechnology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">15,218<span></span>
</td>
<td class="nump">15,250<span></span>
</td>
<td class="nump">16,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">197<span></span>
</td>
<td class="nump">192<span></span>
</td>
<td class="nump">281<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Orthopaedics and Spine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">18,149<span></span>
</td>
<td class="nump">18,090<span></span>
</td>
<td class="nump">12,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">165<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,264<span></span>
</td>
<td class="nump">990<span></span>
</td>
<td class="nump">1,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_syk_CapitalExpendituresDuringPeriod', window );">Capital Expenditures During Period</a></td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">$ 230<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_syk_CapitalExpendituresDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capital Expenditures During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">syk_CapitalExpendituresDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>syk_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_MedSurgAndNeurotechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=syk_OrthopaedicsAndSpineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044245624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="8">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="nump">$ 4,701,000<span></span>
</td>
<td class="nump">$ 4,160,000<span></span>
</td>
<td class="nump">$ 4,294,000<span></span>
</td>
<td class="nump">$ 3,953,000<span></span>
</td>
<td class="nump">$ 4,262,000<span></span>
</td>
<td class="nump">$ 3,737,000<span></span>
</td>
<td class="nump">$ 2,764,000<span></span>
</td>
<td class="nump">$ 3,588,000<span></span>
</td>
<td class="nump">$ 17,108,000<span></span>
</td>
<td class="nump">$ 14,351,000<span></span>
</td>
<td class="nump">$ 14,884,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">2,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,833,000<span></span>
</td>
<td class="nump">2,752,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,321,000<span></span>
</td>
<td class="nump">10,455,000<span></span>
</td>
<td class="nump">10,957,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">1,717,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,717,000<span></span>
</td>
<td class="nump">1,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">Europe, Middle East, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,299,000<span></span>
</td>
<td class="nump">1,818,000<span></span>
</td>
<td class="nump">1,888,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">941,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941,000<span></span>
</td>
<td class="nump">938,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,973,000<span></span>
</td>
<td class="nump">1,630,000<span></span>
</td>
<td class="nump">1,617,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,000<span></span>
</td>
<td class="nump">91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember', window );">Other foreign countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">515,000<span></span>
</td>
<td class="nump">448,000<span></span>
</td>
<td class="nump">$ 422,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Net Property, Plant &amp; Equipment</a></td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 99,000<span></span>
</td>
<td class="nump">$ 78,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=syk_OtherForeignCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364044251416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Asset Impairments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 215<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember', window );">Long-Lived Assets and Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember', window );">In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_GlobalERPSystemMember', window );">Global ERP System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue from Contract with Customer Benchmark | Geographic Concentration Risk | CHINA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_LongLivedAssetsAndIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_GlobalERPSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis=syk_GlobalERPSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140364049087720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule II Valuation and Qualifying Accounts (Details) - SEC Schedule, 12-09, Allowance, Notes Receivable - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Charged&#160;to Costs &amp; Expenses</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Uncollectible Amounts Written Off, Net of Recoveries</a></td>
<td class="nump">23<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesAdjustments', window );">Effect of Changes in Foreign Currency Exchange Rates</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at End of Period</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_AllowanceForNotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>syk-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:syk="http://www.stryker.com/20211231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="syk-20211231.xsd" xlink:type="simple"/>
    <context id="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i260807f9ca594869a1e64938a93873d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.125Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.125Due2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic937960950424623b2f472ba5bd35835_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes2.625Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i168731c7369c4ff38564f21924b77d5f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9063bd1a2e38494a9c87d8c5d2de23d8_I20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2022-01-31</instant>
        </period>
    </context>
    <context id="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic69cd9d39a21490cbfb14c8af977c010_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5100993b55004a07983c6ce4012e89e1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id065545fd0a8490a93760d3d3f7caa20_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b0a96f76e6b47348aeab92e410030dc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i71b5c77df023413fa94d61740f8d881c_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie9d988183992473c80ec9e89791c037f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i9becb79080734381bcde3430445f8f12_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i80170d6b8dff45988d17971402b2a956_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01b0f8910e1148c7bcf2487217ae6387_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i977f185fff7246a097ea0082fe62710a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2670a9c10b1d408ab40717a9709b224d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i867a13b6e18b444dbd004c9492789fdf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7552bdaa82d04e2faaa8351a026b88bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2f4ae1d1be414b55b5e9656c3e8710fe_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib351518cfdd249e5884ad627fecac581_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8c69abfa681e4e24818ac3eadfd6f813_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id9bd43403e564ca1aaf610bb52886cb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d120045c43c4af3a896790950cd8059_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f87b165979c46dfb2cc60987739eabc_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i82d74fabbcc44d498a3ffcb580f01a68_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2367b67252704359babdcb904dbe95f8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i52bca8038e1b46fc9b2afd0ead1648d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id69388e86ae64de6bf4faca02b97d13f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if42e188b90414f3b945a27e7e2b1974f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6b608d92cc6341009d4822438ed62daa_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iea80d9ec270a42ddb859da9ac5218675_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1414fc84d6974d41bca891469be2cf89_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8e2f3cb539e04b21a6d749132943270d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57b5bdf8abc14627b4fc2cab97dcf73d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4d5184394bb4869a0faafe74b973913_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id69e786052ea4b109ba619beabef2d34_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6b444fdfd4114975835f712db85f57df_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i390e0b268e414b8f9d49e0d83841a8a0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i764c1f66472a4d62a4a8976787e08574_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4c0c3f21be164ebea0b665c3e075dca9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e3f8d2756374f598396b4e9f1242e4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i309806bb11ff41a2a9e882a99bad0aed_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id287ce7c576e4ea3925b95b5da00c78c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaf17bc05109f4e979b894e6b5c677384_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i24bf8fb2be2c4a3089319f9462f2f44d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i75b07ba08eb4425189e18508e67ef022_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icadbc6876b0c4a2e9b96d00656980180_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0204ee9ab1854e4bb45e61ddc5a338a2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iac738aea624e43db94884598610ec371_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieed282f1ecf14d7d80d3e4b74e03cdf3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6477d0161a4843db9d24e33b01902361_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if72d972689ad4922b7665802f781c461_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i10b621eadd294693b0520b76f0f11d92_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6fdfaed011624ea2b76682b408d01222_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7728f777c79940228eafdad70914c783_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b08d632247540e0b3c29c04aacd461f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iecb4bd223e1a4a24889683e87146a929_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61e348f6119d46a88d69fe763e6cf9fa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i341271d78c7a4206947bca3b7cde395f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5c49a6e730644609880acbc477da03e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic119b1fa0c0143538533bba2f3b95138_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia4f89663db2e4dcd91f2a239604498e7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i08a811a396c54be69d7679faeabb9796_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia168ec9d45e74093b60a8c0db927613f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib8aa2f3c162a4b938419bc9018039728_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92bc71ae63244b42848463e8f166f45e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i76acfc033a4b4a1fb195cec65bb11702_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i02851b5d44484d838b322bb70419e1fd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i18219da346bb4cf8b4922993ee49a73a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifea456eb74734994a3ba7247aac1dda2_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6858a6cd717d489e810d6a92befb51b9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3313eb4600a44b6faccc26b2974f7496_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id7312fb8079f489ca025dfd4b3f324d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1054325428345d2aca70dffa2f35f05_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i838adf850af9448e83d8cb2ca7ee3cce_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia6aa60e488594c2e9d84921cd2278f0d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib601c6c2389846cf9f085ecbf9e004cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia4f5ff37751b4228bd155d7017fca70e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3c2d20f3fc714b3fb42530500f7a77c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88f85a0225bb45ff93c9e5a28ffbadea_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55b0b8f766624b5aa1783ef3697e9b20_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i304183cc0af4431d9b285023ea26a72d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iab91cf46dd9e42daaab5e9e0c7a6f3d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i99c3ffb583b64bec8e62c626a9117c9c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ied70e04d41a84cddb788cfd887902d21_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6720a7b09590406fa78b5cbf501d252d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6fa7261b15f94c2eb63be5955c04b03d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i697479f2046e497ea88627c07ee8852e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3ec948b236274ddf8f4810eb5cc97ce9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic29ffe107ea24e1389192f99d0a767a7_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib93218ae922f45f5a1cf776dc39c830f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac0d485d1c2f45c1a9cab57c8ab1300c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id2c8448f9de9491eb03da17046dc00a1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd688039b6c24b09ac8456cead87b0be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb7a0419c3734edf884537ca4e542fdf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib81829ee9e6345368cf338d2658cdc6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5349cb00c0ad4a4083b3dc3c6c276bad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i81957f0cf1484ba38b95f8c9ecc5a5d9_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iad0a15234cbb4344bb4ca7e8ab0ab171_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05a31d5a18104fff9025782da56d7787_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a6260841aa5465bb9e462b166e24b07_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if31b6de31d4f46c0a7a11072d41c2800_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id45dd029eb07468ca3154dc544a63e6e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ba7e2e0e4db4edfbca7ef8727fc3908_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i54354e05970043bdb07f6e9c15ed0abf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2f9191aefdf04dd8b33791fa64741598_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i425cac663597403caf6cc7508116f568_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1b53aa1b3f2142aaa114bc47e6623cc9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i06a17e906ae8452da05c7bb782ac6172_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i53bf28c4e64640c1bbea6979d86e3f4f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib993db761cc4478a866ff2db39f59836_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1debb8f23cc84c6fb84fe03a3c972ba6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1fc24ab232c447f986a9240dc08901c5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84b80df0a367428b8b9a465b8e3c21fb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:InstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i282a513298204115a77781c1dd5f4247_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifc3891e66b1a4f0f87e7010e0d1e8784_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idda804ddfb2c4bff8ee7c14205d1311e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:EndoscopyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icfc063acf78e4bd08280c305320cc7e0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ieec5e2be30f44eb99d345e1094f393a1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i678ed992a3df4a148ac4cda3936f752b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:MedicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4fdd98e5a1a84c7fbf7bd96a78a60fdc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03dee15ce37348bbad87d69932241272_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4fef7e7698de4e8caf1c760d79d20d4c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeurovascularMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibd3a823fe4ca4366b2768db2d8b5b0d5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1886d202248d4d57b78e584a981fc5cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib44b439abfc245aebc3340a2b62a8221_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:NeuroCranialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i80ef92b6615045d4b2062896ded9bbc5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie69c1f527ffb40c695af85cc7c5db79f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4c8fc671d26d49df8904f1b61f9081e8_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0b9a67d017a8431f92a32c80c6879b56_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57502b50a979495bb8c5df03c59bac37_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f03e61dba444a09a7a52d84fea542ce_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i55b1c2cee07b498e95d93aa7b85803e9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d762e565f504e11951b765770476668_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07256403bc854160be4404f8370b023a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:KneesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ide46d2faceb7499aab7014ec2fd595c9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ba2d61f5af8485dbf21906bf0f4aa74_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3226395d1abb430c8b2c0c5dc6845197_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:HipsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if7d60c4249bc459a90844052b4ecb962_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5ff7aabafd94e57bd5bb96fbf4651e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i83a3271cb4ba4c8e8f3b440f5b6593b4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:TraumaandExtremitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idccdb90407784aa4a69cbad64bd54ec6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia229486a6b2a46e4b942600ec82f03e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ba6c463bf0b45e09760a30ab1e70dba_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:SpineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5658ed54f3ad41b58d8370fdbe277451_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6f50b1a58554482a86eae0ad88635b27_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i14ef25118cc84ec18b82cbbb33c9b30c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">syk:OtherOrthopaedicsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3bedb945b15e46caa838af3a4e317243_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5797053cbabf44609ba2cdc56f6172fd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icddb0ba9518f400295350436917a4675_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie3f940887fab4704bda5bc6c6fea7411_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib9813457a2c14f50beeed7c796c5110c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iace6d4c12e6c4fe6a1850720afff5392_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ab379c875cb4b7f9423c749112e591b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie7c7e8c817e145e7bc500185970a7013_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87e93dcc049342eebd756e5c81bbfbff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i020998449ee2432dade781d8bc329ee5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4676f03bd98643798e246bce4a1c147c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:ForeignGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i502bdbefb4c34395a270e6c9b341feb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fd7d93013184f0ca7e953d189769dfb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i98fd63c6a75c40488a06a9d1e613e709_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff585920b6b14ebf8d44cd9a2a7fc0db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21f8b1b147fc47e2bbd9b9fe11fe0ced_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i33d0a2073a7a4d0fae7425d288bd85ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i117668a485ee43269f7894ff6ae82f17_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ida582d9988574d51a2b01b103a5a8a6b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27dc0843d36f4d878697133f92c598f0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia95d03ec4c304d95b51a3255f385445c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8fb1a995f6d44f929f32898b0817d377_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f453ede78574f968dfbe085d836b77b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8ab79e1bc08243479d364fa5853b1565_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia21cd3e409fc4facace34555a676001b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i343cabe069354ccc80f2d13debe7af55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabd1e97e19e549f89dabedef1ee76cc1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i40113d80d11149059ac26617f2747527_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c9d232100d84c2e8972344f330c6c32_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i75d60a29285a47bd9dbc5f7c302733eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i422ff4d02b404759bd7b1f0c73386fdf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i72f5e6753fb047f083791a2c3417aef7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic949228136a2440aacee861045d52a3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if052be85296d424e88865bee7451cdfe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1631a54bab5c46b5b4aa3ef428c4dc63_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5884ae7cccbb493f97bb398967d7295a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iffdc28f3e70c4e53945b14cca5be1a87_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae1a4031263e473ca84441dad4d88d84_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if77ef480dc7b44db865d51b857328728_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7a2bb2e21adb4f2195ccceb311822e54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i77590a767d2049249161295a41700dff_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib71901facd4f4729bb4febf8e4920a38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5048a5d933134912a55ce66af02172d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5f71580f58e546cf876aaa64b8e407f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic458786f6f7742209e0810cafdb1e076_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if86c13e7f54a4d9187b804efa3279ece_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cb34c13848b40abb54bfb7dd12daee8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie912fa0d38354d10abc6f0c684c92709_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8cc2de29096642bca27e8292c94be78c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib731b835ed4545e1bf7663a732660d5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba140370805745c5a0fb0139f3a35e36_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7bb0885ab9cf4a3b872895d9b26c1c8d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i768aa1a212a548f6bc9e1ad4200680af_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if80d5916400446cf8c33be284e7e7cd8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0494473994284c7a818935d1810c26c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i324abdc30a554b10b518a4193f5e987c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i460e2f30ab50432dac45998c777bd1cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id4dc5032a74e422eab08db6029f2c3b1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2743dba7228949dca22bfab3555187d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5774498f250b4e62a2507047bb5117c5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7dfbfda7e7d44de0983bcfc3b451374f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8de6a926a954c7a98e473efb5dedd75_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie4707a4f73d24ec7a3a6643b3e285e4d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72ae0b2359894631bfe4ff8951b7344f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd5321432b28479688d8bb70e0d59233_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8b361079402f49b293ad59e81c8db765_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1eda5abebfc549a98ed646efb1e15dd8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i78ff6405f6b0476e87ad1a72d4cb5be6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5680505765904a7ebbce9f048aa9a5ee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib06a055c0fae428c8432833a0e6bf453_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6502455d90c34a3aaf15f94591105bdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i257b8d69f7304529920e40c42cf14686_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4bb4525f47584c4b928961c3e9bf0ff0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia94684ce07ac4a0185a0636e0cf54469_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2e5a4e63e93f48f7aa5592b92b80c4b1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if68a82d67ba747f0a26113ba47cf0600_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i49d219ac7c654bcf972997c5b2dd66b6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic221ec9a6dfc4d74aeaf33001f372d3c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if601c0b3db3f4bf6b658f2a814d47b69_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cdd6bf737b54325b92c62a86f71c0e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2e2f7288e37e48a380d856a6d3266bf1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia56f6022aefe44f2a5667c14a9b6b6eb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c3f013d29b7403e858fcea9c856f7b3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90e7300ba45a44d6a213473b74b90080_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia01979f1a5154e80af303f7109f5141e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie1ea07cf8bba4d6d887c5a458dad34dc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i409d18f675da455fb23e202a25fb4438_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04146303369749e39910cfe8eff8042d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib5a5b88eef254543b043aeb672c43431_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibb9e3dbe30fa4e8483b2654e5a21a079_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7543006b3a34df28528413b4f7b31d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie86883fa09384666942eeaed442415af_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i92f15013f92346ce9cbb36e9eb568f54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i83dc60f460124dd497581e888b4bf1d8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9114115d56ad4c4989ad2dd4e097974d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5dbe5a4ec071427fae8b82afb24fb3ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i325e4a8aeca94b2b83d09801b01f101e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i87e455dc94234eef9fc977210d2059b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad787f8161cd41d2b2c226f217b85d4f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i80cfb23b43fb45ffa9c91c4dc0f78098_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2773bb7f8a4c4bd3a58a536ad8bf8188_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8362bd7aefad4b4fb6e9f334fa0974c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">syk:OtherIncomeexpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i98223ace52234752a935caf8d514b359_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis">us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia32555db427549cf9768af83a8cc5401_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i473fc27ada8b4437a7ed06daba0e7b45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i987f109f9d8b453ea9245f3f52a146d6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i114b53cb59c34cb288582b77e4ec30d5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:GaussMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="ib8d99e6390a74a8995e89bd1ff83d52b_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A1625ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="i02a06683c940495480de29089bda742b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A225ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie342e96c09a9482c9aa9e2e4ff4011f5_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A1625ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i67fb41d08feb476290e5560aab4e4702_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:A225ConvertibleNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7e620065e6e24e2a8d665f88e64e892d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9cfff0a7aec247bc86688fccbb9b397f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">syk:CustomerAndDistributorRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i42136052eabf40fba1fdf489034458a0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i515431d49ca14980ada9296078f4f0a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if70c7c8d0bbd4f9582508d0d23fd23b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:WrightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">syk:VoceraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-01-31</endDate>
        </period>
    </context>
    <context id="i9db0a793155f4536896d92116fb53672_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i66cb47dd385f4d9999a85414eafe4457_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iff23dccda5944e118af54005133b53e7_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i620617bf01d945178f16bb399ad57f75_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99bfd05a796d4880b00788fe7096a885_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86c45f56956e48e19de6ba723be12789_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i537ba5d8a2cc42d0ac3ebe24c14114dd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i60bff9d7fe1740a4b1b56d78df05e951_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i881fb152f349470ca7abba8d476e11a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iededa4a8c527471b85a48d5b54ad644d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i007c06d259e748828bb28c412ab4ac98_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia88bc7ee7b9745fc9352da5322ebb656_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1087bf354d78467a8a499c466b98e2ec_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7b19b159bc734f8dac7b4ac724153ffb_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifae25731565a4034b3ee7bd4f65f29f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib56b6a79e10d4b8da543faad8f04faef_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee70c5decbda497da7a729394169c742_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icf40de1dc0a747ac9e71b3ec9fe5e6ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95da961ae17b47f3858471949c39deb9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3abb2d8e94114546ba385f6ac936e9fe_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib0dadbfef3164e62895c0f78a8172e34_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie504e126295140d895f1b405fdae8218_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75223e6f266b49d0b5c29ab50334c3ca_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idd0b79e9ffdf4577bae842aae7525d95_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c0fc5ea9fc4492a91cafecdf0d6fe28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic68919f3a22244c1b7ff50822c238456_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1dde6a23c87c43a39fd81af819d0e532_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i11a3a9e009874da393fcb3dac86134c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6d6bbd2cf290410eb553761cf7b1b304_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">syk:PerformanceStockUnitPsusMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i30c2cd9df03f4990802edf10bafe3d39_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i509624184e844f5fb011955bbb2c778e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c4be753853f42df931435723368c9e5_D20211001-20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="ia9e6f3514db1476f817d3a34bf82751a_I20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="icfbd20d36f4c4a0187acc94dfb9c9db4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9ef4c1ea02da4ea596abd614114f7393_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i917ab770a5bd4746b5a9e3300c4046b4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iaae71a75450b45cfa06a432fbf4e56b6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib9765b80413243c19a3bd125fa129236_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10c71a79ff0d4a66b82c64b38f8ef166_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba8cdba131854e1fa2af1d12976b473e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icfca18fe7ca64a799cd68aefb09fb4c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0600Due2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3509c57093a64b75a06052277ba0acb3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0227faa616da4a128a3d998d9f6db05d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i480109c130434062bd13171059d5ef31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.250due2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4681c2f77d9349a8a13546c839684f90_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0df1eb79fd5744fd8983118adebb9623_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.150Due2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i23e7e1ef2be4408ea79112316a123192_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0caf73b3889a40929b9da7a96bb99d5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3.375due2025MemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad5a5038c5da499f92e3e8046651aa71_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2fe3da873b14e1e9acb5a1220a5e06d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes350Due2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id90b056e95f44ff5abeae3d32e78c913_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0e14c0d1dcf411ab03235f607eb6313_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iee9e48c2079044c18c3f5e95f5b196b3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes3650Due2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i63e97ef977d04cbe98290d564401c76b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i336901cefd4f43fba19050323af4c966_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes0.750due2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3086dc119ed744e3be6f3fca238a2adf_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i09191cd775d5416fac1419996ab55482_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.950Due2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23484026c90c4eba9c47bf90db97349a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotesDueNovember2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i323fcbeea7cf43648faf64c65504341c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i38d1fc1af0074b52bfb9bcd1fd97816a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.000due2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4e46902a0d4641b6aad2beef3aed8f86_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic725b5e5cada4fe09f8bbb6ff2a948e9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes410Due2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia68e51613f0e40deb45d9d94d6e67b14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7def3071dac84fbf93b4831fce46ae80_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4.375due2044Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idbd80c3cd55641208b41aaa854e69a3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4a79159e25947238adcf8348dd4618a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes4625Due2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10d1a9bafbac4422919540ab667b2004_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8a5a0db81617461dbfb08c50f5a369e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2.900due2050Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa94a4981170459daf10d0648f64494e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibce21f74de924d9091f5bc5d627d39d4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i37083d398075438da83a8349d52ed8c6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes2625Due2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5cc983b0708b43efbe69262c949402dd_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">syk:SeniorUnsecuredNotes1.125Due2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i1cd24230505248839fa2f817aad88236_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie57390308e744f2da47656cbcb7dd7ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f988e7869e24ec3bddc891426b08439_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i01ba6c5c269d4255a194114389cbf28c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18a02b6d2c274ed99fc738e0c58fe623_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91262a514140409ebdc684fab644ffa5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc0ea2e735eb45ac82e987217fe33ed3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia67b9db95e8d4be5bc9dae41d9dc8f3c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanDebtSecurityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if0472521a2c54bd8a5c77c14ed66218b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i232384248c814e63916518edfbade00d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i001424c220ec43b8bcc76dd7bf700136_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i604a2bd489464dd7a650d828b235f087_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f45f3a6f31f4b0da0d211a6aef869d9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1dddab9268854061b35a9e07a6318dd6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife6a4f6e1674412fa1a94fcd3d311a14_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i610ab94283ee44cebe2aff94198af011_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iebfde9edb94c4bffa0897fbc6d059649_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0732c03ffb524a518cf83d8eea84056b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5881fc803ed74916a236a87615ed0ee2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibae7b85422cd47d9891e57aba56d1654_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice25e379b81f4476bc629c2369aaa8d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6a7ab2b119e94e27bd120bc5f0693216_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73ac471a7a3844b192433916f6cb498b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i316fb40a5796411d9e52da1c35ca3e5e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69c2080de3934abf904eba7abade7988_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i47733b1c7ef048cbb418c5fcc8c43a27_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i164f42b17a9f4770bd5118f6cd88f3c2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idccdaec3350743cea685af7c28bdb255_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30492a5243574d7bb61e3c33c92232cf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib06973aac182492f9622c7ad7902fabf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba09bb97f57e482fb3622b4b9a6a4342_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib8b81436534b4ed681424a5481d1d2a3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:DefinedBenefitPlanEquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id692e1a1c6d14320af222fb9457d39b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic458106dafdd43c2a2d64c80f80f0d0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i69cf095ab3ce444bb44754bf320b5332_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie48c458d392e4f3194b70925a5318b6f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b168e0fd23c4ecbb3d1680b32078cc4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84cef904fd4a491cbb3a73b26683ced7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i301b21993d364219b05cf96921f44824_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib9b725428866433e884015213e1d73d8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DefinedBenefitPlanByPlanAssetCategoriesAxis">us-gaap:OtherDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if49057198523407d8323dce5d51c3441_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icf04f9985f9c460593117679dd0de816_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id53460c344454415a413587e43a832f0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1c65783cfed742208972bad227653460_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if094df009b6240eaacd07df8b1201b26_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i45973f2c9a854e2e920f89b3e8dee9d8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie114ed237e0d41beb5a9e2242dabd291_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if615c66e93d841248401204d2f87e7b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:MedSurgAndNeurotechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i05efb2548ebd4f34ab5c73e347583ae8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4c0d499873474314be3c66b63d45f691_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0adfcfa572a94aca9a60b62275d83075_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">syk:OrthopaedicsAndSpineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i74c68f4da1164491bf77ae9dcbfb0545_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1a1b44063cf47ac91f386a31d08238d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i044e8aa931854b8a94b1419803337ca9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i493d054bdb1142bab91a099618a17c2e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i89b60b72af8d496098920a748eea6ac8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifb45f65a673b4ca8bc5380e9dc457005_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i742ba6c7339d481cad355c3643d8c974_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia89a77a86ad54db68756036c89894730_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7510c322dcd240709c6c6e3c9f02d28a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibdaebd90ff5a43aebff037d5206f643c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i508e0970774e4040bebaa29eefb5413a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iabea30f6f342483e92b55ff45d124cfd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i65e2baa3bf9f407e86be3aa79c350743_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i366d502111bb4b0ea5b40b0854ccb69c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i79f9e9c317bd4f439e0b474fd5b011ae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i21fb41ce5c5541289a9c9bda6cc8d0d5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i04ca0caf148b4cfea6977517521fc1a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd51320aa2454e7a9423a3b8924b52cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4c0ca347e0e442d5b711eeee83cb8a15_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id822d7baa9eb43998e1a14bbe5f9067f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84d77376c3524f3bae2890c5d42f27a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i695bf958a588401eb4c0e69af671f48a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i54f6e97d92584c358e1d36baee8c2703_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">syk:OtherForeignCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0df0e910952f41b38ad92de86d9e751c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:LongLivedAssetsAndIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia507b09a8414413ba7d85ab4c02407b5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CN</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1c818b44abbb48aca50ce62cb4244e4d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5fba5cf2d76346acb78e2f001edc09ac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ImpairedLongLivedAssetsHeldAndUsedByTypeAxis">syk:GlobalERPSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55b99ad9aa574362a2b36a60d0085869_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4ba1ecd7eafa4f05988a82a4023b511f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idbe329076697427a86d128a21c73111a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ied06158ff7d045f39f524189c541c016_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000310764</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:AllowanceForNotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="eur">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="rate">
        <measure>utr:Rate</measure>
    </unit>
    <unit id="segment">
        <measure>syk:segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N180LTEtMS0xLTIzMDI1_d10435cb-2318-43cd-99d7-7a726e0974d2">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N182LTEtMS0xLTIzMDI1_1fdaf828-ac13-4b53-bf22-0fac1645c9f8">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N183LTEtMS0xLTIzMDI1_e7245d39-81b4-48e6-876f-e0f7c9cbfddc">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM180L2ZyYWc6YzdjNDI1N2FjMGNkNDc2MTgzYTRiYjIzNGMzMGEyYWUvdGFibGU6ZGNhZDNlNzNiMDEwNDFlOThiYzgzOGYwZGQyMzMxNDcvdGFibGVyYW5nZTpkY2FkM2U3M2IwMTA0MWU5OGJjODM4ZjBkZDIzMzE0N18xMC0xLTEtMS0yMzAyNQ_dde6150e-1c29-4dfa-84ad-21dfd93ba444">0000310764</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6b608d92cc6341009d4822438ed62daa_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i1414fc84d6974d41bca891469be2cf89_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i57b5bdf8abc14627b4fc2cab97dcf73d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6">http://fasb.org/us-gaap/2021-01-31#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <dei:DocumentType
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcz_0fe618e2-40f4-424c-8f6b-de0aff8c5781">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NDY1ZmQyN2M1ODc1NGEyY2I5Y2UzODUxZDQ1YjJjNTEvdGFibGVyYW5nZTo0NjVmZDI3YzU4NzU0YTJjYjljZTM4NTFkNDViMmM1MV8wLTAtMS0xLTIzMDI1_4a5d8ae7-11f0-4d77-aa84-558d1bc7e56c">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8xMjA_0be505a2-238d-4768-88db-032439bd5c5d">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8xMjA_ebf27604-7709-49a7-ac37-a995eae6c4d9">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6Y2Y1NTdmMmJlMjY4NDY4ODk0OTJhZTc2NjBiM2UzMWMvdGFibGVyYW5nZTpjZjU1N2YyYmUyNjg0Njg4OTQ5MmFlNzY2MGIzZTMxY18wLTAtMS0xLTIzMDI1_3ff8ebe5-1543-4255-b05f-8f250d9eefce">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzY5_2e2c8dc2-f8ce-4640-b683-2ece12a451ab">001-13149</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc0_9b9d7101-ba85-469c-8061-8ef3d92fdb0f">STRYKER CORP</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8wLTAtMS0xLTIzMDI1_708a5db1-0720-46d8-88b7-9d66f120f973">MI</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8wLTYtMS0xLTIzMDI1_a1d30f91-b28e-4633-9d15-9c9a8f671914">38-1239739</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTAtMS0xLTIzMDI1_64b339c5-ab53-4d5f-9702-ed906ba4404f">2825 Airview Boulevard,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTItMS0xLTIzMDI1_e9918d3f-ba51-4113-a155-30a0a0ac5af5">Kalamazoo,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTQtMS0xLTIzMDI1_1b19917c-9af5-4a4c-b786-271cb587b3c3">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV8zLTYtMS0xLTIzMDI1_38194ae9-a403-41be-bcf4-d0c7977cd527">49002</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV82LTMtMS0xLTIzMDI1_fae20751-ea19-46e5-8759-49f1530d2a70">(269)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6ZmUxZmFhNDg0MmFjNGYwOWIwMmY4Y2MzMWE5ZmZhNzkvdGFibGVyYW5nZTpmZTFmYWE0ODQyYWM0ZjA5YjAyZjhjYzMxYTlmZmE3OV82LTQtMS0xLTIzMDI1_e1b79e4c-fa0c-4792-a416-315bcf03d6f3">385-2600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTAtMS0xLTIzMDI1_c3f81d73-1c30-42db-a067-91b7c179dfde">Common Stock, $.10 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTEtMS0xLTIzMDI1_2ca0fbf0-5697-4ac6-9be9-ff096ca9d2f3">SYK</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8dadaeb8f4e74ab196e293b64b551cad_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8yLTItMS0xLTIzMDI1_b2e6ef5a-489a-445e-b182-9cc1c9b20615">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTAtMS0xLTIzMDI1_28318eca-5af4-4930-95a2-154ee860de9c">1.125% Notes due 2023</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTEtMS0xLTIzMDI1_9eccedfb-7afa-43ac-b629-c90246372ab2">SYK23</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i260807f9ca594869a1e64938a93873d5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl8zLTItMS0xLTIzMDI1_84f88c2d-28c8-4005-8bb5-ff4b0cf38b47">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTAtMS0xLTIzMDI1_8c72c479-f559-4222-acfa-83ed7dfc4661">0.250% Notes due 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTEtMS0xLTIzMDI1_e4014138-9921-4d87-a1ba-825405e34b7e">SYK24A</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i205d5fcce3144e79a7ce86160b3880dc_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl80LTItMS0xLTIzMDI1_cdb25d2b-ed6e-44ba-90a1-13bc13de02ab">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTAtMS0xLTIzMDI1_9f0587db-fd96-4e10-be51-d7df52dcc1fa">2.125% Notes due 2027</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTEtMS0xLTIzMDI1_0c0dbd7c-9e75-4240-9d8a-b796966fef08">SYK27</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie3b68d799ffe4588ab83d8df2d4d44af_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl81LTItMS0xLTIzMDI1_173c3859-d2c0-4625-acd6-eff492802107">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTAtMS0xLTIzMDI1_cd2088e0-b404-471b-81f1-1bcf1751e8b1">0.750% Notes due 2029</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTEtMS0xLTIzMDI1_0c7d845c-419a-411f-b563-43055f9fe624">SYK29</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic937960950424623b2f472ba5bd35835_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl82LTItMS0xLTIzMDI1_dedbb784-552e-4555-95a1-2990b8b65816">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTAtMS0xLTIzMDI1_c16f9c0b-41ba-4bb1-b7dd-30e250d94fc9">2.625% Notes due 2030</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTEtMS0xLTIzMDI1_f67c0030-4ba0-4029-a417-d8527fd8822e">SYK30</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8017ebfed8654b26b1d787efd3e2e825_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl83LTItMS0xLTIzMDI1_af0c8762-0af7-466c-9b23-454c0f2fb9e8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTAtMS0xLTIzMDI1_f3556ae7-6d44-4d97-85e8-d76694c2ec8e">1.000% Notes due 2031</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTEtMS0xLTIzMDI1_44461ff1-0c9b-4973-a439-8fe2f22890a1">SYK31</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2b946ae911184a959dddf6053669f3eb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6NzczNjE1NDUyMTYwNDhiNmJhMGRmMThkNGUxYjhlNjYvdGFibGVyYW5nZTo3NzM2MTU0NTIxNjA0OGI2YmEwZGYxOGQ0ZTFiOGU2Nl84LTItMS0xLTIzMDI1_6eaa1cf0-1c7f-48eb-8a15-b28e01943685">NYSE</dei:SecurityExchangeName>
    <dei:Security12gTitle
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcw_ce07d6eb-1392-428b-b8ab-259738ce4085">None</dei:Security12gTitle>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcx_b896fdb6-9246-4787-a295-5f569ab96883">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc1_0f515132-ccd8-4971-9bbf-cd8401279077">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc2_2c74957d-0e0a-4cd3-ba95-875e2f11364c">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc3_cb3fc25a-4c15-4dcf-a991-862ef8421b0b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8wLTAtMS0xLTIzMDI1_3551eb71-e9cc-4a18-a785-901f185cd344">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8wLTUtMS0xLTIzMDI1_871146d5-67dc-45fd-b57a-e969b6628265">false</dei:EntityEmergingGrowthCompany>
    <dei:EntitySmallBusiness
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGFibGU6MWM1NGU4MDY0NGUxNDJlZDg0NTU2NDUwNDFiZDJhMmEvdGFibGVyYW5nZToxYzU0ZTgwNjQ0ZTE0MmVkODQ1NTY0NTA0MWJkMmEyYV8xLTMtMS0xLTIzMDI1_fb6af7a0-6924-4d90-8c9a-421716bac389">false</dei:EntitySmallBusiness>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzcy_2abd16d5-c7c3-4cd3-9cc5-4cc5256053b4">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc4_9058fca8-f197-4ef9-adc0-52a65e644f0d">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i168731c7369c4ff38564f21924b77d5f_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNDE4_cc7b02bb-b02c-4d99-adef-1a25bc31896b"
      unitRef="usd">91942474363</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i9063bd1a2e38494a9c87d8c5d2de23d8_I20220131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNDM5_47545ae2-482a-4808-a7fb-21ad9a209f8f"
      unitRef="shares">377544686</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xL2ZyYWc6MWE2MmNjOGExZmJjNDhjOTliNTYyMmY3ZmViNGZmYzYvdGV4dHJlZ2lvbjoxYTYyY2M4YTFmYmM0OGM5OWI1NjIyZjdmZWI0ZmZjNl8yNzc5_9f0dae95-fd89-4f37-9861-8d2998883da4">Portions of the proxy statement to be filed with the U.S. Securities and Exchange Commission relating to the 2022 Annual Meeting of Shareholders (the 2022 proxy statement) are incorporated by reference into Part III.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183L2ZyYWc6ZjAyNzRmODRlMDc3NDZhY2E5ZmZiODlhZjVmYWU1MjMvdGFibGU6NjljNjQ3M2RiOWMyNGE5YjgzNWU0YTU5YTAxOTkyNGIvdGFibGVyYW5nZTo2OWM2NDczZGI5YzI0YTliODM1ZTRhNTlhMDE5OTI0Yl8xNC0xLTEtMS00MTQ1NS90ZXh0cmVnaW9uOjFhZjVhYTRhMGRkODQyZDU5MmY0NzUwMjNlNDNhNmI0XzEwOTk1MTE2Mjc4NTI_660f1a16-29a3-4fbe-881d-cc845a21f112">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183Ni9mcmFnOmM5ZTY3ZmY4ZGE1NDQzOTc5ODc0NTNjYWEyYzQwNTJiL3RleHRyZWdpb246YzllNjdmZjhkYTU0NDM5Nzk4NzQ1M2NhYTJjNDA1MmJfMTA5OTUxMTYzMTQ1OA_63c3477f-44bd-4329-89c1-057e95812330">ERNST&#160;&amp; YOUNG LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183Ni9mcmFnOmM5ZTY3ZmY4ZGE1NDQzOTc5ODc0NTNjYWEyYzQwNTJiL3RleHRyZWdpb246YzllNjdmZjhkYTU0NDM5Nzk4NzQ1M2NhYTJjNDA1MmJfMTA5OTUxMTYzMTQ1OQ_7d5b455e-6224-4aeb-9701-2cd180f51ec4">Grand Rapids, Michigan</dei:AuditorLocation>
    <us-gaap:Revenues
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS0xLTEtMS0yMzAyNQ_576d31c0-b92a-4803-a51a-79bc689f8b8b"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS0zLTEtMS0yMzAyNQ_58cb7640-2719-4f00-96a7-1ede97a18db9"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMS01LTEtMS0yMzAyNQ_caa47653-9a38-474b-847f-a57ca4584b5b"
      unitRef="usd">14884000000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi0xLTEtMS0yMzAyNQ_8970dc25-f1e8-40df-aa6e-2500b8593e9c"
      unitRef="usd">6140000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi0zLTEtMS0yMzAyNQ_611c33c5-c0bb-42a6-b30b-2f1722c825c4"
      unitRef="usd">5294000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMi01LTEtMS0yMzAyNQ_260f64e0-cb6a-4c2a-90c3-0336ef8d64e5"
      unitRef="usd">5188000000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy0xLTEtMS0yMzAyNQ_ce839a67-9817-4a0a-ba75-5d37d06bc5ed"
      unitRef="usd">10968000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy0zLTEtMS0yMzAyNQ_9fbcebcf-8874-4d60-ba62-83ab7d690ba4"
      unitRef="usd">9057000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMy01LTEtMS0yMzAyNQ_e4958492-9dd3-417b-833b-242f5f133c0a"
      unitRef="usd">9696000000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC0xLTEtMS0yMzAyNQ_9d157aac-2fc5-419f-9621-070e07421f44"
      unitRef="usd">1235000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC0zLTEtMS0yMzAyNQ_6cfeee48-c7a6-4583-b53a-619ec52ef826"
      unitRef="usd">984000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNC01LTEtMS0yMzAyNQ_50732c2e-a8a2-4f88-984c-1c059aa79a99"
      unitRef="usd">971000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS0xLTEtMS0yMzAyNQ_f512b7a7-0008-4a75-aedb-651017c3b48e"
      unitRef="usd">6427000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS0zLTEtMS0yMzAyNQ_6793984f-41ca-4c5d-9257-e3b5512a75c9"
      unitRef="usd">5361000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNS01LTEtMS0yMzAyNQ_d25a8e9b-8447-4ab0-b2a7-0e269d868f44"
      unitRef="usd">5356000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi0xLTEtMS0yMzAyNQ_b5ed0d82-2060-4f54-abb1-fa99c6967192"
      unitRef="usd">103000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi0zLTEtMS0yMzAyNQ_4692e582-4e6a-45f3-ba69-0c11438e5179"
      unitRef="usd">17000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNi01LTEtMS0yMzAyNQ_2ffdae45-c9ec-4fb5-8b0f-ba4de7c3b838"
      unitRef="usd">192000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy0xLTEtMS0yMzAyNQ_ebb43dd7-a52a-4df4-b762-8c72fdc9daf0"
      unitRef="usd">619000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy0zLTEtMS0yMzAyNQ_e9d19f31-c2b0-434d-bdfc-d89f41263876"
      unitRef="usd">472000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfNy01LTEtMS0yMzAyNQ_82721372-ad78-473f-a3ab-b91993c2597c"
      unitRef="usd">464000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingExpenses
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC0xLTEtMS0yMzAyNQ_ad7bcb0f-ad2f-46e5-9250-05237e7b78ca"
      unitRef="usd">8384000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC0zLTEtMS0yMzAyNQ_920a7995-adef-433a-a2d3-fc009e5a3386"
      unitRef="usd">6834000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOC01LTEtMS0yMzAyNQ_7910d698-beb9-41c2-a922-3f8881b2fc28"
      unitRef="usd">6983000000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS0xLTEtMS0yMzAyNQ_378bef28-a5fb-4ebd-8aab-91becd77c43b"
      unitRef="usd">2584000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS0zLTEtMS0yMzAyNQ_2f096e34-7489-4cbc-adb4-527b9581f657"
      unitRef="usd">2223000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfOS01LTEtMS0yMzAyNQ_771dda8b-7eb5-4a44-b504-4c9d90d31cb7"
      unitRef="usd">2713000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtMS0xLTEtMjMwMjU_cd3057fa-d2fa-48a1-90b3-7cac711e175f"
      unitRef="usd">-303000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtMy0xLTEtMjMwMjU_0862f688-9f8a-40df-ac1d-f9e11ac4550e"
      unitRef="usd">-269000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTAtNS0xLTEtMjMwMjU_aceedd32-5e16-4543-9e74-96e88fdbc5d5"
      unitRef="usd">-151000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtMS0xLTEtMjMwMjU_c875b40c-68a0-414c-a88a-08a23d36e374"
      unitRef="usd">2281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtMy0xLTEtMjMwMjU_9b386541-ba09-4511-bb2f-fb9d80aa5d0d"
      unitRef="usd">1954000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTEtNS0xLTEtMjMwMjU_eb5434d6-8589-4753-83ae-c7868e7d076a"
      unitRef="usd">2562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItMS0xLTEtMjMwMjU_3802d5e9-5278-44e0-8e7c-35b2e8cfa27e"
      unitRef="usd">287000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItMy0xLTEtMjMwMjU_45f40ecf-1389-4ab1-8ffb-da07edd6e989"
      unitRef="usd">355000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTItNS0xLTEtMjMwMjU_5c3a9407-a5b0-4f52-b6c6-95e0fd5be565"
      unitRef="usd">479000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtMS0xLTEtMjMwMjU_efddda4e-d598-4d28-b0f0-3019930c3370"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtMy0xLTEtMjMwMjU_480a3f47-8839-447a-b439-063e2fd3dcad"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTMtNS0xLTEtMjMwMjU_a279b7c4-737f-4bb5-91f3-1fbe36744b8d"
      unitRef="usd">2083000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtMS0xLTEtMjMwMjU_abfa5a03-f678-434b-a16a-35837c9fc149"
      unitRef="usdPerShare">5.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtMy0xLTEtMjMwMjU_c82e0560-4466-4db2-8c4e-21fc01ad7bf1"
      unitRef="usdPerShare">4.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTYtNS0xLTEtMjMwMjU_524e06c1-f8e7-4d3f-a544-6c860d2e863a"
      unitRef="usdPerShare">5.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctMS0xLTEtMjMwMjU_32fc9a87-94c9-427e-8098-d2a46e524df0"
      unitRef="usdPerShare">5.21</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctMy0xLTEtMjMwMjU_6f99b1db-ad94-4c83-9c8e-7f1f444b523b"
      unitRef="usdPerShare">4.20</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMTctNS0xLTEtMjMwMjU_c8f478e0-b476-4717-b5e4-b5fcab814b11"
      unitRef="usdPerShare">5.48</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtMS0xLTEtMjMwMjU_9c2ed527-2681-41f8-a5ca-973822c1a279"
      unitRef="shares">377000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtMy0xLTEtMjMwMjU_5d26c076-522b-4bb7-973f-4203b77f6d6d"
      unitRef="shares">375500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjAtNS0xLTEtMjMwMjU_768719d2-c1ed-4881-b261-b07b2f2c0164"
      unitRef="shares">374000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtMS0xLTEtMjMwMjU_4fc118e2-9400-4bd1-a404-485b5a8dd19c"
      unitRef="shares">5300000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtMy0xLTEtMjMwMjU_a4daa3dc-ce6c-419e-8db6-03e4fd341729"
      unitRef="shares">4800000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjEtNS0xLTEtMjMwMjU_08e89c29-21bd-42d8-a857-8ed69f3ca274"
      unitRef="shares">5900000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItMS0xLTEtMjMwMjU_70c7546f-9201-4427-b050-663324335acb"
      unitRef="shares">382300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItMy0xLTEtMjMwMjU_4c62a8fb-5243-4530-9891-00514466b247"
      unitRef="shares">380300000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM183OS9mcmFnOjY2NmY1YWZlMmQ2NTRiOGJiNzRkYTdlYjY5NjU4MTM5L3RhYmxlOmNmZDljNDA4MGNjZDQ0Y2Y5NTc3NDU0MzM5YTFlMWU1L3RhYmxlcmFuZ2U6Y2ZkOWM0MDgwY2NkNDRjZjk1Nzc0NTQzMzlhMWUxZTVfMjItNS0xLTEtMjMwMjU_94322009-9631-474e-aa6d-6ffe362f1bc3"
      unitRef="shares">379900000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS0xLTEtMS0yMzAyNQ_efddda4e-d598-4d28-b0f0-3019930c3370"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS0zLTEtMS0yMzAyNQ_480a3f47-8839-447a-b439-063e2fd3dcad"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMS01LTEtMS0yMzAyNQ_a279b7c4-737f-4bb5-91f3-1fbe36744b8d"
      unitRef="usd">2083000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy0xLTEtMS0yMzAyNQ_f55c94b1-7f80-40a3-bffa-f9284a15540f"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy0zLTEtMS0yMzAyNQ_8ea83412-a7ff-40a3-b07c-e5226ae6e27c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfMy01LTEtMS0yMzAyNQ_5f32596a-9b04-400a-96a1-4993a39114f7"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC0xLTEtMS0yMzAyNQ_951742ef-d182-48a1-9301-a54b96431a55"
      unitRef="usd">-104000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC0zLTEtMS0yMzAyNQ_2111338b-c37e-4a92-ae91-38b900bec6a1"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNC01LTEtMS0yMzAyNQ_e65a33c6-92e6-49ec-ada1-2f8fdc92eabf"
      unitRef="usd">42000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS0xLTEtMS0yMzAyNQ_c7b7b901-1b32-4963-94d0-c1a3a89e5fd1"
      unitRef="usd">50000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS0zLTEtMS0yMzAyNQ_b7636fa0-3a8b-4d18-af10-6bf67ec9b3a4"
      unitRef="usd">-57000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNS01LTEtMS0yMzAyNQ_bb900503-d2ba-41ab-8ce1-85b7337d04b1"
      unitRef="usd">-3000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi0xLTEtMS0yMzAyNQ_94ab791e-038e-437c-8a22-c547f2a64b26"
      unitRef="usd">469000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi0zLTEtMS0yMzAyNQ_740a71c7-1b4e-434b-89d5-528e6ea13dc7"
      unitRef="usd">-414000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNi01LTEtMS0yMzAyNQ_93eb0319-6b7b-442f-a655-b783f0f45bf1"
      unitRef="usd">69000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy0xLTEtMS0yMzAyNQ_215ea511-1a3c-4bbc-866c-2bfb8743737d"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy0zLTEtMS0yMzAyNQ_847cab85-47e1-4c3a-a10f-13540b96682e"
      unitRef="usd">-551000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfNy01LTEtMS0yMzAyNQ_b335662d-6d9c-4736-8f4b-f4305bd6452f"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC0xLTEtMS0yMzAyNQ_b5815bc4-2082-4349-b9c9-60ec4441ad51"
      unitRef="usd">2620000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC0zLTEtMS0yMzAyNQ_8fbbdef5-ef04-446d-8949-c3aef9055ee7"
      unitRef="usd">1048000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184Mi9mcmFnOjQ2NDVmYzM5NjVjOTQ0YmNiYmYzZTU1ZDM1ZTlmOTFlL3RhYmxlOmJkOGQ4MTYyMjkzODQzZWY4ZjRkNGQyZmMzNmNjNDI5L3RhYmxlcmFuZ2U6YmQ4ZDgxNjIyOTM4NDNlZjhmNGQ0ZDJmYzM2Y2M0MjlfOC01LTEtMS0yMzAyNQ_cf750b8f-cdf0-4a0d-9702-dd495c6b98f3"
      unitRef="usd">2108000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMy0xLTEtMS0yMzAyNQ_f669424e-adae-4dce-8c4f-bddbfc02e208"
      unitRef="usd">2944000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMy0zLTEtMS0yMzAyNQ_4f7448fa-e388-4b10-81fc-3c49c16a9ac1"
      unitRef="usd">2943000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNC0xLTEtMS0yMzAyNQ_6b0dde91-8375-47e6-9236-9c296e6bf202"
      unitRef="usd">75000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNC0zLTEtMS0yMzAyNQ_c274eaa0-721a-4d5e-a60c-af251e1ad746"
      unitRef="usd">81000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0wLTEtMS0yMzAyNS90ZXh0cmVnaW9uOjkzOGJiODkyYWMwNTRkNmRhMDRiMjBjMDVmZjk0MzkzXzEwOTk1MTE2Mjc4NDI_ab31f520-26ad-42fc-bb27-1b96db9dc39d"
      unitRef="usd">167000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0wLTEtMS0yMzAyNS90ZXh0cmVnaW9uOjkzOGJiODkyYWMwNTRkNmRhMDRiMjBjMDVmZjk0MzkzXzEwOTk1MTE2Mjc4NTA_e56cbd69-307d-4904-b5d4-fc27dca051a8"
      unitRef="usd">131000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0xLTEtMS0yMzAyNQ_3ed000a7-0aae-47e7-bf86-8a669a5bbab9"
      unitRef="usd">3022000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNS0zLTEtMS0yMzAyNQ_7ab29e00-973a-4946-8af6-97fcdb0cb1dd"
      unitRef="usd">2701000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNy0xLTEtMS0yMzAyNQ_d1e2a0b3-8c30-44ce-966c-a54117ff1d55"
      unitRef="usd">691000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNy0zLTEtMS0yMzAyNQ_bdb537f5-a1f6-4f2a-b44a-90ff73717e56"
      unitRef="usd">678000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOC0xLTEtMS0yMzAyNQ_2f9bae07-3495-47fd-b206-17d351f00976"
      unitRef="usd">264000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOC0zLTEtMS0yMzAyNQ_aacb0915-f4d0-4d1e-a486-a8daa641f1b3"
      unitRef="usd">251000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOS0xLTEtMS0yMzAyNQ_68cccc80-3eca-449a-a9e8-23450a6fbfc8"
      unitRef="usd">2359000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfOS0zLTEtMS0yMzAyNQ_1bb5d33a-c7d9-4f6a-a636-e4797f2bf2d5"
      unitRef="usd">2565000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTAtMS0xLTEtMjMwMjU_344bff1a-9d05-46f3-b522-122f4995b8b1"
      unitRef="usd">3314000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTAtMy0xLTEtMjMwMjU_3cd3e72e-add9-4f4b-bc7c-9657bea7b67d"
      unitRef="usd">3494000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTEtMS0xLTEtMjMwMjU_d0354aa2-b21f-484d-83fa-4b0427543935"
      unitRef="usd">662000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTEtMy0xLTEtMjMwMjU_4a59bd0c-1b10-4e41-a0c5-e50bec7b4a9e"
      unitRef="usd">488000000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTItMS0xLTEtMjMwMjU_1f246715-4761-4c29-b4b7-255b44d3b1ad"
      unitRef="usd">10017000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTItMy0xLTEtMjMwMjU_bb24116a-2aa8-451d-8d36-94c87cebdfd8"
      unitRef="usd">9707000000</us-gaap:AssetsCurrent>
    <syk:LandBuildingsAndImprovementsGross
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTQtMS0xLTEtMjMwMjU_8856f107-5ead-4ffc-ae2b-584e34620c2e"
      unitRef="usd">1656000000</syk:LandBuildingsAndImprovementsGross>
    <syk:LandBuildingsAndImprovementsGross
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTQtMy0xLTEtMjMwMjU_071d0cff-b621-4b29-8fb8-6ff412e7c2b3"
      unitRef="usd">1546000000</syk:LandBuildingsAndImprovementsGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTUtMS0xLTEtMjMwMjU_309b4e26-7200-4f0a-ac37-4466d7843da2"
      unitRef="usd">3842000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:MachineryAndEquipmentGross
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTUtMy0xLTEtMjMwMjU_75eb7dee-a784-4778-9510-0bd7b606c50e"
      unitRef="usd">3636000000</us-gaap:MachineryAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTYtMS0xLTEtMjMwMjU_0a2744ff-f3fb-4e11-9f6c-5577f03861d5"
      unitRef="usd">5498000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTYtMy0xLTEtMjMwMjU_3b1ee16e-f0ac-4948-9513-f53779788a36"
      unitRef="usd">5182000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTctMS0xLTEtMjMwMjU_861d6d31-bfbb-4c8d-9d33-7d1ab36a79ca"
      unitRef="usd">2665000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTctMy0xLTEtMjMwMjU_fb761439-f3f4-46c1-ae3a-079ba04b5305"
      unitRef="usd">2430000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTgtMS0xLTEtMjMwMjU_dc772d78-fa73-4cc7-b9fb-7ec1d52e5af6"
      unitRef="usd">2833000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTgtMy0xLTEtMjMwMjU_20565ca6-eab0-4368-840e-dbc13e8125b5"
      unitRef="usd">2752000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTktMS0xLTEtMjMwMjU_e93d0412-3298-4ccb-bba2-1ebb0239b8eb"
      unitRef="usd">12918000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMTktMy0xLTEtMjMwMjU_e035639f-413c-4ffe-80ca-fee10ec0a8cc"
      unitRef="usd">12778000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjAtMS0xLTEtMjMwMjU_d90df628-f9d6-47cd-b2e3-9ba988910c6f"
      unitRef="usd">4840000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjAtMy0xLTEtMjMwMjU_7513880f-eb8f-401f-83c9-8a38ee87c6c2"
      unitRef="usd">5554000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjEtMS0xLTEtMjMwMjU_81bc0299-8998-4045-8708-cebdffd88049"
      unitRef="usd">1760000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjEtMy0xLTEtMjMwMjU_03b13b07-c241-4fdd-ad35-dca09dc5c92b"
      unitRef="usd">1530000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjItMS0xLTEtMjMwMjU_31cc7f3a-d845-488a-97c1-f6e3ca9117a9"
      unitRef="usd">2263000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjItMy0xLTEtMjMwMjU_6a50402a-27c0-4024-a1d8-615b5856de51"
      unitRef="usd">2009000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjMtMS0xLTEtMjMwMjU_d5bcff3a-5859-4106-bf48-9ba9a3979e0e"
      unitRef="usd">34631000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjMtMy0xLTEtMjMwMjU_99b8ec2b-f804-4f28-a012-40dd28a08248"
      unitRef="usd">34330000000</us-gaap:Assets>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjctMS0xLTEtMjMwMjU_91738494-12d8-4bf4-9ffc-502c71e1f4f6"
      unitRef="usd">1129000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjctMy0xLTEtMjMwMjU_f46cc54d-199a-45ec-851b-44e600cf0ae7"
      unitRef="usd">810000000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjgtMS0xLTEtMjMwMjU_3094e8db-daf6-46ee-8c55-18f9ffc32e61"
      unitRef="usd">1092000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjgtMy0xLTEtMjMwMjU_d5eb77cf-543b-4875-97fc-7fbb3d857611"
      unitRef="usd">925000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjktMS0xLTEtMjMwMjU_68ae4a16-0d56-496b-9802-49e9815651e3"
      unitRef="usd">192000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMjktMy0xLTEtMjMwMjU_477b03be-5589-4e81-84f6-58c488173343"
      unitRef="usd">207000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzAtMS0xLTEtMjMwMjU_30232250-9555-479c-9c42-fa62fe7641a7"
      unitRef="usd">263000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:DividendsPayableCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzAtMy0xLTEtMjMwMjU_26c5e234-79bd-4a15-9b2c-5a6154682fe2"
      unitRef="usd">237000000</us-gaap:DividendsPayableCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzEtMS0xLTEtMjMwMjU_6a4ea2d8-7757-44b2-92e1-b6e542936837"
      unitRef="usd">401000000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzEtMy0xLTEtMjMwMjU_57d38da9-1ec7-4532-8ebf-dc76a70c4012"
      unitRef="usd">515000000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzItMS0xLTEtMjMwMjU_db44c85a-5628-4931-855a-7ba12b5f12ad"
      unitRef="usd">1465000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzItMy0xLTEtMjMwMjU_a5a4f516-4c88-4116-9db0-da0699ce7bdd"
      unitRef="usd">1586000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DebtCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzMtMS0xLTEtMjMwMjU_ddfc969c-8e88-4a41-91e7-0000efeb2ce6"
      unitRef="usd">7000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzMtMy0xLTEtMjMwMjU_a2ea9a44-f57c-4f02-823e-c97c58cacf31"
      unitRef="usd">761000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzQtMS0xLTEtMjMwMjU_34dc9f72-0405-44aa-a0b9-fbd8cbf28fd4"
      unitRef="usd">4549000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzQtMy0xLTEtMjMwMjU_50556c53-3d05-4cb3-9306-bdbc74abd253"
      unitRef="usd">5041000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzUtMS0xLTEtMjMwMjU_b79db30b-d0b4-41ef-96c0-49b5bea33dd0"
      unitRef="usd">12472000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzUtMy0xLTEtMjMwMjU_20d36bbe-b53c-49f3-a716-55a79cb691fd"
      unitRef="usd">13230000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzYtMS0xLTEtMjMwMjU_5984005b-3d99-44d0-a0eb-a94bc6292a7a"
      unitRef="usd">913000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzYtMy0xLTEtMjMwMjU_9b74ebc6-f464-4f22-9070-4fc49122cf6d"
      unitRef="usd">990000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzctMS0xLTEtMjMwMjU_c433e3d5-76c4-4ad9-800a-2e2cf7c398a6"
      unitRef="usd">1820000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzctMy0xLTEtMjMwMjU_8fc93805-49fa-4be1-a758-3104e8c056f7"
      unitRef="usd">1985000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzgtMS0xLTEtMjMwMjU_18e11406-1d55-42cf-a3fe-a3c2a1328702"
      unitRef="usd">19754000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfMzgtMy0xLTEtMjMwMjU_11992636-6e70-41d9-a0a1-3803892fb77c"
      unitRef="usd">21246000000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMC0xLTEtMjMwMjUvdGV4dHJlZ2lvbjo2NGM3MzgyZTNkNzE0YjY2OTc0NDM1Y2E2YTdiMjljN18xMDk5NTExNjI3ODE0_270c0ede-f4e7-4d6d-9d4f-5ff960123867"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMC0xLTEtMjMwMjUvdGV4dHJlZ2lvbjo2NGM3MzgyZTNkNzE0YjY2OTc0NDM1Y2E2YTdiMjljN18xMDk5NTExNjI3ODE0_45a0ac46-e0ea-4b97-83c9-fb2d36b45527"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockValueOutstanding
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMS0xLTEtMjMwMjU_a1ae0af4-ebf8-4436-bd77-6ef02b87f776"
      unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDAtMy0xLTEtMjMwMjU_badbdf8a-1d9d-4190-859e-774c6bfcf6e0"
      unitRef="usd">38000000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDEtMS0xLTEtMjMwMjU_860bc0ab-8ec9-4b1f-a157-00c3c7dbfa96"
      unitRef="usd">1890000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDEtMy0xLTEtMjMwMjU_4098aa5c-bb06-4718-9e54-5c70b6e6ea9a"
      unitRef="usd">1741000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDItMS0xLTEtMjMwMjU_56f4af5b-5a0f-4c3f-b7f8-f487987de17f"
      unitRef="usd">13480000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDItMy0xLTEtMjMwMjU_4de7c158-7630-459c-9758-8332b7e4cd3d"
      unitRef="usd">12462000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDMtMS0xLTEtMjMwMjU_e822613a-1a4c-4fa1-9e2e-4c4c96187163"
      unitRef="usd">-531000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDMtMy0xLTEtMjMwMjU_8a17f001-518b-4cc1-a28b-3ba03a2c423e"
      unitRef="usd">-1157000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDYtMS0xLTEtMjMwMjU_ac0e3ea2-08f9-4533-9df1-1ee5b744158f"
      unitRef="usd">14877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDYtMy0xLTEtMjMwMjU_191182c8-116a-48ff-9132-f38ce544d6aa"
      unitRef="usd">13084000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDctMS0xLTEtMjMwMjU_9e318553-03fa-40bf-87cb-9db122966dce"
      unitRef="usd">34631000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM184NS9mcmFnOjQzODhmOWI3NDI2ZjQ0ZDZhZDVlMjdlNzIxMjVhMmE4L3RhYmxlOmQyZTBmNmVmMWQwMzQ1MGM4ZTUxODFkZGFhMDNiYmE4L3RhYmxlcmFuZ2U6ZDJlMGY2ZWYxZDAzNDUwYzhlNTE4MWRkYWEwM2JiYThfNDctMy0xLTEtMjMwMjU_813a28be-176b-40cf-979d-ebbfdc5cb80c"
      unitRef="usd">34330000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy0xLTEtMS0yMzAyNQ_e112e826-d75f-41a0-98bf-50694b4e522e"
      unitRef="shares">376100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy0yLTEtMS0yMzAyNQ_ffd7fe26-7189-4d73-ac69-bf0534c7a091"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy00LTEtMS0yMzAyNQ_7b5de39b-c5aa-4680-828a-52719a3ac4ca"
      unitRef="shares">374500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy01LTEtMS0yMzAyNQ_2a3ec75d-40a6-457f-9c47-d96ba5ad8ff4"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i71b5c77df023413fa94d61740f8d881c_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy03LTEtMS0yMzAyNQ_1bd9161a-e78a-40f7-a85e-6620a1f1cb91"
      unitRef="shares">374400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71b5c77df023413fa94d61740f8d881c_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMy04LTEtMS0yMzAyNQ_fed38a89-59f3-4520-a1a9-372e56b4bb83"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC0xLTEtMS0yMzAyNQ_b4d43c72-6173-4041-a83a-3ee94df8ece5"
      unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC0yLTEtMS0yMzAyNQ_92dfc6ff-8351-4474-a6c3-b0d15bea67d9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC00LTEtMS0yMzAyNQ_6157e2cb-3c53-44b8-9616-b62c267b9d81"
      unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC01LTEtMS0yMzAyNQ_fe8b7ee5-0510-4205-9944-6eda27f0cf3f"
      unitRef="usd">1000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC03LTEtMS0yMzAyNQ_67f01820-86d8-4ca4-8d9e-f22f539d6964"
      unitRef="shares">2000000.0</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNC04LTEtMS0yMzAyNQ_33e2c806-580c-435a-840f-4ee76f95e476"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS0xLTEtMS0yMzAyNQ_14c50095-a9ba-4062-845f-bb931bcb1da0"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="iaf3bf5e2849f493389219be72340e2ad_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS0yLTEtMS0yMzAyNQ_e761221f-b397-488e-90df-d66d7e053b36"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS00LTEtMS0yMzAyNQ_63cbdc03-4378-4b3d-ae81-09a5bd142a31"
      unitRef="shares">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ieb152b61015a4721a6e5253e3ab42b53_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS01LTEtMS0yMzAyNQ_4d02ac4e-8c41-4b67-acc7-c1a8a15e15cc"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS03LTEtMS0yMzAyNQ_bd1b6a4e-00fd-41dc-bb7c-e7c123c6d2ff"
      unitRef="shares">1900000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ie9d988183992473c80ec9e89791c037f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNS04LTEtMS0yMzAyNQ_971de6d4-8dac-4c68-87e3-fc61bfc8e4b8"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i9becb79080734381bcde3430445f8f12_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi0xLTEtMS0yMzAyNQ_76286a11-3fc4-4de1-9b79-642dd02f42b5"
      unitRef="shares">377500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9becb79080734381bcde3430445f8f12_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi0yLTEtMS0yMzAyNQ_d4a72fcb-85b8-47e1-bcef-e97eafd11e52"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi00LTEtMS0yMzAyNQ_ee48170d-7ac7-4857-8194-2926f39936cb"
      unitRef="shares">376100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id065545fd0a8490a93760d3d3f7caa20_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi01LTEtMS0yMzAyNQ_c9e519fe-f499-4887-9cf8-96cca933b451"
      unitRef="usd">38000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi03LTEtMS0yMzAyNQ_f2253c10-cd7b-4219-8e6f-dc0f5fcfbeb6"
      unitRef="shares">374500000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b0a96f76e6b47348aeab92e410030dc_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfNi04LTEtMS0yMzAyNQ_e0def1a7-1927-4c67-b199-5c674f97c0c5"
      unitRef="usd">37000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80170d6b8dff45988d17971402b2a956_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC0yLTEtMS0yMzAyNQ_97ab4dc1-14ea-44a1-8055-7010055f9c76"
      unitRef="usd">1741000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC01LTEtMS0yMzAyNQ_67832f40-6a47-428f-b8c3-bfd730ea6f1a"
      unitRef="usd">1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01b0f8910e1148c7bcf2487217ae6387_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOC04LTEtMS0yMzAyNQ_f29435af-2642-4861-84bd-2fde1c26aeb4"
      unitRef="usd">1559000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS0yLTEtMS0yMzAyNQ_bc12cb53-71bc-499b-b8d1-7418b2e446fd"
      unitRef="usd">-22000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS01LTEtMS0yMzAyNQ_f8998e11-fe0c-429b-bf39-66f52cf73e18"
      unitRef="usd">-29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfOS04LTEtMS0yMzAyNQ_a9ab0641-0087-466b-b914-569b447e74c5"
      unitRef="usd">-50000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtMi0xLTEtMjMwMjU_dbc7f827-6a94-43ce-9057-90af1c78ce2b"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtNS0xLTEtMjMwMjU_836720d8-54ef-4436-853a-d6fe8a9c6843"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTAtOC0xLTEtMjMwMjU_1ab33fa4-13b3-451f-bd3b-f2d6723df349"
      unitRef="usd">8000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i977f185fff7246a097ea0082fe62710a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtMi0xLTEtMjMwMjU_0f889b29-1689-4a1f-95cd-ed20b8e0206d"
      unitRef="usd">171000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i3bb02b0708ae4dfb9588a163e11570a9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtNS0xLTEtMjMwMjU_0e721307-8421-40b3-9918-43e592772d90"
      unitRef="usd">142000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i0ec9ee74f7954e749b367a57e34700c6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTEtOC0xLTEtMjMwMjU_b31e1cf4-0c04-49b5-a48b-e094c2a92abd"
      unitRef="usd">127000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2670a9c10b1d408ab40717a9709b224d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItMi0xLTEtMjMwMjU_b1e33528-10cd-4f93-82f3-71dd2cd96108"
      unitRef="usd">1890000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i80170d6b8dff45988d17971402b2a956_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItNS0xLTEtMjMwMjU_def9d93b-c6fc-47a6-9bfd-fa00848f9076"
      unitRef="usd">1741000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4385d3d3433249a4a4d4dc8c8b811b71_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTItOC0xLTEtMjMwMjU_a7578ed9-b1f2-4f3a-ac2c-45ac3b8c0b1f"
      unitRef="usd">1628000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i867a13b6e18b444dbd004c9492789fdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtMi0xLTEtMjMwMjU_1c0d5c53-bb2c-4f0f-85c3-0f4d22256cbd"
      unitRef="usd">12462000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7552bdaa82d04e2faaa8351a026b88bb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtNS0xLTEtMjMwMjU_23d39ed2-d7ab-4048-8c2d-2e47a7636385"
      unitRef="usd">11748000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2f4ae1d1be414b55b5e9656c3e8710fe_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTQtOC0xLTEtMjMwMjU_4000ea8c-7e8e-4e4d-9c62-1d9f57763443"
      unitRef="usd">10765000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtMi0xLTEtMjMwMjU_5f1825d7-5377-4264-97cc-2a094abceb60"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtNS0xLTEtMjMwMjU_5c9392db-f5e6-46a3-b90f-8a6e6fcc4fe1"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTYtOC0xLTEtMjMwMjU_f6df8f8d-d764-491e-9388-fbc306318ff3"
      unitRef="usd">2083000000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctMi0xLTEtMjMwMjU_8cadb417-a310-4cc5-8edc-a69d326eb8ad"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctNS0xLTEtMjMwMjU_074e5714-3a91-4ea7-8a59-bfcbcc890cae"
      unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTctOC0xLTEtMjMwMjU_bb40b426-79e1-4ad1-a4fe-45a0e9065207"
      unitRef="usd">299000000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:DividendsCash
      contextRef="ib351518cfdd249e5884ad627fecac581_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtMi0xLTEtMjMwMjU_af4c9830-ccfb-4d7c-b593-68b19b2ab8c5"
      unitRef="usd">976000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="if5bae5213a4b4c7cad0f116fe87c3b40_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtNS0xLTEtMjMwMjU_eef5dfdc-94aa-427e-834b-7154a58ba672"
      unitRef="usd">885000000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="ic67bc97f5c864405bf8399c2b7c5afbf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTgtOC0xLTEtMjMwMjU_f0187554-997a-4d7a-ac9a-cb02037d57e6"
      unitRef="usd">801000000</us-gaap:DividendsCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c69abfa681e4e24818ac3eadfd6f813_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktMi0xLTEtMjMwMjU_5efa4b92-f9e6-469d-a1b8-e2b81527a1cb"
      unitRef="usd">13480000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i867a13b6e18b444dbd004c9492789fdf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktNS0xLTEtMjMwMjU_cbdc76bb-139f-42f0-bc11-c8dd29b98da2"
      unitRef="usd">12462000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7552bdaa82d04e2faaa8351a026b88bb_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMTktOC0xLTEtMjMwMjU_736f6562-bac9-4c67-bced-9600f1b4d80a"
      unitRef="usd">11748000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9bd43403e564ca1aaf610bb52886cb9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtMi0xLTEtMjMwMjU_9a7e9862-40f7-44d8-84ee-b32782408e49"
      unitRef="usd">-1157000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d120045c43c4af3a896790950cd8059_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtNS0xLTEtMjMwMjU_1daecf69-3527-4ea2-a133-3d39a1ee1328"
      unitRef="usd">-606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f87b165979c46dfb2cc60987739eabc_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjEtOC0xLTEtMjMwMjU_0eed849d-f514-4185-9f76-94e242711a53"
      unitRef="usd">-631000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItMi0xLTEtMjMwMjU_215ea511-1a3c-4bbc-866c-2bfb8743737d"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i82d74fabbcc44d498a3ffcb580f01a68_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItNS0xLTEtMjMwMjU_8c55c68c-54a4-4141-a3fc-160205264ff8"
      unitRef="usd">-551000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2367b67252704359babdcb904dbe95f8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjItOC0xLTEtMjMwMjU_3d0cf487-e823-4feb-94b1-dbccf6575fed"
      unitRef="usd">25000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52bca8038e1b46fc9b2afd0ead1648d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtMi0xLTEtMjMwMjU_448641b7-6cbd-4954-b7bb-919f331f83b9"
      unitRef="usd">-531000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id9bd43403e564ca1aaf610bb52886cb9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtNS0xLTEtMjMwMjU_14f9ec9c-f77b-4f04-9743-c82667d88cbb"
      unitRef="usd">-1157000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d120045c43c4af3a896790950cd8059_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMjMtOC0xLTEtMjMwMjU_522e7fc3-cf75-4b7f-85a2-ae7edde5e326"
      unitRef="usd">-606000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItMi0xLTEtMjMwMjU_b231cd23-ce38-4f93-8283-262ce677c46f"
      unitRef="usd">14877000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItNS0xLTEtMjMwMjU_d538b82f-fd79-40cc-a35e-e6a4328e006f"
      unitRef="usd">13084000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185MS9mcmFnOjQ4OTAyNzgyYzAzMTRkYTJhMTgxYmNmYjI3MGE4MGRiL3RhYmxlOmQxZWQ3ODk1MzY4NDQ2NTBiZjY1MmI5NTNkYjE5ZGFjL3RhYmxlcmFuZ2U6ZDFlZDc4OTUzNjg0NDY1MGJmNjUyYjk1M2RiMTlkYWNfMzItOC0xLTEtMjMwMjU_385070d0-f442-406f-8791-a915d93221b2"
      unitRef="usd">12807000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi0xLTEtMS0yMzAyNQ_3df55106-f95c-47ac-8a3d-80680765f463"
      unitRef="usd">1994000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi0zLTEtMS0yMzAyNQ_965a96fa-8f12-4d08-8025-6484f947ca2b"
      unitRef="usd">1599000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMi01LTEtMS0yMzAyNQ_2c0daef5-5114-4285-bc60-519c1f88d796"
      unitRef="usd">2083000000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC0xLTEtMS0yMzAyNQ_f2c253e4-e834-4aea-a9b4-00f5d35edda2"
      unitRef="usd">371000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC0zLTEtMS0yMzAyNQ_0e40b889-1143-4f03-bcd4-a4c2571c1a86"
      unitRef="usd">340000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNC01LTEtMS0yMzAyNQ_db115b2d-995c-4092-9355-42a085fe1172"
      unitRef="usd">314000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS0xLTEtMS0yMzAyNQ_70a721a1-b9a0-467a-b1f5-19c1cec0c8d8"
      unitRef="usd">619000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS0zLTEtMS0yMzAyNQ_c33449d3-ae86-4c4b-9b40-23afcbc61821"
      unitRef="usd">472000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNS01LTEtMS0yMzAyNQ_30410867-05ee-499a-a084-e2e0f9599460"
      unitRef="usd">464000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AssetImpairmentCharges
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi0xLTEtMS0yMzAyNQ_a30afed6-6643-40d9-bdc7-a07f9a9cab82"
      unitRef="usd">264000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi0zLTEtMS0yMzAyNQ_a26d73ac-80fa-4141-8832-8085c6098d44"
      unitRef="usd">215000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNi01LTEtMS0yMzAyNQ_8d588abb-efb7-4f89-a543-1a489d936ce2"
      unitRef="usd">16000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ShareBasedCompensation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy0xLTEtMS0yMzAyNQ_ed413208-7825-4204-b17d-d86b85ab78bf"
      unitRef="usd">171000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy0zLTEtMS0yMzAyNQ_4bb403cf-268c-4d7e-9c0e-5239ec6d455f"
      unitRef="usd">142000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNy01LTEtMS0yMzAyNQ_401c82df-1cf6-4523-9e27-be096b4d1a0c"
      unitRef="usd">127000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC0xLTEtMS0yMzAyNQ_a6344878-dd11-41b6-922a-c670ee20dd89"
      unitRef="usd">103000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC0zLTEtMS0yMzAyNQ_13ed8c61-f19a-442b-aff6-5d4e3ed53cc3"
      unitRef="usd">17000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <us-gaap:ProductLiabilityAccrualPeriodExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOC01LTEtMS0yMzAyNQ_8012491c-8d20-4c73-bf4e-517a0cefa06e"
      unitRef="usd">192000000</us-gaap:ProductLiabilityAccrualPeriodExpense>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS0xLTEtMS0yMzAyNQ_028a005b-f46a-4b1a-ac45-19dcebaa6107"
      unitRef="usd">266000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS0zLTEtMS0yMzAyNQ_180582de-0a45-4faa-9f1f-40873ce4ce3b"
      unitRef="usd">48000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <syk:SaleOfInventorySteppedUpToFairValueAtAcquisition
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfOS01LTEtMS0yMzAyNQ_3ceb7d85-0c48-49ef-873a-ca57f8f0942f"
      unitRef="usd">67000000</syk:SaleOfInventorySteppedUpToFairValueAtAcquisition>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtMS0xLTEtMjMwMjU_fecf9d82-598e-47b5-8fa8-5d4494790e53"
      unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtMy0xLTEtMjMwMjU_febbd873-e852-426e-b372-2079257db484"
      unitRef="usd">48000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTAtNS0xLTEtMjMwMjU_20db6c9a-486c-4826-b8c7-b46340a3eb44"
      unitRef="usd">126000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItMS0xLTEtMjMwMjU_73a86460-fe6d-4ef6-844e-9c6dbf8e2673"
      unitRef="usd">377000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItMy0xLTEtMjMwMjU_ecbd7b1d-a679-47d1-9317-aa3919c9cb9c"
      unitRef="usd">-354000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTItNS0xLTEtMjMwMjU_c551603b-a33f-47cf-82de-7ee26b45e7f7"
      unitRef="usd">563000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtMS0xLTEtMjMwMjU_df808829-0b66-49bf-a23d-a7ff3d48d750"
      unitRef="usd">189000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtMy0xLTEtMjMwMjU_4311a59f-9d0a-4ee7-bb15-5efb4a81cd2d"
      unitRef="usd">-27000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTMtNS0xLTEtMjMwMjU_e4901894-9b73-4eac-a3a1-fbeae81d51d0"
      unitRef="usd">400000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtMS0xLTEtMjMwMjU_6b0337d1-f4db-4c34-909f-58f488f7343f"
      unitRef="usd">329000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtMy0xLTEtMjMwMjU_09a33139-e642-4603-84ec-0ad51689a06f"
      unitRef="usd">100000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccountsPayableTrade
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTQtNS0xLTEtMjMwMjU_beda7aee-5bcd-4c15-a65c-d2f353f6886c"
      unitRef="usd">63000000</us-gaap:IncreaseDecreaseInAccountsPayableTrade>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtMS0xLTEtMjMwMjU_662cec57-3744-415e-8137-a03267d25daf"
      unitRef="usd">315000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtMy0xLTEtMjMwMjU_ff6a5d55-0922-4b7d-9fe7-59032a4cccc9"
      unitRef="usd">-54000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTUtNS0xLTEtMjMwMjU_ca30c153-e0cf-4822-9a71-756f3337a7a2"
      unitRef="usd">113000000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtMS0xLTEtMjMwMjU_06363cdf-fefd-4ccf-9e02-4ae259142d34"
      unitRef="usd">-221000000</syk:Changeinaccrualforrecallexpenses>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtMy0xLTEtMjMwMjU_5f4b830b-97d8-4078-a3f4-755bc6a60f03"
      unitRef="usd">-17000000</syk:Changeinaccrualforrecallexpenses>
    <syk:Changeinaccrualforrecallexpenses
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTYtNS0xLTEtMjMwMjU_2c1c2717-9839-4621-b1b1-316a1580a640"
      unitRef="usd">-177000000</syk:Changeinaccrualforrecallexpenses>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctMS0xLTEtMjMwMjU_1e4fdece-4969-4645-a8d0-3d99fac954c7"
      unitRef="usd">-98000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctMy0xLTEtMjMwMjU_7aa5fa75-8457-4daf-9072-da0d4b00d899"
      unitRef="usd">-16000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTctNS0xLTEtMjMwMjU_9db1e658-a6e7-45d0-ab7f-98d73a56ea01"
      unitRef="usd">-105000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtMS0xLTEtMjMwMjU_6d6e6959-38fc-4870-a3f8-92aa71e9aa9f"
      unitRef="usd">47000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtMy0xLTEtMjMwMjU_63a220ae-0f06-49b3-a6d2-3d09dc3851cd"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTgtNS0xLTEtMjMwMjU_589ad054-2ca6-4b09-83d8-6b7440ba085c"
      unitRef="usd">129000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktMS0xLTEtMjMwMjU_cffef309-827c-4b5d-b0d6-199a9257c2e1"
      unitRef="usd">3263000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktMy0xLTEtMjMwMjU_320b19e0-d975-4859-90b7-0bfc18d1d12a"
      unitRef="usd">3277000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMTktNS0xLTEtMjMwMjU_2c9adcc4-3c35-4f61-b2e0-5d94d18d5db9"
      unitRef="usd">2191000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtMS0xLTEtMjMwMjU_a98cb2d5-47e1-47e2-bdc0-87e94e2d5e74"
      unitRef="usd">339000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtMy0xLTEtMjMwMjU_6bbd5ec5-5ebb-4c1d-bd12-2939df494f16"
      unitRef="usd">4222000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjEtNS0xLTEtMjMwMjU_5164b874-d282-43b7-9cd3-c621f5997531"
      unitRef="usd">802000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItMS0xLTEtMjMwMjU_93b20542-4a45-4c76-a61a-cd5e98f72b99"
      unitRef="usd">49000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItMy0xLTEtMjMwMjU_2cda6e37-df87-488f-9644-ab2456db6fba"
      unitRef="usd">54000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjItNS0xLTEtMjMwMjU_0e04ccbb-774e-4ca9-8fee-e04281460f05"
      unitRef="usd">74000000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtMS0xLTEtMjMwMjU_ba6ddc91-4284-4299-80b0-9da825c5aeed"
      unitRef="usd">55000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtMy0xLTEtMjMwMjU_c5d02bb0-4f15-4774-bc95-51e7f55cdcd5"
      unitRef="usd">61000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjMtNS0xLTEtMjMwMjU_43de930b-2f69-4948-a2e0-f2f42c60463e"
      unitRef="usd">69000000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtMS0xLTEtMjMwMjU_67e60813-ccc3-4332-a6e7-bfb7b0ab9205"
      unitRef="usd">525000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtMy0xLTEtMjMwMjU_7ccfa7bc-5865-4143-b655-76922d97902b"
      unitRef="usd">487000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjQtNS0xLTEtMjMwMjU_3da3a8ec-1de3-4fc9-8b29-00a6923f6498"
      unitRef="usd">649000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtMS0xLTEtMjMwMjU_389f108f-148f-4d89-bf27-7320978e475b"
      unitRef="usd">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtMy0xLTEtMjMwMjU_22fa90cc-0ad6-491a-8608-d9fadccb95cc"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjUtNS0xLTEtMjMwMjU_dff97249-6bd6-4e5a-953a-7fbd5e1a6a75"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtMS0xLTEtMjMwMjU_b9585afa-a11f-4b34-8dc1-5e4b54c65227"
      unitRef="usd">-859000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtMy0xLTEtMjMwMjU_0f400da3-b114-4cbd-8896-63eb3df04d81"
      unitRef="usd">-4701000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjYtNS0xLTEtMjMwMjU_18eb4ceb-f4a9-4174-b8a9-3733ae573802"
      unitRef="usd">-1455000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtMS0xLTEtMjMwMjU_ebcdb3b2-13e7-473d-a494-ce99e8fb48b9"
      unitRef="usd">-7000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtMy0xLTEtMjMwMjU_709ed988-a3e0-4fae-8374-b3c71d2ceb21"
      unitRef="usd">-6000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfShortTermDebt
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjgtNS0xLTEtMjMwMjU_c6cb5d35-46a3-47be-ac59-e0781c509119"
      unitRef="usd">-7000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktMS0xLTEtMjMwMjU_9ddc465b-95c6-4523-b849-74a89c73b87f"
      unitRef="usd">5000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktMy0xLTEtMjMwMjU_26e73151-2e87-438b-b499-8c2d5b4df789"
      unitRef="usd">3292000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMjktNS0xLTEtMjMwMjU_4d1671d5-629e-4b3a-8485-03b33ba24849"
      unitRef="usd">2642000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtMS0xLTEtMjMwMjU_4a274cca-9cf5-4e82-aada-b71deda2617d"
      unitRef="usd">1151000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtMy0xLTEtMjMwMjU_ffb97cd1-a2bf-4764-82fe-b6b24fda8f98"
      unitRef="usd">2297000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzAtNS0xLTEtMjMwMjU_a5a5ce1b-dc98-4fa1-b169-170437039275"
      unitRef="usd">1342000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentsOfDividends
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtMS0xLTEtMjMwMjU_3b6d4f42-8c06-47b8-a78c-c829ea5bb4f7"
      unitRef="usd">950000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtMy0xLTEtMjMwMjU_785027ed-9c8f-405d-bae0-3ca28e1f4ab2"
      unitRef="usd">863000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzEtNS0xLTEtMjMwMjU_35c1aa53-72b0-4e3f-af75-f5e1f3273e0b"
      unitRef="usd">778000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItMS0xLTEtMjMwMjU_7a72c17d-9ac4-4493-a1f7-17ba2a4aa5da"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItMy0xLTEtMjMwMjU_ed509646-eb09-43f8-87ca-1dd3610fd069"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzItNS0xLTEtMjMwMjU_fa78d15b-fc03-4108-bb6d-6ee1e3c8fd29"
      unitRef="usd">307000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtMS0xLTEtMjMwMjU_bec53dc4-a56e-4c35-9a83-a7faf5ff97f9"
      unitRef="usd">114000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtMy0xLTEtMjMwMjU_619e3dc8-a04c-461a-9ecb-5d230bbba2a0"
      unitRef="usd">110000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzMtNS0xLTEtMjMwMjU_cb8d6f2b-db38-4384-834a-9ac7aa6ce01c"
      unitRef="usd">136000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtMS0xLTEtMjMwMjU_eb06fa32-fa29-471d-b97a-b4f38a7fe4d8"
      unitRef="usd">-148000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtMy0xLTEtMjMwMjU_bc6e3ec4-b119-495f-a00a-baf5abf24a42"
      unitRef="usd">-27000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzUtNS0xLTEtMjMwMjU_7631844b-1c86-41ed-a1ad-f6977b9c202f"
      unitRef="usd">-69000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtMS0xLTEtMjMwMjU_48d22f50-d08d-469a-a1dd-37c36b3e2da6"
      unitRef="usd">-2365000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtMy0xLTEtMjMwMjU_53fba18c-24d3-4f69-9551-8ae5adbf4430"
      unitRef="usd">-11000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzYtNS0xLTEtMjMwMjU_5d755991-1f62-4400-8495-f2d8652873af"
      unitRef="usd">3000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctMS0xLTEtMjMwMjU_70aca0a7-8b44-42d6-9928-b02893b2306e"
      unitRef="usd">-38000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctMy0xLTEtMjMwMjU_64817ff2-69d8-4aaa-9580-f57d2e3d6f28"
      unitRef="usd">41000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzctNS0xLTEtMjMwMjU_447628f0-13f4-4fb4-acf9-56573797ccf0"
      unitRef="usd">-18000000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtMS0xLTEtMjMwMjU_e0e9f222-e450-4d6d-9a9a-ffa60118e129"
      unitRef="usd">1000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtMy0xLTEtMjMwMjU_48ba9a08-2498-45e3-ae59-ff19a592cd07"
      unitRef="usd">-1394000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzgtNS0xLTEtMjMwMjU_a2907ff5-634c-4ca3-aeaa-9dd75799c4d5"
      unitRef="usd">721000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktMS0xLTEtMjMwMjU_70e12ffa-7c87-4abd-8ee2-b0ecd94b3787"
      unitRef="usd">2943000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktMy0xLTEtMjMwMjU_53e34578-2c41-42d4-b1f4-3b250ae537fe"
      unitRef="usd">4337000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if42e188b90414f3b945a27e7e2b1974f_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfMzktNS0xLTEtMjMwMjU_5d4642ae-bc95-453d-b5f6-16128a92c234"
      unitRef="usd">3616000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtMS0xLTEtMjMwMjU_dbf08034-f1db-4ac2-bb05-9dc67a358846"
      unitRef="usd">2944000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtMy0xLTEtMjMwMjU_5ab8a06e-b216-42a7-96ea-d3e113b15fb4"
      unitRef="usd">2943000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDAtNS0xLTEtMjMwMjU_c1d99b06-6492-4b0b-a14e-d18408bf3e8d"
      unitRef="usd">4337000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtMS0xLTEtMjMwMjU_1ea9d80c-330d-4b6d-a0d4-a692fe0eab07"
      unitRef="usd">622000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtMy0xLTEtMjMwMjU_d9af285e-c62d-44b6-8aa7-5e7fb8245c44"
      unitRef="usd">323000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDMtNS0xLTEtMjMwMjU_735dd655-f1b8-4735-8e6c-69ac7e28a98e"
      unitRef="usd">457000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtMS0xLTEtMjMwMjU_34331bc2-c8d7-4072-b9b6-80954bfdfae3"
      unitRef="usd">325000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtMy0xLTEtMjMwMjU_0abbadca-4205-4d57-a8b4-76b0db9031c6"
      unitRef="usd">304000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM185NC9mcmFnOjFlZmY1YzkxMjAzMTQzZTE4ZmFiMzhhMGQ2YmQ0YjBlL3RhYmxlOjlmMTFiZDkwY2M2MTRhYzhhZDgyMGE4NTk1MjUzZTdmL3RhYmxlcmFuZ2U6OWYxMWJkOTBjYzYxNGFjOGFkODIwYTg1OTUyNTNlN2ZfNDQtNS0xLTEtMjMwMjU_4fa472ad-692f-4287-aa30-52f7b6089d11"
      unitRef="usd">286000000</us-gaap:InterestPaidNet>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDcy_a95e7b67-1cfc-4de6-bc14-dc9250a4c7c2">SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Nature of Operations: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. Prior years' segment results have been reclassified to conform with current year presentation in our Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Use of Estimates: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Revenue Recognition: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cost of Sales: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Research, Development and Engineering Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Selling, General and Administrative Expenses: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Currency Translation: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Cash Equivalents: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Marketable Securities: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounts Receivable: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Inventories: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.333%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Financial Instruments:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2021 and 2020. Refer to Notes 3 and 10 for further details. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Derivatives:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="display:inline-block;max-width:3.333%;min-width:2.333%;vertical-align:top"/&gt;&lt;div style="display:inline-block;vertical-align:top;width:48.334%"&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense in the Consolidated Statements of Earnings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Property, Plant and Equipment:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill and Other Intangible Assets:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Goodwill, Intangibles and Long-Lived Asset Impairment Tests:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Share-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Income Taxes:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In October 2021 the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. We are evaluating the impact this update will have on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NatureOfOperations
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDU2_c9372f3c-04ea-44a0-8436-7d4bb3664e85">Stryker (the "Company," "we," "us," or "our") is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The Company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes. Our products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a variety of medical specialties.</us-gaap:NatureOfOperations>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDcz_c8ba6cb6-cc92-4c8e-9caa-4a63a3bda55c">The Consolidated Financial Statements include the Company and its subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation. We have no material interests in variable interest entities and none that require consolidation. Prior years' segment results have been reclassified to conform with current year presentation in our Consolidated Financial Statements.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDk1_ce977648-3d70-4b7c-9155-0f97da48c476">The preparation of financial statements in conformity with accounting principles generally accepted in the United States (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of net sales and expenses in the reporting period. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTQ5_79bf21ab-67c8-45b7-886f-42623cd467f6">Sales are recognized as the performance obligations to deliver products or services are satisfied and are recorded based on the amount of consideration we expect to receive in exchange for satisfying the performance obligations. Our sales are recognized primarily when we transfer control to the customer, which can be on the date of shipment, the date of receipt by the customer or, for most Orthopaedics products, when we have received a purchase order and appropriate notification the product has been used or implanted. Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales represent the amount of consideration we expect to receive from customers in exchange for transferring products and services. Net sales exclude sales, value added and other taxes we collect from customers. Other costs to obtain and fulfill contracts are generally expensed as incurred due to the short-term nature of most of our sales. We extend terms of payment to our customers based on commercially reasonable terms for the markets of our customers, while also considering their credit quality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A provision for estimated sales returns, discounts and rebates is recognized as a reduction of sales in the same period that the sales are recognized. Our estimate of the provision for sales returns has been established based on contract terms with our customers and historical business practices and current trends. Shipping and handling costs charged to customers are included in net sales.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTMx_2224d0ab-7210-483d-a144-a4db62730723">Cost of sales is primarily comprised of direct materials and supplies consumed in the manufacture of product, as well as manufacturing labor, depreciation expense and direct overhead expense necessary to acquire and convert the purchased materials and supplies into finished product. Cost of sales also includes the cost to distribute products to customers, inbound freight costs, warehousing costs and other shipping and handling activity.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTE4_0da427e1-2e57-480d-b60b-93524163a1ad">Research, development and engineering costs are charged to expense as incurred. Costs include research, development and engineering activities relating to the development of new products, improvement of existing products, technical support of products and compliance with governmental regulations for the protection of customers and patients. Costs primarily consist of salaries, wages, consulting and depreciation and maintenance of research facilities and equipment.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDY3_bd170f0a-f2d0-49c2-8740-70b6152e83ee">Selling, general and administrative expense is primarily comprised of selling expenses, marketing expenses, administrative and other indirect overhead costs, amortization of loaner instrumentation, depreciation and amortization expense of non-manufacturing assets and other miscellaneous operating items.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMjA5_4c5f802a-c34e-4cda-9f0e-819547e26650">Financial statements of subsidiaries outside the United States generally are measured using the local currency as the functional currency. Adjustments to translate those statements into United States Dollars are recorded in other comprehensive income (OCI). Transactional exchange gains and losses are included in other income (expense), net.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTkw_b14145d6-08c1-436a-95da-0590e0c2b013">Highly liquid investments with remaining stated maturities of three months or less when purchased or other money market instruments that are redeemable upon demand are considered cash equivalents and recorded at cost.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDkz_e54d547b-57da-4849-9632-1d75a005cc1f">Marketable securities consist of marketable debt securities, certificates of deposit and mutual funds. Mutual funds are acquired to offset changes in certain liabilities related to deferred compensation arrangements and are expected to be used to settle these liabilities and are recognized in other noncurrent assets. Pursuant to our investment policy, all individual marketable security investments must have a minimum credit quality of single A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) and A2 (Moody&#x2019;s Corporation) at the time of acquisition, while the overall portfolio of marketable securities must maintain a minimum average credit quality of double A (Standard&#160;&amp;amp; Poor&#x2019;s and Fitch) or Aa (Moody&#x2019;s Corporation). In the event of a rating downgrade below the minimum credit quality subsequent to purchase, the marketable security investment is evaluated to determine the appropriate action to take to minimize the overall risk to our marketable security investment portfolio. Our marketable securities are classified as available-for-sale and trading securities. Investments in trading securities represent participant-directed investments of deferred employee compensation.</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDc2_bd6dc106-a5dc-4295-bb4b-24d29f1a102b">Accounts receivable consists of trade and other miscellaneous receivables. An allowance is maintained for doubtful accounts for estimated losses in the collection of accounts receivable. Estimates are made regarding the ability of customers to make required payments based on historical credit experience, current market conditions and expected credit losses. Accounts receivable are written off when all reasonable collection efforts are exhausted.</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDYy_713957b7-03a1-4b55-a606-1950611f3732">Inventories are stated at the lower of cost or net realizable value, with cost generally determined using the first-in, first-out (FIFO) cost method. For excess and obsolete inventory resulting from the potential inability to sell specific products at prices in excess of current carrying costs, reserves are maintained to reduce current carrying cost to net realizable value.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:FairValueOptionTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTIw_3762e395-7625-4e24-b791-b139643e8135">Our financial instruments consist of cash, cash equivalents, marketable securities, accounts receivable, other investments, accounts payable, debt and foreign currency exchange contracts. The carrying value of our financial instruments, with the exception of our senior unsecured notes, approximates fair value on December&#160;31, 2021 and 2020. Refer to Notes 3 and 10 for further details. &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;All marketable securities are recognized at fair value. Adjustments to the fair value of marketable securities that are classified as available-for-sale are recognized as increases or decreases, net of income taxes, within accumulated other comprehensive income (AOCI) in shareholders&#x2019; equity and adjustments to the fair value of marketable securities that are classified as trading are recognized in earnings. The amortized cost of marketable debt securities is adjusted for amortization of premiums and discounts to maturity computed under the effective interest method. Such amortization and interest and realized gains and losses are included in other income (expense), net. The cost of securities sold is determined by the specific identification method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We review declines in the fair value of our investments classified as available-for-sale to determine whether the decline in fair value is a result of credit loss or other factors. Impairments of available-for-sale marketable debt securities related to credit loss are included in earnings and impairments related to other factors are recognized within AOCI.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOptionTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMjEy_7c3950d8-5947-4a4b-adc7-ee2db930f92b">All derivatives are recognized at fair value and reported on a gross basis. We enter into forward currency exchange contracts to mitigate the impact of currency fluctuations on transactions denominated in nonfunctional currencies, thereby limiting our risk that would otherwise result from changes in exchange rates. The periods of the forward currency exchange contracts correspond to the periods of the exposed transactions, with realized gains and losses included in the measurement and recording of transactions denominated in the nonfunctional currencies. All forward currency exchange contracts are recorded at their fair value each period.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts designated as cash flow hedges are designed to hedge the variability of cash flows associated with forecasted transactions denominated in a foreign currency that will take place in the future. These nonfunctional currency exposures principally relate to forecasted intercompany sales and purchases of manufactured products and generally have maturities up to eighteen months. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in cost of goods sold in the Consolidated Statements of Earnings. Cash flows associated with these hedges are included in cash from operations in the same category as the cash flows from the items being hedged.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forward currency exchange contracts are used to offset our exposure to the change in value of specific foreign currency denominated assets and liabilities, primarily intercompany payables and receivables. These derivatives are not designated as hedges and, therefore, changes in the value of these forward contracts are recognized in earnings, thereby offsetting the current earnings effect of the related changes in value of foreign currency denominated assets and liabilities. The estimated fair value of our forward currency exchange contracts represents the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;measurement of the contracts at month-end spot rates as adjusted by current forward points. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate derivative and non-derivative financial instruments as net investment hedges of our investments in certain international subsidiaries. For derivative instruments that are designated and qualify as a net investment hedge, the effective portion of the derivative's gain or loss is recognized in OCI and reported as a component of AOCI. We have elected to use the spot method to assess effectiveness for our derivatives designated as net investment hedges. Accordingly, the change in fair value attributable to changes in the spot rate is recorded in AOCI. We exclude the spot-forward difference from the assessment of hedge effectiveness and amortize this amount separately on a straight-line basis over the term of the forward contracts. This amortization is recognized in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;From time to time, we designate forward starting interest rate derivative instruments as cash flow hedges to manage the exposure to interest rate volatility with regard to future issuance and refinancing of debt. Changes in value of derivatives designated as cash flow hedges are recorded in AOCI on the Consolidated Balance Sheets until earnings are affected by the variability of the underlying cash flows. At that time, the applicable amount of gain or loss from the derivative instrument that is deferred in shareholders&#x2019; equity is reclassified into earnings and is included in interest expense in the Consolidated Statements of Earnings. &lt;/span&gt;&lt;/div&gt;Interest rate derivative instruments designated as fair value hedges have been used in the past to manage the exposure to interest rate movements and to reduce borrowing costs by converting fixed-rate debt into floating-rate debt. Under these agreements, we agree to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated by reference to an agreed-upon notional principal amount.</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTEy_6ad4bc5c-0cce-4e2d-be5e-36b97bae8e94">Property, plant and equipment is stated at cost. Depreciation is generally computed by the straight-line method over the estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzA2_c41ef51d-93c3-4a51-89d9-118446f8bb06"&gt;three&lt;/span&gt; to 30 years for buildings and improvements and &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzU2_624cc7b2-7a44-4404-875e-1f2be67031ee"&gt;three&lt;/span&gt; to 15 years for machinery and equipment.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iea80d9ec270a42ddb859da9ac5218675_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzEy_b9227eb4-99d9-4593-94b1-8d410d8a5e52">P30Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8e2f3cb539e04b21a6d749132943270d_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzEzMzYy_728765da-4faf-494b-b638-e968e827989b">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTY4_2654fa57-3f63-4a88-83a7-99a5c3b6f323">Goodwill represents the excess of purchase price over fair value of tangible net assets of acquired businesses at the acquisition date, after amounts allocated to other identifiable intangible assets. Factors that contribute to the recognition of goodwill include synergies that are specific to our business and not available to other market participants and are expected to increase net sales and profits; acquisition of a talented workforce; cost savings opportunities; the strategic benefit of expanding our presence in core and adjacent markets; and diversifying our product portfolio.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair values of other identifiable intangible assets acquired in a business combination are primarily determined using the income approach. Other intangible assets include, but are not limited to, developed technology, customer and distributor relationships (which reflect expected continued customer or distributor patronage) and trademarks and patents. Intangible assets with determinable useful lives are amortized on a straight-line basis over their estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTEx_2c550d36-f534-489a-8138-91bc94717c1b"&gt;four&lt;/span&gt; to 40 years. Certain acquired trade names are considered to have indefinite lives and are not amortized, but are assessed annually for potential impairment as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In some of our acquisitions, we acquire in-process research and development (IPRD) intangible assets. For acquisitions accounted for as business combinations IPRD is considered to &lt;/span&gt;&lt;/div&gt;be an indefinite-lived intangible asset until the research is completed (then it becomes a determinable-lived intangible asset) or determined to have no future use (then it is impaired). For asset acquisitions IPRD is expensed immediately unless there is an alternative future use.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id4d5184394bb4869a0faafe74b973913_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE0NTE3_5be6124c-3ef5-4723-8cad-33e8d0e47974">P40Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDgy_946ad359-9922-49fc-b025-66bf77c85c96">We perform our annual impairment test for goodwill in the fourth quarter of each year. We consider qualitative indicators of the fair value of a reporting unit when it is unlikely that a reporting unit has impaired goodwill and periodically corroborate that assessment with quantitative information. In certain circumstances, we may also utilize a discounted cash flow analysis that requires certain assumptions and estimates be made regarding market conditions and our future profitability. Indefinite-lived intangible assets are also tested at least annually for impairment by comparing the individual carrying values to the fair value.We review long-lived assets for indicators of impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. The evaluation is performed at the lowest level of identifiable cash flows. Undiscounted cash flows expected to be generated by the related assets are estimated over the asset's useful life based on updated projections. If the evaluation indicates that the carrying amount of the asset may not be recoverable, any potential impairment is measured based upon the fair value of the related asset or asset group as determined by an appropriate market appraisal or other valuation technique. Assets classified as held for sale are recorded at the lower of carrying amount or fair value less costs to sell.</syk:GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDYz_1a88a979-89a6-45b1-9081-dcd22106f28e">hare-based compensation is in the form of stock options, restricted stock units (RSUs) and performance stock units (PSUs). Stock options are granted under long-term incentive plans to certain key employees and non-employee directors at an exercise price not less than the fair market value of the underlying common stock, which is the quoted closing price of our common stock on the day prior to the date of grant. The options are granted for periods of up to 10 years and become exercisable in varying installments.&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We grant RSUs to key employees and non-employee directors and PSUs to certain key employees under our long-term incentive plans. The fair value of RSUs is determined based on the number of shares granted and the quoted closing price of our common stock on the date of grant, adjusted for the fact that RSUs do not include anticipated dividends. RSUs generally vest in one-third increments over a three-year period and are settled in stock. PSUs are earned over a three-year performance cycle and vest in March of the year following the end of that performance cycle. The number of PSUs that will ultimately be earned is based on our performance relative to pre-established goals in that three-year performance cycle. The fair value of PSUs is determined based on the quoted closing price of our common stock on the day of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Compensation expense is recognized in the Consolidated Statements of Earnings based on the estimated fair value of the awards on the grant date. Compensation expense recognized reflects an estimate of the number of awards expected to vest after taking into consideration an estimate of award forfeitures based on actual experience and is recognized on a straight-line basis over the requisite service period, which is generally the period required to obtain full vesting. Management expectations related to the achievement of performance goals associated with PSU grants is assessed regularly and that assessment is used to &lt;/span&gt;&lt;/div&gt;determine whether PSU grants are expected to vest. If performance-based milestones related to PSU grants are not met or not expected to be met, any compensation expense recognized associated with such grants will be reversed.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzE3MDI1_a70c00f8-eecc-438b-ab82-d5c23a6b0352">P10Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTYz_c38b7668-f7d7-4ebd-a97c-1007d53417d6">P3Y</syk:SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTM3_75a86afd-2278-455c-b896-3e444bc781a6">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDg3_3f0a9e05-f9f4-4f2d-ba86-1c754915806b">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMTk0_66723606-d978-4bf6-9cac-20a7a81d8e72">Deferred income tax assets and liabilities are determined based on differences between financial reporting and income tax bases of assets and liabilities and are measured using the enacted income tax rates in effect for the years in which the differences are expected to reverse. Deferred income tax benefits generally represent the change in net deferred income tax assets and liabilities in the year. Other amounts result from adjustments related to acquisitions and foreign currency as appropriate.We operate in multiple income tax jurisdictions both within the United States and internationally. Accordingly, management must determine the appropriate allocation of income to each of these jurisdictions based on current interpretations of complex income tax regulations. Income tax authorities in these jurisdictions regularly perform audits of our income tax filings. Income tax audits associated with the allocation of this income and other complex issues, including inventory transfer pricing and cost sharing, product royalty and foreign branch arrangements, may require an extended period of time to resolve and may result in significant income tax adjustments if changes to the income allocation are required between jurisdictions with different income tax rates.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDAvZnJhZzpmYTdkN2I1OGFmNjA0YTA4ODYyZGVlYTg0NzU2ZWI5Ni90ZXh0cmVnaW9uOmZhN2Q3YjU4YWY2MDRhMDg4NjJkZWVhODQ3NTZlYjk2XzIxMDU1_fa7c769b-610f-4145-b5a6-9a6138588815">&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;New Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In October 2021 the Financial Accounting Standards Board issued Accounting Standards Update 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations: Accounting for Contract Assets and Contract Liabilities from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. This update requires an entity to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Accounting Standards Codification 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;. We are evaluating the impact this update will have on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;No new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM5MTU_24de83e5-abcf-4a74-bde2-5a127ae84f73">REVENUE RECOGNITION&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Products and services are primarily transferred to customers at a point in time, with some transfers of services taking place over time. In 2021 less than 10% of our sales were recognized as services transferred over time. Refer to Note 1 for further discussion on our revenue recognition policies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,006&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,957&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,927&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;MedSurg and Neurotechnology products include surgical equipment and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment and intensive care disposable products (Medical), minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke (Neurovascular), a comprehensive line of products for traditional brain and open skull based surgical procedures; orthobiologic and biosurgery products, including synthetic bone grafts and vertebral &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;augmentation products (Neuro Cranial) and other medical device products used in a variety of medical specialties. Substantially all MedSurg and Neurotechnology sales are recognized when a purchase order has been received and control has transferred. For certain Endoscopy, Instruments and Medical services, we may recognize sales over time as we satisfy performance obligations that may include an obligation to complete installation, provide training and perform ongoing services, generally performed within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Orthopaedics and Spine products consist primarily of implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. Substantially all Orthopaedics sales are recognized when we have received a purchase order and appropriate notification the product has been used or implanted. Substantially all Spine sales are recognized when a purchase order has been received and control has transferred. For certain Orthopaedic products in the "other" category, we recognize sales at a point in time, as well as over time for performance obligations that may include an obligation to complete installation and provide training and ongoing services. Performance obligations are generally satisfied within one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Assets and Liabilities &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The nature of our products and services do not generally give rise to contract assets as we typically do not incur costs to fulfill a contract before a product or service is provided to a customer. Our costs to obtain contracts are typically in the form of sales commissions paid to employees or third-party agents. Certain sales commissions paid to employees prior to recognition of sales are recorded as contract assets. We expense sales commissions associated with obtaining a contract at the time of the sale or as incurred as the amortization period is generally less than one year. These costs have been presented within selling, general and administrative expenses. On December&#160;31, 2021 contract assets recorded in our Consolidated Balance Sheets were not significant.&lt;/span&gt;&lt;/div&gt;Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $529 and $416 on December&#160;31, 2021 and December&#160;31, 2020.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <syk:PercentageofServiceRevenueRecognizeoverTime
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzQyMw_4ffc7b30-2659-43e2-bd5f-b559bf7d3683"
      unitRef="number">0.10</syk:PercentageofServiceRevenueRecognizeoverTime>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM5MTI_407244ed-1aee-40c8-8ac2-ae1017d389d7">&lt;div style="margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,959&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,607&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,538&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,345&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,475&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,570&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,006&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,409&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;United States Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,910&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,218&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;6,470&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,295&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,237&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,321&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,455&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;10,957&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;International Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Instruments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Endoscopy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neurovascular&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Neuro Cranial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,127&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,005&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Knees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Hips&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trauma and Extremities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,275&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,769&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,787&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,896&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,927&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i6b444fdfd4114975835f712db85f57df_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItMS0xLTEtMjMwMjU_fa614726-b80e-42da-b0e6-19534d3a45a4"
      unitRef="usd">2111000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i390e0b268e414b8f9d49e0d83841a8a0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItMy0xLTEtMjMwMjU_c530c6ad-656f-47e3-a974-15b8ee7d3f3c"
      unitRef="usd">1863000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i764c1f66472a4d62a4a8976787e08574_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzItNS0xLTEtMjMwMjU_03d94d4d-5cda-4d21-ae19-cdcb4bb5dbbf"
      unitRef="usd">1959000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c0c3f21be164ebea0b665c3e075dca9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtMS0xLTEtMjMwMjU_14f40034-980e-4888-8061-8a212c489c90"
      unitRef="usd">2141000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e3f8d2756374f598396b4e9f1242e4b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtMy0xLTEtMjMwMjU_e0b63fcc-e5d8-4833-bad6-60d6e3312dbf"
      unitRef="usd">1763000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i309806bb11ff41a2a9e882a99bad0aed_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzMtNS0xLTEtMjMwMjU_386d9901-ac6b-419d-80f2-cb78cab9ab0e"
      unitRef="usd">1983000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id287ce7c576e4ea3925b95b5da00c78c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtMS0xLTEtMjMwMjU_e1ce6fb5-27ab-4bd9-a2d9-961c524ff786"
      unitRef="usd">2607000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf17bc05109f4e979b894e6b5c677384_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtMy0xLTEtMjMwMjU_8c1e014e-238a-406c-811f-855913a46bf9"
      unitRef="usd">2524000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24bf8fb2be2c4a3089319f9462f2f44d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzQtNS0xLTEtMjMwMjU_14ff0c97-feec-4ea1-983e-d4917881560d"
      unitRef="usd">2264000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75b07ba08eb4425189e18508e67ef022_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMS0xLTEtMzE1NjU_19af1f2e-75b7-4a7d-8aaa-7724163048f0"
      unitRef="usd">1188000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icadbc6876b0c4a2e9b96d00656980180_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMy0xLTEtMzE1NjU_3900bf95-65a8-4ce7-8c39-e41ac07847e6"
      unitRef="usd">973000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0204ee9ab1854e4bb45e61ddc5a338a2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtNS0xLTEtMzE1NjA_97a92601-a2e1-4917-bb66-323b4b923f03"
      unitRef="usd">924000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac738aea624e43db94884598610ec371_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMS0xLTEtMzE1NjU_cda187a9-6d28-4847-acfc-82dc37bfd49f"
      unitRef="usd">1214000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieed282f1ecf14d7d80d3e4b74e03cdf3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMy0xLTEtMzE1NjU_536f6432-ca02-47a1-828d-993119478098"
      unitRef="usd">972000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6477d0161a4843db9d24e33b01902361_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtNS0xLTEtMzE1NjA_f148bbc1-e22d-4705-84ef-48c5cf4dc916"
      unitRef="usd">1059000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if72d972689ad4922b7665802f781c461_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMS0xLTEtMjMwMjU_519b6ad3-8e1c-47d0-b426-85f8365cc279"
      unitRef="usd">277000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i10b621eadd294693b0520b76f0f11d92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtMy0xLTEtMjMwMjU_2d0da474-1a1b-470b-84a7-5a47273d7cc1"
      unitRef="usd">250000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6fdfaed011624ea2b76682b408d01222_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzUtNS0xLTEtMjMwMjU_3d7a06a2-506d-4a7e-8200-70585d07d533"
      unitRef="usd">286000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMS0xLTEtMjMwMjU_55703639-0ce6-4f97-93aa-f8ab68d9bd03"
      unitRef="usd">9538000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtMy0xLTEtMjMwMjU_4faecf89-b1ad-4d02-a446-d033febb9300"
      unitRef="usd">8345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7728f777c79940228eafdad70914c783_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzYtNS0xLTEtMjMwMjU_b8f6f2e4-0f7a-4e50-9490-8f57a3e33c34"
      unitRef="usd">8475000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b08d632247540e0b3c29c04aacd461f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtMS0xLTEtMjMwMjU_b4c4500b-6eda-422c-970d-8185aa7be65f"
      unitRef="usd">1848000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb4bd223e1a4a24889683e87146a929_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtMy0xLTEtMjMwMjU_e0a45d4a-e142-468b-aa36-2e7f82a90cbc"
      unitRef="usd">1567000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i61e348f6119d46a88d69fe763e6cf9fa_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzgtNS0xLTEtMjMwMjU_019a0008-048f-4874-aab1-c91df4f20a55"
      unitRef="usd">1815000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i341271d78c7a4206947bca3b7cde395f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktMS0xLTEtMjMwMjU_05ea5c51-2861-4ed7-9cd2-a7ac77b56fdc"
      unitRef="usd">1342000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5c49a6e730644609880acbc477da03e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktMy0xLTEtMjMwMjU_13882114-c07f-4ba2-b1e2-5c5ff16bed99"
      unitRef="usd">1206000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic119b1fa0c0143538533bba2f3b95138_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzktNS0xLTEtMjMwMjU_687aa992-d135-4edd-ba5c-4f2badc9980a"
      unitRef="usd">1383000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4f89663db2e4dcd91f2a239604498e7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTEtMS0xLTIzMDI1_1d313c00-e517-4075-b06a-b54289b994c9"
      unitRef="usd">2664000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08a811a396c54be69d7679faeabb9796_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTMtMS0xLTIzMDI1_c262fc23-b3ed-438e-9979-919d118f5445"
      unitRef="usd">1722000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia168ec9d45e74093b60a8c0db927613f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEwLTUtMS0xLTIzMDI1_17d6f15f-e724-4e2e-b5c3-0b9b7c1429f2"
      unitRef="usd">1639000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib8aa2f3c162a4b938419bc9018039728_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTEtMS0xLTMxNTI2_066b95dc-f07c-4160-bfba-263f90a1c261"
      unitRef="usd">1167000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i92bc71ae63244b42848463e8f166f45e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTMtMS0xLTMxNTM3_fe3c8b2c-ee0b-4d36-bc31-0b6ef6332c62"
      unitRef="usd">1047000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76acfc033a4b4a1fb195cec65bb11702_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEzLTUtMS0xLTMxNTU0_ec1e30f3-f237-4b1b-af53-7e5bd3b6f30c"
      unitRef="usd">1157000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i02851b5d44484d838b322bb70419e1fd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTEtMS0xLTIzMDI1_c359e339-6654-49f5-bdb8-39de1c393018"
      unitRef="usd">549000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i18219da346bb4cf8b4922993ee49a73a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTMtMS0xLTIzMDI1_52adbcfb-6db8-4ee1-a067-93d9dfeb8149"
      unitRef="usd">464000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifea456eb74734994a3ba7247aac1dda2_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzExLTUtMS0xLTIzMDI1_1e98d4ce-fb02-44f7-9f0d-401c2c984e86"
      unitRef="usd">415000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTEtMS0xLTIzMDI1_72423750-332d-47d6-89e4-0ebfb346b346"
      unitRef="usd">7570000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTMtMS0xLTIzMDI1_fd029953-870c-4f94-ac6b-a703ac8d58c3"
      unitRef="usd">6006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6858a6cd717d489e810d6a92befb51b9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzEyLTUtMS0xLTIzMDI1_175345e7-00a0-4245-b687-e9cb0914a230"
      unitRef="usd">6409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTEtMS0xLTIzMDI1_5e4deed3-8850-4ced-ab1c-c9787d64be75"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTMtMS0xLTIzMDI1_7deb32ce-6fc1-4670-8d7c-cb2b34847243"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpiZDFmNGE5MjEzOTE0MjkzYWRiNGQ3NjQ4NTVmNDY3Zi90YWJsZXJhbmdlOmJkMWY0YTkyMTM5MTQyOTNhZGI0ZDc2NDg1NWY0NjdmXzE3LTUtMS0xLTIzMDI1_d17afd4b-eb27-49b6-956f-e6aacd44d15e"
      unitRef="usd">14884000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3313eb4600a44b6faccc26b2974f7496_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItMS0xLTEtMjMwMjU_dd2ebf22-ed52-4c76-bd17-100321b7110d"
      unitRef="usd">1637000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id7312fb8079f489ca025dfd4b3f324d5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItMy0xLTEtMjMwMjU_23bb998d-2d1c-4eb6-90d9-02dc0249cb30"
      unitRef="usd">1471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1054325428345d2aca70dffa2f35f05_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzItNS0xLTEtMjMwMjU_5536f072-6569-46a1-8c19-f06a571e7dcc"
      unitRef="usd">1542000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i838adf850af9448e83d8cb2ca7ee3cce_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtMS0xLTEtMjMwMjU_529b9159-651b-4a28-b90b-3a63fd3b4f81"
      unitRef="usd">1670000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia6aa60e488594c2e9d84921cd2278f0d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtMy0xLTEtMjMwMjU_0ae01584-bd5f-4cd4-9367-492393c0c1a7"
      unitRef="usd">1408000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib601c6c2389846cf9f085ecbf9e004cc_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzMtNS0xLTEtMjMwMjU_7dcca2a5-8899-43fc-bf3e-5904d5eb0a30"
      unitRef="usd">1577000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia4f5ff37751b4228bd155d7017fca70e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtMS0xLTEtMjMwMjU_8bee544a-172a-4e3f-84ae-7f948f6bb15d"
      unitRef="usd">2007000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c2d20f3fc714b3fb42530500f7a77c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtMy0xLTEtMjMwMjU_b9c1bf1e-b7b3-4920-b96a-0fe9fca07fc6"
      unitRef="usd">1910000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i88f85a0225bb45ff93c9e5a28ffbadea_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzQtNS0xLTEtMjMwMjU_f36b90df-2f40-44f9-8192-820abcc89440"
      unitRef="usd">1787000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55b0b8f766624b5aa1783ef3697e9b20_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMS0xLTEtMzE2Mjg_13e34781-0709-4027-ab59-ebe7d7dcc9d2"
      unitRef="usd">451000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i304183cc0af4431d9b285023ea26a72d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMy0xLTEtMzE2Mzk_7e6c63cc-7ced-469e-85d9-f148a9f4a6ab"
      unitRef="usd">381000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iab91cf46dd9e42daaab5e9e0c7a6f3d7_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtNS0xLTEtMzE2NzU_9c7b65b2-f80e-4d61-a021-a88ace6f7874"
      unitRef="usd">391000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i99c3ffb583b64bec8e62c626a9117c9c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMS0xLTEtMzE2Mjg_4bf59dcd-77ee-46f3-951d-cccec28dab36"
      unitRef="usd">988000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied70e04d41a84cddb788cfd887902d21_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMy0xLTEtMzE2Mzk_e1834623-08f6-4af1-93e8-42691f0edec9"
      unitRef="usd">801000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6720a7b09590406fa78b5cbf501d252d_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtNS0xLTEtMzE2NzU_bf8f6058-5469-4ab1-a932-972a24a8b3a4"
      unitRef="usd">890000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6fa7261b15f94c2eb63be5955c04b03d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMS0xLTEtMjMwMjU_a7ecee4a-17fa-4eea-af1a-1a66dd011ee1"
      unitRef="usd">273000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i697479f2046e497ea88627c07ee8852e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtMy0xLTEtMjMwMjU_3c893da3-d41b-49c5-a50d-2bd0e1e51080"
      unitRef="usd">247000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ec948b236274ddf8f4810eb5cc97ce9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzUtNS0xLTEtMjMwMjU_78b57d68-efaa-4dfb-94b9-f0341ad8ca17"
      unitRef="usd">283000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic29ffe107ea24e1389192f99d0a767a7_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMS0xLTEtMjMwMjU_bd3830db-33c6-46ae-b6df-89ef24840948"
      unitRef="usd">7026000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib93218ae922f45f5a1cf776dc39c830f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtMy0xLTEtMjMwMjU_15f9ba47-569c-44ec-af07-38bfff6c451b"
      unitRef="usd">6218000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac0d485d1c2f45c1a9cab57c8ab1300c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzYtNS0xLTEtMjMwMjU_2fe445b7-6a59-4c05-8fe6-838b48c03065"
      unitRef="usd">6470000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id2c8448f9de9491eb03da17046dc00a1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtMS0xLTEtMjMwMjU_0afd6afe-4755-41e9-ad4a-7d9794c2721b"
      unitRef="usd">1351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idd688039b6c24b09ac8456cead87b0be_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtMy0xLTEtMjMwMjU_122dc794-fdb4-48b4-8697-49dbb5186f62"
      unitRef="usd">1170000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idb7a0419c3734edf884537ca4e542fdf_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzgtNS0xLTEtMjMwMjU_3797036d-2c1f-4473-83ef-8ebace78b90a"
      unitRef="usd">1347000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib81829ee9e6345368cf338d2658cdc6c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktMS0xLTEtMjMwMjU_2d049fda-4dec-4de0-9cd7-af1a67593b3f"
      unitRef="usd">822000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5349cb00c0ad4a4083b3dc3c6c276bad_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktMy0xLTEtMjMwMjU_a5f06f35-9b4c-4c6d-a63d-1ca6a680f327"
      unitRef="usd">777000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i81957f0cf1484ba38b95f8c9ecc5a5d9_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzktNS0xLTEtMjMwMjU_cf102e5b-db6e-44fc-9644-0bd93881a0b6"
      unitRef="usd">882000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad0a15234cbb4344bb4ca7e8ab0ab171_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTEtMS0xLTIzMDI1_0a6f242a-bdb7-4826-9808-f442d2ab2e20"
      unitRef="usd">1866000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i05a31d5a18104fff9025782da56d7787_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTMtMS0xLTIzMDI1_adb4785e-9157-4193-afcd-9dcafd1fb601"
      unitRef="usd">1139000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a6260841aa5465bb9e462b166e24b07_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEwLTUtMS0xLTIzMDI1_b2154907-57c5-425d-aa8b-fc81543009a5"
      unitRef="usd">1051000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if31b6de31d4f46c0a7a11072d41c2800_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTEtMS0xLTMxNzE5_a868d2a3-c2bd-47f0-9f25-d4d63a2cc823"
      unitRef="usd">831000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id45dd029eb07468ca3154dc544a63e6e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTMtMS0xLTMxNzI4_28a7870d-50cb-4944-ba37-5420ffa9fed1"
      unitRef="usd">764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9ba7e2e0e4db4edfbca7ef8727fc3908_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEzLTUtMS0xLTMxOTA5_43f0668f-0186-4916-afaa-ebc73e767549"
      unitRef="usd">873000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54354e05970043bdb07f6e9c15ed0abf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTEtMS0xLTIzMDI1_e47b97e6-360b-4549-b2b5-5315e8e7713d"
      unitRef="usd">425000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f9191aefdf04dd8b33791fa64741598_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTMtMS0xLTIzMDI1_f85ef8d2-02f4-4773-b13f-9a4d2126d521"
      unitRef="usd">387000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425cac663597403caf6cc7508116f568_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzExLTUtMS0xLTIzMDI1_c7e2dfa5-72bc-443e-8848-51f88817c3d7"
      unitRef="usd">334000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1b53aa1b3f2142aaa114bc47e6623cc9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTEtMS0xLTIzMDI1_5b197314-036a-49b1-9116-068499c1475e"
      unitRef="usd">5295000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06a17e906ae8452da05c7bb782ac6172_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTMtMS0xLTIzMDI1_74b1c0ba-403f-4759-8b3c-55cacf7e05e9"
      unitRef="usd">4237000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53bf28c4e64640c1bbea6979d86e3f4f_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzEyLTUtMS0xLTIzMDI1_2c37c4f3-723e-43f5-adf8-4a1979a28f6f"
      unitRef="usd">4487000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTEtMS0xLTIzMDI1_d20c92ce-9b3d-4748-8127-37583df5b3b0"
      unitRef="usd">12321000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTMtMS0xLTIzMDI1_47d63077-0185-4351-8c13-a49502296e8c"
      unitRef="usd">10455000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib993db761cc4478a866ff2db39f59836_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZTpjYWVlMWYwYzNkZmI0ZjNlYTUyMjJmZTUzYWIyODI4Mi90YWJsZXJhbmdlOmNhZWUxZjBjM2RmYjRmM2VhNTIyMmZlNTNhYjI4MjgyXzE3LTUtMS0xLTIzMDI1_b3c81fcb-ed29-46ae-bb10-9b50730802ee"
      unitRef="usd">10957000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1debb8f23cc84c6fb84fe03a3c972ba6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItMS0xLTEtMjMwMjU_1e64ddea-525e-4dfa-974a-8b1250ab0de5"
      unitRef="usd">474000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1fc24ab232c447f986a9240dc08901c5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItMy0xLTEtMjMwMjU_17a280d7-353a-435a-ba74-bad3bf107ac1"
      unitRef="usd">392000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84b80df0a367428b8b9a465b8e3c21fb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzItNS0xLTEtMjMwMjU_a3803128-d65c-4f49-a179-25d5d6a9b6da"
      unitRef="usd">417000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i282a513298204115a77781c1dd5f4247_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtMS0xLTEtMjMwMjU_0c6618e8-0d14-4783-b031-1d21c0daaae1"
      unitRef="usd">471000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifc3891e66b1a4f0f87e7010e0d1e8784_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtMy0xLTEtMjMwMjU_4aa32511-6ae8-403e-a38c-9de488c04804"
      unitRef="usd">355000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idda804ddfb2c4bff8ee7c14205d1311e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzMtNS0xLTEtMjMwMjU_e6f21711-e7ff-429b-b661-c95e9d7a9e04"
      unitRef="usd">406000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icfc063acf78e4bd08280c305320cc7e0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtMS0xLTEtMjMwMjU_703e7139-99cb-461f-8620-689d3e715e9c"
      unitRef="usd">600000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieec5e2be30f44eb99d345e1094f393a1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtMy0xLTEtMjMwMjU_7471fd2f-5504-4d2b-ad4f-499af85c1e38"
      unitRef="usd">614000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i678ed992a3df4a148ac4cda3936f752b_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzQtNS0xLTEtMjMwMjU_b32a05eb-cceb-4117-b413-d368e83eb40f"
      unitRef="usd">477000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fdd98e5a1a84c7fbf7bd96a78a60fdc_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMS0xLTEtMzE3NDA_88ec889a-28a3-4833-aee4-c6b9a03e8b27"
      unitRef="usd">737000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03dee15ce37348bbad87d69932241272_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMy0xLTEtMzE3NDc_0ab4451d-93d5-41ad-84c8-b2206d0ea2bd"
      unitRef="usd">592000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4fef7e7698de4e8caf1c760d79d20d4c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtNS0xLTEtMzE5MTk_775d224d-5977-4163-9b58-e6c6240d0614"
      unitRef="usd">533000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibd3a823fe4ca4366b2768db2d8b5b0d5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMS0xLTEtMzE3NDA_54b8a8db-244f-4a09-a1a5-67b8a8431140"
      unitRef="usd">226000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1886d202248d4d57b78e584a981fc5cb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMy0xLTEtMzE3NDc_1acd305e-1792-4236-998f-eca71a80aaf7"
      unitRef="usd">171000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib44b439abfc245aebc3340a2b62a8221_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtNS0xLTEtMzE5MTk_b385474c-5a30-4662-91fa-d59fcc77cb66"
      unitRef="usd">169000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i80ef92b6615045d4b2062896ded9bbc5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMS0xLTEtMjMwMjU_ed3c204a-3ac1-40a6-a36c-f9027b5385b2"
      unitRef="usd">4000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie69c1f527ffb40c695af85cc7c5db79f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtMy0xLTEtMjMwMjU_c5475549-b372-412a-b67e-7282a322676d"
      unitRef="usd">3000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c8fc671d26d49df8904f1b61f9081e8_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzUtNS0xLTEtMjMwMjU_3fb5a27f-be65-4ef6-81fd-b4da8fccdb81"
      unitRef="usd">3000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b9a67d017a8431f92a32c80c6879b56_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMS0xLTEtMjMwMjU_f9d1efcc-6e56-401d-9682-387e481de195"
      unitRef="usd">2512000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i57502b50a979495bb8c5df03c59bac37_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtMy0xLTEtMjMwMjU_0d95e129-68a5-4386-9cd8-a7e3317de8e1"
      unitRef="usd">2127000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f03e61dba444a09a7a52d84fea542ce_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzYtNS0xLTEtMjMwMjU_0366d2a5-e3bd-46dd-9ece-3235ea704bd3"
      unitRef="usd">2005000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i55b1c2cee07b498e95d93aa7b85803e9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtMS0xLTEtMjMwMjU_0d547f30-c8c4-4f12-bb46-911155817e20"
      unitRef="usd">497000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7d762e565f504e11951b765770476668_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtMy0xLTEtMjMwMjU_b1485343-14c7-4c94-8dc9-eaae2a57b88f"
      unitRef="usd">397000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i07256403bc854160be4404f8370b023a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzgtNS0xLTEtMjMwMjU_3d2ec7fb-2564-4152-b059-2b051857f35b"
      unitRef="usd">468000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide46d2faceb7499aab7014ec2fd595c9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktMS0xLTEtMjMwMjU_a527ada7-13bb-4cb0-825b-e44e76705888"
      unitRef="usd">520000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ba2d61f5af8485dbf21906bf0f4aa74_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktMy0xLTEtMjMwMjU_3d439e91-baf2-4fdb-86a7-446e84824968"
      unitRef="usd">429000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3226395d1abb430c8b2c0c5dc6845197_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzktNS0xLTEtMjMwMjU_33251442-f24e-4c0d-8b45-8fc00efdd2bf"
      unitRef="usd">501000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if7d60c4249bc459a90844052b4ecb962_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTEtMS0xLTIzMDI1_1b68d6cc-b7c8-47d2-b1ba-c0bc75c9596e"
      unitRef="usd">798000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic5ff7aabafd94e57bd5bb96fbf4651e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTMtMS0xLTIzMDI1_59faccbd-1388-462b-82b4-0b93961fd2d9"
      unitRef="usd">583000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i83a3271cb4ba4c8e8f3b440f5b6593b4_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEwLTUtMS0xLTIzMDI1_97d9f5cd-9842-4dbf-9d11-8a18968f2c14"
      unitRef="usd">588000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idccdb90407784aa4a69cbad64bd54ec6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTEtMS0xLTMxNzU4_44d25a9b-223c-43ab-b79b-5ef620ffb2e3"
      unitRef="usd">336000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia229486a6b2a46e4b942600ec82f03e1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTMtMS0xLTMxNzY3_3343245d-1d2d-4b41-a194-d875e37d1161"
      unitRef="usd">283000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8ba6c463bf0b45e09760a30ab1e70dba_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEzLTUtMS0xLTMxOTMw_27310203-e4c1-4ffb-8f19-90146831f0ec"
      unitRef="usd">284000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5658ed54f3ad41b58d8370fdbe277451_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTEtMS0xLTIzMDI1_49a9f448-2e66-460f-8e22-e839b0f5e546"
      unitRef="usd">124000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6f50b1a58554482a86eae0ad88635b27_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTMtMS0xLTIzMDI1_09d65a5a-7f74-426d-85be-0a553775e509"
      unitRef="usd">77000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i14ef25118cc84ec18b82cbbb33c9b30c_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzExLTUtMS0xLTIzMDI1_059c180d-d9b8-41c0-af08-10c562b0d9ce"
      unitRef="usd">81000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3bedb945b15e46caa838af3a4e317243_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTEtMS0xLTIzMDI1_23dfe4b7-2325-45a1-aeea-f545467a1cca"
      unitRef="usd">2275000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5797053cbabf44609ba2cdc56f6172fd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTMtMS0xLTIzMDI1_14a1353b-ff91-4813-9892-550659e06463"
      unitRef="usd">1769000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icddb0ba9518f400295350436917a4675_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzEyLTUtMS0xLTIzMDI1_70111dcc-3b4a-44c2-8597-936dd89fc944"
      unitRef="usd">1922000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie3f940887fab4704bda5bc6c6fea7411_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTEtMS0xLTIzMDI1_1342f731-6c79-4cc5-95dd-78dd7877a482"
      unitRef="usd">4787000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib9813457a2c14f50beeed7c796c5110c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTMtMS0xLTIzMDI1_740ae4a7-3a1f-4d60-af6d-5a99340ec7a5"
      unitRef="usd">3896000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iace6d4c12e6c4fe6a1850720afff5392_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90YWJsZToyNWFjODFmMGUxNzE0YmIxODhlZTVkMmExYjFmMjYyMy90YWJsZXJhbmdlOjI1YWM4MWYwZTE3MTRiYjE4OGVlNWQyYTFiMWYyNjIzXzE3LTUtMS0xLTIzMDI1_10926004-0247-4135-a8bd-8f90e54eb611"
      unitRef="usd">3927000000</us-gaap:Revenues>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM4ODg_b9629d30-9da5-4baa-a69e-15a643f65c34"
      unitRef="usd">529000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDMvZnJhZzoyZmEzYTQ5ZGM0MDc0OWRiYmM0MjliNDZmMzNjM2UxNy90ZXh0cmVnaW9uOjJmYTNhNDlkYzQwNzQ5ZGJiYzQyOWI0NmYzM2MzZTE3XzM4OTU_4744393c-318d-4af7-b62d-89a54446c16f"
      unitRef="usd">416000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2NzQ_b59af354-8068-4480-a742-81ac6d17839b">FAIR VALUE MEASUREMENTS &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Financial assets and liabilities carried at fair value are classified in their entirety based on the lowest level of input and disclosed in one of the following three categories:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.107%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Quoted market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Observable market-based inputs or unobservable inputs that are corroborated by market data.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Unobservable inputs reflecting our assumptions or external inputs from active markets.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Use of observable market data, when available, is required in making fair value measurements. When inputs used fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement. We &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;determine fair value for Level 1 instruments using exchange-traded prices for identical instruments. We determine fair value of Level 2 instruments using exchange-traded prices of similar instruments, where available, or utilizing other observable inputs that take into account our credit risk and that of our counterparties. Foreign currency exchange contracts and interest rate hedges are included in Level 2 and we use inputs other than quoted prices that are observable for the asset or liability. The Level 2 derivative instruments are primarily valued using standard calculations and models that use readily observable market data as their basis. Our Level 3 liabilities are comprised of contingent consideration arising from recently completed acquisitions. We determine fair value of these Level 3 liabilities using a discounted cash flow technique. Significant unobservable inputs were used in our assessment of fair value, including assumptions regarding future business results, discount rates, discount periods and probability assessments based on the likelihood of reaching various targets. We remeasure the fair value of our assets and liabilities each reporting period. We record the changes in fair value within selling, general and administrative expense and the changes in the time value of money within other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate swap liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;393&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2021 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income was $68, $102 and $155 in 2021, 2020 and 2019, which was recorded in other income (expense), net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp;amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the &lt;/span&gt;&lt;/div&gt;investments before recovery of their amortized cost basis, which may be maturity.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2ODI_3109835c-91c4-40ae-b5fb-a25d11cb1811">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Assets Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trading marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,137&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,114&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Available-for-sale marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and asset-backed debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign government debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States agency debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States treasury debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total available-for-sale marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;101&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,424&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Liabilities Measured at Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred compensation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;193&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;171&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency exchange forward contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest rate swap liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Contingent consideration:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Beginning&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Change in estimate &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(148)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(30)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Ending&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3 - Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;393&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total liabilities measured at fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;516&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;777&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzItMS0xLTEtMjMwMjU_60092604-734c-45f6-b743-e6b08f8cc85f"
      unitRef="usd">2944000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzItMi0xLTEtMjMwMjU_c02967d1-06b2-434a-8a53-d28aa5af2f4a"
      unitRef="usd">2943000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:TradingSecuritiesDebt
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzMtMS0xLTEtMjMwMjU_2d77047b-4638-40e4-8e59-8a3e2cb548d7"
      unitRef="usd">193000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:TradingSecuritiesDebt
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzMtMi0xLTEtMjMwMjU_9221a273-d1e0-40da-9c4c-8e7b1aa91c7a"
      unitRef="usd">171000000</us-gaap:TradingSecuritiesDebt>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzQtMS0xLTEtMjMwMjU_84c505e6-54eb-4a3a-97e2-ef65122f9658"
      unitRef="usd">3137000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzQtMi0xLTEtMjMwMjU_e169311d-fe98-406c-b982-55ee0716cf78"
      unitRef="usd">3114000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ie7c7e8c817e145e7bc500185970a7013_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzYtMS0xLTEtMjMwMjU_965a0586-370b-46fb-b8b7-e0db7a603482"
      unitRef="usd">48000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i87e93dcc049342eebd756e5c81bbfbff_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzYtMi0xLTEtMjMwMjU_2c497967-e25e-4868-9503-cef83e4996c2"
      unitRef="usd">38000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i020998449ee2432dade781d8bc329ee5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzctMS0xLTEtMjMwMjU_b36a9f06-86e2-4ebc-8544-c71a89ce6be4"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i4676f03bd98643798e246bce4a1c147c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzctMi0xLTEtMjMwMjU_39cc927c-6db9-4912-8d65-1df99d6cdca0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i502bdbefb4c34395a270e6c9b341feb4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzgtMS0xLTEtMjMwMjU_1d8255d0-884f-4993-8d59-d8ea61eb7e1a"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i2fd7d93013184f0ca7e953d189769dfb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzgtMi0xLTEtMjMwMjU_dd879cc7-c544-459a-80ed-83a8dd242a47"
      unitRef="usd">5000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i98fd63c6a75c40488a06a9d1e613e709_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzktMS0xLTEtMjMwMjU_5be2249a-bd7b-4425-aa97-32f1248250b2"
      unitRef="usd">19000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iff585920b6b14ebf8d44cd9a2a7fc0db_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzktMi0xLTEtMjMwMjU_6f6b4f58-1e8e-4fee-9f2e-e6de55721192"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i21f8b1b147fc47e2bbd9b9fe11fe0ced_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEwLTEtMS0xLTIzMDI1_0cdeb44f-700a-499e-8b92-1552991a1a46"
      unitRef="usd">1000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i33d0a2073a7a4d0fae7425d288bd85ec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEwLTItMS0xLTIzMDI1_2246a745-14f3-4f3f-a4b2-5e46bf29a083"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i117668a485ee43269f7894ff6ae82f17_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzExLTEtMS0xLTIzMDI1_00c7d4ea-48a8-4a42-9163-7ef0cb07f00e"
      unitRef="usd">75000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="ida582d9988574d51a2b01b103a5a8a6b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzExLTItMS0xLTIzMDI1_941d5a98-0ada-45e0-ba41-671017c87b2a"
      unitRef="usd">81000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DerivativeAssets
      contextRef="i27dc0843d36f4d878697133f92c598f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEyLTEtMS0xLTIzMDI1_de084dbc-f3a6-4e82-8ed9-4fdc199c8880"
      unitRef="usd">212000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ia95d03ec4c304d95b51a3255f385445c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzEyLTItMS0xLTIzMDI1_d3d5b178-8d15-4b88-9659-8b21881488f6"
      unitRef="usd">20000000</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE0LTEtMS0xLTIzMDI1_59ee5cb7-fe67-4070-b99f-4e08b3305626"
      unitRef="usd">287000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE0LTItMS0xLTIzMDI1_1d6bf7c2-17ac-4270-99b7-c55e4c529da5"
      unitRef="usd">101000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE1LTEtMS0xLTIzMDI1_4854d7bb-830e-4333-b4e8-d84bd9892357"
      unitRef="usd">3424000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTo1ZGYyYjQzNmY1MGU0ZDhkYjUyM2I2ZjA4ZTFkYWEwMS90YWJsZXJhbmdlOjVkZjJiNDM2ZjUwZTRkOGRiNTIzYjZmMDhlMWRhYTAxXzE1LTItMS0xLTIzMDI1_5ba089a3-1bd3-4599-b999-56f258da9b8d"
      unitRef="usd">3215000000</us-gaap:AssetsFairValueDisclosure>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzItMS0xLTEtMjMwMjU_475001d4-bb32-4bf4-9ce7-c5abe1e453d3"
      unitRef="usd">193000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzItMi0xLTEtMjMwMjU_170c5ff9-e054-4afc-9c03-19b5deff62c6"
      unitRef="usd">171000000</syk:FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzMtMS0xLTEtMjMwMjU_9022f586-fbce-404d-a2dc-571c01abf93e"
      unitRef="usd">193000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzMtMi0xLTEtMjMwMjU_e7db1b12-508f-45bb-9a20-91915da8f3c5"
      unitRef="usd">171000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i27dc0843d36f4d878697133f92c598f0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzQtMS0xLTEtMjMwMjU_fbce751e-e00a-4ad0-aca4-aa5da4819927"
      unitRef="usd">17000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="ia95d03ec4c304d95b51a3255f385445c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzQtMi0xLTEtMjMwMjU_c18037d2-07d5-4358-8ecf-ebd2eab04c77"
      unitRef="usd">160000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i1f453ede78574f968dfbe085d836b77b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzUtMS0xLTEtMjMwMjU_709658ea-4260-491b-8932-eeaeda98b402"
      unitRef="usd">0</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure
      contextRef="i8ab79e1bc08243479d364fa5853b1565_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzUtMi0xLTEtMjMwMjU_2f37693a-4f67-49de-ba77-ced38b29be99"
      unitRef="usd">53000000</us-gaap:ForeignCurrencyContractsLiabilityFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzYtMS0xLTEtMjMwMjU_a8ffb9b6-a04f-43e9-848b-5657e8eb00f5"
      unitRef="usd">17000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzYtMi0xLTEtMjMwMjU_a3e19733-bc6f-48b0-a165-f53c6de9d359"
      unitRef="usd">213000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia21cd3e409fc4facace34555a676001b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzgtMS0xLTEtMjMwMjU_cfebb3c5-fb78-4e71-b609-fd2ed4493763"
      unitRef="usd">393000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i343cabe069354ccc80f2d13debe7af55_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzgtMi0xLTEtMjMwMjU_1eb9334d-569c-49af-bbf0-5149915e1c3e"
      unitRef="usd">306000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzktMS0xLTEtMjMwMjU_4053167a-a87b-415c-9fb4-94b560833c7c"
      unitRef="usd">62000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzktMi0xLTEtMjMwMjU_f47d167b-b774-4794-8baa-dae19bd0e9a9"
      unitRef="usd">108000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEwLTEtMS0xLTIzMDI1_07c7e482-89f7-4c08-ba20-82ba1f89567b"
      unitRef="usd">1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEwLTItMS0xLTIzMDI1_0ea3f001-f762-4ce1-b77d-1d999db5eb1f"
      unitRef="usd">-9000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzExLTEtMS0xLTIzMDI1_eea8c6fa-229e-4752-a35c-88494da2a8fd"
      unitRef="usd">148000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i068ef64ed34e4ef398dee2c18771bbff_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzExLTItMS0xLTIzMDI1_c60b5bc1-e4ca-43f6-a789-c6da3229603c"
      unitRef="usd">30000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEyLTEtMS0xLTIzMDI1_36056d0d-41fe-44e1-8905-83fa7208e3d6"
      unitRef="usd">306000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia21cd3e409fc4facace34555a676001b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEyLTItMS0xLTIzMDI1_8fb7111b-d287-41ad-865b-0482269755b0"
      unitRef="usd">393000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEzLTEtMS0xLTIzMDI1_d57a5bb4-e4a4-49d1-ba45-ff8e2237b111"
      unitRef="usd">306000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia21cd3e409fc4facace34555a676001b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzEzLTItMS0xLTIzMDI1_429af5a9-0a0a-4d71-b24e-7177ee570506"
      unitRef="usd">393000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzE0LTEtMS0xLTIzMDI1_917b0f00-c504-4848-a7d9-d07f7d06b405"
      unitRef="usd">516000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZToyNjUyODVlNDFjNGY0NDk3YjhiYTUxM2RmMzViOGVmZi90YWJsZXJhbmdlOjI2NTI4NWU0MWM0ZjQ0OTdiOGJhNTEzZGYzNWI4ZWZmXzE0LTItMS0xLTIzMDI1_100e7f52-c04b-4a48-b5c8-91b0aff4361e"
      unitRef="usd">777000000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzI2ODY_0d22b2c6-ad88-4401-8feb-c5d8d86115e4">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Fair Value of Available for Sale Securities by Maturity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Due after one year through three years&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzItMS0xLTEtMjMwMjU_7148cdd0-d22d-4bd9-9e8d-f34301d93368"
      unitRef="usd">36000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzItMi0xLTEtMjMwMjU_e8e8affe-d186-4c36-880a-9c1f1b3aad4c"
      unitRef="usd">42000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzMtMS0xLTEtMjMwMjU_455c5240-7cdb-47ef-81eb-facb7f1c69b7"
      unitRef="usd">39000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90YWJsZTpkNDM2ZTcwODNiM2Q0MzVlODJhMTI3NGRjNTNiYjJiZC90YWJsZXJhbmdlOmQ0MzZlNzA4M2IzZDQzNWU4MmExMjc0ZGM1M2JiMmJkXzMtMi0xLTEtMjMwMjU_4777f9bb-b1d2-4695-b21e-27e9dd9daffe"
      unitRef="usd">39000000</syk:AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNDQ_77ac7da7-5973-461a-89ed-67785fae0c5c"
      unitRef="usd">68000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNDg_54927b68-ed3a-4a0c-8b32-506e69000a68"
      unitRef="usd">102000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:MarketableSecuritiesGainLoss
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDYvZnJhZzpiZGZlZjBmMGJhZjY0ZmYzOTg3NTUzNDI1OTYwNWYzYi90ZXh0cmVnaW9uOmJkZmVmMGYwYmFmNjRmZjM5ODc1NTM0MjU5NjA1ZjNiXzIyNTU_5939c647-15d1-4ae7-a653-9dc7b4301667"
      unitRef="usd">155000000</us-gaap:MarketableSecuritiesGainLoss>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxNzc_dd4841c9-b48c-4dc0-84d3-e7685bd5bb4e">DERIVATIVE INSTRUMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Foreign Currency Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,266&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;949&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We had &#x20ac;2.0&#160;billion and &#x20ac;1.5&#160;billion at December 31, 2021 and 2020 in certain forward currency contracts designated as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros. In addition to these derivative financial instruments designated as net investment hedges, we had &#x20ac;4.4&#160;billion at December 31, 2021 and 2020 of senior unsecured notes designated as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our Euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2021 the total after-tax gain (loss) in AOCI related to designated net investment hedges was ($34).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Currency Exchange Rate Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Pretax gains (losses) on derivatives designated as cash flow hedges of $9 and net investment hedges of $37 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense), net in earnings within 12 months as of December&#160;31, 2021. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Interest Rate Hedges&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In 2021 a loss of $11 was reclassified from AOCI to other income (expense), net in earnings relating to the termination of forward starting interest rate swaps with notional amounts of $750 designated as cash flow hedges as we now consider it probable that the original forecasted debt issuances will not occur. Pretax gains of $5 recorded in AOCI related to other interest rate hedges closed in conjunction with debt issuances are expected to be reclassified to other income (expense), net in earnings within 12 months of December&#160;31, 2021. The cash flow effect of interest rate hedges is recorded in cash flow from operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxODI_e5c39dd5-c138-45fb-99ed-ad32b2047414">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.424%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.805%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.661%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,266&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,751&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;82&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;195&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross notional amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;949&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,828&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,382&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,159&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Maximum term in years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Fair value:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(121)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total fair value&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(140)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMS0xLTEtMjMwMjU_e40e4ff4-4793-4885-9511-f61656328911"
      unitRef="usd">973000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i40113d80d11149059ac26617f2747527_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMi0xLTEtMjMwMjU_8d8b3c7d-a6e2-4842-ad3e-300d260a4e87"
      unitRef="usd">2266000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i9c9d232100d84c2e8972344f330c6c32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtMy0xLTEtMjMwMjU_6f3c4aa3-d9e1-4d50-b3a2-b1bcb7996c46"
      unitRef="usd">5512000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i75d60a29285a47bd9dbc5f7c302733eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEtNC0xLTEtMjMwMjU_585a0ae3-eb29-4952-9baf-c67f85eca082"
      unitRef="usd">8751000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzItNC0xLTEtMjMwMjU_63d87aee-8a15-4544-ad56-5a82c96cf78b">P4Y10M24D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i422ff4d02b404759bd7b1f0c73386fdf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMS0xLTEtMjMwMjU_2db7af46-26e8-4181-b2bc-9dcf08c58c7b"
      unitRef="usd">15000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i72f5e6753fb047f083791a2c3417aef7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMi0xLTEtMjMwMjU_d1f79bb7-8dbb-4176-8401-e29e0a07eed5"
      unitRef="usd">39000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic949228136a2440aacee861045d52a3b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtMy0xLTEtMjMwMjU_e6601a4d-0e01-4f61-9d4f-e0674a2e133d"
      unitRef="usd">92000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if052be85296d424e88865bee7451cdfe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzQtNC0xLTEtMjMwMjU_7d81b00e-832a-4a52-8efd-624655e797a9"
      unitRef="usd">146000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i1631a54bab5c46b5b4aa3ef428c4dc63_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMS0xLTEtMjMwMjU_4ef4722b-1c39-43dc-9904-e61aa95b25ae"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5884ae7cccbb493f97bb398967d7295a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMi0xLTEtMjMwMjU_8e57fce4-ac4e-4713-af99-8f0183e74b58"
      unitRef="usd">65000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iffdc28f3e70c4e53945b14cca5be1a87_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtMy0xLTEtMjMwMjU_4c85922f-7d83-407e-9a5f-b1e80443064c"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iae1a4031263e473ca84441dad4d88d84_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzUtNC0xLTEtMjMwMjU_85c3c713-ca67-4084-872a-2b5ccada6d46"
      unitRef="usd">66000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if77ef480dc7b44db865d51b857328728_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMS0xLTEtMjMwMjU_a326a88d-51bb-4409-89cf-4dbb34b08b7d"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7a2bb2e21adb4f2195ccceb311822e54_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMi0xLTEtMjMwMjU_965ebd8a-9528-4fb7-9cf3-de29e9072706"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i77590a767d2049249161295a41700dff_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtMy0xLTEtMjMwMjU_32d372f2-96a0-415f-8baf-014ffbff51e5"
      unitRef="usd">10000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="ib71901facd4f4729bb4febf8e4920a38_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzYtNC0xLTEtMjMwMjU_b1ee1e24-b869-4be2-a4a4-04e0578c4d80"
      unitRef="usd">17000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i600b49c4eaaa48cf92f3b433c07dd65f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMS0xLTEtMjMwMjU_1573ddb1-568a-4326-b73b-0c1c8c666444"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i40113d80d11149059ac26617f2747527_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMi0xLTEtMjMwMjU_2b277d64-edd7-4e5c-997d-6d463f38a7f4"
      unitRef="usd">104000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i9c9d232100d84c2e8972344f330c6c32_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtMy0xLTEtMjMwMjU_e20bca9f-fec5-4661-ad3a-72caf2ff6cc8"
      unitRef="usd">82000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i75d60a29285a47bd9dbc5f7c302733eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzgtNC0xLTEtMjMwMjU_54309fcd-493d-4b9e-aeba-b9c014bd866c"
      unitRef="usd">195000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTEtMS0xLTIzMDI1_5ae19bd0-8195-4ac3-9f38-739ad2caa8f6"
      unitRef="usd">949000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5048a5d933134912a55ce66af02172d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTItMS0xLTIzMDI1_ee0168a7-245a-4daf-968e-e9443a3fdcad"
      unitRef="usd">1828000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTMtMS0xLTIzMDI1_f77d8779-3b35-48ca-96f7-29bb4ccf632d"
      unitRef="usd">5382000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEwLTQtMS0xLTIzMDI1_2672b79e-d430-47f4-a340-88afa2302574"
      unitRef="usd">8159000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1
      contextRef="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzExLTQtMS0xLTIzMDI1_450e8ea3-ecb3-4b13-b97d-4e168d11263a">P4Y10M24D</us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5f71580f58e546cf876aaa64b8e407f9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTEtMS0xLTIzMDI1_9690031f-5738-494a-ba62-bd4379d9609e"
      unitRef="usd">9000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ic458786f6f7742209e0810cafdb1e076_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTItMS0xLTIzMDI1_c4324c33-2b20-4fd4-8ff1-b7570a7bdf88"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if86c13e7f54a4d9187b804efa3279ece_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTMtMS0xLTIzMDI1_59fce278-dd67-47b8-965d-220a8db7b153"
      unitRef="usd">7000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8cb34c13848b40abb54bfb7dd12daee8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzEzLTQtMS0xLTIzMDI1_edac5746-9af9-45ea-b139-4c07dcd8c624"
      unitRef="usd">16000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ie912fa0d38354d10abc6f0c684c92709_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTEtMS0xLTIzMDI1_c609ac9a-8c8c-4bb1-b959-8e8026f638fe"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i8cc2de29096642bca27e8292c94be78c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTItMS0xLTIzMDI1_1f9749c3-be5f-4e77-92aa-392cc77a6852"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib731b835ed4545e1bf7663a732660d5b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTMtMS0xLTIzMDI1_bd37312e-dcdc-496d-ad5c-7919305846fc"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iba140370805745c5a0fb0139f3a35e36_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE0LTQtMS0xLTIzMDI1_53259ff1-ef82-44fe-a7c9-d9210cc33362"
      unitRef="usd">4000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i7bb0885ab9cf4a3b872895d9b26c1c8d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTEtMS0xLTIzMDI1_186c0c52-b326-4b3b-8381-6020afe91fe0"
      unitRef="usd">12000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i768aa1a212a548f6bc9e1ad4200680af_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTItMS0xLTIzMDI1_bd338192-3642-4427-835b-a48c1f42fa4b"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="if80d5916400446cf8c33be284e7e7cd8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTMtMS0xLTIzMDI1_0dd13be0-e14b-4995-8ad2-0a1dfe0de7dc"
      unitRef="usd">121000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i0494473994284c7a818935d1810c26c5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE1LTQtMS0xLTIzMDI1_5a1ca5c8-9ef7-4754-aa25-89045ae55904"
      unitRef="usd">133000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i324abdc30a554b10b518a4193f5e987c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTEtMS0xLTIzMDI1_fd93d2fc-a04c-445d-a452-d49a5a01253c"
      unitRef="usd">1000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i460e2f30ab50432dac45998c777bd1cb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTItMS0xLTIzMDI1_fbc9762c-7f2f-4f88-9bd1-f02967c4d5bf"
      unitRef="usd">26000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="id4dc5032a74e422eab08db6029f2c3b1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTMtMS0xLTIzMDI1_cfe46ed8-15dc-4053-9231-727a1db2c179"
      unitRef="usd">0</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i2743dba7228949dca22bfab3555187d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE2LTQtMS0xLTIzMDI1_848c54e2-559b-403e-a8f4-3b8a8d8f0d94"
      unitRef="usd">27000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i79b832e5c6ab44e6ba0df78e6e9d1c31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTEtMS0xLTIzMDI1_104d871a-0d5b-49bd-8f2f-c9d382722e39"
      unitRef="usd">-4000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i5048a5d933134912a55ce66af02172d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTItMS0xLTIzMDI1_83b0f7cb-93e3-4c27-beda-22351e68b852"
      unitRef="usd">-22000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i19f6c7d56a8e43b9a36c433f4e26b03c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTMtMS0xLTIzMDI1_0274c328-ee47-4f70-b74d-d01175250afc"
      unitRef="usd">-114000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeFairValueOfDerivativeNet
      contextRef="i8374a2d512664e3b9b08fe4d2d4aa55d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZTo2NmI4NWNiZmM0YWQ0NTg3YTdhYWM0Nzk2YTgyYWRiNy90YWJsZXJhbmdlOjY2Yjg1Y2JmYzRhZDQ1ODdhN2FhYzQ3OTZhODJhZGI3XzE3LTQtMS0xLTIzMDI1_bef05138-c203-4adc-af72-6ce6988cc591"
      unitRef="usd">-140000000</us-gaap:DerivativeFairValueOfDerivativeNet>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i40113d80d11149059ac26617f2747527_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg0MzE_e395a83d-9987-4164-902f-c75949e348ca"
      unitRef="eur">2000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i5048a5d933134912a55ce66af02172d8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg0NDU_2e625046-36d6-47d5-8000-0f03f4d1c5d5"
      unitRef="eur">1500000000</us-gaap:DerivativeNotionalAmount>
    <syk:DerivativeNotionalAmount1
      contextRef="i40113d80d11149059ac26617f2747527_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg1MDQ_b4c2ad71-c7dc-44d6-893a-9b788777a793"
      unitRef="eur">4400000000</syk:DerivativeNotionalAmount1>
    <syk:DerivativeNotionalAmount1
      contextRef="i5048a5d933134912a55ce66af02172d8_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2NDkyNjc0NTg1MDQ_f25b7af8-d16f-4299-ab16-587418e2ab9c"
      unitRef="eur">4400000000</syk:DerivativeNotionalAmount1>
    <us-gaap:NetInvestmentHedgeDerivativeAssetsAtFairValue
      contextRef="i40113d80d11149059ac26617f2747527_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2MTc_5d62c988-c27c-4dfe-a507-e055e92f140b"
      unitRef="usd">34000000</us-gaap:NetInvestmentHedgeDerivativeAssetsAtFairValue>
    <us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzMxODA_8106341a-c64e-41f5-b157-a470db243afe">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Net Currency Exchange Rate Gains (Losses)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Derivative Instrument&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Recorded in:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash Flow&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net Investment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Non-Designated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;20&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5774498f250b4e62a2507047bb5117c5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItMi0xLTEtMjMwMjU_8f2fc38b-6a3f-4861-8ad1-b59fb22f489c"
      unitRef="usd">-12000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i7dfbfda7e7d44de0983bcfc3b451374f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItMy0xLTEtMjMwMjU_056e3420-b85b-4931-9a9e-4bf171905099"
      unitRef="usd">5000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ib8de6a926a954c7a98e473efb5dedd75_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzItNC0xLTEtMjMwMjU_d9f6527e-a560-4d91-9e7b-0bd14433b5a5"
      unitRef="usd">2000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="ie4707a4f73d24ec7a3a6643b3e285e4d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtMi0xLTEtMjMwMjU_d1405cdf-dfb6-44ac-b7bc-fa575a83d679"
      unitRef="usd">35000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i72ae0b2359894631bfe4ff8951b7344f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtMy0xLTEtMjMwMjU_8194597f-906e-4944-b981-c283c85e4773"
      unitRef="usd">28000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="icd5321432b28479688d8bb70e0d59233_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzMtNC0xLTEtMjMwMjU_310e6f8b-0864-49ac-b4f4-74b3e0a30203"
      unitRef="usd">14000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i8b361079402f49b293ad59e81c8db765_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtMi0xLTEtMjMwMjU_25cb2dec-a3d4-41cd-b592-164a0fae5f81"
      unitRef="usd">-10000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i1eda5abebfc549a98ed646efb1e15dd8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtMy0xLTEtMjMwMjU_27675aa1-82a3-4a55-a0e3-357eefb28122"
      unitRef="usd">-13000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i78ff6405f6b0476e87ad1a72d4cb5be6_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzQtNC0xLTEtMjMwMjU_5dc0fa5d-4069-47d9-b31f-7aa08512927b"
      unitRef="usd">-7000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i739495c8a21944818cd6d7313f240f1a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtMi0xLTEtMjMwMjU_e654c59d-5688-4f7b-a57e-12869cfb89cc"
      unitRef="usd">13000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="id5478041ba5e415fa877507b9dcf00ef_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtMy0xLTEtMjMwMjU_129a0c7a-082e-46db-8708-600303bcaf1b"
      unitRef="usd">20000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i5680505765904a7ebbce9f048aa9a5ee_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90YWJsZToyOGJiOWI4MmFiYTU0ZjM4YjhlNzdlYTE5NDJhNDVmYS90YWJsZXJhbmdlOjI4YmI5YjgyYWJhNTRmMzhiOGU3N2VhMTk0MmE0NWZhXzUtNC0xLTEtMjMwMjU_00012feb-57ca-413c-9153-ab2ba05bf5ee"
      unitRef="usd">9000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE2OTQ_db7f587d-96d5-4057-906a-7931f6047971"
      unitRef="usd">9000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax
      contextRef="ibeca0ddecea74845b0c444c7c505e96d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzE3MjY_282a66de-4338-4f07-9fa9-409369617658"
      unitRef="usd">37000000</us-gaap:DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib06a055c0fae428c8432833a0e6bf453_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTcw_349000ba-9229-43f3-b7ad-7d6f278dc990"
      unitRef="usd">-11000000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i6502455d90c34a3aaf15f94591105bdc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTc5_221607d1-b891-426c-bd0f-1f51e0eeed88"
      unitRef="usd">750000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i257b8d69f7304529920e40c42cf14686_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMDkvZnJhZzphYjJjNzE0MGUyODg0YmFkODkzMzUyN2NlODc0YjIyYy90ZXh0cmVnaW9uOmFiMmM3MTQwZTI4ODRiYWQ4OTMzNTI3Y2U4NzRiMjJjXzExNTQ0ODcyMTA5MTc1_24f428c6-f025-4dbb-8e58-fc5c22bb071f"
      unitRef="usd">5000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90ZXh0cmVnaW9uOmJlNDgxMzdiZGI1MTQ3ZWViY2ZkMDRlNzg3ZDYwNmRkXzgy_e4b1debd-59a8-4492-b040-db6bada5b15f">ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90ZXh0cmVnaW9uOmJlNDgxMzdiZGI1MTQ3ZWViY2ZkMDRlNzg3ZDYwNmRkXzc3_80e1eb03-e566-4b1b-bb6d-5f628e77faa1">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:26.565%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.902%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.871%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Financial Statement Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;47&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(64)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(551)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Reclassifications to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cost of Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;40&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(416)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(531)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4bb4525f47584c4b928961c3e9bf0ff0_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMS0xLTEtMjMwMjU_2a0b2565-1ea8-4b5e-adfc-febe667d725c"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia94684ce07ac4a0185a0636e0cf54469_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMi0xLTEtMjMwMjU_0a500896-f3c1-4609-bd7a-4ed6071c2394"
      unitRef="usd">-179000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2e5a4e63e93f48f7aa5592b92b80c4b1_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtMy0xLTEtMjMwMjU_200baf08-5734-4beb-9487-97c8a0412b85"
      unitRef="usd">47000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="if68a82d67ba747f0a26113ba47cf0600_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtNC0xLTEtMjMwMjU_624bd90f-fc47-4f12-af21-9a717e542283"
      unitRef="usd">-471000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEtNS0xLTEtMjMwMjU_b44e48f6-f839-4201-9c1d-9412359dd743"
      unitRef="usd">-606000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMS0xLTEtMjMwMjU_3a313cc9-94b1-4885-a84d-fc0eb54540cb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMi0xLTEtMjMwMjU_27623612-06f9-4bda-bad5-d2cd508654f5"
      unitRef="usd">-117000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItMy0xLTEtMjMwMjU_6132d724-3577-40e0-9d9d-57b1ca990a55"
      unitRef="usd">-64000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItNC0xLTEtMjMwMjU_35a3fba8-80e8-4160-ab8c-f9cd34616971"
      unitRef="usd">-459000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzItNS0xLTEtMjMwMjU_98fadf19-8e78-4e30-a49a-4510a80bd3a8"
      unitRef="usd">-640000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i7c6a567375db4ba5b834de523781e2e2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMS0xLTEtMjMwMjU_6f75550a-8da8-4af6-9862-7863beaad4f8"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i58fdbcc9848b4a8b9ebbd2e5caca27b9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMi0xLTEtMjMwMjU_4d58d290-7a44-41d6-8bdd-05f614e31c2e"
      unitRef="usd">28000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i88e2a0003eee4498ba56e88ce6149755_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtMy0xLTEtMjMwMjU_26009c8a-ee51-4788-bb54-deb884cb9631"
      unitRef="usd">17000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i702877710c7b453285a4a0df5281d2bc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtNC0xLTEtMjMwMjU_5c0d80f7-4484-4243-9997-d2a8989ed116"
      unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzMtNS0xLTEtMjMwMjU_82b07007-e6bf-466f-98ed-37e6f9a0d4a4"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue
      contextRef="i49d219ac7c654bcf972997c5b2dd66b6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMS0xLTEtMjMwMjU_e8fbd877-b124-4208-a37c-73a10e40fd25"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic221ec9a6dfc4d74aeaf33001f372d3c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMi0xLTEtMjMwMjU_89fe8dff-3fc3-45b2-95f0-be30dfe88275"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if601c0b3db3f4bf6b658f2a814d47b69_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtMy0xLTEtMjMwMjU_5649dc81-6b0c-4b40-a715-85f90db33426"
      unitRef="usd">-5000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i8cdd6bf737b54325b92c62a86f71c0e8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtNC0xLTEtMjMwMjU_f34d3cfe-cf56-4b1e-aed6-8443e2830de3"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i2e2f7288e37e48a380d856a6d3266bf1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzUtNS0xLTEtMjMwMjU_bcb77be8-41af-435c-b627-141e15ec298c"
      unitRef="usd">-5000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia56f6022aefe44f2a5667c14a9b6b6eb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMS0xLTEtMjMwMjU_505868f7-bd5d-47b6-951b-656e698d1295"
      unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i1c3f013d29b7403e858fcea9c856f7b3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMi0xLTEtMjMwMjU_1bae552e-00ae-4ec6-ad6b-a1e427860b51"
      unitRef="usd">12000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i90e7300ba45a44d6a213473b74b90080_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtMy0xLTEtMjMwMjU_a80a28b4-bfc1-436d-a588-c7c1530b79b7"
      unitRef="usd">-6000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ia01979f1a5154e80af303f7109f5141e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtNC0xLTEtMjMwMjU_3b7fd721-f172-43ee-b33a-a48047ef85c1"
      unitRef="usd">-28000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ie1ea07cf8bba4d6d887c5a458dad34dc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzYtNS0xLTEtMjMwMjU_69c337b6-e188-46cd-bc05-b862bb5395a2"
      unitRef="usd">-22000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMS0xLTEtMjMwMjU_e70dc434-83ed-4382-98eb-cd08bc2068f2"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i409d18f675da455fb23e202a25fb4438_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMi0xLTEtMjMwMjU_b4a2605a-f8c3-4bd9-a86b-2081821c643c"
      unitRef="usd">-3000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctMy0xLTEtMjMwMjU_1c61adfc-8a93-45ea-95f1-0f353ebaec2c"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctNC0xLTEtMjMwMjU_8d962153-ba50-4de4-a93e-1cad8a11109f"
      unitRef="usd">7000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzctNS0xLTEtMjMwMjU_125ad22c-a6f4-47a9-b067-54b39f6d1c38"
      unitRef="usd">5000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i6734e2ca0f94472f8bd861c7748dc237_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMS0xLTEtMjMwMjU_ded7e880-f3e7-4063-8b3b-7d28c2cc92dd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i409d18f675da455fb23e202a25fb4438_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMi0xLTEtMjMwMjU_e3059515-e6d2-4868-9d02-480ae4be0023"
      unitRef="usd">-80000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if9ce56c827094e3c82b948c9694b3bb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtMy0xLTEtMjMwMjU_ac046d4c-3085-459f-8ac5-f7443000247f"
      unitRef="usd">-57000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1ecf1726e1084c828da66d4992340aaf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtNC0xLTEtMjMwMjU_5ad0ffa8-b77e-49c8-afaf-2811697c12e2"
      unitRef="usd">-414000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7828606768a647a8a2be18fc36204c3f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzgtNS0xLTEtMjMwMjU_9ae8eeea-da53-4ad0-90f2-14faa39b9a1a"
      unitRef="usd">-551000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i04146303369749e39910cfe8eff8042d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMS0xLTEtMjMwMjU_3ab8fba3-4a77-403a-a699-121a8a4dea40"
      unitRef="usd">-3000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib5a5b88eef254543b043aeb672c43431_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMi0xLTEtMjMwMjU_df84203c-539a-44b6-8c09-2b48db015798"
      unitRef="usd">-259000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibb9e3dbe30fa4e8483b2654e5a21a079_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktMy0xLTEtMjMwMjU_717b168c-0b54-4a18-bdb8-3b47f9e5d1b4"
      unitRef="usd">-10000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic7543006b3a34df28528413b4f7b31d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktNC0xLTEtMjMwMjU_4ca6dcd1-a6f2-45a4-9f49-a93cb8d8b3db"
      unitRef="usd">-885000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzktNS0xLTEtMjMwMjU_177eb9a4-5f64-4c5d-80f4-412236bf2972"
      unitRef="usd">-1157000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTEtMS0xLTIzMDI1_0488ce62-6ef6-4d3a-a902-444fb1438268"
      unitRef="usd">4000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTItMS0xLTIzMDI1_d813e9f1-dbf7-4526-9d8e-bcf41549de41"
      unitRef="usd">123000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTMtMS0xLTIzMDI1_6e115de2-f64b-4d68-bc3c-d31b6cd3db89"
      unitRef="usd">46000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ie86883fa09384666942eeaed442415af_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTQtMS0xLTIzMDI1_6b341d27-3fa2-4da0-8602-f35f2a62ac40"
      unitRef="usd">551000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEwLTUtMS0xLTIzMDI1_62949f42-b3cd-4c1c-b916-e034484108c7"
      unitRef="usd">724000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8386a930e3d84770bc638457b2a4431d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTEtMS0xLTIzMDI1_dcc0e172-99e2-4c64-9624-bc40c9ab95db"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ifa80deee152d4674ba5cfe9cbadcd327_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTItMS0xLTIzMDI1_00de21fd-952e-4aa5-8e3b-1d6ba33a574c"
      unitRef="usd">-32000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i70a5911827054dbc8ce3a34c793feb6b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTMtMS0xLTIzMDI1_b8a00174-a3a7-4f0a-a13c-8616c5589c2a"
      unitRef="usd">-15000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ie86883fa09384666942eeaed442415af_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTQtMS0xLTIzMDI1_566a56a1-8c80-4392-b5c0-b45d37cd3bef"
      unitRef="usd">-54000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzExLTUtMS0xLTIzMDI1_b22fe032-36d7-4d38-a781-def3069bc797"
      unitRef="usd">-101000000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:CostOfRevenue
      contextRef="i92f15013f92346ce9cbb36e9eb568f54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTEtMS0xLTIzMDI1_140f3147-ac1b-425c-b9d8-af0e60463056"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i83dc60f460124dd497581e888b4bf1d8_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTItMS0xLTIzMDI1_1c255202-bb14-47f8-9366-8db4eab90c31"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i9114115d56ad4c4989ad2dd4e097974d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTMtMS0xLTIzMDI1_af784e56-7758-42e2-8f81-e7035401188d"
      unitRef="usd">12000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i5dbe5a4ec071427fae8b82afb24fb3ca_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTQtMS0xLTIzMDI1_ae525f0f-e690-47b1-b254-e2ed2fb031df"
      unitRef="usd">0</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i325e4a8aeca94b2b83d09801b01f101e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzEzLTUtMS0xLTIzMDI1_67bee0ce-1d9e-47c9-bd86-1da220b91908"
      unitRef="usd">12000000</us-gaap:CostOfRevenue>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i87e455dc94234eef9fc977210d2059b3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTEtMS0xLTIzMDI1_d2156aa9-78a0-461b-be64-49fce7a7f76a"
      unitRef="usd">0</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iad787f8161cd41d2b2c226f217b85d4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTItMS0xLTIzMDI1_ec2ba100-623f-4e5b-88ac-23919837cc71"
      unitRef="usd">15000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i80cfb23b43fb45ffa9c91c4dc0f78098_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTMtMS0xLTIzMDI1_70a76aaf-4df5-4bf9-bebc-38c68012b4c3"
      unitRef="usd">6000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i2773bb7f8a4c4bd3a58a536ad8bf8188_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTQtMS0xLTIzMDI1_009be060-b586-42f4-8f3e-2ed6f7ed2e09"
      unitRef="usd">-35000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8362bd7aefad4b4fb6e9f334fa0974c4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE0LTUtMS0xLTIzMDI1_283f0d87-c3ad-4d9e-a777-15470f252074"
      unitRef="usd">-14000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTEtMS0xLTIzMDI1_844a2413-4d12-4072-b69c-f55d831049cb"
      unitRef="usd">-1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i98223ace52234752a935caf8d514b359_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTItMS0xLTIzMDI1_16059a21-8a11-4ce9-a701-dcaad460f83b"
      unitRef="usd">-2000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTMtMS0xLTIzMDI1_60ea4d6b-970f-4822-b3ba-cf062602242d"
      unitRef="usd">1000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTQtMS0xLTIzMDI1_2fa1d505-03e9-490d-8272-bc98a7b97536"
      unitRef="usd">7000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE1LTUtMS0xLTIzMDI1_d3d13f7c-2149-4122-9696-8507ecac6be6"
      unitRef="usd">5000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i2dae3f882da24cfc96d18d7ce54f340a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTEtMS0xLTIzMDI1_d85e66d4-06d9-4c5a-8afb-c0aa015f60e4"
      unitRef="usd">3000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i98223ace52234752a935caf8d514b359_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTItMS0xLTIzMDI1_3d2c7c41-953c-4a2e-bacd-04f0887d1c07"
      unitRef="usd">104000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i72a151e5daed4dd9b4169c9bba2d17da_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTMtMS0xLTIzMDI1_06ba6e65-1ccb-45d3-9e4a-6ce9c5fd1697"
      unitRef="usd">50000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i73c522a4bbbc411ba487be7cce62a1f5_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTQtMS0xLTIzMDI1_fc34c8cd-3150-4066-b75a-76026ce296d9"
      unitRef="usd">469000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i957fcfaaacb747dc99466de6b1a1064b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE2LTUtMS0xLTIzMDI1_d204c003-c2ab-46ad-a9d6-d2d335cf0041"
      unitRef="usd">626000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia32555db427549cf9768af83a8cc5401_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTEtMS0xLTIzMDI1_c8a422c4-9da1-4ef0-8e95-0faface59940"
      unitRef="usd">0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i473fc27ada8b4437a7ed06daba0e7b45_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTItMS0xLTIzMDI1_a907f740-51d0-4782-8dc0-65ab9a6a028d"
      unitRef="usd">-155000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i987f109f9d8b453ea9245f3f52a146d6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTMtMS0xLTIzMDI1_545045a2-854a-41c0-bbba-783433b9a2f2"
      unitRef="usd">40000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i114b53cb59c34cb288582b77e4ec30d5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTQtMS0xLTIzMDI1_fb1a9b28-df70-4da0-9df5-27bdc0e0dc87"
      unitRef="usd">-416000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTIvZnJhZzpiZTQ4MTM3YmRiNTE0N2VlYmNmZDA0ZTc4N2Q2MDZkZC90YWJsZTpiOGY0YjBlOTVmY2E0NWNiYTJhMGE4ZGNiNGE1YmM1My90YWJsZXJhbmdlOmI4ZjRiMGU5NWZjYTQ1Y2JhMmEwYThkY2I0YTViYzUzXzE3LTUtMS0xLTIzMDI1_e2000a9d-f558-4300-8480-5ce9b0548138"
      unitRef="usd">-531000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxNDk_bae58a98-edd0-4b2f-ab11-efacc7c81e51">ACQUISITIONS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $393 and $4,304 in 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In September 2021 we completed the acquisition of Gauss Surgical, Inc. (Gauss) for $120 in cash and up to $40 in future milestone payments. Gauss is a medical device company that has developed Triton, an artificial intelligence-enabled platform for real-time monitoring of blood loss during surgery. Gauss is part of our Instruments business within MedSurg and Neurotechnology. Goodwill attributable to the acquisition is not deductible for tax purposes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November 2020 we completed the acquisition of Wright Medical Group N.V. (Wright) for $30.75 per share, or an aggregate purchase price of $4.1 billion ($5.6 billion including convertible notes). Wright is a global medical device company focused on extremities and biologics. Wright is part of our Trauma and Extremities business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In November and December 2020 note holders elected to redeem the 1.625% and 2.25% convertible notes assumed in the Wright acquisition for $864 and $576. These repayments are classified as financing activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In December 2020 we completed the acquisition of OrthoSensor, Inc. (OrthoSensor). OrthoSensor is a leader in the digital evolution of musculoskeletal care and sensor technology for total joint replacement. OrthoSensor is part of our Joint Replacement business within Orthopaedics and Spine. Goodwill attributable to the acquisition is not deductible for tax purposes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Had the above acquisitions taken place as of the beginning of the comparable prior year, our consolidated financial results of operations in the aggregate would not have been materially different. Accordingly, we have not disclosed pro forma financial information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Purchase price allocations for our significant acquisitions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Wright&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,081&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Weighted average life of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Purchase price allocations for 2021 acquisitions were based on preliminary valuations, primarily related to intangible assets, product liabilities and deferred income taxes. Our estimates and assumptions are subject to change within the measurement period. The purchase price allocations for Wright, OrthoSensor and other 2020 acquisitions were finalized in 2021 without material adjustments. &lt;/span&gt;&lt;/div&gt;In January 2022 we announced a definitive merger agreement to acquire all of the issued and outstanding common shares of Vocera Communications, Inc. (Vocera) for $79.25 per share, or an aggregate purchase price of approximately $3.1&#160;billion (including convertible notes). Pursuant to the agreement we commenced a tender offer to purchase all of the outstanding shares of common stock of Vocera for $79.25 per share in cash. The boards of directors of both Stryker and Vocera have unanimously approved the transaction. We expect the acquisition to close in the first quarter of 2022, subject to completion of the tender offer and other customary conditions. Vocera has emerged as a leading platform in the digital care coordination and communication category. Following closing, we plan to integrate Vocera into our Medical business within MedSurg and Neurotechnology.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzIzNQ_86c49c62-4682-4f10-ad55-2060f4caef19"
      unitRef="usd">393000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzI0Mg_c7598287-951c-413e-a7aa-cd3f6d30ba86"
      unitRef="usd">4304000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzEwOTk1MTE2MjkxMTg1_bf4cd066-f1ee-422a-800c-964beb9318fc"
      unitRef="usd">120000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <syk:BusinessCombinationContingentConsiderationFutureMilestonePayments
      contextRef="i533799a1b3e7496c9ef9d754c3922a1f_D20210901-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzEwOTk1MTE2MjkxMTkx_05ff5648-a304-4967-a1b6-77295eec37b4"
      unitRef="usd">40000000</syk:BusinessCombinationContingentConsiderationFutureMilestonePayments>
    <syk:BusinessCombinationConsiderationTransferredPricePerShare
      contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzM0OA_b0c1abc6-8177-4913-b4fa-88997745c550"
      unitRef="usdPerShare">30.75</syk:BusinessCombinationConsiderationTransferredPricePerShare>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzM5Ng_65294506-c470-4974-878f-f18d8ccdc67c"
      unitRef="usd">4100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes
      contextRef="i903a26c1306c4428b4c6eca860bfd419_D20201101-20201130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzQwMA_a2e9695f-e2f0-41d5-830b-fd6a0924eb49"
      unitRef="usd">5600000000</syk:BusinessCombinationConsiderationTransferredIncludingConvertibleNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib8d99e6390a74a8995e89bd1ff83d52b_I20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzczMA_304aa849-b60f-40ed-83dc-dbff8843022f"
      unitRef="rate">0.01625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i02a06683c940495480de29089bda742b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzczNw_d1572545-f1ab-4612-93ab-6395e377fe26"
      unitRef="rate">0.0225</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ie342e96c09a9482c9aa9e2e4ff4011f5_D20201101-20201130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxMzk_ae31962d-fd8d-46d0-b6de-495ddc92bc77"
      unitRef="usd">864000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i67fb41d08feb476290e5560aab4e4702_D20201201-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzgwMw_510979bf-fb37-4c77-8421-b263405cd892"
      unitRef="usd">576000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzMxNDA_cf842f2f-2959-445c-ad0b-ba0d6f2083e1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Purchase price allocations for our significant acquisitions are:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase Price Allocation of Acquired Net Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Wright&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tangible assets acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(218)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(296)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Customer and distributor relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Developed technology and patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:700;line-height:100%"&gt;Purchase price, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,081&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%"&gt;Weighted average life of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzMtMi0xLTEtMjMwMjU_ec266daa-7c6b-495b-84a1-afa8d45ae12f"
      unitRef="usd">127000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzQtMi0xLTEtMjMwMjU_0a711aec-5eba-41b7-b7fe-44fc4de435e0"
      unitRef="usd">491000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzUtMi0xLTEtMjMwMjU_9d641f57-f0bc-4406-8c1c-58741898f706"
      unitRef="usd">440000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzYtMi0xLTEtMjMwMjU_bbde2715-6adb-451a-8764-c0336092bacb"
      unitRef="usd">343000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzctMi0xLTEtMjMwMjU_2b0f741e-fb54-47e9-ba98-bf35b02fa900"
      unitRef="usd">1446000000</syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzgtMi0xLTEtMjMwMjU_0a7b67fb-e858-40b1-82be-db6876051e47"
      unitRef="usd">503000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzktMi0xLTEtMjMwMjU_dbec81c1-4b4e-40a1-ae6f-f7315590ee83"
      unitRef="usd">218000000</syk:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEwLTItMS0xLTIzMDI1_8cb9ebb3-f2cc-4b6f-a05e-73a42c1cb064"
      unitRef="usd">296000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9cfff0a7aec247bc86688fccbb9b397f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEyLTItMS0xLTIzMDI1_34ace730-16ef-4a15-9414-4de2110cbd96"
      unitRef="usd">182000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i42136052eabf40fba1fdf489034458a0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzEzLTItMS0xLTIzMDI1_882d7760-6fd5-4b58-b91d-5c93a151b7cb"
      unitRef="usd">1506000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i515431d49ca14980ada9296078f4f0a5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE0LTItMS0xLTIzMDI1_816bdda1-d569-4cf1-8769-9cfad8099ac7"
      unitRef="usd">58000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE2LTItMS0xLTIzMDI1_49050f5f-b4dd-4cd1-b4b0-70ed58327af1"
      unitRef="usd">3397000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE3LTItMS0xLTIzMDI1_d936ea7a-1c18-409a-8492-b86f17869aff"
      unitRef="usd">4081000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if70c7c8d0bbd4f9582508d0d23fd23b9_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90YWJsZTo3NzQ0NzA3NDU0OWQ0Y2JiYTdkZGY0ZWI1NmVhMjcyZS90YWJsZXJhbmdlOjc3NDQ3MDc0NTQ5ZDRjYmJhN2RkZjRlYjU2ZWEyNzJlXzE4LTItMS0xLTIzMDI1_1a52c8af-f7a7-42f9-9bd6-1c21f5d74077">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <syk:BusinessCombinationConsiderationTransferredPricePerShare
      contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTU5_d6107e62-7059-4c17-8d6b-be766c8346dd"
      unitRef="usdPerShare">79.25</syk:BusinessCombinationConsiderationTransferredPricePerShare>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTY3_1f1515be-d1a5-4100-9eb9-0489ca993a19"
      unitRef="usd">3100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <syk:BusinessCombinationConsiderationTransferredPricePerShare
      contextRef="i4161d1c9a7144317b51f89075c91e7df_D20220101-20220131"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTUvZnJhZzo0NjNkNDg3MTFjMWU0MmUwYWNjNmNlM2NmMmU2M2UwNC90ZXh0cmVnaW9uOjQ2M2Q0ODcxMWMxZTQyZTBhY2M2Y2UzY2YyZTYzZTA0XzExNTQ0ODcyMTA0NTgx_d908c9ce-7be0-4682-8603-ca697b158127"
      unitRef="usdPerShare">79.25</syk:BusinessCombinationConsiderationTransferredPricePerShare>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMjM_2d4e2b46-d234-4f06-aeb8-cb67659e2d8d">CONTINGENCIES AND COMMITMENTSWe are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters, the most significant of which are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for certain claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Recall Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. In September 2020 we entered into a second settlement agreement to compensate eligible United States patients who had revision surgery prior to September 9, 2020. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. In December 2021, we reached a second agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreements, including the financial terms, are confidential.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;With the acquisition of Wright as more fully described in Note 6, we are responsible for certain product liability claims, primarily related to certain hip products sold by Wright prior to its 2014 divestiture of the OrthoRecon business. We will continue to evaluate each claim and the possible loss we may incur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. In 2021, we recorded charges of $103 and made payments of $221, primarily related to Rejuvenate and ABG II Modular-Neck hip stems. Based on the information that has been received, we have estimated the remaining range of probable loss related to recall matters globally to be approximately $385 to $520. We have recorded reserves representing the remaining minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:115%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. We evaluate our contracts to identify leases, which is generally if there is an identified asset and we &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;have the right to direct the use of and obtain substantially all of the economic benefit from the use of the identified asset. Certain of our lease agreements contain rent escalation clauses (including index-based escalations), rent holidays, capital improvement funding or other lease incentives. We recognize our minimum rental expense on a straight-line basis over the term of the lease beginning with the date of initial control of the asset. Right-of-use assets are recorded in Other noncurrent assets on our Consolidated Balance Sheets. Current and noncurrent lease liabilities are recorded in Accrued expenses and other liabilities and Other noncurrent liabilities, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have made certain significant assumptions and judgments when recording leases. For all asset classes, we elected to not recognize a right-of-use asset and lease liability for short-term leases and not separate non-lease components from lease components to which they relate and have accounted for the combined lease and non-lease components as a single lease component. The determination of the discount rate used in a lease is our incremental borrowing rate which is based on what we would normally pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease expense totaled $133, $130, and $133 in 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Future Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We have purchase commitments for materials, supplies, services and property, plant and equipment as part of the normal course of business. In addition, we lease various manufacturing, warehousing and distribution facilities, administrative and sales offices as well as equipment under operating leases. Refer to Note 10 for more information on the debt obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzEwOTk1MTE2Mjg0MjY1_4ba6df96-1c43-4b88-b703-467003e1b7d4"
      unitRef="usd">103000000</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyAccrualPayments
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzEwOTk1MTE2Mjg0Mjcx_e6feca69-eaf8-4a63-9902-059d04232cb1"
      unitRef="usd">221000000</us-gaap:LossContingencyAccrualPayments>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i9db0a793155f4536896d92116fb53672_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzM1ODM_b271ae7c-ee65-4316-b905-35f2e8c8f723"
      unitRef="usd">385000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i66cb47dd385f4d9999a85414eafe4457_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzM1ODk_253d5fc6-30c8-48d2-8f06-6d16c330d070"
      unitRef="usd">520000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMjU_2c4a309b-abf4-482d-8142-50b4a7166bcb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.359%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.451%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.454%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_82fd36ca-7e62-411a-b76a-c5030481d83f"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMC0xLTEtMjMwMjU_89035fe1-81fc-45bf-9ac1-090e1ab2e6a6"&gt;Right-of-use assets&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_9f8c3165-3297-42eb-b220-2dd3b3f34c48"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMC0xLTEtMjMwMjU_c0ef7c9f-7214-4a42-aa80-f5322352c52b"&gt;Lease liabilities, current&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_d6bf506f-c6a2-44ca-9847-17d01cefb181"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMC0xLTEtMjMwMjU_e1aa4208-8b91-4e94-92bb-2732754bf85b"&gt;Lease liabilities, noncurrent&lt;/span&gt;&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other information:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.6 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMS0xLTEtMjMwMjU_61b53a44-5f9c-49de-a625-f0d1d60a4584"
      unitRef="usd">419000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzItMy0xLTEtMjMwMjU_5a487a44-bb5a-4339-971a-d4307bbb1651"
      unitRef="usd">423000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMS0xLTEtMjMwMjU_e6baf5fb-9cac-4fc0-b49b-4d6bc870bc4c"
      unitRef="usd">112000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzMtMy0xLTEtMjMwMjU_dfa1802a-1c92-4e23-ae76-fbf46f80fe25"
      unitRef="usd">109000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMS0xLTEtMjMwMjU_5e00aa87-cee8-4f1a-aa5d-f1c9d6209696"
      unitRef="usd">310000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzQtMy0xLTEtMjMwMjU_916931ae-6a0f-45d7-a043-f49e2bbefdb6"
      unitRef="usd">325000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzktMS0xLTEtMjMwMjU_8f9b433a-e63a-4a94-9c33-6c38388adb2e">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzktMy0xLTEtMjMwMjU_a6330a76-f043-46b1-afeb-9ac50bdb214f">P5Y7M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzExLTEtMS0xLTIzMDI1_50809e26-3fcd-4119-ab9f-535a6ba2d326"
      unitRef="number">0.0286</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTo1YTEyMWYxMGI4ZWY0Yzg2OTI1Njk3MWRjZDg2NTdiMS90YWJsZXJhbmdlOjVhMTIxZjEwYjhlZjRjODY5MjU2OTcxZGNkODY1N2IxXzExLTMtMS0xLTIzMDI1_a8d6a7c1-d351-4475-ad89-3fa35c128fba"
      unitRef="number">0.0257</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU1OTI_5c0d2cdb-1eb7-4d73-b8d0-5f557732102d"
      unitRef="usd">133000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU1OTY_d15f631a-bf2f-405c-9891-7b41b4686bb3"
      unitRef="usd">130000000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzU2MDQ_f5d9d165-6951-4659-b92d-0c68174c93f7"
      unitRef="usd">133000000</us-gaap:OperatingLeaseExpense>
    <srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90ZXh0cmVnaW9uOjM5ZTM0Zjc5Yjk2MjQ1ZWNhZjk5NmNjYWM5OGY1NDU1XzYwMTY_78a87957-b678-4085-855f-32559a83e193">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt repayments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Purchase obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMS0xLTEtMjMwMjU_a0f86969-6a19-4118-ba96-047c9976ac72"
      unitRef="usd">7000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMi0xLTEtMjMwMjU_4794a3b2-6c26-479e-9906-2ccdee2a7186"
      unitRef="usd">1226000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItMy0xLTEtMjMwMjU_50772e0c-a692-47dd-a7de-0b61fb55473d"
      unitRef="usd">1564000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNC0xLTEtMjMwMjU_3159de3a-8032-42d3-b8db-65d6633fb76f"
      unitRef="usd">1400000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNS0xLTEtMjMwMjU_a18e618f-568d-4f71-b868-cbaa6074d8ba"
      unitRef="usd">1000000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzItNi0xLTEtMjMwMjU_f6506b41-26e9-405b-b86d-cd44f7138137"
      unitRef="usd">7392000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMS0xLTEtMjMwMjU_c1436b6c-24f3-4b1e-9c4b-8e9ecfac4ee9"
      unitRef="usd">1889000000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMi0xLTEtMjMwMjU_47e480d7-5744-4168-8eba-6ade75683f0b"
      unitRef="usd">69000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInSecondYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtMy0xLTEtMjMwMjU_463cd46b-af1c-4d85-8aea-bec5abe27e8a"
      unitRef="usd">54000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInThirdYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNC0xLTEtMjMwMjU_58237d0d-b651-4279-9d19-b5efcf6026b0"
      unitRef="usd">46000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFourthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNS0xLTEtMjMwMjU_4258f37b-d7da-4d75-81e5-838e421f787f"
      unitRef="usd">49000000</us-gaap:RecordedUnconditionalPurchaseObligationDueInFifthYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzMtNi0xLTEtMjMwMjU_cd2ecdad-54f6-4d28-92c1-afe81424224d"
      unitRef="usd">0</us-gaap:RecordedUnconditionalPurchaseObligationDueAfterFifthYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMS0xLTEtMjMwMjU_9d00964f-66b0-46cf-98b4-930d74ff6b46"
      unitRef="usd">112000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMi0xLTEtMjMwMjU_cadf415a-c785-4732-be6a-7603cc651365"
      unitRef="usd">86000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtMy0xLTEtMjMwMjU_b6077530-394f-47b7-9e85-58290e976d98"
      unitRef="usd">60000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNC0xLTEtMjMwMjU_b27718a3-85e2-482a-9bcc-34ab07f2c910"
      unitRef="usd">38000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNS0xLTEtMjMwMjU_8545d4e8-e594-43a5-8748-1e804b3e9bb4"
      unitRef="usd">34000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMTgvZnJhZzozOWUzNGY3OWI5NjI0NWVjYWY5OTZjY2FjOThmNTQ1NS90YWJsZTpmZGYyNGEwMjMxNDM0OGUzODdlYjQ1N2IyYzhmN2E5NS90YWJsZXJhbmdlOmZkZjI0YTAyMzE0MzQ4ZTM4N2ViNDU3YjJjOGY3YTk1XzQtNi0xLTEtMjMwMjU_b19b5153-b814-4c8f-8531-07c169db2d00"
      unitRef="usd">72000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE5NA_8cebc729-22dd-48f1-836d-e0359ff5577c">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We completed our annual impairment tests of goodwill in 2021 and 2020 and concluded in each year that no impairments exist.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,669&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,554&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE0OQ_c820a4c0-b965-4835-8ce7-43b748d55459"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE0OQ_fbf0ac34-da11-4de2-a97e-2284681de21d"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzEwOTk1MTE2MjgwMjc_a767844b-001a-4f72-a2cf-5172eec35887">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.681%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.612%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Changes in the Net Carrying Value of Goodwill by Segment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,377&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;9,069&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,459&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,319&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,778&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Additions and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(129)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,669&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;7,249&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,918&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="iff23dccda5944e118af54005133b53e7_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMS0xLTEtNDMxNjc_dfb11809-1076-4ece-9cdd-19756da25519"
      unitRef="usd">5377000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i620617bf01d945178f16bb399ad57f75_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMi0xLTEtNDMxNjc_cd656150-6127-4fc1-9b30-daeac9e5829d"
      unitRef="usd">3692000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzItMy0xLTEtNDMxNjc_9a2a754a-e008-472f-b056-0dd57de2a758"
      unitRef="usd">9069000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMS0xLTEtNDMxNjc_f44f16f9-13c2-4c3c-ab9c-cf9184da4525"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMi0xLTEtNDMxNjc_5777b3f9-d7d0-4d87-8146-d571a11498ea"
      unitRef="usd">3558000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzMtMy0xLTEtNDMxNjc_93c2f0ea-e7ef-4a9a-b1bc-8b3360a4f13a"
      unitRef="usd">3559000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i37f5cdf4b6714e54b1e1efd427c87513_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMS0xLTEtNDMxNjc_1d07374b-541b-49a7-99c4-c28cc187b8a1"
      unitRef="usd">81000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i1135cdae655a47da8f03e71ddf134597_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMi0xLTEtNDMxNjc_f9cee979-23f6-4912-8aee-bd383b6ac597"
      unitRef="usd">69000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzQtMy0xLTEtNDMxNjc_ca4e8d12-ee26-4eef-aba8-b9238f8b8ee4"
      unitRef="usd">150000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i99bfd05a796d4880b00788fe7096a885_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMS0xLTEtNDMxNjc_7e795822-84ff-4c5d-a7d2-46000e082bd4"
      unitRef="usd">5459000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i86c45f56956e48e19de6ba723be12789_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMi0xLTEtNDMxNjc_0047cf7f-8ba0-4c3c-89b4-e5ebc79946d2"
      unitRef="usd">7319000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzUtMy0xLTEtNDMxNjc_2ae6a15a-c365-4cca-835a-bfae2465167d"
      unitRef="usd">12778000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMS0xLTEtNDMxNjc_c9e89347-2e01-4b5e-8521-f6ba1ac093a0"
      unitRef="usd">223000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMi0xLTEtNDMxNjc_fca43d7f-5977-46a2-a65f-8230d3b7faa7"
      unitRef="usd">59000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzYtMy0xLTEtNDMxNjc_b2f7d438-bcf8-4237-bcbd-4ccebe82a0b1"
      unitRef="usd">282000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="idd7e313db7cf479084c51600ac790ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMS0xLTEtNDMxNjc_d3accd65-7a58-407c-96c4-51806c6eb52a"
      unitRef="usd">-13000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="iaaced62ef8b74b83a99280d437ad9ea6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMi0xLTEtNDMxNjc_7f54bc97-7285-4470-94c7-ddc5885d84bf"
      unitRef="usd">-129000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzctMy0xLTEtNDMxNjc_d9bb8b96-ee8d-4dbd-9ae7-091e7e50dd2d"
      unitRef="usd">-142000000</us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments>
    <us-gaap:Goodwill
      contextRef="i537ba5d8a2cc42d0ac3ebe24c14114dd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMS0xLTEtNDMxNjc_52332105-495b-447e-b3d6-84af232a0fad"
      unitRef="usd">5669000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i60bff9d7fe1740a4b1b56d78df05e951_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMi0xLTEtNDMxNjc_92b13358-817a-4eb2-adaf-3bdb91e22705"
      unitRef="usd">7249000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTpjNjI1MmMwODJkMmU0YTAxOGY5MmE4YWRlMjBiZDc2Ny90YWJsZXJhbmdlOmM2MjUyYzA4MmQyZTRhMDE4ZjkyYThhZGUyMGJkNzY3XzgtMy0xLTEtNDMxNjc_7bac092f-2a2b-45ce-b9ea-71a5f760b0ee"
      unitRef="usd">12918000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzE4Mg_4fdb46d8-fa52-44d0-8ff0-4ef2a387e3a2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.440%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.141%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.888%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Other Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average Amortization Period (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Less&lt;br/&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net&lt;br/&gt;Carrying&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Developed technologies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,542&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,702&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,840&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;8,656&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,102&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5,554&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i881fb152f349470ca7abba8d476e11a0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMS0xLTEtMjMwMjU_57b2b2f7-e7c5-4541-a3fb-d656d5929550">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMi0xLTEtMjMwMjU_0a557ffb-dfd0-4bb0-820c-2f671f6166fc"
      unitRef="usd">5326000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtMy0xLTEtMjMwMjU_aad735f5-1924-44d1-92f6-3e0bae86a89a"
      unitRef="usd">1956000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="icb6553c0eacd41b2b39fb9ee4cb7c974_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzMtNC0xLTEtMjMwMjU_0c3900fe-01e6-48ef-af10-59ee57f2e93a"
      unitRef="usd">3370000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iededa4a8c527471b85a48d5b54ad644d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMS0xLTEtMjMwMjU_0b9cc9ac-0ed9-431f-978e-9f568f763737">P13Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMi0xLTEtMjMwMjU_46812070-31cb-4533-8456-a03cc74440ad"
      unitRef="usd">5305000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtMy0xLTEtMjMwMjU_213e6c62-eeb7-40d2-9365-b84fa1657f9a"
      unitRef="usd">1573000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i007c06d259e748828bb28c412ab4ac98_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzQtNC0xLTEtMjMwMjU_ced90d70-7ecd-4c25-bdda-e39eabba624d"
      unitRef="usd">3732000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ia88bc7ee7b9745fc9352da5322ebb656_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMS0xLTEtMjMwMjU_c7b7cd81-bd5b-4e39-81a9-ba5515c8f2b4">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMi0xLTEtMjMwMjU_70a93eb4-0a03-4ec6-9c3e-8607451d1d39"
      unitRef="usd">2324000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtMy0xLTEtMjMwMjU_f118858f-f572-48a2-b1b1-c4249cdc1e83"
      unitRef="usd">1174000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7e1f8b8839054e4780b9b3de2c701f3b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzYtNC0xLTEtMjMwMjU_6d74daa9-5d9f-46a2-8e3d-81b9b200f82a"
      unitRef="usd">1150000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1087bf354d78467a8a499c466b98e2ec_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMS0xLTEtMjMwMjU_a3d2cf8a-bcba-4160-90cb-f080e38a5ede">P15Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMi0xLTEtMjMwMjU_6e392cc9-1723-4700-8c4c-9de7e6a83e95"
      unitRef="usd">2352000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctMy0xLTEtMjMwMjU_a771294e-cd28-47ba-b669-b5337c67b1c8"
      unitRef="usd">988000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6f95fb9fb7a14ce29e5ab7a143614a2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzctNC0xLTEtMjMwMjU_791d8d97-f433-45c7-a8e0-4f563f3118cb"
      unitRef="usd">1364000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i7b19b159bc734f8dac7b4ac724153ffb_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMS0xLTEtMjMwMjU_6013910b-39e5-4b49-ad1a-d4804b18adb1">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMi0xLTEtMjMwMjU_b60dba45-75f6-4a12-bdc3-71ae64fb490f"
      unitRef="usd">343000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktMy0xLTEtMjMwMjU_fc257bd0-cdb2-45dc-988f-57a8bc2793d0"
      unitRef="usd">286000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifae25731565a4034b3ee7bd4f65f29f5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzktNC0xLTEtMjMwMjU_49acc26e-85fd-4c6c-92ee-3f1c7e4aea6b"
      unitRef="usd">57000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib56b6a79e10d4b8da543faad8f04faef_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTEtMS0xLTIzMDI1_b1e96430-510d-48db-9f76-494e582ed727">P12Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iee70c5decbda497da7a729394169c742_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTItMS0xLTIzMDI1_070b5f5f-dc8a-447f-b939-f751666993ea"
      unitRef="usd">346000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iee70c5decbda497da7a729394169c742_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTMtMS0xLTIzMDI1_7ea089ed-b2df-439a-9041-1ef0c7b6b7aa"
      unitRef="usd">278000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="iee70c5decbda497da7a729394169c742_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEwLTQtMS0xLTIzMDI1_409ccf2b-96a5-45c6-8d5a-0e4cb431ad81"
      unitRef="usd">68000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="icf40de1dc0a747ac9e71b3ec9fe5e6ec_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTEtMS0xLTIzMDI1_79f17832-3ea4-49bf-9737-21d5a540106c">P16Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i95da961ae17b47f3858471949c39deb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTItMS0xLTIzMDI1_9ee847ec-3d03-4787-9d9e-19079d727747"
      unitRef="usd">415000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i95da961ae17b47f3858471949c39deb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTMtMS0xLTIzMDI1_5be52195-7f14-4044-8c74-5ff314555e3e"
      unitRef="usd">199000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i95da961ae17b47f3858471949c39deb9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEyLTQtMS0xLTIzMDI1_ff03b40d-483e-48d9-b906-fde1f6236728"
      unitRef="usd">216000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3abb2d8e94114546ba385f6ac936e9fe_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTEtMS0xLTIzMDI1_bf966f60-b2d2-49ca-b21f-e3a7adf45287">P17Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTItMS0xLTIzMDI1_af52aadf-5ed6-459b-9e84-aeca4004f4e8"
      unitRef="usd">428000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTMtMS0xLTIzMDI1_4f18c356-22b0-4592-befa-26677fbac076"
      unitRef="usd">162000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib0dadbfef3164e62895c0f78a8172e34_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzEzLTQtMS0xLTIzMDI1_6a52bbb1-35ae-4324-9b4d-86aa5de3ee0a"
      unitRef="usd">266000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTItMS0xLTIzMDI1_3454115d-6641-4e85-a498-4c20cf108b47"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTMtMS0xLTIzMDI1_b6439e5d-9701-4f70-ab44-58d25c9faf0c"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5c8b3b16d21f4937bc33eb8ad6ac6b2b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE1LTQtMS0xLTIzMDI1_c6f627f9-9660-4aec-81d7-d5bdfea99b3e"
      unitRef="usd">29000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie504e126295140d895f1b405fdae8218_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTItMS0xLTIzMDI1_a7496b1d-fc12-4427-80e0-da9cf6532d18"
      unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie504e126295140d895f1b405fdae8218_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTMtMS0xLTIzMDI1_92b8cf91-e652-4fa9-82d5-c1b2a927922b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie504e126295140d895f1b405fdae8218_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE2LTQtMS0xLTIzMDI1_97aa6abd-c979-43a2-97c5-43d5ffc7b340"
      unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i75223e6f266b49d0b5c29ab50334c3ca_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTEtMS0xLTIzMDI1_ae31f40e-a55d-4733-b4e9-ed4194426775">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTItMS0xLTIzMDI1_34454b97-b1f6-426d-bc19-251b3cf34d0e"
      unitRef="usd">105000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTMtMS0xLTIzMDI1_43cd4a33-7e1f-4717-9e2b-2f1fb778b2b1"
      unitRef="usd">87000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idd0b79e9ffdf4577bae842aae7525d95_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE4LTQtMS0xLTIzMDI1_a9a7b07f-b153-4808-813e-bc0734a2cefa"
      unitRef="usd">18000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i4c0fc5ea9fc4492a91cafecdf0d6fe28_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTEtMS0xLTIzMDI1_05a1abe5-7d64-4b8d-add8-e0275dd18492">P8Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTItMS0xLTIzMDI1_7c050847-a7f6-4f84-aaa3-049529a362b4"
      unitRef="usd">128000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTMtMS0xLTIzMDI1_1ad0b2bc-8022-40c6-8e41-4e47f721f4ec"
      unitRef="usd">101000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic68919f3a22244c1b7ff50822c238456_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzE5LTQtMS0xLTIzMDI1_62b1c29a-fd94-4c31-b4e9-58b787cee731"
      unitRef="usd">27000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTEtMS0xLTIzMDI1_d9d748e0-5a8e-4dbd-9591-c5a5bae0ceaf">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTItMS0xLTIzMDI1_bcf8d4dc-6da4-4643-9bdd-cd5b1dd5fa9a"
      unitRef="usd">8542000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTMtMS0xLTIzMDI1_5d24ecbd-af97-4725-a0d5-55f8617c5296"
      unitRef="usd">3702000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIxLTQtMS0xLTIzMDI1_05bdc358-4f49-4a9d-b052-81a0b8d7dd94"
      unitRef="usd">4840000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTEtMS0xLTIzMDI1_d476f649-6add-4716-819c-13918b7b6350">P14Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTItMS0xLTIzMDI1_9cdc700b-8adb-42e4-afb2-1e8b84c82ca0"
      unitRef="usd">8656000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTMtMS0xLTIzMDI1_5689f378-f22c-4428-b620-ac1679e7e3c3"
      unitRef="usd">3102000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNTM2M2RhNTk4MWU0NzcyOTYyYjI3NGQyMTA3ZThlNS90YWJsZXJhbmdlOmE1MzYzZGE1OTgxZTQ3NzI5NjJiMjc0ZDIxMDdlOGU1XzIyLTQtMS0xLTIzMDI1_c0d2e434-d182-4e01-b62e-8afac0447191"
      unitRef="usd">5554000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90ZXh0cmVnaW9uOjhjNDdhMDFhNjI3MTRjZTI4YzFhMjlkNDg1YjcwYTZjXzIwMQ_2d34361f-dfbc-4043-aea3-b0d734dd58e2">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.784%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.787%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Amortization Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMC0xLTEtMjMwMjU_2cdd8465-65a0-4d54-8c2e-0db03caccf57"
      unitRef="usd">581000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMS0xLTEtMjMwMjU_f6c7dce3-b779-4878-89fe-44fff28b6da6"
      unitRef="usd">558000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMi0xLTEtMjMwMjU_7da7f344-ef0b-4b50-8080-37a20be58d05"
      unitRef="usd">528000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItMy0xLTEtMjMwMjU_d5a17c40-05aa-483b-972b-46aa77cf2c98"
      unitRef="usd">506000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjQvZnJhZzo4YzQ3YTAxYTYyNzE0Y2UyOGMxYTI5ZDQ4NWI3MGE2Yy90YWJsZTphNmIyOTQwMjhkMGQ0OTYyOGQwYzIyMmEyNWZlNmU4Ny90YWJsZXJhbmdlOmE2YjI5NDAyOGQwZDQ5NjI4ZDBjMjIyYTI1ZmU2ZTg3XzItNC0xLTEtMjMwMjU_f1501e1b-dffa-40e7-8ef1-8582153fe46a"
      unitRef="usd">447000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNTM_3a90fd6f-4c73-4e7e-9bc9-71083641f94f">CAPITAL STOCK&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate number of shares of all classes of stock which we are authorized to issue is up to 1,000,500,000, divided into two classes consisting of 500,000 shares of $1 par value preferred stock and 1,000,000,000 shares of common stock with a par value of $0.10. No shares of preferred stock were outstanding on December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We made no repurchases of shares in 2021. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price and other factors and are subject to regulatory considerations. Purchases are made from time-to-time in the open market, in privately negotiated transactions or otherwise. On December&#160;31, 2021 the total dollar value of shares that could be purchased under our authorized repurchase program was $1,033.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares reserved for future compensation grants of our common stock were 25 million and 28 million&#160;on December&#160;31, 2021 and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the cost of employee stock options based on the grant-date fair value and recognize that cost using the straight-line method over the period in which a recipient is required to provide services in exchange for the options, typically the vesting period. The weighted-average fair value per share of options is estimated on the date of grant using the Black-Scholes option pricing model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The risk-free interest rate for periods within the expected life of options granted is based on the United States Treasury yield &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;curve in effect at the time of grant. Expected stock price volatility is based on the historical volatility of our stock. The expected option life, representing the period of time that options granted are expected to be outstanding, is based on historical option exercise and employee termination data. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2021 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;131.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;150.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,424.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,086.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options, which represents the cumulative difference between the fair market value of the underlying common stock and the option exercise prices, exercised was $253, $258, and $294 in 2021, 2020 and 2019. Exercise prices for options outstanding ranged from $53.60 to $270.94 on December&#160;31, 2021. On December&#160;31, 2021 there was $101 of unrecognized compensation cost related to nonvested stock options granted under the long-term incentive plans; that cost is expected to be recognized over the weighted-average period of approximately 1.5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;187.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;185.46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;210.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;On December&#160;31, 2021 there was $71 of unrecognized compensation cost related to nonvested RSUs. That cost is expected to be recognized as expense over the weighted-average period of approximately one year. The weighted-average grant date fair value per share of RSUs granted was $230.61 and $208.96 in 2021 and 2020. The fair value of RSUs and PSUs vested in 2021 was $63 and $5. On December&#160;31, 2021 there was $18 of unrecognized compensation cost related to nonvested PSUs; the cost is expected to be recognized as expense over the weighted-average period of approximately one year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plans (ESPP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employees may participate in our ESPP provided they meet certain eligibility requirements. The purchase price for our common stock under the terms of the ESPP is defined as 95% of the closing stock price on the last trading day of a purchase period. We issued 183,964 and 209,837 shares under the ESPP in 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <syk:CommonAndPreferredStockSharesAuthorized
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzEzMA_bf07cc8c-9b65-407e-94d7-10c54910ec13"
      unitRef="shares">1000500000</syk:CommonAndPreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE3Mw_0412d01a-3912-48a4-ad38-de6f80934826"
      unitRef="shares">500000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE4Ng_86525ef3-a704-4d7a-ac15-919571e1a12c"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIxOQ_40d3605f-5936-4101-9718-c373838bf833"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2NQ_f8bb0419-251d-404d-ace7-d7d0aa3b859b"
      unitRef="usdPerShare">0.10</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2OQ_4847f81d-260e-4a74-92b3-6e876eaf27bd"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzc3Mg_869042c5-f0a9-4d70-aa85-ea531bdd8171"
      unitRef="usd">1033000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzg0OA_fdc59df4-8a09-46d2-b06a-19ca552c8fe9"
      unitRef="shares">25000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzg2Mw_3eefc531-74f7-40ba-b5d5-d967f4e98b82"
      unitRef="shares">28000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNzA_e74d24a8-359a-4dd5-94fd-b1c10cc0f9f6">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.060%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.555%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Option Value and Assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;53.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assumptions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItMS0xLTEtMjMwMjU_51452e6d-b343-459c-b2ec-5750c5627a1e"
      unitRef="usdPerShare">53.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItMy0xLTEtMjMwMjU_b9e9123e-e452-4015-b20d-3fbd197468cc"
      unitRef="usdPerShare">39.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzItNS0xLTEtMjMwMjU_6e12ad45-7ebb-4faf-8b78-925fb05fb623"
      unitRef="usdPerShare">36.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtMS0xLTEtMjMwMjU_4f61fe78-ebe3-48c1-a9f6-65b3d2309e3a"
      unitRef="number">0.008</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtMy0xLTEtMjMwMjU_f07f9d8f-7b4b-4802-917a-5dcee756bae6"
      unitRef="number">0.014</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzQtNS0xLTEtMjMwMjU_21b1ae12-7424-408d-bb7d-5cccc446d82e"
      unitRef="number">0.026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtMS0xLTEtMjMwMjU_ac9be1ab-52e3-4689-8a90-211bf5a730fe"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtMy0xLTEtMjMwMjU_a9910e73-60c0-426f-8775-22df918a4493"
      unitRef="number">0.010</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzUtNS0xLTEtMjMwMjU_2c2fd7fb-3915-4d68-8a3f-cde90c157419"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtMS0xLTEtMjMwMjU_dd90c22b-03f4-41bd-b495-419ad9c25834"
      unitRef="number">0.269</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtMy0xLTEtMjMwMjU_ac2fad0f-0ee5-45ad-b6ce-82e384012055"
      unitRef="number">0.189</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzYtNS0xLTEtMjMwMjU_167a64f0-11c7-4fe9-9233-d1fe167b461c"
      unitRef="number">0.183</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctMS0xLTEtMjMwMjU_a643b685-2fa4-434e-9cd4-34790c241561">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctMy0xLTEtMjMwMjU_c08219ee-1a23-4ceb-837d-de39cbfe242c">P5Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZToyZmNmNDMwYjdiNzc0MDkzYTFiYzY4MzdmNTJiYzJkNy90YWJsZXJhbmdlOjJmY2Y0MzBiN2I3NzQwOTNhMWJjNjgzN2Y1MmJjMmQ3XzctNS0xLTEtMjMwMjU_064700b3-3e57-44f7-9b30-f4e68d30a17d">P5Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNTg_08c2dec8-4586-48fe-8ac7-a05ccd46ed42">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.479%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.173%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.513%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;2021 Stock Option Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares &lt;br/&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;131.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;96.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Outstanding December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;150.17&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,424.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Exercisable December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;113.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,086.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Options expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;199.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;313.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzItMS0xLTEtMjMwMjU_473aad86-7a72-40e6-bd70-687598334411"
      unitRef="shares">12200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzItMy0xLTEtMjMwMjU_9bc0df0f-a320-45eb-bd58-24fb4bf06e21"
      unitRef="usdPerShare">131.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzMtMS0xLTEtMjMwMjU_bc4a6f73-4f17-4bd4-93cd-e0da6d337115"
      unitRef="shares">1800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzMtMy0xLTEtMjMwMjU_9e6e0643-51b2-4877-b90c-dda1b9852b9a"
      unitRef="usdPerShare">235.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzQtMS0xLTEtMjMwMjU_6f609744-85fb-472e-a952-b105975cae0a"
      unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzQtMy0xLTEtMjMwMjU_39712b1e-8199-48c5-9208-7e1fde211442"
      unitRef="usdPerShare">96.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzUtMS0xLTEtMjMwMjU_260d9320-151b-4a78-bf38-a5f54b7b4641"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzUtMy0xLTEtMjMwMjU_04b772a6-992c-4c58-8648-5c5ad14cdf83"
      unitRef="usdPerShare">192.60</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtMS0xLTEtMjMwMjU_1ab24ef1-682f-40e3-ae05-b784148dcb46"
      unitRef="shares">12100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtMy0xLTEtMjMwMjU_af0b5d7d-353b-4307-82b3-a6adf8af3f6b"
      unitRef="usdPerShare">150.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtNS0xLTEtMjMwMjU_9b4711fb-3a5c-4743-8ce6-b1dc627e5d31">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzYtNy0xLTEtMjMwMjU_d2c0b182-84cb-47a3-b54d-ab0714117525"
      unitRef="usd">1424200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctMS0xLTEtMjMwMjU_f45c5330-09b9-42e4-a97b-c93950327ac6"
      unitRef="shares">7100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctMy0xLTEtMjMwMjU_bf96c117-cee6-4064-a18e-116ad0576ad8"
      unitRef="usdPerShare">113.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctNS0xLTEtMjMwMjU_10b14ac7-0e54-4aa7-9895-b838efd3edc4">P4Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzctNy0xLTEtMjMwMjU_fa60a5c9-8f36-473b-86b0-6524bc6faafa"
      unitRef="usd">1086300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtMS0xLTEtMjMwMjU_a9a0f622-27e2-4e80-86b6-bd0513a2a1a1"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtMy0xLTEtMjMwMjU_c3062977-9f38-4c3a-84be-e94320cb4163"
      unitRef="usdPerShare">199.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtNS0xLTEtMjMwMjU_f79457dd-d0e6-4426-bcd4-aaa50d8484be">P7Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTo0N2Q4NDM4Y2RlY2I0OGMzYTk5YWI0ZGM1YTczYzg2Yi90YWJsZXJhbmdlOjQ3ZDg0MzhjZGVjYjQ4YzNhOTlhYjRkYzVhNzNjODZiXzgtNy0xLTEtMjMwMjU_4b3ec1b5-477b-441e-87f0-3bd92524367a"
      unitRef="usd">313300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5MzE_8e2b18ac-3db3-4d7d-bb36-6cf51bda578c"
      unitRef="usd">253000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5MzU_f59a627b-dcf3-47d4-acc4-d7d333a8f7ff"
      unitRef="usd">258000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzE5NDM_b6f2dbcc-53f6-4cde-9599-7d8f6b457af7"
      unitRef="usd">294000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwMTY_80cdff1d-c96e-4256-86c2-c998131b1b83"
      unitRef="usdPerShare">53.60</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwMjI_a4fdc1ad-4ba8-410d-9897-181446ceb428"
      unitRef="usdPerShare">270.94</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIwNDg_f9ed12a8-a666-42e3-a85f-e811fcec9674"
      unitRef="usd">101000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIyNTQ_e6f4c33c-9cef-4a1c-99d5-e8eefe57776d">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxNjQ_10180a84-36e9-4598-b46c-d3e9d2c78b5f">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.217%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Restricted Stock Units (RSUs) and Performance Stock Units (PSUs) Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Grant&#160;Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;PSUs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on January 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.8&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;187.72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;185.46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;233.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;179.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;153.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Canceled or forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;187.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;160.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Nonvested on December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;0.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;213.16&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;210.73&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1dde6a23c87c43a39fd81af819d0e532_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtMS0xLTEtMjMwMjU_dd4625a8-6af5-43be-956c-564a7256a429"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i11a3a9e009874da393fcb3dac86134c0_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtMy0xLTEtMjMwMjU_c566e50b-7ae2-490f-8d38-675abd9970b1"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1dde6a23c87c43a39fd81af819d0e532_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtNS0xLTEtMjMwMjU_554d923b-48fb-44ee-87e2-373df21ccb27"
      unitRef="usdPerShare">187.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i11a3a9e009874da393fcb3dac86134c0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzMtNy0xLTEtMjMwMjU_63c08f0d-bc64-40ba-bbf3-9e12e9a9b9e2"
      unitRef="usdPerShare">185.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtMS0xLTEtMjMwMjU_4e79e18b-5b5e-471e-b48d-46762666e27d"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtMy0xLTEtMjMwMjU_c6e8b4bc-b077-4a9e-91be-84b41278d77c"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtNS0xLTEtMjMwMjU_3e023301-faa9-4481-9969-5e15acab624f"
      unitRef="usdPerShare">230.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzQtNy0xLTEtMjMwMjU_b38511c4-f5ad-4a9d-878e-d2d5c440f353"
      unitRef="usdPerShare">233.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtMS0xLTEtMjMwMjU_2e5f0fd0-0e8c-43d2-b4b4-44ba21b826c5"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtMy0xLTEtMjMwMjU_d4da3b78-78e7-4fd8-9485-dfca28e2f1aa"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtNS0xLTEtMjMwMjU_1b98f521-4788-4ab3-bda8-fc603094651a"
      unitRef="usdPerShare">179.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzUtNy0xLTEtMjMwMjU_2d17413b-e59c-42f2-9ee4-0fad540012c0"
      unitRef="usdPerShare">153.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtMS0xLTEtMjMwMjU_66e3f60f-02a5-4797-b3a5-554775dd3cb9"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtMy0xLTEtMjMwMjU_b4e79c81-62f3-417e-a514-6f963ccee035"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtNS0xLTEtMjMwMjU_ad4ddedd-42a0-4b9d-af8a-8dc3b2169607"
      unitRef="usdPerShare">187.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzYtNy0xLTEtMjMwMjU_95acbc45-8ddd-40bc-b161-cc819958204e"
      unitRef="usdPerShare">160.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctMS0xLTEtMjMwMjU_988185fe-18e7-410d-841a-2d1bf9b6b867"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctMy0xLTEtMjMwMjU_50ff2ff8-ceb2-42aa-ac2f-c198a1733465"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctNS0xLTEtMjMwMjU_43ceecd2-ab42-4a29-b6ae-714591c45e32"
      unitRef="usdPerShare">213.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90YWJsZTpjM2NjY2ZmMjE1Yjc0MzI5OTEzYzM2OTYxNzExYWQ0Zi90YWJsZXJhbmdlOmMzY2NjZmYyMTViNzQzMjk5MTNjMzY5NjE3MTFhZDRmXzctNy0xLTEtMjMwMjU_9b38373b-78bd-4a24-9db2-bca368dfc0f4"
      unitRef="usdPerShare">210.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i1b5eb0cd0fca4a4885c43ee63adc4a30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzIyNzY_78334624-68e8-4694-94d3-9433befd771c"
      unitRef="usd">71000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI0NDA_2eba4f30-824e-49e9-b4e4-fa56a2c08f73">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1MTc_b943c391-ac25-40ec-be47-f7eee3f3ade6"
      unitRef="usdPerShare">230.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i30c2cd9df03f4990802edf10bafe3d39_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1MjQ_a2425eae-2984-4bdf-8319-03294711d0d0"
      unitRef="usdPerShare">208.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue
      contextRef="i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1OTA_66ce66e1-1606-4f8e-8530-619004a4a1f0"
      unitRef="usd">63000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI1OTc_56bdc8bc-19c8-40ba-ae33-bee097d93abf"
      unitRef="usd">5000000</syk:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6d6bbd2cf290410eb553761cf7b1b304_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI2MTc_e54fee63-75e7-4cc0-9e81-7f1fa2c3df94"
      unitRef="usd">18000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id69e786052ea4b109ba619beabef2d34_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzI3ODA_1a67bb26-b924-4e2b-84cf-30232a703b84">P1Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp
      contextRef="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMwMTU_79280fcc-cd42-4ada-a9a7-fe3de6982145"
      unitRef="number">0.95</syk:PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i8cece3326b1b48508aa6595b2431c47a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxMDE_9d553bbd-fcf0-4e1c-9773-670658fd0eb3"
      unitRef="shares">183964</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i509624184e844f5fb011955bbb2c778e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMjcvZnJhZzo2Y2FkMDFiODlhNGE0MTE0YTUyY2JlMTRhNzUyY2JjYi90ZXh0cmVnaW9uOjZjYWQwMWI4OWE0YTQxMTRhNTJjYmUxNGE3NTJjYmNiXzMxMDg_c1025c00-04ab-4fac-92f0-10e71f157c27"
      unitRef="shares">209837</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NzQ_c5159ae2-cae4-462d-a033-6439034ccf10">DEBT AND CREDIT FACILITIESWe have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on December&#160;31, 2021. &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In October 2021 we entered into a new revolving credit agreement that replaces our previous agreement dated August 19, 2016. The primary changes were to increase the aggregate principal amount of the facility by $750 to $2,250, extend the maturity date to October 26, 2026, increase the leverage ratio to 3.75 and provide LIBOR replacement language. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:112%"&gt;In the first quarter of 2022, our Board of Directors approved an increase to the maximum amount of commercial paper that can be outstanding under our commercial paper program from $1,500 to $2,250, with maturities up to 397 days from the date of issuance. On December&#160;31, 2021 there were no borrowings outstanding under our credit facility or commercial paper program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.600%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,991&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,230&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In March 2021 we repaid $750 of senior unsecured notes with a coupon of 2.625% that were due on March 15, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;In June 2021 we repaid the $400 term loan that was due on November 10, 2023. &lt;/span&gt;&lt;/div&gt;Interest expense, including required fees incurred on outstanding debt and credit facilities that were included in other income (expense), net, totaled $337, $315, and $287 in 2021, 2020 and 2019.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="i1c4be753853f42df931435723368c9e5_D20211001-20211031"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0Mjk_2d8af661-a397-479b-8c6e-87f5c7f8d5ce"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia9e6f3514db1476f817d3a34bf82751a_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0MzU_1843826b-1046-433a-9dfa-7adae2726180"
      unitRef="usd">2250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <syk:DebtInstrumentCovenantLeverageRatio
      contextRef="ia9e6f3514db1476f817d3a34bf82751a_I20211031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI0NDg_d6c3ade7-4e19-4fc2-a82b-199354b9f9f0"
      unitRef="number">3.75</syk:DebtInstrumentCovenantLeverageRatio>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="icfbd20d36f4c4a0187acc94dfb9c9db4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzM2NQ_00ffd9b4-8bfa-42ac-8f23-4554a8781ac0"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i9ef4c1ea02da4ea596abd614114f7393_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MjgzOTQ2_0c03160c-f6e5-45c4-8de2-681368354931"
      unitRef="usd">2250000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i917ab770a5bd4746b5a9e3300c4046b4_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzQyMg_ab9039ea-efca-4685-beed-8a48d3af5bd2">P397D</us-gaap:DebtInstrumentTerm>
    <us-gaap:CommercialPaper
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzQ3NA_6354993f-1413-4561-964c-df78193a8859"
      unitRef="usd">0</us-gaap:CommercialPaper>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1ODE_0bf74acb-751b-4670-91d7-ac4c75143440">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.616%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:35.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.460%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.245%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Summary of Total Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Senior unsecured notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Due&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.600%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 1, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.250%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.150%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 1, 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.500%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.125%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.650%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 7, 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.750%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 1, 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.950%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;November 30, 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;727&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.000%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;December 3, 2031&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.100%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;April 1, 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.375%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;May 15, 2044&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4.625%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;March 15, 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;981&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.900%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;June 15, 2050&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,991&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12,472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;13,230&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Borrowing capacity on existing facilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of senior unsecured notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iaae71a75450b45cfa06a432fbf4e56b6_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtMS0xLTEtMjMwMjU_bcb19652-893c-4494-916b-89d55d642eee"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="iaae71a75450b45cfa06a432fbf4e56b6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtNS0xLTEtMjMwMjU_bdcddc55-21c0-4400-a1fb-68adf03bb084"
      unitRef="usd">0</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ib9765b80413243c19a3bd125fa129236_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzUtNy0xLTEtMjMwMjU_c9f4a914-9347-4a57-a528-568ac4217ac5"
      unitRef="usd">750000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtMS0xLTEtMjMwMjU_9ba98f81-378d-4fd5-81d3-b4ccc96324f2"
      unitRef="number">0.01125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i4912f69fb63b4ffab0779ac89d8a72bb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtNS0xLTEtMjMwMjU_b2acc7c1-11a2-4691-9e93-d99f46d4f52f"
      unitRef="usd">622000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i10c71a79ff0d4a66b82c64b38f8ef166_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzYtNy0xLTEtMjMwMjU_32d38406-ee93-480b-98b0-b1de25a7fc50"
      unitRef="usd">668000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iba8cdba131854e1fa2af1d12976b473e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctMS0xLTEtMjMwMjU_9ca089a3-e877-42ed-9ef4-819d24fa0be3"
      unitRef="number">0.00600</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="iba8cdba131854e1fa2af1d12976b473e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctNS0xLTEtMjMwMjU_dedff6e8-9967-4aae-886d-6bc1b4c6404c"
      unitRef="usd">598000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="icfca18fe7ca64a799cd68aefb09fb4c3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzctNy0xLTEtMjMwMjU_5a7b55ed-3841-463a-bd27-a3cfd8a55c63"
      unitRef="usd">597000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3509c57093a64b75a06052277ba0acb3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtMS0xLTEtMjMwMjU_9d8dd9f1-3af2-4cfc-9acd-48d24e39a9ef"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i3509c57093a64b75a06052277ba0acb3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtNS0xLTEtMjMwMjU_32b133eb-7118-42de-a2f9-2d3853617a6c"
      unitRef="usd">593000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i0227faa616da4a128a3d998d9f6db05d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzgtNy0xLTEtMjMwMjU_c4b58d61-eb04-4772-a9cd-e5322e7123e2"
      unitRef="usd">590000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktMS0xLTEtMjMwMjU_adb2b5d9-912c-41ce-8b60-095cd04d1cc8"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ie1bcd66ea8ce4517a8957dbf826ce376_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktNS0xLTEtMjMwMjU_9edc46f2-5f3a-4d0a-a27e-095444f0cf5f"
      unitRef="usd">958000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i480109c130434062bd13171059d5ef31_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzktNy0xLTEtMjMwMjU_92164e7f-8036-476c-bed0-5b762c6ef2a6"
      unitRef="usd">1030000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4681c2f77d9349a8a13546c839684f90_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTEtMS0xLTIzMDI1_2c22ddf8-b40e-461a-ab20-c566c233dd90"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i4681c2f77d9349a8a13546c839684f90_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTUtMS0xLTIzMDI1_fdc7888c-42e2-4f97-af38-e7f34f720050"
      unitRef="usd">645000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i0df1eb79fd5744fd8983118adebb9623_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEwLTctMS0xLTIzMDI1_898b2198-5893-4255-86db-a82d86a1cbb1"
      unitRef="usd">644000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i23e7e1ef2be4408ea79112316a123192_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTEtMS0xLTIzMDI1_cc283834-242b-4caa-b3b3-0b2f35a83708"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i23e7e1ef2be4408ea79112316a123192_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTUtMS0xLTIzMDI1_cba90777-645c-4694-a7ea-f64e0ba44949"
      unitRef="usd">748000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i0caf73b3889a40929b9da7a96bb99d5c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzExLTctMS0xLTIzMDI1_13df252f-68f7-4009-972c-0e453b544e86"
      unitRef="usd">747000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iad5a5038c5da499f92e3e8046651aa71_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTEtMS0xLTIzMDI1_9a0f024a-0282-4085-8db8-feeb28d614a4"
      unitRef="number">0.03500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="iad5a5038c5da499f92e3e8046651aa71_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTUtMS0xLTIzMDI1_7d3f3901-644e-4e77-8c30-3b162b9ebb42"
      unitRef="usd">994000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ic2fe3da873b14e1e9acb5a1220a5e06d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEyLTctMS0xLTIzMDI1_fb796610-c0dd-4103-ae0f-c5b49da9c677"
      unitRef="usd">992000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTEtMS0xLTIzMDI1_c244fbd4-0c39-4c3f-ae6a-f6d8fd77cd28"
      unitRef="number">0.02125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i2b80495b3a7d47ca82cb457dff5fe2e8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTUtMS0xLTIzMDI1_eea00892-f661-43dd-81d8-92f92e3034f9"
      unitRef="usd">845000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="id90b056e95f44ff5abeae3d32e78c913_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzEzLTctMS0xLTIzMDI1_9b2bf091-ec23-4757-8fa3-14e62f2a796b"
      unitRef="usd">909000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie0e14c0d1dcf411ab03235f607eb6313_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTEtMS0xLTIzMDI1_0a01f452-cafa-4b4a-b49a-f81f42821168"
      unitRef="number">0.03650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ie0e14c0d1dcf411ab03235f607eb6313_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTUtMS0xLTIzMDI1_fbb3ea95-ce7b-4f25-bf6d-648e5e62cc48"
      unitRef="usd">597000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="iee9e48c2079044c18c3f5e95f5b196b3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE0LTctMS0xLTIzMDI1_c2a4dcc3-557a-4c81-8e53-d78b9e3b8ca7"
      unitRef="usd">596000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63e97ef977d04cbe98290d564401c76b_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTEtMS0xLTIzMDI1_bbb63566-4a96-44af-b043-789c2e95a79b"
      unitRef="number">0.00750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i63e97ef977d04cbe98290d564401c76b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTUtMS0xLTIzMDI1_ac10a217-54cd-46b2-8845-d0bfcc1518df"
      unitRef="usd">901000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i336901cefd4f43fba19050323af4c966_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE1LTctMS0xLTIzMDI1_29f2faf4-76d5-4efd-9635-e4d96b03fb33"
      unitRef="usd">969000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3086dc119ed744e3be6f3fca238a2adf_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTEtMS0xLTIzMDI1_1d2ad17c-c663-4190-b728-d9b8f44018cc"
      unitRef="number">0.01950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i3086dc119ed744e3be6f3fca238a2adf_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTUtMS0xLTIzMDI1_ad76eee0-2960-44d8-81bd-2b4087d5e8fe"
      unitRef="usd">990000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i09191cd775d5416fac1419996ab55482_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE2LTctMS0xLTIzMDI1_27243f53-ab67-47b8-aed1-30c4a10107e5"
      unitRef="usd">989000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTEtMS0xLTIzMDI1_07930e44-afc5-4f69-a19a-b8e7326edcf3"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ia6dd65f3786d43d0877fa909d5ed7ee5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTUtMS0xLTIzMDI1_b1119b58-e230-4582-ba28-cbb7183a3fa5"
      unitRef="usd">727000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i23484026c90c4eba9c47bf90db97349a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE3LTctMS0xLTIzMDI1_7b1054cb-b009-44f1-9f5a-2ebf44339e43"
      unitRef="usd">782000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i323fcbeea7cf43648faf64c65504341c_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTEtMS0xLTIzMDI1_f5810192-346c-46e2-b123-6983a31075b7"
      unitRef="number">0.01000</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i323fcbeea7cf43648faf64c65504341c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTUtMS0xLTIzMDI1_7cb88ef5-6de4-4936-8eac-90c7f5c63e88"
      unitRef="usd">840000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i38d1fc1af0074b52bfb9bcd1fd97816a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE4LTctMS0xLTIzMDI1_9119aa74-b57e-49dd-9f22-7f9209aaa2d9"
      unitRef="usd">903000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4e46902a0d4641b6aad2beef3aed8f86_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTEtMS0xLTIzMDI1_b7dc770e-81de-40ff-a374-6ac981456e73"
      unitRef="number">0.04100</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i4e46902a0d4641b6aad2beef3aed8f86_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTUtMS0xLTIzMDI1_14a5e6a1-d57c-4d0e-85d4-cdc0e7ecfa4d"
      unitRef="usd">392000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ic725b5e5cada4fe09f8bbb6ff2a948e9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzE5LTctMS0xLTIzMDI1_5899427b-f69d-47fb-acc2-b71bbb9f29b2"
      unitRef="usd">392000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia68e51613f0e40deb45d9d94d6e67b14_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTEtMS0xLTIzMDI1_e2965202-ad33-45fd-a8a5-94a60cb3322c"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="ia68e51613f0e40deb45d9d94d6e67b14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTUtMS0xLTIzMDI1_3a974246-5b97-4e25-a731-0206d868cbd5"
      unitRef="usd">395000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i7def3071dac84fbf93b4831fce46ae80_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIwLTctMS0xLTIzMDI1_7421c842-eade-43ff-b882-43340af270a0"
      unitRef="usd">395000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idbd80c3cd55641208b41aaa854e69a3d_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTEtMS0xLTIzMDI1_34e9ea78-3911-405f-90c1-a09c028333ce"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="idbd80c3cd55641208b41aaa854e69a3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTUtMS0xLTIzMDI1_83741bcf-05bb-426c-b9b9-27cf2e1753aa"
      unitRef="usd">982000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="ib4a79159e25947238adcf8348dd4618a_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIxLTctMS0xLTIzMDI1_36035a7b-bc1c-44c0-aa1b-cbea756d7a55"
      unitRef="usd">981000000</us-gaap:UnsecuredDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10d1a9bafbac4422919540ab667b2004_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTEtMS0xLTIzMDI1_3b664456-c6b9-4163-906e-5854accbd501"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:UnsecuredDebt
      contextRef="i10d1a9bafbac4422919540ab667b2004_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTUtMS0xLTIzMDI1_155e32b5-70a2-4679-bcd0-f97198f75237"
      unitRef="usd">642000000</us-gaap:UnsecuredDebt>
    <us-gaap:UnsecuredDebt
      contextRef="i8a5a0db81617461dbfb08c50f5a369e5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIyLTctMS0xLTIzMDI1_03dc7edd-e8a2-4be4-bdb8-be8f22ca9ae4"
      unitRef="usd">641000000</us-gaap:UnsecuredDebt>
    <us-gaap:LongTermDebt
      contextRef="iaa94a4981170459daf10d0648f64494e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIzLTUtMS0xLTIzMDI1_f264b713-8878-4abd-9f46-b3ed0a1fed71"
      unitRef="usd">0</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="ibce21f74de924d9091f5bc5d627d39d4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzIzLTctMS0xLTIzMDI1_7dbf3a37-2d6c-4504-94ca-8210108865ad"
      unitRef="usd">400000000</us-gaap:LongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI1LTUtMS0xLTIzMDI1_7e9fecdb-9e5b-4f8d-8c7d-323bbd94b66c"
      unitRef="usd">10000000</us-gaap:OtherLongTermDebt>
    <us-gaap:OtherLongTermDebt
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI1LTctMS0xLTIzMDI1_d50a14d6-f28f-4355-8e65-b264842bf01d"
      unitRef="usd">16000000</us-gaap:OtherLongTermDebt>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI2LTUtMS0xLTIzMDI1_77bd6add-f582-42da-8364-5e9418e996cf"
      unitRef="usd">12479000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI2LTctMS0xLTIzMDI1_2e9d82af-d865-44d7-b61c-71afe0b46b9d"
      unitRef="usd">13991000000</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:DebtCurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI3LTUtMS0xLTIzMDI1_d00a4ad0-3ec8-492f-8faa-973ac418efd1"
      unitRef="usd">7000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI3LTctMS0xLTIzMDI1_bc2e5327-8f28-4b62-a207-9a64183d63d3"
      unitRef="usd">761000000</us-gaap:DebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI4LTUtMS0xLTIzMDI1_ba7469eb-8502-4c24-aebd-5f14834b200b"
      unitRef="usd">12472000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzI4LTctMS0xLTIzMDI1_bd347483-f49e-4ee1-9a52-af4bb80e8a24"
      unitRef="usd">13230000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMwLTUtMS0xLTIzMDI1_3672a8d7-6102-4170-be6a-ab30d8855401"
      unitRef="usd">62000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMwLTctMS0xLTIzMDI1_62babf86-90cb-4d4b-bdd2-e31277195939"
      unitRef="usd">71000000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMxLTUtMS0xLTIzMDI1_949228ad-01ea-4284-8345-b303dea5cab5"
      unitRef="usd">2162000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMxLTctMS0xLTIzMDI1_c8298f08-1537-4de9-a7b9-916f4b3a38f1"
      unitRef="usd">2903000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMyLTUtMS0xLTIzMDI1_0f80134f-47c2-43eb-943b-26a3af252b4a"
      unitRef="usd">13391000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90YWJsZTpjYzRmZWQzYzc4MWU0Nzk5ODQyM2E4MTU2YTMwNWE2Zi90YWJsZXJhbmdlOmNjNGZlZDNjNzgxZTQ3OTk4NDIzYTgxNTZhMzA1YTZmXzMyLTctMS0xLTIzMDI1_36e67ac7-ae6d-4c54-b98f-e173ee110c75"
      unitRef="usd">15022000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i37083d398075438da83a8349d52ed8c6_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NTI_8d64c4a6-12b8-406c-bb8d-f78ef5aecb40"
      unitRef="usd">750000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i37083d398075438da83a8349d52ed8c6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NTg_470a0852-222d-42a3-ac40-092e4231d073"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRepurchasedFaceAmount
      contextRef="i5cc983b0708b43efbe69262c949402dd_I20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzEwOTk1MTE2MzI4NjY_52506499-03f3-479a-bf00-7d0970076e3e"
      unitRef="usd">400000000</us-gaap:DebtInstrumentRepurchasedFaceAmount>
    <us-gaap:InterestExpenseDebt
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1Mzc_9ed4897b-1425-441f-9574-75d419d4f4ff"
      unitRef="usd">337000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NDE_87c850c6-0c08-4d92-b9bf-e6b12ec1a230"
      unitRef="usd">315000000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzAvZnJhZzo1NzA5YmNlOThkODQ0MjJmOTBmNjRjMmE5NzJkMTVjYy90ZXh0cmVnaW9uOjU3MDliY2U5OGQ4NDQyMmY5MGY2NGMyYTk3MmQxNWNjXzI1NDk_e5d45c8e-f526-4542-ad9a-d971c35513f1"
      unitRef="usd">287000000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NTg_4bafe76d-6e26-4240-b1ba-4637fa1ac89b">INCOME TAXES Our effective tax rate was 12.6%, 18.2% and 18.7% for 2021, 2020 and 2019. The effective income tax rate for 2021 reflects the continued lower effective income tax rates as a result of our European operations, certain discrete tax benefits, the tax effect related to the transfer of intellectual property between tax jurisdictions and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries. The effective &lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;income tax rate for 2020 and 2019 reflects the tax effect related to the transfer of intellectual properties between tax jurisdictions, the effective income tax rates as a result of our European operations and the tax effect of future remittances of the undistributed earnings of foreign subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;353&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax (benefit) expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax (benefit) expense &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest and penalties included in other income (expense), net were expense of ($23), ($35) and ($9) in 2021, 2020 and 2019. The United States federal deferred income tax benefit (expense) includes the utilization of net operating loss carryforwards of $283, $41 and $50 in 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and other credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,063&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,860&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued interest and penalties were $150 and $133 on December&#160;31, 2021 and 2020 which were reported in current and noncurrent accrued expenses and other liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards totaling $602 with $192 being subject to a full valuation allowance ($183 and $106 related to the Wright acquisition) on December&#160;31, 2021 are available to reduce future taxable earnings of certain domestic and foreign &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;subsidiaries. United States loss carryforwards of $403 expire through 2045. International loss carryforwards of $198 begin to expire in 2022; however, some have no expiration. We also have tax credit carryforwards of $104 with $83 being subject to a full valuation allowance. The credits with a full valuation allowance begin to expire in 2022; however, some have no expiration. We do not anticipate generating income tax in excess of the non-expiring credits in the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;The Tax Cuts and Jobs Act ("the Act") was enacted in 2017 in the United States. We recorded a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred. The Act also subjects a United States shareholder to tax on Global Intangible Low-Taxed Income (GILTI) earned by certain foreign subsidiaries. We have elected to account for GILTI tax in the year the tax is incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:115%"&gt;We recorded deferred income tax on undistributed earnings of foreign subsidiaries not determined to be indefinitely reinvested. Determination of the total amount of unrecognized deferred income tax on undistributed earnings of foreign subsidiaries is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements and resolutions of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our income tax expense would have been reduced by $445 and $456 in 2021 and 2020 had these uncertain income tax positions been favorably resolved. It is reasonably possible that the amount of unrecognized tax benefits will significantly change due to one or more of the following events in the next 12 months: expiring statutes, audit activity, tax payments, competent authority proceedings related to transfer pricing or final decisions in matters that are the subject of controversy in various taxing jurisdictions in which we operate, including inventory transfer pricing, cost sharing, product royalty and foreign branch arrangements. We are not able to reasonably estimate the amount or the future periods in which changes in unrecognized tax benefits may be resolved. Interest and penalties incurred associated with uncertain tax positions are included in other income (expense), net.&lt;/span&gt;&lt;/div&gt;In the normal course of business, income tax authorities in various income tax jurisdictions both within the United States and internationally conduct routine audits of our income tax returns filed in prior years.&#160;These audits are generally designed to determine if individual income tax authorities are in agreement with our interpretations of complex income tax regulations regarding the allocation of income to the various income tax jurisdictions. Income tax years are open from 2014 through the current year for the United States federal jurisdiction. Income tax years open for our other major jurisdictions range from 2006 through the current year.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzU2_63551539-d65e-4c53-b3ba-fbd5c0828f8c"
      unitRef="number">0.126</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzYw_92524013-cb8f-4f37-b7e4-05363dd02860"
      unitRef="number">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzY3_618d5565-93ec-4f8e-aa78-7c751b627ee2"
      unitRef="number">0.187</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5Nzg_626fcf72-6f77-4f59-82a3-b7e9acd387e5">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Effective Income Tax Rate Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;United States federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;21.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local income taxes, less federal deduction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign income tax at rates other than 21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(4.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Tax related to repatriation of foreign earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Effective income tax rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;12.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;18.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItMS0xLTEtMjMwMjU_359872f4-980f-453a-9bda-cd1f4ba6a874"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItMy0xLTEtMjMwMjU_6193731c-f392-48e7-be2e-531e16fbf122"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzItNS0xLTEtMjMwMjU_4717522d-038a-40b5-9030-c8b8e1aca871"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtMS0xLTEtMjMwMjU_c02cbb40-6019-4e04-bfad-9ccf9e3959ef"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtMy0xLTEtMjMwMjU_6f1ee0b0-2e04-4be7-8e4a-fffc77631449"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzMtNS0xLTEtMjMwMjU_39b1c123-b934-4b66-8d07-9797eb1c65a6"
      unitRef="number">0.017</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtMS0xLTEtMjMwMjU_cad92842-2d6d-4c2e-b0b6-04a31555fb19"
      unitRef="number">0.069</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtMy0xLTEtMjMwMjU_c0ccf61a-251a-4e32-89e2-9cda7f001c49"
      unitRef="number">0.033</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzQtNS0xLTEtMjMwMjU_b44ac4df-69ff-4424-87a1-b638f4a8b9c3"
      unitRef="number">0.046</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctMS0xLTEtMjMwMjU_82a8c13d-3697-432e-95b0-38738f1d8dda"
      unitRef="number">-0.014</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctMy0xLTEtMjMwMjU_151f6948-b506-40fd-9ed6-567568a3e3cf"
      unitRef="number">-0.030</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzctNS0xLTEtMjMwMjU_c2bf68e1-7377-4a57-a976-c7d5f830cf07"
      unitRef="number">0.005</syk:EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtMS0xLTEtMjMwMjU_26e8879c-2007-4a48-8cf5-42d96bb8fa76"
      unitRef="number">0.023</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtMy0xLTEtMjMwMjU_37d0d001-41c2-4f02-baeb-a9bb40bad656"
      unitRef="number">0.014</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzgtNS0xLTEtMjMwMjU_fd0a5c39-572b-4d01-a531-fdf2a3bb7d10"
      unitRef="number">-0.035</syk:EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktMS0xLTEtMjMwMjU_87a24bae-cb67-497d-8122-1cec817f0f1c"
      unitRef="number">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktMy0xLTEtMjMwMjU_6ce70f65-fcb1-4537-9418-f8a4115eb7a6"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzktNS0xLTEtMjMwMjU_fe09361c-d148-4058-88cf-6d6baeef3b6f"
      unitRef="number">-0.024</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTEtMS0xLTIzMDI1_041707be-d789-4298-b2a5-41bf12b31579"
      unitRef="number">0.126</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTMtMS0xLTIzMDI1_7e464275-f01b-4e17-9870-9d80bfd57b07"
      unitRef="number">0.182</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo5ZDgzMWRmNDRlMjc0YTI4YTJlY2IxZDAyYzg5ZTZjOS90YWJsZXJhbmdlOjlkODMxZGY0NGUyNzRhMjhhMmVjYjFkMDJjODllNmM5XzEwLTUtMS0xLTIzMDI1_ba04e098-441c-44c8-bee6-4cc0c6082a02"
      unitRef="number">0.187</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NzQ_7ee3fb1e-655c-4055-ad0d-93e23a17030b">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Earnings Before Income Taxes&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,562&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.259%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Income Tax Expense (Benefit)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Current income tax expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;524&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;307&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;353&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax (benefit) expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(82)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States state and local&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax (benefit) expense &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;48&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;126&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;287&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;479&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItMS0xLTEtMjMwMjU_296e2ba8-4c94-4b1c-a861-87db74af9c70"
      unitRef="usd">433000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItMy0xLTEtMjMwMjU_62fc2d7f-8cf4-4887-9623-6283ce9eec71"
      unitRef="usd">239000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzItNS0xLTEtMjMwMjU_50d52c9d-7b84-49f9-b7d4-d3656a552e95"
      unitRef="usd">366000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtMS0xLTEtMjMwMjU_d8ae28cb-5890-4f9e-9ad1-26eaae022e25"
      unitRef="usd">1848000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtMy0xLTEtMjMwMjU_1b81521e-0b42-42bb-8615-c5a02697f39d"
      unitRef="usd">1715000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzMtNS0xLTEtMjMwMjU_2539cc01-f9fa-4d99-9b99-756b998c7310"
      unitRef="usd">2196000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtMS0xLTEtMjMwMjU_b721ccbd-c072-40ea-85a3-b3e606ce95e2"
      unitRef="usd">2281000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtMy0xLTEtMjMwMjU_af4b2fd6-5704-4f40-9d6e-d7310cfa9d34"
      unitRef="usd">1954000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTplZGNiMjA4ODNmY2Q0Yjc4OTIwYzhiNWVmODc2YTZmZC90YWJsZXJhbmdlOmVkY2IyMDg4M2ZjZDRiNzg5MjBjOGI1ZWY4NzZhNmZkXzQtNS0xLTEtMjMwMjU_d7235464-2433-4489-bd1f-8986e257f8cc"
      unitRef="usd">2562000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItMS0xLTEtMjMwMjU_8c920819-3190-4ca7-9053-1fde67ca067a"
      unitRef="usd">155000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItMy0xLTEtMjMwMjU_4df06e38-3958-4093-bf60-c496859828d7"
      unitRef="usd">80000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzItNS0xLTEtMjMwMjU_8afce2a6-1362-44c1-b1c3-12243a33dfa6"
      unitRef="usd">-17000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtMS0xLTEtMjMwMjU_bdb99c25-00f9-404d-aeb7-7f942844f1f5"
      unitRef="usd">97000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtMy0xLTEtMjMwMjU_64bd5a94-5174-407f-ba7a-c8aa3ba00f70"
      unitRef="usd">20000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzMtNS0xLTEtMjMwMjU_db19f1a9-7762-4c00-987c-3f71d98b85d4"
      unitRef="usd">46000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtMS0xLTEtMjMwMjU_3a30f87f-de5b-4177-bf79-68c79aa9053a"
      unitRef="usd">272000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtMy0xLTEtMjMwMjU_a30a5a02-035f-408d-a306-851cd122f07d"
      unitRef="usd">207000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzQtNS0xLTEtMjMwMjU_a6b57c39-060f-4665-9af0-2070d321b66c"
      unitRef="usd">324000000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtMS0xLTEtMjMwMjU_57349091-bd3c-4b6d-ac74-0051da4c5fd3"
      unitRef="usd">524000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtMy0xLTEtMjMwMjU_e661691b-d8ec-499a-ba17-8bec4242ea36"
      unitRef="usd">307000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzUtNS0xLTEtMjMwMjU_e46afea8-17a1-4137-8c97-cfe54281cee3"
      unitRef="usd">353000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctMS0xLTEtMjMwMjU_040014e9-f209-44f1-b8f9-10ec0608fdc1"
      unitRef="usd">-82000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctMy0xLTEtMjMwMjU_e9415c4d-aa41-42ec-af16-e95db8504b01"
      unitRef="usd">1000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzctNS0xLTEtMjMwMjU_1b88d840-2042-4675-8659-773e5545d1fa"
      unitRef="usd">10000000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtMS0xLTEtMjMwMjU_c9ad2e79-bf26-4be4-ab92-0052f85df668"
      unitRef="usd">-23000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtMy0xLTEtMjMwMjU_505fab99-a82c-49ae-ba40-bfd0d3d544f7"
      unitRef="usd">-25000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzgtNS0xLTEtMjMwMjU_e68bbd36-7f5f-4c4b-8ef5-516dac3a306e"
      unitRef="usd">-1000000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktMS0xLTEtMjMwMjU_63d23911-17f9-47e5-96ec-8125f902e5e7"
      unitRef="usd">-132000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktMy0xLTEtMjMwMjU_231576e8-6e39-4ff9-943b-12c19e421d57"
      unitRef="usd">72000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzktNS0xLTEtMjMwMjU_7b348f52-c24b-4267-acdf-99628278f6b4"
      unitRef="usd">117000000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTEtMS0xLTIzMDI1_d390c488-b953-49d9-a51b-98a32b0614a1"
      unitRef="usd">-237000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTMtMS0xLTIzMDI1_1b97422e-a4b9-4fff-80f1-0a02b646f7af"
      unitRef="usd">48000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzEwLTUtMS0xLTIzMDI1_48f2bbab-9cc5-4a38-a3b7-3fdd3a9e59f3"
      unitRef="usd">126000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTEtMS0xLTIzMDI1_dc20b051-4c45-45f4-b0b3-ba90fc039e81"
      unitRef="usd">287000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTMtMS0xLTIzMDI1_09bd6dee-107b-4e01-8850-0b1bb43802ca"
      unitRef="usd">355000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo1MGQ4Y2UzYmMyZjc0NmU3YWRiMzYwYzcxNzNmN2Y3Ny90YWJsZXJhbmdlOjUwZDhjZTNiYzJmNzQ2ZTdhZGIzNjBjNzE3M2Y3Zjc3XzExLTUtMS0xLTIzMDI1_fb7683d9-7654-4441-a4d8-ad8db960b390"
      unitRef="usd">479000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE3OTE_268d19bd-7dbc-4983-aff8-0c4bf3570751"
      unitRef="usd">23000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE3OTU_a2c72fc5-bcf5-4218-ac7b-5c62329094ff"
      unitRef="usd">35000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE4MDI_baf82994-a1b7-4616-8ef5-802ccbc8f2d9"
      unitRef="usd">9000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NTE_4f76dfeb-2151-405b-a9e9-b70514cccaad"
      unitRef="usd">283000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NTU_14d9b578-7fc8-4220-8a8f-9a351a6fc1e1"
      unitRef="usd">41000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzE5NjI_fd9d5d8d-1a36-4404-87da-64b249e21281"
      unitRef="usd">50000000</syk:IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5ODI_25b39db9-d3c5-4769-9a7e-6eceb10ff88e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.463%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Deferred Income Tax Assets and Liabilities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Product-related liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;State income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net operating loss and other credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,063&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Less valuation allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(164)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,697&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,860&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Deferred income tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,286)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Undistributed earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(114)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,005)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(1,447)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,692&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,413&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzItMS0xLTEtMjMwMjU_6a0273c0-90ab-4b96-b191-d0a585b141cf"
      unitRef="usd">513000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzItMy0xLTEtMjMwMjU_1d0f5e0f-5e1e-44f6-93b1-959030124d9b"
      unitRef="usd">434000000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzMtMS0xLTEtMjMwMjU_8814c025-3910-48f8-b51f-4c2ac51bfb9a"
      unitRef="usd">39000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzMtMy0xLTEtMjMwMjU_9f744985-e6ed-47dd-9daa-ac9391548876"
      unitRef="usd">48000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzQtMS0xLTEtMjMwMjU_50f7ee3c-9f40-4c8c-af00-48eb3bd0189c"
      unitRef="usd">501000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzQtMy0xLTEtMjMwMjU_75dd8419-b994-493a-9c95-5246817af252"
      unitRef="usd">512000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther>
    <syk:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzUtMS0xLTEtMjMwMjU_40ce8810-71bc-49a0-bad2-ef61d30d98b3"
      unitRef="usd">1194000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <syk:DeferredTaxAssetsDepreciationAndAmortization
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzUtMy0xLTEtMjMwMjU_d97af8f0-9651-4de7-96cb-20505a4429bf"
      unitRef="usd">1269000000</syk:DeferredTaxAssetsDepreciationAndAmortization>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzYtMS0xLTEtMjMwMjU_e5de67bb-bbd7-4090-92c1-695ce0b4a7b3"
      unitRef="usd">128000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzYtMy0xLTEtMjMwMjU_cf48fad2-4a8b-4125-a18c-40f654e3bb8d"
      unitRef="usd">108000000</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzctMS0xLTEtMjMwMjU_717026d4-c4c8-424f-83dd-ffeda496759a"
      unitRef="usd">63000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzctMy0xLTEtMjMwMjU_71233818-ecd2-4eb8-a4a8-d94758978874"
      unitRef="usd">56000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzgtMS0xLTEtMjMwMjU_69c0778a-7e5a-4acd-8004-b60b10a30a81"
      unitRef="usd">232000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzgtMy0xLTEtMjMwMjU_98a2fbe9-7ad0-4594-b4b1-ea29d78b472d"
      unitRef="usd">470000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzktMS0xLTEtMjMwMjU_4e001adf-d548-404b-9d69-e83c6837d973"
      unitRef="usd">191000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzktMy0xLTEtMjMwMjU_0ea53301-34c8-434c-b82b-af2cfd2fd30e"
      unitRef="usd">166000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEwLTEtMS0xLTIzMDI1_974bdb82-aaf0-4ac9-a0b1-679da3d858bd"
      unitRef="usd">2861000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEwLTMtMS0xLTIzMDI1_de8ae276-8b33-4e6f-8ee6-a93d06c1b4bf"
      unitRef="usd">3063000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzExLTEtMS0xLTIzMDI1_52a9eb25-1ddc-4a75-be6b-53f00f321f28"
      unitRef="usd">164000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzExLTMtMS0xLTIzMDI1_c58d19db-4318-4784-809a-8e4d3e40465f"
      unitRef="usd">203000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEyLTEtMS0xLTIzMDI1_a2d99987-8f2c-4786-947e-9e8f5a00cf98"
      unitRef="usd">2697000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzEyLTMtMS0xLTIzMDI1_caab2b3d-b285-4b79-ab3c-6aaced7c5b15"
      unitRef="usd">2860000000</us-gaap:DeferredTaxAssetsNet>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE0LTEtMS0xLTIzMDI1_87c95137-347b-4e0f-85aa-469c8cfe1b0e"
      unitRef="usd">891000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <syk:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE0LTMtMS0xLTIzMDI1_7175d4c5-a418-4e76-809f-5c2ceeaf673e"
      unitRef="usd">1286000000</syk:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE1LTEtMS0xLTIzMDI1_cfc4777d-fd19-4791-aa12-c64a2eee7af5"
      unitRef="usd">114000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE1LTMtMS0xLTIzMDI1_f627d6ae-d467-453c-a67b-f67fe7e08f6b"
      unitRef="usd">161000000</us-gaap:DeferredTaxLiabilitiesUndistributedForeignEarnings>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE3LTEtMS0xLTIzMDI1_9b072fe8-3ca9-4307-89d2-9ec8f6526f1a"
      unitRef="usd">1005000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE3LTMtMS0xLTIzMDI1_0c7d023f-da68-4024-8cf3-c26830b41815"
      unitRef="usd">1447000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE4LTEtMS0xLTIzMDI1_00efef77-7e8c-4524-8bb0-cd6aef752c8d"
      unitRef="usd">1692000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzE4LTMtMS0xLTIzMDI1_4d9fa596-b220-475b-926f-2c80f94e5e15"
      unitRef="usd">1413000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIwLTEtMS0xLTIzMDI1_4a6302a9-8909-41c8-8faf-8c0d377e26cb"
      unitRef="usd">1760000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIwLTMtMS0xLTIzMDI1_8f48a59a-4164-496e-a91e-ac5735a0cab8"
      unitRef="usd">1530000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIxLTEtMS0xLTIzMDI1_cb80e344-8e57-4a54-a4f8-29ee7c2869ca"
      unitRef="usd">68000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIxLTMtMS0xLTIzMDI1_dfa41b67-aaa2-49b3-8e53-ebf3a9e47e0f"
      unitRef="usd">117000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIyLTEtMS0xLTIzMDI1_6fd43af1-062d-4ca6-9547-ee08c0afc1c6"
      unitRef="usd">1692000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTo4YWE2Y2M4NzFiMjU0MjYyOGU5MjlmZDQwYTUzOGFiZS90YWJsZXJhbmdlOjhhYTZjYzg3MWIyNTQyNjI4ZTkyOWZkNDBhNTM4YWJlXzIyLTMtMS0xLTIzMDI1_06f7ba01-beda-4439-91c6-4b44e5ba2848"
      unitRef="usd">1413000000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIwMjI_8b8063ee-2dd2-405e-917d-2e0d33e015fd"
      unitRef="usd">150000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIwMjk_96f56ca3-5f08-4c08-bdc9-04eeee43a7c0"
      unitRef="usd">133000000</us-gaap:IncomeTaxExaminationPenaltiesAndInterestAccrued>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIxNzM_89966d7b-2c4b-4f06-bb08-3604112d5f60"
      unitRef="usd">602000000</us-gaap:OperatingLossCarryforwards>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIxODE_8aa3fbc5-2138-4369-88ac-95d246d26c77"
      unitRef="usd">192000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIyMjk_a234bb93-cfe1-4c77-9418-1f6efc39fc78"
      unitRef="usd">183000000</us-gaap:OperatingLossCarryforwards>
    <syk:OperatingLossCarryforwardsSubjectToValuationAllowance
      contextRef="i7e620065e6e24e2a8d665f88e64e892d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzIyMzY_2a77e8ba-b616-415d-914c-ee3359981170"
      unitRef="usd">106000000</syk:OperatingLossCarryforwardsSubjectToValuationAllowance>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i1cd24230505248839fa2f817aad88236_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI0MTA_fa9cd445-b8e6-477b-84a8-2a7c9ddceda9"
      unitRef="usd">403000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI0NzA_3ebd5739-c1c9-4e93-9fbf-eabf36b0991d"
      unitRef="usd">198000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI1NzM_d8f52fbc-882e-4afd-9b13-92a5723ffd8e"
      unitRef="usd">104000000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardValuationAllowance
      contextRef="ie57390308e744f2da47656cbcb7dd7ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzI1ODE_095ed2e8-12d4-4477-99c4-418e0526654a"
      unitRef="usd">83000000</us-gaap:TaxCreditCarryforwardValuationAllowance>
    <us-gaap:SummaryOfIncomeTaxContingenciesTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzQ5NjQ_b3bd2b62-6d33-4639-a1b4-f60939900e3d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.256%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Uncertain Income Tax Positions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;472&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to current year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Increases related to prior year income tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Decreases related to prior year income tax positions:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Settlements and resolutions of income tax audits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Statute of limitations expirations and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending uncertain tax positions&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;444&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;457&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;Income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SummaryOfIncomeTaxContingenciesTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzItMS0xLTEtMjMwMjU_9caf8130-22a0-4fdd-9efb-9152a626a719"
      unitRef="usd">457000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzItMy0xLTEtMjMwMjU_722ee445-2508-4e86-9ff5-eb1244d85b27"
      unitRef="usd">472000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzMtMS0xLTEtMjMwMjU_31ffd91c-bf8e-4d52-93c6-cda6f4cb6475"
      unitRef="usd">13000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzMtMy0xLTEtMjMwMjU_8c403ef2-797c-4413-b878-01208e58b543"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzQtMS0xLTEtMjMwMjU_7f5fa2dd-b4ee-4d58-b8af-1ba0ac7aa16d"
      unitRef="usd">4000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzQtMy0xLTEtMjMwMjU_872ac5f0-4ecc-4a88-85a1-2a3986b483f5"
      unitRef="usd">5000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzYtMS0xLTEtMjMwMjU_7be4a944-ddb7-4d5e-8d71-e7c81660d4ba"
      unitRef="usd">18000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzYtMy0xLTEtMjMwMjU_737a3138-3d0f-4308-8ccd-3693444c4dcf"
      unitRef="usd">41000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzctMS0xLTEtMjMwMjU_20b44f91-3af6-49f1-bc5c-0c7c9c39552b"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzctMy0xLTEtMjMwMjU_ea9d9f30-2948-492e-9d15-75dc040b0563"
      unitRef="usd">7000000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzgtMS0xLTEtMjMwMjU_455a2ce8-f064-48e3-adb7-afa652f91341"
      unitRef="usd">12000000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzgtMy0xLTEtMjMwMjU_e1f61d8b-4fec-4132-872a-4d9b243756b4"
      unitRef="usd">16000000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEwLTEtMS0xLTIzMDI1_e1741942-92b8-4b2c-8756-d5160ffa575b"
      unitRef="usd">444000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEwLTMtMS0xLTIzMDI1_38043969-2955-4dd7-89b6-0bfec6d53dca"
      unitRef="usd">457000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEyLTEtMS0xLTIzMDI1_24100d80-bc02-4e59-b93e-bc1361d79b8b"
      unitRef="usd">444000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90YWJsZTowYTIyMWMzMjRkMGI0YTZjOTVkMTI3MGU3MWVkMzRhYi90YWJsZXJhbmdlOjBhMjIxYzMyNGQwYjRhNmM5NWQxMjcwZTcxZWQzNGFiXzEyLTMtMS0xLTIzMDI1_36d5208d-23b1-4c85-8162-bffd9b7a7e58"
      unitRef="usd">457000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzM0NTU_d1d1ce2c-c25a-4969-b84f-61467e8a9dff"
      unitRef="usd">445000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzYvZnJhZzoxYTRkZGIyNWVjNzI0OTY4Yjk4MDBkZWI4NjJhOTI5YS90ZXh0cmVnaW9uOjFhNGRkYjI1ZWM3MjQ5NjhiOTgwMGRlYjg2MmE5MjlhXzM0NjI_a62eedbc-9d4e-4233-869c-82e4e07a1298"
      unitRef="usd">456000000</us-gaap:UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NDE_f420cf0f-08a5-40b2-9dbd-9ff552e709dc">RETIREMENT PLANS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We provide certain employees with defined contribution plans and other types of retirement plans. A portion of our retirement plan expense under the defined contribution plans is funded with Stryker common stock. The use of Stryker common stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;represents a non-cash operating activity that is not reflected in our Consolidated Statements of Cash Flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:1pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Defined Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries have both funded and unfunded defined benefit pension plans covering some or all of their employees. Substantially all of the defined benefit pension plans have projected benefit obligations in excess of plan assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Discount Rate&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The discount rates were selected using a hypothetical portfolio of high quality bonds on December 31 that would provide the necessary cash flows to match our projected benefit payments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Expected Return on Plan Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The expected return on plan assets is determined by applying the target allocation in each asset category of plan investments to the anticipated return for each asset category based on historical and projected returns. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The actuarial gain (loss) for all pension plans was primarily related to a change in the discount rate used to measure the benefit obligations of those plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Investment Strategy&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The investment strategy for our defined benefit pension plans is to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,056&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;428&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Our Level 3 pension plan assets consist primarily of guaranteed investment contracts with insurance companies. The insurance contracts guarantee us principal repayment and a fixed rate of return. The $5 decrease in Level 3 pension plan assets is primarily driven by the change in the corresponding pension liability. We expect to contribute $21 to our defined benefit pension plans in 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanDisclosuresTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5MzI_3d07e18e-b967-46f6-bb3b-f995c548bf11">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Plan expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expense funded with Stryker common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Stryker common stock held by plan:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dollar amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Shares (in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Value as a percentage of total plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DefinedContributionPlanDisclosuresTableTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtMS0xLTEtMjMwMjU_0076aaeb-0077-4857-9842-20b19afdcbc4"
      unitRef="usd">259000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtMy0xLTEtMjMwMjU_ab91f6cc-7b54-461c-b5a3-d2ac07ff2aa8"
      unitRef="usd">235000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzEtNS0xLTEtMjMwMjU_bc0f6fe3-9cb5-40ab-9a40-f7cb2214c490"
      unitRef="usd">205000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItMS0xLTEtMjMwMjU_d04e3c73-8b27-4eb7-99a8-1f273d80395e"
      unitRef="usd">37000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItMy0xLTEtMjMwMjU_d245053d-0108-4cd2-8ab6-15893787b6d8"
      unitRef="usd">34000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzItNS0xLTEtMjMwMjU_2442aec9-a4c4-4d44-8518-f86c5daae32e"
      unitRef="usd">31000000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtMS0xLTEtMjMwMjU_39d0745e-0f1d-4d9b-96e4-a5a82fe02c8b"
      unitRef="usd">582000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtMy0xLTEtMjMwMjU_abd95d59-889d-47f1-aa67-5545eadf5692"
      unitRef="usd">542000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzQtNS0xLTEtMjMwMjU_b6898402-aee0-48f3-bd71-1819bacba15a"
      unitRef="usd">470000000</syk:DefinedContributionRetirementPlansCommonStockValueHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtMS0xLTEtMjMwMjU_8920ee4c-9124-44bc-8a3b-59e16d2ea29d"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtMy0xLTEtMjMwMjU_cc518458-edc8-4bdc-803f-5f6d4beb2cdc"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:DefinedContributionRetirementPlansCommonStockHeldByCompany
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzUtNS0xLTEtMjMwMjU_14a5bb55-f57f-4bb3-83ef-903e1da6ff7f"
      unitRef="shares">2200000</syk:DefinedContributionRetirementPlansCommonStockHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtMS0xLTEtMjMwMjU_eb01eb96-2449-4048-ad8c-0f6db83b2be9"
      unitRef="number">0.10</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtMy0xLTEtMjMwMjU_555d0305-f518-4c1e-a1e4-27d3f4bce236"
      unitRef="number">0.11</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTpkMDZlNDE3YjZhOGY0MjEzOWUxZmEwMjM2YjRlN2EzMC90YWJsZXJhbmdlOmQwNmU0MTdiNmE4ZjQyMTM5ZTFmYTAyMzZiNGU3YTMwXzYtNS0xLTEtMjMwMjU_66a8b5af-660d-4cf6-b720-c526b266340c"
      unitRef="number">0.12</syk:TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany>
    <us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5Mjc_f5b1e1d4-f69b-472e-ba4b-260695b98752">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.436%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.430%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Components of Net Periodic Pension Cost&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Changes in assets and benefit obligations recognized in OCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Net actuarial gain (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(117)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(74)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Prior service credit and transition amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in other comprehensive income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;138&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total recognized in net periodic benefit cost and OCI&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;64&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Weighted-average rates used to determine net periodic benefit cost:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Rate of compensation increase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate used to determine projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItMS0xLTEtMjMwMjU_cbd85a0e-bd11-4b27-95aa-a13fbfdc46c8"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItMy0xLTEtMjMwMjU_981b8751-09c5-4c0e-9fc3-4703d6a53ee9"
      unitRef="usd">63000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzItNS0xLTEtMjMwMjU_aa8bf3ba-0102-4c58-be53-c619c22006a6"
      unitRef="usd">41000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtMS0xLTEtMjMwMjU_4d743944-9535-447e-ba57-8fd3f32c27a4"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtMy0xLTEtMjMwMjU_c49e37b5-a4c7-427b-b97f-3fb77b3ff8c0"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzMtNS0xLTEtMjMwMjU_9bdb2f1e-da97-4fa5-8091-f478c5e0eb62"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtMS0xLTEtMjMwMjU_e9691ce8-caad-48e5-9d6c-cf6633a0f9bb"
      unitRef="usd">11000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtMy0xLTEtMjMwMjU_13befa4c-b7fb-46b2-9af3-fe883fea7249"
      unitRef="usd">13000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzQtNS0xLTEtMjMwMjU_6c25ab7c-48e0-4667-8c8b-8d2c815a3e42"
      unitRef="usd">12000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtMS0xLTEtMjMwMjU_dac270e4-ab81-4c91-b1de-a530e08c6f11"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtMy0xLTEtMjMwMjU_bbee48d8-c342-4f07-92eb-56a881b04e70"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzUtNS0xLTEtMjMwMjU_3ee6e3c9-0f7b-4f5c-870b-c3bb2bba9cde"
      unitRef="usd">-1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtMS0xLTEtMjMwMjU_3a051aed-4a6c-4d6d-9592-637cad08ed34"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtMy0xLTEtMjMwMjU_f5e01d4a-1b40-4235-a6b3-b4285d11792c"
      unitRef="usd">-13000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzYtNS0xLTEtMjMwMjU_01e422d9-fa07-400c-ae43-9e5c03b0b689"
      unitRef="usd">-9000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMS0xLTEtMzQyODM_d5e68a6f-4f9f-48fa-9a7b-7fcd65983ce8"
      unitRef="usd">9000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMS0xLTEtMjMwMjU_ccd4b9bf-e349-44e9-ab09-f91c705df9cf"
      unitRef="usd">74000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctMy0xLTEtMjMwMjU_a5b4686c-4f4f-4beb-8ffd-87bd964f976f"
      unitRef="usd">70000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzctNS0xLTEtMjMwMjU_d7cc8076-6f5b-4fa4-a599-57db2cb5d1ba"
      unitRef="usd">49000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktMS0xLTEtMjMwMjU_ae449117-49a6-4d35-befa-1eac532c3c2e"
      unitRef="usd">132000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktMy0xLTEtMjMwMjU_074b870a-9ac5-43a7-a977-32346386e45c"
      unitRef="usd">-117000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzktNS0xLTEtMjMwMjU_2c7697a4-1161-468b-91bb-29b13bc4a7fc"
      unitRef="usd">-74000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTEtMS0xLTIzMDI1_6625a3a6-ebf9-4871-8751-9bf803054d93"
      unitRef="usd">-16000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTMtMS0xLTIzMDI1_597a93fc-034d-4041-b74b-bc1d03d27911"
      unitRef="usd">-13000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEwLTUtMS0xLTIzMDI1_ce9450c6-eec7-4ac6-a7a6-bcdbd08e0204"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTEtMS0xLTIzMDI1_d593343a-2f93-461b-990e-8cea111fc3a7"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTMtMS0xLTIzMDI1_2bc8c47d-359d-48e4-9fb9-0b53e4864ddd"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzExLTUtMS0xLTIzMDI1_85f183ab-d73e-481b-8264-388b8de2da09"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTEtMS0xLTM0MzEy_f6a3d9b7-8d77-4028-93e7-27c1b00bd148"
      unitRef="usd">-9000000</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTMtMS0xLTM0MzEy_583b0ded-6d94-4e3d-9f1b-6302a0a01c56"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTUtMS0xLTM0MzEy_dc022016-b37a-43fd-bda8-cae673440b94"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTEtMS0xLTIzMDI1_73d8615d-fdcb-4461-837c-39adb41c5738"
      unitRef="usd">-138000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTMtMS0xLTIzMDI1_58a81195-dc3a-4ce1-b925-e46bb2c2c3eb"
      unitRef="usd">105000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEyLTUtMS0xLTIzMDI1_85fb5e12-61eb-4385-96a5-d8f0ab03dd06"
      unitRef="usd">66000000</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTEtMS0xLTIzMDI1_241c72a5-4670-4612-9b94-4cd9b89f0c30"
      unitRef="usd">64000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTMtMS0xLTIzMDI1_4ca3a661-037f-4089-8d5e-6ee9636da648"
      unitRef="usd">-175000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzEzLTUtMS0xLTIzMDI1_5c3e1124-a2ce-4156-94d6-973059c0e694"
      unitRef="usd">-115000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTEtMS0xLTIzMDI1_0da37e06-b161-4406-b6cb-c76ead196d2c"
      unitRef="number">0.008</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTMtMS0xLTIzMDI1_9bf2c151-0d6e-4950-9beb-a4ed61717263"
      unitRef="number">0.010</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE2LTUtMS0xLTIzMDI1_409f7f31-8ae8-4ba7-b568-09b4d42f3f5f"
      unitRef="number">0.019</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTEtMS0xLTIzMDI1_0ca23ba2-df76-4cbd-b85f-f7b8dced1de0"
      unitRef="number">0.025</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTMtMS0xLTIzMDI1_38780902-037d-4936-94a6-49c4c15f8910"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE3LTUtMS0xLTIzMDI1_4cd64d6b-a2bd-4c59-b9ca-0e4d071b8b59"
      unitRef="number">0.035</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTEtMS0xLTIzMDI1_572f911d-3520-49ed-a73c-947ce17476d0"
      unitRef="number">0.026</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTMtMS0xLTIzMDI1_4e0594ad-46d5-4468-8d79-d3dde803b2ab"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE4LTUtMS0xLTIzMDI1_e2406dfa-2ef8-499c-ac09-e07ba12a9df8"
      unitRef="number">0.029</us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTEtMS0xLTIzMDI1_cfa0dacb-e1f5-49ac-bd37-64a803749487"
      unitRef="number">0.011</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTMtMS0xLTIzMDI1_f3020b82-6b71-4ca0-8a6d-15171aaa66bd"
      unitRef="number">0.008</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo2ZDQxNDFiN2YwNWI0ZTc1YTZiMmY5OGRmMDU4MjZlMi90YWJsZXJhbmdlOjZkNDE0MWI3ZjA1YjRlNzVhNmIyZjk4ZGYwNTgyNmUyXzE5LTUtMS0xLTIzMDI1_52058103-d5d5-4914-9a25-5ef90161718f"
      unitRef="number">0.010</syk:WeightedAverageUsedInDeterminationOfProjectedBenefitObligations>
    <us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NTg_2a35ad95-9984-4bd8-ba7f-8accba2c093d">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,036)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(1,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Funded status&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(493)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(596)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Reported as:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Current liabilities&#x2014;accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&#x2014;other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pre-tax amounts recognized in AOCI:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized net actuarial loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Unrecognized prior service credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEtMS0xLTEtMjMwMjU_96b25926-ae90-4957-924f-ffc488d8a90d"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEtMy0xLTEtMjMwMjU_35f15642-ac32-424e-ba25-b240ba3956e6"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzItMS0xLTEtMjMwMjU_15c0ebac-01d2-4353-80f8-c7dee7ed907f"
      unitRef="usd">1036000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzItMy0xLTEtMjMwMjU_1b0f5742-066e-4038-8884-fe3bbcb1fe64"
      unitRef="usd">1118000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzMtMS0xLTEtMjMwMjU_edc3323b-f27b-451a-a4c7-c9bcacdc6966"
      unitRef="usd">-493000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:DefinedBenefitPlanFundedStatusOfPlan
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzMtMy0xLTEtMjMwMjU_5302603f-4b30-41bf-9bb4-73aacae43511"
      unitRef="usd">-596000000</us-gaap:DefinedBenefitPlanFundedStatusOfPlan>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzUtMS0xLTEtMjMwMjU_402bbfd7-6916-4305-86ff-5e59c71ac361"
      unitRef="usd">2000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzUtMy0xLTEtMjMwMjU_c0516d49-a845-4799-8f8a-29ede4846004"
      unitRef="usd">2000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzYtMS0xLTEtMjMwMjU_e567b62e-dd3b-430b-85d1-047172be7404"
      unitRef="usd">491000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzYtMy0xLTEtMjMwMjU_f39ba92f-74af-4f1e-9576-95c0f3798b94"
      unitRef="usd">594000000</us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i1f988e7869e24ec3bddc891426b08439_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzgtMS0xLTEtMjMwMjU_ba1a46cb-fa58-4062-b7da-81381e04ad2b"
      unitRef="usd">-215000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i01ba6c5c269d4255a194114389cbf28c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzgtMy0xLTEtMjMwMjU_3c2cbcd9-1de1-43d4-830f-dd8d47ad266e"
      unitRef="usd">-354000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i1f988e7869e24ec3bddc891426b08439_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzktMS0xLTEtMjMwMjU_eca8c864-1fab-42fa-8651-9e50807d89cc"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax
      contextRef="i01ba6c5c269d4255a194114389cbf28c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzktMy0xLTEtMjMwMjU_72d00304-deee-4e1c-9284-60c70e92c7bd"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEwLTEtMS0xLTIzMDI1_cb9d8022-1fcb-48eb-84e7-907a96daa4c6"
      unitRef="usd">-208000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NmU1MjAxYzg2YWI0YjZlYWM0MWUyODc5YTZkZWI3Zi90YWJsZXJhbmdlOjQ2ZTUyMDFjODZhYjRiNmVhYzQxZTI4NzlhNmRlYjdmXzEwLTMtMS0xLTIzMDI1_30f2b067-74a6-4344-9876-4598aa1712e6"
      unitRef="usd">-346000000</us-gaap:DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax>
    <us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5MjU_aa843161-aaf8-4588-a1b1-657fab739f18">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Benefit Obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actuarial (gains) losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(71)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Curtailment gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending projected benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,036&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,118&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending accumulated benefit obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,056&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzItMS0xLTEtMjMwMjU_f3bff267-5724-420e-85dc-97700f0a0234"
      unitRef="usd">1118000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzItMy0xLTEtMjMwMjU_79dc21e3-abc0-438a-a886-f15a4c7b3ded"
      unitRef="usd">869000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzMtMS0xLTEtMjMwMjU_bca3abf7-7bea-465c-af74-a51076c4a853"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzMtMy0xLTEtMjMwMjU_59503c01-10bb-445a-ac83-dfa73d968617"
      unitRef="usd">63000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzQtMS0xLTEtMjMwMjU_75992b4e-fcbd-4640-a187-2bb64e9210fe"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzQtMy0xLTEtMjMwMjU_5344486c-183e-443c-9383-78453df01eb2"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzUtMS0xLTEtMjMwMjU_394698f1-94c0-4c66-9eec-c57f9d4789e6"
      unitRef="usd">-70000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzUtMy0xLTEtMjMwMjU_db7e63d0-b8a6-4e5e-a49e-c7dbac75eda2"
      unitRef="usd">80000000</us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzYtMS0xLTEtMjMwMjU_f548e94e-2168-4896-9626-17812f258693"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzYtMy0xLTEtMjMwMjU_72f02a32-ded2-4f92-a44b-fd74a529b4da"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzctMS0xLTEtMjMwMjU_73434bd1-0cdd-495a-963b-15fcf2994824"
      unitRef="usd">-71000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanActuarialGainLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzctMy0xLTEtMjMwMjU_2d850148-8b92-4ab9-97ee-50adda36e486"
      unitRef="usd">110000000</us-gaap:DefinedBenefitPlanActuarialGainLoss>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzktMS0xLTEtMjMwMjU_c76c3ee6-8fc6-4bc6-b3a6-099377ca44d7"
      unitRef="usd">-23000000</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzktMy0xLTEtMjMwMjU_1adcc140-c34a-4ff4-9933-fadaa8e75830"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEwLTEtMS0xLTIzMDI1_fb06f5a1-975b-4c08-b35f-34141585e8a2"
      unitRef="usd">5000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEwLTMtMS0xLTIzMDI1_05c95d53-598d-4244-bbc4-5d0c8e203c2d"
      unitRef="usd">20000000</us-gaap:DefinedBenefitPlanBenefitObligationBenefitsPaid>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzExLTEtMS0xLTIzMDI1_1edebcb4-a923-43ab-a66f-3926c0646e06"
      unitRef="usd">1036000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanBenefitObligation
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzExLTMtMS0xLTIzMDI1_88ec882f-335b-4fe6-b180-2a6934a765b0"
      unitRef="usd">1118000000</us-gaap:DefinedBenefitPlanBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEyLTEtMS0xLTIzMDI1_15377ad8-b772-48a0-b197-3e84e1097f67"
      unitRef="usd">987000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0NDc1NzVjYzBjZDk0NmE0OGQ2ZGZiMTlhYjYzNmY1Ni90YWJsZXJhbmdlOjQ0NzU3NWNjMGNkOTQ2YTQ4ZDZkZmIxOWFiNjM2ZjU2XzEyLTMtMS0xLTIzMDI1_5802478d-f3df-41be-aab4-57c9f940376d"
      unitRef="usd">1056000000</us-gaap:DefinedBenefitPlanAccumulatedBenefitObligation>
    <us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NjU_fb4ddca7-3f2a-4d1e-87a0-058bedcc2826">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.474%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Change in Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Beginning fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;428&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Actual return&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employer contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Employee contributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Foreign exchange impact&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Benefits paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Ending fair value of plan assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.220%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.511%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Valuation of Plan Assets &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;55&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;389&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;99&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;543&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;46&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;372&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;104&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;522&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzItMS0xLTEtMjMwMjU_3c3d1695-f747-4784-8cc2-ccd352a0467a"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzItMy0xLTEtMjMwMjU_22327dfc-a23b-4688-ac49-795b9288fb6d"
      unitRef="usd">428000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzMtMS0xLTEtMjMwMjU_4ea8084a-c9e8-41d4-a37e-e5b0b67a9ae7"
      unitRef="usd">17000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzMtMy0xLTEtMjMwMjU_142b6df0-3f99-469d-bd2b-a62b2209d791"
      unitRef="usd">30000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzQtMS0xLTEtMjMwMjU_fc433650-73d7-452c-a9cc-fd5866cfc979"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanContributionsByEmployer
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzQtMy0xLTEtMjMwMjU_ba69a34f-0acb-4e2c-a4bc-798191bc34b3"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanContributionsByEmployer>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzUtMS0xLTEtMjMwMjU_e9405da9-b0d3-42c0-8a70-0e026362bea3"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzUtMy0xLTEtMjMwMjU_7b6ab299-ef88-4e36-b126-5f333b6cda8d"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzYtMS0xLTEtMjMwMjU_e64f1576-8681-4f4e-8d68-ef6dd4ba50d8"
      unitRef="usd">-29000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzYtMy0xLTEtMjMwMjU_db8af639-849a-4b37-b85e-889bb8570408"
      unitRef="usd">37000000</us-gaap:DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzgtMS0xLTEtMjMwMjU_8926910d-38db-4990-aa91-5edff27153a0"
      unitRef="usd">8000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzgtMy0xLTEtMjMwMjU_edd025c6-8ce0-4b71-97a4-05c004ffa061"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanPlanAssetsBenefitsPaid>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzktMS0xLTEtMjMwMjU_09d2ac28-ce53-4069-b7c5-b5b0ce829220"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTplZjhkZWNmYzJlZTg0YTNmYmFjNjEwNzRlMGUwMTBlMy90YWJsZXJhbmdlOmVmOGRlY2ZjMmVlODRhM2ZiYWM2MTA3NGUwZTAxMGUzXzktMy0xLTEtMjMwMjU_d44d064c-45cc-4a5c-a05b-0d0c7dc4fc22"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent>
    <us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5Mjk_198159bf-33aa-456b-8ed2-c681f278ecc6">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.770%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.649%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.652%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Allocation of Plan Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022 Target&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Actual&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020 Actual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;100&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItMS0xLTEtMjMwMjU_bb23d893-debb-434f-b325-4b287339cd18"
      unitRef="number">0.23</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItMy0xLTEtMjMwMjU_57619031-9e10-455b-a186-d44ca482986b"
      unitRef="number">0.23</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i91262a514140409ebdc684fab644ffa5_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzItNS0xLTEtMjMwMjU_544b9d3b-f853-4eb6-b327-aa5935f9ab77"
      unitRef="number">0.23</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="icc0ea2e735eb45ac82e987217fe33ed3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtMS0xLTEtMjMwMjU_d8ee7b38-6216-451c-b987-973fee95e550"
      unitRef="number">0.39</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="icc0ea2e735eb45ac82e987217fe33ed3_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtMy0xLTEtMjMwMjU_ec9b1a25-3eb9-4a69-b252-6d32be2bf3aa"
      unitRef="number">0.41</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ia67b9db95e8d4be5bc9dae41d9dc8f3c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzMtNS0xLTEtMjMwMjU_5a18f3bf-84af-4072-900b-e3905428a3a1"
      unitRef="number">0.44</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="if0472521a2c54bd8a5c77c14ed66218b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtMS0xLTEtMjMwMjU_1585c374-01fe-4398-a56e-b93a5ed7062c"
      unitRef="number">0.38</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="if0472521a2c54bd8a5c77c14ed66218b_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtMy0xLTEtMjMwMjU_c433042c-ce91-4cee-9864-ac7fdc588034"
      unitRef="number">0.36</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i232384248c814e63916518edfbade00d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzQtNS0xLTEtMjMwMjU_cdedcaf5-211d-46e1-9da6-d75f3e2f98e1"
      unitRef="number">0.33</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtMS0xLTEtMjMwMjU_ef864a7a-3e5b-491c-9593-b7e3388c56c0"
      unitRef="number">1</us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtMy0xLTEtMjMwMjU_41b18140-1e47-4d2d-ad6c-59dcd958f8aa"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozN2Q5YmVhOTdjNDY0ODVjODIwODAzMzEyMjY4MmI4MS90YWJsZXJhbmdlOjM3ZDliZWE5N2M0NjQ4NWM4MjA4MDMzMTIyNjgyYjgxXzUtNS0xLTEtMjMwMjU_f2b5661b-2481-4b2f-8881-edce5795228a"
      unitRef="number">1</us-gaap:DefinedBenefitPlanWeightedAverageAssetAllocations>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i001424c220ec43b8bcc76dd7bf700136_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMS0xLTEtMjMwMjU_38187ed2-bbc0-4c4a-b9dc-b9479889f822"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i604a2bd489464dd7a650d828b235f087_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMi0xLTEtMjMwMjU_b4035904-5cd5-443e-9ea7-7d4c61cf8d56"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5f45f3a6f31f4b0da0d211a6aef869d9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItMy0xLTEtMjMwMjU_8ab2a14a-1ac0-4e96-a5c4-5e0e944f9b56"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i1dddab9268854061b35a9e07a6318dd6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzItNC0xLTEtMjMwMjU_18c4cc59-aa4d-465c-8bf6-748fa9e29563"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ife6a4f6e1674412fa1a94fcd3d311a14_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMS0xLTEtMjMwMjU_1264abae-7d7b-4aab-8dba-365fdf4b5529"
      unitRef="usd">28000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i610ab94283ee44cebe2aff94198af011_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMi0xLTEtMjMwMjU_b2671cda-d7d8-4af7-9959-1656d95cdab3"
      unitRef="usd">119000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iebfde9edb94c4bffa0897fbc6d059649_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtMy0xLTEtMjMwMjU_537834e2-a4af-4db2-90a6-9848c021b15a"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i18a02b6d2c274ed99fc738e0c58fe623_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzMtNC0xLTEtMjMwMjU_86d04425-8147-49e3-a78e-a0640ceee898"
      unitRef="usd">147000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0732c03ffb524a518cf83d8eea84056b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMS0xLTEtMjMwMjU_a756d44b-ac5c-4da2-b7a9-174b9c29eb2a"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5881fc803ed74916a236a87615ed0ee2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMi0xLTEtMjMwMjU_7965a798-33f7-4b25-b153-4397dbdf6618"
      unitRef="usd">202000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ibae7b85422cd47d9891e57aba56d1654_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtMy0xLTEtMjMwMjU_0706eebe-e422-40c1-b805-d261586220f1"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ice25e379b81f4476bc629c2369aaa8d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzQtNC0xLTEtMjMwMjU_543c21a2-3314-4cb8-ae85-4a4c46209858"
      unitRef="usd">204000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i6a7ab2b119e94e27bd120bc5f0693216_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMS0xLTEtMjMwMjU_2100ae6f-89e8-4ae4-ae89-4a91a6f90fd5"
      unitRef="usd">4000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i73ac471a7a3844b192433916f6cb498b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMi0xLTEtMjMwMjU_0e27b468-d376-485a-9022-a12cfc869d75"
      unitRef="usd">68000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i316fb40a5796411d9e52da1c35ca3e5e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtMy0xLTEtMjMwMjU_fe30e129-6d9e-477e-9368-f42824e4d0ec"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69c2080de3934abf904eba7abade7988_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzUtNC0xLTEtMjMwMjU_a87a9a42-5602-4edc-830c-1958f3ab73fc"
      unitRef="usd">171000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i0ab379c875cb4b7f9423c749112e591b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMS0xLTEtMjMwMjU_86e4bd4c-1d40-4347-b73c-19374c0ff35f"
      unitRef="usd">55000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i8fb1a995f6d44f929f32898b0817d377_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMi0xLTEtMjMwMjU_c9c4f292-48b7-482a-b05d-7e5321cadf39"
      unitRef="usd">389000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtMy0xLTEtMjMwMjU_3af8860e-bc3b-4ee8-93ee-871977d886a5"
      unitRef="usd">99000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzYtNC0xLTEtMjMwMjU_2ee97a46-cd47-409e-804f-bbc601ed7718"
      unitRef="usd">543000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i47733b1c7ef048cbb418c5fcc8c43a27_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMS0xLTEtMjMwMjU_bab1e86d-4ee5-47e7-b6f5-6b058973b019"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i164f42b17a9f4770bd5118f6cd88f3c2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMi0xLTEtMjMwMjU_328a92c9-2917-4392-bdcd-8883f88287d2"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="idccdaec3350743cea685af7c28bdb255_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtMy0xLTEtMjMwMjU_132515f3-bceb-45ca-8cc3-15756a0a7cf7"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i30492a5243574d7bb61e3c33c92232cf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzgtNC0xLTEtMjMwMjU_7d67be2b-a48f-49d8-9d34-6070f8059b23"
      unitRef="usd">14000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib06973aac182492f9622c7ad7902fabf_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMS0xLTEtMjMwMjU_14407cea-126d-412b-b60a-32be99a8dbcf"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="iba09bb97f57e482fb3622b4b9a6a4342_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMi0xLTEtMjMwMjU_506bd493-0e97-4ec7-8fc9-92f088468dab"
      unitRef="usd">108000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib8b81436534b4ed681424a5481d1d2a3_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktMy0xLTEtMjMwMjU_bea53d64-dbc7-409b-996b-b155299a7cb9"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i91262a514140409ebdc684fab644ffa5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzktNC0xLTEtMjMwMjU_c307c624-07ac-4735-b98d-78e5fcfca767"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="id692e1a1c6d14320af222fb9457d39b9_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTEtMS0xLTIzMDI1_131f63c7-9780-41a6-9887-aab0e7424ea5"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ic458106dafdd43c2a2d64c80f80f0d0f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTItMS0xLTIzMDI1_d8e9d24b-cf58-4bce-8f6b-39f472c36fd4"
      unitRef="usd">201000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i69cf095ab3ce444bb44754bf320b5332_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTMtMS0xLTIzMDI1_2dc0d47b-6bc7-467f-897e-aa8e0b344283"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ie48c458d392e4f3194b70925a5318b6f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEwLTQtMS0xLTIzMDI1_0bce9e89-3f67-4dd9-b9d9-90cdcbcad1bc"
      unitRef="usd">203000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5b168e0fd23c4ecbb3d1680b32078cc4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTEtMS0xLTIzMDI1_54facd34-7d4d-4c6d-8b3d-10d29955c0ef"
      unitRef="usd">7000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i84cef904fd4a491cbb3a73b26683ced7_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTItMS0xLTIzMDI1_fd66b98a-51ce-4516-ace7-a12412ee64d6"
      unitRef="usd">63000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i301b21993d364219b05cf96921f44824_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTMtMS0xLTIzMDI1_314c2aea-6537-4c8e-b082-c163dc4592aa"
      unitRef="usd">104000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ib9b725428866433e884015213e1d73d8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzExLTQtMS0xLTIzMDI1_b99b4b3e-aa18-4b89-88f8-e78a4cc5d465"
      unitRef="usd">174000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i273e9bd5eb9245d39a63ed29e54ffcdb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTEtMS0xLTIzMDI1_990683b8-b14c-441b-81d6-0075d125b524"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5c05a9cd1b844530a2b5e91eb67ded78_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTItMS0xLTIzMDI1_54221d31-19c9-4de0-a520-016425d61770"
      unitRef="usd">372000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="ia21cd3e409fc4facace34555a676001b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTMtMS0xLTIzMDI1_a2f32e23-6ad7-4428-834f-97b4db1589f4"
      unitRef="usd">104000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanFairValueOfPlanAssets
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTo0ODdmZDM4ODhhMmU0ZWJlYWE4MTU4ZjFiZDBhNzIxNS90YWJsZXJhbmdlOjQ4N2ZkMzg4OGEyZTRlYmVhYTgxNThmMWJkMGE3MjE1XzEyLTQtMS0xLTIzMDI1_06911699-07b6-4f27-9175-4f66e00d4d2a"
      unitRef="usd">522000000</us-gaap:DefinedBenefitPlanFairValueOfPlanAssets>
    <us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets
      contextRef="ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE2NDkyNjc0NDM3MDM_cc6d2882-5100-463c-bfb6-df0103b99f7c"
      unitRef="usd">-5000000</us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear
      contextRef="iabd1e97e19e549f89dabedef1ee76cc1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE2NDkyNjc0NDM2ODk_6d565607-3b6d-4c68-861f-edd095012e7d"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear>
    <us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90ZXh0cmVnaW9uOjFiYmRlNWVmYzhlNDQwNWZiZDExOWQzMjY5NDU5NWE3XzE5NTA_75474dc9-3e3a-47ae-8545-2dce7bd01f64">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Estimated Future Benefit Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2027-2031&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMC0xLTEtMjMwMjU_3c30552c-9d9c-43ff-8448-6659556afb0d"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMS0xLTEtMjMwMjU_77a3eecd-46e2-4b22-879f-4094514353ee"
      unitRef="usd">21000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMi0xLTEtMjMwMjU_b93a2344-8ebd-4336-a86d-ddfdd53ece1d"
      unitRef="usd">27000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItMy0xLTEtMjMwMjU_10352b7f-fa42-452f-be1b-30b9594561fb"
      unitRef="usd">22000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItNC0xLTEtMjMwMjU_83fd8076-a5d5-4b7d-80a4-6e02163f30bc"
      unitRef="usd">23000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive>
    <us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xMzkvZnJhZzoxYmJkZTVlZmM4ZTQ0MDVmYmQxMTlkMzI2OTQ1OTVhNy90YWJsZTozYmM2YzBjY2E0Y2I0NTlmYWRlZDdkYjIwNDA4ZWM4Yy90YWJsZXJhbmdlOjNiYzZjMGNjYTRjYjQ1OWZhZGVkN2RiMjA0MDhlYzhjXzItNS0xLTEtMjMwMjU_3c41cfa8-1c71-4981-be47-4a51363a1846"
      unitRef="usd">138000000</us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter>
    <us-gaap:QuarterlyFinancialInformationTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90ZXh0cmVnaW9uOjU0NmVmOTYxZTQ0ODQ3YmI5YTZhNjAyYmM2NzU2MmUxXzYz_e1e8361b-e596-47dd-9f1b-bca7e6ff914b">SUMMARY OF QUARTERLY DATA (UNAUDITED)&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss) per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;568&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90ZXh0cmVnaW9uOjU0NmVmOTYxZTQ0ODQ3YmI5YTZhNjAyYmM2NzU2MmUxXzU2_9aaa8290-3ef4-42c5-9e2e-2923981c9fae">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.031%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.367%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.368%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,953&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,294&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,160&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,701&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;592&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;662&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings (loss) per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020 Quarters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Mar 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Jun&#160;30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Sep 30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Dec 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,588&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,764&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;3,737&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,262&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Earnings before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;493&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;621&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;568&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net earnings per share of common stock:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(0.22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Dividends declared per share of common stock&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;0.630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:Revenues
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMS0xLTEtMjMwMjU_7a658886-bbd8-4c90-860d-2f10ea2d9413"
      unitRef="usd">3953000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMi0xLTEtMjMwMjU_6d5d8d48-6ce8-4802-9cc2-e6a4961a9471"
      unitRef="usd">4294000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtMy0xLTEtMjMwMjU_47137661-28cb-4bc8-a88a-6e10aab317f6"
      unitRef="usd">4160000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzEtNC0xLTEtMjMwMjU_8ac4d13f-1b33-4482-a5b2-2c3530a1baf3"
      unitRef="usd">4701000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMS0xLTEtMjMwMjU_94d82587-7efa-44c7-b8a0-1370b6560d76"
      unitRef="usd">2509000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMi0xLTEtMjMwMjU_541c82f3-94d9-4793-a730-44252db7410c"
      unitRef="usd">2772000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItMy0xLTEtMjMwMjU_ea169c75-3a95-432e-896d-5959602fc3fd"
      unitRef="usd">2642000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzItNC0xLTEtMjMwMjU_16f89beb-4c70-4faa-b15b-6427289f9d52"
      unitRef="usd">3045000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMS0xLTEtMjMwMjU_75ae51a9-fa54-4b80-b0f2-d34790d322d3"
      unitRef="usd">367000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMi0xLTEtMjMwMjU_7d21a2a6-c97c-442a-b623-334a6324eb77"
      unitRef="usd">662000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtMy0xLTEtMjMwMjU_07daab05-ad5a-4df7-afdc-b1de360156a2"
      unitRef="usd">495000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzMtNC0xLTEtMjMwMjU_0cff2bd8-27f9-46b8-b07c-c3b0ebc99541"
      unitRef="usd">757000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMS0xLTEtMjMwMjU_5aaa3c0f-d081-4265-b81a-5a2ec003b0ef"
      unitRef="usd">302000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMi0xLTEtMjMwMjU_75c37bc3-2427-443c-a3e5-eabc432f86c4"
      unitRef="usd">592000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtMy0xLTEtMjMwMjU_c879cbe4-68db-45bb-ae40-bd2ceeb7dc66"
      unitRef="usd">438000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzQtNC0xLTEtMjMwMjU_da5191db-2a51-4393-9468-6ea1c51a056d"
      unitRef="usd">662000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMS0xLTEtMjMwMjU_61a72a9a-16d0-4911-bc7b-f83115d2e218"
      unitRef="usdPerShare">0.80</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMi0xLTEtMjMwMjU_dd3570a8-9642-4d20-9009-b8dd16f3befa"
      unitRef="usdPerShare">1.57</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtMy0xLTEtMjMwMjU_fc605a3d-9c78-4e54-bfa7-3e69f79cc522"
      unitRef="usdPerShare">1.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzYtNC0xLTEtMjMwMjU_d7555816-c494-4e0a-b2c1-bb7d2470ee66"
      unitRef="usdPerShare">1.75</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMS0xLTEtMjMwMjU_de3bb338-d916-473c-ab5c-dac3b24a58cb"
      unitRef="usdPerShare">0.79</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMi0xLTEtMjMwMjU_ee1b7fad-cf73-4707-a70e-df2419a501b7"
      unitRef="usdPerShare">1.55</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctMy0xLTEtMjMwMjU_df049e7f-0fe6-42a9-9ee9-3ff2285f9b73"
      unitRef="usdPerShare">1.14</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzctNC0xLTEtMjMwMjU_e5118491-392e-423d-b0c9-7be24f8a90cb"
      unitRef="usdPerShare">1.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if49057198523407d8323dce5d51c3441_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTEtMS0xLTIzMDI1_027d075c-2b78-445e-a79a-d849948b17bb"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i33e5633bd3cf45f0b0ab0a73862cf380_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTItMS0xLTIzMDI1_6d9ae1f6-7568-4309-ac85-0be8c115edc7"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i4dcfb8218fcb48989406a82b6d7edeb4_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTMtMS0xLTIzMDI1_08dc71ee-157d-4167-83ba-d56155ff4dd9"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzExLTQtMS0xLTIzMDI1_439db36c-1cfb-4b8e-bd80-59f1d46731a2"
      unitRef="usdPerShare">0.695</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Revenues
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTEtMS0xLTIzMDI1_5afc19f3-ef2b-49e9-afcc-d5f255eddb2e"
      unitRef="usd">3588000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTItMS0xLTIzMDI1_fb1765c2-80f8-4cda-8b0e-e30fb70cbd9e"
      unitRef="usd">2764000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTMtMS0xLTIzMDI1_da230822-4a26-4e8e-b757-c7205c93ec70"
      unitRef="usd">3737000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE0LTQtMS0xLTIzMDI1_b7057368-3add-4596-8c6c-e615a594ce5a"
      unitRef="usd">4262000000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTEtMS0xLTIzMDI1_1ff3e03f-774c-4e35-97ef-21e3b0a97f8a"
      unitRef="usd">2331000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTItMS0xLTIzMDI1_0c77e7bb-66bd-4185-9788-4fdabd6a73e0"
      unitRef="usd">1548000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTMtMS0xLTIzMDI1_a336742b-1a20-4e00-900c-e42a70f10989"
      unitRef="usd">2461000000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE1LTQtMS0xLTIzMDI1_d0cfa3f0-37f4-48a6-9b27-842339c3813b"
      unitRef="usd">2717000000</us-gaap:GrossProfit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTEtMS0xLTIzMDI1_16b40ca3-819d-4b74-811d-cb07699554c7"
      unitRef="usd">590000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTItMS0xLTIzMDI1_ed92e8f4-bf09-47c0-abbc-176320335680"
      unitRef="usd">-87000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTMtMS0xLTIzMDI1_90e904ad-f95b-4b49-a2e7-ca6b62898fb0"
      unitRef="usd">780000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE2LTQtMS0xLTIzMDI1_33f8acc8-a818-4292-b02e-c3113e224acd"
      unitRef="usd">671000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTEtMS0xLTIzMDI1_f849a3f4-6c78-4e6f-86f6-2306593f5813"
      unitRef="usd">493000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTItMS0xLTIzMDI1_67e97f08-40b5-43dc-9d79-25752a686f5e"
      unitRef="usd">-83000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTMtMS0xLTIzMDI1_50bdb909-a93a-4af5-995c-20c05215a338"
      unitRef="usd">621000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE3LTQtMS0xLTIzMDI1_d526b666-6e62-4cc2-93b9-5888942c19d8"
      unitRef="usd">568000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTEtMS0xLTIzMDI1_5ddd63ce-6eb5-43f2-8381-0170b3263cba"
      unitRef="usdPerShare">1.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTItMS0xLTIzMDI1_59493a30-12b7-46a0-9f49-d41e41b1b404"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTMtMS0xLTIzMDI1_d19fc5f3-7c1a-4028-9c0c-c8006008604e"
      unitRef="usdPerShare">1.66</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzE5LTQtMS0xLTIzMDI1_a9f9bd48-87c8-414d-8a8f-8fa04d8c94bc"
      unitRef="usdPerShare">1.51</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTEtMS0xLTIzMDI1_4c950d28-114f-464e-be39-2e7a852915a6"
      unitRef="usdPerShare">1.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTItMS0xLTIzMDI1_ce5cd7f1-17be-4343-94fa-c96909229e48"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTMtMS0xLTIzMDI1_6e1aa472-ae5e-46c3-b195-6a0535b24989"
      unitRef="usdPerShare">1.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzIwLTQtMS0xLTIzMDI1_480d8bfa-e4e3-4405-9b2c-97bb5cfe0a73"
      unitRef="usdPerShare">1.49</us-gaap:EarningsPerShareDiluted>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="icf04f9985f9c460593117679dd0de816_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTEtMS0xLTIzMDI1_04bea81f-0d8b-42d7-b600-053af922ce19"
      unitRef="usdPerShare">0.575</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="iddb2f10f5d8f47fc969ff9bff6f52b0b_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTItMS0xLTIzMDI1_dc206aab-2c03-4a9b-980a-1016c46b4567"
      unitRef="usdPerShare">0.575</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2b6cb4f289f54053baa08140f946573d_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTMtMS0xLTIzMDI1_fc8a914a-3da4-416c-9ecd-a209a5891ef5"
      unitRef="usdPerShare">0.575</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ib84f8f72a7b949e591b363dffc2df219_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDIvZnJhZzo1NDZlZjk2MWU0NDg0N2JiOWE2YTYwMmJjNjc1NjJlMS90YWJsZTphMmM0ZjFmOTM0OWM0NDkzYWY0ODJjNDZjZTc1YmY2ZS90YWJsZXJhbmdlOmEyYzRmMWY5MzQ5YzQ0OTNhZjQ4MmM0NmNlNzViZjZlXzI0LTQtMS0xLTIzMDI1_ad6facca-0949-4231-b264-6585ee719b27"
      unitRef="usdPerShare">0.630</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0Nzk_b8d94263-677b-4a27-a9e6-177a926b8ba6">SEGMENT AND GEOGRAPHIC DATA&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Effective December 31, 2021 we segregate our operations into two reportable business segments: (i) MedSurg and Neurotechnology and (ii) Orthopaedics and Spine. This change realigns the Company's reportable business segments to its new internal reporting structure and how the Company manages its businesses as a result of the transition of responsibilities of our President and Chief Operating Officer, and the division of responsibilities between Group President, MedSurg and Neurotechnology, and Group President, Orthopaedics and Spine, in the fourth quarter of 2021. We have reflected these changes in all historical periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The Corporate and Other category shown in the table below includes corporate and administration, corporate initiatives and share-based compensation, which includes compensation related to employee stock options, restricted stock units and performance stock unit grants and director stock options and restricted stock unit grants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring-related and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,713&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;28,797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;We measure the financial results of our reportable segments using an internal performance measure that excludes acquisition and integration-related charges, restructuring-related charges, reserves for certain product recall matters and reserves for certain legal and regulatory matters. Identifiable assets are those assets used exclusively in the operations of each business segment or allocated when used jointly. Corporate assets are principally property, plant and equipment and noncurrent assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The countries in which we have local revenue generating operations have been combined into the following geographic areas: the United States (including Puerto Rico); Europe, Middle East, Africa; Asia Pacific; and other foreign countries, which include Canada and countries in the Latin American region. Net sales are reported based on the geographic area of the Stryker location where the sales to the customer originated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzEwOTk1MTE2Mjc5ODEz_7d139eaa-16a6-4c55-bab4-768291cf1de0"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NjY_1508db55-2442-490b-84ac-4f2f362d8d43">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Results&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;9,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;8,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;7,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment depreciation and amortization &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,147&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;954&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;945&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;1,044&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Segment operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,002&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;4,388&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Items not allocated to segments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(503)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(480)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Acquisition and integration-related charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(464)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Restructuring-related and other charges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(386)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(226)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Medical device regulations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(81)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Recall-related matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(192)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Regulatory and legal matters&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Consolidated operating income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,584&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,713&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock>
    <us-gaap:Revenues
      contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMS0xLTEtMzc2MTA_95457f49-bb80-4882-bc21-8d6849e5d488"
      unitRef="usd">9538000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMi0xLTEtMzc2MTA_a0d7f320-9b9a-4050-acaf-6850ac43504e"
      unitRef="usd">8345000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMy0xLTEtMzc2MTA_13307655-cdfd-4e2a-91f4-48e4eeabfbdc"
      unitRef="usd">8475000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMS0xLTEtMjMwMjU_549159bb-5286-4b64-877f-0a7688be3927"
      unitRef="usd">7570000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMi0xLTEtMjMwMjU_36ddd8bb-2c2b-4610-9e0e-2c631a015a16"
      unitRef="usd">6006000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEtMy0xLTEtMjMwMjU_e16300e1-5d23-4f7e-b53a-ed77a61aaff6"
      unitRef="usd">6409000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMS0xLTEtMjMwMjU_f835aed6-ac19-4073-be89-0fbf8f70e1ee"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMi0xLTEtMjMwMjU_d46a1480-2428-4b50-b384-af34f926e10d"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMy0xLTEtMjMwMjU_83c5d24f-3c31-4448-9f45-5f1ab87b0b41"
      unitRef="usd">14884000000</us-gaap:Revenues>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMS0xLTEtMzc2MjI_7825f6e0-ba68-4537-aebd-6e0b927767dc"
      unitRef="usd">518000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMi0xLTEtMzc2MjI_8a53f787-2d2f-455b-873c-c15166398a29"
      unitRef="usd">496000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzQtMy0xLTEtMzc2MjI_b0c3a250-9def-466b-aa51-91a28dcb3ce4"
      unitRef="usd">488000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMS0xLTEtMjMwMjU_8961b12f-7bd8-4222-8819-3bc7ec7b8e1c"
      unitRef="usd">629000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMi0xLTEtMjMwMjU_266bd4e3-c17c-444b-99aa-7870fac5e54b"
      unitRef="usd">458000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzUtMy0xLTEtMjMwMjU_65b5f898-dea2-4cd2-b952-5abdd8c6c790"
      unitRef="usd">457000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMS0xLTEtMjMwMjU_fa5f871e-7f2c-4337-afdc-6ad4f8fa4b91"
      unitRef="usd">1147000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMi0xLTEtMjMwMjU_c5061983-314c-4673-9162-1274e045eeaf"
      unitRef="usd">954000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzgtMy0xLTEtMjMwMjU_8126cfef-5ffd-4f0e-ae7d-88ca599af75a"
      unitRef="usd">945000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMS0xLTEtMjMwMjU_72914865-3688-4425-b662-d975bcc93172"
      unitRef="usd">125000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMi0xLTEtMjMwMjU_4a057daa-1305-4beb-9cd7-3b4d50408235"
      unitRef="usd">122000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1c65783cfed742208972bad227653460_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMy0xLTEtMjMwMjU_550093c8-54ca-4d63-91ad-6bd70c2710df"
      unitRef="usd">99000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTEtMS0xLTIzMDI1_56ee9942-b8c9-4750-8ed2-7e889f37e540"
      unitRef="usd">1272000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTItMS0xLTIzMDI1_144fe88d-759f-4b27-889b-74b3ed6bcbde"
      unitRef="usd">1076000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzEwLTMtMS0xLTIzMDI1_a0ec8dc9-85ac-459b-bec6-ab0a7e478c2b"
      unitRef="usd">1044000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OperatingIncomeLoss
      contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMS0xLTEtMzc2MzE_f9b94219-fcb3-492f-81e7-a1434f75853d"
      unitRef="usd">2807000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMi0xLTEtMzc2MzE_be2fa8bc-57c0-4ff4-9c74-9c84bb4a5d38"
      unitRef="usd">2414000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzktMy0xLTEtMzc2MzE_6ea5d344-ae81-4854-b237-7f9734e505c8"
      unitRef="usd">2304000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTEtMS0xLTIzMDI1_9fb42689-8eb7-48e6-877a-77d8f1694113"
      unitRef="usd">2180000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTItMS0xLTIzMDI1_73bcd528-c263-4da3-b3cf-b9917bb5d9e5"
      unitRef="usd">1588000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzExLTMtMS0xLTIzMDI1_39315ac0-2961-4d29-ad84-2a0682854c9f"
      unitRef="usd">2084000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTEtMS0xLTIzMDI1_0403821b-7d45-46e8-8bd3-fddb5418efcf"
      unitRef="usd">4987000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTItMS0xLTIzMDI1_3a7a34c8-8660-4fa7-b2c8-9a273859579c"
      unitRef="usd">4002000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE0LTMtMS0xLTIzMDI1_04989722-eae1-442d-ade6-c04b055c73bd"
      unitRef="usd">4388000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTEtMS0xLTIzMDI1_e4086dbc-ae61-4436-964f-5acb4524c030"
      unitRef="usd">-605000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTItMS0xLTIzMDI1_3d5e5f81-48b6-487c-8409-a9b521628181"
      unitRef="usd">-503000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE2LTMtMS0xLTIzMDI1_6681e19c-e73e-4241-95bf-df2639f1a002"
      unitRef="usd">-480000000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTEtMS0xLTIzMDI1_bb2fbfc7-653e-40f0-892c-32456be66d53"
      unitRef="usd">585000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTItMS0xLTIzMDI1_388d9565-9b23-4c0d-ac79-d49e20273243"
      unitRef="usd">242000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:BusinessCombinationIntegrationRelatedCosts
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE3LTMtMS0xLTIzMDI1_a10c2ae6-baa3-4405-8f14-93d49f596c41"
      unitRef="usd">275000000</us-gaap:BusinessCombinationIntegrationRelatedCosts>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTEtMS0xLTIzMDI1_e3e59f29-cdcb-4499-a453-4c86c76a1f25"
      unitRef="usd">619000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTItMS0xLTIzMDI1_354aa48b-ba87-4f4a-82a4-b791ca691627"
      unitRef="usd">472000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE4LTMtMS0xLTIzMDI1_c51e3688-e050-42b7-841b-517a13f669b3"
      unitRef="usd">464000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:RestructuringCosts
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTEtMS0xLTIzMDI1_ce77936e-4176-42cd-a550-0b321d21802e"
      unitRef="usd">386000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTItMS0xLTIzMDI1_0986b35a-6071-4ad4-a6a1-a33d47075942"
      unitRef="usd">458000000</us-gaap:RestructuringCosts>
    <us-gaap:RestructuringCosts
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzE5LTMtMS0xLTIzMDI1_22295871-bd74-4f24-bc0c-b5c5a02f1493"
      unitRef="usd">226000000</us-gaap:RestructuringCosts>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTEtMS0xLTIzMDI1_09d7806e-da00-4a7e-915f-20331a2b6f0a"
      unitRef="usd">107000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTItMS0xLTIzMDI1_97f5d4ca-76f5-4978-bc69-71ee511e361f"
      unitRef="usd">81000000</syk:MedicalDeviceRegulationsExpense>
    <syk:MedicalDeviceRegulationsExpense
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIwLTMtMS0xLTIzMDI1_3bd65b3c-f230-42e9-8949-01a51bd1e226"
      unitRef="usd">62000000</syk:MedicalDeviceRegulationsExpense>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTEtMS0xLTIzMDI1_57873bdc-5efb-4479-9f2d-c9927815be52"
      unitRef="usd">103000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTItMS0xLTIzMDI1_56e8ec59-0aef-4e3e-b44a-6d438bdfb23a"
      unitRef="usd">17000000</syk:RejuvenateABGIIHipRecallCharges>
    <syk:RejuvenateABGIIHipRecallCharges
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIxLTMtMS0xLTIzMDI1_0ed6225e-7550-4545-af43-e7dccbde003b"
      unitRef="usd">192000000</syk:RejuvenateABGIIHipRecallCharges>
    <us-gaap:LegalFees
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTEtMS0xLTIzMDI1_5abfc781-92c7-4664-b36f-4e553312a8c3"
      unitRef="usd">-2000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTItMS0xLTIzMDI1_71974682-4add-4f59-b59f-7a55b8e56116"
      unitRef="usd">6000000</us-gaap:LegalFees>
    <us-gaap:LegalFees
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIyLTMtMS0xLTIzMDI1_cb3dc646-4447-48f5-9ecc-c40a36eb8206"
      unitRef="usd">-24000000</us-gaap:LegalFees>
    <us-gaap:NetIncomeLoss
      contextRef="if094df009b6240eaacd07df8b1201b26_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTEtMS0xLTIzMDI1_177dcc1f-66ae-4fe1-a10f-10ccffa87a02"
      unitRef="usd">2584000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8ab9957ba64745bbbe9cca9fe634802f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTItMS0xLTIzMDI1_a16d2f4d-d455-4e88-b187-25bc3f955e99"
      unitRef="usd">2223000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia832edcd99fa4d58a2f41ab496804772_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTo2NDkyNjYyNjhlZjM0ZWJiYjhhNTFjYWQwZDBiZWVjMi90YWJsZXJhbmdlOjY0OTI2NjI2OGVmMzRlYmJiOGE1MWNhZDBkMGJlZWMyXzIzLTMtMS0xLTIzMDI1_7ea87a26-5654-4933-9f12-b61d2a128903"
      unitRef="usd">2713000000</us-gaap:NetIncomeLoss>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NzM_c7981d35-6686-4f06-8ed3-63347d0bb398">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.693%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.694%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Segment Assets and Capital Spending&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;15,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;16,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;18,090&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,367&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;33,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;28,797&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,631&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;34,330&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;30,167&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Purchases of property, plant and equipment:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;MedSurg and Neurotechnology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;197&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Orthopaedics and Spine&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total segment purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;362&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;342&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;419&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Corporate and Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total purchases of property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;649&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Assets
      contextRef="i45973f2c9a854e2e920f89b3e8dee9d8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMS0xLTEtMzc2NDE_83847cca-b44c-4526-b9ff-d28c46c80307"
      unitRef="usd">15218000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ie114ed237e0d41beb5a9e2242dabd291_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMi0xLTEtMzc2NDE_4f2f51b2-7fbd-4fde-834b-17e6fe5f3be5"
      unitRef="usd">15250000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if615c66e93d841248401204d2f87e7b9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMy0xLTEtMzc2NDE_98e9284c-1e6d-434c-86ff-2510032a613e"
      unitRef="usd">16270000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i05efb2548ebd4f34ab5c73e347583ae8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMS0xLTEtMjMwMjU_a6d40476-3d48-4d64-9a61-428588f39360"
      unitRef="usd">18149000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4c0d499873474314be3c66b63d45f691_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMi0xLTEtMjMwMjU_8a941633-1452-4d12-9180-ece7a862e2a5"
      unitRef="usd">18090000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0adfcfa572a94aca9a60b62275d83075_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzItMy0xLTEtMjMwMjU_7252e3a5-be81-4b39-acd0-42af62994e12"
      unitRef="usd">12527000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i74c68f4da1164491bf77ae9dcbfb0545_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMS0xLTEtMjMwMjU_27e28d49-2c18-4477-87fd-11aa36c42a8b"
      unitRef="usd">33367000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic1a1b44063cf47ac91f386a31d08238d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMi0xLTEtMjMwMjU_e1da3831-a5b7-4425-97d7-5458ba67d069"
      unitRef="usd">33340000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i044e8aa931854b8a94b1419803337ca9_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzUtMy0xLTEtMjMwMjU_b20b63d1-19ca-4a1a-837c-3f24979daabf"
      unitRef="usd">28797000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i493d054bdb1142bab91a099618a17c2e_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMS0xLTEtMjMwMjU_2c435a4e-7335-41a7-9f64-572bf34ec048"
      unitRef="usd">1264000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i89b60b72af8d496098920a748eea6ac8_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMi0xLTEtMjMwMjU_f8d4843a-272b-4d68-9847-5cdd3644fa24"
      unitRef="usd">990000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifb45f65a673b4ca8bc5380e9dc457005_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzYtMy0xLTEtMjMwMjU_7c3581f9-733a-43f1-b876-5a8b2eda9c10"
      unitRef="usd">1370000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMS0xLTEtMjMwMjU_2dd82e0f-ec5d-4c70-bad7-c9651e732f51"
      unitRef="usd">34631000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMi0xLTEtMjMwMjU_6c1e3134-f50a-4811-bf5b-b91d7dcfaef6"
      unitRef="usd">34330000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id69388e86ae64de6bf4faca02b97d13f_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzctMy0xLTEtMjMwMjU_62e0618f-ded9-430c-91e0-7de1fd2cd347"
      unitRef="usd">30167000000</us-gaap:Assets>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="id53460c344454415a413587e43a832f0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMS0xLTEtMzc2NTA_8b959fcf-f6d8-47e7-87f0-e5c746dcf03c"
      unitRef="usd">197000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="ia8310696c7f9425eab45a3c407ab3de1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMi0xLTEtMzc2NTA_c56a2614-df17-47a4-8679-18ab6aebc071"
      unitRef="usd">192000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i24654eb792da4b94855f53c6a5408a95_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzgtMy0xLTEtMzc2NTA_c429fe15-4fd8-4994-b991-88b1d96c8b5d"
      unitRef="usd">281000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i5d8951ae779e4fa7ae7120a889444cfd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMS0xLTEtMjMwMjU_9854d27c-6bc5-4440-8ae9-80def063ebd6"
      unitRef="usd">165000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i4269ea09e5ba4f9dbaee1cd00972a8a8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMi0xLTEtMjMwMjU_d8910843-23aa-4ef6-b2f6-58127116b46d"
      unitRef="usd">150000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i8a6c3c49d1f74c97ae31df58ded3dd22_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzktMy0xLTEtMjMwMjU_8a6a7126-f924-4ac1-92ba-3ae44e996e9e"
      unitRef="usd">138000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i6d5393be84ab48859bfd5ffe9fb018b6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTEtMS0xLTIzMDI1_e26d9398-52dd-4d34-a20f-43afc6b2ec79"
      unitRef="usd">362000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i4c0dff39a39b48b7ad13c11c671837e3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTItMS0xLTIzMDI1_f6e76dd6-30cf-45e7-a8f5-f5f491a6add3"
      unitRef="usd">342000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i77b44f1898e24ca991616ca726de9feb_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEyLTMtMS0xLTIzMDI1_702a98b9-1f67-4bc5-8ea9-af4dd26eb35f"
      unitRef="usd">419000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="ibacdcc3113d64ce2a0f8e557886ae246_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTEtMS0xLTIzMDI1_83132bf6-92b4-4a3b-8762-bc3031e1c955"
      unitRef="usd">163000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="id6990f2442ee45e89ba5aa42164e138c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTItMS0xLTIzMDI1_093634d9-3b1e-45e1-93d2-c930b6be7803"
      unitRef="usd">145000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i1c65783cfed742208972bad227653460_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzEzLTMtMS0xLTIzMDI1_35ceeafd-b54e-4db3-b640-9b9dcace4be4"
      unitRef="usd">230000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTEtMS0xLTIzMDI1_e70c5b87-5eb9-4749-b8f2-0f45619798c2"
      unitRef="usd">525000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTItMS0xLTIzMDI1_c359389b-0a08-454d-bfd2-ba66d456a021"
      unitRef="usd">487000000</syk:CapitalExpendituresDuringPeriod>
    <syk:CapitalExpendituresDuringPeriod
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZTozYzNmMzg1NzUwMTE0ODA0YThiZjUwNTkwNDhmNGNhZi90YWJsZXJhbmdlOjNjM2YzODU3NTAxMTQ4MDRhOGJmNTA1OTA0OGY0Y2FmXzE0LTMtMS0xLTIzMDI1_6f9d543c-039a-4fbd-9ad8-bbe552f7ccf7"
      unitRef="usd">649000000</syk:CapitalExpendituresDuringPeriod>
    <us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90ZXh0cmVnaW9uOmUwZjRmYTY5ZTA5YjRjMzRhMmMxOGJkODM4ZDA1M2FlXzE0NjM_054deed8-cb18-4925-a3fb-104f7799f1bb">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.750%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.236%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"&gt;Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Net Property, Plant and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;12,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;10,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Europe, Middle East, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;2,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Asia Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;1,617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;17,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,351&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;14,884&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,833&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;2,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock>
    <us-gaap:Revenues
      contextRef="i3c98ae1339ae46f698f2d915141cde7c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMS0xLTEtMjMwMjU_2c6e5a95-ff35-41fc-93b6-945156ea1567"
      unitRef="usd">12321000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1239e64cc07f4da4a637ffd4496a728e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMi0xLTEtMjMwMjU_5b5daa0c-6559-483a-aa4b-cde1c5731747"
      unitRef="usd">10455000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib993db761cc4478a866ff2db39f59836_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtMy0xLTEtMjMwMjU_6d6f3a47-a786-4044-b989-c5e1ab7b3922"
      unitRef="usd">10957000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i742ba6c7339d481cad355c3643d8c974_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtNS0xLTEtMjMwMjU_11070896-8d12-45c8-884f-39dbeb3a7a57"
      unitRef="usd">1717000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia89a77a86ad54db68756036c89894730_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzMtNi0xLTEtMjMwMjU_b94ab027-895e-4eaa-b302-14670e7c5052"
      unitRef="usd">1645000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i7510c322dcd240709c6c6e3c9f02d28a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMS0xLTEtMjMwMjU_1b78003f-8d07-429b-b655-5d54926b91b8"
      unitRef="usd">2299000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibdaebd90ff5a43aebff037d5206f643c_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMi0xLTEtMjMwMjU_12bc8c86-21a5-4c79-b8db-03739c5bcb76"
      unitRef="usd">1818000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i508e0970774e4040bebaa29eefb5413a_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtMy0xLTEtMjMwMjU_f9b738e6-a320-4683-8eed-df1d92561e54"
      unitRef="usd">1888000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="iabea30f6f342483e92b55ff45d124cfd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtNS0xLTEtMjMwMjU_c614f5ba-4807-46fb-accc-ca0f7dff312c"
      unitRef="usd">941000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i65e2baa3bf9f407e86be3aa79c350743_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzQtNi0xLTEtMjMwMjU_bd2b972d-6fad-4c6b-9b46-d17f96c299d0"
      unitRef="usd">938000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i366d502111bb4b0ea5b40b0854ccb69c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMS0xLTEtMjMwMjU_50a05946-7c5d-4232-9ea2-4d0b344be7d9"
      unitRef="usd">1973000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i79f9e9c317bd4f439e0b474fd5b011ae_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMi0xLTEtMjMwMjU_b6453d15-3c6c-4343-967a-a8f5ea9d6d70"
      unitRef="usd">1630000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i21fb41ce5c5541289a9c9bda6cc8d0d5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtMy0xLTEtMjMwMjU_5d4e82ab-cec2-4de7-9517-c9655ecf1793"
      unitRef="usd">1617000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i04ca0caf148b4cfea6977517521fc1a6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtNS0xLTEtMjMwMjU_c6c615d4-4140-46f9-907a-914b3f136cc8"
      unitRef="usd">76000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="icd51320aa2454e7a9423a3b8924b52cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzUtNi0xLTEtMjMwMjU_4256c474-3f42-4ee0-ba41-8c3cad9cc351"
      unitRef="usd">91000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="i4c0ca347e0e442d5b711eeee83cb8a15_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMS0xLTEtMjMwMjU_fed42931-1c6f-422b-b5bc-8a7eae5d719f"
      unitRef="usd">515000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id822d7baa9eb43998e1a14bbe5f9067f_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMi0xLTEtMjMwMjU_ffcd2f92-8b24-471b-8659-119e61801e6a"
      unitRef="usd">448000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84d77376c3524f3bae2890c5d42f27a5_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtMy0xLTEtMjMwMjU_3764d106-f9dd-4d5d-953d-49be66739a76"
      unitRef="usd">422000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i695bf958a588401eb4c0e69af671f48a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtNS0xLTEtMjMwMjU_79527c5d-ca65-43b1-b46c-a63aebe54a2c"
      unitRef="usd">99000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i54f6e97d92584c358e1d36baee8c2703_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzYtNi0xLTEtMjMwMjU_107c9ef1-0306-4b55-9420-f71cd49553a6"
      unitRef="usd">78000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Revenues
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMS0xLTEtMjMwMjU_12fd64a6-5877-441d-8c87-1e134310c736"
      unitRef="usd">17108000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i71b4125231bf40ca9fd6031db11a4933_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMi0xLTEtMjMwMjU_9bddc9af-d706-497a-81ea-43a02051da26"
      unitRef="usd">14351000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3e0d80cc19504f4b9ac4007c44f51c28_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctMy0xLTEtMjMwMjU_af39769e-0daf-41fb-ad99-e15b2c5a576b"
      unitRef="usd">14884000000</us-gaap:Revenues>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ic69cd9d39a21490cbfb14c8af977c010_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctNS0xLTEtMjMwMjU_9b255c75-a7e4-4c66-b936-bf02d20319ba"
      unitRef="usd">2833000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5100993b55004a07983c6ce4012e89e1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDUvZnJhZzplMGY0ZmE2OWUwOWI0YzM0YTJjMThiZDgzOGQwNTNhZS90YWJsZToyYTM0OTBjMDFiM2E0Y2I0YTgwNjQxOTU2NWM2MTJiZC90YWJsZXJhbmdlOjJhMzQ5MGMwMWIzYTRjYjRhODA2NDE5NTY1YzYxMmJkXzctNi0xLTEtMjMwMjU_94b715d2-adf7-4555-b907-17e80bd2b232"
      unitRef="usd">2752000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AssetImpairmentChargesTextBlock
      contextRef="ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzUyMA_65ee8cbf-28b0-4fdc-a605-cbde408b0672">ASSET IMPAIRMENTS&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The government in China has launched regional and national programs for volume-based procurement ("VBP") of high-value medical consumables to reduce healthcare costs. Each VBP program has specific requirements to award contracts to the lowest bidders who are able to satisfy the quality and quantity requirements. The successful bidders may be guaranteed sales volume for certain products, while unsuccessful bidders may lose unit sales volume. We expect that the prices required for a successful bid will, nevertheless, negatively impact our existing commercial operations of joint replacement and trauma products in China. As a result of the outcome of certain regional programs for our trauma products and the national VBP program for hips and knees we recorded charges of $105 to impair certain long-lived and intangible assets in the third quarter of 2021. These charges were included in selling, general and administrative expenses. Spine products are part of the VBP program in one province and it is not clear to what extent spine products will be included in further provincial or national VBP programs. We do not expect any significant impairments related to the potential Spine VBP programs. Our business in China represented approximately 2.5% of our revenues for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Aside from the impairments from the VBP programs, we recorded asset impairments of $159 in 2021 consisting primarily of in-&lt;/span&gt;&lt;/div&gt;process research and development, other intangible assets and property, plant and equipment as a result of COVID-19-related demand impacts on in-process product development and certain other divestiture and restructuring activities. In 2020 we suspended certain in-process investments resulting in charges of $195 to impair certain long-lived assets (primarily the portion of our investment in a new global ERP system that was in-process of being developed for future deployment) and product line and other exit costs. These charges were included in cost of sales and selling, general and administrative expenses</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="i0df0e910952f41b38ad92de86d9e751c_D20210701-20210930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA2OTg1MTU_c6c4e54f-21a9-4c84-b482-187f095077e4"
      unitRef="usd">105000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia507b09a8414413ba7d85ab4c02407b5_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA3MDE3MDQ_f66043b6-abf4-4f83-b1dc-4375a0c6d0fc"
      unitRef="number">0.025</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1c818b44abbb48aca50ce62cb4244e4d_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzM4NDgyOTA3MDE2OTU_29675f32-7ec1-4a35-a5d5-018d20742185"
      unitRef="usd">159000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5fba5cf2d76346acb78e2f001edc09ac_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xNDgvZnJhZzplYTk1ZTQ5NmNiOTM0YzdlYmZiOTc3MzM1NTFlYjFjZi90ZXh0cmVnaW9uOmVhOTVlNDk2Y2I5MzRjN2ViZmI5NzczMzU1MWViMWNmXzY1OTcwNjk3NzEzMjY_171cd60c-baa1-48f0-b427-98ce34820bf0"
      unitRef="usd">195000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i55b99ad9aa574362a2b36a60d0085869_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTMtMS0xLTIzMDI1_1be414fc-ca31-48d6-866c-a1a8034a10af"
      unitRef="usd">131000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTUtMS0xLTIzMDI1_04fc56a2-a07d-4bad-b72f-4b2898440768"
      unitRef="usd">61000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTctMS0xLTIzMDI1_c3bc17d8-5589-4a78-9551-66382c0a6fbe"
      unitRef="usd">23000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="iaa19b1cc54304903a7c8fc614aa0bfa1_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTktMS0xLTIzMDI1_e3ca17ec-d5d7-4ec9-9244-c4a61e87605b"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i4ba1ecd7eafa4f05988a82a4023b511f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE3LTExLTEtMS0yMzAyNQ_97fb3250-bb1d-4363-a70b-904d80b1a2bc"
      unitRef="usd">167000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idbe329076697427a86d128a21c73111a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTMtMS0xLTIzMDI1_090cc894-37e8-4354-bb04-b5193f88a2b6"
      unitRef="usd">88000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTUtMS0xLTIzMDI1_7e4f394a-7a0f-478e-9f2c-287abc397179"
      unitRef="usd">65000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTctMS0xLTIzMDI1_e83d23d9-a38a-4444-a4d0-78288d622837"
      unitRef="usd">22000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="i6e6044ab254b4294b2f74b23e8b4c009_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTktMS0xLTIzMDI1_450008f9-d36b-40a9-a14c-caa2c70c72f7"
      unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="i55b99ad9aa574362a2b36a60d0085869_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE4LTExLTEtMS0yMzAyNQ_51753013-aa0f-4e13-b8ef-a7cb5be52b84"
      unitRef="usd">131000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="ied06158ff7d045f39f524189c541c016_I20181231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTMtMS0xLTIzMDI1_5f3ded63-dd26-4df6-b89a-e1dc130df79b"
      unitRef="usd">64000000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense
      contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTUtMS0xLTIzMDI1_a26b9cce-1dd6-4026-a424-27fd2b00c2c8"
      unitRef="usd">39000000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions
      contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTctMS0xLTIzMDI1_4eb7248f-06bc-4565-892c-532f47fea64e"
      unitRef="usd">13000000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesAdjustments
      contextRef="ib0b8d5c268014285bc3a0979f783463e_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTktMS0xLTIzMDI1_eaffec1c-2b27-4c12-8005-142aa1a97102"
      unitRef="usd">2000000</us-gaap:ValuationAllowancesAndReservesAdjustments>
    <us-gaap:ValuationAllowancesAndReservesBalance
      contextRef="idbe329076697427a86d128a21c73111a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjJlOWI5OGUxMTRhYjRhMmJhMDlhOTU4ZDc4Njc4OWYzL3NlYzoyZTliOThlMTE0YWI0YTJiYTA5YTk1OGQ3ODY3ODlmM18xODEvZnJhZzozMmEzYWU3ZDA4ZTE0NzhkOTM5NDJjNTEwN2RkM2EwNC90YWJsZTo5ZDIwNjQxMjE3Zjc0YmI3YWJiOWU2MjYwYWIwMzA3OS90YWJsZXJhbmdlOjlkMjA2NDEyMTdmNzRiYjdhYmI5ZTYyNjBhYjAzMDc5XzE5LTExLTEtMS0yMzAyNQ_9ad255a3-47c0-42da-983f-47866c1d13a5"
      unitRef="usd">88000000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>108
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M)"(GDL_..@/WU\N^HQM45WQ+^&.Q]9GH1YD*\5T?C.*SCJ,=\91'2DLP^//
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M4;=0-'/>&(J7=K;V7.E)M=M</XT@3(#V'SA71\,DZ![;^"]02P,$%     @
M1&A+5&_A:W%/!0  !Q4  !@   !X;"]W;W)K<VAE971S+W-H965T,RYX;6RM
MF$USVS80AO\*1I-#/.-(!/CML35C2VGK0YI,G#2'3@\P"4D<DX0*0+:37U^
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MCOSRX-AO.'/]S/6]['K4B#L8E9SE8+W>'6/N;HQ:CR>!M\H8U8Z7*\'!XP,
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M/=+]ZS#]A5&'[@61K3)&U=W'O>"ET Y@?]\I95XNW V&EY)N_@]02P,$%
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M^>E]*W7X*,:(:Y//P:ES4S]51#!P$W2$<\;N>=O2937QN<>.&[TXX.8B 57
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MV6?0C)"YMDAT\UVH)=,]!'GI*2[@_TPMQF$H1F$/Q@#^3&T<DXNKA,;+JGQ
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M)SBJ)$W ^$:A)PDOI&#ZN'S^7U!+ P04    " !$:$M4? B*Q5@(  !@%
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MWQH3TP$(V;8W'I2U=/?86@QS<>*X1JC0^0H><>F8.BN;/(*Q"PDS;#3CK2]
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M77:3 '3]2]2&53O_,J^4Q7?>#[?XL7+M''!]K90]&@Z@^:I'_P%02P,$%
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MAC;@^\*AD[8O)&![DS_[&U!+ P04    " !$:$M4?:+<YNT+  #!'@  &0
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M"I7'T@+\OC2(4_Q"!W3_6I__&U!+ P04    " !$:$M410CIHV<$   2"0
M&0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6RM5FUOXS8,_BN$-PQ7(&ML
M^36W-$#Z<KT"?4/373$,^Z#8;*R=;7F2TK3[]2/E).MP:[$/^T)+HOCP(2E1
MGFZT^6IK1 ?/;=/9HZ!VKO\X'MNRQE;:0]UC1YI';5KI:&I68]L;E)4W:INQ
M",-LW$K5!;.I7[LULZE>NT9U>&O KMM6FI=C;/3F*(B"W<*=6M6.%\:S:2]7
MN$#W<W]K:#;>HU2JQ<XJW8'!QZ-@'GT\3GB_W_!%X<:^&@-'LM3Z*T\NJJ,@
M9$+88.D80=+G"4^P:1B(:/RQQ0SV+MGP]7B'_LG'3K$LI<43W3RHRM5'01%
MA8]RW;@[O?F,VWA2QBMU8[V$S; WC0,HU];I=FM,#%K5#5_YO,W#*X,B?,-
M; V$YSTX\BQ/I9.SJ=$;,+R;T'C@0_761$YU7)2%,Z159.=FYUI7&]4T(+L*
M;ER-!BXZ)[N56C8(<VO1V>G8D2?>/RZWJ,<#JG@#-1)PI3M76SCK*JS^"3 F
MBGN>8L?S6+R+>(KE(<31"$0HHG?PXGW<L<>+_TO<WT0,I\J6C;9K@_#K?&F=
MH=/SVSMND[W;Q+M-_N=TOXO*%_>C[66)1P'=3(OF"8/9^<W-Z</%Y27,KT_A
MYO[SV1U<7-_/K\\OCB_/8+Y8G-TOX &AU&W?H,,*]-H0KVXM&U!M+Y6AR^?
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M,L"@ZKZL^0NK-NYKUKVR5E7N="WPRJM) ,^72MGV@C;H/F]>_ %02P,$%
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M$ASDFJ08N2I0!^N#0RW6/HW/0KEP,#BM%]BX%*;L/$SZ]+"4D%;,>I0M1;6
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MR%K@BDF(N68J<F4=4H,HH'RKG&>Q5K7::(?7M"J-^)7 L 3W0CCCWUA9-QL
MP0JZ=@A=3&IE*7:TDG5[<'*W2M7,XY?6ZJ;0'.T-:^(!=W#9M([L;U6EG9-U
M#DDP2O/:&A"=U>N6 "AI:UU?\UOH"K%=(V^M&UUH:;5JOE*_=P:YK^@_+C+6
M/BZTU^>?MMK_77<7/<)!>'XDO7U4\,%<EYJ1>!=E/;(.?ZHU+7#E6)B-*H"X
M% T>6V?LWJL^B6>1>/;@=I^2*!1+69H<'.[TI*##4C5WS)'56E\_DME21+-8
MQ+A_&\0:*%BZH&,#C5BH!2I-XF=BO)B=3<0XG:6X9K/%A(4=6-VJG83NO, #
ME?5JC&>92"'%.)K-)]#8H3CHW6:<\$*@F8!H+GYD-&'Y>)9,: ;>71QU74HT
MT!@E&G];XG;1@3E7A$\,<][C5CH169KBFJ1GN*:+!4M@:Y87(L335;;"=1G/
M13*-SQ;BDW$8!\4T6<6XQ].S><;/\T4BWIIJ9VI5._:O@?]<?$:CTB@Q/O?9
M92+>MM9BXE!"Y2>]^#K/PMKS.:ZK")=QO)P\X4=G2W 3V4,1DV6"\:5(DRP(
MEQ]%AH7F"4F;@@#7>2K>*1C68M7![/&Z$[*7Z)@(XQ6,#DGH%STAP#@A-TGF
MY"N3!U*,XQ2,($H<+X,8Q=<@(PA)NB0,,#1 ))V)#TJ?K+S<I/=L>>9!J,8Q
M2DR2)>= T)9MP4N'B O<QH'59"IJ]+0H8ZKG#H<9GT#$*6XIA"26XQ.$IZZ/
M%]'#>CTD>I#\#D*'TB?]UB&O_=;'.:$+.;>^AOZ1=')I[1[Q=2MMP>Y]DJS2
MJ3C)8L9T,H^.(NV=9! 1;YI&.9_-WVNYQNJLND/^)'GJ,"PNZQMXJ*&$33X9
MIQS)F?A@#67$YUT&*P><$>(PL4\Y,L\M=1)!%XV81S'8)%@>NX<\Y#O")BN#
MNA84$R,%9+@FBS.O\GO)&<Z#7!&MQ-566O6<VO$"74M%2WCZ12KF"_'#E[JE
ME;RCH \I8*7[RD[2!.X6!?#Q&?+\8O&(FWN%<59:+2BVTFF$M=]3[;B191O$
M*]%(^5(YCA<9Q5:$""-X3S!=G"T#\^B@P09J'UKM<>52,CB+)YS,D%P7E,\.
M5NYQ'!/8>(')QW4P-#VSC*)Y8)YERZ\0,X:8"=\S^-='M0-63)40Z0>T 2%)
M/L%BN8CX/D^C(=4 W%__LDKBY!MOVB'H\6)%4E)B[XK.?4AO@A/KPTF(D\M)
M//>!>!*CT$'+V,*H:HVENFU,"%.8YW:K\ZTGLYVTB.@.,\VK[T3X(H3N?'@@
MQ>R0M]]W;D?"T;N3191@@^FV  LQUXH&T9O]0BT>>A&))J\L#SDP\F2\2H.<
MT>)AV_JSI=TO$/_:ZD83Z>2(*B"ZO)&ZE.M2^?8'Z41US25LRR^&/62_A8#Q
M&Z=S!G&XL;R?JX_DU"Q*2:6:EMM:TUYO 2V;SQ[4NR/4\=D*>KL&'H /;'Q2
M3KX16VR;;I2=BH8<=2O17M5A%K.=B9\A?MD8_XX\^6 VXH6B+)@*>O\=EO)5
MR[-M/(='S/KG1"D,!LEO81:]HVQ]C1H8''$0KN"J/N>4&\.. 5[^G'G1Q XK
M =GRWDDU2K$?>+?P(E%)>]N&@O9WLVX0GBBV(Z+!O]&$]\D(SCR$%2KCLF-Z
MSS,8._*DL=1!2'BJ>NYT%79?[+X,V]0''?&0[U'#'[H-9. ;;=JFW/>IRPM
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MY5RI*MZ?49PBE$W9>JY\I'%7PEL.^G%,-3A#HW'%^WCNTDM=:1<.(^Y2SK
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MRYF8G!XV[F/-(_8J\[_ J576<H4@=(WNP2^[F\9_%R$(8N?>$=-L/CC ?'"
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M]"1@F&I"N?\$"<47IJ34(71\BL^(R4)WX,'\MC.2]&*@3JF;"LZT%Z?,6#1
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M0?S''%!(_1Z]!F$3%W/%P\27="W4"H%,[(2A E(7,ITI0.I)*FU5BJA=BFC
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M>"_2&_"],3"7>0-X?I\ W^+Y_R<!7R_]OM!I*?5."?A]L=9&H8S^&* ->MK
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M%H+]S?%-)A1-0/M&XL'<=8B@?^7-_P%02P,$%     @ 1&A+5)W\2\0)!
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MRM([XJ=;>KA1.P62KQ4Y/BP<P?A78/D_4$L#!!0    ( $1H2U1'_ZUQ'@8
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M_U7J@1K>@6%B9.?NWHTT=).[X9Z>3E060/M;*<UI8@.,C_'J/U!+ P04
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M-CVI&Z[,7P!(N\$\SX30NXEU4/]7C/X"4$L#!!0    ( $1H2U3Z1J='9@(
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M'$(2X1IQ+:$_44IW/H&]];)=!D<'MBIHNP:.>I@5^^"C*4NC"D\ % H\L<!
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M =7O]UE6[C_4!SB\3>[J_U!+ P04    " !$:$M4/?TA\4P&  #,(0  &0
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M0VD=S/U&"'T\V #=6YK\!5!+ P04    " !$:$M4XIUD,RL&  !;)0  &0
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M<!35A6>#34M?)X!/<AX^:Z7NUIDHH)5VC58*:*5VM+JV?EHGIU?1WFIRG!X
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M%/WM(8;.NRZ\@US ;5X49+H>^H8HV$+\I"[WIBHW?*9<%L(MH68:/HH4TZ<
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M$["C[O$,1GV_!1T4T$%W0,=;EGL46$0[9Q$#%C$[BS:6>\RVCZA/(;?>:C
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M<\MZD5F/G($SM-;; =_OTW7L;M7I#6>WXNP:.3^R%7V!!4A)S3+F:?A9,9&
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MP6!LY*JY'IH Y<:UY%*B:7 W+,V-"LIN,.LK*?$0V"[O[NCL-U!+ P04
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M\ ?8(%:$4_%R"6*X#<)0K8\8V%+1TT[L>4KE.J&"*Z@@#+<LEBL!GV.?^OL
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MF>55ZOVJW/V<UF^A_:K'B*\.JOT9_9T_N%40RW\L9GJ5F5YNIM=B9L;C&$3
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MS 3]?,5U/LN!,5"=V4S_!5!+ P04    " !$:$M4_\>0_+H&  " )@  &0
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MSYVV)ZIXK#\ NBN4*M;UX8-,EK(T _3OJT(_DKL3\TU1\]'9Y7]02P,$%
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MAN=]!&3R43)?.+W,AJM'[7!4RQX7.'Z#\0+X?::UVRZ\@W*@'_\'4$L#!!0
M   ( $1H2U1_R,6:EP,  *T,   9    >&PO=V]R:W-H965T<R]S:&5E=#8S
M+GAM;)U736_;.!#]*X2 8EV@T*?C)(5M(+:[V!R*!G'3/2SVP$@CBZA$:DEJ
MG?S[#FE%MAN)2GNQ28KO#>?-<#2:[X7\K@H 39ZJDJN%5VA=?PP"E1904>6+
M&C@^R86LJ,:IW 6JED S"ZK*( [#65!1QKWEW*[=R>5<-+ID'.XD44U54?F\
M@E+L%U[DO2S<LUVAS4*PG-=T!UO0#_6=Q%G0L62L JZ8X$1"OO!NHH^;*#0
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M>T\[+/![ J39@,]S(?3+Q!CHOE"6/P!02P,$%     @ 1&A+5,!B2PI: P
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MEW"NA'Y*-*?&4Q;S%-!7_ X2G<WU'4^V%!!?HELL&&$KB1:@[SJ@0^4Y.IN
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MQOP7@+0 \[T00K]7; ?MG\;R-U!+ P04    " !$:$M4ISM'RD0$  #<#P
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M05J!>;\70K\-[ )UC[_\%U!+ P04    " !$:$M4SD<B4@H#   /"0  &0
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MDMZMJ:VBJ+Y%1_',%K U5[H<VF:B_UA & /]?<.YVG=,@.H?:/(/4$L#!!0
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M9I3H$J50,#/,ED7!S>L8I-X,@W:P#SR*Q1)=(!PE*[Z )\#GU<S0+JQ9,E&
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MWOVL6>'Q<H5DPPHINN:EFDIT5H[9&) ?N.4Q<2CH:W>U/B///CLF3HVG+/N
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M^!;NS,;1)* 6[AS2%Q(+=P'HBVADX2YM'(E">WU7@+X@CBW<P,;A"'LV< @
M?1K8GAY!P#A>6^):&L1M&L3.-#AE>NK7L\!REM8C0CJKZN"?^@*4B+&5B)A$
MMNN' ,Z+0MLP".=OMBMI[4J<=CW7=:G3G*6BU)4MT4[!I00[?V*75Q#;"3 $
M<(38"3H"<!&F&ZW"GIGS/*==1ROAJ1I)7JJTG.15(TFE9 HJYT&C<W4YNR%.
M;/,@H ]$=P0"P\UAPRN#+'ZQ+[T<L.-&RVI!A$ '. %P/K4+\13 !8FM[PS
M4<_&G4/Z0ON^%Y =Q*[_2P"W&]N)=P79F]BX08-;J[L$:,E#"!@D=NZ, "#Q
M8D?.$Y,2Q)D2UVQ\NQ"3NCU]9 O!%<NF)2_XY,E!RMA,.WC;<><5,P VTP]^
M8?QQ,.\ VQ..9D" .0!@3/T B L ]*-@<US,Z(0#IR&?A)KR><K&>2;KX-S.
M-<+E(S,HX? -0F)F(?SZ86C0R*XZ, HB>\H9 D!-> #G04#?2S:'Q+ Y=M/Y
MISD3:>VOQH/2Y1]#ICCY]>$@AN2(F^2V'DJ(34<8^_:@-P2 26!WO1&$\S?7
M##'T1MST]NQ)W@8J+S,^8Z!5=D?UDQBR"@!Z "N-("!='V#7[3(]FKA[M)UX
M>C_SNL9-3.,F;]"XB6G<Y'\T;M*U<0- N'%#0%?C)J9Q$W?CWKZ^ FLI 89L
MLW%^ C1 ".=*0\,;Q+W#WG+L)\"V.O:@"@. /H8:!P"DWN;!F!B.(FZ. BML
M:PHFADI(_ ;%92B&N#=L[N*R]U,P!0- F((AH(N"J2$O^I/)B]I<$Q)@<P;@
M_, NPA&(BS9;9KB+=N.NCL5%@0U!W30LPZ M!G"L,H(T>HY#$&KHB[KIZX0+
MG>6I<I4.73D^?0->HH:7J)N7ML\XFUDPL1EH".* L0+ )8Y2,CQ%W3QE_)CQ
M,LN+VI.5WUQN,UQ!WV"/04W_IN[^O<WD1^T-PF[H01$"@($''$A!0'^]&-?M
M,CQ!W5N.H^SO12[S-OGR4K&)J)VX*UBA:VJ,LFDJ)G!KI_8!X&X00Z8"0.)#
MV0@!'7,3-1Q%W1SUJL,W:C,-?/@& <'#-Q#H.'SS#7?Y;NZZ85*)1:860N=G
M&[TJJKQ^<NR(HP^<"-+89MXA! 1Y# (2$FXVTQ"9[R:RZVI>2@LT9@]YQI!@
MDT51!Q6VS&:=70P-B1 P!L[R(=SZV>6Z78;%?#>+Z3Z9%D4;-]W)%!.P302R
MR>X;0Q!HVSX"<8G#*$.F/GW!J#HZ7#S5B5BPB8Z<RS0*# FV739J%Q@3(66.
M0EMY OKR5K+#"-5H67LP!3Z7@(#@@PD("#Z9Z*^\C#)CNNJK5ZPDROBB5,LG
MR>W5]C6NH_IEEA^N'^.]*PQ<'^"]T?(E+:-^^<[8M6XR>2EUJ._UK;P/D5ZM
M6+Z&M?RB^+Q^%>:.*\5G]<<I2\=,5 #]^SWGZOE+=8/V9;C#_P!02P,$%
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M*L<J\U;4.'%3.X$FG( (W+%"I@)\*&(2GQJP5$1M6.@UK!LT:W%'HBO@P)\
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M6=^[\2"E*[+A9BZWGVF94&SY$LFU^X5M:1MXD&RTD7D)Q@AR)G;_Y'LIQ $
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M1<0:3'2:L^"!B@$94<''BH-71G,NEM;< <.D$(4*M&ET(Z<-ENK1PFT[@WO
M\>1<%JJ.;2/8WV.W? =8S4 @%Z(1V"'6,.R75&NFY+69U(MKXQ,H<..[96D4
M3A5=MCN79.U07TR0<:%2IIHP;;(R#?N"92!'\>D,KKHH0P"U+G(S2#F=%I+6
M&E8>;F!H)TR(6WA ?,NVN!?91EWKJLIF: 2YH:6Q$^#?9+/<F[07S^(-2OY0
MZ(]SLQU9SZ%;V(UB&5_4\T76",#8VS@[+4NQ_"#X5.;,;O[@@,,^7?D%LT+Q
M1Q,-6F5B#$R1X($IS2>;EA^*EG=LH5?MM,APS9U7J/G?YGG*)%-4;(HVO7_,
M67ZV8O=&?0G-]6-E5[%79-0]?HWN%''L(N/7(/)5E+MW_"*CY/@UNC/CD8OL
MOMB3?:_(T)V$-HY;6X>MQAK H79 OL(16JR#!N,Y%YI+-YOQ-&7RR9G+T&LZ
M-G_J;?&;]2G+Z%SHNP8<D/7X"TOY/$^:53>0"+=J/?X,VVO'S8G:Q.(R90N6
MCMQ43<?U,# #$]5]P&$7N:X_?@3SL9@? 0R+@RG ?*P7%N=_VD\/W8_%,&T]
M+])#?7JHC_7R(:/ZB\7Q^R3FX]]IDD11'&,9'8V\"D98WN(8?OQLF#;PP.)
MI+_+-5YMO$/V]P%6TWT=@NT4[T1LIWBN ?'G#3R2Q%]M+ YX8%7 >@?B^^-
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M2VX"  #:+P  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=I+;J-
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M462U*+):%%DMBJQK%%G7_U/67][O/SE^?M:#Z\:7?#;_'_WZ-U!+ 0(4 Q0
M   ( $1H2U0'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ 1&A+5(<UFA'N    *P(  !$
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M970R+GAM;%!+ 0(4 Q0    ( $1H2U1OX6MQ3P4   <5   8
M  " @6L2  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " !$
M:$M4 =@-^&@#  #\"@  &               @('P%P  >&PO=V]R:W-H965T
M<R]S:&5E=#0N>&UL4$L! A0#%     @ 1&A+5*S%7SKK!@  6!X  !@
M         ("!CAL  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0
M   ( $1H2U37B\(I5 (  $ %   8              " @:\B  !X;"]W;W)K
M<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !$:$M4#W8(5Z\%  !M'
M&               @($Y)0  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L!
M A0#%     @ 1&A+5$H[[-DF"   H"0  !@              ("!'BL  'AL
M+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( $1H2U1%E_$3.1P
M .]4   8              " @7HS  !X;"]W;W)K<VAE971S+W-H965T.2YX
M;6Q02P$"% ,4    " !$:$M4:.TWHC\)  !H%@  &0              @('I
M3P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( $1H2U1\
M"(K%6 @  & 4   9              " @5]9  !X;"]W;W)K<VAE971S+W-H
M965T,3$N>&UL4$L! A0#%     @ 1&A+5.]OF_QI!P  3Q,  !D
M     ("![F$  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $1H2U081E"&;0@  .H4   9              "
M@=:$  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ 1&A+
M5)%NHFUN!@  ! X  !D              ("!>HT  'AL+W=O<FMS:&5E=',O
M<VAE970Q."YX;6Q02P$"% ,4    " !$:$M4'M=FKA<*  "*&P  &0
M        @($?E   >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0
M   ( $1H2U28(\!$.PD  &47   9              " @6V>  !X;"]W;W)K
M<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ 1&A+5$TI_ =: P  P0<
M !D              ("!WZ<  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q0
M2P$"% ,4    " !$:$M4URG&,_P'   P$P  &0              @(%PJP
M>&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( $1H2U0[V'L:
ME00  /<)   9              " @:.S  !X;"]W;W)K<VAE971S+W-H965T
M,C,N>&UL4$L! A0#%     @ 1&A+5-1[^QLP'   8%H  !D
M ("!;[@  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " !$
M:$M4_["X%E<$  "P"0  &0              @('6U   >&PO=V]R:W-H965T
M<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( $1H2U3)B:8Z+@0   L*   9
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M970S,"YX;6Q02P$"% ,4    " !$:$M4EE2DR$0$  #Q"0  &0
M    @('GZP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    (
M $1H2U2=_$O$"00  &<)   9              " @6+P  !X;"]W;W)K<VAE
M971S+W-H965T,S(N>&UL4$L! A0#%     @ 1&A+5$"- FS- P  %@@  !D
M             ("!HO0  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"
M% ,4    " !$:$M41_^M<1X&  ";$   &0              @(&F^   >&PO
M=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( $1H2U0H>O:%& <
M !X4   9              " @?O^  !X;"]W;W)K<VAE971S+W-H965T,S4N
M>&UL4$L! A0#%     @ 1&A+5+WNSY,_ P  F <  !D              ("!
M2@8! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !$:$M4
M/3^%HWL%  !I#0  &0              @(' "0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,W+GAM;%!+ 0(4 Q0    ( $1H2U0?&E%>+@,  &,,   9
M      " @7(/ 0!X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%
M  @ 1&A+5/I&IT=F @  M@4  !D              ("!UQ(! 'AL+W=O<FMS
M:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " !$:$M4E)Y.*H *  !93@
M&0              @(%T%0$ >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+
M 0(4 Q0    ( $1H2U0]_2'Q3 8  ,PA   9              " @2L@ 0!X
M;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ 1&A+5%WHYL\Z
M @  .04  !D              ("!KB8! 'AL+W=O<FMS:&5E=',O<VAE970T
M,BYX;6Q02P$"% ,4    " !$:$M4Z?Y_1D("  !7!0  &0
M@($?*0$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( $1H
M2U3BG60S*P8  %LE   9              " @9@K 0!X;"]W;W)K<VAE971S
M+W-H965T-#0N>&UL4$L! A0#%     @ 1&A+5.Q5_R0R!   N@\  !D
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M=#0Y+GAM;%!+ 0(4 Q0    ( $1H2U2DX)3DM (  -8'   9
M  " @<Y+ 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @
M1&A+5$0@DC-2 P  1@L  !D              ("!N4X! 'AL+W=O<FMS:&5E
M=',O<VAE970U,2YX;6Q02P$"% ,4    " !$:$M4]H8;GSP#   0#   &0
M            @(%"4@$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4
M Q0    ( $1H2U1VMVZVN ,  . -   9              " @;55 0!X;"]W
M;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ 1&A+5$ZLU$&G!0
MCQX  !D              ("!I%D! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX
M;6Q02P$"% ,4    " !$:$M4"V4"UD4"  "O!0  &0              @(&"
M7P$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( $1H2U3(
M!ATR7P4  #P6   9              " @?YA 0!X;"]W;W)K<VAE971S+W-H
M965T-38N>&UL4$L! A0#%     @ 1&A+5$7TX\H1 P  _ D  !D
M     ("!E&<! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $1H2U3=$X3(+P0  -P/   9              "
M@3N  0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ 1&A+
M5'_(Q9J7 P  K0P  !D              ("!H80! 'AL+W=O<FMS:&5E=',O
M<VAE970V,RYX;6Q02P$"% ,4    " !$:$M4P&)+"EH#  !%#   &0
M        @(%OB $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0
M   ( $1H2U3B.#Y>:0,  '4,   9              " @0", 0!X;"]W;W)K
M<VAE971S+W-H965T-C4N>&UL4$L! A0#%     @ 1&A+5*<[1\I$!   W \
M !D              ("!H(\! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q0
M2P$"% ,4    " !$:$M4D%*4/FP#   L"@  &0              @($;E $
M>&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( $1H2U1H0K$-
M'P,  )0)   9              " @;Z7 0!X;"]W;W)K<VAE971S+W-H965T
M-C@N>&UL4$L! A0#%     @ 1&A+5*-4SCB'!@  N1L  !D
M ("!%)L! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " !$
M:$M4_759%HT#  #O"P  &0              @('2H0$ >&PO=V]R:W-H965T
M<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( $1H2U3.1R)2"@,   \)   9
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M970W-2YX;6Q02P$"% ,4    " !$:$M47N'"ORT%   6%P  &0
M    @(%QM@$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    (
M $1H2U24XGLJ50<  !@G   9              " @=6[ 0!X;"]W;W)K<VAE
M971S+W-H965T-S<N>&UL4$L! A0#%     @ 1&A+5(J4TMSF P  &Q   !D
M             ("!8<,! 'AL+W=O<FMS:&5E=',O<VAE970W."YX;6Q02P$"
M% ,4    " !$:$M47RLX.+\$  !A%@  &0              @(%^QP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( $1H2U2M!7(<<0,
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M<F5L<R\N<F5L<U!+ 0(4 Q0    ( $1H2U2DT+V?^ 4  (XU   /
M      "  1?8 0!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !$:$M4JYPQ
M2VX"  #:+P  &@              @ $\W@$ >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !$:$M41.3?6!X"  "7+@  $P
M    @ 'BX $ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     60!9 &88   Q
%XP$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>499</ContextCount>
  <ElementCount>553</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>118</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - Consolidated Statements Of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ShortName>Consolidated Statements Of Earnings</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - Consolidated Balance Sheets (Parentheticals)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals</Role>
      <ShortName>Consolidated Balance Sheets (Parentheticals)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - Consolidated Statements Of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity</Role>
      <ShortName>Consolidated Statements Of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - Consolidated Statements Of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements Of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113104 - Disclosure - Derivative Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstruments</Role>
      <ShortName>Derivative Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Acquisitions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/Acquisitions</Role>
      <ShortName>Acquisitions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2125107 - Disclosure - Contingencies and Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitments</Role>
      <ShortName>Contingencies and Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Capital Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStock</Role>
      <ShortName>Capital Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2141110 - Disclosure - Debt and Credit Facilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilities</Role>
      <ShortName>Debt and Credit Facilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2145111 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2153112 - Disclosure - Retirement Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlans</Role>
      <ShortName>Retirement Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2163113 - Disclosure - Summary of Quarterly Data (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</Role>
      <ShortName>Summary of Quarterly Data (Unaudited)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2166114 - Disclosure - Segment and Geographic Data</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicData</Role>
      <ShortName>Segment and Geographic Data</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2171115 - Disclosure - Asset Impairments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairments</Role>
      <ShortName>Asset Impairments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RevenueRecognition</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Derivative Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsTables</Role>
      <ShortName>Derivative Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2319304 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Acquisitions (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsTables</Role>
      <ShortName>Acquisitions (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/Acquisitions</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2326306 - Disclosure - Contingencies and Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsTables</Role>
      <ShortName>Contingencies and Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2331307 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Capital Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockTables</Role>
      <ShortName>Capital Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStock</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2342309 - Disclosure - Debt and Credit Facilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesTables</Role>
      <ShortName>Debt and Credit Facilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2346310 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxes</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2354311 - Disclosure - Retirement Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansTables</Role>
      <ShortName>Retirement Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlans</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2364312 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2367313 - Disclosure - Segment and Geographic Data (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataTables</Role>
      <ShortName>Segment and Geographic Data (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicData</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Significant Accounting Policies (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Significant Accounting Policies (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SignificantAccountingPoliciesPolicies</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails</Role>
      <ShortName>Revenue Recognition - Disaggregated Sales Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails</Role>
      <ShortName>Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements (Available-For-Sale Securities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Fair Value Measurements (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2415407 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails</Role>
      <ShortName>Derivative Instruments (Forward Currency Exchange Contracts) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Derivative Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails</Role>
      <ShortName>Derivative Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails</Role>
      <ShortName>Derivative Instruments (Movements out of OCI) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DerivativeInstrumentsTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails</Role>
      <ShortName>Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Acquisitions (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsNarrativeDetails</Role>
      <ShortName>Acquisitions (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails</Role>
      <ShortName>Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AcquisitionsTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427413 - Disclosure - Contingencies and Commitments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails</Role>
      <ShortName>Contingencies and Commitments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Commitments and Contingencies - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails</Role>
      <ShortName>Commitments and Contingencies - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2429415 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails</Role>
      <ShortName>Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/ContingenciesandCommitmentsTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Capital Stock (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockNarrativeDetails</Role>
      <ShortName>Capital Stock (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails</Role>
      <ShortName>Capital Stock (Option Grant Assumptions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails</Role>
      <ShortName>Capital Stock (Summary of Stock Option Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails</Role>
      <ShortName>Capital Stock (Summary of RSU and PSU Activity) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/CapitalStockTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - Debt and Credit Facilities (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails</Role>
      <ShortName>Debt and Credit Facilities (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails</Role>
      <ShortName>Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/DebtandCreditFacilitiesTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2447425 - Disclosure - Income Taxes (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2448426 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails</Role>
      <ShortName>Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Earnings before Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2450428 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Schedule of Provision for Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>66</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2452430 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails</Role>
      <ShortName>Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/IncomeTaxesTables</ParentRole>
      <Position>67</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails</Role>
      <ShortName>Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2457433 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Change in Benefit Obligations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>70</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2458434 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Change in Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2459435 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails</Role>
      <ShortName>Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2460436 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails</Role>
      <ShortName>Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2461437 - Disclosure - Retirement Plans (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansNarrativeDetails</Role>
      <ShortName>Retirement Plans (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2462438 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails</Role>
      <ShortName>Retirement Plans (Expected Benefit Payments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/RetirementPlansTables</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2465439 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails</Role>
      <ShortName>Summary of Quarterly Data (Unaudited) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2468440 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails</Role>
      <ShortName>Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2469441 - Disclosure - Segment and Geographic Data (Segment Information) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails</Role>
      <ShortName>Segment and Geographic Data (Segment Information) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>78</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2470442 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails</Role>
      <ShortName>Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/SegmentandGeographicDataTables</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - Asset Impairments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/AssetImpairmentsDetails</Role>
      <ShortName>Asset Impairments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.stryker.com/role/AssetImpairments</ParentRole>
      <Position>80</Position>
    </Report>
    <Report instance="syk-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2474444 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails</Role>
      <ShortName>Schedule II Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="syk-20211231.htm">syk-20211231.htm</File>
    <File>ex10i2022nqstockoptionawar.htm</File>
    <File>ex10ii2022rsustockoptionaw.htm</File>
    <File>ex10iii2022psustockoptiona.htm</File>
    <File>ex21i1231202110k.htm</File>
    <File>ex23i1231202110k.htm</File>
    <File>ex31i1231202110k.htm</File>
    <File>ex31ii1231202110k.htm</File>
    <File>ex32i1231202110k.htm</File>
    <File>ex32ii1231202110k.htm</File>
    <File>ex4xx1231202110k.htm</File>
    <File>syk-20211231.xsd</File>
    <File>syk-20211231_cal.xml</File>
    <File>syk-20211231_def.xml</File>
    <File>syk-20211231_lab.xml</File>
    <File>syk-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>syk-20211231_g1.jpg</File>
    <File>syk-20211231_g2.jpg</File>
    <File>syk-20211231_g3.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="1460">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="56">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>114
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "syk-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 29,
   "contextCount": 499,
   "dts": {
    "calculationLink": {
     "local": [
      "syk-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "syk-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "syk-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "syk-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "syk-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "syk-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 738,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 9,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 13
   },
   "keyCustom": 31,
   "keyStandard": 522,
   "memberCustom": 48,
   "memberStandard": 64,
   "nsprefix": "syk",
   "nsuri": "http://www.stryker.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - COVER PAGE",
     "role": "http://www.stryker.com/role/COVERPAGE",
     "shortName": "COVER PAGE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Revenue Recognition",
     "role": "http://www.stryker.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Fair Value Measurements",
     "role": "http://www.stryker.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113104 - Disclosure - Derivative Instruments",
     "role": "http://www.stryker.com/role/DerivativeInstruments",
     "shortName": "Derivative Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Acquisitions",
     "role": "http://www.stryker.com/role/Acquisitions",
     "shortName": "Acquisitions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125107 - Disclosure - Contingencies and Commitments",
     "role": "http://www.stryker.com/role/ContingenciesandCommitments",
     "shortName": "Contingencies and Commitments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Capital Stock",
     "role": "http://www.stryker.com/role/CapitalStock",
     "shortName": "Capital Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141110 - Disclosure - Debt and Credit Facilities",
     "role": "http://www.stryker.com/role/DebtandCreditFacilities",
     "shortName": "Debt and Credit Facilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145111 - Disclosure - Income Taxes",
     "role": "http://www.stryker.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.stryker.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153112 - Disclosure - Retirement Plans",
     "role": "http://www.stryker.com/role/RetirementPlans",
     "shortName": "Retirement Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2163113 - Disclosure - Summary of Quarterly Data (Unaudited)",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited",
     "shortName": "Summary of Quarterly Data (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:QuarterlyFinancialInformationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166114 - Disclosure - Segment and Geographic Data",
     "role": "http://www.stryker.com/role/SegmentandGeographicData",
     "shortName": "Segment and Geographic Data",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171115 - Disclosure - Asset Impairments",
     "role": "http://www.stryker.com/role/AssetImpairments",
     "shortName": "Asset Impairments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Significant Accounting Policies (Policies)",
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.stryker.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.stryker.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Derivative Instruments (Tables)",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsTables",
     "shortName": "Derivative Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319304 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Acquisitions (Tables)",
     "role": "http://www.stryker.com/role/AcquisitionsTables",
     "shortName": "Acquisitions (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - Consolidated Statements Of Earnings",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
     "shortName": "Consolidated Statements Of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2326306 - Disclosure - Contingencies and Commitments (Tables)",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsTables",
     "shortName": "Contingencies and Commitments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331307 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Capital Stock (Tables)",
     "role": "http://www.stryker.com/role/CapitalStockTables",
     "shortName": "Capital Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342309 - Disclosure - Debt and Credit Facilities (Tables)",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesTables",
     "shortName": "Debt and Credit Facilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346310 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.stryker.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354311 - Disclosure - Retirement Plans (Tables)",
     "role": "http://www.stryker.com/role/RetirementPlansTables",
     "shortName": "Retirement Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2364312 - Disclosure - Summary of Quarterly Data (Unaudited) (Tables)",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables",
     "shortName": "Summary of Quarterly Data (Unaudited) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2367313 - Disclosure - Segment and Geographic Data (Tables)",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataTables",
     "shortName": "Segment and Geographic Data (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Significant Accounting Policies (Narrative) (Details)",
     "role": "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Significant Accounting Policies (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i10766b7f2b7d443b94885720263c6dbe_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Revenue Recognition - Narrative (Details)",
     "role": "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "syk:PercentageofServiceRevenueRecognizeoverTime",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "role": "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
     "shortName": "Revenue Recognition - Disaggregated Sales Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ie3f940887fab4704bda5bc6c6fea7411_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "role": "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
     "shortName": "Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "role": "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails",
     "shortName": "Fair Value Measurements (Available-For-Sale Securities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Fair Value Measurements (Narrative) (Details)",
     "role": "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i75d60a29285a47bd9dbc5f7c302733eb_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415407 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
     "shortName": "Derivative Instruments (Forward Currency Exchange Contracts) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i739495c8a21944818cd6d7313f240f1a_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i75d60a29285a47bd9dbc5f7c302733eb_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Derivative Instruments (Narrative) (Details)",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
     "shortName": "Derivative Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ib06a055c0fae428c8432833a0e6bf453_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i739495c8a21944818cd6d7313f240f1a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Derivative Instruments (Movements out of OCI) (Details)",
     "role": "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
     "shortName": "Derivative Instruments (Movements out of OCI) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i739495c8a21944818cd6d7313f240f1a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
     "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Schedule of Amounts Recognized in Other Comprehensive Income (Loss)) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Acquisitions (Narrative) (Details)",
     "role": "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
     "shortName": "Acquisitions (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "role": "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
     "shortName": "Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i7e620065e6e24e2a8d665f88e64e892d_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427413 - Disclosure - Contingencies and Commitments (Narrative) (Details)",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
     "shortName": "Contingencies and Commitments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyLossInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Commitments and Contingencies - Lease Cost (Details)",
     "role": "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails",
     "shortName": "Commitments and Contingencies - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429415 - Disclosure - Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "role": "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails",
     "shortName": "Contingencies and Commitments (Future Purchase Obligations and Minimum Lease Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details)",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Changes in Net Carrying Amount of Goodwill by Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Summary of the Company's Other Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:GoodwillImpairmentLoss",
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillImpairmentLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "role": "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets (Estimated Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Capital Stock (Narrative) (Details)",
     "role": "http://www.stryker.com/role/CapitalStockNarrativeDetails",
     "shortName": "Capital Stock (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "syk:CommonAndPreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Capital Stock (Option Grant Assumptions) (Details)",
     "role": "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails",
     "shortName": "Capital Stock (Option Grant Assumptions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Capital Stock (Summary of Stock Option Activity) (Details)",
     "role": "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails",
     "shortName": "Capital Stock (Summary of Stock Option Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i1dde6a23c87c43a39fd81af819d0e532_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "role": "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
     "shortName": "Capital Stock (Summary of RSU and PSU Activity) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i83182c78d60e4d87bbbdb52956d3aa4f_D20210101-20211231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - Consolidated Balance Sheets (Parentheticals)",
     "role": "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals",
     "shortName": "Consolidated Balance Sheets (Parentheticals)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - Debt and Credit Facilities (Narrative) (Details)",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails",
     "shortName": "Debt and Credit Facilities (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommercialPaper",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "role": "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
     "shortName": "Debt and Credit Facilities (Maturities Of Long-Term Debt Disclosures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447425 - Disclosure - Income Taxes (Narrative) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails",
     "shortName": "Income Taxes (Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Earnings before Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450428 - Disclosure - Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
     "shortName": "Income Taxes (Schedule of Provision for Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes (Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsInventory",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452430 - Disclosure - Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "role": "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails",
     "shortName": "Income Taxes (Schedule of Unresolved Income Tax Positions) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:SummaryOfIncomeTaxContingenciesTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id69388e86ae64de6bf4faca02b97d13f_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails",
     "shortName": "Retirement Plans (Schedule of Defined Contribution Plan Disclosures) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
     "shortName": "Retirement Plans (Schedule of Funded Status and Components of the Amounts Recognized in the Consolidated Balance Sheets and in Accumulated Other Comprehensive Gain (Loss), Before the Effect of Income Taxes) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCostsOfRetirementPlansTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i71b5c77df023413fa94d61740f8d881c_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - Consolidated Statements Of Shareholders' Equity",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
     "shortName": "Consolidated Statements Of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i71b5c77df023413fa94d61740f8d881c_I20181231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanBenefitObligation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457433 - Disclosure - Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
     "shortName": "Retirement Plans (Schedule of Change in Benefit Obligations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i5100993b55004a07983c6ce4012e89e1_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458434 - Disclosure - Retirement Plans (Change in Plan Assets) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
     "shortName": "Retirement Plans (Change in Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id69388e86ae64de6bf4faca02b97d13f_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459435 - Disclosure - Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
     "shortName": "Retirement Plans (Schedule of Target and Actual Allocation of Plan Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAllocationOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460436 - Disclosure - Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails",
     "shortName": "Retirement Plans (Schedule of Valuation of the Company's Pension Plan Assets by Pricing Categories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i0ab379c875cb4b7f9423c749112e591b_I20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanFairValueOfPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461437 - Disclosure - Retirement Plans (Narrative) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
     "shortName": "Retirement Plans (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ifb7da484c33648edb0555d2dfc7a197e_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanActualReturnOnPlanAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462438 - Disclosure - Retirement Plans (Expected Benefit Payments) (Details)",
     "role": "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails",
     "shortName": "Retirement Plans (Expected Benefit Payments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfExpectedBenefitPaymentsTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465439 - Disclosure - Summary of Quarterly Data (Unaudited) (Details)",
     "role": "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails",
     "shortName": "Summary of Quarterly Data (Unaudited) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GrossProfit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468440 - Disclosure - Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
     "shortName": "Segment and Geographic Data (Sales And Other Financial Information By Business Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic69cd9d39a21490cbfb14c8af977c010_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469441 - Disclosure - Segment and Geographic Data (Segment Information) (Details)",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails",
     "shortName": "Segment and Geographic Data (Segment Information) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id69388e86ae64de6bf4faca02b97d13f_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "id93a4eec14374c32a4c50c58e90c66cc_D20211001-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470442 - Disclosure - Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "role": "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
     "shortName": "Segment and Geographic Data (Geographic Information on Net Sales and Long-Lived Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i7510c322dcd240709c6c6e3c9f02d28a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - Consolidated Statements Of Cash Flows",
     "role": "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements Of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - Asset Impairments (Details)",
     "role": "http://www.stryker.com/role/AssetImpairmentsDetails",
     "shortName": "Asset Impairments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i0df0e910952f41b38ad92de86d9e751c_D20210701-20210930",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "i55b99ad9aa574362a2b36a60d0085869_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474444 - Disclosure - Schedule II Valuation and Qualifying Accounts (Details)",
     "role": "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails",
     "shortName": "Schedule II Valuation and Qualifying Accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ied06158ff7d045f39f524189c541c016_I20181231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Significant Accounting Policies",
     "role": "http://www.stryker.com/role/SignificantAccountingPolicies",
     "shortName": "Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "syk-20211231.htm",
      "contextRef": "ic452bf72c3c1456a8bf0735b035bab5a_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 118,
   "tag": {
    "country_CN": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "CHINA"
       }
      }
     },
     "localname": "CN",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r784"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r778"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r787"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r777"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r810"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r781",
      "r782",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r780"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security",
        "terseLabel": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r779"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region of Asia Pacific.",
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r143",
      "r202",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r222",
      "r226",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r325",
      "r327",
      "r328",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r143",
      "r202",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r222",
      "r226",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r322",
      "r323",
      "r325",
      "r327",
      "r328",
      "r799",
      "r800",
      "r801",
      "r802",
      "r803",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.",
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": {
     "auth_ref": [
      "r786"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.",
        "label": "Contractual Obligation, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Future Purchase Obligations and Minimum Lease Payments"
       }
      }
     },
     "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r333",
      "r369",
      "r485",
      "r487",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r732",
      "r735",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upper limit of the provided range.",
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r333",
      "r369",
      "r485",
      "r487",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r732",
      "r735",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lower limit of the provided range.",
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r229",
      "r402",
      "r405",
      "r689",
      "r731",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by product and service, or group of similar products and similar services.",
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r229",
      "r402",
      "r405",
      "r689",
      "r731",
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product or service, or a group of similar products or similar services.",
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r333",
      "r369",
      "r434",
      "r485",
      "r487",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r732",
      "r735",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Range [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r333",
      "r369",
      "r434",
      "r485",
      "r487",
      "r679",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r686",
      "r732",
      "r735",
      "r773",
      "r774"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.",
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Range [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r230",
      "r231",
      "r402",
      "r406",
      "r734",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r788",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographical area.",
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r230",
      "r231",
      "r402",
      "r406",
      "r734",
      "r759",
      "r764",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r788",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by geographical components.",
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149",
      "r798"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]"
       }
      }
     },
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "syk_A1625ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.625% Convertible Notes",
        "label": "1.625% Convertible Notes [Member]",
        "terseLabel": "1.625% Convertible Notes"
       }
      }
     },
     "localname": "A1625ConvertibleNotesMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_A225ConvertibleNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.25% Convertible Notes",
        "label": "2.25% Convertible Notes [Member]",
        "terseLabel": "2.25% Convertible Notes"
       }
      }
     },
     "localname": "A225ConvertibleNotesMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_AuditorInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Auditor Information",
        "label": "Auditor Information [Abstract]"
       }
      }
     },
     "localname": "AuditorInformationAbstract",
     "nsuri": "http://www.stryker.com/20211231",
     "xbrltype": "stringItemType"
    },
    "syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.",
        "label": "Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value",
        "verboseLabel": "Due after one year through three years"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationConsiderationTransferredIncludingConvertibleNotes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Including Convertible Notes",
        "label": "Business Combination, Consideration Transferred, Including Convertible Notes",
        "terseLabel": "Purchase price of acquisitions, including convertible notes"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredIncludingConvertibleNotes",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationConsiderationTransferredPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Price Per Share",
        "label": "Business Combination, Consideration Transferred, Price Per Share",
        "terseLabel": "Consideration transferred, price per share (in dollars per share)"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPricePerShare",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "syk_BusinessCombinationContingentConsiderationFutureMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Future Milestone Payments",
        "label": "Business Combination, Contingent Consideration, Future Milestone Payments",
        "terseLabel": "Future regulatory and commercial milestones"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationFutureMilestonePayments",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDebt",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Product Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Product Liabilities",
        "negatedTerseLabel": "Product liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedProductLiabilities",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CapitalExpendituresDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Expenditures During Period",
        "label": "Capital Expenditures During Period",
        "terseLabel": "Capital Expenditures During Period"
       }
      }
     },
     "localname": "CapitalExpendituresDuringPeriod",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CapitalStockAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Stock [Abstract]",
        "label": "Capital Stock [Abstract]",
        "terseLabel": "Capital Stock [Abstract]"
       }
      }
     },
     "localname": "CapitalStockAbstract",
     "nsuri": "http://www.stryker.com/20211231",
     "xbrltype": "stringItemType"
    },
    "syk_Changeinaccrualforrecallexpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in accrual for recall expenses",
        "label": "Change in accrual for recall expenses",
        "terseLabel": "Recall-related payments"
       }
      }
     },
     "localname": "Changeinaccrualforrecallexpenses",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_CommonAndPreferredStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common And Preferred Stock, Shares Authorized",
        "label": "Common And Preferred Stock, Shares Authorized",
        "terseLabel": "Common and Preferred Stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonAndPreferredStockSharesAuthorized",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "syk_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement [Member]",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_CustomerAndDistributorRelationshipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer and Distributor Relationships",
        "label": "Customer and Distributor Relationships [Member]",
        "terseLabel": "Customer and distributor relationships"
       }
      }
     },
     "localname": "CustomerAndDistributorRelationshipsMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_DebtInstrumentCovenantLeverageRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio",
        "label": "Debt Instrument, Covenant, Leverage Ratio",
        "terseLabel": "Leverage ratio"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatio",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "syk_DeferredTaxAssetsDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Depreciation And Amortization",
        "label": "Deferred Tax Assets, Depreciation And Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsDepreciationAndAmortization",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities Depreciation And Amortization",
        "label": "Deferred Tax Liabilities Depreciation And Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DefinedContributionRetirementPlansCommonStockHeldByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Retirement Plans Common Stock Held by Company",
        "label": "Defined Contribution Retirement Plans Common Stock Held by Company",
        "terseLabel": "Stryker common stock held by plan, shares"
       }
      }
     },
     "localname": "DefinedContributionRetirementPlansCommonStockHeldByCompany",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "syk_DefinedContributionRetirementPlansCommonStockValueHeldByCompany": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Retirement Plans Common Stock Value Held by Company",
        "label": "Defined Contribution Retirement Plans Common Stock Value Held by Company",
        "terseLabel": "Stryker common stock held by plan, amount"
       }
      }
     },
     "localname": "DefinedContributionRetirementPlansCommonStockValueHeldByCompany",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_DerivativeNotionalAmount1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative, Notional Amount1",
        "label": "Derivative, Notional Amount1",
        "terseLabel": "Notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount1",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Earnings Repatriation, Percent",
        "negatedTerseLabel": "Tax related to repatriation of foreign earnings"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignEarningsRepatriationPercent",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transfer Of Intellectual Property, Percent",
        "negatedTerseLabel": "Intellectual property transfer"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransferOfIntellectualPropertyPercent",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_EndoscopyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Endoscopy [Member]",
        "label": "Endoscopy [Member]",
        "terseLabel": "Endoscopy"
       }
      }
     },
     "localname": "EndoscopyMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities",
        "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities",
        "verboseLabel": "Deferred compensation arrangements"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_GaussMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gauss",
        "label": "Gauss [Member]",
        "terseLabel": "Gauss"
       }
      }
     },
     "localname": "GaussMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_GlobalERPSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Global ERP System",
        "label": "Global ERP System [Member]",
        "terseLabel": "Global ERP System"
       }
      }
     },
     "localname": "GlobalERPSystemMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]",
        "label": "Goodwill and Long-Lived Assets Impairment Tests Policy [Policy Text Block]",
        "terseLabel": "Goodwill, Intangibles and Long-Lived Asset Impairment Tests"
       }
      }
     },
     "localname": "GoodwillAndLongLivedAssetsImpairmentTestsPolicyPolicyTextBlock",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "syk_HipsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hips [Member]",
        "label": "Hips [Member]",
        "terseLabel": "Hips"
       }
      }
     },
     "localname": "HipsMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment",
        "label": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment [Member]",
        "terseLabel": "In-Process R&amp;D, Other Intangible Assets and Property, Plant and Equipment"
       }
      }
     },
     "localname": "InProcessRDOtherIntangibleAssetsAndPropertyPlantAndEquipmentMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized",
        "label": "Income tax expense (benefit), Portion of Net Operating Loss Carryforward Recognized",
        "terseLabel": "Net operating loss carryforward recognized"
       }
      }
     },
     "localname": "IncometaxexpensebenefitPortionofNetOperatingLossCarryforwardRecognized",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_InstrumentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instruments [Member]",
        "label": "Instruments [Member]",
        "terseLabel": "Instruments"
       }
      }
     },
     "localname": "InstrumentsMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_KneesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Knees [Member]",
        "label": "Knees [Member]",
        "terseLabel": "Knees"
       }
      }
     },
     "localname": "KneesMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_LandBuildingsAndImprovementsGross": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Land, Buildings and Improvements, Gross",
        "label": "Land, Buildings and Improvements, Gross",
        "terseLabel": "Land, buildings and improvements"
       }
      }
     },
     "localname": "LandBuildingsAndImprovementsGross",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_LongLivedAssetsAndIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Lived Assets and Intangible Assets",
        "label": "Long-Lived Assets and Intangible Assets [Member]",
        "terseLabel": "Long-Lived Assets and Intangible Assets"
       }
      }
     },
     "localname": "LongLivedAssetsAndIntangibleAssetsMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_MedSurgAndNeurotechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedSurg and Neurotechnology",
        "label": "MedSurg and Neurotechnology [Member]",
        "terseLabel": "MedSurg and Neurotechnology"
       }
      }
     },
     "localname": "MedSurgAndNeurotechnologyMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_MedicalDeviceRegulationsExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Device Regulations Expense",
        "label": "Medical Device Regulations Expense",
        "negatedTerseLabel": "Medical device regulations"
       }
      }
     },
     "localname": "MedicalDeviceRegulationsExpense",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_MedicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical [Member]",
        "label": "Medical [Member]",
        "terseLabel": "Medical"
       }
      }
     },
     "localname": "MedicalMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_NeuroCranialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neuro Cranial",
        "label": "Neuro Cranial [Member]",
        "terseLabel": "Neuro Cranial"
       }
      }
     },
     "localname": "NeuroCranialMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_NeurovascularMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Neurovascular",
        "label": "Neurovascular [Member]",
        "terseLabel": "Neurovascular"
       }
      }
     },
     "localname": "NeurovascularMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OperatingLossCarryforwardsSubjectToValuationAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject to Valuation Allowance",
        "label": "Operating Loss Carryforwards, Subject to Valuation Allowance",
        "terseLabel": "Operating loss carryforwards, subject to full valuation allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToValuationAllowance",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_OrthopaedicsAndSpineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Orthopaedics and Spine",
        "label": "Orthopaedics and Spine [Member]",
        "terseLabel": "Orthopaedics and Spine"
       }
      }
     },
     "localname": "OrthopaedicsAndSpineMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherForeignCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other foreign countries [Member]",
        "label": "Other foreign countries [Member]",
        "terseLabel": "Other foreign countries"
       }
      }
     },
     "localname": "OtherForeignCountriesMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherIncomeexpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Income (expense) [Member]",
        "label": "Other Income (expense) [Member]",
        "terseLabel": "Other income (expense), net",
        "verboseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherIncomeexpenseMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_OtherOrthopaedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Orthopaedics",
        "label": "Other Orthopaedics [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOrthopaedicsMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP",
        "label": "Percentage of Closing Stock Price Represents Purchase Price Under ESPP",
        "terseLabel": "Percentage of closing stock price under ESPP"
       }
      }
     },
     "localname": "PercentageOfClosingStockPriceRepresentsPurchasePriceUnderEspp",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_PercentageofServiceRevenueRecognizeoverTime": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Service Revenue Recognize over Time",
        "label": "Percentage of Service Revenue Recognize over Time",
        "terseLabel": "Percentage of sales recognized as services over time (less than)"
       }
      }
     },
     "localname": "PercentageofServiceRevenueRecognizeoverTime",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_PerformanceStockUnitPsusMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance Stock Unit (PSUs) [Member]",
        "label": "Performance Stock Unit (PSUs) [Member]",
        "terseLabel": "Performance Stock Units (PSUs)",
        "verboseLabel": "Performance Stock Units (PSUs)"
       }
      }
     },
     "localname": "PerformanceStockUnitPsusMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "label": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]",
        "terseLabel": "Reclassification Adjustments Out of Accumulated Other Comprehensive Income (AOCI) [Abstract]"
       }
      }
     },
     "localname": "ReclassificationAdjustmentsOutofAccumulatedOtherComprehensiveIncomeAOCIAbstract",
     "nsuri": "http://www.stryker.com/20211231",
     "xbrltype": "stringItemType"
    },
    "syk_RejuvenateABGIIHipRecallCharges": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rejuvenate / ABG II Hip Recall Charges",
        "label": "Rejuvenate / ABG II Hip Recall Charges",
        "negatedLabel": "Recall-related matters"
       }
      }
     },
     "localname": "RejuvenateABGIIHipRecallCharges",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SaleOfInventorySteppedUpToFairValueAtAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition",
        "label": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition",
        "terseLabel": "Sale of inventory stepped up to fair value at acquisition"
       }
      }
     },
     "localname": "SaleOfInventorySteppedUpToFairValueAtAcquisition",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SeniorUnsecuredNotes0.250due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.250% due 2024 [Member]",
        "label": "Senior Unsecured Notes 0.250% due 2024 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.250% due 2024",
        "verboseLabel": "0.250% Notes due 2024"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0.250due2024Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes0.750due2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.750% due 2029 [Member]",
        "label": "Senior Unsecured Notes 0.750% due 2029 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.750% due 2029",
        "verboseLabel": "0.750% Notes due 2029"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0.750due2029Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes0600Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 0.600% due 2023",
        "label": "Senior Unsecured Notes 0.600% due 2023 [Member]",
        "terseLabel": "Senior Unsecured Notes 0.600% due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes0600Due2023Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.000due2031Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 1.000% due 2031 [Member]",
        "label": "Senior Unsecured Notes 1.000% due 2031 [Member]",
        "terseLabel": "Senior Unsecured Notes 1.000% due 2031",
        "verboseLabel": "1.000% Notes due 2031"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.000due2031Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.125Due2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.125% Due 2021 [Member]",
        "label": "Senior Unsecured Notes, 1.125% Due 2021 [Member]",
        "terseLabel": "Senior Unsecured Notes, 1.125% Due 2021"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.125Due2021Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.125Due2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.125% Due 2023 [Member]",
        "label": "Senior Unsecured Notes, 1.125% Due 2023 [Member]",
        "terseLabel": "1.125% Notes due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.125Due2023Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.150Due2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.150% Due 2025 [Member]",
        "label": "Senior Unsecured Notes, 1.150% Due 2025 [Member]",
        "terseLabel": "Senior Unsecured Notes, 1.150% Due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.150Due2025Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes1.950Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 1.950% Due 2030 [Member]",
        "label": "Senior Unsecured Notes, 1.950% Due 2030 [Member]",
        "terseLabel": "Senior Unsecured Notes, 1.950% Due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes1.950Due2030Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.125Due2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.125% Due 2027 [Member]",
        "label": "Senior Unsecured Notes, 2.125% Due 2027 [Member]",
        "terseLabel": "2.125% Notes due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.125Due2027Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.625Due2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.625% Due 2030",
        "label": "Senior Unsecured Notes, 2.625% Due 2030 [Member]",
        "terseLabel": "2.625% Notes due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.625Due2030Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2.900due2050Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, 2.900% due 2050 [Member]",
        "label": "Senior Unsecured Notes, 2.900% due 2050 [Member]",
        "terseLabel": "Senior Unsecured Notes, 2.900% due 2050"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2.900due2050Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes2625Due2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 2.625% due 2021",
        "label": "Senior Unsecured Notes 2.625% due 2021 [Member]",
        "terseLabel": "Senior Unsecured Notes 2.625% due 2021"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes2625Due2021Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3.375due2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.375% due 2024 [Member]",
        "label": "Senior Unsecured Notes 3.375% due 2024 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.375% due 2024"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3.375due2024Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3.375due2025MemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.375% due 2025 [Member]",
        "label": "Senior Unsecured Notes 3.375% due 2025 [Member] [Member]",
        "terseLabel": "Senior Unsecured Notes 3.375% due 2025"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3.375due2025MemberMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes350Due2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.50% due 2026",
        "label": "Senior Unsecured Notes 3.50% due 2026 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.50% due 2026"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes350Due2026Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes3650Due2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 3.650% due 2028 [Domain]",
        "label": "Senior Unsecured Notes 3.650% due 2028 [Member]",
        "terseLabel": "Senior Unsecured Notes 3.650% due 2028"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes3650Due2028Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes4.375due2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.375% due 2044 [Member]",
        "label": "Senior Unsecured Notes 4.375% due 2044 [Member]",
        "terseLabel": "Senior Unsecured Notes 4.375% due 2044"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes4.375due2044Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes410Due2043Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.10% due 2043 [Member]",
        "label": "Senior Unsecured Notes 4.10% due 2043 [Member]",
        "verboseLabel": "Senior Unsecured Notes 4.10% due 2043"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes410Due2043Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotes4625Due2046Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes 4.625% due 2046",
        "label": "Senior Unsecured Notes 4.625% due 2046 [Member]",
        "terseLabel": "Senior Unsecured Notes 4.625% due 2046"
       }
      }
     },
     "localname": "SeniorUnsecuredNotes4625Due2046Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2023 [Member]",
        "label": "Senior Unsecured Notes, Due November 2023 [Member]",
        "verboseLabel": "Senior Unsecured Notes, 1.125%, due 2023"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2023Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2027 [Member]",
        "label": "Senior Unsecured Notes, Due November 2027 [Member]",
        "verboseLabel": "Senior Unsecured Notes,2.125%, due 2027"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2027Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_SeniorUnsecuredNotesDueNovember2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Unsecured Notes, Due November 2030 [Member]",
        "label": "Senior Unsecured Notes, Due November 2030 [Member]",
        "verboseLabel": "Senior Unsecured Notes, 2.625% due 2030"
       }
      }
     },
     "localname": "SeniorUnsecuredNotesDueNovember2030Member",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value",
        "terseLabel": "Shares vested during the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValue",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "syk_SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Performance Period",
        "terseLabel": "Performance period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardPerformancePeriod",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "syk_SignificantAccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Abstract]",
        "label": "Significant Accounting Policies [Abstract]",
        "terseLabel": "Significant Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesAbstract",
     "nsuri": "http://www.stryker.com/20211231",
     "xbrltype": "stringItemType"
    },
    "syk_SpineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spine [Member]",
        "label": "Spine [Member]",
        "terseLabel": "Spine"
       }
      }
     },
     "localname": "SpineMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company",
        "label": "Total Percentage of Defined Contribution Retirement Plan Assets Value Held by Company",
        "terseLabel": "Stryker common stock held by plan, value as a percentage of total plan assets"
       }
      }
     },
     "localname": "TotalPercentageOfDefinedContributionRetirementPlanAssetsValueHeldByCompany",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_TraumaandExtremitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trauma and Extremities [Member]",
        "label": "Trauma and Extremities [Member]",
        "terseLabel": "Trauma and Extremities"
       }
      }
     },
     "localname": "TraumaandExtremitiesMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_VoceraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vocera",
        "label": "Vocera [Member]",
        "terseLabel": "Vocera"
       }
      }
     },
     "localname": "VoceraMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "syk_WeightedAverageUsedInDeterminationOfProjectedBenefitObligations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Used in the Determination of the Projected Benefit Obligations",
        "label": "Weighted Average Used in the Determination of the Projected Benefit Obligations",
        "terseLabel": "Weighted-average discount rate used to determine projected benefit obligations"
       }
      }
     },
     "localname": "WeightedAverageUsedInDeterminationOfProjectedBenefitObligations",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "syk_WrightMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wright [Member]",
        "label": "Wright [Member]",
        "terseLabel": "Wright"
       }
      }
     },
     "localname": "WrightMember",
     "nsuri": "http://www.stryker.com/20211231",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "AOCIAttributableToParentNetOfTaxRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r14",
      "r45"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r6",
      "r30",
      "r235",
      "r236"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less allowance of $167 ($131 in 2020)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r22",
      "r698",
      "r719"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r24",
      "r698",
      "r719"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r72",
      "r79",
      "r89",
      "r90",
      "r91",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember": {
     "auth_ref": [
      "r74",
      "r79",
      "r89",
      "r90",
      "r91",
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to prior service cost (credit) component of defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Prior Service Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r43",
      "r289"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "terseLabel": "Less allowance for depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r79",
      "r89",
      "r90",
      "r91",
      "r92",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Hedges"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r68",
      "r69",
      "r70",
      "r79",
      "r89",
      "r90",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r33",
      "r76",
      "r78",
      "r79",
      "r721",
      "r740",
      "r741"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), End of Period",
        "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Beginning of Period",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r89",
      "r90",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r75",
      "r79",
      "r89",
      "r90",
      "r91",
      "r152",
      "r153",
      "r154",
      "r598",
      "r736",
      "r737",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r67",
      "r79",
      "r89",
      "r90",
      "r91",
      "r598",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Financial Statement Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average life of intangible assets",
        "verboseLabel": "Weighted Average Amortization Period (Years)"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r522",
      "r523",
      "r524",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r282"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r489",
      "r491",
      "r527",
      "r528"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r35",
      "r238",
      "r254"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForNotesReceivableMember": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Allowance for portion expected to be uncollectible of receivable from written agreement to receive, at specified future date, money consisting of principal and accrued interest.",
        "label": "SEC Schedule, 12-09, Allowance, Notes Receivable [Member]",
        "terseLabel": "SEC Schedule, 12-09, Allowance, Notes Receivable"
       }
      }
     },
     "localname": "AllowanceForNotesReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r274",
      "r282"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "negatedTerseLabel": "Amortization of intangible assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Capital Stock [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r248",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "verboseLabel": "Corporate and asset-backed debt securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r121",
      "r286"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairments"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.",
        "label": "Asset Impairment Charges [Text Block]",
        "terseLabel": "Asset Impairments"
       }
      }
     },
     "localname": "AssetImpairmentChargesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r136",
      "r210",
      "r217",
      "r224",
      "r252",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r594",
      "r599",
      "r643",
      "r672",
      "r674",
      "r695",
      "r718"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r60",
      "r136",
      "r252",
      "r315",
      "r316",
      "r317",
      "r319",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r594",
      "r599",
      "r643",
      "r672",
      "r674"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total assets measured at fair value"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r246",
      "r247",
      "r709"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsAvailableForSaleSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r245",
      "r255"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Available-for-sale marketable securities:",
        "verboseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-sale Securities [Member]",
        "verboseLabel": "Available-for-sale marketable securities:"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r493",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r609",
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Building and Building Improvements [Member]",
        "terseLabel": "Building and Improvements"
       }
      }
     },
     "localname": "BuildingAndBuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r484",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r484",
      "r486",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r586",
      "r587",
      "r588"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Aggregate purchase price of acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]",
        "terseLabel": "Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/Acquisitions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationIntegrationRelatedCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.",
        "label": "Business Combination, Integration Related Costs",
        "negatedTerseLabel": "Acquisition and integration-related charges"
       }
      }
     },
     "localname": "BusinessCombinationIntegrationRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income tax liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r581",
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r582"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase price, net of cash acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r40",
      "r123"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "verboseLabel": "Available-for-sale marketable securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r117",
      "r123",
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of year",
        "periodStartLabel": "Cash and cash equivalents at beginning of year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r117",
      "r649"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r627"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Cash flow hedge gain (loss) to be reclassified within twelve months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r133",
      "r136",
      "r167",
      "r168",
      "r169",
      "r171",
      "r173",
      "r182",
      "r183",
      "r184",
      "r252",
      "r315",
      "r320",
      "r321",
      "r322",
      "r328",
      "r329",
      "r367",
      "r368",
      "r372",
      "r376",
      "r643",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialPaper": {
     "auth_ref": [
      "r20",
      "r696",
      "r720"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.",
        "label": "Commercial Paper",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r297",
      "r298",
      "r300",
      "r310",
      "r761"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Contingencies and Commitments"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "verboseLabel": "Dividends declared per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r152",
      "r153",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock",
        "verboseLabel": "Common Stock, $.10 Par Value"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedBalanceSheetsParentheticals"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r29",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance, shares",
        "periodStartLabel": "Beginning balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "verboseLabel": "Common stock, $0.10 par value"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred income tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred income tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r84",
      "r86",
      "r87",
      "r97",
      "r705",
      "r727"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r96",
      "r106",
      "r704",
      "r726"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income (AOCI)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCI"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r233",
      "r641",
      "r642",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r233",
      "r641",
      "r642",
      "r743",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r233",
      "r641",
      "r642",
      "r743",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r191",
      "r192",
      "r233",
      "r641",
      "r642"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r233",
      "r641",
      "r642",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r128",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r392",
      "r393",
      "r403"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liabilities"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r435",
      "r478",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r226",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r101",
      "r136",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r643"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of Sales",
        "verboseLabel": "Cost of sales"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Sales"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r560",
      "r568"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "United States federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r560"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r560",
      "r568",
      "r570"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current income tax expense"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current income tax expense:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r560",
      "r568"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "United States state and local"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Customer Refund Liability, Current",
        "terseLabel": "Accrued product liabilities"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.",
        "label": "Debt, Current",
        "terseLabel": "Current maturities of debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r132",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r347",
      "r354",
      "r355",
      "r356",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "verboseLabel": "Debt And Credit Facilities"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r135",
      "r143",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r337",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r359",
      "r360",
      "r361",
      "r362",
      "r661",
      "r697",
      "r700",
      "r716"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r345",
      "r359",
      "r360",
      "r640"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "verboseLabel": "Fair value of senior unsecured notes"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r52",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r53",
      "r135",
      "r143",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r337",
      "r343",
      "r344",
      "r345",
      "r346",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r359",
      "r360",
      "r361",
      "r362",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRepurchasedFaceAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of the original debt instrument that was repurchased.",
        "label": "Debt Instrument, Repurchased Face Amount",
        "terseLabel": "Debt instrument, repurchased face amount"
       }
      }
     },
     "localname": "DebtInstrumentRepurchasedFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Maturities of time deposits"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "totalLabel": "Total debt"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r561",
      "r568"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "United States federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r561",
      "r568"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "International"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Noncurrent deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r137",
      "r561",
      "r568",
      "r569",
      "r570"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) expense",
        "totalLabel": "Total deferred income tax (benefit) expense"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred income tax (benefit) expense:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r25",
      "r26",
      "r550",
      "r699",
      "r715"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r534",
      "r535"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTerseLabel": "Noncurrent liabilities\u2014Other liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r137",
      "r561",
      "r568"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "United States state and local"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r551"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r553"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss and other credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.",
        "label": "Deferred Tax Assets, State Taxes",
        "terseLabel": "State income taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other",
        "terseLabel": "Other accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves": {
     "auth_ref": [
      "r558",
      "r559"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves",
        "terseLabel": "Product-related liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r552"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less valuation allowances"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesUndistributedForeignEarnings": {
     "auth_ref": [
      "r558"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from undistributed earnings of subsidiary and other recognized entity not within country of domicile. Includes, but is not limited to, other basis differences.",
        "label": "Deferred Tax Liabilities, Undistributed Foreign Earnings",
        "negatedLabel": "Undistributed earnings"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesUndistributedForeignEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofDifferenceinIncomeTaxEffectsComprisingCompanysDeferredIncomeTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedBenefitObligation": {
     "auth_ref": [
      "r443"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to employee service rendered, excluding assumptions about future compensation level.",
        "label": "Defined Benefit Plan, Accumulated Benefit Obligation",
        "terseLabel": "Ending accumulated benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax": {
     "auth_ref": [
      "r73",
      "r79",
      "r454"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax",
        "terseLabel": "Unrecognized net actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax": {
     "auth_ref": [
      "r79",
      "r454"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax",
        "terseLabel": "Unrecognized prior service credit"
       }
      }
     },
     "localname": "DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActualReturnOnPlanAssets": {
     "auth_ref": [
      "r427",
      "r478"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in plan assets of defined benefit plan from actual return (loss) determined by change in fair value of plan assets adjusted for contributions, benefit payments, and other expenses.",
        "label": "Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss)",
        "terseLabel": "Actual return"
       }
      }
     },
     "localname": "DefinedBenefitPlanActualReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanActuarialGainLoss": {
     "auth_ref": [
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from change in actuarial assumptions which (increases) decreases benefit obligation of defined benefit plan. Assumptions include, but are not limited to, interest, mortality, employee turnover, salary, and temporary deviation from substantive plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss)",
        "terseLabel": "Actuarial (gains) losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanActuarialGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r416",
      "r450",
      "r473",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "terseLabel": "Recognized actuarial loss"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r416",
      "r451",
      "r474",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "negatedTerseLabel": "Amortization of prior service cost and transition amount"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": {
     "auth_ref": [
      "r19",
      "r414",
      "r415",
      "r432",
      "r478",
      "r694",
      "r717"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans.",
        "label": "Assets for Plan Benefits, Defined Benefit Plan",
        "periodEndLabel": "Ending fair value of plan assets",
        "periodStartLabel": "Beginning fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate": {
     "auth_ref": [
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate for present value of future retirement benefits cash flows, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate",
        "terseLabel": "Discount rate"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostDiscountRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets": {
     "auth_ref": [
      "r457",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of return on plan assets, reflecting average rate of earnings expected on existing plan assets and expected contributions, used to determine net periodic benefit cost of defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average rate of compensation increase used to determine net periodic benefit cost of defined benefit plan. Plan includes, but is not limited to, pay-related defined benefit plan.",
        "label": "Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostRateOfCompensationIncrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]",
        "terseLabel": "Defined Benefit Plan, Assumptions Used in Calculations [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanAssumptionsUsedInCalculationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligation": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation",
        "negatedTerseLabel": "Benefit obligations",
        "periodEndLabel": "Ending projected benefit obligations",
        "periodStartLabel": "Beginning projected benefit obligations"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationBenefitsPaid": {
     "auth_ref": [
      "r424",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant of defined benefit plan which decreases benefit obligation. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Benefit Obligation, Benefits Paid",
        "negatedTerseLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increase benefit obligation.",
        "label": "Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanBenefitObligationContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation": {
     "auth_ref": [
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in benefit obligation of defined benefit plan from business combination.",
        "label": "Defined Benefit Plan, Benefit Obligation, Business Combination",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanBusinessCombinationsAndAcquisitionsBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanByPlanAssetCategoriesAxis": {
     "auth_ref": [
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r459",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Axis]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlanByPlanAssetCategoriesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and cash equivalent in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DefinedBenefitPlanCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInBenefitObligationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Benefit Obligation [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInBenefitObligationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]",
        "terseLabel": "Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward]"
       }
      }
     },
     "localname": "DefinedBenefitPlanChangeInFairValueOfPlanAssetsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanContributionsByEmployer": {
     "auth_ref": [
      "r429",
      "r435",
      "r437",
      "r476",
      "r478",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer",
        "terseLabel": "Employer contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanContributionsByEmployer",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDebtSecurityMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument issued by corporation, government and governmental agency, municipality, and other institution; in which defined benefit plan asset is invested.",
        "label": "Defined Benefit Plan, Debt Security [Member]",
        "terseLabel": "Debt securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanDebtSecurityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanEquitySecuritiesMember": {
     "auth_ref": [
      "r435",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security representing ownership in corporation or other legal entity for which ownership is represented by share of stock, in which defined benefit plan asset is invested. Includes, but is not limited to, common stock, preferred stock, convertible security, stock right and stock warrant.",
        "label": "Defined Benefit Plan, Equity Securities [Member]",
        "terseLabel": "Equity securities"
       }
      }
     },
     "localname": "DefinedBenefitPlanEquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in five fiscal years after fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years",
        "terseLabel": "2027-2031"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsFiveFiscalYearsThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fifth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in fourth fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in third fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of benefit for defined benefit plan expected to be paid in second fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Benefit Payment, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureBenefitPaymentsYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansExpectedBenefitPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear": {
     "auth_ref": [
      "r445",
      "r479"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in next fiscal year following current fiscal year.",
        "label": "Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year",
        "terseLabel": "Estimated future employer contributions in next fiscal year"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r416",
      "r449",
      "r472",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "terseLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFairValueOfPlanAssets": {
     "auth_ref": [
      "r426",
      "r435",
      "r437",
      "r438",
      "r478"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset segregated and restricted to provide benefit under defined benefit plan. Asset includes, but is not limited to, stock, bond, other investment, earning from investment, and contribution by employer and employee.",
        "label": "Defined Benefit Plan, Plan Assets, Amount",
        "terseLabel": "Fair value of plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanFairValueOfPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which (increases) decreases benefit obligation of defined benefit plan.",
        "label": "Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanForeignCurrencyExchangeRateChangesBenefitObligation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": {
     "auth_ref": [
      "r414",
      "r432",
      "r478"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status.",
        "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan",
        "totalLabel": "Funded status"
       }
      }
     },
     "localname": "DefinedBenefitPlanFundedStatusOfPlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInformationAboutPlanAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Information about Plan Assets [Abstract]",
        "terseLabel": "Defined Benefit Plan, Information about Plan Assets [Abstract]"
       }
      }
     },
     "localname": "DefinedBenefitPlanInformationAboutPlanAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r416",
      "r420",
      "r448",
      "r471",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "negatedTerseLabel": "Interest cost",
        "terseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r446",
      "r469",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "negatedTotalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]",
        "terseLabel": "Components of Net Periodic Pension Cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsBenefitsPaid": {
     "auth_ref": [
      "r431",
      "r482"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment to participant under defined benefit plan which decreases plan assets. For pension plan, payment includes, but is not limited to, pension benefits and death benefits. For other postretirement plan, payment includes, but is not limited to, prescription drug benefits, health care benefits, life insurance benefits, and legal, educational and advisory services.",
        "label": "Defined Benefit Plan, Plan Assets, Benefits Paid",
        "negatedLabel": "Benefits paid"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsBenefitsPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant": {
     "auth_ref": [
      "r430"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of contributions received by defined benefit plan from participant which increases plan assets.",
        "label": "Defined Benefit Plan, Plan Assets, Contributions by Plan Participant",
        "terseLabel": "Employee contributions"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsContributionsByPlanParticipant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign exchange impact"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansChangeinPlanAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanPlanAssetsTargetAllocationPercentage": {
     "auth_ref": [
      "r434",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of target investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Target Allocation, Percentage",
        "terseLabel": "Target plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanPlanAssetsTargetAllocationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments": {
     "auth_ref": [
      "r417",
      "r452",
      "r475"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from event reducing expected years of future service of present employees or eliminating accrual of defined benefits for some or all future services of present employees.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Curtailment",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r419",
      "r447",
      "r470",
      "r478",
      "r479"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "negatedTerseLabel": "Service cost",
        "terseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofChangeinBenefitObligationsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanWeightedAverageAssetAllocations": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of actual investment allocation to total plan assets. Includes, but is not limited to, percentage on weighted-average basis if more than one plan.",
        "label": "Defined Benefit Plan, Plan Assets, Actual Allocation, Percentage",
        "terseLabel": "Actual plan asset allocations"
       }
      }
     },
     "localname": "DefinedBenefitPlanWeightedAverageAssetAllocations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r483"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Plan expense"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.",
        "label": "Defined Contribution Plan Disclosures [Table Text Block]",
        "terseLabel": "Defined Contribution Plan Disclosures"
       }
      }
     },
     "localname": "DefinedContributionPlanDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Expense funded with Stryker common stock"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofDefinedContributionPlanDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r121",
      "r287"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r62",
      "r63",
      "r64",
      "r640"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Interest rate swap asset",
        "verboseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r61",
      "r64",
      "r65",
      "r613",
      "r685"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r61",
      "r64",
      "r65",
      "r613",
      "r685"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "negatedTerseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeNet": {
     "auth_ref": [
      "r640"
     ],
     "calculation": {
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.",
        "label": "Derivative, Fair Value, Net",
        "totalLabel": "Derivative, fair value, net"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r611"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Unrealized gains (losses) on designated hedges"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r64",
      "r610",
      "r614",
      "r617",
      "r620"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r628",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Instruments"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r607",
      "r610",
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r607",
      "r610",
      "r617",
      "r620",
      "r621",
      "r625",
      "r626"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Notional amount",
        "verboseLabel": "Derivative, notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r602",
      "r604",
      "r605",
      "r607",
      "r608",
      "r616",
      "r617",
      "r622",
      "r624",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r142",
      "r602",
      "r604",
      "r607",
      "r608",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax": {
     "auth_ref": [
      "r654"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification from other comprehensive income (loss) to earnings from the sale or complete or substantially complete liquidation of an investment in a foreign entity.",
        "label": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "terseLabel": "Derivatives used in Net Investment Hedge, Gain (Loss), Reclassified to Earnings, Net of Tax",
        "verboseLabel": "Net investment hedges expected to be reclassified to cost of sales and other income (expense)"
       }
      }
     },
     "localname": "DerivativesUsedInNetInvestmentHedgeGainLossReclassifiedToEarningsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Designated as Hedging Instrument"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology and patents",
        "verboseLabel": "Developed technologies"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Schedule of Disaggregated Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r390",
      "r712"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedLabel": "Cash dividends declared"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrent": {
     "auth_ref": [
      "r14",
      "r50"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Dividends Payable, Current",
        "terseLabel": "Dividend payable"
       }
      }
     },
     "localname": "DividendsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EMEAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regions of Europe, Middle East and Africa.",
        "label": "EMEA [Member]",
        "terseLabel": "Europe, Middle East, Africa"
       }
      }
     },
     "localname": "EMEAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Net earnings per share of common stock:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r98",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r165",
      "r167",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r630",
      "r631",
      "r706",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic net earnings per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r98",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r167",
      "r171",
      "r172",
      "r173",
      "r175",
      "r176",
      "r630",
      "r631",
      "r706",
      "r728"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted net earnings per share of common stock (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r649"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax, percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails",
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r139",
      "r537",
      "r572"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "United States federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r537",
      "r572"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "negatedTerseLabel": "Foreign income tax at rates other than 21%"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r537",
      "r572"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r537",
      "r572"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "United States state and local income taxes, less federal deduction"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofReconciliationofUSStatutoryIncomeTaxRatetoCompanysEffectiveIncomeTaxRatefromContinuingOperationsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r520"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Compensation cost not yet recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r520"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation cost not yet recognized, period for recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock Purchase Plans"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r89",
      "r90",
      "r91",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r181",
      "r253",
      "r383",
      "r390",
      "r522",
      "r523",
      "r524",
      "r564",
      "r565",
      "r629",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656",
      "r736",
      "r737",
      "r738",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r633",
      "r634",
      "r635",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r345",
      "r359",
      "r360",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r478",
      "r634",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r345",
      "r435",
      "r437",
      "r442",
      "r478",
      "r634",
      "r676"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "(Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r345",
      "r359",
      "r360",
      "r435",
      "r437",
      "r442",
      "r478",
      "r634",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "(Level 2)",
        "verboseLabel": "(Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r345",
      "r359",
      "r360",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r478",
      "r634",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "(Level 3)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r636"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "negatedLabel": "Change in estimate"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r637"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r636"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending",
        "periodStartLabel": "Beginning"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r345",
      "r359",
      "r360",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r478",
      "r676",
      "r677",
      "r678"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails",
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOptionTextBlock": {
     "auth_ref": [
      "r644"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a company's election to apply the fair value option for measurement and reporting of eligible financial assets and liabilities (as defined), as well as certain other eligible items (as defined) included in the statement of financial position, whether such option is elected for a single eligible item or a group of similar eligible items and is in addition to other disclosures concerning fair value which the company may be required to provide.  Such disclosure might be expected to include: (1) for items included in the statement of financial position: (a) the reasons for electing a fair value option for each eligible item or group of similar eligible items; (b) if the fair value option is elected for some but not all eligible items within a group of similar eligible items: (i) a description of those similar items and the reasons for partial election and (ii) information of how the group of similar items relates to individual balance sheet line items; (c) for each line item in the statement of financial position that includes an item or items for which the fair value option has been elected: (i) information of how each line item in the statement of financial position relates to major categories of assets and liabilities presented in accordance with other fair value disclosures and (ii) the aggregate carrying amount of ineligible items included in each line item in the balance sheet, if any; (d) the difference between the aggregate fair value and the aggregate unpaid principal balance (assuming contractual principal amounts and fair value option elected) of: (i) loans and long-term receivables (other than securities otherwise reported at fair value) and (ii) long-term debt instruments; (e) for loans held as assets for which the fair value option has been elected: (i) the aggregate fair value of loans that are 90 days or more past due, (ii) if the policy is to recognize interest income separately from other changes in fair value, the aggregate fair value of loans in nonaccrual status, and (iii) the difference between the aggregate fair value and the aggregate unpaid principal balance for loans that are 90 days or more past due, in nonaccrual status, or both; (f) for investments that would have been accounted for under the equity method if the entity had not chosen to apply the fair value option, the information required for such investments, if material either individually or in the aggregate; (2) for items included in the income statement: (a) the amounts of gains and losses from fair value changes included in earnings and in which line in the income statement those gains and losses are reported whether or not combined with gains and losses from items required to be accounted for at fair value; (b) a description of how interest and dividends are measured and where they are reported in the income statement; (c) for loans and other receivables held as assets: (i) the estimated amount of gains or losses included in earnings attributable to changes in instrument-specific credit risk and (ii) how the gains or losses attributable to changes in instrument-specific credit risk were determined; (d) for liabilities with fair values that have been significantly affected during the reporting period by changes in the instrument-specific credit risk: (i) the estimated amount of gains and losses from fair value changes included in earnings that are attributable to changes in the instrument-specific credit risk, (ii) qualitative information about the reasons for those changes, and (iii) how the gains and losses attributable to changes in instrument-specific credit risk were determined; and (3) certain other disclosures as required or determined to be provided.",
        "label": "Fair Value, Option [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueOptionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Finite-lived intangible asset, useful life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r281"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Less Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsEstimatedAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r275",
      "r277",
      "r281",
      "r284",
      "r690",
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r281",
      "r691"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r275",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r281",
      "r690"
     ],
     "calculation": {
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.",
        "label": "Foreign Tax Authority [Member]",
        "terseLabel": "Foreign Tax Authority"
       }
      }
     },
     "localname": "ForeignCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.",
        "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure",
        "terseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r645",
      "r646",
      "r647",
      "r648"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign currency transaction gains (losses)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Currency Translation"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r64",
      "r435",
      "r619"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency exchange forward contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r435",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by government not domiciled in United States of America (US).",
        "label": "Debt Security, Government, Non-US [Member]",
        "terseLabel": "Foreign government debt securities"
       }
      }
     },
     "localname": "ForeignGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r190",
      "r760"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r263",
      "r265",
      "r674",
      "r693"
     ],
     "calculation": {
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Ending balance",
        "periodStartLabel": "Goodwill, Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r266"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions and adjustments"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r270",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r121",
      "r264",
      "r267",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": {
     "auth_ref": [
      "r268",
      "r269",
      "r578"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Translation and Purchase Accounting Adjustments",
        "terseLabel": "Foreign exchange"
       }
      }
     },
     "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r99",
      "r136",
      "r210",
      "r216",
      "r220",
      "r223",
      "r226",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r643"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r607",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the impaired assets to be held and used by the entity.",
        "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairedLongLivedAssetsHeldAndUsedByTypeAxis": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the categories used to group impaired long-lived assets held and used by the type of asset.",
        "label": "Impaired Long-Lived Assets Held and Used by Type [Axis]",
        "terseLabel": "Impaired Long-Lived Assets Held and Used by Type [Axis]"
       }
      }
     },
     "localname": "ImpairedLongLivedAssetsHeldAndUsedByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "verboseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r100",
      "r122",
      "r157",
      "r158",
      "r159",
      "r160",
      "r170",
      "r173",
      "r592"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent",
        "terseLabel": "Segment operating income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r138",
      "r571"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r94",
      "r210",
      "r216",
      "r220",
      "r223",
      "r226",
      "r692",
      "r702",
      "r707",
      "r729"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Earnings before income taxes",
        "verboseLabel": "Earnings (loss) before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r138",
      "r571"
     ],
     "calculation": {
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "International"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofEarningsbeforeIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r292",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r541",
      "r547",
      "r549",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r139",
      "r538",
      "r548",
      "r555",
      "r566",
      "r573",
      "r575",
      "r576",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.",
        "label": "Income Tax Examination, Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties"
       }
      }
     },
     "localname": "IncomeTaxExaminationPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r140",
      "r163",
      "r164",
      "r208",
      "r536",
      "r567",
      "r574",
      "r730"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income taxes",
        "totalLabel": "Total income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r88",
      "r532",
      "r533",
      "r548",
      "r549",
      "r554",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes, net of refunds"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableTrade": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Payable, Trade",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableTrade",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "verboseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "verboseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Debt Security Category [Axis]",
        "terseLabel": "Debt Security Category [Axis]",
        "verboseLabel": "Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis]"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r273",
      "r279"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangibles, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r105",
      "r351",
      "r358",
      "r361",
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense, debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r116",
      "r118",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest on debt"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r618"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r36",
      "r259"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r5",
      "r58",
      "r674"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory, Net [Abstract]",
        "terseLabel": "Inventories:"
       }
      }
     },
     "localname": "InventoryNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r15",
      "r59",
      "r129",
      "r177",
      "r257",
      "r258",
      "r260",
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r38",
      "r39",
      "r259"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r37",
      "r259"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r744",
      "r745",
      "r746",
      "r747",
      "r748",
      "r749",
      "r750",
      "r751",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Available-for-sale Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Minimum lease payments"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalFees": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.",
        "label": "Legal Fees",
        "negatedTerseLabel": "Regulatory and legal matters"
       }
      }
     },
     "localname": "LegalFees",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r670"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r49",
      "r136",
      "r218",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r595",
      "r599",
      "r600",
      "r643",
      "r672",
      "r673"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r34",
      "r136",
      "r252",
      "r643",
      "r674",
      "r701",
      "r723"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities &amp; shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r51",
      "r136",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r595",
      "r599",
      "r600",
      "r643",
      "r672",
      "r673",
      "r674"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r633"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "terseLabel": "Total liabilities measured at fair value"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of the credit facility.",
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "terseLabel": "Increase in line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r46"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "verboseLabel": "Borrowing capacity on existing facilities"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r46",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r23",
      "r344",
      "r357",
      "r359",
      "r360",
      "r700",
      "r720"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-term Debt, Unclassified [Abstract]",
        "terseLabel": "Long-term Debt, Unclassified [Abstract]"
       }
      }
     },
     "localname": "LongTermDebtAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r143",
      "r314",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, excluding current maturities",
        "verboseLabel": "Total long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r301",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualPayments": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow reducing loss contingency liability.",
        "label": "Loss Contingency Accrual, Payments",
        "terseLabel": "Payments during period"
       }
      }
     },
     "localname": "LossContingencyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r304",
      "r308",
      "r311"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Estimate of possible loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Charges during period"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentGross": {
     "auth_ref": [
      "r11",
      "r288"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment, Gross",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesGainLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).",
        "label": "Marketable Securities, Gain (Loss)",
        "terseLabel": "Marketable securities, gain (loss)"
       }
      }
     },
     "localname": "MarketableSecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.",
        "label": "Segment Reconciling Items [Member]",
        "terseLabel": "Segment Reconciling Items"
       }
      }
     },
     "localname": "MaterialReconcilingItemsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Maximum Remaining Maturity of Foreign Currency Derivatives",
        "terseLabel": "Maximum term"
       }
      }
     },
     "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r185",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of Operations"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r82",
      "r85",
      "r91",
      "r95",
      "r122",
      "r136",
      "r155",
      "r157",
      "r158",
      "r159",
      "r160",
      "r163",
      "r164",
      "r170",
      "r210",
      "r216",
      "r220",
      "r223",
      "r226",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r631",
      "r643",
      "r703",
      "r725"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net earnings (loss)",
        "totalLabel": "Net earnings",
        "verboseLabel": "Net earnings"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue": {
     "auth_ref": [
      "r614"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all derivative assets designated as hedges of net investment in foreign operations.",
        "label": "Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value",
        "negatedTerseLabel": "Derivative, fair value"
       }
      }
     },
     "localname": "NetInvestmentHedgeDerivativeAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements Not Yet Adopted and Accounting Pronouncements Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails",
      "http://www.stryker.com/role/DerivativeInstrumentsMovementsoutofOCIDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other (income) expense, net",
        "verboseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r210",
      "r216",
      "r220",
      "r223",
      "r226"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Segment net earnings (loss)",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r666"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r664"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities, noncurrent"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r663"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r668",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r667",
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CommitmentsandContingenciesLeaseCostDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "verboseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r74",
      "r76",
      "r453"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of cost (credit) of benefit change attributable to participants' prior service from plan amendment or plan initiation of defined benefit plan, that has not been recognized in net periodic benefit cost (credit).",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), after Tax",
        "negatedTerseLabel": "Prior service cost and transition amount"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlanNetPriorServiceCostsCreditArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r73",
      "r76",
      "r593",
      "r597"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedTotalLabel": "Total recognized in OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r71",
      "r76",
      "r453"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of gain (loss) for (increase) decrease in value of benefit obligation for change in actuarial assumptions and increase (decrease) in value of plan assets from experience different from that assumed of defined benefit plan, that has not been recognized in net periodic benefit (cost) credit.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Net actuarial gain (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "auth_ref": [
      "r79",
      "r89",
      "r90",
      "r92",
      "r650",
      "r652",
      "r656"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "terseLabel": "OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r77",
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax": {
     "auth_ref": [
      "r76",
      "r80",
      "r453"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of increase (decrease) to other comprehensive income from settlement and curtailment gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), after Tax",
        "terseLabel": "Curtailment gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Financial statement translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r83",
      "r86",
      "r89",
      "r90",
      "r92",
      "r96",
      "r383",
      "r650",
      "r655",
      "r656",
      "r704",
      "r726"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income (loss)",
        "totalLabel": "Total other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r76"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Pension plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax": {
     "auth_ref": [
      "r76",
      "r80",
      "r81",
      "r453"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, after Tax",
        "negatedTerseLabel": "Recognized net actuarial loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss) for gain (loss) of defined benefit plan.",
        "label": "Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), Reclassification Adjustment from AOCI, Tax",
        "totalLabel": "Total recognized in net periodic benefit cost and OCI"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r68",
      "r76"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r609",
      "r625"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherDebtSecuritiesMember": {
     "auth_ref": [
      "r249",
      "r256",
      "r435",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in debt securities classified as other.",
        "label": "Other Debt Obligations [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r50",
      "r674"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermDebt": {
     "auth_ref": [
      "r23",
      "r700",
      "r720"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt classified as other.",
        "label": "Other Long-term Debt",
        "terseLabel": "Other long-term debt"
       }
      }
     },
     "localname": "OtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLongTermInvestmentsMember": {
     "auth_ref": [
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term investments classified as other.",
        "label": "Other Long-term Investments [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherLongTermInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other noncurrent assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other noncurrent liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "verboseLabel": "Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Categories of Investments [Domain]"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r107",
      "r110"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other investing, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchases of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Payments of dividends"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Cash paid for taxes from withheld shares"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r244"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r434",
      "r436",
      "r442",
      "r458",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r478",
      "r480",
      "r481",
      "r483",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Retirement Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": {
     "auth_ref": [
      "r22",
      "r414",
      "r415",
      "r432",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current.",
        "label": "Liability, Defined Benefit Plan, Current",
        "negatedTerseLabel": "Current liabilities\u2014accrued compensation"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent": {
     "auth_ref": [
      "r24",
      "r414",
      "r415",
      "r432",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as noncurrent.",
        "label": "Liability, Defined Benefit Plan, Noncurrent",
        "negatedTerseLabel": "Noncurrent liabilities\u2014other liabilities"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanAssetCategoriesDomain": {
     "auth_ref": [
      "r434",
      "r435",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r459",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined benefit plan asset investment.",
        "label": "Defined Benefit Plan, Plan Assets, Category [Domain]",
        "terseLabel": "Defined Benefit Plan, Plan Assets, Category [Domain]"
       }
      }
     },
     "localname": "PlanAssetCategoriesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r28",
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par per share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r28"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r261",
      "r262"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from issuance of long-term debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r112",
      "r115"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from (Repayments of) Short-term Debt",
        "terseLabel": "Proceeds and payments on short-term borrowings, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductLiabilityAccrualPeriodExpense": {
     "auth_ref": [
      "r301"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss reported during the period pertaining to product liability.",
        "label": "Product Liability Accrual, Period Expense",
        "terseLabel": "Recall charges"
       }
      }
     },
     "localname": "ProductLiabilityAccrualPeriodExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, plant and equipment:"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r43",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r42",
      "r288"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Total property, plant and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r290",
      "r674",
      "r711",
      "r724"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Net Property, Plant &amp; Equipment",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r41",
      "r290",
      "r762",
      "r763"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property, plant and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PurchaseObligationFiscalYearMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase Obligation, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Purchase obligations"
       }
      }
     },
     "localname": "PurchaseObligationFiscalYearMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialDataAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Quarterly Financial Data [Abstract]",
        "terseLabel": "Quarterly Financial Data [Abstract]"
       }
      }
     },
     "localname": "QuarterlyFinancialDataAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_QuarterlyFinancialInformationTextBlock": {
     "auth_ref": [
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.",
        "label": "Quarterly Financial Information [Text Block]",
        "terseLabel": "Summary of Quarterly Data (Unaudited)"
       }
      }
     },
     "localname": "QuarterlyFinancialInformationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnaudited"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r237",
      "r239",
      "r240",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r79",
      "r89",
      "r90",
      "r92",
      "r650",
      "r654",
      "r656"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "terseLabel": "Reclassification of gain (loss) from AOCI to earnings"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).",
        "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]",
        "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.",
        "label": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]",
        "terseLabel": "Reconciliation of Operating Profit (Loss) from Segments to Consolidated"
       }
      }
     },
     "localname": "ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueAfterFifthYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueAfterFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFifthYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFifthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInFourthYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInFourthYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInSecondYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInSecondYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueInThirdYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueInThirdYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "auth_ref": [
      "r299"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ContingenciesandCommitmentsFuturePurchaseObligationsandMinimumLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedTerseLabel": "Payments on long-term debt",
        "terseLabel": "Repayments of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r530",
      "r688",
      "r775"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research, development and engineering expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research, Development and Engineering Expenses"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)",
        "verboseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCosts": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs",
        "negatedTerseLabel": "Restructuring-related and other charges"
       }
      }
     },
     "localname": "RestructuringCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r32",
      "r390",
      "r525",
      "r674",
      "r722",
      "r739",
      "r741"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r253",
      "r522",
      "r523",
      "r524",
      "r564",
      "r565",
      "r629",
      "r736",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r191",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from Contract with Customer Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r404",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue Recognition [Abstract]",
        "terseLabel": "Revenue Recognition [Abstract]"
       }
      }
     },
     "localname": "RevenueRecognitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r93",
      "r136",
      "r201",
      "r202",
      "r215",
      "r221",
      "r222",
      "r229",
      "r230",
      "r233",
      "r252",
      "r315",
      "r316",
      "r317",
      "r320",
      "r321",
      "r322",
      "r324",
      "r326",
      "r328",
      "r329",
      "r643",
      "r707"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net sales"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r79",
      "r655",
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCITables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAllocationOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major categories of plan assets of pension plans and/or other employee benefit plans.  This information may include, but is not limited to, the target allocation of plan assets, the fair value of each major category of plan assets, and the level within the fair value hierarchy in which the fair value measurements fall.",
        "label": "Schedule of Allocation of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Allocation of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfAllocationOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Capital Stock [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails",
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Allocation Of The Preliminary Purchase Price To The Acquired Net Assets Of Acquisitions"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of beginning and ending balances of the fair value of plan assets of pension plans and/or other employee benefit plans showing separately, if applicable, the effects during the period attributable to each of the following: actual return on plan assets, foreign currency exchange rate changes, contributions by the employer, contributions by plan participants, benefits paid, business combinations, divestitures, and settlements.",
        "label": "Schedule of Changes in Fair Value of Plan Assets [Table Text Block]",
        "terseLabel": "Schedule of Changes in Fair Value of Plan Assets"
       }
      }
     },
     "localname": "ScheduleOfChangesInFairValueOfPlanAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in the benefit obligation of pension plans and/or other employee benefit plans from the beginning to the end of the period, showing separately, if applicable, the effects of the following: service cost, interest cost, contributions by plan participants, actuarial gains and losses, foreign currency exchange rate changes, benefits paid, plan amendments, business combinations, divestitures, curtailments, settlements, and special and contractual termination benefits.",
        "label": "Schedule of Changes in Projected Benefit Obligations [Table Text Block]",
        "terseLabel": "Schedule of Changes in Accumulated Postemployment Benefit Obligations"
       }
      }
     },
     "localname": "ScheduleOfChangesInProjectedBenefitObligationsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCostsOfRetirementPlansTableTextBlock": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the costs related to the various types of retirement plans including defined benefit pension plan cost, defined contribution plan cost, other postretirement benefit plan cost, and net periodic benefit cost.",
        "label": "Schedule of Costs of Retirement Plans [Table Text Block]",
        "terseLabel": "Schedule of Costs of Retirement Plans"
       }
      }
     },
     "localname": "ScheduleOfCostsOfRetirementPlansTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r53",
      "r143",
      "r359",
      "r361",
      "r384",
      "r387",
      "r388",
      "r389",
      "r659",
      "r660",
      "r662",
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "verboseLabel": "Maturities Of Long-Term Debt Disclosures"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r553"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Difference in Income Tax Effects Comprising Company's Deferred Income Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansNarrativeDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofTargetandActualAllocationofPlanAssetsDetails",
      "http://www.stryker.com/role/RetirementPlansScheduleofValuationoftheCompanysPensionPlanAssetsbyPricingCategoriesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": {
     "auth_ref": [
      "r465",
      "r466",
      "r467",
      "r468",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans.",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location"
       }
      }
     },
     "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DerivativeInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of U.S. Statutory Income Tax Rate to Company's Effective Income Tax Rate from Continuing Operations"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries in which material long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets are located, and amount of such long-lived assets located in that country or foreign geographic area.",
        "label": "Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]",
        "terseLabel": "Geographic Information on Net Sales and Long-Lived Assets"
       }
      }
     },
     "localname": "ScheduleOfEntityWideDisclosureOnGeographicAreasLongLivedAssetsInIndividualForeignCountriesByCountryTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfExpectedBenefitPaymentsTableTextBlock": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of benefits expected to be paid by pension plans and/or other employee benefit plans in each of the next five fiscal years and in the aggregate for the five fiscal years thereafter.",
        "label": "Schedule of Expected Benefit Payments [Table Text Block]",
        "terseLabel": "Schedule of Expected Benefit Payments"
       }
      }
     },
     "localname": "ScheduleOfExpectedBenefitPaymentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/RetirementPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r275",
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Summary of the Company's Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r270",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r270",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in the Net Carrying Amount of Goodwill by Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r43",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AssetImpairmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Information [Table Text Block]",
        "terseLabel": "Summary of Quarterly Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SummaryofQuarterlyDataUnauditedTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r210",
      "r213",
      "r219",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r210",
      "r213",
      "r219",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Sales and Other Financial Information by Business Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r504",
      "r509",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Summary of RSU and PSU Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r497",
      "r509",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r55",
      "r133",
      "r182",
      "r183",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r372",
      "r376",
      "r381",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r197",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r233",
      "r295",
      "r296",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r197",
      "r199",
      "r200",
      "r210",
      "r214",
      "r220",
      "r224",
      "r225",
      "r226",
      "r227",
      "r229",
      "r232",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Data"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicData"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SegmentandGeographicDataGeographicInformationonNetSalesandLongLivedAssetsDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Shares, Cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Cancelled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Shares, Nonvested at December 31 (in shares)",
        "periodStartLabel": "Shares, Nonvested at January 1 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average grant date fair value, Outstanding at December 31 (in dollars per share)",
        "periodStartLabel": "Weighted average grant date fair value, Outstanding at January 1 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Shares, Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value, Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares, Exercisable at December 31 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercisable at December 31 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r511"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Shares, Cancelled or forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r501"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Shares, Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value per share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options outstanding at December 31"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r499",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Options outstanding at December 31 (in shares)",
        "periodStartLabel": "Shares, Options outstanding at January 1 (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, Options outstanding at December 31 (in dollars per share)",
        "periodStartLabel": "Weighted average exercise price, Options outstanding at January 1 (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise\u00a0Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r512"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options expected to vest"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Shares, Options expected to vest (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Options expected to vest (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued under the ESPP"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r490",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Equity Award [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails",
      "http://www.stryker.com/role/CapitalStockSummaryofRSUandPSUActivityDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Cancelled or forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r493",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Options exercised during period, exercise price range, lower range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Options exercised during period, exercise price range, upper range limit"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r515",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected option life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockOptionGrantAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r521"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Exercisable at December 31"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Exercisable at December 31 (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Options outstanding at December 31 (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term, Options expected to vest (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r127",
      "r151"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r197",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r217",
      "r218",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r226",
      "r233",
      "r270",
      "r293",
      "r295",
      "r296",
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsChangesinNetCarryingAmountofGoodwillbySegmentDetails",
      "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSalesAndOtherFinancialInformationByBusinessSegmentDetails",
      "http://www.stryker.com/role/SegmentandGeographicDataSegmentInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r133",
      "r136",
      "r167",
      "r168",
      "r169",
      "r171",
      "r173",
      "r182",
      "r183",
      "r184",
      "r252",
      "r315",
      "r320",
      "r321",
      "r322",
      "r328",
      "r329",
      "r367",
      "r368",
      "r372",
      "r376",
      "r383",
      "r643",
      "r785"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/COVERPAGE"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r57",
      "r89",
      "r90",
      "r91",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r164",
      "r181",
      "r253",
      "r383",
      "r390",
      "r522",
      "r523",
      "r524",
      "r564",
      "r565",
      "r629",
      "r650",
      "r651",
      "r652",
      "r653",
      "r654",
      "r656",
      "r736",
      "r737",
      "r738",
      "r811"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAOCIScheduleofAmountsRecognizedinOtherComprehensiveIncomeLossDetails",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/RetirementPlansScheduleofFundedStatusandComponentsoftheAmountsRecognizedintheConsolidatedBalanceSheetsandinAccumulatedOtherComprehensiveGainLossBeforetheEffectofIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/ContingenciesandCommitmentsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r152",
      "r153",
      "r154",
      "r181",
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity",
      "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.stryker.com/role/SignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r28",
      "r29",
      "r383",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r28",
      "r29",
      "r383",
      "r390",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Shares, Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockSummaryofStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r28",
      "r29",
      "r390",
      "r492",
      "r510"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "verboseLabel": "Issuance of common stock under stock compensation and benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining shares authorized to be repurchased"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r28",
      "r29",
      "r383",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase of common stock, shares"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r28",
      "r29",
      "r383",
      "r390"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r90",
      "r136",
      "r152",
      "r153",
      "r154",
      "r156",
      "r162",
      "r252",
      "r253",
      "r390",
      "r522",
      "r523",
      "r524",
      "r564",
      "r565",
      "r590",
      "r591",
      "r601",
      "r629",
      "r643",
      "r650",
      "r651",
      "r656",
      "r737",
      "r738",
      "r811"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedBalanceSheets",
      "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r134",
      "r368",
      "r371",
      "r372",
      "r373",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r382",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Capital Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/CapitalStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r657",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r657",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r657",
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsNarrativeDetails",
      "http://www.stryker.com/role/DebtandCreditFacilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SummaryOfIncomeTaxContingenciesTextBlock": {
     "auth_ref": [
      "r540",
      "r547",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Summary of Income Tax Contingencies [Table Text Block]",
        "terseLabel": "Schedule of Unresolved Income Tax Positions"
       }
      }
     },
     "localname": "SummaryOfIncomeTaxContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosure:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r556"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforward, amount"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxCreditCarryforwardValuationAllowance": {
     "auth_ref": [
      "r552"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from tax credit carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Tax Credit Carryforward, Valuation Allowance",
        "terseLabel": "Tax credit carryforward, valuation allowance"
       }
      }
     },
     "localname": "TaxCreditCarryforwardValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/AcquisitionsAllocationOfThePreliminaryPurchasePriceToTheAcquiredNetAssetsOfAcquisitionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/GoodwillandOtherIntangibleAssetsSummaryoftheCompanysOtherIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecuritiesDebt": {
     "auth_ref": [
      "r242",
      "r243"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).",
        "label": "Debt Securities, Trading",
        "terseLabel": "Trading marketable securities"
       }
      }
     },
     "localname": "TradingSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r141",
      "r435",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "verboseLabel": "United States agency debt securities"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r141",
      "r435",
      "r478",
      "r708"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "verboseLabel": "United States treasury debt securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "verboseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r531",
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending uncertain tax positions",
        "periodStartLabel": "Beginning uncertain tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from foreign currency translation.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation",
        "negatedTerseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromForeignCurrencyTranslation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": {
     "auth_ref": [
      "r545"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities",
        "negatedTerseLabel": "Settlements and resolutions of income tax audits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "negatedTerseLabel": "Interest expense and penalties included in other income (expense), net"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r544"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year income tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation": {
     "auth_ref": [
      "r542"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from foreign currency translation.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromForeignCurrencyTranslation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year income tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense": {
     "auth_ref": [
      "r539"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense for an underpayment of income taxes.",
        "label": "Unrecognized Tax Benefits, Interest on Income Taxes Expense",
        "terseLabel": "Unrecognized tax benefits, interest on income tax expense"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Statute of limitations expirations and other"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/IncomeTaxesScheduleofUnresolvedIncomeTaxPositionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r23",
      "r700",
      "r720"
     ],
     "calculation": {
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "terseLabel": "Unsecured debt"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/DebtandCreditFacilitiesMaturitiesOfLongTermDebtDisclosuresDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r186",
      "r187",
      "r188",
      "r189",
      "r193",
      "r194",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesAdjustments": {
     "auth_ref": [
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in valuation and qualifying accounts and reserves from adjustment.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment",
        "terseLabel": "Effect of Changes in Foreign Currency Exchange Rates"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "auth_ref": [
      "r144",
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "periodEndLabel": "Balance at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesBalance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "auth_ref": [
      "r147"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "terseLabel": "Charged\u00a0to Costs &amp; Expenses"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "auth_ref": [
      "r148"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "terseLabel": "Uncollectible Amounts Written Off, Net of Recoveries"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDeductions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "auth_ref": [
      "r144",
      "r145",
      "r146",
      "r148",
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation and qualifying accounts and reserves.",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]"
       }
      }
     },
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ScheduleIIValuationandQualifyingAccountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r173"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Effect of dilutive employee stock compensation (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r166",
      "r173"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares outstanding (in millions):"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r165",
      "r173"
     ],
     "calculation": {
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.stryker.com/role/ConsolidatedStatementsOfEarnings"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124437754&loc=d3e543-108305"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=d3e1280-108306"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=124502072&loc=SL124452896-108306"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "270",
   "URI": "http://asc.fasb.org/topic&trid=2126967"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6284393-111563"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25383-109308"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=d3e1731-114919"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(6)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(8)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(k)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39716-114964"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e961-128460"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613673-111683"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "825",
   "URI": "http://asc.fasb.org/topic&trid=2134543"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "330",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e640-108580"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r776": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r777": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r778": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r779": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r780": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r781": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r782": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r783": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r784": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r785": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r786": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "303",
   "Subparagraph": "(5)"
  },
  "r787": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r788": {
   "Footnote": "2",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r789": {
   "Footnote": "4",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "29"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r790": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column B",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r791": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column C",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r792": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column D",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r793": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column E",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r794": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column F",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r795": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column G",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r796": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column H",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r797": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "Column I",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "28"
  },
  "r798": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "09"
  },
  "r799": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "01"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e689-108580"
  },
  "r800": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(i)",
   "Subsection": "02"
  },
  "r801": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(ii)",
   "Subsection": "01"
  },
  "r802": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)",
   "Subsection": "01"
  },
  "r803": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "01"
  },
  "r804": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(A)",
   "Subsection": "02"
  },
  "r805": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "01"
  },
  "r806": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(B)",
   "Subsection": "02"
  },
  "r807": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iii)(C)",
   "Subsection": "02"
  },
  "r808": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "01"
  },
  "r809": {
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "13",
   "Subparagraph": "(4)(iv)",
   "Subsection": "02"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL34724391-108580"
  },
  "r810": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>115
<FILENAME>0000310764-22-000028-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000310764-22-000028-xbrl.zip
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M^#,VR==:W'\9N'2']^WXFGT;C1&(@U.)@;7,K$7-<CYS6U?$JL+5F#> %7#
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M&7TO=&%$&Z09YBX@1BN@SLSUL;FR$>6R$YA):)-\2W KK"MCF?*A/D))B4E
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M!@%54LY!/^-N$F[$]=(\@'Q"<K>CC6J(TV\@AO.J4[P-@R0P.L9X_37.8:.
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MT9?1+WF-Z$50J]^I5$W5GSFHK1^2\7ER!HK!\]=/G^[TR$O6WZ(Y8'UYJ66
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MHV P!YE-+ZFB]&^&IQQD'F@C%WE5>,OQ @Q[*FZ=9=#B4O\9Z4KNAK_519Z
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ME8FY:*;F)ED'@2X@S#*"$3C2$P4JNX+6J2N7MF13W*7KIESJH[IW9W:GQ6G
M$J^*/(T.77[3&E,>22W+4TW(FG I,M,BZ1<-LD7+'3F6OGATB\PD6:=487/#
M,YL7!F#H;C*V;'-',R*64$5+[C9,*9."C;ET'B3X<1'0H)0#)DLC,I/$"0.%
M:*OC!O0YU$F[X>@CZ;MB)"ZP1SCC&\M6P+-%>8,-:A.@!<^SM"?(O+W(NXG0
M-,.TB;F1 ;.F$21?DECSRXB1QV3ISV=LH06^IS5B^?I2'I2YL^0L6XM(D40D
M?PD;0RD33-8B!XNEAK6D(A[C28HN*\)WD=.'$&]6^C2%A;P>O6&/6(2'AT7X
MTLO7.NN8#)[122/MN#0\]YU185^_#'.3Q35A<,E4P2-P(\+'&69.FTQ_7-;^
M(LZBL_Q"%QFZ,?!4,G[8K>AH]=>'E14$I2O6,T(%66GE,\WADZ.73Z$98/UZ
M(067?4*U0F2'B98L4.%+:12#7!=S5%#%,*A=O YD'0Y^0SQ$Q(/@0*&?V9A"
M\V#[_;]Q/WL-1S26\V99V]K-Q>/QWMCP[PZ'@ULSX1]COE]PNH[Z^XM4OO?3
M9+LO#I6^HRTQ%$I[ 8-+6-?$&@$_?/_B-6A!>?1/3=K+6C,*][-&]D$HFUN8
M;9B-E67Z"L2RG#?'KO(X0/%Z5XJU28-+1846V5\P;.GH<##% @1R52=88UXL
MNG9N&$LKNRRRV\)L)1Z:!5(KSV6\8&U)&@2:E7CI95ZDL01@+0</$?^DR32I
MO$0;F_N@,X[!4E83^8TX%$C,0QAGJ3DF&#+R\.WDSJ)3RL9'8>%F^53HNX(Z
M8:,DI'N-EAB1]#KXESALHY$J$S1%=PTK;Y5*$*=M_OPHKYD)Z=7RW@0W&P;?
M&\0N NJO,:9Z*4N7@QUM(=N)-L0T64AE[1Z<34[U\6G&<(,D,8?2(TPYD0H[
M3';30S\!B@=CBUM&'B]D8YEX@OS<3=L.:B4IY5X2;5OT:'%*$D.#>>GS(5+4
M1)@7D3;.),FX.5H@@2JT^!]C+)YYH3'[IFX1')1S4VCT(5GE"%IBLJID=+&.
MW63AE=@RL/'4)\T>%N\>6Z73M,?T1%<+1?@6E\4-ZPK=0V1+0Z"&Q%H]2ZPM
M6RXH_-=,)<>AK"DISA.CRDI$U(EMNC1YH#$LZNTOP],G3Z!XMGNG4_(KNY=C
M&WK#\$!>5D_\Y'.[X\%62G),M*N05<L<0*ULID93AZ4QT21[C0/0RP@W5MBB
M&X*=?I0]8L,'J")-,Q>!E-?#5LRZ<N:]01G9-/A\TJ,]AP-@#H8J[X$\V+0$
MD W*:9_F.7PLGVY]/)?A&'R^;:[]/2\^P5J04&AT7"FBD#3HET)C_1].I?2?
MP(K7\Z?+'V.\Q6WJ@B@ BI=@P"?IV4I-N2+&X+(9+?29*F*CMR )]IB%^Y)!
MSS-V;'::9O=GUS]2?WW-<7VD_GJD_KI[#$V/U%^/U%^/U%\/E?KK^/<!'"R/
M7KVO#,00VP+T\UU5GD='3$4;'6;I?$U.NLYRVTEF8SW/EZ&EFG6YB578 7FY
M]&=F2E @A.%2PT)Q4"5K<861$ZS0, >+6S%R2U&M;4/>2P8[D;&3MP+L\O,\
M)KM17&LS5-.KJH->1*C*\DO[.S<S59>/*>C?<MCW[LJX^P(V\Z&@2&^HKIX,
M!?F,E/MKBD4LDW*W+MC0D[/0;^<;- A)EG'0 !)L#AAEJ-;9E4M<,)=$FVA\
M[.(F*E$8F@PE;)<\JM<0CI?>C-RFH$32_81[CT[Z@ 7%<>5[O%Q,LVB:TS)$
M- ;BP:9Z.<8A5L\LAH&<0NCRGJJK9%I/@^Z1ATN)9_$<6DWTCQTM"P&]-JQA
MVV=&.:&*U1@B,<24*S=BZ]:2&N^,VKA_\M],&?OP\;WW1:WLQNJM2Z>T*+RD
M=,6]LB# Y*H/=17]PGS+9FDAFS?*I43D+L7^Y#)Z]B+2T%']KRV;D'B9P,9]
M"X(9"YT@/@KTV;>6L^R82TF4-KL5?CJV^:W$U6KD9%O=L2#J*8F6<IFC/T-%
M&N3#GS!=%"IC5_^,T[B]?$I;Z53KEG@PEH?$.#6EUN:%BSDDJ<0;>HB=+?(+
M*=@F8"\N!T=8+QJ*0E\DFH!'HSR>MXYC]&([HG$P(4%S)X&%4>Q9;%@O<G%%
M;[CM^$I%I6-I3![D]\*8/WO^YNW^P8<^_=62(GH/1.))?__WKU'J^E$:?I8T
M/" (_EH$X3I\VFMA6CPQS*(HMU:H365%(VG &%#O1,(0]J8!B_#K)Z[T0F*5
M#>K9-8O9P8M 'TTN588)J28I]%Z*H]/AN\''1W%T1\71^I6S4S+C3NKB$];K
M3K'6H3%JJ>J7M0>)+X-@+/.5.'L%58%/UJ:FV.>3"IOJ7,39.R8CT10W0[<"
MO:1W0^9A#^9U/<'PP]]"]\6EY-3)?40P3C7777-9C.M,8FS"4NC00I02:K@F
MY]_2L@M%!)7+@Z=E_B$D_ [DY0BR_38--HWQ?TC,KMVJ5=%(99]057=4S(D_
M3HF84'@ZP@&HL]*5B.9]%.VJ&7*TBKI>1K_DJA!,C7TSL^)R9\RM*$%:[S5T
M/9S>R6D82U,\*X^7WN*Z&BF3G!\HEA,ZH8+L27SHI"[(GO+9VQV4ARPIK[0?
MJ0KT6K(J[^5Q?WJP?S+8B_K#_B_1X,/^L'\R6*SE\Q<E5^C(IX;=JC [2::P
M_/$<&.93E=T1O> 66_55](-;'<6&BNV[9=H5>- 4,/EIT*7'KT-$M]D.-VW(
MK8ZJI.:)B9+9% [*'8HY'($T_,F%ME>=9H39[!=J!*.;($N\&$"AE[XSBH'"
MUZ853I@JAQU8!&',N-8&Q0O\- 5\BJ$'XBRT%$M6"7R42-W2A+4X\2^Q*XNE
M\U9T)+XZA.O.Z@*4*ABTLF%W.0&/AQKV(8'U=IE%<8UI%B!?$ /^.5[TKSVU
M)Q3FX.EILNO!'D"$+7UVWB_FRG/G(K-I3&ADC8L./EQ@>QPQAZT'@L&>/,LD
M0N_.4%N%H>F:6VVY],(T 'A$$G,^*!S8TSJSC$BN>+SG#VUME$=R\I;/YUZ4
M>7G:'Y(,'T&P^P'EE,QMSO9>/5))M*?1QC>)4 /).X&O+W2:S^A['$WK_@P'
M@A]&,/^RTC.*Z_&H,KC7TQ4\L#<F4W".4=<T)=56--0EC8^5=VW;E5)^"*J,
M VO+O#1 QAAF])^TXO:6+92/B-/,KPC#=6!NIM4\@A;N(6CA;JFB[_8/?MUS
M@-Y':-E7L9$/\LA'EYT2%=[@"@2K2S1YD BS0B1P0U]Z!R^(\ZFAWO$RZ ('
M%]84T^$HL3^:Q[*1N$KM$IHL9@:2$3\J6B7MH\=H3;MA/Z.DS!-UQ17'<O$>
ME34G/A+_D5&!/<32G>32+NO93%+(5J*O(S;MA[\6?Y<4.P>W\>E)5B?X,[ED
M*$Q\)BL8^46$$FF$7/AV#*IFIDRN^CSBJ0(K:N$N3HA$6K!S5SC*^>!V/:Y:
M#Y"$Q"'SZ#?XZX/Z VYP)=>&F 58<_+K+DQ&/G7XA=\^#'<=?"'0Y9&V3SER
M[2#;%ZSW"^R+_7U3*F9A?4/+A&B2$CDL]TGKF<M3U&'&]V)]7H6\A675@8XS
M:=GS!<X6'-O<H=CP;]*E9RJ)+1 "+X)KL?<V#V^D8?M,_N(@//Q]=%\8R097
M8,T:[J+=5"73]4CKIM<_3'Z.+',/+=(L;Z8 =]7$9M.920_&%@#T.66Q*<IE
M7%YS;A7?4S+#:%>A;".C:#? 1:@P0;/0M$(PZ<1R&005M2W-  4'QC@QUJ'D
M]UT52<D@5HR]T2</]'I=->S%*MBM:0/7U+YN9.QNF,XVAYJ==(L=#P!?F^0K
MH2[@_=>4"@_\(-&I8=_HKJ]N\<+"_Y04A;[(D1EQ;D>)BJ_'4I4@'._/L_L]
M\30FNI"OG K[[TO^>Z".C!\1AP?_@V4^__'_ 5!+ P04    " !$:$M4'RE*
MVA%9  "Y0P( '@   &5X,3!I:3(P,C)R<W5S=&]C:V]P=&EO;F%W+FAT;>V]
M>5<;U[8O^O_[%'63][+A#ID8L&,[WG>/(8/L<&,#1\@[Q^>?,Y:JEJ#B4I5.
M-8#RZ=_L5E.-!#@T$L9[A U2-:N9<Z[9_N8__]?^T=[HR_$@."NG27#\^=W'
M@[W@AV<___S'[M[//^^/]H/?1I\^!B^VGF\'HURE15S&6:J2GW\>'/X0_'!6
MEK-??_[YXN)BZV)W*\M/?QX-?\9'O?@YR;)";T5E],.__HF?P$^MHG_]/__\
M7\^>!?M96$UU6@9AKE6IHZ JXO0T^"/2Q=?@V3.Y:B^;S?/X]*P,=I[O[ 1_
M9/G7^%SQ]V5<)OI?YCG__)G__N?/]))_CK-H_J]_1O%Y$$?_YX?XS:Z:1+NO
M7KU^'KU^\>9YJ+9?O-@)P^?/HU?AJU<O)_^]#8/\&2[G>XIRGNC_\\,T3I^=
M:7S_KR]?S,JW%W%4GOVZ_?SY__=#_3J5G\*EXZPLL^FOS[>VX=I27Y;/5!*?
MIK_2#.".20;SE5O"+,GR7W]\3O_>XC?/)FH:)_-?_]'/8Y7\HU? 6C\K=!Y/
M^.LB_DO_^@:>3']=\+!>P,U)G&HS3![;X/(L'L=EL/U\(XXW__DSWF&FUYID
MQT#CZ6F@DA+6;:I.]7]O[ZBM/V>G/P1%'K8_XZ?(^W=_F5V^K2_'2QCRN<[+
M.%2)O(=>R5^;-=U]-;N\_A+MJ>D85FG!(FUO7VN5?OIQ^Y?G;]L_Z^M%/_B#
M<?ZO!=\UACR9C%_>9%>W7S0&_*ISP+_K\S@U([@%8KKF:X/^5O Q&V>MN2\A
M_Q^6K5GW?;NS&_#(K1# WIF*\T"E4; W.+K>SM[96'9>[[P,^G%^'NN+X%U6
M)?I<Y=$W+/E]#?AWE:BI^BO+@D\' 8C4YSO!YY/^"@_X.-CYY4VP^_I-\&KW
MY>X*#Q3/TJ+,YU]UOA5FTV\01W]35(WBJ2Z"0R#$8395Z=]<=IT7J"\0GX59
M.HDC.*Y!*/W]L=_9#KS7X[Q2^3S8Z9'BL>BDN.$)\M 'VTH.EQ6E2(=9KE"S
M_+5*(YWC5; /<5Z4P:&:ZN"CDM]6F&SVM<H#-^:??GSY^A:4B3L;[D&@IL$L
MT:H ];O,@CB=9/DTF&=54)ZIDGY1N0ZR%/Z;!"HH=*+#,CC-LVJ&G\0IC#F.
M*I440:Y##7^ "J_@=Q!?<8A:?5%FX=>@2N.R"#:&)Y^+S4!=P,$&]Q)G;05_
M:%#]-;Q1PT_ZKL#!Y)HNF^D<!P4R)+@XRX(+'8QU$NMS'5S$20)_!%_U',4*
MO'!<E5E.-V=5CJ.\*,_@#K@L3N%#>$,PJ<HJUUO!"'XOLQ*D4I]>LP\F2/!O
ME50ZV.CO_WL39S?'I\A@BT#-9GEV";IOJ9,YG'3[P?][>=F[O+S<"E9XBV%Q
M<0=I%K@WN*4PY@!W E80U@?V:H:;"@NTETVG61J<T);! ISP&02?YS-ASJU@
M<!GJ61FH(LA@0?.+&'8-5@;(0-.FXBJ/=#XM6*_*@$3PQJ*'9/2L/(MA.>'9
MO-TR#-BA<R 9N"+XI/+P+-C9QFNT@E_Y6O@OUSJ8 X,5L.EP0*<X'7,U2>G=
MK978B&X=^@LL_+2".?[TX^N=G>=O^R$N(_VQ_99FR)26I7AO<!XK^O#SNY/@
M"/X^ 5H,@>;U. #[6P=)%I+1#%RZQ!YXN?,FC,:W/IME$AMUEVI<H-[RTX\O
M7KV%32]H[/37R9??;VB^W,KB \64%UH;ZMHFTN3?=YEV=NYV6-W,N160'(IT
MJ>($13"QC1 \L0;R[E*>4ND<)5,"MO4XT2 '*Q"$\%$$.E943>EZO)LXM,![
MS/.!V6=P]S\*F/[V-MAWZ>DS?$=PD(:HGX&$/4Y4BJ(R TZ-Q,T"[RRS4XVL
MS_(#GY7KA*CQ.,](F%0X,A0[YS Q&EB6+B/G'HT395-Q!I9/! ]4-.XI[!R(
M?W@2L0NRO&65+1@I3I26HD=W3]4<3P15?.4#K8A/^;W3##@/3RC8W',X2^ .
M3\ A%VZ_>EO@REKM-"[G/7@#2'L\\^"(P]G!:80?'V;I,UP_7=++:?3XV4D&
M&Q&7Q!1!_Q0D%GFX-H3GW6W:?2LB8!/W&8ZQ%%Z&=]NU-7.=V..X/;W.!_>"
MN+2'I)X*B67\&%EN\W7[D6:_ SKR\RQ%[PT<?"B8^E$&]YS@I>-Y@X_X:$5I
MCIOETS*<H:&A7(V"CD9PIDAGP/?J:/%DVB_J@3Z@835@2Z9QB=0WKK%"HBY6
MXSSHYGT\#T*5!A/0H2P5 Y'IJ J5_(ZZ!GIOBBO8QXB(H8C: A2UD+DB3L.D
MB@S?P#X$XSP+SRHD(W@Q?C!2E\%_5+AA*!U^^G'W]=N@GQ87P"8@H&ZTA-TF
M]/;S>[>@1>V!0TAH T@;]4%:")4@0>'T+Q3\@EK>3&>@!^-5^A((*M8@ T4#
MQ5M">!AJH'#:BLC8"K[@?>>@,8K@%064%O%,)S/R:(-L3T"2YC!O8*%35+:J
M!#3AJ,I94P[/@*MT>DJZ&5H/.*P#.-ZSKP$(/E()1)_%5\1IA82.KG)=%$;%
MQ7N*"B1D4;1)_G9]= _A#CD!(@9.3^:]#F)L>*J?=WBJGW=[JK>W7WR;J_K-
M:_)4/Y#@(!_P0H_L*OE/VY&!\NTLX_#1KZ0R &LL#*D8@G.WJ'&1)56Y^)8;
MD;C_\RPWCY@!P3P;@_KQ]9F:@/3]5247:EXTWO.=1850;=+YM:3%HKO^;J!B
MYUIZ_LEH^.7WP3#8.QH>'PW[HX.CPQN/](81B[</.^/18/CI).@?[L.<#_</
M<,8G:S/XX> C[-'AAV!T% P'L'D'>Z/!?G R.MK[/?A\># Z"3X,^X?PV=I,
MZ?@SJ%0P9)S2Z+>!V%9'AQ^>X4X%!X=[@\/1P;\'P?''_F$OZ,/>?1H<[L.L
M<0_79IJX6_VN?;FAC/BS K5S,N?9@"8,,Z%SXM8TC.9TN@7C]M8BS_B(U6KC
MS637V&?V9HI5A\:-->*^P:46;*!J+@\3J]P^[S0'%=79;:(W4BX$*KA%-?Y3
MWL0.M2XO 4P SUI4?;-%D_D@[SFN\J)"K5C\I4M] SWT O;!/$/7'YD3\'!R
M!/A3ZAJ2G1]^#!JP]?+9:T,W?/FN:^EN87CT"+S<C D-RQ@,3;!70?&4E\%-
M:&W&9/'F>@*_P[O /CI@TRM4A?C(,<(%-FAI?4Y+-L9X9VJ.'SN@W@+/C;V
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MA5ZRF'9(4Q7Q:95R\*;&<6;3:4-Q*)$HQ:1\TC#XKC*C3-LN#O:6!;GU)@1
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MEJ$FE0<EG"8/O3="N^9++42C2[%X)8+))G["SVHK'+<BP]XLQS*J$7")[9S
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M202E4@_UPD)WO(_!CJ>4PD\J_ZK!8C> WGN?WAM ;TKI>\H@>A091.O,VMT
M=BO!VK]LO?[%L#:S9Z15(M79GGC'$R''2)IQ4$O:'G["%=K>Q>1];EV 83OL
M>^M?*'S^Z;V1$O!TO$[:=[LK36JO5_^(:<K9N<X+G!IG[SZJ Z$;P6HEJ.;U
MUO:NH1J'05O8E%"".V&B$2@3&V]D.%!6)6J-!8S^X$KH3:RW3C3THD7DX9&H
M35ZE \'D=C\J"NG&/5H)"OEEZY55&3B_A/:M:SM=BL:XWAFWH6]Z>$2PK?.E
M>TXP%L4LXZ2!!6+*D-RU&F>WB.+O(&NM([&M@7[Z4043'9XI#)3$:1S&&?Z6
M*-AWQ#%'!%$,J[Q\&^A$OK'79V66G\( 87FS@#OZN-L"%688+L8[4A19>,>>
MDJ>%F!AA--D4K/-7O[PE-99?<=_+1J_H:O32O:\@O\%$AIF\V'V;8CF+PM7Y
MI/-019G1LW6>,:^DJDO17B'*^.%?CU 56 ,%\J-E%U3)@&DR,%>"<P4C(?41
M?0(A"-Z, I0Z,4*96-1<EBWY#K8 ;,H_@1(+CODBJAGR%VF/,\H@XH"NPD9@
MWIN!EYE1L>/QGQJ'0#=.XB+$QG(JM.0?88(BA5%+]0CI: U4RN.,VIV5*O<W
MOT8_N*67>.23:"?]TNW@+&/@08UP58$&V9;1DV#)2;-$"@M)T13MT[L5?GGY
M_"UJ'916-$-T![JWR"Q!,57,'Q59K($>.?"V  E@ED6Y96I$QQHC8]-!SE*H
MMIETK.>*[BS0HW0=8>3ID)B7]2U]HU<A%++B<%G?591DG7%Y5'"LLUFB+?+<
M4%L+#75#3S,\'N[9GHH&W?HF<#<^=B';:VCVH9%H06@-XDWARK/AK0S2W&S
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MV^EF[;NO>[JN:*Q+W1O1;6S*?=/,Z^+!:G.(X,Q4;$ZV9(5251N="4XKRF5
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MK<TGXUQY!6?H>EED6=:+X2S&VWM=C$<4Q M9K=T]LH,F2:J^01X; Z9U>1Z
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MJF+QQ C&;YD:C!J"-16)T)EX.\#$HOLW'?ZWCC5X&&@9@?:IXP6FS)&5V>=
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M5SA,!;ZT(M@<4;^.!3^36/!CL87Q0@B@FB9+PEMQ$YD0(B+%;\4OP=AH^O(
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M\:GM8K_[KZ-/2VUNW5,!@+<:%0"?_"&<]&A:=4U^%!X<BPDFU  /FC$.#)Y
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MB>KUNBT-2TE$J.%B2Q^S'T HDCL?RP!TF "MR$L%$M24O==63&HQI V>SNS
MM144EX#OHKP$H)<D*+$,-EN$-TL_I?+;J1>LT5FI:V)X'@I@B2VJN)'V:K18
M=L:$B$M8L*$J\+>6JS*@0R[!Q.M+-8_PA4'N#OP):)%9QV)*I&%FD_.P$RAH
ML1V3*DM/RLDNY\K:[=KAQ[7A!HXT+,&[.@R@DVBY\"Z3#DL.5JG(B<Q0(T+-
M4D&H!O?1QH6LLR_CQ?B4+ OOC4OJC21]%_IE:46;9"C9TIKP/2973A!#J6U
M0RD-IH<CC2D_C36!\2P#*1C<2J6+'$\V')<,*ZK '0.E F.B%<!"* [,4%J'
M$.MB(!Q'Y;5<".W@Z**XBA*8I;QWE9!"VENV+Y<B\(4SS'7OOT_2='!!:D"M
M+:7O-*8<>_]5J*$:496H=3LX&./S=Z>\XHX 4H;?!I+F()-U2OI%%/%('[0]
MI3,Q.6XY@AO=\$WZ4Z>]?^4"G'B/B@DXVP,.I(PT<![Y8?; %-ULHS]PZFLS
M&WD/G/O:/-5>+"Q)V>-_T\7_(,5!A[E,,B'DRZ3("%$]CF%3,O67IW*Y$?[V
M+Y,0#H^DN/##_*<?]_;WWV$;=N D8E'@*Y676#1"R&&^D(#,?> HGTH-L$$>
MW9OC&_TBIUZ3I@6KNN:[1H6\!SL47&*S5!B9?(,O0^[ECW#>PQ/^+ +0%'Q2
M$;BS+?]*_3#)93>&OY@S!9V^,*S*91#Z+-C;>_%NQDIE"2:;>C*[(#PWHXHU
M32\TFWL% [4MH<L_O+.CC\>(C?J^]^GD]X[WQ\D7KWOPV_')[Y]ZAQ]['>_+
M\6&O?S9 9%'Z_X_]7D^#D)[V3_YY=(;8K][)ARHL*7YL@HFECX-?C^ / ;I]
M>NMZ^JG7/>O1V@HFZ^!+_[@\:^^?1UVO][E[],D[/O$^=6&MX((NW'#:A^_V
MWG9@-??V/%SL6ZA]/'[4TX5P<W&3NX>?CXZ/,)\0=_:G'U^]>"?PS-L')Y\7
M>NH\."DM#04VRZK_N?U_;4JZY_QO]A.6=_H]C0]S!F/P$2NB;;;W]:]YXS'B
M]FZ<IGA$!IO/@["6=[CLL)IMC=ZA/</B0U^_'GWJK2-?C^HG.)5:@U-=:[ 4
M@0*+^LF.4\'^M-"?^[="?SX^)/-C) [7\[0Q09A=CI(*1.9+P*XWS"2N5:=P
M1G9A2^T.+D(PN-"+B!X+[$ 39@V/J5:E/ #LM<1B\F3Z"V5-W+5J>&OWS:-S
M>C/R9EV(CNE_]RA$;R\F?KW]\C6NQX!Q)E+KY!4*(IHP$$JV$ "OZ4A:3)C)
M9=BK*D%N XKXR-AU7K^@"J0XV?;V]U^9Y'XD*#]V@"H,VL:'$ QY2L+[[*=?
M%9CL&O/[X/,'C?E-27!/BDB:@=:6@DA>;;]YI8F$-SI0?B3EN8Z@0-F28G1%
M^SHE90J_X1)=YV)R9-8NP% .=GUU+Q2*^?Q!TQL\':^35M7V2IU6Z=3 88IH
M<JG2#*?&F9/K;*RGD8VURLS>#&RV%,S^9GMW7S.[!;C-3!8E@90PKPL B0D=
M,M8HZQ*EY@-:@;"E[SIL6^9U>E$;5SN2Q>1[THF@TZ&?U''0C%:T%!3R:ONU
MT1DX(X/VK6D[;5+#L-R7MZ)P.BA"L*TW,_><X">R:<+Q_Y;319-<NT=L%E%\
M#QK6*A+;"BBHGWQOK$87/H9*PC@<A0G^%?FP[PB2C@"E&%AY^<Y3D?QBKD_R
M)#V' <+R)AYW_;&W>?XHP8 QWA&CR,([#GQYV@AS'+0J&X-Y_OK5.])C^16/
MO6STBJ9F,,W["O(;;&28R8O]=S%6@/BX.I]5.O*#1"O:*DV85V*_2=->(LKX
MX1^W:'"KR'LKH/=_,NR"FC0P30*:IW?IPTA(ZT>GP @$;T(A2A5IH4PLJB]+
M9OP&6P!&Y9] B1E'?1&+#/F+E/XI)0-Q2-?'9F'.FX&7F5&QW_*?"H= -X[#
M;(3-Y_R1(?\ 4_HHD)K[3Y".5D"E/$VH)5KNI^[FE^@'M_0:CWP2[:1?VAV<
M)@P7J!!FRE,@VQ)Z$BPY:99(82-2-$7[=&Z%/U[NO$.M@Q*+IHB'0/=FB2$H
MIHJ;)T46*Z!']IPM0 *8)D%JF!I1K8;(V'20LQ0J;28=ZZE/=V;H4II'&#DZ
M)&9FS:TEKF:)]L&ORPZ(];P"*H^%?7//#=TX*_-4)=-(&6RYOC*V'&J1C@YY
MVC\P'1HU//I=H&1<=$*V[-! 1'/2@,QJ-)G,J7WN'S $<[43!+SN@UBHO6LP
M#.)S)0U.)B'G@MKNHJT]=<M@M0C6!:_3D\M*&?ZESCL=;C,B+15-!8#IT];2
M"NT1(E2+9MI5*9LZ*Q4+KTCEGU->0"Q%[3Q::X3(PU(A6X:>E'I MY0JHX1H
M^/]YJJ?QR6$L'82QY;$4L=BFNJ83KV6.NW#R(R0^+9I1]DV2_+*SBA&O!TB.
M283(HP;W=4&<\\?L^H ;ITV,H?)P,E$! @QP/]M4@=A/0VH7DQ@*I5.!$_V=
M4TA#"SB=Y&8Q2*>YA!&K:3U_@EA"\'4.+Q\6N6XVG5_,U0+'V]!=L; &K:.K
MV@[PT:<R;J=S^X<BQ5??6E#!<3M9$.?(+#W7FP#K$'=3$1.U/P3]]_P":Z>D
MA_#0C[^:!D 5*5"11>Z)B5AV,2UQM:]HQW0REMZ+",2I$3(K,ZB,ED51I6\$
M"2T]P,JYG0@(\5"!B!QC_@,7- X5A=%5!(N>&M@8W<JNZ:53/]27H?#&QJM>
M !OGIQ0I9:1?T(%2%8]N/+^EYZFK.APU;0BJ<#->Q=M.5$1G#*^4[UY3WC"S
MP<[&<75X&&/G2HX"LUZ8)7;AIY7I!XJBIU(@4UKS;2S$"5G#HE:291Q]%C49
MDT%K8Z8YJ-GMHV4:?CC\2[&O9A83;HS5%;:2HY1+:@32TG$'9E!N/FC _=V.
M]I=*RG*YKY]%4<$7,/B(U#1(<TNW]0)8$EB]2[+*:6!R![(H4]R=5C#4%8Y@
MD=L>!:PTC!!_ELI829,ND**4/B^ 4RE4CU7;5+L;-S1,Q?T98Z87L)=_0Y$>
MOL\@T93GEB=5[@FXTMA]+1U3+CRY/C+TH@^5S]1@GC*."BPHYAKS,/L*E^17
M2MI(D)+C2FC,5D@BVYB^OOXR"<T"58['UF1(&7@$N!(%1SEFH=T"M&..DQ+L
M+ZVK<!^U@+Q5Y+8U<:90+C6DPT])2OQ1(L%JKXF&E2\#$LOA^M2@\@Y./IU\
M?O^-V,,K 8*Q:C#$QY0<CVK$1_1)+!I;.,8V!*9KH!R4#DRN26[=F8F'4975
MR.N=4H%I%X4OZ)&[>V\LW&Z43(:(PL4 @@=)($ (93>(AL(S"'Q!0J%ZBW=.
MW0]!I,0N-(7HG=QZ66,H:%2*$M0?P:%SAE>'LP%,U?I0:7"$P 7RPE=C<T\5
MU%H1@Q =41L;MI8-FEA$<]1SZ(C&(?URZ+EC]#<IYY)UWMB3S!N[+U27>Q4&
ME_[(=K *U"26?)JI?P/G9<0(> T-T.E 115! T]J%K%: %'^EN9BMBX%,\38
M(C=H9*X2YL+*>!'OJ_?%/;9Z:V]B87%*$5'>$<+U)%][>K@)61P:B&ZX8V_@
M)FAM/-"$[Y@AT]?!P6-05[E]C_+^*5'"&]"$,<:\&'_O9B7;V3$G'/ U2J&S
M'2Y-]J79$8+,N3 -U4-;"Z]["@T5']XIVK>2Z3GQOTHA2+DZI"'-3K_GJ;<.
M.3@Y&W2]_M'!LP.>?V)FV&'O^'.W_]NZC/!1C[X!*)WY1#D]CB@DM61PA T1
M-J?4\"Z FM687,<KX@@;\ME0^D29-H'V0+4M8'1;&&U=B8GC>V1$A0A0)E77
M'?'R.2MLP<8H\#<K[*>;UC,BN85#)RQ &_T[QSH:"5Z+(9IY+V@97NHW'OHQ
MPBMAMQ9,:B /Z,E4%P'8S?7Z2O<6]7Y-KA ]SGAV'9-WCO6FI>:A:?_?-ZX#
M[LD$#]JQ?PGT.XQX6>,&.WQ^(B"MB8?WU,3HAZ/C3]WCP[48?50Q^CM()^RE
M)-K9P+_>ZHLM=X2=AI<M,P%A@\5KM3NS)+LN+T,W[8C]X3K5AG( PA@X+.B0
MC*ZM@Y5;.*X+%5D88PJK4JA6>B&<4QA"NZ; 8+Y"E$J*,;)?74*P8A@[41)Z
M%$+)H_N(+[YR-FBB\HLDR)P\!TXWRF>@S",JU)7YG:>-R)>K"-?PH=\]/JCC
M-3RYW(Q5$1[+"/GX?HWH^)V(CF5'YAJ_\5Z0M#QOC6OX7'$-5X!]UN"%#[6N
M:_#"-7CA$F+,K<$+U^"%:_#"=O#"QY452V)??X0SNGO\QY,CU&]NA+Q.Q5FI
M5)P58+%?3T#!_@W^6?NY']55=329)FE.24W'Y(=93$>%WWV**S%>Z$#<T]S.
MJ-V577,W58M]) F1/4X3..:0WS)T#F/1A%/0ISM@Z32NLKOXPK]4D@>B,/'F
M,E17ME%4:DN(_2*_2%+LYA7&WJ\(M/0;_*-SW%.E2V7\ $0L)Y.H:^R$G"GL
MWJ7C=ZD$[?3H.",D-_BBME281L8U"L40BY>&V B,DM#&QLOO+J./*2X9EB"8
MY=#%AY2CD@QQ92@9;JJ(>?! &"N"CO0C&OGH.90!KDJFVR=_RL[F)2C^.QIW
M*@WP.FYAAE3V2%1'UZJ&U][&JTUO B^X,&3J8I_>V/J04@DA(5"B<UG'CZZ0
MC8(PPZ1D711( 2,9@RD;H\K!\'J+W@F7Q2'A[:0W]=<_ TI?E3Y:*]L9MG9$
M+7.CV.]H4K4X$GZQ(B1LRV!T2LT",=X-YH=8?ECV*5CCF0WS55)LA,(H]8>S
M6.&79#0JICIC(#5-3+UL= %_U&I%\+$G[BVV[ZEW1K=DW@G"EY)6JF%.3OIG
M)TX!]8 YC;IVYM+8L$ASX!K,RX^YSM-6F3A*VC )ROJ9!0QIG+<MN)EWLIP@
M;">,0V]#9#&\'1<8)P5&ODS"X,DG^1X='WYC?=[R':"K8NKU71R!OE,*NA@A
MA#:1NI[" 9:!X#$UM0[\ W(&(3R8,G8NST7\8Q125:B&>6 :0HHV)VE@RV0Y
M]T?#ZIJBV;2(E&Z+3,*#?6+'DE?@E.QVRN6\IB]OJ8+>H >4ZGH-^T<AS4*K
MSV.21B@X%<@9J@'@A%'4,FQ.U=@/(SQ1JK7(MC5OY%]A@)GFDJ2EJ3PQ)^U1
MO]>8)_ELG;0KNHV#[J>UIWW98K)+33+_KWO:/5Z3S#RS6@=N5C!PLW &^]S[
M[Z.#D[6Z_JCJ.K9LPM@ &<BBLUV$TP4"NUEM'?,PSV-X@O')IA7,SBHRHD7D
MJ:C#=9,X2%16@[J(W1*BU%D/@P=$?N+R2V3<%"6AV V]3 5.S"<C%(TX W-(
MH45@XB9F\1M?5@7LH:)AK=B3>^&SN@Y' L7%0Z<TZD[K0C3>KG.O";)4RM P
M_O/>SQC05C=X.4_ ,NAX&_XF+43S5C7MA\$7P=O0B0@$B*!8ULBX96,%E\1
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M65F8ZBKE49B.! [0D:VW;5 7UF">*";%"8?*+7Q/8M[+H;KPH[&IO4/X<K%
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M(,0<]4T*'\/%^LAG9D6 EOLL=4QGVL#DOI4*>JS<QT4LJ+I<RTS?B#\"6]7
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MR,B-=X6B:QM001-<?=L"7%\;)H6=8K;K<BAX%17NFMV3STQIAFM]YV(VX91
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M62Y A,Y03R&Z]K,1X@;#"_(5[$YG<M9?FD_'K,T5:9^[M%9UUD4GC R4#+/
M%!,J.[O[^VY&I2FZGO);3*AT71M9?VG?A.?H-4#:$WH.6/VE^9TNZ=!X]H!D
M0Q'" +%^(%.NT>2,QIC'UD^YD@_81LPX&SR_2TZY7:GA)E,,&[,>U9H&4::9
M,<BL>D-%8I=DNDD*8Q8P#K]*%8?W/&28-OP@#B)5$G1UKBGZRLWFZR=4C6@H
M]0;Y! "A,)5WU\M^= W56\I$"I'QW[G=.KF4D&5IFLOYZ=58405QX5_I*#9.
MT8)B9O.!;SS/JV/72+'LA47,;P@UT$Z<;V R/4M1*)'AWO&% 5#P1\:+S67.
MWZ?NNBIHVN;WJWS/';5:ZZJH9=HH* 1U"S2UE_:<V<#,\&1BKV3AA0;(L*S=
MS/6@9.5,CGKKJC@Q%40&3 Y'K.:Z%L0,XU"&S-J(6)I"E,O8<V!%Y-PJ6$H9
M5L_%!:ZKI!5P3_9!66PHW(WQ<W,5K*Z2GH#B5-@J1B?,;O;==-AJ*VF!+>4V
M\X>S&.NMJ^)E5XXP+:W@#.-;X8*;)"-.B=_V,= J]2"%E229@*+D*RW8?+%0
MSP$O>5N1=6@C8[9!RDW5?-Y>KG;A#96<J\,/L4=C.M.<;A _%!XYB7#,ZI>R
M< +,--Q9DQ,EX5>WRZD!TBITCRR(R U+LU', Z(]Y4D4%>ZI,)3LRA?362P-
MD%9""Z4-*:EYG,>2Q  -82C)$M99[ZQ-_"Q-8S J(\H%\9F:\H Y?ZRZZZH0
M)FDL9\O)D)"9)ST>1'Q"<;I GF5*IHR*/X_FB@$F^GJX2A)9-41MM%3PEH(1
MV@X0Q2KJJZEY2_ 6462<(5-S7=^'T7&LNZ[OY.A UEW7]X!\-<:-2ZRU=%N7
M6,LEUG*)M5QB+9=8ZX=WO(@\H[JVBT2ZY_P3!7S4QN9V2U:UEU9!FP<X6MZ/
M[@ V0%H%, \!BL47$6- TQ(46!-V@XJ; JBWKI+7>2Q'*[&*\@$0&2@^M<8@
M)K,$7DV<[FM8-F"BS3ZQQ(F\??/NX,A&=2.7YQB@8=XU>ZZ@/]/F[9O=_=VC
MX$X_)>@ UE;3-P%^8>J>QL;M6Z^YIA)@M;#D+,IZZRJ!=4=P.=TDOG?ED5O!
M4Z:T%#3&P,Y/*<?IIM;]Y'?(*=-0"FICE;<#PZ?(TCMBGI;,QS9NT-8$10MD
M,,X6^>P_C,!=J,P&Z7H9H3-5&J*KPE=T"*B:2\Q]G*$V5J;O*2_&X;AK%>$<
MMGVF4')RZ5VB: AS-2@Y74K%*)K(L[[,3%1H0DGKBHVHL#$&^N.QCD#F!K2&
M;1AH8X W%X<4'!]!0=T20',T5>BR!Y:,9*8FQ*<*Q3360A)*8CT:FZ4,!HBL
M^UP94F;+X4W=2+HANE[&YWLD9.3&+@# _U@RB/38 P\D4GP SO"LVOZ#9D10
M*</);9YJ[DJ*$(8%5P,,R!#'K 5>Q@9U<O,B=56T2@J1\8AY:KCHFYW=V!1=
M*]S\=FXH?L& #+&9>,W"XF5T]:OFNA;$[LEOC&);Y5R2A1/;%[<SM#&:2FA]
M;9@4/-"DC6)2'_MFC $-^)@'F*H7[I04 Z;&TBXTV9V@-IY*L8T759P:V[-]
M9DHSG(MI YF;(E4,6IUZY)%()!&["W58P>D[:GD]>@Y7;24M<"F336@,+<I
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M8=:G?.8#C?*O^US$?KAR]@=02P,$%     @ 1&A+5.@VZ7@E"   9R,  !4
M  !E>#,Q:6DQ,C,Q,C R,3$P:RYH=&WE6FU3XS@2_GZ_0AOJ9J J[PD#!(:J
M3 @[J>4"!9F;VT]7LM4F.FS+*\D)V5]_W9)#$A)FPL[N#LOR(<162^J7IY]N
MV3GYX>RR-_KYJL_&-HG9U:</%X,>*U5JM<^M7JUV-CIC'T?_NF#M:KW!1IJG
M1EJI4A[7:OUAB97&UF:=6FTZG5:GK:K2M[71=8V6:M=BI0Q4A16ETQ.Z@Y_
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M4CK^.>0$UGZGL<"F*V_UQ10>($!S^_249[RW7OGT/T%Q/X8Y_3]02P,$%
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M%<W](KM$(D5A#M>A(48$F^!6H)_#-[A-Q&3)AB;B!$Z,^OM,+D<)ZW/S#CA
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MKVY-4LDGD,42K/7P3^$2TM[ZDZ0/"$U+7R BT>"5;7JS9\JC4M:07X"_X?/
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M/69JW7\Q".ZB@M%J4>TI+4B2J%J,"Z_8OJ(L/2\8/&_\ =0RPJSYI>3N/QA
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M4=<P>\@XD8 F46&#;"SY5@@7[&_$NE"-*.B(**^@[I&K6]L!11=[VO,]YE6
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MJ]*;:^R'YX9.$M^#1;&D U2EYV6+ZJH\U].B^.#H8?755>"T]/( \,5KH#U
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M8?CT1^*2*)4>/7ST^!;,^ME@UB_V>=9$9<=','X23_OD>.^G/10^^Q/P(FI
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ML0A145G-M2/!R6% E73U-CD^)J\R:.&G1S\<)0>2"H46V>'X7,E]<IV3+19
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M12COM6T2<\;APZO0))83!Q'/7%@J5:Q/\R9LT[@P;4WE4?*:]6^$/\?J\Z6
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M\DZ:]K68;]YRR3TJ9CZ%(,SO2N\HY2:DH<<YUY9(<SXVP*6!(\B^O)YWJX;
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MNH*BD23/P+[ZVV\?Q*\^^_M?3YY_\_/O>JF,<>B['(8Q3-,YCH-$0=@ <FT
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MNJER<E65;H,!)[Z8FF0]N) A.)9B S(0IEGIN)*7"%\:>( (.'X^:!'%6(-
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M>.9]W(7W<8<XL.'>WZ[=SNPZFE-TM?I!<S40X@K.E0K0DJ\!A^?FZ<US\W2
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M-">0S%')CN/0(-B*4YF'_6>2[C_<IYS0>F1OD16\)-1A6JJI6"@%TA@Z61\
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M4.7N:JEOV3(2:I2DV7&@@(FAB))*3:W4Z$*)T48P8O@QJ7$P*,6AZ7)%#IX
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M$LNSYIBY/!:-D3*ZY%)7$^2 BXE4HS84M6+B9#9S>;S8BE5VJE:-"R D<14
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MA52B3[GG*RZ"Q$$>*;2<6J VU>4R'PW1CQ(;)67)7,B\4Y!N?PEB8U9L#CJ
M8^H:?%AH[3\:=FMS-:E5T2YXBG+A$BC26<V5 F&BT? R[&^'W48;.#6O==@U
M57J";V78Q%BIV;!ZO$X]_ITM+CSA]?>3#(&4E"E[-M]536D1$T+Q!%0CJ0E-
M- 1^3% _2A2,+!(4C8:9PP19>%A9E+LY#FWIFDT]"EZ:%>XE$(I35FG6HL]@
M.2"ELTK6C+X$BS#10'A)5KC#"?V*$L5G#;X!Q2(U1A-D[8:8)4QU:.WV\MOU
MJMIF<]\VQNOZ;-A+<SX</EQ^)"[4D@/S(0=*ODN:;F/-"[C4E V#G^J\Q3[!
MV^$HS%!$U'(+.0N0.DDU$$MR,4(=5R>P/X3BFVK-[QX^14&J'=N>[%,;]K:E
M4J0;)P1FZPQ(2E,=D[DD?#_.OL2N56HRIE8!*##YRLVJ-J>Y6<"I:]-]V.9>
M9&K-2)Y:Y! "0/526DL.0Z@A(J0\T0AZ^;:YN[CI52USB!5+A<B1FJ+GAK['
M4$MQ!$-LUW_@M?YZ^U97,]OUHFY-'VQ7]?M''=?-_0>/Q@*+Y\ADSA$6T Y+
M;%6B<L7LNZ!QHX-E6&3ZK:W;:GW"RVIO,?EV<SH:4Y%DXJKV8,; @)BZQ9CE
MR%J!XPBVUQ^0J>QP?;9F$0VU!7+@G4E*L61?6Q$OT8U@2>BAF,H.1R-=#56I
M*[S8@,BA"Z;-.^FZ+VJD$2F^?=O,_E4=5JL68\C=G@"[GF/.B9($B+Y"&5-J
M_3M@WCIY<;QZ;>>F-L6D.3G* 3Q"SY6AI2;.>TI)1$(M!<<T.W  $.[%"KNI
MB944,767&K11]!!3"3%FK&1O>CAX=V&%[G AO+$V76R_XKHX[K?U2[_Z<G7\
M<K%\^NY!NZKZ\'MEW<ZO=OWIVNSC#'K^P@=X]_X^P.VH=CY9;C%Y4/%0<D_Q
MBO:$#Z1A*,GS&YTT\^:@>/.N/'.[6K+1!;/3F!OTS,5Y+%PK@3:A2BHCD,R_
MA<=;FJQ.3FQ=%WS\+?>',A+)3-;!\,8N*(-QHLRB^6PC<"L]_S_#)+AX%3!Y
M[TONOXC/S[@0CES<$1=\82G%<1*% EE2=]XQ.E?!]5=C:C.Z5T/=O_ >YJ4\
MEP3)":3:V&6&&)HTL&'=ZC@][1#Y'MARL5H_6O9;..U!\*P0;L@AW3RUX2N-
MQ.L*E9P$'?C8T]GJB:.H#ZFQ#Q3B"&8L#A&?W8VY OG0,C7)4: U%E<*<452
MY!)D! MJ/@2?CLW=U<NS4_6O%4=B0][5P<=1:TZ!<Q8,-8-$;&C-YXG9T&5B
MM#L[$L:JPCYZ3&"^<>#FNZ/K[D^@1)N6';GLW+F?&XL-U5;9#^6S*F?HMD15
M,[(U<=WW08W3LJ'+PF=W]A.3HYJ*H]CQD9*ZCG,IA&'YD>,J<5KV$S^+)>D9
M0# 2 ^KI5VG,V>>AT(@/R%&)4*EE%9=T6@9T:0#ML,^+E^[3LO5 9$-!1T9*
M18?!QUPMEHEE0NZSD-RX+ C0^>[D?'00P>70\Z#HBW>)- T;#Z9E09<&T YS
MH8R^AE:*4@1B[&HN0:X8*2,T&L'ZDP\!R'_FTQN1D$9B04Z;-^F)D*8"T!0)
MXU!>6$V$<IB8B+LT@'9G02%:,6\MB $XM"ZTS^PE\_ W'7"]\S\I$MX -!8[
MJMQ*E(A(#(X""0U;OREW,^K!J$[+CBX9IAT6#-/$R46L:=B=3XV"14,'.2?/
M7$90&/6#8+IP=GDD5M2E@D5E[);DH7L]ZGEJZHXN.$[F\M0RHLN!9X>Q:)AU
MH"21BT*IC*$*](RHM=0L&$[+>MX=-2TC,2$E)RYEH]2ZGFN)Q7A8OQJL8"4_
M,4%WF1CM<%S!F8?JU&MMX#V+BR&FEETQR=%/;60N7_@Y'(D-F9$!UN *N6%/
M&-;8AKKI+8GOBFYB-G19^.S.?G(T*M:H%'50Q0@#.4VY)TB^ECRQ&5;W6;D8
M]J&1&%",F3H4UA0:Q*&K)[DT.#EN4&EJTZN7!M .YX8<9JW>DVD!L"C#.MM6
M.43DP#J"]KP?-NQ#;UQ<=".Q($>>?-72T^P$/C<>^JL0#2LL4P(<P1[7@P1H
MAR,)636G%DLW)(CJL)3&Y(:)!RUF(ZCI\(=U]FB,*$1 Z.EU)5?!A*E"D=:E
M@E 9IB.F9427B=$.(U$8MHF;<>FY4,R C5N&FE,:YO1\G98=^<_Z+9Q)A3B6
MY:81U;?JN3E70%*0)B2U_TZIH,\3,Z)+ VB'<ZP&76T'=@H9O&1F#=V@6F13
M;#BQ50K@SX4"C&:97 E)DJ7*RM#,44,1R:T%)D ;04/# X1GESH.+?GL8W,V
M% 462$I*H-ER$3_2?66_"\_;B3L8RQJ?HMV5N>*'0C+0NGR+ AA[2.INCPU'
M4%;F( ':G06I*+H:JZ;4XT]P*."9A];@EHGC"#J"?A! %_M18"R3JC(LSO:)
M+"2",HSP:&W84R/M@L'CQ 3<9>&SPQI-3CV3<!.N "&0IP2.)??X$]P8B@%]
MT'ZNS^B-P$YC&49 3EU<2T]V?.D6HST#<EB3:XEC)AM!W_"#!&B'&JXK:09"
M[XN#1,JMVY0;QA(R ,&(=PH]M/7)-RM>CL12I%KPK8 :!5!RY%N2FC2'HI%T
M!#7?]PK$#D?5BL.A:!FZDB"B,L;^?R!-P13KFS&!L55FV/<>8;^S:@FI5L(H
MK@QJ.5J3+I7[MZC4W94+^D8S.XIN"OCXS_RE 41'T>U"E%4-$&*/@2G T'>T
M<1C*#PU-NO!BD_U!AY2'_.J\TL\-7J]?M]5Z*$)VCE-=G2ZWZ]>?/WIP\!'%
M4HGDHD,;MB<,=69*3KE*E:):> 2A_=_@\+:"\VIMBZ?+&^>PC"36^T;84<&N
M@ -8C:):D3R$W-4QQ!%T67JPY>U9":Q;_WO:[^O&ZN3%:ME?_J)4]O5:3T].
MC_NQ>M/:8FGZI2W[#]MOCWFYN:[/3S?;X2QW;?MM?WKK![9^N:AV8[79G@,_
M$D"=%\XUU9"[4@LIL3]KS!21JK2 (]C", E =SBP@.R"9 TU%# E:K5$-%<3
M-KO8VW70%OIK>+Y\/?Q]5J[^1@?PZ6J]L%\UM?_EA\[I\&!0)(MM/WXD!DE#
M8Q].'CPX<&2B==@UR9*'E=T\BG&'\>&WPRZ3U1D'*S$-LTI<,1AA";XTB]'T
MZMC?D"N\06\LZH9S$5*A9*@@EJ22LH%7ZBJGQ1$$P[%AMSN[:PY*2,%SJ E$
MD5,MI?H> G,.'D>Q//P/8'?6TN6;U?+I,%9U>_G2SE7,6*)=B$/#G9YL5^Q0
MY4@^)X^F35C-N5'L_1L+:KNS->=ZQ@<U!&<5HJ#46G+/S*65_M88QDEVY"=O
M\&;H0CC\,\B5EWS\'BB^]TU^Q8OU/_CXU+Y\_?;'_^Y?>^A]^/J;H?/A+T84
M+@ZZO7QQNMV<'3&6!8?9 0=10((,PR!/3DXQH Q[Y!R6PZ?4+M *NZ+./OE]
M*)1*#5*+G%OT#8;&Q$X[@SBS-<RD(QBKNC)>:BS+.KVJLE#(B E<]A*'@M>N
M>ZOH474.?*- L5EF:-E\+@ ^-/9,T*I&C=T_C&'UYV4H@\NFU$C'Z[)WW2-
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M])5^GEV6@^KK+MBR3 3R8I2F?!K6UK)U;2E;"S]<_O8M;I1N+7G[5ATZU(U
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M(Y6=L,HZ-3&)J<XXERS%\6W</9$HQ&FY^'C)PS6_QBG20%G-=L8WPRM0$:-
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M.;B;5>.OF1J!Q!",XX33;L4+(-3[8$35>1_R8+W*=ZQ99N:MF"U9DQB2E#1
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M?8UM=&48&/3\H&F EE>_/H.3\@JCKM-&.-G4SN-_B+OA#CE7N>X^7RT B5V
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M@_'&XU1W<.%1]&4OCL.Q3THI;:$NW5[F*:3K1=6:"U#[ 3:EH/F?1,!X;)
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M4R%;Z?Z),94X4TVE-M8AB!E],-<C;V04T9NMY',.8 =>O>J&UA.;*G_OP)#
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M617IX,F^$/]>PEVI@V(G?_OU[,SZ H^#2^_=5S'^;N&8+TSPP\-^_WQV99W
MEU7GQ,?(^D>W97T6\S"2-J&>,""+/PJ+PKMFZ2M:*<?<7,\_*0E&!PRHA._-
M&)E"<</6OX(L6 .]@X_ .1Q,0LS_G/;97N9PY/&J4S0IZMVY1*@O8L6'RP0K
M<S/,>:,GU+ ":3EWLNN#6KIS9N$W+X+MDW]^%RIA(^6BHWGI-R]T2XFT+$Y4
MR88<[8=_>4."F08EX0>RB3+]1FI,JNY]ZDW!BB65NR# V3G=(50BKEI59$ 4
MX^FR[@3_:X(;3Y3)/X[ \'HGD^>Y!RHQI ET:=[%0V/%%+MU>E;Z @7](@W.
MQW8IJ_P(!DC5ZLE>^HZ:8N59[>X[N-'08]"Q$7G&I IZ^@U(1A'D$8R+\31#
M,1FAM0R@/6?0T7V!/<I!K(S<93%<K )RZI)^_,=K"2HM\9DJN-+]^/="C5D@
M.Y<@WV?DR];G*C\#)A"_EE+] R=1F^1CFN ?HL$N@V&*(N8$A65LF$%F$:^F
M+9&6!EK@=RE@AMD,*G0N;_4^$ 1YH<XJQ?&AD9WIK YYFV3!>7\#(MHJ3J@Z
M&&3QN!(@F=V46A.CNI+"U)IA$![AI?PX:U/!X(@<.G61DTZE757F1SU,F30Z
MFQ"J&T]%!]#R-]MC2$FGTV<R9%&)CYOD8.-EEXA:R8F))42OII!WNB$<RV."
MEI93+K=MPK2(27"*JD(7JM.XG4SL0$4)@KB:>'/"Q%()--V(HGY&8KG256:B
MT<H@!^A$,\ZN$L<&W@*UU&CS%S'(I^"QUD<%?%)!ZS'55"L.95DN*6Z2H&1$
MJ'R;1SU'9LA'1E#E5Z27<YW#ELHG2PR;TOQA-GI)1E1HZJ$JW]3J&;-?-V"7
MA(=0$]C_3=VA6+^IMP?V%QB@9$@B,5.8*4.05#(W'1NOYC^:&'(IUG.A7%!A
M5H=RA*A$TIJ  RH[Y\I.D!D4\?5@%6S[NE?YO52T4T&F.):$D$^7I9++I@C<
M""^1,'MK>((S*^-0=MRIYEPI4W%98DQ=)K>P-A%,5:C+QYSRC.:-R2L_]>LC
MSZ?V&*4]I.K)W_>948^<T-.S=+F'%&Y9<JFQ#R1&>*96\JNNST'^<G+QV^E5
MS4 J#'PO&:"F$GV5)91 R;,E2K?*Q0;2:+:4T4QI!FTSDWN$?]#M)#<T%$+K
M[[%N%$3AA=?D,Y6RR/% $0<UA5 .O"V.5O*#\J7*2!?: S]T7TZG]8NVI *A
M1T'0)"Z!B89 #\C0U1**,+Y8*0(_0</'PYB5>IUM_0T#N_&M]0WM7=OZ"/;"
MQ/P<BZ31&?S7T@MD4P2M\'\\H"3]702.]7$M]TC5H%$545!"%<*D#1!9_-DL
MH3%.;5K=88H2UU%S'3774=>TCKK/==1<1UVG.NK"M?J063(RH!;KWO5[F9O'
M1.B=I[+2<-\NU5C64#GC!<"FE<=**_M63*8R#T\S:7V1&;4Y!TQU(2X1%Q=_
M8UR5<6&P5<Y&UV\U#;&2FLQ[@2!+RN#&B1G!%/YL#CHNLV),*R?+#851+E5D
M&G6*DC*2*-NX,A2N992:-AKB0MH_^@ED_JRS_>ICZANC*\<>E?*F=0@FBD8^
M>VE.0S(GLRS5&*X'L*YE;_?*QT&>'3CD.)]M7T'3)%ZD8Z,/B].F290KKBA
M<U.J0H%$F[9P%@;+-TF4].,;@YBS5(V&&HZ$-.S1T_%C>N!$7"O0>R-,0,ZG
M&03';R%_R%Z4PBN]7^4H8$VP :-" ZLD3'?**@.2KC1?BZRBUU"_?C%-FR$K
MI4""!G0@G=054 1/]_IGQ%>XNX5TGVH+T-#XZR#QP6_(EC'&;%%B2;:D"&#P
MTZQ'FDHVIP&%:G-?M[RI]'?2F$@<EN-G96@A*;0-#F?61'>LOTLX5##9H_ ^
MQ>S0: >YJ73J6052/ 8R:D8@EPMR#I643>%MR6TA1)MO^"WF/YXUN"V4T>3B
M7+E8#S<@G%\*DV315#\@7!XU]&%]3T+:?V"B#N7JI++A:9@[(X /I4I4U.=I
MB<E-4<S*LBFR-5/C1"G991PV<TPF)0VC.U4=I &'\WXRE3ZK6\C :LT88Z9
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M#5X)MQGV)T8(_../O\_([L?OXR6#M8UT?M-="W+1%*RU_%U6C)+5F([A=O)
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MGG<5&# WDC;%/Z@ *HTKN5, Z#1@XX-U"[[+G1;3E8GHY5"[UHQF?OAJLD9
M!YR\=S/P2SCT9"=,!=8OD=.$J->$!:-!_,!@#M#YGI4L/E?8:\0I2QNDX8]
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M_R!WF]9](, JEB\$R6ULR0J:3V(L$$0R1S8W==22$#.I$]GJ12A$! \KGVH
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M";W'@DW>^6-!MM,7M2C\^^42R K_85M?Q3(*LW7:UGF4W(8+#[\LGW&Y "K
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M!.,'%@@6B/4"L>&=M:$]#X3:Y_8R6_S]JQLPU7T.+_UUE[ZC GZ*!0Z<0>^
MQZ@\6OU'X&/=QF7B):OXD"^N0*H&!&:-:U37X<_:G?9A!RBR:%14-%IV=VNT
M3A:-(Q&-4:\B8YN/MK1ZW31M9ULTV,J6R9;OL&&5SLQ&/M&/0\EVG7X#:MZ/
M^# ?$0=WU+5072_W#$-R 8U1]F;-JF!:@RYO#W@.PN[G(-C#$<^2W3U51^V*
MR.K1UL^NF:72=H;58$R#B.H.JT)4EO:\P=?:9A(@"_H&]&ST,(T])SROPF35
M=GUJ2PR_7C?X=7=@NZVZ()#PA $6\>< )]N=7EV QUC$6<2?)>+#(4]".ER>
MH!%8W3AXCV6HZLVMC9*X(4_1J(;$L9[<HE^[\XQ47</EAWE_7+RO=3&_ZJ3=
MLI+_A3COE7L0+_[U%]_X@OXO8G*YC*;4H/Y5+*,P$>/; -XX7>D&XT+=0ROV
M\@V-[%YGVQ0AEW ?@V0,[4Z7B_M9,LHDHSLXK&1P)?":>H^NTSG6HO FL;%S
MO&SD$UV !W1Z1U(9SARL.P<;7]M_'B6WX<(3$W\<2UBV!7SG&(K\!W9OT*I&
M*6F#J-JW6RTN\M\]5;NM;7LCN>QY+T7^?8>5R,Z)VN4B_THRYDW?Z7"1_T[I
MN<5L+R[RWVN1?_6BL:]=&UJA.&V3R_L/7OC,DET]R6Y$53]+-DMV,XOYZYKG
M>\%)J8K\-*",OX+1[WU6Q-9'UAI0P-\ 66/=>)#R[09(#G/]6+A>/LS([96-
MV]IED?5N*JSW_Q1>]NL\I?(3(.'P."TZ0%N/@&RWG%Y_]X/ZNDZWM_M!?:_S
MU)[3<I\[Y/#Q 8C=5Z# <-#FIU;HJ2P#37KJ8*.GEJ;6NL-->@G5%?%J6;3G
M3NZ\7"X6,X$]AMXLF]=I_1J%]\FM=1;<A-&<X&%?>:A?A;^Z8D"4CA%]+'_Z
M^I.O^AN9V1O-$*T:^0\Y&W9SUZJ*[-[9,-.GC>PM9NW6G:1[FW-:AZ^^0&3V
M_I *B]6CP\;2S6XP+K@.F]T,<[YF\_!>\)P*LVIG<EF3_:X7S8:,L=[<<*CZ
M\.?-[^NF[&378ZQKL.GM!A/78$-Z]K"UQ2#JNBO5IDR7YMWN1IY9155Z0ZRB
M>+=-VNWC\KQ;=,#]5TX\@FJV)6A@?1SF/86P:DZ"JCVGQDNO_W/VC^ZX_X[+
M,]#ST1)3F2NAJFVV68G6DB,!9VO;KNLR;!]+QFJYOCWL'P96C"6CZI(QZAUF
MF/QC-S+#OQ$28/=8D0";Q,:V<QC 5&;C3MGH'B\N9X/8V&XYA[GMF(T[/8U]
M9UOLO,:PD<VD?(]?SVD="<8J<Y Y6$T.=IT!<[#6'.P[+G.PYAQL'PD']X\U
MOO\=GP:3,!Z'B_7U(@U"]VS;;G?;Q 5CICX=VAUL'?1GJFX0,!]6A*J,N9S7
M(N[6D586]PT"9A5!&&\04=WAUN$K)NI31.VTG0$3==?'?[1U$I(ON[VX>ZZ[
MC<?.DKX)0;<(0S)!GR9H:YNH(!/T:8*VMQDGQP3=A*!;Q,RJ-U6DTA&L+S@J
M[Q%(@@;%7MMVO[6M[?E*172-HFJO?9@*N&93M=VO"%6YDB'OP!ZHPJS)-(4+
MGFFZ8YKVG,,VF321IF_:V\RW8WIND W?'OF=[[?7C7IOGY]A0=^ J-OF9YBH
M3Q&U?Z B\2;3M#UDHN[>96@=TF<XACHL0@&Y\^+Q<N9%QU"+Y=KND#/^NZ;J
M:%"1FJ$FT73KZ""GIO=RT[>=5C48TR"BNB,N;GN-.JR*J.7MK:;]@L-M>/*[
M3G>MC=20+8+%O8LM'L-%T*O*Z6H03;M;>]%,T]T&W_D&>#P<N0G6?:VWV"IL
M\1B*>2@,8GV,O, _CI(>UVZ[%2F3:!!51P-.Q^]>4EN,X%9)SK2W-]98W#<@
M*I=)[9RHA\(:?(D*J;"-V&D_,Q!2GRVVATZ?,:HV=#"'^\?F:#@].TS/W;9J
M[1W^IZ%ZT77:#=?\KM-Z6?RCAF4@Y\FM.(KRC_: F^AW3M,>Y\-W;WY6!$&#
M<W[%Z'A%JG*:153.I+X"42NBEIN1%^L.G4U&*M=ZBRUGR,4?FX,K;.&DL[YB
M@AZ H%SWL1M:_M?_&;;=]LI-VK!=OEG!BWEI[4?Q)GCJ=VMG53Y]ZJHQ87?K
M 6H;[OB@^J5\JR.[UTG-A3V>Q.>D\3:C\@OT'0MV<P1[:'>Z/19L%NSF"79W
MP()]H&3^"PY*1<3'[6:](<<J/7LC]HN&NC1 UCHL:RQK>Y.U%LL:R]I>9&V8
M==>PK+&LO;*]QGKM\++&_L6&)'SC;H/_?@22PUQGKC>5ZQUGQ%P_-J[WV?AE
M4=N7J+59U XB:COJEZA>IN@\2F[#A8=S7V++"R;6Y0*^\_XE12%K>6^R?ZU7
M<!0OJ,4B^06'?T$M%LDO>(47' -"T6^!$/%+6E@K48)1OK>M2S"J4VBQ#K-F
MV#WLV *6C*I*1J]_V%%Z+!E5E8RA6Y'Y,0QO4LS9;MM)MQO&[&V'+XH5U8:-
MAQI[PVS<*1M[!\+R8C;N%C3B0-/2F(T[9:-[(+C""K"1S:1"(K_C#/:-LE4!
M,6 6,@NKLTEDX=ZQ[IB%NV5A;__XC\S"7;-P^ZJV>K+P&/ 1_^XO5I(O&\EM
MS3!#7+O3W7:$ 2.Q/$W5=JLB<'Z-HFIG6!'8.,;&*DY)8B6R:Z*.>#+:*TSP
MXU'0KQ 1=)FHN]:H@ZIH5+[J5D#VA@<'V6L80;<(03)!-R%HBPFZ2X)VMXFP
M,D$W"5D?1H<>0^'P5>0MYQ[UJYS^2"(Q]Q-_M9*XB4'8MMWO5V3L6X.HZMJ#
M-D\YW3U5^YV*#-/DLH9\C*#K;!N[97%_DJB= Y74-IFH_<[6X2PFZE-$[?29
MJ*\Q/[8B0X[YLBL$Q+>-W;*P/T73KG/8AJ\FTG18E7G>#:+IF]8S()F8GH^$
MM0Y$SV,HR"+HE>.HR'*W;ACFD//35&UUF:JO(*N]BE"5T]3%BJQMN^U8W)\D
M:HN)^@J6?44T2(-HZHZX).LU^M"Y)*N*C'DSVJ;UA@5] WKVF9Z[+<AB =UM
MX(H%]&"!0"['VHJXY\FMB(ZA^JK7K4@]2X-HVN5ZMMW3E%'W*LD7=[BU?\7"
MO@%1N>[J%>* 7#6Q<_-AR'57NR?JH"IU$WS9%?,S7"3T"D2MB+0WB:C;]\PS
M49^,N'2Y]&JG].SO'WUK)Z57Q;ONJ=]M-"ME+;>J,59K<R3_K3=]4-$LW^W
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M$MC+. IC^#^S&7PYG"QANTCMV*F_*%CM5KME :U R<+:_!LXK4$"M C$U$N
M?_!/R6')&&3[=!9>>S,0FG@!CR62X9\_GO_C[-,[=P2\"29B[H\=:\UK)T*S
M%/S250'<1/1<E-QRT9.2EF?-"H-*M=7<^_%.JJ<.::</<^"A_$-;_F%5GY6I
MR6>HPFYE5&&Y #UR<#-N@GQT47?0N<W^;)X\Y&_+&6QX3O4SRL^I_&UV3$$.
M?%A<M*3_M"T13,)X'"X>4"*649B(\6T 1)K"'V*<D6A;WP,AUP0/T6<[+E4N
M*TH!WC87$^1H^D/'JJ!"*+_:OHC)Y3*:TMZ_YHE3PYONL=T4M9UK7H!=IU-R
M 7;PKV6R;N-W;\((WAUD!T#\&-]ZP518$>@YD)X0%5%><V:+P,L-S,BB/FNM
MUV<OOTK[*U=IF79<X;(B<:\+/)";"L$C$C.Z%S*+N:"YE%"TLI]XUW )+)/U
M/S&$9PQG2T1U,OQ[7:?;ZVUD^&_SV"X(87>SQS[1MU'Y]HQ/R,W(\N;@W"<D
MTO#D&8D^'"T!WLZ"-*\'1HK^4ACA40QQ8,B]#Q=$O!!C,%[$Q-D@#?5<BI2+
M+,4(]IKW[!2.[QIOS_S?VRC;_!1,$M #W]]Y-W#6WGNS>^\A_NDO>0T/!T@[
MIGU85?'H[F2[;FN#NTIR!RR!$-0KJI,E6)<1?NNGOUY>7?SKM],+,#TOOIU?
MG%R=G7^U#O7_Z&KY?'[QQ7);[WY[POQLK"-=?C\_[;GU7MUS V,MUC9"P1PL
M>'55M.)>;O>T#(O<17JOF#WDS6_@>[70-W_,]]K467#187_267#WZRS06^EB
MV41DCL)9.(^2VW#AX0:D-4H3YFOH)ZS9R&,N D(1KIX5A(M[71>AO>(BN&UZ
MYROY".VMPVT4@GEEI1T6&49^>W:&FB1YLK(,-;7\5Z83^V5>:I^T\*M)(.K=
MH@2VR2_>@>(?I%&BHKIWT5G=7MVO5_(8X8'5P9_*!&AC[2TO!$,<RZ2Q1*-O
MEFWIM<O"B%6[!GZE8_DM"F_\I#8'3RYZ08O&@^&A,XE1!G"#D+%E>1&0I'Y7
M)4'H.B!1[7>R/[6*1R,[%?1?B9C'F 9%<1<@E;8U-=>1?U7/&?V2OF*8OJ+$
MAA'@!N"ZZ<M:3&GQ\E!($;_Q[L!7PO")MFOG_@^[5-35@1'@;L-&]%%;R]P*
ML1)/_<XS%IKTMM8N2)5'A0;YUTFU&;!2BX@[>IF(9/I2OF*8O6*4OF*MF6O*
MA%W*9?W7N1<L;V!=RP@_,\5H&90*DGX3;@)ND00H*E!-XL;$3(R1!::Q.Q83
M-$C67]7USONW.\Z@-]AY^,]U'7>X^ZAB]1[[^"O;[6&5%GN@QXZVJBMY*NJY
MML:^3E\=;1+,E<F$PP>XO\G+H\1A;D+XOKPC9KN=5(53:.TU9B>MINS$'6VQ
MDPVTRS;8;=6DR$92VH!M;B+"]=]F0;X;B\-WH>-7SRSQ/I(Q4%MONH(5ZV[+
M'O5KUIU[F$EG+.(U%?&1W>H-6,)9PALLX?U1Y2?&[%'"#X1H4&]T;<RDL S5
MJ\>TYA+788ECB=NKQ/58X@[<#[U-O*0P\*H"UF8YA\^".Q$D8?0 ;Q.+!=9D
M+3#U>N/YD77GS9;B);,[JG>XRJG0[O>?-])MUU9?@VC:'3))=TS2_J :)-W3
MI+^ZL,5U6'OLFJ8MI\,TW3E->X>CZ1,6E"ZS"D)LNGI,Y? W\]]DPAZ&L'7(
MD9;K@0N!34FJ'O,==5NK@G]9@CZ^]:)IH8)H2Y>[+BJQO:V16L[C5[UE:D;2
MWK87-Y/T*9)V*B*E>\I)U(4M+:==#;XTBJ9=ING!?:D=TI3-TZJ8IW4)27]1
MC3T3<>>/A16)Z7)&L!S/LTAKYJ0?T$5O*$6WO:29HD_&H:M!40Y#%Y*UP[;;
M_E -WC!=F:Y5IRN;IAR2KM<W&Q"2+J^V.9E@7_[SVW9>96)%-4C#@\R-3+MK
MM_LU:X@XP- 0/CQ\>,I:+4"*^>SPV>&S\XRS,VSQO5/5A.$1C"U#3"Z6OZIP
M@X?L/=D>5;/&?);6(Y96UJT5XL8V@RBK!E][(6+A1>-;V_HD[L0L)'!?JJP\
M#6"A0A "YNF/A0CB1S#-#XN!FFUB4MB$,#8AU":V +P=T "B'-YM"C3:;BG$
MZ=[SP4W3)>6Q;Q'NN?#63O&M)J3J)S\>^PNDR\2*O/D".^+@PQ@>+M>"W7%C
M?^8G7@+;74:(JGJ? +W@O6J]BRC\MT#P9_BRHB)0Y3[%<<;O(I*Z!'^&I^.'
M*?2_K^!1_2 14SF2!+<="8+XRX&RCX&=D7^]3.1FB3)J]P4XU*;.IV,8U[IA
MC3*,*\.X[N^K#.-:F8@BP[A6="<,X[HN;%E[X$^&<6W2-AG&=;, "2, U@8!
MT+7;G5Z]PF^,<<D2ODWR>-AE^6;Y;JY\#QB9[N#%#_5&-QPX;1:A>F6$ZRUP
M_;JE?%G@ZBYP[.14%;ZU>HT^=?DF$Y8)6Z]O,F&KTIO(>"35LEO*=__&;;7?
M<M?[[N@Y&#$Y=TC.7O_@Y&0<DCQ+6L[A><+T9'JNIV?W(/1DTY-M^GI]DPE;
M%6>I+H4[#.3"_?0;%?VXG4Z]XN&,1<%GIQ)G9]2J62:)3PZ?G&J<')=/3L7+
MF!J-,^#4;-+Y\< ,L+"N"BO;YY5A!@OK4\):LPKDXQ'6>@&X7(H9_'%J6[^*
M0$3>C& X3B9S/_#C!)$X[D0*WY*%N*JSJW)$EW174V-77GY7F^*Y2!R5',)*
M9X 0*P2M O_LYK%5.GVG98"K_"U,;N4C\$/ZED1-@4>IN8.6GD@(CQZ#,'OP
M8R^.80V( .-'A)GB6!?B1D3XG:]A(BRWA_]$,):/84"'AA[QV0^\8 STLRX1
MK47"K=R$D76SC&C6H1_ ?\VIG&-'>#.=S@K@#/S)+5"E8P#=6(O(!Y$!9EN3
MI2#(F&="T#@O%4D&4ZD;X@>#J3"8ROZ^RF JE0GL,9A*17?"8"KKXH>UA]]@
M,)4F;9/!5#8+5G K?FU:\?MVMUVS.04,-L$2OL5N>W:G7[-@+TLX2_AV$MZK
M6:*8 56J)D08DV<9JE>&MO82QS!G+''[E+B^4[-YADV2..X-JDIO4%V %,XI
MXVZ,+RD..7FG,O]'@:O0<1D(8*<X%:/#=/4VE9[MUO#@]&1DA8*,.ZPS=DM/
MUAE-H"?;HE6Q1:N7$RT7U0L1)]%RG"QQF*&V.\D>#<E*5;6H+_&Q:W-J.[TM
M;OIR!K^J%JP;/;NM+?!ZF)Y/WRK#P\OGGG(/M>%)VW$/SI-FT7,+RY[IN8$E
MVCD(/=D2K8HE6I>HZ(7$DPVC!S(_9V+JS:RYER0B.@J V?:6&15VPY]4?@P7
MN4OY[%9#0#D66LC##MMN^T,U>,-T9;H^0=>6<\"+CJW2JEBEU8N/,H[GGJJ1
MFXBHUK,'O9I-[F,T0CX[E3@[73@[C$?(9X?/SG/.3NV&:C.69Y,0YQ#EB>6O
M*MQ@?,0GI;5F/;,LK4<MK6P75X8;=8;SO!! N9GU41;SV80$%MY89T&\C+Q@
M+*QO40B,G&2)UNKLJ!S*4^U(0V7>BTA8/[NMC@W_.Z $\L_NJ*WA)^T,<5+"
M;WXT?[<".XDXEXM(W/GA,L:_^O%X%B*LY87X]_).! @V28"H?_OU[,SZ$DZ6
M,R]Z]U6,OUNW_@+VCQ"9^(7?/Y]=6?_HMJP;,0\1</16>!/K+IPM@\2+'JR(
M=K$"XCEX.89G!1E9+IHG0)C$_Y-6+64R\8*IC[KC!,%.ZR.2Q9WXV4X(MA6D
MS8NMG_ON"(2T.VA+*>WVNVNE] KQ5A6F:HJDB@\IE5BSH0Q>_T_2FY:>VOLK
MJ.V%]=7YAV.]D1^]Q4?B#V]"%"#K/TLO2D",X+>XCH)0QE:?5C8\(MD\7PAL
MR NF()7C<"XJN/!R4<P6[M/"K8G0R+PEL,82TAC8ZO8R?%X%V0M_ZJ60O5LC
M X?%=>00@ML]1 A.%Y![;[MK "C;JP(_$V 0X/KIV[>P=Q R^1Q4KW/XOPL0
M9R D_":\N4'8Y.N''*#P"U"$*\;=M3S54,L9^R67>PJFVATZ;0.4^J7<S;TF
MQT'%U+[3R=">%2>7P8UW!Y<CZLE%!'<IO'/N_R!EDU\&O'2%R?1<NJ_#.%F$
M :D>_+*8B3$!>L^5 ER@B3-91FLD8PQD]X,EK/TF'"]C"Y4H2$*V1X5R#>^_
M@_\$BH]I]GE!2,S_-01&\:_7!0;#2DE)OZ=N"UABA@*-6+K&KY0^:64_\:Y!
MYRZ3]3]9 1B$CVL#9MT#D>GM'L.XVW$ZW<T>6W<PW$_(S<CRYN"C)73^X<DS
ME%.0W[$ ]VJ!1PBL7Y%^"6YI4"#4[G/OHX OQ-B_\<7$6>N?OYPBY2)+=LD^
MZ>5V"\=WC6]G_N]ME&U^*MY=@\K[_LZ[@;/VWIO=>P_Q3W_)&P=P@-1+.WU8
M5?'H[F2[;FL#BT9R![1T*'$&WH,C+R+\UD]_O;RZ^-=OIQ?6Q_.+;^<7)U=G
MYU^M0_T_,@,^GU]\L=S6N]_*%*Q!WA6M8WQ6T&G7LW#\?46#A0O%DN[0Z70Z
MZQ4JCP>H+X8]CP?@\0#[^RJ/!ZB,1<3C 2JZ$QX/L*XDH?: \CP>H$G;Y/$
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M<]X%ZPW+(DZNZ-OK)*HNQ?Z[;XGM:.TK)("5CZKYKW06'=*LH@5\S1;5CLD
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MZ$H>*\-1$5Z2DC+9G607"2:(D[*DE>P/*A5P"5<)UQ<!5\M9M'..A*G$U=7
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MSK0LX=%A4K$"UL4/6L%3%2QI,*05+.^*J_6E$M$2GJ)*=4F5O9._#_=5W5<
MB!$=)&%?.6FB2?C$:7Y=6TE+]LZP2&#\&\"'41&R/;('837Q"+O&-^]GE$:E
MD*SYNNC/(458C0I:]I6#GVS1^?B$2<E]4G%2E%4S*@E!+B\3OGGX$+>5T@&(
MZ0R&P[RH8L#/')<3C$HXO++$.4Y8#_LH*<."XLNX<!B^!,$_3$<1A:_8>8B%
MEI>DP)::0]C:)6$C?,'3&#:3S8#.=5)= E2#=K7L6!O+,9YZ1G&O,#LL";[,
M@2Y(*LYVF/.-P;QQ2D,X-WR_W@5\6H[2BJ^/*!=I'M1(,2 9N>#K*BL\W O
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MMJ^6VU=YQ9J03^_$Z!F^>\M./,=D8 5)ZQI_9/FTW-5P$F 0N-/YY+5RI6
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M86=EMX\+%E#NE(]..)S;!?.+LL2))L>'90!PL <@YT6\SPJR,+:Q=M8(V]G
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M)' CQ]<" IJEW]-L5S)0R4 E ]T4=Z)DH$_#0"=U?&KYMF?YANI'D:E:NAL
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M&QB+:MFFIOJ>KZN:9NN8'Q<8EHNL1I.L1K*:E;*:Y_+(2%:S)%8SJ63YEFG
M7>"KOF."5.-:5"7$B50GCJGI&+$>A";Z9/P9:I9D-1VE[_>*!"F%?Z/DZMT_
MV8_G@(N!<-G-JD1M/#<B0H_^#--11",E+O*!4EU2!=8?CE+FPKFOJT>YI@4%
M@E4&298,DE)),H6D*=;@2?*H[#=G,;[K=_\,BM_?37W)2=2@?N![5-<M$EC$
MP)YLQ+>]R/4<UP/%_C^>L=-]24"P<R8AQ29-R^&*NG876V0@WCLY/COY>+B_
M>WZPKYR=PS]'!\?G9\K)>V7OY.C3Z<&_#H[/#O\^4 Z/X>^#Z:V+50Y(<9%D
M*D<@K-_T5GR"Z#FA[J,E*8EO,+H7<:M!=([/L-^4#$OZIO[E;924PY3<O$DR
MMG[VTMOQ"7&&"5QF$_*OWUXG477YQO?[KF'@72 L&6)B_JW>9]?$!/7Q[QR0
M2(SY7VM]?>YWMPVKZWW#MQ\T[.W?6;XC%^M[]QKVL7[P991-FR$V<5ZP>KD)
MC3;W"'V68,(4+@FF.\&D^V-@DJTD9 G?EU7"5[:2\*RCI-8J09/<_WOP%33!
MX^]_?S\Y!PUQ<)Q\A4^^G7_6O^T?Z3#NX 2TQ%:K_/</& \TS:\W1]]__#K9
M_^O7MR]?K6_?3W\<?_CKYMO@Z-?QX!BTSD-[2JL<_ 5KO_AY_/WPYN3\R#K>
M/TZ_?;\<P'O:M_U_XSJ,KP9HG=_3N+&3GVDW1[]V;X[_DITDUL=^)5GH"V:A
MLI/$QK#07Q,L5#:2D"Q4LM#5LU#92&)C6*@^P4)E'XFU27Y9/X9W4EW2@KDZ
M"GI)LQ+]( EO-O\J!<I\W5,RRC)B*O)S70Q66SO&=H5-SJ;P(U+\H,*10\-1
MD50)G;)XO:@<SV>P^3 RW^M2.;]\/V<%!7C\HM&_\A2A^($D&=[()]E9<SBP
M]1*^VH<_LXM/S.,)M_=)?$Y^RKMYD;OY9LI"%-MVZ%N!KKJQIZD6Z#IJ$,=$
MC7W#LXANVY86[[Q[=):53.)>,P)?ND7BZ0B\*YG'R4\:J;]HD4O"7XSP)^T:
M'B6>"2B@$C>.!>&#.J52VS <0AUJN"%*PYZA&V\E^6\9^2]=FY;W^WJ0^:3N
M;<>F8?L.4?T LZ<U#7YSB*Y:OF\2T]=U*W9WWCVZ=K0L\[ 0I7Y"$@$*':8P
MQHNNXO DJD<)FX3?[LNCD!V)$]G-(O;4I[RL"EHE!<4,TC]H1N.D^H2GU>:5
M2A;U !9UO#>E@OBV[EH&C=5(]PS5\H [^2:<+K'A7G(L4R>V#2Q*FW91RR3Q
M-23U5^NHA4@2?U82GU0V@$WKIND%:FBZ5+6(#VH']745/O(U+: AB"0[[[SI
M:E.O)7%O+'$_FXXAB?M9B7M2Q:".34PS=%3?H XH%C142027N!%[<13"AR2(
M=]Y9QGH0]TOP<+1*MW(!ZG;)/6FT?*T Q484Q6-2P9>7-+J0KH^G=GWLPXJO
M""9XM;:/]C/@0I(!+<* IJ-<0S=P08[053TP08'P'5/UK4A30YV8Q/.I'4?8
M1&*=:EE**^:ZZ ]S; 62:)=,M),J0> ZIA,33042#50+='^5Q+JF.D'LN#3T
M Y-@4:GIQI_WEQHDO:X;O2Y!)9#T^CST.BGE!ZBIVYJI1D9 5$LG@>J%5%<]
M.W!-TXTT*]!G!0JLA%Q?@@_A?9*1+(118#:0YE&C5:H"QDME;>@5!C0AZWF?
M%[#,;&]4%#0+;\[Q5/@2=[/HO#TC:8MX')=*IGT)%@E<7Z>J9GI4M4PW5#UB
M&&IH6VYL$,<*#&?GG>6L4ZE*:6Y<<UU DOHZD/JD N%:&G'UT 6MWT)2MT @
M\2-;M0V/.I3H9A2Z0.KZM-M0.A76B\K7U:<@:?NY:'M2V?!-"I*9[JM.X 98
MXC56B6/;:N!Z9JS%EAW$H&RLU2V^M75!SO,*=(S\,6DZ,G'S!2=N/JOF)1GP
M0QCP=%J(H=N4V+JNZL0,,643]"C'"54XR<!S0:\RW0@8L.'(A$V9\RY9YR*[
M77^=5C+1AS'1J10;RPU)X-FJY5)=M4*3J$378E4W;4L+?,?Q#+KSSK:GH^\7
M-II+=B;9V=I+@L^JO$LF]C F-N7W,TW;<8Q(=2(?)$'7=%0/SDZ-+5.S@\@!
MZ3[>>6=,MWF6@N"65^[8FV$,6-3R(J#?5N%6HGR$E1GJ-;^L"V'Y4-GL&V/I
MMH,9E\7L1'-9 NKAM\C)=(Y78'NZ'806'!/F>)F6KP9^Z*N.1N'ZMW02V3J6
M@'*,Z2C-=;](EDZT*W8Q29XM>?8Z51:1//MY>/:4^2(.@HC&MDIC+!U@.9'J
M^<"X0Y/0V-=LFU(L'=#3K.GVS9)G2YXM>?;&\.RE6V8DSWX>GCUIK0ECU]8"
M+U;#*-94BVB1ZKN:H4:1Y=NA$_A>;**<K6N29R^YS5R]\"=OC\;&>9-4,$=X
M.Y19![ S2A428N0&R6Y@ZTJ65[14JES9RS,&')8+VH:3G]7AY#.ZRM6;$#/8
M%BQJF)<)(M";@J8LVT)T+Q-<J/.6.#.M?84$L()1-?^56=!\WB9LL*:^QM>U
M:!<VV^I;]L,ZD-TVK&7V3>M^P]YA?%RAC=&]7XM[/,U"(0-@!!5K>@@CIX Y
MK*TB!0(>TH(W6FP>RN'YD@<L72<E(,H0[I8XH5%_;D[$XR$R&V49,WE.>!G&
M.,G.XU?=GPOT@[1WZI<NBQ9B%U0-"DI^J"0& GU#TFMR4^[\/MYN$:A.K-1T
M8"N3]/Y\+23YD8*\D1<L>O,-7#&TP*> 5YZ??OWSX%39.SG]='*Z>WYX<JRL
MZC\T:"KO3TZ/%%U3_YPXUKN[6:ZV2^=95=S\ ,K<RXNA@+-"LD@Y&P5E$B6D
MZ)9<7N,&HW_L?MP]WCM0SOYU<'!^MM'-1!]QC[EVW_?,Y?>\A 7I#VW">7N#
M3NMI%FLL\]*]1_'VC6B0>*]VFUNWZ?'FF>LK9]UO0[ME2:OYE6 ZEJG[*%<+
M'/)].A@L/.6FGP;/.*E C+WGJ3P-X)^R0\3ZY5/OD?*2R2@A_D+_.TJN2(I:
M\&,2V-?"6CI[OPN'J:V/O?/QV>".'T9^9/K$T"U?"X,XT*W0(['ONJ&F:_\Y
MO&<X :#*;A;A/P<MPNQ6>Z0HT-;R-TE'=#,,GL=GC<'SU\G^Y0#F,H_W#XUO
MW]'P^.WRV_[?Z='W*#W^=?CSZ/O?,/>!U1H\_X*Y_A@<#_X>''WYZ_KHUU_Z
MT8<CZ]OYYY\G^^]_?/OP'M:)1M/VG=K@^6W_W^G1AZ_&MR]??W[;W_UUO/_Y
M^NNOR_3X_, Z^G+ZX^N7@^LC ]=].;-_A>/XEF%1+#E'52L*J>J%5JP&413$
MH6900_/0X.E;CRX?NW[E9"0GVGA.9,,;OF\&MJUI%M%<T+-")Z06Z!K4\ZG.
M.-%]G.22$STS)YIJ%!J[EN7%1*6FYZE6H&NJI\>A:H:6'^H.\4FH<TZT3MUT
MMB Z]:F[?&UO-OVRQ*#=*Y*D".KW>7$&/*3M[+%/@ZK]2^@UDM,LP&EF%,QW
M BV*L'RV9[HLN0A+[YKP(S1\ASI!#*>V\\Z=#LF7-6XVFUZ7)2Q(>GU2>IV4
M#$+#M2@AFNH:.@$=Q09MQ=%"E<2&K5.=1*[E[+SS'MV$9X.K62S+ W@_DML-
M0^XJ+FA(058&2N@I*2U+A:1I?DVRD&(EB]]6<976"P#2W,]'016/TGJYI\UJ
M)6$^@##/M.LQPCSSM6__[U(+!W]GY(L_.L%(K0__3D[V?]Q\_7)T?7Q^^N-X
M '#:/TV.OO_Q_6C_[\&W[S^THU\_?OV_7P?7)P '@(UQ!'"#O?Z'!*8>VX:F
M&@Z)5,L T3\(#"Q/Y3M1X$>AZ4<[[W1GNJ*M\FH13%O:)2 Q;1,Q[7SW/]1V
MPB!R?-747, T7[/4P(XL-8:+)@J)9NO$ TPSIR\4#*!!['@](TID2\L3KX*'
M3U'1,:T:0I(FF*51V:1B9-((,(BXJD;0&.Q25PUBSU$]XC@^L8. !/[..[.G
M&=/-2#;>&/S"B7=IUZ(DWN<AWJEZGB0P?*IIJN^:H"7Y%M)M[,"?<1@%P(WU
M*$+[J:MM8;?2]8M!.,RN .-S#-1[<Y^XD >;<E8YQDMH!G5$*HJ#E"RXH1P-
MA^E#+>';>WLL2_2KJ>;FE%PW@-_-HC,!=I8$=4IA/U>TE#?&(C?&M.\_TJE!
MM,!4O=#45,L*J>ICD4)B6[KNQK$>8>-8QU^G^T(*>^LD[$ER?4)RG>KX% 6V
MZ<:V2G00ZZS8(&I@643UM3AV35=WJ>T N;K3F8D;+]ZMM8#P)2]^H&%H6.0A
M+:6/_(DE P3W8?:) ULRF(<RF!E%AHS8#PC57-6T?/2+QY$:&)JCZFYDVGH,
M5X8+#,9P9"/Y;2/2I<L#DDB71:234@ A8:#YNJW&V*+5 AE>)9;GJ,2+"'$L
M/=8#K% PHRCNQGO#UUH*>)]D27F)':/S/)+F@2<6 FIH?T!@3_ 7:6->$O.9
M=A Y7@C_>9IJTI"HEN43E?C44PW3LC7BQ$$<LFP!TWYT:QEI,U@S&EZZC"!I
M^%EH>%* T(/ CDR3J*$;^:H5.T##CNFHU')]-S:"V(ALI&';>70 [/H9$M;/
M3\3;0R6MM^B!]9Q>9.6YK2\LMW3!B77REMQU25E,Y[O(6;F4]/WH^NC[Y_^8
MEA7$L4Y4/])LU7)B4PULPU!UPX@MW[<#C_7Y[IDS&FMN5@6Y;2GJ*3GG-G+.
MI8NKDG,NFW/>3'#.,#*I:V J.A-,K4 -0C=4?<=V TK<P,&>>6;/\B7G7)>\
MDV>#]_]G[UN;VDJ2;?^*@GOCG)D(TE/OA_L$$;0??7RF#6Z;GKGN+QWUM&4+
MB2,)M_&OOUE;$@\); 02;$3UQ&#08^_:5;56KLS*RGHS3$<..RM]/4K]49HD
MXTP/5;U>M9?'Z;6O2D!.^__%I/OKKH:;4-Z+!;$8"9?".0:>T0S"B B&9P?"
M$\&T%-SRDH&C:KKUIN%R5?*DXG(EN)R3(L))ZR,)0$L9"I$$!4>"A"2)3T%[
MX6S:VA%F U-MVN?B3")DW[?RU=5[Q*[>RO:=-5.K[E59.<&^6A ^-#.A-"U9
M1JH<[<LL>.$U,"F]$)%[ZLIF7[)-Z.)^W^KLU3!9Y<YVA<DJ=ZZ/.^?$J?=,
M4*H<,.<,"$G1:8RE?!':/!V2CSF:K1V[K4FES@V.DUT._3?#P1&VX62[<]1S
M12[W8U.+]Z@<2'.SC8C7=>3O\QJ/89_!KSB6VQU_W.V5)D\BH-W#H^'@R^2T
MH;KQ8*5>P>CD\]/2Y3_/.GRW'U^=Z^Y?AH-1S51:H:7[;<%+,$:J3(D&F4I)
MH)P#N,0\2",2%XJ1P%(Y05-)U:)LY[HEH0T!T@K?NX?OG% EFD82<@:O&#KY
M'IU\D[T!E;/ 4=2!E:T*=%N*-L'W,6Q6>.W"1WQQ>')1']:UT[7$%4][&RGH
MQ:RO*_^LF']^7TS%(]:+Q!1H1@C*!^+ !:[+4=PJ:B-X=*PDE!A1UU<W#;NK
MBFM5[-X1=N>T@Y;)ZY@2. 0J"*T-6!Q3(#YJKX@*DJ2"7<5OK1W:MP;;:NTP
M68X]^EZ<Z3:1B-NM-CP\HEI=@M9D0-Z4X:ADM4:R>K\@-(AC6@AT=#+/'D2B
M%&Q6 :34.A-N%"U;JN2VL+=.&'E@:XL5^7>1 E:1?V?(G\]9]S0EJA*@<Q%*
MT<U&IG#(DFMMM3&.JX)\:F[M8CRPI;%6:YA?+YY5@ A!A!T-$13-4=LU#K*N
MNM['A\<]-T[Q^;G>QM][J?R"W+5[.,!^^=:\?B6O54I;':6%Q4475"LJ<@HX
MS"AF@HF 8\]!1^H\5T[;X,K^<-6J_>$U:M(F25*1WDJDSXF7[+6B@MOBM@@0
M*E!PB3O <?>.""\Y:2I!"$Y:A/2-S7/_;NK.=J>?%N(J-7/S$6=NKCUP5#<\
MKY1_/RSN_@M:LZ@-SA_-46D%#=YF#SH%&B5+TN52;W/;\,43;VLB9\V!KTS:
MKASXRJ1WQJ1S2I81J61P"I+S! 17!HP@":(/E"=#F?2-DM5R,0Q7F71C4N(O
M[^]27_"O;J]7HWIKT8^S[JT,MSJ&^[R@%9/ED0C*@#-KBE;TX+UC0)/WA''K
M3?);.Y1M6]JF3>DU+->FL%R%ZEJ@.B=&$N%2<9M!4![*KH4$A@0'.25*4B#.
MA-! 56_B42WML__[396H;G_L^A^ZOI=&E\;2'OEVB]45&IUU\V1',+H^+[Z&
MWG'IKTH_*Z>?3XL%2*,E,2MF(-NH0.A03G%)'*QWUAA+25!Y:T=LHX/4HET7
M==-4FX1"1?&=HW@A_YER8TB&Y TJ"4(SX%A:,(Z;E(S&864EL4C*-IW&M+$Q
MA+U!?U: *J:<\+>(BB(,#E-G[+[6TI/KE!3/IQW^JNGO _?UE),J!:V.@A:+
M4QKJ V$6.<>6D ,1$HPF!IH2(SDB.PE;MF]JU:;T@!IQ:).0J-B](^S.;[WF
MGG)/- 0F*(@<([C()<3@B(U!!LM\L_6ZIO;<70BB?R8B;B$8-M=[695@:'I[
M2C2G75[Y9G5\LUC/D=,0=.8.HD&9((QQ8'6@D%7BP5E*M;-E 9:IQ526&G1X
MV+!=E5:HL%T_;.=D@G*2",(<,"18E/A,@*/1@*+22R-53)(6V.( MPBV&Q!E
M^%ZEZR4K7$\?[G%EJ"W]T \[0VVU%:XKIZZ.4U\OKK]('W*10DB@%@0E"GPN
M^T*]LXY;;5-3N4)L*[YX1G?;D]&6Q=T]1W$J:3YBTEQM:>M*FBLES3DA:DL"
M6V >LB$"1&8&' X-2M(8F7'$,&$:TN27!*PJ:5[0Q;.&S)K,&DJ\G%&7*<A\
MUGR.#8R#8]]+"^V_QH76>\\?. >M]P%^[3K?[77'W>D9=Z./;I@^#GK8#Z/_
M;/8#CD^N4<9[/>.QD3T^/;2@TSOK^0?5P0_!W[V<1W=#P&:/1YTC=^(0V;=9
M<VB%0KO\,9=6:.T18:V)Z<^FRIO)3#D8NICJ:2,K5V:+Y4 LU=P(*X"R:$"@
M*PNV%&*7A 5-$\VB;%*EVY3=.D38OBR 2D /GH!66-+D:@*J'+,<Q\P7(A$J
M!"DB4&L=")D"&$D]")$4(2$3E_36CJ$U5^%N1-GP.)6'.BQGRMZ\(-KFKGBN
M2M2\.#SJ#4Y2>IN:4DGG7+\J;59..XOU-SBQ(IGH(;JL0*B4P 0I@9I<) YG
M2=$B;8A=5?'&FK30%@BO2A9< \(5I<NA]&1^/2UYI-4,4G"4!$9+L!H=$)V]
MY]%(K2BBU+);5R.L&0H_1MBKTST/WPF2/<Z4Z15&.HK^.LV8KDQR,R99K*&@
MC$O"404D2K3W5GFPAC#\+5E#I9(TE?.H;F_MVQ?(>.387&$0H&)S-=B<L_)"
M:T^X3R"EL8"RG((1J,JE"<(8JCD7B$UVR9'&-02P<F0][W[IQM2/5ZW+/'+?
M864;&Z?=/(LI5BZY 9=\6ZR P GCC$D"5J(W+[0-8(-@.%D4RTDK09U&+JE;
M$38.F2O;MEB1N1IDSM=I5$$FQ@5HZR.@%D=?WK, TBDJA3((3X;(Y+>V\M67
MOWZ@_V@XB,?A>ODOC]-]6)7!?W8\PH=,0[PJ]MLL5GA2V>4F[+)8L$ YD5S)
M4M!:EE->/0/+$@6ODA3,<F4XVGTT!BWR(:I_WR:[7P&Z6H#.F7^I(S?16: I
M($ E9V"2SQ"#5DZ34,9K:T?2-ATLM+%._LS\IZ]EF7^:;3QH"A7<5@ELKH.Q
MTA(%=;U_G?2S6*0@>H%C)1W(4AY16$[!2/Q3>T>9EYDR%\MZO[C]R68U,M R
MX*ZT2$$%[IJ!.Z<;G'0B2ZK*:80(7(J_V>@)1$>4M2%I'QO@2G/KP^!KX.#'
ML)MMF,'Y?CR<[%0:9$2-OUE1Y<UU2U97 =&/JP]R$RZY9'M^S,'BN*#G4;C$
M"0J6)@UEJJ2</ M);>VT:9FQA@C:)  J%F^!Q7F[SI*S3@C(4I>3$@@#PWB"
M8'60)KB0<31VM&I3P&X#X@'?*SX4?KP9]D=/^KB*:BS]T ^[J,:J)$UUH=9)
MM;\MYD2(&&S6#(@@$H1P#ASQ%K*/!@>1F1Q%.15"BL5MG&VOK[$L!.M9HY4_
M'WI1HLJ?:^;/^:4K(J4*D@./A3^#YV!Y*>T6?=#"^<@D+^=Q$/'PBKK=%7]N
M;$#LUT'_ XS3\+ )@FUWTNRLG%,Y?18JJR&R]>A)'((#'('BGM?JP>O@Q-\7
M-*77-GI./$3B!0B:,EA5Z@A;+WURG,=(FH,.A:Y;:C8-N"L3,A6XZP?NPG'I
MD2OO$WA93BBUF8/35(&43MO@E:6YK*?Q;5:/!WD0NVHW=]U^?;MJSY--Y9,E
M^.3]@A"0UN! 2X_.D;4@1"3@2/+@K/!!,<N<=EL[EM8--YL&S_5MK*WPO#D\
MYXLK>RT2 A&R4$UQ90:6:-3I.0A+&0M9H;FWMDWG 6]LK&#A*+"Z[>:NDVVK
MF[$.WEDL'1H$YXE'"5H%Y!T7+1A"'+"$E*,#M\8UI4,-:Y.74<,#;1(&%;MW
MA-TYS6!RL-R4I0Z;'0B?*#@M#7!*1#*!2)5UP:XU=;/.G27GU*2<NJA\1TDY
ME5U7QZZ+E4>I290*HH#&4J$$Y1 XGA/^",Q1SHPFK%0BV]92U.7DFHY3F?/A
MI.-4YEPI<\[I4DJM98HK4*E$L"CZE(XX"JA5N;$LEU*Q6SN,;C.QN!>L,N?&
M!-<N1_Z[FQV6=7/G_CZO<=?.3NQ^N<M-AH/#PT&YU2!\WN[\W^]Q^ILT; 9^
M):KXU=[+A:H@35/>E9:\<</]X;MQ*?7]+]<[3F>WGO(ZJ;S^0U[?>[X[?OWL
M J]_B;_\2\3__I_>'ZSWQ7\:L+U?7G/D?VS/WN>];_C<G]ZS_8- ]IZ_IN_9
M"_;^('9??^I]VJ/FZ^OGGR7>Y^O>IU?8#R_(GTR30%),D$72(***8*/(('.V
MJEASH_3W9<(54^IF<J%.J8<_I81$F1&$@D12B8=9#3CV9?\$*[DT0DJ&4XH\
MN>2,FH47.D=NV/E2QOK4-C7<6M>45UMM[0QC#;#VC\>CL>N7[JHR?%ELS04P
M''6)N"P@^6Q "%XRX;5&59X)\T9GK=76#C<M6E&N"1]M6M>IX%PA..=\9.^B
MC]DX0.\XHH]L"1AI$V@M@O(Y9)5(R\"Y 1[I%576L'VE;UT/K7XW0K??">ZH
M.W:]FNRQGD3/TPY_@_W]JO]LTMOG^*8&Z%9'/HM%6(TB/A#GP224Q\+3#([*
M4E\E\*"CS\Y.DCYNGVY6DSY:AN&598-6#-\MAN</8R'6."<#>$\4"$T-V"0%
MR*")5TF5JBT%P_J2S:XU^6/E"'R;Q@Y?C)WDAGUL:=TCLA[I,.OG%]-NW@WA
M^/"X.=?Q><K=T*TY9RNDG<7ZK%)EX;+T(!W)( +/X'4VD(5!4Z)CHCHWV]*$
M:5.J>@TLM$D[5!#?,8CGM4-,.E!I0"M.0,AR^%))'#6<,Z^3")''R:9PU:93
ME3<W '$V_Z?5W<O![L/T,?5'W2^ITQN,'L6^D[_=B: 8X</A;Y=L;YL-0I/0
M_NS\$$PVO?V*X["7QOOYP'VM)+04"2T6>4V&,46Y ^I$*2SI*#HP+*&F$,$J
M:C15I5H/7W1?_EZC#P\6MC>7$*N";146*\3T_(X4A_*?$ J2&H](#A0<P]^X
M=X0[%@3CJ00EJ%PLWGPOJ/Z!I(C=T5'/G91VIN\3P5U]<M,:_! B/M_;[C.Z
M1C9CS5Y_Q-GKJPI\-2'UZ41[T4PS-&Z3"G9O!L/2BMWQ>-CUQ^-R&.K!H&S"
MQ'8,!SUL_H=7V*)A&E6_>H7F;['&B@LD\>08$)-M.3N-@XV9 DU)>BT$NMPE
M.":VC5ZT?S7QO6X9JJ3;KBU#E71;2+KSNXTLI88% Y0J!\+D#)9R!IF;D*00
M43G7K$@04_=I;G!H]9J;\CO_X0Z/?KJ=;I\^_'14)@_UE&/7Q\$Q\L#IR#PN
M&[/Z7GG81F@-._YW^W'1)%7SLCKSLE@@R29.C90<""]%5HC/8'3PY7!#RIA5
M*H:TM</%MKHD4MUV\[)RR-YS=+TR=F7L%K@-E;'OE+'G%R$H+XL.":A6'AD[
MH$.@;83D?8Y!!F](:!B;7U(YNS+V,A[#/QJ_=[8W$G_,&G[N6B$5-W@UB*=D
MUJ?-=9Z6C.-N^'XOLZ;H0$H=%TI6A>N?E$,_^H,Q^@+C0>?9H-]T3I-\\;+;
M=_V ]^\TFWT/L>FC)Q<W@)Y[R.D=I,!&'0U&33KTTV'JN7'W2_KIKVX<?YQQ
MT+EO3<>,G'W%>6S!\?CJKUS6FTW/GUVS&6WLU9X[&J6GLU]^FJW(=/M-GS1?
M^NG0#3]T^[/)(X\61KJYW^3MLS8](9-V3;W$Z9VG;S]IWIJ;O9/WI'@BI+SR
M;?*$7OG>]RXK^!,NKG?9'SBW]^C#ZFM9L.=E-(<==XA$,!YUNOT.7KF',V=4
M3K%)"."C-)QXM*<?&N#G1Y-DHK^Z(YPH1VA=<C?%)]>HM7&+ZA.73-F&3.ZR
MOQB_9,_V)7QU_F=I>F-M6;+>-J6_G!>.>4>LL])$;90V-O,_+=V:?>GC\*S'
M/B3PP^0^@\L(T*>N]Y<[&6W]XT*G'"+JIBT5[(DNR)N'_(II\JI^0E*<C"J*
MCL'0-32$5B8-RZ>0+@_>OO_GB[>=9_MOW^R_W3UXM;_7N:__BI/<>;G_]G6'
M$OCGW,C.4_)%:N,7Y^YZ+-%WNA@[<CP\^8S@?#88'DW[N>/ZL?/NV(^ZL>N&
MY\M$WKD1_6[3G^WOO=O_]=7SW8,7SSOO#O"?UR_V#MYU]E]VWOWW[ML7_[W_
MZ_,7;]_]Q_\QC.J?.B]^^_W5P?LKGV5Q8*:O%(4B+X[3I^/1N)M/[MS(6?O$
M2'X3&R?$$\WTRFV<?J*,:-%5O_^>Y*Q%;:T]\*.KVE6*IROS'-5U5,6$WNX_
M5E!LS1+Z:&,>FCS"AZ;VPD/?=IZ?BUHNX7JWL6N:RE97[S?8G ?=;7RE54S]
MS>F3.OAU\!_EX-]1GC)VV5T^Z/D*G3<JLKI, LJ-JJ?>U0T>1"-K+]SL!BM*
M7VH60O0D,'=?.+Y\E>CG]*';+WNE'\,VT"M7;)L0]VANT382):60.1)GA"7.
M<JU(Y)%G'9QCY(I%6_F=:G<3.]C"<G?R]=F:K-@_V#W9^_;AY/VWW6]XK\_X
MO8^O#SY\?7^X=_C^TRO^^I<7XO4O;[OGUF2__O'O<KW/]/6W]V+O^6]L[^#G
M[A^?WM/7AZ_DWL'>Y_>?7L@_?GGY:7%-]F6OM!V?X=O>IP]D[SE^YY?_.=S[
M]/O)^T]X/?:V^_J@]_G]O_?RZ7KL.W+R^ANV\;<_$RTKZ$Q!U#*#H(Z -3Z#
M),H*+Y)DK"31:/6D3<5JEKQ-*U)"+D?4TBDA[4GJN'71BAORP]IRP2N3+,,D
M)W-,DG/4.2&3:&HLB*@YN* L^$PD%T$[4M;G;E\WL^X<;Y^EUQ[1J[)627FA
MN3 N.6]9$G@Q3F(H2*:V6OJ[Q">9PZ?V,B9N/03I' AE"!AF'$BFJ77<!1%<
ML?3B29O.)*R6?A,L_0WYH5KZ5C )G6,2YG@*6D80Q"D04F>P06B(5GDG730Y
MB\(D[:*1:NE78NFIET'KF GC@O+LK(B*:D&RB<;0"9)-M?1WB4\^AT_JHZ6*
M.DC:E(TQ68,S,H%2C#B::?"-$D=+O[CMLEKZ:NEO9>EOQ@_5TK>"2<2\3Y\B
M-P[=>6DS1TO/"#CJ+'#-DD0IY[WA+;/T*UHMG+ +>\+:M^+P:C0Z=OV0.H-<
MJE&>KB)VFC3AZ>]E0T7JC\[R6GWJI]P==XYZ>.='70+[4EWC,O=9)F:$S<+R
M<AHJM3YI9#&2F(M_/B\9: 3_!Y?N#5X0. V!E:%*\?GQL- 6/L4@3L1.\_-G
M-TKQV;EQJFRU!%OM/5M8R_ B"AXT S0XR%9$4-0]W %/":U0-BDDN;5#;Z]Z
MUE3^^C& ;U$QW!9YETN'1>0U!V5=!;SSNSYS]VN*\"T-!Q60RP%R?DG LIB#
MRAD,EQ2$T *<"AP\B53ZY)2.MNRS-(RRGUH*REJ3_A96-7DJF5>(7>F$9M2I
M))GDB3LOF)>\P3:98?L:J0#5JJX=Q//K!HI*G5CPP(-$JRJ\ :NH J]88$I[
M&PTM5G7QP/AV /@Q@&_1JMX6>2NQJA5XRP!O/LR>D_$Z)0E$4@*"$0G6"@$J
M1<=T)B'S4K.RI;"K=O,V=M-&:PPUW%HF- ^&I&"3L=K20+C.!;W43M%[G87U
M:C?7#M_Y*+Q"B%+#"!@5#8C@!)AH$V3&LN0V*JO$U@Y[TM;#F!X#^"ZQF[=$
M7O5&6P/(^6 VYRAC#5$@#0D@N'1@1#DJ+26MLI5)E%/7V^>-KC*%OIT1[;?I
MZ'@8/B(0YF/:-:G^;@+59R,0=_OQ;1IWAY<IA4I-JZ"F=PN1:RJ"),1*<-:7
M%7O%D)ID!N\MISYX&AU9&36M*:WF,2#RKJ+7/X1C(Q\J&E>#QOFP-<H!RAA%
M^'&K01B3P)*8(2H5=2*2>[XZH5"3W-IG8]<3MJXV]DY1O1#'YL%'].%0^6OT
MQSV/X)*A0*R3/E+!'(YBRU']&!!Y5['L:F/O$HWSP6T1"7-!)#!!4$2CTN!"
MT!"H,X[*1&4(;4=CM;'7/&ST#F/<US:R%;[+P'<^N(T&TRN'\"4D1Q T!O15
M=8!R>CGC0466R]K4$]N.PT0W%''W'M>N-O0N03@?T+::QJ1B65=R 410!HQ.
M'')0U.=@DO"FC39TE2G:]UP3YO+:3B^:;4RW2;*^W6DG;3_?XU(]8'T*7EMB
MB.:"&^I#3/@+$4)FDRF[XE"FNK-L;8S378A3:\6,<I0"ST& B(F"Q3$#)5A$
M09^+.U;V@^A+]I"W_?R..SQ%=;WH?VAG'3VR$U!OR'-UAUPK&'%^K2 *IUD.
M'HST!H1&1O0A94A6)Y<CI4FR2ZO>5#J\MYS!1RBN:BF^]E')_ )%2L)032)H
M%\JRH]1@J!7 +%,9_7:N@K^J%%]EDRJNJKBJ)04?-B/.+Q(%FR2U.4$6UI9$
M# TVY++_* 0<6NZ%O+RD8*7#*J[N3ES5ZH?MHY+Y!:O,F.2!$@A1>Q",6C!)
M98B!9)E#]LFKJZH?5C:IXJJ*JUK%\6$SXOSJ82(Q9>HT4,MT63W4X"G*+(F_
MB6QU($%>6MNITN%2YY*U\_B976Q<&4W7ZQRY;H1NOQ/<43FU>[E#ABXYX'R)
M@T;6\]%'W;QZX,IM\O)J!<K[5BFWSG0RI 11E3<Q9R&M,9%JJZD@S#-GI;KK
M$-#YW*?^\2'$07.V=[EOE3!+2)C]2^I+:>=%#!2H2 Z$<!0,D1(TP5DC9;:A
M[.BEVUJT[/":E:805[I[S'0GN)$EP"TX9\(ZX41$2)A@O*'4:WK73EFENY71
MW7PX7&G#618$E!/HL3&3P9M23B]'S4ER"MVY0G>*;?(A.Y7N'C/=$>I)-I:2
M1*DP0?N0F3":4>V2XD;?=7WQ2G<KH[N%XN/,EB(M&9@2#(11J.Z$C\!R3#0P
MY9(7A>ZD7-QELAG)[>VLUK+.^N.U:MPUM]1=DE>J=4:PX^-I)I0C)0&1$,-R
M4DQ3XJY1B6*$3XF_U=*/=TM]BQ4H?* L>,E!4Q] 6.M1Z44*Z,@:SY(0*L>M
M'<9NL;NNQ64?*PG<F 2X]X1YHHEQ2<3LK33&4<51+4E-G+W&5OE* O=$ @OU
M7XVU!@<.<BKUZE@A@<PM*)4E"UGCH!HD@=MLL:TDL(DDT&SM35ID;:7 ?ZWG
M2CNI$Q>:D*"NL=>WDL ]D<"\$^2L\T0)"BCE- BED 0L%2"5]4)H'-VR2B\7
MB\C>"PG44I6U3,@*@STK<&EJT8)[/5+N8'?\>K:-^-/KOUY_^OW/Z(/.AFE0
MS@H0/)3J>E+C#Y=IT"8DYMM8M:!%<>Q'3@LK<'(J+=PW+9Q6P9W2@D&-RD@T
M@)(U@Q!<@9'<050Y&6>#,H)76GATM'#'?L\M>*'B?RG\[S^[B'_J/.?9":#<
MEZ-F2_G=R#UD%I$8>,Q<V*V=Q87M>ZDGMOF+/(TW#[[,^@MK.77EIOU>SF[\
M=#P:'Z;^>'0P.$OT?N.Z\57_V23+NQE?/Q^M>9O^][@[ZH[3NS3\T@UI0G!O
M4QA\Z#=7J5RW/->]6'"!2#;&>F:!*F-!..0Z*T.$%!GQ)J%F57%KA^I-/MNK
M\D5KW)_*%RWCBWG?B"3-*"<:C& 4!$&!9"TU('B2EFG-HB7(%V)Q/;CR1>6+
ME;M%E2]:QA?SOI3G--&0!9! !." 2W#">$C$BL"<9<X7?<$6]W9NQBEG#[$H
M[!K3FA_7IORE'_IA;\IGJFB^0(FG4: D]()HJIW5!#T,)N)=EY.L"=&KXO57
M"WZCIXESR0Q0@MZBR):#8;ED"<;(0K2*$E,RHHU=S =H^Z[]96&[ ?'ZRMN/
MF+?K-N7-Y>UY_SVF;*/E'H+* 81V"JS/$2<>(4:8;,G5^Y0K;U?>KKS='MZN
M^ZTWE[?GXRA.2VU2M.!I9JBWN0,7&#*X=(%[$]#GRE=MN*Z\O=*E\I8%<]ZF
ML<,78R>Y8:E%M-X=C?4:FW6-#8IUUAI=M8K##9Q?I1WE7B5JO! B^DB("%98
MIHW-,5?G]Z&*J-\6@I8TD"B#Y.!]D4Z99# R<"!91,:85&&R&+4MU*W7KS<S
MK[<2WH,G/"TE\]$YPR(1B66'OW))'6'*&^-]]1H?+N'-1_L8C]RFR"!JYT$0
M8< $%H$EH9U67'$CD?!*N*_6Z:J$MYF$Q[)PB4;JDZ#"2^EEL@IM/4]&4Y)3
MK=/U< EO/DR&DX4D9P+H9!*()"+8H!C0:+/4R'BB;-VB9%NKQ<,U6ENI*W9'
M1SUW4AJ;OL]O]9,W_>3F[Z/92^.[B1$^SMQ6CR):4A-RC$S8)(T1+BJF<PHN
M2$.7WCN#XX4&9G"8?AV,1M5LK,YLO%\(#,A,#9-1@^2ZE+-5 JP. 9@C5C@?
MDE<EJWW;6M&B/-6VQ) K]K/T+DE&N1->!!U<))G2LEU<!^X%67H?3,7^VK _
M[R/+8+EET4.628%0CH.W)3+H5%(Y!)$3;6J[VEO7=JW8WT#L!Z5]L#K+8)00
M1/ILN+6!>1VDRSXOO:>E8G]MV)]W%[.*V603(6I5=J?0!)8; ]D'3A2G)F=T
M%]DV,;Q%V*^ES6JQDC8[+K6&T5TS6UCP: QJ4"^H!L<I 1&"!)-B *=LY$PE
M;URL-8PJ+=RA3U-IX>YI86'[OA9):BJ .TM!)*?1SY$6? X^!&-)<*G2PJ.C
MA65*FZW<WZFES=:'_X7M^$C<7C %VB;$OXL4G,BII)&39(F2C.A2R/TVE=QK
M<;,ED/?,C3YV8O=+-Z9^'!6<]!S._+H^LWKB6KF?\WPV;&40*S4M14T?%CP6
MET6PAA,((7L040?PTG)0QE/KF?.FE)>W6K6COGP-P+8&V"OW5"JP;P/L>9\#
MU8",.0:PPCD03"<P7'C05 HGC7=*LZT=8Q83<BJP'S>P5^YJ5&#?!M@+JR>$
M&BVE &NU*Q:[[$FU#H)'EN4Z2IT4 ILL5A)X\"?"U+)>M<S 8RDS8(*RSF>G
M#$TB,6&H<8$GAS9=94-Y+>OU4"G]\V(B7,HHHBV#;)MD&!O!46\@,6^H9-K1
MX+=V*-\6IM;U>@#!ZDK<CYFXZ];FC27N>2<[^!BT\AXHMQF=[$S !THAF!B9
M]=9$QZ[<VER)NQ)W)>[V$'?=HKVYQ#T?1-%<9245 YSU%D10&HD[1;"*D$R]
MB(:X*[=H5^+>Y,I>NR$<'Q[WW#C%SF#\,0V;XZ^&Z6/JC[I?4N=OO<%H]/=.
MMTD6KU6_ZC5JU:]:]>L1UX189FDI6A\%%X0GJ41PU+FL*/%>,F-4\/9JWWB$
M#X>_5:W5<JWU:?&P.^MTL@:UEB!9@T!M!4:D!)XS;9@@)I6#/>DVE8O'T=Q+
M_ML#<D@KZ;6?]'2DC! A@^!!N,R=L4I;8B4)Z&9(>[5?N6;2J[RV%*_-!_]H
M="ED98%+IDM6/P-'.8=2_<O1E"AG9FM'D=NDSE56JZS63E83V6A/E;3:!J%B
M]BP$1:S1FMOD?+BZOE=EM3:QVGQDC*04C; 1LJ0"!#X)V*P5V)*$P#2E3G)D
M-7Z;]**Z5V$)4.Y?$H.:!)^FH:BZ:V'UU26$9#YK%GB@0BIG?"::2T_P_\[+
MY4]D;P;QV?DQ/"LVL9?&^_G ?:W4M11U+9Z.QZA,3E(*U/$ POL 1JD .)3>
M:,$UUQ&IBRT*LEI19D,QOXRB,2QJD1U.FR!$%-8XGG/PTI!,J%/F&AL:KI V
M%?UK0/^\.V:"E$&9 %*X(EP$!1S  (AL1B13(F=TQZ1L25YT!7Y;C#WC2GNE
M&7KQ1'!IT<+'X"T1T2<KLUEZOT.%^QK@/N^G\$A"%D9#,HR#R,FCB^(I1*3O
MK*26.:&Q9[>N-URW0M2M$#4Q:_5/NXPR0V<L.$.X2=0+E4/9F)PC22Y2)4R4
M5^^%J+&F]G#XZP6'30BC!/4:RA% (*P4X+5'(J<V<TZSX=ZB9%M%K*EFL5:R
M?!QD67,L'@&3+JQ%BFQ3L &RUKZ<L59*J0L.P3"E=#0F>+^R'(O*I95+'P>7
MUM2-S:#+^>"!9"SI') ?LY8@O"Y'4I;\C:13C$DFSM2*4C?N.PN_?6?^;-XG
MZQ#<^R?K$-S[)^L0W/LGZQ#<^R?K$-S[)^L0W/LGZQ#<^R<W<W?NP6#L>IW1
M1S=,4S?Z/SNI<:37D0;YH^]-G;N)0_:4HP<7!\?HN)\Z>(\K/+3Z7FEA_&BI
M2IHV1%NV@S J+ D^>RJ"<=EJ'0@EM8;; PTI?5M,/O4XBB$R#B%Q R);#H89
M#DRQD!2.MU!Y:X>*;:,70_!MKRBQ<F!O0-9<M0W5-MS"-DC\AK7<2TF(<$1;
MPX,*21#*DK&)UC)Q#]<VS*_.1LF--RQ#CMJ"("& XS)!4DYP9A(AC6W@V\0L
MGG1=;4.U#=4V/"K;$%4Y#S<9Y9(2,2F?17;!$>:MCI3G6HGNX=J&A3QV(XDF
MD4 6HI1(41F,MA2<I3):SACUDQ*BAE2_X7:+Y/]HICG^&[M?=OX+?\P:?NY:
M(959OQI>H&36I\UUGG;'>(_P_5YFI9??I=1QH6SY=?T3?/1.?S!.H\YXT'DV
MZ#>=TU2G>]GMNW[ ^W?>C?&%0VSZZ,GIV,P_Y/0.@DUV#AP-1MTRAYX.4\^-
MNU_23W]UX_CCC*S.?7$Z;.3L*\YC(X['5W_EL@YM.O_LFLV 8\?VW-$H/9W]
M\M,LDMGM-]W2?.FG0S?\T.W/YD]I_7P0LMQO\O99FYZ02;NF,=#IG:=O/VG>
MFIO D_>D>"*DO/)M\H1>^=[W+BOX$RZN=]D?A&Z7C-"NTM3I:YFZYV4TAQUW
MB%PP'G6Z_0Y>N8<S9]1)7T-"#!^EX22(>_JA 7Y^-"FX^%=WA!/E" U,[J;X
MY!J!W9OVR.53MN&3N^PO)BZB]BK*.O^S-+TQN"R50M.)4N&\<,P[8IV5)FJC
M2L%Q_J<56[,O?1R>]=B'!'Z8W&=P&0'ZU/7^<B>CK7]<Z)1#1-VTI5SAH\SC
M?<4T>54G(2E.AA1%QV#H&@Y"*Y.&Y5-(EP=OW__SQ=O.L_VW;_;?[AZ\VM_K
MW-=_):#;>;G_]G6'$OCGW+#.4_)%7N,7)^YZ+-%WNA@[<CP\^8S(?#88'DW[
MN>/ZL?/NV(^ZL>N&W32ZTK[<;].?[>^]V__UU?/=@Q?/.^\.\)_7+_8.WG7V
M7W:>[;[[[\[+7_?__>[*MD\'HNB/N5UUGXY'XVX^N7/[9>T3H^A-S)<23RBS
M*S=?%.TI4S>Z[/??$W;UMO;A-?9Z W9-87"-D,9W+.8$O??O,!<J7<+V;\Q#
MDT?XT-1>>.@[REVX^R?=1^&+=A5=NN+!?T%WZIQ%O4$ \EJ.\WT7P][01JYH
M.W_[)NE>&G>2&Y9"W@N3<YF'VXC8=.M*-]X^*V75Q<UPOIP5.'D8T>*]9[-H
M\<O>'X?OZ?MOG[^^_E2BQ;]]^^/@A?CC\&7W];>/'U__\AM[?_@;>?_IY]YI
MM/@37N/@9?>/YY__>L]>LZ9]^-D_GG\X*9'E/;S?ZT^_XW7BX7RT&-O[]?6_
M_^?S_L'/G]Y_>_]U[Y>7G_9_>?EY__FKO]X??*#X;"=[!WN]/?9'/LTP>4=.
M7G_;/=G[[4\>LY24*,A6!A#:!3".1S!$&:*5S$+QLLW3VH>WCMB^4K>5ZQX\
MUVGJ!642*<QG08*S.2K":?24.F$Y7_J0^LIUZ^*Z;W-<9Y5T5F4')E,&(A*#
M-,<D*&%$MD('QYHM[=+:RG65ZRK7\42B(2%0*XG(PEL7<++J($26-+#EZ]A5
MKEL7U]$YKF.!1)>R!$E+T6UF)/B@"/YI \W&1&W5U@[;)H8_9J[;@+#0Y5VZ
M&\LZ0[. 7U;YAPF!';J]U.F?<\7+.^7OX$8?.T?#P9=N3+'C3SJ#2X)*3^O)
M=&N^QMU7<[S[>?D\'>%<[#8K@5=.J.]5C;VN>GAX56-7'D4YW]?5GBYA3_>>
M+<1),@M,\B0@&8[VU"4'SGH!A&09N4RQ.9>;Z\7"@@]>R#]R6*[<X:^PO#DL
MYUUZD@3QQEA E5MJ-A..,C<*< +AJFF@SJ#,Y8)46&X8+%?NFU98WAR6\]YG
M(4?I603;K"H0R\!R*=$/=<3(G"C5Q5K2Q36%!^\*MEI][QZ631K?)GEX@]SI
M]L>N_Z%;TM#<:)3&5V<./,Z#'%8NR<_<\I>#X?G1J(RS#..\6]#GFCC-J*.
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M[(YWS\:BDM,RY+28\TZ8<81(#UDHE!*>.D";4G+>8TC>.46)+LDTMUX+K$'
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MZP4)'[,AQC +Q"L%POH,CG%4!SIG'H6)6I*M'6H6BYM>GUUJML@CEO 5K+<
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MC$Y6)'PC:8&^"Z\UI3<)LRL/12R'V:J55PCH^95S[Q&TH12:]J7&)(T(:,J
M66YC%E9DJK9VQ#9CBZOG%=(/%](K=WZK&5XC:A>6SJD2WF@!D1D&@GL--D0.
M03&:I;5:XG#M&-(2S&Z ,WDYXMX<#\-'5\K3H>P_=,//:5Q2OCNC%(Z'-Z]0
MM\$).^N7_Z]/A^'=Z2A4PEF*<!:/@[3<,R)+35LG4/P'K< IZB"@>+ &Q].7
M[3.B):DZ-;GN@<C^BM558/5D/OP=G4I<0\Q&0ZD4#U8) <XS9-SH5?;NEE7I
M*E;;AM7UZ_F*U15@=5[(DT1$".AY:RT2VE5GP>24 %]FAHI2<T9N[>B68'5C
MP_AOA@/LI3CJY.'@L#/"*;UB1?_ (@GW*NBG8_$2A^(=CL1N/[YVX]+Y)_NY
MDM"M26CQH$CO5(S!4D#.$?C#(@D13\!&9Y@,TN%PH&"H]:<W#;NK%_@5N^O&
M[LG\$=*1,(]@%9F653DMP <K0=*DLY0AHH>^M:,6$UTJ=A\V=E<O^"MVUXS=
M>?$O>$RV%)QDN923LL* *WEJF67!@B)"\838O?7Q;C62OV0D_VA8MK^-3[8[
M1SW7'S=GSR1T@H^*1UPC^G<=T7\S'8XW93"0EE[,AJ(RT%(,=,D)DSHI8BB'
M$ ('P3F;%-GQV6M/G+>LA!\DNTUIG1HK;!MBUQ_7KXA=&6+GZ]B%D)WV :11
MJ/>IX."5E*"592Q:;=$;V-H1IM:HV23$KC^Z7Q&[*L3.JWP>'7<F!: QH8W-
MP8+QS (A#C'+LQ+6H,IOR]KYQL;XFSHNG>YL^\?-B]<]L)A"*[3\R\'P?'RA
M&8O3G3CG]\55LEF";!;/DN3&9DI,!BKPAXC&HI9G&C1GQ&J3A)8H#VYSW$P-
M!+8L$+B^ G85O&L&[WSB#LO.HLHKQ\67*G;4@4'W'*+-93^KMS*$R\!;0_D/
M&\'K*U-=$;Q>!,]K_9BSU4Q84+X@.$D'5G('.I==-M0IIV6[$+P! ?T?5+4[
M'J6(LO],^=^DHMWTJ1]7/9"E'[J%]4#:<4C/%95!*@7?EH(7C]Q$E62DRPX<
MI>@!>2[ Q$!!)N&E"$HRIK=VC%Q!N*4U58Y^$#VMK/:866U]_N$RK%;W<*^0
M\N;\1H+C2J+C@$,J0 0?P1BK0/'D><Q$1$/+'FY-5G#.<"6]2GKM)[WUN=25
M].Z'].9=;6J2%R%YR,)9$+0DOAK\C6O.79*:&\+0U=X6E^2MMX_T?N"&M][;
M?MGMNWY8NJK:$@7'VOG1#0B?_&!'5,E]/)J&$3M(NJ./@^$8QFEXV$%4# =_
MX6.,ZDE@=QI..!_+?9MFH[.?WY6Q.<"A>9Y\3=Q8SL(LG@:6?(B>>P:4EW,'
M-8^ #I. D*Q-)GMA2AG1FFBU29A=XV)JQ>PZ,#N?'DELBM88<.@!@,@N@>%%
M&O*@:62H%QFZPK<YY;=BMFV87>/R:<7L&C [[\D%%;R,I5*W<ASMK$_@@K20
MB#8T2&(I;8^=W=CTR(LE$+JCT3$Z=*GLANH-^A\F@C_B='\,*9-M*7_P:CH*
M^_E7'(-*.#<BG,43KFR,02CIP<J@  >0@S?"@A;.V*"Y-SIO[=1R!YN&U;66
M.[@*JS4&O$(@SR=,JJ0YE3A<J50ZX\:#%Z5Z26!1>A&S-K8Y2<G>^NC?"N:6
M@7FM]0\JF-</YH5J")$J]-$E*&932=QQ8(210+CGW#LFT$274WN4:!.8-W<!
MX%S,?P4>P ;''U;N IP/-53^60O_?-M=\ J$8UJ$X,"&+$$DP\"YZ, C*:7H
MF*(ZE@5EU!OM"$74\&%;0OX5OO< WSE?(&=O=8@4')(Q"*T$&)83>.69R-&9
M7+99,_0%6A))K/!M2_2_PO?NX3NO_IUT,B3J(09KRL(=!4^5!:J)X)IPRYJ=
M4]O\$O5?%P+6(_QS)W9+DF,_CCJ/(>S?BDH)^_GYK-,KJ2Q%*HNG%7*O(MH$
M!B805586#3AM @3#;'+2>Y'UU@X:CEH/88.@N;;R9A6:MX#F?**.D83I%-';
M+H5*B(S@72+ @V,FT2R<9UL[1O$*S0V"YMKJF%5HWAR:"P7+9*#.20Z:E;KB
MB6=P64O($G')F<9!]%L[6IMV0'-C(_#HB)XO2AP&AX<E_WX\")\?0PB^#6+\
MY6!X-@K[^5DS!._*"%R,!N3N5S1EW])P4-EG*?99/&E0.QQ'JE$8H&T @8(-
M',T:J/:..8'$%-W6SG_\'\,H^^FV"X$UG-<R)*]-NU<DKQ_)<Q(_14FL$@J2
M)Q8$SP:,#@YHC%Q1DB-1MB+Y02&Y%5K_>U"ND%T*LO/2/SMM(I4><B <!"4&
MO%<15$HT<?34(RL)=:0E2V@;&X,O%08Z1ZX;BVWJC-W7-,W+_ZL[_O@Q];![
M/[KAXSB+L!51^;>IY\8I'@P.W-=_ES$8]$KG(16]*P/Q,S)11"(Z2OV1*XVL
M3+04$UUR)F$*DD?T )Q4Y6!4+M$A,.@+Z.RR+&46,S(1I;<Y&;7&!]N&W[7)
M_XK?=>-W3OPK:A/BUX C(H!0U(%-P8.,C!/OBR]/"G[KTMLFX7=MFK_B=\WX
M7=B4ZTU4F7F(GINRM4: X<*5J)QV3H5$:*E%SF^SE?[N%@%B=W34<R>EG>G[
MD'_(G]S8E9#)T2UY5F.J5ANZMVI#YV(PS:"<UOVJ%8QO2+V+9[@D3U1VG.%$
M8A:$IA&\U0Z\R-R@_Y-$-$B]XC;KKS5<VC;\WDWEH8K?->!WSO7Q026>@BCE
M>,NQSC*C$T00ORY+YS,33K"M'=:2&&J%;UL\GPK?>X'OO.>C%:=&" \T& 6"
MI@B.N@A96:V]#<B^^=)3V>L2R%K.;SF:5EKN^)/.WZ:'N?S]S!FXR6DNTSYX
M7"7 EW[H!UX"_,Y/<[F4C.N>L54Q]>)1+\)$QK(D$(F)()0MA[[$"%P'KCQ/
M+#I5MGQR=9L2X,OBYIY#T)7T'C/IW?EA+U6!KH#7YAQ(R;-WU 1@(I83PY4%
M*R4%XY)T$0=6\&;MK)):);6'2FKWN:A8J6QM5#;O3,NHI;26 LV*@<!Q R.L
MA,RB49(9S1TZTXN;_&98N+-8S\TJB-WWN3 /=TGO1<XIC,N^IO0U?'3]#ZDS
M=./4F?S>5!UKO/]R_$CS2_K?X^X7Q&)_?+.LQPV./:[/TYV,TGY^,1VCMSA$
M^_U"GN7_+\Z&Y&T:C8?=,$ZQO+';CQ=?./?)2JE+46I8W"!%7'#$:3!>"! L
M*K"6&?"$&<L]XT0EI-2Z.MAVB-]G7F0%=@N /9\R*0S5.3-0-AH0SI7#XPV!
M+'5DB9=T++.U(VY]>GQ%=]L,^/H6#RO.[Q_G"X6.A5;,9 *49S3@V0MP(5N0
M2FJNK0XAE_!.2PSXQBXP/IMX'=TE'(T:AGK$8:B5[RV[%0N_P<<=Q%?],$QN
ME)ZGR;_X=^^X=/AYOI_8@$K;2]'V)<=!DF0S8PR2D 1$5*5$A760LU.$4I-H
MV1N[J,YJ**LN!50.;OWZYEVS<4T,62%5G\PGAGAD9F* B5),6"8.+DF+5$VM
MDY:%2'133-BN8/MP)<Y*G*T7KRM?0ZWBM=6,N%!>G5FB<Y:@>-F.'5QAQ!)@
MC%%+;6T046[M:%;EZZ-;B7UV5?2CX\8=GSYT^_V29CW(G9/DAH]A[74)7I7X
M#6NYEY(0X8BVA@<5DD#EF8Q-],]7UUN/N65$MHK)55'GXFFQFJ!GCTX^Z% .
MF70^@DF)@2<I1"L\UT:7+&,K%M-8ZLK,PX9W5)8;DXQR28F8%#J=N:R^,V]U
MI#P7>*]=+55XKQ3>"\FVB0NIT5<,@I9TBK)O,PO@GDF"7B/7.6WMB&W.%S=L
M5G@_;'AGP1(UQELBJ,C<6R$=TTDGYJG58@)O4^']@."]F( JE& N@0]6@I \
M@I=9 564&6=98%R4(Z(57:QD<W_PWMQ%U^\Y&PE?O\+-J,&K1QR\"LJBTH[<
M.D:%)<%G3T4P+ENM Z&D<;+6O>!::7I5-+WW?/'PW>@S,80+R#1Z=+("^E>>
M2+ Q*.VX-$:HB9.U&+&O$:JZ3E"I=C546^-9FT>U\PZO\\81A8J8484.K]-@
M57(0>:*4>RJS%U?%LRK55JJM5+L:JJVQQ8VCVH4BNC1:ZXD")2P#X8D'1T6"
M2(T@QF>>3+PJMEBI]D(H9-:069-90Z27\_ /HYT;]-$?1(I:'Q!Z=WQTU$NE
MJ)WK38)"N3?XJQ.[H] ;C(Z'Z>F5*\YM'YK5C>)2L4;]1,O6YAF<GFG3[8?!
M89H<;=/4<RZ1OV'*^(S7WW9QW96)=G3 ]9709<_UL%=:5KYYXE4S?P[*]'F#
M<VHOU1RQY=3*XI$[-#E;D@2!<Q)1K:@(CD0!3EF6$TG.EZQ9Q5B+%DI6M Y:
M&>;!,\S*M\A7AKD]P\R%GJ)UF1F9("B&#(,4 \8Y#3+I[ T3,HBR&,LV,)&J
M,LR#9YB5Y]!7AKDUPRP4[^8R1B4E9.H-"/P33%(!5#FW*)6,#U.RN62;<KE6
ME.SQH)R_<1JFT;A4^8K)+YSE<TGPX@%RX@91WQK<M\D,J+QW$][[;<%WXX*C
M\ T,@HD:!-$,O"WRBE@I?([9)5Z4U6(A[._RW@-:*WO@9'&]YWK8++(&%ZVR
MR*U89,X_(\Y[%X,#P8@$$:4&I'H!6GD2O<6Q"JH<_[Z8@W6SQ:-*+Y5>6NV?
M57JY#;TL%#[+3FCF(I2 ,G*,07IQG(!D67M%C(V4;NTP<^M,_!722^.<_6/L
M?"_AO['[9>>_\,?LUN>N%5*9+5-H[/R7'_[C= G_VE^[):(HF4&JN<[3[ACO
M$;X/,M8LPJ;4<2$,#K$-)V6S;W\P3J/.>-!Y-N@W2_KE\.7.M$"ZZW7>C?&%
MYB2R)]=YR*:?K]<UTW9)@8]R-!AUR_ _'9;3G[M?TD]_=>/XXXP9SGUK,F9/
MR=E7G,=V'X^O_LIE8] ,\]DUF\P&'(N>.QJEI[-??IH=O=OM-SW9?.FG0S?\
MT.W#M"'%!Y^;5LW])F^?M>D)F;1KZOU/[SQ]^TGSUMQDG[PGQ1,AY95ODR?T
MRO>^=UG!GW!QO<NV-^] 7ROOX'D9S6'''2)OC$>E"B!>N8<S9U0*DB=DBZ,T
M[(S*X>*G'QK@Y_%G.7COK^X()\H1&H_<3?')$CD*R_;(CQ%U)_U5/,?SD+V*
M',__+$UO#"5+UEN3*!7."\>\(]99B9ZJ4=K8S/^T>FOVI8_#LQ[[D, /D_L,
M+B- G[K>7^YDM/6/"YURB*B;MI0K?)1YO*^86:_J).31R9"BH!@,FS/HGZ)%
M2L/R*638@[?O__GB;>?9_MLW^V]W#U[M[W7NZ[\2H>F\W'_[ND,)_'-N6.?Y
M>(&JSKTW1X2^-PB?%VAO<#0=$F&><,[G+G&1-OE%7'PZ'HV[^635QO$[0[BU
ML[=_\.)=YV ?1VKOW?ZOKY[O'KQXWGGY:F]W[]FKW5\[[P[PA=<O]@[>+9JP
MZ\UU[,NM2SKZ[GKBAXE9IQW1H1WH3!7XWO$A7B>L("YX462_P^=#$@VN/]Y%
M"8)$BRSY!C5'Z*;1 =[IYS*M[E=Q?WW]?/?+'_W_^?C'MZ/#]P?Q\QY[A9]Y
M>;CW:1>_MROPLR=__/*O'JI@LO?M=_8'MF6O:\D?_^\C"8?_ZKM_V^/]PS\^
M[K'?^/M/OXOW_T;M_1S;^/P#MNM_/O_Q[W]]W'_^&]\[^*/W_M-G]O^^O<)[
MAI,_<>HDU,8::,@!2IHP>.QJB,&6[>DBZ, F;E"W?YSB[KA)+(Z<16D"<US8
M:+TRA+,@8_9,.6^V.@D=F:-B4(;'A9M>_;+WZN6K9[M[!YW=9\_V?]\[>+7W
M2^<-SOYGKUZ\FXGQZ028DV[XWO3N#>=-A^F'+;C88N^83,EJPXD0+BJG<U89
MG0*=*7>!W!=G7!,I;GR,*F&0._NH&9IN&#WMW&7^+COG*:\+IY.GW,]GS_@H
M,?D[^S-8KEGF 8A(#G#"EC.-N (=A?=<*9&,7,#8>'CR&07EWU \=K:>33RM
M[:W.UE^I_#P>X4^4EUN#X^'6WSO=<OY-,Z/*Q_\:#'OQ/T>=7G)%078.4RP&
MMC-.X6,?9]2'D\[$=4/"+'NKM]%Q^Y"*2NW\U1U_['11N@:$Q0 GQFB[7#P.
MT9GJ%__NT'U.G8_)]<8?0Y&Z/HU1:3WI'.!]IZW$9F3\(DKD_N!+XX:5(WGC
M<1@W=^O@;/W2#:G1T*^G32NOOSM&F.(?VYV]=#P<G+5VN[,_''\<'+GRX<DU
MWAWA=,:'=6-L3.^HTSTLI_[BC?!^Z)PUG_DX&!T5C[8S.!Z7=?/1D\[^\?"L
M+=VF?!RJ\NE]F]WE1X>SKY^^W'=?NA\F9#4Z&:$;._JI[#P?C,+@"''3;$X?
M'!X>]_'3S3P_^]BL.1_Q0PC #]L==(*''U(_G)R.RL6[EI7._JCT6=.]13$-
M1HV7.6OW3YU^Z9[3YI5O-:]\<:-P7'R4F)K^_:GT2L\51V1Z"G+GTP"OWQDF
M?#FDTWN.A^[XT#4/C$Q0OOC:?1YTW@Z0,;L!=H>'G=W1J#LJ+OW9J/R$[@SZ
M][VSVZ&O\U?J]4Y]GK.NGMW?=;XXO,.XS)'3#FB\(IQ0>.<GW[<=+>;TG]VH
M@#!WW@S3J"2G-_.E].Y91*1(_(VC^0N/U\BPDT<NPK[]&8QW*G@%(91M/,$D
ML,$A]3O%'??121GF"7]"H#\(GIURUO@<W3:T@>^-COVH&[L%8$AUNPC$T9E4
MGJ10A-E7)L)Y-(-_?S2)F^(+2#JIUT4GN6E$.>S@_  _Z?P;Z=\A/?6++<!+
ME@;.TC,:2B\(;PCK-&D#6]X<CCBAJL&,N(>%^?!V<S=X,^RB82LU/4;_B;;B
M0T-3>)WC'EZ_N;5/:(N&*?0<LE()IQ3#A%<I.],F%BP<#X?E:^4JR$+G$(D-
M1)-YK3#E12;J/!@J^GW4*($7>.,R0ALH+?$)]_/I\SU*EOE,_PSH &DE#/"H
M"0BO U@J)9!L=73"!*'592R#>#AR$TE>YDD^G?VC\SPS U07C76#*7?J;.,5
MD(>Z1SV$-&H9E/>]7L,IZ6C*&86>?N]WRU\-I$:=O_VRN_OF[S/,CY [^N[#
M1(+,5&6:#6C#$XCMX\.C"2DU=.$F!T"62^,##(;EXJ>!UEP^GZ:$UD/^Z?;.
M*.=L;UCYX,23_-"(G\N_,Y@\0"&'F:2^M),:\KRB.66#TLCUIBU(7X]0U4TD
M[]DWFJYL*ALC78?Q,5Y]QG/8U;W2\**D.WDX.,2O#4;G^NCA*J6W"5V)X]1Y
MF\( S=-FJJ+I0YY[QBJ-7A_\)O_4UF=&G0>E0ZFT[S48H\KBKF(\1*%T5O/1
MGJP"DU((3X,3U%.7"3'4&1T"XY':!=]Y@KMAP5G3_]\*-D<-\A!OS0;V?D!L
M^][4L6N6+B/JGB_GO1:4(:>^:KG:"#\[:O1&0U#3ZP\CON!=\7"FQ#&A@2G7
MH"2;QC_0.6J((#24AU]-Q<U#1C@]T+:DNDYNTBRJ?J>]$U=V=-F#(CDCY!$F
MG;\^IN:FC< K1%*Z=3CHE=N7:\]\_&W\9#>@:D+L^31/?Z./$_=T^\*K3?./
MQAU_<N%2V&?;S6,<#E#X77#;9]VZ?=JN1LQ-^P'[LW-T/,2.*.JE+*1..OD(
MOX9/5.[:1V\T3WWL2=],KHC7&4TT8>-FEG3AB=^;8E&3ET4>2I>=]=.L?X93
M)3D+?902<]BJQF<NQ-T]3-L36SAJMJ).O];P_>FEQ^YSP^O%P^X,RGPJW_L!
M75\:%/WAM&\)S5^1(M#,331T$_6]/# :JW<V%O,X.1VTB2"Y9)2?=/9.C3!^
M=1+K*7]MHX_20POD8IQB>1*N:/86E\:4E?O2FHM-0,PU'PN#XNE@2P=^[+H3
M)S\?]W(7/:X&8:YI"4ZQ,W$T%0 -#:%V.F[F6L0V3*$X^HAZ -!?.D1#,HL.
M-QC"?P<SJ#?>%XYJJ7M8/MO,O"-W,I-1Y8-G/7;*224ZA;Y?MVE).3EAT&\<
MM,DEFL[$)N $^IPFXN7"=1IVP$^[WFAP.FY3>NKBY_!)NN/._Z)Z0:EX=79'
MV^;G;IDT7[JC,O]*%\R459S.F&'"8>CCTQ?U>.8L#Y-O)&IW-&=<'/Y=YN!4
M54\N,I5[(]0&4Z4WT;*3%Q?)>T+KLZ;,Q.?%AEYHWAGWX9=P4+NCC^>MT6PZ
M3H>ZX:Z+DZ0)E';QKV$3B_/'(^RI46'K$A$(4_TZ\Z?'^#/B-'R'-N&HS('F
MZ]/@YA08B-'AAP4F':99[*)Q$$[E\=R$^<<<$[9D"EVN9)]-\=E0W>9IV/)X
M^[EYN"I>7Q^\_OHG8TQ$@N)58]>!,#R6\CP"G(A>,<V)9GQ!O#K)K _2>QG1
ME%-OC8\R$J.-8L[J>?$ZFU13 AF=TRDE>C?L-M#.2$O#8J)F,;BIZ2O%48H+
M6W@:I\6I,XX"\C@CHJ>696HOM\^'[,\^4K#<<[Y(N5CL-UJ.AM:F1FSJ4S>W
M_[ZL643S@EFX-"7DT'V%20X(;U) ?BHY.Y,7V.2%Q:21RU(D;I!O(J:X6I1C
M/UQSGAMX3JTS// 4*!-6)A-SB(QQR:/R7/-VR[<K).F/)O-.4;P?DSL->2#3
MHQ$9N>%),0@N3$*^DS6S?AF*B86;*O]XU7Q&"3XH09B)?9M.WR>=BV!I%,K4
MRDR\O6*1&M>N6\J9^>/QN:7(\_9I&[_F2T(P2KZF%R:V#*4/&JZ/@V(49^;M
M3"Z.+C6"Q6Q^F2BAQ=G?.FUT58AFE!R.R';G>?J2>H.SY<D7?6QHFNB_%].@
MUN99OMGS[_;CN0Z8/N_$%CY*$_A"_$FB$TPG[+LD-9I $L$KXL%RR015W%$7
MYTW:V72*<],IG9M.4WB5!:$S!7EJ<L[<I@GJSY;"AM>Z^A26W48ZE^3PXL!,
M?*_S7VLBMW^=BU5,$PMF;Z:OR"3G/<[MR8KX9"$;V0K=N',&=C3+#D 6:T(X
MC0+_4$BR/RUA-DP?CGO3(-3,%3MJLA]FKL1%L3Y-*1C-NN&\/.B71?HI'S;+
M@(7 /I1_&CW0&\_8ZH)9+R\<NB;Q8!)FRJ=]VD%!<#Z2?IJK\'##S^]0[C29
M&+],G//FN7;C8;$MX^$D765SF6WZ]--G1WZ[^.2S!Z]Z_S7>_T\?J2:9.,@L
MHMZW@8'1@H F7E')DN$I+02?9_/KP[GYY2[.KQFK7:WN1Y.KG"X<;4_#,Q=?
MF[OLF33I]J?Z_%2.3?6,.RSK3M].%_]Z ]=O/H\7.3Z<K9)O+Q+$A2_.VE_8
M<M"'BY[#N46U26/^/WMOVAS5D:T+_Y4*W7O/;4<H.3FLG.S[$N$VN ]]6L(V
MPF[\19$C*I"J=*I*@/CU[\K<>]<H@4"R*$F[.PQ"57O(83UKR+6>=3*<!AP.
M/@@-J<&X20?$+PY+CM0=/F?_J09%POG@H(0BC^]I?L_/XV(1C[K!'BPEBR!\
M+ V]!XU24RD/(<AL*'<D"$@$0G3$9IJ(85:"3EPI2==!X^>+CI<+#"RE])0T
MQA)[O>!P?>D0'LVGD^3*67<<-&Y+^3JN1V%+[39L>Q:6ST9U(9<^>H2JL(A2
M\P;%0&H7.+4'T"LY OCYZHLT15+3U;.QDG+3!LX1X=)1F]_8$GK^[?E/S[Y[
M-%C:5R4GLHOTOT:[I#V@'T^G:3.0V.%=<Z\6F+ZK!*%WUT:IY#=+I-OW#U5:
MFO'U-L\]@AR\?7_H&>"\1D6H"8R 4(@@$F&$2DL3#=Q3)M81Y+]P[5#^CX<X
MFT4PWJ5.B*O+,4G%PB]P4 6XQEE073?I+N6489(0.'"1C^JQ]W$Y JC'M(O(
M#/ZZU>?C43IO[9$ERZ%+TZFB'Q,^L)PQG9U6RJ:3[L2\.T!*%W7TJN<K+6JX
M)@9S=X5XKTY0G807*;23??\D>3',Q2@?;HCDR=N/ATE"1$WOB=0HM&# $JL$
M)RQJZ2B5(;"\+KY+FV4ZG\9EC_YD\85"@+;T+73N2T2[9D8TTHS&>ZEJ;QS[
MLYI75FFR'PWVEOY5Q;$-R-98RSAGM-P'C>9M4@#QQN6$>SDYKD9/F@MB:I,F
MBF)'O=MZ"Y-)N<$B1:ZF%-?C_>8RGYI$#?P1GS<[KA8-FA;K:7MK>2US98^;
MN3N/;'R-1X-?SB;3,[<X!%_@W^"T[D7T?(Z/JUOT;AC+%)QL3/CY"FJ>(& T
M"2IN4)RLD[.3M:/N:I\AHN(=?AS\#0V@4723V!!/_(<[.?UA\,MX//F/_V4X
MTS\T(_IY. M'WS41!S[XV]YX',_G7_AI/#EM"X&_&[1GQ"5UI"8WEF5JB JZ
MX_CR<?'NRKA*U"GC.,=K.V5I*]7QU"A/35F8C\F56Z"AM3FV.#[S7SXVU!(_
MND\-[='@67,D53+DZM9V@]8AC./WH]<3%TN&=^'TKP=7%\]],8Q1=;1Y#YV2
MVEU*9+AL:8O3G4K^QV(7E\/QIIPHK20<M0PRQ0HN^:DE3[6\#>[&E=E'I_UM
MM_$^\^SY0C4'_1<O5563B]SVDEOPS@V/R]=('D](.>SH$O=K?=?BVC*YBSU<
MSOXVOK*4DG/JRDG8$!71C#3Q@K1J.E0L:64\G9P>C\]36A'VNZN=?^PJ('ZK
MZ49E<N^?;EZ,K3>M2V4./_11Q<"H(D[&0(!;2;P'3SA$;C-SC'*_KIOG6V4R
MG\Y.,S?&<X6LR^)=BXM*4<ZHZ*'Q^QIG'T[G@)P:FM,"N;-\=KRHSUG-3&I]
MX/9,O\U2:R-Y;O,M'RUJ0)K @*O'):\1RKO 0*-QSU>/&;J$_#99/W8I9DLI
M94LI0RTR%PT_&28<V.X\7:CU$7"RXK M+VJ3X2O4M%<VHRHI\)OS7%[[/0+7
M+)5!YL8GJ:"[2&-;FH>4<<+:4Z3TX<B=E9K%NPM2!<Q'99[OH^/0#>Z\AZ8]
MO.>A9L)*[36APJ'7[Z4D3B%2%78ZQ5@66O!U:%K:($V&>N/<M]8C DW)R,Y-
M&@0B2<FZ0\$Y'GZL@E.S8-N,YOJ511QQ;A0M1Q'S<#*=D2&:H,U/X[/9X&\_
M/_OY^7?-Y2=I=E1J67XNH/6AI'TTJ%B8M?!^U;2H*]Z6N93[MK4M"4VC6:D3
MK-6$'2I5#^'XN.--"DO'JK-R<M(6D;?/JAC6 $] )^1\?JB\6\\S)^_F,#@'
MW9INC'=,%U]9/K]HSCZ#*)>E/?7<93UW6<]==A>XR]27<Y?U-&3;34-V83[C
M9W,TUW(Z9:+ 7796<0E6&:=2TLDZYDP"H]=XA^X4W=G5+-+%0>6S1>#_^ULW
M3?]JCK&?W7#R>]'TSVL%\H.V30^>O3\46O&$YBG!OR6!Q(%X;1GQ:+,J$,DP
M(3?RGYTPSECP5G#0FCK!LV31.<^ITV&# *,$Q!9EULOG2DMA\')FM+MQ<K1[
M<21M]R*G>'=^9#R/<RU]#SW=YDLUR%XKNYK\A\7A^?QL>E[KU; ?S2W'IKBL
M+:.Z<$2MS5VCH%7_MCY\+?1*H\)_<3:JXTBQH=;=;0*3'UIO/N/^[)XS&CS!
MP9WX-&GBLX+M-E!9WK[0XC\:_%:">,68W:\TO:)^Q&B-+N2S29T/M/C=\!C'
M\A65BI]=ZBW!M$LJP8XO.@X8;A1G%:=C,?&;F1+%0UI:E\LB\?-3TL_'>#<J
MF(>C4 (?J9IGJ+&;?\S;H:[V2"U[K,3Z0S@[.6L.;3Z5A_%C2<0HMF&U X_&
MQV@$3-L0?A6VV7F;RW:3P^X"U)N'/<E-RH%U*UUM_EF*K3/[J1.Q$EEKWK*-
MJZUGO>'H3X9G)PMVB$;X:]QKU@3MRQR=E>NK,=2(:B6@:*:L9;;I/-X79^%H
M]2D=EU?]6G.P77Q(O.&U4EH:I.FJ'A8C1O\O5J*VA=_>5F;/?>=A+/[UO("Z
M??4MC(5=+*5_E/WQ;IC>EWU?/I['05=WW^KQW_3S4K9R!/3^J.'!:_+"ZW/*
M8Y8>,6Q*/4O\HBJD10QSD2%1DB''I6#XV<DI7CD_3+G@Z9_8Q4LGK<M/6=\N
MG9PT6V[I@4O7K[S6NJRU.%'D_RY78S[!JQJZP7MHD"X-K@^7[KUY>GZH ]JC
M-!HB+6@"#CQQ,6B2$H]HA]!LRTG.JDFJ 7V[3 7C.D&2V4JG8Z#*0 Q.)[9Q
M\G-<V WG,_])>Z %^98)J&B P>M)D5=?F &;ROVB#]I2MO'DO9O$3UF5S7GS
MK#!^-.?-1;;#;!'FQ*OR\5GA#6K.5L:C52HWQ/OQ$H\;[L[-A,]J)1=P2+XD
MCY7GH3(N&-J<:A>E_;YR$2TB02WX->0(BV21^0@FE9^H:JJFYGTZ9U&ZPJC#
M&#^;GHY'L;,NUFZ""G%<TT>6QKK;9;E=IF.7 ;/F"#0YLO-2H2;MK(X]?W(6
MR\67S61#NG>50:[DQS;1^N%D>3,EAP9%RPWU%0;YYS?ZFJ\FG&/4&\HC!^\#
M0I2(SD<:'.0HMX9/^6+P_?D*,QY3(4-L3D>FC0.92X[)48JO6\ENOM(HS/KK
MNM@-G>'BE+2[<EJ2C\:E1*)5H=53Q(]G:WMS?0>Y39>R$;/"'U(331KNF,ZZ
M.2M%VU6<II=LO?-&)LX*KUI+S=92?32)V^/E5UOA@5PPE'4I--/&M)Y7B\?5
M4K;%"5'-C5K*(CT[K?5Z95D*'4632_IH\-,"(.8FVC*D7F%=EA/)BY'2$12M
M<#C^W1W70_471ZE4GQ2BNN,ETZ@$MJOYOC",UQ:V_*H)?#;'/_-U1JF>M:P=
ME0"HS1)")=R<4,\Y;0KHU.39@OKS<ZW%8)<B ,W]JKW>IM=\VN]JV$86EFS5
M(:N&WRK&=2["ZW%!SL8[N&#67JQ4&SR=>UP_7;[+FUR]I>59>6R]K@Q]/&?]
M7B%!*3F*K\L)8%N"L"1.\QFK=4$#G\HRU.?<(2_E*E!4)JU+@&QS+HO"[61X
MSL[57+<L.'-?;@-!EC'F8E;#W:52LQ4,:$->\_3K1;9* SGK!M!H/%N3VFXS
M5";Q8DN4U]M=M@T:>6M'T>R@N9K<4(J;(8"%B=+,UZP[D>Y.;>>BT/CHG3QW
M'E"X (2^8@H;FV:1CK/I>%Y%]\_S[QH)N,>,&9^U*M:LD!0#=[XT]DP":CN^
MC%_FP'!-/?ZXW5;(LDG9[K^EO3UK-"(IU%UHW<X:*[F&)+I(%6[O;C]W^ZAR
MS]68[%W!OPKB)6NYH%A#F)<6<+&L#5LR:++TJXO#_SA'HUII,D^C;0'G@FC/
M4M)Z!;F1:TVE57+LGVOX] +%O!2G7,8X?-6:>9S/&ZJOB]YG=RU(6!E>FWCC
MJAWP?Z>KIL(JE1A^4&R<%6^R/K/@]7C4[JX:K)ES<:?C>7(]*I8V[#?NPI.5
M>*5X0=/%VU6.KQ(:+1-XN3UVX;PWF7K56SH^WUW35<L.\:SA7&FXYL;K^F N
M!=T$+-MX+=/=@NR\?)MT8M'PXI9<PX75T(RPD[[&?E\=[E(9<[EG">0UMMNT
MX4-.J!FKWUX*JLN>)C7\YQMF_W=M5+!R]*W[L\LG0<U]%Y'@C>7]=,GB/1'T
M;FJF,]<0'<^#X9,U'%@3]0T7H$;E"UGTPOMOK:356[X;E[RIXSE?=9/H6KV?
MZD+A0I0:D=!%:EJP:5S^$GOMG95OY*PL&@5TO A?X*K<B8CUEW!L?=X*>G85
M45K=JTNPW&[612>%KCE+C;6YZ>S*$G?2$N.T3.CS7$H_GDS&[Q></OZ\(_NJ
M&9_##RF2]M7]K(V''H]K#=#B]X\&+[N3M\+_\WJ24G=VWOZSX0=JM,INL;#F
M*6K->^)PIRUI\4)?^#1[7P9=WZ(YX&\?O71<UZ; H<D;VH-37Z(IW3V*/ATU
M[Q!)+7 MU,35S)B'7]J;7, "MHW&W,4G*K],BA<_0QW_2Z%3;@C .@:@^W?&
MT@VW#O;'49P/M3]QP?<Z/U0N@@\R$!I"*DE D?@D$Q'*6^U=,LG"^@G*8@N=
MSK?0HN$5ZH%%QGJM]AX\62:>&2Y36\Q/Y+N#[14KK35UYV;:PDM'>"LE-<=5
M@Z/J6-FPN!4#&7X@1\.(_O_W#VA1GW[<^_@C/PS 4LG5(58$0<!)1HR-EC!F
M %0VWE.U\[CR [0"7^#O4Y*8G*'1IL U=<!C]$;:Z%"-2<Z,TO(ZDOBRKN6_
MACGM#"HM?@D;($3B*GX?SR:EW<^#D\ZRD"B=WG*NDP=BR_*!M()8\+B:$1B-
MQLDD^<YC03?XEFJGI>H+^K/A<5Q.)9BL*/A><.;S_9(?*@XA:,^)=@ $@ (Q
M&M&09>Z3TE2PE+Y,<$PJ32*]%#91\)PY%358)K@%@<(4>\&Y^84L=5?<:%7H
M52"[3 "%AG@E#$E6F62XML;ZG<=,?D)P3EPX0B4T.;\O)(G_&(]C/8\LXVFZ
M'J#3@8;VL%("U.CX_3, NU&CX"Q&VPRV-P'W#E[!(5<2I41J(K(JUH(QQ BG
M4><X&81766P2H$<FLT$ TX$%X*88 C0YSO%&FFK8*+>>[[VU@Y)%E=^\3TPM
M 6QLOM6SF/E6+0',]C"GH]$H 8RNS4&:=K622PP;M<<-.I2E=F?N"Y:R[;":
M3M<E5';-#KMG=J0D/[?I=C5\4D.$#0-U>[XW6?2&ZDYJZ[#G;6G/$5%>KZ3.
MSL__6K:)>;>&)I8^6R08+MZRK<%>XGJXF)6E2RU>ZUR&-D >EJ:SRQ-423MF
M-?>^' N/)V\1!4/ZH3EVGKIWU8@85S;<LU$]._MA;K//TFL<@4>['F_<<.KB
M6\4N[ZA9\R;_(8Q;KG 7W[BPJ"@OKU,S=W'EI\.F6=)XT=IWB6;C:WJ1?W:_
MKN7.*)4"1,N5$! 1;0*/@4M# ?\"[[?[U.I@)8&V.5.YPNY>B%+-:)EO1'32
M_'#4$0$M-UFZL**X#8+7V@;4H5V'G<W'M4*QBT^:S4^A:[Y:W;US[N>TW*%X
M=]&6JDWT;D00-7939#L>%0[WZ>!O3?^K2<JU[<^"H*!;Z.7^5BOW.76SR;B$
MRKZ;,[*DLD?G7,T-5?.SC0'5$'4W)PU3VK*?VE9BMBGOGSV5&$YZA_>SYA[=
M/WCZX9 '*6D4BF0IT&Y'^2:&H;EGF0\6-$.Q1Y'-""=7--LC1(G.LD##T8-1
MUM'L7$Z(%%8+--^O4FXV+"R:_RIMT-8,C]YNOV0AQ:%$-XNA$T9$RI* YH*8
MX"(1(IE($VBK8><Q7.+P/AK\U)X3+RC0*H]+69GI.E5AR0AT-< >R[D1+E8G
MIZTFK<JWD]<%2C6'DC70C#JF1+&*N[!$=3!/UR]!^HB&$ )+L4\*_]7=.0Q\
M-FHZXK4'\DNF0ANN;]M^X#LCT%<S;LXPW]#1+QCX__;LE]^>?'>A/35>O757
MM=<5^4PO5$/30;EA"26NKN<5*1L^GX_3DSCT) X]B<,6DCCHGL3AOI$XW "Y
MPH4^WV=Y'=9\/HK?"1*R<N" 9>I= )VR<4[EF!/?;I_ODFS-S_JQOCCC2S80
M.:Z->]=5=9O/TL0X6BU?U>_)::&!BH._S0J+&SK_/A7WKR2W+7M"E]SVNZ;F
M>>Y%=C;9:)[@4W+?YO<N.2;5NDKQN]9VJ"^W8D%TIL&\/>OPY"3%89,+=C:J
M--@U];B6?1;FN3:G\%U:>NA=;O751=MVEWS4QJS]UWCTFE2?I GX+A6S#@[0
MV[Q' >#I^=OEX&\9>1UX$_M=C+L.NPD%]P%A_.S\T()RB!666,LY 9L#\91+
MHA0NA0Y&!KO1SIU;-"R4H.""@<"-IPBF-!7_F6=TF=<#PG_,NZ WWD5UI99=
MIUE)VBDNP%(,M<W/+.06)75W,FN8\&I=77$ :X)IYQ&TM,)=$E4L-?+CR:)L
M<26V[-J\W!+#*L'-AI.R01R$C.';@AU-R';]FZ59;P=*BY>MD:):ZE=45\UT
MF$S&?CQI"C_=;#FWM<:-_J=P72_>MPD,%#K>PJW<Y3^'X22<G4QG)=.P<<-.
MW'G3(_&LY$E^+-36'?E!1\=?TQG=R!V?E_!2?7C+ CJ=WQC?YNSD=(G/<TXR
MZC<X1B]F *VE$@U\-O'E-K6QO/]GE$L;&BNC*,O>I(X<)U=9%I9\[*7MX9O<
M$3=91!WG-."KI"T7$%K<A3.\+]'RGQ6^):*%XZ(!FF5HY[[.[(I\+,USD8-4
M I*5V;LZ'\M<\LO;L;M)6K3#GJ]$FZ-:-FN)JOCFI*1P;5=*VUJ"T_!WMRE"
M+3BL\EY.RZYXEX[K.RZ'LI=S95^.+MK_TW6V^B8':2GUJ*LK6MJ1B_#K/ 6I
M?OI_IXMX;$X+ MVSTR:M%??_FX:\MH2)VPKGI>&U\S2]?*):D&JLFXMG;7=0
M"[TN"CL5$N*N7U#S<C6A<1/V-L8]F)M4KR?CL],F@+7,/E+LI24V]18*RJ_<
M<(IO,:?+6 RWZ:7X/Y5=IYG;5?J.HW0<YTW0+ZJB7N(\79^FE3/"XR9*-&W*
M[ O)Z%TVXEX4IY_\O2[?3TOT[-_ 0GOQ5S<P+$.M(UT>:$/35L_M2V@,(:MD
MP#SD/B2O/AZB\VJ<U988ZQ0!Z1FQU# 2"\4AHRISD]9M,R^\<M2+S *%0+V1
M,@#/+C+!:0P;?4OJQFMP8Z4)R'#!SC-NZF6F,S23!^/3-BI<$JUQ?Q0T:3XI
M!M)T\+??7KR<?M>91-6P*6?!*U_YI7SET>#%\@TK%KR>N-&"LJEJKUJM,^PV
M14U";3H_M[;,VW0^[VS0':./R+S70=,5H7+F%/L"%4.:A.$\\Z >0C8^HEO"
MS!;I5J!SN5IC?'(R'C5CJMT\&O^X?.M_SL95%1V/ITV3V6&81]67+^NJ2B+"
M/7YI/)GWLBU(6[()RE0TRO*B&:JG$ M:C:9V_U.2RZA&DUYG[G4$$-Z",5*C
MD"H15/3IJR7WQT6WF+^?+[[R2\,X_V.I(:I__)YJW]U?ZDNS_C!L?A@F]IX\
M8X=.TT!I-B2E$ @(XXGSAI,H Q=.%83E.X_99=F?9>,WP9ANB[?'_J7PZ+PI
MCD#3[?BX9H-^35;%YX%E+:N"X?>=R;C/(K 0K4F.F\ S=Y8KMN6,)'^THC8H
M<%9DZ^HX@Q_]TEYT,4@UZ%80X5*$:P1_U7ZK;[+&$-<9HY74YJQ02%:D+E(X
MG6-%S6OX*FQ:@J+=54*^!BI#6UI67RV.*YQVV4_%P2WI2N6*ZJVEVL"J?G51
M$U J4VM)93G5.AI.8I/&U):)%4/<?3KE5C##@S91T031:.]]]));J:)P#O)G
M8D85K_PG(,V?+[ZR#&F_+'1;@V@7 MI[M&RG:?3@,*TF&WX\#(ABJ'4,R3IJ
M LE'@N9,((Q2':4 IF-7FD *C&U@6Z/AYF?T3;.QIGJQ;-1'C:!5[\U-1IWK
M]ND=$Y5-VB@J>7+@&;7>*69]<CYE'@5L@R)\R/MF3QQJZ8QR.1+.M4&[5P;B
MC55$) #P*.W,?7;?S"W/<![:;EL=UNS5 XW6K"O7XQ*4GCY==*DP/-1/W6SS
M3@TR+["V@?HY_5-IBG'2G#[X^:X<+O7=J5F.2S?M\@QJ%S0TQ?$=47,/IT<U
MP.B.6S,<[]]OZCN[J9^\%H<B4V<3E23;# 1R*;[#;4Y8T!(LDX8J_V6;^B(C
MX9?/& E?XY_,O9$M#*=<;+TM[^!%3?HZC<,5*]17)_ R\J :P2N2,.V^V=B/
MY<Z/!A>^T-+;M(FK]8BR>T)WUP76M/=?#FY63&L2W6?N;5L$/9Z?BW14QBLW
MK;<I$IK3<%8YY^8C+)1QM7MWUPJLJ_9?>M?/,VS4 X=IR;$K37O*#FL4^9*O
MO+  %P21BW9E)??=5\LYGR&HOFO Y1$B=\G4K6'/9A+:!+$EHMRF%.!HF-[-
MB7R6!:>!U'5*-)2:9KD:YNDNYV^27I\=N\GQ>6M"KQ[D#*=S$K#/IJ+=)U*H
M>YDZ\5EG=9-A>FG3K)=BE U;#P.6MEX;9,-QX(?CT2H]]-J]1@WU3^WX-9ZM
MGV;@)\UY0/@,JJQO\VDA.6\?4ZV5>LA02C"Z'GMW,WK^K"E"."BL^?<GIV'1
M9J^,#@?79RSL';REATII+DI?O6B+=^"S(C:X0$JG"F=8-$GSC1(VQWQ40D:O
M%"C@5N207!2616YI=.M1\2<+HIRN(<,EE((MT]BFM;6@+)DN<99T]&B+O(*F
MS\#\*;ZC<+WL<:TO/#_S6]3BI)%K&P#/[]9PU U'':UB%[II@H;X^T8AKU*L
M;.)9"Q*%W&%S7MI"L&6=ONA0O,HM5BK3XM6GMK71FFR/IK"HRXM=IK!>[F>Q
MA*FKF>87-8(IK&R+\\W[EBCPV3U?@IP-RVM=G)/BNYX>I^6%>7,V&4[CL.5!
MQ@$?=<T&RL*\' WG9O-TT3"CH^P[/E\CFCM9F&^UF_DG&G<WQ9IMJ6+W0N,F
M^V?.0+KV=IWD=1R,]65P(W968NVC65(8/ZR(2#7RNO/[I3UY-CL:3Y8WXL83
M%_9AE][DSN)PML1K.+];QCU=V:Y6GE"_? $_[]KX*]5=5VDW6FX"4\<RG9Z5
M_* F\-JX %V;SDIC75H'%4>O0YNFQO.HIM/LSDLN)^-S=]QVB.DDQ>/EI<)C
M$02HG9K..TN].5&;I5$YOV^-^/*^+:L<"NGXN"6*;*ZJ0EO"=WCWVLFD+M-B
M1I8D>9CGR2>M6=_-P&)NFOR!KB2X!=G5-6K*]%ILFVU@XV?-GK]6M^^G]VW3
MY!(\F8Q'^&-H)KK/4NR")R_9878Z:&4]05L\$\#I)CC!J/B=8L)(8PR3ZSI\
M.Q#[8HL5UWVP6/C!ZLJ7)E^#5Z@J?XSC4X2%.Z.'GHT&S\-L7*(5M4J@".VB
MW^#2>%%CC&*-9?Q]7&(1%<+BQ=]X6?.LZ@T)-;M_21?M>IOOAS.<N7"%<?Z]
MJU+[::E*[?OEUR]VUD\MIVB7"%50</Z[?RV9.=6(Z3YI$>NGKI?[K;LS+0-J
MD]ZVR!TM2%]25L\;8&]]S ;:&U-T3J*Z;,[-?[=BPWZ^]+QI>X:F0XW:U"FY
M<'?\-(Z+CECH%&S%_OBMY$^>I:U;V#^:C+LN.[%+IFVZTLR65KT&!VIM1GMB
ML1(F78CT(F"ZC;'ABZ'W<MC]+94S>+3F6MR]*L]CJ1MK?S,;GVX!#N^7IN?O
MN^K:)LZ_,M+WJ673+0;SI"2.E-8.R^WQEL.R-?!YY.)N31A=<PW++ME%*2[!
MY4F7FEH(_+]NXVRX8!?2P3:)T,EZ:Q)CX#PX[AVUSDH3M5':V"P.&147!4.W
M;4/N/S]X.N #\E?'D5I4*KS/'2;]@8C4 =+VV)A[K8V)UYT\_?CJX%?YYS_V
MZ-Z30)__\=OPU0G^_.9XN/_DSY.]C_MO]OC+#_OG:S;FFW^B?;I_M/_D^.VK
MC[^^W_]8[H'/_/CK.;X[W3]Y]7&/[WW\\^"I^/?'/;EW\/*00TQ&)$F<#VAB
M.@W$Q\2)=(QKEPSDS6[2C"<MF=8J)@J2"9>H*S5W@BF=N=P@T_SMZ>]/]U\^
M'?SV]*?G_]A_5NHXOR(3Z_-/7:MU-(:SY#4(ED"&[)S7-$-*PCICP&Z+J7QI
M)E8<3MWKUZ4FI1Q@(:HL&([\^=R!K2=138NC\>N).SU"&9I[BL4@ZX('39/>
MUW/"\O>%5/BXG!@U)8TU,G$Z+"K[:/R^.8,K;9(*SM7PTV[Q<.?>=)/CU=!Z
MK[Y<_7BI$<\:+3@:4:5A29AWF[Q4WWS;%?AEN7]4>Z(W72,'Z@(-[>E=Q[;3
MI-TV73"J5FEXYNMA1/7#V\NF33?4]M;M26;31:LY5<3K:FU4]2L6&;LM9/X\
M:5IUU03C"IC-H>G.#8!H3 $'>3S]_W;X<N;8+VE2K 6'FRV_:%Z\!=C?.N.X
MO/D!OOC. $&@4O?P!X>MOY[OO3^$G(/V@A*NI"4@$%5]E!E=>&EQ/:)01BSG
MMG;+^?C_S,6URE,U6U;[*2_VS-(&7-HR*XVS!VRU8?9PBOMT6H-LC;4R:0WW
M96:WTQ*!J3U'KD@X<@MAHR<+0"RU$[G=>0<EY_=AZ_%GAT U!TB1,)<2 1H,
M,2YPXA+.*.XU8Z/>Z%N44G21!R>H 9:CTUZR%+P%ZJS1:2.TM*ZT>S:9GDVF
M9Y/9;C89T[/)]&PR5V.3^:S'M*8_#$U6196%R &X]U;R(/'_7EB\ 8=+.\5\
M3N]<Y)F5&).\S"V[.PK /+)2W[@"8.P1E^JK;OOI1W+Q=7>]7R]K[[AJ-9^-
MZ%^L/%XTX8+!/OKV+XHO\@7ZDI9![MS!KV[O,EY-X^^E^.)LTD1I]M/99+P@
M%O[^>O9.8V]_^Q$6[?G7[,3M'C1]@(-F=F70GQ%.[\+;PNHQBJ1]KQ!2ROF'
MM;$.RM_ZD9;?5H W H^TR2>8=\-;7_#/#;,U?8JM5$99SZ &W6LNSP$=; %^
M73S\__W7#?J'=4_LVX_VTE#NV32NQ7&5!X <<P3&P&IIA,R:\=*H*DL=+R[Z
M7<1QB;KD:&RZ4K?V_>CLA,1Q]:+*E?,PKKJCD;57?_QS^N?!Z?#/)S^?[/_C
MJ=Q[\_3C<WS>WINW'U_A=?OXG/TWO\+^P>\G^_B\/X?M-?_^YY$_B<?/3_[Y
M=N^/5_AN;\_W#DJT[=?SYP?[1W_^XQG%,?'])Z_9/GZ^_R:>_/OCL]G>"_KA
M7P=/9WMO]M[OO7EYF)UBH+DB'OTE CPZXFE2A%E9^"H=2(>>$M]EC&U$@O_C
M?S%%?_C+!*)#PB\0C$_HD\^"[[I.ZM'L :.9L#11SY5)P,";;"/81*,1!I@S
MCE8THQV:T1[-OA&:G:^B69""!N4B45)E CJ)0FX A$EO4M)19!%V'K-=HT2/
M9CV:/10TTPH"RTJAHG<0%?[AC-5*&YVHD;HR$3#;HAFS/9I]&S3;7[/-J(@6
M(D0B0VFD&#DK!Z:6A!@\>"^C][F@F97VKJ#9%WO(N?[O3GG(3T=Q/ WCT_-+
M R+\RP9\(>3>/12"0(/(G/G$%"2?'/5*R2 2U3(&9WL/<0M0:&_#0V20<>D%
M$%L]1%.Z4U+%B'&<\0#&!DNKAPC7]A _(>Q_E=FT]LA+ Y,/5&23R"9R+970
MD*4UPBH/R6;&@2?PO1NT'2*[Y@:AZZI$#H$D&0V*K!#$NZB(HE$E(4I4KAH.
M^OIN4"^R6R:R@MK"6N49RQF8X\XF8_!/BSN NA1[6W\K1';=UA=&18O+0EQ0
MG@"S$;5LYB1X;8+SUGF:JJUOMDED'\*!UUZJ'42^RIB_8+CW!&8B-SHD':16
M"9(3EDMO)?JDCM* 6[8WYK< 9G[=,.83"TEE+PG7#F'&1TL<QS^L8D%RR%D;
M58QY1?4-A12V* ;ZP$769:9]H))1F]&&U]8;"TEY&936PD!OS&^'R*X9\R:P
M1!DDPH5Q!*@*Q*!Q1XR4E@D'RF=;1!;%MQ?9>R:R''PVV7.?>("2D&P%L]F"
MXIEG@-Z8WPZ173?F&2I2&JPF.:5 T#QB!.WV1")8I@LM#CKB162YVB:1?0BQ
M^9IR^LY-0^$(Z^/SJZ>$TE/M'37) W#)C$W,2/RGTBE3SGN3?@O YN7"I/_X
ME.T7L+%HV&6>"*Z?+AP)D1CG'-&: RL]"4VF)7+ C-FBR$$?[+L)D0TN^J",
M5IZB?5#)5U2D5$EE#67F.FE*O51^F52>KTJEL)2B82Z)DLX0"$D3$X0E"9@+
M5!O0"1UMJ[<IFM?+Y$W(),H9I&2=1^4)";P'F12+,4@GT(/CU[#9>YG\(IG<
M7]&4/QY:78CC2XR=)T:*+4Z\5XH(+CQXRT4NY%3V^GYT'V'_<J-\\-/$C89]
MG'T]:!<T@D9RBB.6B%A;1(*T1C&:@M"L-\JW &I>;1CE(3IF$&Z(BKR<P(,F
M+N1 #(^X:CY'L/4$GK-MB@#T0;N;$-F4<,UY9BED!E%'0Z- .T!#HB+$+'JC
M_-:D<LTHET)E!8*3X"@GH!U#@3216"L8LZ -M:88Y;R7R7LFDPJTCI0IYA"+
MBQJ-J$^%\,42YT*Q/I"^%0*[;K$C@!KO R.)\X@"2R4QD#(JU"!#AA@L4T6-
MTAO+@.\#Z5>3O=KYI0^@KX!,UCRB\E#&.K3O."]]=J6A/&O# JCKV.H]CGQ=
MC+P]D)/,>N6B(":Q@#@2*?' %3$R&Z%D"%R7,W1][:27/AJW93+)J%><)1P8
MMZ L:GS)*0IFIIFQ:'EOC-]ZA+R521YI=%"*<QWS1;=[U.U.$XF_Y%I$'0)#
MF92;#+2]3-YMF2PM25U"<YR5J):K>M)P#]3@[SCO(^2W'R'OLM"C=E0Y3B15
ML9PE)W20*25H>!L9J8Y2B,+:J;9()J\;(;_?E?(7,U?=UTKYBT?[)6GM42?!
M1/0:W4MMJ8$@<6-3%_ ?R:D^W+X%N/5JT[Z7F@HE+*$A*0+9:F*%<R0;YY6)
MUL=ZLK<KQ68.S WV?+J:IMS2TOP>/GOXO';QH<XRQ Q>:09)@F>)I1R!ZV"T
M9-<Y^NCA\R\X%VGA$] <#]E8XIE#LR]23AR (HB:(B?OK:!TY['9%2![^.SA
MLX?/OP@^M>8F:ZW1V+1 .3?)Y>BBII9!T$;TIU1; 9_K7K,W666>@-"L'4&]
M1XD%2XG)4CN1A @""GR"[N'S+SXSVSZP>SZ9'8U/72DB;YJUO3C%[UR%Z_SK
MPXK]/1Y&XN1_C])FUX-K9W=LQ]B^V$C8'CO@^H=6GIJH!.>H,: 0T8K ;:#@
M7(B@6,^EO0UVP.N-*)2' ))23U0J?(V<!V(UC<0P(YW3/BE9DSX-7+L2:_L2
MS'K8N?.PDPJM:.1<).; <3#&*B.2T0R4L]SVT9OM@)T-MC<',H(CB0$GH(PG
MS@E%>-*Y,'_1X"OIM53WD-.EAYT[#SN*)0'H0C-FT;IQ!DT?FY-6(JF0;79]
MU&,K8&>#G9I9AQO'D%)A3L!H0-CQC 3+8H;,J9.R6CML,^K1Y^;^E;+W7\/3
MRWOA/<R4(P&,:Q:U"=H!I\J"]L$)KT-,PLK>H]H&C'F[X5%1F9P,$A?%*$8@
M14ULB)PX[8+67JH<JVDCX-HE.WV6X):)K Q@G4I:4 6@J#6&.K1D2R&/H^B5
M]-[(=HCLFC?"1.G3S( $JM$L\(X3SQ(G*,8Y,^53M+96OM)M2B+L1?9&Z&C0
MA/<L.QHH R&%D4)XW %9>"MQ8_26_%:([+HEKXQVSEI.(A.R:-E(/*I=@D:\
M=S%8B\A;M6S//7W+LG<P<6<GKAX;/OTPFZ23X6SXB3[7#[.VUT$V5BD1/4\0
M0[0L<\>%513 FJ1[VWX+4.?I^XHX%7F>?=Q[\HP=LBB8")22))DF0+4DGBI'
MO 1NK+<60B6V55O%DMG7X]\(299QAC&'0AHD^*1LU$K;[)+SWFJK>N-^2V1V
M;U5F U<\!RZ(%RD2$"81B^M%++.1,9,E0 WZ:=YS:-PWF75,F11L!)DT4"N\
MHLX$&KWE6C&1>^M^2V3VY9J>U5%E)C-)F@.:]SRAB@V"4&^]#@RXS;S(K!(]
MB<;M"E]-!>PC]2LHXXTK 8/ 2IM:;TO#;>N#+6RVPFIN>FM^&U#FX\*:W_NP
M?_",'U*EO)4QD$QU(("P07SVCG ELJ6.H>7 *@WU];,0^KC?ELFLY3YHYI(2
M',"C]P8&E$@F,Z4RF@N]-;\E,KNW)+-[XC G$8SG@:1$/8$H%/%!,+0,5,I*
M"!Y4M0PH]#)[WV16JT)(2H5 +0N.9<^L#"DH65I':GH=$HY>9F]29E\NR>Q+
M>I@"2X)F03(7FH!GGK@L!=%)^H@^61:T'HDSN4TR^Q""]5]/B7=_8P:4&\F\
MC !H$D0CC!><>Z\I6O6)Y=A3XMT2D'S8"+\'(6T2PA*E)!"P61(?O2'"QL2"
ML )=KIW'$K8I*- '\FZDO,AP9J,3H+R'D(TO9)76BI3 .BU<SXEW>T*Y%E^7
MO'3TR9ZH(HJ0$B..JL)F$VW,R1L&=N<Q]"=B]TXH<W(@5?(:M !KP0GO- ?M
M7& Q]FUC;E,HUP/HR9H((9'L"VT\9)3'3",!R@(/UD J39/A7N6Y7[G.IKWN
M8?&2?/&@[S8O"6)0BHHG-!4T>"-*LIBA$81VT?:L>%L"7.<;)C[J#RZTI$2(
M2I\?%3&V\)0DGWTQ__"_G<=Z5^I-DMUM)R;Y4A'\QM'&'C\?,'XR)F2(+BE9
MR*VC,YF*I-&LRTR M+H_']D2_%SSQG*DZ!=+08RF)1W: G%!>>(T%2Z8*$T0
M.X_5+KV@EJ''SQX_>_R\&?Q41AJG0M1,1T +QC :"R.%3]E+YFU_5K4E^+F1
M>29%R18DE#I*@(,D7AE-D@V^<!HZ+FC!3Z";0>8>/V_TY&S[T.Y@/-OL]GI%
M'L+F;;\7.*=Q?.:/TWS*'Y8>N/E9N=N*(H#D/FL>1& @E3,^4RVDI_B?\]+U
M@8IM4!1B(U A$\242G\N(U%1A!2)\RR08+7148%/NI05Z%U&[SJ!_PT(Z993
M+O48W6/TIQ+/F ?&)4*OST"#LSDJ*ECTC#FPHN\1L"T8O18,T3%YP4,B*@=&
M0&E*3-2(T9Y[43J<<Q"(T; K).LQNL?H;P]*/49_-5U6HM'0$)B5%#)XZP**
MF0X 6;+ >R*/;<'HM8!+9-KE")XDSS4!ZQ6Q4F625*6.ALADJAAMS&8&48_1
M7Q*2^<^9PX?BWW'X[O'_PS^Z%U^Z5T@H4Q.\K'YW/K+F_7!4Q^YTFK[O?O@A
M#J>GQ^[\^^&HSE6]Z(<3-WD]''7#+8G/:^]6G]=\_,/[89P=E=E]1!N1;P-'
M[9/;CQ_5C];FN_E,FD=6ZDL_IH_8I9]]ZK:,/>)2?=5M/_U(+K[NKO?K9>V5
M;ON92.(W#!B:#B[J;;X?SO 1X0H:[25JL!0'+V9NEJ:#_30;O$#]<3D_SN9@
MK]!V8CN_NKV+>35C9"_%%V>3UY7::#^=3<:S%(Y&^,37YU?IC?*)\36@^^U'
M6 *,?\U.W.Y!TP<X:&97!OT0JIV>C::SR=D)+L$7=Z"Y6[[E#1&VWQ'7\?I,
MRX*)Y*'T3 ;P*KL0 E>>6PU9@^US13_I.KYY]<?OQ^@"OG_U<?_MGR?H]KW!
M=SAX>;[WYI\G?QZ\1#?RV?GS)\]@;\-U1#?QCY<?_GSS=[SG;R<XKI,]_OO1
M_L&S\[V3/X_WT8U\]0:O>_/Z_-\?GVTP+<?(D\^<DQ0E)Q"T(AZ]28+K+SCS
MFC$:&Y*8FVHB<<]":3V:W4<TBUHPGKVAVF8P-CC*92P1%I$%ARC[PXKM0+,U
M$FHNO+?61,(C"P12B8/1: GE,5 .-OB2>,1V06\>5?1HUJ/9/46SQ*@$P0N_
MJ@ 9N0M.TYAS(=R2F<H^K+\5:+;.SRVE4)EJ3I14EH!RC)C +,E4.:E9TC$T
M#;ZNWP7CCK7[W6H/^>DHCJ=A?'K>,_RMH) 1QL5L)'79 IAD1#3!<\2BE 1N
MP-Y#W (4VMOP$"6WWC)I$868)^"X(=Y23X13(D?A(9M*\*<N*";LR<+NML@Z
MY9RB"8R1%@)/-AJPG(7(N3:9QMX-V@Z177.#J$N420/$1YD)A C$"E42 [BP
M(M# G*YNT 59M;W(WFV1]8JRH (7QAJHC32ID2GX;!.E$$)OZV^%R*[;^L66
M=]Q)8HQ%6U_D0'P6B4A+(<KDJ6LB%U+W]'ZW*WM[*9;G]P1_Z\UW9,Y":S0*
M@7/C(Y,R:LIT+L&%WIC?!ICY=<.8-SXE"> (T]P12"(3 RX1C2Z9R<I[)F/I
MO4/I/>P9_L!%5@0>.<VH6C0K!QDHMU)026G63NO0LU%LB<BN&?/>!N8S2\1K
M+XH)3]'_5H[0G"QB+47 5<4RL.S:_G<OLELFLL9D(QWE7'H/J&_1>;-).FYR
M]BXFUQOS6R&RZ\9\%LI;&C/A&6@A#K3$,,N)X=3Y$(P%J,:\-MND91]";+ZF
MG+YSTW!V[+Z.L_O^1@ZD]-2;K)52'+QTCFDC$NYEJY/UG#YXSNY;PI.7"ZO]
MXU..OSMD(@G0AA&JJ25 N2;.2TN23SJ6R(&-?.<Q7%!_V4?S[K9,"@K,B!"H
MRP""191#(RD7R7'E-+]. +Z7R2^3R?,EF?SX]E G%12N#-&%M0*43<3(:$EF
M8)S-X)3S.X^%Z67ROLFD\Y:%#"I&FX!'YQ"+DTTT:*>RB/K!,W;?FDSN+^G)
M_8\O#VW07DG/238T$8BJL.AS_,,8%Y+*:&\#RJ3=)IE\""'T:G4/?IJXT; /
MI*_WT+-!H#<OC?"%[RB8I$K[->4L8SK8T%O=MX,FKS:L;O!9VA@BT3HAFB"V
M$RL9;DG<C(&;Z+Q0.X^MN?89>A]VVS*93%'31"$"<P9"C%X;$W(T1EO*(V>]
MU7UK,KEF=2?TAD!Q0:C)BH#+C%B1# &N+,LTX2+8G<>&WE1Z?R^3VR*32G/J
MM*>V9$10E9TV7@:$:,HBEXTGW%O=MR&3ZU:WSRB+5!HBH:2I.X\&MQ6<6,T=
M!V>\<&AU&[M-QU,/(=;]]7TI[Z_O7G"#*^:9S#6AU2OAD[12!@J>BKXOY>W'
MN-LS,Z<3BG?-3,DE,R4Y@MH=_^F4BI$REA+;><RUV"+?O8^GW8A,6@W:9DY!
M); Z.6,4UX&BUV6,Y-?I(M_+Y-?%N%N9%,%8$9T@Z EY C9(XB2-A/M($TN2
M44-1)OLN\?=.)@7Z46 \%RB)$"-:>& 836AQ!ZM#ND[GC5XFOR[&W26*H]NC
MHS(D98=Z,F9/+/A2%"J N6B"8QIETFR3GKQNC/M^%[/?+(GMMA>S7[_7 [<Y
M)X;F 7J7B0ECF>79VDB=5MKI/O-\"W#KU89][Z,P@D9/A BJ%+,GXE7,I3%E
MYF" HKXI/2DIOWL]U7HND!X^[PI\>BLX,RY9SC/(+!T+66L5@[ !!33W50#;
M 9]KKE@)6'D'FDAE P%(@;A,-1'&HY6F DCF2TLU7-L>/GOX[.'SKVJ)'F@$
M(R,+!3X#<S8X=,B"<9X)2OORZNV SW6OF><$(+TFRDE+(%!)3$Z*&,1/,($*
MJF3M2'D'.Z+?,>ZF[0.[YY/9T?C4E3KO:24F?W&*W[D*'?G7AQ7[>SR,U,?_
M'J7-Q@373M_8CK%]L9&P/7; ]0EB>3  )MN8+%B6RN&Q8YH">E*4.M9'H;;
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M>_4RN64RB=Z6!V&=+Q4JTB4?A "*7I;BJ#\YZZWNVY+)=:O;"R-!0R#2"4I
M*4Y*^RP2I<TA:!V\4BB3RFZ13#Z$6/?7-V"\O[Z[H2E;7E*?) 49P7.JN+$J
MIFB]#[VU??LQ[BY#+8K *3@B7& $D5T1)U0@V5*NO42,\7SG<=]9^;Y)9%(V
ML"RYSMD##<K*FK00=)#1:YM[6_O6(]RM1 ;4ZK+V014:;6W&'?%*)Z)+.8Q
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MEK1H865DSGL0-!C/ PTR!F5 ,JM[8_NV9'+#V"Z<Y "<9 X)]22-Q'B0Q.1
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M+V<RO=:?/-OXX_'.QA]/!AM;SW>>O=A\LK7S?-Z1.S_A+P7FWU_XXHV"R:F
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M8\"E8L#3BPQHBDH0@F+9HV"0-6=1!<FBB"E:[TT"L[*F?])B/M>H,6!CP,:
M*T.K,VD%Z:73 6S,/L>DBTV*2ZL4QL: R\2 6[]<9$!-H\8#*H91>@9>2^9C
M*"P96YS&%+B3*VON)ZOG6[XV!KQO:R*7O];-Z;+W,1X=U$7\2S="+K(7]-P;
MOZ2RU@)58]H5+ILUR[5UZM*D *L\<4ER00H/X(1+V62KA"H2>!%720J8SLIG
M>!"&-<GEK$#1=IEF-)PE-'PV'&-QP5C0<Z5'^>2HSN=F'JY@'C;FS(-1V=F
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M:Q1WKVIF-8KKB>+F"F2!XKZDS, K^B-Z9 %C8-$G+B!F9TPB&>?GLTP;QSV
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MVJ$&DXJS)H1@(#H$;HM?W!]H=5/ZLB\?YQ: O/&<*U&8MLHQ\!!8#$:R2.Z
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MIZ8/"N)S(9%DN _)!^:22PQB)'_&:\\<.B[)8U6N8"O9O(SX<RG)6@B0>V-
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MA0_))J,AIN*M)/F1=)0Y&Q/-PJ:LONSM\@S_PL,3;"'+7BS7B[F0);H2,SD
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M<2PJ;J0W,9F@!/?,T)SU.L)!,\)!;!BN<' !*O#N;!?& 6.C]>,3N/\A.0"
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MGLNT^NW<3,TEYRX"_EM+*#<T614<=SP8;Z2CP65/9*W$^A_=UH_29OT!]CN
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M7/LTD)&SHPC6[=25)R(MY1='#1D+=K2>_^IE#0AQ%':9B.1,QI1RIT#@*J4
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M^&"U#C@'YCN&.03^U3=?]5MQ5=]5&WY^A.LMWWZYKXH]6YX!X;>@/09I5HD
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MO1!Z5O!Z8B$/1A1N%QC?V# ?.8M54?49HVI;Q+:BZF.@ZG0/@62C82Y#-$B
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MF1)#FZ47*%C>7L2U 7V%Y,>'Y-83$!62VX+DJ<0#L3ZJF!)0HCV(A"-BC"1
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M.L\]\>A/V^KT_PE#$DO$8C$0FM4*9!8+8F- W$J/>) !&6$HDDQY&[".@7$
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M*O$0=G+9*BV 2^L2BBQW+N'1(.LPN$F&>(5%2,:GC2W%'['<N4[!C@)@+Q/
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MV90/FB+#D5"#) P5XDI%9!C87.)44QYYP-%O;)F2Z% G(Y/@:V*-0V2&<>N
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MU40ZU9.=R[^'G48]9OAY3&@G'E7/92ZKT4\2VFV+S-W$FID_$-F,,&2PGJ<
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M["C8,<<>R((=#X4=?UW$#LY,<$QZ1 #[<Y'1B%S0& F32.!2,9++HP%VW+U
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MH%NP8CZQ8J[=- 4U;HL:$XX:'X4/*A%$E(N(,\Z0X<FBO'784&HBUW=VU!3
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M(9*)U,0"0(\$0*V+ &1Q4(E1C(PSN9R,P,AZFY#4 EO/F:C+R>A%QN^<(5
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MVAI.)&.(<$&!R0A%AFB,HH_*:DDCM:)F,FSN+.H+D\U2DMF0?+)"4=A!ZRU
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MT6>9%A4R@BCDC10B^D24836[S2QQ9(Z2WEXXRV+N+?8V$:X=]RE::92"S1?
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MC.P< 2:?(V=XV!&\;\P;YZD9GMUMOOL-WA>;L0-F]ZM.=U#Y=K2]/-GCC 5
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M'-Z\7P"2^!>P8RY.]>GYY(Q>,OCJR[>&ATMZ'?R$8YIUNT__VO78YOW*-O#
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M(=HQW4OV$=-X88%)O -C+P6SE\0DWF8D7GNBB%_:LIZK)?65F-QCC+F,,0V
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M #'B 9F$H$'1T@1+P^^89#;2=I(,[!C8'0K8L=C9<N/8JYT5!6B*) ")A]0
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MLW4Y'4WJ?(8!J\B-;!3I0$Q1)Q",4[?2EW/D>4A=*)>L"VXAU*PIH0O19OC
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M5G6Z%_3%!+Z?R7'+4WH9'/<97+,,GW49CK/'_?*UMH+#GW&*9;P<"51><Z)
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MZK0V"-E]]CEL@G!2Z.&OJT-="\&O79_:-OO=[#6L>IIQ):SVR;(DE&=:"\]
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M*V;,0)#G;6N2H@\$<%XR%*++8!.3%J5)HED.R=H@OP$%:\!6CS&MS: NIL9
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M3)+5% ?TDO31H0(?I(94@J2-0;)@>Z3P^JN?((5;2ZZ!NS2//5_YAFAC-%%
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M"%Y?IC=)D3"5&HB@#0V490$",@>>^7KL(M')-IO(8\BZ[YWSYTT'05LMBY'
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M%@<[UR%=J/8ZH'J/A-\+9_>1\)[H&K>2=<_A\/O!9<U%]H1+,ZE ,<G &UO
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M\F*-$VWRVW:O)(^$5_:C(YO(OUTSHI__3//ZOR7 Y6U$08K(JR'E4=7ELV:
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MODGH)J)]AG6WX_[^8Y\.LFX02?DU_#D\/3M]CU4JM,;_&F9S8^-MN77%P=4
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MYV5 .C(4C##2&E8#@ADBB@):>Y>K4\\L.Q(EZ5(&U$Q'-I'_SLN F ]26^X
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M3@] O0)ZK7QT';A-S8\- >_'&&FF .LK6F_L-3!7-H4MI>-%6]J09?TBN(3
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M\N&W?,/ZT3,%#1:<RW.U"FUYD7JLF<W2@RQ%@*(?P*.PP+.D$2>;?:-F="O
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M XPJ%:U\8+[-J+W],9ZO\O3&3(,%N&MLK_^L,2NLP"^$,IK'Q50E+FJ G$%
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MIN^9SPQB#AF0[GZ1E- NM\F*]0+_+T5M0'.#.O7[.!\,&RRC ^]P7N,'LQI
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M=B>XIW&[6_"^2[6:D=; NND&NM11 UXZ0%47JFG%P =7TYXYHW(FVT9#Z9Z
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M.T/WMN4])):NW\/5;]=_Q3##__V__C]02P,$%     @ 1&A+5#'('F<D;@
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MCOQ6$GK1!\<U1K@* A6!GBQZA5K*Z4^EEN]5EU2+MPZ5:SBH^WA!*$C-?9L
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M%)$XODT6V"T"E82%^86AA]*/B])O'_7AIH^IQOLOU;A=I)(TN4-#J9.FU(W
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M)$K@C*B$L)65A9B(J)7D5O\+&"0.IA[<_[O<6V&0T!@_"20M+B(N(2)UYJR
MA<39LP(B(I)G!:2LSZ($+*1$K*REK$4MK5&HK=&^9Z8L''\=%5Z5%32BJ)*4
MV%DE!7%1,6$Q$1$E<87S9\^<EU 6%E42E10YJZ3(SF:%E+;&N#A90")BYV1A
M@Q*R=T;9L+/]OA1*L@6B)408L>\[89?L#S10+G9N*"ME%XP3&T5$I>W^A#"2
M(N*6UJ+"* $I$4D+@3/B4A8"4F+"9P20UE:B*)0DRDI*[ S[C_Y6_[]0^-X7
M\^^00>@/B*G:N4(RZ?$=]GWCZZ&N_RA^+SO:L5$VEK0%$E8&<NRN%A IV'\
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M?7S?T=:>G&9^M8/:7SEBV DXP4QH,X5O:=/N9$M&!6M+1@,%KOL2 %4U)RR
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M=V7#FMMQ8R:#TK'.I5G\0J'^.)SGS)[:X"0-(Q.VU(<?J6-@S;($^:)W=X,
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M-[@E\BM+8NSG\JM7W"V#AKYD5=B'TC+F,#/8IE\P*+K#^4) G#=H9U>J_?@
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MOO7(F,N"QUL(DY;E+@&O1GL6USB,RN35IP]Y'">$YFVTJ83<4..QE4I*NL(
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M;5"ZZQ%/LG,E&=6XFS4YKFN71D&OKS.$J@9S]SK4L*EW5B\P<RCHQAJ F1+
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MA@,4TM=SB@K!M=H!3PK]6VT8#1@O\!NM^O5"9&7H&=CFYA)8X+3V^,X3#W/
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M)B62\:)->4V^=C8U@54Z>@JY@%;Z3YWB5KG^"< ):T*_F;ZGG82-780UM O
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M!3[$( S2J'BLY2])M<AY4+EAS)EZXQ<CY$IBH?AS1<EO87*;LV&SE2MA5&9
MX1[^,*HJZ#[1HB6-:L _X'6.94VD_%/*E!H_UQ'6D+X;W_S/S6RKD6WGD$*
M]J0>1TUZVO480RI!PP!RPP0=;(T_G'>*H,KY^TKXM5E-E]7E]0V[F?\>6>U]
MV1L<S8("PEM)0K%5:YO*"9)]9I497*]U?$[4ITHSO59#_:*!HGV%(/A[T$G,
M[3&XZME?2$ZRJ9??]TK!!.D9IE[6PY0S(W5=ZJ:LZ[HO(4)437^QN7N1RB:B
M;F.DNR;9YQC3L[Q6DQ--L/F%9=EV!,>/N%GV6?_$W27IX9(MT5VC,,1]T;+-
ME358)JR"!FH/@'IF)TG* 2B"A$,3OBS%^\R/H47[Q32HTDMQ20'I<6N(?[4S
MX\0BW>E\?]B#6D?\2KNGJ!O)64WH[01^?/V&\<(!Z@EPYM@=K@HLE8'!$R9(
MW,"IU+_U"M'RS7V:60W7SS1G,)',JUT08L/>&FI;WEM7?W=-*G,D6[<4?.$9
M/]&((492,LBJA*E6/T$6X2H3/NOL*A?U@TRV[4O;YN_=>Z^::_*N&C-\[87?
MH30W\Y$O$+KR<5J(8[,DBY'LYX2I"1%^<:?PALQ]D]#L*J$W2.<D\+HZ-GRY
M/K.K;6?33*R6ZY+,."KDZFN5^CU8%JQ\>KE\ 38U94<#O=DS#B7K,R=T?L_G
M[G"3^AC]MEB%[?3S>.P:,@9M+(2#A?GT^VVFU?MFYT\9!ER=ZB@O=K<[UC<+
MN79#!"*LK>$/F=,+IY0NV ;.&H36Q@KV]2NNO(E_'>BSJI$,4[2E4\8#354?
MQ93V62ZR>]E:W9'G@V[7V@,QOWB$\A*D/*E=;&!*=;X[5EN9;%;M#M-'U^\J
M):@LQ5F7_%5IP4S':):O_IK08D,-6VL)F8QLC7%:<UH[/WRBSW4Q%@HZS[@"
M":>!\*:H"*@ ^28X*K]V5%-B7N1>1SF!_\1L$ WD8Z,(.1S[BQU$*!!LHT+)
M\D7^469.MAK&-4&%DV?_3O$_G_-30_%32J$.$&XR'' J:G7Y9CD)=(T)U@XK
MG[?G-:CAN%KP2S'UF<JG_=^Z >GD4T8+CPL).CCM\CF48(/=AB1_]B9L+5OS
MG57R+CNCS\77GXCW,T&$G:DXXE_ GC PQY.+\^2T=7VP/C*M<U'^3W*,2MDF
M>>)08!4*HH'FOF:S:3+BW=HD)?Z@?)Z/5DTQU=1:5.VNBSNI75^N3P(NY$=Z
M!\L1S?ZL5 R_>+$B-#9GR%PA#6[ZRX4M0?123PYZ0IT\H_9LG#-?C&BG\KK(
M5"5D)&F^TU<"?ZW#0XCO\>9;8DXE?P&5H)[Y88=$N>QJ:V$#IP=]B??\S2QH
MH.H:<F94)_28P88&6E7>('G$Y3L72ZT1!:OESC!W5LE);GK_'KQF=_/8#=E3
M #>C<[7  #7\1GW6M6-!\C-\5"MD'-J:=9J0A>9)R+]$"CN3<FD7,^5TQ,MZ
M"9'5./]E%#-78"<IQ$72I[.]N&LF##^KDF7/I76#(1(JND?GS.Q65> KK@$L
M#$RR'9B _6WZOP-.=^ML![\E7!O0:M5IE]A]ST0#>9,X*!))AA61O%R^OH0V
M%B8WO@AR^0U2%@3/2L0"3L<Z, FYVYC:8?CM+RDY&[S1'F*0($?VQ]U?KN_$
M'M:3)^C%^P%^I0)0G4]B(+OA?;Y9:5?R%+VU#4Z%H].>FRG=N['6<2]_5%69
M)(>;MO299C0>-=N>GNI6^TG=#:<X\R(,^80G#44>*#-G?)@#J;]S6\+$0O#W
MZ8D'/NBIDC]S )5P>UNNC\8OU61%M\R%+<93'EY!R=+_]AW9&[N#WN&&<^&U
M.GI*@(@%]13+ZK/GMZ+GF%Y?O=H]R@LSH0Y@*H7",$ZS3!;.)+TDM\O?I1YC
M_IR+U\1>6U@)[GC.M0+R!OELW)!D=:*!F._B/\>W-IK@-[JRQ,ME(6YIW:\5
MZJ8K&5>-@RWQ??/8-PA%_]<27FVB2V7HIU)A=^7WNDR<=/8ND&)G1ALU\MP$
MMSR1WR=F6MK=]%^=J$]>"Y/;4UU0#?.@@9Y )BO;9M3Q\166<'6"\ESBL0D7
M/#K4<U8GZ=!(77+*F7M@$)R0+=$H=PP%[+B1G173.OG&ZE-R5BT.[BOY(N+F
M*0"4RB&+]^K6OC3<>#UO=KVT<-VK%%UO].2^45:&1JVX^=#AI'MBS8N8(!?/
M8%:>PE=\/S$V)]UVBZD<IRL $^(OO(:_8^_,;QKH^-P?^=R:-U)'PR::3_%?
M7JLR9C^](;VED)!=D][N&1ZXWRP>O2ZI2+B+W%#*YFDE1KXA&4RTD+@[_$[4
M@R?RB5^K*+E?L;?M3HV197V^:1K)B':<NW;ZI<&%M^QK P(H>G7XX/-;H2P3
MXQ,NC_?<7A=DF_TIXW6H:ZA_FB'C)*U9KL88;[]AER]0<N7G@+ABUU;[U0*F
MA=%!)O0OLB$0\0U^ :^-FN\/7D[2'\;M;5NQD;LYWZK94=R^%WALSHW*S\RL
MLVT_>?MT/H.Q&'P+S!(*N8!L'VAFB9STD7BB>HBL3$3N7]Q'ALY6L[9C)L4Z
ML)-";R[[L*,Y-72"+DY/"IOW\12^??WZ]48G/(X>]1OX.V0E0DW;;&S@Y61/
M@:SL5T2CSK!IP:M#/\_%B+P*;[K;GM4'0Y"UW%FM\+]3Y^7%[I57&=_[?;TC
M[:T47]G7V$6>&]#>T,_&<(+;<0#Y3"-0H WI+/G[V7O=.(]5!:BY5BP ;?RM
ML@CYF.>+J3KL]*=RD-D)?G%<.7(-UK*)?7X$6[4)#NKEQQAY9>A$%PUD2(EJ
ME".\YC1,MZO!?OM3MMBZ9]7S2>;U*<K0TL[ L?<)J)-;>[,*8IP&XD'2$U?
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MS)ZB,E''D$+:,OZ>W:*'44J.6$UM:4$]]B%I,9FKW'V)B&=N!W=B6;UPLUQ
M+G$LO6/RCILH.$IZ:'*7-W H^O 2<_<'?0G?Y>8YFRVQ^H5,'WXVPL"D']$>
MC]W2F$-NVKKYI.6[WJWW*&5CL;:D-_'=[PFIJ ]DUB+$V&REQ#O_QPNM1(P@
M7/'I<;%8<8!AG87^-,<$JS!5Z._#)XRA,.30C8%(36/"'K$"B'(DF;]!<"';
M.%]=&?<Q?OHG\]*AS;O<]8=8]^,SU"Y5&+M/W&PTE,_G+,&S@W+[';;28*3T
M778C[]3.]558HIHP2W-Y3@C'412QG!+E#9V\NCO2D:GW;>8D8?I=J"#*'=*G
MK;V3*<1UA_A$AZ'+  3.M_!XH.Z4*+<7Z9F$N$*)P=#1@6\-<\I'WJT#QD.^
MLQQ\E1@PXX!^\_-7Y%G[I)0 _?OANXPC_"?4P3R +'$)\')5LH5V2$((>I_!
M/9X!13;=,E/!EC-75ZA,7?4F;-1NC !"T3^GVYJ20_:NIR8[G<Z"LKFX5_0:
M,O1FW&+6NT_=-KGUZBTB Y^]Q8['=DW>M4I+6DC@61Z^F>K49/"18'XZJ;=Q
M=F%E:PC?/9<4J>#Q#%O2:#3/_$!>*5CEE;21K/OOND<W C^M#(J"CA;F2N-?
MT=O;Q@")]XK=+B[VEQ V%P6D3#_>"E%CK);;UVL6_^=.!UF>()E7Z(]=2$IP
M7ZK"PITT@C-GG(G/3AQ/WLA/9:X/,O_KS:@M3LG%/%,06,/P=G?"0D2+ /O.
M88/GF!%!3RG.2,U*%#/BF;;SN(!]>/R*PB#2!369WJ[B\G0>%J(J*=T<_4(]
M\MV\4CHE1]4>>H,5'=RJR^"UM].M#MVR/K;NTE0H6GT,96_D]&]5!G^B?+?P
MZL6<S9Y^6*"U*[<)#44R::H>0^%:/_#ID>Z]UC=4!WQ.2_K\[=XQ.B-A0;WQ
MA(O!+EP7%$#/-4R$RJP8XB20W>IW3THT+U>??YP&,C]_E-S4_.3:IC'<'._9
MG8V&;F[,65 EC? ^9">>]&8)A<<Q>Z(7GMWPY5+](I,\.+>@R4'ASPG1?DB)
MIH* [A95A!(00U#2H6L4&BC^<N-$;D*[F#^K!KLXUV>,@GM.(W;!B:P\T GF
M!AI:D^:2Z##6IES<K?RV-M'7DAPIPR*BQIWD>CP6>V)EQ;/E,YC8 )R:XQ9J
M%54-)2MJQ^3WG[%$71;Y/G6I7WHQC)5Y2CS0?'KF7"-! M-^?/Q9=&P&R5\:
M&N3F$G,2_?M7A.QQ0_&WG! HO8%W]HS"H%%;BG,?H5Q ?JND6%5Y=:/U4K#V
M8O%1;.*'LS'"[=G#395SJ&B,:Q^8#S#7(9B':RHZS &2<FY3Q0$9^48^($'Q
MN6KFX!AZ0'XC-.'L^.XM3CQUKVWF''J6/Z2I=/$)>^FY;CZ](,C]P40T 4GG
M_&,KZL]*HQQGDCNF$\9T:\E=WLI>)@9B+VG@#T"\7MU?ZT?$W;\!.;4.0;-N
M:959?;3E) 9\U,>\JMFR:LS[>@L9S?QJ9%8)\1M3;A);UGP>'#<KX?.> (D?
M,]'N-C+?.UWYJK=<2QN&>\3P,/;X62QH=V!2S K(_0JHSR#?D+0S2OU#_A;U
ML11TVI\\E&;R@C'!#8 SQP_I&#V"FXV91(7ML_EL\:CE5$?.K$8+2VMPMRQF
M/=>BR!U<C 4=F<_M)&!<W:WG'\>Y$1A;FX6'R1!I0^)Q,;M-OVCTI^^#%@<O
MPU>-@Q_1%?Z_W@:9ATV-$.T(W1TH"7^A>7#;L;-UI[K&AVWQ7U+/!-Z\;398
M<>%2I$X'HW49M5]3WM! 3EOZ1"2@2(2<M-9AC46[]2@<0"^$<W=\CC4)+NX,
M%J,O?)1+W 88R^ O <^<OX VVS="?N2! 9I;^=O+[,MZ!UR!STN<J PVR$W6
M8W7_'9Q=.8&S"W+J6;Q_<8=9A^!-M=3>$_UGY)/FGWU"EL/LAVZT-6H0WQ%D
MNR@LQD)4 =:H*MM7,K-TZMIR<J#+O(8:)O/:H1M)O^05< I;MM^H0U;Y7?YP
M =PR02_7C6CH/KE*^2";RA_ ^6GEA=QLH?(A;'.G%&Z*U3SE]XK@I#^B!.,M
MW?NF0C(3C)[:O%7RVJ2_%K,H-UKPQ:D'5E.SN3:/B1U#\!!JVM'<"QC6F;@X
MBT-F%^F_J-W%)Q7U>BV2;$Q^* 7"2B=XLF'!K_V(S AN)>(3E@O!XVB)0!?-
MVL9J82^12[[/G;(,!H11@U;G.;-8G^)7NB"5F,V&7, $YQ 1B9YO.C>I9+'3
M8R&;\:%Q^^7KJYL=P6X+](8YFUZ6KCN3<J;XB)4830'<AB5<T?O0]UG7:H&?
M8TPT/"7Y@WE^(6JDE\Z0-%#(S&7*=V4H9-P2?@>?%*64S1;]_)2MRW#E7>$S
MXR#9!GOE54A58A/![^:@4H#V2>? >W5%AKY]P9(E2_=/CQLXM(IOMZ">Y(1"
M/J@/M$$G:VPH7Y1HH+@]0+:];]Y(^+'PUC!]-XL*[B=_6F$<:_Y%R20;$MH[
M3@$A\*=X8MQ77;Y6R@?O=,>K[Y[O^2UF?4B"F-DMZ3)RG,\)E90]?DCMJP=O
M79]3&=X149H].4$]O#.6IMGC+FLC_OIG$&K^BMOR#@/PD=A(^;2);9_L#C\#
MH'.L$=MCNY,+O^HMNJ<E'6]*0V;_ZM\EP!!T+HUHO$^8(J*!9*=SR3AH>-R<
M?AWLTGIF54@/C__?;_^0Z7P3(Q%*B;4'P 4SP%27:+%__OR]@M*5V9]&>04(
M6]-J(\55F[U$%H;KI._T:EC,GHHCJC8!^'I8@B:O;Z9YAS'WC= ),KI!U[TW
M+VK:YWH[@C7>?&S45!H'9:$.0]"P-][CWB@!.$<]P6&I/KJK\,EMO1?(4^0I
M+^JJ0.!*R^Q_X>X]@YJ*XK7?T 2IHG2$H("@"-@ I218:"(&"]*)2I>FT@*&
M1$2*2!%14!""(H*T@#2E13J("-("04A(5&H@H80-:6\\Y_UP[]RY<\^=.W//
M.^^'_263V=EK[[6>_^]96>O98%Q 2P!LA*/A/X34!UP%^PTX3[R/&^64W!"T
M.-!W ';^AUG-(\C,NUC,:[ DAX_SDUC3TPW;C\#,;L6=,FDR\\X?EQW50UDT
M[!4^5_JY;=LB1KT,,<)X]W16*G$UT!0\^]KT@=[;NSEY*<\;)LEUX$5GR>45
MLZ7%.]H":Y1NC!#T#E8%B1B"'"4"^N;IG=%'NNMIY\,LF@*E4K^NLWQQ13&N
M-/5N<&U]'9U?+.3)S%[:WXS9:X()MGF&EOZ/'TH\Y(<)Y^S<2>:?_3<[B!5A
ME^.\B%*<T7RIA.$U^#)FKS\3<VE<_5+M!8HV!7A&\@H7]/)\PVR1X=OF$;>4
M(@H/KVEY[*$P;LHGWV6VMS/*L&$\,^3+6J*HZ?>4%#3RN,K)+C]$/[F8>H]>
M!LLTIV$[9(%;$D-K?\?"#[?_*$68@#7T5;[^,I&&(ZZ8KR!@RZG,8P34 (0O
M_P>9'HZ171Q1;O%T\M[^\&S#_++K'6:^C=9';,2[9$'D;J8-J@^ZER5%GX2<
M0 HAR*.5-8>*B\ICC?J^!AY0=M=0^!:ADS%H,.P/KX-1CS-D:EO9;X+_C-VK
MG>XZ;'MUYK/>9:@2TR-Y%U*S%#7(<[JF\ZW'Z/"NN.)#)8VZ8\7Q2)7B?LY3
M_WM'/'_<1Z>$"7WJP.]WE**!VWC,2URFTE@(VPZ/7;2!L4>#FM]:V/VG<HF*
MBH+B=W4VLGCE\@>\KJ$C1!EYA_T<VVQ4O,!8 X8Y,S]LRL?=,XY^ZQV.]\SG
MDT@O0FSBVJ12,9]>;M;7T7Q^C'3F*XWIOLMTHGF\/3P9$+%'&''L;-N9>2NS
M4'@DKS#)P#ECF-J6+NSDQNID^QKQ2C?D9]3A@+LQ=RLEH4ISK;LXO7 9E ;R
M?BW01-^R;\C_V]9,-3EGM;?T&#/94=GS0M\VZ(QI9G[ :K*V6#S2@AF$^MX*
M&4?I(FPI5NVO/''TRTGJMA5FF(!+U<?]OJ63A4,+]>].([ -?@52@_I/C8NI
MAYD>"(^IV5$N2!0SVYT190HK720\GK"\<+-33R'OB^+4*$41^P4ESX*.M,JP
MS&A<T..P\EP5U1\F%R*8PT'V8@U-^S-7 DIXE'*8_1YW&RH]0#_)D=MJD_!&
M&E *..$S^8-_VA"LX)O1AV]"O-7*5.^]R93+9MIQ1CU4:N10!]B8(CR6HHR:
M*NRK/RS".2@6R?B*K9\OD/K!!:D@]!E8=I5F^@7\<@5$!K'79RK2[U/&T2=<
MD)W,WN%[+)-'3$<"4:A5 A%"LNI@F[2C%&N=CE+MHVJJ5(-&/V\7/=OR@6:?
M[8J\;B_<#U5A.3,O.[',QWDRF>BQAS931AI//E77-*KIG??T0JN/N=F;*M6O
MC@,8$$J6,PZNR46\ 0+:("J-O$8_HH;HM1+#7 ,>_19L4P W![>.[83R4"4>
MN/<10>:"9@TQ462J\;>>'CN?U5!OO\ZIBF[),6$S8\=V8JUP'#H 3=#ZFHDX
MW^DA3!NKS]HZ_FL[R^CHI[^&W]9L%%@Z&VG)(. IZ4,1TQDPA@H"L&LT6/PL
M+>NE1&6NP?"/ 6-"YR.SZ;NN=]+&-J!4V0K6]:%F=4]HN[NR[?CFW^;KG^,<
M;E>7*[L>/69E4L\)7QRU%_Z#287LXHRI&@-;A4A7',TC#OSDU/M8M4?*GW1[
MDZK=_RF**7X279.8#($&S&B,O0.:9BO$S@^KU][XE&V3\7HFAB0;F-G]"S]T
MRE[X.[0>MNP=Q+1V]=_AQ):D2R*8UN#YZ.>/Y,+W)_U6%Q>!AL?V#M[SL"7A
MGL+KMMJF1$RA9'1\&?V@LL%:YO5/N3&=R:>5WXL+T%D6D:J_\409>^%VE![0
MQ'1#WASQ'D+JT*HA2D^KJS=C+I*.T@^3EI$OKZ7-WC?9$S )]21.&A,90;25
MPLC213&RU/ZED+^+.1V'CS[8MA[(FN*IR%\UU;$-"QF^]72J,)E(T#]/+]^#
M/$QK2-S$2BI[^^L9V"AZ[_-]=LQ*=@W:GOZ(6.?8MIJ<KTMGI))P4H/EB!S_
M#\W)B_.UVL,7A^N_'C/_-:=HIK.IQ!OY*9R!5C6@!^O?.(6$#X6E2JZ<\52*
M7M!SLGYLN#:I]2R"X_,E?6IJ5CX98H@$-=/PCP,IK>,:+0VO;SV_HD# /K\?
M,$_0%IC]R)%F!;.?LRQ"']!\877T](?A;FZ_$.?M7]84N^TQ>HK<$Y'YYF;L
MHI1+0REJE%@[4^0WGL,S")'%=_0,Q0;.V='4P>2O]T9F6@F\L;:7G<L%>0X^
M4>*"NCN!'CK1(=$>'W2?@'I1J2E=+W+5G.^*O5SG'>.\Z8 5LZN']4XU];[E
M@EQHC<6GMY.?05WJKH</6,_OZ+U%U0_/&%0T9SY%6'JXE[K>9KZY&>,GL&[+
MV;U4!*R>9U>P[LUR0?L6'?&#[YPO9S_K0V[M:3N0+7KF]*!Z$2H/WP^N@K6[
MA[1#9.DAJ<WPXH%B!*X[NAF_98@_(OBL4R&IAWQ&?;RU^#\GJO\?-SR_!)[0
M:MKA<F'7W@,X\QK\\LD,68+7VQ6'!$4TOTXIK^4.HSC2:RBH3CGA)5+_GH\4
MJZ:A.:B0L]/'#BBDR2\+TTQF9RI"/BYP1!N:6AN"Z#8EUB/QD":I;^@] ?/1
MVBH3$Q1K3R>*A?6HD,.5AZ!Y4/$5"_[_[B"0_QV/,^@D+F@ORXB6W5X#9'9%
MOXFV?"J8T:4Y6O#R1H1H8?I5<^S1$70P-G:GNS# TY_2KUA9Z>5T.T7]S^LT
MT,*21PL%Q@^@R8:Q>HGD&-5!]V'-L.>V.L"%ZI,ZNZY>IS\S5U^ YX(;BMOA
MNY ZP#3M#E@8\+U$^^7HF#12F1M8]<3ZU<WZGP,"5HN:,E?^<P]QZ=DRIVDW
MA0/-CYP30I6LQ>[A4\8:@0>,$/9CECLMA/%J#*6^&,UY_:#(?:#$NKY^GFRO
ME9%W5H/R,*I ZK/?_P*) /^EU(!.M!^&8'(-V!=5>+:893+>?+_Q\7V3OO>?
MKX34QB9\R__"UIDJ*9"*8^ES04)V,&4WMZEYL##2HAP6^+8X[0==I5"0)*<*
MWX\?QPFA-*>1;D",)]F5* %'7";_^7V^:%%#L7#BSUE3R<^#ES=IN':J(70R
MA"-ZK0*XN2]H=E"Y>] W-O[0M;\62FFS7CZP=ISUO+(I%T09[#8S(H';6T*Z
M=RJ:9ES]2U_5IK:;KJR4R-JHH +9?%@]]DMH4) RXSW>@*HZTI&=KSP:]FKO
M[-OF/*\3EM97$5=2]N+R$$26#*SS/O(RD$<K))EE/L\9+Y8K+"WW_;MG1;N0
M S#/QS@$F) -7X8P-3E$50&Z97Y9T"Q<94HO-48IM?0Y,B/8<V15 <,!^0EL
M[+6<5#8T"E+LJ4"Z4Z0 [?%"$H9Z>!/VR$.[?B30V^\W+F?VZM%=:H:78J0V
ML;6-:\:.75P0[;J^XF6<*.LD;=7N%P&7LHF@.GB>@5R5QJD/98.W^@JDAY!B
M[*9*SAD$KH/@CFE/W^.? ZG62&IDC901.J55GN[=X^5MN+D8,,TYCKQ#R_Z:
M+@PCP^47 VYY*D[M#UBWNPOT6H\ K\9PC]%2%2@9U@E>72EO3PK+U:;V>:20
M?"Q9;M6L@/7&)=LF=C,NF JSP.MY\3!%H$USPKG3VN;@D[&+7%"+1HH >"4N
M);Q RG,8&B+UA"@W-@=<H^E<&ZNMN[WK8ZE;8'S/;9!8^O?1:!QUG:X^*V;)
M!<FA=BU&Z^6J>S*O7<(@M4W>J$RRK+'UIZ8-1ZRJ&JJKZI-__)@6O#OU-7:O
M@0I_"4DTW>5G(-+B_;1_3MY[HYV849_#U,H]QM;%)6HT/X'7@"W]03L7I-RL
MZ$].WWW'IF0A>[_J\#DV)0,=GWC//0_EQ=J?QF3HLEOU6A6=W6ST8UDWOS%H
MWWNDR\I,89N6S@<'Z:"3PSB[DETR5YPY:IPA3OLH]-/5PP;0 YSO-6<NG @R
MB=PCN>L>(19LP!F"-A ?<\2 2:1LH5\VQXR>]#7;;MB)3RP_:3!AF_[(\K2@
M%_X0KA9/-8F1FJJ ^A8E]R5L-GQN@OKI3!7&8MHK4!V8:B[H"4042._BG 1>
MG&JYUIW3TGVSI>[5+X6Q)U%N)P^^](TXT^,MRS 0@)@"H;Q!)#,2@CK@#"B3
M(Q^%0Q-4U;[<$[]_YX1P@__NKX*D($'ZFXSG.LN:-[_NN2^EE@Q,<43S2!(Z
MG> :]\$G6K4IBP0):LV4NZ#J[?>?RB_G-E(A/O=&U)08^A/$[@;B'J@/&K2D
M]&;@7HEA[OZ3/^9T=0H(3IAK*4/"^<CK[(9P;$*K(3Y,FR,.8-QJAO]X<<;K
M7AS=IZVHASOPE?7@!KJ#"P(.:\6:.M,:.O//C(?E#DHZ+<C;3UKX>;N^7OWP
MTOGE07OAT]< QQ','NCO\W0M=EPP>N.:XY]LUE[,K%UB)U'VSDX6+DCU;2'"
MX59C776>P#E\YJ,RG<.SR4=U'T;+#Q8)S,?HX>JU>M"*SGFA;>B:/\NM2A->
MR797YP*WM(U?V#L*,@11X8SS=S*<Y[D@@E)<4<KQMKG+(\<<DH3Z@[4*]G,<
M[H(*0,=T9O]=:T-7A4=_1[XB<'Z6]R3VI>^_7/7]^K/N7Z?A1SV9*PZPZE-B
MH=<Z<;2K$E WNG=/ FH/(.P,O/W8V24Q\'HM:$W2B/_LK^+1ER7ZT#NK!&@[
M@UJZ1*SYGNE'ESKA/;(RB%&2O'Q_8'!(:6MULH<122,N$VF,D8Y&&1U=BG:F
M_>BD>=9:(/)'SR>&PS)T;XS+0T@8.Q<=K,_/&5:JW1%Z(Y^O0G>3?@VW&NU6
M>1%#3>TFMW3SR6ZXHU!<4)L%1'J*I=Y"6Z7RD4ZY[^N*OO%1/+(_L.E@XPWQ
M"VG"]RV[.6N]H<.MX\ 5RA0Z&2J!-"!/G:TG.E4G4QU'[J]!38>$G7GV73T-
MJ* '\ :.$%(EDAPBMWAOH=']<S=,7X?R.!7])/T67-,?2K.')L'E*S7AC^&"
MX6;1W8?FKHWZ3HGI>\8V@..4UO53<X*X(.I'9O1YVH^ !4\:-(ZRKD>);[WA
M(#)RF@ORS[$F#][<K;*^<WZ6*+F0O^]GX$:J:K>$B5UMBH507?,M:1GQNT("
MD'.-["^0@ZPC:2:8ISA!@R!ARTA10G>Z=KXV^_X;S*CC4\Y,ONE/B!;K CN_
M^=IL_QCN9]V9O0%1^)%!Q:LFQ\X(1JCA%V(XF(#229CO@R#9Z??SGEF[AW@2
M\:B\^)'46VS/(*%F5AS#SP7=P8H GG8Y9TE- Y=5?"VK;U^<W/V!W^D%X\K!
M5N&W@FNAYN-SR^[(;/I)QO(X1!FHZ32^AI2G0XJ+Y]<:ZRO$OU79*E52U+8E
MY15994L79UM-T'U[@'@NZ/9*(1?T?MA>O:/9A'=3=]-\BFERL"<Y61D/BLIS
MXA8BC/??%WO:-#E*.GJ3;U-K/RAZH_(.D5'/+C"U^'V'H+^\^D J8?H%%U3L
M[K- T? >Y6_Y\N>!(\^*MNEP)-LHV%H$OE.=6N\AV_B<>.Y31JA,Y%[6\&!:
M?.+9A3?);),"*0EV <Y?]QHIICM>);$C-:2;<C6^*&+XC7:].EC'&Z8%+;J+
MX4>'N,)3H0H\0\DS!\+7:95553:G< 3Y(]VZR<H!:N;WSXONU.-.0Y31WUR1
M/.EQXZG^L$DTB*G,2 #^E"#%AL(JK& TRS+*$_W*U!J7A:.RL\J*#?77Z6L4
M.C;W5#IPY#A^LVP:; <8D&VI+KT9H=X2!,5;:J05N+ZZ<#+S$^YDJZD8;E*?
M(RHQNYHD5_R--ICB=>T!>W!F3S9?D]P/MVB?AU8S4 '.87?63=I^55Y?;WT[
MN_MWCG7:ZX_'3FK?^.KYE;2YX-9 E6>>7T3S:PS)PX 'Y< 2T_ZRVX*>_/(,
M/#MU^]I6PQMT8P A0+@G_T05\(#4$M+9F/NX>KA"HRE;M^&N@X8VY#U)ZKZV
M-#V\@26K[8'(@4NZLO;3]Q-8FH]S B/]?,_MNNS83Q'(86K-KJ9@NHE2&[!]
M,PN90-2FF$9S-JSUUE^78+<7H;&]JW!YWE,R8 F$4]![@"W*W]84 N9)B$]]
MU;JPCB3M!VOK=.K9#0E7-.TZ/'6GYR%*89XC1F-1@TH0GR(:ON0<O% 6*/R]
MQ&HK38:Y+WE7 +#%$35YVT$)2!=!'J<%5]"M7.-3[ [ES+A_SBR6J%T!T?--
MQI0QA%S&BZ&@'\6EG$%=PY<*Q*.&CKY4T;RH[:1!4L $%^25/EECS<Y%R2P0
M3.7H?63EDG&*XZBAU GG"7Y[HZU]*R6,P:L!4_,"?XD\F9JGP:E"E0.SQ9^:
M:8DI!_LX76-)4H>,'P=*=$8J[&II(,-2M&A2L>'8/5/^\L8;.^$U;H=R?>[I
MMEW)>]KVFZU#1@.'B[]N#-56:%&R'[LRE;L@X.;XD&#=ZUHYY22+D])CX^?*
M!AWN2][564)/$LD/D-Z SBQ8H5_I?'BIDY5!YY4WC[,5[FTG@[;1G5#:M8](
M,.,07;@M?>_\LYE+:@FN4T46$10U'XBUL,$B5!8:%* O@F@%"P%&;2Z#G2%*
M=>6.)Q=R;,14L*]B7WJ]>B1P\Y'5?FD D<Z2XWL/3^2")+[#ERSKCL.VFM^F
MC[?FL)^W2K?1L"1.IFX;$_YD<S[;<;SN\/6HD5^7WG[+Q-_9)5)8(#;D\]#4
M!,ZNA/H-[G*U+5]"UTQQ03?-32<Y?6$>?H4JD7MZ,.]R-M&3(8PA6B+5AOW6
MNXC@[N=Q8(2RS\W?\?W)*"_*_=,"=P4?(A1ZL05EZZYDW\=!:-]5X'!(QS2L
MO5HOSY<\F1$<.*M\>_IDU,E;5@HF'7Q#TCD"H1NE/$=QEB?4?/^+',)M:)H#
M3.27OX<*3:M+]X +T9$V4_*L91D>XQGQW=.L%<D)9^CS"DI2/7AOJSSPH/O&
M</?133.("?X(RNE5I==Y#F77M94/U3B_P?@JE@^@0QX4Z=UCA_96J\_H1GYY
M^#W0K(V_59K]A@OR&P0<<%7"G>XG[7WB.B&RS9]_DCYE9DG=MW'8634")]N;
M_1SB]!K'#/(T(!!I [1]O##BKPI^;BMQ&//29O=QJZH=D6&?'D]MK"L7]"@7
MJ8TA"R^O&K846U)+@<L+!M?]/J,UO#7/+,LZX5C\3?H36B0F2YF=PS+RCH@-
MCW%2N;W=F*GQ-6B.\Z44I8%O"<C1+7YRROV\S>C!?1-PU[Z >]+S],:7MX!'
M?I+%>9SOX'W*Y*VO,"'$!_\; 5,#QL<1_4-NVE/:7%!K+#9S95. >0[==KFB
M8A8<2-OJ*#O1>E/QB=X>Y-?TU2CL02YH"GH'/H$AU^&6MXI9GH #F8D[C!0P
MFRD+,;)X8._4>UVU.,)5H+JRAK,[DV3[T70?!9Q,J(5XE%$J/!Z43+!7#W@%
MXQAC1=!+]B>IEC\DC?&4AN7<66+JSE8G)CD;+A(>I'ZIY>G5YV9V=?<CC_G_
M.2+_QVQTCH:=*&5U '#R'W8R%Q3,!2G,>^C>&&%I411WU[7>8A:M>TG(=#+L
MF3]Q34U:_+'JH]!98?9G+F@^F);^%PU,@VEQG%_H#2.$U3J4%=RZ:.4L[6[M
M?>M9QS.+PZ<5345!K-E<QEGV>],8.K[- TI?J9@M8Z:*^NT9\+_;2Y[6\#TB
M8]7W/7T;/\]&AG_@3'@< EXR?:QH/;/LNK0BTL"Q8^-UABDUAU.D==1]%21[
MXT83L-5^NV2SR>G[_//%:2N%E4M&]R;\79 2H:&AA[<]4RUM##["(2BB_?0
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M] #YB:[76/G[%]4US_H4+ -+!&.G"%^P4P\8Y;#)[-GIYAQ;5W?$H,-KSY%
MWZND=U4G>K^=(0CW<]8K>(,FQK-+]0#@.EMQK3NB:@+(61O0TP\*PM^YL'RR
M5NI6,@C <T2I7-!!1QXR,*5X4O1NO'6)UJ"J. SB@C"GT1M\<%%TFSONMRT
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M-:EV[(2A/T3-%6D!C)#[6C40PS,6SPF'?AT-2G[S8338^JJ-*$*07V<!DT2
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M^^G>BW_0 ;IWX 1;!I4&;JO/L4$>+QQ4;*T1/V>CU_TY]ZX*^GY2P:;RE$K
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M*ZB6/?B*\._)C(P&MJ5TR=(8HR+KE0'O;X%_#/A_;GDKA8RW'O+1!1//MVC
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MH;Z(Q8]IZ1WNX]]U?EE$7GN#*M_,$>("1-&/8)B*2V2C8D8F+OG*G6^&I]Y
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MHZR%J^&YYI,"(-&/.%)R1MI.5Y97Z,6W93P$'7+Y)PZ&28) F4W'89(-,N-
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M$SDSD\_\RM*"27ZZP^E&10U1G%[A0#4%U@0^62<'#:][E*V?/_RS0Q-DS.[
M1D9]:6K0!%-,T!)(W8$S6&)XV[CEM4JO];'Q\#LGEC/R'R+6@F%H%CH EPA,
M[EK29(38:T&Z+=#Y%?C4)]@9F^)H)5*EY(G9FR:,8(^@Q $_(C1DDR6; )A)
MM'&?XMTGS]LT'09*P:3'+XP@Y?VL&$U!.Z\-1W73(H!@_B@GZFP],5^Z.*Y]
M.<#A6\1K/P_ZY>FU=M.FNBA6?\K$)=&<U#$2//+\TV3&DS=*;>CMB#>" &%B
M\[9V^MF]B\S?%?N@4E-,X; -D&=!U1M4NC_UZ\O%I]&NAT:KGY)C>O?,4;]V
M+5>,B'8*UP9]T@K%SD/FQQ4KBCD5;[1QR5B6]^IA(  /!=4]I=%4+_)]-X@^
M^C$W28;;YWFPW?:-KA=LNJ/U'/^CS]+]9_O/]I_M_]?V>39=&S%J].1!EGW1
M- @J:&X1N"=?KG!VQ<FN]U;H"?!5!:T/BP+>A'H/Y?)=87$[+_>K-;-ITH?L
MK@ZFQ($$S\IM%0QN'"G,_97INGT\[I(Q_!1;>/%4U*YX4P )$:U75F_.4\,F
M)?'A>?,&KNNR9?0<]G'!5/$]BW-O=^VW2\MJSG]LV)A75<Q_Z-)4KNEE .O;
MZ[3*C9NXE&#Y(.M.DI\4VY;Z'9_.2P86_^CP0.3;A" M C<UR_;2J&-1BOBC
M(AOD>^;\/.3UW'J1-A$6WE5,0N0Y;\"?ZA ND_WTP5AHJ$.*9ZP[)(@7<^C*
MO41/DXK!M,'E&D/+#07^MTVYAQ]T],]8C]CLCJ=OZ0M9+LIUAGJB+@-A$T<:
M*BMMCOG,ML\^4UENEW'(W"SJJX.3X?1P1>C2Y#[HJ3KE@UO*X_4/J8BO0CM/
M/U@LIZ_9]1M6)A(7'A>[?G3T<6(X!RB_HM]&VF6ES58>S^MTIG_;JW'X,!4P
MQ'B.Y4!/F\%W=Q-WSOOY+%-6SU5HRS<_]A28_3"5%J" 3PJ7?'13R-/B;/]]
MHWF6.@TZ]OV_=%7Y_TH-L=8&YR]OR.$H/,$8('<DCH2;_7Z: R@4^6M8ICZ)
M?1V/G-]8U&*^FT]7[KW;(BE17^KXJ^0X9J1=89?0-206VI;H+5?QIE7E56UX
MYE04\QG)N4&0E&K5>F:OIC+1>#65?G?+:5[3BSGPRS$T<3LK;Q'_8Q0(QF&.
M(E(7O=T;158?[X-\ IER<E3<38K[;83(=^5\.^5N^8T_?II$$?INZCJ><UZN
MQ5ZJK*1Q/1K^-NZ'UC[(K*O>D"Q6CG_M\?BUQVO;T\*2P3;LFT40T72YD:>V
M5M8:J>8S^R#!0;R^=[U2K->)_MGFF>>^)@6[RALZ9'OJ:C&)Y].*UYDZS1VI
MUT1#(-4G+U;G6N;8+_=G3O=2N&#:VHF,'+D<-Z1$>5D55:WP^9>^=F[$M7U0
MH-230++Z/%[PO/L<)71C_-QJI,;5]L^HX=W47PH_-VX1%' MT%&!6/W.G(DO
M"O?&-_'Z;N=Y6DB48?=;%R0;+]>BH.?-($ 0J=/)G.KXL7XHQU.'K];[V0AG
M5#&UDGDM";RUQN(;8DV PSY(.@=#Y]FYO]8VN7/D 9J 9_YV._P@%2CB;NFJ
M^S-9'E=82:__]>[RW:ZSG_7/=-!V/HHT^3G3.;T[GO]2:SDV-B,\MPN+]5DH
MCWXP>;_&>=3'/ >0]KNYQA1&_X36[H.*2M'SI^N2C1[6S&0)OE022MP''2B*
M61*-:)I).9UI?MM4:Z0\R*$^AN*=/]!"UB1]Q%HL!H&+;M%V=9?CBXV.RYYK
M_GP9)T#!Q93_ZC[F\JWSB^TOH830)TY3432,P 48_R)O^V&I9^C#._N@1ORZ
MF@ML:]QM";$M&M$\)^HM/_#V;D#V*!XOL>SO+W'.Y\*[F<NY!)_I;GL@EMQ&
M*:R[3PNV9SYZ8Q,OMAN_M \BX#3[/73LR%?.C-=M=$6-&9<UBD!"9)-)S3\F
M5*LV5$-C#Z!KN[<Z38BQ(FT:UCKF\]OG):(%+.Y/R^D"N+==JHKV_BWJE'?O
MK'JS1V_G-*3:T;<\\GJE^YL>+3RD7"C@%-:TFK!QZ_$-)X_#F[3:A[><4A'2
M'@G-&HHA@V8[G0$-]:1H#Y%FCP+EM4]/[D?PDQ4AUNNQUXCXZ'+C$%U2N^=%
MD$C"C-'WHE4HQ_@B[,C#7ES*P_H8 2Z/#BZ'2NRM8["[S<) -+^Q> C-0C'S
MK+G/W9I ^?$%O\ QM[R>#2_YA^=,8^V=)Q:,WVVN^N?1YB*1\((3&56I1FF*
M4I&TTVST@C+ +QOQJ1WF.'BF.JY#_N>3^&WIXBD0&M94I=W-"X0W^7&0E[>/
MMRGO!%3*.>^#@@\OUK%3%>Y6#:UX,PP>><$UUYM+8CO:\W1W<#'$/Q:*$#?C
MO1<^Q @O&[P/S=RTKWQ['(F!@4TM+I3LIH;DP5,W%RI_TP[+?\)_,?O=]+<*
M__]*K4Z.)/=:R5W'Y#DMJ<3(PW-O9IT@)3C@N6:_HH],%J#,')%I:N>SMHU3
M6C2R*UJ:8QKF)\\*_EJLB;>L*<=H )K$!>\][;&E]V*BN9YBW"*<SFL[V+Y:
M,T%G%]+Y(XN-%-[H]8O,XR=#K-]:WK>))Y8L?]$T:^516R.D;N^M.D6T#;0\
MME=PL5.?\<"DEO/S+S+%Z\?4ZR@WPV>2I)X'-0H_M$*$M_BN&\F-P:6"C06U
M5=DPM[9Q65Q\C:)"W@NP%&6>>8,7,1<3[V%'*L?] J'T@[O*6PD>L@M*CH3=
M?9!J$TI\0:.BX4))@HU15LRS7RI'.84KJ8FF-75#7ZUY_&7O<'#KRX$OXFP_
MU>_J<!LD&=^5M1C/4U=R4RBP,8;]("7Y:#XF1T];WARJ;D&>*4V:;%+F^WU>
M4+TEQ8CC")?PK+TB12F'N'+5HV+=[.F#]W.Q+RX$GO16WSPCW)_RW$!0I8,R
MXG,S]N:KLJ?)DSYSCH19Q_"N<T2JND*;EID/2WGN-,S!"&O+H3$$C82QS?5A
M#4@[@5J41<P+AL\.90S@I +=;+SJ=1I#I!W8V?OJL<Y\'WAW24EU2'QSC??%
M,NK[9=L"+5\7=8^*VF>FOTJ*"3#(V_F.=V(W3X[1F3<V]D%1]MS8EF/7T(]$
M4ORYAJEQ11^+5_DW<-I]2'T2E#,[J6))C:O=,^J&'RC(P%!X\XRT_+,,<&%
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MD."7?,M_;<@'/AI(:G^%]S#CI9\>@F_:, 3O?GSBLN).,YK6>5&2+Y=UX*6
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MTI]8N_"UJ*[ ,O#)CE^KW-LGO 9-JALQ'S8SG'K*+%\B)1@9>6E$I8]D6&3
M;+R#9+6?ELOQ78_7/Q4I,D7Q)2V2EO$?[QF]!LL_UURR;YWJ/CD/.UIF,5BG
MFZ^?/RSB'!,?=C^6L":=!?K1'%, \C]Y6]HW:K8NB"K7#.79]![4N?/U2K:5
MT;E&0>/J="O^Z]=O6PWORLO6@8GA+3C@)MJ-[W[W-6IZ#HG_\ 3">U':I(Y-
MH(.\(N[[]:E:/,=$=Z(>V+37WJL U0L^4@8]:I9E#WP:51CS#ZUO_FI>7U^7
M!YSY>+M5W*OW_3'[R).1:FXR[D4Q[ IG?TAM2O6P?RY2;MX'B>J(D'!"M@#<
MB'JHG%;M^CMQN 7\.P(G P4KDX>R*H#Q*9MNS@G$E\F6(4M)R=(J-YO8JP+=
M)\TY1BV^J5P(W,S@V0<)-4@.LTB=#TF9TS7!Z#BVT,K(4>W-!ZT"WB=!"M-F
M85 0WKF;10_Y?";#[$_ V8'P9@VSYXKEL3=)I(G90RF^U1?/O=/](:J3V'6Y
M:)MLV/I#&>E @;4V\%.7EX@F9BW_6UWG%0YG]RWP$=$B.E&#!.%3HXM>@B""
MZ#V"*!,F6@R&"8G>":(-HM=!C#H(HT1$;S'JC!#=C#KZ\9V+<R[^YUR\]_O9
MSW[6^OW66OO=P&)W\;DAMHT3<:K>P8SG?S@E6*B%YBY(\$W?KP$,""6-%[B1
M*(\C)0T#P#SZ$[A84XE%J"+=^!*3O*<ZPGL9?0UPXKO\?"%45;Q;*]U)NY5(
MN3C$&&(C7N70^/"6CN*/GKJM?F*FP]R 1L2Y-D06=]6NG S%9KMZ[JQ9!T72
MZ1X?[S?>*OI6P5+HF(QZO&7S[[LSL3>[1P;Q6(92S3^&_>UA'KS? S,I%JG6
M%9<D-7F0H$JD-O)D78!XK@PNB-_Y&PVQQ,(C*#!";;$@JODEF>+*I>X/9(@$
M)7S/7(1J<FV1HXKN^ W&$BW31&8A^C+AX% /4/57RYK7$=-!>=]XO*O%HUF>
MDO\!\22XTJW[[7/MZ.#(5K3[\UA<OPX:X>*;/EXH5&I6NJ&#)WTRVE*4P[;(
M;GNC*)LBE$[AE8>VKP=[K/1AI27SQ6MY ?0C)#W0]T\=TARV-0/ZBL^-+H3'
M\J>*._!IN67C7T2P.AQ?GT7S.KX9ZB]0)/[.GS]$K+!$?F,ET&[QXIN0K)5N
MM+7D8M DFMVVW?T6TJW4TSA_.# $G(E 0U1Q2STJ\3!*).ZD5^<EJU2FIR/N
M\[W2@:FO?L)-? MJ[.8P):&Z&ZX?(2)(FB GCCS :EZ.33OQ3$4'O< D<@8=
M-@FM=VJHY$E#GE%7>.:5!,0PS(#NXA$^,0+B%0#"M.W1Q@L9A=J^KLVB RE6
M#?/&/>:NV&>Y2]1[ ^]A(7)@=JQ,084%P;]'YBS^^ O,8ZI,AR>-YQH "[55
M<[H&N*EQ) 3D4Z_%X#K#.A$ND2&/"2.]@51MES!]29-@9=3C7VP[3#INY$[L
M\ISLI.WC_T>?MX9YQ3_J0F]Y+_SLJA,C!%38<=%K#.IIZ# 3'XZBE%]]QKUS
M^^/(<\<LP&X9G*B)<%EE?37X#J*?M-':"*^PGFO,< $R]#+8V.@FH2@&ZU[S
MOJ-@6>8D%;Q*QK>9X;6W&Y7Y9J$N&ZV]':F/"H. /NR#=U^J%Y=\^O#]XWYR
M#G[=E7AN'2XW'B*@N7P#D^O^>0Q^U>SJ,W ,@XX'.\L8!:M Q2_+,.*P!;D1
MID4W>41">\G<)IO''[;P\&Z*!ZV()!V.F*!*XC#EST2>,6L0'SP92IFX+AZI
MC142HQ%97*_^TYKKZ/_6VY +J>4S&KJ(_'C\%C_<A!6+X;K7H+!W;V"%BD:K
MN59>?^54)&HM0>L5)]^=%<$GQ_DT!:XU,OTK_*$(,5K12"!VZ%&P:='CXGK;
M!Q+/Y 1*Y=YP+=S.VA*M6:Y#I*^M.34U1>L-",<Q&:D.\,+"/CSZVC)$AM7^
MA#0"!OD4@O.TIW:V"QEL]1VAC!NW:)^Y"/8(=-<-'"I_=N>B5^0K6F^TZCV)
M/@P2>71RI03:!6$3* C\?Y*_"+VCT4!_D)<7^KL0A'W:04LXQ6SL*H+KP616
M8[L(,KT6D=X<3?'5!N_PV^4C@+JA(*Z/%\&8D2@V/7<8^W05HEKI_M>@V"<?
M*^2/S/K5E:C^'6>QR\67?L_J0&:)9,1*9>>^T&%C64Y8-<A\>/E'8^S+JU4U
M_H\VBW7G>F#^&TIG1IVW^^LU(O5E@N8&8V-[HZQUZ[\GJVK<9?:2;)1U(C_S
M4>6LT]3D^V5DC4#]C+Y5<\#S^ XSZW"PN,WQ1[QLUY5@BN\8Q/3KYAZ(*U?B
MMSOM\&N#/9EI!>V6?.JLF#5^0L'REBWIB$U>;Z PFPA&R*-LL.QI^@'MLP>\
M(H@H[@0:1ZTZO$:W/&FX6[4](56O:1Q.+>(Y-,[8?+3_@Q\*;8-])IH8LT23
M135T,KD9N@?*% (K-B;N]ONY" ZR![.^$)+MXZ)#BB\S-H'H@(WR:LT*#@F;
MK^IU@[8-D+^/&8G&QFRF.GLZ*18(^D@CYJC#?MSFW_>EQT6THM3D8CG$,/$9
M11,[MAO%IV'1#'X4CQ51)EB49OO6_2)6_<(?5-YE^EU%G&5YE.Q#R)P]Y94T
MQ!<W-1.J2 7$#-J3+Q9)V+FS110(FQM+M#B2:\9_>%[E\F3@CY?=#BYDI$<>
MA%IXV-]SIIQ1X)Z>3.GC6#@O=3S !BE'9)KLDSWW>HF&V.%$"TH7[:T((Z@3
M&3/W:C\?ZE+B?L";.R5:5.$D4<1R?Z:7(I'ZA80V?;:(R(I9H P)6MRO=)X7
M?\\X@B@I.<F5^,7_.>6%IXE9E,<W?0J1@BB-5DE7/QI!*0NF8R<O2W4#2B.P
M M.::MRY:O1BF5/@V27I(8C79:&B#JYS)3*LP5K!^LD%VXE9NMW#YO1'DNHG
M57AT:^/VP[WH;TD^.ZHCQ0)P!OQ,(M*YY&ITD0(7$E^QH5>P.3W#%E'(U)<U
MKN_A<6=_4. +3>[/$EU(RXA<KR\;_PX?;J7'CA<Q>G@-H.]7.IH?\@#R6 VG
MS[PL1_'*W@W[AR60)^MVH#-CW+\#:8)E [S+1'9&92&3UX"[#74=*SV2(G7-
MP*=(?5'\SFJF#JG<JD7,DQ\JOCG+*P7Y-!9?D</GQRD$KV)[RAMEI1<)G[!B
MGTS8'<8R\&JT>L:!E$BG!NE5^U[\,]W9 $5E+Q&A"3^YZ/O0)%,3O^>&CMUZ
M)N9Y/KNFW((!Y5YIC7["JW*F:08LIIVK$B@M1Z7;7\_9/IS0($+(_?W6'+$V
MRAG/2\/RF?CW3M>V6[I*@SFJ6@]S5;J2#668Z_SD.Q]<:?[X9VV)A4"7@*RW
MZJG/0#Y-*@+Z&[K"=+)#Q]_W#.*" 5_HW,>T-"(\E!W?EA%IJBL.]7@H'N2D
MVON[0=^R^=5.WA4)7H7#/+KH,OJ'&NB?L1Y)]Q+:5CI#(93 K_-;6?N6UEL"
M\-*;E1?I??B-9OQ*U[S+8CQP6 /OX>2IQ?6%!E2[2^APYKE1P,QC*!Z]^^"4
M%%7\Y1R@3RRU#F>\S.ETB^=:64LNL]'@F)9-6K+C?3]N]>(+(L'_6>Y"$K=W
M3/%G<>X4!;.%O!UQW)+A]-<);CRE5,KB?66%DMH6:]GFVQ_IY[_T\-638TZY
M0X=N*:G'G*)62':K,=< ]-QR5-T,0L!W(5!?=\EP_!-JNS[J;1%X[HUDL_B(
M'6J\7;:?BPM"B=NS3-69/BJ--8JA\U%J+X[OG;/N@:X6=3P'K<+;L!^4[L0L
M(_7P<]]#:%)5;1U[TJ>-@%WL^JU.R=4UQ,'SSRL<66_R8[C&<AZ:^+L]G:):
M4(&K/*YU6AAS_CS=Q\H Q*.1$U#&IWG H-*3R4BT[FL>=O'/954#3324$>F,
MX=.+!6WGJBM0*6O5ME#Y0NK')=<4M8A8V'_^\9:/.:GXC]+8_WX=T,N"#G[P
M 0;> XHX1BN7%J+!YKUL%:XSWG8;(,7I5+E3#KE<9B!71G)7/DV^ #P+Z@I'
M2_8LW;EZ!%91'ZVN@DLUF['O,1HH"@_=+QIO$/_\(#+=OY C!Z=YDQZ1.BM!
M7#&+MW'7@ AI6]%IE)5U)KR@?8(3:['<1.Z4S/'\ _V$^A=!KYP_A_DT5E^1
M/T+&N:@S>I)=1;":YV\S' WT$NN&A1?_EJ:(O@_@.^A;N 1OV66KDC =P/M!
M"?8T1TM4A$*4&4RA?=SO4H27=.^9SDLYT60*"]C63U?3;W&5CZ7'+_@)Y:5@
MT+$+CB;FPJ.&$HIP/=976IW^FQ+P)_X%D\D]?\>\-#7^\5#8H&; =-H*B ("
MP>TV%1&@/>:C \2\LGG."7KLYS(_G'_Y:-V73"A^IP7\"P];8DQ9.99L1N*7
M$OULJ8.VVC5></);\+; YH#-YGQT81B3?57.9>P'Y9]?D5^A"3 B@G4104\+
MSQR79;V@U<?@X./G(:E73I5/QDX;-C3C^A>6UA: ;^NR@B9L(UE]JDZ5'R'G
MCH.5=OBI1/]0WVD<*O+@X9>[3TW#2'Y#-](S-V ?V<&&9T2+%L*_>"XWZ^FL
M6;-'B[S*Q#<^$;TG22\^CY2,<W)A9;RQA!M/H;G1C4^XW1:LU(1T],,4U^J_
MB!P*4QX)\?AC#Y\&3L:4%X#;20+$8^LU*IC$WA&*"\?1OU,7#RJI[ W"WB/2
M#1Y:Z.J6W@UW,GVE/=YVYS^.$L&^'WTT$]$A ]$DR))[*S_8;+7=J5A9E9FA
M%W0''UV.>@>+FW6ZQ0[>L.*_[F/D4Q!-#XU>Y- 7'#(/EZ]R&53/]W.\)VGO
M-$\PUT;B26 MRIE T;HW\??;#WKNC@G=?6RV2<1X:8T*-&NY21J;\L'M.WUY
MLF@1/MCCH=NYL@5*-,WY+@-7BCBEF;!_^ZD?KSC&D)JE!&.#<<@#F=S")7>T
M]\)WE_A"\Z=F*8_YQ*.&-5P >+O8<RF"5C^J0XX #P*ME%TXE[M;Y59NUEFZ
M/>H;_KGQ"D7>X6_^1H,UN.J=B4NJW1A6C'*#4W1B* %1,N?^_M/NOF<A=<L1
MZX:Q:R!U+J9:1D1%M_ZC07WLI["%6V47) #()1Z]I3L!=:<)\X?QIRS2T%2X
M1]^=V:Y\F[%&,[^:O4IM_HL2Y@U>J]N6O@;<:=H9*5=.+7/[NOFWZ^L_,(H)
MAA>BRJ:WN3+#CCEFQF$/<7VIV!WQPQV@?N.4L$W8](D1V4MMC8^+W]YVL!*,
M]8'W$+CC7.+?<=92[S?9'N1@7LC]S0*<^F"4BY>W#'Y#>Z9AO%E=8O>4S)0"
M%S<F7X#B>^:04RHR^P0>Q>4:!?.FJX%:8&/G-Q"J&:G[B.WG!FUT^(^'JLA3
MAV_#[]]NV5:?H.SO;%KM \WMN"9VI4T4PN?3-^UY.KP&:I( ^8#' L0K>7%9
MOPF4YT_!V48(BRISK%BXU<2+%+GO(M6HA[UDRE6B@7X*P97QA(^84V7 )B<_
MP1339MI83T@N^CWG.EH/HEL:D+":KQUAG1/2A2X,!0]6@>V?X:EZX\Y@V4"H
M]*=N[-3N0VJ')%\__H*3<K$+E1+WK/#XH]7P]J'5V P$S *E**Q%\3*0(]"0
M;* 381X!X5J>[71))*W?. L)=</&6BBCI*+9+G-I1==N)\BQ.BY5NP.S^B-]
M.PD"-)^<Z]LFL"G06[8H0:M!%HG:%JUH<K+T/MV$(E]L1\:T(L]70AB&?_*P
M4N^TT#::KT=P5<OGPS-L@<$M0J#"C]T9S3IFHYU9E:2V&=?O77U@@"'97W@L
MTD11YUP(\FK*=\>^^XH"MS-< .6Z>$C[.[9:?7-9EUA'N%K .2UJX4.D>]PA
MT]:-6!_I*QC>Q$SC*<[-\;4?6^EX'? X3W_;MJ?,M\.MWS#$$=>%D/V=^U8G
M)LKW)UX4!$8H9']\V[9J/"G+<5@NUL%)<#$95:D3/12BC.>62[+4N?7E(W&2
M^LK'PWQ*90:\5NJ*"#65L4:S=;N$^@#C /O#QG&3M-MWXQ+(EX_A21T/W?S/
MQ*([),!P3$;<(:]I\S[$%@-B456,C::?EH!D-GD:XB4$?O2I]0;G.CJ"2BQ1
M;FZWWT_7YB?(O3:LB"$% 'R9AC:7[B"Y:K;LT6>1$8=S0P8/XB<;-VV21U.7
M\/G4T&,WO"8\KN,6@=VB?C0;)>,O[Q3R(F7V&J"E^3.<]4\-,X]2%)P*AXC\
MI&AZ#2"Y30CE6)J5A^V1SGY//U])MOQ5Q<<>U&Q'\XX"7K,2[Q!OQ&3$^$HP
M#J DQ-G?946:429R69+H[!%8'-4<0V(IX4TS%'>0>CI*-KCX.+:[X_9EXQ6%
M:ZO/1JM2>C:F6G><W32-5HWSES87/W<@L<T9N$(O*#$!2LU=/R'*-WUTWBED
M/HD *FC&S9,(\X>YF7G7_:F0T.I*,P<Q'5T5+.>2F2*#!JLY?P9-7P,RHKG-
M4N?6^H ]D/O+7,P$LN]G)Y]JD Q [%S;5O8&%,-];D.>$19@.[5[.XYWGOC#
MG-HYTI",X?P9&(I:I,=!MP^6+^V-:UN;:O'4V7?W%,M9FI]5\]H_B0C9<+8+
M](F9GI$VH-Z -LU\4AX(*D&/^&/8VRRG_RDT%MLK$-=25805:X=,;:C<4B::
M@R@0%#"@.X0*!2YZ=[0)_=.3%,TUP<C,/W0%7KF5-QG$P2YFD11W8*\-1HM$
MM\6GI?C<VGO9C-9P5'P58D)T8+X]@O4@Z^YD")'7K+"90]O:0E1ETFO3?L%Y
M?S_K+B.IU?/K PSP O2#'2WXOX=P@!@2Z7+I^\]]19=V:/@@VXY<01O6D__1
MGA-D'Y3SHWRRX\E#/S?"KLGK,98607X1KZ\)@-#A7OX\.\ R1U[=7MS-ZO^^
M*#+IM[%"O&I-;LK9JPP+'J\]VK\LR[9JP\%CD,&XN[F1/9R2W[*?-Q+S;LBF
M5&5$S@L#N2^ .VU<Q 2H'MZL &NMSSF\9#_Y0"^H75?N0Q9X=-4TNQPP!81'
M=#"UXX<RXOZ."O/A;7-$0* J*>[Y7O9;5167JMS)A%')U=YQB"46-.>(#:]&
M3,>D6+EF!6[@"&%C-3SG/-P2+&3/F><Y$B[,ZT)^*M,UX0Q0"NVB(SWO[?B^
MZ;^YQ&;HJS=.]Y:^/L;_)3AZ;XKWL^S8]B=TT!,4L*!9@QC($X<:Z1I(>FNL
M<.8FT5:B^]+HX7T%E+Q^8T;1K$:IV_3 *LK#,Y2.>91(E>MQ/W5N);1+5;H2
MRER,O :XX#Z)8'Y+ TJ$I;9%V?@\[^82]<O!5<;1<VJIQ[W7@'#/]0RC60V1
MUHTJ=J<EY[Q?^^HG]\,.E82V:;@@CW#^O0(>K_&@B,/+8!$+))?'IR=QL#8#
M(_VQ$%J"$*J#6]]'#]>7Z5!9W(Q@3C_>3 E0I67@*>OBP>?3I'7PNW90-?Q;
MSM]@/H/(>.ESQCLK)P=1C[T#U9;(:'.))W7:>;_PL7_MJN<5@,E]XO<,M:#G
MQH4N3-:B_,S>Q66#MX'EG:M<R(U?/%?4<%M>>$3EI.MBC6AB3U?WMJ#^<!YJ
M%ZJ:& %2E 7A.GM5Z*^H"._'E_13^^UX)_:$7X<]KA$6Q;YO5_13.Q8*/S1^
M?%3Q3<W9[ZOFN4RV@"C;2%\C.KBZND=W-^M.>;N$: "@B.&I]66MP@S:7YD$
M=_0W3@1BJASO(A8MXI$U3&7TE12,<6SNJY[\1Q%;<+-O/IA$P@LH1O*JN^X:
M\ F^_77PW'& RVU?C7]P:0;$GQA("H;V)%*OFR\AX-U*$IOCP]9Z^NR&KL*V
MYH.VE>&72^JD<BMQ)IPTG6-(!GSB<;@>F"=6MZFAOC/O16WW:GP,R-ETW9HC
MQP_N/*E,"68VP?-?\#*',$V(2G=*Z1^?<I-Z+/^1V6TI=<TCA5!AVKWU7?1P
M-9F.%3]KZNTT/&\G<#B$*G6=Y-/$(9WO7R9^OUED*Q*.H2)^BISVS<[ET9F@
M'?"_Z_D=?J:&MNQNY)7KTUEK/^^=EB?-.[=RRXJ .Y?V.W*%^ED/QL9F^PJ=
MMPW2CXOSI%3" D-MVQ.W)W#?])LF7S7B.*,9Y4,7_%@0)$[<?YPX<U+ U=![
M$&:<;,*.;S:(%FRO/[4\KC7'LEMP5Z0/\""XPW2E]-8'>0^AEW5XTD2/(&=>
M?ZO@235LLO;/=6TRLCHF/-7?2(^0>Q!=0C\N[VE3TYAU?X:,;)9(CY&P]VVD
M ]//_@1=K:YA,@#;>0F+8U/XP^A[<H6&93&/&:D!MVH1*I%7[--(RQ(P[!KP
MM+X-3YW!KNE<KD?NMC/6L5_H!Q@EZU7^!^><%X&=@;Z9TY-[D5$-+IGV8)NV
M0%UF:\'$E0:>[S.YZ!B_NSH6JL1#PX]2SX$;G/?'V)].2 V)?=^$J#A7665Z
MT,:&?3NEF!BZPS.PR;QE;VX#9D:=P"0:\$YHI9P./@0"R"*M%<6Z$IKMH_7?
M9Z82_!>3%Q["-ZOAALTE';1I"K_XD;ZK-,=>8G+$%0X(T-ZN7/9:#EJ*INW%
M5DO:Q6S92 Z4NN*DS%I-N^P7NS_@!]#/[@OE$HYP*Z;XR/XA&HL;2VFP-HC*
M4HY\<-6%%XE+G35PVE_^P4)<UP1!.AW8/R78=P?*AOE:2.62/6\<]_T-G4*C
M^^B8EXC;?:[D"?\LVT=GQ2.N 3$0L5*@__38EX*6UEB)APPI!9%R(^Z 4UG4
M-8#V$$H'H?FH:T^T$>C9<0V@<QY_-+%;,W*LOKGHFZ+GM49R6C!O\:G?N,&%
MM6;O^_$)&KJ3R9E=XQ["U3GIC+/!KBUI-M(*&/EQ3J5Y^].RXF'O%H_V3CK)
M+UC+" \@]WTPN3(@RC(BWY(/ <1DW.%'(R$( TT"\XT'HE+<)-Q@=.-5Q>.9
M67T6U=_!E,'8ZID;2-7HG3GS_PYG@Q@0-!T+K+JX$CM& C!@[#?;>.GY<H_W
M^2MY_-X&'[O#'>W?@+FZ6LU1>Q0;,*XQX5<3#5LL]P1V=D8%XZ@-[@_\R=H7
M@78M"N.U=_0Q<(9-9;H#Q0>8;,I*#YE3D,?%"&+8R Y3*-;V*DZ>*'[V+;9]
M\]_Z<NA_#(,IA\RAI6<N_CDWN+<QEV&,>U/G G\ZEOBE+W'U5^'O?AZ7#;L
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MCT,"!H7*1O6GT_OG)UP^IA2:J QD7T\-OQ'\R5MI!<([3JC4"D<37X(WGR$
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M 8W?WEIE$A' _O4N(Y?N:Q(1 U2MB!_3-^UK-#0-7Q+N>F??3=V?I;CW^HG
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M(A%!<5[_!0]BB$ZQNE71/ZANB,H:*I9, #?@"1L2-<G\ "(Q=BJ")<W+$L8
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MOR>-05?7B-Q_G97?X5MTF[4FNA]>)>P4_+6=*].&]NQMQ>-'O85HY1!"ZNA
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M. #C4[ALX^AB-;KRY>N[Q;)"%Z[6!TUW] 5;]$;D-BO1)M0ZA'/"B 7)IYJ
M:D .%5P%M-XN<>!%C:Z7]:(E#& 8SR=&?&UIC@EV=[_5][>T'Y 1O73[4K;1
MR^>@*3IH,FE"D_H"K02W G*)_'@C"H]&"[C<,UZ<L!TAKVDQ!>5</#WB4YGZ
M-FJ+,9<*JT7W5N\>='"_H'NWN#6 \DG$8NP&$4?A#B1% #O$=-(3("\[N!LJ
MBMX'Z]S%-HIQ]Y6;$,X.S*X>_5#K;M&1$ECP<M;77XA?SC.SY'V4&4=Y!C7J
MG%@0^0:,F^0/))"U@#PLN"+TK!OEC!"LGNA':GE+\HUR<3MFPY]EYBW'52[;
MR<;L<+V0M>PXP$1Z 1&$N#'$-4[D1R5 *#N<[3T,W$#CH"93W/'0$,B]TD #
MO^9E?U?%V8'9T,>216GIZCJQ7!RJ'76S=NS1N%?0\O659H(^J0T0+PKNA)8[
MA4H-4H2GCH(&O&$^Z1U,#X]FG9DV5<THN?9*C^LDZ^3IL=/GCQ"@>R"3+^F@
M4HZ5WFD]>! AKY%V@O^[2[)+K^Z448RVY*"[1.6S/<=4W^:]NV6=$<;T(.&^
M("@VXQ$<3T1=)JR'K"$FLQ[2.FM\DEQ3:NI&/,/L/L2="V*FL.5K-=UF/R@8
MWMY&KDTZO<0SF 0(=5PJH8-"A&C-P<<):>) 4? )N JF5_%!^DN?Y:[#C37Y
MCN062[[IZY9E[1;I?L(%:^O#WVD'RLC@X [<806T).4(X/_>>LG*-E7[)?[%
M%E+0M:8H+[S0R<>_2*7 >O3EG=ZCOCIC*?D"LMG!"ZSB!-T?&Y/*@!_Q[>AT
M59BV  [[?G%W=:XZQX4;J#5#7NQ1M2XY4MTG7Q[E8=78.6=TVJ '^]MI^X?[
MY9L>!?;SF)P3@Q*M25<!-V),<]>T$8\;3::J%L;%+98\=:8H>^0):.5B[&[6
MUA24'^& BD#N_^$3^4AHJ9ZR#N^#.]_-<*VA#!Z]<.'6/?9@T\1V45W>K548
M=/4.'219-HF@)CRD@Q9/&;,4(_[%$)"':?-AWLLVN@;A9]:N9,T4I'R\>VYT
MM*?\UP@6+CJH#:K+T MZ&>;T_TR4T?7!QAKOK.,U'US6?'7=A8_S'ZJ5R'K[
MZSAC?E9"_D?"=_2AK(L]L+=+#7G5PZ+E]][<.KV2%)#6^\O_Y'_QR__WH.M/
M&^H;]\E[IQ^H,#!<4U=8G7*13C,?*7DE**^W $*]I!T/'A>:V8VM<6J,4]ZO
M('ZW(!]WR58/,6*FOA\R,6;T:A&JU@2W3+I?L;^OM:\L%<N#.FX=J#CAGCOO
ME<P;AYV<RM3%&.95 Q:--;[9>7HJO6,ABO;&7/AGMU5=?HXU@D?A$T:9IIW"
MYSI<27[=@OH5%1-(@>MZ[7,GBG8'O^&8$,XX5KACK]1%@5X??76&4#N0N_?>
M^K&3+3-;"Q::).E6/(X3<(HZ"37//GXA9^24GMI";Y+GY^V-$XUS'Z_=VCDV
M$O1RX.<OZOK@E3ANCFK-KN5Z'3QYW$4R!7C_.OY-TGWFAVGKJRPN^:X/8=:3
MN @GHN.[B'NE(Z<[Y.R6)>9GMQOGM90/G7<CG&H*UJHV<)I>CQF],8*?(JR]
M^,J.W+.R7\ E<NM>P$.YD2QXB:EW:4WPA+ZNW,@S:*:^RLC2JSS)?H7.B*AY
M>+G%J?5O<#KH\YQY/E$,VS2X 7A-0B,JP-RVET>E^D:(4[U%"057'V &7;=$
M#Q2D*:UTPL\?<Z6#A#5MO%!C!1XQ!B&7XUO&=F7%;B6LGU8^^\06F;MHY1AU
MAR\UQZ7;ROI"[9VJRLAC1S99U7GO/GMXW,[^O6.%5ADN4=%*GS96.U\5$&_3
M$RE_ZMVZY7=_=W MJI,.$F<?Q*]'%+HG=;:-80^Z\JF__BC[7@LDLN?Z+]%S
MT$M)T:5#2T-_3G'H8]1RC+O2"!2OM*HT!8W <: E$4Z+0H@A6KL+-<Y!*77.
M\KPX9>/"EX=KK4D!DP\>V][P8LCU(]0/A:LSM35 9TDS%W_B*';W/NLK^V1:
MPJ)9LD>;P9OBKF]T$"M@8=BGLBB5%OA4YTOT;[>48_<507XB;]07!G6S'B5;
M8^\FN8 %4MN0VVT=KQ97A/TT'I_PZW3["'"2[P>/TD%<P7(NMONZZQR<BL>7
M;.'FN[[9N<.CGZS;GNX4$R\4\\G[OSG>X1_HW[F_U_ +MX$-&$KQ ;()WR?C
M,HLSC[FF#4;Y.&YL<K"YI%[;]ML08V'2$.^R$&=B 67)-:'%;U&TJ%FK\AAG
MH]&<YE-N8LKH5*?':)$%>8\W(7<OCP:J[Y'RW^8]=%*#-YK2M"HMM3R53CD.
MI+Z#'Z.^5"EAZ H1_<EBLD0;,J*I +L?)C7GL',[CN.W\?V^H^6K1\6UL61E
M&C8 TIC 9T!<GDZ(E0*BB$ZF"30IL9/].6(V(4\1W\J!X-5"V0/&9ON.(&N*
M/@3P$)XMG+_1[)SU7FXJ%;EM-[<5Q#WN?^-!?XFJZ$'>=*NKGOB$U.W<F7*H
M2Q'R)2!-T@+:R8[+*3A>AAHX\[&;(GFPPPN?$%)Y-J;.9/H9\D9J@O8]KUD0
M;\#A:EA7OY ?UO.@"]]A%ZMKIE8CHY=*K*VMOUQ7SS$)T[GQZ08(!)K<8[UI
M+I!A<TU?;Y&WW+RC=\MC=<O)D(-)=U^ZQ;-9HM[R\0#T>%*I#==_QG+EGJW^
M^OH=D-IHY1#_Q,?O4/,WYRD)ENJ[$$X;U9]B$7-30S;S[TT]+_94_G9<O>:>
M=S[BI_;EY>L[+ UTT"V+'=:T?YS;%]BJ<%XNR5>_ ;+__@]L>_-^ASRAF)!-
M8*<^T=C1U%HZR*&>I;6F*J+(?5V*V-I(MN^7[%7E9!\NCD_5=/%BB^M\7/[=
M=SWEF'K?*OB:Q?PZ%CHD36-U(3O#-;O7_E+:N>K&=MBFWF8Z8A4<B@"Y(\_Q
M(VMM.MXOK73YG?HH8<!<'2Y*#CEYRYBE#U*J20=]:,ESFTK@"FZN4<)V"/H8
M/)@GS@2S?EN]IV18D,*N>N78I32Y#W[A^L\MS=;:6%175.<@I>LK=F2YX&;;
M_1 .B /BL9@HP?"E8B],Q>VPHE*F5Y2B!]A[\/I!9):%[WQ1@ \#T%N7D.6H
M3P+E76++URFVW>8=>*_/2$XE8>/S'!%I<I?JGMEH^S9='Q\P;]\Q^QX-6EU
M@8 ;C*7/N$+<*5Y 6"Y%"M @WX>?(JI%551_^5$9!R@=F5K:.%<X*QYW,T7C
M1CS+;=?Q*@K/-.W O#\111-$]Y(Z 2_I! Q>W)V)QKF7:%#=!ZG@L]M3NG'1
MXWOHJ]8RP;&3 X^T>GY8';_?AR\8_SO;]7_][X\]=,3OE)W"WS_XKVV[_V.[
M^1P'J;5PIZ#7<.U>N+C=J<NJ!2UJDD:XZ,.%I@N6W0SB=&,8^EC2.L%GHHQ
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MQ*@8"*9->.]DO[SHH<?__+; 0[EI3T#"J4$I'%J6VHH;F9_$-. .(>P!KXM
M_YO<L,2:%/QWZ=!RO=PD/4>G)!?[%#T)?PE'/S_'NWI2Z(EB??SVIZXP))NF
MR[119# 3 3.DFA 9,'.V-59)>U03,\)?8GG>0:16PO=FB:?;WD"[_7F.4VQ\
M=_=\5UHIC"+?"6;P*%Z$NY'(YS( .CF'"2*T3LX^QSH*:\3<.#^E8,_TG-O
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MB=+F ?RF@WA]@H2GP)$4 WR.&^FX>RRI5RL7G2>YP,VA8.8ON.^&/._%$XW
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MKE9PN[SW?F7_/SEL>G[.O@;=ZL7,@%FH#Z SLJX1/XNA?[AV#"H5XL81CJE
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MW5M>6W5784UD\X) LK#8V%,C$1&FC3-JT?#C&=-V8;&YAM=]$\[JJ7V3RI5
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ML+F9'G>9:+$R.@';?O?(ON7&V1F1)) J,8*BK$8U U/>,% [0IT!6LEG*$(
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MCY/Z;/W5U*RO.(DM4,/Y:5V9OOC3DI;(PB]?SAD?D-@#U:!]A1!N< RGDG*
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MI<V?#;>VMK:T;G5R^HOS+UKFZ5^=?RRN0?^\ ^=_C[_GK]<_[ ZQ(2M2K(!
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MHMNYM\VMSE;4+-_J;$-?FBN7U=MG=GM7Z*#TM-&BZTZM=V#IG"(V9^Z*\QM
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M7J/%7>\\)9%[O.6YVGO]B63;0$DZ*%EQ84>Z 5Q61>%!3F5EC?C@HNO 9$W
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MW3FQ"AU_I3_V^0=(00']O#.8WX&;\WM(]RR;63#L[%_A3?@]J,8L12:V^G^
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M/X]>RG "VA^,#7&)&INW4Z2O3)FHJUVRH?DG_$V&?__V\A[NL[W"Y8)W$,O
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M\W#&:FS1-:@VMEI+9A)7<PVY5F+M/M%.<*NY/3;8JI*0+3M>+'MZF7T-#R)
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MJ^DG_[@E(I[X"_A[2B6L7'W\;>O6]MC8T,0YCB/:GN9%'^^R2]UT_F:$.HG
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MONW#?6OOU.\-C=XE 0^/SRE_DQ+3A&9^,W)C;1(.-;Y4"^D;CEX20?O!X@]
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M&T/U,V3QC@J'+GQQPJ*X_U6 H/WX\1K4,8K^I@?YXG5,=Q93@/PR9ZB%-&C
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MXNQ@N/3D4 %'Z"6N!&CVA4]';[RP[OCK^&:-:TWET"/5'*".$DW$M>\\:SX
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MUEO[&^(*T(G;=>FG2(@TM4R($E3MAQ7W*X4253,9B@5R?'D84+%H1C12 ]L
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MD^\9:V\^]^J<I0-JPU$Z9\M_Z.MBHDT$A@4INCB98^C=#(T$,,#N<P#JGBY
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M#^-&7&U[*QD-;?>J,\6]7;8<';7/I#-8_(JCC5&+NX5)8>I2EK9XPJI_>DH
MD\O)5UR9)^E&DY?3 M'\%;L;B*W#N=_O%P8'R 1/N8:(7ST7$M+ >;?&>_MW
M00!?67(8MMP;^?&O*N(F3 ?Z=G,I:6O88.@4.: YK/[[?DS],\WY&UNTRS\%
M^-5'8^;;?3X:B/\T V>RC-O<;M:;&LFHQQ%>X[BV4:I(ATECGW> ,@D>'T9#
MQSKM#Y;]%,6_]#PU65*;LZ[JGTDB>*43Y3YEDVX1&T3PG&NP+8?EU-G$?^^.
M&.[N+*8+YG:C&^6XNYM$TN\'\S;;1/PYWL,]7[$^>D=;QUN+K^RN->CV(VFM
M]2D\=6%+0VTYYY1P1=JEIZ\ZUH\:'S<#OV)9+>0F/Q_011#;BB6',[GB(_ST
M._GC84>V0I":Q%2>I?C=(Y3:S[\7SA>\].8-T&UUXM*Z@"S*O'XC*B5M[P D
ML;L%87*K4KJH5J,XOR6!BVJ-,4QIH+%;1J\5BVR,66XC]X]NJ86T_UA<V=Z1
M-AT",D2=(1K;[N!"!PNIXQ5G>S_$O7,0OJDB#9(N_>CF-J>3'!PLY>NJ_]4!
MM#C#'MIW[<DY:CY__Q('(L@%^-?B;IL1A_:"\>,KP$+&7)2LSN/(\^0R*[X_
MS_/)%;^^E2TL6!Z[F21I-74.S*/J.7?GC-)E!N<!B%,6P'2A_N6/J-/O8:=;
MS_OXJ!<1-]R#355;"I.KB@UC2H_WGHC:>G)E-.,I#%Y45!$NZ-$7+/%-Q>%,
MV1/MIV\//7I[>WGCJCWG#SNZZ+TY0LE3B,].] 'H.)'QH=[#J<N!\<Z8,ZS8
MM(G"X3&SZ ZMZ% 8S_>=DX-*U&5Q/ .E6WBAIO.T&"],E5%X"!CBBV.AI:W#
M98#\1<J?Y\;&K <+<WDP:'A["BLV?M+U>7Q8:,F" 2[125^KS/WCJSSWA^;W
M\E,G#9]OV(Y7%T?]H'9R%=9G##2DNT3KV$7IGY)?,5"X_5#I">0$FO !)]3&
MZX(T8!2;2KD%9?QD^6 ^\G"[T T8W1Y#N]B#)V.C>.8>+V@9S KV&CFE+6YO
M'TZ3V)Q/_\CAJK ?VR>C!6A2&ID\/*0#T)&?BR?)J_$$"GC3@MOUYQ%$2-95
MYVD-9;./#<B14>-[U1Q:AI^^OK!;^C6+OS+PVZUW9?G7?"U[$Z0Y$EIO;09.
MA-5ME].D$074?S6[ 73]Q@DD[]2TY[FH)=*1#+@NEBNLM"1J3S7H"WSR4GS1
M[QS)B#&/GJ1$X2>QW*BOK"D:ZV!N;*0=M0B DM$.(S=92#P&'>@1 N$'PKO&
M.]4>E(MC*^5NO;AX?(Z7[\&?9Z=!;^@CYW@YYZPE+/5ZGYY7(/#>NV)-_^G/
M_GN<ZD[QB\'=! .G-;:,"-5X7,]#4\%QTW, QIJE2!@)1/J6FLX62O<C37?Q
M==;5-,$%_)?$1%\O>7.2Q=4FW34<^1H87T[UFT![#UZ\,3V!J.O@[&,*C</I
MUCY5#$Q7J)U>8W"\Q@YQL;K$O=5_.N%=6@%<]L70'(N>ZN2JWJB-U'<;5]M1
M*^S+AH=Q?TE.L71\>@1#5874'(#\&.D:=7'T&LY,O3N]>EL_DT(30'0#1@D]
MDBRX2KW&P+5R5B&OD*^\"^+O&3X$)'9=]<\L+W;A;*DA4R*A5^*^*:?7B32I
MZMRKR;WJ*K(07A^I3[LQ\Z\_<4WLEA>Y8;A/:VV)A_4_&C((Y^ZL3*;2*%9:
M;[4K'9C:#CZ7W)L?LJ4>7)"Y?.6Y8\+*I V*X4@YT\30<'D/#1#4Y046V^_-
M_,2XI?Y#/IZ#NPRG3LGR",TVGKCH@IM16H4"=\T@,2 $FB[TF)C5L1,%JTE]
MQ@0CCP Q+!T2!'@NNT^1,S\OE[X/*MU=;<FQ2K*5.EL]$]6@EII9L-DIW61;
MR/2A6P#Q9/[>);(=##@=DHU>KN8.3%DZ0;=#%YU7*@G6#$#7//A461(7<@[B
MGYPF_>A+S/DO<KC #_G\7\'QSJ:\P"E:,! /(>1M$1/!<3(:+.5!(3#71K>,
M-<)"IF44*<9B4U<#PK6>W9J>[AMLNIUYX=<7B0LN520ME #2FQ%E[$.A,;GZ
MEZN?+*J3_>@*HLK=$GX)*PGK(I.;\!!CZ4BI!GS-\-NL>X&2'33HCF)NX4V7
M%J']GXZ5V$BY(>+VEDZY?U&Z4[JU_%/'[!G0@)6XPI:X"=E$A?T7C,FU]8'Y
MY0"$55SJF&DS0HVTZ8Q# G$Q;6<_OR&!NVBVVI?JIB#UJ;G':L/T#>]^PECF
MG),(CU W;DC]XOCBJWS2#& -V0RGG4$MYLD 1:'!1)<#D,]2$EIH[_%.U/1.
MY"W\E6B*G-'M^N8).=LG/4$/7WA:^),N2EV-=SE=--FBO"'U*"17A)Y3X22@
M-C%:9GNOADV^;#4PL]=*W("SV-;6#"2;%/V_='>FQ>-(GV(W:_2'10LXATVS
M:\D+.=D]!;*J,E,4UI6ZKR*AS.3S.@"1/K"')'2SC#6+O,Q,.!)_ (IV00-E
MP#"3>Y4$/X9(9(K\H<LS96O:?J'K6W=J%@I;M*G&?@$&0\>TU_S9MQ^I4M0_
MOV%R_2[]V0S9>DR4ACI/R-8WIFXQ;__1>F8QA+EWQ#6.7>'IG@[;?J[%+73G
M-R#T &3!;LY"(Q40NB.87,N40H^:C4+(0?P'(!$SR0>.D1K.8V'?SJ/?KV?^
M>2%Z6JD^]_8%J,,K!>=!--G)#I]!4MY\2M/\B3MA?%*OIMA?=7E0[AL)FH0T
M>:=4%$F$\-FH1C8Z/L=;K4#].WO?Y)URTM1\T4O3>\%?HE*==P#R3A5"I)+\
MXJM09^DZ#*P\,$@.ZI8YT8#F7K=EO#HS)9$SK(SW#MB4C1ZX)F1VZ%+>[<OI
ML;=<#O_=N,SXQ,+*P_%+9/O4Q*4Z3%0KNK*O"GD:*"&^)I%-,X@;0;DG$(+N
M1JJ5UZZU?:)ISYO,QRONWNWA_2;[R<;<*MMI)8YSS5:$ J8++U&WIBMPA)?[
MN*UAVA$ZHFW<W! 7"XUMM>9\[H705;79"K?[^&I*[>I@=]J)D.^W7PD?ZK#R
M!46CB79;JK3S=%8HBFJ&H3M,=9<2Q^G7R6&K'6G+1KE!CF,/ %WT45@ET&!C
M4ZHS]_AQ>!1)NTT7X733,ESK]@O^.O_J=!RA$E=?W0V?11/#G[\C*]51.#M%
M#7]4:@.-I.$H4R%(8@'9-RM8[/4?,;U%]][$,Y6\C[\[S8GE?=4_G?9M?:D^
MO-M6N7.I%K>Y1.ZC?OZG/M6H$:;"Q&V(9+ .G]Y"$9D1$S-4&69267'VC=4/
M3;7Z''@\-2)EL]@BG[_1OWIH.('EI>V281RZD(2EFCZZ0N@&6! +3LWC!,((
M_.+K;@_$'T/$+."A 8_#>*U>])N\A=I['K]ZS8\KS.B[\B*3!QD)Q!#@@$IL
M(H[ HCJ"R(A(TH8W&7.9]?'2\<"IAAJ81<B?WS\;IZXQ,D_<>J$PZCXH&=?%
M%B8G>$$)9/KZ?9L5XR-*A^6W69LQ3'4"1,BT9=^2]X ^Z66>)DS"7V_?,EMK
M@66^ :<B@FL#MF[G2'WI-IV6S'J*_>TA^J^+9@@C5N=-I9OJC@PB38UN1.$S
M%B+EVC*E@ZP#\@.WIT8+'SW;\A?L5<[</IH>\!4JKSDS\&$S'WQI%*:-[F 9
MP!T,+QW,R$5I FCB<+>&8,"B$1G>);D0$NS<P12+=&C5EG>_0KVVD!%L+!"+
ML%:5RSS.^?)9,G(20U3>:B38Q6)J_G3922(#I^GGJQ#/5PEMR22<"/HF$++C
MU/I\LD(N8D\R;I-T7T(GZI86NY7W2\LJ[[OY8&L'3^G0_QS!)%:V.A#YN?HI
M;[0 6H<^2IWL04=)3\"N3#T(<K>KG[_1@6SX,3GP\+O5*!=RDL-'RZS:!0A?
M7CI&OTK6>T41ZU3]D*SA5FO3PK\5++IQI4G3X&NV6M5R L)::BM-I.FGF:2.
MP_^=1OG_Q;"G0&/HD&48_P+@W.-VW1D?MFNIVF+=>_7ZKNF\,\L9= FCOJ)W
M+V(AM-TENN.C9&&VE25R#[@6PQ#8XF<R]%DN"?:OU-T>Q8T\!9@<@(Y"Z*I@
M=I<U'!Z"1X?0)(ZO1J!OS[[-&'^\S%B&Y8=UT[T9;YE\2/2_>J*81L+.%GP3
M8T2#,)7$!"(\0X:U&9?C6TS=PH8T>[7NL?UE]ZRC'4,H=V*.HP/M> #]WGTI
MB<RL".I2O>N-J*NVF?K'FOH*3F,^5+?\EVZ6E;A82 U\<Y2<U>N$%D"!D;K,
MX<G= Y#V9A9Z3K_V+^IVL"0]_?+7>RE=+QY]OQ]MQ@(5O ZT4P>@T6,C!Z"=
M<33E.OI_?OID B0VCPOP(NZ1JY\8GPLN"NA7M6K(++O &>+RR\YM&1V %D,^
M(#OE$DW<"5D=_?1PCCPU%^,@XH81334H7L>YIE70FL?SF["2^2>:*H>?!T%X
M_ETBO\W[)Q#=70U N:\/S(Z$,]Z9&J([]-N._[?%_6&\_*?^ ]=WMTM_#%?%
MWKH9E;7/MG+FV]+5U=J>R_H.O_G0UG+*)7')CGL;C5;;S(M\Y']C^;>7'^T/
M][?4R]FGZ-_H/S*??9\AL @NNB?P8^'2U_\L+ZYY\*-[L<^J4EZ]2Y\N/7K[
M9'?U8M,G4KV7#HA%^JRYY%'G?WV7!O/GQ_^X>#_\_K;^[Y;]#R99?3_ WQ+_
MP>^]0(5_^)6M^MRW*M(? HNUSCVV(M^BZF:NR=P^6;+_]M$E!C_--KGR9&KO
MY-A]2>&@^^W]G/^D_IC^J%QHLI_O'\]+.<Y_5[3M%B_+G.4Z=_',PL;GM1-F
MW#V@DF+,[QP;*L+X+%YBG]F?R!_9']E=/RQOV9^2+UGQV^7J&[7L\X(5X>$7
M%_L:/8UT<BSD6UB=\UN6VWRVW >NM\HJX:>WR7_P[9?Z=WZ7^)NG'\,?VK>N
MW2J;_:#]J+UX17O ![O.<JG#<KV/5IHJUR_/?&_9*?W&/K_A\/Y30L=3;G!]
MT@J_^R6 _7GX4?L?:N7'WO?,.G\T_[:MC<&L_".]Y=\:/I@?R6>L4/K/$+B=
M)Z=&F7?OUK6]9TZ\Y2D7G]#KNF/"$K=W N_,3FZ_;\?][_Q_!@$;T%'QXA_;
M_XAP/U)ORJ_1SOS/P#7=^T?E@[W,H3NV5]]<>^G?XZ!]>^?F/IVJ%#XKNR+9
M]VG'MK*$A9/M?2XZR"O\NP',0_49_M*@ RSL4_W[[/G^,;R.^MYL)^[YV.SC
M\HZ<KW/51#9++9LHNW3;B;S\I'DY7LOK3IR[*BF]*[SI3\+?B?MSY<7JCM9O
MDS_DR_W-]R/+/<4?:W^[ZW?M84VH\5V@<:5D[2_!WXX3MRI,$/P[TU)3,_SG
MXD.3_.Y?[@+&^N9'X@?7WW9_.+UW?XX^2T;]INT=?\H7_+M4)S,YXH-^9TEM
MN8?;Q:V2-N9R4\TFKU(]^R17H'/M(T///'4WMP2[Q*YG-J:_3?Y=_<\ [.+V
M_Y/]$_%Q^A_AN-N/X]O_>/^VJG ^$&?V(?;<RH<O2_/9LF<I['%4R:TM_.:Y
M)D_L5\ SS4XVTW3F5OOE(0&@0P6WZ;_1_>C^;>$/T8?K;YX^6+_Y6.N'BW6B
M%045QQ_^6_]0FE?V2W>^F-,ZG2W2UIFJ;F)><A[O9D7H/MSI%LHJN,3QZ_PW
MQQ_?[XT7^L?VHQS8?]@2?N#T^G8Y\QV7%\NI?9AZ;'UJW;3R1H?I)^>=JWP\
MB>EWE]##;X^+5IY8]XV^Z\!'\2@>ZOC_30!02P,$%     @ 1&A+5+SA!S\P
M7P$ L*,. !0   !S>6LM,C R,3$R,S%?;&%B+GAM;.2]:W/<.)8M^GU^!6Y-
MW#FN"*&*#Y $>AXGY%>WSW'9NK:K^TQ4W,C 4^94*E--9LI6__H+\)%)Y1-@
M@A1K;DQ,M2R1Q-H+Y,(&L+'WO_W/[W=S\""+,E\N_OV'\*?@!R 7?"GRQ>V_
M__#KE[<0__ __^.?_NG?_B\(_\_+3^_!ZR5?W\G%"KPJ)%U) ;[EJZ_@;T*6
MOP-5+._ WY;%[_D#A? _JIM>+>\?B_SVZPI$013M_K7X$U,R2[(H@")(8XBB
M((8LB#DD'"4RPD+$&;ZZ_5-"68*%5%!@HB *L81,J10BAM*0*)7IBZN'SO/%
M[W\R_V&TE$ ;MRBK?_[[#U]7J_L__?SSMV_??OK.BOE/R^+VYR@(XI_;JW]H
M+O^^=_VWN+HZ)(3\7/UU<VF9'[I0/S;\^?_\\OXS_RKO*,P7Y8HNN&F@S/]4
M5K]\O^1T57%^%A<X>H7Y%VPO@^97,(Q@'/[TO10__,<_ 5#342SG\I-4P/SO
MKY_>'6V2_&RN^'DA;TW/WL@B7XK/*UJLWE,FYQI]];35X[W\]Q_*_.Y^+MO?
M?2VD.OS8>5$\>:I!20S*,#4H__E88S]? -\3WM4^5@_@*G,_^,)XBM,/WN!^
MT?H@AP?<:>9BR/4+]68AQGIW-TU=#'UXQ+Y>B^6*SD=X+;;-="#/S2_>ZY^:
M9LR#3HAIU4XCW1VH\OM*+H2LU?+)HT$N_OT'_=-L7<);2N]G+]=EOI!E^6IY
MQ_)%)=Z?)%_>+O)_2/%.Z#$Q5SEE<WE=EG)57O._K_-"BFO]7NA?Y_-\E<M2
M_TT/G^*U5++0?_Q"O]=7S](,!PSA!').$HC2&$&2" ;C..4H4YRQ",]6FP]D
M)A?PU\^M+17@$='^X,#YZHAV%+)<K@N^'77OYH>&4CV*FG$7_[R@=[*\I\T-
MVF3CH-0L_$<+$.3:=;F38$6_ UHA_;>?MP0]=Q?/_U@=-Q^VSUH[0<=0L+44
M=$T%-7K0&@OH0H".N:"Q]PILW@1M<G/7T5=@R9\8-S<>V;+8[9HE'[=KMG)9
M:E:K?E&T9!6Q#1#=25'XLYRORO8WT/P&!F'C^_WS.(A_WONBKHN64UKP,R]9
M<\7/?*E=X_L5?/*^F:G$,Y"_6C[#QUB_?IJ.'\"R$++0T[ #U.Z)U?NEP:41
M+&[UC.WQFO-B3><W]-%,S_2 $J$P"&@(4X$R,V.BD$H90);&. T"+KB2+@/*
MZ>:F-B*TN(!8%QHQN*]\-+?1X S!=G+NC[:!]=@ !1VDH(%Z!5JP_H34CA2O
M2GBFR5&ES,[\72VRO*N?F/Q%BEO]X->RS&]KG7N]O*/Y8D8"I3*222BCB&@9
MD1PRI#U4'$8!9R)6G%(7&3G6T-0$I,$).D#!;S74_]=-1HY2:R<@/@@;6#IZ
M<>4L&N>(\"H71QL;52C.F;PK$6>O[R<.G]?W>CYO9(;.7]'RZ]OY\MN[A5H6
M=U4;UZQ<%92O9C+CDB&D(%8T@H@C!HF(,!0!5TE L@2SP$4K+-N=FG1T80.N
M<0.E@0.1EWR^+->%_).;@-C2;Z<G Y ZL+P\X=- !@8SZ( &O[6P/>J-(U%>
MY<>V[5'5R)&077%RO;V?5FFW:'VWGC?KW[\N"DGGU61M\2#+E6G]SUH0C2_U
MB[QCLIB1C$>*<@9I&BB((A7JGT@*.9)1' 6$9JG3/,D5P-34ZQ=:_"Y7U:K+
M9\GU[,E,8=T$R[D/[)1K2&8'EK#KCZ_>78&. <! !2\,V!_-JA5;==C65S[0
M?&[Z .KO Y9T+LTTK##[KK_5QGD4NKZ\>E4\9Q"C2E]?BG8UL/=S^HGA:ZGR
MA10OY4+_L+K1K^0U7ZUID=-YV\Z,BC1*DRR#DO(0(B$09(0AB*E )$@#BHC3
MQH-%FU.3O U \.)60RQ_!-I/*UU5SX9L.Z'S3.' VM:@!0U<8/!>;?[UD<WS
MVVJ -_K7\MQ1/W\ZYD";5^FR:7=4M7(@8E>@7&[MITEOE))\E3_(=]5>W1?Z
M_9.60[.JON#Y/*]]P=5;J9](YY]7=+76O?[XY.*9HD1%@=*C(\,2HC )(<Y(
M#-,XPXSQF"="N&B6!TQ3T[1?%[EQ,PQ860)50P=EBQT4^O=N^N:CX^ST;^3N
M&%@?-]: &F&U-6DP@J<670&Z HU18&/5[DW:#Y0:V&+E3S<]TNU55WW@&E5W
M/1*YJ\L^']U/MP]LA;Y;K.1MT>R*5D[MJV6Y*F<D"D.5!@ED&8\ABIF69Z;G
MU1D7"G.9ICQ+9WLQ7WTB(XX@L/KZ[4+<_/J9?U_G95ZM6)D(AGR+'A8U?,"_
MTN+6U?5TZ)O>02B74/U\$257H(,;-,!!A7S0N) S; T=Y'&L^>>.V#A#BT7X
MQ;DG]!.W5^O"+*Y4WI()WM!=/M>R^>;[O5R4LO&&9XA2*F@BH(B2P.R%)I":
M+F%$L2@.(SUA3EW<3JM6I^U8&H=25F)F/I.YFVS9L6ZG6-ZY'%BL&KPUCW4\
MFX%<^7D-:/"B@>UQCNQ$DU>5LFMY5(%R(F-7F]QN[KGQJIT!^9*61N3NS'-K
M/Z\H])M4[:2\?-Q>TD2"7'^CA7BC'8V5=O_*55&=UBD_KK[*XLM7NOAX;QY1
M_E66*[/L6,>NSV(AM5.&0BAEC" *)(.4Q R&E"')<1+H/_;PV,;"/U%_K[*M
MO (U6/ B7X"R^M7Q#_IY7P/+'>0I]>I(6]#&'FA.61GG<6LTZ%@-V"/H7M=8
M#BK3KT!M/.A8#RKSP4K;#QH"-N^*?E5N3H<LNN]GC]QM?C?$QP(_[H[ZR%VR
MMR4_=OO]AL&W-"_^2N=K^8ND)GZF:G'SR[_DLM"/_/K8A-7%C*. R0RJ1#&(
M&.>0R#2  19<"1QC/<ZY>.E.K4_-6S<X0044;)!6WN:'Z[_VC&=TZPV[(64P
MC@<>%RZCUUG">]'D58?=$(PJIKW(V57$?@_I)VL?Y*I>H*VVACDGC,0X@#Q)
MM0L>I3%D+%0P#+A@@H9QDJ2SU>8HY-E/ZLG3G63IR*E.G]^-!@<D+1;YXM9Q
MJ?,I:4H$$4G3%,J4$*WU(H)8A@3R-$$D([&D4LT>9,&6MFK?F[9N*],G+D,T
MX"%"D$1"0"0#";%B E*1L930((O<3@?U?]M&& 2[I($7\Y-1!Q;<V0UIO1D9
M>,@R9#1[BG4 !KA>K8J<K>N8O]6R"33S-VH=9,+KJ/2TA5%'G8/&[8XJAR_J
M-VI\DESF#Z:ORIOE/.>/7^3WU4L-Z?=9FF 2A"2&E*0*HHSJJ2C&&*(P(PR'
M&<^(TT=]O*FI?>'7G"_79DJ]A>SVA9]@U>YS]\/5P-_^%B3XK48)#$Q0X?3H
MIYXGP^OG?Z*Y4;7@O-F[PF!Q1S^5^'@OS2;9XO:]]F/E)Y. Z:/ZM:S/*<^T
M3C"6" K#-*':UTP8I RGD"&.D<AP&*3(S6TZV=[TW*@*(%PJN"YEKTP1I_FU
MDPQOG VL&AN<H )Z!3;L:;!UD@5_TF%%BE?U.-WBJ )B9?RNAMC=U',#BG^5
M8CV7'U6[%=^)82E?/G;^M1TP58JQ9#R"$B&IYQ8L@31!%*HPY3)5C''.G8X!
M]@ Q.0=E/F\2OH&/"GSY*L%-(>?Y7;Z@Q2.XT<U\-9G>;HJ<2_!E65VQR79B
M7/8F XJ^N6N\XSY2G]ZTW!,:N(^&WM]IX(.E ILPHJX%5V9WIQN_]=N7RHT:
MQ'VZA$R_NRY]@(R[@W(!57N[(9<\J^=IQ?:<U]ME\9G.Y?8,F#D2MOU7$VPP
MXU@2GJ8)C$BHI94&%.(@B2$BF(8DS"*>)FZ.FR."Z;ERG?.*9=_SBHZ]('&(
M49IRJ*IDI)()B,,PT3]IMQIQ*GGH=/Q@P#X896S;.ZP([@YUBN.Q=]=>L1NH
M!N1ZX#'*ZI!H ]OCX=!^?/D]&^J(8=RCH?T(VCL9VO,QO0^&/LU%MIU$F"Q#
MM"@>]3ME=OK+688YSU*$(5'*N/,R@D0*IGUZ%84!BQEGK@=$;=N>FM(91WRY
MF0V;C81JLW=9Q?%P;5.^ KQK@/,)4NM>L5.[@;@>7.GVDCA>@<XJ1)6IS(KF
M/F=(70GS?9;4NOVQSY2Z$G/@;*GS(_K)FYY;UTU]7FD?O0[#_+A>F2SL)K']
M3!(<(A0&4,0IA2C#*:0R4%#%^G^$=J,SKEPD[4Q[4Y.Q#5Q0&KQ78+G%VC]*
M]1SI=HKED<J!56K+XN>:Q1HLZ*#UITN6M'C5HG-MCJH_E@3L:H[M;;[R:YCC
M2;J)E3F4--/^DDIXRB QDT6$J828I )&,HPD"6),2)^H^M.M6GTAX\?"MQ !
MUQ@O3:SQA.4P3C,:)@$DA&LQYYEQ34,.HS )LS@3 1%.I[(\T#NBE@_'J[6'
MZ8FMX9W* VE*-O2].D6?AU0DAU@9. O)DR:?.0')(?//YQXY>%?/M"-W]_/E
MHY3-H=%.>NYV_2CC+$D8SV!&HDC/<Y&$)(D#B*-$II$,(IY&3DE%SK4X-2FI
M,@J;(^B=LP".*4+.DFPG*EZI&UA76JR;$_P=M .LQUE3XS<5Q]E6QTVT84O"
M7AH-ZQO[J4P=Y5>="361XVV1K^OO>3D3F!,>L0!2'B"M+SR$.!013",2IPGB
MG*=.D\X3;4U-69IXTPU6T((%OQFXC@=03I%LIR^>J!M867JSYBPJ%GQXE9-3
M[8TJ)!:&[TJ(S2T]C[GE)K7"^_S!')S3$]3;O%-89),W\OIN6:SR?U2-SB3-
M$B1#!&D8Q1"I5+LK)-&4XUA& :8HXX[[P>X@IK<E_+Z.WM@F6^W"=3SLYMXG
M=A(T+,\#*U,-'E;HP1;^9JW>F7OWDW"]Z?-[',X=QKAGXGK3M'<PKO^3W-2P
M+%:S3^;\<9N?.TD3R5(!9<(Q1#@,H)Z?(<@I)22E.!8RLW&;=IX[-1>I@N9X
M(G>7JM/*<P$! \N)&4SS<I6;_#>=<Y<>#] >L?V4%NA;.CJ@_[6K ;O/'.7#
M/F)(^[4>^W//0P1F7WOW:V_>M90DC#!&82J8_BR3,(,L3#D4#(F8DE@BFKC,
M9DZT-;5/M8+J>%S@!)-V_H(G?@;^DNN,)GL>P0!)ZRWX\'M*X$1[XYX1.&_X
MW@D!BUL<!^G'WV>_2&$4NWF+>2 Q3D0$%<8$(LH3B'F"(!**,,5"'F:QU3"]
M^^2I??T-.,L1>H^G,V/T)=8/_&TWN,Y_RV<8$$M>Y8QI9K!#,/&DB0DP8N^G
M'+.ZUC+]YTJ?]&2_\4'VKA_'"SD&<^.''+W UT;[M@SK![DIFO%Z+;\L7ZV+
M%<WG=9'.))1<3Q$4C#AFYDAT")DTBZXHDBI+$./*2I8N!3(U%>M@ Z;FQ:4[
MQY;=8>?KC$'RP&)Y>+?9Q(_6&;%ROOF3V=P$+UY5T:,_7G5+8P!MH4G(T+%Q
MR"UJ-Y('WKRV!//,V]INE)W?\'9\GIN8"IG/FD#RQS??^5<S3_R@W^$9BS,6
M(15#)>,J'%)"S(((QEF(,H;"+%56$33'&IB:^+4800L2&)1V$GB4Q-/2YH.:
MH5=AW%BQ%IQSIA\0DE+RGVZ7#S_K6RL-^3LR/\+ZQTHXCCYT%$$X9U+[H9^]
MSOT#?K-859D7^;*X7]9YT*N]J%<F_TGQ^&HIY"P4)([22,"4)!E$A"60L3C4
M4S-) L)0H"*K$QN6[4WM\ZXA@R>8KYI$V\L"-,B!@6[_S=OP?EX"/+,YL"+X
M(-)))ASHZ:T:-FV,)B(.!G<UQ>6VGN%RO[RY;N;K61HQCI($!D0E$$4QAC2)
M)&0*BY1D89(HJPV8_4=/3CC6Q?)>7H%?<B'F$KRAY>H*7*M"3V,=X^"V[-G-
M>/IQ,O3GKT$-L'*[;ZO?4+7MX\>-2=LS:R_X;/^*J94%>+LLE,Q7:_T:_4V:
M3#)27#_(@M[*/^N'KUYKC=DD0YWQA @<9N8\@TFT+*2"5$0,"D:I)%$6Q<PM
MS\LDS)J:*+6  :T1@UL#&0@S""N3?OC!H+X"KZA^3>?SILZ 6,[GM"C!O2SJ
MTUR3*3G@](K9J><TP$Y(N<<K5] AZ IL7M6&(U"1! Q+8)LI^X]0T:!/O_]!
MZATXF?;?I!I"G^X<KU9"+W071'08_(7\JDW8U)/<7XDLK\5_K>N2Y!_DZJ/Z
M0K_?F-@N4V9RFR[XR[).%CS3$P*.PHA JI">)*0DA$1P!I,PBVC&*3/YI-OC
MAO9)S(?":Z75.X<D1TB+7K4!BLTBL"D#\_'5NQZQ)D/TL=U@_*Q=-F:4RQ,;
MP8O:RA^K[!17X/#^#U7:8ZRR6IBT(9\DG].RS%7>A/5O^;@:/"GWT-WD/_AF
M"+#C1^X,2/G!L)\AV^N9\TZ(*H<>G=_07+Q;O*+WN98]#?3.+&.9G).<IQAC
MPB&52ICD=A%D(M&>:DHI"U"J5!([IKD[VZB+OHQSC&&+&=QKT% /!KR&[9A(
M[3SA=M+NE\2!1;K#GD%KAM(&[Q6H$==Y.SRF2K.FQV]VM//-CIL0S9J&O1QH
M]G?Z"B.Z+LOU7>V&_UK*JLTY-V<9S&^NF?;9*5_-&.%1%B *4QQI[U9E'&+"
M8AADC&9QBJA$[+(H(BL<4UN:.NSD=$P!QI;ZR]M: WYK[7$\]]FW]_H&'7GO
MDV>).?+1'1Z"BYS('#BVR [+,X<6.1%V/K+([7$C[TOL+X1L2M)F0E DD@PF
M6*40R9!!JC()$QY*1E@29"D>LS+Q<:A]UA1&+$*\W1]8%D#5\)^E*/&)SAYX
MN?_"OOO#K-T?6IV?5$7A\QTQC<7T$SC_&"OCYXGVMLQMT92/4D8[*^2?I#DA
MVOY1Z^E=.$L9)YAP"0,55DD1D$FT$D*51C166 8!<CN:Z A@:FYZBQBV.\A%
MBQG,#6B@0=Q=4O[(HD\LUXX'9'KH->'=(DE[FZ$;_/45X,LIUB^LFV1/W8"E
ME"Q /&-U)7N*3A=<<GA.S[0PRT(WL:@35/''+UJ)2^VK5W[[0E3_;-SXW<J%
M84P%"V,$B4@#B(C0$D!%!I&(9!93'E/FE!FS-Y*I*6)K >A@=LP+T[M3[)1P
M%*H'EL3&!O"4[<:*:@>L:P=H"E(.6ICR8EK]9H_IC6;<)#*7DK:72^;B!_9,
M"V]VP;0SNQ#5UMC-LEP5<I77V48.[(HU.0$[60)G@6!10!"#J0@$1&&0F K:
M!.(LSE0D*$51V&,YXG)D$UU]:(""^1;IO_PSCL+H7^G%V48]=*>=&(_4.^.H
M<HOJ\5B0@O>4I?[H\YO>_G)8XV; ]T;C7I)\?T^^("RM3DOR09/1Y I.8DPR
M&1(8Q*:X6L92B+%2D)!4Q2@EF"KN6*7X4#O3V_BOXXL6&X3]*A0?Y-0AANL2
MGD8)P&JS#6XA>@Z/.L: _]BFO9;&#TPZ9NS!J**C%_O:E_\@5VVBA.:W)DW"
M=D.>D5 I%L,L$ @B)4-(>)) &:1<9B@(PL@IE[(K@,E-:+43M5Q44?I+]33-
M1"/NIPL<^.F5OAOM_KA^EAWV\UD]1MICM^-QX,WU,R">>5?=CJ+SV^F6S^F9
M1?[NGIK"W^^7B]LJXVHMMW^1<Z%]-+-]__+QBWYTE?$\2A%*$AS"A)I:9M0X
M2$P[34@$&8E)+%(>.*65=VA\:C+88@<&?).>N,E :/!7:TY5# Q[!,:&?NGG
M77K'3A*'XGQ@.?1-MWO>^AZ\^4UD[P)@W,SV/:C92W7?YQF^/, WW^\E7TGQ
M2:[6Q>+CH@EBTNW/1( EC4/M^&4DU)*'"*2Q=@%C)&(N&&4L0I=Y?\<;GYKD
MM4A!44$%VM.[UQ?TFC(Z=4)?9\\/M<_BZ&VXKK&W6=HTY>;OC?0-Z>"=YVY@
MY^X$@&=V[,Y3<]ZILWA&S\#(MEK(RW6IVRS+S_*V.@I:%P9"*$RRD,.,91BB
M2#MOC&<(9F&,$DZDX-RI\-C)UJ:F7RVV7J[8:5Z36)(LSE(8$!E!E(8)I!(E
M,,':+>8XEIA%;NN'WI@=9QUQ0&[MU-\;7P/+O2U1[A&2-@3XC74\V>*X48LV
MQN_%'UK=U-?)+/('NM*>[%Y4!B8RQJ&*81A3/8O&*(4DR3BDE%-"LQ!SMUPV
MQYN:F@!WD+IZBT?9M/4-?7 TN">X 7DU2HC*>58\^WA'FQO9HSMG]K[_=O:.
MD8^Q;+)T= [;M#[EZ_PA%W(A/FEYFY%8$11E,52QT!Z?BK301)Q")9(0(Q(R
MA.0HF;-L$4]-M#8S,=& !(^YG!\_VO!,_6SI)4VI]X;VM"X_W;+-)-4]V]B9
MG;>F V/[!$Z[N';3-,Z^6*/^8YR$<>T$;^=BG!ON-V@]0;4P2QAM_$Y>\OG2
MU%3;[-/&(:(!#BG,A#D@0\,0TE RF*HH04$:$(RHR_#CT/;4!I(MUG:MK__Y
M=)<NL!L9!B)V8(WOR:FS(/=@QZNTNK0_JDCV(&97[OH\HF_)])MBR?5$_Y,L
MI;[[JV[NM7R0\^6]::])HQR*6#&&&(Q1%$"4*@89QQQB+J)(AB) V#$CD%6[
MTUO3>[> ]S5N4#3 JWU6L87N6DW=AG_+?6S?G Z]@;T #6#PJ4MF!_, ";"=
M6/)<=]VFY9$KL#N0L5^+W>7FGHX5+;^:_S=I/!_HW"Q%ZM9616X<./.'2AZ[
MO^A<6<<(O5OPPIP&?"WK_]7_GJ]%OKAM:X(8_^^-4MHGG&4)E0D6&.(DCDWU
MQ @2EJ8F\Q BBB2"1F2VLL^@.2Y\)_=NA(2:K^I"-E7FM++^MJL?Y-9&1Q]O
MW+?!TDV<;!\/K-_&%)/91/=HQZ(KL#6V_F.=;?/I[Y[<4), 6A; BY:''Z_
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MIB:"-5)PKW\)J,$.Z :U<P;_7OUBNZ$S--N#[^4<.B)M_MM,DJ] TQ=;0Z[
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M9==JT#&[.G;>N:XQ'52V7X':^B?QU/7<::4)  T#G?='_UBQX/'H^M@=Y_?
M^VCHQSTF/W:G[!VN'QU /Y=I$VG^BZ0F(9UITKAFORZ6K)1%5?#XW>)^715
MUMSG\[P^AO#)G. I3/ F+?-RL\Q<G^-0$8\DHQAF)(GU.$@$9"Q@$"5)D$H1
M!P$1[N[1(%BGZ0J]E+?YPH2ZN0UJP_1FHF(<IF$,<4H41$R$$#,I8):$41@3
M(A5CKE[-1/IR> ]&MS"1;K3S0YZ]8P;V.;:'IJY Q\1Z9:%K)*BM!$_-K/+Z
MUW968;]E9S_5]UFL0;O"JQ<Q#-)1/89!R=[U#H9MK)\G8)Y1.RGS^?*;2:-@
M\M9^D@:/++_HAUY_S\N90"K @60P5-34< V0*1I(88:4$%&4I3)SRHQHU^S4
M%G@_OWD%VOQ)5R",8$"NP,84L+6ERNS<6@.,.> W8Y!C^C++SK&3>/^4#SU/
M'(YM9U%V(\^KREHV/:ILNM&QJX..=_>,R&N20+Z6;/4+7:V+ZL#F)WG?1,1\
M5#=:47E^3^?O%A_D]]67;W+^(']9+E9?RYGV<1/.]2R&QJD)3.$IQ":O2T*3
M$*>4<YEE3M%YEZ"9F@SJ%S5RC-2[J#,LH_;&HGCH"#Z37]88 HPEVEVM;7EL
M8O4^+GQ&ZOG@S&_4WD6(QHW@\T'>7C2?EX?VD\Q?]6MI4D'^0PK3O"G+8L2Y
M/=:%22H3EC"8B5A"Q+C4/F"<0B;"&&,AD@@1MY.TIQMT^2;'.5+;P0N$!@SR
M!C'@RW+E>&[E#-MVHN>/P8%5K4N=00I:J/Z/U=EQXE6USC0YJBS9F;^K.Y9W
M]1.6=POMELARU3S--#"CF"'!(JTF@=(>EHP99(G9/M4.EL02A2'F+A[6@3:F
MYC>U$-NSME>5B+BIQB$J[:3B0H(&UH<--V]:;EZ?XL99%$Y8[U4)#K4SZN=_
MPM#=;_[4I3T29O;=^]HF E,12V+!!90RXA"%G$$<B!2F6'(6*YRBP*J0HQ\X
M4Y./.BH"-!$18EVM1J^^2E!O:CBDA+R\ITY+SOC\CQ&R %Z>#EEXV80L--<]
M"5FPR=HV1#\YY/4<M;_&2OHY1K^YI0;U1O.IO*&7-S)>4E%OA#S)..KOJ?U<
MWIM"3]EST0RMK^J*R#,B98 5X7K.G"B(,IE"FIK*!SPD&1*A2B*G_#('6YG:
MN-6 ;+W>>KE^685KM97.JX)[CO/GPPS;^<(7\S;P>--2MG&&&XC^_.&3#'CU
MB ^W-*I/?-+87:_X],4]*W7F);V]+4P^%2U#'U43&5]55]F>ZI"<4JFT,,28
M:?<W2 BD8<HA40'AE)-0TLBI,*=-JU-3BVYIHHX!TNSP5? =:W%:,6^G&M[Y
M'%A%GN(UA+;':^I*3F"0@S1.+/DMHFG5\K@U,UW(V"N1Z73S"-ND9@/J;?X@
M9YC%*5)A#$D0:J62D8 42PH%2TF6L !%W.G$7R\44U,N_5:F VZ+;L@?8#NT
M#Z7/NPUJT#[3/N@N6<^W_[E!,MU]SUVR+MKOW'M8/\W[LUS>%O3^:\Y?&8O-
MR40CL)_R\O>F'$J4BAC10$$9F/"/B!&(42QAE(8!)511P9S"W<ZV.#4MVP(&
M3Q # ]E-Y,ZS;2=H7CD<6+Q.TC= K6!K;KQJU?E61]4E:Q)V-<C^QDOK!K]9
MK/00]K=<2.W;\?G21 %_7&S;ORXD+8TDOM<J)^JZ$.\6[Q8B?\C%FLZ;NB"O
MEFL-4NODR\?ZQ\?M5$8IGH;FZ$V:RA B)3)(TB2&<<"#(&,Q2F(GUVQ,\!-6
MP4YQ5%,+PI1L^4SGS6)6Y:M45C=56OI6*1[A_; 3VZGV^M#[/$\7'QIS38=W
M7H7*XJO]3C>%>[9V;VKX;"PW9UH;VP>=@#]'WPU4CGD$ YZICO-X77.\ /2(
M&'HNF]9YA:OD(3E;&_$UZ5M?+<M5DV/G'U+, D$QS\P2!(H#B$*3E2,*%11"
M4#WBI8(RIT@BJU:G-E09A/UR^-N1;+E"ZINZH5=(F\357<!-]FJ#V>.BJ LQ
M?A=%K5H>=U'4A8R]15&GFR>;4>C3<F[TT]PT"Y6*&<\43(,40X1Q!%F2)!!E
M-$T%"Y(H=1*P<>%/30F?,;V(<1N;**W?#$.@H<CQV-_(KY_EC&"R+]70<X(_
MTOLTQ3PV![KUCY;,IFO"?[>,-@>ZYQG2VAQ"T6_P?KDNM8-0EAHJRQ?U2M[&
M,7@G-(I<Y6;VW91=Y1ICH:<W"]$>K-=3&?TW#5B\6ZRTB;F^N)Q)0<)$HAA&
M#)LCH5)"2A(&(Q42Q@1C1#&747H@G%,;CK?0FBBO/[D-AD-UI]VH-X%.&GAX
M:RT$'1.OP-9(T+6R7>EJ[:Q7/[>6@L;4*_ V7^0KV:R/=2SW-W(-W#5>AZBA
ML(XZ%@U,^.Z@,W1S_4:77RC_JF$5C[H=,[K=FV'MS\6R+&<QS@0*,PP#3K&9
MO&&(,0UAF&)"*&=9$%D5LSC?U-0T?H.TT@/98G43^A/,VFFU'[X&EMNG5&U@
M7H$*J#]U/$^&5X$[T=RH&G7>[%V9L;CCHL7K3MFQ6JBTEVO^T?S>>,!-%/PL
M8"D+><!@G.(8H@AG$'.&H%1!FDDFT@@C]_R)SCA<OI9GR(T(E#F2\V#.:)CY
ML:D8V>O\@'O_\#C!4: 0%(QF$'%.( Y"";6TASB,@RQ@V#4CX@B],U:VP^?K
M&*?-B6&H'GC8:/QNM2RJ[0G0@CU<>]/[OH4[9T/L83B@>([]#'>2CNQM]'B0
M^W'M;<$X/=2]HD7QJ.KEE_+SFOV7Y*LOR_T\7;,L"5@<8 IQA"A$"9.0THS4
M*7[3($Y":EVPK1>"J;F^VSJ+<VT%X%TSKD!9&V(J+JKU?%Z)8[UX3%N#[(\#
M]^NQT]HX2C\,K(V=4I>F"UX][8+/VRXXD#MP:/;MSU\/W@LC';D>I#><CEA?
MQ.2)4]7]GCO:0>J+S.Z>G;[L01Z759KP\(0IF012P##-D%E7"2%.0@8#JG J
MN0@1LLH*8M'6U$:7(ZL%'A96G$+O/3'V/$LK X3;6_ Q_.K*<X386QANM;[B
M):S^U?+N3A8\I_,;JB6K>:/C+&:A#%+("=$>:JJT6J2!@"+,LBA@4JG(22T.
MMC(UG=B"!!5*-X$X3*2=-%Q,S\"BL,O, &IPD@*O.G"XI5$5X*2QN]_^Z8O[
M>@K?\[OUW2=Y1W.S'-B>"_VHVG#D:FK,'U_+(G_03LJ#+,.92A&-4RT(&36%
M27F20!93!2."%*$DBI"B;CY$#Q134XW&"*#;NG-U*?IT@JVS,3"U@[LA-:L;
M S9'E\VJZ.942&,$Z%CATT&Y@$//KDL?)",[-1>0M>_N7/*POKFFEEQ*49I"
MJ]V3TY^_+HM5>[AZ)A6C%$48RC ,M 3*&#(9)5 )S)),X#C*G+:GK5J=FN2U
MH*LI0HO9G.\J#6IHE!"P95$LO^F^*Z_ 0CI.MNSZPDX)O3,\L/)MR*VJ-[_8
M0M;"]R/XO&78;VI7)YH\I[:R:7GD5%<.9.RGOG*YN>^V>*M[FU1[']7VE]6&
MQRSE&0L"@J&(F81(90+25 L6R3!B22!IE#C%6MHT.C6IVL*K=U%=-U$M:+;=
M-_5+WL JU.&M@G8%NL7?JLB.^@\^=TGM&?*\,6K1\,A[H?94[&]_.MS;3WU,
MD2%]T]?KA7@M'^1\62U'-;G^;I;SG#_.(B&3.#)Y7U"HQ4<R#AD)*:099U0Q
M$J>14QH^BS:GICTM9!->L$%<+ZLN;O.%E%7NZ<8$Q_ .FRZP$R;/Q ZL2RW:
MBL8NK9LDGS5D\%OSOX,D!W#@S*M2V;0[JE Y$+&K4RZW>CO#\FJY*',AZ]0T
M7PJZ*)74,TD1SA0V@D4"&+  F;6M"+*,9# C*E81RRB2Z84'4XXV/C7ANF[3
MA8)[_<BOM-0_%#FO M*HB1 O\^K<T<5G4(YWAYUV#47RP")V^+3($^2@ WW0
MTQYG^1KZ",=Q ,]]+N,L-1:'+<X_HV?VO>52?,OG\^X19))&C!"E9WE9K"4L
M%";I,4UA'&&$2)!P%&*G?'O[;4Q-J5J(%YT4/\2EG?Y<R-# ,N-*CGO"O./F
M^TV1=Z"=<9/B'3=T+PW>B4O=/G4A\UF=7.BOR_EZL:+%X]M\KC^J62#".. 9
M@R1&'")&$DCUA I2/;4B283C#%G553W:PM0^\QHDV* $-4R[S_PXCZ<_<B_L
M#/R)NQ)C_8F?-?[ !UY*_M/M\N%G?6_U;?\=F1]A_6/U01]_ZBB?\UFCVH_Y
M_(5#U(F_%O^U+E?5:O$L2B7/>*B@2G (48;U)QZI $82QPEA2,3,*0#'NN7)
M??I*F5!7/?-X]=4D2J@2!.[M_[[YSJN_@D]ZUN(X+['O%#NG8!"J!]:1?E7B
MK\"[!3?I[21X\5K6/_T(MA:.53G^ *<C%H_OMCZA^O$'2'$K(7_H 3VWUMLS
M.*_TUWF[-%D.7R_-UOZ,1$013E(H*!(0!4) (G &HRS3/DR0IF'DE+3K:$M3
MD[5#!\ZNZE-I]6FE*]"8\ A^JTUPG-4<)]URW]P'E8/O4GEDT7W+_!Q#?K?)
MC[8V[M;X.:/WML//WG!YS949HE%&0\(@XF9&9%8]".<!I$F2A4&:"*Z<5F^[
M#Y^:=%0IDZL($/?"QT](L].!OE0,_.EO6? ;!W/(W,%JDSQ?R9%C7^O!:_I]
MH,VIVW83>IL=><:B,,.Q(C!260P11A'$+)*0"X*3,$YC@9T*@QQM:6J?[I?E
MBLZ;X_S@3KO+ZRK]TZISZ-_M>S[.L=W'[86Y@;_T=B3?!J!TLLK[^_#/4N%5
M!8ZW-JHDG#5Z5Q_.W]!/+#9/?+>X7Z_*]V9'.&S.T @ILQ1'%$9,)1#%*8$X
M"6)(8Q4$ <^(Q-'L019L:2L8)UIS>?&[;0[W_K^HX('P1S=I.,6HG3AX8FE@
M>>C&I=5 KT##V #'E"PX\:H3I]H;52DL#-_5"IM;^JG%!S.;*+_>%,N'7$CQ
M\O'7TJ2G>U>E0<T7M]=\E3_4J>M8N2HH7\U$Q#!7&8,25_$=6$&*33$RQ+!V
M/A"/$J>5!G<(4W-&-E !W6!UDY@>W6"G/,.2.[ @F:I&!CUHX9N\UB^,!2!?
M_ BVM&^M +^U=GB4JOXD>E6P'C!&%;;^-.WJW05/ZAN':VS,YWE3VO;71;')
M[?F%?F\S';WYSN=KDUOL^LY4EBEO9+&JSU5]6;[Y3N_,$IJ^_)-<K8M%V8V"
MD P)%E(ME4EJ(DI0#'&:)3"5*0]$JD&%3F70A@8\-8E]:J_9Q.I:#+0-[=*E
M=EHV5H/&;+"UVZ1Z:2VO;FMLORCN9?#7QT[LI_12##PT3.9]Z!'Q/$XG>0Z7
M'ACTR+'6XW3!?J#V2.U>%@GY[NY>SS?,=J7)N#1C@N),)BGD0F80Q1&%-.0,
M,L%PF-(8T<0I5\'A9J8VX+0HKT"^P5GEU.L7$;G#J9V>7\[4P"J\)6D+L<JS
MYC\R\C '@P1'[C3U+/&1A\T]%B)YY.I^,O!NP9=W4@O,=DER,^FD/$5"I1R&
M0<BA_A%!ELD0L@3).(M4&E"GLV@GVIJ:(-10*Q>A4XK58KKI3+*=.'BB;F"%
MZ,V:LU!8\.%5+4ZU-ZID6!B^JQLVM_0-L?Y\1^?S]OS&+(VS-$Z#5"L$%EHP
MA)[W*HPABW 2I$&4<&R5Y>/(\Z<F$DT4<841M"!=@ZN?,GA:#3SP,K "N%'2
M(ZSZH.$7!E4_?>;((=4'#=H/J#Y\6;\Q_\A,I U*+3_)<CTW*V\F%4<=*[RZ
MJ;+YZZMOELTIQEG")5(\4##(1 013C&D699 C%*DB HQ"ZR.4_B%-361V, '
MA9S3E11F#:+)H X>)2U 7H^:*SUJWB]['1'UU*%VKLCXW32P9IU82]K$:6^,
MJM,+-6:!VJ[JIINS7>?LY/AEVJL_Y G:J*Z37SIWO2S/3^\9W-DI/K80GU=+
M_OO7Y5S?7];%,&=!E)* Q2E442 AXB*$Q(1^4IR1."8DRJ)@MC+A5G::?:Y!
M)S7>-#MT)-F\4S3P7^C=_;^"TE00;9#_CZJ(V.K1,43T'/5VZNJ3T(%ULUMZ
ML4UZ?8(U]Y!22RK\AIF>:W3<T%-+"O;"46WOZR<S]>&R_$%NII;F_-C.@K<I
MMML]!9:F*B%IP& 6I@E$B:"0Z/_"-$I4$/)(XL0I!60?$%-S#BM\;CK3BWL[
M[1F:T:'GGBU\T%F',A: IR9<-?7/.U9<&4^.>SUZ=PF97A6M%Y!15>X2JG:5
M[Z)GN1>R:M?D3>'7Y>*VJCA<Q_IN5^F_R')5UIF9ZO^:W%I5:JT91EF:)(I
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MB(2(I FD9GH0X#0.8BJIY$[IB\:%/S5U;;$"6H,%LD%;IV4UH<+UOP5XD2^
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M60MEJER]5RVMHD]7V"O[P/_4>S91^'^2O7,Z / )=,<Q@)=E)CL,\ E*^TC
MZWT'9IA_^W6C[[<N?8P[N>:F>Z5D^V^2FX&T^E]U1Z4DI8)FL6G0K8Q]GT*
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M[Y6W,3!!'W>PT:_J.Z%WS@A]4_XW:LE^$QW5JOYH-O?E[]Y9[// N>9!=B+
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ME0"7^<2<I8!!KFU*2#E&PJ1V$+N&U;XPG:9==87JJPK67QH+T1>JW4SL"ZG
M_%M!].'%%V] 3M_EQ]DZL\\'7!/E]PV%S2GCKP^/CKR_BY=.EOW7)WP[![#W
MLU[+81>2,TRH*@"6A@YSQ@"5+ $,X233;SM*6;YXD-OE1K_TZ'9O9[5>6,WE
MR_MRS8 A;GFW7*]-5L>CWLGMGB[793GJPZ:>H^ZE(G4!,P[-C"10Q";_,H<:
M\T(2H-_O::R*.,LQJY%^M[8L9?&&<[-BP"/:M0@.L9T_X &TP"^BBX6XP6MI
M@QC^E]::0WWK)5._[^.>>MZ529*++,Y9(J4"2%,!@#13@,F<@:2 @F89D] T
M![9/S3Z_C).=/T&6=G6D(AJ?M]T(H!1Z9-^["EH[2A@/6&!&.-OMKA0R8)^[
M9R"$;7%7+77=[G;/U.UM;/?\TT.[A;_9W-]OUJUPPN?'_6Y/RW?E@F1$YI(P
M(&+% 620 %+D!#".XH+G0L'"ZKS#;KFYA0'J5MB5R"\B8BVQ73N(=R+>S1;^
M<0S,&F,A'-!5W :9D;W%.Y>8N,.XC;JG?<:MKG*/(E99:,N?\C#=P.2A?95&
MF^5J688!WF^V<GFW?D>WQN,IN_SNM]6?ODC]M5OO%Y(R2G%!0 *%IAV%&& )
ME2;O \(,QFDN4H=>1_XDLWJRIF]P9%[)6S-N3[^>]QO]XU%PDY&J*KTB62MF
M'T;RM)_]L;D)MV?*?&!S8ML:NU)F!#]7ZB:JU8H:O:*V8C=1K=KD>V8?*)Q^
M[R8**TZVATYQ2+]P=T0M/2TT68S3+S#MB*CG.P\UU6^%T%_OJJ'UY^V7[>:G
M]ECE@D"N,"HHR"G4OGMB^M-P!@&"L>FDRDB2*C<C_?Q",S7/:V&;UNN;;=0(
M[&J87\#7UB0?C]HTQO@ P :8X=UHC#3 +]Q\8M.[6\53H[OG\^[FMIF9\7%#
MU\W9GE!8F9H[P@MN^K]@P JL "I01C')4<J9[5']\UO/[=$O)\08\>S-HA=8
M]9NDPQ$(_!@?E!]P+OSR&V-MY U'8R)CK?\KX61EG=>WPUIZ<<%D5L]Y0=O6
MRX5/##L_,$:/_KCX75M":U$>G='5%[V)/^A.?F:KY5U5#O(H3<?,Y?KSNJQ4
M7L0J%W%,(8"89P#F@@*:T!BD*(.8);G^N],HL8%RS(W(]-<H=3ME&+H!=L<0
M$\ :F!T;#:)G*D2-#M%1B3,=$[0Z_DXS1F+I];ACJ"R3GH>,!.SE@<G8VXT[
M8#VXBM5AC>EKR7(LD<HET X; C!E&< P+0#/:9Z0G$B9NDZ\N+#4W&CND_X"
M5*,LO9^VGL'9[<1U''I3G;JV(E#-X:O79J#]: 0Y?CVSW%6.8"^K?>D8MN.*
MT<6O]=C76V8*1_A^00M))),Q@ H2_9]" D9P"DB2DD3$*&>YE6/7O]3<B*,6
MKUWV.KB^]26J=C3A!ZO -/&L>+7![(]&4(\U\OUHA*I:?;G<M2I6+ZC=4:UZ
MZ8IA-/%_'NE6/WFKIT,MLQD4??A2"XP@9YR#6,385']10)C&-D,JB[.49]RM
M^JM[N;G1Q4':Z%CI74XOMW@6AJ!M1R'^, Q,(V/@<Z82.U2\TDG/DI-2BIWZ
M+VG%\JK@<^(_K \#-FDL82Y% JCBTDQ*%@ G+ :82X0ASA OW(R3(5+,C8C<
MQYL. ]_2A@D-:6CSYN)4^  #3$>!=:UA\"U)YCH)_A2L$6/@S]QL:#S[IUP_
MEF?Y=^LR1O1ELUKRI^_RK_UKK>D_%CGE!:<*@D28^J2$Y(!D(C:)L*E,81S+
MS"EJT[OBW+BL%CAJ2>P:LN[#V#8X[1&YX&'H"K0_*A$C(V-4"NG1A+(&Q',L
MN6_5B:/&EB"<QH=M+W0_F7]3-F'4-AKGVT>Z4AOM G*Z6C5M<18<Q7F*4 Q$
M0:GVTS((*"&QZ666Q 7+)"'(]JR^;['Y$8J1#C09JPV]VY]B]Z+;S2>^,0M,
M)96H9DQ4+:Q)Z(TJ<1W[+%F!9Y\4X!/$B=($QH'IE$)@BTY'4D'O+29+,[!5
MIIUX8'W-P#Y(-6]\W]SR?SXNM_+UXVZY-NW3333^LRK[VU9_$8LLAA+I_P<H
M-N.34:&I5E+];A,"\CA6LA#,;8B?R_)6#\*D8_Q*R>K2Y[(%ARD4J'J,US([
M]DERV0P[<\\[P!/U4*K%-MD%M7C14?+RV,Y@7;;WONW#VKVKT@#0_/98<A%@
MVHY+ Z YZ;\TY!Y#$PG8_MC?\N@KB3@M8(%SH$S.-T2Q #1&$B0Q80(II&U)
M9=<^J&<EEV=JF@Y"1M#H=BVB-QK>Y3YZ3_F@0\%+T-KQD@>X E-0B=-1Q.B/
M(-YG#PZ>\P7.KS5QLD"GPJ>9 MT?'T8+MUS;R8^EY_1]2]>[56DPWXK_>=SM
M#375F;T)9 1JA@ JBS5+2%H  K'^*8^E(%BR#!&7J)7=LG/S-(_'6&72O1$T
M:HGOQAJ6R-N1B'\\ W-*2^!#N5MULLU-24DC=W2[WV^7['%/V4H:$^@+K9(1
MO/7B&H:@5S:R7'I2<G*#XR57.5[M'A!K=:]HI4:\E0_:):RJY$RWW/O-=K_\
M5Q5XX 0*QH0":1+G0-,9!@Q)"2!!2J59GF@?SK$(W%F( 7[;%/7>;8FKYMLM
MF>TC0>Y[TA]7"P/Q%5K<M*2/GN%M[,_;B?"V#\4%Q7VBV)QG_)V"=8/QZXC>
MN=]SLG#>8'7;\;WA-QDXI('_D.)Q);6;O;E_V*RK,^%#(F[=7;UNE/;=&" M
MK]EDOR$6 XDXUU8PD8 E) 9F4&&")54R=;*'1\@R-R.Y4<5$I<JBU)UYS$Q8
M_)AT[CS(8<16V1G0$VU X%=.&_NC'N9?K83_6I?H5:W-+]JA+\WK(&Z]!V#]
M3HD8(<^THR/& W<R3\+#+0=RK>D*]9KNI# KZU4J/M]NS9&.L05>/QT_4D=%
M;_^D6_'YH3Q3>/>7W/+ESHCT7]I7_*$MX]N?<DOO9/T7^66[Y'(1JZQ@68X
M+!*A;?LT!4Q2">(B*:2",<]PXL3+T\@]-PYO9(UH)6PD:VFC!R/N3=32RXP+
M>RMYZ=%%66(ZLD=BLUK1[2YZT+\J)V;\XLCW$WU=+-\-\_L2A'Z/&'4 ,_I$
M;9VCEM(1>XK:GZL5CTK-S6CQ^C"PI?U-=/ABU0 T?Y51"8''U\ZT>^;W%361
M[-.^SJ;=D)-7W\3+#WM-'B;1?5@_/.YW'^5/N<KJ0'#.84)8G@".8E7W5.9%
M!A0L.$E03 O;.1\6J\WOL.Y5*5Z4.;Y)NA"U8W]/* 5F[..(R9NH$O0FJA$+
M$"RWP,0K(W:M-RF+62C^DGEL+AG<&V"YEJ*VU[_H[X.QX,WH[?>/^\=M8\@W
M20:'*@^<DI33E (8$VTD(YH!E@C3G9V+'"M""N$T=G*@'',S>MV+;(9N@&UB
M0'!8PT? C091+6ED=+B)&BVB2HWC7RM%@E3AC,32=[."0;),W<E@#&!GVAR,
MNMU <ZHZ6/YUHTV4M;FQR:'X)GE="E2; 5+F.80$ TI5#*#43(ACEH(\181)
ME"844Q<ZM%IU;N37G,'?':2.A$G[V1WD=K2[K*"WM,!\ QJ<]C1PM7Q/-]%1
M[ALS(UQ_)(1%YH*17]O,:N5IK307,$[L-:>+1X1#6;\WRBYXHZWV^B^\T:_R
MGBY-R^ WFW59Q/U(5Z8(,ETP0B#%B&B&*\R<2,( C>,<I!2A."X4@5GN'!J=
M5H>YD68C-VC"I-M&\H@?18^T*/>'@%BT.>I]+G3ZI%]]NR'ATHF_3@ZAT_E^
M2?X7A5%;2)P)HQ[0B%IP1 8/SR'5Z^RE__#JQ'I,'VJ]SD:=#;M>292A097M
M\B>MNO/O]MLR4>GK<O>/V[^6NT6:9#+'60$$SA+]#N4$,*PDB G)BSS-H,B=
MCA>[%IO;R^XH:W04-OK#B.K8!:D38MO8B!_@@GL" S ;$-SH!\-S!*-CP8G#
M%/VJG\8B+*X91AZ?'HTI]UE]E0^;;9FS_DW>E1&-!<R+)$MB"!0WU)&* F!6
M,, 4QUAF-(;*J6/UY:7F1AR5I"8):7N0-=K5PKHQ1P>^=KSA![7 K'$$["AF
M]*T/,&?:Z,?"*VET+#<I9?2K_9(P+*X81A=-M:>VC=AR79I&7P]#>C\(O<)2
M+<UZ55/8IA+T=BU:";+Z;YK"1#EF_=@8N;IBD2090TKEFFM2!*#^V?2(A@ Q
M2C,L<S.HVX5U@DL\-_(JA1S443K\YMI1WJRV+#!S-KI&+65OHJ.Z45O?NO/U
MH6J^+'UIUPG42FO?N_P2M+J.WW9_'YRI>+(]\LKHX:6>],4PV2:\?+],M_"P
MUU3=<?B]U)=H)_MEHO!"8:H0AD2_9$Q3\111P* 00.4Y%9C%"4F=#M!ZUIO;
M*^+W]=*$XLJ2X%VD*JG=WA5]"-LQO4?< O-TTU.\%O5\68(_>K4$QBLY]JTY
M*;59 O"2F&PO"SW[Z</Z_5+M?Y2#ASA.M+>,4D!260!8( @TR61 X8**'*4,
MQUF8R4\M*>9&0?H[6(2:^]0&WXZ'@D,:F)U&S7QZO_QYE:%/9Z"\TLBGMB0S
M'?AT!JSAXY[.W<Q])N_;NBBZ[)>PK&Q $VY80"XI+&@"TH1JPLL( RQ/"J *
MB'(D!9/,RH7O6F1N?-;(&1T%K6-A]D-X+P+:36*^8 I]LN".D-/4W3X(!D_<
MO7CCR:;M]JG6GK3;^]E1B8E-PYOR[I2;V_]*E^N/F]WNM53Z,]KD6D D(*)Y
M H24"D"LO2O,<@)XH1"1148SXI2WX[#VW&BA25+D3:.@_5'XZ$Y+OXM>K3:F
M>YYKE8C#?MC90(%0#LPJ)YV86G)'1O#HE1']EQMM]!CIC>/F/8?1!;,0F8Q6
MZU\CG]$%F M9C4ZW&,9M53FYN>-[K8C)SEBN'Y?KN\\/VHDLDSH662:2(LZ-
MTY;' ')MS> 4<9#$(D]EG!4%=_+A^I><&Y/5!TC1II)P?5?/KW2C+0NH[=C*
M+X"!2:IN95$Q462>EN@H<704^= ;5W^G;RXTDO-'7O80>N4LBV4GI2I[&%XR
ME,.5 S.[ECMZ=[>5E>-FCG/+@0T?EVOY82_O=XL$9JG*,J2=K)P#J/]EABA@
MD!4\3H@4 L=.EE;?@G,CI>?R5OD']=@1(W-4"NV:Z]4'NAU!^80RM&<V#D7W
M["]+:/QF@/4M.FT6F"4$)YE@MM<-S ;;K _O]XK=ZOCY(DM9+@E-@,QP!B#B
M.2 X@R!A7+*4Q!QA[E;+?W$MER=CFDK^ZC2]GM?]JI[>\$LY-< Q&^PBOI+G
M*L\+#.(8EQ..8T#-V%*1I; @4,F8QD[)=C[0G2Y=Y54%[B_-!!*OV-H1MA?$
M C-U6\:F0=JK6DR/IX^]4/A-L[NXVK19=GU*GR39]5XPN$E"TU6R2H;0/S2_
MJU?X*G=R^U/N3'O):K;,KOG5@A9I$L<I!A#'VC",3;%7IO0_*10JH:C@N1.3
MC!-G;G3S9;L1CWQ_F+TU>*[ZR%VR-"(GPSZTB=GN;%NI<E/^?/C#NX;X&^G+
MY+9&I>.OO798\ "N[T8+8T2:NM^"!_C.M%WP<=>A@4!M3>LOS=,G>9A6OZ!8
MXB1/<Y!RG&L6307 Q(S0RA!."4."2NP6^CM=9&XLV<BH6?$_70-\9R"T#>F-
M R9X$*\6KXK2A9@(WX6 YQC<F84FCKI=5O4TSM;QV6%/^KO[A]7F2<IOFC:6
M7)[OM:<-/,TIIH#3U'?NOF_V=-7^^YO-;O]IL_]ON3\FOWZ1V^5&O-]L6U-5
MDP6#.4XP$@ *J+UG@1!@#'- \AQ13&F:I5;#3J\C_MS8Z5EA.M=:1.O-/GK2
M#^7VH,B-Z>2J56FF6]:_=B.SB;\E=C0YW[T/3,!G>PX<Z[++5C65TDTK J.E
M_FWUW?C:^FY\.7XW;(9Z.Q/Y=?;(ZRMB8A4F??E<9WM>OM:N),7$[=#?_?-Q
MN7\ZUBWORH#?]Q]T73=,.&CXHEW"K_K6^[?:23^THUQ(Q@0I8@A2G$L "T$
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M,X.7-]IC-#S$-_?W9CX-747WC0:6C.1GS[HI:_*=",QIYQO0'-6)GNESTXQ
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MJ&ZTV(&K'>OY02LPJ9T%ZB:JY(S^J/\WR,E)/SY>V:ECN4G)IU_ME]QB<<7
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M($PE4R!-F/9W$)8F*B0!8WHKN*("I[E;2Q2;99TX:8*F*.7LR$AHV5WS+:Q
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MC72K^Y(G>CX]."UM:\RMM[+ZWP]5RMN/S4K?8V><NOW3U\UJ]7ZS_9-NQ:*
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M?C2=&CT>8'5"X_>XZOQ2TQY.=:I[<A35_>F!/>HOG6H=RFNY( GAL  H@2F
MQ/ $RA* A(PIBV7.$^C"$[TKSHTRCH>X#X=#7-D([=@4MA]N.P[Q"N)U#\$#
M-'&U1L=O!_S>5:?MAV\+PDEW?.L+AU&.:0%UNZ_2?<S1^??-%VH.O)K^3FVW
MGN8R(THE0(A8:4<D-3G21(!$2,%PGL<9=S)2'-:>&PW=<FT</JY,K\/(HB-=
MW1O>-%0>$X=QV2P[Z@JT!8%)S$@=M<6.]INH$GP(ULZ4-@ UK^3FLOZD-#<
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M$OL_/##@4"822/%QL[XK"X6JT3/&^;U=B]]W]2\^Z8U^N[G7[O5"9#1/)(6
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MP)3ZI7XG[HP]^= U,FV86VVQ(6X>M2>0)W:F]YNF&V+T8J[:S?/!:O[]:'O
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M,-,OE[P %,,49)#R3. BS_/$-C/#=M&YO2=.Q[-4$W>?GR99VN-.Z/>G9X3
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MV]EHT$U42OYOT=LJ'&19[NB _+"PYC@\KQ+0/('24R#S#*;C0ICCL+UJ\'(
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M+W*9DZ9%]W?[H(3M^E9/\O-NW=\GB%(8N^ZAL>MJ)HVXEG>L#7]A%X;:XB-
MO:9-?=%LCEZ]T8^+US"&*VB!K=H+BU_9.NV&I-_*[+G>O1[@I$7*6_FPE7Q9
M9:.MQ>V]Z9+ZKRIW.H44,\QR@%6" $P0!0RG$*10Q SGA2!V9R&N"\_/#CR*
M6G83HBUA[?/7G;#O9JZ0B$YEV+4[.#U#^-;T:PJ/L'V=0"BD)ZH6\(BX4\'
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MJ=9QQ:TNE:O4GKC1'S*P2IQ)9<K)S.J2?_T+<,FD<F$")$AQ[(CIDD3BG/.
M?'@ G"7.4,;L5N-'X\[M"U"J9A]MVT:HFY4'V#TR=Y9:]8@T;MMN'T[<$X.)
M8H8ML7 *"3YC<4?<;_OJR8)[SZC8CN ]]^>>G8R_WVTD+7:;T[4BSC"1*,:
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M9KMX4^3T*^4FU:LN^D.EH!&+(:!"ZI</J100*C 0%#-"B,()LJOI?V[TV;V
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MVN#(.TYS8WU*,0KBXY]:> 2[SVF%,VJ^3R_L%9CZ-,,9FC.G&^YC]&V"K->
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M@'*C5C&L5W4A CA.!8!9A  1! *&4QY"R94@3N?UIR+F1AD'#0.C8J_-[S-
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M#UMX^\B_>B_$I+'/8%NO<TKFL7-W7L5_CLVY3GB][;]U2_'Y?:@DO5F)3V5
M4?Y#FA.QXNMZF?/GA4FK#DDL@,0L,YW)$X 36?8C$S$G1* 0#O\(=.HP2Z8'
M;T\HQ0?-=T_&$"[W!O&$A+TGXA97_U%I/-+"NS]T$Q!KMQXS8$\KH.PHTFXH
M]VSRSW0EWN[RI6DV7ICA'Y\VZQ_EHZ7)=ET4"TQ8'#(.09:R$, D-&E1)BF&
MRQ#S)$X@B:TZ,ME(FQNW&85O M:H7&Y.YBVE[7.CKP/=S6;>X1N9MRKDWKY
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M$?I1VZ7D&',<TVSP?Y6:6K5TOC')R^]E]=\WK"A=\$4HXA#&(@$\% C 3"I
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M]%>D/G8J]I^5KW)%E^:C\F8ERM1!+?S#3Z.S7$280Q&I#&"A.1VJA&L7-$.
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M=X9P F(28I&:3I.A58A5'^%S^YC\;MH>B+)+N%Z_%^8_9=UT\Y(O75-@'.;
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MF3F6:E_%7;#=WRZ_BNYQ,KVP^ V2.=W4N!$RO>X>A<?T7SU035_S_&JSBX%
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M%5?;YL?6='6$Y83"J^L3KI95>2,?UI(W*VG]\U*:'S2?=M-Z];):V[%Y-%/
MC?Z;D1%[, P[3S#"2F41S C6:UB29!!G6,(4L2Q/XB1B;GN6O@R;&A]^,(>4
M=+DL_Z#Z70*J7 /1\6^P0LMUO6='D"_1)X'ILZOITO5I!O9>U</44U&#G6>S
M>D6\F=67[-T+HO3B!?!0$C#7&?=2VC!>(.T1C?'S?/="W*_+^_NZH4^ZN^5Z
M+46=K- 4^;O9;KZ5:Z/K-9=IKBDZ0IJRLPRB7#)(4Y:;74B)9$$(2JT+;ENV
M.34V;LRN/]^]X4U>S:RM+PKHWGCWJJ,NO=%/P8$P#LRN+;PWI^!MRXL>[/8/
MJ7UEZP#0CE3!V@_$3O6I'<'JJ4-M^Z31ZDT[NM:M*^UZJ]=PJ?WJX!#*L%_\
M4AQE,A$,LB1%>F8><XACC"%*,$T2'K,$.:G@N)LP-=8_+(X]1TOU=8/=%#LL
MN('I_D+TU 'V@Q=!MB6&@SA&0%6?&5,(K+* R3+ RN9) W5O3A9AZ-3O>/5X
MN*0M[W%CSJ0:W?-#TD!5%^C[^HVNVN(-?Y?5QMC^2:X7I7A6-OL7_?S-&SVW
M?T<7Z[_3Y5;.$Y93R3B&!59Z$BVS!%*"&4P3G*=$JC1#J9/(SE0\FQII[RO5
MT[92_9TQ&9A(#J"TT>"[L7H&&C?KN;HHETNZKH!^#9MYNV/1T<GTA:W"T%3L
MG="8U*WSTT6E6^S'#%,GZP$9;&:[TA<=>$!3E'6C 6KK!%7[%T^_=PU*,[!_
M95N@0(T4,% !@Q6HP?(HIS2U_O>KW309[\85BIJ,VV<&_^D9Z+YEUC&BC7)0
M.*:14BF,BB@UE;LU.8@HARPJ\I1&<9%&5K5S3SY]:F-KQT#[79ACS"YO85V%
M1/"3U ._7PSUL$##?O?I*E1&VF=R0L=I.^FL]ST;1\?WC+9%=-;<[F;0^8L&
M"@3MPY;-F8'^B3]V*OF*5' <,<A2%D/$J(*:NC*8<I+E.";",7.^K[&I,9<>
M5!:U&-8G_=3=5U#OYS_QPE%%J ]MNZFX+PR#;]!WS)R!QE#P6_MOD/P*&V3\
MR@[U-3BN )&%ZT=21#;W#,V[__)-+I=FUD97CW,I98(3A6"&X]P<!V*(N:DD
M0566)BB-HM@J@N/TXZ=&'&W^>&TB:&UTS:Y_ E\_+UP/2F F<,)C0 []*;>O
M3)Y_\LB1L^9/N7.<+G_RJBMV/-GE519[OLK:+X]NJFI[WRRL=K4ZOLKU?3QG
M!4LB03&416&4=PB!-,LDI AEE$1)HKA3J:QPIDZ.1'8U3\JF@/=RH23XZ5'2
MM6V$P C=Z[!W^.*=-OW-P,.^'>@XW"E_8WSVO*47M%O\[]&%,7?\3;>@L)_<
M10O;XK"!Y\,A0/_U=FW*G<TQ3Q@I\@@J09 >,&@*,4YSF"E.5((I$2)V$6(Y
M;L*)Z$<07/EJV@"\,:Z;L^#&\B>PM&/GZQ *S*H=XV:@-<\? YYWW2MSG6AF
M5,8Y[^9SINBY<M@7_O;^85D^2EG'*[6;E[2($H4YAB@SV]^8%9!BDILM)HGB
M2&8)=CK6/M'&Y"9SK8FMKOJ^?I,)S77\SD\A:O>A7XE3Z$7B4XC\)T3VN._U
M:S_5SJB?>X^CS[_WODN'??#M]*'Z+.LX]:_E5_KC'XO-MV]EG3CYKER?/M.;
MQX)+Q-,42I+%1I@HA8Q( C,2XR3/LC@B?'Y4U/[B2S_4'JLO@S1?QI%5 3=5
M30C< UV(.KMG0W_(JM&S^</X))>B#2)WXY3!G69'/$'[8!QV:EV8 6TZZ-@^
M.[V>.TRM_?'7M2AZ);G!QHS*A-="]IPNKW[>]55\=B+^":5"B0@2:O;5)$.0
M,95 D@M61$(1&5LIV)YO8FI3J.>E:0:I\)] TO+,[2I\0I^T.4)S5<6>@&+X
M)YIYL5H]_9+V/5<.W0E9R5OUM#;(W^B/Q?WV_E6Y7I=_--G9^B^;QWD2$ZQ2
MFD(1I:;VL :3THA#/4U*,!)4\"QQ^?A=&I\:+;1V K8S%/#64M?M$X<.L-U8
M"0-K\"V7E:SK<SZM#&1*<C10[XT'KR]!/6!'QATSSWLU#@:,O(OC#LWQ_LZ
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M1X31(K;2 ;)L;VJ#U,[<;LFIGUBK0 MD8[MSW?%>Q'%*"QDC/6%(: Z1GB5
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M)-T%8#X?A=GLY<F*I+):3402TB"/D$/99((Y>,TX!('%..ELYD/5KMYX\78
M>2X)U7TE.S(PWJ6R?'&2I_2-%^LUKLX4\786ODYRI)<AV4..DB1B/0.74H:8
M(H5K68D@]S^E??C]V\'DN61;!Y)S'V;D&T7X%T;0)QX\[9CD>&.IYP>%]L\L
MH<AB9&(*N1K,BEQ[[W;H>"YIUSWEV@4J/I[$V32]G2W">N*<STQGV@IED$#!
MNR-7RB 85,73V\G/T@.!XMIKM\/$<TF[[B?5+B!QK6_;YV\DP]6'DW7M]%O/
MG28Q)1.8M)"08SV-SF3VO(2<BXA*.2X&N%GU8SJVNZ[YO#*P@\F]DUMYJZMR
M?LPO3S]52G">\ O^N7Y)7_Y]HC+/Z+@'$6HM)7E8$)'V4"ME;8[ R2'?OS)@
M:W*VP]1S2=>VT<+(T'I!'.7*U<8%BXE[AHG6A/"*''9=(+(00(@<+&I-._'^
M):PW7KD=1)Y+DG9W:79B8:XN+[^E3U83K\CS=B)!"6=&DM%6*Y"<,0KN%4O1
M7_D1>]N36R_?#AK/)1<[A(2[ LE9*X0S)FQ2F=EHP7!9^_)D"MVXL*!#,-89
M8ZW9OT#QP==O!Y3GDI(=1LI]^+W$QC+,WLTS_OEO>#KAD3,IG )O:'-4LD9U
M+GA VAWI[TRQ.-25X%NOW@XBSRL9NX]T!X/'/_U\1Z+$W^\[SA399(:NB>HF
MN5N-%KGSB"$FC#Q.UYZ#1FH[N_.4V+577,ZO$(8[HT2L]Z$HVM4L 'F5$2RB
M5!:=RUK]0":/OV$O]_'LJ6^GRZ-W><)L]LB% EXBKZ0:($R2WYM%+;%W4L3]
MTQTW7CE.4[(!-7;#>]Q9F&,'$6>$;XHD&5KR85*!(C<WLVB[BM4>!6.RUB[&
M@H-A8.NZT\'CA[8(>+(@^]#_^_-151.ELE H:/_Q4E#@XQVX@@4P8XK%TKXF
M]^]6>>NEX[0;:XN#G03:Z=;^:C%?+6;37),FEX-45A_*F["<3^=?5SML]3]\
MY"##Q9Y$]YZNP$6CW)IA.L++UUWB*>G$=$(&DAFR"=(*\-Q&0)8<)WA9(1Y;
M6+O/57F H'TGQWS"[S@_P=4D(->%7%Z@^*9VM#$4!1=&\0U]FD0IM$X>"R!W
M9^R"@G'GQ RA[]O#8G:2;1?3A%;K#^6<^DGV$JVUNK9"(\OG-*>?O (;=2*3
MR KQU@08-\@8=TI,"W3L+N4.(/*WY6*U^KA<E.EZ0MZ1<"X(P)09*($67"*'
MR5#XG$2TPCTZV'!W@%PC8MRI,"W@L:N$=P?'8AUF@X#C$TF?"/CV8IY?$[QG
MB^,JE3=_'N-\A1.?<Q B&K"AU":+(8-7'(%I;U$I<M;*8\4\^VPTCY U[I28
M-KO/4%KHP-Y\QMFL5CWB')=A1BR]R$?3^:8C7ZVJON"*I.50HX+":UU"O4WN
M41LP223MZT"#1T_/]ABMN15]X\Z6:0&R!GKI &UD=O-)6K^?ACB=U186*2U/
M+DX"+GBR13 KR:G+IEXBH]\@1A.!%8:,D8]7'AT(L3O6MJ%NW*$T+9 VN$XZ
MP-F+HWJ'Z#\W>OE0WI&&YE^G<88O5BM<KR;:,J$XK16GR3PKI3.X8#ADP:*P
MV8B@'ZM+VAUAC],U[@2;%M@:4 \=H.K#,5;K._]ZOBI6$PR:H4(!I?A(\6>B
M95&LH[7!9<R:!5L>RPCO#J0[I(S3X+4E=O:3=@?>^B4#9])Y3V''1 8*/GV,
M8'/6H'Q)1+WU@%Q:NQFT+!Z[CCX 8*Z(&:>OZT$@LZ/$.P#-KXOYXB87%UNP
M<QRSMAJ2) =/B9K2<"E D5GEPI5P^K%ZI=VA\R!)([5Z;8F@8<0_ZKBUF^*I
M:^ MB>[58DX\G1!;YXMD,5^]Q+)8XMGWOH0_<?7F3Y(@Z6TZ#\O331T'R2/1
MOR3B9AN)T&:*J_4D2%UT"0EXXHPL,<6W@0>DE24HXHT4XMK';JCNFZQOPM1(
M'6E;HKD7"'1@5R]9/%_/+RFPKAE 0P&-4E8!&E4KBVR!@)+8*"JGD'5RH<V&
M_ !!(S6Z;8_"_43?@??_*ZZON14B:Q-]B.#BV;#6!%[Y!(5E[5E@/+HV";$;
M9(S4YK;I#KRSF#NP,A<GYQ]QN;F5<RF1( G/M;2540A3&P](\#$S2$9X(83W
MCP\1VATN#U$T4CO<EL@91/A=N&ZW.7D95M,T0:>R1Q*&39XB&:$4R28)H*@W
M8T"F3&YSOG,O.>-6%0RCZQ\ Z.EB[Q(]KZ>SDS7FB8^!96\=>%=H;24*7J(7
M!D2@[98K([UIX^H\0-"XE0<'0= NHN\"0W_'Z==O1/D+>FCX>MY8^D.Y<]7T
MFM1"+J7*BM<.!QD+.%\T<(W6D^4.V3S6$FUW<#V5TI%Z?[?<^)HJJP//>UO^
MSNRU2QDS8@3IG0,*, PXA@BE."^]]<8].IRO/1([V#[;(F9'>#Y=??V:RG/#
M?U>@^?^>K-9UY4^\3,PIJ0A&6"=WL R^3M(-1A2+*8O VN1S=R1XW.UZ?,0.
MK-)^[>I#C$ZTR*$86VOS60*E(T)P3%(P7FQP/!9BXY"6]2%"QZU9'!^I ZEP
ML'S*(6Y;+$KMJK3$;SA?3;^?9[0'NWAQ_]/;W<'8@IN!KF-<OK.69]2WO)CG
M>]Y]"5;R3H4,T<-FH(A23-5K/PYD,,$+S"&*-HFL)Q(Z;+87T?%2[S"CJT7D
M6.\?RQ2A!*:M)6OO39OSKAVRO:WL6DND/)X$?HKTNW )/ZR_X?(>V51NB+4/
MY4OX\ZR^CCY?8ECA:SS[\U)ZBBLGB@M@G"(W6-;K=9P;R+Y6=1IEV:-#+?8H
M%-F;]G$=Q4/"],!Z[L!E?(CCW^;$UFSZGYC_=3&KGL;?PG1>Q?!A?CY;9(JK
M%\OIBO[J-?TZ_WHFEPLI35)$@]QQX+*.T_5>@ \R@Q-6%<FC#"@/BO=].1K7
M6!\:F5LNC(/"I./E4EG^6#\@-,SSYEMUK.<2U]/EQGB=GY%_G(7YZBK O!(#
MT](P+D&GZL;GX,EH605%U=P)#]&Y-E<'&S$T[I;1Z6(Y)$B>OE;\V5J9X]<:
MNGP9;,F\)D%_W]QQN;(-5Y\1<Q/AF<B)^RK<>N>E1'!,9Y!,U#L)60?^6"/(
MW<'_0]+&33R,#.-A%=>Y\7Z[6.+TZ_QLX$@Z_;*D)5CGD&R6ZN:WV9G>[R[+
M*'E!+1%X"1&4,PRBD0)J+;+*)@3/V^1]V_ S[OW.CDWW@2#2^4*YY,DH;4N*
MIIY^N[H;<1*S+<"3SKH$QXQJ<RRW#77CWA_M&,0[J:^#0KQ[V+E:7:+$1/2"
MEG4;4LI#]!A N%2RDAH#;U-']0A1XWH.A\R9#*699W Z\3*09Y[P\S>LESOW
M.XNX^:RA3QX>H73X<X:WTSF];!IF%,U,;_044]88)[2&(%@^[RHM2X*B#7.9
MY^1RFP/&;:C;^T[RYL[K):]&)Q&\LL!BO3_AE  G=<UQEZ3)3?9%MSE(N4E'
M-V<*PZ#BS@7DW87>@6-U1OWY5,-+)C)W)7+'0":TH*R0X#/?]-8N#H-5*-KL
M7_>2,RZ ]M'OO5#91]@=(.956-6^-/6/-_]Q0K'WK!XGOUB_"LOEZ73^]=_#
M[ 0G*N20&2<7+B/ML\45"$E;2#$I;[-4&!IU'MN&O!X0M1<,;GL\@^NDBT/.
M%]_#E#Z>(06ZGXFGJP3^:XSKJ]\NAK)*Q7A4&L$754 9[\ ;H0 %#TX98V6C
MO,<3"1TW%ST\_%KJJ0\@IK0XH17U"1/2ZB).*:"XX$9XQU1T%+=F5]MQ64D[
M H7(N<1B$+7EMLT]O<>H&C?::P"QH330P0[Z;OZ=J%XL3XF%*Q=4<VDC^15)
M&>(A^RH7;L"';'@HH<1')S+O<TOX+C7C9ER'1\_>$N\)-9_"'[]03+.D0&9%
MF_[GD^/C&1G738JC-@Y<?L?5Q"(SJ6;K.*OY74T;?K"AEGTF57*PPJ8V)UA/
M(G/LOL'[HN(AF VNHI[P]_?%\O=W\X_+1<+5+9:P:(Y!2@*'HN"H\ Q!FPP>
M(R\VR5 :]0?=@KBQNQ"WPMI ZN@)86]K&\IOF/^V6.1;+&FMDZ\'$"X8!*4$
MN8Z\(#C'-P._C,UM7/PMB!N[D7$KA VDCIX05FL%K"XNHPE0#Q-(-HI#C/0?
MG9D07F'AV*9K_G4JQNY=W HS3Q5P!P=Z'Y=X'*87_4@O8@NC?%#)4C A+2%<
M" ,.?2(F#&<Y"BU#FR3ZO>2,>XH\O&.^O\P[L"HWQ#*)48O,:/D$)PCUR16(
M1B.$Y(2420G5R >Z0<:X380;Q/\[R[@+RU([_JU/:QGEFN*!FJ,]OG$W7RA9
MK*O]M7G-B!5/B"^.;&XV1<I(_EIJT]O@AZ3UD*L<Y/!E6"6,:';JU*SW89Y?
MGDPW!>XUPGQW=+Q<?#^[V;>9/C'QFCO!M0/T]493<!8<XW44FI1%<6Z3OH6H
M>P<?_O!%XX;P RMUT4K"'>Q2OP22Y1R7I]?%=,8)=Y%IZQUH:6N<2!%C*-)
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M'S9K>7(MA7'%B$N.0A:RZ0QC;2&>#3CM+11K+'-,>EZ:G=;=3]*X:>QV]FH
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MO\[.XN;;C-J8HBFUX5(RE5%O(3++P46!7!8N:;TV@>K.)(]SE'P8M!Y&CQT
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M(\-B=^4MVDAR9%!\6*Z_+8X#YFFJ@WX^']-B.>?"*:TTEPY*/8A6*4?PP@A
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M-G+CFPQF*<^?ULQ>WD=M!U93!A.,I9@@8*IM&:VE4)<GX%P5;X0)& _7//I
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MN\+1?8-_=&0H&/%"X >E+#FF* IH[5W6JOJMK#&.GM4DMR?I_DF3W)Z@B Y
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MF4PM5<5^Q@ECW*GL):1 _U(U?':\<J81$Z7Z+K)3O.8\1^.X/>3-@L%&2NH
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MFP>_ 9D8=TC.Z'AOKO=N;_*?+)'__7)%0K]:CWS3#U%_;%LVMI;AU:-KD[Z
M0XEHW#XPB&Q&>3X(GFS$U@C$V;I<*0JH 0I8*5..T<1@=BJ4[/OYX/;Z]VW7
M#GW/[07Q[Q=3^NYOX>*/V5M2Q*=_XL5W_).H^K(DNPX^N,P DZ#LF9-Q!R$L
M4&82F<6L,V]S!W<4V>?T_+ /"A^^S9]*MQV$*7LQ6WO4/OUS/N$%-<>H(/A"
MN;4/&4*T"((K5[SUS*@VO;R'4'M.#QDG@^TAFCQ+M!+\<.*\$H:[.D8M!U ,
M,[BZB4VD(&,,=7=++WBM])[30\AI$;NW-L\1L[_/+Q<3G7..J>Y7C;%0Z)\$
M,:D]84QQARYK)MM431U$[CF]DYP4L7OK\BP!._V.DV2-D1P%G1_%@#*%4:Z:
M'8G5B*#(-I-L$_<?1.XY/9N<%K#[ZO*\ /NJT-=>\XG*>.$I..=:"E!"$9^%
M>2C>1)N3#TF5L3%[A^)S>ATY$6P/UV@'R'UXP?-P&,C-K:17)F)&"+K4S%)E
M\-E(H  ^.(D,52,/NP^5Y_2L<0Q"FVFN U360:VDJ/S7+,UG>7TQ'2X>,OSK
M)?[/=/5E.GLWP\KVQ*F<I?8(C!E3KZL+Q)A)J$*6R(.P% @U >B!!(][H=4.
M0?/3J_.L4/O'["/6GUESJ6W@C-5F559'LTJ6("IGP!?N..I8M&L3 QQ&[[BW
M61UB]F!EGAED/WV9+C9,"D=\"#3 DB2Y2EW *R9!8M;>>?K31MO3#R)WW,NL
M+@%[F"K/#*_UYF/U9<VEX5$7I0R$I,DJ':MRY0X$QA!Y<BDT&IIP&+WC7F9U
MB=@#E7END)V6+9.4*\H@@ZEE'Y'LDD(?8DP3SR88)ES0LDTG]$'DCGN9U2=@
M#U+E6>%U??%QPZ<3Q61O/&"6$E1 "3[% &@\\Y'.$@J&1H;L78K'O<OJ$+5'
M*+0#X*[+D9;7(O.!HU1,0)5-[9NKBZRL!1FE*RHZG7*CJ]4[=)Q3U>%1%Z:'
M2[\+["R7B$]43EZ7N%WB@V*;R++4PI&-Q!H_4S2RV2ZKA#2:#).Y1EOE#Z5X
MY&F>1Z#D >!.H+(S@N9500UJ[9,H"(ZQNN_8(D3!R:;IHTG81;!6LYGV(W3D
MZ7&G!^(A"CHW_*W+8[3,W 8DMGPM%9>U?)RI MX$.DBD*+I1L\#>I(Y[-306
M!O=6TIFA<%/R(K H51Q$PW/=8ZK (S=0-"<OGUF1KLU3T+Z4CGO9,Q(&]U;1
MN4&PE@(4Y-(:+T"65/,G2_F3< I8]*D4'5QDX_O!\6N1QH+@OBHZ(PC>+4G1
M+"OF/ 6\RE' $42!$+6'D&346G+G0JO53P>0.^ZMS A@/%Q9G7;<7:W0#;/\
M;O4%%_>WE![0/_?3CQRB&VX_N@?J;;NU;_C^]SUR0\,$LF(T0=&%6A<9$CB;
M$+)C1BJ!&GW;+><[D3G44O=GO^QF*Y7TY*Q%#J!CW<@<2X9((02XX(V4VF9I
MVDR<V(_.<6]>VN'LJ87Q#;1WI@[OX.6=.W[P*9Q?PS6>^T$S%1E$D!K$NL!6
M,@0? @-NT47E?#;N!;C JP5\[\K5U]ZRF*R$9-5$=" )."7 6_1UVFY$[RA0
MR#NM -I; L\0=4[.;1\$/5@1,9!>.D@F;EAY9J/\O060$2E=$MF#RXKR)9$"
M.,,E$(>19>&M;50!?@"QXUXPCP')-GKL"*KSYUC<3*QX]76^6$W_'3;#3-;S
MR._Q[J2UQCH/3)&M*HL*O(P(MM2*#.8+<[HIAH?@8MR;Z].#^^2:/]-0\_67
MNC-K.9V]Q=7KL%C\F,X^DV N9ZOY]8D5?WS$S_7VX?!Y-DW(.$48>[Q\QLG[
M;2A&:0/(#25))1:(2F3@'#.WPG.AVBR/'3OH7>_TJA-+,#,-V5CBW@@''IT!
M3HEBM);5#4JG"GC'WYW;#CD[!+M[ZZ.'Z.%JWMDOEV3XN%QNS7NY7BI:T'E2
MOP413"$!>:S3_#U(]%XQSQ*Z-LT,SY(U\F*T(13_U'*]H[70Q4Z%JR-B7D=3
M3Z*)WFNT$#7I6H60P3O+ (LOE/4Y"CC:U+[>(:.3;7K'*_@^= Z6]:A0H:AI
M\B?FCY>+S^2KW^+E8K["]&4VOYA__K%=2&H9RYC(,PO!*3:V64 LNH! FS-:
M37:F?A*+[? U(P/C</7-VTARS,V^Q,J[Q>K+_%O /$VU+/?C-S*7+1=2JNR3
ML:#KY #RL RB- JX#Y9K*XH.N^#AZ6\8>4?B(% 82'X=A"97Q^N;ZVULS'!!
M#$2P46F2B='@5<H$X\ I<'."^;:/66_Z6._;(@0Y3MH=P>7#_.+B]_GBGV&1
M)ZE$D0(YNH)L[??4IM&(IQB30.95HYV9CQ#31V)TH'J? ,NALNX(+I/DHC>U
MJ"3(6 ?6209!&W*T7 J7ZVVO;OMFU@<P#E;E$]#82ZX'X^';>H,T1=>+U:"H
M>)7^<3DE(GZ]7$QGG[=[JJV,V4I1E]G9&J87"4YD":RP8M#H'&R;K0;/4=7'
M2\[0Z#E:_AUYF$^+,%M>;%0RRU?-A:_2>BE.O6+-?[]<KK:;JYG,PDN274FU
M_Z'6H >K@(5 66#ALK@VN?(!Q/;QS#(T\EIIJR- 3NIKNPX\D70<Y1:YE+K!
M3E D@$I[S]#E-M=Z>QUYS>KZVQUY>\CUR"/OMUD>[1WMX^77KV'Q8U[H+U_/
MOWX+LQ_+1W^PW1O:WB2<XOWL.+F,\G:68XDI20(KUHLA(2EC#"+4<U5;QHN0
MC=HP1JF9_8-T,EVL-[S/E\M)SL8'%BU@TD@94,D0"OTJTV^]+PIEHX*=Q^GI
M(P\8'C=/N<LCM-'!87IS!W,5JSY=A/'+CS_#W^>+UQ=AN2DVFEC#LK'*47)4
M.PP3G1DNF3HTW5E*RV,JLDW;R5%D]Y%KM$?HZ73; 9"?J1VZS=OZH4J+7$)-
MN71BIE9Q9J D/X)-T499=ZN$-L4&>Q#9R^MP<^C,3Z/'OB%ZP]C;\!6W;R<9
M,7+#&7AE+"BFZVS48H#%B F9YIRWB6KV)'1<J#8#S.[ /%I['8#S5_R.%_-O
MF#]=O[JN%\8NMZ]N*5@*;+0%*6J;)*62X*R(8*24+F<6I&Q34OL3PKH%W_&@
MF+?34!?U-:\OEZOY5UQ\P,U%U?++]-LU,S[Z]:UHS*ENQ\P6HD ),@=B4RCK
M&QW1SQ U;MQX2J@-I9DN8/8^K.HUYY9\QZ2VECNP3C(22_1T!)"]<!:0PA;I
ME8I-@'6'C'$OG4\)I<.EW\&A^&D1,GX-B_^]!K\SF"A*@*@9^=C -42IZO9%
MKGP@\61LTY=WGY)QKYY/":"C=- !AOZ8O5_,$RZ7'TA'1,D72ORW1WF]--HR
MQ3,SP28!Z#3E^28'"$5*\+E$$:P@IMO4!.U$WKC38TZ)MN&UU<49^.C]_95/
M+B%&EQ)D7W?>>TE)48GDHE,I7)*-66SSC/8,4>-.B#DEX(;23 >>[N=71<LW
MUW5;'KGS1AA $1QE*R5"\,Q!TD8D';$DU^;58A\J>ZF///4E7#--G@=*_P=K
M7HWY%;G@\!G_6F*YO'@S+3BA@)6)A+7_WWM0(FK*L8, D7F.B8X%2K/'0NV3
M5(][1=(.2_N#=AC%=G&B/\/E?RWJ0Z1/W@NF$W!1'R)9]A!"H7S+.1>M$"KJ
M-L?ZSR@;UZF>#(Z#*JAWR+U*Z?+KY46HMG6K1W]2-QI8LBSPCLX?)9#5<10:
MM+%!4;04<J-!#/O3.NZ53 ^P'$*)O0/U+:XFC/G$:X,T"X;XR3Z J]=1PGHZ
M C!YX=M4ISY/U[A7.CT <%_E'!Y-SE?A8K3"P]^6J^G7^U:V'6?2KM9PEV\]
M17GAWMR/,X(NF9QX*8!:U+VD*H%/5D)@63O#)"^V;6WQ22H*GSL,'FKGP9H-
MI60)J!1H=(Q23.(F2&V %U[0.)^E:5/^=1S=YU2AN \.]SGJ!]9N!WG]?MQ>
M;>HP10DCLP$=*!)7J03PVIBZ'+.(Z(H4J0<(=[%0I5?D'J++\P3L>JU'4K9$
MM!FT"I'83 6"(\%B45*6^@J/W4!V_ TL78-V;WV>)6S7FT!R0<^S*R"D)"Y]
M4G7\LP>=K<AH ^/8IC_Y,'K[:.WJ$;1[:_,\,5L7-63I<PI&@%%"@^)%@_-%
M0<[2"BV+YJ5-K=!A]([[2M\U9O?5YH#76,/>+;P.WZ:K</%Q50?$[G])<.<_
M'R+;?YJ>(]/V.@3H]H??("<&;E!8T!(#*$D*I=@N@M#6(Y:L'LS)?'1\TF.?
M??P40OJP+_,+,K3E;_^XG*Y^O)VO\+&-",PIBQHSD+>L=_^:@Q.&02%$!L)H
M-*71?/==21PG21Y$ZP_'$K902Z?3@V]+[^"E%(]\R-#.HL&RB2?!@ZPP2>$T
M4%[H0!5FP L1P3+A+3%MH]IEXEH3EW%=X_'Q"UG&+V&)>;LXZE7MZ%]_V;MO
MZR+L_PX7EQL+7"XOOV[^[-[XZY0#<S$%,-917%87/<><'?U6868A2-YX\/DP
M?'3F?/;!S]--F"=7< >!]V/<UYD"%)BM&;W-_:NTFGXGYWR/8Z8LEU91:(C<
M@C(N4Z1(!P&B*YSQPI)JW6-\*.WC7->=#,8-%7D&T'V"2Y,8!0E,0TIUN9\6
M!2(J!.-]2<Q+-*S1F."#Z!WG<FX4B Z@L#.(^=Z&15U&^?V(E^1G/V[H./!Y
M>EM%A-%HK3,YGU2< 16B!><U R>#E=;HD)P?/2)\-5M-\_3BLDKG(Z;+Q70U
MQ>5O_TH7ER22W\F:*KPO-PIX5WX+B]ET]GGY'A=K ]B4 3L5,_*4ZE*64A.G
M""ZAAB)#]CY'YW3KB' (/CJ+"/?!SS-C.4ZMX Z.U770^XE^>-V0GQF64O-X
MM(J(Q[I/37(%.G-!?VY"*FW:?.^0T<VLC9/CX7X)]<'*Z0!93YSZ=+S,/J^7
M%BQ_^?%X#G;#]BR_OPBS6ZT]6J;":U5NC1% ^1H=,,PD5^F=XE:R1H^M+;@9
MN1'@<'#=]Z!C:[H#M'] .HJF:86;&X2_9M/5\L/'O[:=8RQAUD(K*(P3"ZH@
M'4UITYN6/)>LU?WRLV2-[&='1\V\E0I'7G9!!U"9+[Z&6<)K3MXO+Z_:&)%E
M64*I.R L!4LYD8R",D"A4^*),8N>[Q!L/_\M([?J]8*M@=71@:/[C3+6^0_<
ML+)EP<=D@I$>9"F4L]-OP-?'(9XE22C9[!M-QGJ$F''+F[H!WE#JZ@!Q1X;A
M;V[:)$SF3@L%!ITD2^,<O H:+#>HO.+)V4;9S4 <=-/_/'IB- 8D1C[5B:.O
MF^GQ5U^^MNDU0\M7EZLO\\7TWY@G3"@IO$"PM0),.;1 3$2(*EH7;&84J>QR
ME[;;UXV<PXR"@WE;I73@<G_"33!,>\<4!!X=22M0+%S;$'6(7!H92LYM'E4&
MP&*[3N8QL=A <=W!\'U8O%NL5U[F^C*/5Y*;%.5,4 SK0 T26.U6=(71<5+J
MVY5S5OLV^[AVHV_D3N;^8#F((CN Y\;Y/VYICO-B60G @D.*;K@$[R*%W,X%
M&2RSOE$CTS-$C=S1W ,0AU)9%WWUMYAYTJ2<]#E(2R854ZFCT2CFT%P!U]8H
MI30CGEOC\"C'V*Q OC<\#J+"#KSB8R'(N\O5<A5FF00XD=X;'ER=7!'JS%''
MP+D8P7B661'1JI1/%CS>(FS<&7==H'%(U76 Q#47'_#;=MO:^\7\\R)\_8#U
M4JWN7+MV_3<_\^IK7<C&)U*B+%8AU)LR8E<5LCF?@2E5 L\F&]6H;.Q@FG?"
MKWW1^#V1PCN ]JUSXZH@9FVM=4SJXCL)?+[X_7)UN< _ELO+^O)0-]=XS[P
MY.OQ 5J!,X5"G,190F9*C&W6C.Y-ZDY =B\:R&W5VP%^?_I.\M0SR;:F^;=_
MX2)-E[C\8[99X_JICA#Z8[9:3&?+:5H'4),2,S=1% KCZW3SY&H=JRX@K!#6
M)&NT;N3$3\#=3E;B7[25= >B;@WK?J[[UXS@<:M'H#XX7HOC_6*:\$.5X9OY
M/W&Q^=7TZW0U*;SN+&4(@4F]"0*=U@X,T\')E+,3;1[06G*UVPL&^P^TI!%0
M\](LZ*]OW^[((L5<> X>9,B9O(E,$*1!T#X@2J8=8VW&;+?D:C<+>IF/@-VA
MI@,+NJXYH5B56'I<-&_GL^^XK','ZXF\7!^]M__^]7RY>CM?_5]<?< T_SQ;
M7]'*(I&K5( )(4A#1H!SQ0,WS =+)[14;5YZFK&TF^V\[$?+/O#RD@UG$]Y2
MUKC]H_IS?.)<<JE4<>@Z@<6[ E$&25Z&TZFLZN2%-E<"I^5S-Q-[V0^P'2.K
M [L[.)'<C"_Y8[9<+2[7U9WK$;N?OH39-L7\+_J(U75^>6_?P?HO?PTK_#U,
M%YML4[GL,-1=-5@+/-?MV<HD*)H<6"Y6D??JZ\IB:!'L9JTO^Y6Z&V7LA<>1
MZR,/%MH-MSK)8$IF]>H_4J9:"GCN.% 4X:U#YW/8I3/B>$IV,X*7^30^@B['
M[]=)5;^?\5UY?3%?DBPW%0'KA!"WZE^^OW[6HC]>9Y*_+;]]FUC%G8V(('P=
M0<.UWBR&D!F3$IA=9GH'T!Y%Q&YX?9F/YZ?5X#E'2YO;D/ID52=%;HZ@B5*8
MO5$9R"Y##14%62S658Y":F=,Q$8I_:!L[&8 +_SU?31<G,$<F$W\M8ZP;DT3
M&V8HS/.?/?2$F#TX:34N)GCT@BD'244/*M1=2$%$*!R]9RESZ<4.1UZ3<3%'
MODGN&Z"[F%11VH.7NEX-&P;.\P I49"3@\F6MYF)?&)&.QLXLP\"AWZV;@F1
M<PXOKCF^Y98^3)?_^_L"\8\9$8C+U0>2S"2E$AG:!'24^'HK["!:74"[8)A4
MS/@XTA"18UGK;,+A*%;2! 8OS2[J,/8ZZ>+7Z?=IIC-Z+1 9&!-)6LC9)U"H
M)81, DDF9[1T=BK;6;W4KJQU-E:Q&[LX&@8OU2[^>WY!'W,Q7?U8BP1U-M%4
M-14E0-E(&;HAX5CIN"909RWP?"SC+G/C=(6=CVT< 85>K"/^7"1Q'Y%\PL57
M3ADZ5R[4=2&N3G$(D==N30$VL60,BA1,FYV,[7@:IR.MG2V,K_@SN)KY>/GU
M:UC\F)=;UQM7PXF'N:#9Y1N&OJ;9FZM6ES4E:18),*"*"X06,NE@E0&CE,R1
ML:+33O-(.KRLN=4;]V%^<?'[?%'_<F*YTKKH&D"5.HV64HQ(QP8XG077=4EW
M[BR_?):?SJY>]L'3T%<O RB\EYA@&"F\O5Q/%)/1Y!BR!T&A$2B="P032 !<
MQQB2"(6WZ>D=G)7.9V*> )_M3.8 L!QL+=_6EZ,?5V&QZL)F[E[:3D)47@H=
M0?B@208J@,LQ J>@+E-^C:&WA/)1/CJ?\GE^UG($3'HX6.I!O7G'_?5R06+=
ML+%YW[V]DN:JY2%/1/ FAA HL9&*CO1"SB!)!EHIX1VW&'VCEK*]:>U\LN@(
M8&^K[OT![3> GN'GL$E6.PF82-@%I[5?^\:TH[7%:&7!ZII$8PIU*%L!KIB4
M0MF<4Z.5D\,S,^Y@J1XM8V3 O!S3>21\U$7RH"2DF*L+,0JB21J8DZ07YOB#
M[9&=&,YAN4:S(M\7:#;'@>7(7..W6>["8K:';9VQO!6"]29[DQA(:VL77,[@
MA5?@$'42Q::0.BNQ?(J5SNH;QKR*.D[-/20+1PK@OS>M:K-\_3@QKW_TT <(
MQZ(M9/Z>BUBGBD;PKA9:*PP^<B>\:#,"\50<=E;=,*95- '%"S"66P*X5S!X
M=_H '>1E>Y#SC"SJDL&J.A'-U0&415'D:2*/43.C19^GQOZ\=E8"T<D+1PN@
M_.>8TD0K[[%D#S(F!,700Y3,0L*<G7'9B?L[3<_+?E[,2TD3G(]CEGN![GS>
M5IY<FK1+1?Q= 9629$XA K>>@F3#!03)#$B9K>-HA&BU?_=T3+Z85YDN+',D
M\)W#2?DST3P8L/BL='S.)C#-R6,5BGVT-%!W0$'TWEAG"V>RM]VNA_#Y8IZ1
MSL(ZVT'P)1CH(^\,S\I'^"*X*Q:\D20?M:[\E Q$4:%83_^7VDR,.C6G+^9%
MZRR,M"4,S\%,!PK^,62M=!% _]:@LG 0"T4;-BE,JG ;PDBQ[0DSSG-X+^O"
M*$< W<M[87O>3<FLA4,.@>.VD<Y+9!!#<B:@B\[V616[(X.==<MT\AHW&"1>
MP,GU\^>89Z5E@I6F. -1JP@J1A(4I\Q9,H=,(-.J]'F@'<?W.)NHNK2K$P+H
M!9C;JYS7 UC#Q:_39;J8+VM$?:U'&626M7U0>I*#0H>U,H=^9;S5:)2G'^C2
MFIYE:YRU5UT:RW#J[\46#NE?_6G\>KT/[/5\MA;-9;BHC:UB$EPID7D'.IBZ
M!$S6!=U2 Q:EF$IUXTO#ZXW3,GO>SW<#0GVHOND3X>X%F.;3P?)3(N(3$6TR
MUFK@S-9"SN3!BR3!!D;R\J%8V? U_;3,GO?[7;^FV1IW+\ T]XZWGY9<UM88
MG27(XC+%WBI!4"%!C)IG+5$5$;JTV.%D<-Y/??T:\D@H[<6^A[G5O;?GD%M#
ML0;/D'RD5+F07?FB.3CG&<=D%<M]5DD_R=)YO^$UMK[1,=2+,0T33]P5!)]H
M';1768,MN<[1EID\2@F0@Q(J.*^*:K@ILPE/Y_WZUN]A-A"*>K&GII>]KSY_
M7JP[5.\YGB P>*,M%(R:M%8$!$Y*1$JLDY,<K>OS\#J8Y7'>",[$&KO'X#E-
MQ?OP\2]B_/W'OQK-Q'OR\YM-Q-N-HV;+"TKTQ28#'F4!Q64$ST2&+ G70A?.
M[@]^.-T\O/0%\^4%OML,#?SEQ^N+L%Q^JD?31-27-)/I\#%&@6):U:G "E"X
MZ'C.1N5&Z?S31'4VF6X?S3[P6P.)OH,P8.U./]$/O_K7=$DY@58I1P[$/KG%
MZ!RXJ..ZADE2LF!S;//J>(>,D5\[AE+N?"A)=P"3PZM&;]@F+WX19F_#5_QU
M7F]X)CEA3L)8BI.5)1,,ZXHY!SZ%)$-F-K=\P1N8FW%!>P2X!JL/'DC3':#]
M P61BVD-*-<NX*_9=+6D..1/7'>C\\@,*UZ#T8'BW% RK <L!Q:0H>)>%-,$
MML^2U?D3<7/4S%NI</Q]DV6^^!IF":\Y>;^\7&XYB;84RT6"Q&,@ ]<D([M>
MWJR*U-(Q@3LNE'SF6SI_XSP5M@961P>.;AW:; .=-]=[!4L)6@3.(7OO03EB
MQV6G0?L2(M<JAMC&P3U*SLC@:Q0-'B_Y#N!S\/W-3U=?7V^WOSVMK(CL54X9
MA"FJENM9\+(V7$13A$ZE<-]9B?Y!?(Y[D@\ S),M2#\:)?\9-K2=HF1*-H[K
M!%[$!,KJ $$P"4GS8NAHXE@ZFW&R+XN=Q\ CXOST)GD Z,YGQLG!XKDW,MQ+
M$YU"<J::LG4EA88H70!!<HH97<FEL_&H>W+8>>;PGV"11T#N11^/F\?#FQ7F
M03/&/ <GZI5 # &B\1F0V9"<LLFRSI8\[,GAF=8WOB13/ )R+V!(^$_%LYTL
M<4M"@5.$P)2"Z$P E7RHS;?DK$BMG (+%6W#LN33,'FFE8\OR2Z/ ]Y_@FG>
M#^L=CX:">8H=E+&@' KP&!7(XCGZJ**6#=>)=I-+]E=!^9+,\AC0G?OTDMV%
M<Z][8AWN_TI^Y7HU[!U%HY?9J !LW6.?Z[IPQ31HD[T+,DGASBW*/4@0X^:E
M9WG'V@QG+SK+W%U\$Z=S=LX@!.,I'<BU-BV%#!D3+RQKD=S9GJD_Y?[%7]VV
M,Y\.7<%>6/Z/N_;]N?@**USPC,"%8W43$L5CGF3(BW)2*Q32=3;]96@1O/B+
MXQ?@#UJB^D4'!7?O 7<07,PAQ"A!ICKIF&<!,9L P5H=G39,A7,K?-A3!"_^
M\OH%N(.6J'[1[N#61.6?2\T7'GD,"3(7AJ2F SA-NN<BD@T'$[CM;!7MH/R_
M^-OR%^ (FN'Y17N!/;*K8HMU8OT<H10H2;IW3')2.WIM'.<IG5O9R, W!>=\
M,?\"/$ C+ ]ZJ3]L-_:O&&O+^6NB:+KZ/:3IQ70UQ4/ZKI_ZI"$ZK'>B\LA>
MZBMTO9G//M>Q3?4[K[MN&1>!*93@G="@/"O@'(\0G6.$5&E+C$T\UV/4''L6
MU,^Z&8GPB>3V"_WU_TYBL,1+5L!]LJ 4Q;3.<@;%!FF\165$FT>6)P@:]V[U
M:!S<=UM#B/U@3T)^+,X;3G5XPD+7#2<#>I/MYS7T*8]1W-*S8*A3^4V$D%D]
M1W0B,&D!S*+T-G/%&E6WM_ L-UU']5-O';0W:/=<%:X<'91*UFDK$B&6DH Y
MY@U'Y$(T6L#V4]HZ]#?[H./I:0^#*./<7,_;0 'A:OH=#Q\EL^LG-W1'SW/1
MTC$%3X=/41FD%9F.NKK60%D.*)--ADD;5)MDK85CJM4*[\H=X?[8-$,JD65@
MW **Z,C"@@3G98#"R-BB#+J(-E.]GB2I0S>T#Q;NNZ%A1-_!%<I=+[H>6,&B
MLTJ17$RJPWATL.0_G02!.DM.Y$?1YE+S(2TCHV88)3\2,1\A\>XP<ZN/GV5/
MB82/D',I]6#W9%$^0>#%Y"QDBJS-UJ&G*!H7/\=J^EG@'"CVD0=H;(SIU><%
MKN^TMH,:LBZ*9PH(T2=B(!8RIUJ@(IV+R6@22G(_B6J>_/">('"HSN9#"K #
M!_)Z_O5K'=T:+MZ';[C8,H&,>\N*@>),M0UK(6C,('0H.6'=6]HF-GN4G'%K
M7@;%S7!B']E[?,39=+[X:[;$=$G?_':^PJ4P0O]ZB56U6X:8$SQ[58>@)@3E
M*,<,(1M@.6>TPE9;V<&;[/1EXY9"#.Y=AA=PAXCA?^/W.:(S.'#K)>CD+:4"
M5D 0:(%A"););*R-!T+FX;>-^VI^$LP<*>(>CJ@[4?\Z=K/$ *HZEDI&RA>%
MCA#K3"F;BM?982JE35+]D)9Q#Z<V>=&1$N\.,UNS"K((C"E#"76W88X1G!$%
M"/(R9\FD;]2<]Q@U(T\S.E+#SP+F '%W )D/^'U^\;VNU[G#S-9GEFRX#-&2
MS\SUH,T*?$P4GRFCO;/2H6A3>?XL63V!Z!"M/QA..90*.L#3Q\NXQ']<DAQ_
M^T[_NAY"FY/.A7$-P2</RB1B(Q@D[ZQ+D*8H3(UZ]Q\G:-RXN<T!-H3L^X30
MULJ,BS+50)\()EOP]*MHN((8 J/X36/0;>I%GB1IY$:U(13^<Q =(/W^8+1U
MIUH*R@,8G?(U?U2FMM62P8'F*)GU7&77:+O38^1T!Y]#5/T\@ Z0>P?@><Q!
MO[GNS?:1<U]K$Z4JE$I:H<");*%X2B(Y+U(V"HN>)6O<M+[-D3:<'CH%U1^S
MM,"PQ%]Q\[^_SQ>;CIFWN)I@4DC_N-K^KRBJ%!D<BQ(X1JF$X**$-J.7]Z6T
MOV?2 T&R _P&TUBGB/PS_&OZ]?+K+_/%8O[/FI6$;_0WJQ\3S51BR 2!I6A0
MK!3P3CK @-%&2G^<:?,LOP^5_5U,M4/B()H:^7[\[FWPZSF%#&&V>H/;Y;]5
M<Y,4:A*L.7 Z,D )F2$D'T&SDB-/WJ+;9>W6#E_57U9X''I:2+@#MW67I5I7
M-3$REAA3 ,<=<6!8@5B8AZ*DM"8)QD6;6\Z'M/07APWC@HZ4>@>XN??^/ DY
M%AU3 FL-D1\X)27!",IUF/0Y\(B-.N?N$3)N$UL[Q!PC[P[@<A?P'_#;Y2)]
MJ=UO)"5\]75^.5M-HN#1:L=!!)TIX%,!HBX!DC8N%Z-L,6W>Y'8@;MQ%LZ=R
M1,?KI3NH_3&C3\;EB@YG_+BJ4T$IPTA5>9]Q@KE@#+[>S7@*[J2K]L,98%2I
M:.4#\VU:/7:G<2?@V7,'WF!:Z@!_5[S4U<FSFMO&U40HHWD4=*33,5[W!C((
M*"B+T#P$C4B>NPW0'B%F)T2Y\T/4L7+O=!OU$VTW?X;5Y6+]JW?E=D?$K4WB
M@[<5[?&=#1N.#N6\92M2*<59F2G5\QQ!J6@AUMTLIA23I0HAYC;%\FU[)#]^
MF2]65Q^_N8%V-C%E#4)*%!$HA@P<2@/.EN!ECIA9HUF:SU#584/2/HAX9@OV
M<0KHX#1\I&\B:X-:! -,*.) :5L?5P6Q@3[4U@F9VC04]]:3-)R>?]Z6M(_0
MNX/-K<I6[HJU4@; L&X(9@Y"QFIA]&L3%2;>YAWG;-J2]M+TKFU)^XB]PS+Q
MAW7OV7FM3 I@G"4I16/K="P*%%7FQ>48XDX7X<,U%IR^;6DOG>[=6+"/@#M$
M##'S=OY]S0HQ):^8BF1:4EC(W)#(N*H5A)).=4HGBL_!YZP.1,VC7]AIX]*0
MR#E>T /.?1@./\PPMC&(*Y8X1AV4+Z"-2E54'%RF\YW+(G7*GOQS.! [#[ZL
MTU:F(7%SG( []#CR;]+JO.9(75=Z<7*CW@$JIXBC',"7&,#)%#B6K!)/!T+F
MX;=UVLHT)&:.%'&'H&%_$YK=Y2B;C)8G!MQZ$I,M"4+D"HPUM68F<=2'GE$/
MOVW<Y[;3.)KC1-PA:/C?N-[Z3KWE2%I5RYDMZ%#%I+'.,@BB=H760F?#HC\4
M- ^_;=S'M). YD@1=PB:6[YSR]&6KY2**X)YL"@"A6ITXD8C*85.P5L3?3UX
MCS^D[GSGN(]BISZJ#A=WCS"Z,@NSY<>Y(I,@*4F'J18R4-1F*7X+RDGT)MBB
MS*'PN?==X[Y\G08VQXBW0[C<S0[M3?^YL"D)4$QK4*AE[8!0((TD44868CAT
M*L2C7[@3</Q9 ^=X07>9ADMS91#N:N"%]RH;.G>=2 8HZ#>U"=0#ZI@%L6DI
M53S4W]S_LMTN_MA9 ^<X"7?H<MC?[%6\[[<<>>:L%98#P3V2$\T%G%[W(^A@
MHZB%X/Y S#S\MMU <][7Q4?*N$/4\+_YK1U(=N4\N2_:& =9,8K41)80I&+D
M/&V)C#RH+X=>^#W\MMU0<]Y7Q4?*N$/4W#EUKYG2!;45/%!^N'XZL1H<TF^M
MUE$'5HKTAQY1CW[A;M@Y[^OBXR7=97S#_\;8QI'*JX>W4GL% C*P!C/%;"Z"
M4ZX.9Z* #6.4(AQ^E7/_VW:#SGG?&A\IXP[=CN(;-ZJNG]N$\CY+ RDXBO.=
MI>!-(P>.RIOB@^%)'XB9^]^U&V+.^\KX*/EVZ6?4]764NKH$1V:9<K4.N\;Z
M*@0/7H8$VH120G JW=\XLSMF'GS;;J@Y[SOC(V7<HY^YJ@I15]=1:+VP CT%
M:)'7I50:HN6UV,I)A0R]<_90T-S_LMTP<][7Q,=)N$/(B+_Y[6&KKX(T(0PZ
ML>YR<W61H<T09?:@@Y>B2,9-//05_.&W[0::\[XD/E+&(Z.FELF^F8?9%=Z%
MY4PG5U?"5,$8!=Z[ CI:917C):9=GI_N?NIN*#B?&]\C9-9!,?"Z(ZQ*XLUU
MHU#F/C*9.02*Q"F@BI3W:W)U/J>416:VY#8UY ]I&;=&KUD-^9%"[P V>[08
MYFA*0JF!2U_C++049V& 9(W#6+14["P:0=NU*AR)AL.[/_=130>@NSYIU_V'
MDLQ/E5+'8]>SU04$K^E7=+X*5R(%]Z7-E,4[9(SLH8:%SN$"[@ =MUO%)B8)
M3Q 6($NH4ZX\"2 P\LXIL61<DB7G)N"X3<6XE<(#8^-@\78 C?6FYSL,2%<\
MP5J J\T32L1: Z\R>!35#4K'69N1*@](&;<T>&"0'"?H#I!2::[TTR=^?37+
MZ[BO_OKU_&LD">7MV [G;?16>@K^- 5_H>(_F0(F%1>TSES+-NYE-_I&WC8_
M?#PSL$H.!]I\%2X& ]KKRT65YT1Z6S3G'+BGTU8Y0=92+'$BA$(OM'CPJC0@
MFK9$C%LWW  RAPBW P=TVWF^G<_2E@OA.8]&<;#!L>TJ(8V^9ILB%B&S,JEY
M/'-#S[A%P@TCFP-%/NJ[TDWT'KZ2;YS^>Q.__[%<7H99PNW,E@DWA66,"$S&
M BI)"3&Y!,5I9CSWG(DV$'J>KG$+AP=/H 9301>0>O/(1*$/6*]+I[//#P>Z
MHG*62ZV LU#KS%2$8'4 BO*,S3&ST,I+[47GN"7'0WNO=BKJ H)WK[-^#]/%
M?X>+2[(E9[P4&L%+1>>Z3B2N&#BDJ#'$H$T4;3:U/$'0R/7(32\1#Y/Z@/#I
M;.S7Y%YA_FD&?]&W=C'ZZS[WU\.__L^!^OAC1K_$3^%?>,A M=O_]1#R>9*:
M@8:<77_^C61O)EO9.HJ/1T"L"TW(,X/W/ .74413O&>QS;W",T0=/[/QP4=_
M(E'^0C_SOQ/+N%76Y=H$8R@BR@%"H-\&%WG*3*;HV^RY>8ZJ<9^#AL+'PQF.
M ^FATV&.M^QV_4)[I"_9?L; 'N4QRD[A5Y112&$ I) MX<8(\#H&2!BL#\:+
M!_-1^O<K-Z_SOY6":37]CM??5E\[/V"B9)Y.M[7"UH*_P7M.A:$UD>C6L>*=
M!&)X E0BF\@X4]@F4SF&ZH[]TA[X>GHB8V,]=G"[=\/KZ_G7;_,9B9W"K6MV
MM_<$O^ ,RW1UC]50BA=U8*^2M<Z9 FYPF7,0212A8R*&&ZV$.YSH<5_'VR.V
MK1:[ NRO6P*(P5?+):Z6KV;YS33$;?IPC\TDE8V:*6!)D%U&82$Z;4$8);6+
M@J729O7<@02/^U3?'JCMM-<#2"^_?@V+'[=,\/5\MIK./B.=&\3<-5\B!\RU
MJTA[)%D67L QY\%S;Y2G_V>VS4/;KA2.6PS0#(8M]--_%O(V+!:AAC.'#XM_
M[M,&SDR>I_8$.8H/.ME2."B'#)3-I/=:,\)<*!&1%:[:U/.=XN[C!O#;;:,N
MHQ3D2,&XDD )3PEWK8M1OCBIBTU.M%G(\R1)_687^R#CR5N/HS30P2%765A?
MV;XF0_U1YHM_AD5>#Z7F*@11B@'+@P*E<X+@1 9CC U),B5CF\3@29(Z@=)Q
M*I^WD'^O0+K5!^-068E&@G2^'L(J@D?*L).+(>9B,X8V=T4_(6Q<4 VD_EU
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MK97&(B1MDJSUQ5F1<<4C1)D1N(TFQ<B2#,>:?[<_%[V-)3FZI7(D '3IW^W
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MNW21[_I]O6/K()4O&\M_8DR]7]!CD7"]_O1V4RU]GR-B\LG7Y'HL8@Y<:&=
M!DO<.JG)>"5WUP>3=!W!H'C> 6V'4S)M;/1X.#RRSB9&Z%_.EC&<O?OT\?/E
MFMRG*P:,RZA#SI!3J561B! 5F<HY.)D$/1QZIT$9CW[XM%&&X^'H<,EV8+0]
MB?1?;RIHDU,RA>! AUIX)HP YWP 5J(,G/RJ$MH,X7F9MHF77A[#8QA901U
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M=&EO;F%W87(N:'1M4$L! A0#%     @ 1&A+5!\I2MH160  N4," !X
M         ( !+5@  &5X,3!I:3(P,C)R<W5S=&]C:V]P=&EO;F%W+FAT;5!+
M 0(4 Q0    ( $1H2U2'-LX]"6<  *C0 @ >              "  7JQ  !E
M>#$P:6EI,C R,G!S=7-T;V-K;W!T:6]N82YH=&U02P$"% ,4    " !$:$M4
MH\%16,$0  "F@P$ %               @ &_& $ 97@R,6DQ,C,Q,C R,3$P
M:RYH=&U02P$"% ,4    " !$:$M4X=;YD.D#  "9$@  %
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M &5X,S)I:3$R,S$R,#(Q,3!K+FAT;5!+ 0(4 Q0    ( $1H2U0X"QQ"F88
M $ L P 4              "  9U( 0!E>#1X>#$R,S$R,#(Q,3!K+FAT;5!+
M 0(4 Q0    ( $1H2U2&%5(4][8# '@Z,0 0              "  6C/ 0!S
M>6LM,C R,3$R,S$N:'1M4$L! A0#%     @ 1&A+5,GWER"B%@  OO,  !
M             ( !C88% '-Y:RTR,#(Q,3(S,2YX<V102P$"% ,4    " !$
M:$M4S4S$FL8I  #OJ0$ %               @ %=G04 <WEK+3(P,C$Q,C,Q
M7V-A;"YX;6Q02P$"% ,4    " !$:$M4@48BM:5W  #A+04 %
M    @ %5QP4 <WEK+3(P,C$Q,C,Q7V1E9BYX;6Q02P$"% ,4    " !$:$M4
M,<@>9R1N  "$M   $P              @ $L/P8 <WEK+3(P,C$Q,C,Q7V<Q
M+FIP9U!+ 0(4 Q0    ( $1H2U2$];>ZF.0  "X' 0 3              "
M 8&M!@!S>6LM,C R,3$R,S%?9S(N:G!G4$L! A0#%     @ 1&A+5#P#/^(<
MR@  K/D  !,              ( !2I(' '-Y:RTR,#(Q,3(S,5]G,RYJ<&=0
M2P$"% ,4    " !$:$M4O.$'/S!? 0"PHPX %               @ &77 @
M<WEK+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4    " !$:$M4XAV$]J;-   0
MC0D %               @ 'YNPD <WEK+3(P,C$Q,C,Q7W!R92YX;6Q02P4&
2     !, $P#[!   T8D*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
